Citrus Sinensis ID: 039595
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1078 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.925 | 0.955 | 0.464 | 0.0 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.905 | 0.871 | 0.434 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.884 | 0.865 | 0.369 | 1e-167 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.917 | 0.898 | 0.358 | 1e-165 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.923 | 0.885 | 0.351 | 1e-158 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.906 | 0.860 | 0.342 | 1e-148 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.911 | 0.787 | 0.324 | 1e-148 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.893 | 0.843 | 0.346 | 1e-144 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.833 | 0.718 | 0.353 | 1e-144 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.883 | 0.858 | 0.334 | 1e-140 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 851 bits (2198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/1018 (46%), Positives = 657/1018 (64%), Gaps = 20/1018 (1%)
Query: 7 IILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPC- 65
++LI+ ++L+ S V++ + EA ALL WK++ NQ +SS LSSW N + S C
Sbjct: 30 VLLIISIVLSCSFAVSA-TVEEANALLKWKSTFTNQT-SSSKLSSWV----NPNTSSFCT 83
Query: 66 SWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNL 125
SW+G++C+ +I +NL+ + GTF+DF FSS P+L ++LS N F G I P G
Sbjct: 84 SWYGVACSLGS--IIRLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRF 141
Query: 126 SKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNN 185
SKL+ DL NQL G I PE+G L+ L L+L N+L+G+IP IG+L+ + E + N
Sbjct: 142 SKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNL 201
Query: 186 VSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNL 245
++G IPSS GNL+KL LYL NSL G IP+ +GNL +L L L +N L G IP + NL
Sbjct: 202 LTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNL 261
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS 305
N+ L +++N LSG IP IGN+ +L L L N+L+G IP + GN+ + ++ L+ N
Sbjct: 262 KNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQ 321
Query: 306 LSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365
L+GSIPP LG ++S+ L + N+L G +P S G L++L L L +N L G IP I
Sbjct: 322 LNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANS 381
Query: 366 KSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNN 425
L+ L+L NN +G +P ++ L L + +NH GP+PKSL+ SL RVRF N+
Sbjct: 382 TELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNS 441
Query: 426 LVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS 485
G + EAFG +P L F+DLS NNF G++S NW KL FI+S N+I G+IP EI +
Sbjct: 442 FSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNM 501
Query: 486 SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANK 545
++L LDLSSN I G++P + + ++KL L+ N+LSG +P LT L+YLDLS+N+
Sbjct: 502 TQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNR 561
Query: 546 LSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNM 605
SS IP ++ NL +LYY+NLS N TIP KL L LDLS+N L EI Q ++
Sbjct: 562 FSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSL 621
Query: 606 ESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDG---LMEGNKG 662
++LE+L+LSHNNLSG IP F+ M +L+ +D+ +N LQGPIP++ F++ EGNK
Sbjct: 622 QNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKD 681
Query: 663 LCGNF---EAFSSCDAFMSHKQTSRKKWIV-IVFPILGMVLLLISLIGFFFFFRQRKKDS 718
LCG+ + C S K + I+ I+ PI+G +++L G F FR+R K
Sbjct: 682 LCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQI 741
Query: 719 QEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIV 778
EE T S + LS+ +FDGK+ ++EIIKAT +FD K+ IG GG G VYKA+LP+ I+
Sbjct: 742 -EEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IM 799
Query: 779 AVKKFNSQLLS--GNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRG 836
AVKK N S N + + EFLN + AL EIRHRN+VK GFCS+ R++FLV EY+ RG
Sbjct: 800 AVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERG 859
Query: 837 SLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEA 896
SL ++L ND AK+L W +RINV+KGVA+ALSY+HHD P+I+HRDISS N+LL ++EA
Sbjct: 860 SLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEA 919
Query: 897 HVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
+SDFG AK ++P SSN + GT+GY APE+AY M+ TEK DVYSFGVL EVIKG HP
Sbjct: 920 KISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHP 979
Query: 957 RDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
D S SS + + + I D RL P+P + ++++ I++VA+LCL P+ARPTM
Sbjct: 980 GDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTM 1037
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 810 bits (2093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/1093 (43%), Positives = 646/1093 (59%), Gaps = 117/1093 (10%)
Query: 27 AEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINLST 86
AEA ALL WK++ N SS LSSW + S SW+G+SCN GS + +NL+
Sbjct: 32 AEANALLKWKSTFTN----SSKLSSWVHDANTNTSFSCTSWYGVSCNSRGS-IEELNLTN 86
Query: 87 LCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEI 146
+ GTFQDF F S +L ++LS NL G IPPQ GNLSKL DL N L+G ISP +
Sbjct: 87 TGIEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSL 146
Query: 147 GKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLN 206
G L L LYL N L IP +G + + + + N ++G IPSSLGNL L +LYL
Sbjct: 147 GNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLY 206
Query: 207 NNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSII 266
N L G IP +GN++S++ L LSQN+L G IP TL NL NL L+LY+N L+G IP I
Sbjct: 207 ENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEI 266
Query: 267 GNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGN---------- 316
GN++S+ L L +N+L+GSIP S GNL + TL+SLF N L+G IPP LGN
Sbjct: 267 GNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELS 326
Query: 317 --------------LKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIP--- 359
LK+L+ L LY N L GVIPP +GN+ S+ +L L NN L GSIP
Sbjct: 327 NNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSF 386
Query: 360 ---------------------EEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLL--- 395
+E+G ++S+ L L +N L+G +P S GN T L L
Sbjct: 387 GNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLR 446
Query: 396 ----------------------------------NMCE-----------NHLFGPIPKSL 410
+C+ NHL GPIPKSL
Sbjct: 447 VNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSL 506
Query: 411 KSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVS 470
+ SL R RF N G ++EAFG +P+L F+D S N F G+IS NW PKL I+S
Sbjct: 507 RDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMS 566
Query: 471 MNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEF 530
NNI G+IP EI + ++L LDLS+N++ G++P + L +L++L L+ NQLSG VP
Sbjct: 567 NNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGL 626
Query: 531 GSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLS 590
LT L+ LDLS+N SS IP++ + LKL+ +NLS N+F +IP KL L++LDLS
Sbjct: 627 SFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLS 685
Query: 591 HNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNST 650
HN L EIP Q+ +++SL+KL+LSHNNLSG IP FE M +L+ +DI N+L+GP+P++
Sbjct: 686 HNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTP 745
Query: 651 VFKDGL---MEGNKGLCGNF--EAFSSCDAFMSHKQTSR-KKWIVIVFPILGMVLLLISL 704
F+ +E N GLC N + C K+ WI++ PILG VL+++S+
Sbjct: 746 TFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILV--PILG-VLVILSI 802
Query: 705 IGFFFFFRQRKKDSQEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQ 764
F + RK+ Q + +S+ + DGK +++II++T++FD IG GG
Sbjct: 803 CANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGY 862
Query: 765 GSVYKAELPSGDIVAVKKFNSQL---LSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS 821
VY+A L I+AVK+ + + +S + Q EFLN V AL EIRHRN+VK GFCS
Sbjct: 863 SKVYRANL-QDTIIAVKRLHDTIDEEISKPVVKQ-EFLNEVKALTEIRHRNVVKLFGFCS 920
Query: 822 NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHR 881
+ RH+FL+ EY+ +GSL ++L ND AK L+W +RINV+KGVA+ALSY+HHD + I+HR
Sbjct: 921 HRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHR 980
Query: 882 DISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVY 941
DISS N+LLD ++ A +SDFG AK ++ SSN + GT+GY APE AYTM+ TEK DVY
Sbjct: 981 DISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVY 1040
Query: 942 SFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAI 1001
SFGVL+ E+I G HP D S + SS + + I D R+ P +KL+ ++E+A+
Sbjct: 1041 SFGVLILELIIGKHPGDLVS-SLSSSPGEALSLRSISDERVLEPRGQNREKLLKMVEMAL 1099
Query: 1002 LCLDESPEARPTM 1014
LCL +PE+RPTM
Sbjct: 1100 LCLQANPESRPTM 1112
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 590 bits (1522), Expect = e-167, Method: Compositional matrix adjust.
Identities = 379/1027 (36%), Positives = 552/1027 (53%), Gaps = 73/1027 (7%)
Query: 58 NASKISPCSWFGISCNHAGS--RVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFF 115
N++ PC W G+ C++ S V+S+NLS++ L+G S HL L+LS+N
Sbjct: 52 NSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSP-SIGGLVHLKQLDLSYNGLS 110
Query: 116 GNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSL 175
G IP +IGN S L+ L L NNQ G I EIGKL L L + N++ G++P IG L
Sbjct: 111 GKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLS 170
Query: 176 IHEFSFCHNNVSGRIPSSLGN--------------------------------------- 196
+ + NN+SG++P S+GN
Sbjct: 171 LSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLS 230
Query: 197 ---------LSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSN 247
L KL+ + L N G+IP + N SL TL L +NQL G IP L +L +
Sbjct: 231 GELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQS 290
Query: 248 LDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLS 307
L+ L+LY+N L+G+IP IGNL ++D EN L+G IPL GN+ L+ LF N L+
Sbjct: 291 LEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLT 350
Query: 308 GSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKS 367
G+IP L LK+LS L L +N L G IP L L L LF N L G+IP ++G+
Sbjct: 351 GTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSD 410
Query: 368 LSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
L L + N+LSG IP + + +++LN+ N+L G IP + + +L ++R +NNLV
Sbjct: 411 LWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLV 470
Query: 428 GKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSK 487
G+ N+T ++L QN F G I N L ++ N G +P EIG S+
Sbjct: 471 GRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQ 530
Query: 488 LQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLS 547
L L++SSN + G++P ++ L +L + N SG++P E GSL +L+ L LS N LS
Sbjct: 531 LGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLS 590
Query: 548 SSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLS-KLDLSHNILQEEIPPQVCNME 606
+IP ++GNL +L L + N F+ +IP E L L L+LS+N L EIPP++ N+
Sbjct: 591 GTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLV 650
Query: 607 SLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLMEGNKGLCG- 665
LE L L++NNLSG IP F + SL + YN L GPIP GN+GLCG
Sbjct: 651 MLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCGP 710
Query: 666 ------NFEAFSSCDAFMSHKQTSRKKWIVIVFPILGMVLLLISLIGFFFFFRQRKKDSQ 719
+ F+ + K I I ++G V L+ LI + +R +
Sbjct: 711 PLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLM--LIALIVYLMRRPVRTV 768
Query: 720 EEQTISMNPLRLLSVLNFDGK--IMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDI 777
P + + F K ++++ ATD+FDE F +G+G G+VYKA LP+G
Sbjct: 769 ASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYT 828
Query: 778 VAVKKFNSQLLSGNMADQD-EFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRG 836
+AVKK S GN + D F +L L IRHRNIVK HGFC++ + L+ EY+ +G
Sbjct: 829 LAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKG 888
Query: 837 SLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEA 896
SL IL + + L W++R + G A L+YLHHDC P I HRDI S N+LLD +FEA
Sbjct: 889 SLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 946
Query: 897 HVSDFGIAKFVE-PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 955
HV DFG+AK ++ P+S + + G++GY APE AYTM+ TEK D+YS+GV++ E++ G
Sbjct: 947 HVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKA 1006
Query: 956 PRDFFS-----INF-SSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPE 1009
P +N+ S+ + +LD RL+ ++ +++++++A+LC SP
Sbjct: 1007 PVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPV 1066
Query: 1010 ARPTMEK 1016
ARP+M +
Sbjct: 1067 ARPSMRQ 1073
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 583 bits (1504), Expect = e-165, Method: Compositional matrix adjust.
Identities = 387/1079 (35%), Positives = 553/1079 (51%), Gaps = 90/1079 (8%)
Query: 9 LILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWF 68
L + +L +FS + + E LL +K L + N L+SW +N PC+W
Sbjct: 8 LAIVILCSFSFILVRSLNEEGRVLLEFKAFLNDSN---GYLASWNQLDSN-----PCNWT 59
Query: 69 GISCNHAGSRVISINLSTLCLNGTF-------------------------QDFSF----- 98
GI+C H + V S++L+ + L+GT QD S
Sbjct: 60 GIACTHLRT-VTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLE 118
Query: 99 ------SSFPHLVNLNLSF-----------NLFFGNIPPQIGNLSKLQNLDLGNNQLSGV 141
+ F ++ + L+ N FG+IP QIGNLS LQ L + +N L+GV
Sbjct: 119 VLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGV 178
Query: 142 ISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLA 201
I P + KL QLR + N G IP I + N + G +P L L L
Sbjct: 179 IPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLT 238
Query: 202 LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261
L L N L G IP +GN+ L L L +N G IP + L+ + L+LY N L+G
Sbjct: 239 DLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGE 298
Query: 262 IPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLS 321
IP IGNL ++D ENQL+G IP FG++ + L+ LF N L G IP LG L L
Sbjct: 299 IPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLE 358
Query: 322 TLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGV 381
L L +N+LNG IP + L L +L LF+N L G IP IG+ + S L + N+LSG
Sbjct: 359 KLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGP 418
Query: 382 IPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLT 441
IP L+LL++ N L G IP+ LK+ SL ++ N L G + + NLT
Sbjct: 419 IPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLT 478
Query: 442 FLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGK 501
L+L QN G IS + L L+ ++ NN G IP EIG+ +K+ ++SSN + G
Sbjct: 479 ALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGH 538
Query: 502 IPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLY 561
IP +L ++ +L LS N+ SG + E G L L+ L LS N+L+ IP S G+L +L
Sbjct: 539 IPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLM 598
Query: 562 YLNLSNNQFSHTIPIEFEKLIHLS-KLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSG 620
L L N S IP+E KL L L++SHN L IP + N++ LE L L+ N LSG
Sbjct: 599 ELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSG 658
Query: 621 FIPRCFEKMRSLSCIDICYNELQGPIPNSTVFK---DGLMEGNKGLCGNFEAFSSCDAFM 677
IP + SL +I N L G +P++ VF+ GN GLC + S C +
Sbjct: 659 EIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQR--SHCQPLV 716
Query: 678 SHKQ---------TSRKKWIVIVFPILGMVLLLISLIGFFFFFRQRKKD--SQEEQTISM 726
H + R+K + I ++G V LI+ +G + ++R+ + E+QT
Sbjct: 717 PHSDSKLNWLINGSQRQKILTITCIVIGSV-FLITFLGLCWTIKRREPAFVALEDQT--- 772
Query: 727 NPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQ 786
P + S ++ ++ AT +F E +G+G G+VYKAE+ G+++AVKK NS+
Sbjct: 773 KPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSR 832
Query: 787 LLSGNMADQD-EFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGND 845
G A D F + L +IRHRNIVK +GFC + + L+ EY+ +GSL L
Sbjct: 833 ---GEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRG 889
Query: 846 ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905
L WN R + G A L YLHHDC P I+HRDI S N+LLD F+AHV DFG+AK
Sbjct: 890 EKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAK 949
Query: 906 FVE-PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP-------R 957
++ YS + + G++GY APE AYTM+ TEK D+YSFGV++ E+I G P
Sbjct: 950 LIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG 1009
Query: 958 DFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
D + S NMI + ++ D RL T + ++ ++++A+ C SP +RPTM +
Sbjct: 1010 DLVNWVRRSIRNMIPTI-EMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMRE 1067
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 559 bits (1440), Expect = e-158, Method: Compositional matrix adjust.
Identities = 385/1095 (35%), Positives = 571/1095 (52%), Gaps = 100/1095 (9%)
Query: 5 IFIILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSL--LSSWTLYPTNASKI 62
+ ++ +L LL+ S ++ SD + L+N+ SL L +W N
Sbjct: 17 VGVLFLLTLLVWTSESLNSDGQ--------FLLELKNRGFQDSLNRLHNW-----NGIDE 63
Query: 63 SPCSWFGISCNHAGSR-------VISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFF 115
+PC+W G++C+ GS V S++LS++ L+G S +LV LNL++N
Sbjct: 64 TPCNWIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSP-SIGGLVNLVYLNLAYNALT 122
Query: 116 GNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSL 175
G+IP +IGN SKL+ + L NNQ G I EI KL+QLR + N+L G +P IG L
Sbjct: 123 GDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYN 182
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQN--- 232
+ E NN++G +P SLGNL+KL N G IPT +G +L L L+QN
Sbjct: 183 LEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFIS 242
Query: 233 ---------------------QLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKS 271
+ +G IP + NL++L+TL LY NSL G IPS IGN+KS
Sbjct: 243 GELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKS 302
Query: 272 LHQLDLIENQLSGSIPLSFGNL------------------------SSWTLMSLFSNSLS 307
L +L L +NQL+G+IP G L S L+ LF N L+
Sbjct: 303 LKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLT 362
Query: 308 GSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKS 367
G IP L L++L+ L L +N L G IPP NL+S+R L LF+N L G IP+ +G
Sbjct: 363 GIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSP 422
Query: 368 LSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
L + +N LSG IP + + L+LLN+ N +FG IP + SL ++R N L
Sbjct: 423 LWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLT 482
Query: 428 GKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSK 487
G+ NL+ ++L QN F G + KL ++ N ++P EI S
Sbjct: 483 GQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSN 542
Query: 488 LQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLS 547
L ++SSN + G IP ++ L +L LS N GS+P E GSL +L+ L LS N+ S
Sbjct: 543 LVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFS 602
Query: 548 SSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLS-KLDLSHNILQEEIPPQVCNME 606
+IP +IGNL L L + N FS +IP + L L ++LS+N EIPP++ N+
Sbjct: 603 GNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLH 662
Query: 607 SLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLME---GNKGL 663
L L+L++N+LSG IP FE + SL + YN L G +P++ +F++ + GNKGL
Sbjct: 663 LLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGL 722
Query: 664 CGNFEAFSSCDA-------FMSHKQTSRKKWIVIVFPILGMVLLLISLIGFFFFFRQRKK 716
CG SCD S K S ++ +I+ + + + LI F +
Sbjct: 723 CGGH--LRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPV 780
Query: 717 DSQEEQTISMNPLRLLSVLNF--DGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPS 774
+ P S + F + ++I++AT F + + +G+G G+VYKA +PS
Sbjct: 781 EPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPS 840
Query: 775 GDIVAVKKFN---SQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFC--SNARHSFLV 829
G +AVKK + + + F +L L +IRHRNIV+ + FC + + L+
Sbjct: 841 GKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLL 900
Query: 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVL 889
EY+ RGSL +L + + + W R + G A L+YLHHDC P IIHRDI S N+L
Sbjct: 901 YEYMSRGSLGELL-HGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNIL 959
Query: 890 LDLEFEAHVSDFGIAKFVE-PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 948
+D FEAHV DFG+AK ++ P S + + G++GY APE AYTM+ TEK D+YSFGV++
Sbjct: 960 IDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLL 1019
Query: 949 EVIKGNHPRDFFSI--NFSSFSNMIIE----VNQILDPRLSTPSPGV-MDKLISIMEVAI 1001
E++ G P + ++++ I ++ILDP L+ V ++ +I++ ++A+
Sbjct: 1020 ELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAV 1079
Query: 1002 LCLDESPEARPTMEK 1016
LC SP RPTM +
Sbjct: 1080 LCTKSSPSDRPTMRE 1094
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 527 bits (1358), Expect = e-148, Method: Compositional matrix adjust.
Identities = 374/1092 (34%), Positives = 553/1092 (50%), Gaps = 115/1092 (10%)
Query: 9 LILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWF 68
+ L L L F + TS S+ E AL++W S + + S+ S W N S PC W
Sbjct: 20 ITLSLFLAFFISSTSASTNEVSALISWLHS--SNSPPPSVFSGW-----NPSDSDPCQWP 72
Query: 69 GISCNHAGSRVIS-INLSTLCLNGTFQD--FSFSSFPHLV-------------------- 105
I+C+ + +++++ IN+ ++ L F SF+S LV
Sbjct: 73 YITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSEL 132
Query: 106 -NLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRL-----YLDM 159
++LS N G IP +G L LQ L L +N L+G I PE+G L+ L YL
Sbjct: 133 IVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSE 192
Query: 160 N--------------------QLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSK 199
N +L G IP IG + +SG +P SLG LSK
Sbjct: 193 NLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSK 252
Query: 200 LALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS 259
L L + + L G IP +GN L L L N L+G +P L L NL+ + L++N+L
Sbjct: 253 LQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLH 312
Query: 260 GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKS 319
G IP IG +KSL+ +DL N SG+IP SFGNLS+ + L SN+++GSIP IL N
Sbjct: 313 GPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTK 372
Query: 320 LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLS 379
L + NQ++G+IPP IG L L + N L G+IP+E+ ++L L L +N L+
Sbjct: 373 LVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLT 432
Query: 380 GVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPN 439
G +P + L L L + N + G IP + + TSL R+R N + G++ + G N
Sbjct: 433 GSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQN 492
Query: 440 LTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIV 499
L+FLDLS+NN G + N +L +S N + G +PL + +KLQ LD+SSN +
Sbjct: 493 LSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLT 552
Query: 500 GKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLK 559
GKIP L L SLN+LILS N +G +P G T LQ LDLS+N +S +IP+ + ++
Sbjct: 553 GKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQD 612
Query: 560 L-YYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNL 618
L LNLS N IP L LS LD+SHN+L ++ + +E+L LN+SHN
Sbjct: 613 LDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDL-SALSGLENLVSLNISHNRF 671
Query: 619 SGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKD---GLMEGNKGLCGNFEAFSSCDA 675
SG+ +P+S VF+ MEGN GLC + F SC
Sbjct: 672 SGY------------------------LPDSKVFRQLIGAEMEGNNGLCS--KGFRSCFV 705
Query: 676 FMSHKQTSRK----KWIVIVFPILGMVLLLISLIGFFFFFRQRK-----KDSQEEQTISM 726
S + T+++ + I +L V +++++G R ++ DS+ + +
Sbjct: 706 SNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWT 765
Query: 727 NPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKF--- 783
LNF E ++K E IGKG G VYKAE+P+ +++AVKK
Sbjct: 766 WQFTPFQKLNF----TVEHVLKC---LVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPV 818
Query: 784 ---NSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLAR 840
N + + +D F V L IRH+NIV+F G C N L+ +Y+ GSL
Sbjct: 819 TVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGS 878
Query: 841 ILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900
+L + L W R +I G A L+YLHHDC+P I+HRDI + N+L+ +FE ++ D
Sbjct: 879 LLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGD 938
Query: 901 FGIAKFVE--PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 958
FG+AK V+ ++ + G++GY APE Y+M+ TEK DVYS+GV+V EV+ G P D
Sbjct: 939 FGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPID 998
Query: 959 FF---SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
++ + I ++ Q++D L +++++ + VA+LC++ PE RPTM+
Sbjct: 999 PTIPDGLHIVDWVKKIRDI-QVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMK 1057
Query: 1016 KGFGHHIGYCDE 1027
C E
Sbjct: 1058 DVAAMLSEICQE 1069
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1352), Expect = e-148, Method: Compositional matrix adjust.
Identities = 399/1228 (32%), Positives = 576/1228 (46%), Gaps = 245/1228 (19%)
Query: 31 ALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGS-RVISINLSTLCL 89
LL K SL L W N+ I+ CSW G++C++ G RVI++NL+ L L
Sbjct: 29 TLLEVKKSLVTNPQEDDPLRQW-----NSDNINYCSWTGVTCDNTGLFRVIALNLTGLGL 83
Query: 90 NGTFQDFSFSSFPHLVNLNLSFN------------------LFF---------------- 115
G+ + F F +L++L+LS N LF
Sbjct: 84 TGSISPW-FGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSL 142
Query: 116 --------------GNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQ 161
G+IP +GNL LQ L L + +L+G I ++G+L +++ L L N
Sbjct: 143 VNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNY 202
Query: 162 LHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNL 221
L G IP +G S + F+ N ++G IP+ LG L L +L L NNSL G IP+ +G +
Sbjct: 203 LEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEM 262
Query: 222 KSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP------------------ 263
L L L NQL GLIP +L +L NL TL L N+L+G IP
Sbjct: 263 SQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNH 322
Query: 264 -------SIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGN 316
SI N +L QL L QLSG IP+ S + L +NSL+GSIP L
Sbjct: 323 LSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFE 382
Query: 317 LKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKN 376
L L+ L L+ N L G + PSI NL++L+ L L++N L G +P+EI L+ L L L +N
Sbjct: 383 LVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYEN 442
Query: 377 NLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGD 436
SG IP +GN T L +++M NH G IP S+ L L + QN LVG + + G+
Sbjct: 443 RFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGN 502
Query: 437 HPNLTFLDLSQNNFDGKI--SFNW-------------------------RNLPKLD---- 465
L LDL+ N G I SF + RNL +++
Sbjct: 503 CHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHN 562
Query: 466 ----------------TFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKL 509
+F V+ N IPLE+G+S L L L N + GKIP L K+
Sbjct: 563 RLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKI 622
Query: 510 FSLNKLILSLNQLSGSVPLE------------------------FGSLTELQYLDLSANK 545
L+ L +S N L+G++PL+ G L++L L LS+N+
Sbjct: 623 RELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQ 682
Query: 546 ------------------------LSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKL 581
L+ SIP+ IGNL L LNL NQFS ++P KL
Sbjct: 683 FVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKL 742
Query: 582 IHLSKLDLSHNILQEEIPPQVCNMESLE-KLNLSHNNLSGFIPRCFEKMRSLSCIDICYN 640
L +L LS N L EIP ++ ++ L+ L+LS+NN +G IP + L +D+ +N
Sbjct: 743 SKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHN 802
Query: 641 ELQGPIPNSTVFKDGL-------------------------MEGNKGLCGNFEAFSSCDA 675
+L G +P S L GN GLCG+ S C+
Sbjct: 803 QLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGS--PLSRCNR 860
Query: 676 FMSHKQ----TSRKKWIVIVFPILGMVLLLISLIGFFF-----FFRQRKKDSQEEQTISM 726
S+ + ++R I+ L + L+I +I FF FF++ S + S
Sbjct: 861 VRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSS 920
Query: 727 NPLRLLSVLNFDGK----IMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKK 782
+ L +G I E+I++AT + E+F IG GG G VYKAEL +G+ VAVKK
Sbjct: 921 SSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKK 980
Query: 783 FNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH--SFLVCEYLHRGSLAR 840
L ++ F V L IRHR++VK G+CS+ + L+ EY+ GS+
Sbjct: 981 I---LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWD 1037
Query: 841 ILGNDATAKE-----LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE 895
L D E L W R+ + G+A + YLHHDC+P I+HRDI S NVLLD E
Sbjct: 1038 WLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNME 1097
Query: 896 AHVSDFGIAKFV----EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 951
AH+ DFG+AK + + + + T F ++GY APE AY+++ATEK DVYS G+++ E++
Sbjct: 1098 AHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIV 1157
Query: 952 KGNHPRDFF---SINFSSFSNMIIEV-----NQILDPRLSTPSPGVMDKLISIMEVAILC 1003
G P D ++ + +EV ++++DP+L P D ++E+A+ C
Sbjct: 1158 TGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQC 1217
Query: 1004 LDESPEARPTMEKGFGHHIGYCDEILAV 1031
SP+ RP+ + CD +L V
Sbjct: 1218 TKTSPQERPSSRQA-------CDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 514 bits (1325), Expect = e-144, Method: Compositional matrix adjust.
Identities = 358/1034 (34%), Positives = 533/1034 (51%), Gaps = 71/1034 (6%)
Query: 42 QNLNSSLLSSW-----------TLYPTNASKISPCS-WFGISCNHAGSRVISINLSTLCL 89
QN +S+L SW +L+ N+ +PC+ W I+C+ G + I++ ++ L
Sbjct: 35 QNPEASILYSWLHSSSPTPSSLSLFNWNSIDNTPCNNWTFITCSSQG-FITDIDIESVPL 93
Query: 90 NGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKL 149
+ + +F L L +S G +P +G+ L+ LDL +N L G I + KL
Sbjct: 94 QLSLPK-NLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKL 152
Query: 150 NQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYL-NNN 208
L L L+ NQL G IPP I + S + N ++G IP+ LG LS L ++ + N
Sbjct: 153 RNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNK 212
Query: 209 SLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGN 268
+ G IP+ +G+ +L+ L L++ ++G +P +L L L+TL +Y +SG IPS +GN
Sbjct: 213 EISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGN 272
Query: 269 LKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLN 328
L L L EN LSGSIP G L+ + L+ NSL G IP +GN +L + L LN
Sbjct: 273 CSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLN 332
Query: 329 QLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGN 388
L+G IP SIG LS L + +N GSIP I SL +L+L KN +SG+IP +G
Sbjct: 333 LLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGT 392
Query: 389 LTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQN 448
LT L L N L G IP L T L+ + ++N+L G + NLT L L N
Sbjct: 393 LTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISN 452
Query: 449 NFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEK 508
+ G I N L + N I G IP IG K+ FLD SSN + GK+P ++
Sbjct: 453 SLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGS 512
Query: 509 LFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNN 568
L + LS N L GS+P SL+ LQ LD+SAN+ S IP S+G L+ L L LS N
Sbjct: 513 CSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKN 572
Query: 569 QFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLE-KLNLSHNNLSGFIPRCFE 627
FS +IP L LDL N L EIP ++ ++E+LE LNLS N L+G IP
Sbjct: 573 LFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIA 632
Query: 628 KMRSLSCID-----------------------ICYNELQGPIPNSTVFKD---GLMEGNK 661
+ LS +D I YN G +P++ +F+ +EGNK
Sbjct: 633 SLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNK 692
Query: 662 GLCGN-----FEAFSSCDAFMSHKQTSRKKWIVIVFPILGMVLLLISLIGFFFFFRQRK- 715
LC + F + + SR + + + +L + +++ ++G R R+
Sbjct: 693 KLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRN 752
Query: 716 ----KDSQEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAE 771
+DS+ +T LNF ++II+ E IGKG G VY+A+
Sbjct: 753 IDNERDSELGETYKWQ-FTPFQKLNFS----VDQIIRC---LVEPNVIGKGCSGVVYRAD 804
Query: 772 LPSGDIVAVKKFNSQLLSGNMADQ-----DEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826
+ +G+++AVKK +++G ++ D F V L IRH+NIV+F G C N
Sbjct: 805 VDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTR 864
Query: 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 886
L+ +Y+ GSL +L ++ L W+ R ++ G A L+YLHHDCLP I+HRDI +
Sbjct: 865 LLMYDYMPNGSLGSLL-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKAN 923
Query: 887 NVLLDLEFEAHVSDFGIAKFVEPYSSNRTE--FVGTFGYAAPEIAYTMRATEKYDVYSFG 944
N+L+ L+FE +++DFG+AK V+ R G++GY APE Y+M+ TEK DVYS+G
Sbjct: 924 NILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYG 983
Query: 945 VLVFEVIKGNHPRDFF---SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAI 1001
V+V EV+ G P D I+ + ++LD L + + D+++ ++ A+
Sbjct: 984 VVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTAL 1043
Query: 1002 LCLDESPEARPTME 1015
LC++ SP+ RPTM+
Sbjct: 1044 LCVNSSPDERPTMK 1057
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 513 bits (1320), Expect = e-144, Method: Compositional matrix adjust.
Identities = 344/972 (35%), Positives = 506/972 (52%), Gaps = 73/972 (7%)
Query: 107 LNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTI 166
LNL N G IP ++ L+ LQ LDL +N L+GVI E ++NQL L L N+L G++
Sbjct: 269 LNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSL 328
Query: 167 PPVI--------------GQLS--LIHEFSFCH---------NNVSGRIPSSLGNLSKLA 201
P I QLS + E S C N ++G+IP SL L +L
Sbjct: 329 PKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELT 388
Query: 202 LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261
LYLNNNSL G + + + NL +L L N L G +P + L L+ ++LY+N SG
Sbjct: 389 NLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGE 448
Query: 262 IPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLS 321
+P IGN L ++D N+LSG IP S G L T + L N L G+IP LGN ++
Sbjct: 449 MPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMT 508
Query: 322 TLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGV 381
+ L NQL+G IP S G L++L ++NN L G++P+ + LK+L+ + N +G
Sbjct: 509 VIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGS 568
Query: 382 IPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLT 441
I G+ + + ++ EN G IP L T+L R+R +N G++ FG L+
Sbjct: 569 ISPLCGS-SSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELS 627
Query: 442 FLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGK 501
LD+S+N+ G I KL ++ N + G IP +G L L LSSN VG
Sbjct: 628 LLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGS 687
Query: 502 IPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLY 561
+P ++ L ++ L L N L+GS+P E G+L L L+L N+LS +P +IG L KL+
Sbjct: 688 LPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLF 747
Query: 562 YLNLSNNQFSHTIPIEFEKLIHL-SKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSG 620
L LS N + IP+E +L L S LDLS+N IP + + LE L+LSHN L G
Sbjct: 748 ELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVG 807
Query: 621 FIPRCFEKMRSLSCIDICYNELQGPIPNS-TVFKDGLMEGNKGLCGNFEAFSSCDAFMSH 679
+P M+SL +++ YN L+G + + ++ GN GLCG+ S C+ S
Sbjct: 808 EVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGS--PLSHCNRAGSK 865
Query: 680 KQTS-RKKWIVIVFPILGMVLLLISLIGFFFFFRQ--------RKKDSQEEQTISMNPLR 730
Q S K +VI+ I + + + ++ FF+Q R +S S +
Sbjct: 866 NQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAP 925
Query: 731 LLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG 790
L S I ++I++AT +E+F IG GG G VYKAEL +G+ +AVKK L
Sbjct: 926 LFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI---LWKD 982
Query: 791 NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH--SFLVCEYLHRGSLARIL-GNDAT 847
++ F V L IRHR++VK G+CS+ + L+ EY+ GS+ L N+ T
Sbjct: 983 DLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENT 1042
Query: 848 AKE--LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905
K+ L W R+ + G+A + YLH+DC+P I+HRDI S NVLLD EAH+ DFG+AK
Sbjct: 1043 KKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAK 1102
Query: 906 FVEPYSSNRTE----FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 961
+ TE F G++GY APE AY+++ATEK DVYS G+++ E++ G P +
Sbjct: 1103 ILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAM- 1161
Query: 962 INFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI----------------SIMEVAILCLD 1005
F ++M+ V +LD + P +KLI ++E+A+ C
Sbjct: 1162 --FDEETDMVRWVETVLD---TPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTK 1216
Query: 1006 ESPEARPTMEKG 1017
P+ RP+ +
Sbjct: 1217 SYPQERPSSRQA 1228
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 499 bits (1285), Expect = e-140, Method: Compositional matrix adjust.
Identities = 358/1071 (33%), Positives = 534/1071 (49%), Gaps = 119/1071 (11%)
Query: 47 SLLSSWTLYPT------NASKISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSS 100
SL WT P+ NAS +PCSW G+ C+ V ++NLS+ ++G F S
Sbjct: 33 SLTRHWTSIPSDITQSWNASDSTPCSWLGVECDRR-QFVDTLNLSSYGISGEFGP-EISH 90
Query: 101 FPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMN 160
HL + LS N FFG+IP Q+GN S L+++DL +N +G I +G L LR L L N
Sbjct: 91 LKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNLRNLSLFFN 150
Query: 161 QLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGN 220
L G P + + + F N ++G IPS++GN+S+L L+L++N G +P+ +GN
Sbjct: 151 SLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVPSSLGN 210
Query: 221 LKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIEN 280
+ +L L L+ N L G +P TL+NL NL L + NSL G+IP + K + + L N
Sbjct: 211 ITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVSCKQIDTISLSNN 270
Query: 281 QLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGN 340
Q +G +P GN +S FS +LSG IP G L L TL L N +G IPP +G
Sbjct: 271 QFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIPPELGK 330
Query: 341 LSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCEN 400
S+ +L L N L G IP E+G L L L L NNLSG +P S+ + L L + +N
Sbjct: 331 CKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSLQSLQLYQN 390
Query: 401 HLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRN 460
+L G +P + L L + +N+ G + + G + +L LDL++N F G I N +
Sbjct: 391 NLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFTGHIPPNLCS 450
Query: 461 LPKLDTFIVSMNNIFGSIPLEIGDSSKLQ-----------------------FLDLSSNH 497
KL ++ N + GS+P ++G S L+ F DLS N+
Sbjct: 451 QKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLPDFVEKQNLLFFDLSGNN 510
Query: 498 IVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSAN------------- 544
G IP L L ++ + LS NQLSGS+P E GSL +L++L+LS N
Sbjct: 511 FTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILKGILPSELSNC 570
Query: 545 -KLSS----------SIPKSIGNLLKLYYLNLSNNQFSHTIPIEF--------------- 578
KLS SIP ++G+L +L L+L N FS IP
Sbjct: 571 HKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNL 630
Query: 579 --------EKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMR 630
L L L+LS N L ++P + ++ LE+L++SHNNLSG + R ++
Sbjct: 631 LAGDIPPVGALQALRSLNLSSNKLNGQLPIDLGKLKMLEELDVSHNNLSGTL-RVLSTIQ 689
Query: 631 SLSCIDICYNELQGPIPNS-TVFKDG---LMEGNKGLCGNFEA----------FSSCDAF 676
SL+ I+I +N GP+P S T F + GN LC N A C+
Sbjct: 690 SLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINCPADGLACPESSILRPCN-M 748
Query: 677 MSHKQTSRKKWIVIVFPILGMVLLLISLIGFFFFFRQRKKDSQEEQTISMNPLRLLSVLN 736
S+ + I +LG +L +I L F F K S +E IS
Sbjct: 749 QSNTGKGGLSTLGIAMIVLGALLFIICLFLFSAFLFLHCKKSVQEIAISAQ--------E 800
Query: 737 FDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQD 796
DG +++ ++++AT++ ++K+ IGKG G++YKA L + AVKK + +G
Sbjct: 801 GDGSLLN-KVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKL---VFTGIKNGSV 856
Query: 797 EFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRR 856
+ + + ++RHRN++K F + ++ Y+ GSL IL K L W+ R
Sbjct: 857 SMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDWSTR 916
Query: 857 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--R 914
N+ G A+ L+YLH DC P+I+HRDI N+LLD + E H+SDFGIAK ++ +++
Sbjct: 917 HNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPS 976
Query: 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN--------FSS 966
GT GY APE A+T + + DVYS+GV++ E+I D S N S
Sbjct: 977 NTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALD-PSFNGETDIVGWVRS 1035
Query: 967 FSNMIIEVNQILDPRL--STPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
E+ +I+DP L VM+++ + +A+ C ++ + RPTM
Sbjct: 1036 VWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAEKEVDKRPTMR 1086
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1078 | ||||||
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.917 | 0.952 | 0.531 | 0.0 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.916 | 0.952 | 0.531 | 0.0 | |
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.926 | 0.968 | 0.517 | 0.0 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.893 | 0.893 | 0.515 | 0.0 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.926 | 0.968 | 0.515 | 0.0 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.885 | 0.958 | 0.505 | 0.0 | |
| 255545702 | 1008 | receptor protein kinase, putative [Ricin | 0.904 | 0.967 | 0.493 | 0.0 | |
| 186511602 | 1045 | Leucine-rich repeat-containing protein [ | 0.925 | 0.955 | 0.464 | 0.0 | |
| 7267528 | 1027 | receptor protein kinase-like protein [Ar | 0.925 | 0.971 | 0.463 | 0.0 | |
| 297813345 | 1019 | hypothetical protein ARALYDRAFT_489780 [ | 0.925 | 0.979 | 0.461 | 0.0 |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 978 bits (2529), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/1014 (53%), Positives = 687/1014 (67%), Gaps = 25/1014 (2%)
Query: 18 SHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNAS--------KISPCSWFG 69
S +V+S S+ E ALL WK SLQN N +SSLLS W LYP N++ SPC W+G
Sbjct: 24 SDHVSSYSNEETQALLKWKASLQNHN-HSSLLS-WDLYPNNSTNSSTHLGTATSPCKWYG 81
Query: 70 ISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQ 129
ISCNHAGS VI INL+ LNGT DFSFSSFP+L +++S N G IPPQIG L +L+
Sbjct: 82 ISCNHAGS-VIKINLTESGLNGTLMDFSFSSFPNLAYVDISMNNLSGPIPPQIGLLFELK 140
Query: 130 NLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGR 189
LDL NQ SG I EIG L L L+L NQL+G+IP IGQL+ ++E + N + G
Sbjct: 141 YLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIGQLASLYELALYTNQLEGS 200
Query: 190 IPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD 249
IP+SLGNLS LA LYL N L G IP MGNL +L + + N L G IP T NL L
Sbjct: 201 IPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVEIYSNNNNLTGPIPSTFGNLKRLT 260
Query: 250 TLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309
L+L+ NSLSG IP IGNLKSL +L L EN LSG IP+S +LS TL+ L++N LSG
Sbjct: 261 VLYLFNNSLSGPIPPEIGNLKSLQELSLYENNLSGPIPVSLCDLSGLTLLHLYANQLSGP 320
Query: 310 IPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLS 369
IP +GNLKSL L L NQLNG IP S+GNL++L L L +N L G IP+EIG L L
Sbjct: 321 IPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLV 380
Query: 370 ELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGK 429
L++ N L G +P + LV + +NHL GPIPKSLK+ +L R F N L G
Sbjct: 381 VLEIDTNQLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGN 440
Query: 430 VYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQ 489
+ E GD PNL F+DLS N F G++S NW P+L ++ NNI GSIP + G S+ L
Sbjct: 441 ISEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLT 500
Query: 490 FLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSS 549
LDLSSNH+VG+IP ++ L SL LIL+ NQLSGS+P E GSL+ L+YLDLSAN+L+ S
Sbjct: 501 LLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGS 560
Query: 550 IPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLE 609
IP+ +G+ L L+YLNLSNN+ SH IP++ KL HLS+LDLSHN+L IPPQ+ ++SLE
Sbjct: 561 IPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLE 620
Query: 610 KLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLME---GNKGLCGN 666
L+LSHNNL GFIP+ FE M +LS +DI YN+LQGPIP+S F++ +E GNK LCGN
Sbjct: 621 MLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGN 680
Query: 667 FEAFSSCD-AFMSHKQ---TSRKKWIVIVFPILGMVLLLISLIGFFFFFRQRKKDSQEEQ 722
+ C F +Q S K +I+FP+LG ++LL + IG F +R++ + E+
Sbjct: 681 VKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAERRERTPEIEE 740
Query: 723 TISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKK 782
N L S+ NFDG+ M+EEIIKAT DFD +CIGKGG GSVYKAELPS +IVAVKK
Sbjct: 741 GDVQN--DLFSISNFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKK 798
Query: 783 FNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL 842
+ MA+Q +FLN + AL EI+HRNIVK GFCS+ RH FLV EYL RGSLA IL
Sbjct: 799 LHPS--DTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATIL 856
Query: 843 GNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902
+ AK+L W R+N+IKGVA+AL+Y+HHDC P I+HRD+SS N+LLD ++EAH+SDFG
Sbjct: 857 SREE-AKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISDFG 915
Query: 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD-FFS 961
AK ++ SSN++ GTFGY APE+AYTM+ TEK DV+SFGV+ EVIKG HP D S
Sbjct: 916 TAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILS 975
Query: 962 INFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
++ S + I + +LDPRL +P ++I+I++ AI CL +P++RPTM+
Sbjct: 976 LSVSPEKDN-IALEDMLDPRLPPLTPQDEGEVIAILKQAIECLKANPQSRPTMQ 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2524), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/1014 (53%), Positives = 687/1014 (67%), Gaps = 26/1014 (2%)
Query: 18 SHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTN--------ASKISPCSWFG 69
S +V+S S+ E ALL WK +L N N +SSLLS WTLYP N +++SPC W+G
Sbjct: 24 SDHVSSYSNEETQALLKWKATLHNHN-HSSLLS-WTLYPNNFTNSSTHLGTEVSPCKWYG 81
Query: 70 ISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQ 129
ISCNHAGS VI INL+ L GT Q FSFSSFP+L +++S N G IPPQIG LSKL+
Sbjct: 82 ISCNHAGS-VIRINLTESGLGGTLQAFSFSSFPNLAYVDISMNNLSGPIPPQIGLLSKLK 140
Query: 130 NLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGR 189
LDL NQ SG I PEIG L L L+L NQL+G+IP IGQL+ ++E + N + G
Sbjct: 141 YLDLSINQFSGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEIGQLTSLYELALYTNQLEGS 200
Query: 190 IPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD 249
IP+SLGNLS LA LYL N L G IP MGNL +L L N L G IP T NL +L
Sbjct: 201 IPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVQLYSDTNNLTGPIPSTFGNLKHLT 260
Query: 250 TLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309
L+L+ NSLSG IP IGNLKSL L L N LSG IP+S +LS TL+ L++N LSG
Sbjct: 261 VLYLFNNSLSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLCDLSGLTLLHLYANQLSGP 320
Query: 310 IPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLS 369
IP +GNLKSL L L NQLNG IP S+GNL++L L L +N L G P+EIG L L
Sbjct: 321 IPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQEIGKLHKLV 380
Query: 370 ELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGK 429
L++ N L G +P + L + +NHL GPIPKSLK+ +L R F N L G
Sbjct: 381 VLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGN 440
Query: 430 VYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQ 489
V E GD PNL F+DLS N F G++S NW P+L ++ NNI GSIP + G S+ L
Sbjct: 441 VSEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLI 500
Query: 490 FLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSS 549
LDLSSNH+VG+IP ++ L SL LIL+ NQLSGS+P E GSL+ L+YLDLSAN+L+ S
Sbjct: 501 LLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGS 560
Query: 550 IPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLE 609
IP+ +G+ L L+YLNLSNN+ SH IP++ KL HLS+LDLSHN+L IP Q+ +ESLE
Sbjct: 561 IPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLTGGIPAQIQGLESLE 620
Query: 610 KLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLME---GNKGLCGN 666
L+LSHNNL GFIP+ FE M +LS +DI YN+LQGPIP+S F++ +E GNK LCGN
Sbjct: 621 MLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGN 680
Query: 667 FEAFSSCD-AFMSHKQ---TSRKKWIVIVFPILGMVLLLISLIGFFFFFRQRKKDSQEEQ 722
+ C F +Q S K +I+FP+LG ++LL + IG F +R++ + E+
Sbjct: 681 VKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAFIGIFLIAERRERTPEIEE 740
Query: 723 TISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKK 782
N LLS+ FDG+ M+EEIIKAT DFD +CIGKGG GSVYKAELPSG+IVAVKK
Sbjct: 741 GDVQN--NLLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKK 798
Query: 783 FNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL 842
+ + +MA+Q +FLN V A+ EI+HRNIV+ GFCS RHSFLV EYL RGSLA IL
Sbjct: 799 LHPSDM--DMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATIL 856
Query: 843 GNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902
+ AK+L W R+ +IKGVA+ALSY+HHDC P I+HRDISS N+LLD ++EAH+S+ G
Sbjct: 857 SREE-AKKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLG 915
Query: 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD-FFS 961
AK ++ SSN+++ GT GY APE AYTM+ TEK DVYSFGV+ EVIKG HP D S
Sbjct: 916 TAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQILS 975
Query: 962 INFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
I+ S N++++ +LDPRL +P ++++I+++A CL+ +P++RPTME
Sbjct: 976 ISVSPEKNIVLK--DMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQSRPTME 1027
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/1022 (51%), Positives = 678/1022 (66%), Gaps = 23/1022 (2%)
Query: 6 FIILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKIS-- 63
+ L L+++L S NV+S S+ E ALL WK +L NQNL LL W+L+P N + S
Sbjct: 12 LVSLGLWIMLVCSDNVSSHSNEETQALLKWKATLLNQNL---LL--WSLHPNNITNSSAQ 66
Query: 64 -------PCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFG 116
PC WFGISC AGS VI INL+ L L GT QDFSFSSFP+L +++ N G
Sbjct: 67 PGTATRTPCKWFGISCK-AGS-VIRINLTDLGLIGTLQDFSFSSFPNLAYFDINMNKLSG 124
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLI 176
IPPQIG LSKL+ LDL NQ SG I EIG L L L+L NQL+G+IP IGQL +
Sbjct: 125 PIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLHLVENQLNGSIPHEIGQLKSL 184
Query: 177 HEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG 236
+ S N + G IP+SLGNLS L LYL+ N L G IP MGNL L L L+ N L G
Sbjct: 185 CDLSLYTNKLEGSIPASLGNLSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNANNLTG 244
Query: 237 LIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSW 296
IP TL NL +L L LY N LSG IP+ IGNLK L L L N LSG IP+S G+LS
Sbjct: 245 PIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLGDLSGL 304
Query: 297 TLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYG 356
+ LF N LSG IP +GNL+SL L + NQLNG IP S+GNL +L L L +N L
Sbjct: 305 KSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTSLGNLINLEILYLRDNKLSS 364
Query: 357 SIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSL 416
SIP EIG L L EL++ N LSG +P + L + +N L GPIP+SLK+ SL
Sbjct: 365 SIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSL 424
Query: 417 KRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFG 476
R R +N L G + EAFG PNL ++LS N F G++S NW KL ++ NNI G
Sbjct: 425 ARARLQRNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITG 484
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTEL 536
SIP + G S++L L+LSSNH+VG+IP +L + SL KLIL+ N+LSG++P E GSL +L
Sbjct: 485 SIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADL 544
Query: 537 QYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQE 596
YLDLS N+L+ SIP+ +GN L L YLNLSNN+ SH IP++ KL HLS LDLSHN+L
Sbjct: 545 GYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTG 604
Query: 597 EIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKD-- 654
EIP Q+ ++SLEKLNLSHNNLSG IP+ FE M L +DI YN+LQG IPNS F++
Sbjct: 605 EIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVT 664
Query: 655 -GLMEGNKGLCGNFEAFSSCDAFMSHKQTSRKKWIVIVFPILGMVLLLISLIGFFFFFRQ 713
+++GNKGLCG+ + C+ + K T K +I+F +LG +L+L + IG Q
Sbjct: 665 IEVLQGNKGLCGSVKGLQPCENRSATKGT-HKAVFIIIFSLLGALLILSAFIG-ISLISQ 722
Query: 714 RKKDSQEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELP 773
+++++ E+ + L S+ FDG+ +E II+AT DFD +CIG+GG GSVYKAELP
Sbjct: 723 GRRNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELP 782
Query: 774 SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYL 833
SG+IVAVKK + +MA Q +F+N + AL EI+HRNIVK GFCS++RHSFLV EYL
Sbjct: 783 SGNIVAVKKLHR--FDIDMAHQKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYL 840
Query: 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE 893
RGSL IL + AKE+ W R+N+IKGVA+ALSYLHHDC+P I+HRDISS NVLLD +
Sbjct: 841 ERGSLGTILSKELQAKEVGWGTRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLLDSK 900
Query: 894 FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 953
+EAHVSDFG AKF++ SSN + GT+GY APE+AYTM+ TEK DVYSFGVL EV++G
Sbjct: 901 YEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRG 960
Query: 954 NHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
HP D S +S + + +LDPRL P+ +++S++++A CL+ SP++RPT
Sbjct: 961 RHPGDLISSLSASPGKDNVVLKDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQSRPT 1020
Query: 1014 ME 1015
M+
Sbjct: 1021 MQ 1022
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 924 bits (2388), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/1017 (51%), Positives = 659/1017 (64%), Gaps = 54/1017 (5%)
Query: 20 NVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYP-----TNAS-----KISPCSWFG 69
++ SDS+ E ALL WK++L N N S L SWTLYP TN+S PC W+G
Sbjct: 52 DMKSDSNEETQALLKWKSTLHNHN--HSFLLSWTLYPDPNNSTNSSTHHGTATGPCKWYG 109
Query: 70 ISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQ 129
ISCNHAGS VI INL+ L GT Q FSFSSFP NL++
Sbjct: 110 ISCNHAGS-VIRINLTESGLRGTLQAFSFSSFP-----NLAY------------------ 145
Query: 130 NLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIG---QLSLIHEFSFCHNNV 186
+D+ N LSG I P+IG L++L+ L L NQ G IPP IG L ++H + N +
Sbjct: 146 -VDVCINNLSGPIPPQIGLLSKLKYLDLSTNQFSGGIPPEIGLLTNLEVLHLLALYTNQL 204
Query: 187 SGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLS 246
G IP+SLGNLS LA LYL N L G IP MGNL +L + N L GLIP T NL
Sbjct: 205 EGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLANLVEIYSDTNNLTGLIPSTFGNLK 264
Query: 247 NLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSL 306
L TL+L+ N LSG IP IGNL SL + L N LSG IP S G+LS TL+ L++N L
Sbjct: 265 RLTTLYLFNNQLSGHIPPEIGNLTSLQGISLYANNLSGPIPASLGDLSGLTLLHLYANQL 324
Query: 307 SGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLK 366
SG IPP +GNLKSL L L NQLNG IP S+GNL++L L L +N L G P+EIG L
Sbjct: 325 SGPIPPEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNHLSGYFPKEIGKLH 384
Query: 367 SLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNL 426
L L++ N LSG +P + LV + +N L GPIPKS+K+ +L R F N L
Sbjct: 385 KLVVLEIDTNRLSGSLPEGICQGGSLVRFTVSDNLLSGPIPKSMKNCRNLTRALFGGNQL 444
Query: 427 VGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSS 486
G + E GD PNL ++DLS N F G++S NW P+L ++ N+I GSIP + G S+
Sbjct: 445 TGNISEVVGDCPNLEYIDLSYNRFHGELSHNWGRCPQLQRLEMAGNDITGSIPEDFGIST 504
Query: 487 KLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKL 546
L LDLSSNH+VG+IP ++ L SL +L L+ NQLSGS+P E GSL L +LDLSAN+L
Sbjct: 505 NLTLLDLSSNHLVGEIPKKMGSLTSLLELKLNDNQLSGSIPPELGSLFSLAHLDLSANRL 564
Query: 547 SSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNME 606
+ SI +++G L L+YLNLSNN+ S+ IP + KL HLS+LDLSHN+L EIPPQ+ +E
Sbjct: 565 NGSITENLGACLNLHYLNLSNNKLSNRIPAQMGKLSHLSQLDLSHNLLSGEIPPQIEGLE 624
Query: 607 SLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDG---LMEGNKGL 663
SLE LNLSHNNLSGFIP+ FE+MR LS IDI YN+LQGPIPNS F+D L++GNK L
Sbjct: 625 SLENLNLSHNNLSGFIPKAFEEMRGLSDIDISYNQLQGPIPNSKAFRDATIELLKGNKDL 684
Query: 664 CGNFEAFSSCDAFMSHKQTSRKKW----IVIVFPILGMVLLLISLIGFFFFFRQRKKDSQ 719
CGN + C Q KK +IVFP+LG ++LL + IG F + K+ +
Sbjct: 685 CGNVKGLQPCKNDSGAGQQPVKKGHKIVFIIVFPLLGALVLLFAFIGIFLIAERTKRTPE 744
Query: 720 EEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVA 779
E+ N L S+ FDG+ M+EEIIKAT DFD +CIGKGG GSVYKAEL SG+IVA
Sbjct: 745 IEEGDVQN--DLFSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNIVA 802
Query: 780 VKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLA 839
VKK + + +MA+Q +F N V AL EI+HRNIVK GFCS+ RHSFLV EYL RGSLA
Sbjct: 803 VKKLYASDI--DMANQRDFFNEVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSLA 860
Query: 840 RILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS 899
+L + AK+L W RIN+IKGVA+ALSY+HHDC P I+HRDISS N+LLD ++E H+S
Sbjct: 861 AMLSREE-AKKLGWATRINIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHIS 919
Query: 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD- 958
DFG AK ++ SSN++ GTFGY APE AYTM+ TEK DVYSFGV+ EVIKG HP D
Sbjct: 920 DFGTAKLLKLDSSNQSALAGTFGYVAPEHAYTMKVTEKTDVYSFGVITLEVIKGRHPGDQ 979
Query: 959 FFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
S++ S I+ + +LDPRL + ++ISI+ +A CL +PE+RPTM+
Sbjct: 980 ILSLSVSPEKENIV-LEDMLDPRLPPLTAQDEGEVISIINLATACLSVNPESRPTMK 1035
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 920 bits (2379), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/1022 (51%), Positives = 675/1022 (66%), Gaps = 23/1022 (2%)
Query: 6 FIILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKIS-- 63
+ L+L+++L S NV+S S+ E ALL WK +L NQNL LL W+L+P N + S
Sbjct: 12 LVSLLLWIMLVCSDNVSSHSNEETQALLKWKATLLNQNL---LL--WSLHPNNITNSSAQ 66
Query: 64 -------PCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFG 116
PC WFGISC AGS VI INL+ L L GT QDFSFSSFP+L +++ N G
Sbjct: 67 PGTATRTPCKWFGISCK-AGS-VIRINLTDLGLIGTLQDFSFSSFPNLAYFDINMNKLSG 124
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLI 176
IPPQIG LSKL+ LDL NQ SG I EIG L L L+L NQL+G+IP IGQL +
Sbjct: 125 PIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLHLVENQLNGSIPHEIGQLKSL 184
Query: 177 HEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG 236
+ S N + G IP+SLGNLS L LYL+ N L G IP MGNL L L L+ N L G
Sbjct: 185 CDLSLYTNKLEGTIPASLGNLSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNANNLTG 244
Query: 237 LIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSW 296
IP TL NL +L L LY N LSG IP+ IGNLK L L L N LSG IP+S G+LS
Sbjct: 245 PIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLGDLSGL 304
Query: 297 TLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYG 356
+ LF N LSG IP +GNL+SL L + NQLNG IP +GNL +L L L +N L
Sbjct: 305 KSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTLLGNLINLEILYLRDNKLSS 364
Query: 357 SIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSL 416
SIP EIG L L EL++ N LSG +P + L + +N L GPIP+SLK+ SL
Sbjct: 365 SIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSL 424
Query: 417 KRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFG 476
R R N L G + EAFG PNL ++LS N F G++S NW KL ++ NNI G
Sbjct: 425 ARARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITG 484
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTEL 536
SIP + G S++L L+LSSNH+VG+IP +L + SL KLIL+ N+LSG++P E GSL +L
Sbjct: 485 SIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADL 544
Query: 537 QYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQE 596
YLDLS N+L+ SIP+ +GN L L YLNLSNN+ SH IP++ KL HLS LDLSHN+L
Sbjct: 545 GYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTG 604
Query: 597 EIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKD-- 654
EIP Q+ ++SLEKLNLSHNNLSG IP+ FE M L +DI YN+LQG IPNS F++
Sbjct: 605 EIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVT 664
Query: 655 -GLMEGNKGLCGNFEAFSSCDAFMSHKQTSRKKWIVIVFPILGMVLLLISLIGFFFFFRQ 713
+++GNKGLCG+ + C+ + K T K +I+F +LG +L+L + IG Q
Sbjct: 665 IEVLQGNKGLCGSVKGLQPCENRSATKGT-HKAVFIIIFSLLGALLILSAFIG-ISLISQ 722
Query: 714 RKKDSQEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELP 773
+++++ E+ + L S+ FDG+ +E II+AT DFD +CIG+GG GSVYKAELP
Sbjct: 723 GRRNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELP 782
Query: 774 SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYL 833
SG+IVAVKK + +MA Q +F+N + AL EI+HRNIVK GFCS++RHSFLV EYL
Sbjct: 783 SGNIVAVKKLHR--FDIDMAHQKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYL 840
Query: 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE 893
RGSL IL + AKE+ W R+N+IKGV++ALSYLHHDC+P I+HRDISS NVLLD +
Sbjct: 841 ERGSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLLDSK 900
Query: 894 FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 953
+EAHVSDFG AKF++ SSN + GT+GY APE+AYTM+ TEK DVYSFGVL EV++G
Sbjct: 901 YEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRG 960
Query: 954 NHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
HP D S S + + +LDPRL P+ ++ S++++A CL+ SP++RPT
Sbjct: 961 RHPGDLISSLSDSPGKDNVVLKDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQSRPT 1020
Query: 1014 ME 1015
M+
Sbjct: 1021 MQ 1022
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/1006 (50%), Positives = 652/1006 (64%), Gaps = 51/1006 (5%)
Query: 18 SHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGS 77
S +V+S S+ E ALL WK SLQN + +SSLLS W LYP N++ S H G+
Sbjct: 24 SDHVSSYSNEETQALLKWKASLQNHD-HSSLLS-WDLYPNNSTN---------SSTHLGT 72
Query: 78 RVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQ 137
C+N NLS G IPPQIG LS+L+ LDL NQ
Sbjct: 73 ATSPCK----CMN-----------------NLS-----GPIPPQIGLLSELKYLDLSINQ 106
Query: 138 LSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNL 197
SG I EIG L L L+L NQL+G+IP IGQL+ ++E + N + G IP+SLGNL
Sbjct: 107 FSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIGQLASLYELALYTNQLEGSIPASLGNL 166
Query: 198 SKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNS 257
S LA LYL N L IP MGNL +L + N L G IP T NL L L+L+ N
Sbjct: 167 SNLAYLYLYENQLSDSIPPEMGNLTNLVEIYSDTNNLIGPIPSTFGNLKRLTVLYLFNNR 226
Query: 258 LSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNL 317
LSG IP IGNLKSL L L EN LSG IP S G+LS TL+ L++N LSG IP +GNL
Sbjct: 227 LSGHIPPEIGNLKSLQGLSLYENNLSGPIPASLGDLSGLTLLHLYANQLSGPIPQEIGNL 286
Query: 318 KSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNN 377
KSL L L NQLNG IP S+GNL++L L L +N L G IP+EIG L L L++ N
Sbjct: 287 KSLVDLELSENQLNGSIPTSLGNLTNLETLFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQ 346
Query: 378 LSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDH 437
L G +P + L + +NHL GPIPKSLK+ +L R F N L G + E GD
Sbjct: 347 LFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCKNLTRALFGGNQLTGNISEVVGDC 406
Query: 438 PNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNH 497
PNL ++++S N+F G++S NW P+L ++ NNI GSIP + G S+ L LDLSSNH
Sbjct: 407 PNLEYINVSYNSFHGELSHNWGRYPRLQRLEMAWNNITGSIPEDFGISTDLTLLDLSSNH 466
Query: 498 IVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNL 557
+ G+IP ++ + SL KLIL+ NQLSG++P E GSL +L YLDLSAN+L+ SIP+ +G+
Sbjct: 467 LFGEIPKKMGSVTSLWKLILNDNQLSGNIPPELGSLADLGYLDLSANRLNGSIPEHLGDC 526
Query: 558 LKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNN 617
L L YLNLSNN+ SH IP++ KL HLS+LDLSHN+L +IPPQ+ ++SLE LNLSHNN
Sbjct: 527 LGLNYLNLSNNKLSHGIPVQMGKLGHLSQLDLSHNLLTGDIPPQIEGLQSLENLNLSHNN 586
Query: 618 LSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLME---GNKGLCGNFEAFSSCD 674
LSGFIP+ FE+M LS +DI YN+LQGPIPNS F+D +E GNKGLCGN + C
Sbjct: 587 LSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSKAFRDATIEALKGNKGLCGNVKRLRPCK 646
Query: 675 AFMSHKQTSRKK----WIVIVFPILGMVLLLISLIGFFFFFRQRKKDSQEEQTISMNPLR 730
Q KK +I+FP+LG ++LL + IG F +R++ + ++ N
Sbjct: 647 YGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAARRERTPEIKEGEVQN--D 704
Query: 731 LLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG 790
L S+ FDG+ M+EEIIKAT DFD +CIGKGG GSVYKAELPS +IVAVKK +
Sbjct: 705 LFSISTFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLHPS--DT 762
Query: 791 NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKE 850
MA+Q +FLN + AL EI+HRNIVK GFCS+ RH FLV EYL RGSLA IL + AK+
Sbjct: 763 EMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREE-AKK 821
Query: 851 LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910
L W R+N+IKGVA+AL+Y+HHDC P I+HRDISS N+LLD ++EAH+SDFG AK ++
Sbjct: 822 LGWATRVNIIKGVAHALAYMHHDCSPPIVHRDISSNNILLDSQYEAHISDFGTAKLLKLD 881
Query: 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD-FFSINFSSFSN 969
SSN++ GTFGY APE+AYTM+ TEK DV+SFGV+ EVIKG HP D S++ S +
Sbjct: 882 SSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKD 941
Query: 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
I + +LDPRL +P ++I+I++ A CL +P++RPTM+
Sbjct: 942 N-IALEDMLDPRLPPLTPQDEGEVIAIIKQATECLKANPQSRPTMQ 986
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2239), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/1015 (49%), Positives = 654/1015 (64%), Gaps = 40/1015 (3%)
Query: 12 FLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNAS----KISPCSW 67
F ++ + N+ SDS+ +A +LL W +L NQ ++ S W L P N++ K SPC+W
Sbjct: 17 FGVMYAAFNIASDSAEQANSLLKWAATLHNQKYSNR--SPWPLLPENSTNPNAKTSPCTW 74
Query: 68 FGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSK 127
G+SCN GS V+ INL+T LNGT + SFS+FP L L+LS N IP +I L K
Sbjct: 75 LGLSCNRGGS-VVRINLTTSGLNGTLHELSFSAFPDLEFLDLSCNSLSSTIPLEITQLPK 133
Query: 128 LQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVS 187
L LDL +NQLS G IPP IG L+ ++ N +
Sbjct: 134 LIFLDLSSNQLS------------------------GVIPPDIGLLTNLNTLRLSANRLD 169
Query: 188 GRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSN 247
G IPSS+GNL++LA L+L +N G IP+ MGNLK+L L + N L G IP T +L+
Sbjct: 170 GSIPSSVGNLTELAWLHLYDNRFSGSIPSEMGNLKNLVELFMDTNLLTGSIPSTFGSLTK 229
Query: 248 LDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLS 307
L LFLY N LSG IP +G+LKSL L L N LSG IP S G L+S T++ L+ N LS
Sbjct: 230 LVQLFLYNNQLSGHIPQELGDLKSLTSLSLFGNNLSGPIPASLGGLTSLTILHLYQNQLS 289
Query: 308 GSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKS 367
G+IP LGNL SLS L L N+L G IP S+GNLS L L L NN L G IPE+I L
Sbjct: 290 GTIPKELGNLNSLSNLELSENKLTGSIPASLGNLSRLELLFLKNNQLSGPIPEQIANLSK 349
Query: 368 LSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
LS L+L N L+G +P ++ L ++ +N L GPIPKS++ SL R+ N +
Sbjct: 350 LSLLQLQSNQLTGYLPQNICQSKVLQNFSVNDNRLEGPIPKSMRDCKSLVRLHLEGNQFI 409
Query: 428 GKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSK 487
G + E FG +P L F+D+ N F G+IS W P L T ++S NNI G IP EIG++++
Sbjct: 410 GNISEDFGVYPYLQFVDIRYNKFHGEISSKWGMCPHLGTLLISGNNISGIIPPEIGNAAR 469
Query: 488 LQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLS 547
LQ LD SSN +VG+IP +L KL SL ++ L NQLS VP EFGSLT+L+ LDLSAN+ +
Sbjct: 470 LQGLDFSSNQLVGRIPKELGKLTSLVRVNLEDNQLSDGVPSEFGSLTDLESLDLSANRFN 529
Query: 548 SSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMES 607
SIP +IGNL+KL YLNLSNNQFS IPI+ KL+HLSKLDLS N L EIP ++ M+S
Sbjct: 530 QSIPGNIGNLVKLNYLNLSNNQFSQEIPIQLGKLVHLSKLDLSQNFLIGEIPSELSGMQS 589
Query: 608 LEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLME---GNKGLC 664
LE LNLS NNLSGFIP ++M LS IDI YN+L+GP+P++ F++ +E GNKGLC
Sbjct: 590 LEVLNLSRNNLSGFIPGDLKEMHGLSSIDISYNKLEGPVPDNKAFQNSSIEAFQGNKGLC 649
Query: 665 GNFEAFSSCDAFMSHKQTS----RKKWIVIVFPILGMVLLLISLIGFFFFFRQRKKDSQE 720
G+ + C + + +S ++ ++VI P+ G L+L S +G FF +R K++ E
Sbjct: 650 GHVQGLQPCKPSSTEQGSSIKFHKRLFLVISLPLFGAFLIL-SFLGVLFFQSKRSKEALE 708
Query: 721 EQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAV 780
+ S +L + +FDGK MH+EII+ATD F++ +CIGKGG GSVYKA+L SG VAV
Sbjct: 709 AEKSSQESEEILLITSFDGKSMHDEIIEATDSFNDIYCIGKGGCGSVYKAKLSSGSTVAV 768
Query: 781 KKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLAR 840
KK + Q Q EF + + AL EI+HRNIVKF+GFCS + +SFLV E + +GSLA
Sbjct: 769 KKLH-QSHDAWKPYQKEFWSEIRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEKGSLAT 827
Query: 841 ILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900
IL ++ AKEL W +R N+IKGVANALSY+HHDC P I+HRDISSKN+LLD E EA VSD
Sbjct: 828 ILRDNEAAKELEWFKRANIIKGVANALSYMHHDCSPPIVHRDISSKNILLDSENEARVSD 887
Query: 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 960
FGIA+ + SS+RT GTFGY APE+AY++ TEK DVYSFGVL EVI G HP +
Sbjct: 888 FGIARILNLDSSHRTALAGTFGYMAPELAYSIVVTEKCDVYSFGVLALEVINGKHPGEII 947
Query: 961 SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
S SS S + + I+D RL PSP V +L++I+ +A CL+ +P+ RPTME
Sbjct: 948 SSISSSSSTRKMLLENIVDLRLPFPSPEVQVELVNILNLAFTCLNSNPQVRPTME 1002
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186511602|ref|NP_849538.2| Leucine-rich repeat-containing protein [Arabidopsis thaliana] gi|281185491|sp|Q8VZG8.3|Y4885_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At4g08850; Flags: Precursor gi|18086327|gb|AAL57627.1| AT4g08850/T32A17_160 [Arabidopsis thaliana] gi|224589610|gb|ACN59338.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332657282|gb|AEE82682.1| Leucine-rich repeat-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/1018 (46%), Positives = 657/1018 (64%), Gaps = 20/1018 (1%)
Query: 7 IILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPC- 65
++LI+ ++L+ S V++ + EA ALL WK++ NQ +SS LSSW N + S C
Sbjct: 30 VLLIISIVLSCSFAVSA-TVEEANALLKWKSTFTNQT-SSSKLSSWV----NPNTSSFCT 83
Query: 66 SWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNL 125
SW+G++C+ +I +NL+ + GTF+DF FSS P+L ++LS N F G I P G
Sbjct: 84 SWYGVACSLGS--IIRLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRF 141
Query: 126 SKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNN 185
SKL+ DL NQL G I PE+G L+ L L+L N+L+G+IP IG+L+ + E + N
Sbjct: 142 SKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNL 201
Query: 186 VSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNL 245
++G IPSS GNL+KL LYL NSL G IP+ +GNL +L L L +N L G IP + NL
Sbjct: 202 LTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNL 261
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS 305
N+ L +++N LSG IP IGN+ +L L L N+L+G IP + GN+ + ++ L+ N
Sbjct: 262 KNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQ 321
Query: 306 LSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365
L+GSIPP LG ++S+ L + N+L G +P S G L++L L L +N L G IP I
Sbjct: 322 LNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANS 381
Query: 366 KSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNN 425
L+ L+L NN +G +P ++ L L + +NH GP+PKSL+ SL RVRF N+
Sbjct: 382 TELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNS 441
Query: 426 LVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS 485
G + EAFG +P L F+DLS NNF G++S NW KL FI+S N+I G+IP EI +
Sbjct: 442 FSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNM 501
Query: 486 SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANK 545
++L LDLSSN I G++P + + ++KL L+ N+LSG +P LT L+YLDLS+N+
Sbjct: 502 TQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNR 561
Query: 546 LSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNM 605
SS IP ++ NL +LYY+NLS N TIP KL L LDLS+N L EI Q ++
Sbjct: 562 FSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSL 621
Query: 606 ESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDG---LMEGNKG 662
++LE+L+LSHNNLSG IP F+ M +L+ +D+ +N LQGPIP++ F++ EGNK
Sbjct: 622 QNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKD 681
Query: 663 LCGNF---EAFSSCDAFMSHKQTSRKKWIV-IVFPILGMVLLLISLIGFFFFFRQRKKDS 718
LCG+ + C S K + I+ I+ PI+G +++L G F FR+R K
Sbjct: 682 LCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQI 741
Query: 719 QEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIV 778
EE T S + LS+ +FDGK+ ++EIIKAT +FD K+ IG GG G VYKA+LP+ I+
Sbjct: 742 -EEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IM 799
Query: 779 AVKKFNSQLLS--GNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRG 836
AVKK N S N + + EFLN + AL EIRHRN+VK GFCS+ R++FLV EY+ RG
Sbjct: 800 AVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERG 859
Query: 837 SLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEA 896
SL ++L ND AK+L W +RINV+KGVA+ALSY+HHD P+I+HRDISS N+LL ++EA
Sbjct: 860 SLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEA 919
Query: 897 HVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
+SDFG AK ++P SSN + GT+GY APE+AY M+ TEK DVYSFGVL EVIKG HP
Sbjct: 920 KISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHP 979
Query: 957 RDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
D S SS + + + I D RL P+P + ++++ I++VA+LCL P+ARPTM
Sbjct: 980 GDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTM 1037
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7267528|emb|CAB78010.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|7321074|emb|CAB82121.1| receptor protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2195), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/1018 (46%), Positives = 657/1018 (64%), Gaps = 20/1018 (1%)
Query: 7 IILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPC- 65
++LI+ ++L+ S V++ + EA ALL WK++ NQ +SS LSSW N + S C
Sbjct: 12 VLLIISIVLSCSFAVSA-TVEEANALLKWKSTFTNQT-SSSKLSSWV----NPNTSSFCT 65
Query: 66 SWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNL 125
SW+G++C+ +I +NL+ + GTF+DF FSS P+L ++LS N F G I P G
Sbjct: 66 SWYGVACSLGS--IIRLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRF 123
Query: 126 SKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNN 185
SKL+ DL NQL G I PE+G L+ L L+L N+L+G+IP IG+L+ + E + N
Sbjct: 124 SKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNL 183
Query: 186 VSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNL 245
++G IPSS GNL+KL LYL NSL G IP+ +GNL +L L L +N L G IP + NL
Sbjct: 184 LTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNL 243
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS 305
N+ L +++N LSG IP IGN+ +L L L N+L+G IP + GN+ + ++ L+ N
Sbjct: 244 KNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQ 303
Query: 306 LSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365
L+GSIPP LG ++S+ L + N+L G +P S G L++L L L +N L G IP I
Sbjct: 304 LNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANS 363
Query: 366 KSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNN 425
L+ L++ NN +G +P ++ L L + +NH GP+PKSL+ SL RVRF N+
Sbjct: 364 TELTVLQVDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNS 423
Query: 426 LVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS 485
G + EAFG +P L F+DLS NNF G++S NW KL FI+S N+I G+IP EI +
Sbjct: 424 FSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNM 483
Query: 486 SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANK 545
++L LDLSSN I G++P + + ++KL L+ N+LSG +P LT L+YLDLS+N+
Sbjct: 484 TQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNR 543
Query: 546 LSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNM 605
SS IP ++ NL +LYY+NLS N TIP KL L LDLS+N L EI Q ++
Sbjct: 544 FSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSL 603
Query: 606 ESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDG---LMEGNKG 662
++LE+L+LSHNNLSG IP F+ M +L+ +D+ +N LQGPIP++ F++ EGNK
Sbjct: 604 QNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKD 663
Query: 663 LCGNF---EAFSSCDAFMSHKQTSRKKWIV-IVFPILGMVLLLISLIGFFFFFRQRKKDS 718
LCG+ + C S K + I+ I+ PI+G +++L G F FR+R K
Sbjct: 664 LCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQI 723
Query: 719 QEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIV 778
EE T S + LS+ +FDGK+ ++EIIKAT +FD K+ IG GG G VYKA+LP+ I+
Sbjct: 724 -EEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IM 781
Query: 779 AVKKFNSQLLS--GNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRG 836
AVKK N S N + + EFLN + AL EIRHRN+VK GFCS+ R++FLV EY+ RG
Sbjct: 782 AVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERG 841
Query: 837 SLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEA 896
SL ++L ND AK+L W +RINV+KGVA+ALSY+HHD P+I+HRDISS N+LL ++EA
Sbjct: 842 SLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEA 901
Query: 897 HVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
+SDFG AK ++P SSN + GT+GY APE+AY M+ TEK DVYSFGVL EVIKG HP
Sbjct: 902 KISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHP 961
Query: 957 RDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
D S SS + + + I D RL P+P + ++++ I++VA+LCL P+ARPTM
Sbjct: 962 GDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTM 1019
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297813345|ref|XP_002874556.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] gi|297320393|gb|EFH50815.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 843 bits (2177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/1015 (46%), Positives = 653/1015 (64%), Gaps = 17/1015 (1%)
Query: 7 IILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPC- 65
++LI+ ++L+ S V S + EA ALL WK++ NQ +SS LSSW N + S C
Sbjct: 7 VLLIISIVLSCSL-VVSATVEEANALLKWKSTFTNQT-SSSKLSSWV----NPNTSSFCT 60
Query: 66 SWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNL 125
SW+G+SC ++ +NL+ + GTF++F FSS P+L ++LS N F G I P G
Sbjct: 61 SWYGVSCLRGS--IVRLNLTNTGIEGTFEEFPFSSLPNLTYVDLSMNRFSGTISPLWGRF 118
Query: 126 SKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNN 185
SKL DL NQL G I PE+G L+ L L+L N+L+G+IP IG+L+ + E + N
Sbjct: 119 SKLVYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNL 178
Query: 186 VSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNL 245
++G IPSS GNL++L LYL NSL G IP+ +GNL +L L L +N L G IP + NL
Sbjct: 179 LTGPIPSSFGNLTRLVNLYLFINSLSGPIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNL 238
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS 305
N+ L +++N LSG IP IGN+ +L L L N+L+G IP + GN+ + ++ L+ N
Sbjct: 239 KNVSLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAILHLYLNQ 298
Query: 306 LSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365
LSGSIPP LG+++++ L + N+L G +P S G L+ L L L +N L G IP I
Sbjct: 299 LSGSIPPELGDMEAMIDLEISENKLTGPVPDSFGKLTVLEWLFLRDNQLSGPIPPGIANS 358
Query: 366 KSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNN 425
L+ L+L NN +G +P ++ L L + +NH GP+PKSL++ SL RVRF N+
Sbjct: 359 TELTVLQLDTNNFTGFLPDTICRSGKLENLTLDDNHFEGPVPKSLRNCKSLVRVRFKGNH 418
Query: 426 LVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS 485
G + +AFG +P L F+DLS NNF G++S NW KL FI+S N+I G+IP EI +
Sbjct: 419 FSGDISDAFGVYPTLNFIDLSNNNFHGQLSANWEQSTKLVAFILSNNSISGAIPPEIWNM 478
Query: 486 SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANK 545
++L LDLS N I G++P + + ++KL L+ NQLSG +P LT L+YLDLS+N+
Sbjct: 479 TQLNQLDLSFNRITGELPESISNINRISKLQLNGNQLSGKIPSGIRLLTNLEYLDLSSNQ 538
Query: 546 LSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNM 605
IP ++ NL +LYY+NLS N TIP KL L LDLS+N L EI Q ++
Sbjct: 539 FGFEIPATLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFGSL 598
Query: 606 ESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDG---LMEGNKG 662
++LE+L+LSHNNLSG IP F+ M +L+ ID+ +N LQGPIP++ F++ +EGN
Sbjct: 599 QNLERLDLSHNNLSGQIPTSFKDMLALTHIDVSHNNLQGPIPDNAAFRNASPNALEGNND 658
Query: 663 LCGNFEAFSSCDAFMSHKQTSRKKWIV-IVFPILGMVLLLISLIGFFFFFRQRKKDSQEE 721
LCG+ +A C S K + I+ I+ PI+G +++L G F FR+R K EE
Sbjct: 659 LCGDNKALKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQI-EE 717
Query: 722 QTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVK 781
+ S + LS+ +FDGK+ ++EIIKAT +FD K+ IG GG G VYKA+LP+ I+AVK
Sbjct: 718 NSDSESGGETLSIFSFDGKVRYQEIIKATGEFDSKYLIGTGGHGKVYKAKLPNA-IMAVK 776
Query: 782 KFNSQLLSG--NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLA 839
K N S N + + EFLN + AL EIRHRN+VK GFCS+ R++FLV EY+ RGSL
Sbjct: 777 KLNETTDSSITNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLR 836
Query: 840 RILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS 899
++L ND AK+L W +RINV+KGVA+ALSY+HHD P+I+HRDISS N+LL ++EA +S
Sbjct: 837 KVLENDDEAKKLDWGKRINVVKGVADALSYMHHDRSPAIVHRDISSGNILLGEDYEAKIS 896
Query: 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 959
DFG AK ++P SSN + GT+GY APE+AY M+ TEK DVYSFGVL EVIKG HP D
Sbjct: 897 DFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDL 956
Query: 960 FSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
S SS + + + I D RL P+P + ++++ I++VA++CL P+ARPTM
Sbjct: 957 VSTLSSSPPDTSLSLKTISDHRLPEPTPEIKEEVLEILKVALMCLHSDPQARPTM 1011
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1078 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.907 | 0.935 | 0.438 | 1.5e-209 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.856 | 0.824 | 0.424 | 2.3e-188 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.829 | 0.811 | 0.367 | 2.4e-147 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.825 | 0.808 | 0.367 | 1.8e-142 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.831 | 0.797 | 0.353 | 2.2e-137 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.841 | 0.799 | 0.342 | 5.4e-134 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.891 | 0.881 | 0.329 | 2.2e-128 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.827 | 0.712 | 0.333 | 4.8e-126 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.849 | 0.802 | 0.337 | 6.1e-126 | |
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.888 | 0.878 | 0.335 | 9.9e-126 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2026 (718.2 bits), Expect = 1.5e-209, P = 1.5e-209
Identities = 437/997 (43%), Positives = 601/997 (60%)
Query: 28 EACALLNWKTXXXXXXXXXXXXXXWTLYPTNASKISPC-SWFGISCNHAGSRVISINLST 86
EA ALL WK+ W N + S C SW+G++C+ GS +I +NL+
Sbjct: 50 EANALLKWKSTFTNQTSSSKLSS-WV----NPNTSSFCTSWYGVACS-LGS-IIRLNLTN 102
Query: 87 LCLNGTFQDFSFSSFPHLVXXXXXXXXXXGNIPPQIGNLSKLQNLDLGNNQLSGVISPEI 146
+ GTF+DF FSS P+L G I P G SKL+ DL NQL G I PE+
Sbjct: 103 TGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPEL 162
Query: 147 GKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLN 206
G L+ L L+L N+L+G+IP IG+L+ + E + N ++G IPSS GNL+KL LYL
Sbjct: 163 GDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLF 222
Query: 207 NNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSII 266
NSL G IP+ +GNL +L L L +N L G IP + NL N+ L +++N LSG IP I
Sbjct: 223 INSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEI 282
Query: 267 GNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLY 326
GN+ +L L L N+L+G IP + GN+ + ++ L+ N L+GSIPP LG ++S+ L +
Sbjct: 283 GNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEIS 342
Query: 327 LNQLNGVIPPXXXXXXXXXXXXXXXXXXYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSV 386
N+L G +P G IP I L+ L+L NN +G +P ++
Sbjct: 343 ENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTI 402
Query: 387 GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLS 446
L L + +NH GP+PKSL+ SL RVRF N+ G + EAFG +P L F+DLS
Sbjct: 403 CRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLS 462
Query: 447 QNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL 506
NNF G++S NW KL FI+S N+I G+IP EI + ++L LDLSSN I G++P +
Sbjct: 463 NNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESI 522
Query: 507 EKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGXXXXXXXXXXX 566
+ ++KL L+ N+LSG +P LT L+YLDLS+N+ SS IP ++
Sbjct: 523 SNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLS 582
Query: 567 XXQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCF 626
TIP KL L LDLS+N L EI Q ++++LE+L+LSHNNLSG IP F
Sbjct: 583 RNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSF 642
Query: 627 EKMRSLSCIDICYNELQGPIPNSTVFKDG---LMEGNKGLCGNF---EAFSSCDAFMSHK 680
+ M +L+ +D+ +N LQGPIP++ F++ EGNK LCG+ + C S K
Sbjct: 643 KDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKK 702
Query: 681 QTSRKKWIV-IVFPILGMVLLLISLIGXXXXXRQRKKDSQEEQTISMNPLRLLSVLNFDG 739
+ I+ I+ PI+G +++L G R+R K EE T S + LS+ +FDG
Sbjct: 703 SHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQI-EEHTDSESGGETLSIFSFDG 761
Query: 740 KIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG--NMADQDE 797
K+ ++EIIKAT +FD K+ IG GG G VYKA+LP+ I+AVKK N S N + + E
Sbjct: 762 KVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQE 820
Query: 798 FLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI 857
FLN + AL EIRHRN+VK GFCS+ R++FLV EY+ RGSL ++L ND AK+L W +RI
Sbjct: 821 FLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRI 880
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF 917
NV+KGVA+ALSY+HHD P+I+HRDISS N+LL ++EA +SDFG AK ++P SSN +
Sbjct: 881 NVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAV 940
Query: 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDXXXXXXXXXXXXXXEVNQI 977
GT+GY APE+AY M+ TEK DVYSFGVL EVIKG HP D + I
Sbjct: 941 AGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSI 1000
Query: 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
D RL P+P + ++++ I++VA+LCL P+ARPTM
Sbjct: 1001 SDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTM 1037
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1826 (647.8 bits), Expect = 2.3e-188, P = 2.3e-188
Identities = 399/940 (42%), Positives = 558/940 (59%)
Query: 84 LSTLCLNGTFQDFSFSSFPHLVXXXXXXXXXXGNIPPQIGNLSKLQNLDLGNNQLSGVIS 143
LS L G+ S + +L+ G IPP++GN+ + +L L N+L+G I
Sbjct: 181 LSQNKLTGSIPS-SLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIP 239
Query: 144 PEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALL 203
+G L L LYL N L G IPP IG + + + N ++G IPSSLGNL L LL
Sbjct: 240 STLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLL 299
Query: 204 YLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP 263
L N L G IP +GN++S+ L+LS N+L G IP +L NL NL L+LY+N L+G IP
Sbjct: 300 SLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIP 359
Query: 264 SIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTL 323
+GN++S+ L L N+L+GSIP SFGNL + T + L+ N L+G IP LGN++S+ L
Sbjct: 360 PELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINL 419
Query: 324 GLYLNQLNGVIPPXXXXXXXXXXXXXXXXXXYGSIPEEIGYLKSLSELKLCKNNLSGVIP 383
L N+L G +P G+IP + L+ L L NN +G P
Sbjct: 420 DLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFP 479
Query: 384 HSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFL 443
+V L +++ NHL GPIPKSL+ SL R RF N G ++EAFG +P+L F+
Sbjct: 480 ETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFI 539
Query: 444 DLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIP 503
D S N F G+IS NW PKL I+S NNI G+IP EI + ++L LDLS+N++ G++P
Sbjct: 540 DFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELP 599
Query: 504 VQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGXXXXXXXX 563
+ L +L++L L+ NQLSG VP LT L+ LDLS+N SS IP++
Sbjct: 600 EAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDM 659
Query: 564 XXXXXQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIP 623
+F +IP KL L++LDLSHN L EIP Q+ +++SL+KL+LSHNNLSG IP
Sbjct: 660 NLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIP 718
Query: 624 RCFEKMRSLSCIDICYNELQGPIPNSTVFKDGL---MEGNKGLCGNF--EAFSSCDAFMS 678
FE M +L+ +DI N+L+GP+P++ F+ +E N GLC N + C
Sbjct: 719 TTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKK 778
Query: 679 HKQTSRKK-WIVIVFPILGMVLLLISLIGXXXXXRQRKKDSQEEQTISMNPLRLLSVLNF 737
K+ WI++ PILG VL+++S+ RK+ Q + +S+ +
Sbjct: 779 PKKNGNLVVWILV--PILG-VLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSV 835
Query: 738 DGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQL---LSGNMAD 794
DGK +++II++T++FD IG GG VY+A L I+AVK+ + + +S +
Sbjct: 836 DGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVK 894
Query: 795 QDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWN 854
Q EFLN V AL EIRHRN+VK GFCS+ RH+FL+ EY+ +GSL ++L ND AK L+W
Sbjct: 895 Q-EFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWT 953
Query: 855 RRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914
+RINV+KGVA+ALSY+HHD + I+HRDISS N+LLD ++ A +SDFG AK ++ SSN
Sbjct: 954 KRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNW 1013
Query: 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDXXXXXXXXXXXXXXEV 974
+ GT+GY APE AYTM+ TEK DVYSFGVL+ E+I G HP D +
Sbjct: 1014 SAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALS-L 1072
Query: 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
I D R+ P +KL+ ++E+A+LCL +PE+RPTM
Sbjct: 1073 RSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTM 1112
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1439 (511.6 bits), Expect = 2.4e-147, P = 2.4e-147
Identities = 339/922 (36%), Positives = 496/922 (53%)
Query: 116 GNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSL 175
G++P +IGNL L L +N +SG + IG L +L N + G++P IG
Sbjct: 159 GSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCES 218
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235
+ N +SG +P +G L KL+ + L N G+IP + N SL TL L +NQL
Sbjct: 219 LVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLV 278
Query: 236 GLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS 295
G IP L +L +L+ L+LY+N L+G+IP IGNL ++D EN L+G IPL GN+
Sbjct: 279 GPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEG 338
Query: 296 WTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPXXXXXXXXXXXXXXXXXXY 355
L+ LF N L+G+IP L LK+LS L L +N L G IP
Sbjct: 339 LELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLS 398
Query: 356 GSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTS 415
G+IP ++G+ L L + N+LSG IP + + +++LN+ N+L G IP + + +
Sbjct: 399 GTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKT 458
Query: 416 LKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIF 475
L ++R +NNLVG+ N+T ++L QN F G I N L ++ N
Sbjct: 459 LVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFT 518
Query: 476 GSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTE 535
G +P EIG S+L L++SSN + G++P ++ L +L + N SG++P E GSL +
Sbjct: 519 GELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQ 578
Query: 536 LQYLDLSANKLSSSIPKSIGXXXXXXXXXXXXXQFSHTIPIEFEKLIHLS-KLDLSHNIL 594
L+ L LS N LS +IP ++G F+ +IP E L L L+LS+N L
Sbjct: 579 LELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKL 638
Query: 595 QEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKD 654
EIPP++ N+ LE L L++NNLSG IP F + SL + YN L GPIP
Sbjct: 639 TGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISM 698
Query: 655 GLMEGNKGLCGNFEAFSSC---DAFMSHKQTSR------KKWIVIVFPILGMV-LLLISL 704
GN+GLCG + C F + T + K I I ++G V L+LI+L
Sbjct: 699 SSFIGNEGLCG--PPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIAL 756
Query: 705 IGXXXXXRQRKKDSQEEQTISMNPLRLLSVLNFDGK--IMHEEIIKATDDFDEKFCIGKG 762
I R S + P + + F K ++++ ATD+FDE F +G+G
Sbjct: 757 IVYLMRRPVRTVASSAQDG---QPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRG 813
Query: 763 GQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDE-FLNVVLALNEIRHRNIVKFHGFCS 821
G+VYKA LP+G +AVKK S GN + D F +L L IRHRNIVK HGFC+
Sbjct: 814 ACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCN 873
Query: 822 NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHR 881
+ + L+ EY+ +GSL IL +D + L W++R + G A L+YLHHDC P I HR
Sbjct: 874 HQGSNLLLYEYMPKGSLGEIL-HDPSCN-LDWSKRFKIALGAAQGLAYLHHDCKPRIFHR 931
Query: 882 DISSKNVLLDLEFEAHVSDFGIAKFVE-PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDV 940
DI S N+LLD +FEAHV DFG+AK ++ P+S + + G++GY APE AYTM+ TEK D+
Sbjct: 932 DIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDI 991
Query: 941 YSFGVLVFEVIKGNHPRDXXXXXXXXXXXXXXEVNQ------ILDPRLSTPSPGVMDKLI 994
YS+GV++ E++ G P + + +LD RL+ ++ ++
Sbjct: 992 YSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSHML 1051
Query: 995 SIMEVAILCLDESPEARPTMEK 1016
+++++A+LC SP ARP+M +
Sbjct: 1052 TVLKIALLCTSVSPVARPSMRQ 1073
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1393 (495.4 bits), Expect = 1.8e-142, P = 1.8e-142
Identities = 340/926 (36%), Positives = 478/926 (51%)
Query: 116 GNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSL 175
G+IP QIGNLS LQ L + +N L+GVI P + KL QLR + N G IP I
Sbjct: 153 GSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCES 212
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235
+ N + G +P L L L L L N L G IP +GN+ L L L +N
Sbjct: 213 LKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFT 272
Query: 236 GLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS 295
G IP + L+ + L+LY N L+G IP IGNL ++D ENQL+G IP FG++ +
Sbjct: 273 GSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILN 332
Query: 296 WTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPXXXXXXXXXXXXXXXXXXY 355
L+ LF N L G IP LG L L L L +N+LNG IP
Sbjct: 333 LKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLE 392
Query: 356 GSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTS 415
G IP IG+ + S L + N+LSG IP L+LL++ N L G IP+ LK+ S
Sbjct: 393 GKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKS 452
Query: 416 LKRVRFNQNNLVGKV-YEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNI 474
L ++ N L G + E F + NLT L+L QN G IS + L L+ ++ NN
Sbjct: 453 LTKLMLGDNQLTGSLPIELF-NLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNF 511
Query: 475 FGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLT 534
G IP EIG+ +K+ ++SSN + G IP +L ++ +L LS N+ SG + E G L
Sbjct: 512 TGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLV 571
Query: 535 ELQYLDLSANKLSSSIPKSIGXXXXXXXXXXXXXQFSHTIPIEFEKLIHLS-KLDLSHNI 593
L+ L LS N+L+ IP S G S IP+E KL L L++SHN
Sbjct: 572 YLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNN 631
Query: 594 LQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFK 653
L IP + N++ LE L L+ N LSG IP + SL +I N L G +P++ VF+
Sbjct: 632 LSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQ 691
Query: 654 --DGL-MEGNKGLCGNFEAFSSCDAFMSHKQTS---------RKKWIVIVFPILGMVLLL 701
D GN GLC + S C + H + R+K + I ++G V L
Sbjct: 692 RMDSSNFAGNHGLCNSQR--SHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFL- 748
Query: 702 ISLIGXXXXXRQRKKD--SQEEQTISMNPLRLLSVLNFDGK-IMHEEIIKATDDFDEKFC 758
I+ +G ++R+ + E+QT P ++ F K ++ ++ AT +F E
Sbjct: 749 ITFLGLCWTIKRREPAFVALEDQT---KP-DVMDSYYFPKKGFTYQGLVDATRNFSEDVV 804
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDE-FLNVVLALNEIRHRNIVKFH 817
+G+G G+VYKAE+ G+++AVKK NS+ G A D F + L +IRHRNIVK +
Sbjct: 805 LGRGACGTVYKAEMSGGEVIAVKKLNSR---GEGASSDNSFRAEISTLGKIRHRNIVKLY 861
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
GFC + + L+ EY+ +GSL L L WN R + G A L YLHHDC P
Sbjct: 862 GFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQ 921
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVE-PYSSNRTEFVGTFGYAAPEIAYTMRATE 936
I+HRDI S N+LLD F+AHV DFG+AK ++ YS + + G++GY APE AYTM+ TE
Sbjct: 922 IVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTE 981
Query: 937 KYDVYSFGVLVFEVIKGNHPRDXXXXXXXXXXXXXXEVNQIL------DPRLSTPSPGVM 990
K D+YSFGV++ E+I G P + ++ D RL T +
Sbjct: 982 KCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTV 1041
Query: 991 DKLISIMEVAILCLDESPEARPTMEK 1016
++ ++++A+ C SP +RPTM +
Sbjct: 1042 HEMSLVLKIALFCTSNSPASRPTMRE 1067
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1345 (478.5 bits), Expect = 2.2e-137, P = 2.2e-137
Identities = 328/929 (35%), Positives = 481/929 (51%)
Query: 116 GNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSL 175
G +P +IG+L L+ L N L+G + +G LN+L N G IP IG+
Sbjct: 171 GPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLN 230
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235
+ N +SG +P +G L KL + L N G+IP +GNL SL TL L N L
Sbjct: 231 LKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLV 290
Query: 236 GLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS 295
G IP + N+ +L L+LY+N L+G+IP +G L + ++D EN LSG IP+ +S
Sbjct: 291 GPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISE 350
Query: 296 WTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPXXXXXXXXXXXXXXXXXXY 355
L+ LF N L+G IP L L++L+ L L +N L G IPP
Sbjct: 351 LRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLS 410
Query: 356 GSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTS 415
G IP+ +G L + +N LSG IP + + L+LLN+ N +FG IP + S
Sbjct: 411 GVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKS 470
Query: 416 LKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIF 475
L ++R N L G+ NL+ ++L QN F G + KL ++ N
Sbjct: 471 LLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFS 530
Query: 476 GSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTE 535
++P EI S L ++SSN + G IP ++ L +L LS N GS+P E GSL +
Sbjct: 531 SNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQ 590
Query: 536 LQYLDLSANKLSSSIPKSIGXXXXXXXXXXXXXQFSHTIPIEFEKLIHLS-KLDLSHNIL 594
L+ L LS N+ S +IP +IG FS +IP + L L ++LS+N
Sbjct: 591 LEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDF 650
Query: 595 QEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKD 654
EIPP++ N+ L L+L++N+LSG IP FE + SL + YN L G +P++ +F++
Sbjct: 651 SGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQN 710
Query: 655 GLME---GNKGLCGNFEAFSSCDAFMS---H----KQTS--RKKWIVIVFPILGMVLLLI 702
+ GNKGLCG SCD S H K S R + I+IV ++G + LL
Sbjct: 711 MTLTSFLGNKGLCGGH--LRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLL- 767
Query: 703 SLIGXXXXXRQRKKDSQEEQTISMNPLRLLSVLNFDGK--IMHEEIIKATDDFDEKFCIG 760
LI + + P S + F K ++I++AT F + + +G
Sbjct: 768 -LIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVG 826
Query: 761 KGGQGSVYKAELPSGDIVAVKKF--NSQLLSGNMADQDE-FLNVVLALNEIRHRNIVKFH 817
+G G+VYKA +PSG +AVKK N + + N + D F +L L +IRHRNIV+ +
Sbjct: 827 RGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLY 886
Query: 818 GFC--SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
FC + + L+ EY+ RGSL +L + + + W R + G A L+YLHHDC
Sbjct: 887 SFCYHQGSNSNLLLYEYMSRGSLGELL-HGGKSHSMDWPTRFAIALGAAEGLAYLHHDCK 945
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE-PYSSNRTEFVGTFGYAAPEIAYTMRA 934
P IIHRDI S N+L+D FEAHV DFG+AK ++ P S + + G++GY APE AYTM+
Sbjct: 946 PRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKV 1005
Query: 935 TEKYDVYSFGVLVFEVIKGNHPRDXXXXXXXXXXXXXXEV------NQILDPRLSTPSPG 988
TEK D+YSFGV++ E++ G P + ++ILDP L+
Sbjct: 1006 TEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDD 1065
Query: 989 V-MDKLISIMEVAILCLDESPEARPTMEK 1016
V ++ +I++ ++A+LC SP RPTM +
Sbjct: 1066 VILNHMITVTKIAVLCTKSSPSDRPTMRE 1094
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
Identities = 329/960 (34%), Positives = 492/960 (51%)
Query: 77 SRVISINLSTLCLNGTFQDFSFSSFPHLVXXXXXXXXXXGNIPPQIGNLSKLQNLDLGNN 136
S +I I+LS+ L G S +L G IPP++G+ L+NL++ +N
Sbjct: 130 SELIVIDLSSNSLVGEIPS-SLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDN 188
Query: 137 QLSGVISPEIGKLNQLRRLYLDMN-QLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLG 195
LS + E+GK++ L + N +L G IP IG + +SG +P SLG
Sbjct: 189 YLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLG 248
Query: 196 NLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYK 255
LSKL L + + L G IP +GN L L L N L+G +P L L NL+ + L++
Sbjct: 249 QLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQ 308
Query: 256 NSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILG 315
N+L G IP IG +KSL+ +DL N SG+IP SFGNLS+ + L SN+++GSIP IL
Sbjct: 309 NNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILS 368
Query: 316 NLKSLSTLGLYLNQLNGVIPPXXXXXXXXXXXXXXXXXXYGSIPEEIGYLKSLSELKLCK 375
N L + NQ++G+IPP G+IP+E+ ++L L L +
Sbjct: 369 NCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQ 428
Query: 376 NNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFG 435
N L+G +P + L L L + N + G IP + + TSL R+R N + G++ + G
Sbjct: 429 NYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIG 488
Query: 436 DHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSS 495
NL+FLDLS+NN G + N +L +S N + G +PL + +KLQ LD+SS
Sbjct: 489 FLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSS 548
Query: 496 NHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI- 554
N + GKIP L L SLN+LILS N +G +P G T LQ LDLS+N +S +IP+ +
Sbjct: 549 NDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELF 608
Query: 555 GXXXXXXXXXXXXXQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLS 614
IP L LS LD+SHN+L ++ + +E+L LN+S
Sbjct: 609 DIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSA-LSGLENLVSLNIS 667
Query: 615 HNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLMEGNKGLCGNFEAFSSCD 674
HN SG++P K+ + +L G MEGN GLC + F SC
Sbjct: 668 HNRFSGYLPD--SKV---------FRQLIG----------AEMEGNNGLCS--KGFRSCF 704
Query: 675 AFMSHKQTSRK----KWIVIVFPILGMVLLLISLIGXXXXXRQRK-----KDSQEEQTIS 725
S + T+++ + I +L V +++++G R ++ DS+ + +
Sbjct: 705 VSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLW 764
Query: 726 MNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKF-- 783
LNF E ++K E IGKG G VYKAE+P+ +++AVKK
Sbjct: 765 TWQFTPFQKLNFTV----EHVLKC---LVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWP 817
Query: 784 ----NSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLA 839
N + + +D F V L IRH+NIV+F G C N L+ +Y+ GSL
Sbjct: 818 VTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLG 877
Query: 840 RILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS 899
+L + L W R +I G A L+YLHHDC+P I+HRDI + N+L+ +FE ++
Sbjct: 878 SLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIG 937
Query: 900 DFGIAKFVEP--YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 957
DFG+AK V+ ++ + G++GY APE Y+M+ TEK DVYS+GV+V EV+ G P
Sbjct: 938 DFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPI 997
Query: 958 DXXXXXXXXXXXXXXEVN--QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
D ++ Q++D L +++++ + VA+LC++ PE RPTM+
Sbjct: 998 DPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMK 1057
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1260 (448.6 bits), Expect = 2.2e-128, P = 2.2e-128
Identities = 339/1028 (32%), Positives = 501/1028 (48%)
Query: 28 EACALLNWKTXXXXXXXXXXXXXXWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTL 87
+ ALL+WK+ W AS+ +PC W GI CN G +V I L +
Sbjct: 31 QGLALLSWKSQLNISGDALSS---W-----KASESNPCQWVGIKCNERG-QVSEIQLQVM 81
Query: 88 CLNGTFQDFSFSSFPHLVXXXXXXXXXXGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIG 147
G + L G+IP ++G+LS+L+ LDL +N LSG I +I
Sbjct: 82 DFQGPLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLDLADNSLSGEIPVDIF 141
Query: 148 KLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNN 207
KL +L+ L L+ N L G IP +G L + E + N ++G IP ++G L L +
Sbjct: 142 KLKKLKILSLNTNNLEGVIPSELGNLVNLIELTLFDNKLAGEIPRTIGELKNLEIFRAGG 201
Query: 208 N-SLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSII 266
N +L G +P +GN +SL TL L++ L+G +P ++ NL + T+ LY + LSG IP I
Sbjct: 202 NKNLRGELPWEIGNCESLVTLGLAETSLSGRLPASIGNLKKVQTIALYTSLLSGPIPDEI 261
Query: 267 GNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLY 326
GN L L L +N +SGSIP+S G L + L+ N+L G IP LG L + L
Sbjct: 262 GNCTELQNLYLYQNSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTELGTCPELFLVDLS 321
Query: 327 LNQLNGVIPPXXXXXXXXXXXXXXXXXXYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSV 386
N L G IP G+IPEE+ L+ L++ N +SG IP +
Sbjct: 322 ENLLTGNIPRSFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEIDNNQISGEIPPLI 381
Query: 387 GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLS 446
G LT L + +N L G IP+SL L+ + + NNL G + + NLT L L
Sbjct: 382 GKLTSLTMFFAWQNQLTGIIPESLSQCQELQAIDLSYNNLSGSIPNGIFEIRNLTKLLLL 441
Query: 447 QNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL 506
N G I + N L ++ N + G+IP EIG+ L F+D+S N ++G IP ++
Sbjct: 442 SNYLSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDISENRLIGNIPPEI 501
Query: 507 EKLFSLNKLILSLNQLSGSVPLEFGSLTE-LQYLDLSANKLSSSIPKSIGXXXXXXXXXX 565
SL + L N L+G +P G+L + LQ++DLS N L+ S+P IG
Sbjct: 502 SGCTSLEFVDLHSNGLTGGLP---GTLPKSLQFIDLSDNSLTGSLPTGIGSLTELTKLNL 558
Query: 566 XXXQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLE-KLNLSHNNLSGFIPR 624
+FS IP E L L+L N EIP ++ + SL LNLS N+ +G IP
Sbjct: 559 AKNRFSGEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISLNLSCNHFTGEIPS 618
Query: 625 CFEKMRSLSCIDICYNELQGPIPNSTVFKDGLMEGN------KGLCGNFEAF-------- 670
F + +L +D+ +N+L G + N L+ N G N F
Sbjct: 619 RFSSLTNLGTLDVSHNKLAGNL-NVLADLQNLVSLNISFNEFSGELPNTLFFRKLPLSVL 677
Query: 671 -SSCDAFMSHK-----QTSRKKWIVIVFPILGMVLLLISLIGXXXXXRQRKKDSQEEQTI 724
S+ F+S + QT + + + IL +++ L+ + ++ ++E+
Sbjct: 678 ESNKGLFISTRPENGIQTRHRSAVKVTMSILVAASVVLVLMAVYTLVKAQRITGKQEELD 737
Query: 725 SMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFN 784
S + L L+F ++I+K + IG G G VY+ +PSG+ +AVKK
Sbjct: 738 SWE-VTLYQKLDFS----IDDIVK---NLTSANVIGTGSSGVVYRVTIPSGETLAVKKMW 789
Query: 785 SQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-G 843
S+ N A E +N L IRHRNI++ G+CSN L +YL GSL+ +L G
Sbjct: 790 SK--EENRAFNSE-INT---LGSIRHRNIIRLLGWCSNRNLKLLFYDYLPNGSLSSLLHG 843
Query: 844 NDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903
+ W R +V+ GVA+AL+YLHHDCLP I+H D+ + NVLL FE++++DFG+
Sbjct: 844 AGKGSGGADWEARYDVVLGVAHALAYLHHDCLPPILHGDVKAMNVLLGSRFESYLADFGL 903
Query: 904 AKFVEPYS---------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN 954
AK V SNR G++GY APE A TEK DVYS+GV++ EV+ G
Sbjct: 904 AKIVSGEGVTDGDSSKLSNRPPLAGSYGYMAPEHASMQHITEKSDVYSYGVVLLEVLTGK 963
Query: 955 HPRDXXXXXXXXXX-------XXXXEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDES 1007
HP D + +ILDPRL + +M +++ + V+ LC+
Sbjct: 964 HPLDPDLPGGAHLVQWVRDHLAGKKDPREILDPRLRGRADPIMHEMLQTLAVSFLCVSNK 1023
Query: 1008 PEARPTME 1015
RP M+
Sbjct: 1024 ASDRPMMK 1031
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1238 (440.9 bits), Expect = 4.8e-126, P = 4.8e-126
Identities = 310/929 (33%), Positives = 467/929 (50%)
Query: 116 GNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLN-QLRRLYLDMNQLHGTIPPVIGQLS 174
G I + +++L+ L L N+LSG + I N L++L+L QL G IP I
Sbjct: 302 GVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQ 361
Query: 175 LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQL 234
+ +N ++G+IP SL L +L LYLNNNSL G + + + NL +L L N L
Sbjct: 362 SLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNL 421
Query: 235 NGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLS 294
G +P + L L+ ++LY+N SG +P IGN L ++D N+LSG IP S G L
Sbjct: 422 EGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLK 481
Query: 295 SWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPXXXXXXXXXXXXXXXXXX 354
T + L N L G+IP LGN ++ + L NQL+G IP
Sbjct: 482 DLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSL 541
Query: 355 YGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLT 414
G++P+ + LK+L+ + N +G I G+ + + ++ EN G IP L T
Sbjct: 542 QGNLPDSLINLKNLTRINFSSNKFNGSISPLCGS-SSYLSFDVTENGFEGDIPLELGKST 600
Query: 415 SLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNI 474
+L R+R +N G++ FG L+ LD+S+N+ G I KL ++ N +
Sbjct: 601 NLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYL 660
Query: 475 FGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLT 534
G IP +G L L LSSN VG +P ++ L ++ L L N L+GS+P E G+L
Sbjct: 661 SGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQ 720
Query: 535 ELQYLDLSANKLSSSIPKSIGXXXXXXXXXXXXXQFSHTIPIEFEKLIHL-SKLDLSHNI 593
L L+L N+LS +P +IG + IP+E +L L S LDLS+N
Sbjct: 721 ALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNN 780
Query: 594 LQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNS-TVF 652
IP + + LE L+LSHN L G +P M+SL +++ YN L+G + + +
Sbjct: 781 FTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRW 840
Query: 653 KDGLMEGNKGLCGNFEAFSSCDAFMSHKQTSRK-KWIVIVFPILGMVLLLISLIGXXXXX 711
+ GN GLCG+ S C+ S Q S K +VI+ I + + + ++
Sbjct: 841 QADAFVGNAGLCGS--PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFF 898
Query: 712 RQR----KKDSQEEQTISMNPLRLLSVLNFDG----KIMHEEIIKATDDFDEKFCIGKGG 763
+Q KK S N + L +G I ++I++AT +E+F IG GG
Sbjct: 899 KQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGG 958
Query: 764 QGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823
G VYKAEL +G+ +AVKK L ++ F V L IRHR++VK G+CS+
Sbjct: 959 SGKVYKAELKNGETIAVKKI---LWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSK 1015
Query: 824 RH--SFLVCEYLHRGSLARIL-GNDATAKE--LSWNRRINVIKGVANALSYLHHDCLPSI 878
+ L+ EY+ GS+ L N+ T K+ L W R+ + G+A + YLH+DC+P I
Sbjct: 1016 ADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPI 1075
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVEP-YSSN---RTEFVGTFGYAAPEIAYTMRA 934
+HRDI S NVLLD EAH+ DFG+AK + Y +N T F G++GY APE AY+++A
Sbjct: 1076 VHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKA 1135
Query: 935 TEKYDVYSFGVLVFEVIKGNHPRDXXXXXXXXXXXXXXEV----------NQILDPRLST 984
TEK DVYS G+++ E++ G P + V +++D L +
Sbjct: 1136 TEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKS 1195
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPT 1013
P + ++E+A+ C P+ RP+
Sbjct: 1196 LLPCEEEAAYQVLEIALQCTKSYPQERPS 1224
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1237 (440.5 bits), Expect = 6.1e-126, P = 6.1e-126
Identities = 320/949 (33%), Positives = 477/949 (50%)
Query: 80 ISINLSTLCLNGTFQD--FSFSSFPHLVXXXXXXXXXXGNIPPQIGNLSKLQNLDLGNNQ 137
+ + + L NG D +S S +L G IPP I SKL++L L +N
Sbjct: 129 LGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNL 188
Query: 138 LSGVISPEIGKLNQLRRLYLDMN-QLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGN 196
L+G I E+GKL+ L + + N ++ G IP IG S + +VSG +PSSLG
Sbjct: 189 LTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGK 248
Query: 197 LSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKN 256
L KL L + + G IP+ +GN L L L +N L+G IP + L+ L+ LFL++N
Sbjct: 249 LKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQN 308
Query: 257 SLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGN 316
SL G IP IGN +L +DL N LSGSIP S G LS + N SGSIP + N
Sbjct: 309 SLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISN 368
Query: 317 LKSLSTLGLYLNQLNGVIPPXXXXXXXXXXXXXXXXXXYGSIPEEIGYLKSLSELKLCKN 376
SL L L NQ++G+IP GSIP + L L L +N
Sbjct: 369 CSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRN 428
Query: 377 NLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGD 436
+L+G IP + L L L + N L G IP+ + + +SL R+R N + G++ G
Sbjct: 429 SLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGS 488
Query: 437 HPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSN 496
+ FLD S N GK+ + +L +S N++ GS+P + S LQ LD+S+N
Sbjct: 489 LKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSAN 548
Query: 497 HIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGX 556
GKIP L +L SLNKLILS N SGS+P G + LQ LDL +N+LS IP +G
Sbjct: 549 QFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGD 608
Query: 557 XXXXXXXXXXXX-QFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSH 615
+ + IP + L LS LDLSHN+L+ ++ P + N+E+L LN+S+
Sbjct: 609 IENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISY 667
Query: 616 NNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLMEGNKGLCGNFEAFSSCDA 675
N+ SG++P + R LS D+ N+ + F +GN GL + +A
Sbjct: 668 NSFSGYLPDN-KLFRQLSPQDLEGNKKLCSSTQDSCFLT-YRKGN-GLGDDGDA------ 718
Query: 676 FMSHKQTSRKKWIVIVFPILGMVLLLISLIGXXXXXRQ--RKKDSQEEQTISMNPLRLLS 733
+T + + + + L +VL+++ + R ++DS+ +T
Sbjct: 719 ----SRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQ-FTPFQ 773
Query: 734 VLNFDGKIMHEEIIKATDDFDE--KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN 791
LNF ++II+ + + K C G + V E+ + + N
Sbjct: 774 KLNFSV----DQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKT 829
Query: 792 MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKEL 851
+D F V L IRH+NIV+F G C N L+ +Y+ GSL +L ++ L
Sbjct: 830 KNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRGSSL 888
Query: 852 SWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911
W+ R ++ G A L+YLHHDCLP I+HRDI + N+L+ L+FE +++DFG+AK V+
Sbjct: 889 DWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGD 948
Query: 912 SNRTE--FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDXXXXXXXXXXX 969
R G++GY APE Y+M+ TEK DVYS+GV+V EV+ G P D
Sbjct: 949 IGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVD 1008
Query: 970 XXXEVN---QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ ++LD L + + D+++ ++ A+LC++ SP+ RPTM+
Sbjct: 1009 WVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMK 1057
|
|
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1235 (439.8 bits), Expect = 9.9e-126, P = 9.9e-126
Identities = 345/1029 (33%), Positives = 502/1029 (48%)
Query: 31 ALLNWKTXXXXXXXXXXXXXXWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLN 90
ALL+WK+ W + T SPC+W G+ CN G V I L + L
Sbjct: 31 ALLSWKSQLNISGDAFSS---WHVADT-----SPCNWVGVKCNRRGE-VSEIQLKGMDLQ 81
Query: 91 GTFQDFSFSSFPHLVXXXXXXXXXXGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLN 150
G+ S S L G IP +IG+ ++L+ LDL +N LSG I EI +L
Sbjct: 82 GSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIFRLK 141
Query: 151 QLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN-S 209
+L+ L L+ N L G IP IG LS + E N +SG IP S+G L L +L N +
Sbjct: 142 KLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGGNKN 201
Query: 210 LFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNL 269
L G +P +GN ++L L L++ L+G +P ++ NL + T+ +Y + LSG IP IG
Sbjct: 202 LRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYC 261
Query: 270 KSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQ 329
L L L +N +SGSIP + G L + L+ N+L G IP LGN L + N
Sbjct: 262 TELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENL 321
Query: 330 LNGVIPPXXXXXXXXXXXXXXXXXXYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNL 389
L G IP G+IPEE+ L+ L++ N ++G IP + NL
Sbjct: 322 LTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNL 381
Query: 390 TGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKV-YEAFGDHPNLTFLDLSQN 448
L + +N L G IP+SL L+ + + N+L G + E FG NLT L L N
Sbjct: 382 RSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLR-NLTKLLLLSN 440
Query: 449 NFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEK 508
+ G I + N L ++ N + GSIP EIG+ L F+D+S N +VG IP +
Sbjct: 441 DLSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISG 500
Query: 509 LFSLNKLILSLNQLSGSV-----P--LEF----------------GSLTELQYLDLSANK 545
SL L L N LSGS+ P L+F G LTEL L+L+ N+
Sbjct: 501 CESLEFLDLHTNSLSGSLLGTTLPKSLKFIDFSDNALSSTLPPGIGLLTELTKLNLAKNR 560
Query: 546 LSSSIPKSIGXXXXXXXXXXXXXQFSHTIPIEFEKLIHLS-KLDLSHNILQEEIPPQVCN 604
LS IP+ I FS IP E ++ L+ L+LS N EIP + +
Sbjct: 561 LSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRFVGEIPSRFSD 620
Query: 605 MESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLMEGNKGLC 664
+++L L++SHN L+G + +++L ++I YN+ G +PN+ F+ + L
Sbjct: 621 LKNLGVLDVSHNQLTGNL-NVLTDLQNLVSLNISYNDFSGDLPNTPFFRRLPLSD---LA 676
Query: 665 GNFEAFSSCDAFMSHKQTSRKKWIV-IVFPILGMVLLLISLIGXXXXXRQRKKDSQE-EQ 722
N + S T+R +V + IL +V ++ L+ R R Q +
Sbjct: 677 SNRGLYISNAISTRPDPTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRARAAGKQLLGE 736
Query: 723 TISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKK 782
I + L L+F I ++I+K + IG G G VY+ +PSG+ +AVKK
Sbjct: 737 EIDSWEVTLYQKLDFS--I--DDIVK---NLTSANVIGTGSSGVVYRITIPSGESLAVKK 789
Query: 783 FNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL 842
S+ SG F + + L IRHRNIV+ G+CSN L +YL GSL+ L
Sbjct: 790 MWSKEESG------AFNSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRL 843
Query: 843 GNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902
+ W R +V+ GVA+AL+YLHHDCLP+IIH D+ + NVLL FE +++DFG
Sbjct: 844 HGAGKGGCVDWEARYDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFG 903
Query: 903 IAKFVEPYSS---------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 953
+A+ + Y + NR G++GY APE A R TEK DVYS+GV++ EV+ G
Sbjct: 904 LARTISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVLTG 963
Query: 954 NHPRDXXXXXXXXXX-------XXXXEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDE 1006
HP D + +++LDPRL + +M +++ + VA LC+
Sbjct: 964 KHPLDPDLPGGAHLVKWVRDHLAEKKDPSRLLDPRLDGRTDSIMHEMLQTLAVAFLCVSN 1023
Query: 1007 SPEARPTME 1015
RP M+
Sbjct: 1024 KANERPLMK 1032
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q8VZG8 | Y4885_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4646 | 0.9257 | 0.9550 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| AT4G08850 | kinase; kinase; FUNCTIONS IN- kinase activity; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- plasma membrane, membrane; EXPRESSED IN- 23 plant structures; EXPRESSED DURING- 13 growth stages; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Protein kinase, core (InterPro-IPR000719), Leucine-rich repeat, N-terminal (InterPro-IPR013210), Tyrosine protein kinase, active site (InterPro-IPR008266), Leucine-rich repeat (InterPro-IPR001611), Serine/threonine protein kinase-related (InterPro-IPR017442), Protein kinase-like (InterPro-IPR011009); B [...] (1045 aa) | ||||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Rps2 | RPS2 (RESISTANT TO P. SYRINGAE 2); protein binding; Encodes a plasma membrane protein with leuc [...] (909 aa) | • | • | • | 0.878 | ||||||
| AT2G31880 | leucine-rich repeat transmembrane protein kinase, putative; Encodes a putative leucine rich rep [...] (641 aa) | • | • | 0.754 | |||||||
| AT5G48380 | leucine-rich repeat family protein / protein kinase family protein; leucine-rich repeat family [...] (620 aa) | • | • | 0.704 | |||||||
| EDA39 | EDA39 (embryo sac development arrest 39); calmodulin binding; embryo sac development arrest 39 [...] (526 aa) | • | 0.696 | ||||||||
| RPP13L4 | disease resistance protein (CC-NBS-LRR class), putative; disease resistance protein (CC-NBS-LRR [...] (852 aa) | • | 0.645 | ||||||||
| AT2G39210 | nodulin family protein; nodulin family protein; FUNCTIONS IN- molecular_function unknown; INVOL [...] (601 aa) | • | 0.641 | ||||||||
| PEN3 | PEN3 (PENETRATION 3); ATPase, coupled to transmembrane movement of substances / cadmium ion tra [...] (1469 aa) | • | 0.631 | ||||||||
| DL3220C | zinc finger (C3HC4-type RING finger) family protein / ankyrin repeat family protein; zinc finge [...] (376 aa) | • | 0.625 | ||||||||
| AT1G19380 | unknown protein; unknown protein; INVOLVED IN- biological_process unknown; EXPRESSED IN- 24 pla [...] (147 aa) | • | • | 0.614 | |||||||
| AT4G38550 | unknown protein; LOCATED IN- chloroplast; EXPRESSED IN- 21 plant structures; EXPRESSED DURING- [...] (612 aa) | • | 0.605 | ||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1078 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-135 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-26 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 9e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 434 bits (1117), Expect = e-135
Identities = 326/1029 (31%), Positives = 496/1029 (48%), Gaps = 119/1029 (11%)
Query: 4 PIFIILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKIS 63
P I ++ FL LNFS + E LL++K+S+ + LS+W S
Sbjct: 10 PYLIFMLFFLFLNFS----MLHAEELELLLSFKSSINDP---LKYLSNWN------SSAD 56
Query: 64 PCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIG 123
C W GI+CN++ SRV+SI+LS ++G F P++ +NLS N G IP I
Sbjct: 57 VCLWQGITCNNS-SRVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIF 114
Query: 124 NLS-KLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFC 182
S L+ L+L NN +G I G + L L L N L G IP IG S +
Sbjct: 115 TTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLG 172
Query: 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTL 242
N + G+IP+SL NL+ L L L +N L G IP +G +KSL + L N L+G IP +
Sbjct: 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232
Query: 243 DNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLF 302
L++L+ L L N+L+G IPS +GNLK+L L L +N+LSG IP S +L + L
Sbjct: 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS 292
Query: 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362
NSLSG IP ++ L++L L L+ N G IP ++ +L L+ L L++N G IP+ +
Sbjct: 293 DNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352
Query: 363 GYLKSLSELKLCKNNLSGVIPHSV---GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV 419
G +L+ L L NNL+G IP + GNL L+L + N L G IPKSL + SL+RV
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS---NSLEGEIPKSLGACRSLRRV 409
Query: 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479
R N+ G++ F P + FLD+S NN G+I+ ++P L ++ N FG +P
Sbjct: 410 RLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469
Query: 480 LEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYL 539
G S +L+ LDLS N Q SG+VP + GSL+EL L
Sbjct: 470 DSFG-SKRLENLDLSRN------------------------QFSGAVPRKLGSLSELMQL 504
Query: 540 DLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIP 599
LS NKLS IP + + KL L+LS+NQ S IP F ++ LS+LDLS N
Sbjct: 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN------- 557
Query: 600 PQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVF---KDGL 656
LSG IP+ + SL ++I +N L G +P++ F
Sbjct: 558 -----------------QLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASA 600
Query: 657 MEGNKGLCGNFEAFSSCDAFMSHKQTSRKKWIVIVFPILGMVLLLISLIGFFFFFRQR-- 714
+ GN LCG K S W I + ++L + GF F +
Sbjct: 601 VAGNIDLCGGDTTSGLPPCKRVRKTPSW--WFYITCTLGAFLVLALVAFGFVFIRGRNNL 658
Query: 715 --KKDSQEEQTISMNPLRLLSVLNFDGKIMHEEIIKAT-DDFDEKFCIGKGGQGSVYKAE 771
K+ E+ T + FD K+ I E+ I +G +G+ YK +
Sbjct: 659 ELKRVENEDGTWEL--------QFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGK 710
Query: 772 LPSGDI-VAVKKFNSQLLSGNMADQDEF-LNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829
+ VK+ N D + + + + +++H NIVK G C + + ++L+
Sbjct: 711 SIKNGMQFVVKEIN---------DVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761
Query: 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVL 889
EY+ +L+ +L N LSW RR + G+A AL +LH C P+++ ++S + ++
Sbjct: 762 HEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815
Query: 890 LDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFE 949
+D + E H+ ++ F+ + Y APE T TEK D+Y FG+++ E
Sbjct: 816 IDGKDEPHL----RLSLPGLLCTDTKCFISS-AYVAPETRETKDITEKSDIYGFGLILIE 870
Query: 950 VIKGNHPRDFFS------INFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILC 1003
++ G P D + ++ + ++ +DP + ++++ +M +A+ C
Sbjct: 871 LLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHC 930
Query: 1004 LDESPEARP 1012
P ARP
Sbjct: 931 TATDPTARP 939
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 82/268 (30%), Positives = 122/268 (45%), Gaps = 21/268 (7%)
Query: 758 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
+G G G+VYKA +G IVAVK S + L + H NIV+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILK--KRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 817 HGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
+ H +LV EY G L L + LS + + + L YLH +
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE-IAYTMRAT 935
IIHRD+ +N+LLD ++DFG+AK + SS+ T FVGT Y APE +
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 936 EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG---VMDK 992
K DV+S GV+++E++ G P F N + + + +IL P L P ++
Sbjct: 178 PKVDVWSLGVILYELLTGKPP--FSGEN---ILDQLQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 993 LISIMEVAILCLDESPEARPTMEKGFGH 1020
+++ CL++ P RPT E+ H
Sbjct: 233 AKDLIKK---CLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 72/265 (27%), Positives = 125/265 (47%), Gaps = 23/265 (8%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G G VY A + +G +VA+K + + D++ L + L +++H NIV+ +
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK---DRERILREIKILKKLKHPNIVRLY 63
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+ +LV EY G L +L LS + ++ + +AL YLH
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEARFYLRQILSALEYLHSKG--- 117
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
I+HRD+ +N+LLD + ++DFG+A+ ++P T FVGT Y APE+ +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 938 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM--DKLIS 995
D++S GV+++E++ G P F ++ +I P+ P P +
Sbjct: 177 VDIWSLGVILYELLTGKPP-------FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229
Query: 996 IMEVAILCLDESPEARPTMEKGFGH 1020
++ L + PE R T E+ H
Sbjct: 230 LIR---KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 64/194 (32%), Positives = 103/194 (53%), Gaps = 11/194 (5%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+GG G+VY A +G VA+K + S + +E L + L ++ H NIVK +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL---EELLREIEILKKLNHPNIVKLY 57
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
G + H +LV EY GSL +L + +LS + + ++ + L YLH +
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 878 IIHRDISSKNVLLD-LEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE-IAYTMRAT 935
IIHRD+ +N+LLD + ++DFG++K + S VGT Y APE + +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 936 EKYDVYSFGVLVFE 949
EK D++S GV+++E
Sbjct: 173 EKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 72/266 (27%), Positives = 113/266 (42%), Gaps = 30/266 (11%)
Query: 759 IGKGGQGSVYKAEL----PSGDI-VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+G+G G VYK +L + VAVK + +EFL + ++ H N+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE---DASEQQIEEFLREARIMRKLDHPNV 63
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
VK G C+ ++V EY+ G L L +LS + ++ +A + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA--APEIAYT 931
IHRD++++N L+ +SDFG+++ + R G APE
Sbjct: 122 N---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR-GGKLPIRWMAPESLKE 177
Query: 932 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM-IIEVNQILDPRLSTPSPGVM 990
+ T K DV+SFGVL++E+ F++ + M EV + L P P
Sbjct: 178 GKFTSKSDVWSFGVLLWEI---------FTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC 228
Query: 991 -DKLISIMEVAILCLDESPEARPTME 1015
+L +M C E PE RPT
Sbjct: 229 PPELYDLML---QCWAEDPEDRPTFS 251
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 78/279 (27%), Positives = 119/279 (42%), Gaps = 46/279 (16%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
D + +G+G G VYK P+G I A+KK + + +EF L E++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-------VDGDEEFRK--QLLRELK 51
Query: 810 ------HRNIVKFHG-FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG 862
+VK +G F S +V EY+ GSLA +L E V+
Sbjct: 52 TLRSCESPYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKIPE-------PVLAY 103
Query: 863 VA----NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFV 918
+A L YLH IIHRDI N+L++ + E ++DFGI+K +E FV
Sbjct: 104 IARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV 161
Query: 919 GTFGYAAPE----IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974
GT Y +PE +Y+ A D++S G+ + E G P F SF ++ +
Sbjct: 162 GTVTYMSPERIQGESYSYAA----DIWSLGLTLLECALGKFP--FLPPGQPSFFELMQAI 215
Query: 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
P L P+ + + CL + P+ RP+
Sbjct: 216 CDGPPPSL--PAEEFSPEFRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 76/266 (28%), Positives = 113/266 (42%), Gaps = 31/266 (11%)
Query: 759 IGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRN 812
+G+G G VYK L VAVK L Q +EFL + ++ H N
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKT----LKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
IVK G C+ +V EY+ G L L KELS + ++ +A + YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA--APEIAY 930
IHRD++++N L+ +SDFG+++ + + + G APE
Sbjct: 122 KN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK-GGKLPIRWMAPESLK 177
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM-IIEVNQILDPRLSTPSPGV 989
+ T K DV+SFGVL++E+ F++ + M EV + L P P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEI---------FTLGEEPYPGMSNAEVLEYLKKGYRLPKPPN 228
Query: 990 M-DKLISIMEVAILCLDESPEARPTM 1014
+L +M C E PE RPT
Sbjct: 229 CPPELYKLML---QCWAEDPEDRPTF 251
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 74/278 (26%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 753 FDEKFCIGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADQ-DEFLNVVLALN 806
+K +G+G G VYK L G+ VAVK L G ++ +EFL +
Sbjct: 3 LGKK--LGEGAFGEVYKGTLKGDGEGTETKVAVKT----LKEGASEEEREEFLEEASIMK 56
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
++ H NIV+ G C+ ++V EY+ G L L ++L+ + + +A
Sbjct: 57 KLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKG 114
Query: 867 LSYLH-HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA- 924
+ YL + +HRD++++N L+ +SDFG+++ + R G
Sbjct: 115 MEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR---KRGGGKLP 167
Query: 925 ----APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE--VNQIL 978
APE + T K DV+SFGVL++E+ F++ + M E + +
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEI---------FTLGEQPYPGMSNEEVLELLE 218
Query: 979 D-PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
D RL P D+L +M + C PE RPT
Sbjct: 219 DGYRLPRP-ENCPDELYELM---LQCWAYDPEDRPTFS 252
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 75/272 (27%), Positives = 121/272 (44%), Gaps = 32/272 (11%)
Query: 752 DFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
F+ IGKGG G VYKA +G VA+K + + +++ +N + L + +H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKIINEIQILKKCKH 56
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRIN------VIKGVA 864
NIVK++G ++V E+ GSL +L S N+ + V K +
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL--------KSTNQTLTESQIAYVCKELL 108
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA 924
L YLH + IIHRDI + N+LL + E + DFG++ + + R VGT +
Sbjct: 109 KGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD-TKARNTMVGTPYWM 164
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
APE+ K D++S G+ E+ +G P + + ++ P L
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPP--YS--ELPPMKAL-FKIATNGPPGL-- 217
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+P + CL ++PE RPT E+
Sbjct: 218 RNPEKWSD--EFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 67/267 (25%), Positives = 113/267 (42%), Gaps = 34/267 (12%)
Query: 758 CIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
+G+G GSVY A +G+++AVK +L + + + + L+ ++H NIV++
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 817 HGFCSNARHSFL--VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN----ALSYL 870
+G + + L EY+ GSL+ +L E VI+ L+YL
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYL 117
Query: 871 H-HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE--PYSSNRTEFVGTFGYAAPE 927
H + I+HRDI N+L+D + ++DFG AK + GT + APE
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987
+ D++S G V E+ G P +S N + + +I P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP-------WSELGNPMAALYKIGSSGEPPEIP 226
Query: 988 -GVMDKLISIMEVAILCLDESPEARPT 1013
+ ++ + CL P+ RPT
Sbjct: 227 EHLSEEAKDFLR---KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 36/273 (13%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
+G+G G VYK +L D VAVK + + ++ +FL + ++ H N+V
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVK---TLKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 815 KFHGFCSNARHSFLVCEYLHRGSL------ARILGNDATAKELSWNRRINVIKGVANALS 868
+ G C+ +LV EY+ G L +R + LS ++ +A +
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG-----Y 923
YL +HRD++++N L+ + +SDFG+++ V R T G +
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK---KTGGKLPIRW 173
Query: 924 AAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
APE T K DV+SFGVL++E+ G P + ++ + + ++ P
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEVLEYLRKGYRLPKP-- 229
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
D+L +M C PE RPT
Sbjct: 230 ----EYCPDELYELML---SCWQLDPEDRPTFS 255
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 758 CIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA----LNEIRHRN 812
IG+G G VYK L +GD VA+K+ + ++E L ++ L ++H N
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQIS------LEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
IVK+ G + +++ EY GSL +I+ E + + V L+YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE---SLVAVYVYQVLQGLAYLHE 117
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM 932
+IHRDI + N+L + ++DFG+A + S + VGT + APE+
Sbjct: 118 Q---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 933 RATEKYDVYSFGVLVFEVIKGNHP 956
A+ D++S G V E++ GN P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 80/288 (27%), Positives = 126/288 (43%), Gaps = 39/288 (13%)
Query: 740 KIMHEEIIKATDDFDEKFC----IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMAD 794
K ++I+ D E + IG+G G VYKA + +G VA+KK +
Sbjct: 5 KAALKDIVSE-GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-------LRK 56
Query: 795 QDEFLNV--VLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDATAKEL 851
Q++ L + +L + + +H NIV ++ ++V EY+ GSL I+ N E
Sbjct: 57 QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE- 115
Query: 852 SWNRRIN-VIKGVANALSYLH--HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908
+I V + V L YLH + +IHRDI S N+LL + ++DFG A +
Sbjct: 116 ---PQIAYVCREVLQGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167
Query: 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS 968
S R VGT + APE+ K D++S G++ E+ +G P +
Sbjct: 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY----LREPPLR 223
Query: 969 NM-IIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ +I I P L P + + CL + PE RP+ E
Sbjct: 224 ALFLITTKGI--PPLKNPE-KWSPEFKDFLN---KCLVKDPEKRPSAE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 39/269 (14%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMAD-QDEFLNVVLALNEIRH---RNI 813
IG+G G+VY+ +P+G +VA+K N +++D Q E V L+++R NI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQRE----VALLSQLRQSQPPNI 64
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVI-KGVANALSYLHH 872
K++G +++ EY GS+ R L E + I+VI + V AL Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAE----KYISVIIREVLVALKYIHK 119
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM 932
+IHRDI + N+L+ + DFG+A + SS R+ FVGT + APE+
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 933 RATE-KYDVYSFGVLVFEVIKGNHP---RDFFSINFSSFSNMIIEVNQILDPRL--STPS 986
+ + K D++S G+ ++E+ GN P D F + M+I ++ PRL + S
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMMLIPKSK--PPRLEDNGYS 228
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTME 1015
+ E CLDE P+ R + E
Sbjct: 229 K-------LLREFVAACLDEEPKERLSAE 250
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 78/267 (29%), Positives = 119/267 (44%), Gaps = 24/267 (8%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG G VY A LP+ + VA+K+ + L DE V A+++ H N+VK++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRID---LEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+LV YL GSL I+ + L V+K V L YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN----RTEFVGTFGYAAPEIAYTMR 933
IHRDI + N+LL + ++DFG++ + R FVGT + APE+ +
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 934 A-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD--PRLST-PSPGV 989
K D++SFG+ E+ G P +S + M + + + + P L T
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP-------YSKYPPMKVLMLTLQNDPPSLETGADYKK 235
Query: 990 MDKLISIMEVAILCLDESPEARPTMEK 1016
K S ++ LCL + P RPT E+
Sbjct: 236 YSK--SFRKMISLCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 37/266 (13%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G V+ + + VA+K N G M+++D F+ + ++ H +V+ +G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEED-FIEEAKVMMKLSHPKLVQLYG 66
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
C+ + ++V E++ G L L +LS + +++ + V + YL + S
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SF 121
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYSSNRTEFVGTFGYAAPEIAYTMRAT 935
IHRD++++N L+ VSDFG+ ++V E SS+ +F ++ PE+ + +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVKWSPPEVFNFSKYS 179
Query: 936 EKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSN-----MIIEVNQILDPRLSTPSPGV 989
K DV+SFGVL++EV +G P F SN MI ++ P+L++
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMP-------FEKKSNYEVVEMISRGFRLYRPKLAS----- 227
Query: 990 MDKLISIMEVAILCLDESPEARPTME 1015
+++ EV C E PE RPT
Sbjct: 228 ----MTVYEVMYSCWHEKPEGRPTFA 249
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 73/210 (34%), Positives = 110/210 (52%), Gaps = 18/210 (8%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA-----LNEIRHRN 812
IG G GSVY SG+++AVK+ +S + D+ + LA L E++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
IV++ G +A H + EY+ GS+A +L N+ A E + R N ++ + L+YLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVR--NFVRQILKGLNYLHN 124
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS------SNRTEFVGTFGYAAP 926
IIHRDI N+L+D + +SDFGI+K +E S R G+ + AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
E+ T K D++S G LV E++ G HP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G+VY A ++ +G VA+K+ N Q ++ +N +L + E +H NIV +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKHPNIVNYL 82
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
++V EYL GSL ++ T + + V + AL +LH +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---Q 135
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
+IHRDI S N+LL ++ ++DFG + P S R+ VGT + APE+ K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 938 YDVYSFGVLVFEVIKGNHP 956
D++S G++ E+++G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 72/274 (26%), Positives = 120/274 (43%), Gaps = 18/274 (6%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH-RNIVKFH 817
+G+G G VY A +VA+K +L S + + FL + L + H NIVK +
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVER-FLREIQILASLNHPPNIVKLY 64
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
F + +LV EY+ GSL +L LS + + ++ + +AL YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 878 IIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYSSNR------TEFVGTFGYAAPEIAY 930
IIHRDI +N+LLD + + DFG+AK + S + VGT GY APE+
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 931 TM---RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF-SNMIIEVNQILDPRLSTPS 986
+ A+ D++S G+ ++E++ G P + + ++ + II
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ ++ L + P+ R + H
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 5e-23
Identities = 65/259 (25%), Positives = 112/259 (43%), Gaps = 18/259 (6%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG G VY G + +K+ + L + + ++++ LN V L ++ H NI+K++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKE-LSWNRRINVIKGVANALSYLHHDCLP 876
+V EY G L++ + + + ++ + AL YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATE 936
I+HRDI +N+ L + DFGI+K + VGT Y +PE+
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNY 182
Query: 937 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISI 996
K D++S G +++E+ HP F N + I+ P S S +L ++
Sbjct: 183 KSDIWSLGCVLYELCTLKHP--FEGENLLELALKIL--KGQYPPIPSQYS----SELRNL 234
Query: 997 MEVAILCLDESPEARPTME 1015
+ L + PE RP++
Sbjct: 235 VS---SLLQKDPEERPSIA 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 75/262 (28%), Positives = 129/262 (49%), Gaps = 28/262 (10%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G V+ VAVK L G M+ + FL + ++RH +V+ +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT----LKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYA 68
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
CS ++V EY+ +GSL L + K+L + +++ +A ++YL +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVEP--YSSNRTEFVGTFGYAAPEIAYTMRATE 936
IHRD++++N+L+ ++DFG+A+ +E Y++ R + APE A R T
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTI 183
Query: 937 KYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSPGVMDKL 993
K DV+SFG+L+ E++ G P + +N EV + ++ R+ P P ++L
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP-------YPGMTNR--EVLEQVERGYRMPRP-PNCPEEL 233
Query: 994 ISIMEVAILCLDESPEARPTME 1015
+M + C D+ PE RPT E
Sbjct: 234 YDLM---LQCWDKDPEERPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 68/242 (28%), Positives = 122/242 (50%), Gaps = 27/242 (11%)
Query: 778 VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGS 837
VA+K + G+M+ +DEF+ + ++ H +V+ +G C+ R ++V EY+ G
Sbjct: 31 VAIK----MIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85
Query: 838 LARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH 897
L L K ++ + + K V ++YL IHRD++++N L+D +
Sbjct: 86 LLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVK 140
Query: 898 VSDFGIAKFV---EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-G 953
VSDFG++++V E SS ++F ++ PE+ + + K DV++FGVL++EV G
Sbjct: 141 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198
Query: 954 NHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
P + F N S + + ++ P L++ +K+ +IM C E E RPT
Sbjct: 199 KMPYERF--NNSETVEKVSQGLRLYRPHLAS------EKVYAIMYS---CWHEKAEERPT 247
Query: 1014 ME 1015
+
Sbjct: 248 FQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 77/266 (28%), Positives = 124/266 (46%), Gaps = 35/266 (13%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G V+ + VA+K G M+ +D+F+ + ++ H N+V+ +G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMS-EDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 819 FCSNARHSFLVCEYLHRGSLARIL----GNDATAKELSWNRRINVIKGVANALSYLHHDC 874
C+ R F+V EY+ G L L G T L + V A+ YL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYLESNG 120
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYSSNRTEFVGTFGYAAPEIAYT 931
IHRD++++N L+ + VSDFG+A++V + SS T+F +A PE+
Sbjct: 121 ---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDY 175
Query: 932 MRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990
R + K DV+SFGVL++EV +G P + FS N S + ++ P+L+
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-N-SEVVESVSAGYRLYRPKLAPT----- 228
Query: 991 DKLISIMEVAILCLDESPEARPTMEK 1016
+ + C E PE RP +K
Sbjct: 229 ----EVYTIMYSCWHEKPEDRPAFKK 250
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 78/286 (27%), Positives = 123/286 (43%), Gaps = 42/286 (14%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALN 806
+D++ IG G G VYKA ++ +G++VA+K + D+F + + L
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-------LEPGDDFEIIQQEISMLK 55
Query: 807 EIRHRNIVKFHGFCSNARHSFL--VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
E RH NIV + G S R L V EY GSL I T LS + V +
Sbjct: 56 ECRHPNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETL 111
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA 924
L+YLH IHRDI N+LL + + ++DFG++ + + R F+GT +
Sbjct: 112 KGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM 168
Query: 925 APEIA---YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981
APE+A K D+++ G+ E+ + P F + ++ +
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPM---------FDLHPMRALFLI-SK 218
Query: 982 LSTPSPGVMDK------LISIMEVAILCLDESPEARPTMEKGFGHH 1021
+ P P + DK ++ CL + P+ RPT K H
Sbjct: 219 SNFPPPKLKDKEKWSPVFHDFIKK---CLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 8e-22
Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G+V+ A ++ +G VA+K+ N Q ++ +N +L + E+++ NIV F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELIINEILVMKELKNPNIVNFL 82
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
F+V EYL GSL ++ T + + V + AL +LH +
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---Q 135
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
+IHRDI S NVLL ++ ++DFG + P S R+ VGT + APE+ K
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 938 YDVYSFGVLVFEVIKGNHP 956
D++S G++ E+++G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-22
Identities = 70/259 (27%), Positives = 121/259 (46%), Gaps = 26/259 (10%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G V++ + VA+K L S ++ Q +F V AL +RH++++
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKI----LKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
CS +++ E + +GSL L + L I++ VA ++YL +
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NS 125
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFV-EP-YSSNRTEFVGTFGYAAPEIAYTMRATE 936
IHRD++++N+L+ + V+DFG+A+ + E Y S+ + + + APE A +
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFST 183
Query: 937 KYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI- 994
K DV+SFG+L++E+ G P + +N EV + P P + I
Sbjct: 184 KSDVWSFGILLYEMFTYGQVP-------YPGMNNH--EVYDQITAGYRMPCPAKCPQEIY 234
Query: 995 SIMEVAILCLDESPEARPT 1013
IM + C PE RP+
Sbjct: 235 KIM---LECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 75/259 (28%), Positives = 122/259 (47%), Gaps = 22/259 (8%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G V++ + VAVK L G M D +FL + ++RH +++ +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKT----LKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
C+ ++V E + GSL L A + L + I++ VA+ ++YL +
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNY 124
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
IHRD++++NVL+ V+DFG+A+ E R + APE A R + K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 938 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP-GVMDKLISI 996
DV+SFG+L+ E++ + + + +N EV Q +D P P G +L I
Sbjct: 185 SDVWSFGILLTEIVT------YGRMPYPGMTNA--EVLQQVDQGYRMPCPPGCPKELYDI 236
Query: 997 MEVAILCLDESPEARPTME 1015
M + C E P+ RPT E
Sbjct: 237 M---LDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G+VY A ++ +G VA+++ N Q ++ +N +L + E ++ NIV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYL 83
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
++V EYL GSL ++ T + + V + AL +LH +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
+IHRDI S N+LL ++ ++DFG + P S R+ VGT + APE+ K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 938 YDVYSFGVLVFEVIKGNHP 956
D++S G++ E+I+G P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 78/276 (28%), Positives = 124/276 (44%), Gaps = 32/276 (11%)
Query: 759 IGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+G+G G V P GD VAVK N SG + +F + L + H NI
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH---SGEEQHRSDFEREIEILRTLDHENI 68
Query: 814 VKFHGFCSNA--RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
VK+ G C R L+ EYL GSL L +++ R + + + YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV----EPYSSNRTEFVGTFGYAAPE 927
IHRD++++N+L++ E +SDFG+AK + + Y F Y APE
Sbjct: 127 SQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIK-GNH----PRDFFSINFSSFSNMIIE--VNQILD- 979
T + + DV+SFGV ++E+ G+ P +F + + MI+ + + +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242
Query: 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
RL P P D++ +M+ LC + P+ RP+
Sbjct: 243 ERLPRP-PSCPDEVYDLMK---LCWEAEPQDRPSFA 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 67/270 (24%), Positives = 115/270 (42%), Gaps = 33/270 (12%)
Query: 752 DFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR 811
+ IGKG G V + G VAVK A FL + +RH
Sbjct: 7 ELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDD---STAAQA--FLAEASVMTTLRHP 60
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
N+V+ G ++V EY+ +GSL L + A ++ +++ V + YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE 119
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF--GYAAPEIA 929
+ +HRD++++NVL+ + A VSDFG+AK +++ + G + APE
Sbjct: 120 EK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL 171
Query: 930 YTMRATEKYDVYSFGVLVFEVI---KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
+ + K DV+SFG+L++E+ + +PR I +E ++ P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPR----IPLKDVVPH-VEKGYRMEAPEGCPP 226
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ +V C + P RPT ++
Sbjct: 227 E--------VYKVMKDCWELDPAKRPTFKQ 248
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-21
Identities = 82/267 (30%), Positives = 126/267 (47%), Gaps = 27/267 (10%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG G G+VY A ++ + ++VA+KK + N QD + V L ++RH N +++
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQQLRHPNTIEYK 81
Query: 818 GFCSNARHS-FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
G C H+ +LV EY GS + IL + K L + G L+YLH
Sbjct: 82 G-CYLREHTAWLVMEYC-LGSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM---R 933
IHRDI + N+LL ++DFG A V P +S FVGT + APE+ M +
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDEGQ 190
Query: 934 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKL 993
K DV+S G+ E+ + P F++N S + + Q P LS+ D
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP--LFNMNAMS---ALYHIAQNDSPTLSS--NDWSDYF 243
Query: 994 ISIMEVAILCLDESPEARPTMEKGFGH 1020
+ ++ CL + P+ RP+ E+ H
Sbjct: 244 RNFVD---SCLQKIPQDRPSSEELLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 73/285 (25%), Positives = 132/285 (46%), Gaps = 35/285 (12%)
Query: 752 DFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNM--ADQDEFLNVVLALNEI 808
D++ IGKG G+V K G I+ K+ + GNM ++ + ++ V L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDY----GNMTEKEKQQLVSEVNILREL 56
Query: 809 RHRNIVKFHGFCSN--ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI------NVI 860
+H NIV+++ + + ++V EY G LA+++ K+ + I ++
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK---CKKE--RKYIEEEFIWRIL 111
Query: 861 KGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFV 918
+ AL H+ P ++HRD+ N+ LD + DFG+AK + SS +V
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 919 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN-QI 977
GT Y +PE M EK D++S G L++E+ + P F + N ++ I E +
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--FTARNQLQLASKIKEGKFRR 229
Query: 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022
+ R S+ ++++I L+ P+ RP+ E+ +
Sbjct: 230 IPYRYSSE----LNEVIK------SMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 66/265 (24%), Positives = 117/265 (44%), Gaps = 24/265 (9%)
Query: 752 DFDEKFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
DF+ IGKG G V+K + + A+K+ + L N +++E ++ L ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQID--LSKMNRREREEAIDEARVLAKLDS 58
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARIL---GNDATAKELSWNRRINVIKGVANAL 867
I++++ + +V EY G L ++L ++ W I ++ G L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
++LH I+HRDI S N+ LD + D G+AK + ++ VGT Y +PE
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987
+ EK DV++ GV+++E G HP D +N + +I+ S
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD--------ANNQGALILKIIRGVFPPVSQ 223
Query: 988 GVMDKLISIMEVAILCLDESPEARP 1012
+L +++ CL + RP
Sbjct: 224 MYSQQLAQLID---QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 9e-21
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G+VY A ++ +G VA+K+ N Q ++ +N +L + E ++ NIV +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKNPNIVNYL 82
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
++V EYL GSL ++ T + + V + AL +LH +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---Q 135
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
+IHRDI S N+LL ++ ++DFG + P S R+ VGT + APE+ K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 938 YDVYSFGVLVFEVIKGNHP 956
D++S G++ E+++G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 78/280 (27%), Positives = 122/280 (43%), Gaps = 33/280 (11%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DD + +G G G V K P+G I+AVK L N A Q + L + L++
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---RLEINEAIQKQILRELDILHKCN 57
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
IV F+G N + EY+ GSL +IL +I V V L+Y
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTY 115
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE-- 927
LH IIHRD+ N+L++ + + DFG++ + +S FVGT Y APE
Sbjct: 116 LHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTFVGTSSYMAPERI 171
Query: 928 --IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV-NQILD---PR 981
Y++++ D++S G+ + E+ G P + + I E+ I++ PR
Sbjct: 172 QGNDYSVKS----DIWSLGLSLIELATGRFPYPPENDP----PDGIFELLQYIVNEPPPR 223
Query: 982 L-STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
L S ++ LCL + P RP+ ++ H
Sbjct: 224 LPSGKFSPDFQDFVN------LCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 77/268 (28%), Positives = 120/268 (44%), Gaps = 29/268 (10%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+ FD +G+G GSVYKA +G +VA+K + D E + + L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCD 56
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVI-KGVANALS 868
IVK++G ++V EY GS++ I+ T K L+ I I L
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLT-EEEIAAILYQTLKGLE 113
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
YLH IHRDI + N+LL+ E +A ++DFG++ + + R +GT + APE+
Sbjct: 114 YLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 929 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP--- 985
+ K D++S G+ E+ +G P + I+ I + P LS P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP--YSDIH---PMRAIFMIPNKPPPTLSDPEKW 225
Query: 986 SPGVMDKLISIMEVAILCLDESPEARPT 1013
SP D + CL + PE RP+
Sbjct: 226 SPEFND-FVK------KCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 34/267 (12%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
IGKG G VYK L VAVK S L + +FL L + H NIVK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
C + ++V E + GSL L L+ + + + A + YL
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAK----FVEPYSSNRTEFVGTFGYAAPEIAYTMRA 934
IHRD++++N L+ +SDFG+++ + S + + APE R
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRY 172
Query: 935 TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST----PSPGVM 990
T + DV+S+G+L++E FS+ + + M NQ R+ + P+P +
Sbjct: 173 TSESDVWSYGILLWET---------FSLGDTPYPGM---SNQQTRERIESGYRMPAPQLC 220
Query: 991 -DKLISIMEVAILCLDESPEARPTMEK 1016
+++ +M C PE RP+ +
Sbjct: 221 PEEIYRLML---QCWAYDPENRPSFSE 244
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 72/262 (27%), Positives = 126/262 (48%), Gaps = 33/262 (12%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
IG G G V+ VA+K +S +++F+ + ++ H +V+ +G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-----EEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
C+ LV E++ G L+ L A + S + + V ++YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFV--EPY-SSNRTEFVGTFGYAAPEIAYTMRAT 935
IHRD++++N L+ VSDFG+ +FV + Y SS T+F +++PE+ + +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYS 179
Query: 936 EKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVN---QILDPRLSTPSPGVMD 991
K DV+SFGVL++EV +G P + N S+ S ++ +N ++ PRL++
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYE----NRSN-SEVVETINAGFRLYKPRLASQ------ 228
Query: 992 KLISIMEVAILCLDESPEARPT 1013
S+ E+ C E PE RP+
Sbjct: 229 ---SVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 76/264 (28%), Positives = 122/264 (46%), Gaps = 33/264 (12%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G V+ VAVK L G M+ + FL + ++RH +V+ +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKT----LKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYA 68
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
S ++V EY+ +GSL L D + L +++ VA ++Y+ +
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNY 123
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAAPEIAYTM 932
IHRD+ S N+L+ ++DFG+A+ +E E+ G + APE A
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIED-----NEYTARQGAKFPIKWTAPEAALYG 178
Query: 933 RATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991
R T K DV+SFG+L+ E++ KG P + +N EV + ++ P P D
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP-------YPGMNNR--EVLEQVERGYRMPCPQ--D 227
Query: 992 KLISIMEVAILCLDESPEARPTME 1015
IS+ E+ + C + PE RPT E
Sbjct: 228 CPISLHELMLQCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 19/241 (7%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G VYKA + +G+IVA+KK + S + L + L E+ H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA--LREIKLLKELNHPNIIKLL 64
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+ +LV E++ L +++ + L + + + + L++ H
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA-TE 936
I+HRD+ +N+L++ E ++DFG+A+ T +V T Y APE+ + +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 937 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISI 996
D++S G + E++ R F + I ++ +I L TP P V K S+
Sbjct: 179 PVDIWSVGCIFAELLSR---RPLF-----PGKSEIDQLFKIFR-TLGTPDPEVWPKFTSL 229
Query: 997 M 997
Sbjct: 230 A 230
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 81/311 (26%), Positives = 121/311 (38%), Gaps = 81/311 (26%)
Query: 749 ATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE 807
T F+ IG+G G VYKA +G +VA+K + + D++E + N
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK------IMDIIEDEEE--EIKEEYNI 55
Query: 808 IR----HRNIVKFHGFCSNARHS------FLVCEYLHRGSLARILGNDATAKELSWNRRI 857
+R H NI F+G +LV E GS+ D +R+
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT-----DLVKGLRKKGKRL 110
Query: 858 N------VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911
+++ L+YLH + +IHRDI +N+LL E + DFG++ ++
Sbjct: 111 KEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167
Query: 912 SNRTEFVGTFGYAAPE-IA--------YTMRATEKYDVYSFGVLVFEVIKGN------HP 956
R F+GT + APE IA Y R+ DV+S G+ E+ G HP
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARS----DVWSLGITAIELADGKPPLCDMHP 223
Query: 957 -RDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM------DKLISIMEVAILCLDESPE 1009
R F I PR P P + K + CL ++ E
Sbjct: 224 MRALFKI-----------------PR--NPPPTLKSPENWSKKFNDFISE---CLIKNYE 261
Query: 1010 ARPTMEKGFGH 1020
RP ME+ H
Sbjct: 262 QRPFMEELLEH 272
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 72/273 (26%), Positives = 108/273 (39%), Gaps = 44/273 (16%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQ--DEFLNVVLALNEIRHRNIVK 815
IG G G VY A L +G+++AVK+ Q + DE L ++H N+VK
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKV----LELLKHPNLVK 63
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN----ALSYLH 871
++G + ++ EY G+L +L E +VI+ L+YLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP----YSSNRTEFVGTFGYAAPE 927
I+HRDI N+ LD + DFG A ++ GT Y APE
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 928 IAYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983
+ T + + D++S G +V E+ G P F ++ V P +
Sbjct: 174 V-ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ----IMFHVGAGHKPPIP 228
Query: 984 TP---SPGVMDKLISIMEVAILCLDESPEARPT 1013
SP D L CL+ P+ RPT
Sbjct: 229 DSLQLSPEGKDFL-------DRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 46/275 (16%)
Query: 759 IGKGGQGSVYKA--ELPSGD--IVAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRNI 813
IG G G V + +LP VA+K L +G+ Q +FL + + H NI
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIK----TLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDATAKELSWNRRINVIKGVANALSYLHH 872
++ G + +R ++ EY+ GSL + L ND + + + + +++G+A+ + YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSE 124
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAAP 926
+HRD++++N+L++ VSDFG+++ +E + T T G + AP
Sbjct: 125 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT----TKGGKIPIRWTAP 177
Query: 927 E-IAYTMRA-TEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSN--MIIEVNQILDPR 981
E IAY R T DV+SFG++++EV+ G P + SN +I V R
Sbjct: 178 EAIAY--RKFTSASDVWSFGIVMWEVMSYGERP-------YWDMSNQDVIKAVED--GYR 226
Query: 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
L P MD ++ ++ + C + RPT +
Sbjct: 227 LPPP----MDCPSALYQLMLDCWQKDRNERPTFSQ 257
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 40/274 (14%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR------HR 811
+GKG GSVYK + L A+K+ + +S Q E + A+NEIR H
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-----QKERED---AVNEIRILASVNHP 59
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAK-----ELSWNRRINVIKGVANA 866
NI+ + + +V EY G L++ + + + W I +++G
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG---- 115
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAP 926
L LH I+HRD+ S N+LL + D GI+K V + +T+ +GT Y AP
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISK-VLKKNMAKTQ-IGTPHYMAP 170
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
E+ + K D++S G L++E+ P S ++ +V + P +
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP-----FEARSMQDLRYKVQRGKYPPIPPIY 225
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ I M L P+ RP +K
Sbjct: 226 SQDLQNFIRSM------LQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 43/283 (15%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALN-EIR------ 809
IGKG G VY A + +G+++AVK+ ++G ++V AL EI
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGR--HDSRQKDMVKALRSEIETLKDLD 66
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN---- 865
H NIV++ GF + + + EY+ GS+ L +E +++
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTEQVLE 119
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGY 923
L+YLH I+HRD+ + N+L+D + +SDFGI+K + N G+ +
Sbjct: 120 GLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 924 AAPEIAYTMRA--TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM--IIEVNQILD 979
APE+ ++ + K D++S G +V E+ G P +S+ I + ++ +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP----------WSDEEAIAAMFKLGN 226
Query: 980 PRLSTPSPGVMDKLISIMEVAIL--CLDESPEARPTMEKGFGH 1020
R + P P + +S + + L C +P+ RPT + H
Sbjct: 227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 77/278 (27%), Positives = 119/278 (42%), Gaps = 49/278 (17%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+ F CIGKG G VYKA + + +VA+K + L + ++ + L++ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQCR 57
Query: 810 HRNIVKFHGFCSNARHSFL-------VCEYLHRGSLA-----RILGNDATAKELSWNRRI 857
I K++G SFL + EY GS L A
Sbjct: 58 SPYITKYYG-------SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------- 102
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF 917
+++ V L YLH + IHRDI + N+LL E + ++DFG++ + S R F
Sbjct: 103 -ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158
Query: 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQI 977
VGT + APE+ EK D++S G+ E+ KG P S M +
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL-------SDLHPMRV---LF 208
Query: 978 LDPRLSTPSPGVMDKLIS--IMEVAILCLDESPEARPT 1013
L P+ + PS + S + LCL++ P+ RP+
Sbjct: 209 LIPKNNPPS--LEGNKFSKPFKDFVSLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 85/302 (28%), Positives = 126/302 (41%), Gaps = 57/302 (18%)
Query: 743 HEE-------IIKATD---DFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGN 791
HE+ ++ D D IG+G G V A + +G VAVKK +
Sbjct: 1 HEQFRAALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD------- 53
Query: 792 MADQD--EFL-NVVLALNEIRHRNIVKFHGFCSNARHSFLV-------CEYLHRGSLARI 841
+ Q E L N V+ + + +H NIV+ + S+LV E+L G+L I
Sbjct: 54 LRKQQRRELLFNEVVIMRDYQHPNIVEMYS-------SYLVGDELWVVMEFLEGGALTDI 106
Query: 842 LGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDF 901
+ T ++ + V V ALS+LH +IHRDI S ++LL + +SDF
Sbjct: 107 V----THTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDF 159
Query: 902 GIAKFVEPYSSNRTEFVGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 960
G V R VGT + APE I+ TE D++S G++V E++ G P +F
Sbjct: 160 GFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPP--YF 216
Query: 961 SINFSSFSNMIIEVNQILD--PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGF 1018
N M +I D P V +L S ++ L P R T +
Sbjct: 217 --NEPPLQAM----KRIRDNLPPKLKNLHKVSPRLRSFLD---RMLVRDPAQRATAAELL 267
Query: 1019 GH 1020
H
Sbjct: 268 NH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 70/265 (26%), Positives = 127/265 (47%), Gaps = 33/265 (12%)
Query: 759 IGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRNI 813
IG G G V++ L VA+K L G Q +FL+ + + H NI
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKT----LKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDATAKELSWNRRINVIKGVANALSYLHH 872
++ G + + + ++ EY+ G+L + L +D E S + + +++G+A + YL
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSD 125
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVG---TFGYAAPE-I 928
+ +HRD++++N+L++ E VSDFG+++ +E G + APE I
Sbjct: 126 ---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 929 AYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987
AY + T DV+SFG++++EV+ G P + SN EV + ++ P+P
Sbjct: 183 AYR-KFTSASDVWSFGIVMWEVMSFGERP-------YWDMSNH--EVMKAINDGFRLPAP 232
Query: 988 GVMDKLISIMEVAILCLDESPEARP 1012
MD ++ ++ + C + RP
Sbjct: 233 --MDCPSAVYQLMLQCWQQDRARRP 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 73/267 (27%), Positives = 129/267 (48%), Gaps = 29/267 (10%)
Query: 759 IGKGGQGSVYKAEL--PSGDIVAVKKFN--SQLLSGNMADQDE-FLNVVLALN----EIR 809
+G G G VYK +++A+K+ N + + ++D+ ++V + ++R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 810 HRNIVKFH-GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI-NVIKGVANAL 867
H NIV+++ F N R ++V + + L + K+ RI N+ + AL
Sbjct: 68 HPNIVRYYKTFLENDR-LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
YLH + I+HRD++ N++L + + ++DFG+AK +P S T VGT Y+ PE
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTSVVGTILYSCPE 183
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987
I EK DV++FG +++++ P F+S N S + I V + +P
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKI--VEAVYEP------- 232
Query: 988 GVMDKLIS--IMEVAILCLDESPEARP 1012
+ + + S + +V CL EARP
Sbjct: 233 -LPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G V A E SG VAVK + + ++ N V+ + + +H+N+V+ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLR----KQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+++ E+L G+L I+ + L+ + V + V AL YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQ---G 137
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE-IAYTMRATE 936
+IHRDI S ++LL L+ +SDFG + R VGT + APE I+ T TE
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 937 KYDVYSFGVLVFEVIKGNHPRDFFS 961
D++S G++V E++ G P +FS
Sbjct: 198 -VDIWSLGIMVIEMVDGEPP--YFS 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 41/214 (19%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDE-----FLNVVLALNEIRHRN 812
+G+G G V K +G+IVA+KKF ++ DE L V L ++RH N
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKE-------SEDDEDVKKTALREVKVLRQLRHEN 61
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARI------LGNDATAKELSWNRRINVIKGVANA 866
IV +LV EY+ R L + L DA + W + A
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAV-RSYIWQ--------LLQA 112
Query: 867 LSYLH-HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV-EPYSSNRTEFVGTFGYA 924
++Y H H+ IIHRDI +N+L+ + DFG A+ + +S T++V T Y
Sbjct: 113 IAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168
Query: 925 APEIAYTMRATEKY----DVYSFGVLVFEVIKGN 954
APE+ + Y DV++ G ++ E++ G
Sbjct: 169 APEL---LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 72/279 (25%), Positives = 107/279 (38%), Gaps = 50/279 (17%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G+G GSV K L + ++ K + N Q + L + + IVK++G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALK--TITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 819 -FCSNARHSFLVC-EYLHRGSLARILGNDATAKELSWNRRIN------VIKGVANALSYL 870
F + S + EY GSL I K RI + + V LSYL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYK-----KVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE--- 927
H IIHRDI N+LL + + + DFG++ E +S F GT Y APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYMAPERIQ 176
Query: 928 -IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
Y++ + DV+S G+ + EV + P F P P
Sbjct: 177 GKPYSITS----DVWSLGLTLLEVAQNRFP--F--------------------PPEGEPP 210
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025
G ++ L I+ + L + P + F I C
Sbjct: 211 LGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQC 249
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 759 IGKGGQGSVYKAELPS-GDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEIRHRN---- 812
I KG G V+ A+ S GDI A+K + ++ N DQ VL +I +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQ------VLTERDILSQAQSPY 54
Query: 813 IVKFHGFCS--NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
+VK + S ++ +LV EYL G LA +L N + E R I + AL YL
Sbjct: 55 VVKL--YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE-DVAR--IYIAEIVLALEYL 109
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF--------VEPYSSNRTEFVGTFG 922
H + IIHRD+ N+L+D ++DFG++K + VGT
Sbjct: 110 HSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 953
Y APE+ ++ D +S G +++E + G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 745 EIIKATDDFDEKFCIGKGGQGSVYKAEL--PSGD----IVAVKKFNSQLLSGNMADQDEF 798
EI + F E+ +G+G G VYK EL P+ VA+K + Q EF
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKE---NAEPKVQQEF 55
Query: 799 LNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-------------GND 845
+++++H NIV G C+ + + ++ EYL G L L G++
Sbjct: 56 RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 846 ATAKELSWNRRINVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903
L + +++ +A + YL HH +HRD++++N L+ +SDFG+
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGL 170
Query: 904 AKFVEPYSSNRTEFVGT----FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 958
++ + YS++ + PE + T + D++SFGV+++E+ G P
Sbjct: 171 SRDI--YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP-- 226
Query: 959 FFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+ FSN EV +++ R P P D + + I C +E P RP
Sbjct: 227 -----YYGFSNQ--EVIEMIRSRQLLPCP--EDCPARVYALMIECWNEIPARRPR 272
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 759 IGKGGQGSVYKAEL----PSGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G G V+ E P D +VAVK + N A +D F L +H N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKE--TASNDARKD-FEREAELLTNFQHEN 69
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL-----------GNDATAKELSWNRRINVIK 861
IVKF+G C+ +V EY+ G L + L D+ EL+ ++ + +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 862 GVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGT- 920
+A+ + YL +HRD++++N L+ + + DFG+++ V Y+++ G
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV--YTTDYYRVGGHT 184
Query: 921 ---FGYAAPEIAYTMRATEKYDVYSFGVLVFEV 950
+ PE + T + DV+SFGV+++E+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G V A E +G VAVKK + + ++ N V+ + + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
++V E+L G+L I+ T ++ + V V ALSYLH+
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ---G 138
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
+IHRDI S ++LL + +SDFG V R VGT + APE+ + +
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 938 YDVYSFGVLVFEVIKGNHP 956
D++S G++V E+I G P
Sbjct: 199 VDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 70/262 (26%), Positives = 124/262 (47%), Gaps = 29/262 (11%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G+G G V+ VA+K L G M+ + FL + ++RH +V+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKT----LKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 68
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
S ++V EY+ +GSL L + K L + +++ +A+ ++Y+ +
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNY 123
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVE--PYSSNR-TEFVGTFGYAAPEIAYTMRAT 935
+HRD+ + N+L+ V+DFG+A+ +E Y++ + +F + APE A R T
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFT 181
Query: 936 EKYDVYSFGVLVFEV-IKGNHPRDFFSINFSSFSNMI-IEVNQILDPRLSTPSPGVMDKL 993
K DV+SFG+L+ E+ KG P + M+ EV ++ P P +
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP----------YPGMVNREVLDQVERGYRMPCPPECPE- 230
Query: 994 ISIMEVAILCLDESPEARPTME 1015
S+ ++ C + PE RPT E
Sbjct: 231 -SLHDLMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 759 IGKGGQGSVYKAEL--PSGDI--VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
+G G G V + E G + VAVK S LS M D+FL ++ + H N++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM---DDFLKEAAIMHSLDHENLI 59
Query: 815 KFHGFCSNARHSF-LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
+ +G H +V E GSL L DA + + +AN + YL
Sbjct: 60 RLYGVVLT--HPLMMVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRYLE-- 114
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV----EPYSSNRTEFVGTFGYAAPEIA 929
IHRD++++N+LL + + + DFG+ + + + Y V F + APE
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESL 172
Query: 930 YTMRATEKYDVYSFGVLVFEV 950
T + DV+ FGV ++E+
Sbjct: 173 RTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 72/264 (27%), Positives = 116/264 (43%), Gaps = 24/264 (9%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG G VYK + + ++VA+K + + + D + + V L++ I +++
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITV---LSQCDSPYITRYY 68
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
G +++ EYL GS +L L +++ + L YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE---R 121
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
IHRDI + NVLL + + ++DFG+A + R FVGT + APE+ K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 938 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS-PGVMDKLISI 996
D++S G+ E+ KG P S M + L P+ S P+ G K
Sbjct: 182 ADIWSLGITAIELAKGEPP-------NSDLHPMRV---LFLIPKNSPPTLEGQYSK--PF 229
Query: 997 MEVAILCLDESPEARPTMEKGFGH 1020
E CL++ P RPT ++ H
Sbjct: 230 KEFVEACLNKDPRFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 65/236 (27%), Positives = 98/236 (41%), Gaps = 30/236 (12%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+GKG G V + +G + A+K + + + + L L+ I H IVK H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-KRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 818 GFCS--NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH-HDC 874
+ +LV EY G L L + E R + AL YLH
Sbjct: 60 --YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE-ERARFY--AAEIVLALEYLHSLG- 113
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI----AY 930
II+RD+ +N+LLD + ++DFG+AK + S F GT Y APE+ Y
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
D +S GVL++E++ G P F++ + +IL L P
Sbjct: 171 GKAV----DWWSLGVLLYEMLTGKPP--FYA------EDRKEIYEKILKDPLRFPE 214
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 69/264 (26%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G V+ VA+K L G+M + FL + +++H +V+ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIK----SLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
+ +++ EY+ GSL L K L+ N+ I++ +A ++++ +
Sbjct: 69 VVTQ-EPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAAPEIAYTM 932
IHRD+ + N+L+ ++DFG+A+ +E E+ G + APE
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIED-----NEYTAREGAKFPIKWTAPEAINYG 178
Query: 933 RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP-GVMD 991
T K DV+SFG+L+ E++ + I + +N EV Q L+ P P +
Sbjct: 179 TFTIKSDVWSFGILLTEIVT------YGRIPYPGMTNP--EVIQNLERGYRMPRPDNCPE 230
Query: 992 KLISIMEVAILCLDESPEARPTME 1015
+L +M LC E PE RPT E
Sbjct: 231 ELYELM---RLCWKEKPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 71/263 (26%), Positives = 126/263 (47%), Gaps = 31/263 (11%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G+G G V+ VA+K L G M + FL + ++RH +V +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKT----LKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYA 68
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
S ++V E++ +GSL L + K L + +++ +A+ ++Y+ +
Sbjct: 69 VVSE-EPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNY 123
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVE--PYSSNR-TEFVGTFGYAAPEIAYTMRAT 935
IHRD+ + N+L+ ++DFG+A+ +E Y++ + +F + APE A R T
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFT 181
Query: 936 EKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMI-IEVNQILDPRLSTPSP-GVMDK 992
K DV+SFG+L+ E++ KG P + M+ EV + ++ P P G +
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP----------YPGMVNREVLEQVERGYRMPCPQGCPES 231
Query: 993 LISIMEVAILCLDESPEARPTME 1015
L +M+ LC + P+ RPT E
Sbjct: 232 LHELMK---LCWKKDPDERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 759 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G V A + SG +VAVKK + + ++ N V+ + + +H N+V+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
++V E+L G+L I+ T ++ + V V ALS LH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLHAQ---G 136
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
+IHRDI S ++LL + +SDFG V R VGT + APE+ + +
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 938 YDVYSFGVLVFEVIKGNHP 956
D++S G++V E++ G P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 2e-16
Identities = 79/266 (29%), Positives = 124/266 (46%), Gaps = 25/266 (9%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG G G+VY A ++ + ++VA+KK + N QD + V L I+H N +++
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIKHPNSIEYK 91
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
G ++LV EY GS + +L + K L + G L+YLH +
Sbjct: 92 GCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSH---N 145
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATE- 936
+IHRDI + N+LL + ++DFG A P +S FVGT + APE+ M +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQY 201
Query: 937 --KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994
K DV+S G+ E+ + P F++N S + + Q P L S D
Sbjct: 202 DGKVDVWSLGITCIELAERKPP--LFNMNAMS---ALYHIAQNESPTLQ--SNEWSDYFR 254
Query: 995 SIMEVAILCLDESPEARPTMEKGFGH 1020
+ ++ CL + P+ RPT E+ H
Sbjct: 255 NFVDS---CLQKIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 80/271 (29%), Positives = 122/271 (45%), Gaps = 29/271 (10%)
Query: 751 DDFDEKFC----IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLAL 805
DD +E F IG G G+VY A + ++VAVKK + N QD + V L
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFL 75
Query: 806 NEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
+++H N +++ G ++LV EY GS + +L + K L + G
Sbjct: 76 QQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQ 132
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
L+YLH + IHRDI + N+LL + ++DFG A P +S FVGT + A
Sbjct: 133 GLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMA 185
Query: 926 PEIAYTMRATE---KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
PE+ M + K DV+S G+ E+ + P F++N S + + Q P L
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMS---ALYHIAQNDSPTL 240
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPT 1013
S D ++ CL + P+ RP
Sbjct: 241 Q--SNEWTDSFRGFVD---YCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 22/263 (8%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG G V+K + + +VA+K + + + D + + V L++ + K++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITV---LSQCDSPYVTKYY 68
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
G +++ EYL GS +L A + ++K + L YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHSE---K 121
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
IHRDI + NVLL + + ++DFG+A + R FVGT + APE+ K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 938 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIM 997
D++S G+ E+ KG P S+M L P+ + P+ +
Sbjct: 182 ADIWSLGITAIELAKGEPPN----------SDMHPMRVLFLIPKNNPPTL-TGEFSKPFK 230
Query: 998 EVAILCLDESPEARPTMEKGFGH 1020
E CL++ P RPT ++ H
Sbjct: 231 EFIDACLNKDPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 22/220 (10%)
Query: 759 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG G V + + + A+K N Q + ++ LN L E+ H +V
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRN-VLNERRILQELNHPFLVNLW 66
Query: 818 -GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIK----GVANALSYLHH 872
F + +LV + L G L L E +K + AL YLH
Sbjct: 67 YSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSE-------EQVKFWICEIVLALEYLHS 118
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM 932
IIHRDI N+LLD + H++DF IA V + T GT GY APE+
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTSGTPGYMAPEVLCRQ 174
Query: 933 RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 972
+ D +S GV +E ++G P + + + + I
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP---YRGHSRTIRDQIR 211
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 75/269 (27%), Positives = 133/269 (49%), Gaps = 39/269 (14%)
Query: 759 IGKGGQGSVYKAEL-PSG---DIVAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRNI 813
IG G G V + L G VA+K L SG Q +FL+ + + H NI
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKT----LKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILG-NDATAKELSWNRRINVIKGVANALSYLHH 872
+ G + +R ++ E++ G+L L ND + + + + +++G+A + YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSE 124
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAAP 926
+ +HRD++++N+L++ VSDFG+++F+E +S+ T + + G + AP
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT-YTSSLGGKIPIRWTAP 180
Query: 927 E-IAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQI-LDPRLS 983
E IAY + T DV+S+G++++EV+ G P + SN + +N I D RL
Sbjct: 181 EAIAYR-KFTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDV-INAIEQDYRLP 231
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARP 1012
P MD ++ ++ + C + ARP
Sbjct: 232 PP----MDCPTALHQLMLDCWQKDRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 22/259 (8%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G V+ + VAVK L G M+ Q FL + ++H +V+ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKT----LKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYA 68
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
+ +++ EY+ +GSL L +D K + + I+ +A ++Y+ +
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGK-VLLPKLIDFSAQIAEGMAYIERK---NY 124
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVG-TFGYAAPEIAYTMRATEK 937
IHRD+ + NVL+ ++DFG+A+ +E E + APE T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 938 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP-GVMDKLISI 996
DV+SFG+L++E++ + I + SN +V L P D+L I
Sbjct: 185 SDVWSFGILLYEIVT------YGKIPYPGMSNS--DVMSALQRGYRMPRMENCPDELYDI 236
Query: 997 MEVAILCLDESPEARPTME 1015
M+ C E E RPT +
Sbjct: 237 MK---TCWKEKAEERPTFD 252
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 46/272 (16%)
Query: 759 IGKGGQGSVYKAE-LPSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+G G G+VYK +P G+ VA+K + E L+ + + H ++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE---ETSPKANKEILDEAYVMASVDHPHV 71
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKE----LSWNRRINVIKGVANALSY 869
V+ G C +++ L+ + + G L + N L+W +I A +SY
Sbjct: 72 VRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSY 124
Query: 870 L--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG----- 922
L ++HRD++++NVL+ ++DFG+AK ++ + E+ G
Sbjct: 125 LEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV---DEKEYHAEGGKVPIK 176
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981
+ A E T K DV+S+GV V+E++ G P + I +++ + ++ P
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE--GIPAVEIPDLLEKGERLPQPP 234
Query: 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+ T I + V + C E+RPT
Sbjct: 235 ICT---------IDVYMVLVKCWMIDAESRPT 257
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 38/274 (13%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQD---EFLNVVLALNEIRHRNIV 814
+G G GSVY+ L GD AVK+ + L Q+ + + L++++H NIV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVS--LADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 815 KFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKE---LSWNRRINVIKGVANALSYLH 871
++ G + ++ E + GSLA++L + E + R+I + G L YLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI--LLG----LEYLH 119
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
+ +HRDI N+L+D ++DFG+AK V +S ++ F G+ + APE+
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEV--- 172
Query: 932 MRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987
+ Y D++S G V E+ G P +S V + S P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPP-------WSQLE----GVAAVFKIGRSKELP 221
Query: 988 GVMDKL-ISIMEVAILCLDESPEARPTMEKGFGH 1020
+ D L + + CL P RPT + H
Sbjct: 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 37/253 (14%)
Query: 759 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G GG G V ++ A+K + + Q+ + L E H IVK +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 818 GFCSNARHSFLVCEYLHRGSLARILG-----NDATAKELSWNRRINVIKGVANALSYLHH 872
+ ++ +++ EY G L IL ++ TA+ I V A YLH+
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY--------IACVVLAFEYLHN 111
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT-EFVGTFGYAAPEI--- 928
II+RD+ +N+LLD + DFG AK + S +T F GT Y APEI
Sbjct: 112 R---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEIILN 166
Query: 929 -AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN----FSSFSNMIIEVNQILDPRLS 983
Y D +S G+L++E++ G P F + +++++ ++ P
Sbjct: 167 KGYDFSV----DYWSLGILLYELLTGRPP---FGEDDEDPMEIYNDILKGNGKLEFPNYI 219
Query: 984 TPSPG-VMDKLIS 995
+ ++ +L+
Sbjct: 220 DKAAKDLIKQLLR 232
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-16
Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 25/281 (8%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG G G+VY A ++ + ++VA+KK + N QD + V L ++RH N +++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHPNTIQYR 81
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
G ++LV EY GS + +L + K L V G L+YLH +
Sbjct: 82 GCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATE- 936
+IHRD+ + N+LL + DFG A + P + FVGT + APE+ M +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQY 191
Query: 937 --KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994
K DV+S G+ E+ + P F++N S + + Q P L S +
Sbjct: 192 DGKVDVWSLGITCIELAERKPP--LFNMNAMS---ALYHIAQNESPALQ--SGHWSEYFR 244
Query: 995 SIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILAI 1035
+ ++ CL + P+ RPT E H + VI+ +
Sbjct: 245 NFVDS---CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 55/195 (28%), Positives = 102/195 (52%), Gaps = 18/195 (9%)
Query: 762 GGQ-GSVYKAELPS-GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGF 819
GGQ G VY+ VAVK L M +EFL + EI+H N+V+ G
Sbjct: 16 GGQYGEVYEGVWKKYSLTVAVKT----LKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 820 CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSII 879
C+ +++ E++ G+L L + +E++ + + +++A+ YL + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 880 HRDISSKNVLLDLEFEAHVSDFGIAKFV--EPYSSNR-TEFVGTFGYAAPE-IAYTMRAT 935
HRD++++N L+ V+DFG+++ + + Y+++ +F + APE +AY +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSI 184
Query: 936 EKYDVYSFGVLVFEV 950
K DV++FGVL++E+
Sbjct: 185 -KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 69/267 (25%), Positives = 120/267 (44%), Gaps = 31/267 (11%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA----LNEIRHRNI 813
+G G S Y+A ++ +G ++AVK+ ++Q+E + + + + H +I
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYV--RNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
++ G H L E++ GS++ +L KE IN + + LSYLH +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN 122
Query: 874 CLPSIIHRDISSKNVLLDLEFE-AHVSDFGIAKFVEPYSSNRTEF----VGTFGYAAPEI 928
IIHRD+ N+L+D + ++DFG A + + EF +GT + APE+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 929 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP--- 985
+ DV+S G ++ E+ P + + S+ +I ++ S P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWN--AEKHSNHLALIFKIASATTAP-SIPEHL 236
Query: 986 SPGVMDKLISIMEVAILCLDESPEARP 1012
SPG+ D V + CL+ PE RP
Sbjct: 237 SPGLRD-------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 15/193 (7%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
IGKG G V + G+ VAVK N A FL + ++RH N+V+ G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK------NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 819 FCSNARHS-FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+ ++V EY+ +GSL L + + L + + V A+ YL + +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN---N 122
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
+HRD++++NVL+ + A VSDFG+ K E S+ T + + APE + + K
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL-PVKWTAPEALREKKFSTK 179
Query: 938 YDVYSFGVLVFEV 950
DV+SFG+L++E+
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 75/270 (27%), Positives = 124/270 (45%), Gaps = 38/270 (14%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G G GSV K + +P+G ++A K + + + + L + ++E R IV F+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKK---VVHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA----LSYL--- 870
G N + + E++ GSL RI K+ + ++ +A A L+YL
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIY------KKGG-PIPVEILGKIAVAVVEGLTYLYNV 122
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY 930
H I+HRDI N+L++ + + DFG++ E +S FVGT Y +PE
Sbjct: 123 HR-----IMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADTFVGTSTYMSPERIQ 175
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI--NFSSFSNMIIE-VNQILD---PRL-S 983
+ T K DV+S G+ + E+ G P F +I + I++ + QI+ PRL S
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+ P + + CL + P RPT
Sbjct: 236 SDFPEDLRDFVDA------CLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-15
Identities = 38/92 (41%), Positives = 54/92 (58%)
Query: 347 LSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPI 406
L L N GL G IP +I L+ L + L N++ G IP S+G++T L +L++ N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 407 PKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHP 438
P+SL LTSL+ + N N+L G+V A G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-15
Identities = 46/134 (34%), Positives = 65/134 (48%), Gaps = 11/134 (8%)
Query: 64 PCS-----WFGISC---NHAGSRVIS-INLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLF 114
PC W G C + G I + L L G + S HL ++NLS N
Sbjct: 396 PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSI 454
Query: 115 FGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLS 174
GNIPP +G+++ L+ LDL N +G I +G+L LR L L+ N L G +P +G
Sbjct: 455 RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR- 513
Query: 175 LIHEFSFCHNNVSG 188
L+H SF + +G
Sbjct: 514 LLHRASFNFTDNAG 527
|
Length = 623 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 24/264 (9%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG G V+K + + +VA+K + + + D + + V L++ + K++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV---LSQCDSPYVTKYY 68
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
G +++ EYL GS +L L + +++ + L YLH +
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---K 121
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
IHRDI + NVLL E ++DFG+A + R FVGT + APE+ K
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 938 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS-PGVMDKLISI 996
D++S G+ E+ KG P S M + L P+ + P+ G K +
Sbjct: 182 ADIWSLGITAIELAKGEPPH-------SELHPMKV---LFLIPKNNPPTLEGNYSK--PL 229
Query: 997 MEVAILCLDESPEARPTMEKGFGH 1020
E CL++ P RPT ++ H
Sbjct: 230 KEFVEACLNKEPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 38/227 (16%)
Query: 756 KFCIGKGGQGSVYKAE----LPSGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
K+ +G+G G V+ AE LP D +VAVK L + + + +F L ++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQDFQREAELLTVLQ 65
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL------------GNDATAKELSWNRRI 857
H++IV+F+G C+ R +V EY+ G L R L G D +L+ + +
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 858 NVIKGVANALSY---LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914
+ +A+ + Y LH +HRD++++N L+ + DFG+++ + YS++
Sbjct: 126 AIASQIASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDY 177
Query: 915 TEFVG----TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHP 956
G + PE + T + D++SFGV+++E+ G P
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 80/279 (28%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 759 IGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+GKG GSV +G++VAVKK L +F + L ++H NI
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKK----LQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 814 VKFHGFCSNA--RHSFLVCEYLHRGSLARILGNDA----TAKELSWNRRINVIKGVANAL 867
VK+ G C +A R+ LV EYL GSL L K L + +I KG +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--CKG----M 121
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV----EPYSSNRTEFVGTFGY 923
YL +HRD++++N+L++ E + DFG+ K + E Y F Y
Sbjct: 122 EYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 924 AAPEIAYTMRATEKYDVYSFGVLVFEV-----IKGNHPRDFFS-INFSSFSNMII-EVNQ 976
APE + + DV+SFGV+++E+ + P +F + MI+ + +
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 977 ILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+L RL P PG ++ +IM+ C + P RP+
Sbjct: 238 LLKNNGRLPAP-PGCPAEIYAIMK---ECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI------RHR 811
IG+G G VYKA +G++VA+KK + +++ F + A+ EI RH
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME------NEKEGF--PITAIREIKLLQKLRHP 58
Query: 812 NIVKFHGFC-SNARHS-FLVCEYL-HRGSLARILGNDATAKELSWNRRINVIKGVA---- 864
NIV+ S + S ++V EY+ H L +L D+ + + + IK
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH--DLTGLL--DSPEVKFT----ESQIKCYMKQLL 110
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR-TEFVGTFGY 923
L YLH + I+HRDI N+L++ + ++DFG+A+ +S T V T Y
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 924 AAPEIAY-TMRATEKYDVYSFGVLVFEVIKG 953
PE+ R + D++S G ++ E+ G
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 755 EKFC-IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR--- 809
EK IG+G G V+K +G IVA+KKF + +D+ + +AL EIR
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKF--------VESEDDPVIKKIALREIRMLK 55
Query: 810 ---HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
H N+V R LV EY L + + + + + +I A
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQA 112
Query: 867 LSYLH-HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
+++ H H+C IHRD+ +N+L+ + + + DFG A+ + + T++V T Y A
Sbjct: 113 VNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRA 168
Query: 926 PEIAYTMRATEKY----DVYSFGVLVFEVIKG 953
PE+ + +Y DV++ G + E++ G
Sbjct: 169 PEL---LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA----LNEIRHRNI 813
I KG GSVY A+ +GD A+K L +M +++ NV + + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIK----VLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 814 VKFHGFCSNARHSFLVCEYLHRG---SLARILGNDATAKELSWNRRINVIKGVANALSYL 870
K + + + +LV EYL+ G SL + LG W + I V + L
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG----GLPEDWAK--QYIAEVVLGVEDL 113
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY 930
H IIHRDI +N+L+D ++DFG+++ +FVGT Y APE
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL----ENKKFVGTPDYLAPETIL 166
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHP 956
+ + D +S G ++FE + G P
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 46/277 (16%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNS----QLLSGNMADQDEFLNVVLALNEI 808
+G+G G V+ A+ + +V VK L S EF + ++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS-------EFRRELDMFRKL 65
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL----GNDATAKE--LSWNRRINVIKG 862
H+N+V+ G C A +++ EY G L + L D K LS +++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
+A + +L + +HRD++++N L+ + E VS ++K + Y+S +
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALI 180
Query: 923 ---YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE--VNQI 977
+ APE + K DV+SFGVL++EV F+ F + E +N++
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV---------FTQGELPFYGLSDEEVLNRL 231
Query: 978 LDPRLSTPSP-GVMDKLISIMEVAILCLDESPEARPT 1013
+L P P G +L +M C +P+ RP+
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTR---CWAVNPKDRPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 44/277 (15%)
Query: 759 IGKGGQGSVYKAEL----PSGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G G V+ AE P+ D +VAVK L +A + +F L ++H +
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKA----LKDPTLAARKDFQREAELLTNLQHEH 68
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL---GNDA----------TAKELSWNRRINV 859
IVKF+G C + +V EY+ G L + L G DA EL ++ +++
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVG 919
+A+ + YL +HRD++++N L+ + DFG+++ V YS++ G
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYRVGG 183
Query: 920 ----TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEV 974
+ PE + T + DV+SFGV+++E+ G P +F ++ + I +
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLSNTEVIECITQG 241
Query: 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEAR 1011
+ PR+ + ++ + C P+ R
Sbjct: 242 RVLERPRVCPK---------EVYDIMLGCWQREPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 74/281 (26%), Positives = 120/281 (42%), Gaps = 65/281 (23%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMAD--QDEFLNVVLALNEIRHRNIVK 815
IG G G+VYK P+G + A+K ++ GN D + + + L ++ H N+VK
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALK-----VIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 816 FHGFCSNARHSFLVCEYLHRGSL--ARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
H + ++ E++ GSL I A + L+ +V + + + ++YLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHI----ADEQFLA-----DVARQILSGIAYLHRR 187
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGI----AKFVEPYSSNRTEFVGTFGYAAPEIA 929
I+HRDI N+L++ ++DFG+ A+ ++P +S+ VGT Y +PE
Sbjct: 188 ---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----VGTIAYMSPERI 240
Query: 930 YTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
T Y D++S GV + E G P F +
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP---FGV---------------------- 275
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025
G S+M AI C+ + PEA T + F H I C
Sbjct: 276 ---GRQGDWASLM-CAI-CMSQPPEAPATASREFRHFISCC 311
|
Length = 353 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G V+KA + +G+ VA+KK + L G + +Q L + AL +H +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ--ALREIKALQACQHPYVVKLL 65
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGN------DATAKELSWNRRINVIKGVANALSYLH 871
+ LV EY+ L+ +L + +A K ++KGVA Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYM----RMLLKGVA----YMH 116
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAY 930
+ I+HRD+ N+L+ + ++DFG+A+ F E + V T Y APE+ Y
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 931 TMRA-TEKYDVYSFGVLVFEVIKG 953
R D+++ G + E++ G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 77/268 (28%), Positives = 123/268 (45%), Gaps = 35/268 (13%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
IGKG G VY L D AVK N ++ + ++FL + + + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR---ITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 815 KFHGFCSNARHSFLVC-EYLHRGSLARILGNDA---TAKELSWNRRINVIKGVANALSYL 870
G C + S LV Y+ G L + ++ T K+L I VA + YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYS-SNRTEFVGTFGYAAP 926
+HRD++++N +LD F V+DFG+A+ + E YS N T + A
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985
E T + T K DV+SFGVL++E++ +G P + ++ + +++ ++L P P
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVDSFDITVYLLQGRRLLQPEY-CP 228
Query: 986 SPGVMDKLISIMEVAILCLDESPEARPT 1013
P + EV + C PE RPT
Sbjct: 229 DP--------LYEVMLSCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 29/260 (11%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
IG+G G+V + E +G VAVK + + FL + ++ H+N+V+ G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA------QAFLEETAVMTKLHHKNLVRLLG 66
Query: 819 -FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
N + +V E + +G+L L A +S + + VA + YL L
Sbjct: 67 VILHNGLY--IVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESKKL-- 121
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
+HRD++++N+L+ + A VSDFG+A+ V + ++ + APE + + K
Sbjct: 122 -VHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKL--PVKWTAPEALKHKKFSSK 177
Query: 938 YDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISI 996
DV+S+GVL++EV G P S+ +E ++P P+ + +
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC---VEKGYRMEPPEGCPAD-----VYVL 229
Query: 997 MEVAILCLDESPEARPTMEK 1016
M C + P+ RP+ K
Sbjct: 230 MTS---CWETEPKKRPSFHK 246
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 66/241 (27%), Positives = 101/241 (41%), Gaps = 17/241 (7%)
Query: 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALNEIRHRNIV 814
+GKG G V AEL + ++ AVK ++ D E VLAL +H +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAG-KHPFLT 59
Query: 815 KFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC 874
+ H F V EY++ G L + E R + L +LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE---PRARFYAAEIVLGLQFLHER- 115
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA 934
II+RD+ NVLLD E ++DFG+ K + F GT Y APEI
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 935 TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR-LSTPSPGVMDKL 993
D ++ GVL++E++ G P F + I+E +++ PR LS + ++
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSP--FEGDDEDELFQSILE-DEVRYPRWLSKEAKSILKSF 230
Query: 994 I 994
+
Sbjct: 231 L 231
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 37/89 (41%), Positives = 56/89 (62%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262
L L+N L G+IP + L+ L +++LS N + G IP +L ++++L+ L L NS +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 263 PSIIGNLKSLHQLDLIENQLSGSIPLSFG 291
P +G L SL L+L N LSG +P + G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRN 812
IG+G G VY+A + SG+IVA+KK M ++ + + + + L +RH N
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR-------MDNERDGIPISSLREITLLLNLRHPN 67
Query: 813 IVKFHGFC--SNARHSFLVCEYLHRGSLARILGN------DATAKELSWNRRINVIKGVA 864
IV+ + FLV EY + LA +L N ++ K L + +++G
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM----LQLLRG-- 120
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA 924
L YLH + IIHRD+ N+LL + ++DFG+A+ + T V T Y
Sbjct: 121 --LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175
Query: 925 APEIAYTMRA-TEKYDVYSFGVLVFEVIKGN 954
APE+ T D+++ G ++ E++
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 64/264 (24%), Positives = 111/264 (42%), Gaps = 33/264 (12%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
IG+G G V+ L + + K + L ++ + +FL L + H NIV+ G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
C+ + ++V E + G L + L I +++ A + YL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVEP--YSSNRTEFVGTFGYAAPEIAYTMRATE 936
IHRD++++N L+ + +SDFG+++ E Y+S + APE R +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 937 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM-------IIEVNQILDPRLSTPSPGV 989
+ DV+SFG+L++E FS+ ++N+ IE L P
Sbjct: 176 ESDVWSFGILLWEA---------FSLGAVPYANLSNQQTREAIEQGVRLPCPELCP---- 222
Query: 990 MDKLISIMEVAILCLDESPEARPT 1013
D + +ME C + P RP+
Sbjct: 223 -DAVYRLME---RCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 77/271 (28%), Positives = 111/271 (40%), Gaps = 45/271 (16%)
Query: 759 IGKGGQGSVYKA--ELPSGDI--VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
+G G GSV K + SG VAVK A + EFL + ++ H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ---EHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 815 KFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIK------GVANALS 868
+ G C LV E G L + L R I V VA ++
Sbjct: 60 RLIGVCK-GEPLMLVMELAPLGPLLKYLKK---------RREIPVSDLKELAHQVAMGMA 109
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN-RTEFVGTF--GYAA 925
YL +HRD++++NVLL +A +SDFG+++ + S R G + + A
Sbjct: 110 YLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166
Query: 926 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI-IEVNQILDP--RL 982
PE + + K DV+S+GV ++E FS + M EV +L+ RL
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEA---------FSYGAKPYGEMKGAEVIAMLESGERL 217
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPT 1013
P ++ SIM C PE RPT
Sbjct: 218 PRP-EECPQEIYSIML---SCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-14
Identities = 39/103 (37%), Positives = 57/103 (55%), Gaps = 3/103 (2%)
Query: 240 CTLDNLSN---LDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSW 296
C D+ +D L L L G IP+ I L+ L ++L N + G+IP S G+++S
Sbjct: 409 CQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468
Query: 297 TLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIG 339
++ L NS +GSIP LG L SL L L N L+G +P ++G
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 66/278 (23%), Positives = 118/278 (42%), Gaps = 44/278 (15%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMAD-QDE-----FLNVVLALNEIRHRN 812
+G G G VYKA K + + + E F+ + L+E +H N
Sbjct: 13 LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
IV + +++ E+ G+L I+ + L+ + V + + AL++LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY-- 930
+IHRD+ + N+LL L+ + ++DFG++ + R F+GT + APE+
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 931 TMRATE---KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM--IIEVNQILDPRLSTP 985
T + K D++S G+ + E+ + P + M ++++ + P L P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPH-------HELNPMRVLLKILKSEPPTLDQP 231
Query: 986 ---SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
S D L S CL + P+ RPT + H
Sbjct: 232 SKWSSSFNDFLKS-------CLVKDPDDRPTAAELLKH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 72/271 (26%), Positives = 124/271 (45%), Gaps = 30/271 (11%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G VYKA+ +A K + + + + ++++ + L H IVK G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKV---IETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELS---WNRRINVI-KGVANALSYLHHDC 874
+++ E+ G++ DA EL +I VI + + AL YLH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAV------DAIMLELDRGLTEPQIQVICRQMLEALQYLHSM- 129
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY--TM 932
IIHRD+ + NVLL L+ + ++DFG++ R F+GT + APE+ TM
Sbjct: 130 --KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 933 RATE---KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
+ T K D++S G+ + E+ + P + +++++ + P LS PS
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEPPTLSQPSKWS 242
Query: 990 MDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
M+ ++ A LD+ PE RP+ + H
Sbjct: 243 ME-FRDFLKTA---LDKHPETRPSAAQLLEH 269
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-14
Identities = 77/222 (34%), Positives = 108/222 (48%), Gaps = 8/222 (3%)
Query: 190 IPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD 249
+L NL L L LN N L I ++ L +L++LDL N + + P SNL
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLK 143
Query: 250 TLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309
L L N + S+PS + NL +L LDL N LS +P NLS+ + L N +S
Sbjct: 144 ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-D 200
Query: 310 IPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLS 369
+PP + L +L L L N + + S+ NL +L L L NN L +PE IG L +L
Sbjct: 201 LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLE 258
Query: 370 ELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLK 411
L L N +S S+G+LT L L++ N L +P
Sbjct: 259 TLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIAL 298
|
Length = 394 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-14
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALNEIRHRNIVK 815
+GKG G+VY G ++AVK+ S +A + E+ + V L ++H NIV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDT-SNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
+ G C + + E++ GS++ IL E + + K + + ++YLH++C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC- 122
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE------FVGTFGYAAPEIA 929
++HRDI NV+L + DFG A+ + + T GT + APE+
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHP 956
K D++S G VFE+ G P
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFL--NVVLALNE 807
DDF IG+G +V A E + A+K + + L + + V+ LN
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN- 59
Query: 808 IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANAL 867
H I+K + + + + V EY G L + + + + R + AL
Sbjct: 60 -GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTR--FYAAEILLAL 115
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN-------------- 913
YLH IIHRD+ +N+LLD + ++DFG AK ++P SS
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 914 ------RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
FVGT Y +PE+ A + D+++ G ++++++ G P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 28/204 (13%)
Query: 758 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV--VLALNEI-RHRNI 813
+G G GSVY A +G++VA+KK + S +E +N+ V +L ++ H NI
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-----WEECMNLREVKSLRKLNEHPNI 60
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
VK + V EY+ G+L +++ D K S + ++I + L+++H
Sbjct: 61 VKLKEVFRENDELYFVFEYME-GNLYQLM-KDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE---PYSSNRTEFVGTFGYAAPEIAY 930
HRD+ +N+L+ ++DFG+A+ + PY T++V T Y APEI
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY----TDYVSTRWYRAPEI-- 169
Query: 931 TMRATEKY----DVYSFGVLVFEV 950
+R+T Y D+++ G ++ E+
Sbjct: 170 LLRST-SYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-13
Identities = 38/92 (41%), Positives = 54/92 (58%)
Query: 224 LSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS 283
+ L L L G IP + L +L ++ L NS+ G+IP +G++ SL LDL N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 284 GSIPLSFGNLSSWTLMSLFSNSLSGSIPPILG 315
GSIP S G L+S +++L NSLSG +P LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-13
Identities = 35/80 (43%), Positives = 49/80 (61%)
Query: 188 GRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSN 247
G IP+ + L L + L+ NS+ G IP +G++ SL LDLS N NG IP +L L++
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 248 LDTLFLYKNSLSGSIPSIIG 267
L L L NSLSG +P+ +G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 66/228 (28%), Positives = 97/228 (42%), Gaps = 41/228 (17%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DDF+ +G G G V SG A+K + + + + LN L IR
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIR 59
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI-----NVIK--- 861
H +V +G + + +LV EY+ G L S R+ V +
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGEL------------FSHLRKSGRFPEPVARFYA 107
Query: 862 -GVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT-EFVG 919
V AL YLH I++RD+ +N+LLD + ++DFG AK V+ RT G
Sbjct: 108 AQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCG 160
Query: 920 TFGYAAPEI----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 963
T Y APEI Y D ++ G+L++E++ G P FF N
Sbjct: 161 TPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP--FFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (179), Expect = 1e-13
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 758 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHR 811
+G+G G VYKA + +G+IVA+KK + +++E + + L E++H
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR-------LDNEEEGIPSTALREISLLKELKHP 58
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA----NAL 867
NIVK R +LV EY L + L D LS N+IK + L
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLS----PNLIKSIMYQLLRGL 111
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
+Y H I+HRD+ +N+L++ + ++DFG+A+ T V T Y APE
Sbjct: 112 AYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPE 168
Query: 928 IAYTMRATEKY----DVYSFGVLVFEVIKG 953
I + Y D++S G + E+I G
Sbjct: 169 ILLGSK---HYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 69/277 (24%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 745 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA 804
EI + + ++K +G G G V+ A VAVK G+M+ + FL
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKP----GSMS-VEAFLAEANV 54
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
+ ++H +VK H + +++ E++ +GSL L +D +K+ + I+ +A
Sbjct: 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIA 112
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG-- 922
++++ + IHRD+ + N+L+ ++DFG+A+ +E E+ G
Sbjct: 113 EGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED-----NEYTAREGAK 164
Query: 923 ----YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978
+ APE T K DV+SFG+L+ E++ + I + SN EV + L
Sbjct: 165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT------YGRIPYPGMSNP--EVIRAL 216
Query: 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ P P + + + + C PE RPT E
Sbjct: 217 ERGYRMPRPENCPE--ELYNIMMRCWKNRPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 65/262 (24%), Positives = 122/262 (46%), Gaps = 24/262 (9%)
Query: 759 IGKG--GQGSVY-KAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
+GKG G+ ++Y + E +V K+ N LS ++ + LN ++ L+ ++H NI+
Sbjct: 8 LGKGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEK--ERRDALNEIVILSLLQHPNIIA 63
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
++ + + EY + G+L + + + + + +A+SY+H
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-- 120
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRAT 935
I+HRDI + N+ L + DFGI+K + S VGT Y +PE+ ++
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN 179
Query: 936 EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDK-LI 994
K D+++ G +++E++ R F + N + I++ N TP V LI
Sbjct: 180 FKSDIWALGCVLYELL--TLKRTFDATNPLNLVVKIVQGNY-------TPVVSVYSSELI 230
Query: 995 SIMEVAILCLDESPEARPTMEK 1016
S++ L + PE RPT ++
Sbjct: 231 SLVHS---LLQQDPEKRPTADE 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 12/255 (4%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G VY+A L G VA+KK L A D + L L ++ H N++K++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDL-LKQLNHPNVIKYY 68
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+V E G L+R++ + K L + V K S L H
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEK--TVWKYFVQLCSALEHMHSRR 126
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEK 937
++HRDI NV + + D G+ +F ++ VGT Y +PE + K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 938 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIM 997
D++S G L++E+ P F+ + +S + ++ Q P L PS ++L ++
Sbjct: 187 SDIWSLGCLLYEMAALQSP--FYGDKMNLYS-LCKKIEQCDYPPL--PSDHYSEELRQLV 241
Query: 998 EVAILCLDESPEARP 1012
+C++ PE RP
Sbjct: 242 N---MCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 759 IGKGGQGSVYKAELPSGDI---VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
IG+G G V KA + + A+K+ + D L V+ L H NI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNIIN 72
Query: 816 FHGFCSNARHSFLVCEYLHRGSL------ARILGND-------ATAKELSWNRRINVIKG 862
G C + + +L EY G+L +R+L D +TA LS + ++
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
VA + YL IHRD++++N+L+ + A ++DFG+++ E Y +
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 189
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVI 951
A + Y++ T DV+S+GVL++E++
Sbjct: 190 MAIESLNYSVYTTNS-DVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 57/284 (20%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGN---MADQDEFLNVVLALNEIRHRNIV 814
+G G G VYKA L +G++ AVK +L G+ + Q+ F+ + E +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII--KLEPGDDFSLIQQEIFM-----VKECKHCNIV 69
Query: 815 KFHGFCSNARHSFLVC-EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
+ G +R +C EY GSL I EL + V + L+YLH
Sbjct: 70 AYFG-SYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAYLHSK 125
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMR 933
+HRDI N+LL + ++DFG+A + + R F+GT + APE+A
Sbjct: 126 ---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA---- 178
Query: 934 ATEKY-------DVYSFGVLVFEVIKGN------HP-RDFFSINFSSFSNMIIEVNQILD 979
A EK D+++ G+ E+ + HP R F ++ S+F
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ----------- 227
Query: 980 PRLSTPSPGVMDKL---ISIMEVAILCLDESPEARPTMEKGFGH 1020
P + DK + + L ++P+ RPT E+ H
Sbjct: 228 ------PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 80/224 (35%), Positives = 112/224 (50%), Gaps = 11/224 (4%)
Query: 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQ 161
+L L+LS N ++P + NL L+NLDL N LS + + L+ L L L N+
Sbjct: 140 SNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197
Query: 162 LHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNL 221
+ +PP I LS + E NN + SSL NL L+ L L+NN L +P +GNL
Sbjct: 198 IS-DLPPEIELLSALEELD-LSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNL 254
Query: 222 KSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQ 281
+L TLDLS NQ++ + L +L+NL L L NSLS ++P I L L+L+ N
Sbjct: 255 SNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA---LLLLLLELLLNL 309
Query: 282 LSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGL 325
L L S ++ SN S P L L+SL+ L
Sbjct: 310 LLTLKALELKLNSILLNNNILSNGE-TSSPEALSILESLNNLWT 352
|
Length = 394 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 73/277 (26%), Positives = 130/277 (46%), Gaps = 52/277 (18%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR----NI 813
+GKG GSVYK P+G +A+K+ +L D+ +F +++ L +I H+ I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL------DESKFNQIIMEL-DILHKAVSPYI 61
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWN--RRIN--VIKGVANALSY 869
V F+G ++ EY+ GSL ++ + + + RRI V+KG L +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG----LKF 117
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE-- 927
L + +IIHRD+ NVL++ + + DFG++ + S +T +G Y APE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SLAKTN-IGCQSYMAPERI 173
Query: 928 --------IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979
YT+++ DV+S G+ + E+ G +P +++N+ +++ I+D
Sbjct: 174 KSGGPNQNPTYTVQS----DVWSLGLSILEMALGRYPYP-----PETYANIFAQLSAIVD 224
Query: 980 ---PRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
P L + ++ CL++ P RPT
Sbjct: 225 GDPPTLPSGYSDDAQDFVA------KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 41/284 (14%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+DF+ IG G G VYKA + +G++ A+K +L G D ++ + + +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI--KLEPGE--DFAVVQQEIIMMKDCK 64
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H NIV + G ++ E+ GSL I LS ++ V + L Y
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQGLYY 121
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
LH +HRDI N+LL ++DFG++ + + R F+GT + APE+A
Sbjct: 122 LHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 930 YTMRA---TEKYDVYSFGVLVFEVIKGNHP-------RDFFSINFSSFSNMIIEVNQILD 979
R + D+++ G+ E+ + P R F + S+F
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ----------- 227
Query: 980 PRLSTPSPGVMDKLI---SIMEVAILCLDESPEARPTMEKGFGH 1020
P + DK+ S + L ++P+ RPT EK H
Sbjct: 228 ------PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 73/286 (25%), Positives = 135/286 (47%), Gaps = 45/286 (15%)
Query: 759 IGKGGQGSVY--KAELPSG-DI-VAVKKFNSQLLSGNMADQD-EFLNVVLALNEIRHRNI 813
IG G G V + +LP +I VA+K L +G Q +FL+ + + H NI
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIK----TLKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDA--TAKELSWNRRINVIKGVANALSYL 870
+ G + ++ +V EY+ GSL L +D T +L + +++G+A+ + YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYL 122
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG-----YAA 925
+HRD++++N+L++ VSDFG+++ +E + G + A
Sbjct: 123 SD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEAAYTTRGGKIPIRWTA 177
Query: 926 PE-IAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983
PE IAY + T DV+S+G++++EV+ G P + SN +V + ++
Sbjct: 178 PEAIAYR-KFTSASDVWSYGIVMWEVMSYGERP-------YWEMSNQ--DVIKAIEEGYR 227
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEIL 1029
P+P MD ++ ++ + C + RP F + D+++
Sbjct: 228 LPAP--MDCPAALHQLMLDCWQKDRNERPK----FEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 759 IGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
IG+G G V +A + + I +K+F S+ + A + L V+ L H N
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGE---LEVLCKLGH--HPN 64
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSL------ARILGND-------ATAKELSWNRRINV 859
I+ G C N + ++ EY G+L +R+L D TA L+ + +
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVG 919
VA + YL IHRD++++NVL+ + ++DFG+++ E Y +
Sbjct: 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 951
A + Y++ T K DV+SFGVL++E++
Sbjct: 182 VRWMAIESLNYSVYTT-KSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 76/290 (26%), Positives = 128/290 (44%), Gaps = 36/290 (12%)
Query: 743 HEEIIKATDDFDEKFCIGKGGQGSVYK---AELPSGDIVAVKKFNSQLLSGNMADQDEFL 799
H+ +K E G G+ S+Y A +G++VAVK + N + + +
Sbjct: 2 HKRYLKKIRVLGE----GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEI 57
Query: 800 NVVLALNEIRHRNIVKFHGFCSNA--RHSFLVCEYLHRGSLARILGNDATAKELSWNRRI 857
N+ L + H NIVK+ G CS + L+ EY+ GSL L +L+ + +
Sbjct: 58 NI---LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLL 110
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYSSNR 914
+ + ++YLH IHRD++++NVLLD + + DFG+AK V Y R
Sbjct: 111 LFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 167
Query: 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-----KGNHPRDFFS-INFSSFS 968
+ + A E + + DV+SFGV ++E++ K + P+ F I
Sbjct: 168 EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ 227
Query: 969 NMIIEVNQILDPRLSTPSPGVMDKLISIMEVAIL---CLDESPEARPTME 1015
++ + ++L+ + P P EV IL C + + RPT
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCP-----QEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 70/263 (26%), Positives = 115/263 (43%), Gaps = 31/263 (11%)
Query: 759 IGKGGQGSVYKA---ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
+G G G+V K S VAVK + + + A +DE L + ++ + IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELLREANVMQQLDNPYIVR 60
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
G C A LV E G L + L + E ++ V+ + YL
Sbjct: 61 MIGICE-AESWMLVMELAELGPLNKFLQKNKHVTE---KNITELVHQVSMGMKYLEET-- 114
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYSSNRTEFVGTFGYAAPEIAYTM 932
+ +HRD++++NVLL + A +SDFG++K + E Y +T + APE
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 933 RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI-IEVNQILD--PRLSTPSPGV 989
+ + K DV+SFGVL++E FS + M EV Q+++ R+ P
Sbjct: 174 KFSSKSDVWSFGVLMWEA---------FSYGQKPYKGMKGNEVTQMIESGERMECP-QRC 223
Query: 990 MDKLISIMEVAILCLDESPEARP 1012
++ +M+ LC + RP
Sbjct: 224 PPEMYDLMK---LCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 66/247 (26%), Positives = 102/247 (41%), Gaps = 28/247 (11%)
Query: 759 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFL----NVVLALNEIRHRNI 813
+G+G G V AE +G++ A+K + D+ E L + N RH +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANSERHPFL 64
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
V H V EY G L + D S R + V L YLH +
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV----FSEPRAVFYAACVVLGLQYLHEN 120
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMR 933
I++RD+ N+LLD E ++DFG+ K + + F GT + APE+
Sbjct: 121 ---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS 177
Query: 934 ATEKYDVYSFGVLVFEVIKGNHPRDFFSIN-----FSSFSNMIIEVNQILDPR-LSTPSP 987
T D + GVL++E++ G P F + F S N ++ PR LS +
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESP---FPGDDEEEVFDSIVND-----EVRYPRFLSREAI 229
Query: 988 GVMDKLI 994
+M +L+
Sbjct: 230 SIMRRLL 236
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 70/262 (26%), Positives = 112/262 (42%), Gaps = 33/262 (12%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+GKG G V+K L VAVK L + +FL+ L + H NIVK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ---ELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
C+ + ++V E + G L EL + + A ++YL +
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLE---SKNC 114
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVEP--YSSNRTEFVGTFGYAAPEIAYTMRATE 936
IHRD++++N L+ +SDFG+++ + YSS+ + + + APE R +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173
Query: 937 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDP------RLSTPSPGVM 990
+ DV+S+G+L++E FS+ + M NQ R+S P
Sbjct: 174 ESDVWSYGILLWET---------FSLGVCPYPGM---TNQQAREQVEKGYRMSCPQKCPD 221
Query: 991 DKLISIMEVAILCLDESPEARP 1012
D + +V C D PE RP
Sbjct: 222 D----VYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 750 TDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI 808
+F + IGKG VYKA L G +VA+KK + A QD + L L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDL-LKQL 59
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI-NVIKGVANAL 867
H N++K+ +V E G L+R++ + K L R I + +AL
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE---FVGTFGYA 924
++H I+HRDI NV + + D G+ +F +SS T VGT Y
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYM 173
Query: 925 APEIAYTMRATEKYDVYSFGVLVFE 949
+PE + K D++S G L++E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-13
Identities = 41/109 (37%), Positives = 58/109 (53%), Gaps = 1/109 (0%)
Query: 320 LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLS 379
+ LGL L G IP I L L++++L N + G+IP +G + SL L L N+ +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 380 GVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVG 428
G IP S+G LT L +LN+ N L G +P +L L R FN + G
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDNAG 527
|
Length = 623 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 759 IGKGGQGSVYKAELPSGDI---VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
IG+G G V KA + + A+K+ + D L V+ L H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNIIN 60
Query: 816 FHGFCSNARHSFLVCEYLHRGSL------ARILGND-------ATAKELSWNRRINVIKG 862
G C + + +L EY G+L +R+L D +TA LS + ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
VA + YL IHRD++++N+L+ + A ++DFG+++ E Y +
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVI 951
A + Y++ T DV+S+GVL++E++
Sbjct: 178 MAIESLNYSVYTT-NSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 73/278 (26%), Positives = 111/278 (39%), Gaps = 47/278 (16%)
Query: 759 IGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G G G VY+ VAVK S + D+ +FL L +++ H+N
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE---SCSEQDESDFLMEALIMSKFNHQN 70
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL----GNDATAKELSWNRRINVIKGVANALS 868
IV+ G F++ E + G L L L+ + + VA
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFE---AHVSDFGIAKFVEPYSSNRTEFVGTFGYA- 924
YL + IHRDI+++N LL + A ++DFG+A+ + Y R + G A
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIY---RASYYRKGGRAM 182
Query: 925 ------APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI-IEVNQI 977
PE T K DV+SFGVL++E+ FS+ + + EV +
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI---------FSLGYMPYPGRTNQEVMEF 233
Query: 978 LDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+ RL P G + IM C +PE RP
Sbjct: 234 VTGGGRLDPP-KGCPGPVYRIMTD---CWQHTPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 292 NLSSWTL--MSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSL 349
W + + L + L G IP + L+ L ++ L N + G IPPS+G+++SL L L
Sbjct: 414 TKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDL 473
Query: 350 FNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVG 387
N GSIPE +G L SL L L N+LSG +P ++G
Sbjct: 474 SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-13
Identities = 35/89 (39%), Positives = 50/89 (56%)
Query: 131 LDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRI 190
L L N L G I +I KL L+ + L N + G IPP +G ++ + +N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 191 PSSLGNLSKLALLYLNNNSLFGYIPTVMG 219
P SLG L+ L +L LN NSL G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 750 TDDFDEKFCIGKGGQGSVYKAELPSGDI-VAVKKFNSQLLSGNMADQDEFLNVVLALNEI 808
D+ E+ +GKG G VY A S + +A+K+ + + + + +
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYL 62
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALS 868
+HRNIV++ G S + E + GSL+ +L + + + I K + L
Sbjct: 63 KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 869 YLHHDCLPSIIHRDISSKNVLLD-LEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
YLH + I+HRDI NVL++ +SDFG +K + + F GT Y APE
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE 179
Query: 928 I------AYTMRATEKYDVYSFGVLVFEVIKGNHP 956
+ Y A D++S G + E+ G P
Sbjct: 180 VIDKGPRGYGAPA----DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 40/272 (14%)
Query: 759 IGKGGQGSVYKA-ELPSGDI----VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+G G G+V+K +P GD VA+K + SG Q E + +LA+ + H I
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQ-EITDHMLAMGSLDHAYI 71
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
V+ G C A LV + GSL + + L R +N +A + YL
Sbjct: 72 VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEH 128
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP------YSSNRTEFVGTFGYAAPE 927
+ +HR+++++N+LL + ++DFG+A + P YS ++T + A E
Sbjct: 129 RM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT----PIKWMALE 181
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
R T + DV+S+GV V+E++ G P + + +++ + ++ P++ T
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEP--YAGMRPHEVPDLLEKGERLAQPQICT-- 237
Query: 987 PGVMDKLISIMEVAILC--LDESPEARPTMEK 1016
I + V + C +DE+ RPT ++
Sbjct: 238 -------IDVYMVMVKCWMIDEN--VRPTFKE 260
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G VYKA +G++VA+KK + + + + L E+ H NIVK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 65
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAK-ELSWNRRINVIKGVANALSYLHHDCLP 876
+LV E+LH+ L + + DA+ + + + + L++ H
Sbjct: 66 DVIHTENKLYLVFEFLHQ-DLKKFM--DASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAYTMR-A 934
++HRD+ +N+L++ E ++DFG+A+ F P + E V T Y APEI +
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYY 178
Query: 935 TEKYDVYSFGVLVFEVI 951
+ D++S G + E++
Sbjct: 179 STAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 759 IGKGGQGSVYKAEL----PSGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G G V+ AE P D +VAVK + + A +D F L ++H +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKD-FHREAELLTNLQHEH 68
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL---GNDAT-------AKELSWNRRINVIKG 862
IVKF+G C +V EY+ G L + L G DA EL+ ++ +++ +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVG--- 919
+A + YL +HRD++++N L+ + DFG+++ V YS++ G
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDV--YSTDYYRVGGHTM 183
Query: 920 -TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHP 956
+ PE + T + DV+S GV+++E+ G P
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 58/302 (19%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI---- 808
+G+G G V KAE D VAVK L + ++D ++V + +
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKM-----LKDDATEKD-LSDLVSEMEMMKMIG 73
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSL-------------ARILGNDATAKELSWNR 855
+H+NI+ G C+ ++V EY G+L A + L+
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 856 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE--PYSSN 913
++ VA + +L IHRD++++NVL+ + ++DFG+A+ + Y
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 914 RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973
T + APE + T + DV+SFGVL++E+ F++ S + I
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI---------FTLGGSPYPG--IP 239
Query: 974 VNQILD-----PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028
V ++ R+ P +L +M C E P RPT F + D +
Sbjct: 240 VEELFKLLKEGYRMEKP-QNCTQELYHLM---RDCWHEVPSQRPT----FKQLVEDLDRM 291
Query: 1029 LA 1030
L
Sbjct: 292 LT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 78/272 (28%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---LNEI------ 808
IG G G V A +G VA+KK + + F +++ A L EI
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-----------NVFDDLIDAKRILREIKLLRHL 56
Query: 809 RHRNIVKFHG-FCSNARHSF----LVCEYLHRGSLARILGNDATAKELSWNRRI-----N 858
RH NI+ + F +V E + L +++ + + L+ + I
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSP---QPLT-DDHIQYFLYQ 111
Query: 859 VIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR-- 914
+++G L YLH S +IHRD+ N+L++ + + DFG+A+ V+P +
Sbjct: 112 ILRG----LKYLH-----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 915 -TEFVGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVI------KGNHPRDFFSIN 963
TE+V T Y APE+ + ++ +Y D++S G + E++ G D
Sbjct: 163 LTEYVVTRWYRAPEL---LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL--- 216
Query: 964 FSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995
N+I+EV L TPS + + S
Sbjct: 217 -----NLIVEV-------LGTPSEEDLKFITS 236
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-12
Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 1/103 (0%)
Query: 491 LDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSI 550
L L + + G IP + KL L + LS N + G++P GS+T L+ LDLS N + SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 551 PKSIGNLLKLYYLNLSNNQFSHTIPIEF-EKLIHLSKLDLSHN 592
P+S+G L L LNL+ N S +P +L+H + + + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 36/218 (16%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR----HRNI 813
+G G G VYK + +G + A+K + +DE + L +N ++ HRNI
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD--------VTEDEEEEIKLEINMLKKYSHHRNI 75
Query: 814 VKFHGF------CSNARHSFLVCEYLHRGSLARILGNDA--TAKELSWNRRI--NVIKGV 863
++G + +LV E+ GS+ ++ N KE W I +++G+
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWIAYICREILRGL 134
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGY 923
A+ + H +IHRDI +NVLL E + DFG++ ++ R F+GT +
Sbjct: 135 AHL--HAHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 187
Query: 924 AAPEIAYTMR---ATEKY--DVYSFGVLVFEVIKGNHP 956
APE+ AT Y D++S G+ E+ +G P
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 11/201 (5%)
Query: 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+GKG G V+ AEL + A+K ++ M D E V + + + H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 818 GFCS--NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
+C+ + F V EYL+ G L + + + + R + L +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK-- 115
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRAT 935
I++RD+ N+LLD + ++DFG+ K + F GT Y APEI +
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 936 EKYDVYSFGVLVFEVIKGNHP 956
D +SFGVL++E++ G P
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 75/320 (23%), Positives = 137/320 (42%), Gaps = 53/320 (16%)
Query: 759 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+G+G G V +AE D VAVK ++AD + ++ + +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG--KH 77
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-------------GNDATAKELSWNRRI 857
+NI+ G C+ +++ EY +G+L L ++LS+ +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE--PYSSNRT 915
+ VA + YL IHRD++++NVL+ + ++DFG+A+ V Y +
Sbjct: 138 SCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-EV 974
+ APE + T + DV+SFG+L++E+ F++ S + + + E+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI---------FTLGGSPYPGIPVEEL 245
Query: 975 NQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVI 1032
++L R+ PS + + + E C P RPT F + D++LA +
Sbjct: 246 FKLLREGHRMDKPSNCTHELYMLMRE----CWHAVPTQRPT----FKQLVEALDKVLAAV 297
Query: 1033 LAIEASADYGQTTLCLETYS 1052
S +Y ++ E YS
Sbjct: 298 -----SEEYLDLSMPFEQYS 312
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 9/172 (5%)
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
L +++H NIV F H ++V EY G L + + K + + +
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKI-KLQRGKLFPEDTILQWFVQMC 110
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA 924
+ ++H ++HRDI SKN+ L + + DFG A+ + + +VGT Y
Sbjct: 111 LGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYV 167
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQ 976
PEI M K D++S G +++E+ HP F N S+ N+I++V Q
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP---FQAN--SWKNLILKVCQ 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 74/269 (27%), Positives = 117/269 (43%), Gaps = 39/269 (14%)
Query: 759 IGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSG---NMADQDEFLNVVLALNEIRHRNIV 814
+GKG G V + G +KK N + S A+Q+ L L++++H NIV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQL-----LSQLKHPNIV 62
Query: 815 KFHGFCSNARHS--------FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
+ R S ++V + G L L + K L N+ + +A A
Sbjct: 63 AY-------RESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMA 114
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAP 926
L YLH I+HRD+ ++NV L V D GIA+ +E + +GT Y +P
Sbjct: 115 LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
E+ K DV++ G V+E+ H F + + +S IIE P+ +P
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHA--FNAKDMNSLVYRIIEGKLPPMPKDYSPE 229
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTME 1015
G +LI+ M L + PE RP+++
Sbjct: 230 LG---ELIATM------LSKRPEKRPSVK 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 64/280 (22%), Positives = 120/280 (42%), Gaps = 45/280 (16%)
Query: 759 IGKGGQGSVYK---AELPSGDI---VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G G VY+ + G+ VA+K N + +M ++ EFLN + E +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE---NASMRERIEFLNEASVMKEFNCHH 70
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL-----GNDATAKE--LSWNRRINVIKGVAN 865
+V+ G S + + +V E + +G L L + + + I + +A+
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG--- 922
++YL +HRD++++N ++ + + DFG+ + + T++ G
Sbjct: 131 GMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGGKGL 182
Query: 923 ----YAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEV-NQ 976
+ APE T K DV+SFGV+++E+ P + SN EV
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP-------YQGLSNE--EVLKF 233
Query: 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
++D DKL+ +M +C +P+ RPT +
Sbjct: 234 VIDGGHLDLPENCPDKLLELMR---MCWQYNPKMRPTFLE 270
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 40/279 (14%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKF 816
+G G G VYK + +G + A+K + ++G+ +++E + L + HRNI +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGD--EEEEIKQEINMLKKYSHHRNIATY 68
Query: 817 HGFCSNAR------HSFLVCEYLHRGSLARILGNDA--TAKELSWNRRINVIKGVANALS 868
+G +LV E+ GS+ ++ N T KE W I + + LS
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIAYI--CREILRGLS 125
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
+LH +IHRDI +NVLL E + DFG++ ++ R F+GT + APE+
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 182
Query: 929 AYTMRATE-----KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983
+ K D++S G+ E+ +G P +M L PR
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP----------LCDMHPMRALFLIPR-- 230
Query: 984 TPSPGVMDKLISIMEVAIL--CLDESPEARPTMEKGFGH 1020
P+P + K S + + CL ++ RPT E+ H
Sbjct: 231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 758 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFL-NVVLALNEIRHRNIVK 815
+G+G G VY ++ +G +AVK+ S + L + L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 816 FHGFCSNARHSFLVCEYLHRGSLAR------ILGNDATAKELSWNRRINVIKGVANALSY 869
++G + + EY+ GS+ L T K + R+I ++GV Y
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK---YTRQI--LEGVE----Y 119
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT---EFVGTFGYAAP 926
LH + I+HRDI N+L D + DFG +K ++ S+ T GT + +P
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
E+ K DV+S G V E++ P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 753 FDEKFC--IGKGGQGSVYKAEL----PSGD----IVAVKKFNSQLLSGNMADQDEFLNVV 802
F+++F I G+G K EL P GD VAVK + ++AD + + +
Sbjct: 1 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI- 59
Query: 803 LALNEIRHRNIVKFHGFCSN--ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVI 860
L + H NIVK+ G C+ L+ E+L GSL L + L + V
Sbjct: 60 --LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV- 116
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEF 917
+ + YL +HRD++++NVL++ E + + DFG+ K +E Y + + +
Sbjct: 117 -QICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 951
+ APE + DV+SFGV ++E++
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-12
Identities = 38/94 (40%), Positives = 52/94 (55%), Gaps = 1/94 (1%)
Query: 476 GSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTE 535
G IP +I LQ ++LS N I G IP L + SL L LS N +GS+P G LT
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 536 LQYLDLSANKLSSSIPKSIGN-LLKLYYLNLSNN 568
L+ L+L+ N LS +P ++G LL N ++N
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 744 EEIIKATDDFDEKFCIGKGGQGSVYK-AELPSGDIVAVKKFNSQLLSGNMADQDEFL--- 799
E + TD ++ IGKG G VYK G + AVK + ++D DE +
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP------ISDVDEEIEAE 68
Query: 800 -NVVLALNEIRHRNIVKFHGFCSNARHS-----FLVCEYLHRGSLARIL-GNDATAKELS 852
N++ +L H N+VKF+G A +LV E + GS+ ++ G + L
Sbjct: 69 YNILQSLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 853 WNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912
++ G L +LH++ IIHRD+ N+LL E + DFG++ +
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 913 NRTEFVGTFGYAAPEI-----AYTMRATEKYDVYSFGVLVFEVIKGNHP 956
R VGT + APE+ Y + DV+S G+ E+ G+ P
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 75/277 (27%), Positives = 116/277 (41%), Gaps = 42/277 (15%)
Query: 759 IGKGGQGSVYKAELP------SGDI-VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR 811
+G G G VY+ SG I VAVK ++ EFL ++ H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK---GATDQEKKEFLKEAHLMSNFNHP 59
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKE-----LSWNRRINVIKGVANA 866
NIVK G C +++ E + G L L DA + L+ +++ VA
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 867 LSYLHHDCLPSIIHRDISSKNVLL-----DLEFEAHVSDFGIAK--FVEPYSSNRTEFVG 919
YL IHRD++++N L+ D + + DFG+A+ + Y E +
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQIL 978
+ APE + T + DV+SFGVL++E++ G P + + +N EV Q +
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP-------YPALNN--QEVLQHV 226
Query: 979 DP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
RL P DK+ +M C + P RPT
Sbjct: 227 TAGGRLQKP-ENCPDKIYQLMT---NCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDA--TAKELSWNRRINVIKG 862
L E+ H IVK H +L+ ++L G L L + T +++ + +
Sbjct: 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----YLAE 106
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
+A AL +LH II+RD+ +N+LLD E ++DFG++K + F GT
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
Y APE+ T+ D +SFGVL+FE++ G+ P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 63/276 (22%), Positives = 109/276 (39%), Gaps = 36/276 (13%)
Query: 759 IGKGGQGSVYKAELPSGDIVA---VKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
IG G G V E G A VK+ + S +Q FL V E+ H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRA---SATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI--NVIKGVANALSYLHHD 873
G C + LV E+ G L L ++ + + + VA+ L +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIA--KFVEPYSSNRTEFVGTFGYAAPEIA-- 929
IH D++ +N L + + D+G+A ++ E Y + + APE+
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 930 -----YTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983
T+K +++S GV ++E+ + P + S+ + + + +
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-------YPDLSDEQVLKQVVREQDIK 229
Query: 984 TPSPGV----MDKLISIMEVAILCLDESPEARPTME 1015
P P + D+ +M+ L PE RPT E
Sbjct: 230 LPKPQLDLKYSDRWYEVMQFCWL----DPETRPTAE 261
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+GKG G V AEL G+ AVK ++ + D E V + + N H
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTH 60
Query: 818 GFCS--NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
+C+ H F V E+L+ G L + + R + L +LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK-- 115
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR-TEFVGTFGYAAPEIAYTMRA 934
II+RD+ NV+LD + ++DFG+ K + NR + F GT Y APEI ++
Sbjct: 116 -GIIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 935 TEKYDVYSFGVLVFEVIKGNHP 956
T D +SFGVL++E++ G P
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 46/143 (32%), Positives = 67/143 (46%), Gaps = 10/143 (6%)
Query: 817 HGFCS--NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC 874
H FC+ H F V EYL+ G L + + ++ R + L +LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKK- 115
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE-FVGTFGYAAPEIAYTMR 933
II+RD+ NVLLD + ++DFG+ K + F GT Y APEI +
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 934 ATEKYDVYSFGVLVFEVIKGNHP 956
E D +SFGVL++E++ G P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 759 IGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+GKG G V AEL D + A+K +L ++ QD+ +V + E R + H
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIK-----VLKKDVILQDD--DVDCTMTEKRILALAAKH 55
Query: 818 GFCSNARHS--------FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
F + A H F V EY++ G L + +++ R V AL +
Sbjct: 56 PFLT-ALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMF 111
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
LH +I+RD+ N+LLD E ++DFG+ K T F GT Y APEI
Sbjct: 112 LHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHP 956
+ D ++ GVL++E++ G P
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 50/200 (25%), Positives = 79/200 (39%), Gaps = 39/200 (19%)
Query: 753 FDEKFCIGKGGQGSVYKA---ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
++ + CIG+G G VYKA G A+KKF Q + L L E++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIAL-LRELK 60
Query: 810 HRNIVKFHG-FCSNARHS-FLVCEY----------LHRGSLARILGNDATAKELSWNRRI 857
H N+V F +A S +L+ +Y HR + + + K L W
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI-PPSMVKSLLWQ--- 116
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH----VSDFGIAKFVE----- 908
+ N + YLH + ++HRD+ N+L+ E + D G+A+
Sbjct: 117 -----ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 909 PYSSNRTEFVGTFGYAAPEI 928
+ V T Y APE+
Sbjct: 169 LADLDPV--VVTIWYRAPEL 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI------RHR 811
+G+G G V K + +G IVA+KKF + +D+ + +A+ EI RH
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKF--------LESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
N+V + +LV E++ L + + L +R + + + + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
+IIHRDI +N+L+ + DFG A+ + T++V T Y APE+
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL--- 171
Query: 932 MRATEKY----DVYSFGVLVFEVIKGN 954
+ KY D+++ G LV E++ G
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 68/293 (23%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFL---NVVLALN 806
+D + IG+G G+V K PSG I+AVK+ S + + +Q L +VV+ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV---DEKEQKRLLMDLDVVMRSS 60
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL----------------ARILGNDATAKE 850
+ IVKF+G +C L SL ILG A A
Sbjct: 61 DCP--YIVKFYGALFREGDC-WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA-- 115
Query: 851 LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA-KFVEP 909
AL+YL + IIHRD+ N+LLD + DFGI+ + V+
Sbjct: 116 ------------TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD- 160
Query: 910 YSSNRTEFVGTFGYAAPE-IAYTMRATEKYD----VYSFGVLVFEVIKGNHPRDFFSINF 964
S +T G Y APE I + R + YD V+S G+ ++EV G P +
Sbjct: 161 -SIAKTRDAGCRPYMAPERIDPSAR--DGYDVRSDVWSLGITLYEVATGKFP-------Y 210
Query: 965 SSFSNMIIEVNQILD---PRLSTPSPGVM--DKLISIMEVAILCLDESPEARP 1012
++++ ++ Q++ P LS S ++ + LCL + RP
Sbjct: 211 PKWNSVFDQLTQVVKGDPPILS-NSEEREFSPSFVNFIN---LCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGN--MADQDEFLNVVLALNEIRHRNIVK 815
IG+G G+VYKA +L +G VA+KK L ++ E + ++ L H NIV+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE-IALLKQLESFEHPNIVR 65
Query: 816 FHGFCSNARHS-----FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
C R LV E++ + LA L L ++++ + + +L
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK-CPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
H I+HRD+ +N+L+ + + ++DFG+A+ + + T V T Y APE+
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVVTLWYRAPEV 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 29/232 (12%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEI 808
DD + +G G G V+ + S A+K +++ + + N L E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR--LKQEQHVHNEKRVLKEV 58
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG------ 862
H I++ + R +++ EY+ G L L N + R + G
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFSNSTGLFYASE 109
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT-EFVGTF 921
+ AL YLH I++RD+ +N+LLD E ++DFG AK + +RT GT
Sbjct: 110 IVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTP 162
Query: 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973
Y APE+ + + D ++ G+L++E++ G P FF N I+
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP--FFDDNPFGIYEKILA 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYK-AELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DDF++ +G G G V+K + PSG I+A K + ++ A +++ + + L+E
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN 61
Query: 810 HRNIVKFHG-FCSNARHSFLVC-EYLHRGSLARILGNDATAKELSWNR-RINVIKGVANA 866
IV F+G F S+ S +C E++ GSL ++L E + I VIKG
Sbjct: 62 SPYIVGFYGAFYSDGEIS--ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG---- 115
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAP 926
L+YL I+HRD+ N+L++ E + DFG++ + S FVGT Y +P
Sbjct: 116 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSP 171
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
E + + D++S G+ + E+ G +P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 51/279 (18%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G G G+VYKA L + I+AVK L + Q + ++ + L + I+ F+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI---PLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 818 G-FCSNARHSFLVCEYLHRGSL-------ARILGNDATAKELSWNRRINVIKGVANALSY 869
G F R S + E++ GSL +LG A A V+KG L+Y
Sbjct: 66 GAFFVENRIS-ICTEFMDGGSLDVYRKIPEHVLGRIAVA----------VVKG----LTY 110
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
L I+HRD+ N+L++ + + DFG++ + +S +VGT Y APE
Sbjct: 111 LWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVST--QLVNSIAKTYVGTNAYMAPERI 165
Query: 930 YTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQ-ILD---PR 981
+ E+Y DV+S G+ E+ G P N S M +++ Q I+D P
Sbjct: 166 ----SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--MPLQLLQCIVDEDPPV 219
Query: 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
L P +K + + C+ + P+ RP E H
Sbjct: 220 L--PVGQFSEKFVHFI---TQCMRKQPKERPAPENLMDH 253
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 18/267 (6%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKF- 816
IG+G VY+A L VA+KK + A QD + L L ++ H N++K+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDL-LKQLNHPNVIKYL 68
Query: 817 HGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI-NVIKGVANALSYLHHDCL 875
F + + +V E G L++++ K L R + + +A+ ++H
Sbjct: 69 DSFIEDNELN-IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-- 125
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRAT 935
++HRDI NV + + D G+ +F ++ VGT Y +PE +
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 936 EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995
K D++S G L++E+ P F+ + FS + ++ Q P L P+ +KL
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP--FYGDKMNLFS-LCQKIEQCDYPPL--PTEHYSEKL-- 237
Query: 996 IMEVAILCLDESPEARPTMEKGFGHHI 1022
E+ +C+ P+ RP + G+ H I
Sbjct: 238 -RELVSMCIYPDPDQRPDI--GYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 15/240 (6%)
Query: 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFL---NVVLALNEIRHRNIV 814
IGKG G V A+ G AVK +++ N +Q + NV+L ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLL--KNVKHPFLV 59
Query: 815 KFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC 874
H + V ++++ G L L + + E R +A+AL YLH
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS-- 114
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA 934
+I++RD+ +N+LLD + ++DFG+ K S T F GT Y APE+
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 935 TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994
D + G +++E++ G P F+ + + + I+ +L P S + ++++L+
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP--FYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-11
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 31/220 (14%)
Query: 759 IGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKGG G VY A P VA+KK L S N + FL ++ H IV +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGN----DATAKEL----SWNRRINVIKGVANALSY 869
CS+ + Y+ +L +L + ++ +KEL S +++ + + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE---------------PYSSNR 914
+H ++HRD+ N+LL L E + D+G A F + S+
Sbjct: 129 VHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 915 T---EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 951
T + VGT Y APE + A+E D+Y+ GV++++++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DDF+ +G G G V K + PSG I+A K + ++ A +++ + + L+E
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN 61
Query: 810 HRNIVKFHG-FCSNARHSFLVC-EYLHRGSLARILGN-DATAKELSWNRRINVIKGVANA 866
IV F+G F S+ S +C E++ GSL ++L +E+ I V++G
Sbjct: 62 SPYIVGFYGAFYSDGEIS--ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG---- 115
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAP 926
L+YL I+HRD+ N+L++ E + DFG++ + S FVGT Y +P
Sbjct: 116 LAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSP 171
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
E + + D++S G+ + E+ G +P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 63/263 (23%), Positives = 119/263 (45%), Gaps = 44/263 (16%)
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL------GNDAT-------AKELSWNR 855
+H+NI+ G C+ +++ EY +G+L L G D + ++L++
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 856 RINVIKGVANALSYL-HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE--PYSS 912
++ VA + YL C IHRD++++NVL+ + ++DFG+A+ V Y
Sbjct: 136 LVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 913 NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 972
T + APE + T + DV+SFGVL++E+ F++ S + + +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI---------FTLGGSPYPGIPV 242
Query: 973 -EVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEIL 1029
E+ ++L R+ P+ + + + E C P RPT ++ E L
Sbjct: 243 EELFKLLKEGHRMDKPANCTHELYMIMRE----CWHAVPSQRPTFKQ--------LVEDL 290
Query: 1030 AVILAIEASADYGQTTLCLETYS 1052
+L + ++ +Y ++ E YS
Sbjct: 291 DRVLTVTSTDEYLDLSVPFEQYS 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 66/271 (24%), Positives = 122/271 (45%), Gaps = 38/271 (14%)
Query: 759 IGKGGQGSVYKA-ELPSGDIV----AVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+G G G+VYK +P G+ V A+K N +G A+ EF++ L + + H ++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANV-EFMDEALIMASMDHPHL 71
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILG--NDATAKELSWNRRINVIKGVANALSYLH 871
V+ G C + LV + + G L + D +L N + + KG + YL
Sbjct: 72 VRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG----MMYLE 126
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG-----YAAP 926
++HRD++++NVL+ ++DFG+A+ +E + E+ G + A
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE---GDEKEYNADGGKMPIKWMAL 180
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985
E + + T + DV+S+GV ++E++ G P D E+ +L+ P
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---------EIPDLLEKGERLP 231
Query: 986 SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
P + I + V + C ++RP ++
Sbjct: 232 QPPICT--IDVYMVMVKCWMIDADSRPKFKE 260
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 35/91 (38%), Positives = 45/91 (49%)
Query: 443 LDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKI 502
L L G I + L L + +S N+I G+IP +G + L+ LDLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 503 PVQLEKLFSLNKLILSLNQLSGSVPLEFGSL 533
P L +L SL L L+ N LSG VP G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 20/171 (11%)
Query: 563 LNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFI 622
L L N IP + KL HL ++LS N ++ IPP + ++ SLE L+LS+N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 623 PRCFEKMRSLSCIDICYNELQGPIPNS--------TVFKDGLMEGNKGLCGNFEAFSSCD 674
P ++ SL +++ N L G +P + F N GLCG +C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN---FTDNAGLCG-IPGLRACG 538
Query: 675 AFMSHKQTSRKKWIVIVFPILGMVLLLISLIGFFFFFRQRKKDSQEEQTIS 725
H K I I F G+ + + L+ + +R+++ Q I+
Sbjct: 539 ---PHLSVGAK--IGIAF---GVSVAFLFLVICAMCWWKRRQNILRAQRIA 581
|
Length = 623 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
C+ KG VYK D VA+K ++ + +DE + ++++ + IV+
Sbjct: 10 CVKKG----VYKMRKKQID-VAIKVLKNE---NEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
G C A LV E G L + L E++ + + ++ V+ + YL +
Sbjct: 62 GVCE-AEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGK---N 115
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYSSNRTEFVGTFGYAAPEIAYTMRA 934
+HRD++++NVLL + A +SDFG++K + + Y R+ + APE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 935 TEKYDVYSFGVLVFEVIK-GNHP 956
+ + DV+S+G+ ++E G P
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 50/208 (24%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 759 IGKGGQGSVYKAELPSGDI-------VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR 811
+G+G G VY+ + G + VA+K N + +M ++ EFLN + E
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNE---AASMRERIEFLNEASVMKEFNCH 69
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARIL-------GNDATAKELSWNRRINVIKGVA 864
++V+ G S + + ++ E + RG L L N+ S + I + +A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG-- 922
+ ++YL+ + +HRD++++N ++ +F + DFG+ + + R G
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEV 950
+ +PE T DV+SFGV+++E+
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 11/238 (4%)
Query: 759 IGKGGQGSVYKAELPSGDIV-AVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG G V A + + AVK + + ++ + L ++H +V H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
A + V +Y++ G L L + E R +A+AL YLH +
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLE---PRARFYAAEIASALGYLHS---LN 116
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAYTMRATE 936
I++RD+ +N+LLD + ++DFG+ K +E + T F GT Y APE+ +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYDR 175
Query: 937 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994
D + G +++E++ G P F+S N + + I+ L P ++ + +++ L+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 66/285 (23%), Positives = 123/285 (43%), Gaps = 46/285 (16%)
Query: 759 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+G+G G V AE D VAVK +++D + ++ + +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--KH 80
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILG-------------NDATAKELSWNRRI 857
+NI+ G C+ +++ EY +G+L L +++++ +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 858 NVIKGVANALSYL-HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE--PYSSNR 914
+ VA + YL C IHRD++++NVL+ ++DFG+A+ V Y
Sbjct: 141 SCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-E 973
T + APE + T + DV+SFGVL++E+ F++ S + + + E
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI---------FTLGGSPYPGIPVEE 247
Query: 974 VNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ ++L R+ P+ ++L +M C P RPT ++
Sbjct: 248 LFKLLKEGHRMDKPA-NCTNELYMMMRD---CWHAIPSHRPTFKQ 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 757 FCIGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR 811
C G Q KA + + +VAVK + +++FL V L+ +
Sbjct: 23 LCEADGLQDFSEKAFAENDNADAPVLVAVKVL---RPDASDNAREDFLKEVKILSRLSDP 79
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARIL--------GNDATAKELSWNRRINVIKGV 863
NI + G C+ ++ EY+ G L + L G +K LS++ + + +
Sbjct: 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQI 139
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGT--- 920
A+ + YL + +HRD++++N L+ + ++DFG+++ YSS+ G
Sbjct: 140 ASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSR--NLYSSDYYRVQGRAPL 194
Query: 921 -FGYAAPEIAYTMRATEKYDVYSFGVLVFEV 950
+ A E + T K DV++FGV ++E+
Sbjct: 195 PIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 70/269 (26%), Positives = 115/269 (42%), Gaps = 41/269 (15%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKK---FNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
IG+G G +Y A+ S V K + A + E V+ L +++H NIV
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKE----VILLAKMKHPNIVT 63
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGND-----ATAKELSWNRRINVIKGVANALSYL 870
F F+V EY G L + + + + LSW +I++ L ++
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHI 117
Query: 871 HHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYSSNRTEF----VGTFGYAA 925
H I+HRDI S+N+ L A + DFGIA+ + ++ E VGT Y +
Sbjct: 118 HDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYYLS 170
Query: 926 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985
PEI K D++S G +++E+ HP F N + +++++ Q +
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP---FEGN--NLHQLVLKICQ---GYFAPI 222
Query: 986 SPGVMDKLISIMEVAILCLDESPEARPTM 1014
SP L S++ SP RP++
Sbjct: 223 SPNFSRDLRSLIS---QLFKVSPRDRPSI 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 53/285 (18%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVV-LALNEI 808
DD + +G+G G V K +P+G I+AVK+ + + N +Q L + +++ +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDLDISMRSV 57
Query: 809 RHRNIVKFHG---------FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINV 859
V F+G C + L Y + D K I V
Sbjct: 58 DCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK-------IAV 110
Query: 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA-KFVEPYSSNRTEFV 918
+ AL YLH S+IHRD+ NVL++ + + DFGI+ V+ S +T
Sbjct: 111 --SIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDA 164
Query: 919 GTFGYAAPE--------IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM 970
G Y APE Y +++ DV+S G+ + E+ G P D S+
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKS----DVWSLGITMIELATGRFPYD-------SWKTP 213
Query: 971 IIEVNQILDPRLSTPSPGV-MDKL-ISIMEVAILCLDESPEARPT 1013
++ Q+++ PSP + +K + CL ++ + RP
Sbjct: 214 FQQLKQVVE----EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 34/208 (16%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDE-----FLNVVLALNEIRHRN 812
IG+G G VYKA + + + +A+KK + +DE + + L E++H N
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIR-------LEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 813 IVKFHGFCSNARHSFLVCEYL------HRGSLARILGNDATAKELSWNRRINVIKGVANA 866
IV+ + + +LV EYL H S N K + +++G+A
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY----QILRGIA-- 116
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEA-HVSDFGIAK-FVEPYSSNRTEFVGTFGYA 924
Y H ++HRD+ +N+L+D A ++DFG+A+ F P + E V T Y
Sbjct: 117 --YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYR 170
Query: 925 APEIAYTMRA-TEKYDVYSFGVLVFEVI 951
APEI R + D++S G + E++
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 65/243 (26%), Positives = 111/243 (45%), Gaps = 21/243 (8%)
Query: 759 IGKGGQGSVYKAELPS-GDIVAVKKFN-SQLLSGN-----MADQDEFLNVVLALNEIRHR 811
IGKG G V A+ + G AVK +L MA++ NV+L ++H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAER----NVLL--KNVKHP 56
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
+V H A + V +Y++ G L L + + R +A+AL YLH
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLH 113
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
+II+RD+ +N+LLD + ++DFG+ K +S + F GT Y APE+
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 932 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991
D + G +++E++ G P F+S + + + I+ L P +S + +++
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP--FYSRDTAEMYDNILNKPLRLKPNISVSARHLLE 228
Query: 992 KLI 994
L+
Sbjct: 229 GLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 56/206 (27%), Positives = 83/206 (40%), Gaps = 21/206 (10%)
Query: 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE------IRHR 811
+GKGG G V ++ +G + A KK + + L +Q +ALNE + R
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQ-------MALNEKKILEKVSSR 53
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
IV LV ++ G L + N R I + L +LH
Sbjct: 54 FIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH 112
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE-PYSSNRTEFVGTFGYAAPEIAY 930
I++RD+ +NVLLD +SD G+A VE GT GY APE+
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQ 167
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHP 956
D ++ G ++E+I G P
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 3e-10
Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 40/215 (18%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKK----FNSQLLSGNMAD-QDEFLNVVLALNEIR-HR 811
+GKG G V+KA + + ++VA+KK F N D Q F ++ L E+ H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAF------RNATDAQRTFREIMF-LQELGDHP 67
Query: 812 NIVKFHGF--CSNARHSFLVCEY----LHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
NIVK N + +LV EY LH A IL +++ + ++ +
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL------EDV---HKRYIMYQLLK 118
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR-----TEFVGT 920
AL Y+H ++IHRD+ N+LL+ + ++DFG+A+ + N T++V T
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 921 FGYAAPEI--AYTMRATEKYDVYSFGVLVFEVIKG 953
Y APEI T R T+ D++S G ++ E++ G
Sbjct: 176 RWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNV------VLA 804
DF+ +GKG G V AE + ++ A+K +L ++ QD+ + VLA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK-----ILKKDVVIQDDDVECTMVEKRVLA 55
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
L + + + + H + V EY++ G L + KE + + ++
Sbjct: 56 LQD-KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEIS 111
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK--FVEPYSSNRTEFVGTFG 922
L +LH II+RD+ NV+LD E ++DFG+ K V+ ++ RT F GT
Sbjct: 112 VGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT-RT-FCGTPD 166
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 958
Y APEI + D +++GVL++E++ G P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 73/280 (26%), Positives = 114/280 (40%), Gaps = 63/280 (22%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFL---NVVLALNEIRHRNIV 814
IG G G VYK +G ++AVK+ +GN + L +VVL ++ + IV
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRR---TGNKEENKRILMDLDVVLKSHDCPY--IV 77
Query: 815 KFHG-FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRIN----------VIKGV 863
K +G F +++ +C L L ++L +RI + +
Sbjct: 78 KCYGYFITDS--DVFICMELMSTCLDKLL------------KRIQGPIPEDILGKMTVAI 123
Query: 864 ANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF-VEPYSSNRTEFVGT 920
AL YL H +IHRD+ N+LLD + DFGI+ V+ S +T G
Sbjct: 124 VKALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD--SKAKTRSAGC 177
Query: 921 FGYAAPE--------IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 972
Y APE Y +RA DV+S G+ + E+ G P + + F +
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRA----DVWSLGISLVELATGQFP---YKNCKTEFEVLTK 230
Query: 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARP 1012
+ +P P+ G S ++ LCL + RP
Sbjct: 231 ILQ--EEPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 89/336 (26%), Positives = 136/336 (40%), Gaps = 42/336 (12%)
Query: 293 LSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGL-YLNQLNGVIPPSIGN-----LSSLRN 346
LSS TL + S++ + P + S L +N+L + + LS L +
Sbjct: 12 LSSNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLS 71
Query: 347 LSLFNNGL--YGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFG 404
L L + E + L L L L N L I + LT L L++ N++
Sbjct: 72 LDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNIT- 129
Query: 405 PIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKL 464
IP + L S + +N + + + PNL LDLS N+ + NL L
Sbjct: 130 DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188
Query: 465 DTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSG 524
+ +S N I +P EI S L+ LDLS+N I+ ++ L L +L+ L LS N+L
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE- 245
Query: 525 SVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHL 584
+P G+L+ L+ LDLS N++SS L +L
Sbjct: 246 DLPESIGNLSNLETLDLSNNQISSISS--------------------------LGSLTNL 279
Query: 585 SKLDLSHNILQEEIPP--QVCNMESLEKLNLSHNNL 618
+LDLS N L +P + + L L
Sbjct: 280 RELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKA 315
|
Length = 394 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 4e-10
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 11/206 (5%)
Query: 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
DF +G+GG G V+ A+ +G+IVA+K+ LL + + L L +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKS 60
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
+VK + + +L EY+ G +L N E R + + A+ L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH--ARFYMAEMFE-AVDAL 117
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY 930
H IHRD+ +N L+D ++DFG++K + Y+++ VG+ Y APE+
Sbjct: 118 HE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS---VVGSPDYMAPEVLR 171
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHP 956
D +S G +++E + G P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G VYKA+ ++A K + + + + ++++ + L H NIVK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKV---IDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELS---WNRRINVI-KGVANALSYLHHDC 874
+ +++ E+ G++ DA EL +I V+ K AL+YLH +
Sbjct: 70 AFYYENNLWILIEFCAGGAV------DAVMLELERPLTEPQIRVVCKQTLEALNYLHEN- 122
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA 934
IIHRD+ + N+L L+ + ++DFG++ R F+GT + APE+ +
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 935 TE-----KYDVYSFGVLVFEVIKGNHP 956
+ K DV+S G+ + E+ + P
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 11/216 (5%)
Query: 759 IGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG G V A+ S G AVK + + + L ++H +V H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
A + V +Y++ G L L + E R VA+A+ YLH +
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE---PRARFYAAEVASAIGYLHS---LN 116
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAYTMRATE 936
II+RD+ +N+LLD + ++DFG+ K VEP + T F GT Y APE+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYDR 175
Query: 937 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 972
D + G +++E++ G P F+S + S + I+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP--FYSRDVSQMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H NIV G C+ ++ EY G L L L+ ++ VA +++
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAF 156
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF---GYAAP 926
L + IHRD++++NVLL + DFG+A+ + SN + AP
Sbjct: 157 LASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIM-NDSNYVVKGNARLPVKWMAP 212
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985
E + T + DV+S+G+L++E+ G++P ++ S F +I E ++ P +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIKEGYRMAQPEHAP- 270
Query: 986 SPGVMDKLISIMEVAILCLDESPEARPT 1013
++ IM+ C D P RPT
Sbjct: 271 -----AEIYDIMKT---CWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 37/212 (17%)
Query: 755 EKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDE-----FLNVVLALNEI 808
EK IG+G G VYKA + +G+IVA+KK + +DE + + L E+
Sbjct: 5 EK--IGEGTYGVVYKARDKLTGEIVALKKIR-------LETEDEGVPSTAIREISLLKEL 55
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG----VA 864
H NIV+ + +LV E+L L + + ++ + + IK +
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMD---SSPLTGLDPPL--IKSYLYQLL 109
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGY 923
++Y H ++HRD+ +N+L+D E ++DFG+A+ F P + E V T Y
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWY 165
Query: 924 AAPEIAYTMRATEKY----DVYSFGVLVFEVI 951
APEI + + +Y D++S G + E++
Sbjct: 166 RAPEI---LLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 57/192 (29%), Positives = 89/192 (46%), Gaps = 39/192 (20%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR------HR 811
IG+G G V+KA + IVA+KK M ++ E + AL EI+ H
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVL-------MENEKEGFPIT-ALREIKILQLLKHE 71
Query: 812 NIVKFHGFC-------SNARHSF-LV---CEYLHRGSLARILGNDATAKELSWNRRINVI 860
N+V C + + SF LV CE+ LA +L N LS ++ V+
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH----DLAGLLSNKNVKFTLSEIKK--VM 125
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEF-- 917
K + N L Y+H + I+HRD+ + N+L+ + ++DFG+A+ F +S +
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 918 -VGTFGYAAPEI 928
V T Y PE+
Sbjct: 183 RVVTLWYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 752 DFDEKFCIGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADQDEFLNV------VLA 804
DF+ +GKG G V AE D + A+K +L ++ QD+ + VLA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK-----ILKKDVIIQDDDVECTMVEKRVLA 55
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
L + + + H + V EY++ G L + KE + +A
Sbjct: 56 LPG-KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIA 111
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGY 923
L +LH II+RD+ NV+LD E ++DFG+ K + + RT F GT Y
Sbjct: 112 IGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDY 167
Query: 924 AAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 958
APEI + D ++FGVL++E++ G P D
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 65/218 (29%), Positives = 92/218 (42%), Gaps = 29/218 (13%)
Query: 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
DF+ +G G G V A+ +G+ A+K + + M L E+ H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSH 77
Query: 811 RNIVK-FHGFCSNARHSFLVCEYLHRGSL------ARILGNDATAKELSWNRRINVIKGV 863
IV F R FL+ E++ G L A ND AK +
Sbjct: 78 PFIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPND-VAKFYHAE--------L 127
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT-EFVGTFG 922
A YLH II+RD+ +N+LLD + V+DFG AK V +RT GT
Sbjct: 128 VLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPE 180
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 960
Y APE+ + + D ++ GVL++E I G P FF
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP--FF 216
|
Length = 329 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 68/284 (23%), Positives = 124/284 (43%), Gaps = 44/284 (15%)
Query: 759 IGKGGQGSVYKAELPSGDI--------VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+G+G G V AE D VAVK S +++D + ++ + +H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG--KH 83
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILG-------------NDATAKELSWNRRI 857
+NI+ G C+ +++ EY +G+L L ++LS+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE--PYSSNRT 915
+ VA + YL IHRD++++NVL+ + ++DFG+A+ + Y T
Sbjct: 144 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-EV 974
+ APE + T + DV+SFGVL++E+ F++ S + + + E+
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI---------FTLGGSPYPGVPVEEL 251
Query: 975 NQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
++L R+ PS ++L +M C P RPT ++
Sbjct: 252 FKLLKEGHRMDKPS-NCTNELYMMMRD---CWHAVPSQRPTFKQ 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DDF++ +G G G V K PSG I+A K + L A +++ + + L+E
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH---LEIKPAIRNQIIRELKVLHECN 57
Query: 810 HRNIVKFHG-FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNR-RINVIKGVANAL 867
IV F+G F S+ S + E++ GSL ++L E + I V++G L
Sbjct: 58 SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENILGKISIAVLRG----L 112
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
+YL I+HRD+ N+L++ E + DFG++ + S FVGT Y +PE
Sbjct: 113 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPE 168
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
T + D++S G+ + E+ G +P
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 35/220 (15%)
Query: 759 IGKGGQGSVYKAE----LPSGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
IG+G G V++A LP +VAVK + S +M Q +F + E H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADM--QADFQREAALMAEFDHPN 69
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDATAKE------------------LSW 853
IVK G C+ + L+ EY+ G L L A+ LS
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 854 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPY 910
++ + K VA ++YL +HRD++++N L+ ++DFG+++ + + Y
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEV 950
++ + + + PE + R T + DV+++GV+++E+
Sbjct: 187 KASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 759 IGKGGQGSVYKAE------LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G G V KA VAVK + + ++ + L+ L ++ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE---NASSSELRDLLSEFNLLKQVNHPH 64
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSL------ARILGNDATAKELSWNRR---------- 856
++K +G CS L+ EY GSL +R +G + + N
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 857 -----INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV--EP 909
I+ ++ + YL ++HRD++++NVL+ + +SDFG+++ V E
Sbjct: 125 TMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHP 956
R++ + A E + T + DV+SFGVL++E++ G +P
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 56/164 (34%), Positives = 83/164 (50%), Gaps = 6/164 (3%)
Query: 460 NLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKL-FSLNKLILS 518
+ N S E+ + + L LDL +N+I IP + L +L +L LS
Sbjct: 90 LNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLS 148
Query: 519 LNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEF 578
N++ S+P +L L+ LDLS N LS +PK + NL L L+LS N+ S +P E
Sbjct: 149 DNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEI 205
Query: 579 EKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFI 622
E L L +LDLS+N E+ + N+++L L LS+N L
Sbjct: 206 ELLSALEELDLSNN-SIIELLSSLSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
L LH + I++RD+ +N+LLD +SD G+A V P VGT GY A
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMA 169
Query: 926 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
PE+ R T D ++ G L++E+I G P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 66/275 (24%), Positives = 126/275 (45%), Gaps = 37/275 (13%)
Query: 759 IGKGGQGSVYKAELPSGDI---VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
+G+G GSV + +L D VAVK + + ++ ++FL+ + + E H N+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 816 FHGFC--SNARHSF----LVCEYLHRGSLARIL-----GNDATAKELSWNRRINVIKGVA 864
G C + + ++ ++ G L L G+ + L + + +A
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD--CPQYLPTQMLVKFMTDIA 122
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYSSNRTEFVGTF 921
+ + YL S IHRD++++N +L+ V+DFG++K + + Y R +
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEV-IKGNHPRDFFSINFSSFSNMIIEVNQILDP 980
A +A + T K DV+SFGV ++E+ +G P + + S + + + N++ P
Sbjct: 180 WIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTP--YPGVENSEIYDYLRQGNRLKQP 236
Query: 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
P +D L S+M C +P+ RP+ E
Sbjct: 237 ------PDCLDGLYSLMSS---CWLLNPKDRPSFE 262
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 753 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR 811
F + +GKGG G V ++ +G + A K+ + + + LN L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA-LNEKQILEKVNSQ 60
Query: 812 NIVKFHGFCSNARHSF-LVCEYLHRGSLA---RILGNDATAKELSWNRRINVIKGVANAL 867
+V + + + LV ++ G L +GN +E R + + L
Sbjct: 61 FVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE----RALFYAAEILCGL 115
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
LH + + ++RD+ +N+LLD +SD G+A + S R VGT GY APE
Sbjct: 116 EDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-VGTVGYMAPE 171
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
+ R T D + G L++E+I+G P
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 759 IGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
+GKG GSV +A+L S VAVK + + S +D +EFL + E H N++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS--SDIEEFLREAACMKEFDHPNVI 64
Query: 815 KFHGFCSNARHS------FLVCEYLHRGSLARILGNDATAKE---LSWNRRINVIKGVAN 865
K G +R ++ ++ G L L +E L + + +A+
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
+ YL + IHRD++++N +L+ V+DFG++K + YS +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKI--YSGDYYRQGCASKLPV 179
Query: 926 PEIAYTMRATEKY----DVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP 980
+A A Y DV++FGV ++E++ +G P + + S N +I+ N
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--YAGVENSEIYNYLIKGN----- 232
Query: 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
RL P P ++ + +M C P+ RP+
Sbjct: 233 RLKQP-PDCLEDVYELM---CQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+GKG G V A L SG + AVK +L ++ QD+ +V + E R ++ + H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVK-----VLKKDVILQDD--DVECTMTEKRILSLARNH 55
Query: 818 GFCSN-------ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
F + F V E+++ G L + + ++ R + +AL +L
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFL 112
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY 930
H II+RD+ NVLLD E ++DFG+ K + F GT Y APEI
Sbjct: 113 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHP 956
M D ++ GVL++E++ G+ P
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 24/202 (11%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKK----FNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+G G G V A + +G VA+KK F++ +L+ + + L +RH NI
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK------HLRHENI 71
Query: 814 VKFHG-FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+ F S + V E L L R+L + K+ +++G L Y+H
Sbjct: 72 ISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRG----LKYVHS 126
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT- 931
++HRD+ N+L++ + + DFG+A+ +P T +V T Y APEI T
Sbjct: 127 ---AGVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTW 180
Query: 932 MRATEKYDVYSFGVLVFEVIKG 953
+ + D++S G + E+++G
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-09
Identities = 42/158 (26%), Positives = 67/158 (42%), Gaps = 19/158 (12%)
Query: 808 IRHRNIVKF--HGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
+ H NIV G F V EY+ +L +L D L ++ V +
Sbjct: 35 LYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADGA---LPAGETGRLMLQVLD 90
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFGIAKFV-------EPYSSNRT 915
AL+ H+ I+HRD+ +N+++ + A V DFGI + + T
Sbjct: 91 ALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 953
E +GT Y APE T D+Y++G++ E + G
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQL-LSGNMADQDEFLNVVLALNEIRHRNIVKF 816
IG G G+VYKA + SG VA+K Q G + ++ L H NIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 817 HGFCSNARHS-----FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
C+ +R LV E++ + R + L ++++ L +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQD--LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
+C I+HRD+ +N+L+ + ++DFG+A+ + T V T Y APE+
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 932 MRATEKYDVYSFGVLVFEVIK 952
D++S G + E+ +
Sbjct: 182 STYATPVDMWSVGCIFAEMFR 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKA--ELPSGDI--VAVKKFNSQLLSGNMADQDEFLNVVLALN 806
+D CIG+G G VY+ P + VAVK + + + +++FL +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMR 62
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
+ H +IVK G + ++V E G L L + L I ++ A
Sbjct: 63 QFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTA 119
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFGY 923
L+YL +HRDI+++NVL+ + DFG+++++E Y +++ + +
Sbjct: 120 LAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKW 174
Query: 924 AAPEIAYTMRATEKYDVYSFGVLVFEVI 951
APE R T DV+ FGV ++E++
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 13/136 (9%)
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYA 924
AL +LH I++RDI +N+LLD E ++DFG++K F+ F GT Y
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 925 APEIAYTMRATEK-YDVYSFGVLVFEVIKGNHPRDFFSI-----NFSSFSNMIIEVNQIL 978
APEI K D +S G+L+FE++ G P F++ S S I++ +
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP---FTLEGERNTQSEVSRRILKCDPPF 230
Query: 979 DPRLSTPSPGVMDKLI 994
+ + ++ KL+
Sbjct: 231 PSFIGPEAQDLLHKLL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 66/250 (26%), Positives = 103/250 (41%), Gaps = 24/250 (9%)
Query: 759 IGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-----RHRN 812
IG+G V L + I A+K +L+ + DE ++ V + H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELV-----NDDEDIDWVQTEKHVFEQASNHPF 57
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+V H F V EY++ G L + + ++L ++ AL+YLH
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM 932
II+RD+ NVLLD E ++D+G+ K + F GT Y APEI
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 933 RATEKYDVYSFGVLVFEVIKGNHPRDFFSI------NFSSFSNMIIEVNQILDPR-LSTP 985
D ++ GVL+FE++ G P D N + +I QI PR LS
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231
Query: 986 SPGVMDKLIS 995
+ V+ ++
Sbjct: 232 AASVLKSFLN 241
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 63/274 (22%), Positives = 118/274 (43%), Gaps = 32/274 (11%)
Query: 759 IGKGGQGSVYKAELPSGDI----VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
+G+G GSV + +L D VAVK + + ++ +EFL+ + + H N++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNVM 64
Query: 815 KFHGFC--SNARHSF----LVCEYLHRGSLARILGNDATA---KELSWNRRINVIKGVAN 865
K G C +++ ++ ++ G L L ++L + + +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF--GY 923
+ YL + + IHRD++++N +L + V+DFG++K + R + +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 924 AAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
A E T K DV++FGV ++E+ +G P + + + + N RL
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHEIYDYLRHGN-----RL 234
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
P +D+L +M C P+ RPT K
Sbjct: 235 KQP-EDCLDELYDLM---YSCWRADPKDRPTFTK 264
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 35/212 (16%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKK---FNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
IG+G G V A P+G VA+KK F Q L + L +H NI+
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT------LREIKILRRFKHENII 66
Query: 815 KFHGF-CSNARHSF----LVCEY----LHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
+ SF +V E L++ + L ND L R
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR--------- 117
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFG 922
L Y+H +++HRD+ N+LL+ + + DFG+A+ +P ++ TE+V T
Sbjct: 118 GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 923 YAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKG 953
Y APEI + T+ D++S G ++ E++
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 66/246 (26%), Positives = 116/246 (47%), Gaps = 29/246 (11%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKF- 816
IGKG G V A + +G+ VA+KK N + +++D L + L +RH +IV+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIND--VFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 817 HGFCSNARHSF---LVCEYLHRGSLARILG-NDATAKELSWNRRINVIKGVANALSYLHH 872
H +R F V L L +++ ND E +++ L Y+H
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRA----LKYIHT 121
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYSSNRTEFVGTFGYAAPEI- 928
++ HRD+ KN+L + + + + DFG+A+ P + T++V T Y APE+
Sbjct: 122 ---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 929 -AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987
++ + T D++S G + EV+ G + F N++ +++ I D L TPSP
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTG---KPLF-----PGKNVVHQLDLITD-LLGTPSP 229
Query: 988 GVMDKL 993
+ ++
Sbjct: 230 ETISRV 235
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-09
Identities = 32/85 (37%), Positives = 40/85 (47%)
Query: 539 LDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEI 598
L L L IP I L L +NLS N IP + L LDLS+N I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 599 PPQVCNMESLEKLNLSHNNLSGFIP 623
P + + SL LNL+ N+LSG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 35/94 (37%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT-EFVGTFGYA 924
AL +LH II+RDI +N+LLD E ++DFG++K R F GT Y
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 925 APEIAYTMRA--TEKYDVYSFGVLVFEVIKGNHP 956
APE+ + D +S GVL FE++ G P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 14/241 (5%)
Query: 759 IGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
+GKGG G V++ +G I A+K + N D L ++H IV
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 815 KFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC 874
+L+ EYL G L L + E + + ++ AL +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFME---DTACFYLSEISLALEHLHQQ- 119
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAYTMR 933
II+RD+ +N+LLD + ++DFG+ K + + T F GT Y APEI
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILMRSG 176
Query: 934 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKL 993
+ D +S G L+++++ G P F + N + I++ L P L+ + ++ KL
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPP--FTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKL 234
Query: 994 I 994
+
Sbjct: 235 L 235
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 32/212 (15%)
Query: 759 IGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
+ K G+GS KA L G +K+ N +S +++E V L+ ++H NIV
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK--EREESRKEVAVLSNMKHPNIV 62
Query: 815 KFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA----NALSYL 870
++ + ++V +Y G L + +IN +GV L +
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYK---------------KINAQRGVLFPEDQILDWF 107
Query: 871 HHDCLP-------SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGY 923
CL I+HRDI S+N+ L + + DFGIA+ + +GT Y
Sbjct: 108 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 924 AAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 955
+PEI K D+++ G +++E+ H
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 4e-09
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 39/211 (18%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA-----LNEIRHRN 812
+G+G VYKA +G IVA+KK + G + + +N L E++H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKK----IKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 813 IVKFHG-FCSNARHSFLVCEYLHRGSLARILGN------DATAKELSWNRRINVIKGVAN 865
I+ F + + LV E++ L +++ + A K S+ +
Sbjct: 64 IIGLLDVFGHKSNIN-LVFEFME-TDLEKVIKDKSIVLTPADIK--SY------MLMTLR 113
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYA 924
L YLH + I+HRD+ N+L+ + ++DFG+A+ F P + T V T Y
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-NRKMTHQVVTRWYR 169
Query: 925 APEIAYTMRATEKY----DVYSFGVLVFEVI 951
APE+ + Y D++S G + E++
Sbjct: 170 APELLF---GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 752 DFDEKFCIGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADQDEFLNV------VLA 804
DF+ +GKG G V AE D + A+K +L ++ QD+ + VLA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK-----ILKKDVVIQDDDVECTMVEKRVLA 55
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
L+ + + + H + V EY++ G L + KE + +A
Sbjct: 56 LSG-KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE---PHAVFYAAEIA 111
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA 924
L +LH II+RD+ NV+LD E ++DFG+ K F GT Y
Sbjct: 112 IGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYI 168
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 958
APEI + D ++FGVL++E++ G P +
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 36/277 (12%)
Query: 759 IGKGGQGSVYKAELPSG---DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
IG G G V E+ SG V VK+ S ++ +Q +FL ++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRV---SASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI--NVIKGVANALSYLHHD 873
G C+ LV E+ G L L + A+ ++ + + +A L +LH +
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIA--KFVEPYSSNRTEFVGTFGYAAPEIAYT 931
+ IH D++ +N LL + + D+G++ K+ E Y + + APE+
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 932 MRA-------TEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983
+ T++ +V+S GV ++E+ + G+ P + S+ + + + +L
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQP-------YRHLSDEQVLTYTVREQQLK 229
Query: 984 TPSPGVM----DKLISIMEVAILCLDESPEARPTMEK 1016
P P + D+ +M+ L PE RP+ E+
Sbjct: 230 LPKPRLKLPLSDRWYEVMQFCWL----QPEQRPSAEE 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK-- 815
+G G GSV A + +G+ VA+KK + S A + + + L L ++H N++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR-AYRELTL-LKHMQHENVIGLL 80
Query: 816 --------FHGFCSNARHSF-LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
F F LV Y+ + L +I+G+ LS ++ ++ +
Sbjct: 81 DVFTSAVSGDEF-----QDFYLVMPYM-QTDLQKIMGH-----PLSEDKVQYLVYQMLCG 129
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAP 926
L Y+H IIHRD+ N+ ++ + E + DFG+A+ + + T +V T Y AP
Sbjct: 130 LKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD---AEMTGYVVTRWYRAP 183
Query: 927 EIAYT-MRATEKYDVYSFGVLVFEVIKG 953
E+ M + D++S G ++ E++ G
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 10/204 (4%)
Query: 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+GKGG G V ++ +G + A KK + + L ++ L + L ++ IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-LEKVNSPFIVNLA 59
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+ H LV ++ G L + N + L R I+ + + +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVE-PYSSNRTEFVGTFGYAAPEIAYTMRATE 936
I++RD+ +NVLLD + +SD G+A VE T+ GT GY APEI +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 937 KYDVYSFGVLVFEVIKGNHP-RDF 959
D ++ G ++E++ G P +D
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 64/244 (26%), Positives = 117/244 (47%), Gaps = 32/244 (13%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG G QG V A + G VAVKK + + A + + +VL L + H+NI+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR-AYRELVL-LKCVNHKNIISLL 86
Query: 818 GFCSNAR------HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
+ + +LV E L +L +++ + + +S+ ++ + + +LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVME-LMDANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH 140
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIA 929
IIHRD+ N+++ + + DFG+A+ +N T +V T Y APE+
Sbjct: 141 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVI 194
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
M E D++S G ++ E++KG S+ F ++ I + N++++ +L TPS
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG-------SVIFQG-TDHIDQWNKVIE-QLGTPSAEF 245
Query: 990 MDKL 993
M++L
Sbjct: 246 MNRL 249
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 32/228 (14%)
Query: 796 DEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNR 855
+ F ++++ H+++V +G C S +V EY+ GSL L + +SW
Sbjct: 44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW-- 101
Query: 856 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH--------VSDFGIAKFV 907
++ V K +A AL +L + H ++ +KNVLL E + +SD GI+ V
Sbjct: 102 KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158
Query: 908 EPYSSNRTEFVGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVIKG-NHPRDFFSINFS 965
P + + + PE I + D +SFG ++E+ G + P
Sbjct: 159 LP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS----ALD 210
Query: 966 SFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
S + Q + R P+P K + + C+D P+ RP+
Sbjct: 211 SQKKL-----QFYEDRHQLPAP----KWTELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN---RTEFVGTFGYAAP 926
+HH +IHRDI S N+LL + DFG +K S+ RT F GT Y AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAP 214
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
EI ++K D++S GVL++E++ P D ++ M + DP + S
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME----EVMHKTLAGRYDPLPPSIS 270
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILAI 1035
P M ++++ A+L D P+ RP+ K I C ++ +L I
Sbjct: 271 PE-MQEIVT----ALLSSD--PKRRPSSSKLLNMPI--CKLFISGLLEI 310
|
Length = 496 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 9e-09
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 43/214 (20%)
Query: 759 IGKGGQGSV-YKAELPSGDIVAVKK----FNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+G G G+V + +G VA+KK F S+L + + + L ++H N+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRE------LRLLKHMKHENV 76
Query: 814 V-------------KFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVI 860
+ +FH F YL + LG ++LS +R ++
Sbjct: 77 IGLLDVFTPDLSLDRFHDF------------YLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGT 920
+ L Y+H IIHRD+ N+ ++ + E + DFG+A+ + S T +V T
Sbjct: 125 YQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD---SEMTGYVVT 178
Query: 921 FGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKG 953
Y APE+ M T+ D++S G ++ E++ G
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+V H FLV EY++ G L + + ++L + AL++LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAYT 931
II+RD+ NVLLD + ++D+G+ K + P + T F GT Y APEI
Sbjct: 115 R---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRG 170
Query: 932 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 963
D ++ GVL+FE++ G P D + N
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 46/196 (23%), Positives = 85/196 (43%), Gaps = 26/196 (13%)
Query: 769 KAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828
K ELP VA+ + + + FL L L + H NIV+ G + +
Sbjct: 31 KRELP----VAIHTLRA---GCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83
Query: 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNV 888
V EY+ G+L L +L + + ++ G+A+ + YL +H+ +++ V
Sbjct: 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKV 138
Query: 889 LLDLEFEAHVSDFGIAKFVEPYSSNRTEFV-GTFG------YAAPEIAYTMRATEKYDVY 941
L++ + +S F +++E + T +AAPE + DV+
Sbjct: 139 LVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVW 192
Query: 942 SFGVLVFEVIK-GNHP 956
SFG++++EV+ G P
Sbjct: 193 SFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 859 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF--VEPYSSNRTE 916
+ K + L YLH IIHRD+ ++N+ ++ + + D G A+F V P
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLG 215
Query: 917 FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 966
GT APE+ + K D++S G+++FE++ +P F S+
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 48/137 (35%), Positives = 70/137 (51%), Gaps = 20/137 (14%)
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYA 924
AL++LH II+RD+ NVLLD E ++D+G+ K + P + T F GT Y
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163
Query: 925 APEIAYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSN------MIIEV 974
APEI +R E Y D ++ GVL+FE++ G P D ++ + N +I
Sbjct: 164 APEI---LRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219
Query: 975 NQILDPR-LSTPSPGVM 990
QI PR LS + V+
Sbjct: 220 KQIRIPRSLSVKASSVL 236
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGDI--VAVKKF-NSQLLSGNMADQDEFLNVVLALNE 807
+DF+ +G G G V A + D VA+K+F S+++ D + LN
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH--VFSERKILNY 87
Query: 808 IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI-NVIKGVANA 866
I H V +G + + +LV E++ G L N+R N + A
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR---------NKRFPNDVGCFYAA 138
Query: 867 LSYLHHDCLPS--IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA 924
L + L S I++RD+ +N+LLD + ++DFG AK V+ + GT Y
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD---TRTYTLCGTPEYI 195
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
APEI + + D ++ G+ ++E++ G P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 72/298 (24%), Positives = 132/298 (44%), Gaps = 57/298 (19%)
Query: 745 EIIKATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEF 798
EI +T F E+ +G+ G VYK L VA+K + ++EF
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEF 55
Query: 799 LNVVLALNEIRHRNIVKFHG-------------FCSNAR-HSFLVCEYLHR--GSLARIL 842
+ + + ++H NIV G +CS++ H FLV H GS
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGST---- 111
Query: 843 GNDATAKE-LSWNRRINVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVS 899
+D T K L ++++ +A + +L HH ++H+D++++NVL+ + +S
Sbjct: 112 DDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKIS 166
Query: 900 DFGIAKFVEPYSSNRTEFVGT----FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GN 954
D G+ F E Y+++ + +G + +PE + + D++S+GV+++EV G
Sbjct: 167 DLGL--FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 955 HPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARP 1012
P + +SN +V +++ R P P D + + + C +E P RP
Sbjct: 225 QP-------YCGYSNQ--DVIEMIRNRQVLPCPD--DCPAWVYTLMLECWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAP 926
L LH + I++RD+ +N+LLD +SD G+A + + R VGT GY AP
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR-VGTVGYMAP 170
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
E+ R T D + G L++E+I+G P
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFL----NVVLALNEIRHRNI 813
IGKG G V+K +G AVK + + D DE + N++ AL++ H N+
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP------IHDIDEEIEAEYNILKALSD--HPNV 77
Query: 814 VKFHGF-----CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRIN--VIKGVAN- 865
VKF+G N +LV E + GS+ D L R+ +I + +
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVT-----DLVKGFLKRGERMEEPIIAYILHE 132
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
AL L H + IHRD+ N+LL E + DFG++ + R VGT + A
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 926 PE-IAYTMRATEKY----DVYSFGVLVFEVIKGNHP 956
PE IA + Y DV+S G+ E+ G+ P
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 40/273 (14%)
Query: 760 GKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGF 819
GK +G +Y + +VA+K N EF + E+ H NIV G
Sbjct: 19 GKIYKGHLYLPGMDHAQLVAIKTLKD---INNPQQWGEFQQEASLMAELHHPNIVCLLGV 75
Query: 820 CSNARHSFLVCEYLHRGSLARIL-------------GNDATAKE-LSWNRRINVIKGVAN 865
+ + ++ EYL++G L L D T K L +++ +A
Sbjct: 76 VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA 135
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN----RTEFVGTF 921
+ YL +H+D++++N+L+ + +SD G+++ E YS++ + + +
Sbjct: 136 GMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSR--EIYSADYYRVQPKSLLPI 190
Query: 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDP 980
+ PE + + D++SFGV+++E+ G P + FSN EV +++
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP-------YYGFSNQ--EVIEMVRK 241
Query: 981 RLSTPSP-GVMDKLISIMEVAILCLDESPEARP 1012
R P ++ S+M C E P RP
Sbjct: 242 RQLLPCSEDCPPRMYSLMTE---CWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G G V K + +IVA+KKF N ++ L + L ++ NIV+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 818 GFCSNARHSFLVCEYLHRGSLARI--LGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
+LV EY+ + L + + N +++ + I + A+ + H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-----SYIYQLIKAIHWCHKN-- 119
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAYTMRA 934
I+HRDI +N+L+ + DFG A+ E ++N TE+V T Y +PE+
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 935 TEKYDVYSFGVLVFEVIKG 953
+ D++S G ++ E+ G
Sbjct: 179 GKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 64/245 (26%), Positives = 111/245 (45%), Gaps = 26/245 (10%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+GKG G V E SG A+K +++ +DE V L E R + H
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIA----KDE---VAHTLTESRVLKNTR-H 54
Query: 818 GFCSNARHSF-------LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
F ++ ++SF V EY++ G L L + + S +R + +AL YL
Sbjct: 55 PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE---RVFSEDRTRFYGAEIVSALDYL 111
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY 930
H I++RD+ +N++LD + ++DFG+ K ++ F GT Y APE+
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR-LSTPSPGV 989
D + GV+++E++ G P F++ + +I+ + I PR LS + +
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHEKLFELIL-MEDIKFPRTLSADAKSL 225
Query: 990 MDKLI 994
+ L+
Sbjct: 226 LSGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG G VY+ + + I A+K + + + + + + I R ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-----AKKEVAHTIGERNILVRTLLDES 55
Query: 818 GFCSNARHSF-------LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
F + SF LV +Y+ G L L + E +R I + AL +L
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE---DRAKFYIAELVLALEHL 112
Query: 871 H-HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
H +D I++RD+ +N+LLD + DFG++K + F GT Y APE+
Sbjct: 113 HKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 930 YTMRA-TEKYDVYSFGVLVFEVIKGNHP 956
+ T+ D +S GVLVFE+ G P
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 759 IGKGGQGSVYKA---ELPSGDI---VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G G VY+ ++ G+ VAVK N S ++ ++ EFLN + +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 70
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLA---RILGNDA---------TAKELSWNRRINVI 860
+V+ G S + + +V E + G L R L +A T +E+ I +
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM-----IQMA 125
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGT 920
+A+ ++YL+ +HRD++++N ++ +F + DFG+ + + R G
Sbjct: 126 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 921 F--GYAAPEIAYTMRATEKYDVYSFGVLVFEV 950
+ APE T D++SFGV+++E+
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-08
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 45/227 (19%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLN------VVL----ALNE 807
+G+G G V KA +G IVA+KK +S ++ + + L +NE
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 808 IRHRNIVKFHG-FCSNARHSF--LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
I+H NI+ + F LV + + L +++ L+ ++ ++ +
Sbjct: 77 IKHENIMGLVDVYVEG---DFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQIL 129
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA-KFVEP----------YSSN 913
N L+ LH +HRD+S N+ ++ + ++DFG+A ++ P
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 914 RTEF---VGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKG 953
R E V T Y APE+ + EKY D++S G + E++ G
Sbjct: 187 REEMTSKVVTLWYRAPEL---LMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 63/269 (23%), Positives = 106/269 (39%), Gaps = 60/269 (22%)
Query: 751 DDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA- 804
D ++ IG G G V A + SG VA+KK F LA
Sbjct: 1 FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-----------PHAFDVPTLAK 49
Query: 805 --------LNEIRHRNIVK----FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELS 852
L +H NI+ ++ + ++V + L L I+ +D E
Sbjct: 50 RTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTE-- 106
Query: 853 WNRRIN-----VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-- 905
I +++G L Y+H +IHRD+ N+L++ + E + DFG+A+
Sbjct: 107 --EHIRYFLYQLLRG----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 906 --FVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSI 962
+ TE+V T Y APE+ ++ T D++S G + E++ F
Sbjct: 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL--FPGK 215
Query: 963 NFSSFSNMIIEVNQILDPRLSTPSPGVMD 991
N+ +I+ V L +PS V++
Sbjct: 216 NYVHQLKLILSV-------LGSPSEEVLN 237
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-08
Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 520 NQ-LSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEF 578
NQ L G +P + L LQ ++LS N + +IP S+G++ L L+LS N F+ +IP
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 579 EKLIHLSKLDLSHNILQEEIPPQV 602
+L L L+L+ N L +P +
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-08
Identities = 80/309 (25%), Positives = 122/309 (39%), Gaps = 57/309 (18%)
Query: 214 IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLH 273
+P+ + L SL L S L NL L +L L N L +I S + L +L
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGS-ENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLT 119
Query: 274 QLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGV 333
LDL N ++ PL S+ + L N + S+P L NL +L L L N L+
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-D 177
Query: 334 IPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLV 393
+P + NLS+L NL L N + +P EI L +L EL NN + S+ NL L
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEEL-DLSNNSIIELLSSLSNLKNLS 235
Query: 394 LLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGK 453
L N+ +P+S+ +L++L+ + + N +
Sbjct: 236 GLE-LSNNKLEDLPESIGNLSNLETLDLSNNQI--------------------------- 267
Query: 454 ISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLN 513
+ +L L + L+ LDLS N + +P+ L L
Sbjct: 268 --SSISSLGSL---------------------TNLRELDLSGNSLSNALPLIALLLLLLE 304
Query: 514 KLILSLNQL 522
L+ L L
Sbjct: 305 LLLNLLLTL 313
|
Length = 394 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 43/224 (19%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEF----LNVVLAL 805
D FD IG+G G VYKA + +G++VA+KK +++ F + + L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD------NEKEGFPITAIREIKIL 60
Query: 806 NEIRHRNIVKFH----------GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNR 855
++ HRNIV F + +LV EY+ L +L ++ S +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL--ESGLVHFSEDH 117
Query: 856 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE-----PY 910
+ +K + L+Y H + +HRDI N+LL+ + + ++DFG+A+ PY
Sbjct: 118 IKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 911 SSNRTEFVGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEV 950
+N+ V T Y PE+ + E+Y DV+S G ++ E+
Sbjct: 175 -TNK---VITLWYRPPEL---LLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYA 924
AL +LH II+RDI +N+LLD ++DFG++K F E F GT Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 925 APEIAYTMRA--TEKYDVYSFGVLVFEVIKGNHP 956
AP+I + D +S GVL++E++ G P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 759 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+GKGG G V ++ +G + A KK + + + LN L ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKRILEKVNSRFVVSL- 65
Query: 818 GFCSNARHSF-LVCEYLHRGSLA---RILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
+ + + LV ++ G L +GN ++ R I + L L +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ----RAIFYAAELCCGLEDLQRE 121
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMR 933
I++RD+ +N+LLD +SD G+A + + R VGT GY APE+ +
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR-VGTVGYMAPEVINNEK 177
Query: 934 ATEKYDVYSFGVLVFEVIKGNHP 956
T D + G L++E+I+G P
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 21/198 (10%)
Query: 801 VVLALNEIRH---RNIV---KFHGFCSNARHSF-------LVCEYLHRGSLARILGNDAT 847
V++A +E+ H N V H F + ++SF V EY + G L L +
Sbjct: 32 VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-- 89
Query: 848 AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907
+ S +R + +AL YLH + ++++RD+ +N++LD + ++DFG+ K
Sbjct: 90 -RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146
Query: 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 967
+ F GT Y APE+ D + GV+++E++ G P F++ +
Sbjct: 147 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHEKL 204
Query: 968 SNMIIEVNQILDPRLSTP 985
+I+ + +I PR +P
Sbjct: 205 FELIL-MEEIRFPRTLSP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 58/245 (23%), Positives = 91/245 (37%), Gaps = 53/245 (21%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI- 808
F + +GKG G V+ L +G + A+K +L + + VL EI
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALK-----VLDKKEMIKRNKVKRVLTEQEIL 55
Query: 809 ---RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNR-RINVIK--- 861
H + + + LV +Y G L R+L + V +
Sbjct: 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL------QRQPGKCLSEEVARFYA 109
Query: 862 -GVANALSYLHHDCLPSIIHRDISSKNVLL-----------DLEFEAHVSDFGIAK---- 905
V AL YLH L I++RD+ +N+LL DL ++ V ++K
Sbjct: 110 AEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 906 --------------FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 951
F E S FVGT Y APE+ D ++ G+L++E++
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
Query: 952 KGNHP 956
G P
Sbjct: 227 YGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 64/279 (22%), Positives = 120/279 (43%), Gaps = 41/279 (14%)
Query: 759 IGKGGQGSVYKAEL---PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
IG G G V +E+ V VK+ + + + +Q+EFL ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKA---NASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIK-------GVANALS 868
G C A LV EY G L L + W+RR + + +A ++
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVT 113
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI--AKFVEPYSSNRTEFVGTFGYAAP 926
++H + +H D++ +N L + V D+GI +++ E Y + + AP
Sbjct: 114 HMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 927 EIA-------YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQI-- 977
E+ T T+ +V++ GV ++E+ + N + + ++ N +I+ Q+
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-NAAQPYSHLSDREVLNHVIKDQQVKL 229
Query: 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
P+L P ++ +++ L SPE R T E+
Sbjct: 230 FKPQLELPYS---ERWYEVLQFCWL----SPEKRATAEE 261
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-08
Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 28/163 (17%)
Query: 863 VANALSYL-HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF 921
VA + +L +C IHRD++++NVLL A + DFG+A+ + N + +V
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM----NDSNYV-VK 271
Query: 922 GYA-------APEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIE 973
G A APE + T + DV+S+G+L++E+ G P +N S F M+
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKMVKR 330
Query: 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
Q+ P + P ++ SIM+ +C + P RPT +
Sbjct: 331 GYQMSRPDFAPP------EIYSIMK---MCWNLEPTERPTFSQ 364
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-08
Identities = 64/242 (26%), Positives = 116/242 (47%), Gaps = 28/242 (11%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK-F 816
IG G QG V A + +G VA+KK S+ + + +VL + + H+NI+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKL-SRPFQNVTHAKRAYRELVL-MKLVNHKNIIGLL 81
Query: 817 HGFCSNA-----RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
+ F + +LV E L +L +++ D + +S+ ++ + + +LH
Sbjct: 82 NVFTPQKSLEEFQDVYLVME-LMDANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLH 135
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
IIHRD+ N+++ + + DFG+A+ S T +V T Y APE+
Sbjct: 136 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILG 191
Query: 932 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991
M E D++S G ++ E+I+G ++ F ++ I + N+I++ +L TPS M
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRG-------TVLFPG-TDHIDQWNKIIE-QLGTPSDEFMS 242
Query: 992 KL 993
+L
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 23/201 (11%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G G V+ +V +K+ + ++ + ++ N L + H NI++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD--ERLAAQNECQVLKLLSHPNIIEYY 65
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRIN-------VIKGVANALSYL 870
+ +V EY G+LA + +R N ++ L L
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYI-----------QKRCNSLLDEDTILHFFVQILLAL 114
Query: 871 HHDCLPSIIHRDISSKNVLLDL-EFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
HH I+HRD+ ++N+LLD + + DFGI+K + S T VGT Y +PE+
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELC 173
Query: 930 YTMRATEKYDVYSFGVLVFEV 950
+K D+++ G +++E+
Sbjct: 174 EGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 6/200 (3%)
Query: 759 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+GKGG G V ++ +G + A KK N + L + + + L ++ R IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI-LAKVHSRFIVSLA 59
Query: 818 GFCSNARHSFLVCEYLHRGSLA-RILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
LV ++ G L I D R + + L +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATE 936
II+RD+ +NVLLD + +SD G+A ++ S + GT G+ APE+
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 937 KYDVYSFGVLVFEVIKGNHP 956
D ++ GV ++E+I P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 65/244 (26%), Positives = 108/244 (44%), Gaps = 32/244 (13%)
Query: 759 IGKGGQGSV---YKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
IG G QG V Y A L VA+KK + + A + + +VL + + H+NI+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKR-AYRELVL-MKCVNHKNIIS 80
Query: 816 FHGFCSNAR------HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
+ + +LV E L +L +++ EL R ++ + + +
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVME-LMDANLCQVI-----QMELDHERMSYLLYQMLCGIKH 134
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
LH IIHRD+ N+++ + + DFG+A+ S T +V T Y APE+
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
M E D++S G ++ E+++ H F ++ N +IE +L TP P
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVR--HKILFPGRDYIDQWNKVIE-------QLGTPCPEF 241
Query: 990 MDKL 993
M KL
Sbjct: 242 MKKL 245
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 41/212 (19%)
Query: 759 IGKGGQGS---VYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNI 813
+GK G+G+ V KA +G A+K S +Q L + AL + H NI
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LEQVNNLREIQALRRLSPHPNI 60
Query: 814 VKFHGFCSNARHS--FLVCEYLHRGSLARILGNDATAKELSWNRR--------INVIKGV 863
++ + + LV E + D EL R+ + + +
Sbjct: 61 LRLIEVLFDRKTGRLALVFELM-----------DMNLYELIKGRKRPLPEKRVKSYMYQL 109
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYSSNRTEFVGT 920
+L ++H + I HRDI +N+L+ + ++DFG + + PY TE++ T
Sbjct: 110 LKSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY----TEYIST 161
Query: 921 FGYAAPEIAYTM-RATEKYDVYSFGVLVFEVI 951
Y APE T K D+++ G + FE++
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-07
Identities = 42/173 (24%), Positives = 78/173 (45%), Gaps = 23/173 (13%)
Query: 800 NVVLALNEIRHRNIVKF--------HGFCSNARHSFLVCEYLHRGSLARILGNDATAKEL 851
N +LAL + H NI+K + + ++ F + +++ + D + L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265
Query: 852 SWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA-KFVEPY 910
R ++K + A+ Y+H L IHRDI +N+ L+ + + + DFG A F +
Sbjct: 266 LKQTR-AIMKQLLCAVEYIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 963
+ +VGT +PEI E D++S G+++ +++ DF I
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS----HDFCPIG 370
|
Length = 501 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 35/210 (16%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G +VYK +G+IVA+K+ + L + + + E++H NIV+ H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH---LDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 818 GFCSNARHSFLVCEYL------------HRGSLARILGNDATAKELSWNRRINVIKGVAN 865
LV EY+ RG+L + T K ++ ++KG+A
Sbjct: 65 DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGAL-----DPNTVKSFTYQ----LLKGIA- 114
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYA 924
+ H + ++HRD+ +N+L++ E ++DFG+A+ F P ++ E V T Y
Sbjct: 115 ---FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYR 167
Query: 925 APEIAYTMRA-TEKYDVYSFGVLVFEVIKG 953
AP++ R + D++S G ++ E+I G
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 20/240 (8%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G G GSV A + VAVKK + S + + L ++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLL 80
Query: 818 GFCSNARHSFLVCE-YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
+ A E YL + L N ++LS +I + L Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---A 137
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRAT 935
IIHRD+ NV ++ + E + DFG+A+ + T +V T Y APEI M
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLARQAD---DEMTGYVATRWYRAPEIMLNWMHYN 194
Query: 936 EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995
+ D++S G ++ E++KG + F N + I ++ +I++ + TPSP V+ K+ S
Sbjct: 195 QTVDIWSVGCIMAELLKG---KALFPGN-----DYIDQLKRIMEV-VGTPSPEVLKKISS 245
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 22/241 (9%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G G GSV A + +G VAVKK + S A + + L ++H N++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 82
Query: 818 GFCSNARHSFLVCE-YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
+ AR + YL + L N ++L+ + +I + L Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 139
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRAT 935
IIHRD+ N+ ++ + E + DFG+A+ + T +V T Y APEI M
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYN 196
Query: 936 EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS-TPSPGVMDKLI 994
+ D++S G ++ E++ G R F ++ I ++ IL RL TP ++ K+
Sbjct: 197 QTVDIWSVGCIMAELLTG---RTLF-----PGTDHIDQLKLIL--RLVGTPGAELLKKIS 246
Query: 995 S 995
S
Sbjct: 247 S 247
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 13/205 (6%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-VLALNEIRHRNIVKF 816
+G+G G VY ++ +G +A K+ S + + L + L ++H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 817 HGFCSNARHSFLVC--EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC 874
+G + L EY+ GS+ L E S R+ + + +SYLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE-SVTRKYT--RQILEGMSYLHSNM 126
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT---EFVGTFGYAAPEIAYT 931
I+HRDI N+L D + DFG +K ++ + T GT + +PE+
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 932 MRATEKYDVYSFGVLVFEVIKGNHP 956
K DV+S G V E++ P
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 26/200 (13%)
Query: 801 VVLALNEIRHRNIVKFHGFCSNARHSFL---------------VCEYLHRGSLARILGND 845
V++A +E+ H V N RH FL V EY + G L L +
Sbjct: 32 VIIAKDEVAH--TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE 89
Query: 846 ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905
E R + +AL YLH +++RDI +N++LD + ++DFG+ K
Sbjct: 90 RVFTE---ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 143
Query: 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 965
+ F GT Y APE+ D + GV+++E++ G P F++ +
Sbjct: 144 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 201
Query: 966 SFSNMIIEVNQILDPRLSTP 985
+I+ + +I PR +P
Sbjct: 202 RLFELIL-MEEIRFPRTLSP 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 13/138 (9%)
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAK--FVEPYSSNRTEFVGTFGYAAPEIAYTMRATE 936
IHRD++++N+LL + DFG+A+ + +P + + APE + T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 937 KYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995
+ DV+SFGVL++E+ G P IN F + + ++ P +TP
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGTRMRAPENATP---------E 305
Query: 996 IMEVAILCLDESPEARPT 1013
I + + C P+ RPT
Sbjct: 306 IYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-07
Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 39/236 (16%)
Query: 743 HEEIIK-------ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQ 795
+E+I++ +D+D IG+G G V S V K S+ +D
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 796 DEFLNVVLALNEIRHRNIVKFHG-------FCS--NARHSFLVCEYLHRGSLARILGN-D 845
F R+I+ F FC+ + ++ ++V EY+ G L ++ N D
Sbjct: 88 AFFW---------EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD 138
Query: 846 ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905
K W + V AL +H +IHRD+ N+LLD ++DFG
Sbjct: 139 VPEK---WAKFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190
Query: 906 FVEPYSSNRTEF-VGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKGNHP 956
++ R + VGT Y +PE+ + Y D +S GV +FE++ G+ P
Sbjct: 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 10/132 (7%)
Query: 851 LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA-KFVE- 908
L + I + + + AL+YLH IIHRD+ ++N+ LD A + DFG A K
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS 968
P + + GT +PE+ K D++S G+++FE+ N F S S
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT--LFGKQVKSSS 296
Query: 969 NM---IIEVNQI 977
+ II Q+
Sbjct: 297 SQLRSIIRCMQV 308
|
Length = 392 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 4e-07
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDE-F-------LNVVLALNEIR 809
I +G G VY+A + +G+IVA+KK M + E F +N++L L +
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLK-------MEKEKEGFPITSLREINILLKL---Q 62
Query: 810 HRNIVKFHG--FCSNARHSFLVCEYL-HRGSLARILGNDATAKELSWNRRINVIKGVANA 866
H NIV SN ++V EY+ H L ++ + + + ++ + +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEH--DLKSLM--ETMKQPFLQSEVKCLMLQLLSG 118
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR---TEFVGTFGY 923
+++LH + I+HRD+ + N+LL+ + DFG+A+ Y S T+ V T Y
Sbjct: 119 VAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR---EYGSPLKPYTQLVVTLWY 172
Query: 924 AAPEIAY-TMRATEKYDVYSFGVLVFEVI 951
APE+ + D++S G + E++
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRRINVIKGV 863
L+++ H IVKFH ++ EY L ++ T K LS N+ +
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGY 923
+ Y+H I+HRD+ +KN+ L + DFG+++ + T F GT Y
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYY 171
Query: 924 AAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983
+PE K D++S G +++E+ H F NF S I+E P L
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA--FEGQNFLSVVLRIVEGPT---PSLP 226
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARPT 1013
++ ++ M L++ P RP+
Sbjct: 227 ETYSRQLNSIMQSM------LNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 13/141 (9%)
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAK--FVEPYSSNRTEFVGTFGYAAPEIAYTMRATE 936
IHRD++++N+LL + DFG+A+ + +P + + + APE + T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 937 KYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995
+ DV+SFGVL++E+ G P I+ F + E ++ P +TP + S
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEGTRMRAPEYATPE------IYS 307
Query: 996 IMEVAILCLDESPEARPTMEK 1016
IM + C +PE RPT +
Sbjct: 308 IM---LDCWHNNPEDRPTFSE 325
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 26/213 (12%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
C + K + P+ +VAVKK N L S + D ++ +++H NI+ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKIN--LDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATA--KELSWNRRI-NVIKGVANALSYLHHDC 874
++V + GS +L EL+ I ++K V NAL Y+H
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA----IAFILKDVLNALDYIHSK- 120
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIA-KFVEPYSSNRTEFVGTFG--------YAA 925
IHR + + ++LL + + +S + ++ R V F + +
Sbjct: 121 --GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK--HGKRQRVVHDFPKSSVKNLPWLS 176
Query: 926 PEIAY-TMRA-TEKYDVYSFGVLVFEVIKGNHP 956
PE+ ++ EK D+YS G+ E+ G+ P
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 34/127 (26%), Positives = 61/127 (48%), Gaps = 18/127 (14%)
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIA---KFVEPYSSNRTEFVGTFGYAAPEI-----A 929
+++RD+ N+LLD +SD G+A +P++S VGT GY APE+ A
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 172
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHP-RDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988
Y A D +S G ++F++++G+ P R + + M + + L S
Sbjct: 173 YDSSA----DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 989 VMDKLIS 995
+++ L+
Sbjct: 229 LLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDE-----FLNVVLALNEIRHRN 812
IG+G G+V+KA + +IVA+K+ + D DE L + L E++H+N
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVR-------LDDDDEGVPSSALREICLLKELKHKN 60
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
IV+ + + + LV EY + L + D+ ++ + + + L++ H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQ-DLKKYF--DSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAYT 931
+++HRD+ +N+L++ E ++DFG+A+ F P E V T Y P++ +
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFG 173
Query: 932 MRA-TEKYDVYSFGVLVFEVIKGNHP 956
+ + D++S G + E+ P
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 15/233 (6%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-VLALNEIRHRNIVKF 816
+G+G G VY + +G +AVK+ S + + L + L + H IV++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 817 HGFCSNARHSFL--VCEYLHRGSLARILGN-DATAKELSWNRRINVIKGVANALSYLHHD 873
+G + L E++ GS+ L + A + ++ +++GV SYLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV----SYLHSN 125
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT---EFVGTFGYAAPEIAY 930
I+HRDI N+L D + DFG +K ++ + T GT + +PE+
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983
K D++S G V E++ P F + F N +L P +S
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEI 808
DFD K +G+G G V E +GDI A+K S LL+ E +L+++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALS 868
I + + + +LV EY G L +L + + + + A+
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF--YLAELVLAIH 116
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF----VGTFGYA 924
+H +HRDI +NVL+D ++DFG A + ++N+ VGT Y
Sbjct: 117 SVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARL---TANKMVNSKLPVGTPDYI 170
Query: 925 APEIAYTMRATEK--YDV----YSFGVLVFEVIKGNHP 956
APE+ TM K Y V +S GV+ +E+I G P
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-07
Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 15/214 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+DF+ IG+G G V +L + D V K ++ A+ F L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGN--DATAKELSWNRRINVIKGVANALS 868
+ I H + + +LV +Y G L +L D ++++ ++ + +++
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVH 119
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG-IAKFVEPYSSNRTEFVGTFGYAAPE 927
LH+ +HRDI N+L+D+ ++DFG K +E + + VGT Y +PE
Sbjct: 120 QLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 928 IAYTM-----RATEKYDVYSFGVLVFEVIKGNHP 956
I M + + D +S GV ++E++ G P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-07
Identities = 45/186 (24%), Positives = 89/186 (47%), Gaps = 27/186 (14%)
Query: 836 GSLARILGNDATAKELSWNRRINVIKGVANALSYL-HHDCLPSIIHRDISSKNVLLDLEF 894
+ +L +D + + L+ ++ VA + +L +C +HRD++++NVLL
Sbjct: 220 SEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGK 274
Query: 895 EAHVSDFGIAKFVEPYSSNRTEFVGTF---GYAAPEIAYTMRATEKYDVYSFGVLVFEVI 951
+ DFG+A+ + + SN TF + APE + T DV+S+G+L++E+
Sbjct: 275 IVKICDFGLARDIM-HDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI- 332
Query: 952 KGNHPRDFFSINFSSFSNMIIE---VNQILDP-RLSTPSPGVMDKLISIMEVAILCLDES 1007
FS+ + + MI++ N+I R++ P + + ++ + C +
Sbjct: 333 --------FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQE----VYDIMVKCWNSE 380
Query: 1008 PEARPT 1013
PE RP+
Sbjct: 381 PEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 7e-07
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
+ N +K + + + L+ +Y+ G L +L + +LS +I+ + AL+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALND 124
Query: 870 LH-HDCLPSIIHRDISSKNVLLD-LEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
LH H +IIH DI +NVL D + ++ D+G+ K + S GT Y +PE
Sbjct: 125 LHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPE 176
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
+D ++ GVL +E++ G HP
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 33/124 (26%), Positives = 62/124 (50%), Gaps = 6/124 (4%)
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
+ +AL YLH +++RD+ +N++LD + ++DFG+ K + F GT
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
Y APE+ D + GV+++E++ G P F++ + +I+ + +I PR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHEKLFELIL-MEEIRFPRT 217
Query: 983 STPS 986
+P
Sbjct: 218 LSPE 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
AL LH ++I+RD+ +N+LLD + + DFG+ K F GT Y A
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLA 161
Query: 926 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
PE+ T+ D ++ GVL++E++ G P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 863 VANALSYL-HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGT- 920
VA +S+L +C IHRD++++N+LL + DFG+A+ + N + +V
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI----RNDSNYVVKG 274
Query: 921 -----FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEV 974
+ APE + T + DV+S+G+L++E+ G+ P ++ S F MI E
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEG 333
Query: 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
++L P + ++ IM+ C D P RPT ++
Sbjct: 334 YRMLSPECAPS------EMYDIMKS---CWDADPLKRPTFKQ 366
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 16/128 (12%)
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIA---KFVEPYSSNRTEFVGTFGYAAPEIAYTMRA 934
+++RD+ N+LLD +SD G+A +P++S VGT GY APE+ A
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGTA 172
Query: 935 TEKY-DVYSFGVLVFEVIKGNHP------RDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987
+ D +S G ++F++++G+ P +D I+ + + + +E+ P L +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-VNVELPDSFSPELKSLLE 231
Query: 988 GVMDKLIS 995
G++ + +S
Sbjct: 232 GLLQRDVS 239
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-07
Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 13/138 (9%)
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAK--FVEPYSSNRTEFVGTFGYAAPEIAYTMRATE 936
IHRD++++N+LL + DFG+A+ + +P + + + APE + T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 937 KYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995
+ DV+SFGVL++E+ G P I+ F + E ++ P +TP
Sbjct: 261 QSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAPDYTTP---------E 310
Query: 996 IMEVAILCLDESPEARPT 1013
+ + + C P RPT
Sbjct: 311 MYQTMLDCWHGEPSQRPT 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 38/184 (20%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 777 IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRG 836
+VAVK + + +++FL + ++ +++ NI++ G C + ++ EY+ G
Sbjct: 46 LVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG 102
Query: 837 SLARILGNDATAKELSWNRRI------NVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 890
L + L + I N++ S + + + +HRD++++N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 891 DLEFEAHVSDFGIAKFVEPYSSNRTEFVG----TFGYAAPEIAYTMRATEKYDVYSFGVL 946
+ ++DFG+++ + YS + G + A E + T DV++FGV
Sbjct: 163 GNHYTIKIADFGMSRNL--YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT 220
Query: 947 VFEV 950
++E+
Sbjct: 221 LWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 10/111 (9%)
Query: 851 LSWNRRINVI------KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904
L+ R I + + V A+ YLH + IIHRDI ++N+ ++ + + DFG A
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
Query: 905 KFVEPYSSNRTE-FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN 954
F ++N+ + GT APE+ D++S G+++FE+ +
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA--LNEIRHRNIVK 815
+G+G +VYK +G +VA+K ++S + F + A L ++H NIV
Sbjct: 13 LGEGSYATVYKGISRINGQLVALK-----VISMKTEEGVPFTAIREASLLKGLKHANIVL 67
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
H V EY+H LA+ + +N R+ + + + L+Y+H
Sbjct: 68 LHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLH-PYNVRLFMFQ-LLRGLAYIHGQ-- 122
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRAT 935
I+HRD+ +N+L+ E ++DFG+A+ S + V T Y P++ + AT
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV--LLGAT 179
Query: 936 E---KYDVYSFGVLVFEVIKG 953
+ D++ G + E+++G
Sbjct: 180 DYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 23/156 (14%)
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
+A +SYL ++HRD++++NVL+ ++DFG+A+ ++ + TE+ G
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD---IDETEYHADGG 171
Query: 923 -----YAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQ 976
+ A E R T + DV+S+GV V+E++ G P D E+
Sbjct: 172 KVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---------EIPD 222
Query: 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARP 1012
+L+ P P + I + + + C E RP
Sbjct: 223 LLEKGERLPQPPICT--IDVYMIMVKCWMIDSECRP 256
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 43/234 (18%)
Query: 753 FDEKFCIGKGGQGSVYKAE------LPSGD-----------IVAVKKFNSQLLSGNMADQ 795
F EK +G+G G V+ E LP+ +VAVK N +
Sbjct: 9 FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRP---DANKNAR 63
Query: 796 DEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-----------GN 844
++FL V L+ ++ NI++ G C + ++ EY+ G L + L GN
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 845 DATAKE-----LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS 899
DA +S++ ++V +A+ + YL + +HRD++++N L+ ++
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIA 180
Query: 900 DFGIAK--FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 951
DFG+++ + Y + V + A E + T DV++FGV ++E++
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 798 FLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI 857
F + ++ H++IV +G C + +V E++ G L + + W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLL-----DLEFEAHV--SDFGIAKFVEPY 910
V K +A+ALSYL ++H ++ +KN+LL D E + SD GI V
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV--- 162
Query: 911 SSNRTEFVGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEV 950
+R E V + APE + + + D +SFG ++E+
Sbjct: 163 -LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 583 HLSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNE 641
+L LDLS+N L IP + +L+ L+LS NNL+ P F + SL +D+ N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 642 L 642
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 66/282 (23%), Positives = 128/282 (45%), Gaps = 43/282 (15%)
Query: 746 IIKATDDFDEKFCIGKGGQGSVYKA-ELPSGD----IVAVKKFNSQLLSGNMADQDEFLN 800
I+K T+ F + +G G G+VYK +P G+ VA+K+ + A++ E L+
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANK-EILD 58
Query: 801 VVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL----GNDATAKELSWNRR 856
+ + + ++ + G C + L+ + + G L + N + L+W +
Sbjct: 59 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 117
Query: 857 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE 916
I A ++YL L +HRD++++NVL+ ++DFG+AK + ++ E
Sbjct: 118 I------AKGMNYLEERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLL---GADEKE 165
Query: 917 FVGTFG-----YAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNM 970
+ G + A E T + DV+S+GV V+E++ G+ P D I S S++
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEISSI 223
Query: 971 IIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARP 1012
+ + ++ P + T I + + + C ++RP
Sbjct: 224 LEKGERLPQPPICT---------IDVYMIMVKCWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-06
Identities = 36/131 (27%), Positives = 65/131 (49%), Gaps = 16/131 (12%)
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
L Y+H IIHRD+ N+ ++ + E + DFG+A+ + T +V T Y A
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRA 183
Query: 926 PEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
PEI M + D++S G ++ E++ G + F S+ I ++ +I++ + T
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTG---KTLF-----PGSDHIDQLKRIMN-LVGT 234
Query: 985 PSPGVMDKLIS 995
P ++ K+ S
Sbjct: 235 PDEELLQKISS 245
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 10/196 (5%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G VYK +G IVA+KK +L S + + L E++H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI--RLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+L+ E+L L + L + + + + + + + + H
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAY-TMRAT 935
++HRD+ +N+L+D + ++DFG+A+ F P E V T Y APE+ + R +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYS 180
Query: 936 EKYDVYSFGVLVFEVI 951
D++S G + E+
Sbjct: 181 TPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 15/206 (7%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-VLALNEIRHRNIVKF 816
+G+G G VY + +G +AVK+ S + + L + L +RH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 817 HGFCSNARHSFL--VCEYLHRGSLA-RILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
+G + L EY+ GS+ ++ A + ++ +++GV SYLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV----SYLHSN 125
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT---EFVGTFGYAAPEIAY 930
I+HRDI N+L D + DFG +K ++ + T GT + +PE+
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHP 956
K DV+S V E++ P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 61/276 (22%), Positives = 113/276 (40%), Gaps = 29/276 (10%)
Query: 747 IKATDDFDEKFCIGK-GGQGSVYKAELPSGDIV--AVKKFNSQLLSGNMADQDEFLNVVL 803
I++ D + K Q S+YK + +++ KKF+ G+ D N +
Sbjct: 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHK----GHKVLIDITENEIK 70
Query: 804 ALNEIRHRNIVKFHGF----CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINV 859
L I NI+K +GF + L+ EY RG L +L + K+LS+ ++++
Sbjct: 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDM 127
Query: 860 IKGVANALSYLH-HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFV 918
L L+ + P +++++S + L+ ++ + G+ K + F+
Sbjct: 128 AIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM 184
Query: 919 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978
F Y ++ T K D+YS GV+++E+ G P F ++ ++II N L
Sbjct: 185 VYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIP--FENLTTKEIYDLIINKNNSL 241
Query: 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
L P + I + C RP +
Sbjct: 242 KLPLDCP--------LEIKCIVEACTSHDSIKRPNI 269
|
Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G +V+K + ++VA+K+ + G + V L ++H NIV H
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA---IREVSLLKNLKHANIVTLH 69
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
R LV EYL L + L N + N +I + + + LSY H
Sbjct: 70 DIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMH-NVKIFMFQ-LLRGLSYCHKR---K 123
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY-TMRATE 936
I+HRD+ +N+L++ + E ++DFG+A+ + + V T Y P++ + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 937 KYDVYSFGVLVFEVIKG 953
D++ G +++E+ G
Sbjct: 184 PIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 20/197 (10%)
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGN-DATAKELSWNRRINVIKGVANALSYLH 871
IV+ H + ++ ++V EY+ G L ++ N D K W R V AL +H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---WARF--YTAEVVLALDAIH 159
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE-FVGTFGYAAPEIAY 930
IHRD+ N+LLD ++DFG ++ R + VGT Y +PE+
Sbjct: 160 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 931 TMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL----DPRL 982
+ Y D +S GV ++E++ G+ P F++ + + I++ L D +
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP--FYADSLVGTYSKIMDHKNSLTFPDDIEI 274
Query: 983 STPSPGVMDKLISIMEV 999
S + ++ ++ EV
Sbjct: 275 SKQAKDLICAFLTDREV 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 63/246 (25%), Positives = 99/246 (40%), Gaps = 49/246 (19%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVL---ALN 806
DDF+ IG+G G V+ + +G + A+K L +M +++ +V L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMK----VLRKSDMIKRNQIAHVRAERDILA 56
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
+ IVK + + H +LV EY+ G L +L E R I + A
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETARFY--IAELVLA 113
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAK--------FVEPYSSNRTE 916
L +H IHRDI N+L+D + H+ +DFG+ K S+
Sbjct: 114 LDSVH---KLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 917 F---------------------VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 955
F VGT Y APE+ + D +S GV+++E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 956 PRDFFS 961
P F+S
Sbjct: 229 P--FYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 759 IGKGGQGSV---YKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
IG G QG V Y A L VA+KK + + A + + +VL + + H+NI+
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKR-AYRELVL-MKCVNHKNIIG 87
Query: 816 FHGFCSNARH------SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
+ + ++V E L +L +++ EL R ++ + + +
Sbjct: 88 LLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI-----QMELDHERMSYLLYQMLCGIKH 141
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
LH IIHRD+ N+++ + + DFG+A+ S T +V T Y APE+
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
M E D++S G ++ E+IKG + F ++ I + N++++ +L TP P
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG-------GVLFPG-TDHIDQWNKVIE-QLGTPCPEF 248
Query: 990 MDKL 993
M KL
Sbjct: 249 MKKL 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 69/270 (25%), Positives = 110/270 (40%), Gaps = 39/270 (14%)
Query: 759 IGKGGQGSVYKAEL---PSGDIVAVKKFNS---QLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G ++YK L DIV + S ++L + D F ++++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+VK +G C + +V EY+ G L L + L W +++V K +A+AL YL
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 873 DCLPSIIHRDISSKNVLL---DLEFE----AHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
++H ++ KN+L+ L +SD GI V R E V + A
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIA 172
Query: 926 PEIAYTMRA--TEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
PE +A T D +SFG + E+ G P S+ S+ E RL
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEP-------LSTLSSSEKERFYQDQHRL 225
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARP 1012
P + LI+ C P RP
Sbjct: 226 PMPDCAELANLIN------QCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-06
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 859 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF- 917
V + + +A+ Y+H + IIHRDI ++NVL++ + + DFG A F S +
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 918 -VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 961
GT APE+ T D++S G+++FE H FS
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA--AVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 47/237 (19%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQ-LLSGNMADQDEFLNVVLALNEI 808
+DF+ I G G+VY + A+KK N Q L+ N Q V
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQ------VFV---- 50
Query: 809 RHRNIVKFHG-------FCS--NARHSFLVCEYLHRGSLARILGN-DATAKELSWNRRIN 858
R+I+ F FCS RH +V EY+ G A +L N A +++ R+
Sbjct: 51 -ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA---RMY 106
Query: 859 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK---------FVEP 909
+ V AL YLH+ I+HRD+ N+L+ ++DFG++K E
Sbjct: 107 FAETVL-ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162
Query: 910 YSSNRT-EFV-----GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 960
+ T EF+ GT Y APE+ + D ++ G++++E + G P FF
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP--FF 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGD-IVAVKKFN--SQLLSGNMADQDEFLNVVLALNE 807
DDF+ IG+G G V ++ + I A+K N L A E NV++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD- 59
Query: 808 IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGN--DATAKELSWNRRINVIKGVAN 865
+ I H + + +LV +Y G L +L D ++++ ++ + +
Sbjct: 60 --CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-H 116
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG-IAKFVEPYSSNRTEFVGTFGYA 924
++ LH+ +HRDI NVLLD+ ++DFG K + + + VGT Y
Sbjct: 117 SIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170
Query: 925 APEIAYTMR-ATEKY----DVYSFGVLVFEVIKGNHP 956
+PEI M KY D +S GV ++E++ G P
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLA--LNE 807
D +++ +G+G +VYK + +G +VA+K Q G F + A L
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-----PFTAIREASLLKG 59
Query: 808 IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANAL 867
++H NIV H LV EY+H L + + D L + + L
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYM--DKHPGGLHPENVKLFLFQLLRGL 116
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
SY+H I+HRD+ +N+L+ E ++DFG+A+ S + V T Y P+
Sbjct: 117 SYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPD 173
Query: 928 IAY-TMRATEKYDVYSFGVLVFEVIKG 953
+ + + D++ G + E+I+G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-06
Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 55/248 (22%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---LN 806
DDF+ IG+G G V + +G I A+K L +M ++++ ++ L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKI----LRKADMLEKEQVAHIRAERDILV 56
Query: 807 EIRHRNIVK-FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
E +VK F+ F + R+ +L+ E+L G + +L T E + I +
Sbjct: 57 EADGAWVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF-------- 917
A+ L IHRDI N+LLD + +SDFG+ ++ ++RTEF
Sbjct: 116 AIHQL------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK--KAHRTEFYRNLTHNP 167
Query: 918 -----------------------------VGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 948
VGT Y APE+ + D +S GV+++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 949 EVIKGNHP 956
E++ G P
Sbjct: 228 EMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 8e-06
Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 22/156 (14%)
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN-----RTEFVGT 920
AL +H + +HRD+ S N+ L + DFG +K YS + + F GT
Sbjct: 181 ALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVSLDVASSFCGT 234
Query: 921 FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDP 980
Y APE+ R ++K D++S GV+++E++ + P F S I + Q+L
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP-------FKGPSQREI-MQQVLYG 286
Query: 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ V + ++++ L ++P RPT ++
Sbjct: 287 KYDPFPCPVSSGMKALLDP---LLSKNPALRPTTQQ 319
|
Length = 478 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 759 IGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G +VYK D +VA+K+ + G + V L +++H NIV H
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA---IREVSLLKDLKHANIVTLH 70
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+ LV EYL + L + L + + + N ++ + + + L+Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH-NVKLFLFQ-LLRGLNYCHRR---K 124
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY-TMRATE 936
++HRD+ +N+L++ E ++DFG+A+ + + V T Y P+I + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
Query: 937 KYDVYSFGVLVFEVIKG 953
+ D++ G + +E+ G
Sbjct: 185 QIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 759 IGKGGQGSVYKA-ELPSGD-IVAVKKFNSQLLSGNMA-DQDEFLNVVLALNEIRHRNIVK 815
IG+G G V+KA +L +G VA+K+ Q M + V+ L H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 816 FHGFCSNARHS-----FLVCEYLHRGSLARI--LGNDATAKELSWNRRINVIKGVANALS 868
C+ +R LV E++ + + + E + +++G L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG----LD 124
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
+LH ++HRD+ +N+L+ + ++DFG+A+ + + T V T Y APE+
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAPEV 180
Query: 929 AYTMRATEKYDVYSFGVLVFEVIK 952
D++S G + E+ +
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-06
Identities = 19/43 (44%), Positives = 24/43 (55%), Gaps = 7/43 (16%)
Query: 31 ALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCN 73
ALL +K+SL S LSSW N S PCSW G++C+
Sbjct: 7 ALLAFKSSLNG--DPSGALSSW-----NPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-05
Identities = 22/66 (33%), Positives = 34/66 (51%)
Query: 584 LSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+ L L + L+ IP + + L+ +NLS N++ G IP + SL +D+ YN
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 644 GPIPNS 649
G IP S
Sbjct: 480 GSIPES 485
|
Length = 623 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 39/185 (21%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 777 IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRG 836
+VAVK N +++FL + ++ ++ NI++ C + ++ EY+ G
Sbjct: 48 LVAVKMLRE---DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 837 SLARIL--------GNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNV 888
L + L A +S++ I + +A+ + YL + +HRD++++N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161
Query: 889 LLDLEFEAHVSDFGIAK--FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVL 946
L+ + ++DFG+++ + Y + V + + E + T DV++FGV
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 947 VFEVI 951
++E++
Sbjct: 222 LWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 70/276 (25%), Positives = 110/276 (39%), Gaps = 66/276 (23%)
Query: 751 DDFDEKFCIGKGGQGSV-YKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLA 804
DDF+ IG+G G V + +G I A+KK L M ++++ +V +LA
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKK----LRKSEMLEKEQVAHVRAERDILA 56
Query: 805 LNEIRHRNIVKFHGFCS--NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG 862
E + +VK + S + + +L+ EYL G + +L T + I
Sbjct: 57 --EADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT---FTEEETRFYIAE 109
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF----- 917
A+ +H IHRDI N+LLD + +SDFG+ ++ S+RTEF
Sbjct: 110 TILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTEFYRILS 164
Query: 918 -----------------------------------VGTFGYAAPEIAYTMRATEKYDVYS 942
VGT Y APE+ ++ D +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224
Query: 943 FGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978
GV+++E++ G P F S N II + L
Sbjct: 225 LGVIMYEMLVGYPP--FCSDNPQETYRKIINWKETL 258
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGN-DATAKELSWNRRINVIKGVANALSYLHHDC 874
F+ F + R+ ++V EY+ G L ++ N D K W R V AL +H
Sbjct: 109 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVLALDAIHS-- 160
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF-VGTFGYAAPEIAYTMR 933
IHRD+ N+LLD ++DFG + R + VGT Y +PE+ +
Sbjct: 161 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 934 ATEKY----DVYSFGVLVFEVIKGNHP 956
Y D +S GV ++E++ G+ P
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-05
Identities = 46/150 (30%), Positives = 67/150 (44%), Gaps = 14/150 (9%)
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP-YSSNRTEFVGTFGYAA 925
L YLH I+HRDI N+L++ + DFG+A+ EP S + T+ V T Y A
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 926 PEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
PEI R T D++S G + E++ I F + + I +++ I D L T
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRR-------ILFQA-QSPIQQLDLITD-LLGT 223
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTM 1014
PS M IL P + P +
Sbjct: 224 PSLEAMRSACEGARAHILRGPHKPPSLPVL 253
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 45/197 (22%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G +V+K + ++VA+K+ + G + V L +++H NIV H
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA---IREVSLLKDLKHANIVTLH 70
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+ LV EYL + L + + D +S + + + L+Y H
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYM--DDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY-TMRATE 936
++HRD+ +N+L++ E ++DFG+A+ + + V T Y P++ + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
Query: 937 KYDVYSFGVLVFEVIKG 953
+ D++ G + FE+ G
Sbjct: 185 QIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 66/264 (25%), Positives = 117/264 (44%), Gaps = 57/264 (21%)
Query: 759 IGKGGQG---SVYKAELPSGDIVAVKK----FNSQLLSGNMADQDEFLNVVLALNEIR-- 809
+G+G G S AE + VA+KK F+ ++L+ AL E++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR------------ALRELKLL 55
Query: 810 -----HRNIVKFHG----FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVI 860
H+NI + F N +L E L L +I+ + + L+ + I
Sbjct: 56 RHFRGHKNITCLYDMDIVFPGNFNELYLY-EELMEADLHQIIRSG---QPLTDAHFQSFI 111
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR------ 914
+ L Y+H +++HRD+ N+L++ + E + DFG+A+ +S N
Sbjct: 112 YQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR---GFSENPGENAGF 165
Query: 915 -TEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 972
TE+V T Y APEI + ++ T+ DV+S G ++ E++ + F + +
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR---KPVF-----KGKDYVD 217
Query: 973 EVNQILDPRLSTPSPGVMDKLISI 996
++NQIL L TP + ++ S
Sbjct: 218 QLNQILQ-VLGTPDEETLSRIGSP 240
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 41/153 (26%), Positives = 61/153 (39%), Gaps = 20/153 (13%)
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKE---LSWNRRINVIKGVANALS 868
N+V H + + FLV ++ G L + E W + V AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
LH + I+ RD++ N+LLD ++ F VE E V Y APE+
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDG--EAVENM-YCAPEV 153
Query: 929 AYTMRATEKYDVYSFGVLVFEVIKGN-----HP 956
TE D +S G ++FE++ G HP
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 3e-05
Identities = 60/247 (24%), Positives = 115/247 (46%), Gaps = 38/247 (15%)
Query: 802 VLALNEIRHRNIVKF-HGFCSNARHS-FLVCEYLHRGSLAR-ILGNDATAKELSWNRRIN 858
V + E++H+NIV++ F + A +++ E+ G L+R I ++ + ++
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122
Query: 859 VIKGVANALSYLHH----DCLPSIIHRDISSKNVLLDLEFE-----------------AH 897
+ + + +AL+Y H+ ++HRD+ +N+ L A
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 898 VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY--TMRATEKYDVYSFGVLVFEVIKGNH 955
+ DFG++K + S + VGT Y +PE+ T +K D+++ G +++E+ G
Sbjct: 183 IGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 956 PRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
P F N +FS +I E+ + P L P G K ++I+ +L L S + RP+
Sbjct: 242 P--FHKAN--NFSQLISELKR--GPDL--PIKG-KSKELNILIKNLLNL--SAKERPSAL 290
Query: 1016 KGFGHHI 1022
+ G+ I
Sbjct: 291 QCLGYQI 297
|
Length = 1021 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 798 FLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI 857
F ++++ H ++ HG C + +V E++ G L L + ++W +I
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLL-DLEFEAHVSDFGIAKFVEPYSS---- 912
V + +A+ALSYL +++H ++ +KN+LL L S F K +P S
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPF--IKLSDPGVSFTAL 175
Query: 913 NRTEFVGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEV 950
+R E V + APE + + D +SFG + E+
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 35/211 (16%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQ------LLSGNMADQDEFLNVVLALN 806
IG GG G VY+ + S + ++ ++ L+ N+ D D+ + + ++
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDK-IALWKNIH 78
Query: 807 EIRHRNIVKFHGFCSNAR----HSFLVCEYLHRGSLARILGNDATAKELSWNRRI--NVI 860
I H I K++G S R + F++ E L + + + N+++ N++
Sbjct: 79 NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENT------KEIFKRIKCKNKKLIKNIM 132
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA-------KFVEPYSSN 913
K + L Y+H I H DI +N+++D ++ D+GIA K +E
Sbjct: 133 KDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189
Query: 914 RTEFVGTFGYAAPEIAYTMRATEKYDVYSFG 944
+ GT YA + T + D+ S G
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLG 220
|
Length = 294 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 45/221 (20%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQD------EFLNVVLALNEIRHR 811
IG+G G VYKA + +G +VA+KK + M ++ ++++ L+E +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLE-----MDEEGIPPTALREISLLQMLSESIY- 62
Query: 812 NIVKF----HGFCSNARHS-FLVCEYL----------HRGSLARILGNDATAKELSWNRR 856
IV+ H N + S +LV EYL + R L T K +
Sbjct: 63 -IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPL-PAKTIKSFMYQ-- 118
Query: 857 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEA-HVSDFGIAK-FVEPYSSNR 914
++KGVA + H ++HRD+ +N+L+D + ++D G+ + F P S
Sbjct: 119 --LLKGVA----HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 915 TEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGN 954
E V T Y APE+ + D++S G + E+ +
Sbjct: 170 HEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-05
Identities = 22/57 (38%), Positives = 28/57 (49%)
Query: 536 LQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHN 592
L+ LDLS N+L+ + L L L+LS N + P F L L LDLS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-05
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 20/155 (12%)
Query: 863 VANALSYL-HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYSSNRTEFV 918
VAN + +L +C +HRD++++NVL+ + DFG+A+ + Y S + F+
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 919 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQI 977
+ APE + T DV+SFG+L++E+ G P +N F N I
Sbjct: 304 -PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-EQFYNAIKR---- 357
Query: 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARP 1012
R++ P+ D++ IM+ C +E E RP
Sbjct: 358 -GYRMAKPAHA-SDEIYEIMQ---KCWEEKFEIRP 387
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 753 FDEKFC-IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR 811
F+ + C +G+G G VYKA+ G K++ + + G + L L E++H
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIAL-LRELKHP 58
Query: 812 NIVKFHG-FCSNA-RHSFLVCEY----------LHRGSLARILGNDATAKELSWNRRI-- 857
N++ F S++ R +L+ +Y HR S A K + R +
Sbjct: 59 NVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRAS-------KANKKPMQLPRSMVK 111
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE----FEAHVSDFGIAK-FVEPYS- 911
+++ + + + YLH + ++HRD+ N+L+ E ++D G A+ F P
Sbjct: 112 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 912 -SNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVI 951
++ V TF Y APE+ R T+ D+++ G + E++
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 9e-05
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 559 KLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNN 617
L L+LSNN+ + F+ L +L LDLS N L I P+ + SL L+LS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 618 L 618
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 9e-05
Identities = 23/60 (38%), Positives = 29/60 (48%)
Query: 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282
+L +LDLS N+L + L NL L L N+L+ P L SL LDL N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-05
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 20/154 (12%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKF-NSQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
I +G G VY + + + AVK + +++ NM Q + LAL+ + IV
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS--KSPFIVHL 69
Query: 817 HGFCSNARHSFLVCEYLHRG---SLARILG--NDATAKELSWNRRINVIKGVANALSYLH 871
+ +A + +LV EYL G SL I G ++ A + I VA AL YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA--------VKYISEVALALDYLH 121
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905
IIHRD+ N+L+ E ++DFG++K
Sbjct: 122 RH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-04
Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 368 LSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
+ L L L G IP+ + L L +N+ N + G IP SL S+TSL+ + + N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 428 GKVYEAFGDHPNLTFLDLSQNNFDGKI 454
G + E+ G +L L+L+ N+ G++
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 21/60 (35%), Positives = 27/60 (45%)
Query: 199 KLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSL 258
L L L+NN L L +L LDLS N L + P L +L +L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 753 FDEKFC-IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR 811
F+ + C +G+G G VYKA+ G + + + + G + L L E++H
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGISMSACREIAL-LRELKHP 58
Query: 812 NIVKFHG-FCSNA-RHSFLVCEY----------LHRGSLARILGNDATAKELSWNRRI-- 857
N++ F S+A R +L+ +Y HR S A K + R +
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRAS-------KANKKPVQLPRGMVK 111
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE----FEAHVSDFGIAK-FVEPYS- 911
+++ + + + YLH + ++HRD+ N+L+ E ++D G A+ F P
Sbjct: 112 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 912 -SNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVI 951
++ V TF Y APE+ R T+ D+++ G + E++
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 45/136 (33%), Positives = 71/136 (52%), Gaps = 4/136 (2%)
Query: 484 DSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSA 543
+ L+LSSN ++ +P L +L SL+ L S S +L L LDL+
Sbjct: 45 VAVNRLALNLSSNTLL-LLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNL 102
Query: 544 NKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVC 603
N+L S+I + + L L L+L NN + P+ +L +LDLS N + E +P +
Sbjct: 103 NRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLR 160
Query: 604 NMESLEKLNLSHNNLS 619
N+ +L+ L+LS N+LS
Sbjct: 161 NLPNLKNLDLSFNDLS 176
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 23/60 (38%), Positives = 30/60 (50%)
Query: 487 KLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKL 546
L+ LDLS+N + + L +L L LS N L+ P F L L+ LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFN--SQLLSGNMADQDEFLNVVLALNE 807
DDF+ IG+G G V ++ +G + A+K N L A E +V++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 808 IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGN--DATAKELSWNRRINVIKGV-- 863
R I H + + +LV +Y G L +L D ++++ R + + V
Sbjct: 61 ---RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYLAEMVLA 114
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF-VGTFG 922
+++ L + +HRDI NVLLD ++DFG + + ++ VGT
Sbjct: 115 IDSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 923 YAAPEIAYTMR-ATEKY----DVYSFGVLVFEVIKGNHP 956
Y +PEI M +Y D +S GV ++E++ G P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 24/61 (39%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 511 SLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQ 569
+L L LS N+L+ +P F L L+ LDLS N L+S P++ L L L+LS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 570 F 570
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-04
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 25/159 (15%)
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI---NVIK 861
L +++H NIV H + LV EYL L + + + + N R+ +++
Sbjct: 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRLFLFQLLR 114
Query: 862 GVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI--AKFV--EPYSSNRTEF 917
G L+Y H ++HRD+ +N+L+ E ++DFG+ AK V + YS+
Sbjct: 115 G----LAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE---- 163
Query: 918 VGTFGYAAPEIAYTMRATE---KYDVYSFGVLVFEVIKG 953
V T Y P++ + +TE D++ G + +E+ G
Sbjct: 164 VVTLWYRPPDV--LLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-04
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 758 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
IG+G G V A + + VA+KK + N D L + L + H N++
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 817 HGFCS-NARHSF----LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
R +F +V E L L +I+ +++ LS + + + L Y+H
Sbjct: 70 KDIMPPPHREAFNDVYIVYE-LMDTDLHQII---RSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
+++HRD+ N+LL+ + + DFG+A+ TE+V T Y APE+
Sbjct: 126 S---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL--- 179
Query: 932 MRATEKY----DVYSFGVLVFEVI 951
+ +Y DV+S G + E++
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 43/233 (18%)
Query: 749 ATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE 807
D++ +G+G G VYKA ++ +G +VA+KK +L M ++ + + AL E
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKK----IL---MHNEKDGFPIT-ALRE 57
Query: 808 I------RHRNIVKF-------HGFCSNARHSF-LVCEYL-HRGSLARILGNDATAKELS 852
I +H N+V R S +V Y+ H L+ +L N + S
Sbjct: 58 IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH--DLSGLLENPSVKLTES 115
Query: 853 WNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV--EPY 910
+ + + ++YLH + I+HRDI + N+L+D + ++DFG+A+ P
Sbjct: 116 QIK--CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 911 SSNR---------TEFVGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVIKG 953
+ T V T Y PE + R T D++ G + E+
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 46/157 (29%), Positives = 65/157 (41%), Gaps = 26/157 (16%)
Query: 486 SKLQFLDLSSNHIVGKIPVQLEKL---FSLNKLILSLNQLSGS-VPLEFGSLTELQY--- 538
LQ LDLS N + LE L SL +L L+ N L + L L +L
Sbjct: 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140
Query: 539 -LDLSANKLSSSIPKSIGNLL----KLYYLNLSNNQFSH----TIPIEFEKLIHLSKLDL 589
L L N+L + +++ L L LNL+NN + + +L LDL
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200
Query: 590 SHNILQE-------EIPPQVCNMESLEKLNLSHNNLS 619
++N L + E + SLE LNL NNL+
Sbjct: 201 NNNGLTDEGASALAETLASLK---SLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 74/310 (23%), Positives = 113/310 (36%), Gaps = 87/310 (28%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLA 804
+DF IGKG G V + +G I A+K LL M +D+ +V VLA
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK----TLLKSEMFKKDQLAHVKAERDVLA 56
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
E +V + +A++ +L+ E+L G L +L T E
Sbjct: 57 --ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE-------------- 100
Query: 865 NALSYLHHDCLPSI--------IHRDISSKNVLLDLEFEAHVSDFGIA------------ 904
+ + +C+ +I IHRDI N+L+D +SDFG++
Sbjct: 101 DVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160
Query: 905 ------KFVEPYSSNRTEF-----------------------------VGTFGYAAPEIA 929
K + NR VGT Y APEI
Sbjct: 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF 220
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL----DPRLSTP 985
++ D +S G ++FE + G P F S N II + L D LS
Sbjct: 221 LQQGYGQECDWWSLGAIMFECLIGWPP--FCSENSHETYRKIINWRETLYFPDDIHLSVE 278
Query: 986 SPGVMDKLIS 995
+ ++ +LI+
Sbjct: 279 AEDLIRRLIT 288
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 26/100 (26%), Positives = 38/100 (38%), Gaps = 16/100 (16%)
Query: 859 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFV 918
V AL LH R S N+LL ++ + G F P S +
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILLT--WDGLLKLDGSVAFKTPEQSRPDPYF 70
Query: 919 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 958
APE+ TEK D+YS G+ ++E + P +
Sbjct: 71 M-----APEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 55/248 (22%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---LN 806
+DF+ IG+G G V + +G + A+K L +M ++++ ++ L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKI----LRKADMLEKEQVGHIRAERDILV 56
Query: 807 EIRHRNIVK-FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
E +VK F+ F + + +L+ E+L G + +L T E I
Sbjct: 57 EADSLWVVKMFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF---YIAETVL 112
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF-------- 917
A+ +H IHRDI N+LLD + +SDFG+ ++ ++RTEF
Sbjct: 113 AIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSL 167
Query: 918 -----------------------------VGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 948
VGT Y APE+ + D +S GV+++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 949 EVIKGNHP 956
E++ G P
Sbjct: 228 EMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.003
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 44/221 (19%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR------HR 811
+G G G V+ A + VAVKK + D +V AL EI+ H
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIV-------LTDPQ---SVKHALREIKIIRRLDHD 62
Query: 812 NIVKFHG--FCSNARHS------------FLVCEYLHRGSLARILGNDATAKELSWNRRI 857
NIVK + S + + ++V EY+ LA +L ++E +
Sbjct: 63 NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMY 121
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYSSNR-- 914
+++G L Y+H +++HRD+ NV ++ E + DFG+A+ V+P+ S++
Sbjct: 122 QLLRG----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 915 -TEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKG 953
+E + T Y +P + + T+ D+++ G + E++ G
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1078 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.37 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.19 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.13 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.12 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.1 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.06 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.04 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.04 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.0 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.88 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.87 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.72 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.55 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.38 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.33 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.33 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-115 Score=1127.98 Aligned_cols=907 Identities=33% Similarity=0.539 Sum_probs=659.8
Q ss_pred CHHHHHHHHHHHHhcCCCCCCccccCCCCCCCCCCCCCCCCcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCC
Q 039595 25 SSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHL 104 (1078)
Q Consensus 25 ~~~~~~all~~k~~~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L 104 (1078)
.++|+.||++||+++.++ .+.+++|+. +.|||.|.||+|++ .++|+.|+|+++.+.|.++ ..|..+++|
T Consensus 27 ~~~~~~~l~~~~~~~~~~---~~~~~~w~~------~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~-~~~~~l~~L 95 (968)
T PLN00113 27 HAEELELLLSFKSSINDP---LKYLSNWNS------SADVCLWQGITCNN-SSRVVSIDLSGKNISGKIS-SAIFRLPYI 95 (968)
T ss_pred CHHHHHHHHHHHHhCCCC---cccCCCCCC------CCCCCcCcceecCC-CCcEEEEEecCCCccccCC-hHHhCCCCC
Confidence 468999999999999532 466889962 46899999999985 4699999998887777663 467778888
Q ss_pred cEEeccCCcccccCCCCCC-CCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeeccc
Q 039595 105 VNLNLSFNLFFGNIPPQIG-NLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183 (1078)
Q Consensus 105 ~~L~L~~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~ 183 (1078)
++|+|++|.+.|.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|+|++|.+++.+|..++.+++|++|++++
T Consensus 96 ~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~ 173 (968)
T PLN00113 96 QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG 173 (968)
T ss_pred CEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECcc
Confidence 8888888888877777655 788888888888888777764 4577788888888888777777777777888888877
Q ss_pred ccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCC
Q 039595 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP 263 (1078)
Q Consensus 184 n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 263 (1078)
|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|
T Consensus 174 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 253 (968)
T PLN00113 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253 (968)
T ss_pred CcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccC
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred cccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCc
Q 039595 264 SIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSS 343 (1078)
Q Consensus 264 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 343 (1078)
..++++++|++|+|++|++++.+|..+.++++|+.|++++|.+++.+|..+.++++|++|++++|.+++..|..+..+++
T Consensus 254 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~ 333 (968)
T PLN00113 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333 (968)
T ss_pred hhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCC
Confidence 77777777777777777777777777777777777777777776666666666666666666666666666666666666
Q ss_pred CcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccC
Q 039595 344 LRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQ 423 (1078)
Q Consensus 344 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 423 (1078)
|+.|++++|.+.+.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|.+.+.+|..+..+++
T Consensus 334 L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~-------- 405 (968)
T PLN00113 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS-------- 405 (968)
T ss_pred CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCC--------
Confidence 666666666666666666666666666666666666666655555555555555555555555544444444
Q ss_pred ccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcc
Q 039595 424 NNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIP 503 (1078)
Q Consensus 424 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~ 503 (1078)
|+.|++++|+++ +..|..+..++.|+.|++++|.+++.++
T Consensus 406 ----------------L~~L~L~~n~l~------------------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 445 (968)
T PLN00113 406 ----------------LRRVRLQDNSFS------------------------GELPSEFTKLPLVYFLDISNNNLQGRIN 445 (968)
T ss_pred ----------------CCEEECcCCEee------------------------eECChhHhcCCCCCEEECcCCcccCccC
Confidence 444444444333 2333444445555555555566555555
Q ss_pred cccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccc
Q 039595 504 VQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIH 583 (1078)
Q Consensus 504 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 583 (1078)
..+..+++|+.|+|++|++.+.+|..+ ..++|+.|||++|++++..|..+.++++|++|+|++|++++.+|..+..+++
T Consensus 446 ~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 524 (968)
T PLN00113 446 SRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524 (968)
T ss_pred hhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccC
Confidence 555666666666666666666666554 3477888888888888888888888999999999999998889999999999
Q ss_pred cCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCCCCcc---ccCccccCC
Q 039595 584 LSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTV---FKDGLMEGN 660 (1078)
Q Consensus 584 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~~~~---~~~~~~~~n 660 (1078)
|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.+++++|+++|.+|.... +..+.+.||
T Consensus 525 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n 604 (968)
T PLN00113 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGN 604 (968)
T ss_pred CCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999998765 455789999
Q ss_pred CCcCCCcc--cccccccccCCcccccceeEEeehhHHHHHHHHHHHhhhcceeeecccchhhhhhhccCccccccccc--
Q 039595 661 KGLCGNFE--AFSSCDAFMSHKQTSRKKWIVIVFPILGMVLLLISLIGFFFFFRQRKKDSQEEQTISMNPLRLLSVLN-- 736 (1078)
Q Consensus 661 ~~lc~~~~--~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~lll~~i~~~~~~r~rk~~~~~~~~~~~~~~~~~~~~~-- 736 (1078)
+++||... ...+|... ...+.+++++.+++++++++++++++++++|+|++...+.......... .....
T Consensus 605 ~~lc~~~~~~~~~~c~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 678 (968)
T PLN00113 605 IDLCGGDTTSGLPPCKRV-----RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWE-LQFFDSK 678 (968)
T ss_pred ccccCCccccCCCCCccc-----cccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccccccccc-ccccccc
Confidence 99999643 23456421 1223344444444554444444444444433332211111000000000 00000
Q ss_pred CCCCccHHHHHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceee
Q 039595 737 FDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815 (1078)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 815 (1078)
.......+++ ...|+..+.||+|+||.||+|.. .++..||||++..... ...+|++.+++++|||||+
T Consensus 679 ~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~ 747 (968)
T PLN00113 679 VSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVK 747 (968)
T ss_pred cchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcce
Confidence 0011222333 34577888999999999999976 5789999999864321 1124578899999999999
Q ss_pred EEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 039595 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE 895 (1078)
Q Consensus 816 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 895 (1078)
++++|.++...|+||||+++|+|.++++ .++|.++.+++.|||+|++|||..+.++|+|||+||+||+++.++.
T Consensus 748 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~ 821 (968)
T PLN00113 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE 821 (968)
T ss_pred EEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc
Confidence 9999999999999999999999999993 3789999999999999999999665569999999999999999998
Q ss_pred EEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh----
Q 039595 896 AHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI---- 971 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~---- 971 (1078)
+++. ||.+..... .....|++.|||||++.+..++.++|||||||++|||+||+.||+.............
T Consensus 822 ~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 896 (968)
T PLN00113 822 PHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY 896 (968)
T ss_pred eEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc
Confidence 8876 665543321 1233688999999999999999999999999999999999999753322211111111
Q ss_pred --hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 972 --IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 972 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.....++++..........++..++.+++.+||+.||++||||+|+++..
T Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred CccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 11233445555444344456677889999999999999999999998764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-63 Score=642.84 Aligned_cols=514 Identities=40% Similarity=0.590 Sum_probs=426.4
Q ss_pred eEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEc
Q 039595 78 RVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYL 157 (1078)
Q Consensus 78 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 157 (1078)
++..|+|+++.+.|.++...+..+++|++|+|++|.++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|
T Consensus 94 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 171 (968)
T PLN00113 94 YIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL 171 (968)
T ss_pred CCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEEC
Confidence 5677899999999999877777999999999999999998885 67899999999999999999999999999999999
Q ss_pred cCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCC
Q 039595 158 DMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL 237 (1078)
Q Consensus 158 ~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 237 (1078)
++|.+++.+|..++.+++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.
T Consensus 172 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 251 (968)
T PLN00113 172 GGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP 251 (968)
T ss_pred ccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCC
Q 039595 238 IPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNL 317 (1078)
Q Consensus 238 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l 317 (1078)
+|..|+++++|++|+|++|++++.+|..+.++++|+.|+|++|.+++.+|..+.++++|+.|++++|.+++.+|..++++
T Consensus 252 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l 331 (968)
T PLN00113 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331 (968)
T ss_pred cChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeec
Q 039595 318 KSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNM 397 (1078)
Q Consensus 318 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 397 (1078)
++|+.|++++|.+++.+|..++.+++|+.|++++|++.+.+|..+..+++|+.|++++|++.+.+|..+.++++|+.|++
T Consensus 332 ~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L 411 (968)
T PLN00113 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411 (968)
T ss_pred CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEEC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCC
Q 039595 398 CENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGS 477 (1078)
Q Consensus 398 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~ 477 (1078)
++|++++.+|..|..++.|+.|++++|.+.+..+..+..+++|+.|++++|+
T Consensus 412 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~---------------------------- 463 (968)
T PLN00113 412 QDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK---------------------------- 463 (968)
T ss_pred cCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCce----------------------------
Confidence 9999998888877777666666666655554444444444444444444443
Q ss_pred CCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccc
Q 039595 478 IPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNL 557 (1078)
Q Consensus 478 ~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 557 (1078)
+.+..|..+ ..++|+.|++++|++++..|..|..+++|++|+|++|.+.+.+|..+.++
T Consensus 464 --------------------~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 522 (968)
T PLN00113 464 --------------------FFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC 522 (968)
T ss_pred --------------------eeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCc
Confidence 333333322 22445555555555555555555566666666666666666666666666
Q ss_pred cccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEc
Q 039595 558 LKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDI 637 (1078)
Q Consensus 558 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l 637 (1078)
++|++|+|++|++++.+|..|.++++|+.|||++|++++.+|..+..+++|++|++++|++++.+|.. ..+..+....+
T Consensus 523 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~ 601 (968)
T PLN00113 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAV 601 (968)
T ss_pred cCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhh
Confidence 66666666666666666666666666666666666666666666666666777777777776666643 23334444556
Q ss_pred ccCcCC
Q 039595 638 CYNELQ 643 (1078)
Q Consensus 638 ~~N~l~ 643 (1078)
.+|+.-
T Consensus 602 ~~n~~l 607 (968)
T PLN00113 602 AGNIDL 607 (968)
T ss_pred cCCccc
Confidence 677633
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=404.46 Aligned_cols=263 Identities=26% Similarity=0.350 Sum_probs=218.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC-eeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR-HSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~l 828 (1078)
.+.+..+.||+|..|+||++.++ +++.+|+|++... .+.+.++++.+|++++++.+||+||.+||.|..++ ..++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 45666788999999999999765 7899999999543 25667888999999999999999999999999888 5999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
+||||++|+|+++++. .+++++....+|+.+|++||.|||+.+ +||||||||+|||++..|+|||||||.++.+.
T Consensus 156 ~mEYMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred ehhhcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 9999999999999943 367999999999999999999999732 99999999999999999999999999999876
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||............. ...+.+...+..+..
T Consensus 231 nS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L---l~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 231 NS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL---LCAIVDEPPPRLPEG 305 (364)
T ss_pred hh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH---HHHHhcCCCCCCCcc
Confidence 53 5678899999999999999999999999999999999999999976542323333332 233333222222221
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
....++.+++..||++||.+||+++|+++|||....+.
T Consensus 306 --~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 306 --EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred --cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 12235677788899999999999999999999886544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=402.84 Aligned_cols=266 Identities=27% Similarity=0.358 Sum_probs=220.2
Q ss_pred hhcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChh---hHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMA---DQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
..+.|.+.+.+|+|+||.|-+| +.++|+.||||++.+........ ....+.+|+++|+++.|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567888999999999999999 66789999999998765443221 2334679999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEecc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE---FEAHVSDF 901 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Df 901 (1078)
..||||||++||+|.+++- ..+.+.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999984 345577788899999999999999999 99999999999999766 67999999
Q ss_pred cccccccCCCCCceeeccccccccccccccCCC---CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 902 GIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA---TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 902 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
|+|+.... .....+.+||+.|.|||++.++.+ ..++|+||+||++|-+++|.+||.....+ .... .++.
T Consensus 324 GlAK~~g~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-~sl~------eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSGE-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-PSLK------EQIL 395 (475)
T ss_pred chhhcccc-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-ccHH------HHHh
Confidence 99998863 556778999999999999987643 44889999999999999999997533222 1122 2333
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
..++...++.+.+...+..++|.+||..||++|||++|+++|||+.....
T Consensus 396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 44444444445556668899999999999999999999999999986543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=416.12 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=225.3
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.+|...+.||+|||+.||.++. .+|+.||+|++.+.... .....+.+.+||++.++++|||||+++++|++...+|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 5799999999999999999976 78999999999886554 345577899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
.|+|+.|+|.++++ ..+++++.+++.+.+||+.|+.|||+. +|+|||||..|+|++++.+|||+|||+|..+..
T Consensus 97 LELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 97 LELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999995 456799999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
......+.+|||.|.|||++....++..+||||+|||+|-|+.|++||+ .....+....+......++..+.
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe--tk~vkety~~Ik~~~Y~~P~~ls------ 242 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE--TKTVKETYNKIKLNEYSMPSHLS------ 242 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc--cchHHHHHHHHHhcCcccccccC------
Confidence 7778889999999999999999999999999999999999999999965 33334444444443333333222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
....++|.++|++||.+|||+++|+.|+|+...
T Consensus 243 ----~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 243 ----AEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred ----HHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 246788999999999999999999999998543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=411.69 Aligned_cols=279 Identities=41% Similarity=0.642 Sum_probs=231.9
Q ss_pred CCCccHHHHHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEE
Q 039595 738 DGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817 (1078)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 817 (1078)
...++++++.+|+++|...+.||+|+||.||+|...+|+.||||++....... ..+|.+|+.++.+++|||+|+++
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEE
Confidence 34578999999999999999999999999999999989999999876543111 44599999999999999999999
Q ss_pred eeeecCC-eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 039595 818 GFCSNAR-HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEA 896 (1078)
Q Consensus 818 ~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 896 (1078)
|||.+.+ +.++|||||++|+|.++++..... .++|.++.+||.++|+||+|||+.+.+.|+||||||+|||+|+++++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999888 599999999999999999765443 89999999999999999999999988889999999999999999999
Q ss_pred EEecccccccccCCCCCceee-ccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccc-cccchhh-----
Q 039595 897 HVSDFGIAKFVEPYSSNRTEF-VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI-NFSSFSN----- 969 (1078)
Q Consensus 897 kl~DfG~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~-~~~~~~~----- 969 (1078)
||+|||+|+............ .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+.... .......
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999996554312222222 899999999999999999999999999999999999998764331 1111111
Q ss_pred -hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 970 -MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 970 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
......+++||++........+.+..+..++.+|++.+|++||+|.||++..
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 1125677889987632221126777899999999999999999999986654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=381.36 Aligned_cols=259 Identities=26% Similarity=0.350 Sum_probs=219.1
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||+||.++. ++++.||+|++++..... ..+.+....|..++.+++||+||+++..|++.+..|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 457899999999999999999954 579999999998876553 345677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+|+||+.||.|...|+ ..+.+++..+.-++.+|+.||.|||++ ||||||+||+|||+|.+|+++|+|||+++..
T Consensus 102 lVld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999994 456799999999999999999999999 9999999999999999999999999999977
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
...+....+++||+.|||||++.+..|+.++|.||+|+++|||++|.+||. ..+.......+.... ......
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~--~~~~~~~~~~I~~~k------~~~~p~ 247 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY--AEDVKKMYDKILKGK------LPLPPG 247 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc--CccHHHHHHHHhcCc------CCCCCc
Confidence 666666777899999999999999999999999999999999999999954 333333333322222 111111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCC----ChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARP----TMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RP----t~~ell~h~~~~~ 1025 (1078)
.... +..+++.+.+..||++|. .++++-+|+|+..
T Consensus 248 ~ls~---~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 248 YLSE---EARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred cCCH---HHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 1122 466888889999999995 7899999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=380.33 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=210.2
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
...+|...+.||+|+||+||+|+++ ++..||||.+.+... ..+..+.+..|+.++++++|||||+++++++.++.+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 4568889999999999999999765 689999999987643 3455777889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC------CcEEEecc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE------FEAHVSDF 901 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~Df 901 (1078)
+|||||+||+|.+|+++ .+.+++..++.+..|+|.||++||++ +||||||||+|||++.. -.+||+||
T Consensus 86 lVMEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 99999999999999954 34699999999999999999999999 99999999999999875 45899999
Q ss_pred cccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 902 GIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 902 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
|+|+...+ .....+.+|++.|||||++....|+.|+|+||+|+++|++++|++||+.... .+....+.....++...
T Consensus 160 GfAR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~--~eL~~~~~k~~~~~~~~ 236 (429)
T KOG0595|consen 160 GFARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP--KELLLYIKKGNEIVPVL 236 (429)
T ss_pred chhhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH--HHHHHHHhccccccCch
Confidence 99998874 4455678999999999999999999999999999999999999999763322 22222222222221111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
..... ....+++...+..+|.+|-+..+-+.|++....
T Consensus 237 ~~~~s-------~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 237 PAELS-------NPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred hhhcc-------CchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 11000 123455666688889999998888888775543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=393.38 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=206.4
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC-eeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR-HSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv 829 (1078)
+++...+.+|+|+||+||+|.+.....||||++........ ..+.|.+|+.++.+++|||||+++|+|.+.. ..++|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~--~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE--SRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 34445556999999999999997444499999987654322 2778999999999999999999999999887 79999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCCCCCeeeCCCC-cEEEecccccccc
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS-IIHRDISSKNVLLDLEF-EAHVSDFGIAKFV 907 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~kl~DfG~a~~~ 907 (1078)
|||+++|+|.+++++. ....+++..+++++.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++..
T Consensus 119 tEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999654 467799999999999999999999999 7 99999999999999998 9999999999876
Q ss_pred cCCCCCceeeccccccccccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAY--TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
.......+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ...... .......|.++..
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~--v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASA--VVVGGLRPPIPKE 270 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHH--HHhcCCCCCCCcc
Confidence 65333444578999999999999 56999999999999999999999999764433 111111 1111122222221
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. ..+..++.+||+.||+.||++.+++...-
T Consensus 271 ---~~---~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 271 ---CP---PHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred ---CC---HHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 22 25667788899999999999999886543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=360.59 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=213.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+...++|+|+||+||+++.+ +|+.||||++... .+++.-.+-..+|++++++++|||+|.++++|...+..++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 56888899999999999999765 6999999999654 33455667788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+|||+.. +.+-+++. ...++.+.+.+++.|++.|+.|+|++ +++||||||+|||++.+|.+|+||||+|+.+..
T Consensus 80 FE~~dhT-vL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 80 FEYCDHT-VLHELERY--PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eeecchH-HHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9999984 44445333 33478899999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh-------hhhhhcC--
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-------EVNQILD-- 979 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~-------~~~~~~~-- 979 (1078)
.+...+..+.|..|+|||.+.+ -.|+..+||||.||++.||++|.+-|...++- ........ +...++.
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-DQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-DQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH-HHHHHHHHHHcccCHHHHHHhccC
Confidence 7788899999999999999887 68999999999999999999999987544331 11111111 1111111
Q ss_pred C-----CCCCC------CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 980 P-----RLSTP------SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 980 ~-----~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
| +++.+ ....+....-+++++++|++.||++|++.+|++.|+|+
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 1 11111 11122333467899999999999999999999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=362.12 Aligned_cols=255 Identities=23% Similarity=0.329 Sum_probs=208.2
Q ss_pred hcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEe-eeecCC-ee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG-FCSNAR-HS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~-~~ 826 (1078)
..+|++.++||+|.||+||++ ...+|..||.|.+.-.. -+..+++....|+.++++++|||||++++ .+.++. .+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~--md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM--MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh--ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 346888899999999999999 56789999999997432 24566778899999999999999999998 454444 48
Q ss_pred EEEEeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 827 FLVCEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLP-SIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
+||||||++|+|..++++.+ ..+.+++..+|+++.|++.||.++|.+-++ -|+||||||.||+++.+|.||++|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999999996543 455689999999999999999999994322 2889999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
+++..........+|||.||+||.+.+.+|+.||||||+||++|||+.-++||. +.++......+.. ..+++
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~--g~n~~~L~~KI~q------gd~~~ 247 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY--GDNLLSLCKKIEQ------GDYPP 247 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc--cccHHHHHHHHHc------CCCCC
Confidence 999876666778999999999999999999999999999999999999999954 3343333333222 22221
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhH
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1016 (1078)
.+ ..-...++..+|..|+..||+.||+.-.
T Consensus 248 ~p--~~~YS~~l~~li~~ci~vd~~~RP~t~~ 277 (375)
T KOG0591|consen 248 LP--DEHYSTDLRELINMCIAVDPEQRPDTVP 277 (375)
T ss_pred Cc--HHHhhhHHHHHHHHHccCCcccCCCcch
Confidence 11 1233457888888999999999998433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=400.43 Aligned_cols=499 Identities=29% Similarity=0.377 Sum_probs=369.4
Q ss_pred CccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccc
Q 039595 96 FSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSL 175 (1078)
Q Consensus 96 ~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~ 175 (1078)
..++.-..++.|++++|.++ .+.+.+.+|..|.+|++++|+++ ..|++++.+..++.|+.++|+++ ++|++++.+.+
T Consensus 39 e~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~ 115 (565)
T KOG0472|consen 39 ENWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLIS 115 (565)
T ss_pred hhhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhh
Confidence 35666778889999999987 45667899999999999999998 78999999999999999999998 89999999999
Q ss_pred cceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccc
Q 039595 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYK 255 (1078)
Q Consensus 176 L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 255 (1078)
|+.++.++|++. ++|++++.+..|+.|+..+|+++ ..|++++++.+|..|++.+|+++...|..+ +++.|++|+..+
T Consensus 116 l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~ 192 (565)
T KOG0472|consen 116 LVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNS 192 (565)
T ss_pred hhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccch
Confidence 999999999998 78889999999999999999997 677888899999999999999997655444 489999999999
Q ss_pred cccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCC
Q 039595 256 NSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIP 335 (1078)
Q Consensus 256 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 335 (1078)
|-+. .+|..++.|.+|+.|+|..|++. .+| +|.+++.|..|.++.|.++-.......++.+|.+|||..|+++ ..|
T Consensus 193 N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~P 268 (565)
T KOG0472|consen 193 NLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVP 268 (565)
T ss_pred hhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCc
Confidence 9988 67888999999999999999998 455 7888888888888888877333334457888888888888887 567
Q ss_pred CCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCC--CCceeecccCcCCCCCCcccccc
Q 039595 336 PSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLT--GLVLLNMCENHLFGPIPKSLKSL 413 (1078)
Q Consensus 336 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~~l~~l 413 (1078)
+.++.+++|++||+|+|.|+ ..|..++++ +|+.|.+.+|.+..+-.+.+..-+ -|++|.= .+....+..-.
T Consensus 269 de~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs---~~~~dglS~se-- 341 (565)
T KOG0472|consen 269 DEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS---KIKDDGLSQSE-- 341 (565)
T ss_pred hHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH---hhccCCCCCCc--
Confidence 77777888888888888887 567777877 788888888877633222111100 0111110 01000000000
Q ss_pred CCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCC---cccE
Q 039595 414 TSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSS---KLQF 490 (1078)
Q Consensus 414 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~---~L~~ 490 (1078)
+-.-+ .-++. ..........-+.++|.+++-+++. +|.+..... -...
T Consensus 342 ---------~~~e~--------------~~t~~-----~~~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~ 392 (565)
T KOG0472|consen 342 ---------GGTET--------------AMTLP-----SESFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTS 392 (565)
T ss_pred ---------ccccc--------------cCCCC-----CCcccchhhhhhhhhhccccccccc-CCHHHHHHhhhcceEE
Confidence 00000 00000 0000111122334444444444443 333322222 3678
Q ss_pred EeccCCccCCCcccccccCccCcE-EeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcc
Q 039595 491 LDLSSNHIVGKIPVQLEKLFSLNK-LILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQ 569 (1078)
Q Consensus 491 L~Ls~N~i~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 569 (1078)
.+++.|++. .+|..+..+..+.+ +.+++|.+. .+|..++.+++|+.|+|++|.+. .+|..++.+..|+.||+|+|+
T Consensus 393 VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~Nr 469 (565)
T KOG0472|consen 393 VNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNR 469 (565)
T ss_pred EecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccc
Confidence 888899888 67887777776554 556666665 78888899999999999999887 678888888889999999999
Q ss_pred cccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCC
Q 039595 570 FSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGP 645 (1078)
Q Consensus 570 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~ 645 (1078)
|. ..|.....+..|+.+-.++|++....+..+.+|.+|.+|||.+|.+. .+|+.+++|++|++|++.||++.-+
T Consensus 470 Fr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~P 543 (565)
T KOG0472|consen 470 FR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQP 543 (565)
T ss_pred cc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCCC
Confidence 86 78888888888888888889998666666888999999999999998 6788899999999999999999843
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=384.80 Aligned_cols=247 Identities=28% Similarity=0.477 Sum_probs=201.6
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+.++..+.||+|.||+||.|.++....||+|.++... ...+.|.+|+.+|++++|++||+++++|..++.+||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-----MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-----cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 3455667899999999999999877799999987642 23567899999999999999999999999989999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
|||+.|+|.++|+. .....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..|||+|||+|+...+.
T Consensus 281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999999965 3456789999999999999999999999 9999999999999999999999999999965432
Q ss_pred CC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC-
Q 039595 911 SS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP- 987 (1078)
Q Consensus 911 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 987 (1078)
.. ......-+..|.|||.+..+.++.|||||||||+||||+| |+.||..+.. .+.... ++...+.+.|
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--~ev~~~-------le~GyRlp~P~ 427 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--EEVLEL-------LERGYRLPRPE 427 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--HHHHHH-------HhccCcCCCCC
Confidence 22 2233344779999999999999999999999999999999 9999653332 122222 2222222222
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHH
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGF 1018 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell 1018 (1078)
.+++ .+.+++..||+.+|++|||++.+.
T Consensus 428 ~CP~---~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 428 GCPD---EVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCH---HHHHHHHHHhhCCcccCCCHHHHH
Confidence 2233 466788889999999999998544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=382.03 Aligned_cols=257 Identities=24% Similarity=0.401 Sum_probs=215.9
Q ss_pred cCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
..|+...+||+|+.|.||.| +..+++.||||++.... ...++-+.+|+.+|+..+|+|||++++.|..++..|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~----Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK----QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc----CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 46888889999999999999 55678999999997653 22356678999999999999999999999989999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
||||+||+|.+.+. ...+++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999983 34489999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
....+...+||+.|||||++....|+.|+||||||++++||+-|++||-.... ..++ ..+...-.|.+.. .
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-lrAl----yLIa~ng~P~lk~----~ 492 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRAL----YLIATNGTPKLKN----P 492 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-HHHH----HHHhhcCCCCcCC----c
Confidence 77778889999999999999999999999999999999999999999543221 1111 1111111222222 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
......+.+++.+||..||++||++.|+|+|+|.....
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 22233677888899999999999999999999986543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=376.20 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=217.9
Q ss_pred HHhhcCCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCC
Q 039595 747 IKATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 747 ~~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 824 (1078)
.+...+|.+++.||+|+|++|++|+ .++++.||||++.+.....+. ..+.+..|-.+|.++ .||.|++++-.|.++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~-KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEK-KVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhc-ccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 4456789999999999999999994 457999999999876654322 234567788888888 8999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
.+|+|+||+++|+|.+++++ -+.+++..++.++.+|+.|++|||++ |||||||||+|||+|.||++||+|||.|
T Consensus 148 sLYFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred ceEEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999999954 36799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC-------------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh
Q 039595 905 KFVEPYSS-------------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI 971 (1078)
Q Consensus 905 ~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~ 971 (1078)
+.+.+... ....++||..|.+||++.+...++.+|+|+|||++|+|+.|++||..... -...+.+
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--yliFqkI 299 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--YLIFQKI 299 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--HHHHHHH
Confidence 87743211 12458999999999999999999999999999999999999999754332 2233333
Q ss_pred hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 972 IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....-+.+.++ ..+.+++.+.|..||.+|+|++||.+|||+..
T Consensus 300 ~~l~y~fp~~fp----------~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 300 QALDYEFPEGFP----------EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred HHhcccCCCCCC----------HHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 444444444443 25678889999999999999999999999764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=347.84 Aligned_cols=254 Identities=26% Similarity=0.309 Sum_probs=217.9
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|+..+.||.|+||+|.+++.+ +|..+|+|++.+.... .....+...+|..+++.+.||+++++++.|.+.+..||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-HHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 467899999999999999999665 6889999999876544 34456677889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||++||.|..+++ ..+++++..++.++.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||+|+.+.
T Consensus 122 vmeyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999994 456799999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
. ...+.+|||.|+|||++..++|..++|.|||||++|||+.|.+||. +.....+...+......+++.+..
T Consensus 196 ~---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~--~~~~~~iY~KI~~~~v~fP~~fs~---- 266 (355)
T KOG0616|consen 196 G---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY--DDNPIQIYEKILEGKVKFPSYFSS---- 266 (355)
T ss_pred C---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc--CCChHHHHHHHHhCcccCCcccCH----
Confidence 3 3667899999999999999999999999999999999999999954 433344444444444344333332
Q ss_pred cHHHHHHHHHHHHhcccCCCCCC-----CChhHHHHHhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEAR-----PTMEKGFGHHIGYC 1025 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~R-----Pt~~ell~h~~~~~ 1025 (1078)
++.+++.+.++.|-.+| +..++|..|+|+..
T Consensus 267 ------~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 267 ------DAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred ------HHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 56788888999999999 46789999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=370.66 Aligned_cols=270 Identities=21% Similarity=0.311 Sum_probs=213.8
Q ss_pred hhcCCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCC-e
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNAR-H 825 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~ 825 (1078)
..++|..+++||.|+||.||+|+ ..+|+.||||++++.... .++. .=.+|+..++++. |||||++.+++.+.+ .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 45789999999999999999995 457999999999876543 2222 2357999999998 999999999998877 9
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
+++|||||+. +|+++++++ .+.+++.++..|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+||
T Consensus 85 L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence 9999999977 999999654 67899999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccccccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh-------------
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI------------- 971 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~------------- 971 (1078)
.+.. ....+..+.|..|+|||++. .+.|+.+.|||++|||++|+.+-++-|...+.- ..+....
T Consensus 159 ev~S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 159 EVRS-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cccc-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHHHHHHHHhCCCccccchh
Confidence 8764 44567889999999999865 567999999999999999999999886543321 1111110
Q ss_pred -hhhhhhcCCCCCCCCCcc-----HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHH
Q 039595 972 -IEVNQILDPRLSTPSPGV-----MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEIL 1029 (1078)
Q Consensus 972 -~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~ 1029 (1078)
......+.-.++...+.. .....+.++++.+|+++||++|||++|+++|||++.....
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 000111111111111111 1123478899999999999999999999999998875544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=378.98 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=215.5
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCCh-hhHHHHHHHHHHHhcCC-CCceeeEEeeeecCC
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNM-ADQDEFLNVVLALNEIR-HRNIVKFHGFCSNAR 824 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 824 (1078)
.....|.+.+.||+|+||+|+.|.. .+++.||+|++.+....... ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999954 57899999987765332122 23455678999999999 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEecccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGI 903 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~ 903 (1078)
.+++||||+.||+|.+++.+ .+++.+.++..+++|++.|++|+|++ ||+||||||+||+++.+ +.+||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999943 56788899999999999999999999 99999999999999999 9999999999
Q ss_pred cccccCCCCCceeeccccccccccccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTMR-AT-EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
+...........+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+. .+.......+......++..
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--~~~~~l~~ki~~~~~~~p~~ 245 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--SNVPNLYRKIRKGEFKIPSY 245 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--ccHHHHHHHHhcCCccCCCC
Confidence 998753345567889999999999999877 74 799999999999999999999775 22222222222211112111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
+. ..++.+++.+|+..||.+|+|+.+++.|+|+..
T Consensus 246 ~~---------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 246 LL---------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cC---------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 11 336788999999999999999999999999887
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=387.24 Aligned_cols=486 Identities=30% Similarity=0.387 Sum_probs=385.0
Q ss_pred EeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCc
Q 039595 81 SINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMN 160 (1078)
Q Consensus 81 ~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 160 (1078)
.+.++.+.+.-. ...+.++..|+.|++++|++. +.|++++.+..++.|+.|+|+++ ++|.+++.+.+|+.|++++|
T Consensus 49 ~lils~N~l~~l--~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n 124 (565)
T KOG0472|consen 49 KLILSHNDLEVL--REDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSN 124 (565)
T ss_pred hhhhccCchhhc--cHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccc
Confidence 344554443322 235678999999999999996 78999999999999999999999 89999999999999999999
Q ss_pred cCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCC
Q 039595 161 QLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPC 240 (1078)
Q Consensus 161 ~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 240 (1078)
.+. ++|++|+.+..|..++..+|+++ ..|.+++++.+|..|++.+|++....|+.+. ++.|+.||.-.|-++ .+|.
T Consensus 125 ~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~ 200 (565)
T KOG0472|consen 125 ELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPP 200 (565)
T ss_pred cee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCCh
Confidence 998 99999999999999999999999 7899999999999999999999966555554 999999999999998 4688
Q ss_pred cccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccc-cccCCceeeecccCCCCCCCccccCCCc
Q 039595 241 TLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFG-NLSSWTLMSLFSNSLSGSIPPILGNLKS 319 (1078)
Q Consensus 241 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~l~~l~~ 319 (1078)
.++.+.+|+-|+|.+|++. .+| +|.++..|++|+++.|+|+ .+|...+ +++++..|||.+|+++ ..|+.+.-+++
T Consensus 201 ~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrs 276 (565)
T KOG0472|consen 201 ELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRS 276 (565)
T ss_pred hhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhh
Confidence 9999999999999999999 677 7999999999999999998 6676655 9999999999999999 78999999999
Q ss_pred cCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCC---CCeEEcccccCccccCCCCccCCCCceee
Q 039595 320 LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKS---LSELKLCKNNLSGVIPHSVGNLTGLVLLN 396 (1078)
Q Consensus 320 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 396 (1078)
|++||+++|.|++ .|.+++++ .|+.|.+.+|.+.. +-.++-+... |++|. ..+....+..-.. ..-..-+
T Consensus 277 L~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLr---s~~~~dglS~se~-~~e~~~t 349 (565)
T KOG0472|consen 277 LERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLR---SKIKDDGLSQSEG-GTETAMT 349 (565)
T ss_pred hhhhcccCCcccc-CCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHH---HhhccCCCCCCcc-cccccCC
Confidence 9999999999995 68889999 99999999999873 3322221111 11111 0111100000000 0000000
Q ss_pred cccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCC--CCcEecCCCCccCCccCccccCCCCCceeccccccc
Q 039595 397 MCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHP--NLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNI 474 (1078)
Q Consensus 397 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i 474 (1078)
... ........+.+.+.|++++-+++.++.+.|..-. -.+..+++.|++..
T Consensus 350 ----~~~-~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~e---------------------- 402 (565)
T KOG0472|consen 350 ----LPS-ESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCE---------------------- 402 (565)
T ss_pred ----CCC-CcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhh----------------------
Confidence 000 1112233455677777777777777777775443 26667777777653
Q ss_pred CCCCCccccCCCcc-cEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcc
Q 039595 475 FGSIPLEIGDSSKL-QFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKS 553 (1078)
Q Consensus 475 ~~~~~~~~~~l~~L-~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 553 (1078)
+|..+..+..+ +.+++++|.+. .+|..+..+++|..|+|++|-+. .+|.+++.+..|+.||+|.|++. ..|..
T Consensus 403 ---lPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~ 476 (565)
T KOG0472|consen 403 ---LPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPEC 476 (565)
T ss_pred ---hhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHH
Confidence 44444444443 34566666665 88888899999999999999887 67888889989999999999998 78888
Q ss_pred cccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCcccc
Q 039595 554 IGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLS 619 (1078)
Q Consensus 554 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 619 (1078)
+-.+..|+.+-.++|++....|..+.++.+|.+|||.+|.|. .+|+.+++|.+|++|+|++|+++
T Consensus 477 ~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 477 LYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 888888888888889998777777999999999999999997 68889999999999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=357.17 Aligned_cols=264 Identities=28% Similarity=0.400 Sum_probs=214.1
Q ss_pred hcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.+.|+....||.|..++||+| ..+.++.||||++.-+.. ..+.+.+++|+..++.++||||++++..|..+...|+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc---~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC---NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh---hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 468999999999999999999 556789999999976542 3346889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||.||.+|++.++++.....+ +++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+.
T Consensus 102 VmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999997654443 89999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCc----eeeccccccccccccccC--CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 909 PYSSNR----TEFVGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 909 ~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
..+... ..++||+.|||||++.+. .|+.|+||||||+...|+.+|..||..+..- ....... +--.|.+
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm----kvLl~tL-qn~pp~~ 252 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM----KVLLLTL-QNDPPTL 252 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH----HHHHHHh-cCCCCCc
Confidence 444332 456899999999996543 5899999999999999999999997644321 0000110 0011111
Q ss_pred CC---CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 ST---PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. +..........+.+++..||.+||++|||+++++.|.|+..
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~ 298 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK 298 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence 11 11112223347888899999999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.87 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=206.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC--ee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR--HS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~ 826 (1078)
..+|...+.||+|+||+||++... +|+..|||.+.... ....+.+.+|+.++++++|||||+++|...... .+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 356788899999999999999654 58999999986652 112667899999999999999999999854444 69
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEecccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-EFEAHVSDFGIAK 905 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~a~ 905 (1078)
+++|||+++|+|.+++.+... .+++..+..+++||++||+|||++ |||||||||+|||++. ++.+||+|||.+.
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 999999999999999965432 699999999999999999999999 9999999999999999 7999999999998
Q ss_pred cccC---CCCCceeeccccccccccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 906 FVEP---YSSNRTEFVGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 906 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
.... .........||+.|||||++..+. ...++||||+||++.||+||+.||..... ...........-.-|.
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~---~~~~~~~ig~~~~~P~ 243 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE---EAEALLLIGREDSLPE 243 (313)
T ss_pred ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc---hHHHHHHHhccCCCCC
Confidence 7763 122345678999999999999643 34599999999999999999999875311 1111111111111122
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
++.. .. .+..+++.+|+..||++||||+++++|+|....+.
T Consensus 244 ip~~---ls---~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 244 IPDS---LS---DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCcc---cC---HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 2211 11 25678888999999999999999999999766554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=377.34 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=215.8
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.-|+.++.||+|+.|.|.+|++ .+|+.+|||++.+...- .......+.+|+.+|+-+.||||+++|+++++..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccc-ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 3577888999999999999954 58999999999776321 223345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
.||++||.|++++ ...+++++.++++++.||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|....
T Consensus 91 lEyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV- 163 (786)
T ss_pred EEecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence 9999999999999 4457799999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.++.-.+.+|.+.|.|||++.+.+| +.++||||+|||||.|+||+.||+ +++.......+......++..+
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--DdNir~LLlKV~~G~f~MPs~I------ 235 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--DDNIRVLLLKVQRGVFEMPSNI------ 235 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--CccHHHHHHHHHcCcccCCCcC------
Confidence 3555677899999999999999987 679999999999999999999977 3333333333333222222111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
..+.++++++|+..||++|.|++||+.|||.....
T Consensus 236 ----s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 236 ----SSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred ----CHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 12678999999999999999999999999977643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=392.77 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=205.2
Q ss_pred hcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
..+....+.||+|+||+||+|+.. +...||||.++... +...+++|++|++++..++|||||+++|+|.++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 345566788999999999999643 34579999998763 344688999999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCC-------C----CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 039595 824 RHSFLVCEYLHRGSLARILGNDA-------T----AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL 892 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~-------~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 892 (1078)
+.+|||+|||..|||.+||+... . ..+++..+.+.||.|||.||+||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 99999999999999999995321 1 33488999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccccccccCC--CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhh
Q 039595 893 EFEAHVSDFGIAKFVEPY--SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 893 ~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~ 969 (1078)
+..|||+|||+++.+-.. .+......-+.+|||||.+..++++.+||||||||+|||+++ |+.||..... .+..+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--~EVIe 716 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--QEVIE 716 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--HHHHH
Confidence 999999999999976332 222334456889999999999999999999999999999998 9999643332 22222
Q ss_pred hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
. +-.....+.+...+. ++++++..||+.+|.+||+++||-..
T Consensus 717 ~------i~~g~lL~~Pe~CP~---~vY~LM~~CW~~~P~~RPsF~eI~~~ 758 (774)
T KOG1026|consen 717 C------IRAGQLLSCPENCPT---EVYSLMLECWNENPKRRPSFKEIHSR 758 (774)
T ss_pred H------HHcCCcccCCCCCCH---HHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 2 222233222333333 56778888999999999999987654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=334.40 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=211.6
Q ss_pred cCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|...+++|+|+||.||+| ..++|+.||||+++.....+.. .....+|++.++.++|+||+.++++|...+...+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi--~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI--NRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc--cHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 57888899999999999999 5568999999999876433222 23568899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+|||+. +|+..++. ....++..++..++.++++|++|+|++ .|+|||+||.|+|++++|.+||+|||+|+.+..
T Consensus 80 fEfm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEeccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 999987 99999954 346789999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh-----------------
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI----------------- 971 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~----------------- 971 (1078)
.....+..+-|..|.|||.+++. .|+..+||||.||++.||+-|.+-|...++ ........
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCcccCcccccc
Confidence 76666666889999999998875 599999999999999999998876542221 11111000
Q ss_pred ---hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 972 ---IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 972 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
......-.+.... -......+..+++.+|+..||.+|+|+.|+++|+|+..
T Consensus 233 pdY~~~~~~P~~~~~~---lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNN---LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccHHHHhcCCCCcccc---ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 0000000111111 12223346689999999999999999999999999764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=369.97 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=215.4
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|.+.+.||+|.||+||||+. .+.+.||+|.+.+.. ...++.+.+.+|++++++++|||||.++++|+...+.|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 5688888999999999999954 478899999998764 2445677899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+.| +|..++. ..+.++++.+..++.+++.||.|||+. +|.|||+||+|||++.+|++|+||||+|+....
T Consensus 80 te~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred ehhhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 999988 9999994 456699999999999999999999999 999999999999999999999999999998877
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.....+...|||-|||||...+.+|+..+|.||+||++||+++|++||. ....... ...+.......+ .
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~--a~si~~L------v~~I~~d~v~~p-~-- 221 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY--ARSITQL------VKSILKDPVKPP-S-- 221 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch--HHHHHHH------HHHHhcCCCCCc-c--
Confidence 6666778899999999999999999999999999999999999999953 2211111 112221111111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....+..++...+.+||..|.|..+++.|+|-..
T Consensus 222 -~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 222 -TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred -cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 33446778888899999999999999999998554
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=340.79 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=219.7
Q ss_pred hhcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..+.|++.+.||+|+|+.||++ ...+|+.+|+|++........ +.+++.+|+.+.+.++|||||++.+.+...+..|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 3467888889999999999999 556899999999876655433 5778899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEeccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE---FEAHVSDFGIA 904 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~a 904 (1078)
+|+|+|+||+|..=+-. ....++..+-.+++||+++|.|+|.+ +|||||+||+|+++... .-+|++|||+|
T Consensus 87 lvFe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEEecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceE
Confidence 99999999998654421 24578888999999999999999999 99999999999999543 45999999999
Q ss_pred ccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
..+. .+.....++|||+|||||++...+|+..+|||+.||+||-++.|.+|| .+.+...+...+.....-++++.
T Consensus 161 i~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF--~~~~~~rlye~I~~g~yd~~~~~-- 235 (355)
T KOG0033|consen 161 IEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF--WDEDQHRLYEQIKAGAYDYPSPE-- 235 (355)
T ss_pred EEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCC--CCccHHHHHHHHhccccCCCCcc--
Confidence 9887 455667889999999999999999999999999999999999999994 44444444444444433333322
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHHHH
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAV 1031 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~~~ 1031 (1078)
+.....+..+++++||..||.+|.|+.|+++|||....+..+.
T Consensus 236 ----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As 278 (355)
T KOG0033|consen 236 ----WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVAS 278 (355)
T ss_pred ----cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHH
Confidence 2222235678899999999999999999999999886655544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=365.01 Aligned_cols=261 Identities=25% Similarity=0.283 Sum_probs=213.0
Q ss_pred hhcCCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|+..+.||+|+||.||+|+ ..+|+.+|+|++++.... ...+.+.++.|..+|...++|.||+++..|++...+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35789999999999999999994 457999999999887544 3445677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
|||||++||++..+| ...+.+++..+..++.+++.|++.+|+. |||||||||+|+|||..|++||+|||++.-+
T Consensus 218 LiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999999 4456799999999999999999999999 9999999999999999999999999999532
Q ss_pred cC------------------------CCC---Cc--------------------eeeccccccccccccccCCCCccchh
Q 039595 908 EP------------------------YSS---NR--------------------TEFVGTFGYAAPEIAYTMRATEKYDV 940 (1078)
Q Consensus 908 ~~------------------------~~~---~~--------------------~~~~gt~~y~aPE~~~~~~~~~~sDv 940 (1078)
.. ... .. ...+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 000 00 01589999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCC---hhHH
Q 039595 941 YSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT---MEKG 1017 (1078)
Q Consensus 941 wSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~el 1017 (1078)
||+|||+|||+.|.+||. ..+..+....+...+..+...-.. ....+..++|.+|+. ||++|.. ++||
T Consensus 372 WSLG~ImyEmLvGyPPF~--s~tp~~T~rkI~nwr~~l~fP~~~------~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFC--SETPQETYRKIVNWRETLKFPEEV------DLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHhhhccCCCcC------cccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 999999999999999964 333333333333333222111111 111467789999999 9999984 9999
Q ss_pred HHHhhhhh
Q 039595 1018 FGHHIGYC 1025 (1078)
Q Consensus 1018 l~h~~~~~ 1025 (1078)
.+|||+..
T Consensus 443 K~HPfF~~ 450 (550)
T KOG0605|consen 443 KKHPFFKG 450 (550)
T ss_pred hcCCcccc
Confidence 99999774
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.11 Aligned_cols=267 Identities=24% Similarity=0.341 Sum_probs=208.5
Q ss_pred hcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--Cee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--RHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 826 (1078)
.+.|+.+++||+|+||.||+| ...+|+.||+|+++.... +.....-..+||.++++++||||+++.+...+. +.+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 356778889999999999999 556899999999976542 233345567899999999999999999998665 789
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|||+|||+. ||.-++.. ..-.+++.++..+++|++.||+|+|++ ||+|||||.+|||+|.+|.+||+|||+|++
T Consensus 194 YlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence 999999998 89888843 345699999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCC-ceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccc--ccchhhhhhhh-hhhcC--
Q 039595 907 VEPYSSN-RTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSIN--FSSFSNMIIEV-NQILD-- 979 (1078)
Q Consensus 907 ~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~--~~~~~~~~~~~-~~~~~-- 979 (1078)
+...... .+..+.|..|.|||.+.+. .|+.++|+||.|||+.||++|++.|...... ...+....... ...+.
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 8765543 6778899999999998875 6999999999999999999999996533221 00011100000 00000
Q ss_pred --C-----CCCCCCCccHHH-----HHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 980 --P-----RLSTPSPGVMDK-----LISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 980 --~-----~~~~~~~~~~~~-----~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
| ....+......+ ....++++..+|..||++|.|+.++++++|+.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 0 000111111111 12567888999999999999999999999984
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=365.74 Aligned_cols=253 Identities=27% Similarity=0.480 Sum_probs=207.4
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+.....+-+|.|+.|.||+|+.+ ++.||||+++.- -..+|+-+++++||||+.|.|+|.....+||||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc-CceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 33444567999999999999886 788999987532 134788899999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
|||..|-|+++|+ ....++......+.++||.|+.|||.+ .|||||||.-||||..+..|||+|||.++...+.
T Consensus 192 EfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 192 EFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999994 445688899999999999999999999 9999999999999999999999999999977653
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
..+..++||..|||||+++..+.++|+||||||||||||+||..||. +.+..++...+.. ..+.-..+...+
T Consensus 266 -STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk--dVdssAIIwGVGs--NsL~LpvPstcP--- 337 (904)
T KOG4721|consen 266 -STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK--DVDSSAIIWGVGS--NSLHLPVPSTCP--- 337 (904)
T ss_pred -hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc--ccchheeEEeccC--CcccccCcccCc---
Confidence 44567899999999999999999999999999999999999999954 3333333332221 122222222222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHHHHH
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVI 1032 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~~~~ 1032 (1078)
..+.-+++.||+..|..||++++++.|.-....+++++.
T Consensus 338 ---~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~t 376 (904)
T KOG4721|consen 338 ---DGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTT 376 (904)
T ss_pred ---hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhccc
Confidence 245667888999999999999999999876666666543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.99 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=215.1
Q ss_pred cCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
..|+..+.||+|.||.||+| ...+++.||+|++.... ...+.+.+++|+.++.+++++||.++|+.+..+..+|++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 46788899999999999999 45689999999997654 334567789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
||||.||++.+.++ ....+.+.++.-+.++++.|+.|+|++ +.+|||||+.||++..+|.||++|||.+.....
T Consensus 90 Mey~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999999993 334457888888999999999999999 999999999999999999999999999998887
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
......+++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+..... .+....++...++....
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---------mrvlflIpk~~PP~L~~- 233 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---------MRVLFLIPKSAPPRLDG- 233 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---------ceEEEeccCCCCCcccc-
Confidence 77777899999999999999988999999999999999999999999653332 11111222222211111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.....+.+++..||++||+.||+|.+++.|.|....
T Consensus 234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 234 -DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred -ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 223356778888999999999999999999998764
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=373.88 Aligned_cols=395 Identities=25% Similarity=0.252 Sum_probs=257.1
Q ss_pred CCeeecCCcccCCCCCCcccCC--CCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeee
Q 039595 224 LSTLDLSQNQLNGLIPCTLDNL--SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSL 301 (1078)
Q Consensus 224 L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 301 (1078)
-..||.+++.+....-..+.+. +.-+.|++++|+++..-+..|.++++|+.++|..|.++ .+|..-....+|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 3457777777764322222211 23345777777777666666777777777777777776 45554444444666666
Q ss_pred cccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccc
Q 039595 302 FSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGV 381 (1078)
Q Consensus 302 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 381 (1078)
.+|.|+..-...+..++.|+.|||+.|.|+.+.-.+|..-.++++|+|++|+|+..-...|..+.+|..|.|++|+++..
T Consensus 133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL 212 (873)
T KOG4194|consen 133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL 212 (873)
T ss_pred eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence 66666655555566666666666666666554444555555566666666666555455555555555555555555555
Q ss_pred cCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCC
Q 039595 382 IPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNL 461 (1078)
Q Consensus 382 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 461 (1078)
.+.+|.++++|+.|+|..|+|. ....-+|.++++|+.|.|..|.|......+|-.+
T Consensus 213 p~r~Fk~L~~L~~LdLnrN~ir------------------------ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l 268 (873)
T KOG4194|consen 213 PQRSFKRLPKLESLDLNRNRIR------------------------IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGL 268 (873)
T ss_pred CHHHhhhcchhhhhhcccccee------------------------eehhhhhcCchhhhhhhhhhcCcccccCcceeee
Confidence 5555555555555555555554 3334444444444444444444444444444444
Q ss_pred CCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeec
Q 039595 462 PKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDL 541 (1078)
Q Consensus 462 ~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 541 (1078)
.++++|+|+.|++...-..++.+++.|+.|+||+|.|..+.++...-+++|++|+|++|+|+...+..|..+..|+.|+|
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 45555555555555555566777777888888888887777777777778888888888888777778888888888888
Q ss_pred cCccccCCCCcccccccccccccccCcccccccch---hhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccc
Q 039595 542 SANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPI---EFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNL 618 (1078)
Q Consensus 542 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 618 (1078)
++|.|+......|..+.+|++|||++|.|+..+.+ .|.+|++|+.|+|.+|+|..+...+|.++++|++|||.+|.|
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 88888776667777888888888888887764433 477888888888888888765566788888888888888888
Q ss_pred cCCcccccccCCcCcEEEcccCcCCC
Q 039595 619 SGFIPRCFEKMRSLSCIDICYNELQG 644 (1078)
Q Consensus 619 ~~~~~~~l~~l~~L~~l~l~~N~l~~ 644 (1078)
..+.|+.|..+ .|++|-++.-.+-+
T Consensus 429 aSIq~nAFe~m-~Lk~Lv~nSssflC 453 (873)
T KOG4194|consen 429 ASIQPNAFEPM-ELKELVMNSSSFLC 453 (873)
T ss_pred eeecccccccc-hhhhhhhcccceEE
Confidence 88888888888 78877776555443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=328.86 Aligned_cols=258 Identities=28% Similarity=0.386 Sum_probs=218.9
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
+.++|++.+.||+|-||.||.|+. +++-.||+|++.+..... .....++.+|+++-..++||||+++|++|.+....|
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 457899999999999999999954 568899999997765332 233467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+++||..+|+++..++. ...+++++.....+++|+|.|+.|+|.+ +|+||||||+|+|++.++..|++|||.+..-
T Consensus 99 LilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999954 3456789999999999999999999999 9999999999999999999999999999754
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
. ...+.+.+||..|.|||...+..++..+|+|++|++.||++.|.+||.... ..+....+.+.+..++....
T Consensus 175 p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~~~p~~is---- 246 (281)
T KOG0580|consen 175 P--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDLKFPSTIS---- 246 (281)
T ss_pred C--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHccccCCcccC----
Confidence 3 456678899999999999999999999999999999999999999965433 33344444443333332221
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....++|.+|+..+|.+|.+..|++.|||...
T Consensus 247 ------~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 247 ------GGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ------hhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 25678999999999999999999999999754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=347.56 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=217.6
Q ss_pred hcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..+|++.+.||+|+||.|-+| .++.|+.||||.+++.... +..+.-.+++||++|..++||||+++|++|+..+.+.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-deqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 457888899999999999999 5578999999999887543 56667789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||..+|.|++|+. ..+.+++.+++.+++||..|+.|+|.+ ++||||+|.+|||+|.++.+||+|||++-.+.
T Consensus 131 vMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999994 456799999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
+ ...-.+++|++-|.+||++.+.+| ++.+|.||+||+||-++.|..|||..+- . ..+.++....+..+..
T Consensus 205 ~-~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--k------~lvrQIs~GaYrEP~~ 275 (668)
T KOG0611|consen 205 D-KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--K------RLVRQISRGAYREPET 275 (668)
T ss_pred c-ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--H------HHHHHhhcccccCCCC
Confidence 4 345678999999999999999988 6789999999999999999999774432 1 1223333344443322
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. .+..-+|++||..+|++|.|+++|..|=|..-
T Consensus 276 P-----SdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 276 P-----SDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred C-----chHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 1 13346788999999999999999999987543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=370.22 Aligned_cols=365 Identities=26% Similarity=0.252 Sum_probs=251.4
Q ss_pred CCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecc
Q 039595 224 LSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFS 303 (1078)
Q Consensus 224 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 303 (1078)
-+.||+++|+++..-+..|.++++|+++++.+|.++ .||...+...+|+.|+|.+|.|+.+-...+.-++.|+.|||+.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 345777777777776667777777777777777777 5666555555677777777777766667777777777777777
Q ss_pred cCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccC
Q 039595 304 NSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIP 383 (1078)
Q Consensus 304 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 383 (1078)
|.|+...-..|..-.++++|+|++|.|+..-.+.|..+.+|..|.|++|+++...+..|..+++|+.|+|..|+|.-+--
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 77775555667777788888888888887777888888888888888888886666677778888888888888875445
Q ss_pred CCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCC
Q 039595 384 HSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPK 463 (1078)
Q Consensus 384 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 463 (1078)
-.|.++++|+.|.|..|.++..-...|..+.++++|+|+.|+++....+.+-++..|+.|+||+|.|..+....|.-.++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 66777788888888777777777777777777777777777777777777777777777777777777777666666666
Q ss_pred CceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcc---cccccccccceee
Q 039595 464 LDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVP---LEFGSLTELQYLD 540 (1078)
Q Consensus 464 L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~ 540 (1078)
|++|+|+.|+|+...+..|..+..|++|+|++|.|+..-..+|..+.+|+.|||++|.|+..+. ..|..+++|+.|+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 6666666666666556666666666666666666655555555556666666666666554332 2345555555555
Q ss_pred ccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecC
Q 039595 541 LSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLS 590 (1078)
Q Consensus 541 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 590 (1078)
|.+|+|..+.-.+|.++..|++|||.+|.|..+.|.+|..+ +|++|.++
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 55555554444555555555555555555555555555555 55555443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=351.94 Aligned_cols=265 Identities=25% Similarity=0.320 Sum_probs=208.7
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccC----------ChhhHHHHHHHHHHHhcCCCCcee
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG----------NMADQDEFLNVVLALNEIRHRNIV 814 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~niv 814 (1078)
-.+..++|++.+.||+|.||.|-+|.. .+++.||||++.+..... .....+..++||.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 345678999999999999999999954 479999999997643211 122235789999999999999999
Q ss_pred eEEeeeec--CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 039595 815 KFHGFCSN--ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL 892 (1078)
Q Consensus 815 ~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 892 (1078)
+++++..+ .+.+|||+|||..|.+...= .....+++.+++++++++..||+|||.+ ||+||||||+|+|+++
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 99999865 46899999999998775432 2333399999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccccccccCCC-----CCceeeccccccccccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccccc
Q 039595 893 EFEAHVSDFGIAKFVEPYS-----SNRTEFVGTFGYAAPEIAYTMR----ATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 963 (1078)
Q Consensus 893 ~~~~kl~DfG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~p~~~~~~~ 963 (1078)
+|+|||+|||.+....... ..-...+|||.|||||...++. .+.+.||||+||+||.|+.|+.|| .+..
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF--~~~~ 323 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF--FDDF 323 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc--ccch
Confidence 9999999999998663221 1223478999999999987632 367899999999999999999995 3332
Q ss_pred ccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 964 FSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
..+ -.+.++...+..+.. .+...++.++|+++|.+||+.|.+..+|..|||....
T Consensus 324 ~~~------l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 ELE------LFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHH------HHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 111 222333333332221 2333467899999999999999999999999998764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=373.98 Aligned_cols=281 Identities=22% Similarity=0.398 Sum_probs=217.0
Q ss_pred CCCccHHHHHHhhcC---------CCccceeccCCceeEEEEEeCC----CCEEEEEEeccccccCChhhHHHHHHHHHH
Q 039595 738 DGKIMHEEIIKATDD---------FDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADQDEFLNVVLA 804 (1078)
Q Consensus 738 ~~~~~~~~~~~~~~~---------~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~ 804 (1078)
....+||+--.|..+ ..+.++||.|.||.||+|+++- ...||||.++... ....+.+|..|+.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsI 683 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASI 683 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhh
Confidence 344555554444333 3456789999999999997652 3479999998754 33456789999999
Q ss_pred HhcCCCCceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 039595 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 884 (1078)
Q Consensus 805 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 884 (1078)
|.+++||||+++.|+......++||+|||++|+|+.||+.. .+++++.+...+.++||.|++||.+. ++|||||.
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLA 758 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLA 758 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhh
Confidence 99999999999999999999999999999999999999654 36699999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCCC-ceee--ccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcc
Q 039595 885 SKNVLLDLEFEAHVSDFGIAKFVEPYSSN-RTEF--VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 960 (1078)
Q Consensus 885 ~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~--~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~ 960 (1078)
++||||+.+-.+|++|||+++.+++.... .+.. ..+.+|.|||.+..+.++.+|||||||+++||.++ |..||=
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW-- 836 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW-- 836 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc--
Confidence 99999999999999999999988654422 2222 23679999999999999999999999999999886 888842
Q ss_pred cccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHHHHHHHHhhccc
Q 039595 961 SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILAIEASAD 1040 (1078)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~~~~~~~~~~~~ 1040 (1078)
+....+..+.+.. +-+++++ . +....+.+++..||++|-.+||++.|++.+. +++.+.+......++
T Consensus 837 dmSNQdVIkaIe~-----gyRLPpP-m---DCP~aL~qLMldCWqkdR~~RP~F~qiV~~l----DklIrnP~SLk~~~~ 903 (996)
T KOG0196|consen 837 DMSNQDVIKAIEQ-----GYRLPPP-M---DCPAALYQLMLDCWQKDRNRRPKFAQIVSTL----DKLIRNPNSLKTIAP 903 (996)
T ss_pred ccchHHHHHHHHh-----ccCCCCC-C---CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH----HHHhcCchhhcccCC
Confidence 2211122222211 1122221 2 2223688999999999999999999999763 344444444444333
Q ss_pred c
Q 039595 1041 Y 1041 (1078)
Q Consensus 1041 ~ 1041 (1078)
.
T Consensus 904 ~ 904 (996)
T KOG0196|consen 904 E 904 (996)
T ss_pred C
Confidence 3
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=359.48 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=209.3
Q ss_pred HHHHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 744 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
++++...+++.+...||+|.||+||+|+|. | .||||++..... ..+..+.|++|+.++++-+|.||+=+.|||..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 556666677888899999999999999885 3 499999987643 345678999999999999999999999999988
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
.. .||+.+|+|.+|+.+++..+ ..+...+.+.|++|||+|+.|||.+ +|||||+|..|||+.++++|||+|||+
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 77 99999999999999996543 5688999999999999999999999 999999999999999999999999999
Q ss_pred cccccCC--CCCceeecccccccccccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 904 AKFVEPY--SSNRTEFVGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 904 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
+..-... ........|...|||||+++. .+|++.+||||||+|+|||+||..||..... ..+..++. +...
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIifmVG--rG~l 610 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIFMVG--RGYL 610 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEEEec--cccc
Confidence 9754322 222334567889999999874 4789999999999999999999999762222 22222222 2223
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.|+..........+ +.+++..||..++++||.+.+++..
T Consensus 611 ~pd~s~~~s~~pk~---mk~Ll~~C~~~~~~eRP~F~~il~~ 649 (678)
T KOG0193|consen 611 MPDLSKIRSNCPKA---MKRLLSDCWKFDREERPLFPQLLSK 649 (678)
T ss_pred CccchhhhccCHHH---HHHHHHHHHhcCcccCccHHHHHHH
Confidence 34444444444444 4566677999999999999998864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=322.13 Aligned_cols=266 Identities=23% Similarity=0.355 Sum_probs=223.1
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChh----hHHHHHHHHHHHhcC-CCCceeeEEe
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMA----DQDEFLNVVLALNEI-RHRNIVKFHG 818 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~ 818 (1078)
+.......|+..+.+|.|..++|.++. .++|+.+|+|++.........+ -.++-.+|+.+++++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 334455678888999999999999994 4578999999986533222222 234456799999998 7999999999
Q ss_pred eeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 819 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
+|+.+...++|+|.|+.|.|+|++ ...-.+++++.++|.+|+..|++|||.+ .|||||+||+|||++++..+||
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEE
Confidence 999999999999999999999999 4456699999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCceeecccccccccccccc------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT------MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 972 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~ 972 (1078)
+|||+|+.+.+ +..-...+|||+|.|||.+.- ..|+..+|+|++||++|-++.|.+||- . ...+.
T Consensus 165 sDFGFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--H------RkQml 235 (411)
T KOG0599|consen 165 SDFGFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--H------RKQML 235 (411)
T ss_pred eccceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--H------HHHHH
Confidence 99999998875 344567899999999998752 357889999999999999999999942 2 22334
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..+.+....+.-..+.+.+......++|.+||+.||.+|.|++|+++|||+..
T Consensus 236 MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 236 MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 45556666666666777777778899999999999999999999999999753
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=363.62 Aligned_cols=251 Identities=21% Similarity=0.262 Sum_probs=203.8
Q ss_pred ceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCC
Q 039595 757 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHR 835 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 835 (1078)
+.||+|+||.||+|.. .+|+.||+|++...... .......+.+|+.++++++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999965 47899999999764322 223345678899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCce
Q 039595 836 GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT 915 (1078)
Q Consensus 836 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 915 (1078)
|+|.+++.. .+.+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 80 GELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 999999843 35689999999999999999999999 999999999999999999999999999986433333345
Q ss_pred eeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHH
Q 039595 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995 (1078)
Q Consensus 916 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1078)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+ .......+.. -+..++. .. ..+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~~~~----~~~~~p~---~~---~~~ 221 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILM----EEIRFPR---TL---SPE 221 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--HHHHHHHHHc----CCCCCCC---CC---CHH
Confidence 5679999999999999999999999999999999999999974322 1111111111 1111111 11 235
Q ss_pred HHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhh
Q 039595 996 IMEVAILCLDESPEARP-----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 996 l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~ 1026 (1078)
+.+++.+||+.||++|| +++++++|+|+...
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 77899999999999999 89999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=359.46 Aligned_cols=275 Identities=24% Similarity=0.297 Sum_probs=217.9
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
..++|...++||+|.||+|++|..+ +++.||||++++..+-++ .+.+....|..++... +||.+++++.+|...+++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~-d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR-DEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc-ccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3478999999999999999999765 688999999998765532 3455666676666655 699999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|.||||+.||++..+. ..+.+++..+..++..|+.||.|||++ ||||||||.+|||+|.+|.+||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999955443 346799999999999999999999999 999999999999999999999999999997
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.-..+....+++||+.|||||++.+..|+.++|.|||||++|||+.|+.||...+ ..+....+... ++.++..
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd--Eee~FdsI~~d----~~~yP~~- 590 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD--EEEVFDSIVND----EVRYPRF- 590 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHhcC----CCCCCCc-
Confidence 6555667788999999999999999999999999999999999999999965332 22222222111 1222111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhhHHHHHHHHHhhccccCCc
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCDEILAVILAIEASADYGQT 1044 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1078)
...+.+.++++++.++|++|.. +++|..|||+..-. ...++.....-++.++
T Consensus 591 -----ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~-w~~L~~r~i~PPf~P~ 647 (694)
T KOG0694|consen 591 -----LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID-WDDLLNRRIKPPFVPT 647 (694)
T ss_pred -----ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC-HHHHhhccCCCCCCcc
Confidence 1125678888899999999996 57899999865433 3333443334444443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=356.47 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=207.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|..+ +++.||+|++...... .....+.+.+|+.++++++||||+++++++.++...++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 47889999999999999999654 7899999998654221 223355688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.. .+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 80 MEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999999943 34688999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ...+... .
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~~~i~~~----~~~~~~~---~ 221 (291)
T cd05612 154 ---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGIYEKILAG----KLEFPRH---L 221 (291)
T ss_pred ---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC----CcCCCcc---C
Confidence 22345789999999999998999999999999999999999999753221 1111111111 1111111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhhH
Q 039595 990 MDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCDE 1027 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~~ 1027 (1078)
...+.+++.+||+.||.+||+ ++|+++|+|+..-+
T Consensus 222 ---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 222 ---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred ---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 225778999999999999995 99999999986533
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=348.39 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=205.5
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.....++++||+|.||.|.++....+..||||+++... ....+.+|.+|+++|.+++|||||+++|+|..++.+++|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34567788999999999999988878999999998754 344568899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+|||++|+|..|+.+..... ..-+...+|+.||+.|++||.+. ++||||+.++|+|++.++++||+|||+++.+-.
T Consensus 614 ~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999996543222 45566788999999999999999 999999999999999999999999999996533
Q ss_pred --CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh--CCCCCCcccccccchhhhhhhhhhhcC-CCC--
Q 039595 910 --YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK--GNHPRDFFSINFSSFSNMIIEVNQILD-PRL-- 982 (1078)
Q Consensus 910 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 982 (1078)
+.......+-+.+|||||.+.-++++.++|||+||+.+||+++ ...||.....+. .+......++ +..
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----VVENAGEFFRDQGRQV 764 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----HHHhhhhhcCCCCcce
Confidence 2233445677899999999999999999999999999999875 678865443321 1111111111 111
Q ss_pred -CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 983 -STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 983 -~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...++.+ ...+++++.+||+.|-++||+++++..+.
T Consensus 765 ~l~~P~~c---p~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 765 VLSRPPAC---PQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred eccCCCcC---cHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 1111112 23677999999999999999999987664
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=377.05 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=202.8
Q ss_pred cCCCccceeccCCceeEEEEEeC--CCC----EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP--SGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
...+..+.||+|+||.||.|... .|. .||||.+.+.. +..+..+|.+|..+|+.++|||||+++|+|.+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~---~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS---SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 45566788999999999999664 343 49999987653 4667889999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCC----CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 825 HSFLVCEYLHRGSLARILGNDAT----AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
..+|++|||+||+|..||++.+. ...++..+.+.++.|||+|+.||+++ ++|||||.++|+|++....|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999965422 45689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCc--eeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhh
Q 039595 901 FGIAKFVEPYSSNR--TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQI 977 (1078)
Q Consensus 901 fG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 977 (1078)
||+|+.+....... ....-+..|||||.+..+.++.|+|||||||++||++| |..||...+. .+.... ..
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--~~v~~~-----~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--FEVLLD-----VL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--HHHHHH-----HH
Confidence 99999553322211 11234579999999999999999999999999999999 8999643221 111111 11
Q ss_pred cCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHH
Q 039595 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFG 1019 (1078)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 1019 (1078)
...++..+ ..+.+ .+++++..||+.+|++||++..+++
T Consensus 919 ~ggRL~~P-~~CP~---~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 919 EGGRLDPP-SYCPE---KLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hCCccCCC-CCCCh---HHHHHHHHHccCChhhCccHHHHHh
Confidence 12233322 22223 4668899999999999999999998
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=350.00 Aligned_cols=261 Identities=22% Similarity=0.260 Sum_probs=206.6
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.|+..+.||+|+||.||+|.. .+|+.||+|++...... .......+.+|+.++++++|++|+++++++.+++..++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 377889999999999999965 57999999998754322 1223446788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 80 TIMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999999887432 234588999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
.......||..|+|||++.+..++.++||||+||++|||++|+.||....... ...... ........ ......
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~--~~~~~~~~-~~~~~~- 228 (285)
T cd05631 156 -ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVD--RRVKEDQE-EYSEKF- 228 (285)
T ss_pred -CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHH--HHhhcccc-cCCccC-
Confidence 22234578999999999999999999999999999999999999976432211 001110 01111111 111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCD 1026 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~ 1026 (1078)
...+.+++.+||+.||++||+ ++++++|+|+...
T Consensus 229 --s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 229 --SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred --CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 235778999999999999997 8999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=357.23 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=202.8
Q ss_pred ceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCC
Q 039595 757 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHR 835 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 835 (1078)
+.||+|+||.||+|.. .+|+.||+|++.+.... .......+.+|+.+++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999965 47899999999764322 233456788899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCce
Q 039595 836 GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT 915 (1078)
Q Consensus 836 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 915 (1078)
|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 80 g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 80 GELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 999998843 34689999999999999999999999 999999999999999999999999999976433233334
Q ss_pred eeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHH
Q 039595 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995 (1078)
Q Consensus 916 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1078)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ......+.. .+..++. .. ..+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~~~~~~~~~----~~~~~p~---~~---~~~ 221 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM----EDIKFPR---TL---SAD 221 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--HHHHHHhcc----CCccCCC---CC---CHH
Confidence 56799999999999998999999999999999999999999753221 111111100 1111111 11 225
Q ss_pred HHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhh
Q 039595 996 IMEVAILCLDESPEARP-----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 996 l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~ 1026 (1078)
+.+++.+||.+||++|| +++|+++|+|+...
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 77899999999999997 89999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=350.77 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=202.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|..+ +++.||+|+++.... ......+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 57999999999999999999654 789999999865432 22244577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++ +|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 82 FEYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EeCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 999975 899988432 23578899999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh---------------
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE--------------- 973 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~--------------- 973 (1078)
.........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--EELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhcccc
Confidence 3333345578999999998875 56899999999999999999999997533211 10000000
Q ss_pred ---hhhhcCCCCCCCC--CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 974 ---VNQILDPRLSTPS--PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 974 ---~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
......+...... ........+..+++.+|+..||.+|||++|+++|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0000001100000 0000112357799999999999999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=360.41 Aligned_cols=255 Identities=24% Similarity=0.271 Sum_probs=208.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|..+ +++.||+|++...... .....+.+.+|+.++++++||||+++++++.+++..|+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 367999999999999999999664 6899999998754322 22345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 96 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999999943 34678899999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... .+.......+ .
T Consensus 170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~------~i~~~~~~~p--~ 236 (329)
T PTZ00263 170 DR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIYE------KILAGRLKFP--N 236 (329)
T ss_pred CC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHHH------HHhcCCcCCC--C
Confidence 32 2345799999999999999999999999999999999999999743221 11111 1111111111 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCD 1026 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~ 1026 (1078)
.. ...+.+++.+||+.||++||+ +++++.|+|+...
T Consensus 237 ~~--~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 237 WF--DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred CC--CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 11 125678999999999999997 7999999998653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.59 Aligned_cols=267 Identities=21% Similarity=0.238 Sum_probs=208.0
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--CCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN--ARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 826 (1078)
.++|+....|++|+||.||+|+. ++++.||+|+++...... --.-...+||.++.+.+|||||.+-++... -+.+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~--GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE--GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC--CCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 46788889999999999999965 479999999997653111 112235789999999999999999988753 4579
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|||||||+. +|..++.... .++...++.-+..|+++|++|||.. .|+|||+|++|+|+...|.+||+|||+|+.
T Consensus 153 y~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence 999999998 9999996543 6789999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccc--cchhhhhhhhhhhcCCCC-
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SSFSNMIIEVNQILDPRL- 982 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~- 982 (1078)
+....+..+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|...+.-. ..+........+.+-|.+
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 98887888889999999999998865 59999999999999999999999865333210 011111100000000000
Q ss_pred ----------C--------CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 ----------S--------TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ----------~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. ...+... -...-.+++..++..||.+|.|++|.+.|.|+..
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 0 0001110 1124568888899999999999999999999764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=356.48 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=203.8
Q ss_pred ceeccCCceeEEEEEe----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 757 FCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
+.||+|+||.||+|+. .+++.||+|++..............+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999964 357899999997654333334455678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 912 (1078)
+++|+|.+++.+ .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999843 34578889999999999999999999 999999999999999999999999999975433333
Q ss_pred CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHH
Q 039595 913 NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDK 992 (1078)
Q Consensus 913 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1078)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ... ...+.......+ +..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--~~~------~~~~~~~~~~~~-~~~--- 223 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--KKT------IDKILKGKLNLP-PYL--- 223 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--HHH------HHHHHcCCCCCC-CCC---
Confidence 34456799999999999998899999999999999999999999753221 111 111111111111 111
Q ss_pred HHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhh
Q 039595 993 LISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 993 ~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~ 1026 (1078)
...+.+++.+||+.||++|| +++++++|+|+...
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 12577899999999999999 89999999997653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=353.97 Aligned_cols=265 Identities=24% Similarity=0.305 Sum_probs=209.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|..+ +|..||+|++.... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999655 68899999986542 23345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. ...+++..+..++.|++.|+.|||++. +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 81 CMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EeecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999999943 345889999999999999999999862 69999999999999999999999999998654
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh----------------
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII---------------- 972 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~---------------- 972 (1078)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 156 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred cc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCc
Confidence 32 233457899999999999989999999999999999999999997532211 0000000
Q ss_pred ------------------------hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 973 ------------------------EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 973 ------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
....+......... ......++.+++.+||+.||++|||++|+++|+|+...++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 00000000000000 0012236889999999999999999999999999876543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.12 Aligned_cols=268 Identities=23% Similarity=0.332 Sum_probs=206.8
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec----
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN---- 822 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---- 822 (1078)
.....|...+.||+|+||.|+.|.. .+|+.||||++.... ++....++..+|+..++.++|+||+.+.+++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3445666678999999999999954 579999999997543 345667888999999999999999999999854
Q ss_pred -CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecc
Q 039595 823 -ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDF 901 (1078)
Q Consensus 823 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 901 (1078)
-..+|+|+|+|+. +|...++ ....++...+..+.+|+++||.|+|+. +|+|||+||.|++++.+..+|||||
T Consensus 97 ~f~DvYiV~elMet-DL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 97 KFNDVYLVFELMET-DLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ccceeEEehhHHhh-HHHHHHH---cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 4578999999944 9999994 344599999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCC--CCCceeeccccccccccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-------------c
Q 039595 902 GIAKFVEPY--SSNRTEFVGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF-------------S 965 (1078)
Q Consensus 902 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-------------~ 965 (1078)
|+|+..+.. ....+..+.|..|.|||++. ...|+.+.||||.|||+.||++|++-|...+... .
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 999987642 33357788999999999865 4579999999999999999999999865333210 0
Q ss_pred chhhhhh--hhhhh---cCCCCCCCC-CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 966 SFSNMII--EVNQI---LDPRLSTPS-PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 966 ~~~~~~~--~~~~~---~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
+....+. ..... .++....+. ..........++++.+||..||.+|+|++|+++|||..
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 0000000 00111 111111110 00111122567899999999999999999999999954
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=351.58 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=219.3
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 826 (1078)
..+.|++.+.||+|.||.||++..+ +|+.+|+|++.+..... ..+.+.+.+|+.+|+++. |||||.++++|++...+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 3457888899999999999999665 59999999998765442 335678999999999998 99999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC----CcEEEeccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE----FEAHVSDFG 902 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfG 902 (1078)
++|||++.||.|.+.+.+. .+++.++..++.|++.|+.|||+. ||+|||+||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998544 299999999999999999999998 99999999999999643 579999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
+|..... .......+||+.|+|||++....|+.++||||+||++|.|++|.+||...... .... .+....+
T Consensus 185 la~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--~~~~------~i~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--EIFL------AILRGDF 255 (382)
T ss_pred CceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh--HHHH------HHHcCCC
Confidence 9998876 55677889999999999999999999999999999999999999996543321 1111 2223333
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.-..+.+......+.+++++|+..||.+|+|+.++++|||...
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence 3333334444557788999999999999999999999999664
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.14 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=218.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe-eE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH-SF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~ 827 (1078)
.++|..++.+|+|+||.++.++++ +++.||+|.+...... ...+....+|+.++++++|||||.+.+.|.+++. .+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 367899999999999999999665 6789999999766433 3345578899999999999999999999988888 99
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
|||+|++||++.+.+.+.+ ...++++.+..++.|++.|+.|||++ .|+|||||+.|||++.++.|||+|||+|+..
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence 9999999999999996544 56799999999999999999999998 9999999999999999999999999999998
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.+........+||+.||.||.+.+.+|..|+||||+||++|||++-+++|+..+. ... +.++.... +.+.+
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--~~L---i~ki~~~~---~~Plp- 227 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--SEL---ILKINRGL---YSPLP- 227 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--HHH---HHHHhhcc---CCCCC-
Confidence 8766677788999999999999999999999999999999999999999664332 222 22211111 11111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
..+..++..+++.|++.+|+.||++.+++.+|.....
T Consensus 228 --~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 228 --SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred --ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 1233467888999999999999999999999775543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=356.32 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=203.1
Q ss_pred ceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCC
Q 039595 757 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHR 835 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 835 (1078)
+.||+|+||.||+|.. .+|+.||+|++...... .......+.+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 4699999999999965 47899999999764322 233455678899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCce
Q 039595 836 GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT 915 (1078)
Q Consensus 836 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 915 (1078)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 80 GELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 999998843 34689999999999999999999999 999999999999999999999999999875433233334
Q ss_pred eeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHH
Q 039595 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995 (1078)
Q Consensus 916 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1078)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ..... .+.......+ ... ...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~~------~~~~~~~~~p-~~~---~~~ 221 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFE------LILMEEIRFP-RTL---SPE 221 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--HHHHH------HHhcCCCCCC-CCC---CHH
Confidence 56799999999999999999999999999999999999999753221 11111 1111111111 111 235
Q ss_pred HHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhhH
Q 039595 996 IMEVAILCLDESPEARP-----TMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 996 l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~~ 1027 (1078)
+.+++.+||+.||++|| ++.++++|+|+...+
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 67899999999999998 899999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=354.60 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=201.7
Q ss_pred eccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCC
Q 039595 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGS 837 (1078)
Q Consensus 759 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 837 (1078)
||+|+||.||+|... +++.||+|++...... .......+.+|+.++++++||||+++++++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 699999999999654 6889999998754322 23345667889999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceee
Q 039595 838 LARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF 917 (1078)
Q Consensus 838 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 917 (1078)
|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 80 LFHHLQR---EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 9999943 34689999999999999999999999 99999999999999999999999999998654333334456
Q ss_pred ccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHH
Q 039595 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIM 997 (1078)
Q Consensus 918 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 997 (1078)
.||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..... .+.......+ ... ...+.
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--~~~~~------~~~~~~~~~~-~~~---~~~~~ 221 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--NEMYR------KILQEPLRFP-DGF---DRDAK 221 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--HHHHH------HHHcCCCCCC-CcC---CHHHH
Confidence 799999999999999999999999999999999999999753221 11111 1111111111 111 12567
Q ss_pred HHHHhcccCCCCCCC---ChhHHHHHhhhhhh
Q 039595 998 EVAILCLDESPEARP---TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 998 ~li~~cl~~dP~~RP---t~~ell~h~~~~~~ 1026 (1078)
+++.+||+.||++|| ++.|++.|||+...
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 889999999999997 57999999998764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=358.43 Aligned_cols=261 Identities=22% Similarity=0.292 Sum_probs=210.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|... +++.||||++...... .......+.+|+.+++.++||||+++++++.++...|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 36899999999999999999765 6899999999764322 223456688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 80 MEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999943 34688999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc-CCCCCCCCCc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL-DPRLSTPSPG 988 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 988 (1078)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+....... .+....+.
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~-- 226 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--NETWENLKYWKETLQRPVYDDPR-- 226 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--HHHHHHHHhccccccCCCCCccc--
Confidence 23456799999999999999999999999999999999999999754322 11111111111111 11111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.....++.+++.+||..+|++||+++|+++|+|+...
T Consensus 227 -~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 227 -FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred -cccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 1122367788999999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=358.73 Aligned_cols=254 Identities=22% Similarity=0.258 Sum_probs=206.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-C-CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-S-GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||.||+|..+ + +..||+|++...... .....+.+.+|+.+++.++||||+++++++.+++..|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 457999999999999999999654 2 368999998654322 2234566889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+.+|+|.+++.+ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999943 34688999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. ......||+.|||||++.+..++.++||||+||++|||++|+.||..... ...... +.......+ .
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~------i~~~~~~~p-~ 249 (340)
T PTZ00426 182 DT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--LLIYQK------ILEGIIYFP-K 249 (340)
T ss_pred CC---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--HHHHHH------HhcCCCCCC-C
Confidence 43 23456799999999999998899999999999999999999999753221 111111 111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~ 1025 (1078)
... ..+.+++.+|++.||++|+ +++++++|||+..
T Consensus 250 ~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 250 FLD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred CCC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 111 2467899999999999995 8999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=351.22 Aligned_cols=267 Identities=21% Similarity=0.292 Sum_probs=204.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|..+ +++.||||++..... ......+.+|+.+++.++||||+++++++.++...++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 468999999999999999999765 789999999865431 1223456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+. ++|.+++... ...++++.+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 81 VFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 999996 5888877432 34588899999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh------------
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN------------ 975 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~------------ 975 (1078)
..........|++.|+|||++.+ ..++.++||||+||++|||++|+.||..................
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 33333345678999999999865 45889999999999999999999998643221111110000000
Q ss_pred --hhcCCCCCCCCCccHH-------HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 976 --QILDPRLSTPSPGVMD-------KLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 976 --~~~~~~~~~~~~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...........+.... ....+.+++.+||+.||++|||++|+++|+|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 0000000000000000 1135678999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=354.02 Aligned_cols=262 Identities=21% Similarity=0.259 Sum_probs=207.0
Q ss_pred CCCccceeccCCceeEEEEEe----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
+|++.+.||+|+||+||+|+. .+++.||+|++.+..........+.+..|+.+++.+ +||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999864 368899999997644333334456678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999843 34588999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCC-CCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 907 VEPYS-SNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 907 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
..... .......||+.|||||++.+. .++.++|||||||++|||++|+.||........ ...........++.+..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 232 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILKCDPPFPS 232 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhcCCCCCCC
Confidence 54322 223356799999999998865 478999999999999999999999764322111 11111111111222221
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhhH
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~~ 1027 (1078)
. . ...+.+++.+||+.||++|| +++++++|+|+....
T Consensus 233 ~---~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 233 F---I---GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred C---C---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 1 1 22567889999999999999 788999999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=353.50 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=203.0
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||.||+|..+ +++.||+|++++.... .....+.+..|..++..+ +||||+++++++.+....|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999654 6889999999765322 233455678899999888 79999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.+ .+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 80 GGDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 9999998843 35689999999999999999999999 99999999999999999999999999997533323334
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc-chhhhhhhhhhhcCCCCCCCCCccHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS-SFSNMIIEVNQILDPRLSTPSPGVMDKL 993 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1078)
....||+.|+|||++.+..++.++||||+||++|||++|+.||+....... ...........+.......+ ... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~---~ 229 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP-RSL---S 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC-CCC---C
Confidence 456799999999999999999999999999999999999999864322110 00000000111111111111 111 2
Q ss_pred HHHHHHHHhcccCCCCCCCC------hhHHHHHhhhhh
Q 039595 994 ISIMEVAILCLDESPEARPT------MEKGFGHHIGYC 1025 (1078)
Q Consensus 994 ~~l~~li~~cl~~dP~~RPt------~~ell~h~~~~~ 1025 (1078)
..+.+++.+||+.||.+||+ ++|+++|+|+..
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 25778999999999999997 789999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=329.34 Aligned_cols=260 Identities=22% Similarity=0.249 Sum_probs=212.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+.|+..+.||+|.-|+||+++.+ ++..+|+|++.+..... .....+.+.|.++++.++||.++.+|..|+.+...|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 56777889999999999999776 46899999998876543 33355678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
||||+||+|....++ +..+.+++..++.++.+|+-||+|||.. |||+|||||+||||.++|++.++||.++.....
T Consensus 156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999998854 5677899999999999999999999999 999999999999999999999999999843210
Q ss_pred ---------------------------------CCC-----------------------CceeeccccccccccccccCC
Q 039595 910 ---------------------------------YSS-----------------------NRTEFVGTFGYAAPEIAYTMR 933 (1078)
Q Consensus 910 ---------------------------------~~~-----------------------~~~~~~gt~~y~aPE~~~~~~ 933 (1078)
..+ ....++||-.|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 012368999999999999999
Q ss_pred CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCC
Q 039595 934 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013 (1078)
Q Consensus 934 ~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1013 (1078)
++.++|.|+|||++|||+.|+.||...+.. +.+.+.+.. +..++.. ......+.++|++.|.+||.+|..
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv~~-----~l~Fp~~----~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIVGQ-----PLKFPEE----PEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHhcC-----CCcCCCC----CcchhHHHHHHHHHhccChhhhhc
Confidence 999999999999999999999996533321 222222211 1222221 244457889999999999999998
Q ss_pred ----hhHHHHHhhhhh
Q 039595 1014 ----MEKGFGHHIGYC 1025 (1078)
Q Consensus 1014 ----~~ell~h~~~~~ 1025 (1078)
+.||-+|||+.-
T Consensus 382 ~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 382 SKRGAAEIKRHPFFEG 397 (459)
T ss_pred cccchHHhhcCccccC
Confidence 999999999764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=356.30 Aligned_cols=254 Identities=21% Similarity=0.341 Sum_probs=199.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||.||+|... +++.||||++.... .....+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 45677789999999999999654 78999999986432 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999999986432 345677889999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeecccccccccccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
.........||..|+|||++.. ...+.++|||||||++|||++|+.||..... ...............+...
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~- 297 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICMSQPPEAP- 297 (353)
T ss_pred ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhccCCCCCC-
Confidence 4333445689999999998743 3345789999999999999999999763221 1111111111100111111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. ....++.+++.+||+.||++|||++|+++|+|+..
T Consensus 298 --~---~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 298 --A---TASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred --C---ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 1 11236788999999999999999999999999665
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=359.62 Aligned_cols=260 Identities=23% Similarity=0.251 Sum_probs=204.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|+.. +|+.||||++...... .......+.+|+.+++.++||||+++++++.++...|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 47899999999999999999654 6899999999754321 123345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..+..
T Consensus 80 ~E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 80 MEYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred ECCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999999843 34589999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC--------------------------------------CceeeccccccccccccccCCCCccchhHHHHHHHHHHH
Q 039595 910 YSS--------------------------------------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 951 (1078)
Q Consensus 910 ~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell 951 (1078)
... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 110 001246999999999999999999999999999999999
Q ss_pred hCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCC---hhHHHHHhhhhhh
Q 039595 952 KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT---MEKGFGHHIGYCD 1026 (1078)
Q Consensus 952 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~h~~~~~~ 1026 (1078)
+|+.||..... ......+.. .......+.. ......+.+++.+|+. +|.+|++ ++|++.|+|+...
T Consensus 234 ~G~~Pf~~~~~--~~~~~~i~~----~~~~~~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 234 VGYPPFCSDNP--QETYRKIIN----WKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred cCCCCCCCCCH--HHHHHHHHc----CCCccCCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999753321 111111110 0111111111 0112256678888986 9999998 9999999998654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=352.62 Aligned_cols=258 Identities=26% Similarity=0.329 Sum_probs=202.1
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||.||+|..+ +++.||+|++.+.... .....+.+.+|+.++.++ +||||+++++++..+...++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 46999999999999654 6889999999765322 233455677888888776 89999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 80 GGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 9999988843 34689999999999999999999999 99999999999999999999999999997643333334
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh-hhhhhcCCCCCCCCCccHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-EVNQILDPRLSTPSPGVMDKL 993 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 993 (1078)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+.............. ....+......-+ ... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-~~~---~ 229 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-RSL---S 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC-CCC---C
Confidence 4567999999999999999999999999999999999999998643221110000000 0111111111111 111 2
Q ss_pred HHHHHHHHhcccCCCCCCCC------hhHHHHHhhhhh
Q 039595 994 ISIMEVAILCLDESPEARPT------MEKGFGHHIGYC 1025 (1078)
Q Consensus 994 ~~l~~li~~cl~~dP~~RPt------~~ell~h~~~~~ 1025 (1078)
..+.+++.+||+.||++||+ ++++++|+|+..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 35678999999999999998 589999999865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.08 Aligned_cols=255 Identities=23% Similarity=0.261 Sum_probs=202.9
Q ss_pred eccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCC
Q 039595 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGS 837 (1078)
Q Consensus 759 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 837 (1078)
||+|+||+||+|..+ +++.||+|++...... .....+.+..|+.+++.++||||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 699999999999654 7899999998754322 12234567789999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCcee
Q 039595 838 LARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE 916 (1078)
Q Consensus 838 L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 916 (1078)
|.+++... .....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||.+............
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 99887432 2345689999999999999999999999 9999999999999999999999999999876544333445
Q ss_pred eccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHH
Q 039595 917 FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISI 996 (1078)
Q Consensus 917 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 996 (1078)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... .............. .. .....+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~-~~---~~~~~~ 228 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILNDSVTY-PD---KFSPAS 228 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhcccCCCC-cc---cCCHHH
Confidence 67899999999999999999999999999999999999997643221110 00111111111111 11 122357
Q ss_pred HHHHHhcccCCCCCCC-----ChhHHHHHhhhhh
Q 039595 997 MEVAILCLDESPEARP-----TMEKGFGHHIGYC 1025 (1078)
Q Consensus 997 ~~li~~cl~~dP~~RP-----t~~ell~h~~~~~ 1025 (1078)
.+++.+||+.||++|| +++++++|+|+..
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 7889999999999999 8899999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=348.32 Aligned_cols=264 Identities=23% Similarity=0.299 Sum_probs=204.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|..+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 47899999999999999999765 688999999875432 223456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||++++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 79 FEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99999987765542 234588999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh--------hhh-hcC
Q 039595 910 YSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE--------VNQ-ILD 979 (1078)
Q Consensus 910 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~--------~~~-~~~ 979 (1078)
... ......|++.|+|||++.+..++.++||||+||++|||++|++||....... ........ ... ..+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhcc
Confidence 222 2334578999999999998899999999999999999999999976432210 00000000 000 000
Q ss_pred CCC---CCCC---Cc-c-----HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 980 PRL---STPS---PG-V-----MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 980 ~~~---~~~~---~~-~-----~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
+.. ..+. .. . ......+.+++.+||+.||++|||++|+++|||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0000 00 0 0112368899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=354.55 Aligned_cols=257 Identities=24% Similarity=0.378 Sum_probs=198.5
Q ss_pred hhcCCCccceeccCCceeEEEEEe------CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCS 821 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 821 (1078)
..++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 346899999999999999999963 235689999986432 223456788999999999 8999999999886
Q ss_pred cC-CeeEEEEeecCCCCHHHHhcCCCC-----------------------------------------------------
Q 039595 822 NA-RHSFLVCEYLHRGSLARILGNDAT----------------------------------------------------- 847 (1078)
Q Consensus 822 ~~-~~~~lv~E~~~~g~L~~~l~~~~~----------------------------------------------------- 847 (1078)
.. ...++||||+++|+|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 468999999999999999854211
Q ss_pred ------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC--Cceeecc
Q 039595 848 ------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVG 919 (1078)
Q Consensus 848 ------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g 919 (1078)
..++++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++....... ......+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 13478889999999999999999999 999999999999999999999999999986533221 1223356
Q ss_pred ccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHH
Q 039595 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIME 998 (1078)
Q Consensus 920 t~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 998 (1078)
++.|+|||++.+..++.++|||||||++|||++ |+.||....... .+... ..+......... ....+.+
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~------~~~~~~~~~~~~---~~~~l~~ 308 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQR------LKDGTRMRAPEN---ATPEIYR 308 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHH------HhcCCCCCCCCC---CCHHHHH
Confidence 788999999999999999999999999999997 999976433211 11111 111111111111 1235778
Q ss_pred HHHhcccCCCCCCCChhHHHHHh
Q 039595 999 VAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 999 li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
++.+||+.||++|||+.|+++..
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEIL 331 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHH
Confidence 99999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=354.11 Aligned_cols=261 Identities=27% Similarity=0.377 Sum_probs=205.1
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEeCC--C--CE-EEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEee
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAELPS--G--DI-VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGF 819 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 819 (1078)
.++-..++....++||+|+||.||+|+++. + .. ||||..+.... .......+|.+|+++|+.++|||||++||+
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-LTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-ccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 344445566677899999999999996542 2 23 89999875321 245667889999999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEe
Q 039595 820 CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS 899 (1078)
Q Consensus 820 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 899 (1078)
+....++++|||+|.||+|.++|++.. ..++..+...++.++|.||+|||++ +++||||.++|+|++.++.+||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence 999999999999999999999996543 2589999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhc
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
|||+++.-..+........-+.+|+|||.+..+.|+.++|||||||++||+++ |..||...... .... .+.
T Consensus 305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~------kI~ 376 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKA------KIV 376 (474)
T ss_pred ccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHH------HHH
Confidence 99999865433222223346789999999999999999999999999999998 88896533221 1111 111
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...++.+.+... ...+..++.+||..||+.||+|.++.+..
T Consensus 377 ~~~~r~~~~~~~--p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 377 KNGYRMPIPSKT--PKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred hcCccCCCCCCC--HHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 222222222211 22566777799999999999999987643
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=360.43 Aligned_cols=260 Identities=21% Similarity=0.230 Sum_probs=201.5
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.|+.++.||+|+||+||+|.. .+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 588899999999999999954 57889999999764322 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++.+ ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 81 DYIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999999843 34588899999999999999999999 9999999999999999999999999997643110
Q ss_pred CC-----------------------------------------------CceeeccccccccccccccCCCCccchhHHH
Q 039595 911 SS-----------------------------------------------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSF 943 (1078)
Q Consensus 911 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 943 (1078)
.. .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 0123479999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh--cccCCCCCCCChhHHHHHh
Q 039595 944 GVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAIL--CLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 944 G~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~ell~h~ 1021 (1078)
||++|||++|+.||...... .....+.. .......+ .......++.+++.+ |+..+|..||+++|++.|+
T Consensus 235 G~il~elltG~~Pf~~~~~~--~~~~~i~~----~~~~~~~~--~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT--ETQLKVIN----WENTLHIP--PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH--HHHHHHHc----cccccCCC--CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 99999999999997533221 11111110 01111111 111112245667766 5566777799999999999
Q ss_pred hhhhh
Q 039595 1022 IGYCD 1026 (1078)
Q Consensus 1022 ~~~~~ 1026 (1078)
|+...
T Consensus 307 ~f~~~ 311 (381)
T cd05626 307 FFSEV 311 (381)
T ss_pred ccCCC
Confidence 98653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=349.44 Aligned_cols=255 Identities=24% Similarity=0.305 Sum_probs=204.1
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCC-ceeeEEeeeecCCeeEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR-NIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv 829 (1078)
+|++.+.||+|+||.||+|..+ +++.||||++.+.... .....+.+..|..++..++|+ +|+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 5888999999999999999654 6789999999764322 223455677888999988764 688999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 80 MEYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999999843 34588999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... +.......+ ...
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~------i~~~~~~~~-~~~ 224 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQS------IMEHNVSYP-KSL 224 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHH------HHcCCCCCC-CCC
Confidence 33334556799999999999999999999999999999999999999753321 111111 111111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCh-----hHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTM-----EKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~h~~~~~ 1025 (1078)
...+.+++.+||+.||.+|++. +++++|+|+..
T Consensus 225 ---~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 225 ---SKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred ---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 2256789999999999999986 89999999765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=355.12 Aligned_cols=251 Identities=21% Similarity=0.257 Sum_probs=202.1
Q ss_pred ceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCC
Q 039595 757 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHR 835 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 835 (1078)
+.||+|+||.||+|.. .+|+.||+|++...... .......+.+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999965 47899999999765322 223455677899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 836 GSLARILGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 836 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
|+|.+++.. ...+++.++..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 80 GELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 999998843 3468999999999999999999997 6 99999999999999999999999999987543333333
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.. ....++. .. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i~~----~~~~~p~---~~---~~ 221 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM----EEIRFPR---TL---SP 221 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--HHHHHHHhc----CCCCCCC---CC---CH
Confidence 456799999999999999999999999999999999999999753221 111111110 1111111 11 22
Q ss_pred HHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhh
Q 039595 995 SIMEVAILCLDESPEARP-----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~ 1026 (1078)
++.+++.+||+.||++|+ +++++++|+|+...
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 577889999999999997 99999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=350.18 Aligned_cols=254 Identities=24% Similarity=0.299 Sum_probs=202.0
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHH---HhcCCCCceeeEEeeeecCCeeEE
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---LNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
|++.+.||+|+||.||+|..+ +++.||||++++.... .....+.+.+|+.+ ++.++||||+++++++..+...|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 677889999999999999654 6899999999764322 12234455666554 456789999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|..++.. ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 80 v~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 80 VMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999988832 4589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........|++.|||||.+.+..++.++|||||||++|||++|+.||..... ......+... .+..+. .
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~----~~~~p~---~ 223 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--EEVFDSIVND----EVRYPR---F 223 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC----CCCCCC---C
Confidence 333344556799999999999999999999999999999999999999753321 1111111110 111111 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~ 1026 (1078)
. ...+.+++.+||+.||.+|| +++++++|+|+...
T Consensus 224 ~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 224 L---SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred C---CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 1 12567899999999999999 69999999997653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=355.33 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=200.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|..+ +++.||+|++.+.... .......+.+|+.++.+++||+|+++++++.+....|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 47899999999999999999654 6899999999764322 123345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.+ .+.+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 80 MEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EcCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999999943 35689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC-----------------------------------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCC
Q 039595 910 YSS-----------------------------------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN 954 (1078)
Q Consensus 910 ~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~ 954 (1078)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 012357999999999999999999999999999999999999
Q ss_pred CCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc--CCCCCCCChhHHHHHhhhhhh
Q 039595 955 HPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLD--ESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 955 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.||..... ......+..... ...++... .... ++.+++.+++. .++..||+++|+++|||+...
T Consensus 234 ~Pf~~~~~--~~~~~~i~~~~~--~~~~p~~~-~~s~---~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 234 PPFCSETP--QETYKKVMNWKE--TLIFPPEV-PISE---KAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCCCCH--HHHHHHHHcCcC--cccCCCcC-CCCH---HHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 99753221 111111111000 01111111 1122 34455555433 334457999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=340.25 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=216.0
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 827 (1078)
....|++.++||+||.+.||++...+.+.||+|++... ..+....+-|.+|+..+.++ .|.+||++++|-..++.+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~--~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL--EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh--hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34579999999999999999998877888999987543 34566778899999999999 5999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
|||||-+. +|..+|+..... ...-.+..+.+|++.|+.++|.+ ||||.||||.|+|+ -.|.+||+|||+|..+
T Consensus 437 mvmE~Gd~-DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECGDI-DLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAI 509 (677)
T ss_pred EEeecccc-cHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhccc
Confidence 99998654 999999554322 23237788999999999999999 99999999999998 5789999999999987
Q ss_pred cCCCC--CceeeccccccccccccccCC-----------CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh
Q 039595 908 EPYSS--NRTEFVGTFGYAAPEIAYTMR-----------ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 908 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
..... .....+||+.|||||.+.... .+.++||||+|||||+|+.|++|| ..+.+.+.+.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf-------~~~~n~~aKl 582 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF-------GQIINQIAKL 582 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch-------HHHHHHHHHH
Confidence 65433 245679999999999986533 457999999999999999999994 4556667778
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..+.+|....+.+...+.. +++++++.||.+||++|||+.|+|+|+|.+.
T Consensus 583 ~aI~~P~~~Iefp~~~~~~-~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPEND-ELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HhhcCCCccccccCCCCch-HHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 8888886554444443332 3889999999999999999999999999775
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=323.79 Aligned_cols=253 Identities=26% Similarity=0.354 Sum_probs=215.0
Q ss_pred CCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|.++.++|+|+||.||+|.+ .+|+.||||++... .+.+++.+|+.++++.+.|+||++||.|.....+|+|||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 56677899999999999944 57999999998643 357789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
||..|+..++++. ..+++++.++..+++.-++||+|||.. .-+|||||+.|||++.+|.+|++|||.|..+.+.-
T Consensus 109 YCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 9999999999953 457899999999999999999999998 88999999999999999999999999999887666
Q ss_pred CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHH
Q 039595 912 SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1078)
..+.+..||+.|||||++..-.|..++||||+|+...||.-|++||.....- +.-..++...++.......
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------RAIFMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------RAIFMIPTKPPPTFKKPEE 254 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------ceeEeccCCCCCCCCChHh
Confidence 6677889999999999999999999999999999999999999996522210 0001122222222333334
Q ss_pred HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 992 KLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 992 ~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...++-+++++||-+.|++|-|+-++++|+|...
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 4567889999999999999999999999999763
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.46 Aligned_cols=250 Identities=25% Similarity=0.318 Sum_probs=197.9
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHH-HHHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVV-LALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||+||+|..+ +|+.||+|++....... ......+..|. .+++.++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999664 78999999997643221 22233444444 45688999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.+ ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 80 GGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 9999999843 34688999999999999999999999 99999999999999999999999999997643333344
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ..... .+........ +.. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~------~i~~~~~~~~-~~~---~~ 221 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--AEMYD------NILNKPLRLK-PNI---SV 221 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--HHHHH------HHHcCCCCCC-CCC---CH
Confidence 556799999999999999999999999999999999999999753221 11111 1111111111 111 23
Q ss_pred HHHHHHHhcccCCCCCCCCh----hHHHHHhhhhh
Q 039595 995 SIMEVAILCLDESPEARPTM----EKGFGHHIGYC 1025 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~----~ell~h~~~~~ 1025 (1078)
.+.+++.+||+.||++||++ .|+++|+|+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 57789999999999999997 69999999765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=357.97 Aligned_cols=260 Identities=24% Similarity=0.273 Sum_probs=209.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|... +|+.||||++...... .......+.+|+.+++.++||||+++++++.++...|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 47899999999999999999665 7899999999764322 223456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.+. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 80 MEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999999543 5689999999999999999999998 999999999999999999999999999986644
Q ss_pred CC-----------------------------CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 039595 910 YS-----------------------------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 960 (1078)
Q Consensus 910 ~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~ 960 (1078)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 1233457999999999999999999999999999999999999997533
Q ss_pred cccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCC-hhHHHHHhhhhhh
Q 039595 961 SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT-MEKGFGHHIGYCD 1026 (1078)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ell~h~~~~~~ 1026 (1078)
.. ......+ .... .....+.. ......+.+++.+|+. ||.+||+ ++|+++|+|...-
T Consensus 234 ~~--~~~~~~i---~~~~-~~~~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 234 TL--QETYNKI---INWK-ESLRFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred CH--HHHHHHH---hccC-CcccCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 21 1111111 1100 11111111 0022357788899997 9999999 9999999997653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=347.39 Aligned_cols=263 Identities=23% Similarity=0.295 Sum_probs=207.0
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.++||+|+||.||+|..+ ++..+|+|++.... .....+.+.+|+.++++++||||++++++|.+++..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 468999999999999999999665 68899999886542 22345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. .+.+++..+..++.|++.|+.|||+.. +++||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999999943 345788999999999999999999752 79999999999999999999999999997653
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh----------------
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII---------------- 972 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~---------------- 972 (1078)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred hh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcCcccCCccccccCccc
Confidence 22 2234578999999999998889999999999999999999999976432110 000000
Q ss_pred ----------------------hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 973 ----------------------EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 973 ----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
....+.......... .....++.+++.+||+.||++|||++|++.|+|+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS--GVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCC--CCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000000000000000 0112357899999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=346.33 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=197.3
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhc-CCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE-IRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||+||+|... +++.||+|+++..... .....+.+..|..++.. .+||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999654 6889999999764322 12233445556666654 489999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 gg~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 80 GGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 9999999843 34689999999999999999999999 99999999999999999999999999998654333344
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. ..+.++. .. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~----~~~~~~~---~~---~~ 221 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELFDSILN----DRPHFPR---WI---SK 221 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc----CCCCCCC---CC---CH
Confidence 556799999999999998999999999999999999999999753322 111111110 1111111 11 12
Q ss_pred HHHHHHHhcccCCCCCCCChh-HHHHHhhhhhh
Q 039595 995 SIMEVAILCLDESPEARPTME-KGFGHHIGYCD 1026 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~~-ell~h~~~~~~ 1026 (1078)
++.+++.+||+.||++||++. ++++|+|+...
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 567889999999999999875 78899997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=349.05 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=200.7
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||.||+|+.+ +++.||+|++...... .....+.+..|.++++.+ +||||+++++++..++..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 36899999999999664 6889999998764322 223345567788888765 79999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 80 GGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 9999998843 34588999999999999999999999 99999999999999999999999999998654333334
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..... .+.......+ ... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--~~~~~------~i~~~~~~~p-~~~---~~ 221 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--DDLFE------SILHDDVLYP-VWL---SK 221 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--HHHHH------HHHcCCCCCC-CCC---CH
Confidence 556799999999999998999999999999999999999999764322 11111 1111111111 111 12
Q ss_pred HHHHHHHhcccCCCCCCC-------ChhHHHHHhhhhh
Q 039595 995 SIMEVAILCLDESPEARP-------TMEKGFGHHIGYC 1025 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RP-------t~~ell~h~~~~~ 1025 (1078)
++.+++.+||+.||++|| +++++++|+|+..
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 577899999999999999 8999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=357.09 Aligned_cols=262 Identities=23% Similarity=0.288 Sum_probs=207.1
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|+.+ +++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.++...|
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4568999999999999999999654 6889999998654221 2223455788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999843 3478889999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCC-CceeeccccccccccccccC----CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 908 EPYSS-NRTEFVGTFGYAAPEIAYTM----RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 908 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .... ..+.....
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~------~~i~~~~~ 264 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTY------SKIMDHKN 264 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--HHHH------HHHHcCCC
Confidence 43222 22346799999999998653 478999999999999999999999753321 1111 11111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCC--CCChhHHHHHhhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEA--RPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~h~~~~~~ 1026 (1078)
....+........+.+++.+|+..+|++ ||+++|+++|+|+...
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 1111111112336778999999999988 9999999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=354.18 Aligned_cols=258 Identities=19% Similarity=0.238 Sum_probs=199.6
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..+|++.+.||+|+||.||+|.. .+++.||+|+.. ...+.+|+.++++++||||+++++++..+...++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 35799999999999999999954 578999999643 2346789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|+|++. ++|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 161 v~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 161 ILPRYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEecCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999985 689888843 34588999999999999999999999 99999999999999999999999999997543
Q ss_pred CCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc---c--chhhhhhh---------
Q 039595 909 PYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF---S--SFSNMIIE--------- 973 (1078)
Q Consensus 909 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~---~--~~~~~~~~--------- 973 (1078)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||-...... . .....+..
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 222 22345679999999999999899999999999999999999998753211000 0 00000000
Q ss_pred -------hhh----h-----cCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 974 -------VNQ----I-----LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 974 -------~~~----~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
... . ..+..............++.+++.+||+.||++|||++|+++|+|+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 000 0 00000000001112234688999999999999999999999999974
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=345.73 Aligned_cols=252 Identities=24% Similarity=0.297 Sum_probs=199.1
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhc-CCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE-IRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||.||+|..+ +|+.||+|+++...... ....+.+..|..++.. .+||+|+++++++.+.+..|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 46999999999999665 68899999997643211 1234455667777765 489999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 80 GGDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 9999998843 34688999999999999999999999 99999999999999999999999999987543333334
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+. ...+..+.. . ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~----~~~~~~~~~---~---~~ 221 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIR----VDTPHYPRW---I---TK 221 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHH----hCCCCCCCC---C---CH
Confidence 556799999999999999999999999999999999999999753321 11111111 111111111 1 22
Q ss_pred HHHHHHHhcccCCCCCCCCh-hHHHHHhhhhhhH
Q 039595 995 SIMEVAILCLDESPEARPTM-EKGFGHHIGYCDE 1027 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~-~ell~h~~~~~~~ 1027 (1078)
++.+++.+||+.||++||++ +++++|+|+....
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 56789999999999999998 5888999986643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=349.32 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=200.9
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||+||+|+.+ +++.||||++.+.... .....+.+..|..++... +||||+++++++...+..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999664 6889999998764322 123345667788888766 79999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 80 GGDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 9999998843 34688999999999999999999999 99999999999999999999999999987643333334
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... +.......+ .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~~~------i~~~~~~~~-~~---~~~ 221 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--DDLFEA------ILNDEVVYP-TW---LSQ 221 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHH------HhcCCCCCC-CC---CCH
Confidence 456799999999999998999999999999999999999999753322 111111 111111111 11 123
Q ss_pred HHHHHHHhcccCCCCCCCCh------hHHHHHhhhhhh
Q 039595 995 SIMEVAILCLDESPEARPTM------EKGFGHHIGYCD 1026 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~------~ell~h~~~~~~ 1026 (1078)
++.+++.+||+.||++||++ ++++.|+|+...
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 57789999999999999998 999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=356.28 Aligned_cols=263 Identities=22% Similarity=0.265 Sum_probs=205.3
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
...++|++.+.||+|+||.||+|..+ +++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.++...
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34578999999999999999999665 6889999998653222 222345678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999943 3478899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC-CceeeccccccccccccccC----CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 907 VEPYSS-NRTEFVGTFGYAAPEIAYTM----RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 907 ~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
...... ......||+.|||||++.+. .++.++||||+||++|||++|+.||..... .... ..+....
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--~~~~------~~i~~~~ 263 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--VGTY------SKIMDHK 263 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--HHHH------HHHHhCC
Confidence 643322 22356799999999998754 378899999999999999999999753221 1111 1122111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCC--CCChhHHHHHhhhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEA--RPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~h~~~~~~ 1026 (1078)
.....+........+.+++.+|+..+|.+ ||+++|+++|+|+...
T Consensus 264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 11111111112235667888899865544 8999999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=352.30 Aligned_cols=265 Identities=22% Similarity=0.324 Sum_probs=199.3
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----Ce
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA-----RH 825 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 825 (1078)
+|++.+.||+|+||.||+|.. .+++.||||++..... .......+.+|+.++++++||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc--cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 588899999999999999965 4789999999865321 223345688999999999999999999988533 35
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 79 IYVVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 799999995 689998843 34589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC---Cceeecccccccccccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccccccc-------------ch
Q 039595 906 FVEPYSS---NRTEFVGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS-------------SF 967 (1078)
Q Consensus 906 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~-------------~~ 967 (1078)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6532211 1234578999999999875 6789999999999999999999999754321100 00
Q ss_pred hhhh-----hhhhhhcCCCCCCCC-CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 968 SNMI-----IEVNQILDPRLSTPS-PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 968 ~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...+ ......+.+....+. .........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 0000 000000001100000 000011235678999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=346.42 Aligned_cols=251 Identities=25% Similarity=0.311 Sum_probs=201.2
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||+||+|..+ +++.||||++++.... .....+.+..|..+++.+ +||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999665 6889999999764322 123345667788888877 79999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.+ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 80 GGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 9999998843 34689999999999999999999999 99999999999999999999999999997543333333
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+ .......+ ... ..
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i------~~~~~~~~-~~~---~~ 221 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSI------LEDEVRYP-RWL---SK 221 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHH------HcCCCCCC-CcC---CH
Confidence 456799999999999999999999999999999999999999753321 1111111 11111111 111 23
Q ss_pred HHHHHHHhcccCCCCCCCCh-----hHHHHHhhhhhh
Q 039595 995 SIMEVAILCLDESPEARPTM-----EKGFGHHIGYCD 1026 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~-----~ell~h~~~~~~ 1026 (1078)
.+.+++.+||+.||++||++ .++++|+|+...
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 57789999999999999999 999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.97 Aligned_cols=256 Identities=30% Similarity=0.462 Sum_probs=192.6
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhc--CCCCceeeEEeeeecCC---
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE--IRHRNIVKFHGFCSNAR--- 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~--- 824 (1078)
.+..+..+.||+|.||.||+|.+. ++.||||++.. .+++.|.+|-.+.+. ++|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 345666778999999999999886 69999999854 346677777666554 58999999999886655
Q ss_pred -eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC------CCCcEecCCCCCCeeeCCCCcEE
Q 039595 825 -HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC------LPSIIHRDISSKNVLLDLEFEAH 897 (1078)
Q Consensus 825 -~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~k 897 (1078)
.+++|+||.+.|+|.+||+ ...++|.+..+|+..+++||+|||+.. .++|+|||||++||||..|+++.
T Consensus 281 ~eywLVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred cceeEEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 8999999999999999994 356999999999999999999999864 46899999999999999999999
Q ss_pred EecccccccccCCCCC--ceeeccccccccccccccCC------CCccchhHHHHHHHHHHHhCCCCCCc-----ccccc
Q 039595 898 VSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMR------ATEKYDVYSFGVLVFEVIKGNHPRDF-----FSINF 964 (1078)
Q Consensus 898 l~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltG~~p~~~-----~~~~~ 964 (1078)
|+|||+|..+...... ....+||.+|||||++.+.. .-.+.||||+|.|+|||++.....+. +...+
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9999999988654322 34578999999999987642 22478999999999999985433210 00001
Q ss_pred -------cchhhhh-hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHH
Q 039595 965 -------SSFSNMI-IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGF 1018 (1078)
Q Consensus 965 -------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell 1018 (1078)
..+-.+. ...+.-.+|.++...... ..+..+-+.+..||+.||+.|.|+.=+.
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 0010000 111122233333332222 3455788899999999999999986443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=376.69 Aligned_cols=489 Identities=31% Similarity=0.343 Sum_probs=358.1
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeec
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l 181 (1078)
.+++.|+++.|.+....-+.+..--+|+.||+|+|+++ ..|..|..+.+|+.|+++.|.+. ..|.++..+++|++|.|
T Consensus 21 ~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL 98 (1081)
T KOG0618|consen 21 EALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNL 98 (1081)
T ss_pred HHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhhee
Confidence 34778888888665321122333445888888888876 67888888888888888888887 77788888888888888
Q ss_pred ccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCC
Q 039595 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261 (1078)
Q Consensus 182 ~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 261 (1078)
..|.+. ..|.++..+++|+.|+++.|++. .+|..+..++.++.++.++|..... ++... ++.++|..|.+.+.
T Consensus 99 ~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~ 171 (1081)
T KOG0618|consen 99 KNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGS 171 (1081)
T ss_pred ccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccc
Confidence 877776 67888888888888888888874 6777788888888888888833222 22222 77778888888877
Q ss_pred CCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCC
Q 039595 262 IPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNL 341 (1078)
Q Consensus 262 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 341 (1078)
++..+.++.. .|||.+|.+. -..+.++..|+.+.+..|+++.. --..++|+.|+.++|.++...+. ..-
T Consensus 172 ~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~--p~p 240 (1081)
T KOG0618|consen 172 FLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVH--PVP 240 (1081)
T ss_pred hhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeeccc--ccc
Confidence 7777776666 6888888776 33456677777777777777622 22446777777888877733222 223
Q ss_pred CcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEc
Q 039595 342 SSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRF 421 (1078)
Q Consensus 342 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 421 (1078)
.+|+++++++|+++ .+|++++.+.+|+.++..+|+++ .+|..+..+++|+.|...+|.+. -+|....+++.|+.|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 56778888888877 45677777888888888888875 56666777777777777777775 45556666777777777
Q ss_pred cCccccccchhhccCCCC-CcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCC
Q 039595 422 NQNNLVGKVYEAFGDHPN-LTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVG 500 (1078)
Q Consensus 422 ~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~ 500 (1078)
..|+|...+...|.-... |..|+.+.|++.... ...=..+..|+.|.+.+|++++
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp------------------------~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLP------------------------SYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccc------------------------cccchhhHHHHHHHHhcCcccc
Confidence 777776666544444333 555555555544222 1112234678888888898887
Q ss_pred CcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhc
Q 039595 501 KIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEK 580 (1078)
Q Consensus 501 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 580 (1078)
..-..+.+.+.|+.|+|++|+|.......+.++..|++|+||+|+++ .+|+.+.++..|++|...+|+|. ..| .+..
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 77777888889999999999998666677889999999999999998 78899999999999999999997 677 8999
Q ss_pred ccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccC
Q 039595 581 LIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYN 640 (1078)
Q Consensus 581 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N 640 (1078)
+++|+.+|+|.|+|+...-.....-++|++|||++|.-.....+.|..+.++...++.-|
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 999999999999998754333323389999999999865566777888888888888777
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=325.14 Aligned_cols=270 Identities=21% Similarity=0.250 Sum_probs=207.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc-eeeEEeeeecCC---
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN-IVKFHGFCSNAR--- 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~--- 824 (1078)
...|+..++||+|+||+||+|+. .+|+.||+|+++-....+ -......+|+.++++++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E--G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE--GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc--CCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 45677778899999999999954 579999999997654321 12344678999999999999 999999997766
Q ss_pred ---eeEEEEeecCCCCHHHHhcCCCCC-CcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 825 ---HSFLVCEYLHRGSLARILGNDATA-KELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 825 ---~~~lv~E~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
..++|+||++. +|.+++...... ..++...+..+..||++|++|||++ +|+||||||+||+++++|.+||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 78999999977 999999554322 3466688999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh------
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE------ 973 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~------ 973 (1078)
||+|+...-+....+..++|..|+|||++.+. .|+...||||+||+++||+++++-|...... .........
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPNE 242 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCCc
Confidence 99999776555556777899999999999887 7999999999999999999998886543321 000000000
Q ss_pred --hh-hhcCCCC----CCC--CCccHH----HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 974 --VN-QILDPRL----STP--SPGVMD----KLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 974 --~~-~~~~~~~----~~~--~~~~~~----~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.. ...-|.+ ... ...... ...+..+++.+|++.+|.+|.|++.++.|+|+...
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 00 0000111 100 000111 11267899999999999999999999999997654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=340.77 Aligned_cols=264 Identities=20% Similarity=0.281 Sum_probs=196.7
Q ss_pred cCCCccceeccCCceeEEEEEe-C-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC---CCCceeeEEeeee----
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-P-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI---RHRNIVKFHGFCS---- 821 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 821 (1078)
.+|++.+.||+|+||+||+|.. . +++.||+|+++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 3789999999999999999965 3 46789999987543221 1223455666666555 7999999999885
Q ss_pred -cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 822 -NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 822 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
.....++||||++ ++|.+++... ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence 3456899999996 5899998543 234589999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh----h
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN----Q 976 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~----~ 976 (1078)
||+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||...... ........... .
T Consensus 154 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 154 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 231 (290)
T ss_pred ccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChh
Confidence 9999866432 2334567899999999999889999999999999999999999997643221 11111100000 0
Q ss_pred hc-------CCCCCCCCCccH-----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 977 IL-------DPRLSTPSPGVM-----DKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 977 ~~-------~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.+ ...+........ .....+.+++.+||+.||++|||+.|+++|||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 00 000000000001 112356789999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=358.24 Aligned_cols=259 Identities=23% Similarity=0.231 Sum_probs=201.8
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|.. .+++.||||++.+.... .....+.+.+|+.++++++||||+++++++.++...|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 4789999999999999999955 47899999998654221 223356788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 80 MEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999943 34688899999999999999999999 999999999999999999999999999964321
Q ss_pred CCC-----------------------------------------------CceeeccccccccccccccCCCCccchhHH
Q 039595 910 YSS-----------------------------------------------NRTEFVGTFGYAAPEIAYTMRATEKYDVYS 942 (1078)
Q Consensus 910 ~~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 942 (1078)
... .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 001246999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCC---CChhHHHH
Q 039595 943 FGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEAR---PTMEKGFG 1019 (1078)
Q Consensus 943 lG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ell~ 1019 (1078)
|||++|||++|+.||..... ......+.. . ..... .+.......++.+++.+|+. +|.+| ++++|++.
T Consensus 234 lGvil~elltG~~Pf~~~~~--~~~~~~i~~---~-~~~~~--~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS--HETYRKIIN---W-RETLY--FPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH--HHHHHHHHc---c-CCccC--CCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 99999999999999753221 111111111 0 01111 11111112357788899997 66665 69999999
Q ss_pred Hhhhhh
Q 039595 1020 HHIGYC 1025 (1078)
Q Consensus 1020 h~~~~~ 1025 (1078)
|+|+..
T Consensus 305 hp~~~~ 310 (377)
T cd05629 305 HPFFRG 310 (377)
T ss_pred CCCcCC
Confidence 999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=357.16 Aligned_cols=258 Identities=20% Similarity=0.218 Sum_probs=200.5
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.|++.+.||+|+||+||+|.. .+++.||+|++.+.... .......+.+|+.++++++||||+++++++.++...|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 588999999999999999965 46889999998754321 2233557889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++.+ ...+++..+..++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 81 DYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999999843 34578899999999999999999999 9999999999999999999999999997532100
Q ss_pred C-----------------------------------------------CCceeeccccccccccccccCCCCccchhHHH
Q 039595 911 S-----------------------------------------------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSF 943 (1078)
Q Consensus 911 ~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 943 (1078)
. ......+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 00123468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC-CCccHHHHHHHHHHHHhcccCCCCCCCC---hhHHHH
Q 039595 944 GVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP-SPGVMDKLISIMEVAILCLDESPEARPT---MEKGFG 1019 (1078)
Q Consensus 944 G~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~ 1019 (1078)
||++|||++|+.||...... .... .... .......+ ..... .+..+++.+|+ .+|++|++ ++|+++
T Consensus 235 Gvil~elltG~~Pf~~~~~~--~~~~---~i~~-~~~~~~~p~~~~~s---~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPL--ETQM---KVIN-WQTSLHIPPQAKLS---PEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHH--HHHH---HHHc-cCCCcCCCCcccCC---HHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999999997533221 1111 1100 11111111 11112 24556666665 59999997 999999
Q ss_pred Hhhhhhh
Q 039595 1020 HHIGYCD 1026 (1078)
Q Consensus 1020 h~~~~~~ 1026 (1078)
|+|+...
T Consensus 305 hp~f~~~ 311 (382)
T cd05625 305 HPFFKTI 311 (382)
T ss_pred CCCcCCc
Confidence 9997653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=345.25 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=198.8
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhc-CCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE-IRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||+||+|... +++.||||+++...... ....+.+..|..++.. .+||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 46999999999999664 68899999997653211 1223445566777765 499999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 80 GGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 9999999843 34588899999999999999999999 99999999999999999999999999997543333344
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+ ....+.++.. . ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i----~~~~~~~~~~---~---~~ 221 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSI----RMDNPCYPRW---L---TR 221 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCCCCCCcc---C---CH
Confidence 556799999999999998999999999999999999999999753321 1111111 1111211111 1 12
Q ss_pred HHHHHHHhcccCCCCCCCChh-HHHHHhhhhhh
Q 039595 995 SIMEVAILCLDESPEARPTME-KGFGHHIGYCD 1026 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~~-ell~h~~~~~~ 1026 (1078)
++.+++.+||+.||++||++. ++.+|+|+...
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 567889999999999999996 89999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=356.46 Aligned_cols=260 Identities=20% Similarity=0.208 Sum_probs=201.9
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|++.+.||+|+||.||+|+. .+++.||||++.+.... .....+.+.+|+.++++++||||+++++.+.+++..|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 689999999999999999965 46899999998654322 1223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++.+ .+.+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999943 34578899999999999999999999 9999999999999999999999999997532100
Q ss_pred C-------------------------------------------CCceeeccccccccccccccCCCCccchhHHHHHHH
Q 039595 911 S-------------------------------------------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLV 947 (1078)
Q Consensus 911 ~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 947 (1078)
. ......+||+.|||||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 001134799999999999999999999999999999
Q ss_pred HHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCC---ChhHHHHHhhhh
Q 039595 948 FEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARP---TMEKGFGHHIGY 1024 (1078)
Q Consensus 948 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~ell~h~~~~ 1024 (1078)
|||++|+.||...... .....+.. .......+. .......+.+++.+|+ .+|.+|+ +++|+++|+|+.
T Consensus 235 yell~G~~Pf~~~~~~--~~~~~i~~----~~~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~ 305 (376)
T cd05598 235 YEMLVGQPPFLADTPA--ETQLKVIN----WETTLHIPS--QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFK 305 (376)
T ss_pred eehhhCCCCCCCCCHH--HHHHHHhc----cCccccCCC--CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcC
Confidence 9999999997543321 11111110 011111110 0111224566777766 5999999 999999999977
Q ss_pred hhH
Q 039595 1025 CDE 1027 (1078)
Q Consensus 1025 ~~~ 1027 (1078)
..+
T Consensus 306 ~~~ 308 (376)
T cd05598 306 GID 308 (376)
T ss_pred CCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=350.06 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=197.8
Q ss_pred ceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHH-HHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVL-ALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||+||+|.. .+|+.||+|++.+.... .......+..|.. +++.++||||+++++++..++..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 3699999999999965 47899999999764322 1223344555544 5778999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.. ...+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 80 GGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 9999998843 45689999999999999999999999 99999999999999999999999999997543333344
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ...... +........ +. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~------~~~~~~~~~-~~---~~~ 221 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--AEMYDN------ILHKPLVLR-PG---ASL 221 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--HHHHHH------HHcCCccCC-CC---CCH
Confidence 556799999999999999999999999999999999999999753221 111111 111111111 11 123
Q ss_pred HHHHHHHhcccCCCCCCCCh----hHHHHHhhhhh
Q 039595 995 SIMEVAILCLDESPEARPTM----EKGFGHHIGYC 1025 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~----~ell~h~~~~~ 1025 (1078)
.+.+++.+|++.+|.+||++ .++++|+|+..
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 56788999999999999987 58999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=339.86 Aligned_cols=259 Identities=21% Similarity=0.336 Sum_probs=196.8
Q ss_pred cCCCccceeccCCceeEEEEEeCC-----------------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCce
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPS-----------------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 813 (1078)
++|++.+.||+|+||.||+|.+++ +..||+|++.... .......+.+|+.++++++||||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCCe
Confidence 578899999999999999996432 3369999986542 23345678999999999999999
Q ss_pred eeEEeeeecCCeeEEEEeecCCCCHHHHhcCCC----------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 039595 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDA----------------TAKELSWNRRINVIKGVANALSYLHHDCLPS 877 (1078)
Q Consensus 814 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 877 (1078)
+++++++.+....++||||+++|+|.+++.... ....+++..+++++.||+.||+|||+. +
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 999999999999999999999999999984321 113478889999999999999999999 9
Q ss_pred cEecCCCCCCeeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh--C
Q 039595 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK--G 953 (1078)
Q Consensus 878 ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G 953 (1078)
|+||||||+||+++.++.+||+|||+++....... ......++..|||||++.++.++.++||||||+++|||++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 99999999999999999999999999986543221 1223345789999999998899999999999999999987 5
Q ss_pred CCCCCcccccccchhhhhhhh-hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 954 NHPRDFFSINFSSFSNMIIEV-NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 954 ~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
..||..... .......... ............+.. ...+.+++.+||+.||++|||++|+.+.
T Consensus 239 ~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RPs~~~i~~~ 301 (304)
T cd05096 239 EQPYGELTD--EQVIENAGEFFRDQGRQVYLFRPPPC---PQGLYELMLQCWSRDCRERPSFSDIHAF 301 (304)
T ss_pred CCCCCcCCH--HHHHHHHHHHhhhccccccccCCCCC---CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 566543221 1111111110 000000000011111 2367889999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=307.43 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=204.2
Q ss_pred hhcCCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec-----
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN----- 822 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----- 822 (1078)
..++|++.+.+|+|||+-||.++ ..+++.||+|++... ..++.+...+|++..++++||||++++++...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 34689999999999999999995 567899999998755 34567888999999999999999999998743
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCC-cCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecc
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAK-ELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDF 901 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 901 (1078)
....|++++|...|+|.+.+++....+ .+++.++++|+.+|++||++||+. .++++||||||.||++.+++.+++.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 345899999999999999997655444 789999999999999999999998 234999999999999999999999999
Q ss_pred cccccccCCCCC---------ceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhh
Q 039595 902 GIAKFVEPYSSN---------RTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 902 G~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 969 (1078)
|.++...-.... ......|..|.|||.+. +...++++|||||||++|+|+.|..||+..-..-...+-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 999754321111 11234588999999876 345689999999999999999999998743322112221
Q ss_pred hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.+. .+.+..+... .....+.+++++|++.||.+||++.+++.+.
T Consensus 254 Av~------n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~ 297 (302)
T KOG2345|consen 254 AVQ------NAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKL 297 (302)
T ss_pred eee------ccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 111 1122111111 1334688999999999999999999998764
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=344.63 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=203.3
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 829 (1078)
+|++.+.||+|+||+||+|..+ +++.||+|++.+.... .....+.+..|..++... +|++|+++++++.+.+..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 5888999999999999999655 6789999999764322 122344566677777776 589999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 80 MEYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999999998843 34588999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +.......+ ...
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~------i~~~~~~~p-~~~ 224 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQS------IMEHNVAYP-KSM 224 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHH------HHhCCCCCC-CcC
Confidence 33334456799999999999999999999999999999999999999764322 111111 111111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCh-----hHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTM-----EKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~h~~~~~ 1025 (1078)
..++.+++.+|++.||++|++. +++++|+|+..
T Consensus 225 ---s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 225 ---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred ---CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 2356789999999999999984 89999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=349.75 Aligned_cols=262 Identities=23% Similarity=0.236 Sum_probs=206.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|..+ +|+.||+|+++..... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 46899999999999999999654 7899999999765321 233456688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.+. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 80 MEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred ECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999999543 24689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-ceeeccccccccccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 910 YSSN-RTEFVGTFGYAAPEIAY------TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 910 ~~~~-~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
.... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+... ....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~~~i~~~----~~~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--AKTYNNIMNF----QRFL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--HHHHHHHHcC----CCcc
Confidence 3322 23347899999999986 45678999999999999999999999753221 1111111110 0001
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
. .+........+.+++.+|+. +|++|||+++++.|+|+...+
T Consensus 229 ~--~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 229 K--FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred C--CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 0 01111122356788888997 999999999999999987543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=347.55 Aligned_cols=251 Identities=23% Similarity=0.281 Sum_probs=196.1
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHR 835 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 835 (1078)
+.||+|+||+||+|..+ +++.||+|++..............+.++..+++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999665 67889999987643222222222233344457888999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCce
Q 039595 836 GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT 915 (1078)
Q Consensus 836 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 915 (1078)
|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 999999843 34578889999999999999999999 999999999999999999999999999976543333445
Q ss_pred eeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHH
Q 039595 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995 (1078)
Q Consensus 916 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1078)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... +....... .+.. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~------i~~~~~~~-~~~~---~~~ 222 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDN------ILNKPLQL-KPNI---TNS 222 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--HHHHHH------HHhCCcCC-CCCC---CHH
Confidence 56799999999999999999999999999999999999999753221 111111 11111111 1111 225
Q ss_pred HHHHHHhcccCCCCCCCChh----HHHHHhhhhh
Q 039595 996 IMEVAILCLDESPEARPTME----KGFGHHIGYC 1025 (1078)
Q Consensus 996 l~~li~~cl~~dP~~RPt~~----ell~h~~~~~ 1025 (1078)
+.+++.+|++.||.+||++. ++.+|+|+..
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 67889999999999999876 8999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.22 Aligned_cols=260 Identities=23% Similarity=0.266 Sum_probs=206.5
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.|+..+.||+|+||+||+|.. .+++.||+|++...... .......+.+|+.++++++||||+++++++..+...++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 478889999999999999965 47899999998654322 1223445778999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++... ....+++..+..++.|++.|+.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 80 TLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred eccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999888543 234689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ..... ....+.........
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--~~~~~---~~~~~~~~~~~~~~--- 226 (285)
T cd05605 156 E-TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--VKREE---VERRVKEDQEEYSE--- 226 (285)
T ss_pred C-ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh--hHHHH---HHHHhhhcccccCc---
Confidence 2 223457899999999999889999999999999999999999997643221 00011 11111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhh
Q 039595 991 DKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYC 1025 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~ 1025 (1078)
.....+.+++.+||+.||++|| +++++++|+|+..
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 1223577899999999999999 8999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.95 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=213.9
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.-|...+.||+|.|++|-+|++ =+|++||||++.+... +......+.+|+..|+-++|||||++|++...+..+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 3577778899999999999954 3899999999987654 334456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeccccccccc
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-EFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~a~~~~ 908 (1078)
+|.-++|+|++|+-+. ...+.+.-+.+++.||+.|+.|+|+- .+||||+||+||.+-+ -|-||++|||++-.+.
T Consensus 96 LELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999999433 34588899999999999999999999 8999999999998754 5899999999998876
Q ss_pred CCCCCceeeccccccccccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRAT-EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
+ +..-++.+|+..|-|||++.+..|+ +++||||+|||||-+++|++||+.+.+. + ....++|-.+.-+.
T Consensus 171 P-G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--E------TLTmImDCKYtvPs- 240 (864)
T KOG4717|consen 171 P-GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--E------TLTMIMDCKYTVPS- 240 (864)
T ss_pred C-cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--h------hhhhhhcccccCch-
Confidence 5 4455678999999999999998875 5899999999999999999997654432 2 22334444443221
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....++.++|..||..||.+|.+.+||..+.|.+.
T Consensus 241 ---hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 241 ---HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred ---hhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 22347889999999999999999999999999873
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=346.84 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=197.2
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHH-HHHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVV-LALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||.||+|+.. +++.||+|++.+..... ......+..|. .+++.++||||+++++++.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999664 68899999987643222 22233444444 46788999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|..++.+ ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 80 GGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 9999988843 35688899999999999999999999 99999999999999999999999999987543333334
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ..... .+.......+ + ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~------~i~~~~~~~~-~---~~~~ 221 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQMYD------NILHKPLQLP-G---GKTV 221 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--HHHHH------HHhcCCCCCC-C---CCCH
Confidence 456799999999999998999999999999999999999999753221 11111 1111111111 1 1123
Q ss_pred HHHHHHHhcccCCCCCCCCh----hHHHHHhhhhhh
Q 039595 995 SIMEVAILCLDESPEARPTM----EKGFGHHIGYCD 1026 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~----~ell~h~~~~~~ 1026 (1078)
.+.+++.+||+.||.+||++ .|+++|+|+...
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 57789999999999999975 599999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.14 Aligned_cols=258 Identities=24% Similarity=0.301 Sum_probs=202.5
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||+||+|... +++.||+|++.+.... .....+.+.+|+.++.++ +||+|+++++++.+....|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 46999999999999654 6789999999765322 233456678899988888 69999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.. .+.+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 80 GGDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 9999998843 34689999999999999999999999 99999999999999999999999999997543333334
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+.......... .......+.......+ ... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~p-~~~---~~ 228 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT-EDYLFQVILEKPIRIP-RFL---SV 228 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc-HHHHHHHHHhCCCCCC-CCC---CH
Confidence 556799999999999999999999999999999999999999864322111000 0000111111111111 111 12
Q ss_pred HHHHHHHhcccCCCCCCCC------hhHHHHHhhhhhh
Q 039595 995 SIMEVAILCLDESPEARPT------MEKGFGHHIGYCD 1026 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt------~~ell~h~~~~~~ 1026 (1078)
.+.+++.+||+.||++||+ ++++++|+|+...
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 5678999999999999998 5799999997653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=348.33 Aligned_cols=250 Identities=26% Similarity=0.316 Sum_probs=202.1
Q ss_pred ceeccCCceeEEEEEe----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 757 FCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
+.||+|+||.||+++. .+|+.||+|++..... .......+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999854 3688999999976432 122345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 912 (1078)
+++|+|.+++.+ ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 80 LRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 999999999843 34589999999999999999999999 999999999999999999999999999986654333
Q ss_pred CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHH
Q 039595 913 NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDK 992 (1078)
Q Consensus 913 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1078)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ..... .+.......+ ...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~------~i~~~~~~~p-~~~--- 221 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KETMT------MILKAKLGMP-QFL--- 221 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--HHHHH------HHHcCCCCCC-CCC---
Confidence 34456799999999999988899999999999999999999999753321 11111 1111111111 111
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhh
Q 039595 993 LISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCD 1026 (1078)
Q Consensus 993 ~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~ 1026 (1078)
...+.+++.+||+.||++||+ +++++.|+|+...
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 125678899999999999999 6779999997654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=333.34 Aligned_cols=246 Identities=21% Similarity=0.311 Sum_probs=194.3
Q ss_pred cceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec----CCeeEEEEe
Q 039595 756 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN----ARHSFLVCE 831 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E 831 (1078)
...||+|++|.||+|.+ +|+.||||++..... ......+.+.+|+.++++++||||+++++++.+ ....++|||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 36799999999999987 589999999876432 122234678899999999999999999999866 457899999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+++|+|.+++.. ...+++....+++.|++.|+.|||+.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 103 y~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 103 YCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP- 176 (283)
T ss_pred eCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc-
Confidence 9999999999954 346889999999999999999999842 7889999999999999999999999999865432
Q ss_pred CCceeecccccccccccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 912 SNRTEFVGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+.. ....+..+ ...
T Consensus 177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~~~~i~~--~~~~~~~~---~~~ 247 (283)
T PHA02988 177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIYDLIIN--KNNSLKLP---LDC 247 (283)
T ss_pred --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh--cCCCCCCC---CcC
Confidence 223468899999999876 6799999999999999999999999764321 111111110 01111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...+.+++.+||+.||++|||++|+++..
T Consensus 248 ---~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 248 ---PLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred ---cHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 23577889999999999999999998764
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=342.71 Aligned_cols=263 Identities=22% Similarity=0.242 Sum_probs=201.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|..+ +++.||+|++.+.... .....+.+.+|+.+++.++|+||+++++++.++...|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 47899999999999999999654 6899999998753221 223355688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.+. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999999532 34588999999999999999999999 999999999999999999999999999976644
Q ss_pred CCCC-ceeecccccccccccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 910 YSSN-RTEFVGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 910 ~~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
.... .....||+.|||||++.. ..++.++||||+||++|||++|+.||..... ......+...... ....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--~~~~~~i~~~~~~--~~~~ 230 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKEH--FQFP 230 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCc--ccCC
Confidence 3322 233569999999999863 4578899999999999999999999753221 1111111110000 0111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCC--CCCCCChhHHHHHhhhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDES--PEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~d--P~~RPt~~ell~h~~~~~~ 1026 (1078)
...... ...+.+++.+|+..+ +..||+++++++|+|+...
T Consensus 231 ~~~~~~---~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 231 PDVTDV---SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CccCCC---CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 111111 224567777766544 3448899999999998653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=374.20 Aligned_cols=488 Identities=27% Similarity=0.278 Sum_probs=357.7
Q ss_pred eEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEc
Q 039595 78 RVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYL 157 (1078)
Q Consensus 78 ~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 157 (1078)
+++.++++.+.+-..--++.-.+.+ |+.|||++|.+. ..|..+..+.+|+.|+++.|.+. .+|.+++++.+|++|.|
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~-L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL 98 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVK-LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNL 98 (1081)
T ss_pred HHHhhhccccccccCchHHhhheee-eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhhee
Confidence 4667777765433211111112344 999999999884 78999999999999999999998 78999999999999999
Q ss_pred cCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCC
Q 039595 158 DMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL 237 (1078)
Q Consensus 158 ~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 237 (1078)
..|.+. .+|.++..+++|+.|+++.|.+. .+|.-+..++.++.+..++|.... .++... .+.++|..|.+.+.
T Consensus 99 ~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~ 171 (1081)
T KOG0618|consen 99 KNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGS 171 (1081)
T ss_pred ccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccc
Confidence 999998 99999999999999999999997 889999999999999999993322 233333 89999999999999
Q ss_pred CCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCC
Q 039595 238 IPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNL 317 (1078)
Q Consensus 238 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l 317 (1078)
++..+.+++. .|+|++|.+. . ..+.++.+|+.|....|+++... -..++|+.|+.++|.++...+. .--
T Consensus 172 ~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~--p~p 240 (1081)
T KOG0618|consen 172 FLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH--PVP 240 (1081)
T ss_pred hhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc--ccc
Confidence 9988888777 7999999998 2 34678899999999999987432 2346899999999999844332 233
Q ss_pred CccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeec
Q 039595 318 KSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNM 397 (1078)
Q Consensus 318 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 397 (1078)
.+|+++++++|++++ +|.+++.+.+|+.|+..+|++. .+|..+....+|+.|.+.+|.++ .+|.....++.|+.|+|
T Consensus 241 ~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 689999999999995 5699999999999999999997 89999999999999999999998 56777888999999999
Q ss_pred ccCcCCCCCCccccccCC-CCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCC
Q 039595 398 CENHLFGPIPKSLKSLTS-LKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFG 476 (1078)
Q Consensus 398 ~~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~ 476 (1078)
..|+|....+..|.-+.. |+.++.+.|++.......=..++.|+.|++.+|.++..
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~----------------------- 374 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDS----------------------- 374 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccccc-----------------------
Confidence 999998766655555544 78888888888765532222334555555555555544
Q ss_pred CCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCccccc
Q 039595 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGN 556 (1078)
Q Consensus 477 ~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 556 (1078)
.-..+.++.+|+.|+|++|++..+....+.++..|++|+||+|+|+ .+|.....+..|+.|...+|.|. ..| .+.+
T Consensus 375 -c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 375 -CFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred -chhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 3344555556666666666666555555566666666666666665 45566666666666666666665 444 5556
Q ss_pred ccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCc
Q 039595 557 LLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHN 616 (1078)
Q Consensus 557 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 616 (1078)
++.|+.+|+|.|+|+...-..-..-++|++|||++|.-.......|..+.++...++.-|
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 666666666666665322221122256666666666432233334444444444444444
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=332.21 Aligned_cols=254 Identities=23% Similarity=0.286 Sum_probs=198.9
Q ss_pred eccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCC
Q 039595 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGS 837 (1078)
Q Consensus 759 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 837 (1078)
||+|+||.||++..+ +|+.||+|++....... ......+..|++++++++||||+++++++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 699999999999654 68999999986543221 1223445679999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceee
Q 039595 838 LARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF 917 (1078)
Q Consensus 838 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 917 (1078)
|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++...... ......
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~ 154 (277)
T cd05607 80 LKYHIYNV-GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQR 154 (277)
T ss_pred HHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeecc
Confidence 99888443 234588899999999999999999999 9999999999999999999999999999866432 223345
Q ss_pred ccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHH
Q 039595 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIM 997 (1078)
Q Consensus 918 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 997 (1078)
.|+..|+|||++.+..++.++||||+||++|||++|+.||......... ................... ..++.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~ 227 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK----EELKRRTLEDEVKFEHQNF---TEESK 227 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH----HHHHHHhhccccccccccC---CHHHH
Confidence 7899999999999988999999999999999999999997543221110 0111111211211111111 23578
Q ss_pred HHHHhcccCCCCCCCCh----hHHHHHhhhhh
Q 039595 998 EVAILCLDESPEARPTM----EKGFGHHIGYC 1025 (1078)
Q Consensus 998 ~li~~cl~~dP~~RPt~----~ell~h~~~~~ 1025 (1078)
+++.+||+.||++||++ ++++.|+|+..
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 89999999999999999 66789999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=351.64 Aligned_cols=260 Identities=22% Similarity=0.248 Sum_probs=202.4
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||+||+|..+ +++.||+|++...... .......+.+|+.++..++||+|+++++++.+++..|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 47889999999999999999654 6899999999754321 223456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.+ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 80 MEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999999843 34688999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC-----------------------------------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCC
Q 039595 910 YSS-----------------------------------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN 954 (1078)
Q Consensus 910 ~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~ 954 (1078)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 011347999999999999999999999999999999999999
Q ss_pred CCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCC---ChhHHHHHhhhhhh
Q 039595 955 HPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARP---TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 955 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~ell~h~~~~~~ 1026 (1078)
.||..... ......+...... ..++.. .... .++.+++.+|+ .||.+|+ +++|+++|+|+..-
T Consensus 234 ~Pf~~~~~--~~~~~~i~~~~~~--~~~p~~-~~~s---~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 234 PPFCSETP--QETYRKVMNWKET--LVFPPE-VPIS---EKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCCCCH--HHHHHHHHcCCCc--eecCCC-CCCC---HHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 99753322 1111111110000 011111 1111 24566777766 4999998 48999999997753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.62 Aligned_cols=256 Identities=22% Similarity=0.298 Sum_probs=203.1
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCeeEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 829 (1078)
+|+..+.||+|+||+||+|..+ +|+.||+|++.+.... .....+.+..|..+++.+. |++|+++++++.+.+..|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 4778899999999999999654 6899999998764322 1223456777888888775 57888999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 80 MEYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999999843 34689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..... .+.......+ ...
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~------~i~~~~~~~p-~~~ 224 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQ------SIMEHNVSYP-KSL 224 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHH------HHHhCCCCCC-ccC
Confidence 33333456799999999999998999999999999999999999999754322 11111 1111111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCD 1026 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~ 1026 (1078)
..++.+++.+||+.+|.+|++ .+++.+|+|+..-
T Consensus 225 ---~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 225 ---SKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ---CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 235678999999999999997 4789999997653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=343.45 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=204.0
Q ss_pred CCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-C-----CceeeEEeeeecCC
Q 039595 752 DFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-H-----RNIVKFHGFCSNAR 824 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~ 824 (1078)
+|++.+.||+|+||.|.+| ..++++.||||+++.. ..-..+...|+.++..++ | -|+|+++++|....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 8999999999999999999 6678999999999764 233455677899998886 4 38999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC--cEEEeccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF--EAHVSDFG 902 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DfG 902 (1078)
+.|||+|.+.. +|+++++.... ..++...++.|+.||+.||.+||+. +|||+||||+|||+...+ .+||+|||
T Consensus 262 HlciVfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 HLCIVFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ceeeeehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999866 99999976544 4599999999999999999999999 999999999999997654 69999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh-----------
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI----------- 971 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~----------- 971 (1078)
.|++...... ..+-+..|+|||++.+.+|+.+.||||||||++||++|.+-|...+. +..++..+
T Consensus 337 SSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne-~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 337 SSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE-YDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 9997754322 56678899999999999999999999999999999999876532211 00000000
Q ss_pred ----------------------------------hh-----hhhhcCC-CCCCCCCccH-HHHHHHHHHHHhcccCCCCC
Q 039595 972 ----------------------------------IE-----VNQILDP-RLSTPSPGVM-DKLISIMEVAILCLDESPEA 1010 (1078)
Q Consensus 972 ----------------------------------~~-----~~~~~~~-~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~ 1010 (1078)
.. ......| .......... ..-..+++++++|+.+||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 00 0000001 0000001111 22347899999999999999
Q ss_pred CCChhHHHHHhhhhhh
Q 039595 1011 RPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 1011 RPt~~ell~h~~~~~~ 1026 (1078)
|+|+.|+++|||....
T Consensus 493 R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 493 RITPAQALNHPFLTGT 508 (586)
T ss_pred cCCHHHHhcCcccccc
Confidence 9999999999998743
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=347.33 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=200.8
Q ss_pred hhcCCCccceeccCCceeEEEEEe------CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCS 821 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 821 (1078)
..++|++.+.||+|+||.||+|.+ .++..||||+++... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 345799999999999999999953 245689999986542 223456788999999999 8999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCC------------------------------------------------------
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDAT------------------------------------------------------ 847 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~------------------------------------------------------ 847 (1078)
+++..++||||+++|+|.++++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999854211
Q ss_pred ------------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 848 ------------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 848 ------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
...+++..+.+++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 12478889999999999999999999 999999999999999999999999999986643
Q ss_pred CCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 910 YSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 910 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...... ........
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~-------~~~~~~~~ 338 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMI-------KEGYRMLS 338 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHH-------HhCccCCC
Confidence 2211 122345678999999999999999999999999999998 888865332211 111111 11111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
+.. ...++.+++.+||+.||++||+++|+++...
T Consensus 339 ~~~--~~~~l~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 339 PEC--APSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred CCC--CCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 111 1236789999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.25 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=203.1
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 35799999999999999999965 578899999986432 2234567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++.. ...+++.++..++.|++.|+.|||+. +|+|||++|+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 84 CMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 9999999999999843 34688999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
..........|+..|+|||.+. ...++.++||||+||++|||++|+.||....... ..... .......+...
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-~~~~~--~~~~~~~~~~~-- 232 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLM--SKSNFQPPKLK-- 232 (267)
T ss_pred ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-hheee--ecCCCCCCCCc--
Confidence 4333334557889999999874 3457889999999999999999999964322110 00000 00000111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
........+.+++.+||+.+|++|||++++++|+|
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 11112246788999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.48 Aligned_cols=262 Identities=23% Similarity=0.271 Sum_probs=196.9
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC---C--
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA---R-- 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~-- 824 (1078)
-.|+..+.+|.|+||.||+|.. .+++.||||++-.+.. .-.+|+.+|+.++|||||++.-+|... +
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 3577788999999999999965 4578999999865432 123588899999999999999888432 2
Q ss_pred eeEEEEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEeccc
Q 039595 825 HSFLVCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFG 902 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG 902 (1078)
...+|||||+. +|.++++.. .....++..++.-+..||++||+|||+. +|+||||||+|+|+|.+ |.+||||||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence 34589999988 999988532 2345678888999999999999999998 99999999999999987 999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccc--cchhhhhh-----hh
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SSFSNMII-----EV 974 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~~~~-----~~ 974 (1078)
.|+.+..... .....-|..|+|||.+.+. .|+.+.||||.|||+.||+.|++-|...+... ..+....+ .+
T Consensus 172 SAK~L~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 172 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred cceeeccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9998865433 3556678899999998875 69999999999999999999999965433210 11111000 00
Q ss_pred h-------hhcCCCCCCCC-C--ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 N-------QILDPRLSTPS-P--GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 ~-------~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. ....|.+.... . .......+.++++.+++..+|.+|.++.|++.|+|+..
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 0 00011111110 0 01111236789999999999999999999999998543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=357.73 Aligned_cols=256 Identities=20% Similarity=0.206 Sum_probs=205.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-C-CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-S-GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..|.+.+.||+|+||.||+|... + ++.||+|.+... .......+.+|+.+++.++||||+++++++..++..|+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34889999999999999999543 4 678888876433 23345567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 829 VCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
||||+++|+|.+++... ....++++.++..++.||+.||+|+|++ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999988532 2345688999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 908 EPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 908 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... .+........
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~~~------~~~~~~~~~~ 291 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIMQ------QVLYGKYDPF 291 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH------HHHhCCCCCC
Confidence 54322 23455799999999999999999999999999999999999999753221 11111 1111111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.... ..++.+++.+||..||++||++++++.|+|..
T Consensus 292 ~~~~---s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 292 PCPV---SSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred CccC---CHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence 1111 23578889999999999999999999998865
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=314.34 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=216.0
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|+..+.||+|+||+|.+++- .+|+.||+|++++..... ..+...-..|-.+++..+||.+..+-..|...+++|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 357899999999999999999954 479999999998876542 334555677899999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+.||.|+.++. ..+.+++...+.+...|+.||.|||++ +||.||+|.+|.++|.||++||+|||+++.-
T Consensus 245 FVMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999998884 355689999999999999999999999 9999999999999999999999999999976
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
-..+.....++|||.|.|||++....|+.++|.|.+||++|||++|+.|| +..+.......+.....-++..+.+
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPF--yn~dh~kLFeLIl~ed~kFPr~ls~--- 393 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPF--YNKDHEKLFELILMEDLKFPRTLSP--- 393 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcc--cccchhHHHHHHHhhhccCCccCCH---
Confidence 66667778899999999999999999999999999999999999999994 4444444444333322222222221
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~ 1025 (1078)
+...++...|.+||.+|. .+.||.+|.|+..
T Consensus 394 -------eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 394 -------EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred -------HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 344666778999999998 4899999998664
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=349.23 Aligned_cols=266 Identities=21% Similarity=0.251 Sum_probs=205.6
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
+.....++|++.+.||+|+||.||+|..+ +++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34445689999999999999999999665 6889999998653221 222345678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999999843 3478889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC-CceeeccccccccccccccC----CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 904 AKFVEPYSS-NRTEFVGTFGYAAPEIAYTM----RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 904 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
++....... ......||+.|||||++.+. .++.++||||+||++|||++|+.||..... ..... .+.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~------~i~ 260 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYS------KIM 260 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--HHHHH------HHH
Confidence 987643322 22356799999999998754 378999999999999999999999753221 11111 111
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCC--CCChhHHHHHhhhhhh
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEA--RPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~h~~~~~~ 1026 (1078)
........+........+.+++.+|+..++.+ ||+++|+++|+|+...
T Consensus 261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 261 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred cCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 11100011111112235677888899844443 7899999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=334.59 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=207.2
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...|+|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC----cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 5799999999999999999964 478999999986543 22356688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999999843 3478899999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..... ....+......+
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-~~~~~------~~~~~~~~~~~~-- 239 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYL------IATNGTPELQNP-- 239 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-HhHHH------HhcCCCCCCCCc--
Confidence 333334457889999999999888999999999999999999999997533221 00000 001111110011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
......+.+++.+||.+||++|||++|++.|+|....
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 1122357789999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=335.90 Aligned_cols=257 Identities=29% Similarity=0.438 Sum_probs=204.3
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|++.+.||+|+||+||+|... +++.||+|++...... ........+|+.++++++||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE--EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH--HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc--ccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 677899999999999999665 5678999999775322 1222234569999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+++++|.+++. ....+++.++..++.|+++||+|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 79 YCPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp EETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred cccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999995 456689999999999999999999999 99999999999999999999999999998653333
Q ss_pred CCceeeccccccccccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccc-cccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 912 SNRTEFVGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI-NFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.......++..|+|||++. +..++.++||||+|+++|+|++|+.||..... +......... .......... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~----~ 226 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL--KRPLPSSSQQ----S 226 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH--HTHHHHHTTS----H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc--cccccccccc----c
Confidence 4455677899999999998 78899999999999999999999999764411 1011111000 0000000000 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
......+.+++.+||+.||++||+++++++|||+
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0001478899999999999999999999999995
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=343.74 Aligned_cols=266 Identities=23% Similarity=0.296 Sum_probs=201.7
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC--
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR-- 824 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 824 (1078)
...++|++.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 3458899999999999999999965 4689999999875432 2334566789999999999999999999986443
Q ss_pred ----eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 825 ----HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 825 ----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
..|+||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 57999999976 5666652 2378889999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-------------cch
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF-------------SSF 967 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-------------~~~ 967 (1078)
||+++..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||...+... ...
T Consensus 167 fg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 167 FGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CCCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9999765332 22344578999999999999999999999999999999999999986432110 000
Q ss_pred hhhhh-hhhhhc--CCCCCCC--------------CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 968 SNMII-EVNQIL--DPRLSTP--------------SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 968 ~~~~~-~~~~~~--~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..... ...... .+..... ..........+.+++.+||..||++|||++|+++|||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00000 000000 0111000 0000011235789999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=356.70 Aligned_cols=263 Identities=25% Similarity=0.313 Sum_probs=208.1
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
.....++|++.+.||+|+||+||+|.. .+|+.||||++..... .......+.+|+..+..++|+||+++++.+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 334557999999999999999999954 5799999999876532 2344567889999999999999999988774332
Q ss_pred --------eeEEEEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 039595 825 --------HSFLVCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE 895 (1078)
Q Consensus 825 --------~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 895 (1078)
..++||||+++|+|.++++.. .....+++..+..++.|++.||.|+|+. +|+||||||+||+++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence 368999999999999998543 2345689999999999999999999999 9999999999999999999
Q ss_pred EEEecccccccccCCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh
Q 039595 896 AHVSDFGIAKFVEPYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 973 (1078)
+||+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--~~~~~---- 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--EEVMH---- 255 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHH----
Confidence 9999999998764321 223456799999999999999999999999999999999999999753221 11111
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
...........+... .++.+++.+||+.||++||++.++++|+|..
T Consensus 256 --~~~~~~~~~~~~~~~---~~l~~li~~~L~~dP~~RPs~~ell~~p~~~ 301 (496)
T PTZ00283 256 --KTLAGRYDPLPPSIS---PEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301 (496)
T ss_pred --HHhcCCCCCCCCCCC---HHHHHHHHHHcccChhhCcCHHHHHhCHHHH
Confidence 111111111111122 3577889999999999999999999999854
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=329.01 Aligned_cols=257 Identities=22% Similarity=0.293 Sum_probs=204.4
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG-NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
+.|+..+.||+|++|.||+|.. .+++.||+|.+....... .....+.+.+|+.++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999964 468999999986543211 12234568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|+||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999843 34588899999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCc---eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 909 PYSSNR---TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 909 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
...... ....|+..|+|||.+.+..++.++||||+|+++|||++|+.||..... .... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~------~~~~~~~~~~~ 227 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--MAAI------FKIATQPTNPQ 227 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--HHHH------HHHhccCCCCC
Confidence 322111 234678899999999998999999999999999999999999653211 1000 01111111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.+. .....+.+++.+||..+|++|||++|+++|+|+
T Consensus 228 ~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 228 LPS--HVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCc--cCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 111 112357789999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=319.78 Aligned_cols=256 Identities=27% Similarity=0.374 Sum_probs=193.0
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhc--CCCCceeeEEeeeecC----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE--IRHRNIVKFHGFCSNA---- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~---- 823 (1078)
..+.+..+.||+|.||.||+|.|. |+.||||+|... +.....+|.++.+. ++|+||+.+++.-..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 457888899999999999999997 899999999654 24445666666654 4999999999876443
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD-----CLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
.+.|+|++|.+.|+|+|||.+ ..++.+.+++++..+|.||++||.. ..|.|.|||||+.||||.++|++.|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 368999999999999999943 4688999999999999999999974 3578999999999999999999999
Q ss_pred ecccccccccCCC----CCceeeccccccccccccccCC------CCccchhHHHHHHHHHHHh----C------CCCCC
Q 039595 899 SDFGIAKFVEPYS----SNRTEFVGTFGYAAPEIAYTMR------ATEKYDVYSFGVLVFEVIK----G------NHPRD 958 (1078)
Q Consensus 899 ~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~ellt----G------~~p~~ 958 (1078)
+|+|+|....... -.....+||.+|||||++...- .-..+||||||.|+||+.. | ++||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999998765432 2245679999999999987532 2347999999999999985 2 45654
Q ss_pred cccccccchhhhhh-hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHH
Q 039595 959 FFSINFSSFSNMII-EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGF 1018 (1078)
Q Consensus 959 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell 1018 (1078)
..-.....+..+.. ...+.+.|..+... ...+.+..+.++++.||..+|..|-|+-.+-
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRW-KSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 33332222222110 11112222222211 1235677899999999999999999975443
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=326.50 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=208.9
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|+||.||+|..+ +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 4778899999999999999654 689999999865432 2445677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++++|.+++... ....+++..++.++.|++.|+.|||+. +++||||||+||+++.++.++++|||++......
T Consensus 79 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 79 EYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999999643 245688999999999999999999998 9999999999999999999999999999876554
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
........|++.|+|||+..+..++.++||||||+++|||++|+.||..... .... ..+..........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~------~~~~~~~~~~~~~--- 223 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALI------LKIIRGVFPPVSQ--- 223 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHH------HHHHcCCCCCCcc---
Confidence 4334455788999999999999999999999999999999999999753331 1111 1111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.....+.+++.+||+.+|++||++.++++|+|.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 122367889999999999999999999999983
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=337.79 Aligned_cols=264 Identities=19% Similarity=0.287 Sum_probs=202.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|..+ +++.||+|++..... ......+.+|+.++++++||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 57899999999999999999654 688999999875432 22234577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++ +|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++....
T Consensus 83 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 83 FEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EeCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 999976 888887432 34578899999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh--------------
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV-------------- 974 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~-------------- 974 (1078)
.........+++.|+|||.+.+ ..++.++||||+||++|||+||+.||...... .....+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--DELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhhcc
Confidence 3333344578899999998865 46899999999999999999999997543221 110000000
Q ss_pred -hh---hcCCCCCCC--CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 -NQ---ILDPRLSTP--SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 -~~---~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. .-.+..... .........++.+++.+||+.||++|||++|+++|+|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 00 000000000 0000011235679999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=345.81 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=200.4
Q ss_pred HHhhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEee
Q 039595 747 IKATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGF 819 (1078)
Q Consensus 747 ~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 819 (1078)
.-..++|++.+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 344568999999999999999998632 34579999987542 223356788999999999 89999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHhcCCC-----------------------------------------------------
Q 039595 820 CSNARHSFLVCEYLHRGSLARILGNDA----------------------------------------------------- 846 (1078)
Q Consensus 820 ~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------- 846 (1078)
|...+..++||||+++|+|.++++...
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999884321
Q ss_pred --------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC
Q 039595 847 --------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912 (1078)
Q Consensus 847 --------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 912 (1078)
...++++.++++++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 113478899999999999999999999 999999999999999999999999999986543221
Q ss_pred C--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 913 N--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 913 ~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
. .....++..|||||++.+..++.++|||||||++|||++ |+.||....... ...... .....+... ..
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~---~~~~~~~~~----~~ 339 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMV---KRGYQMSRP----DF 339 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHH---HcccCccCC----CC
Confidence 1 112335678999999998899999999999999999997 999975432211 111111 111111111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...++.+++.+||+.||++|||++++++..
T Consensus 340 --~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 340 --APPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred --CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 123678899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.03 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=202.5
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeec---
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSN--- 822 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--- 822 (1078)
.+...|+..+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 3556788899999999999999965 468899999986532 2345678899999998 79999999999864
Q ss_pred ---CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEe
Q 039595 823 ---ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS 899 (1078)
Q Consensus 823 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 899 (1078)
....|+||||+.+|+|.+++... ....+++..+..++.|++.|++|||++ +|+|||+||+||+++.++.++|+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 24689999999999999998543 234688999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
|||++..............|+..|+|||++. +..++.++||||+||++|||++|+.||....... .. ...
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~-~~~ 228 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----AL-FLI 228 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HH-HHH
Confidence 9999987654333445567899999999986 3457889999999999999999999975332210 00 000
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.....+.. .... ....+.+++.+||..||.+|||++|+++|+|+
T Consensus 229 ~~~~~~~~--~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 229 PRNPAPRL--KSKK---WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred hcCCCCCC--CCCC---cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00001111 1111 12357789999999999999999999999995
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=339.00 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=206.3
Q ss_pred eeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCC
Q 039595 758 CIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRG 836 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 836 (1078)
++|+|+||+||.|+.. +..++|||-+... +....+-+.+||...+.++|.|||+++|.+.++++.-|.||-++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 6999999999999654 5668999988654 3445566889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCcC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEecccccccccCCCCC
Q 039595 837 SLARILGNDATAKEL--SWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-LEFEAHVSDFGIAKFVEPYSSN 913 (1078)
Q Consensus 837 ~L~~~l~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfG~a~~~~~~~~~ 913 (1078)
+|.+.++..- +++ .+..+-.+.+||++||.|||+. .|||||||-+||||+ ..|.+||+|||.++.+..-...
T Consensus 658 SLSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 658 SLSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred cHHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 9999995432 344 6788889999999999999999 999999999999995 5699999999999988766666
Q ss_pred ceeeccccccccccccccC--CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHH
Q 039595 914 RTEFVGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991 (1078)
Q Consensus 914 ~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1078)
..++.||..|||||++..+ .|++++|||||||.+.||.||++||-..+...+++.. ....-..|.++. +
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---VGmyKvHP~iPe------e 803 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---VGMYKVHPPIPE------E 803 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---hcceecCCCCcH------H
Confidence 7789999999999999876 4899999999999999999999996544332221111 111112222221 2
Q ss_pred HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 992 KLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 992 ~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
...+...+|.+|+.+||.+||++.+++.+||.+..
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 23467889999999999999999999999998865
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=333.30 Aligned_cols=262 Identities=21% Similarity=0.257 Sum_probs=202.9
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 5788899999999999999664 689999999865421 2223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+. ++|.+++........+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9997 58999886554456789999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh-----------------
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII----------------- 972 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~----------------- 972 (1078)
........+++.|+|||.+.+. .++.++|||||||++|||+||+.||...... ........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhcchhhH
Confidence 3333444678899999988654 5789999999999999999999997532211 00000000
Q ss_pred hhhhhcC----CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 973 EVNQILD----PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 973 ~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
......+ ......... ...++.+++.+||..||++|||+++++.|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKN---LDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHHhcCC---CCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000000 000000001 12356789999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=330.31 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=202.7
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 4678888999999999999965 468999999986542 22345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+++++|.+++.. .+.+++.++..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||.+.....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 85 MEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 999999999999843 34689999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.........|+..|+|||++. ...++.++||||+||++|||++|+.||...... ... ... .......+....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-~~~-~~~-~~~~~~~~~~~~-- 233 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RAL-FLM-TKSNFQPPKLKD-- 233 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-hhH-Hhh-hccCCCCCcccc--
Confidence 333344567899999999874 456889999999999999999999996422211 000 000 000111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.......+.+++.+||..+|++||+++++++|+|
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred --cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 1111235778999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.38 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=203.3
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.++++++||||+++++++..+...++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 3688889999999999999954 578999999986542 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 78 TEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999999996543 367888999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||........... .........++.......
T Consensus 148 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-- 222 (279)
T cd06619 148 S--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-PLQLLQCIVDEDPPVLPV-- 222 (279)
T ss_pred c--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-hHHHHHHHhccCCCCCCC--
Confidence 2 23345789999999999998999999999999999999999999754322111110 001111111111111100
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....++.+++.+||+.+|++||+++|+++|+|...
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 011235778999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=325.77 Aligned_cols=249 Identities=26% Similarity=0.424 Sum_probs=199.3
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
++|++.+.||+|+||.||+|.++++..+|+|.+.... ...+.+.+|+.++++++||||+++++++..+...++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 4688889999999999999988888899999876432 22457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999999985432 3588999999999999999999999 9999999999999999999999999999865332
Q ss_pred CCC-ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 911 SSN-RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 911 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.... ....+ ..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~-----~~~~~-~~ 225 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGF-----RLYRP-KL 225 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC-----CCCCC-CC
Confidence 211 122345678999999998889999999999999999999 8999653321 11111111111 11001 11
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
....+.+++.+||+++|++||+++++++.
T Consensus 226 ---~~~~~~~li~~c~~~~p~~Rps~~~l~~~ 254 (256)
T cd05114 226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRA 254 (256)
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12367899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=336.00 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=208.3
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+-|+++..||.|+||.||+|..++ +-..|.|++... ..++.+.|.-||+++...+||+||++++.|.....+||.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 346667789999999999996553 445566776543 355678899999999999999999999999888999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
.|||.||....++-. -...+++.++..+++|++.||.|||++ .|+|||+|+.|||++-+|.++++|||.+.....
T Consensus 108 iEFC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EeecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 999999999887732 345799999999999999999999999 999999999999999999999999999986655
Q ss_pred CCCCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
.......+.|||.|||||+.. +.+|++++||||||+.|.||..+.+|-. ..+. ...+..+...-+|.+..
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh--elnp---MRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH--ELNP---MRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc--ccch---HHHHHHHhhcCCCcccC
Confidence 445567889999999999754 5689999999999999999999999922 1111 11122222233344433
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
+ ......+.+++.+||.+||+.||+++++++|||..
T Consensus 258 P----S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 258 P----SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred c----chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 2 23345678889999999999999999999999987
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=337.72 Aligned_cols=258 Identities=19% Similarity=0.280 Sum_probs=190.2
Q ss_pred cceeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--CCeeEEEE
Q 039595 756 KFCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN--ARHSFLVC 830 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 830 (1078)
.++||+|+||+||+|..+ +++.||+|++.... ....+.+|+.++++++||||+++++++.. +...|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 457999999999999754 46789999986432 13346789999999999999999998843 56789999
Q ss_pred eecCCCCHHHHhcCCC------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----CCCCcEEEec
Q 039595 831 EYLHRGSLARILGNDA------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----DLEFEAHVSD 900 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~D 900 (1078)
||+.+ +|.+++.... ....+++..+..++.||+.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99865 8888874321 223588999999999999999999999 99999999999999 4568899999
Q ss_pred ccccccccCCCC---CceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccch----hhhhh
Q 039595 901 FGIAKFVEPYSS---NRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF----SNMII 972 (1078)
Q Consensus 901 fG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~----~~~~~ 972 (1078)
||+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|++||.....+.... .....
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 999987653221 22346789999999998764 58999999999999999999999986433211000 00000
Q ss_pred hhhhhcC-------------C------------CCCC-CCCccH-----HHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 973 EVNQILD-------------P------------RLST-PSPGVM-----DKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 973 ~~~~~~~-------------~------------~~~~-~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
....... + .... ...... .....+.+++.+||+.||++|||++|+++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 0000000 0 0000 000000 0012467999999999999999999999999
Q ss_pred hh
Q 039595 1022 IG 1023 (1078)
Q Consensus 1022 ~~ 1023 (1078)
|+
T Consensus 316 ~f 317 (317)
T cd07868 316 YF 317 (317)
T ss_pred CC
Confidence 95
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.13 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=206.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+.|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 67889999999999999999664 5889999998653 334466788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|..++.+. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 88 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 88 IEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999999998887432 24588999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
.........+++.|+|||++. ...++.++|||||||++|||++|+.||...... ...........+....
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~ 237 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEPPTLSQ 237 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHHHhcCCCccCCC
Confidence 333345567889999999985 345688999999999999999999997533211 1111111111111111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
......++.+++.+||..||++||+++|+++|+|...
T Consensus 238 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 238 ----PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred ----CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1122236788999999999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=305.11 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=209.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 828 (1078)
++.+.+..||.|+.|+||+++.. +|...|||.+.+. ++.++.+++...+.++..- ++|+||+.+|||..+..+++
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 44555667999999999999665 6899999999765 3666777777777766554 69999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
.||.|.. .++.++++. .+++++.-+-++...+..||.||.+++ +|+|||+||+|||+|+.|.+|+||||++.++.
T Consensus 169 cMelMs~-C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHH-HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence 9998854 566666443 356888888899999999999999986 99999999999999999999999999998775
Q ss_pred CCCCCceeecccccccccccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
+ ....+..+|.+.|||||.+.- ..|+.++||||||+.++|+.||+.||.....++........ -.+|.++..
T Consensus 244 d-SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln----~ePP~L~~~ 318 (391)
T KOG0983|consen 244 D-SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN----EEPPLLPGH 318 (391)
T ss_pred c-ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh----cCCCCCCcc
Confidence 4 344566789999999999874 36889999999999999999999997765555443332221 122333221
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHHH
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILA 1030 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~~ 1030 (1078)
....-++.+++..||.+|+.+||...++++|+|....|.+.
T Consensus 319 ----~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 319 ----MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE 359 (391)
T ss_pred ----cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence 12334677888889999999999999999999988766554
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=332.35 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=210.2
Q ss_pred HHHHHHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee
Q 039595 743 HEEIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS 821 (1078)
Q Consensus 743 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 821 (1078)
+++++....+.++.++||-|.||.||.|.|+ ..-.||||.++.. ..+.++|..|.++|+.++|||+|+++|+|.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT 333 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 333 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence 3666667778889999999999999999876 4568999998654 456889999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecc
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDF 901 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 901 (1078)
.+...|||+|||..|+|.+|+++ .....++.-..++++.||+.|++||..+ ++|||||.++|+||.++..|||+||
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRe-cnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRE-CNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHH-hchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeecc
Confidence 99999999999999999999954 4556677778899999999999999999 9999999999999999999999999
Q ss_pred cccccccCCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcC
Q 039595 902 GIAKFVEPYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILD 979 (1078)
Q Consensus 902 G~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 979 (1078)
|+++++.... .......-++.|.|||.+....++.|+|||+|||+|||+.| |-.||. +.+....+. .+.
T Consensus 410 GLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP--GidlSqVY~-------LLE 480 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYG-------LLE 480 (1157)
T ss_pred chhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC--CccHHHHHH-------HHh
Confidence 9999875422 11222233678999999999999999999999999999998 778843 332222222 222
Q ss_pred CCCCCCCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 980 PRLSTPSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 980 ~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
..++...+ .+.. .++++++.||++.|.+||+++|+-+..-
T Consensus 481 kgyRM~~PeGCPp---kVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPP---KVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred ccccccCCCCCCH---HHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 22222222 1222 5678888999999999999999876643
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.34 Aligned_cols=253 Identities=28% Similarity=0.392 Sum_probs=207.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.++++++||||+++++++.++...|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 67999999999999999999765 48899999986432 166789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+.+++|.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+.....
T Consensus 77 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 77 MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999999998432 35689999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........++..|+|||++.+..++.++||||||+++|+|++|+.||....... ..........+.... .
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~----~ 222 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-----AIFMIPNKPPPTLSD----P 222 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-----hhhhhccCCCCCCCc----h
Confidence 4333445568899999999998899999999999999999999999976432210 000000001111111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
......+.+++.+||+.||++|||++|++.|+|+
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 1122367889999999999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=350.54 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=194.5
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec------
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN------ 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 822 (1078)
..+|++.+.||+|+||+||+|.. .+++.||||++... .....+|+.+++.++||||+++++++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--------cchHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 45799999999999999999965 46899999988543 1223569999999999999999987632
Q ss_pred --CCeeEEEEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEE
Q 039595 823 --ARHSFLVCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHV 898 (1078)
Q Consensus 823 --~~~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl 898 (1078)
....++||||+++ ++.+++... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++ .+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence 1246799999986 777766321 2345689999999999999999999999 999999999999998664 7999
Q ss_pred ecccccccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh---
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV--- 974 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~--- 974 (1078)
+|||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|++||...... ......+...
T Consensus 213 ~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p 290 (440)
T PTZ00036 213 CDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTP 290 (440)
T ss_pred eccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence 9999998764322 23345789999999998764 6899999999999999999999997533211 1111110000
Q ss_pred ----hhhcCCCC-----CCCCCc-cH-----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 975 ----NQILDPRL-----STPSPG-VM-----DKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 975 ----~~~~~~~~-----~~~~~~-~~-----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.....+.+ +..... .. ....++.+++.+||..||.+|||+.|+++|||+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 00000100 000000 00 0123678999999999999999999999999964
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=333.02 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=207.2
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..+|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 36899999999999999999965 579999999986532 2234668889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++.+ ..+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+....
T Consensus 94 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 94 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred eecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 9999999999999843 3478899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........+++.|+|||.+.+..++.++|||||||++|++++|+.||........ . ..... ...+.... +
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-~-~~~~~---~~~~~~~~--~- 238 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L-YLIAT---NGTPELQN--P- 238 (297)
T ss_pred CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-e-eeecc---CCCCCCCC--c-
Confidence 443334455788999999999988899999999999999999999999753322110 0 00000 00111110 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
......+.+++.+||+.+|++||++++++.|+|+..
T Consensus 239 -~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 239 -ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred -cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 111234678899999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.70 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=204.8
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.|+..+.||+|+||.||+|.. .+++.||+|.+...... .....+.+.+|+.++++++|++|+++++.+.+++..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 367788999999999999955 47899999998754322 2223455778999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+.+|+|.+++... ....+++.++..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 80 TLMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999988432 234588999999999999999999998 9999999999999999999999999999765432
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||......... ............... ...
T Consensus 156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~---~~~- 228 (285)
T cd05630 156 Q-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEVQEEYS---EKF- 228 (285)
T ss_pred c-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhhhhhhhcC---ccC-
Confidence 2 223457899999999999989999999999999999999999997643211100 000000000111111 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYC 1025 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~ 1025 (1078)
...+.+++.+||+.||++||| ++|+++|+|+..
T Consensus 229 --~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 229 --SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred --CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 125678899999999999999 899999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=348.47 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=206.4
Q ss_pred hcCCCccceeccCCceeEEEEEeCCC-CEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEee-ee-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSG-DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGF-CS----- 821 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~----- 821 (1078)
..++++.+.|.+|||+.||.|....+ ..||+|++-.. +......+.+||.+|++++ |||||.+++. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 35678889999999999999976554 99999998544 5677888999999999996 9999999993 21
Q ss_pred c-CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 822 N-ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 822 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
. ..+++|.||||.||.|-+++..+... .+++.++++|+.|+++|+++||.. .++|||||||.||||+..+|..||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 1 24678999999999999999544333 499999999999999999999986 45799999999999999999999999
Q ss_pred ccccccccCCCCCc---------eeecccccccccccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchh
Q 039595 901 FGIAKFVEPYSSNR---------TEFVGTFGYAAPEIA---YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS 968 (1078)
Q Consensus 901 fG~a~~~~~~~~~~---------~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 968 (1078)
||.|...-...... -...-|+.|+|||.+ .+.++++|+|||+|||+||-|+....||+..+.
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99997442222111 123468999999976 467899999999999999999999999763322
Q ss_pred hhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 969 NMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
..+++..+.-+. ...+...+.+||+.||++||++||++.|++.+.+....
T Consensus 264 ------laIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 ------LAILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ------eeEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 123333333222 23455678899999999999999999999998776643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=342.48 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=200.4
Q ss_pred CCccceeccCCceeEEEEEe-CCCC----EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 753 FDEKFCIGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
....++||+|+||+||+|.+ ..|+ +||+|++.... ..+..+++.+|+..|.+++|||+++++++|.... ..
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 45567899999999999954 4454 68888886543 3445678999999999999999999999998765 88
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
||++|++.|+|.++++.. ...+-.+..+.|..|||+||.|||++ ++|||||.++||||.....+||+|||+|+..
T Consensus 774 lvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 999999999999999654 34577899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCceee--ccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 908 EPYSSNRTEF--VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 908 ~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
.......... .-.+.|||-|.+....|+.++|||||||.+||++| |..||+... ..++......... +..
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--~~eI~dlle~geR-----Lsq 921 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--AEEIPDLLEKGER-----LSQ 921 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--HHHhhHHHhcccc-----CCC
Confidence 6655443333 33678999999999999999999999999999999 999965333 2333333333222 222
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
++. ...++.-++.+||..|++.||+++++....
T Consensus 922 Ppi----CtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 922 PPI----CTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred CCC----ccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 221 123677888999999999999999877653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=344.98 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=202.3
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC-----e
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR-----H 825 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 825 (1078)
+|+..+.||+|+||.||+|.. .+|+.||||++.... .+....+.+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 478899999999999999965 478999999986532 22334567889999999999999999999998766 7
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.|+|+||+. ++|.+++. ....+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEEEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence 899999996 48888773 335689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCC-CCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh-----------
Q 039595 906 FVEPYS-SNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII----------- 972 (1078)
Q Consensus 906 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~----------- 972 (1078)
...... .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||...... .....+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAM 229 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHH
Confidence 654322 223345688999999998874 4799999999999999999999997643221 0000000
Q ss_pred -----hhhh-hcCCCCCCCC-----CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 973 -----EVNQ-ILDPRLSTPS-----PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 973 -----~~~~-~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.... +.......+. ........++.+++.+||+.||++|||++|+++|+|+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 0000 0000000000 0000112367889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=330.98 Aligned_cols=261 Identities=24% Similarity=0.306 Sum_probs=205.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|... ++..||+|.+.... ......++.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 46899999999999999999654 68889999886532 223456688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.++++.. ..+++..+..++.|++.||+|||+.+ +++||||||+||+++.++.+||+|||++.....
T Consensus 78 ~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 78 MEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred eeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999999543 56889999999999999999999732 899999999999999999999999999876533
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh----------------
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE---------------- 973 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~---------------- 973 (1078)
. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ........
T Consensus 153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 153 S--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred c--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccC
Confidence 2 223457899999999998888999999999999999999999997532211 00000000
Q ss_pred --------------hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 974 --------------VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 974 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
........... .+ ......++.+++.+||..||++|||++|+++|+|+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPK-LP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCcc-Cc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000000000 00 0012235789999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.80 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=203.5
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 667788999999999999665 5778899988543 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+++|+|.+++.+ ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++.......
T Consensus 83 ~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 83 FCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred ecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 9999999988743 234689999999999999999999999 99999999999999999999999999997654433
Q ss_pred CCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 912 SNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.......++..|+|||++. +..++.++||||+||++|||++|+.||...... . ..........+....+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~---~~~~~~~~~~~~~~~~- 231 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--R---VLLKIAKSEPPTLAQP- 231 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--H---HHHHHhhcCCCCCCCc-
Confidence 3334557899999999874 345788999999999999999999997533211 0 0111111111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
. .....+.+++.+||+.||++||+++++++|+|....
T Consensus 232 ~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 232 S---RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred c---ccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 1 112367889999999999999999999999997754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.89 Aligned_cols=262 Identities=21% Similarity=0.235 Sum_probs=200.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||++..+ +++.||+|++.+.... .......+.+|+.++..++|++|+++++++.+....|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 47899999999999999999765 5788999998653221 122345578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.+. ...+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred EeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999999542 34588899999999999999999999 999999999999999999999999999976533
Q ss_pred CCCC-ceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 910 YSSN-RTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 910 ~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
.... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+.. .......+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--~~~~~~i~~--~~~~~~~p 230 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMN--HKERFQFP 230 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--HHHHHHHhC--CCccccCC
Confidence 2222 23457999999999986 34678999999999999999999999753221 111111110 00001111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCC--CCChhHHHHHhhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEA--RPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~h~~~~~ 1025 (1078)
...... ...+.+++.+|+..+|++ |++++|+++|+|+..
T Consensus 231 ~~~~~~---s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 231 AQVTDV---SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CccccC---CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 111111 235667788877554444 789999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=343.56 Aligned_cols=250 Identities=24% Similarity=0.250 Sum_probs=194.2
Q ss_pred eccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC---CCCceeeEEeeeecCCeeEEEEeecC
Q 039595 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI---RHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 759 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
||+|+||+||+|+.+ +++.||||++.+..... ......+..|..++... +||+|+++++++.+....|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 699999999999654 68999999986543221 12233444566666554 79999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++.+ ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 80 GGELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 9999998843 45689999999999999999999999 99999999999999999999999999997644333334
Q ss_pred eeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKL 993 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1078)
....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...... +.......+.... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--~~~~~~------i~~~~~~~~~~~~---~ 222 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--QQMYRN------IAFGKVRFPKNVL---S 222 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--HHHHHH------HHcCCCCCCCccC---C
Confidence 456799999999998764 489999999999999999999999753221 111111 1111111111111 1
Q ss_pred HHHHHHHHhcccCCCCCCC----ChhHHHHHhhhhhh
Q 039595 994 ISIMEVAILCLDESPEARP----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 994 ~~l~~li~~cl~~dP~~RP----t~~ell~h~~~~~~ 1026 (1078)
..+.+++.+||++||++|| +++|+++|+|+...
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 2567889999999999998 79999999998653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.08 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=206.8
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.+|++.+.||.|+||.||+|.. .+++.||+|.+.... ....+.+.+|+..++.++||||+++++++..+...++|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 4699999999999999999954 578999999986542 22356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 95 MEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999999998842 3588999999999999999999999 999999999999999999999999999886654
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........++..|+|||.+.+..++.++|||||||++|+|++|+.||....... .. ........+....+ ...
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-~~----~~~~~~~~~~~~~~-~~~ 241 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-AL----YLIATNGTPELQNP-EKL 241 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH----HHHHhcCCcccCCc-ccC
Confidence 3333344578899999999998889999999999999999999999975433210 00 00000111111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...+.+++.+||..||++||++++++.|+|...
T Consensus 242 ---~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 242 ---SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ---CHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 225678899999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.23 Aligned_cols=266 Identities=20% Similarity=0.259 Sum_probs=203.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|..+ +++.||+|.+..... ......+.+|+.++++++||||+++++++..+...++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 57999999999999999999654 688999999865432 22344577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||++ ++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 83 ~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 83 FEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred Eeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 99997 4898888543 34578899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh---------hhhh--
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE---------VNQI-- 977 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~---------~~~~-- 977 (1078)
.........+++.|+|||.+.+. .++.++|||||||++|||++|++||...+.. .....+.. ....
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhc
Confidence 33333445678999999988654 5788999999999999999999997643221 00000000 0000
Q ss_pred ----cCCCCCCCCCcc-----HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 978 ----LDPRLSTPSPGV-----MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 978 ----~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
............ ......+.+++.+|++.||.+|||++|+++|+|+..-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000000000000 01122567899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=341.76 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=201.5
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC---
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--- 823 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--- 823 (1078)
...++|+..+.||+|+||.||+|.. .+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 4567999999999999999999965 4688999999875432 233456678899999999999999999988543
Q ss_pred ---CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 824 ---RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 824 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
...++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEee
Confidence 357999999976 6777663 2478899999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh--------
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-------- 972 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~-------- 972 (1078)
||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... ........
T Consensus 163 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 163 FGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPE 240 (355)
T ss_pred CcccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 9999865432 2234467899999999999989999999999999999999999997533211 00000000
Q ss_pred -------hhhhhcC--CCC--------------CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 973 -------EVNQILD--PRL--------------STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 973 -------~~~~~~~--~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
....... +.. .............+.+++.+||+.||++|||++|+++|+|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 0000000 000 000000011123678999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.20 Aligned_cols=252 Identities=19% Similarity=0.315 Sum_probs=198.0
Q ss_pred hcCCCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.++|++.+.||+|+||.||+|.++ .+..||+|+++... .......+.+|+.++++++||||+++++++..+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 357889999999999999999653 35689999987542 22335678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++|+|.+++... ...+++.+++.++.|++.|++|||++ +++||||||+||+++.++.++++|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 99999999999999999543 24689999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 906 FVEPYSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 906 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
....... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ......+ .....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~~~~~~---~~~~~~--- 227 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--QDVIKAV---EDGFRL--- 227 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHH---HCCCCC---
Confidence 5422111 1112335678999999999999999999999999999875 9999753322 1111111 111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
+.... ....+.+++.+||+.+|++||+++|+++.
T Consensus 228 ~~~~~---~~~~~~~li~~c~~~~p~~RP~~~~i~~~ 261 (266)
T cd05064 228 PAPRN---CPNLLHQLMLDCWQKERGERPRFSQIHSI 261 (266)
T ss_pred CCCCC---CCHHHHHHHHHHcCCCchhCCCHHHHHHH
Confidence 11111 12357788999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.83 Aligned_cols=258 Identities=27% Similarity=0.397 Sum_probs=210.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||.|+||.||+|... +++.||+|++.... .......+.+|+.++++++||||+++++++.++...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 46888899999999999999654 68999999986542 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.++....
T Consensus 78 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 78 MEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999999999432 689999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. .........+.....
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~---~~~~~~~~~~~~~~~---- 221 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RV---LFLIPKNNPPSLEGN---- 221 (274)
T ss_pred cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HH---HHHhhhcCCCCCccc----
Confidence 434444567889999999999888999999999999999999999997533211 11 111111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
....++.+++.+||..+|++|||+++++.|+|......
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 02235778899999999999999999999999876433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=331.89 Aligned_cols=253 Identities=30% Similarity=0.430 Sum_probs=202.8
Q ss_pred CCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|.-.+.||.|+||.||.|. ..+.+.||||++...... ..+.-..+.+|+..+++++|||++.+-|+|..+...|+|||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ-s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccc-cHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 5566789999999999995 457889999999765422 23335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
||-| +-.|++... .+++-+-++..|+.+.+.||+|||+. +.||||||+.|||+++.|.||++|||.|....+
T Consensus 107 YClG-SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHhc-cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 9966 777777432 45688899999999999999999999 999999999999999999999999999987653
Q ss_pred CCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 912 SNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
...++|||.|||||++. .+.|+-|+||||+|++..|+.-.++|+ +.-+.....+.+ .+.-.|.+. .+.
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl--FnMNAMSALYHI---AQNesPtLq--s~e 249 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHI---AQNESPTLQ--SNE 249 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc--cCchHHHHHHHH---HhcCCCCCC--Cch
Confidence 45789999999999875 567999999999999999999999993 332211111111 111222232 233
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
+.. .+..++..||++-|.+|||.++++.|+|..+.
T Consensus 250 WS~---~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 250 WSD---YFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred hHH---HHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 444 45566667999999999999999999997753
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.50 Aligned_cols=260 Identities=20% Similarity=0.297 Sum_probs=206.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|..+ +++.||||.+...... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 57899999999999999999654 7899999988653222 334456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 830 CEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
+||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.++++|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999998884322 234578899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........|++.|+|||.+.+..++.++||||+|+++|||++|+.||............ .......+...
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~----- 229 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ---KIEQCDYPPLP----- 229 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH---HHhcCCCCCCC-----
Confidence 4333333456889999999999888999999999999999999999996432221111111 11111111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.......+.+++.+||..+|++||+++++++..-
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 1122346788999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=327.15 Aligned_cols=262 Identities=27% Similarity=0.349 Sum_probs=210.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||.||+|..+ +++.||+|++.... .....+++.+|+.++++++||||+++++++..+...++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 36888899999999999999665 68999999987643 224456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
+||+++++|.+++.... ..+++..+.+++.|++.|++|+|+ . +++||||||+||+++.++.++|+|||.+....
T Consensus 78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999999995432 568899999999999999999999 7 99999999999999999999999999987654
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||......................+.....
T Consensus 153 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 227 (265)
T cd06605 153 NSLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG--- 227 (265)
T ss_pred HHHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh---
Confidence 3221 12678899999999999899999999999999999999999976443221111111111111111111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
.....+.++|.+||..||++|||+.|++.|+|+...|
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 0233578899999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=324.17 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=202.1
Q ss_pred HHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 747 IKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 747 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
+.+++.+.....||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++|+||+++++++..++.
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 34556666677899999999999965 467889999886542 3345678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-EFEAHVSDFGIA 904 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~a 904 (1078)
.++|+||+++++|.+++.........++..+..++.||+.|++|||++ +|+||||||+||+++. ++.++|+|||.+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999999995432221227788899999999999999999 9999999999999976 679999999999
Q ss_pred ccccCCCCCceeeccccccccccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMR--ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
..............|++.|+|||++.+.. ++.++||||+|+++|+|++|+.||............ .......+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~ 233 (268)
T cd06624 157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---VGMFKIHPEI 233 (268)
T ss_pred eecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---hhhhccCCCC
Confidence 86643333333456889999999986643 788999999999999999999997532211100000 0000011111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
+ .. ...++.+++.+||+.+|++|||++|++.|||+
T Consensus 234 ~---~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 234 P---ES---LSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred C---cc---cCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 1 11 12357788999999999999999999999994
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.79 Aligned_cols=263 Identities=23% Similarity=0.300 Sum_probs=195.2
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC---CCCceeeEEeeeec-----
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI---RHRNIVKFHGFCSN----- 822 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 822 (1078)
+|++.+.||+|+||+||+|..+ +++.||+|.+....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 5888999999999999999654 78999999987543221 1122345566665554 79999999998854
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
....++||||+.+ +|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence 3468999999975 898888543 234589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh----hhhc
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV----NQIL 978 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~----~~~~ 978 (1078)
+++..... .......|+..|+|||++.+..++.++||||+||++|||++|++||...... .......... ...+
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 154 LARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhC
Confidence 99866432 2233457899999999999889999999999999999999999997533211 0000000000 0000
Q ss_pred CC-------CCCCCCCc-----cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 979 DP-------RLSTPSPG-----VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 979 ~~-------~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.. .+...... .......+.+++.+||+.||++|||++|++.|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 00000000 01112356799999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.82 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=204.3
Q ss_pred CCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG--NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+|+..+.||+|+||+||+|...+++.+|+|.+....... .......+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 578889999999999999987789999999986543211 122345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999432 4578899999999999999999999 999999999999999999999999999976532
Q ss_pred C------CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 910 Y------SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 910 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
. ........|+..|+|||++.+..++.++||||+||++|+|++|+.||...+.. ... ...... ....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~-~~~~~~-~~~~~~~~ 231 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-AAM-FYIGAH-RGLMPRLP 231 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-HHH-HHhhhc-cCCCCCCC
Confidence 1 11123456889999999999888999999999999999999999997532211 000 000000 00111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.. ....+.+++.+||+.+|++||+++|++.|+|+
T Consensus 232 ---~~---~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 232 ---DS---FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ---CC---CCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 12356789999999999999999999999994
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=321.00 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=204.8
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec-CCeeEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN-ARHSFLV 829 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 829 (1078)
.|++.+.||+|++|.||+|..+ +++.||+|++..... .....+.+.+|+.++++++|||++++++.+.. +...++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 4888999999999999999654 678999999865432 23345668889999999999999999998764 4568999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.+++... ....+++.+++.++.|++.|++|+|+. +++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 79 MGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999999542 234589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........+++.|+|||.+.+..++.++||||+|+++|+|++|+.||+..+.. .... ............
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~------~~~~~~~~~~~~-- 224 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--SLVY------RIIEGKLPPMPK-- 224 (257)
T ss_pred cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHH------HHHhcCCCCCcc--
Confidence 333444567899999999999999999999999999999999999997532211 1111 111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.....+.+++.+||+.||++|||+.++++|+|+
T Consensus 225 -~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 225 -DYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -ccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 122367889999999999999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=327.29 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=201.4
Q ss_pred cCCCccceeccCCceeEEEEEeCC------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPS------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
++|++.+.||+|+||.||+|.... ...||+|.+.... .......+.+|+..+++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 578889999999999999996532 2579999986442 2334567899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 039595 825 HSFLVCEYLHRGSLARILGNDAT-------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 891 (1078)
..+++|||+++|+|.+++..... ...+++.+++.++.|++.|++|||+. +++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence 99999999999999999954321 14588899999999999999999999 999999999999999
Q ss_pred CCCcEEEecccccccccCCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchh
Q 039595 892 LEFEAHVSDFGIAKFVEPYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFS 968 (1078)
Q Consensus 892 ~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~ 968 (1078)
.++.++|+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ....
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~~~ 236 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEVI 236 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence 99999999999998653322 12234456889999999998899999999999999999998 9999653221 1111
Q ss_pred hhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 969 NMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.. +........... ...++.+++.+||+.||++||+++|++++.
T Consensus 237 ~~------i~~~~~~~~~~~---~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 237 EM------IRSRQLLPCPED---CPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HH------HHcCCcCCCccc---CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11 111111111111 124678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=325.94 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=200.4
Q ss_pred hcCCCccceeccCCceeEEEEEeC---CCC--EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP---SGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
.+..+..++||.|.||.||+|.+. .|+ .||||.-+... ...+.+.|..|..+|+.++|||||+++|+|.+ .
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 344556678999999999999653 233 48888877654 44557889999999999999999999999986 4
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..|+|||.++-|.|.+|++.. ...++......++.||+.||+|||+. .+|||||.++||||.....||++|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 689999999999999999654 35688899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCce-eeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 905 KFVEPYSSNRT-EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 905 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
+.+++...... ...-+..|||||.+.-.+++.++|||.|||++||++. |..||...... +....+.. ..++
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--DVI~~iEn-----GeRl 611 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--DVIGHIEN-----GERL 611 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc--ceEEEecC-----CCCC
Confidence 99876543332 2334679999999999999999999999999999987 99997543221 11111111 1222
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
+.+ +.++. .++.++.+||+.||.+||++.|+....
T Consensus 612 P~P-~nCPp---~LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 612 PCP-PNCPP---ALYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred CCC-CCCCh---HHHHHHHHHhccCcccCCcHHHHHHHH
Confidence 222 22223 466888999999999999998877654
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.67 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=207.7
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++..+...++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 356889999999999999999664 6889999998643 23445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++.+. ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 80 LIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred EeeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999999998542 24589999999999999999999999 99999999999999999999999999987665
Q ss_pred CCCCCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
..........+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ...........+...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~ 229 (280)
T cd06611 155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLKILKSEPPTLD 229 (280)
T ss_pred ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHHHhcCCCCCcC
Confidence 4433445567899999999875 345778999999999999999999997533211 111111111111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.+ . .....+.+++.+||+.+|++||+++++++|+|....
T Consensus 230 ~~-~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 230 QP-S---KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred Cc-c---cCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 11 1 112357788999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=338.97 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=201.4
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA- 823 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~- 823 (1078)
.....++|+..+.||+|+||+||+|.. .+++.||||++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 344568899999999999999999964 5788999999865421 223345677899999999999999999987533
Q ss_pred -----CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 824 -----RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 824 -----~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
...|+++|++ +++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl 159 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRI 159 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEE
Confidence 3568999987 779988873 24589999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh---
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV--- 974 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~--- 974 (1078)
+|||+++.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .........
T Consensus 160 ~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~ 234 (343)
T cd07878 160 LDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGT 234 (343)
T ss_pred cCCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCC
Confidence 99999986543 2334578999999999876 56899999999999999999999997532211 000000000
Q ss_pred --------------hhhcCCCCCCCCCccH-----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 --------------NQILDPRLSTPSPGVM-----DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 --------------~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.... ..+........ .....+.+++.+|+..||++|||++|+++|+|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 235 PSPEVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred CCHHHHHhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0000 00000000000 01124678999999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=321.61 Aligned_cols=256 Identities=27% Similarity=0.374 Sum_probs=207.2
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|.. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++.++...|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 5789999999999999999965 467899999987542 22467788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+.+++|.+++... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999999998542 24688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccccccccccccC---CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTM---RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.........++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ..........+.. .
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~----~~~~~~~~~~~~~---~ 226 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA----LFLISKSNFPPPK---L 226 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCCCcc---c
Confidence 33334456788899999998876 789999999999999999999999753321110 0000011011111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
........++.+++.+||..+|.+|||+++++.|+|
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 111223446889999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=323.12 Aligned_cols=261 Identities=30% Similarity=0.411 Sum_probs=208.7
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||.|+||+||+|.. .++..+|+|++...... ...+.+.+|+..++.++|+||+++++.+..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ---TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc---hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 4789999999999999999965 46889999998654322 2467789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+++++|.++++.......+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999999999996544445689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC----ceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 910 YSSN----RTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 910 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
.... .....|+..|+|||++... .++.++|||||||++|||++|+.||...... ..... ......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~----~~~~~~~~~~~ 229 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLML----TLQNDPPSLET 229 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHH----HhcCCCCCcCC
Confidence 3222 2345689999999998877 7899999999999999999999997533221 10111 11111111111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
. .........+.+++.+||..||++||+++|++.|||+
T Consensus 230 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 230 G-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred c-cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 1 1111223467889999999999999999999999995
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.41 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=205.8
Q ss_pred HhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
+...+|++.+.||+|+||.||+|..++++.+|+|++.... ......+.+|+.+++.++||||+++++++......+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 3456799999999999999999988779999999986542 234567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence 999999999999999653 345689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
...........++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ....... .....+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~---~~~~~~~~---~ 226 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQI---TAGYRMPC---P 226 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHH---HhCCcCCC---C
Confidence 443222334456778999999998899999999999999999998 8999753321 1111111 11111111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
. .....+.+++.+||+.||++|||++++.+..
T Consensus 227 ~---~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 227 A---KCPQEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred C---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 1 1123577899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=341.80 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=201.5
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC---
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--- 823 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--- 823 (1078)
...++|++.+.||+|+||.||+|.. ..++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 3457899999999999999999965 4688999999875432 233456678899999999999999999987543
Q ss_pred ---CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 824 ---RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 824 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
...|+||||+++ ++.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 357999999976 7777773 2478889999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh--------
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-------- 972 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~-------- 972 (1078)
||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+.. ........
T Consensus 170 fG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 170 FGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPE 247 (364)
T ss_pred CCCccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHH
Confidence 9999865432 2234457899999999999999999999999999999999999997543211 00000000
Q ss_pred -------hhhhhc--CCCCCC--------------CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 973 -------EVNQIL--DPRLST--------------PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 973 -------~~~~~~--~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
...... .+.... ...........+.+++.+|++.||++|||++|+++|+|..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 000000 000000 0000001123678999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.92 Aligned_cols=255 Identities=29% Similarity=0.433 Sum_probs=204.0
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCC-----hhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN-----MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
+|.+...||+|+||.||+|.. .+++.||+|.+........ ....+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477888999999999999965 4688999999865433221 1123568889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++|+||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999943 34588899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCC------CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcC
Q 039595 906 FVEPYS------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979 (1078)
Q Consensus 906 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 979 (1078)
...... .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||...... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~ 229 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIFKIGENAS 229 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHHHHhccCC
Confidence 764211 1122345889999999999888999999999999999999999997643211 11111111112
Q ss_pred CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 980 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
+.... . ....+.+++.+||+.||.+||++.|+++|+|+
T Consensus 230 ~~~~~---~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 PEIPS---N---ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcCCc---c---cCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 22211 1 12367788999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=320.94 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=199.3
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
++|++.+.||+|+||+||+|+.+++..||+|.+.... ...+.+.+|+.++++++||||+++++++......++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 4688889999999999999988777789999886432 22466889999999999999999999999889999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+.+|+|.+++.... ..+++.+++.++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 79 EYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999999995432 3689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCC-ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 911 SSN-RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 911 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ...... ...........
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~------~~~~~~~~~~~ 225 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKV------SQGLRLYRPHL 225 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH------hcCCCCCCCCC
Confidence 211 112345678999999988889999999999999999998 99997533321 111111 11111111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
....+.+++.+||+.||++||++.+++++
T Consensus 226 ---~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 226 ---ASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---CCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 12467889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=325.73 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=205.0
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.|+..+.||+|+||+||+|.. .+++.||+|.+...... .......+.+|+.++++++|++|+++++++..++..++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 367778999999999999965 47899999998654322 1223445778999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 80 TIMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EeccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999999888543 234689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
.......|+..|+|||++.+..++.++|+||+||++|||++|+.||....... ...... ......... .....
T Consensus 156 -~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~--~~~~~~~~~-~~~~~- 228 (285)
T cd05632 156 -ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVD--RRVLETEEV-YSAKF- 228 (285)
T ss_pred -CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH--Hhhhccccc-cCccC-
Confidence 22234578999999999998899999999999999999999999976332211 000110 111111100 01111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCD 1026 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~ 1026 (1078)
...+.+++.+||+.||++||+ +++++.|+|+...
T Consensus 229 --~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 229 --SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred --CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 225678899999999999999 8899999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=334.96 Aligned_cols=262 Identities=22% Similarity=0.229 Sum_probs=202.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+.... .......+.+|+.++..++|++|+++++++.+++..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 47899999999999999999664 6889999998653211 223345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.+. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999542 24588899999999999999999999 999999999999999999999999999986644
Q ss_pred CCCC-ceeecccccccccccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 910 YSSN-RTEFVGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 910 ~~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
.... .....||+.|+|||++.+ +.++.++||||+||++|||++|+.||..... ......+... .....++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~~~i~~~--~~~~~~p 230 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNH--EERFQFP 230 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--HHHHHHHHcC--CCcccCC
Confidence 3222 233579999999999875 4678899999999999999999999753221 1111111000 0001111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCC--CCChhHHHHHhhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEA--RPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~h~~~~~ 1025 (1078)
.... ....++.+++.+|+..++++ |++++++++|+|+..
T Consensus 231 ~~~~---~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 231 SHIT---DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred Cccc---cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 1111 12235677888888866554 579999999999765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=342.14 Aligned_cols=259 Identities=21% Similarity=0.257 Sum_probs=201.3
Q ss_pred hcCCCccceeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
..+|++.+.||+|+||.||+|... .+..||+|.+... ....+|+.++++++||||+++++++......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 457999999999999999999543 4578999987542 1245799999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+||||+. ++|.+++. ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.++|+|||+++.
T Consensus 162 ~lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 99999986 58888883 345689999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc--cchhhhhh----------
Q 039595 907 VEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SSFSNMII---------- 972 (1078)
Q Consensus 907 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~~~~---------- 972 (1078)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.....
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 6543221 234679999999999999999999999999999999999999964322110 00000000
Q ss_pred ------------hhhhhcCCCCCCCCCccH---HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 973 ------------EVNQILDPRLSTPSPGVM---DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 973 ------------~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.......+... .+... ....++.+++.+||..||++|||+.|++.|||+...
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYT--IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred CccchhHHHHHHhhcccccCCcc--ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00000001110 00000 112367789999999999999999999999998653
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=342.59 Aligned_cols=258 Identities=20% Similarity=0.223 Sum_probs=198.0
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
...|.+.+.||+|+||.||+|... +++.||||... ...+.+|+.++++++|||||++++++..++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 447999999999999999999664 58899999632 1235679999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|||++. ++|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 238 v~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 238 VLPKYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999995 6898888432 24689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc-c-----cchhhhhhhhhhhcCC
Q 039595 909 PYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN-F-----SSFSNMIIEVNQILDP 980 (1078)
Q Consensus 909 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~-~-----~~~~~~~~~~~~~~~~ 980 (1078)
.... ......||..|+|||++.+..++.++|||||||++|||++|..|+-..... . ..+...+....... .
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~-~ 390 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV-D 390 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc-c
Confidence 3221 123457999999999999999999999999999999999987663211110 0 01111111100000 0
Q ss_pred CCC----------------------CCCCccH---HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 981 RLS----------------------TPSPGVM---DKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 981 ~~~----------------------~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.+. .....+. .....+.+++.+||+.||.+|||++|+++|+|+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 000 0000000 1112577899999999999999999999999975
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.89 Aligned_cols=264 Identities=24% Similarity=0.323 Sum_probs=205.2
Q ss_pred HHHHHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 743 HEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 743 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
.+++..+.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 455666788999999999999999999965 468899999875421 1235677899999998 799999999987
Q ss_pred e-----cCCeeEEEEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 039595 821 S-----NARHSFLVCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF 894 (1078)
Q Consensus 821 ~-----~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 894 (1078)
. .+...++||||+++|+|.+++... .....+++..+..++.|++.|+.|||+. +++||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 3 456789999999999999987532 2335688899999999999999999999 999999999999999999
Q ss_pred cEEEecccccccccCCCCCceeecccccccccccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhh
Q 039595 895 EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 895 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 969 (1078)
.++++|||.++.............|++.|+|||++.. ..++.++||||+||++|||++|+.||...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-~---- 236 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-R---- 236 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-H----
Confidence 9999999999876543333345578999999998753 45788999999999999999999997533211 0
Q ss_pred hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
..........+.... +. .....+.+++.+||+.||++|||++|+++|+|+
T Consensus 237 ~~~~~~~~~~~~~~~--~~--~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 237 ALFKIPRNPPPTLHQ--PE--LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHhhccccCCCcccC--CC--CcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 001111111111111 10 011257789999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=332.86 Aligned_cols=265 Identities=19% Similarity=0.256 Sum_probs=197.1
Q ss_pred ccceeccC--CceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 755 EKFCIGKG--GQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 755 ~~~~lG~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
+..+||+| +||+||++.. .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 45679999 6889999955 5799999999865432 12234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 80 FMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred ccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999999985432 23588999999999999999999999 99999999999999999999999998765432111
Q ss_pred C-------Cceeecccccccccccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc----
Q 039595 912 S-------NRTEFVGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL---- 978 (1078)
Q Consensus 912 ~-------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 978 (1078)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 1 1122356778999999876 45899999999999999999999998643221100000000000000
Q ss_pred ---------------CCCC---------CC-----C-CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 979 ---------------DPRL---------ST-----P-SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 979 ---------------~~~~---------~~-----~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
+... .. . .+........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0000 00 0 0000111236789999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=352.84 Aligned_cols=262 Identities=18% Similarity=0.212 Sum_probs=194.3
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC------CCceeeEE
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR------HRNIVKFH 817 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~ 817 (1078)
++....++|++.+.||+|+||+||+|.. .+++.||||+++... .....+..|+.++++++ |+++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 3444568899999999999999999965 468899999986421 11233455666666554 45689999
Q ss_pred eeeecC-CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeCCCC-
Q 039595 818 GFCSNA-RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDLEF- 894 (1078)
Q Consensus 818 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~- 894 (1078)
+++... .++|+|||++ +++|.+++.+ ...+++.++..|+.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDT 270 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCc
Confidence 988654 5789999987 6789888843 3468999999999999999999997 5 999999999999998765
Q ss_pred ---------------cEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 039595 895 ---------------EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 959 (1078)
Q Consensus 895 ---------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~ 959 (1078)
.+||+|||.+.... ......+||+.|||||++.+..++.++|||||||++|||++|+.||+.
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999886432 233456899999999999999999999999999999999999999864
Q ss_pred ccccccchhhhhhhh-----------------hhhc------CCCCCC----------CCCccHHHHHHHHHHHHhcccC
Q 039595 960 FSINFSSFSNMIIEV-----------------NQIL------DPRLST----------PSPGVMDKLISIMEVAILCLDE 1006 (1078)
Q Consensus 960 ~~~~~~~~~~~~~~~-----------------~~~~------~~~~~~----------~~~~~~~~~~~l~~li~~cl~~ 1006 (1078)
.... .....+... ...+ .+.... .... ......+.+++.+||..
T Consensus 348 ~~~~--~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 348 HDNL--EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVRE-VIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CChH--HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhh-hhchHHHHHHHHHhCCc
Confidence 3321 000000000 0000 000000 0000 00123567999999999
Q ss_pred CCCCCCChhHHHHHhhhh
Q 039595 1007 SPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 1007 dP~~RPt~~ell~h~~~~ 1024 (1078)
||++|||++|+++|||+.
T Consensus 425 dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 425 DRQKRLNARQMTTHPYVL 442 (467)
T ss_pred ChhhCCCHHHHhcCcccc
Confidence 999999999999999974
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=331.26 Aligned_cols=257 Identities=18% Similarity=0.293 Sum_probs=189.5
Q ss_pred ceeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee--cCCeeEEEEe
Q 039595 757 FCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS--NARHSFLVCE 831 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~E 831 (1078)
.+||+|+||+||+|..+ ++..||+|.+.... ....+.+|+.++++++||||+++++++. .+...++|+|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 57999999999999754 45789999986432 1335678999999999999999999884 4567899999
Q ss_pred ecCCCCHHHHhcCC------CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----CCCCcEEEecc
Q 039595 832 YLHRGSLARILGND------ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----DLEFEAHVSDF 901 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Df 901 (1078)
|+.+ +|.+++... .....+++..+..++.||+.||.|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9875 787777421 1223588899999999999999999999 99999999999999 56689999999
Q ss_pred cccccccCCCC---Cceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccch----hhhhhh
Q 039595 902 GIAKFVEPYSS---NRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF----SNMIIE 973 (1078)
Q Consensus 902 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~----~~~~~~ 973 (1078)
|+++....... ......||+.|+|||++.+ ..++.++||||+||++|||+||++||.....+.... ......
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 99987644322 2234578999999999876 458999999999999999999999986432211000 000000
Q ss_pred hhhhcC-------------CCC-------C---CCCCcc--------HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 974 VNQILD-------------PRL-------S---TPSPGV--------MDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 974 ~~~~~~-------------~~~-------~---~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
....+. +.. . ...... ......+.+++.+|+..||.+|||++|+++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 000000 000 0 000000 001125778999999999999999999999999
Q ss_pred h
Q 039595 1023 G 1023 (1078)
Q Consensus 1023 ~ 1023 (1078)
+
T Consensus 317 f 317 (317)
T cd07867 317 F 317 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.46 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=206.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|..+ +++.||+|.+.... .....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 46889999999999999999765 78999999886432 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.+++........+++..+..++.|++.|+.|||+.+ +++||||||+||+++.++.++|+|||.+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 999999999999865433457899999999999999999999732 899999999999999999999999999976533
Q ss_pred CCCCceeeccccccccccccccC------CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTM------RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
. ......++..|+|||.+.+. .++.++||||+||++|||++|+.||..... ..... ....+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~---~~~~~~~~~~~ 228 (286)
T cd06622 156 S--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFA---QLSAIVDGDPP 228 (286)
T ss_pred C--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHH---HHHHHhhcCCC
Confidence 2 22334678899999998654 358899999999999999999999753221 11111 11112221111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
...+. ...++.+++.+||..+|++||++++++.|+|+...
T Consensus 229 ~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 229 TLPSG---YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CCCcc---cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 11111 23357788999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=354.93 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=199.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.+|++.++||+|+||.||+|... +|+.||+|++..... ......+++.+|+.++++++||||+++++++.+++..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 57999999999999999999654 689999999975432 2334456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCC--------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecc
Q 039595 830 CEYLHRGSLARILGNDA--------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDF 901 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 901 (1078)
|||++||+|.+++.... .....++..+++++.||+.||+|||++ +|+||||||+||+++.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence 99999999999985321 123456778899999999999999999 9999999999999999999999999
Q ss_pred cccccccCCC------------------CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc
Q 039595 902 GIAKFVEPYS------------------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 963 (1078)
Q Consensus 902 G~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~ 963 (1078)
|+++...... ......+||+.|||||++.+..++.++||||+||++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998652110 0112346999999999999999999999999999999999999997542211
Q ss_pred ccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 964 FSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
... .......+....+.. .....+.+++.+|++.||++||+..+.+.+
T Consensus 238 --ki~----~~~~i~~P~~~~p~~---~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 --KIS----YRDVILSPIEVAPYR---EIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred --hhh----hhhhccChhhccccc---cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 110 001111111111111 112356788999999999999876555544
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=339.98 Aligned_cols=259 Identities=19% Similarity=0.260 Sum_probs=195.2
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++..+...+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3457999999999999999999664 5788999975332 2345888999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+|+||+. |+|.+++.. ....+++.++..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||.++..
T Consensus 134 lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999995 588888843 235689999999999999999999999 9999999999999999999999999999754
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCC-CCcccccccch----hhhhhhhhh---hcC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP-RDFFSINFSSF----SNMIIEVNQ---ILD 979 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p-~~~~~~~~~~~----~~~~~~~~~---~~~ 979 (1078)
.. ........||+.|+|||++.+..++.++|||||||++|||+++..| |+......... ......... ..+
T Consensus 208 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 208 VV-APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred cc-CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 32 1223346789999999999999999999999999999999986554 33211110000 000000000 000
Q ss_pred CCCCC-------------------CCCc-----cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 980 PRLST-------------------PSPG-----VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 980 ~~~~~-------------------~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
..+.. +... ......+..+++.+||+.||++|||++|+++|||+.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 01100 0000 001122456689999999999999999999999975
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.79 Aligned_cols=255 Identities=20% Similarity=0.329 Sum_probs=206.6
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|+||.||++.. .+|+.||+|++..... .....+++.+|+.++++++||||+++++++......++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 588899999999999999954 4689999999865422 2334567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++++|.+++... ....+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 79 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 79 DYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred ecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999999998542 223578899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
........|++.|+|||+..+..++.++|||||||++|+|++|+.||..... .... ..+..........
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~------~~~~~~~~~~~~~--- 223 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLV------LKIIRGSYPPVSS--- 223 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--HHHH------HHHhcCCCCCCcc---
Confidence 3333445688999999999988899999999999999999999999653211 1111 1111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
....++.+++.+||+.+|++||+++|+++|+|+
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 112367889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=339.07 Aligned_cols=257 Identities=21% Similarity=0.352 Sum_probs=199.9
Q ss_pred hhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCS 821 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 821 (1078)
..++|++.+.||+|+||.||+|... .+..||||++.... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 4568999999999999999999642 23479999986542 2334567899999999996 999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCC-------------------------------------------------------
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDA------------------------------------------------------- 846 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------------------- 846 (1078)
+....|+||||+++|+|.+++....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999999885321
Q ss_pred --------------------------------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCe
Q 039595 847 --------------------------------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNV 888 (1078)
Q Consensus 847 --------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI 888 (1078)
....+++.++..++.||+.|++|||+. +|+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 012478888999999999999999999 999999999999
Q ss_pred eeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 039595 889 LLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFS 965 (1078)
Q Consensus 889 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~ 965 (1078)
+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....+.
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~- 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS- 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence 999999999999999986543221 1223456788999999999899999999999999999997 999975332211
Q ss_pred chhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 966 SFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 966 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
..... ......+... . .....+.+++.+||+.||++||++.++.+..
T Consensus 348 ~~~~~---~~~~~~~~~~---~---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 348 TFYNK---IKSGYRMAKP---D---HATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred HHHHH---HhcCCCCCCC---c---cCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 11111 1111111111 1 1123678899999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=326.62 Aligned_cols=248 Identities=32% Similarity=0.507 Sum_probs=189.4
Q ss_pred ccceeccCCceeEEEEEeC-----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 755 EKFCIGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 755 ~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
..+.||.|+||.||+|.++ .+..|+||++... ......+.+.+|+..+++++||||++++|++...+..++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeeccccccccccccccccccccccccccccc
Confidence 4568999999999999765 3567999999542 2344578899999999999999999999999988889999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+++|+|.+++... ....+++.++..|+.||+.||+|||++ +++||||+++||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999999554 235689999999999999999999999 999999999999999999999999999987632
Q ss_pred CCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 910 YSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 910 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.... .....+...|+|||.+.+..++.++||||||+++||+++ |+.||..... ....... .+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~------~~~~~~~~~ 227 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKL------KQGQRLPIP 227 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHH------HTTEETTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc------cccccceec
Confidence 2111 223456789999999999899999999999999999999 7888653321 1111111 111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.... ..+.+++.+||+.||++|||++++++.
T Consensus 228 ~~~~---~~~~~li~~C~~~~p~~RPs~~~i~~~ 258 (259)
T PF07714_consen 228 DNCP---KDIYSLIQQCWSHDPEKRPSFQEILQE 258 (259)
T ss_dssp TTSB---HHHHHHHHHHT-SSGGGS--HHHHHHH
T ss_pred cchh---HHHHHHHHHHcCCChhhCcCHHHHHhc
Confidence 1112 256788999999999999999999864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.92 Aligned_cols=256 Identities=21% Similarity=0.365 Sum_probs=199.7
Q ss_pred hhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN 822 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 822 (1078)
+.++|+..+.||+|+||.||+|..+ ++..||+|++.... ......++.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4578999999999999999998643 35679999985432 22345678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCC-------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDAT-------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE 895 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 895 (1078)
+...++||||+++|+|.+++.+... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence 9999999999999999999854321 23467889999999999999999998 9999999999999999999
Q ss_pred EEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhh
Q 039595 896 AHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMII 972 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 972 (1078)
++++|||+++........ .....+++.|||||++.+..++.++|||||||++|||++ |..||..... .....
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~--- 232 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLR--- 232 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH---
Confidence 999999999765432211 122345778999999998899999999999999999999 7888653221 11111
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.............. ...+.+++.+||+.||++|||+.|++++.
T Consensus 233 ---~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 233 ---FVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred ---HHHcCCcCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 11111111111111 23578899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=320.55 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=201.5
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++.++...++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 46789999999999999999988888899999876432 2356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.+. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.++....
T Consensus 80 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 80 TEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999999543 334688899999999999999999998 999999999999999999999999999987643
Q ss_pred CCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 910 YSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 910 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..... ....... . ...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~---~~~~~~~--~-~~~ 227 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSA---LQRGYRM--P-RME 227 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHH---HHcCCCC--C-CCC
Confidence 221 1223345678999999998889999999999999999998 99997532211 11111 1111111 1 111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
. ...++.+++.+||+.+|++||+++++.+.
T Consensus 228 ~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 257 (261)
T cd05072 228 N---CPDELYDIMKTCWKEKAEERPTFDYLQSV 257 (261)
T ss_pred C---CCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1 12357789999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.22 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=204.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||.||+|..+ +|+.||+|++..... .....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 46889999999999999999765 689999999865421 122345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||++++.+..+... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 79 FEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 999999888887732 34589999999999999999999998 999999999999999999999999999987755
Q ss_pred CCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh-------hhhc---
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV-------NQIL--- 978 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~--- 978 (1078)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .......... ....
T Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcccc
Confidence 4333344567889999999876 45789999999999999999999997533221 1111000000 0000
Q ss_pred -------CCCCCCCCC---ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 979 -------DPRLSTPSP---GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 979 -------~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.+......+ ........+.+++.+||+.+|++||++.|++.|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000000000 001112467899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.85 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=204.9
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 3466678899999999999965 467899999886442 223456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 81 MEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 999999999999842 4588899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........|+..|+|||++.+..++.++|||||||++|||++|+.||...... .... .......+...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~---~~~~~~~~~~~------ 222 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--RVLF---LIPKNSPPTLE------ 222 (277)
T ss_pred cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--hHHh---hhhcCCCCCCC------
Confidence 333334456889999999999988999999999999999999999996532211 0000 00001111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
......+.+++.+||+.+|++||++.+++.|+|...
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 112346788999999999999999999999999654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=317.95 Aligned_cols=255 Identities=21% Similarity=0.313 Sum_probs=207.6
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|+||.||.++. .+++.+++|.+..... .......+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 588899999999999999954 5689999999865432 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++.+.. ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999996432 35689999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
........|++.|+|||...+..++.++||||||+++|||++|+.||+.... .... ..+..........
T Consensus 155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~------~~~~~~~~~~~~~--- 223 (256)
T cd08221 155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLV------VKIVQGNYTPVVS--- 223 (256)
T ss_pred cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--HHHH------HHHHcCCCCCCcc---
Confidence 3334456789999999999888899999999999999999999999753221 1111 1111122221111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.....+.+++.+||..+|++||+++|+++|+|.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 122357788999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=319.36 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=199.1
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.+|++.+.||+|+||.||+|.++++..+|+|++.... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-----MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 4588889999999999999988777889999986432 12456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 9999999999985432 3689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCC-ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 911 SSN-RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 911 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||+..... .... ............
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~---~~~~~~~~~~~~---- 224 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVE---SVSAGYRLYRPK---- 224 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHH---HHHcCCcCCCCC----
Confidence 111 112234567999999998899999999999999999999 89997543221 1111 111111111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.....+.+++.+||..+|++|||++|+++.
T Consensus 225 --~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 225 --LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred --CCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 122367899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=326.35 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=204.9
Q ss_pred HHHHHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 743 HEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 743 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
..+...+...|++.+.||+|+||.||+|.. .+++.||+|++... ......+..|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 344555668899999999999999999965 46889999987543 22345678899999988 799999999998
Q ss_pred e------cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 039595 821 S------NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF 894 (1078)
Q Consensus 821 ~------~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 894 (1078)
. .....|+||||+.+|+|.+++.... ...+++..+..++.|++.|++|||+. +++|||++|+||+++.++
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 4 3467899999999999999985432 34578888999999999999999999 999999999999999999
Q ss_pred cEEEecccccccccCCCCCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhh
Q 039595 895 EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 895 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 969 (1078)
.++|+|||++..............|+..|+|||.+. +..++.++|||||||++|||++|+.||...... ..
T Consensus 159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~--- 234 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-RA--- 234 (282)
T ss_pred CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-hh---
Confidence 999999999986644333344567899999999876 346788999999999999999999997532211 00
Q ss_pred hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.........+... .. .....+.+++.+||+.||.+|||+.|+++|+|+
T Consensus 235 -~~~~~~~~~~~~~--~~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 235 -LFLIPRNPPPKLK--SK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -hhhHhhCCCCCCc--cc---ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0000111111111 11 122367889999999999999999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=328.78 Aligned_cols=253 Identities=27% Similarity=0.388 Sum_probs=203.4
Q ss_pred CCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|.....||+|+||.||+|.. .+++.||||++... .....+.+.+|+..++.++||||+++++++..++..++|||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 33346699999999999965 46889999998543 23345668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+++++|.+++.. ..+++.++..++.||+.|++|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 100 FLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999998832 3588999999999999999999999 99999999999999999999999999997654433
Q ss_pred CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHH
Q 039595 912 SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1078)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... . ..........++..... ..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~---~~~~~~~~~~~~~~~~~----~~ 243 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--L---QAMRRIRDNLPPRVKDS----HK 243 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHHHhcCCCccccc----cc
Confidence 334456789999999999888899999999999999999999999653221 1 11111112222222211 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 992 KLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 992 ~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....+.+++.+||..||.+|||++|+++|+|+..
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 2225678889999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=318.60 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=203.2
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|++.+.||+|+||.||++... +++.||+|.++... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 5788899999999999999654 68999999986432 2334567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++... ....+++..+..++.|++.|+.|||+. +++|+||||+||++++++.++++|||.++.....
T Consensus 78 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 78 EYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred eeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999999988532 334578999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
........|++.|+|||++.+..++.++||||||+++|+|++|+.||+.... ..... . ............
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~---~---~~~~~~~~~~~~-- 223 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--KNLIL---K---VCQGSYKPLPSH-- 223 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--HHHHH---H---HhcCCCCCCCcc--
Confidence 4344456789999999999988899999999999999999999999753221 11111 1 111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
....+.+++.+||+.||++||++++++..
T Consensus 224 -~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 -YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 12357789999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=323.36 Aligned_cols=267 Identities=25% Similarity=0.288 Sum_probs=206.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--CCeeE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN--ARHSF 827 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 827 (1078)
++|+..+.||+|++|.||+|..+ +++.||+|.+.... .......+.+|++++++++||||++++++|.+ ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 46888899999999999999764 68899999987542 22345678899999999999999999998854 44789
Q ss_pred EEEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 828 LVCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
+||||+++++|.+++... .....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 999999999999887432 2345588899999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
..... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||+.....................+......
T Consensus 155 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 155 LVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred ccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 53321 2244678899999999988999999999999999999999999865432111111111111111111121111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.........+.+++.+||+.+|++|||+.|++.|+|...
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 111122346789999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=334.48 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=198.8
Q ss_pred hhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCS 821 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 821 (1078)
..++|++.+.||+|+||.||+|... +++.||+|+++... .....+.+..|+.+++++ +||||++++++|.
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 3468999999999999999999532 35789999986532 223345678899999999 8999999999885
Q ss_pred c-CCeeEEEEeecCCCCHHHHhcCCCC-----------------------------------------------------
Q 039595 822 N-ARHSFLVCEYLHRGSLARILGNDAT----------------------------------------------------- 847 (1078)
Q Consensus 822 ~-~~~~~lv~E~~~~g~L~~~l~~~~~----------------------------------------------------- 847 (1078)
. +...++++||+++|+|.+++.....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 4678899999999999999853211
Q ss_pred -----CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC--Cceeeccc
Q 039595 848 -----AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGT 920 (1078)
Q Consensus 848 -----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt 920 (1078)
...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||+++.+..... ......++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 12688999999999999999999999 999999999999999999999999999987643221 12234567
Q ss_pred cccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 039595 921 FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEV 999 (1078)
Q Consensus 921 ~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 999 (1078)
..|+|||++.+..++.++|||||||++|||++ |+.||...... ......... ...+... . ....++.++
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~---~~~~~~~---~---~~~~~~~~l 308 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKE---GTRMRAP---E---YATPEIYSI 308 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhc---cCCCCCC---c---cCCHHHHHH
Confidence 78999999999999999999999999999998 99997532211 111111110 0111111 1 112367889
Q ss_pred HHhcccCCCCCCCChhHHHHHhh
Q 039595 1000 AILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 1000 i~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
+.+||+.+|++||+++|+++|.-
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=356.38 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=203.6
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--CC
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN--AR 824 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 824 (1078)
...++|++.+.||+|+||+||+|... +++.||+|++..... .......+..|+.++++++|||||+++++|.. ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 44578999999999999999999654 677899999875432 23345678899999999999999999998843 45
Q ss_pred eeEEEEeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCC----CCcEecCCCCCCeeeCC-------
Q 039595 825 HSFLVCEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCL----PSIIHRDISSKNVLLDL------- 892 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlk~~NIll~~------- 892 (1078)
.+|+||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 7899999999999999985422 23568999999999999999999998521 25999999999999964
Q ss_pred ----------CCcEEEecccccccccCCCCCceeecccccccccccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 039595 893 ----------EFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDFF 960 (1078)
Q Consensus 893 ----------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~ 960 (1078)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 245999999999866432 22344579999999999864 45889999999999999999999997532
Q ss_pred cccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 961 SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.. ...... .... .+.+. .. ....++.++|.+||..+|++||++.|++.|+|..
T Consensus 247 ~~-~~qli~---~lk~--~p~lp--i~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 247 NN-FSQLIS---ELKR--GPDLP--IK---GKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred Cc-HHHHHH---HHhc--CCCCC--cC---CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 21 111111 1111 11111 11 1123678899999999999999999999999975
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=319.37 Aligned_cols=257 Identities=22% Similarity=0.318 Sum_probs=198.8
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEecccccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--CCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLS-GNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN--ARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 826 (1078)
.+|+..+.||+|+||.||+|.. .+++.||+|++...... ......+.+.+|+.++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999965 46899999998654321 122334568899999999999999999998865 4678
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 34578899999999999999999998 999999999999999999999999999976
Q ss_pred ccCCC---CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 907 VEPYS---SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 907 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
..... .......++..|+|||.+.+..++.++||||+||++|||++|+.||...... ..... .......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-~~~~~---~~~~~~~~~~~ 231 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-AAIFK---IATQPTNPQLP 231 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-HHHHH---HhcCCCCCCCc
Confidence 53311 1123345888999999999888999999999999999999999997533211 00000 00001111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. .. ...+.+++ +||..+|++||+++|+++|||+.
T Consensus 232 ~---~~---~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 232 S---HI---SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred h---hc---CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 1 11 12344555 68889999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=319.25 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=200.9
Q ss_pred cCCCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
++|++.+.||+|+||+||+|.++ +...||||+++... .......+.+|+..+++++||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 57899999999999999999764 24579999886542 233456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|+|.+++... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++++|||+++.
T Consensus 81 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 81 MIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 9999999999999999543 23689999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCc--eeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 907 VEPYSSNR--TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 907 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
........ ....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+ ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~------~~~~~~ 227 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAV------EDGYRL 227 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHHH------HcCCCC
Confidence 75222211 12334678999999998899999999999999999998 9999643221 1111111 111010
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
+... .....+.+++.+||+.+|++||+++|++++.-
T Consensus 228 ~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 228 PPPM---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263 (266)
T ss_pred CCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111 11235789999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.00 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=208.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
..|+..+.||+|+||.||+|..+ +++.||+|++.... .....+.+.+|+.++++++||||+++++++.++...++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 35777889999999999999654 68899999986542 223456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.. ..+++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 81 MEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999999999842 3578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........++..|+|||++.+..++.++|||||||++|||++|+.||...... ... ......... ...
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~-------~~~~~~~~~--~~~ 222 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--RVL-------FLIPKNNPP--TLT 222 (277)
T ss_pred CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--hHh-------hhhhcCCCC--CCc
Confidence 333334456888999999999888999999999999999999999997533211 000 001111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
......+.+++.+||+.+|++||++++++.|+|......
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 223456889999999999999999999999999765433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=302.32 Aligned_cols=268 Identities=20% Similarity=0.288 Sum_probs=212.6
Q ss_pred HHHHHHhhcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 743 HEEIIKATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 743 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
.+++.+.++ +.||+|+|+.|.-+ ..++|..||||++.+. ....+.++.+|++++.+. .|+||++++++|
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 466666655 46999999999998 6789999999999775 234577889999999888 699999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEE
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF---EAH 897 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~k 897 (1078)
+++...|+|||-|.||.|...+++ .+.+++.++.+++++|+.||.|||.+ ||.|||+||+|||..... -||
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cccceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence 999999999999999999998843 45689999999999999999999999 999999999999997664 489
Q ss_pred EecccccccccCCC-------CCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcc-c---
Q 039595 898 VSDFGIAKFVEPYS-------SNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFF-S--- 961 (1078)
Q Consensus 898 l~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~-~--- 961 (1078)
||||.++.-+.... ..-.+.+|+..|||||+.. .-.|++++|.||+|||+|-|++|.+||... +
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 99998886442211 1123568999999999753 235899999999999999999999997532 1
Q ss_pred -ccccchhh--hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 962 -INFSSFSN--MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 962 -~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
++..+.-. ...-...+-+..+.-+..++.....+..+++...+..||..|.++.++++|||...
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 11111111 11123344455565555566666667788888899999999999999999999764
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=322.32 Aligned_cols=254 Identities=21% Similarity=0.363 Sum_probs=198.9
Q ss_pred cCCCccceeccCCceeEEEEEe-----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
++|++.+.||+|+||+||+|.. .++..||+|.+.... .......+.+|+.++++++||||+++++++..+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 5688889999999999999964 246789999986532 23344678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCC--------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 039595 826 SFLVCEYLHRGSLARILGNDA--------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 891 (1078)
.|+||||+++|+|.+++.... ....+++.++..++.|++.||+|||++ +++||||||+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence 999999999999999984221 123478899999999999999999999 999999999999999
Q ss_pred CCCcEEEecccccccccCCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchh
Q 039595 892 LEFEAHVSDFGIAKFVEPYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFS 968 (1078)
Q Consensus 892 ~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~ 968 (1078)
.++.+|++|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~ 236 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVI 236 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence 99999999999998653322 11233445778999999988889999999999999999998 8888643221 1111
Q ss_pred hhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 969 NMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.... . ........... ..+.+++.+||+.||++||++.++.++.
T Consensus 237 ~~~~---~---~~~~~~~~~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 237 EMVR---K---RQLLPCSEDCP---PRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHH---c---CCcCCCCCCCC---HHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 1111 0 11111111111 3567888999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=323.68 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=201.6
Q ss_pred hcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
.++|.+.+.||+|+||.||+|... +++.||||++.... ..+..+.+.+|+++++.++||||+++++++..+
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 356888899999999999999653 34789999986542 223456889999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 039595 824 RHSFLVCEYLHRGSLARILGNDA-----------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL 892 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 892 (1078)
...++||||+++|+|.+++.... ....+++.++..++.|++.|+.|+|+. +++||||||+||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence 99999999999999999995432 234578899999999999999999999 9999999999999999
Q ss_pred CCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhh
Q 039595 893 EFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 893 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~ 969 (1078)
++.+||+|||.++....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--~~~~~ 235 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--EEVIE 235 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH
Confidence 99999999999976532221 1233446788999999999999999999999999999998 9999643221 11111
Q ss_pred hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
. +........... ....+.+++.+||..||++||+++|+++..
T Consensus 236 ~------~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 236 C------ITQGRLLQRPRT---CPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred H------HHcCCcCCCCCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 1 111111111111 123578899999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=329.19 Aligned_cols=252 Identities=22% Similarity=0.396 Sum_probs=197.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCC----EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.+|+..+.||+|+||.||+|.+. +++ .||+|++.... .....+++.+|+.+++.++||||+++++++..+ .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 56899999999999999999653 344 48999986432 233456788999999999999999999999765 5
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++|+||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 67999999999999999543 24578899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCc--eeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 906 FVEPYSSNR--TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 906 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
......... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||+.... ......... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~~~~~-----~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK-----GERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhC-----CCCC
Confidence 765432221 12234678999999999999999999999999999998 9999753221 111111110 1111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
..+ +. ...++.+++.+||..+|++||++.+++.+..
T Consensus 231 ~~~-~~---~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 231 PQP-PI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred CCC-CC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111 11 1235778999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=326.49 Aligned_cols=266 Identities=20% Similarity=0.263 Sum_probs=201.4
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
+.++|++.+.||+|+||.||+|.. .+++.||+|++...... .....+.+|+.+++.++|+||+++++++..+...|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE---GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC---CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 457899999999999999999965 46899999998654321 22345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+|+||+. +++.+++... ...+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 80 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9999996 6777776332 24577888999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh--------------
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-------------- 972 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~-------------- 972 (1078)
...........+++.|+|||.+.+. .++.++|||||||++|||++|+.||+..............
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 4433333445678999999998764 5788999999999999999999998644322111111000
Q ss_pred hhhhhcCCCCCCCCCc-------cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 973 EVNQILDPRLSTPSPG-------VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 973 ~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
..............+. .......+.+++.+|+..||++|||++|++.|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000000000000000 00112367789999999999999999999999995
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=325.90 Aligned_cols=263 Identities=27% Similarity=0.352 Sum_probs=205.0
Q ss_pred HHHHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeee
Q 039595 744 EEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCS 821 (1078)
Q Consensus 744 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 821 (1078)
+++..+.++|++.+.||+|+||.||+|.. .+++.+|+|++.... ...+.+.+|+.+++++ +|||++++++++.
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 44555678999999999999999999965 468899999985431 2245677888899988 8999999999986
Q ss_pred cC-----CeeEEEEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 039595 822 NA-----RHSFLVCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE 895 (1078)
Q Consensus 822 ~~-----~~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 895 (1078)
.. +..++||||+++|+|.++++.. .....+++..++.++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 43 4689999999999999988532 2345689999999999999999999999 9999999999999999999
Q ss_pred EEEecccccccccCCCCCceeeccccccccccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhh
Q 039595 896 AHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-----RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM 970 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~ 970 (1078)
+||+|||.+..............|+..|+|||.+... .++.++|||||||++|||++|+.||...... ..
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----~~ 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----KT 241 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----HH
Confidence 9999999998765433333445788999999987643 3688999999999999999999996532211 00
Q ss_pred hhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 971 IIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.........+....+ ......+.+++.+||+.+|++||++.|+++|+|+
T Consensus 242 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 242 LFKIPRNPPPTLLHP----EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred HHHHhcCCCCCCCcc----cccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 111111111111111 1122367889999999999999999999999996
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=321.50 Aligned_cols=258 Identities=22% Similarity=0.327 Sum_probs=205.6
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|.. .+++.||||.+...... +....+++.+|+.+++.++||||+++++++.+++..++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 5688889999999999999964 57899999988654321 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 830 CEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|||+++++|.+++... .....+++..++.++.||+.|++|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999988532 2345689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........|+..|+|||.+.+..++.++||||||+++|+|++|..||........... ........+... .
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~---~- 230 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC---KKIEQCDYPPLP---S- 230 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh---hhhhcCCCCCCC---c-
Confidence 433333455789999999999988899999999999999999999999753222111111 111111111111 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
......+.+++.+||+.||++|||++++++.
T Consensus 231 -~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 231 -DHYSEELRQLVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred -ccccHHHHHHHHHhcCCCcccCCCHHHHHHH
Confidence 1123367889999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=326.72 Aligned_cols=265 Identities=20% Similarity=0.299 Sum_probs=200.9
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|+..+.||+|+||.||+|..+ +++.||+|.+...... .....+.+|+.++++++||||+++++++.++...++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 367999999999999999999665 6899999998754321 123446789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+.+ +|.+++.+.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.++...
T Consensus 81 v~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred EEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 9999985 9999885432 3688999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh----hh-------
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV----NQ------- 976 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~----~~------- 976 (1078)
..........++..|+|||.+.+ ..++.++||||+|+++|||++|+.||................. ..
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 32222233456889999998875 4588999999999999999999999753331110000000000 00
Q ss_pred ---hcCCCCCCCCC-------ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 977 ---ILDPRLSTPSP-------GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 977 ---~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
........... ........+.+++.+|++.+|++|||++|++.|+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000000000 001111467789999999999999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.07 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=200.6
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|++.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 46789999999999999999987778889999986532 2356688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999999995433 34689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCC-ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 910 YSSN-RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 910 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.... ......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+ ......... .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~---~~~~~~~~~---~ 227 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQV---DQGYRMPCP---P 227 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH---HcCCCCCCC---C
Confidence 2211 112223468999999998899999999999999999999 9999753221 1111111 111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.....+.+++.+|++.+|++||+++++...
T Consensus 228 ---~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~ 257 (261)
T cd05068 228 ---GCPKELYDIMLDCWKEDPDDRPTFETLQWK 257 (261)
T ss_pred ---cCCHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 122367889999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.06 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=202.3
Q ss_pred CCCccceeccCCceeEEEEEeC--CCC--EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP--SGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
+....++||+|.||+|++|.|+ .|+ .||||.++..... ...+.|.+|+.+|-+++|||++++||+..+ ....
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 3445567999999999999775 344 5999999776433 257789999999999999999999999987 6788
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
||||.++.|+|.+.|++ .....+-......++.|||.||.||.++ ++||||+.++|+++.....|||+|||+.+-+
T Consensus 187 MV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence 99999999999999976 4556788888999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCce---eeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 908 EPYSSNRT---EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 908 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
........ ...-+..|+|||.+....++.++|||+|||.+|||+| |+.||-.... ..+...+. -..++.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qIL~~iD-----~~erLp 335 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQILKNID-----AGERLP 335 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHHHHhcc-----ccccCC
Confidence 65444332 2234679999999999999999999999999999998 8889753322 11111111 112222
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.+ +.+ ..+++++++.||..+|.+|||+..+.+..+
T Consensus 336 RP-k~c---sedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 336 RP-KYC---SEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred CC-CCC---hHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 22 222 236889999999999999999998876544
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=323.54 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=204.9
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCC-
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNAR- 824 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~- 824 (1078)
.+.++|++.+.||+|+||.||+|..+ +++.||+|++.... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 35689999999999999999999764 67899999986542 2356788999999999 7999999999996543
Q ss_pred -----eeEEEEeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 825 -----HSFLVCEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 825 -----~~~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
..++||||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+++
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence 5899999999999999985422 245689999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCceeecccccccccccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 973 (1078)
+|||.+..............|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...... .....
T Consensus 155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~ 229 (275)
T cd06608 155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-----RALFK 229 (275)
T ss_pred CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----HHHHH
Confidence 999999876544444455678999999998753 34678999999999999999999997532211 00011
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
......+... ........+.+++.+||..||++|||++|++.|+|.
T Consensus 230 ~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 230 IPRNPPPTLK----SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhccCCCCCC----chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1111111111 111123467889999999999999999999999994
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.84 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=207.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|... +|+.||+|.++..... .....+.+.+|++++++++|++|+++++++.+++..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57999999999999999999665 7999999998753322 233466788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 830 CEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|||+++|+|.+++.... ....+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999985432 234588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........++..|+|||.+.+..++.++|||||||++|+|++|+.||............ ... .....+...
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~---~~~~~~~~~- 230 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---KIE---KCDYPPLPA- 230 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh---hhh---cCCCCCCCh-
Confidence 4433344567899999999999888999999999999999999999997533221111111 111 111111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
......+.+++.+||..+|++|||+.++++..
T Consensus 231 -~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 231 -DHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred -hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 12223677899999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=325.46 Aligned_cols=259 Identities=26% Similarity=0.373 Sum_probs=208.7
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 6899999999999999999964 468899999985432 23356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+++++|.+++.+ ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999999999843 3478899999999999999999999 999999999999999999999999999876654
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........|++.|+|||.+....++.++||||||+++|++++|+.||........ ... . ...+... ....
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~-~-----~~~~~~~--~~~~ 238 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-I-----ATNGTPE--LQNP 238 (293)
T ss_pred cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eee-h-----hcCCCCC--CCCc
Confidence 44334445788999999999888899999999999999999999999754322110 000 0 0011100 1111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHH
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEIL 1029 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~ 1029 (1078)
......+.+++.+||..+|++||++++++.|+|+.....+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence 1122357789999999999999999999999998765533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=325.98 Aligned_cols=264 Identities=20% Similarity=0.251 Sum_probs=200.0
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|+||.||+|..+ +|+.||+|++...... ......+.+|+.++++++||||+++++++.+....++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc--ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 4788899999999999999664 7899999998654321 222345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++ +|.+++... ...+++..++.++.||++||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 79 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 79 EYCDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred ecCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 99975 788877432 34589999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh-----------hhhhhc
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-----------EVNQIL 978 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~-----------~~~~~~ 978 (1078)
........++..|+|||.+.+. .++.++||||+||++|||++|+.|+............... ......
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 3333445678999999998764 4789999999999999999999885322111000000000 000000
Q ss_pred CC-CCCCCCCc------cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 979 DP-RLSTPSPG------VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 979 ~~-~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
+. ........ ......++.+++.+||+.||.+|||++|++.|+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 00000000 00112366789999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=326.86 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=202.9
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|+....||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 334457999999999999654 68999999986432 2234568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 99 FLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred cCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 9999999998732 4588999999999999999999999 99999999999999999999999999997654433
Q ss_pred CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHH
Q 039595 912 SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1078)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||...... . ..........+... ... .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~---~~~~~~~~~~~~~~-~~~---~ 242 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--Q---AMKRLRDSPPPKLK-NAH---K 242 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H---HHHHHhccCCCCcc-ccC---C
Confidence 3344567899999999999889999999999999999999999997532211 1 11111111111111 111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 992 KLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 992 ~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
....+.+++.+||+.+|++||+++++++|+|+...
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 12357788999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.49 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=200.6
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|++.++||+|+||.||+|..++++.||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 46789999999999999999988889999999986542 23567889999999999999999999875 4568999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999985432 35689999999999999999999998 999999999999999999999999999987653
Q ss_pred CC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 910 YS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 910 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. .......++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..... ........... .
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~---~~~~~~~~~~~---~ 226 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQ---NLERGYRMPRP---D 226 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHH---HHHcCCCCCCC---C
Confidence 22 12223446778999999998889999999999999999999 9999753321 11111 11111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
. ...++.+++.+||+.+|++||+++++....
T Consensus 227 ~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 227 N---CPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred C---CCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 1 123688899999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=324.32 Aligned_cols=255 Identities=25% Similarity=0.294 Sum_probs=207.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|++++++++||||+++++++.++...++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 46889999999999999999654 6899999998654322 223456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 80 MEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999999443 5688999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..... .+.......+ ...
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~------~~~~~~~~~~-~~~ 221 (290)
T cd05580 154 R---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYE------KILEGKVRFP-SFF 221 (290)
T ss_pred C---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHH------HHhcCCccCC-ccC
Confidence 2 3345688999999999888899999999999999999999999753331 11111 1111111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhhH
Q 039595 990 MDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~~ 1027 (1078)
...+.+++.+||..||.+|| +++|+++|+|+..-.
T Consensus 222 ---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 222 ---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred ---CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 23677899999999999999 999999999976544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.29 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=198.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.+|++.+.||+|+||.||+|..+ +++.||+|++... ....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 45788899999999999999654 6889999998643 23356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999998543 234588999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCC-ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 910 YSSN-RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 910 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..... .......+... .
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~---~~~~~~~~~~~---~ 228 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYE---LLEKGYRMERP---E 228 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH---HHHCCCCCCCC---C
Confidence 2211 112234668999999998899999999999999999998 8999653221 11111 11111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
. ....+.+++.+||+.||++||++.++++.
T Consensus 229 ~---~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 229 G---CPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred C---CCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 1 12367889999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=323.99 Aligned_cols=265 Identities=25% Similarity=0.330 Sum_probs=207.5
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|.. ++|+.||+|++.... .....+.+.+|+++++.++||||+++++++......++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 35788889999999999999965 468899999886432 23345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. .+.+++..+..++.+++.|+.|||+.+ +++||||+|+||+++.++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 81 CMEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 9999999999999843 346899999999999999999999742 89999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc--cchhh-hhhhhhhhcCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SSFSN-MIIEVNQILDPRLSTP 985 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 985 (1078)
.. ......|+..|+|||++.+..++.++|||||||++|++++|+.||+...... ..... .......+........
T Consensus 156 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd06620 156 NS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233 (284)
T ss_pred hh--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence 22 1234578999999999988899999999999999999999999986433210 00000 0011111221111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.. ......+.+++.+||+.||++|||++|+++|+|+...
T Consensus 234 ~~--~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 234 PS--SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred Cc--hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00 1122367889999999999999999999999986553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.99 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=205.3
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|+||.||+|.. .+++.||+|.++..... ....+.+.+|+.++++++|+||+++++++......++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 588889999999999999965 47899999998765322 345678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 79 EYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred ecCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999999943 34578899999999999999999999 9999999999999999999999999999876443
Q ss_pred CCCc----eeeccccccccccccccCC---CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 911 SSNR----TEFVGTFGYAAPEIAYTMR---ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 911 ~~~~----~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
.... ....++..|+|||++.+.. ++.++||||||+++||+++|+.||........ .... ......+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~---~~~~~~~~~~ 228 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFH---VGAGHKPPIP 228 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHH---HhcCCCCCCC
Confidence 2221 1356788999999988766 88999999999999999999999754322111 0000 0111111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
........+.+++.+||+.+|++||+++|++.|+|.
T Consensus 229 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 229 ----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 111112356789999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.94 Aligned_cols=259 Identities=26% Similarity=0.369 Sum_probs=211.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|++|.||+|..+ +++.||+|++..... ....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 36888999999999999999665 599999999876532 13467789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
+||+++++|.+++... ..+++..++.++.|+++|++|+|+ . +++||||+|+||+++.++.++|+|||.+....
T Consensus 78 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 78 LEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999543 568999999999999999999999 8 99999999999999999999999999998775
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... ..+...........
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~---~~~~~~~~~~~~~~ 226 (264)
T cd06623 152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELM---QAICDGPPPSLPAE 226 (264)
T ss_pred cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHH---HHHhcCCCCCCCcc
Confidence 544433456788999999999998999999999999999999999999754432 0111111 11111111111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....+.+++.+||+++|++||+++|+++|+|...
T Consensus 227 --~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 227 --EFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred --cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 02236788899999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=330.74 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=203.2
Q ss_pred cceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC--eeEEEEee
Q 039595 756 KFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR--HSFLVCEY 832 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E~ 832 (1078)
..+||+|+|-+||+|.+ .+|..||--.++.....+.....++|..|+.+++.++||||+++|+++.+.. ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 45699999999999954 4677787655555555666777899999999999999999999999997655 47899999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEecccccccccCCC
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~a~~~~~~~ 911 (1078)
+..|+|..|.++ .+..+.+.+..|++||++||.|||++ .|+|+|||||-+||||+.+ |.|||+|+|+|+.....
T Consensus 125 ~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999954 45578899999999999999999997 4689999999999999765 89999999999977542
Q ss_pred CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHH
Q 039595 912 SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1078)
.....+|||.|||||.+. ..|.+.+||||||+++.||+|+..||.-... .+.++ .++-.-+.|.--....
T Consensus 200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-~AQIY---KKV~SGiKP~sl~kV~---- 269 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-PAQIY---KKVTSGIKPAALSKVK---- 269 (632)
T ss_pred -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-HHHHH---HHHHcCCCHHHhhccC----
Confidence 333479999999999887 6899999999999999999999999642221 11111 1111111111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 992 KLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 992 ~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
..++.++|.+|+.. .++|||+.|+|.|+|+..+.
T Consensus 270 -dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 270 -DPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred -CHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 12577899999999 99999999999999988763
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.50 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=206.0
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee--cCCeeEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS--NARHSFL 828 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l 828 (1078)
+|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++. .+...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 578889999999999999954 5788999999865432 2344567889999999999999999999875 3456899
Q ss_pred EEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHH-----hcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 829 VCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLH-----HDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
+|||+++++|.+++... .....+++..++.++.|++.|++||| +. +++||||+|+||+++.++.+|++|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence 99999999999998543 22456899999999999999999999 76 99999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
++..............++..|+|||.+.+..++.++||||||+++|+|++|+.||+... ....... +.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~------~~~~~~ 227 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASK------IKEGKF 227 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHH------HhcCCC
Confidence 99877654433445678999999999999889999999999999999999999976433 1111111 111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
..... .....+.+++.+|++.+|++||+++++++|||.
T Consensus 228 ~~~~~---~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 228 RRIPY---RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CCCcc---ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 11111 122367889999999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=326.31 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=208.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+.+|+.+++.++||||+++++++..+...|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 46888999999999999999664 5899999999765322 123456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+.+++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 80 MDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999998533 345689999999999999999999999 999999999999999999999999999875532
Q ss_pred CCC-----------------------------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 039595 910 YSS-----------------------------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 960 (1078)
Q Consensus 910 ~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~ 960 (1078)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 111 111346888999999999988999999999999999999999997533
Q ss_pred cccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCC----hhHHHHHhhhhh
Q 039595 961 SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT----MEKGFGHHIGYC 1025 (1078)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ell~h~~~~~ 1025 (1078)
+.. . ....+.......+.. ......+.+++.+||..||++||| ++|++.|+|+..
T Consensus 236 ~~~--~------~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 236 NRD--E------TFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred chH--H------HHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 221 0 111111111111111 112346889999999999999999 999999999753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.75 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=203.8
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG-NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+|+..+.||+|+||+||+|..+ +++.||+|.+....... ..+..+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999665 78999999986533211 123456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+++++|.+++.+ ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999943 34588999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCceeeccccccccccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||..... . ......... .........
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~---~~~~~~~~~--~~~~~~~~~ 226 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--V---AAVFKIGRS--KELPPIPDH 226 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--H---HHHHHHHhc--ccCCCcCCC
Confidence 32 234456889999999987766 89999999999999999999999753321 0 000111110 111111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
....+.+++.+||+.+|++||++++++.|+|.
T Consensus 227 ---~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 227 ---LSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ---cCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 12356788999999999999999999999984
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.40 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=205.1
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC---CCceeeEEeeeecCCeeE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR---HRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~ 827 (1078)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+++.+|+.++++++ |||++++++++.++...+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 477788999999999999965 578999999986542 2234567888999998886 999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++++|.++++. ..+++..++.++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 99999999999999843 2688999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
...........|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...... ...........+.+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~- 225 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIPKSKPPRLEDN- 225 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccccCCCCCCCcc-
Confidence 6544444556789999999988754 5689999999999999999999997532211 00000001111111110
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
....++.+++.+||+.||++||++.|++.|+|+...
T Consensus 226 ----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 226 ----GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred ----cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 123467889999999999999999999999998543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=325.10 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=203.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||.||+|..+ +++.||+|++...... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc--chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 46888999999999999999765 6899999998654322 22345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||++++++.++... ...+++.++..++.||+.|++|||+. +++|||++|+||++++++.++++|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 79 FEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999999999887733 23489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh-------hh------h
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-------EV------N 975 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~-------~~------~ 975 (1078)
.........++..|+|||++.+ ..++.++||||||+++|||++|++||..... ......... .. .
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccc
Confidence 4433444568899999999875 4578899999999999999999999753221 000000000 00 0
Q ss_pred hhc----CCCCCCCC---CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 976 QIL----DPRLSTPS---PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 976 ~~~----~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.+. .+...... .........+.+++.+||+.+|++||+++++++|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 00000000 0001123468899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.64 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=199.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHH-HHhcCCCCceeeEEeeeecCCeeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVL-ALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
++|++.+.||+|+||.||+|..+ +|+.||+|++...... .....+..|+. .++..+||||+++++++..+...++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 47889999999999999999664 6999999998754321 22334444555 4667799999999999999999999
Q ss_pred EEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 829 VCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
||||++ |+|.+++... .....+++..++.++.||+.|++|||+++ +++||||||+||+++.++.+||+|||.++..
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999997 5888877432 23356899999999999999999999853 8999999999999999999999999999865
Q ss_pred cCCCCCceeecccccccccccccc----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYT----MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
... .......|+..|+|||.+.+ ..++.++|+||+||++|||++|+.||............ ......+...
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~ 229 (283)
T cd06617 155 VDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ----VVEEPSPQLP 229 (283)
T ss_pred ccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH----HHhcCCCCCC
Confidence 432 12233568899999998865 45688999999999999999999997532221111111 1111111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
... ...++.+++.+||..+|++||++++++.|+|+....
T Consensus 230 --~~~---~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 230 --AEK---FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred --ccc---cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 111 123577899999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.47 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=204.0
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN--MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
+|+..+.||+|+||.||+|.. .+++.||+|++........ ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999964 5789999999865432111 1234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEecccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHVSDFGIAKFV 907 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a~~~ 907 (1078)
|+||+++++|.+++.+ ...+++..+..++.|++.|++|||++ +++||||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999953 34688999999999999999999999 999999999999998776 5999999999876
Q ss_pred cCCCC----CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 908 EPYSS----NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 908 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
..... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ....... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~---~~~~~~~~~ 229 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SNHLALI---FKIASATTA 229 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cchHHHH---HHHhccCCC
Confidence 54321 12235688999999999888899999999999999999999999753221 1111111 111111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
...+ .....++.+++.+|+..+|++||++.|++.|+|+
T Consensus 230 ~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 230 PSIP--EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred CCCc--hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 1111 1122467889999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=322.29 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=198.2
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCC--EEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 825 (1078)
.++|++.+.||+|+||.||+|..+ ++. .+|+|.+.... .......+.+|+.++.++ +||||+++++++..++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC---CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 457888999999999999999754 454 45777765321 223456788999999999 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 039595 826 SFLVCEYLHRGSLARILGNDA-------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL 892 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 892 (1078)
.|+||||+++|+|.+++++.. ....+++.+++.++.|++.|++|||++ +++||||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC
Confidence 999999999999999995432 123578999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhh
Q 039595 893 EFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMI 971 (1078)
Q Consensus 893 ~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~ 971 (1078)
++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||..... .....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~-- 234 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYE-- 234 (303)
T ss_pred CCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--HHHHH--
Confidence 9999999999986432111 1122234678999999988889999999999999999998 9999753221 11111
Q ss_pred hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 972 IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
... .......+. .....+.+++.+||+.+|++||++++++.+....
T Consensus 235 -~~~----~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 -KLP----QGYRLEKPL--NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -HHh----cCCcCCCCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 111111111 1123578899999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.46 Aligned_cols=260 Identities=25% Similarity=0.358 Sum_probs=201.4
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCC------hhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN------MADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
+|...+.||+|+||.||+|.. .+|+.||+|.++....... ....+.+.+|+.++++++||||+++++++..+.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477788999999999999954 4689999998864321111 112346788999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++||||+++|+|.+++++. ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999543 5688899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC--CceeeccccccccccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCC
Q 039595 905 KFVEPYSS--NRTEFVGTFGYAAPEIAYTMR--ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDP 980 (1078)
Q Consensus 905 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 980 (1078)
+....... ......|+..|+|||.+.... ++.++||||+|+++||+++|+.||...... . ...........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~---~~~~~~~~~~~~ 231 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-A---AMFKLGNKRSAP 231 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-H---HHHHhhccccCC
Confidence 76543211 123456889999999987654 789999999999999999999997532211 0 000000000111
Q ss_pred CCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 981 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
..... ........+.+++.+||.++|++||+++++++|+|.
T Consensus 232 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 PIPPD--VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cCCcc--ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 11111 111223467888999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=315.56 Aligned_cols=256 Identities=22% Similarity=0.285 Sum_probs=200.3
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--Cee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG-NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--RHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 826 (1078)
++|++.+.||+|+||.||+|.. .+++.||+|.+....... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5788999999999999999965 468999999886432211 223456788899999999999999999998653 467
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++++|.+++.+. ..+++..+.+++.|++.||+|||++ +++||||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998432 3478899999999999999999999 999999999999999999999999999986
Q ss_pred ccCCC---CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 907 VEPYS---SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 907 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .... .....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~--~~~~~~~~~ 228 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAIF--KIATQPTNP 228 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHHH--HHhcCCCCC
Confidence 54211 1223356889999999998888999999999999999999999997532111 0111 111111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
. .+ ......+.+++.+|+. +|++||+++|+++|+|.
T Consensus 229 ~-~~--~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 229 V-LP--PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred C-Cc--hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 1 11 1223367788888985 99999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.84 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=198.9
Q ss_pred hcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
.++|.+.+.||+|+||+||++... ++..+|+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 357888999999999999999642 3456899988643 233456789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCC----------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC
Q 039595 824 RHSFLVCEYLHRGSLARILGNDA----------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE 893 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 893 (1078)
...++||||+++++|.+++.... ....+++.++..++.|++.||+|||++ +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 99999999999999999985332 223589999999999999999999999 99999999999999999
Q ss_pred CcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhh
Q 039595 894 FEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNM 970 (1078)
Q Consensus 894 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~ 970 (1078)
+.++|+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~~~~~~ 234 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIEC 234 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH
Confidence 9999999999986543221 1223345778999999998899999999999999999998 8999643321 111111
Q ss_pred hhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 971 IIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
+ ............ ..++.+++.+||+.||.+|||++|+....
T Consensus 235 i------~~~~~~~~~~~~---~~~l~~li~~~l~~~p~~Rpt~~~v~~~l 276 (288)
T cd05093 235 I------TQGRVLQRPRTC---PKEVYDLMLGCWQREPHMRLNIKEIHSLL 276 (288)
T ss_pred H------HcCCcCCCCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 1 111111111111 23578999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.22 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=198.8
Q ss_pred hhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN 822 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 822 (1078)
..++|++.+.||+|+||.||+|.+. .+..||+|.+.... .......|.+|+.++++++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3467899999999999999999664 35678999875432 23334568899999999999999999999998
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCC----CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---c
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDAT----AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF---E 895 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~ 895 (1078)
....++||||+++|+|.+++..... ...+++.++++++.||+.|++|||++ +++||||||+||+++.++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcc
Confidence 8899999999999999999854321 23589999999999999999999999 999999999999998765 5
Q ss_pred EEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhh
Q 039595 896 AHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMII 972 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 972 (1078)
+|++|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |+.||+.... ........
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~~~~~~~~ 235 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEVMEFVT 235 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH
Confidence 999999999866322111 112234568999999998899999999999999999997 9999753221 11111111
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
. ...+.. .... ...+.+++.+||+.+|++||++.++++|.
T Consensus 236 ~---~~~~~~---~~~~---~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 236 G---GGRLDP---PKGC---PGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred c---CCcCCC---CCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 1 011111 1111 23678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.19 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=201.1
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|+||.||+|..+ +|+.||||++...... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc--cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 4788899999999999999654 6899999998654321 223456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+. ++|.+++... ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||.+......
T Consensus 79 e~~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 79 EFLH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eccc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9996 5898888543 345689999999999999999999999 9999999999999999999999999999866443
Q ss_pred CCCceeeccccccccccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh-----------hh-
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN-----------QI- 977 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~- 977 (1078)
........++..|+|||.+.+.. ++.++||||||+++|||+||+.||...... ........... ..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 33334446788999999887644 688999999999999999999997532211 11100000000 00
Q ss_pred -cCCCCCCCCCccH-----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 978 -LDPRLSTPSPGVM-----DKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 978 -~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
....+........ .....+.+++.+||+.||++|||++|++.|||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000000000000 011356789999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=347.67 Aligned_cols=267 Identities=23% Similarity=0.246 Sum_probs=213.5
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
+....++|++++.||+|+||.|..++.+ +++.||+|++.+.... ...+...|.+|..+|..-+.+-|++++-.|.++.
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl-Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML-KRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh-hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3334679999999999999999999664 7899999999875433 2345677999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
+.|+|||||+||+|..++.+. .+++++.++.++..|+.||..+|+. |+|||||||+|||+|..|++|++|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999543 2699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCC-ceeeccccccccccccc----c-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 905 KFVEPYSSN-RTEFVGTFGYAAPEIAY----T-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 905 ~~~~~~~~~-~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
-.+...+.. ....+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||. .+.....+..+......+
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY--adslveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY--ADSLVETYGKIMNHKESL 300 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch--HHHHHHHHHHHhchhhhc
Confidence 888755544 45678999999999986 2 578999999999999999999999953 333322222222221111
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCC---hhHHHHHhhhhhhHH
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT---MEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~h~~~~~~~~ 1028 (1078)
.-| +.........++|.+.+. +|+.|.. ++++-.|||+.-.+-
T Consensus 301 ----~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 301 ----SFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ----CCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 111 111122345566666555 7888887 999999999876544
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=313.38 Aligned_cols=250 Identities=27% Similarity=0.445 Sum_probs=198.2
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|++.+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++||+++++++++.. ...++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEE
Confidence 357889999999999999999888888999999875432 24568899999999999999999998864 567899
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999999998543 234589999999999999999999999 999999999999999999999999999986643
Q ss_pred CCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 910 YSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 910 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
... ......++..|+|||...+..++.++||||||+++|||++ |+.||..... ...... ......+ +.+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~---~~~~~~~----~~~ 225 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQ---VERGYRM----PCP 225 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH---HHcCCCC----CCC
Confidence 221 1222345678999999988889999999999999999999 8889653221 111111 1111111 111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
......+.+++.+||.++|++|||++++.+-
T Consensus 226 --~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 256 (260)
T cd05070 226 --QDCPISLHELMLQCWKKDPEERPTFEYLQSF 256 (260)
T ss_pred --CcCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1122368899999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=319.51 Aligned_cols=254 Identities=19% Similarity=0.301 Sum_probs=198.2
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
.+|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 35777889999999999999653 24689999987542 2233567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCC-------------CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 039595 825 HSFLVCEYLHRGSLARILGND-------------ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 891 (1078)
..++++||+.+++|.+++... .....+++..+..++.|++.||+|+|++ +++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence 999999999999999998421 1123578889999999999999999999 999999999999999
Q ss_pred CCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchh
Q 039595 892 LEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFS 968 (1078)
Q Consensus 892 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~ 968 (1078)
+++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~ 236 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVI 236 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence 999999999999886543221 1223445789999999988889999999999999999998 8888643221 1111
Q ss_pred hhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 969 NMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
..+..+.......... ..+.+++.+||+.+|++||++++++...
T Consensus 237 ------~~i~~~~~~~~~~~~~---~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 237 ------EMIRNRQVLPCPDDCP---AWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred ------HHHHcCCcCCCCCCCC---HHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 1111222111112222 2467899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=316.32 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=204.7
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
-|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|+..+++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 477788999999999999965 468899999875432 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 82 e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 82 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99999999999842 3588999999999999999999998 9999999999999999999999999999866543
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
........++..|+|||.+.+..++.++|||||||++|+|++|..||...... ... ........+... .
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~---~~~~~~~~~~~~---~--- 223 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVL---FLIPKNNPPTLE---G--- 223 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHH---HHHhcCCCCCCC---c---
Confidence 33334456888999999998888899999999999999999999997532211 000 001011111111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....+.+++.+||+.+|++||++++++.|+|...
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 11235778899999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=318.92 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=204.1
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.|+..+.||+|++|.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..+...++|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 455567899999999999965 478899999885432 233456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 99999999999843 4588999999999999999999999 9999999999999999999999999998765443
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ..........+..... .
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~---~~~~~~~~~~~~~~~~----~ 239 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQ---AMKRIRDNLPPKLKNL----H 239 (285)
T ss_pred CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HH---HHHHHHhcCCCCCccc----c
Confidence 3333445789999999999988899999999999999999999999643221 11 1111111111111111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....+.+++.+||+.+|++||++.++++|+|+..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 12236788999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.92 Aligned_cols=255 Identities=20% Similarity=0.349 Sum_probs=198.7
Q ss_pred hhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN 822 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 822 (1078)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+..++.++||||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4678999999999999999999543 24579999876432 23344568889999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCC-------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDAT-------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE 895 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 895 (1078)
+...++||||+++|+|.++++.... ....++..+..++.|++.|+.|||++ +|+||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 9999999999999999999954221 23457788999999999999999999 9999999999999999999
Q ss_pred EEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhh
Q 039595 896 AHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMII 972 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 972 (1078)
++++|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~~~~~--- 232 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLK--- 232 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH---
Confidence 999999999865432211 122345778999999998899999999999999999998 7888643221 11111
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.+.+.......... ...+.+++.+||+.||++|||+.++++.
T Consensus 233 ---~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~ 274 (288)
T cd05061 233 ---FVMDGGYLDQPDNC---PERVTDLMRMCWQFNPKMRPTFLEIVNL 274 (288)
T ss_pred ---HHHcCCCCCCCCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11111111111111 2367889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=317.14 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=193.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCC----EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
++|++.+.||+|+||+||+|.+. +++ .||+|.+.... ......++..|+..+++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc---chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 57888899999999999999753 455 47777764321 22334567788889999999999999998864 45
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++++||+++|+|.+++... ...+++..+..++.||+.|++|||++ +++||||||+||+++.++.+||+|||.++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence 78899999999999999542 34589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 906 FVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 906 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
....... ......++..|+|||.+.++.++.++|||||||++||+++ |+.||...... .......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~-----~~ 230 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGE-----RL 230 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC-----cC
Confidence 6643221 1233456789999999998899999999999999999998 99997533221 1111111111 11
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.. +.. ...++.+++.+||..||++|||+.|+++..
T Consensus 231 ~~--~~~--~~~~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 231 AQ--PQI--CTIDVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred CC--CCC--CCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11 111 112567889999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=312.33 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=191.4
Q ss_pred eeccCCceeEEEEEe---CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 758 CIGKGGQGSVYKAEL---PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
.||+|+||.||+|.+ ++++.||+|++.... ......+++.+|+.+++.++||||+++++++.. ...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence 589999999999954 357889999986442 233445678999999999999999999998864 56789999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC-
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN- 913 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~- 913 (1078)
+|+|.+++.. ...+++..+..++.|++.|++|+|++ +++||||||+||+++.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 79 LGPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999999943 34588999999999999999999999 9999999999999999999999999999876433221
Q ss_pred --ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 914 --RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 914 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
.....++..|+|||.+....++.++|||||||++|||++ |+.||..... ......+. ....+..+ ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~---~~~~~~~~---~~~- 223 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIE---SGERMECP---QRC- 223 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH---CCCCCCCC---CCC-
Confidence 122234578999999988889999999999999999998 9999764322 11111111 11111111 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
..++.+++.+||+.||++||++++|....
T Consensus 224 --~~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 224 --PPEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred --CHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 23577899999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.83 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=196.6
Q ss_pred cCC-CccceeccCCceeEEEEEe-----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--
Q 039595 751 DDF-DEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN-- 822 (1078)
Q Consensus 751 ~~~-~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-- 822 (1078)
++| ++.+.||+|+||+||++.. .+++.||+|.+.... .....+.+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 344 8889999999999988643 357889999986542 12345678899999999999999999998864
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
....++||||+++|+|.+++.. ..+++.+++.++.|++.|++|||++ +++||||||+||+++.++.++|+|||
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence 3468999999999999999843 3489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh------hh
Q 039595 903 IAKFVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI------IE 973 (1078)
Q Consensus 903 ~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~------~~ 973 (1078)
+++........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 99876432211 1223456679999999988899999999999999999999999754332211111000 00
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.....+.....+.+. .....+.+++.+||+++|++|||++++++..
T Consensus 233 ~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 233 LIELLERGMRLPCPK--NCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred hhhhhhcCCCCCCCC--CCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 111111111111111 1123678899999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.89 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=201.9
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
...++|+..+.||+|+||.||+|... ....||+|++.... .......+.+|+.+++++ +||||+++++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34467889999999999999999653 23679999987542 223456688999999999 899999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCC-------------CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 039595 821 SNARHSFLVCEYLHRGSLARILGND-------------ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 887 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 887 (1078)
..++..++||||+++|+|.++++.. .....+++..++.++.|++.|++|||+. +|+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence 9999999999999999999998542 2345689999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccc
Q 039595 888 VLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINF 964 (1078)
Q Consensus 888 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~ 964 (1078)
|+++.++.+|++|||.++........ .....++..|+|||++.+..++.++|||||||++||+++ |..||.....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 99999999999999999876432211 122335678999999998899999999999999999997 8888643221
Q ss_pred cchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 965 SSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
....... ... ..... .. .....+.+++.+||+.||++|||++|++++.-
T Consensus 241 ~~~~~~~---~~~--~~~~~-~~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 241 EELFKLL---KEG--YRMEK-PQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred HHHHHHH---HcC--CcCCC-CC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 1111111 111 11111 11 11236788999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=319.56 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=196.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCC--EEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
++|++.+.||+|+||.||+|..+ ++. .+|+|.++... .....+.+.+|+.+++++ +||||+++++++......
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 57899999999999999999664 333 47888876321 223356788999999999 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC
Q 039595 827 FLVCEYLHRGSLARILGNDA-------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE 893 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 893 (1078)
++|+||+++|+|.+++.... ....+++..++.++.|++.|++|||++ +++||||||+||+++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence 99999999999999995432 123588899999999999999999998 99999999999999999
Q ss_pred CcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhh
Q 039595 894 FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMII 972 (1078)
Q Consensus 894 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 972 (1078)
+.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |+.||...... ... .
T Consensus 156 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~~---~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELY---E 229 (297)
T ss_pred CeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH---H
Confidence 999999999987432211 1111233567999999998889999999999999999997 99997533221 111 1
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.......+... ... ...+.+++.+||+.+|.+||+++++++...
T Consensus 230 ~~~~~~~~~~~---~~~---~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 230 KLPQGYRMEKP---RNC---DDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred HHhcCCCCCCC---CCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111111111 111 235778999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=316.72 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=200.6
Q ss_pred hcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
.++|++.+.||+|+||.||+|..+ ++..||+|.+.... .......+.+|+.+++.++||||+++++++..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 357889999999999999999653 24689999986432 234456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCC-------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 039595 824 RHSFLVCEYLHRGSLARILGNDAT-------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEA 896 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 896 (1078)
...++||||+++|+|.+++..... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 999999999999999999854322 23478899999999999999999999 99999999999999999999
Q ss_pred EEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhh
Q 039595 897 HVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIE 973 (1078)
Q Consensus 897 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 973 (1078)
||+|||+++....... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ......
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~--- 233 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKF--- 233 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHH---
Confidence 9999999986543221 2233456789999999988889999999999999999998 8999653221 111111
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
............. ...+.+++.+||+.+|++|||+.++++.
T Consensus 234 ---~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 234 ---VIDGGHLDLPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred ---HhcCCCCCCCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1111111111111 2367889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=322.38 Aligned_cols=267 Identities=21% Similarity=0.240 Sum_probs=203.8
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN-MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+|+..+.||+|+||.||+|... +++.||||++........ ......+..|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999654 689999999976543211 12234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+ +|+|.+++.... ..+++.++..++.||++||+|||++ +++||||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889999995432 3689999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh-------------
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN------------- 975 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~------------- 975 (1078)
.........++..|+|||.+.+ ..++.++|||||||++|||++|.+||..... ............
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhcccc
Confidence 4333344567889999998865 4678999999999999999999877643221 110000000000
Q ss_pred -hhcCCCCCCCC---CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 976 -QILDPRLSTPS---PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 976 -~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
........... .........+.+++.+||++||++|||++|++.|+|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 00000000000 000112346789999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.94 Aligned_cols=254 Identities=20% Similarity=0.338 Sum_probs=204.0
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|+||.||+|.. .+++.+|+|++..... .......+.+|+.++++++||||+++++.+..++..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 588899999999999999955 4788999999875432 2334667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEecccccccccC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~a~~~~~ 909 (1078)
||+++++|.+++... ....+++..+.+++.|++.|++|||++ +++||||+|+||+++.+ +.+|++|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 79 EYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred ecCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999999543 234588999999999999999999999 99999999999999865 4689999999987644
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||+.... ...... ...........
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~------~~~~~~~~~~~-- 223 (256)
T cd08220 155 KS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--PALVLK------IMSGTFAPISD-- 223 (256)
T ss_pred Cc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--HHHHHH------HHhcCCCCCCC--
Confidence 22 22345688999999999988899999999999999999999999753322 111111 11111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.....+.+++.+||+++|++|||++|++.|||.
T Consensus 224 -~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 224 -RYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -CcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 112357789999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=311.45 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=191.9
Q ss_pred ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCC
Q 039595 757 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHR 835 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 835 (1078)
+.||+|+||.||+|..+ +++.||+|.+.... .......+.+|++++++++||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 36899999999999654 78999999876432 233456789999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC--
Q 039595 836 GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN-- 913 (1078)
Q Consensus 836 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 913 (1078)
++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||++.........
T Consensus 78 ~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 78 GDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred CcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 9999999532 23588999999999999999999999 9999999999999999999999999999764322111
Q ss_pred ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHH
Q 039595 914 RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDK 992 (1078)
Q Consensus 914 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1078)
.....++..|+|||.+.++.++.++||||||+++|||++ |..||+..... ... ........... +. ..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~---~~~~~~~~~~~----~~--~~ 221 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTR---EAIEQGVRLPC----PE--LC 221 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHH---HHHHcCCCCCC----cc--cC
Confidence 111123467999999998899999999999999999998 88886532211 000 11111111111 11 11
Q ss_pred HHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 993 LISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 993 ~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
...+.+++.+||..+|++|||++|+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2367889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=321.25 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=200.0
Q ss_pred hcCCCccceeccCCceeEEEEEeC--------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 367999999999999999999642 23579999987542 223456788899999999 799999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDAT-------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 887 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 887 (1078)
...+..|+||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999964321 23588999999999999999999998 99999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccc
Q 039595 888 VLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINF 964 (1078)
Q Consensus 888 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~ 964 (1078)
|+++.++.+||+|||.++........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-- 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence 99999999999999999765432211 112234568999999998889999999999999999998 8888643221
Q ss_pred cchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 965 SSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
....... .... .. ...... ..++.+++.+||..+|++|||+.+++++...
T Consensus 249 ~~~~~~~---~~~~--~~-~~~~~~---~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 249 EELFKLL---KEGH--RM-DKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HHHHHHH---HcCC--CC-CCCCcC---CHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 1111111 1111 11 111111 2367788999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=319.42 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=200.2
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
.+|.+.+.||+|+||.||+|+.. ++..+|+|.+... .....+.+.+|+..+++++||||+++++++..+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 46788899999999999999642 3456899987543 2334567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 039595 825 HSFLVCEYLHRGSLARILGNDA-------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 891 (1078)
..++||||+++++|.+++.... ....+++..++.++.||+.|++|||++ +++||||||+||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence 9999999999999999995432 234589999999999999999999999 999999999999999
Q ss_pred CCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchh
Q 039595 892 LEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFS 968 (1078)
Q Consensus 892 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~ 968 (1078)
.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|||+| |+.||...... ...
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~ 235 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVI 235 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999976543221 1233456788999999999999999999999999999999 99996533221 111
Q ss_pred hhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 969 NMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
. .+........... ....+.+++.+||+.||++|||++++++...
T Consensus 236 ~------~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 236 E------CITQGRVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred H------HHhCCCCCCCCcc---CCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 1 1111111111111 1235789999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=317.31 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=197.1
Q ss_pred CCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
+|++.+.||+|+||.||+|... ....+|+|.+.... .......+.+|+.+++.++||||+++++++..++.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 4788899999999999999642 23578888876532 22345678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCC---------------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 039595 826 SFLVCEYLHRGSLARILGNDA---------------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 884 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 884 (1078)
.++|+||+.+|+|.+++.... ....+++..++.++.|++.|++|||+. +++|||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dik 154 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLA 154 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhh
Confidence 999999999999999985321 123578999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccc
Q 039595 885 SKNVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFS 961 (1078)
Q Consensus 885 ~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~ 961 (1078)
|+||++++++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999986533221 1223345678999999988889999999999999999998 999964322
Q ss_pred ccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 962 INFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
. ...... .........+. ....++.+++.+||+.+|++||+++|++...
T Consensus 235 ~--~~~~~~-------~~~~~~~~~~~--~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 235 P--ERLFNL-------LKTGYRMERPE--NCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred H--HHHHHH-------HhCCCCCCCCC--CCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 1 111111 11111111111 1123677899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=321.59 Aligned_cols=264 Identities=22% Similarity=0.223 Sum_probs=205.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||.||+|..+ +++.||+|.+...... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 46889999999999999999654 6789999998654321 223355788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.+++.. .+.+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 80 MEYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999943 34588999999999999999999999 999999999999999999999999999864211
Q ss_pred CC---------------CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh
Q 039595 910 YS---------------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 910 ~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--~~~~~~~~~~- 230 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELFGQVIS- 230 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHh-
Confidence 00 01112457889999999998889999999999999999999999964221 1111111100
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCC---hhHHHHHhhhhhhHHHH
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT---MEKGFGHHIGYCDEILA 1030 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~h~~~~~~~~~~ 1030 (1078)
.......... .....+.+++.+||+.||++||+ +.++++|+|+...+...
T Consensus 231 ---~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 231 ---DDIEWPEGDE---ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred ---cccCCCCccc---cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 0001111111 11235678999999999999998 79999999986655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=319.12 Aligned_cols=260 Identities=20% Similarity=0.337 Sum_probs=196.9
Q ss_pred hcCCCccceeccCCceeEEEEEeCC---------------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCcee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPS---------------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 814 (1078)
.++|++.+.||+|+||.||+|.... ...||+|+++... .......+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3579999999999999999985432 2358999986542 233456789999999999999999
Q ss_pred eEEeeeecCCeeEEEEeecCCCCHHHHhcCCC---------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 039595 815 KFHGFCSNARHSFLVCEYLHRGSLARILGNDA---------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISS 885 (1078)
Q Consensus 815 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 885 (1078)
++++++......++||||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++||||||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp 157 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT 157 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence 99999999999999999999999999985421 112468889999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh--CCCCCCccc
Q 039595 886 KNVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK--GNHPRDFFS 961 (1078)
Q Consensus 886 ~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~p~~~~~ 961 (1078)
+||+++.++.+|++|||++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999999976533221 1122345778999999998899999999999999999998 556654322
Q ss_pred ccccchhhhhhhh-hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 962 INFSSFSNMIIEV-NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 962 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
. .......... ............+. ....+.+++.+||+.||++||+++++++.
T Consensus 238 ~--~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 292 (295)
T cd05097 238 D--EQVIENTGEFFRNQGRQIYLSQTPL---CPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292 (295)
T ss_pred h--HHHHHHHHHhhhhccccccCCCCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 1 1111111110 00001111111111 12368899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=323.71 Aligned_cols=257 Identities=22% Similarity=0.315 Sum_probs=213.0
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
...|.+.+.||+|.|++|.+|.+ .++..||||.+++... +......+.+|+.+|+.+.|||||+++++.+....+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 45688889999999999999955 4799999999987643 44555568999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+.+|.+++++.+. ++..+..+..++.|+..|++|+|++ .|||||||++||+++.++.+||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999544 4455688899999999999999999 99999999999999999999999999999887
Q ss_pred CCCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
. ......++|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+... ..............++-.+
T Consensus 207 ~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--lk~Lr~rvl~gk~rIp~~m----- 278 (596)
T KOG0586|consen 207 Y-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--LKELRPRVLRGKYRIPFYM----- 278 (596)
T ss_pred c-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--cccccchheeeeeccccee-----
Confidence 3 455677899999999999998876 679999999999999999999976322 2222221111111111111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
..++-+++++++-.+|.+|++++++..|.|.....
T Consensus 279 -----s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 279 -----SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred -----echhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 12566889999999999999999999999976543
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=312.33 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=197.3
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.+|++.++||+|+||.||+|..+++..||+|++..... ..+.+.+|+.++++++||||+++++++.+ ...++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 56999999999999999999877677899999875321 24578899999999999999999998754 5579999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++... ....+++..+..++.|++.||+|+|+. +++||||||+||+++.++.++|+|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 80 EYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999999543 234578999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCC-ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 911 SSN-RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 911 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
... .....++..|+|||+..+..++.++|||||||++|||++ |+.||..... ...... .........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--~~~~~~---~~~~~~~~~------ 224 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ---VERGYRMPC------ 224 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--HHHHHH---HhcCCCCCC------
Confidence 221 123346778999999988899999999999999999999 8888653221 111111 111011111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.......+.+++.+|+++||++||+++++++-
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAF 256 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 11223467899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.20 Aligned_cols=255 Identities=27% Similarity=0.326 Sum_probs=207.2
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|++.+.||+|+||.||+|..+ +++.||+|++...... .....+.+.+|+.++++++||||+++++++.++...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 4888999999999999999665 6899999999764322 2234667899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+.+++|.+++... ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 80 DLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred eCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999999432 5688999999999999999999999 9999999999999999999999999999866442
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
. ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ...........+..+. .
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~---~-- 224 (258)
T cd05578 154 T-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR---DQIRAKQETADVLYPA---T-- 224 (258)
T ss_pred c-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH---HHHHHHhccccccCcc---c--
Confidence 2 23445688899999999988899999999999999999999999764432111 1111100001111111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCh--hHHHHHhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPTM--EKGFGHHIG 1023 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~--~ell~h~~~ 1023 (1078)
....+.+++.+||+.||.+||++ +|+++|+|+
T Consensus 225 -~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 225 -WSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -CcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 12467789999999999999999 999999985
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=330.71 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=201.6
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEe
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHG 818 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~ 818 (1078)
.....++|.+.+.||+|+||.||+|.+. .++.||+|++.... .....+.+.+|+.++.++. ||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3444567888999999999999999753 34689999997542 2223456889999999997 999999999
Q ss_pred eeecCCeeEEEEeecCCCCHHHHhcCCCC---------------------------------------------------
Q 039595 819 FCSNARHSFLVCEYLHRGSLARILGNDAT--------------------------------------------------- 847 (1078)
Q Consensus 819 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------------------------------------------- 847 (1078)
++...+..++||||+++|+|.+++++...
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 99999999999999999999999954311
Q ss_pred --------------------------------------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 039595 848 --------------------------------------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDI 883 (1078)
Q Consensus 848 --------------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 883 (1078)
...+++.+++.++.|++.||+|||+. +++||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdl 265 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDL 265 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccC
Confidence 12367788899999999999999998 9999999
Q ss_pred CCCCeeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcc
Q 039595 884 SSKNVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 960 (1078)
Q Consensus 884 k~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~ 960 (1078)
||+||+++.++.+|++|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999986532211 1223457889999999998889999999999999999998 88997533
Q ss_pred cccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 961 SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
... ......+ ........+. .....+.+++.+||..+|.+||+++|+++.+-
T Consensus 346 ~~~-~~~~~~~-------~~~~~~~~p~--~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 346 PMN-EQFYNAI-------KRGYRMAKPA--HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred Cch-HHHHHHH-------HcCCCCCCCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 211 1011111 1111111111 11236788899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=319.67 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=200.8
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
...++|++.+.||+|+||.||+|... ++..||+|+++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 34467999999999999999999531 34579999986542 223456789999999999 799999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
...+..++||||+.+|+|.++++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence 99999999999999999999995432 23489999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhh
Q 039595 901 FGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQI 977 (1078)
Q Consensus 901 fG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 977 (1078)
||+++....... ......++..|+|||.+.+..++.++||||+||++|||++ |+.||...... ..... .
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~-------~ 256 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYK-------L 256 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHH-------H
Confidence 999986543221 1122345778999999999999999999999999999998 99996533221 01111 1
Q ss_pred cCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.........+.. ....+.+++.+||+++|++|||+.|++...
T Consensus 257 ~~~~~~~~~~~~--~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 257 IKEGYRMAQPEH--APAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred HHcCCcCCCCCC--CCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 111111111111 123678899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=318.73 Aligned_cols=262 Identities=21% Similarity=0.345 Sum_probs=200.2
Q ss_pred hcCCCccceeccCCceeEEEEEeCC-----------------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPS-----------------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 812 (1078)
..+|++.+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+.++++++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCC
Confidence 3578999999999999999986542 2458999987542 2345677889999999999999
Q ss_pred eeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCC--------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 039595 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDA--------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 884 (1078)
Q Consensus 813 iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 884 (1078)
|+++++++..++..++|+||+++++|.+++.+.. ....+++..++.++.|++.||+|||+. +++|||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 9999999999999999999999999999985432 123689999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh--CCCCCCcc
Q 039595 885 SKNVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK--GNHPRDFF 960 (1078)
Q Consensus 885 ~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~p~~~~ 960 (1078)
|+||+++.++.++++|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999999986533221 1233456788999999998889999999999999999998 66776432
Q ss_pred cccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 961 SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.. ......................+ .....++.+++.+||+.||++|||+.|+++..
T Consensus 238 ~~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 238 TD--QQVIENAGHFFRDDGRQIYLPRP--PNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred Ch--HHHHHHHHhccccccccccCCCc--cCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 21 11111111100000000000001 11123688999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.99 Aligned_cols=262 Identities=22% Similarity=0.246 Sum_probs=208.7
Q ss_pred hhcCCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..+.|+.-++||+|+||.||-+. ..+|+.||.|++.+..... ........+|-.++.++..+.||.+-..|+..+..|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34678888999999999999994 4589999999987654332 222345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+|+..|.||+|.-+|.... ...++++.++.++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|.|+|..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999998885443 35799999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc-CCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL-DPRLSTPS 986 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 986 (1078)
... ......+||.+|||||++.+..|+...|.||+||++|||+.|+.||....... .+........- +..++
T Consensus 338 ~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---k~eEvdrr~~~~~~ey~--- 410 (591)
T KOG0986|consen 338 PEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---KREEVDRRTLEDPEEYS--- 410 (591)
T ss_pred CCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---hHHHHHHHHhcchhhcc---
Confidence 653 33445599999999999999999999999999999999999999976332211 01000000000 11111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~ 1025 (1078)
....+ +..++.+..|.+||++|. .++++-+|||+..
T Consensus 411 ~kFS~---eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 411 DKFSE---EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred cccCH---HHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 22222 455666678999999998 4779999998764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.44 Aligned_cols=260 Identities=21% Similarity=0.222 Sum_probs=206.9
Q ss_pred hhcCCCcc-ceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhc-CCCCceeeEEeeeec---
Q 039595 749 ATDDFDEK-FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE-IRHRNIVKFHGFCSN--- 822 (1078)
Q Consensus 749 ~~~~~~~~-~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~--- 822 (1078)
.+++|++. ++||-|-.|.|..+.. .+++++|+|++... ...++|++..=. -.|||||+++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 45666663 5799999999999954 48999999997532 335667765433 379999999999853
Q ss_pred -CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEE
Q 039595 823 -ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE---FEAHV 898 (1078)
Q Consensus 823 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl 898 (1078)
...+.+|||.|+||.|+..++.. ....+++.++..|.+||+.|+.|||+. +|.||||||+|+|.... ..+|+
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence 45678999999999999999543 456799999999999999999999999 99999999999999754 57999
Q ss_pred ecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
+|||+|+..... ....+.+-|+.|.|||++....|+..+|+||+||++|-|++|.+||..... ..+... ....+.
T Consensus 206 tDfGFAK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispg--Mk~rI~ 280 (400)
T KOG0604|consen 206 TDFGFAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPG--MKRRIR 280 (400)
T ss_pred cccccccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChh--HHhHhh
Confidence 999999866542 233456779999999999999999999999999999999999999643222 222211 112333
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
...+.-+.+++.....+..++|+.+|+.+|++|.|++|+++|||....
T Consensus 281 ~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 281 TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 344455556667777788999999999999999999999999998754
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=311.46 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=198.8
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.+|++.+.||+|+||.||+|.+.+++.+|+|++.... .....+.+|++++++++||+|+++++++......++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-----MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-----CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 4688889999999999999987778899999886432 22456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++... ...++++.+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 79 EFMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 999999999998542 23578899999999999999999999 9999999999999999999999999999765332
Q ss_pred CC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 911 SS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 911 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ......++..|+|||.+.++.++.++||||+|+++|||++ |+.||..... ...............+..
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~------ 225 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETINAGFRLYKPRL------ 225 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHhCCCCCCCCCC------
Confidence 11 1122345678999999998899999999999999999998 9999653221 111111111101111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
....+.+++.+||+.+|++|||++|++++
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 12367889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=316.11 Aligned_cols=253 Identities=23% Similarity=0.403 Sum_probs=197.8
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
++|+..++||+|+||.||+|... ++..+|+|.+... .....+.+.+|+..++.++||||+++++++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 56788899999999999999532 3568999987643 2344567899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCC------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 039595 825 HSFLVCEYLHRGSLARILGNDAT------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL 892 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 892 (1078)
..++||||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 99999999999999999854322 13578999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhh
Q 039595 893 EFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 893 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~ 969 (1078)
++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |++||..... .....
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~ 235 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEAIE 235 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHHHH
Confidence 99999999999975532211 1123345788999999999899999999999999999998 8999643221 11111
Q ss_pred hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
. ............. ...+.+++.+||+.||.+||+++|+.+..
T Consensus 236 ~------~~~~~~~~~~~~~---~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 236 C------ITQGRELERPRTC---PPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred H------HHcCccCCCCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 1 1111111111111 12567899999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=297.48 Aligned_cols=276 Identities=20% Similarity=0.258 Sum_probs=205.4
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CC----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PS----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN 822 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 822 (1078)
+....|+.+..||+|+||.||+|.. ++ ...+|+|+++..... ..-....-+|+..+++++||||+.+..++..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~--tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG--TGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC--CCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 4456799999999999999999933 22 236999999765321 1112346789999999999999999999866
Q ss_pred -CCeeEEEEeecCCCCHHHHhcC--CCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC----Cc
Q 039595 823 -ARHSFLVCEYLHRGSLARILGN--DATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE----FE 895 (1078)
Q Consensus 823 -~~~~~lv~E~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~ 895 (1078)
+..+++++||.+. +|.++++- ....+.++...+..|..||+.|+.|||+. =|+|||+||.||||..+ |.
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence 8899999999988 99998843 33446788999999999999999999999 89999999999999888 89
Q ss_pred EEEecccccccccCCCCC---ceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccch----
Q 039595 896 AHVSDFGIAKFVEPYSSN---RTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF---- 967 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~---- 967 (1078)
|||+|||+++.+...-.. ....+-|..|.|||.+.+. .|+.+.|||+.|||+.||+|-++-|.....+...-
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 999999999988654322 3456789999999998875 58999999999999999999888764332211100
Q ss_pred hhhhhhhhhhcCC----CCCC--CCCcc-----------------HHH-------HHHHHHHHHhcccCCCCCCCChhHH
Q 039595 968 SNMIIEVNQILDP----RLST--PSPGV-----------------MDK-------LISIMEVAILCLDESPEARPTMEKG 1017 (1078)
Q Consensus 968 ~~~~~~~~~~~~~----~~~~--~~~~~-----------------~~~-------~~~l~~li~~cl~~dP~~RPt~~el 1017 (1078)
.....++-.++.- .++. ..++. ... .....+++.++|..||.+|.|++++
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 0011111111100 0000 00000 000 0136788999999999999999999
Q ss_pred HHHhhhhhhHHH
Q 039595 1018 FGHHIGYCDEIL 1029 (1078)
Q Consensus 1018 l~h~~~~~~~~~ 1029 (1078)
++|+|+..++..
T Consensus 335 leh~yF~~d~lp 346 (438)
T KOG0666|consen 335 LEHPYFTEDPLP 346 (438)
T ss_pred hcccccccCCCC
Confidence 999998876443
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=316.97 Aligned_cols=258 Identities=27% Similarity=0.371 Sum_probs=208.8
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..+.|+..+.||+|+||.||+|..+ +++.||+|++..... ..+.+.+|+++++.++|+||+++++++..+...+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 4567888899999999999999765 688999999865421 4567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+|+||+++++|.+++.... ..+++.++..++.|++.|++|||+. |++|+|++|+||+++.++.++|+|||.+...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 9999999999999995432 3689999999999999999999998 9999999999999999999999999998766
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
...........++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .... .+....... ..
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~------~~~~~~~~~-~~ 237 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALF------LITTKGIPP-LK 237 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHH------HHHhcCCCC-Cc
Confidence 54333334456788999999999888999999999999999999999997533221 0000 011111100 00
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
........+.+++.+||+.+|.+||+++++++|+|...
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 11112236778999999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.92 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=204.8
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|+||.||+|..+ +|..||+|.+...... ....+.+.+|+.+++.++|+||+++++++..+...++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP--VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc--chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 4788899999999999999654 6889999998654321 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEecccccccccC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHVSDFGIAKFVEP 909 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a~~~~~ 909 (1078)
||+++++|.+++.+.. ...+++..+..++.|++.|++|||+. +++||||||+||++++++ .+|++|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 79 EYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred ecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999999985432 23578999999999999999999999 999999999999999886 469999999987654
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........|++.|+|||...+..++.++||||||+++|||++|+.||..... .. .. ............+
T Consensus 155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~---~~---~~~~~~~~~~~~~-- 224 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--HQ---LV---LKICQGYFAPISP-- 224 (257)
T ss_pred CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HH---HH---HHHhcccCCCCCC--
Confidence 33333445689999999999888899999999999999999999999753221 11 11 1111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
....++.+++.+||..+|++|||++|++.|+|+
T Consensus 225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 225 -NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -CCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 112367888999999999999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=312.87 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=186.7
Q ss_pred ceeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeec
Q 039595 757 FCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 833 (1078)
+.||+|+||.||+|... ++..+|+|.++... .......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 35899999999999654 34579999886543 2233457888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCC--CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 834 HRGSLARILGNDA--TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 834 ~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
++|+|.+++.... .....++..+..++.|++.|++|||+. +++||||||+||+++.++++|++|||.+.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999999995432 223467778889999999999999999 99999999999999999999999999997543222
Q ss_pred C--CceeeccccccccccccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 912 S--NRTEFVGTFGYAAPEIAYTM-------RATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 912 ~--~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
. ......++..|+|||++.+. .++.++||||||+++|||++ |+.||....... ....... .....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~~~---~~~~~ 229 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTVR---EQQLK 229 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHhh---cccCC
Confidence 1 12234578899999988642 35789999999999999996 999975433211 1111000 00111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
...+... ......+.+++.+|| .+|++|||++|++..
T Consensus 230 ~~~~~~~-~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~ 266 (269)
T cd05087 230 LPKPRLK-LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLL 266 (269)
T ss_pred CCCCccC-CCCChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence 1111000 011124567788898 589999999999854
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=335.80 Aligned_cols=371 Identities=28% Similarity=0.420 Sum_probs=271.4
Q ss_pred cCCCCeeecCCcccC-CCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCcee
Q 039595 221 LKSLSTLDLSQNQLN-GLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLM 299 (1078)
Q Consensus 221 l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 299 (1078)
|+-.+-.|+++|.++ +.+|.....+++++-|.|...++. .+|+.++.+.+|++|.+++|++.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~---------------- 68 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI---------------- 68 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH----------------
Confidence 344555666666666 346666666666666666666666 56666666666666666666665
Q ss_pred eecccCCCCCCCccccCCCccCeeeccccccC-ccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccC
Q 039595 300 SLFSNSLSGSIPPILGNLKSLSTLGLYLNQLN-GVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNL 378 (1078)
Q Consensus 300 ~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 378 (1078)
.+...++.++.|+.+.+..|++. .-+|..+-.+..|+.||||+|+++ +.|..+..-+++-.|+||+|+|
T Consensus 69 ---------~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~I 138 (1255)
T KOG0444|consen 69 ---------SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNI 138 (1255)
T ss_pred ---------hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcc
Confidence 12223344444444555555443 124555556666666666666666 5666666667777777777777
Q ss_pred ccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccc
Q 039595 379 SGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNW 458 (1078)
Q Consensus 379 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 458 (1078)
..++-..|-+++.|-.|+|++|++. .+|.....+..|+.|.|++|.+.......+..+..|++|.+|+.+=+
T Consensus 139 etIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT------- 210 (1255)
T KOG0444|consen 139 ETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT------- 210 (1255)
T ss_pred ccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch-------
Confidence 6554455667777777777777775 44555666666666666666666555555566666777777665422
Q ss_pred cCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccce
Q 039595 459 RNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQY 538 (1078)
Q Consensus 459 ~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 538 (1078)
...+|..+..+.+|..+|||.|.+. ..|..+.++.+|+.|+||+|+|+ .+....+.-.+|+.
T Consensus 211 ----------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEt 272 (1255)
T KOG0444|consen 211 ----------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLET 272 (1255)
T ss_pred ----------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhh
Confidence 1246778888999999999999998 88999999999999999999998 45556667788999
Q ss_pred eeccCccccCCCCcccccccccccccccCccccc-ccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCcc
Q 039595 539 LDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSH-TIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNN 617 (1078)
Q Consensus 539 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 617 (1078)
|+||.|+++ ..|+++.++++|+.|++.+|+++. -+|..+++|.+|+.+..++|.+. ..|+.++.+..|+.|.|++|+
T Consensus 273 LNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~Nr 350 (1255)
T KOG0444|consen 273 LNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNR 350 (1255)
T ss_pred hccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccc
Confidence 999999998 899999999999999999999864 37889999999999999999996 789999999999999999999
Q ss_pred ccCCcccccccCCcCcEEEcccCcCCCCCC
Q 039595 618 LSGFIPRCFEKMRSLSCIDICYNELQGPIP 647 (1078)
Q Consensus 618 l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~ 647 (1078)
|- .+|+.+.-++.|+.||+..|+=-.-.|
T Consensus 351 Li-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 351 LI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred ee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 97 579999999999999999997554333
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=320.88 Aligned_cols=264 Identities=25% Similarity=0.353 Sum_probs=204.4
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|+..+.||+|+||.||+|..+ +++.||+|+++.... .....+.+.+|++++++++|+||+++++++..++..++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 36889999999999999999665 688999999865432 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||++++.+..+... ...+++.++..++.||+.|++|||+. +++|||++|+||++++++.+||+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 79 FEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 999998777666532 34588999999999999999999999 999999999999999999999999999987655
Q ss_pred CCC-CceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh-------hhh--c
Q 039595 910 YSS-NRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV-------NQI--L 978 (1078)
Q Consensus 910 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~--~ 978 (1078)
... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... .......... ... .
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHhhhccc
Confidence 432 33446788999999999888 8899999999999999999999997533211 0000000000 000 0
Q ss_pred CCCCC-----CCC-Cc-----cH-HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 979 DPRLS-----TPS-PG-----VM-DKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 979 ~~~~~-----~~~-~~-----~~-~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
++... ... .. .. ....++.+++++||..+|++||++++++.|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000 000 00 00 013467899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=312.00 Aligned_cols=250 Identities=25% Similarity=0.300 Sum_probs=201.7
Q ss_pred eccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCC
Q 039595 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGS 837 (1078)
Q Consensus 759 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 837 (1078)
||+|+||.||+|... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.++...++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999664 5899999999765322 22345678999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceee
Q 039595 838 LARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF 917 (1078)
Q Consensus 838 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 917 (1078)
|.+++.+. ..+++..+..++.|++.||+|+|+. +++|+||+|+||+++.++.++++|||.+....... .....
T Consensus 80 L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~ 152 (262)
T cd05572 80 LWTILRDR---GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTF 152 (262)
T ss_pred HHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccc
Confidence 99999543 4588999999999999999999998 99999999999999999999999999998765432 23345
Q ss_pred ccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHH
Q 039595 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIM 997 (1078)
Q Consensus 918 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 997 (1078)
.|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....+..... ..+.........+... ...+.
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~--~~~~~ 224 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY------NDILKGNGKLEFPNYI--DKAAK 224 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH------HHHhccCCCCCCCccc--CHHHH
Confidence 688999999999888899999999999999999999999764432111111 1111111111111111 23678
Q ss_pred HHHHhcccCCCCCCCC-----hhHHHHHhhhh
Q 039595 998 EVAILCLDESPEARPT-----MEKGFGHHIGY 1024 (1078)
Q Consensus 998 ~li~~cl~~dP~~RPt-----~~ell~h~~~~ 1024 (1078)
+++.+||+.+|++||+ ++|+++|+|+.
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence 9999999999999999 99999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=316.94 Aligned_cols=260 Identities=19% Similarity=0.322 Sum_probs=197.4
Q ss_pred hcCCCccceeccCCceeEEEEEeC-----------------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-----------------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 812 (1078)
.++|++.+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.+++.++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCC
Confidence 357999999999999999998532 23468999986542 2334567899999999999999
Q ss_pred eeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCC--------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 039595 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDAT--------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 884 (1078)
Q Consensus 813 iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 884 (1078)
|+++++++..++..++||||+++|+|.+++..... ...+++.++..++.|++.|++|||+. +++|||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk 157 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA 157 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence 99999999999999999999999999999854321 23477889999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh--CCCCCCcc
Q 039595 885 SKNVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK--GNHPRDFF 960 (1078)
Q Consensus 885 ~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~p~~~~ 960 (1078)
|+||+++.++.++++|||+++.+..... ......++..|+|||...++.++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999986543221 1122344678999999888889999999999999999998 67786433
Q ss_pred cccccchhhhhhh-hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 961 SINFSSFSNMIIE-VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 961 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
... ........ ..........+.... ....+.+++.+||+.||++||+++|+.+.
T Consensus 238 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 293 (296)
T cd05095 238 SDE--QVIENTGEFFRDQGRQVYLPKPAL---CPDSLYKLMLSCWRRNAKERPSFQEIHAT 293 (296)
T ss_pred ChH--HHHHHHHHHHhhccccccCCCCCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 221 11111100 000000011111111 12367889999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.78 Aligned_cols=249 Identities=25% Similarity=0.415 Sum_probs=196.8
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
++|++.+.||+|+||.||+|..+.+..||+|++.... ...+.+.+|+.++++++|||++++++++.. ...++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 5688899999999999999988777789999876432 234568889999999999999999998864 5678999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+.+|+|.+++... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 80 EFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999999543 234578999999999999999999999 9999999999999999999999999999866432
Q ss_pred CC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 911 SS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 911 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ......++..|+|||...+..++.++||||||+++|||++ |+.||..... ....... .....+ +.+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~---~~~~~~----~~~- 225 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQV---ERGYRM----PCP- 225 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---HcCCCC----CCC-
Confidence 21 1223346678999999998899999999999999999999 8999653221 1111111 111111 111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
......+.+++.+||++||++||+++++.+-
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 256 (260)
T cd05069 226 -QGCPESLHELMKLCWKKDPDERPTFEYIQSF 256 (260)
T ss_pred -cccCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1123467889999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=326.18 Aligned_cols=257 Identities=24% Similarity=0.386 Sum_probs=196.4
Q ss_pred hcCCCccceeccCCceeEEEEEe------CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeec
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSN 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 822 (1078)
.++|++.+.||+|+||+||+|.+ .+++.||||+++... .......+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 46899999999999999999963 357789999986532 223345688899999999 68999999998854
Q ss_pred -CCeeEEEEeecCCCCHHHHhcCCCC------------------------------------------------------
Q 039595 823 -ARHSFLVCEYLHRGSLARILGNDAT------------------------------------------------------ 847 (1078)
Q Consensus 823 -~~~~~lv~E~~~~g~L~~~l~~~~~------------------------------------------------------ 847 (1078)
+...++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4567899999999999999853210
Q ss_pred ----------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC--Cce
Q 039595 848 ----------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS--NRT 915 (1078)
Q Consensus 848 ----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~ 915 (1078)
...+++.++..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||++........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 12468888999999999999999999 999999999999999999999999999986532211 112
Q ss_pred eeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 916 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
...++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....... .. .... .+... ..
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~---~~--~~~~--~~~~~--~~ 309 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLK---EG--TRMR--APDYT--TP 309 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHh---cc--CCCC--CCCCC--CH
Confidence 2345678999999998899999999999999999997 899975432210 1111100 00 0111 11111 12
Q ss_pred HHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 995 SIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
++.+++.+||+.||++|||+.|+++|.-
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 5778899999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=312.48 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=193.4
Q ss_pred CCccceeccCCceeEEEEEeCC-CC--EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec------C
Q 039595 753 FDEKFCIGKGGQGSVYKAELPS-GD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN------A 823 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~ 823 (1078)
|.+.+.||+|+||.||+|.... ++ .||+|.++.... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC--TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 3567889999999999997653 33 689998865422 23445678899999999999999999998742 2
Q ss_pred CeeEEEEeecCCCCHHHHhcCC---CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 824 RHSFLVCEYLHRGSLARILGND---ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
...++||||+++|+|.+++... .....+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence 3568999999999999887322 1234588999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhh
Q 039595 901 FGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQI 977 (1078)
Q Consensus 901 fG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 977 (1078)
||+++........ .....+++.|+|||...+..++.++|||||||++|||++ |+.||..... .......
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~------ 227 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYL------ 227 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH------
Confidence 9999876432221 122346778999999999899999999999999999999 7888653221 1111111
Q ss_pred cCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
........... ....+.+++.+||+.||++|||+++++++.
T Consensus 228 ~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 228 RQGNRLKQPPD---CLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred HcCCCCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11111111111 123578899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=315.50 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=203.6
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+.+|+.++++++||||+++++++..+...++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 5888899999999999999654 7899999998765322 223567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+ +++|.+++.... ..+++.+++.++.||+.||+|||+. +++|+||||+||+++.++.++++|||.+......
T Consensus 79 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 79 EYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred ccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 999 999999985432 5689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-CceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh-------------
Q 039595 911 SS-NRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN------------- 975 (1078)
Q Consensus 911 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~------------- 975 (1078)
.. ......|+..|+|||.+.+. .++.++||||+|+++|||++|++||...... ...........
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCc
Confidence 21 23345789999999998654 4689999999999999999998876432210 00000000000
Q ss_pred -hhcCCCCCCCCCc-----cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 976 -QILDPRLSTPSPG-----VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 976 -~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.+..-........ .......+.+++.+|++.+|++|||+++++.|+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000000000000 011225778999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.32 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=194.3
Q ss_pred ceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCC
Q 039595 757 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRG 836 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 836 (1078)
+.||+|+||.||+|..++++.||+|++.... .......+.+|+.++++++||||+++++++......++||||+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 3689999999999988888999999986542 2233456889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC-ce
Q 039595 837 SLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN-RT 915 (1078)
Q Consensus 837 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~ 915 (1078)
+|.+++... ...+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++......... ..
T Consensus 78 ~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 78 DFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 999998543 24578999999999999999999999 9999999999999999999999999999754332211 11
Q ss_pred eeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 916 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
...++..|+|||++.+..++.++||||||+++||+++ |..||...... ... ............ . ....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~---~~~~~~~~~~~~---~---~~~~ 221 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAR---EQVEKGYRMSCP---Q---KCPD 221 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHH---HHHHcCCCCCCC---C---CCCH
Confidence 2244678999999998889999999999999999998 99997533221 111 111111111111 1 1123
Q ss_pred HHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 995 SIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.+.+++.+||+.+|++||++.|+.+.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHH
Confidence 67889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=310.78 Aligned_cols=248 Identities=26% Similarity=0.411 Sum_probs=199.8
Q ss_pred ceeccCCceeEEEEEeCC----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 757 FCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
+.||+|+||.||+|.... +..||+|++...... ...+.+.+|+..++.++|+||+++++++..+...++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE---EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch---hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 468999999999996653 788999998765322 2467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCC------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 833 LHRGSLARILGNDAT------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
+++++|.+++..... ...+++.+++.++.|++.|++|||++ +++||||+|+||+++.++.++++|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence 999999999965421 36789999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 907 VEPYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 907 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
..... .......++..|+|||.+....++.++||||+|+++|||++ |..||..... ........ .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~------~~~~~ 226 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLR------KGYRL 226 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHH------cCCCC
Confidence 65432 22334567889999999998889999999999999999999 6999764321 11111111 11111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...... ..++.+++.+||..+|++|||++|++++.
T Consensus 227 ~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 227 PKPEYC---PDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCccC---ChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111111 23678899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=312.29 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=196.8
Q ss_pred CCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe---
Q 039595 753 FDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH--- 825 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 825 (1078)
|++.+.||+|+||.||+|... .+..||+|+++.... .....+.+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 567889999999999999654 246799999875422 23345678999999999999999999998865444
Q ss_pred ---eEEEEeecCCCCHHHHhcCCC---CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEe
Q 039595 826 ---SFLVCEYLHRGSLARILGNDA---TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS 899 (1078)
Q Consensus 826 ---~~lv~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 899 (1078)
.++|+||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 799999999999999884322 234689999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhh
Q 039595 900 DFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQ 976 (1078)
Q Consensus 900 DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 976 (1078)
|||.++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..... .
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~------~ 227 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYD------Y 227 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHH------H
Confidence 99999866433221 122335678999999988899999999999999999999 8888653221 11111 1
Q ss_pred hcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
............ ....+.+++.+||+.||++|||+.|++++.-
T Consensus 228 ~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 228 LRHGNRLKQPED---CLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred HHcCCCCCCCcC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111111111 2236788999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=308.26 Aligned_cols=252 Identities=29% Similarity=0.436 Sum_probs=206.1
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||+|+++++++..+...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4788899999999999999765 788999999876532 34677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 77 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 77 EFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred ecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 9999999999985432 5689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ...........+.... ..
T Consensus 152 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~----~~ 221 (253)
T cd05122 152 KA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFKIATNGPPGLRN----PE 221 (253)
T ss_pred cc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHhcCCCCcCc----cc
Confidence 22 34567889999999999888999999999999999999999997643211 1111111111111111 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.....+.+++.+||+.||++|||++|++.|+|
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 11236788999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=315.54 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=199.3
Q ss_pred eccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCC
Q 039595 759 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGS 837 (1078)
Q Consensus 759 lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 837 (1078)
||+|+||+||+|.. .+|+.||+|.+...... .......+..|++++++++||||+++++++...+..|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 69999999999954 46899999998754322 12234456789999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceee
Q 039595 838 LARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF 917 (1078)
Q Consensus 838 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 917 (1078)
|.+++.+... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+..... .......
T Consensus 80 L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGR 154 (277)
T ss_pred HHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccc
Confidence 9999854332 4689999999999999999999999 999999999999999999999999999986543 2223345
Q ss_pred ccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHH
Q 039595 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIM 997 (1078)
Q Consensus 918 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 997 (1078)
.++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ...... .... ......... ...+.
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~--~~~~-~~~~~~~~~---~~~~~ 226 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEELKR--RTLE-MAVEYPDKF---SPEAK 226 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHHHHh--cccc-ccccCCccC---CHHHH
Confidence 678899999999888899999999999999999999999754332110 000000 0110 000011111 23677
Q ss_pred HHHHhcccCCCCCCC-----ChhHHHHHhhhhh
Q 039595 998 EVAILCLDESPEARP-----TMEKGFGHHIGYC 1025 (1078)
Q Consensus 998 ~li~~cl~~dP~~RP-----t~~ell~h~~~~~ 1025 (1078)
+++.+||+.||++|| ++++++.|+|+..
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 899999999999999 8888999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=318.99 Aligned_cols=263 Identities=21% Similarity=0.265 Sum_probs=201.4
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--CeeE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--RHSF 827 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 827 (1078)
++|+..+.||+|+||.||+|..+ +++.||+|.++..... ......+.+|+.++++++||||+++++++... ...|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 57888999999999999999765 6889999998754322 22234567899999999999999999998777 8999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+|+||+++ +|.+++.... ..+++.++..++.||+.||+|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 83 lv~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EEehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99999975 9999885432 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh------------
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV------------ 974 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~------------ 974 (1078)
...........+++.|+|||.+.+. .++.++||||+|+++|||++|+.||...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhh
Confidence 5543333445678899999998764 4689999999999999999999997543221 0000000000
Q ss_pred --hh-----hcCC---CCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 975 --NQ-----ILDP---RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 975 --~~-----~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.. .... .+....+.. .....+.+++.+||+.||++|||++|++.|+|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00 0000 000001110 012357789999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=341.84 Aligned_cols=275 Identities=17% Similarity=0.217 Sum_probs=195.1
Q ss_pred hhcCCCccceeccCCceeEEEEEeC--CCCEEEEEE--------------eccccccCChhhHHHHHHHHHHHhcCCCCc
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP--SGDIVAVKK--------------FNSQLLSGNMADQDEFLNVVLALNEIRHRN 812 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 812 (1078)
..++|++.+.||+|+||+||+|..+ ++..+++|. +.+. ..........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~-~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKR-VKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHH-hhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3578999999999999999998543 222222221 1111 1112233456889999999999999
Q ss_pred eeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCC--CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 039595 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDA--TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 890 (1078)
Q Consensus 813 iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 890 (1078)
|+++++++...+..|+|+|++.+ ++.+++.... ........++..++.||+.||+|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 99999999999999999999854 7777764321 122344677888999999999999999 99999999999999
Q ss_pred CCCCcEEEecccccccccCCCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCC-CCcccccc-cch
Q 039595 891 DLEFEAHVSDFGIAKFVEPYSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP-RDFFSINF-SSF 967 (1078)
Q Consensus 891 ~~~~~~kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p-~~~~~~~~-~~~ 967 (1078)
+.++.+||+|||+++.+..... ......||..|+|||++.+..++.++|||||||++|||++|+.+ |....... ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987654322 23346799999999999999999999999999999999998764 32211110 111
Q ss_pred hhhhhhh--------------hhhcCC-CCCCCCCccHH------HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 968 SNMIIEV--------------NQILDP-RLSTPSPGVMD------KLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 968 ~~~~~~~--------------~~~~~~-~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
...+... ...++. .+......... ...++.+++.+||+.||.+|||+.|++.|||+...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 1111000 000000 00000000000 01256778899999999999999999999998764
Q ss_pred HH
Q 039595 1027 EI 1028 (1078)
Q Consensus 1027 ~~ 1028 (1078)
..
T Consensus 461 ~~ 462 (501)
T PHA03210 461 EE 462 (501)
T ss_pred Cc
Confidence 43
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.18 Aligned_cols=251 Identities=22% Similarity=0.396 Sum_probs=195.6
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCC----EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
.++|+..+.||+|+||+||+|.+ .+|+ .||+|++.... .....+.+.+|+..++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 35788999999999999999964 3454 48999986532 233456788999999999999999999998754
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence 568999999999999998542 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 905 KFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 905 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
+........ .....++..|+|||...+..++.++|||||||++|||++ |..||+.... ........ ... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~---~~~--~ 229 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLE---KGE--R 229 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH---CCC--c
Confidence 876432221 112234678999999998899999999999999999998 8999753321 11111111 100 1
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.. ... ....++.+++.+||+.||++||++.++++.
T Consensus 230 ~~-~~~---~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 230 LP-QPP---ICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred CC-CCc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 111 122367789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=317.83 Aligned_cols=251 Identities=27% Similarity=0.364 Sum_probs=201.4
Q ss_pred cceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 756 KFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
..+||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++|+||+++++++..++..++||||++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 35799999999999966 47899999987543 22345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+..........
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 101 GGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 9999998732 3578899999999999999999999 99999999999999999999999999987664433333
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....|+..|+|||.+.+..++.++||||+|+++|||++|+.||...... .. ........++..... .....
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~---~~~~~~~~~~~~~~~----~~~~~ 244 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KA---MKMIRDNLPPKLKNL----HKVSP 244 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH---HHHHHhhCCcccCCc----ccCCH
Confidence 4456889999999998888999999999999999999999997532211 11 111111122222111 11223
Q ss_pred HHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 995 SIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.+.+++.+||+.+|.+||++++++.|+|+...
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 56788999999999999999999999996653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=317.05 Aligned_cols=263 Identities=21% Similarity=0.310 Sum_probs=203.3
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|++|.||+|..+ +|+.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 5888999999999999999765 689999999875432 223456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++ +|.+++........+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 99985 8988885544445689999999999999999999999 9999999999999999999999999999866443
Q ss_pred CCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh------------hh--
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE------------VN-- 975 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~------------~~-- 975 (1078)
........++..|+|||.+.+. .++.++||||+||++|+|++|+.||...... .....+.. ..
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHHHhcC
Confidence 3333445678899999988654 5788999999999999999999997543221 10000000 00
Q ss_pred hhcCCCCCCCCCcc-----HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 976 QILDPRLSTPSPGV-----MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 976 ~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.............. ......+.+++.+|++.||++||+++|+++|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00000000000000 0112357789999999999999999999999995
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=317.65 Aligned_cols=263 Identities=25% Similarity=0.314 Sum_probs=200.2
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCeeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 828 (1078)
++|+..+.||+|+||.||++.. .+++.||+|++..... ......+.+|+.++.++. ||||+++++++..+...++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3566678899999999999965 4689999999875432 244567888999999996 9999999999999999999
Q ss_pred EEeecCCCCHHHHhcC--CCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 829 VCEYLHRGSLARILGN--DATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
+|||+.. ++.++... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 9999865 55554321 112356899999999999999999999742 899999999999999999999999999976
Q ss_pred ccCCCCCceeeccccccccccccccC---CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTM---RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
..... ......|+..|+|||.+.+. .++.++||||+||++|||++|+.||...... ............+...
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 158 LVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQLTQVVKGDPPILS 232 (288)
T ss_pred hccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHHHhhhcCCCCCcCC
Confidence 54322 22334688999999998876 6899999999999999999999997543311 1111111111111221
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
... .......+.+++.+||+.||++|||+++++.|+|+...
T Consensus 233 ~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 233 NSE--EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CcC--CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 111 11223467899999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=318.69 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=200.8
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC--------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEe
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHG 818 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 818 (1078)
...++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 34567889999999999999999631 24579999886432 233456788999999999 8999999999
Q ss_pred eeecCCeeEEEEeecCCCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 039595 819 FCSNARHSFLVCEYLHRGSLARILGNDAT-------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISS 885 (1078)
Q Consensus 819 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 885 (1078)
++......++||||+.+|+|.+++..... ...+++.++..++.||+.||+|||+. +++||||||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 165 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 99999999999999999999999964321 23578899999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccc
Q 039595 886 KNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSI 962 (1078)
Q Consensus 886 ~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~ 962 (1078)
+||+++.++.+||+|||.++........ .....+++.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999999876432221 222345678999999998889999999999999999998 7888643221
Q ss_pred cccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 963 NFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
....... ... .... ... .....+.+++.+||+.+|++|||+.|+++...
T Consensus 246 --~~~~~~~---~~~--~~~~-~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 246 --EELFKLL---KEG--HRMD-KPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred --HHHHHHH---HcC--CcCC-CCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 1111111 100 1111 111 12236778899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.17 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=200.2
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+....++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 457889999999999999999765 88999999865421 466788999999999999999999999989999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.++....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence 99999999999995432 23689999999999999999999999 999999999999999999999999999986632
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ........ ....+... ..
T Consensus 155 ~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~---~~~~~~~~---~~ 223 (256)
T cd05039 155 GQ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVE---KGYRMEAP---EG 223 (256)
T ss_pred cc---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHh---cCCCCCCc---cC
Confidence 21 13345678999999998889999999999999999997 9999753321 11111111 10111111 11
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
....+.+++.+||..+|++|||++|++...
T Consensus 224 ---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 224 ---CPPEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred ---CCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 123678899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=317.56 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=200.3
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|++.+.||+|++|.||+|..+ +|+.||+|++...... ....+.+.+|+.++++++|||++++++++.++...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 677889999999999999654 7999999998754321 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|++ ++|.+++.... ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 79 FLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred ccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 995 58999985432 24689999999999999999999998 99999999999999999999999999998654333
Q ss_pred CCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh-----------------
Q 039595 912 SNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE----------------- 973 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~----------------- 973 (1078)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... .........
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchh
Confidence 333334668899999987664 5789999999999999999999997533221 100000000
Q ss_pred hhhhcCCCCCC-C-CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 974 VNQILDPRLST-P-SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 974 ~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
..... +.... . ..........+.+++.+||+.||++|||++|++.|+|+
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 233 YKPTF-PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhc-ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00000 00000 0 00001112367899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=320.89 Aligned_cols=267 Identities=25% Similarity=0.274 Sum_probs=201.2
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--Cee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--RHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 826 (1078)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++..... ......+.+|+.++++++|+||+++++++.+. +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46899999999999999999965 46899999998654321 11223456799999999999999999998654 568
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+.+ +|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 84 ~lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999999975 888888542 25689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh----hhc---
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN----QIL--- 978 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~--- 978 (1078)
............++..|+|||.+.+ ..++.++||||+||++|||++|++||...... ........... ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChhhchhh
Confidence 6543333344456788999999875 45789999999999999999999997533221 11111000000 000
Q ss_pred ---C--CC--CCCC-CCcc----HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 979 ---D--PR--LSTP-SPGV----MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 979 ---~--~~--~~~~-~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
+ .. .... .... ......+.+++.+|++.||++|||++|+++|+|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0 00 0000 0000 001335678999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.57 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=189.4
Q ss_pred eeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 758 CIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
.||+|+||.||+|.+. ++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 3899999999999653 35579999986542 23345678999999999999999999999864 56899999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+|+|.+++... ...+++.++.+++.|++.|++|||++ +++||||||+||+++.++.+|++|||++..........
T Consensus 78 ~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 78 GGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99999998532 34689999999999999999999999 99999999999999999999999999998654332211
Q ss_pred ---eeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 915 ---TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 915 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
....++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .....+ .....+... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~---~~~~~~~~~---~~-- 222 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFI---EQGKRLDCP---AE-- 222 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH---HCCCCCCCC---CC--
Confidence 11223578999999988889999999999999999996 99997533221 111111 111111111 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...++.+++.+||..||++||++.++.+..
T Consensus 223 -~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 223 -CPPEMYALMKDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred -CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 123677899999999999999999997764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=313.75 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=195.4
Q ss_pred cCCCccceeccCCceeEEEEEe-----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--C
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN--A 823 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~ 823 (1078)
.+|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 4788899999999999999964 35789999998654 23345678899999999999999999998743 4
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...++|+||+++|+|.+++.+. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 5689999999999999999532 23588999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccch-------hhhhhh
Q 039595 904 AKFVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF-------SNMIIE 973 (1078)
Q Consensus 904 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~-------~~~~~~ 973 (1078)
++........ .....++..|+|||++.+..++.++|||||||++|||++|..|+......+... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 9876432221 111223456999999998899999999999999999999877743222111000 000000
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...........+.+ ......+.+++.+||+.+|++|||++|+++..
T Consensus 235 ~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 235 LIELLKNNGRLPAP--PGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred HHHHHhcCCcCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 01111111111111 11123578899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=314.28 Aligned_cols=252 Identities=20% Similarity=0.228 Sum_probs=193.1
Q ss_pred eeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHH---hcCCCCceeeEEeeeecCCeeEEEEeec
Q 039595 758 CIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLAL---NEIRHRNIVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~E~~ 833 (1078)
.||+|+||.||+|.. .+++.||+|.+........ .....+.+|..++ ...+||+|+.+++++..++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 489999999999965 4689999999876533221 1122334444333 3447999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 039595 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN 913 (1078)
Q Consensus 834 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 913 (1078)
++|+|.+++.. .+.+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||++...... .
T Consensus 80 ~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~ 151 (279)
T cd05633 80 NGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--K 151 (279)
T ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--C
Confidence 99999999843 34689999999999999999999999 9999999999999999999999999999755432 2
Q ss_pred ceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHH
Q 039595 914 RTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDK 992 (1078)
Q Consensus 914 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1078)
.....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......... .........+...... .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~------~ 222 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTVNVELPDS------F 222 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhhcCCcCCccc------c
Confidence 233468999999998864 56899999999999999999999997543221111 1111111111111111 1
Q ss_pred HHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhhH
Q 039595 993 LISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 993 ~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~~ 1027 (1078)
..++.+++.+||+.||++|| +++|+++|+|+....
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 23677889999999999999 699999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=317.55 Aligned_cols=266 Identities=20% Similarity=0.255 Sum_probs=199.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCe---
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARH--- 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~--- 825 (1078)
++|+..+.||+|+||.||+|... +++.||+|++...... ......+.+|+.++++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 46889999999999999999654 6899999998654321 223456788999999995 6999999999876555
Q ss_pred --eEEEEeecCCCCHHHHhcCCCC--CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEec
Q 039595 826 --SFLVCEYLHRGSLARILGNDAT--AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-EFEAHVSD 900 (1078)
Q Consensus 826 --~~lv~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~D 900 (1078)
.|+||||+++ +|.+++..... ...+++..++.++.||+.||.|||+. +++||||+|+||+++. ++.+||+|
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 8999999986 89888754322 34689999999999999999999999 9999999999999998 89999999
Q ss_pred ccccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh----h
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV----N 975 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~----~ 975 (1078)
||+++.+...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...... .......... .
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (295)
T cd07837 155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQLLHIFKLLGTPTE 233 (295)
T ss_pred cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHhCCCCh
Confidence 9999866443333334467889999998865 45789999999999999999999997532211 1110000000 0
Q ss_pred hhc-----------CCCCCCCC--CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 976 QIL-----------DPRLSTPS--PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 976 ~~~-----------~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
... .+...... .........+.++|.+||.+||.+||+++|++.|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~ 294 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence 000 00000000 0001122357889999999999999999999999996
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=314.10 Aligned_cols=255 Identities=21% Similarity=0.325 Sum_probs=200.0
Q ss_pred hcCCCccceeccCCceeEEEEEeCC-----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec-C
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPS-----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN-A 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~ 823 (1078)
.++|+..+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+.++++++||||+++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA---SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4678899999999999999997654 6789999876432 34446678899999999999999999998765 5
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCC-----CcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATA-----KELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
...++++||+++|+|.+++...... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+|+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 7789999999999999998543322 4689999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhh
Q 039595 899 SDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVN 975 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 975 (1078)
+|||+++.+...... .....++..|+|||++.+..++.++|||||||++||+++ |+.||..... .........
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~-- 234 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKD-- 234 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHc--
Confidence 999999865332211 122345678999999998889999999999999999999 9999753321 111111111
Q ss_pred hhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 976 QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 976 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.. .... ... ....+.+++.+||..||++|||+.++++..
T Consensus 235 -~~--~~~~-~~~---~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 235 -GY--RLAQ-PIN---CPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred -CC--CCCC-CCc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 11 1111 111 123577899999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=318.91 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=199.4
Q ss_pred hhcCCCccceeccCCceeEEEEEeC--------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGF 819 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 819 (1078)
..++|.+.+.||+|+||.||+|+.. ....||+|.+.... .....+.+.+|+.+++++ +||||++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3468889999999999999999642 24579999886532 233456788999999999 69999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 039595 820 CSNARHSFLVCEYLHRGSLARILGNDA-------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 886 (1078)
Q Consensus 820 ~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 886 (1078)
+...+..++||||+++|+|.+++.... ....+++.++..++.|++.||.|||++ |++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 999999999999999999999995432 124588999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEecccccccccCCCCCc--eeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccc
Q 039595 887 NVLLDLEFEAHVSDFGIAKFVEPYSSNR--TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSIN 963 (1078)
Q Consensus 887 NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~ 963 (1078)
||+++.++.+||+|||.++......... ....++..|||||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~- 242 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV- 242 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999998664322111 12234568999999998899999999999999999999 8888643221
Q ss_pred ccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 964 FSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
........ ........... ..++.+++.+||+.+|++|||+.|+++...
T Consensus 243 -~~~~~~~~------~~~~~~~~~~~---~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 243 -EELFKLLR------EGHRMDKPSNC---THELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred -HHHHHHHH------cCCCCCCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111111 11111111111 225678999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=315.36 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=198.8
Q ss_pred hcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
.++|+..+.||+|+||.||+|..+ ++..||+|++.... .......+.+|+.++++++||||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 467999999999999999999753 46789999986532 233456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCC-------------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 039595 824 RHSFLVCEYLHRGSLARILGNDA-------------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 884 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 884 (1078)
...++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 99999999999999999995321 123478889999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccc
Q 039595 885 SKNVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFS 961 (1078)
Q Consensus 885 ~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~ 961 (1078)
|+||+++.++.++++|||.++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876533211 1222345678999999998899999999999999999997 888854221
Q ss_pred ccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 962 INFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
. ..... .+.+......... ...++.+++.+||+.||++|||++|+++-
T Consensus 238 ~--~~~~~------~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~el~~~ 285 (288)
T cd05050 238 H--EEVIY------YVRDGNVLSCPDN---CPLELYNLMRLCWSKLPSDRPSFASINRI 285 (288)
T ss_pred H--HHHHH------HHhcCCCCCCCCC---CCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 1 11111 1111111111111 12367889999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.17 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=207.9
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--CeeEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--RHSFL 828 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 828 (1078)
+|+..+.||+|++|.||+|... +++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 4778899999999999999765 7899999998765322 34567889999999999999999999999888 89999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|+||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+....
T Consensus 79 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 79 FLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999999999999543 3789999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...............
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~ 225 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-------AALYKIGSSGEPPEI 225 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------HHHHhccccCCCcCC
Confidence 5432 1344578899999999998889999999999999999999999976444110 011111111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
+... ...+.+++.+|+..||++||++.|++.|+|+
T Consensus 226 ~~~~--~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 226 PEHL--SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred Cccc--CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 1111 2467888999999999999999999999994
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.03 Aligned_cols=252 Identities=26% Similarity=0.454 Sum_probs=201.2
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.+.||+|+||.||+|..+++..||||.+.... ...+++.+|+.++++++||||+++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 346899999999999999999988778899999986532 235678899999999999999999999999899999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++... ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 79 v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 79 VTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred EEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceecc
Confidence 99999999999999543 234689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
... .......++..|+|||.+.+..++.++||||+|+++||+++ |+.||..... ..... ...........
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~---~~~~~~~~~~~--- 226 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLE---QVERGYRMPRP--- 226 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH---HHHcCCCCCCC---
Confidence 321 11122335678999999998889999999999999999998 9999643221 11111 11111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
... ...+.+++.+|++.+|++||+++++.+-
T Consensus 227 ~~~---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~ 257 (261)
T cd05034 227 PNC---PEELYDLMLQCWDKDPEERPTFEYLQSF 257 (261)
T ss_pred CCC---CHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 111 2357889999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.82 Aligned_cols=238 Identities=23% Similarity=0.367 Sum_probs=185.5
Q ss_pred ceeccCCceeEEEEEeCC-------------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 757 FCIGKGGQGSVYKAELPS-------------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
+.||+|+||.||+|...+ ...||+|.+... .......+.+|+.+++.++||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 358999999999996432 225888887543 223355788899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc-------E
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE-------A 896 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~ 896 (1078)
...++||||+++|+|..++... ...+++..+++++.||+.|++|||++ +|+||||||+||+++.++. +
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence 9999999999999999988432 34589999999999999999999999 9999999999999987664 8
Q ss_pred EEecccccccccCCCCCceeeccccccccccccc-cCCCCccchhHHHHHHHHHHH-hCCCCCCcccccccchhhhhhhh
Q 039595 897 HVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 897 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell-tG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
+++|||.+..... .....++..|+|||.+. +..++.++|||||||++|||+ +|+.||...... ..
T Consensus 152 ~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~------- 218 (262)
T cd05077 152 KLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EK------- 218 (262)
T ss_pred EeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HH-------
Confidence 9999999875432 23346788999999887 467899999999999999998 588886432211 10
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
............+ ...++.+++.+||+.||++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 219 ERFYEGQCMLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHhcCccCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0111111111111 12357889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=312.35 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=183.2
Q ss_pred eeccCCceeEEEEEeCC---CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 758 CIGKGGQGSVYKAELPS---GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
.||+|+||+||+|.... ...+|+|.+.... .......+.+|+..++.++||||+++++++......++||||++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 58999999999996543 3468888765432 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCC--CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC
Q 039595 835 RGSLARILGNDAT--AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912 (1078)
Q Consensus 835 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 912 (1078)
+|+|.+++..... ....++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999955432 23356788899999999999999999 999999999999999999999999999875432211
Q ss_pred --Cceeecccccccccccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 913 --NRTEFVGTFGYAAPEIAYT-------MRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 913 --~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
......++..|+|||++.. ..++.++|||||||++|||++ |..||...... ...... ........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~---~~~~~~~~ 230 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQV---VREQDIKL 230 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHH---hhccCccC
Confidence 1223345778999998643 356889999999999999999 78886533211 111110 01111111
Q ss_pred CCC--CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 983 STP--SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 983 ~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
..+ ..... ..+.+++..|| .||++|||++|+++-
T Consensus 231 ~~~~~~~~~~---~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 231 PKPQLDLKYS---DRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred CCCcccccCC---HHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 111 11112 24456677788 599999999998864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.94 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=195.0
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeee-ecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFC-SNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|... |+.||+|.+... ...+.+.+|+.++++++|+|++++++++ ..+...++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 57889999999999999999765 788999987543 2245788999999999999999999976 455678999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+++|+|.+++.... ...+++..+..++.|++.|++|||++ +++||||||+||+++.++.+|++|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999999985432 33588999999999999999999999 999999999999999999999999999875533
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+ .....+... +.
T Consensus 155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~---~~~~~~~~~---~~ 223 (256)
T cd05082 155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRV---EKGYKMDAP---DG 223 (256)
T ss_pred cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---hcCCCCCCC---CC
Confidence 21 23345678999999998889999999999999999997 9999653221 1111111 111111111 11
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
. ...+.+++.+||+.+|++|||+++++++.
T Consensus 224 ~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 224 C---PPVVYDVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred C---CHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 1 23577889999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=321.40 Aligned_cols=267 Identities=20% Similarity=0.293 Sum_probs=200.0
Q ss_pred CCCccceeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--Cee
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--RHS 826 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 826 (1078)
+|++.+.||+|+||.||+|..+ +++.||+|.+..... ......+.+.+|+.++++++||||+++++++.+. ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 4788899999999999999664 478999999876431 1122245677899999999999999999999887 889
Q ss_pred EEEEeecCCCCHHHHhcCCC--CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC----CCcEEEec
Q 039595 827 FLVCEYLHRGSLARILGNDA--TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL----EFEAHVSD 900 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~D 900 (1078)
++||||+++ ++.+++.... ....+++..++.++.||+.|++|||+. +++||||||+||+++. ++.+||+|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999975 7777664322 223688999999999999999999999 9999999999999999 89999999
Q ss_pred ccccccccCCCC---CceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccc-ch---hhhhh
Q 039595 901 FGIAKFVEPYSS---NRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS-SF---SNMII 972 (1078)
Q Consensus 901 fG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~-~~---~~~~~ 972 (1078)
||+++....... ......++..|+|||.+.+. .++.++|||||||++|||++|++||........ .. .....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999987643322 12345678899999987764 578999999999999999999999764332210 00 00000
Q ss_pred hhhhhcC---------------------CCCCCCCC--ccH-------HHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 973 EVNQILD---------------------PRLSTPSP--GVM-------DKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 973 ~~~~~~~---------------------~~~~~~~~--~~~-------~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.....+. .......+ ... ....++.+++.+|+++||++|||++|+++|+|
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 0000000 00000000 000 12236789999999999999999999999999
Q ss_pred h
Q 039595 1023 G 1023 (1078)
Q Consensus 1023 ~ 1023 (1078)
+
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=353.90 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=207.1
Q ss_pred hcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
+-+++....||.|.||.||-| ...+|+..|+|-++..... ....+...+|..++..++|||+|+++|+-...+..+|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 346777788999999999999 5668999999988765433 3445677899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
.||||++|+|.+.++.. +-.++.....+..|++.|++|||++ |||||||||.||+++.+|.+|.+|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999999432 3355566677899999999999999 99999999999999999999999999999876
Q ss_pred CCC----CCceeeccccccccccccccC---CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 909 PYS----SNRTEFVGTFGYAAPEIAYTM---RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 909 ~~~----~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
... +.-...+||+.|||||++.+. ....++||||+|||+.||+||+.||..++..++-++.........++.+
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER 1465 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh
Confidence 542 122456899999999999864 4677999999999999999999999876665443332211111111111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
...+-.+++.+|+..||++|.++.|+++|-|..
T Consensus 1466 ----------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1466 ----------LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred ----------hhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 122456888999999999999999999998854
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.48 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=183.2
Q ss_pred eeccCCceeEEEEEeCCCC---EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 758 CIGKGGQGSVYKAELPSGD---IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
.||+|+||+||+|...++. .+++|.+.... .....+.+.+|+..++.++||||+++++++.+....++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 5999999999999654333 45666654432 23346788999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC--
Q 039595 835 RGSLARILGNDAT-AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS-- 911 (1078)
Q Consensus 835 ~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~-- 911 (1078)
+|+|.+++.+... ....++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999965322 23466777889999999999999999 99999999999999999999999999986432211
Q ss_pred CCceeecccccccccccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhh--hhhhcCCC
Q 039595 912 SNRTEFVGTFGYAAPEIAYT-------MRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIE--VNQILDPR 981 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 981 (1078)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||..... ......... .....++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhhcccccCCCc
Confidence 12234567899999998753 245789999999999999997 5667643221 111111111 11112222
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.... .. ..+.+++.+|| .+|++||+++++++.
T Consensus 234 ~~~~---~~---~~~~~l~~~c~-~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 234 LELP---YS---ERWYEVLQFCW-LSPEKRATAEEVHRL 265 (268)
T ss_pred cCCC---Cc---HHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence 2211 12 24566788899 679999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.69 Aligned_cols=251 Identities=22% Similarity=0.394 Sum_probs=197.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-C---CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-S---GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
.+|++.+.||+|+||.||+|... + +..||+|.++... .....+.+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 56888999999999999999653 2 3379999986532 223456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|+|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999999999543 24589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCc---eeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 907 VEPYSSNR---TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 907 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
........ ....++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ......+. .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~---~~~~~-- 228 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIE---EGYRL-- 228 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHh---CCCcC--
Confidence 64422211 11223568999999998899999999999999999886 9999653321 11111111 11111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.. .. .....+.+++.+||+.+|.+||++.++++.
T Consensus 229 ~~-~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 262 (267)
T cd05066 229 PA-PM---DCPAALHQLMLDCWQKDRNERPKFEQIVSI 262 (267)
T ss_pred CC-CC---CCCHHHHHHHHHHcccCchhCCCHHHHHHH
Confidence 11 11 112356789999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.34 Aligned_cols=256 Identities=29% Similarity=0.382 Sum_probs=201.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
..|+..+.||+|+||+||+|... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45888899999999999999654 6899999998644222 233446788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+.+ ++.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999974 777776332 24589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||..... ...... ......+...
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--~~~~~~---~~~~~~~~~~--- 235 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYH---IAQNDSPTLS--- 235 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--HHHHHH---HhcCCCCCCC---
Confidence 23456788999999874 45688999999999999999999999643221 110000 0000011111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
.......+.+++.+||+.||++||++.+++.|+|.....
T Consensus 236 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 236 --SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred --chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 111234678899999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.51 Aligned_cols=244 Identities=27% Similarity=0.371 Sum_probs=190.6
Q ss_pred ceeccCCceeEEEEEeC-C---CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 757 FCIGKGGQGSVYKAELP-S---GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
++||+|+||.||+|.+. . +..||+|.+...... ...+++.+|+.+++.++||||+++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEe
Confidence 46999999999999643 2 368999998765321 345678899999999999999999998764 567999999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 912 (1078)
+++|+|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 77 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 77 APLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999999543 3689999999999999999999999 999999999999999999999999999986644332
Q ss_pred Cc---eeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 913 NR---TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 913 ~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ....++..|+|||.+.+..++.++|||||||++|||++ |+.||+.... ......... ... . .....
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~---~~~--~-~~~~~ 222 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLES---GER--L-PRPEE 222 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHc---CCc--C-CCCCC
Confidence 21 11223568999999998899999999999999999998 9999754322 111111111 100 0 11111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
....+.+++.+||..+|++||++.++.+..
T Consensus 223 ---~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 223 ---CPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred ---CCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 123677899999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.94 Aligned_cols=260 Identities=21% Similarity=0.346 Sum_probs=197.7
Q ss_pred cCCCccceeccCCceeEEEEEe-----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA-- 823 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-- 823 (1078)
.-|++.+.||+|+||.||+|.. .++..||+|.++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3478889999999999999963 357889999986542 233356789999999999999999999998764
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...++||||+++++|.+++.+. ...+++.++..++.|++.||+|+|++ +++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence 5689999999999999998543 23589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-------hhhhhhh
Q 039595 904 AKFVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS-------FSNMIIE 973 (1078)
Q Consensus 904 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~-------~~~~~~~ 973 (1078)
++........ .....++..|+|||.+.+..++.++|||||||++|||++++.|+......... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 9876432221 12345677899999998888999999999999999999987763211100000 0000000
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
..........+... .....+.+++.+||+.+|++|||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 236 VRVLEEGKRLPRPP---NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred HHHHHcCccCCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 00111111111111 1234688999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=305.65 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=208.9
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++|||++++++.+..+...++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 5788899999999999999654 689999999875432 2345667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 831 EYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
||+++++|.+++.+.. ....+++.++..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 9999999999995532 236789999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.........|++.|+|||...+..++.++||||+|+++|+|++|+.||+.... ..... . .............
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~---~---~~~~~~~~~~~~~ 227 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--LELAL---K---ILKGQYPPIPSQY 227 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--HHHHH---H---HhcCCCCCCCCCC
Confidence 43334455788999999999888899999999999999999999999753321 11111 1 1111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
...+.+++.+||..+|++|||++|+++|+|+
T Consensus 228 ---~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 228 ---SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 2357788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.60 Aligned_cols=246 Identities=27% Similarity=0.406 Sum_probs=195.0
Q ss_pred ceeccCCceeEEEEEeCC--CC--EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 757 FCIGKGGQGSVYKAELPS--GD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
+.||+|++|.||+|.+.+ ++ .||||.+...... ...+.+.+|+..+++++||||+++++++.+ ...++|+||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 368999999999996542 33 6999998765422 456788999999999999999999999988 889999999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 912 (1078)
+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999965432 5689999999999999999999999 999999999999999999999999999987644221
Q ss_pred C---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 913 N---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 913 ~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
. .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... ........ .......+ .
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~----~~~~~~~~-~- 224 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDK----EGERLERP-E- 224 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHh----cCCcCCCC-c-
Confidence 1 123456789999999998899999999999999999998 99997533221 11111110 11111111 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.....+.+++.+||+.+|++||+++++++.
T Consensus 225 --~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 225 --ACPQDIYNVMLQCWAHNPADRPTFAALREF 254 (257)
T ss_pred --cCCHHHHHHHHHHCCCCcccCCCHHHHHHH
Confidence 122367889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=307.92 Aligned_cols=253 Identities=25% Similarity=0.469 Sum_probs=198.6
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CC---CEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SG---DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.++|+..+.||+|+||.||+|..+ ++ ..+|+|++.... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 357888899999999999999764 33 379999886542 23345678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 81 AMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence 99999999999999998542 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCce---eeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 906 FVEPYSSNRT---EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 906 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
.......... ....+..|+|||++.+..++.++|||||||++||+++ |+.||..... ......+. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~------~~- 226 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAIN------DG- 226 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHh------cC-
Confidence 6643222111 1223457999999998889999999999999999997 9999743221 11111111 11
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...+.. ......+.+++.+||..+|++||++.++++..
T Consensus 227 ~~~~~~--~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 227 FRLPAP--MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred CCCCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111111 11223678999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.94 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=216.8
Q ss_pred cceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 756 KFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
.+.||+|.||+||-|++ ++|+.||||++.+..+.... .+.+++|+++++.+.||.||.+.-.|+..+.+++|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq--esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ--ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch--HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 46899999999999954 58999999999887665433 4678999999999999999999999999999999999996
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEecccccccccCCC
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE---FEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~a~~~~~~~ 911 (1078)
| ++.+++-. ...+++++.....++.||+.||.|||.+ +|||.|+||+|||+.+. -.+||||||+|+.+.+ +
T Consensus 647 G-DMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-k 720 (888)
T KOG4236|consen 647 G-DMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-K 720 (888)
T ss_pred c-hHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch-h
Confidence 5 66666522 3456789888899999999999999999 99999999999999765 4799999999998875 4
Q ss_pred CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHH
Q 039595 912 SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 991 (1078)
..+...+||+.|+|||++..+.|...-|+||.||++|--+.|..||....+ +...+......+++ ..+.+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----IndQIQNAaFMyPp------~PW~e 790 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----INDQIQNAAFMYPP------NPWSE 790 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----hhHHhhccccccCC------Cchhh
Confidence 456778999999999999999999999999999999999999999753222 22222222222222 22333
Q ss_pred HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHHHHHHHHhh
Q 039595 992 KLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILAIEA 1037 (1078)
Q Consensus 992 ~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~~~~~~~~~ 1037 (1078)
.....+++|...|+..-++|.+.++.+.|+|.+..+...-+...+.
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~ 836 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEV 836 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHH
Confidence 4446778899999999999999999999999988777666555544
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=320.32 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=199.4
Q ss_pred hcCCCccceeccCCceeEEEEEeC--------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
..+|++.+.||+|+||.||+|... .+..||+|.+.... .....+++.+|+.+++++ +||||+++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 457899999999999999999542 12368999876432 233456788999999999 899999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDA-------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 887 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 887 (1078)
..++..++|+||+++|+|.+++.+.. ....+++.++..++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999986432 234578899999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccc
Q 039595 888 VLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINF 964 (1078)
Q Consensus 888 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~ 964 (1078)
|+++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999866432211 122234567999999999999999999999999999998 8888643221
Q ss_pred cchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 965 SSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
....... .......... .....+.+++.+||+.+|++||++.|++++..
T Consensus 243 ~~~~~~~------~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 243 EELFKLL------KEGHRMDKPA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred HHHHHHH------HcCCCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 1111111 1111111111 11236778999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=321.56 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=201.1
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC---
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--- 823 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--- 823 (1078)
...++|+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 3457899999999999999999965 4789999999865422 233345677899999999999999999988543
Q ss_pred ---CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 824 ---RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 824 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
...|+||||+.+ +|.+.+.. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 357999999965 88888732 278899999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc--cc-----------h
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SS-----------F 967 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~-----------~ 967 (1078)
||.++...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...+... .. +
T Consensus 162 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 162 FGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred CccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99998764322 2334567899999999999999999999999999999999999975332100 00 0
Q ss_pred hhhhh-hhhhhcCCCCC-------C--------C-CCc-cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 968 SNMII-EVNQILDPRLS-------T--------P-SPG-VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 968 ~~~~~-~~~~~~~~~~~-------~--------~-~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
..... ........+.. . . ... .......+.+++.+||+.||++|||++|++.|+|..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 00000 00000000000 0 0 000 011233577999999999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=313.88 Aligned_cols=267 Identities=21% Similarity=0.260 Sum_probs=200.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|++|+||+|..+ +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.++...++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 57899999999999999999665 789999999865432 122345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeccccccccc
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-EFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~a~~~~ 908 (1078)
|||++ +++.+++.... ...+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++....
T Consensus 80 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred Eeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 99996 48888774332 33467888899999999999999999 9999999999999985 5679999999997654
Q ss_pred CCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh----hh------
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN----QI------ 977 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~----~~------ 977 (1078)
..........+++.|+|||++.+ ..++.++||||+||++|+|+||+.||...... ........... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhcccccc
Confidence 33333344567889999998876 45789999999999999999999997533211 11111000000 00
Q ss_pred ------cCCCCCCCC--CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 978 ------LDPRLSTPS--PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 978 ------~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..+...... .........+.+++.+|++.+|++||+++++++|+|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 000000000 000011235678999999999999999999999999754
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=304.12 Aligned_cols=246 Identities=28% Similarity=0.401 Sum_probs=194.5
Q ss_pred ceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCC
Q 039595 757 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRG 836 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 836 (1078)
++||+|+||.||+|...+++.||+|++..... ....+.+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 46899999999999776699999999865432 234567899999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC--c
Q 039595 837 SLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--R 914 (1078)
Q Consensus 837 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~ 914 (1078)
+|.+++... ...+++..+..++.+++.|++|||++ +++||||||+||+++.++.++|+|||.+......... .
T Consensus 78 ~l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 78 SLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 999998543 23578899999999999999999999 9999999999999999999999999999865421111 1
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKL 993 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1078)
....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...... +........+. ...
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~-------~~~~~~~~~~~--~~~ 221 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRER-------IESGYRMPAPQ--LCP 221 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHH-------HhcCCCCCCCc--cCC
Confidence 12234567999999998899999999999999999999 8888643321 111111 11111111111 112
Q ss_pred HHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 994 ISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 994 ~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
..+.+++.+||..+|++|||++|+++..
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 3688899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.08 Aligned_cols=250 Identities=23% Similarity=0.249 Sum_probs=191.5
Q ss_pred ceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHH-HHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 757 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVL-ALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.||+|+||.||+|.. .+|+.||+|++.+...... .....+..|.. +....+|||++++++++..+...|+|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH-HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 4689999999999965 4689999999865432111 11223344444 3455689999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 914 (1078)
+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+..... .
T Consensus 81 ~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~ 150 (260)
T cd05611 81 GGDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N 150 (260)
T ss_pred CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence 9999999943 34588999999999999999999999 999999999999999999999999999875432 2
Q ss_pred eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHH
Q 039595 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLI 994 (1078)
Q Consensus 915 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1078)
....|+..|+|||.+.+..++.++||||+|+++|||++|..||..... ......... .......... .....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~----~~~~~~~~~~--~~~~~ 222 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DAVFDNILS----RRINWPEEVK--EFCSP 222 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh----cccCCCCccc--ccCCH
Confidence 345688899999999888899999999999999999999999753221 111111111 0111111111 01123
Q ss_pred HHHHHHHhcccCCCCCCCCh---hHHHHHhhhhh
Q 039595 995 SIMEVAILCLDESPEARPTM---EKGFGHHIGYC 1025 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~---~ell~h~~~~~ 1025 (1078)
.+.+++.+||+.+|++||++ +|++.|+|+..
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 67899999999999999954 79999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.76 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=199.2
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.+.||+|+||.||+|....+..+|+|.+... ....+.+.+|+.++++++|+||+++++++.. ...++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 34689999999999999999998777888999987643 2235678899999999999999999999887 77899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
+|||+++|+|.+++... ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999999999553 234578899999999999999999998 99999999999999999999999999998654
Q ss_pred CCCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.... ......++..|+|||++....++.++|||||||++|++++ |+.||..... ....... .. ....+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~---~~----~~~~~~ 224 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRAL---ER----GYRMPR 224 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH---hC----CCCCCC
Confidence 3221 1223345678999999998889999999999999999999 8999653221 1111111 11 111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
. .....++.+++.+||+++|++||+++++...
T Consensus 225 ~--~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~ 256 (260)
T cd05073 225 P--ENCPEELYNIMMRCWKNRPEERPTFEYIQSV 256 (260)
T ss_pred c--ccCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1 1122367889999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.75 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=207.3
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|+..+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++|||++++++++.++...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 5788899999999999999654 6889999999765422 245677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 79 EYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred ecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999999543 5689999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
........++..|+|||...+..++.++||||+|+++|+|++|+.||..... . ... ........+... ...
T Consensus 153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-~---~~~-~~~~~~~~~~~~---~~~- 223 (254)
T cd06627 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-M---AAL-FRIVQDDHPPLP---EGI- 223 (254)
T ss_pred cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-H---HHH-HHHhccCCCCCC---CCC-
Confidence 4434456788999999999888889999999999999999999999753321 0 000 011111111111 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
...+.+++.+||..+|++|||+.|++.|+|+
T Consensus 224 --~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 224 --SPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --CHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 2357788999999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=306.77 Aligned_cols=253 Identities=20% Similarity=0.257 Sum_probs=194.2
Q ss_pred HHHHhhcCCCcccee--ccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhc-CCCCceeeEEeee
Q 039595 745 EIIKATDDFDEKFCI--GKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE-IRHRNIVKFHGFC 820 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~l--G~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~ 820 (1078)
+.....++|++.+.+ |+|+||.||++.. .+++.+|+|.+....... . |+..... .+||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~-----e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I-----EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h-----hHHHHHHhhcCCCEEEEEEEE
Confidence 334445677777766 9999999999965 478899999986542211 1 1111111 2799999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEe
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHVS 899 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~ 899 (1078)
..+...|+||||+++|+|.+++... ..+++.++..++.|+++|+.|||+. +++||||||+||+++.++ .++|+
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 9999999999999999999999543 3789999999999999999999999 999999999999999998 99999
Q ss_pred cccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcC
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 979 (1078)
|||.++..... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||............. .....
T Consensus 153 dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~ 224 (267)
T PHA03390 153 DYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL----LKRQQ 224 (267)
T ss_pred cCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH----HHhhc
Confidence 99998765422 23468899999999999899999999999999999999999976332211111111 11111
Q ss_pred CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCC-hhHHHHHhhhh
Q 039595 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPT-MEKGFGHHIGY 1024 (1078)
Q Consensus 980 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ell~h~~~~ 1024 (1078)
.... .. ......+.+++.+||+.+|.+||+ ++|+++|+|+.
T Consensus 225 ~~~~-~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 225 KKLP-FI---KNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ccCC-cc---cccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 1111 11 122336788899999999999996 69999999964
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=307.14 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=189.1
Q ss_pred eeccCCceeEEEEEeC-CCC--EEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEEEeec
Q 039595 758 CIGKGGQGSVYKAELP-SGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~ 833 (1078)
.||+|+||.||+|..+ ++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 5899999999999764 344 46888876431 233456788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 834 HRGSLARILGNDA-------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 834 ~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
++|+|.+++.... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 9999999985432 123478999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcC
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILD 979 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 979 (1078)
||++....... .......+..|+|||++....++.++|||||||++|||++ |+.||..... ..... .. .
T Consensus 156 fgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~---~~----~ 225 (270)
T cd05047 156 FGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYE---KL----P 225 (270)
T ss_pred CCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHHHH---HH----h
Confidence 99986432211 1112233567999999988889999999999999999997 9999743221 11111 11 1
Q ss_pred CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 980 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.......+. ....++.+++.+||+.+|.+|||+++++...
T Consensus 226 ~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 226 QGYRLEKPL--NCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred CCCCCCCCC--cCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 111111111 1123578999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=308.33 Aligned_cols=251 Identities=25% Similarity=0.463 Sum_probs=196.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CC---CEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SG---DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
.+|++.+.||+|+||.||+|..+ ++ ..||||++.... ......+|..|+.+++.++||||+++++++.++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 35788899999999999999654 33 369999986542 234466799999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|+|.+++... .+.+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 81 MIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999999999543 34689999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCc--ee-e--ccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCC
Q 039595 907 VEPYSSNR--TE-F--VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDP 980 (1078)
Q Consensus 907 ~~~~~~~~--~~-~--~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 980 (1078)
........ .. . ..+..|+|||.+.+..++.++||||+||++||+++ |..||..... ......+ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i---~~~~-- 228 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAI---EQDY-- 228 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHH---HcCC--
Confidence 54322111 11 1 12457999999999899999999999999999886 9999643221 1111111 1111
Q ss_pred CCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 981 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.... .... ...+.+++.+||..+|++||++++++..
T Consensus 229 ~~~~-~~~~---~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 229 RLPP-PMDC---PTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred cCCC-cccC---CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111 1111 2356789999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=295.84 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=203.4
Q ss_pred ccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHH-HhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 755 EKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA-LNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 755 ~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
-...||.|+||+|++..+ +.|+..|||+++... ...+.+++..|.+. ++.-++||||++||.+..++..|+.||.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 345699999999999955 479999999998754 24556777777765 4555899999999999999999999999
Q ss_pred cCCCCHHHHhcC--CCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 833 LHRGSLARILGN--DATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 833 ~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
|+- ++..+-+. ......+++.-.-.|....+.||.||.+.. .|+|||+||+|||++..|.+|+||||++..+..
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~- 220 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD- 220 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence 965 66544321 122345788888889999999999998875 899999999999999999999999999987643
Q ss_pred CCCceeecccccccccccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 911 SSNRTEFVGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
+-..+..+|...|||||.+.. ..|+.+|||||+|+.|||+.||+.||+.++..+..+... ..-+|........
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V-----v~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV-----VIGDPPILLFDKE 295 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH-----HcCCCCeecCccc
Confidence 233455688999999999874 358999999999999999999999977554433222221 1223333333333
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEIL 1029 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~ 1029 (1078)
.......+..+|.-|+.+|-..||...++..++|....++.
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 34455577788888999999999999999999997665543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.73 Aligned_cols=386 Identities=31% Similarity=0.422 Sum_probs=224.9
Q ss_pred ccccccceeeccccccc-CCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCc
Q 039595 171 GQLSLIHEFSFCHNNVS-GRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD 249 (1078)
Q Consensus 171 ~~l~~L~~L~l~~n~~~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 249 (1078)
|-|+-.+-.|+++|.++ +..|.+...+++++.|.|...++. .+|+.++.|.+|+.|.+++|++.. +-+.+..|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhH
Confidence 34455566677777777 456667777777777777777765 567777777777777777777663 345566666777
Q ss_pred EEeccccccCC-CCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeecccc
Q 039595 250 TLFLYKNSLSG-SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLN 328 (1078)
Q Consensus 250 ~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N 328 (1078)
.+.+.+|++.. -+|..+..|..|+.||||+|+++ ..|..+..-+++-.|+|++|
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-------------------------EvP~~LE~AKn~iVLNLS~N 136 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-------------------------EVPTNLEYAKNSIVLNLSYN 136 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-------------------------hcchhhhhhcCcEEEEcccC
Confidence 77777776642 24555555666666666666665 44555666666666666666
Q ss_pred ccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCC-CCCC
Q 039595 329 QLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLF-GPIP 407 (1078)
Q Consensus 329 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~ 407 (1078)
+|..++-..|-++..|-+||||+|++. .+|..+..+.+|++|+|++|.+...--..+..+++|++|++++.+-+ ..+|
T Consensus 137 ~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~P 215 (1255)
T KOG0444|consen 137 NIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIP 215 (1255)
T ss_pred ccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCC
Confidence 666444445566666677777777776 56666667777777777777665433334445666667777665432 2455
Q ss_pred ccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCc
Q 039595 408 KSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSK 487 (1078)
Q Consensus 408 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~ 487 (1078)
.++..+.+|..++++.|++.. .++.+..+++|+.|+||+|+|+.
T Consensus 216 tsld~l~NL~dvDlS~N~Lp~-vPecly~l~~LrrLNLS~N~ite----------------------------------- 259 (1255)
T KOG0444|consen 216 TSLDDLHNLRDVDLSENNLPI-VPECLYKLRNLRRLNLSGNKITE----------------------------------- 259 (1255)
T ss_pred CchhhhhhhhhccccccCCCc-chHHHhhhhhhheeccCcCceee-----------------------------------
Confidence 555555555555555554432 22333334444444444444432
Q ss_pred ccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCcccc-CCCCccccccccccccccc
Q 039595 488 LQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLS-SSIPKSIGNLLKLYYLNLS 566 (1078)
Q Consensus 488 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls 566 (1078)
+........+|++|+||+|+++ .+|.+++.+++|+.|.+.+|+++ .-+|..++++.+|+.+..+
T Consensus 260 --------------L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aa 324 (1255)
T KOG0444|consen 260 --------------LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAA 324 (1255)
T ss_pred --------------eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhh
Confidence 2222222334444444444444 44555555555555555555443 1355566666666666666
Q ss_pred CcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEc
Q 039595 567 NNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDI 637 (1078)
Q Consensus 567 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l 637 (1078)
+|.+. .+|..++.+.+|+.|.|++|++- .+|+.+.-++.|+.|||..|+-.-.+|+--..-++|..-++
T Consensus 325 nN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 325 NNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred ccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeec
Confidence 66664 56666666666666666666664 35666666666666666666554344443333344554443
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=308.57 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=199.3
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 57888999999999999999753 34679999875432 2224567899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCC------CcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 825 HSFLVCEYLHRGSLARILGNDATA------KELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
..++||||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence 999999999999999999654322 2589999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhh
Q 039595 899 SDFGIAKFVEPYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQ 976 (1078)
Q Consensus 899 ~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 976 (1078)
+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~~----- 231 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRL----- 231 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHHH-----
Confidence 9999987543211 12233456788999999988889999999999999999998 7888642221 1111111
Q ss_pred hcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.........+. .....+.+++.+||+.+|++||++.|++.+.
T Consensus 232 -~~~~~~~~~~~--~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 232 -QAGKLELPVPE--GCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred -HcCCcCCCCCC--CCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 11111111011 1123678899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=308.17 Aligned_cols=238 Identities=22% Similarity=0.354 Sum_probs=183.7
Q ss_pred eeccCCceeEEEEEeCC-------------------------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc
Q 039595 758 CIGKGGQGSVYKAELPS-------------------------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 812 (1078)
.||+|+||.||+|.... ...||+|++.... ......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 58999999999996421 1358889875432 223456888999999999999
Q ss_pred eeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 039595 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL 892 (1078)
Q Consensus 813 iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 892 (1078)
|+++++++.++...++||||+++|+|..++.+. ...+++..+..++.||++||+|||++ +|+||||||+||+++.
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~ 152 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR 152 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence 999999999999999999999999999998542 34688999999999999999999999 9999999999999976
Q ss_pred CC-------cEEEecccccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHH-hCCCCCCccccc
Q 039595 893 EF-------EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVI-KGNHPRDFFSIN 963 (1078)
Q Consensus 893 ~~-------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell-tG~~p~~~~~~~ 963 (1078)
.+ .+|++|||.+..... .....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALS----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cCcccCccceeeecCCcccccccc----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 54 489999999864422 123457888999998875 56899999999999999995 689996533221
Q ss_pred ccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 964 FSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.... ........+.+ . ...+.+++.+||+.+|++|||+++++++.
T Consensus 229 --~~~~-------~~~~~~~~~~~-~---~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 --EKER-------FYEKKHRLPEP-S---CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred --HHHH-------HHHhccCCCCC-C---ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1101 11111111111 1 12577899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=304.83 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=199.9
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEecccccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--Cee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLS-GNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--RHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 826 (1078)
.+|++.+.||+|+||.||+|.. .+++.||+|.+...... ........+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999965 46899999987543211 1233456788999999999999999999998654 568
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++|+||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999843 24578899999999999999999999 999999999999999999999999999986
Q ss_pred ccCCC---CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 907 VEPYS---SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 907 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
..... .......|+..|+|||.+.+..++.++|||||||++||+++|+.||...... . ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~---~~~~~~~~~~~ 227 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----A---AIFKIATQPTK 227 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----H---HHHHHHcCCCC
Confidence 54311 1123456889999999999888999999999999999999999997532111 1 11111111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
...+. .....+.+++.+||. +|..||++.+++.|||
T Consensus 228 ~~~p~--~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 228 PMLPD--GVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred CCCCc--ccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 11111 112357888999999 5799999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=321.44 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=200.8
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA----- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 823 (1078)
.++|++.+.||+|+||+||+|.. .+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 46799999999999999999954 4789999999875422 223345677899999999999999999988543
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...|+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 35799999996 689988843 35689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh----------
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII---------- 972 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~---------- 972 (1078)
+..............++..|+|||.+.. ..++.++|||||||++|+|++|+.||...... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITELLGSPSEED 232 (337)
T ss_pred ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCChHH
Confidence 9876543333344568889999998765 46889999999999999999999997533210 0000000
Q ss_pred -------hhhhh---cCCCCCCC-CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 973 -------EVNQI---LDPRLSTP-SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 973 -------~~~~~---~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
..... ........ .........++.+++.+||+.+|++|||++|+++|+|..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 00000 00000000 000011224578999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=305.40 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=187.0
Q ss_pred ceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee-cCCeeEEEEe
Q 039595 757 FCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS-NARHSFLVCE 831 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E 831 (1078)
+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.+++.++||||+++++++. .++..++|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 36899999999999643 24579999875421 2344567889999999999999999999775 4566899999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+.+|+|.+++.+. ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 78 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 78 YMKHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999999999543 23467788899999999999999999 99999999999999999999999999998653321
Q ss_pred ----CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhC-CCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 912 ----SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG-NHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 912 ----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.......++..|+|||.+.+..++.++|||||||++|||++| .+||..... .... ............
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~------~~~~~~~~~~~~ 224 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDIT------VYLLQGRRLLQP 224 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH------HHHhcCCCCCCC
Confidence 111233467789999999888999999999999999999995 555432111 1111 111111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
... ...+.+++.+||..+|++||++.|++...
T Consensus 225 ~~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 225 EYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred CcC---CHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 111 23577899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=314.68 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=196.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR---- 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 824 (1078)
.++|+..+.||+|+||.||+|... +++.||||++...... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc--CCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 457999999999999999999654 6899999998654321 122334567999999999999999999986543
Q ss_pred ----eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 825 ----HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 825 ----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
..++||||+.+ ++.+++... ...+++.++..++.||+.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 45999999965 888887432 23589999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCC----ceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh
Q 039595 901 FGIAKFVEPYSSN----RTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN 975 (1078)
Q Consensus 901 fG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 975 (1078)
||.+......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....... .........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~ 240 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLC 240 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence 9999866432211 2234678899999988764 47889999999999999999999975432210 000000000
Q ss_pred hhcCCC---------------CCCCCC-ccH------HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 976 QILDPR---------------LSTPSP-GVM------DKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 976 ~~~~~~---------------~~~~~~-~~~------~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
...++. ...... ... .....+.+++.+||..||++|||++|+++|+|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000000 000000 000 011256789999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=312.19 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=199.6
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
..++|++.+.||+|+||.||+|..+ +++.||||++..... ......+..|+.++.+. +||||+++++++.++...
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 3467899999999999999999776 489999999875421 22344556666666556 599999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+||||+.+ ++.+++... ...+++..+..++.|++.|++|||+.. +|+||||+|+||+++.++.+||+|||++..
T Consensus 90 ~~v~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 90 FICMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred EEEeeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 999999854 777776432 236889999999999999999999732 899999999999999999999999999986
Q ss_pred ccCCCCCceeeccccccccccccccCC----CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMR----ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
..... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||......... ...+.....
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~ 236 (296)
T cd06618 165 LVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-------LTKILQEEP 236 (296)
T ss_pred ccCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH-------HHHHhcCCC
Confidence 64322 223345788999999987554 788999999999999999999997533221111 111111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
... +.......++.+++.+||+.||++||++++++.|+|+...+.
T Consensus 237 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 237 PSL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred CCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 110 000012236788999999999999999999999999776433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=307.73 Aligned_cols=252 Identities=19% Similarity=0.221 Sum_probs=193.2
Q ss_pred eeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHH---HHHHhcCCCCceeeEEeeeecCCeeEEEEeec
Q 039595 758 CIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALNEIRHRNIVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 833 (1078)
.||+|+||.||+|.. .+++.||+|.+........ .....+..| ...++...||+|+++++++...+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 389999999999965 4688999999876432211 111223333 33445568999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 039595 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN 913 (1078)
Q Consensus 834 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 913 (1078)
.||+|.+++.. ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++...... .
T Consensus 80 ~g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~ 151 (278)
T cd05606 80 NGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--K 151 (278)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--C
Confidence 99999998843 35689999999999999999999999 9999999999999999999999999999765432 2
Q ss_pred ceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHH
Q 039595 914 RTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDK 992 (1078)
Q Consensus 914 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 992 (1078)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||......... . ........++..... .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~-~~~~~~~~~~~~~~~------~ 222 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E-IDRMTLTMAVELPDS------F 222 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--H-HHHHhhccCCCCCCc------C
Confidence 2345789999999998754 6899999999999999999999997643221110 0 011111111121111 1
Q ss_pred HHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhhH
Q 039595 993 LISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 993 ~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~~ 1027 (1078)
...+.+++.+|+..+|.+|| +++++++|+|+...+
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 23678889999999999999 999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=310.43 Aligned_cols=262 Identities=22% Similarity=0.263 Sum_probs=204.3
Q ss_pred CCCccceeccCCceeEEEEEe----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
.|++.+.||+|+||.||+|.. .+|+.||+|++............+.+.+|+.+++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999965 368899999987643332333456788899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 34578899999999999999999999 999999999999999999999999999986
Q ss_pred ccCCC-CCceeeccccccccccccccC--CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 907 VEPYS-SNRTEFVGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 907 ~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
..... .......|+..|+|||.+... .++.++||||||+++|+|++|+.||...... ..... .........+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~-~~~~~~~~~~~~~ 232 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAE-ISRRILKSEPPYP 232 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHH-HHHHhhccCCCCC
Confidence 54322 122345688999999998753 4688999999999999999999997643221 01111 1110000111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhhH
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~~ 1027 (1078)
. . ....+.+++.+||+.||++|| ++++++.|+|+....
T Consensus 233 ~---~---~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 233 Q---E---MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred c---c---CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 1 1 122567889999999999997 899999999977643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=320.09 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=198.4
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA----- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 823 (1078)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 46899999999999999999964 478999999986421 223345678899999999999999999987543
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...++|+||+.+ ++.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred ceEEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 357999999975 8888873 24589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC---Cceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh--------
Q 039595 904 AKFVEPYSS---NRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI-------- 971 (1078)
Q Consensus 904 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~-------- 971 (1078)
+........ ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~ 230 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPS 230 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCC
Confidence 986543221 1233568899999998754 46899999999999999999999997532210 000000
Q ss_pred -hhhhh--------hcC-CCCCCCCC---ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 972 -IEVNQ--------ILD-PRLSTPSP---GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 972 -~~~~~--------~~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..... ... .......+ .......++.+++.+||+.||++|||+.|+++|+|...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 00000 000 00000000 00111236789999999999999999999999999663
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=305.35 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=199.1
Q ss_pred CCCccceeccCCceeEEEEEeCC--CCEEEEEEecccccc------CChhhHHHHHHHHHHHhc-CCCCceeeEEeeeec
Q 039595 752 DFDEKFCIGKGGQGSVYKAELPS--GDIVAVKKFNSQLLS------GNMADQDEFLNVVLALNE-IRHRNIVKFHGFCSN 822 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 822 (1078)
.|++.+.||+|+||.||+|..+. ++.+|+|.+...... .......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999997654 788999988643211 122334556778887765 799999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 823 ARHSFLVCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
++..++||||+++++|.+++... .....+++..++.++.|++.|+.|||+ . +++||||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999987432 234568999999999999999999996 5 899999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCC
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDP 980 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 980 (1078)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... .....
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~~~~------~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSLAT------KIVEA 228 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--HHHHH------HHhhc
Confidence 99998765433 33455788999999999988899999999999999999999999642211 11111 11111
Q ss_pred CCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 981 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...+.... .....+.+++.+||+.||++||++.|+.++.
T Consensus 229 ~~~~~~~~--~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 229 VYEPLPEG--MYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred cCCcCCcc--cCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 11111110 1123677899999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=308.02 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=200.4
Q ss_pred cCCCccceeccCCceeEEEEEeC-----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--C
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN--A 823 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~ 823 (1078)
++|+..+.||+|+||.||+|.+. +++.||||++...... ...+.+.+|+.+++.++||||+++++++.. +
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 46788899999999999999753 4678999998755321 346679999999999999999999999877 5
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence 67899999999999999995432 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchh------hhhhhh
Q 039595 904 AKFVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS------NMIIEV 974 (1078)
Q Consensus 904 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~------~~~~~~ 974 (1078)
+......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 9876532211 1123455679999999988999999999999999999999999653222111100 001111
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...+......+.+. ....++.+++.+||+.+|++|||+.|+++..
T Consensus 236 ~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 236 LELLKEGERLPRPP--SCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred HHHHHcCCcCCCCc--cCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 11111111111111 1123678899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=306.38 Aligned_cols=251 Identities=24% Similarity=0.423 Sum_probs=196.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCC----EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.+|++.+.||+|+||+||+|..+ +|+ .||+|.+.... ......++.+|+..+++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 57888999999999999999654 333 58999876542 23445678899999999999999999999987 78
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++|+||+++|+|.+++... ...+++..+..++.||+.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred eEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 89999999999999999543 23489999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCc--eeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 906 FVEPYSSNR--TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 906 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
......... ....++..|+|||.+....++.++||||||+++||+++ |+.||+.... ......+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~-----~~~~ 230 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEK-----GERL 230 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhC-----CCCC
Confidence 765322211 11223568999999988889999999999999999998 9999764322 111111111 0111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
..+ .. ....+.+++.+||..||.+||++.++++..
T Consensus 231 ~~~-~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 231 PQP-PI---CTIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred CCC-CC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 111 11 113577889999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=308.86 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=200.2
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--CeeEEE
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--RHSFLV 829 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 829 (1078)
|++.+.||+|+||.||+|... +++.||+|++.... ........+.+|+.++++++|||++++++++.+. +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 677889999999999999765 58899999997653 1223345688899999999999999999999887 899999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+||+++ +|.+++... ...+++.+++.++.||+.|++|||+. +++|+||+|+||++++++.++++|||.+.....
T Consensus 79 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 79 FEYMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred eccccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 999975 898888433 24689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-Cceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc---------
Q 039595 910 YSS-NRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL--------- 978 (1078)
Q Consensus 910 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------- 978 (1078)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+..... .............
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhccccc
Confidence 321 1233466889999998765 45789999999999999999999997543321 1000000000000
Q ss_pred ------CCCCCCCCCcc----H-H-HHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 979 ------DPRLSTPSPGV----M-D-KLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 979 ------~~~~~~~~~~~----~-~-~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
........+.. . . ....+.+++.+||..+|++||+++++++|+|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000000 0 0 13467899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=311.31 Aligned_cols=267 Identities=24% Similarity=0.307 Sum_probs=200.1
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC--
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR-- 824 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 824 (1078)
...++|++.+.||+|+||.||+|..+ +|+.||+|+++..... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 35678999999999999999999765 6899999998754321 223456778999999999999999999986654
Q ss_pred --------eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 039595 825 --------HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEA 896 (1078)
Q Consensus 825 --------~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 896 (1078)
..++|+||+++ ++.+.+... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999986 777777432 34689999999999999999999999 99999999999999999999
Q ss_pred EEecccccccccCCCC-Cceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh
Q 039595 897 HVSDFGIAKFVEPYSS-NRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 897 kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
||+|||.+........ ......++..|+|||.+.+ ..++.++||||+||++|||++|++||+..... ..........
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~ 234 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLC 234 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence 9999999987654331 2223456788999998765 35789999999999999999999997633211 1000000000
Q ss_pred hh----hcC-----CCCCC---------C-CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 975 NQ----ILD-----PRLST---------P-SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 975 ~~----~~~-----~~~~~---------~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.. ..+ +.... . ..........+.+++.+||+.||.+||++++++.|+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 00 000 00000 0 00000112367899999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=309.61 Aligned_cols=259 Identities=21% Similarity=0.253 Sum_probs=194.2
Q ss_pred CCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecC--CeeEE
Q 039595 753 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNA--RHSFL 828 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~l 828 (1078)
|++.+.||+|+||.||+|.. .+++.||+|+++..... .......+|+.+++++. ||||+++++++.++ +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC---chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 67788999999999999965 46899999998764321 12223456888888885 99999999999877 88999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|+||+++ ++.+++... ...+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.++...
T Consensus 78 v~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 78 VFELMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEecCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9999975 888877432 24689999999999999999999999 9999999999999999 999999999998764
Q ss_pred CCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh-------hhhhhhcCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI-------IEVNQILDP 980 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~-------~~~~~~~~~ 980 (1078)
... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+.. ....... ........+
T Consensus 151 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 151 SKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred cCC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHHHcCCCCHHHHHhhcc
Confidence 322 2233467899999997654 56789999999999999999999997543221 0000000 000000000
Q ss_pred ------CCCCCCCc-----cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 981 ------RLSTPSPG-----VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 981 ------~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
........ .......+.+++.+||+++|++||+++++++|+|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00000000 01223578899999999999999999999999995
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=311.38 Aligned_cols=254 Identities=25% Similarity=0.341 Sum_probs=205.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCeeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 828 (1078)
++|+..+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.++++++ ||||+++++++..+...++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 46889999999999999999654 7999999998764322 2233467888999999998 9999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++.+ ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 80 v~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 80 VLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999954 33689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCC--------------------CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchh
Q 039595 909 PYS--------------------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS 968 (1078)
Q Consensus 909 ~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 968 (1078)
... .......++..|+|||......++.++||||+|+++|++++|+.||...... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~ 231 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--LTF 231 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--HHH
Confidence 322 1123346789999999998888999999999999999999999997633311 111
Q ss_pred hhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCCh----hHHHHHhhh
Q 039595 969 NMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTM----EKGFGHHIG 1023 (1078)
Q Consensus 969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~ell~h~~~ 1023 (1078)
..........+ ... ...+.+++.+||+.+|++||++ +|+++|+|+
T Consensus 232 ------~~~~~~~~~~~-~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 232 ------QKILKLEYSFP-PNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred ------HHHHhcCCCCC-Ccc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 11111111111 111 2357789999999999999999 999999985
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=315.14 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=195.0
Q ss_pred ccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecC
Q 039595 755 EKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 755 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
+.+.+|.|+++.||++.. +++.||||++..... .....+.+.+|+..+++++||||+++++++.+....+++|||++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 334455555555555544 689999999876422 23456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC--
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS-- 912 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~-- 912 (1078)
+|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 83 YGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 999999996432 24588899999999999999999999 999999999999999999999999999875532211
Q ss_pred -----CceeeccccccccccccccC--CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc-------
Q 039595 913 -----NRTEFVGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL------- 978 (1078)
Q Consensus 913 -----~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------- 978 (1078)
......++..|+|||++.+. .++.++|||||||++|||++|+.||....................+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 12234567889999998763 5889999999999999999999997643221100000000000000
Q ss_pred -------------CCCCC--CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 979 -------------DPRLS--TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 979 -------------~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
++... ...........++.+++.+||..||++|||++|+++|+|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 00000 00011112234678899999999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=309.39 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=202.6
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|++.+.||+|++|.||+|..+ +++.+|+|++...... ......+.+|+.++++++||||+++++++..+...++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES--EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 667889999999999999654 7899999998765322 2335678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+++ ++.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 79 FMDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred ccCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 9976 888888442 25689999999999999999999999 99999999999999999999999999998775543
Q ss_pred CCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh---------------
Q 039595 912 SNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN--------------- 975 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~--------------- 975 (1078)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+.. ...........
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCchHhcccchhhhh
Confidence 233345678899999998876 7899999999999999999999997533211 00000000000
Q ss_pred ---hhcCCCCCCCCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 976 ---QILDPRLSTPSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 976 ---~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
............ .......++.+++.+||++||.+||++++++.|+|.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000000000000 011123478899999999999999999999999994
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=304.53 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=196.9
Q ss_pred hcCCCccceeccCCceeEEEEEeCC----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.++|+..+.||+|+||.||+|...+ ...||||...... .....+.+.+|+.++++++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 3568888999999999999996543 2468999876542 23445678999999999999999999999875 45
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++|+|.+++... ...+++..+..++.|++.|++|+|+. +++||||||+||+++.++.++++|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence 78999999999999999543 23589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCC-ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 906 FVEPYSSN-RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 906 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
........ .....++..|+|||.+....++.++||||||+++||+++ |+.||...... ...... .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~---~~~~--~~~ 228 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRI---ENGE--RLP 228 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH---HcCC--cCC
Confidence 66433211 122334568999999988889999999999999999986 99997533221 111111 1111 111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
..... ...+.+++.+|+..+|++|||+.+++...-.
T Consensus 229 -~~~~~---~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 229 -MPPNC---PPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred -CCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111 2367888999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=320.62 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=215.3
Q ss_pred HhhcCCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeee----
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCS---- 821 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~---- 821 (1078)
..++.|++.+.||+|.+|.||+++ .++|+.+|+|+..... ...+++..|..+++.. .|||++.++|+|.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 346789999999999999999995 4578999999986643 2345567788888887 6999999999983
Q ss_pred -cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 822 -NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 822 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
.++.+|+|||||.+|+..|+++... ...+.|+.+..|++.++.|+.+||.. .++|||||-.|||++.++.||++|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 4679999999999999999997765 67899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCceeecccccccccccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN 975 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 975 (1078)
||.+..++.......+.+||+.|||||++.. ..|+.++|+||+|++..||.-|.+|+-.+..- +..
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------raL 237 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------RAL 237 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------hhh
Confidence 9999999887778888999999999999863 34778999999999999999999994322210 111
Q ss_pred hhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 976 QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 976 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..+++..++..........++.++|..|+.+|-++||++.++++|||...
T Consensus 238 F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 238 FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 11222222222223445568899999999999999999999999999884
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=301.74 Aligned_cols=244 Identities=25% Similarity=0.423 Sum_probs=193.7
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.+|++.+.||+|+||.||+|.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++..+ ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 5688999999999999999975 57889999985431 245788999999999999999999998765 479999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999999999543 234578999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
......+..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....... .....+. ....
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~---~~~~~~~---~~~~- 221 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--KEVKECV---EKGYRME---PPEG- 221 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHH---hCCCCCC---CCCc-
Confidence 122334578999999998899999999999999999997 9999653321 1111111 1111111 1111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
....+.+++.+||+.+|++||++++++..
T Consensus 222 --~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 222 --CPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred --CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12357789999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=318.92 Aligned_cols=265 Identities=22% Similarity=0.296 Sum_probs=201.6
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee----cCC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS----NAR 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~ 824 (1078)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+.++++++||||+++++++. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 47899999999999999999965 4799999999875432 2233556778999999999999999999875 345
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++||||+. |+|.+++.. ...+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred eEEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence 6899999996 589998843 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCC----ceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh-------
Q 039595 905 KFVEPYSSN----RTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII------- 972 (1078)
Q Consensus 905 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~------- 972 (1078)
......... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.. .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~ 232 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPS 232 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCCh
Confidence 765432211 234578899999998765 46899999999999999999999997533221 0000000
Q ss_pred -------------hhhhhcCCCCCCCCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 973 -------------EVNQILDPRLSTPSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 973 -------------~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
......+.....+.. .......++.+++.+||+.+|++||++++++.|+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 000000000000000 00112346889999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=310.20 Aligned_cols=253 Identities=23% Similarity=0.407 Sum_probs=194.9
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCC----EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
..+|+..+.||+|+||.||+|... +|+ .||+|.+.... ......++.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 356788899999999999999653 454 47888875432 233345688999999999999999999998754
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++++||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred CceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence 467999999999999998532 23578899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 905 KFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 905 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
+........ .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ......... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~-----~~~ 229 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEK-----GER 229 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHC-----CCC
Confidence 876432221 122345678999999998899999999999999999997 8999653221 111111110 111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
...+ +. ...++.+++.+||..+|++||+++++++...
T Consensus 230 ~~~~-~~---~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 230 LPQP-PI---CTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCCC-CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111 11 1236778899999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=302.81 Aligned_cols=236 Identities=26% Similarity=0.394 Sum_probs=185.4
Q ss_pred ceeccCCceeEEEEEeCC-C----------CEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 757 FCIGKGGQGSVYKAELPS-G----------DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
+.||+|+||.||+|.... + ..|++|.+.... .....+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 368999999999997653 3 247778765432 115678899999999999999999999987 77
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-------cEEE
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-------EAHV 898 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl 898 (1078)
.++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+|+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence 899999999999999995432 2688999999999999999999999 999999999999999888 7999
Q ss_pred ecccccccccCCCCCceeeccccccccccccccC--CCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhh
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVN 975 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 975 (1078)
+|||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||..... ........
T Consensus 150 ~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~--- 220 (259)
T cd05037 150 SDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQ--- 220 (259)
T ss_pred CCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHh---
Confidence 99999986543 2234567889999998876 78999999999999999999 5777543321 11101000
Q ss_pred hhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 976 QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 976 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
....... +. ...+.+++.+||..+|++|||+.|+++.
T Consensus 221 --~~~~~~~--~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 221 --DQHRLPM--PD----CAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred --cCCCCCC--CC----chHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0111111 11 1477899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=318.52 Aligned_cols=254 Identities=27% Similarity=0.378 Sum_probs=202.9
Q ss_pred CCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC------C
Q 039595 752 DFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA------R 824 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 824 (1078)
-|...+.||+||||.||+|+ ..+|+.||||.++... .....+..-+|++++++++|||||+++++-++. +
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 35566789999999999997 4589999999997754 445577788999999999999999999987543 3
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--CCC--cEEEec
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD--LEF--EAHVSD 900 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~D 900 (1078)
...+|||||.||+|+..+.+......+++.+.+.++.+++.||.|||++ |||||||||.||++- .+| ..||+|
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence 6689999999999999998888888899999999999999999999999 999999999999994 334 489999
Q ss_pred ccccccccCCCCCceeeccccccccccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccccc--cchhhhhh-----
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SSFSNMII----- 972 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~~~~----- 972 (1078)
||.|+.+++.. .....+||..|.+||.+. ++.|+..+|.|||||++||..||..||....... .++...+.
T Consensus 168 fG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 168 FGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 99999887644 677889999999999998 5889999999999999999999999986554431 11111110
Q ss_pred ----------hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCC
Q 039595 973 ----------EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARP 1012 (1078)
Q Consensus 973 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1012 (1078)
.....+...++.+..-.......+-..+..+|..+|++|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0001111222333333344455667777778999999998
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=305.87 Aligned_cols=238 Identities=23% Similarity=0.369 Sum_probs=184.6
Q ss_pred ceeccCCceeEEEEEeC-C-------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 757 FCIGKGGQGSVYKAELP-S-------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
+.||+|+||.||+|..+ . ...||+|.+... .....+.+.+|+.+++.++||||+++++++..+...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 35899999999999653 2 234888877543 23345678889999999999999999999999899999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc--------EEEec
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE--------AHVSD 900 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~D 900 (1078)
||||+++|+|.++++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++. ++++|
T Consensus 77 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence 999999999999995432 3578899999999999999999999 9999999999999987765 69999
Q ss_pred ccccccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCC-CCCCcccccccchhhhhhhhhhhc
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGN-HPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
||.+..... .....++..|+|||.+.+. .++.++|||||||++|||++|. .|+...... .... ... .
T Consensus 152 ~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~---~~~--~ 220 (258)
T cd05078 152 PGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQ---FYE--D 220 (258)
T ss_pred cccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHH---HHH--c
Confidence 999875432 2234678899999998874 5799999999999999999985 554322111 0000 000 0
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.+.++.. ...++.+++.+||+.||++|||++++++.
T Consensus 221 ~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 RHQLPAP------KWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cccCCCC------CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 1111111 12357899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=332.90 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=196.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec------
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN------ 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 822 (1078)
..+|+..+.||+||||.||+++.+ +|+.||||++.... .......+.+|+..+++++|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 357888889999999999999776 89999999997654 23445678899999999999999998732200
Q ss_pred --------------------------------------------------------------------------------
Q 039595 823 -------------------------------------------------------------------------------- 822 (1078)
Q Consensus 823 -------------------------------------------------------------------------------- 822 (1078)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHH
Q 039595 823 -------------------------A--------RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869 (1078)
Q Consensus 823 -------------------------~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~ 869 (1078)
. ...||=||||+...+.+++++..... .....++++++|+.||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 0 12578899999988888885433221 457889999999999999
Q ss_pred HHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc------------------CCCCCceeecccccccccccccc
Q 039595 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE------------------PYSSNRTEFVGTFGYAAPEIAYT 931 (1078)
Q Consensus 870 LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~ 931 (1078)
+|++ |||||||||.|||+++++.|||+|||+|.... ......+..+||.-|+|||.+.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998721 01113466899999999999886
Q ss_pred CC---CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCC
Q 039595 932 MR---ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESP 1008 (1078)
Q Consensus 932 ~~---~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 1008 (1078)
.. |+.|+|+||+|||++||+.- |.-. .+.+ .......++.++.+..-..++...-..+|++|+++||
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~yP---F~Ts----MERa---~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLYP---FGTS----MERA---SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhcc---CCch----HHHH---HHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence 54 99999999999999999964 3211 1111 2222233444444422223333344688899999999
Q ss_pred CCCCChhHHHHHhhhh
Q 039595 1009 EARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 1009 ~~RPt~~ell~h~~~~ 1024 (1078)
.+|||+.|+|.+.|.-
T Consensus 860 ~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 860 SKRPTATELLNSELLP 875 (1351)
T ss_pred ccCCCHHHHhhccCCC
Confidence 9999999999997765
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=303.06 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=206.2
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|++.+.||+|+||.||+|.. .+++.+|+|++...... ......+.+|+.++++++||||+++++++.+....++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 478889999999999999954 47889999998764322 334567788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 831 EYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
||+++++|.+++.+.. ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999999999985422 235688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
. ......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||+..+. ..... .+..........
T Consensus 156 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~------~~~~~~~~~~~~-- 223 (256)
T cd08530 156 N--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRY------KVQRGKYPPIPP-- 223 (256)
T ss_pred C--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH------HHhcCCCCCCch--
Confidence 3 23335688999999999998899999999999999999999999754322 11111 111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
....++.+++.+|+..+|++||++.|+++||+
T Consensus 224 -~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 224 -IYSQDLQNFIRSMLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred -hhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence 23346889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.47 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=197.4
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC---CCCceeeEEeeeecCCe---
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI---RHRNIVKFHGFCSNARH--- 825 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~--- 825 (1078)
|++.+.||+|+||.||+|..+ +++.||+|+++..... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc--chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 677889999999999999776 5899999999754321 12234455677666555 69999999999987766
Q ss_pred --eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 826 --SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 826 --~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
.+++|||+.+ +|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999975 8998885432 23589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh---------
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV--------- 974 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~--------- 974 (1078)
+....... ......++..|+|||.+.+..++.++|||||||++|||++|++||+..... ..........
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 154 ARIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ceeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcC
Confidence 98764322 223345788999999999989999999999999999999999997643221 0000000000
Q ss_pred ------hhhcCCCCCCCCCc-cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 975 ------NQILDPRLSTPSPG-VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 975 ------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.............. .......+.+++.+||+.||++||+++|++.|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00000001110000 11223467889999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.60 Aligned_cols=250 Identities=27% Similarity=0.419 Sum_probs=196.8
Q ss_pred CCccceeccCCceeEEEEEeCC-----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 753 FDEKFCIGKGGQGSVYKAELPS-----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
|++.+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 4567889999999999996653 3889999986542 2224678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.++..
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999954322 2289999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCce-eeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 908 EPYSSNRT-EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 908 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
........ ...+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||..... ....... .. ......
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~---~~---~~~~~~ 225 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYL---KK---GYRLPK 225 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---hc---CCCCCC
Confidence 54322111 2337789999999988889999999999999999998 7888653211 1111111 11 111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
... ...++.+++.+|+..||++|||+.|+++.
T Consensus 226 ~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 226 PEN---CPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred CCc---CCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 111 22367789999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=305.76 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=192.3
Q ss_pred ceeccCCceeEEEEEeCC-------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 757 FCIGKGGQGSVYKAELPS-------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+.||+|+||.||+|+.++ ++.||+|.+.... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 358999999999996542 2579999876432 123456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCC----CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-----cEEEec
Q 039595 830 CEYLHRGSLARILGNDA----TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-----EAHVSD 900 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~D 900 (1078)
|||+++|+|.+++.+.. ....+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++++|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999999999995432 223478899999999999999999998 999999999999999887 899999
Q ss_pred ccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhh
Q 039595 901 FGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQI 977 (1078)
Q Consensus 901 fG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 977 (1078)
||+++....... ......++..|+|||++.++.++.++|||||||++|||++ |+.||..... ......+ ..
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~---~~- 228 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHV---TA- 228 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHH---hc-
Confidence 999976532211 1123345788999999999999999999999999999998 9999753221 1111111 00
Q ss_pred cCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
..... .... ....+.+++.+||..+|.+||+++++++..
T Consensus 229 -~~~~~-~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 229 -GGRLQ-KPEN---CPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred -CCccC-Cccc---chHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 01111 1111 123677899999999999999999988653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=304.44 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=200.0
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG-NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+|.+.+.||+|+||.||+|... .+..+++|+++...... .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999654 35556676665432211 122344567889999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 830 CEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
+||+++++|.+++... .....+++.++..++.|++.|+.|||+. +++|+|++|+||+++. +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988532 2345689999999999999999999999 9999999999999975 679999999998765
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ..... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~---~~~~~~~~~~~-- 226 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVL---RIVEGPTPSLP-- 226 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH---HHHcCCCCCCc--
Confidence 433334455688999999999888889999999999999999999999642211 11111 11111111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.....++.+++.+||+.+|++||++.|+++|+|+
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 227 -ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -chhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 1222367889999999999999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=311.25 Aligned_cols=262 Identities=21% Similarity=0.275 Sum_probs=195.9
Q ss_pred ceeccC--CceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeec
Q 039595 757 FCIGKG--GQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 757 ~~lG~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 833 (1078)
..||+| +||+||+|.. .+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|..++..++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 346666 9999999965 4799999999875432 2234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 039595 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN 913 (1078)
Q Consensus 834 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 913 (1078)
.+|++.+++.+.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 82 AYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred cCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999999985533 23588899999999999999999999 9999999999999999999999999866433221111
Q ss_pred c-------eeeccccccccccccccC--CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh-----------
Q 039595 914 R-------TEFVGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE----------- 973 (1078)
Q Consensus 914 ~-------~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~----------- 973 (1078)
. ....++..|+|||++.+. .++.++||||+||++|||++|+.||........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTF 236 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCcccccc
Confidence 1 112345679999998764 478999999999999999999999754321100 0000000
Q ss_pred ---hh------------------------hhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 974 ---VN------------------------QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 974 ---~~------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.. ........ .+........+.+++.+||..||++|||++|+++|+|+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred chhhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00 00000000 01111234578899999999999999999999999997554
Q ss_pred H
Q 039595 1027 E 1027 (1078)
Q Consensus 1027 ~ 1027 (1078)
+
T Consensus 315 ~ 315 (328)
T cd08226 315 K 315 (328)
T ss_pred H
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=315.36 Aligned_cols=269 Identities=22% Similarity=0.305 Sum_probs=203.2
Q ss_pred cHHHHHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeee
Q 039595 742 MHEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFC 820 (1078)
Q Consensus 742 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 820 (1078)
..+++..+.++|+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3456677889999999999999999999954 5789999999875421 223345678899999999999999999988
Q ss_pred ecC------CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 039595 821 SNA------RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF 894 (1078)
Q Consensus 821 ~~~------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 894 (1078)
... ...+++++++ +++|.+++.. ..+++..+..++.|+++|++|||+. +++||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 543 3467888876 7799888732 3588999999999999999999999 999999999999999999
Q ss_pred cEEEecccccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh
Q 039595 895 EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973 (1078)
Q Consensus 895 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 973 (1078)
.+||+|||+++.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+..
T Consensus 158 ~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~--~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILR 232 (345)
T ss_pred CEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 999999999986432 2234567889999998866 46889999999999999999999997532211 00000000
Q ss_pred hh--------------------hhcCCCCCCCCCc-cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 974 VN--------------------QILDPRLSTPSPG-VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 974 ~~--------------------~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ...+......... .......+.+++.+|++.||++||++.++++|+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 00 0000000000000 0011235779999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=308.39 Aligned_cols=253 Identities=27% Similarity=0.375 Sum_probs=199.3
Q ss_pred CCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.|+..+.||+|+||.||+|.. .+++.||+|++...... .......+.+|+.++++++|||++++++++.++...++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 377788999999999999965 46899999998654322 2233457888999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+.+ ++.+++... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99975 787777432 34589999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC-CCCCC
Q 039595 911 SSNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR-LSTPS 986 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 986 (1078)
.....|+..|+|||.+. .+.++.++|||||||++|||++|+.||..... ..... .+.... .....
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~------~~~~~~~~~~~~ 246 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALY------HIAQNESPTLQS 246 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHH------HHHhccCCCCCC
Confidence 23456888999999874 45688999999999999999999999643211 11011 111111 11111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
. .....+.+++.+||+.+|.+||+++++++|+|....
T Consensus 247 ~---~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 247 N---EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred c---cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 1 122357789999999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=305.48 Aligned_cols=249 Identities=27% Similarity=0.351 Sum_probs=199.7
Q ss_pred eccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCC
Q 039595 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGS 837 (1078)
Q Consensus 759 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 837 (1078)
||+|+||.||+|... +|+.||+|++...... .....+.+.+|+.++++++||||+++++.+..+...|+|+||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-RKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh-hhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999765 5999999998654322 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC-----
Q 039595 838 LARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS----- 912 (1078)
Q Consensus 838 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~----- 912 (1078)
|.+++.+. ..+++..+..++.||+.||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 80 L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 80 LASLLENV---GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99999543 3689999999999999999999999 999999999999999999999999999876533211
Q ss_pred ---CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 913 ---NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 913 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
......++..|+|||...+..++.++||||||+++||+++|+.||...... ..... ........+ ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~------~~~~~~~~~--~~ 223 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EIFQN------ILNGKIEWP--ED 223 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH------HhcCCcCCC--cc
Confidence 223456788999999998888999999999999999999999997533211 11111 111111111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCh---hHHHHHhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTM---EKGFGHHIGY 1024 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~---~ell~h~~~~ 1024 (1078)
......+.+++.+||+.+|++|||+ .++++|+|+.
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 1112367889999999999999999 9999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=313.11 Aligned_cols=267 Identities=20% Similarity=0.237 Sum_probs=198.4
Q ss_pred cCCCc-cceeccCCceeEEEEEeC-CCCEEEEEEeccccccCCh----------hhHHHHHHHHHHHhcCCCCceeeEEe
Q 039595 751 DDFDE-KFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNM----------ADQDEFLNVVLALNEIRHRNIVKFHG 818 (1078)
Q Consensus 751 ~~~~~-~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~ 818 (1078)
++|.. .+.||+|+||+||+|..+ +++.||||++......... .....+.+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999654 7899999998654322111 01124678999999999999999999
Q ss_pred eeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 819 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
++..+...++||||+. |+|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 589998843 34588999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccC--------------CCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccc
Q 039595 899 SDFGIAKFVEP--------------YSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 963 (1078)
Q Consensus 899 ~DfG~a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~ 963 (1078)
+|||.+..... .........++..|+|||.+.+. .++.++||||+||++|||++|+.||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999976541 11112234568889999998764 4689999999999999999999997533321
Q ss_pred ccchhhhhhhhhhh----cC---------CCCCCCCCcc----HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 964 FSSFSNMIIEVNQI----LD---------PRLSTPSPGV----MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 964 ~~~~~~~~~~~~~~----~~---------~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
............. +. +......... .....++.+++.+||+.+|++|||++|++.|+|+..
T Consensus 241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 241 -DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred -HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 0000000000000 00 0000000000 011235789999999999999999999999999754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=305.24 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=198.5
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCeeEEEE
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 830 (1078)
|++.+.||+|+||+||+|... +++.||||++...... .+.....+|+..+++++ ||||+++++++.+++..++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 677889999999999999765 5889999998654321 22334456888999998 999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+ +|+|.+++.... ...+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 78 EYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred ecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 999 779999885432 34689999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh--------------hhhh
Q 039595 911 SSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI--------------IEVN 975 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~--------------~~~~ 975 (1078)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ...... ....
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 153 P-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred C-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhhhhHhhhh
Confidence 2 2234568889999998754 457899999999999999999999975332110 000000 0000
Q ss_pred hhcCCCCCCCCCccH-----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 976 QILDPRLSTPSPGVM-----DKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 976 ~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
...+........... ....++.+++.+||+.||++|||++|++.|+|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 001101110000000 112468899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=262.51 Aligned_cols=265 Identities=20% Similarity=0.288 Sum_probs=200.9
Q ss_pred CCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
+|...++||+|+||+||+|+ ..+++.||+|+++...- +........+|+.+++.++|+|||++++....+...-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46677889999999999995 45789999999976542 2223456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
|||+. +|..++. .-++.++.+.+..+..|+++|+.++|++ ++.|||+||+|.+++.+|+.|++|||+++.+.-.
T Consensus 81 e~cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HHhhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 99977 8988883 3456789999999999999999999999 9999999999999999999999999999987665
Q ss_pred CCCceeeccccccccccccccCC-CCccchhHHHHHHHHHHHh-CCCCCCcccccc--cchhhhhhhh-hhhcC-----C
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIK-GNHPRDFFSINF--SSFSNMIIEV-NQILD-----P 980 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~--~~~~~~~~~~-~~~~~-----~ 980 (1078)
-......+-|..|.+|.++.+.. |+...|+||.||++.|+.. |++-|...+.+. ..+....... ...++ |
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 55556667899999999998764 8999999999999999997 565543322211 1111110000 00000 0
Q ss_pred CCC--CCCC---ccHHHH----HHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 981 RLS--TPSP---GVMDKL----ISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 981 ~~~--~~~~---~~~~~~----~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.+. +..+ .+.... ..=.+++.+.+.-+|.+|.++++.++|+|+.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~ 287 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS 287 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence 000 0000 011111 1224666777888999999999999999965
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.38 Aligned_cols=261 Identities=23% Similarity=0.280 Sum_probs=201.9
Q ss_pred CCCccceeccCCceeEEEEEe----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 752 DFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
+|++.+.||+|+||.||+|.. .+++.||||+++...........+.+.+|+.++.++ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999964 357889999987543322333456788999999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999843 34588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCC-CceeeccccccccccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 907 VEPYSS-NRTEFVGTFGYAAPEIAYTMR--ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 907 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
...... ......|+..|+|||.+.+.. ++.++||||||+++|||++|+.||....... . ..... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~-~~~~~--~~~~~~~~~ 230 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-S-QSEIS--RRILKSKPP 230 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-h-HHHHH--HHHHccCCC
Confidence 543222 123346889999999987665 7889999999999999999999975322111 0 01111 111111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCC---hhHHHHHhhhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPT---MEKGFGHHIGYCD 1026 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~h~~~~~~ 1026 (1078)
.... ....+.+++.+||+.||++||| +.++++|+|+..-
T Consensus 231 -~~~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 231 -FPKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred -CCcc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 1111 1135678899999999999998 4677999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=315.65 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=203.6
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC-----e
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR-----H 825 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 825 (1078)
+|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 5888999999999999999764 589999999876431 2334567889999999999999999999987765 7
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.|+||||+.+ +|.+++.+ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 79 ~~lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 79 VYIVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred eEEEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 8999999974 89988843 33789999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCC---CCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh-------
Q 039595 906 FVEPYS---SNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV------- 974 (1078)
Q Consensus 906 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~------- 974 (1078)
...... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... .....+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEE 229 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChh
Confidence 765433 123345678899999999887 7899999999999999999999997533211 000000000
Q ss_pred -------------hhhcCCCCCCCCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 -------------NQILDPRLSTPSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 -------------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
............. ........+.+++.+||+++|++||++++++.|+|+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0000000000000 00011236788999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=306.96 Aligned_cols=256 Identities=28% Similarity=0.375 Sum_probs=199.5
Q ss_pred CCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|...+.||+|+||+||+|.. .+++.||+|++...... .......+.+|+.+++.++|||++++++++.++...|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 66667899999999999965 46889999998654322 22334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+. |++.+++... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+....
T Consensus 102 ~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 102 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred cCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 996 5787777432 34588999999999999999999999 99999999999999999999999999986432
Q ss_pred CCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 912 SNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
......|+..|+|||++. ...++.++|||||||++|||++|+.||..... ....... .....+... ..
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~---~~~~~~~~~--~~- 243 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHI---AQNDSPTLQ--SN- 243 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHH---HhcCCCCCC--cc-
Confidence 223457889999999974 45688899999999999999999999643221 1101100 000111111 11
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEIL 1029 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~ 1029 (1078)
.....+.+++.+||+.+|.+||++++++.|+|+......
T Consensus 244 --~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~ 282 (313)
T cd06633 244 --EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282 (313)
T ss_pred --ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchh
Confidence 112357789999999999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=306.52 Aligned_cols=262 Identities=25% Similarity=0.322 Sum_probs=202.3
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|+..+.||+|+||.||+|... +++.||+|++.... ......+.+..|+.++++++||||+++++++.+.+..++|+|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 566788999999999999665 59999999987653 122334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+. ++|.+++.+.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.++......
T Consensus 79 ~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 79 YCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred CcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 998 48999995432 4689999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh-----------hhhh--
Q 039595 912 SNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE-----------VNQI-- 977 (1078)
Q Consensus 912 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~-----------~~~~-- 977 (1078)
.......++..|+|||.+.+. .++.++|||||||++||+++|+.||...... ......... ....
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhccccc
Confidence 333444567889999998776 7899999999999999999999997533211 000000000 0000
Q ss_pred cCCCCCCCCCc-----cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 978 LDPRLSTPSPG-----VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 978 ~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.+..+...... .......+.+++.+||..||++||++++++.|||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00111100000 00113468899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.66 Aligned_cols=255 Identities=28% Similarity=0.386 Sum_probs=199.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+.|+..+.||+|+||.||+|... +++.||+|.+...... ......++.+|+.+++.++|+|++++++++..+...++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 44777788999999999999654 6889999998643222 223345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+. |++.+++... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99996 5887776332 34588999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||...... .... .......+... .
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---~~~~~~~~~~~--~ 236 (308)
T cd06634 168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY---HIAQNESPALQ--S 236 (308)
T ss_pred ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHH---HHhhcCCCCcC--c
Confidence 23446788999999875 356788999999999999999999996432211 0000 00011111111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
......+.+++.+||+.+|++||++++++.|+|....
T Consensus 237 ---~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 237 ---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ---ccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 1122357789999999999999999999999997754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.30 Aligned_cols=246 Identities=28% Similarity=0.349 Sum_probs=200.4
Q ss_pred eccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCC
Q 039595 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGS 837 (1078)
Q Consensus 759 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 837 (1078)
||+|+||.||++... +++.||+|++...... .....+.+..|+.++++++||||+++++.++.+...++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999665 5899999998765432 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceee
Q 039595 838 LARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF 917 (1078)
Q Consensus 838 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 917 (1078)
|.+++... ..+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||.+.............
T Consensus 80 L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 80 LFSHLSKE---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 99999433 3589999999999999999999998 99999999999999999999999999998765433334456
Q ss_pred ccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHH
Q 039595 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIM 997 (1078)
Q Consensus 918 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 997 (1078)
.++..|+|||...+...+.++|+||||+++|++++|+.||...+. ..... .........+ ... ...+.
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~------~~~~~~~~~~-~~~---~~~l~ 221 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYE------KILKDPLRFP-EFL---SPEAR 221 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHH------HHhcCCCCCC-CCC---CHHHH
Confidence 788899999999988899999999999999999999999753321 11111 1111111111 111 23567
Q ss_pred HHHHhcccCCCCCCCCh---hHHHHHhhh
Q 039595 998 EVAILCLDESPEARPTM---EKGFGHHIG 1023 (1078)
Q Consensus 998 ~li~~cl~~dP~~RPt~---~ell~h~~~ 1023 (1078)
+++.+||..||++||++ ++++.|+|+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 89999999999999999 999999995
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=315.77 Aligned_cols=261 Identities=22% Similarity=0.334 Sum_probs=197.4
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA----- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 823 (1078)
.++|...+.||+|+||.||+|.. .+|+.||||++...... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc--ccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 47899999999999999999965 47899999998764322 22245678899999999999999999998654
Q ss_pred -CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 824 -RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 824 -~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
...++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred CceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 346999999965 7777652 3588899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh-------
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV------- 974 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~------- 974 (1078)
+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+...
T Consensus 163 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 163 LARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHH
Confidence 9976532 2234467889999999876 4688999999999999999999999764321 1000000000
Q ss_pred ----------hhhcC--CCCCCC-CC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 975 ----------NQILD--PRLSTP-SP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 975 ----------~~~~~--~~~~~~-~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
..... +..... .. ........+.+++.+||+.||++||+++|++.|+|+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 000000 00 000112357799999999999999999999999997553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=313.08 Aligned_cols=266 Identities=25% Similarity=0.337 Sum_probs=200.1
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeec--CC
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSN--AR 824 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--~~ 824 (1078)
..++|++.+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++++ +||||+++++++.. +.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC--cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 4567899999999999999999654 688999999865321 223345677899999999 99999999999854 34
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..|+||||+++ +|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 68999999974 999988432 678889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC-----Cceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh------
Q 039595 905 KFVEPYSS-----NRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII------ 972 (1078)
Q Consensus 905 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~------ 972 (1078)
........ ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~ 233 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPS 233 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence 86643221 2234568999999998765 457899999999999999999999975332110 0000000
Q ss_pred ----------hhhhhcC----CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 973 ----------EVNQILD----PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 973 ----------~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....++ ................+.+++.+||+.||++|||+.++++|+|...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 0000000 0000000000112346789999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=310.88 Aligned_cols=266 Identities=22% Similarity=0.310 Sum_probs=201.0
Q ss_pred HHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec-CC
Q 039595 747 IKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN-AR 824 (1078)
Q Consensus 747 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 824 (1078)
...+++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 45678899999999999999999964 4799999999865422 12234567789999999999999999999865 56
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++|+||+ +++|.++++. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++++|||.+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 789999998 5689988842 3477888889999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccc--cchhhhhh---------
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SSFSNMII--------- 972 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~~~~--------- 972 (1078)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ........
T Consensus 156 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 156 RIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 75432 2233467889999998766 568999999999999999999999975432100 00000000
Q ss_pred ----hhhhh---cCCCCCCCCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 973 ----EVNQI---LDPRLSTPSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 973 ----~~~~~---~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..... .......+.. ........+.+++.+||+.+|++|||+++++.|+|...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 00000 0000000000 00011246789999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=297.00 Aligned_cols=273 Identities=19% Similarity=0.246 Sum_probs=209.1
Q ss_pred CCCccHHHHHHhhcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-C-C---
Q 039595 738 DGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-H-R--- 811 (1078)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~--- 811 (1078)
+|.+.++......++|++...+|+|+||.|-.+ ..+.+..||||+++... +-.++..-|+.+++++. + |
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~ 150 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGK 150 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCc
Confidence 344444444455789999999999999999999 44468899999987542 23455677899999983 2 2
Q ss_pred -ceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 039595 812 -NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 890 (1078)
Q Consensus 812 -niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 890 (1078)
-+|++.++|+..++.|+|+|.+ |-+++++++.. ...+++..++..|++|++++++|||+. +++|.|+||+||++
T Consensus 151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILf 225 (415)
T KOG0671|consen 151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILF 225 (415)
T ss_pred eEEEeeehhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEE
Confidence 3888899999999999999987 55999999654 345789999999999999999999999 99999999999999
Q ss_pred CC--------------------CCcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHH
Q 039595 891 DL--------------------EFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEV 950 (1078)
Q Consensus 891 ~~--------------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~el 950 (1078)
.+ +-.++++|||.|++..+. ....+.|..|.|||++.+-.++.++||||+||||+|+
T Consensus 226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred eccceEEEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 42 235899999999876543 3667889999999999999999999999999999999
Q ss_pred HhCCCCCCcccccccchhhhhhhhhhhcCC---------------CCC---------------------CCCCccHHHHH
Q 039595 951 IKGNHPRDFFSINFSSFSNMIIEVNQILDP---------------RLS---------------------TPSPGVMDKLI 994 (1078)
Q Consensus 951 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~---------------------~~~~~~~~~~~ 994 (1078)
.||..-|+--+ +.+..+ ++..+...++. ++. ........+..
T Consensus 303 ytG~~LFqtHe-n~EHLa-MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~ 380 (415)
T KOG0671|consen 303 YTGETLFQTHE-NLEHLA-MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV 380 (415)
T ss_pred eccceecccCC-cHHHHH-HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence 99999875333 211111 11000000000 000 00011124445
Q ss_pred HHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 995 SIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 995 ~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+++++++||..||.+|+|+.|++.|||+..
T Consensus 381 ~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 381 QLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 8999999999999999999999999999764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=299.35 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=193.7
Q ss_pred CCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC----
Q 039595 753 FDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR---- 824 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 824 (1078)
|++.+.||+|+||.||+|..+ +++.||||++..... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF--SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC--ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 567788999999999999643 468899999865432 2334667889999999999999999999885432
Q ss_pred --eeEEEEeecCCCCHHHHhcCC---CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEe
Q 039595 825 --HSFLVCEYLHRGSLARILGND---ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS 899 (1078)
Q Consensus 825 --~~~lv~E~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 899 (1078)
..++++||+.+|+|.+++... .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 347899999999998887322 1223578899999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhh
Q 039595 900 DFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQ 976 (1078)
Q Consensus 900 DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 976 (1078)
|||.++....... ......+++.|++||.+.+..++.++|||||||++|||++ |+.||..... ..........
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~-- 231 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKG-- 231 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC--
Confidence 9999986543221 1223345678999999998899999999999999999999 8888643221 1111111110
Q ss_pred hcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.....+ . .....+.+++.+||+.+|++||++.+++.+.
T Consensus 232 ---~~~~~~-~---~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 232 ---NRLKQP-P---DCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred ---CcCCCC-C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111111 1 1223678899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=310.16 Aligned_cols=265 Identities=22% Similarity=0.252 Sum_probs=196.2
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA----- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 823 (1078)
.++|++.+.||+|+||.||+|..+ +++.||+|++....... .....+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 478999999999999999999654 68999999986543211 1233567899999999999999999987433
Q ss_pred ---CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 824 ---RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 824 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
...++|+||+.+ ++...+.. ....+++.++..++.|+++||+|||+. +++||||||+||++++++.++++|
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 356999999876 67776643 234689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCC-----------ceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchh
Q 039595 901 FGIAKFVEPYSSN-----------RTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS 968 (1078)
Q Consensus 901 fG~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 968 (1078)
||+++........ .....+++.|+|||.+.+. .++.++|||||||++|||++|++||...... ....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~ 237 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLH 237 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 9999865432211 1234578889999987654 5789999999999999999999997533221 0000
Q ss_pred hhhhhhh--------------hhcCCCCCCCC-Ccc----HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 969 NMIIEVN--------------QILDPRLSTPS-PGV----MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 969 ~~~~~~~--------------~~~~~~~~~~~-~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
....... ...+....... +.. ......+.+++.+|+..||++|||+.|++.|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0000000 00000000000 000 0111367899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=313.86 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=201.5
Q ss_pred HHHhhcCCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
+....++|++.+.||+|+||.||+|. ..+++.||||++.... ......+.+.+|+.++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 33456789999999999999999995 4579999999986532 12233456789999999999999999999986543
Q ss_pred ------eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 825 ------HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 825 ------~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
..++||||+ +++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+++
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 458999998 7799888832 4588999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh----
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE---- 973 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~---- 973 (1078)
+|||++..... ......+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||...... .........
T Consensus 160 ~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~ 235 (343)
T cd07880 160 LDFGLARQTDS---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTP 235 (343)
T ss_pred eeccccccccc---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCC
Confidence 99999986543 2234467889999998876 45889999999999999999999997633211 000000000
Q ss_pred ------------hhhhcC--CCCCCC-CC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 974 ------------VNQILD--PRLSTP-SP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 974 ------------~~~~~~--~~~~~~-~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
...... +..... .. ........+.+++.+|++.||++|||+.+++.|+|+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000 000000 00 000112257899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=314.10 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=195.6
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC------
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA------ 823 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 823 (1078)
.+|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 6799999999999999999955 468999999986543 23456788899999999999999999876543
Q ss_pred --------CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CC
Q 039595 824 --------RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-EF 894 (1078)
Q Consensus 824 --------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~ 894 (1078)
...|+|+||++ ++|.+++. ...+++..+..++.||+.|+.|||+. +++||||||+||+++. ++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35789999997 48988883 23588999999999999999999999 9999999999999974 56
Q ss_pred cEEEecccccccccCCCC---Cceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhh
Q 039595 895 EAHVSDFGIAKFVEPYSS---NRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM 970 (1078)
Q Consensus 895 ~~kl~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~ 970 (1078)
.+|++|||.++....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~ 231 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLI 231 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 789999999986543211 1223467889999998654 568889999999999999999999975332110 00000
Q ss_pred hh---------------hhhhhcC---CCCCCCCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 971 II---------------EVNQILD---PRLSTPSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 971 ~~---------------~~~~~~~---~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ....... .....+.. .......++.+++.+||..||++|||++|++.|+|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 0000000 00000000 00011236778999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=301.06 Aligned_cols=257 Identities=21% Similarity=0.226 Sum_probs=181.1
Q ss_pred cCCCccceeccCCceeEEEEEeCC----CCEEEEEEeccccccCChhh-------HHHHHHHHHHHhcCCCCceeeEEee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMAD-------QDEFLNVVLALNEIRHRNIVKFHGF 819 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~ 819 (1078)
++|++.+.||+|+||+||+|...+ +..+|+|+..........+. ......+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 589999999999999999997653 44566665432211000000 0112233445667789999999997
Q ss_pred eecCC----eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 039595 820 CSNAR----HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE 895 (1078)
Q Consensus 820 ~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 895 (1078)
+.... ..++++|++.. ++.+.+.. ....++..+..++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 65433 34678887644 66666633 22356788899999999999999999 9999999999999999999
Q ss_pred EEEecccccccccCCC-------CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchh
Q 039595 896 AHVSDFGIAKFVEPYS-------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS 968 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 968 (1078)
++|+|||+|+.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999998663221 112234699999999999999999999999999999999999999875532211111
Q ss_pred hhhh-hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHH
Q 039595 969 NMII-EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFG 1019 (1078)
Q Consensus 969 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 1019 (1078)
.... ....+..+.... +... ..+.+++..|+..+|++||+++++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKI--KNAN---KFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhcc--CCCC---HHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111 111111121111 1112 35678888899999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=332.72 Aligned_cols=149 Identities=28% Similarity=0.338 Sum_probs=132.3
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.++||+|+||+||+|... +++.||||+++..... .......+.+|+.+++.++||||+++++++......|+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 367999999999999999999665 7899999999764322 23345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
||||+.+++|.+++.. .+.+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999943 34578899999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=280.33 Aligned_cols=282 Identities=23% Similarity=0.302 Sum_probs=221.2
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 827 (1078)
..+|+..++||+|+|++|..++++ +.+.||+|++++.... +.++.+-.+.|-.+..+- +||.+|-++.+|..+...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~n-ddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcC-CcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 468999999999999999999654 7889999999887654 344566666666655544 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+|.||++||+|-..+ +....++++.++.+..+|+.||.|||++ ||+.||+|.+|||+|..|.+|++|+|+++.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999998777 3455699999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
-..+....+++||+.|.|||++++..|+..+|.|++||+++||+.|+.||+..+.+........-....++...++.+..
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence 66666778899999999999999999999999999999999999999999876544333222222222223332322221
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCC------hhHHHHHhhhhhhHHHHHHHHHhhccccCC
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPT------MEKGFGHHIGYCDEILAVILAIEASADYGQ 1043 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt------~~ell~h~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1078)
-. .....+++.-+++||.+|.. ++++-.|+|+. .--..++++.+...++.+
T Consensus 482 ls----vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr-~idwd~leqk~v~ppf~p 538 (593)
T KOG0695|consen 482 LS----VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR-SIDWDLLEQKQVLPPFQP 538 (593)
T ss_pred ee----hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh-hCCHHHHhhcccCCCCCC
Confidence 11 23446667789999999974 78899998865 222334444444444443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=279.84 Aligned_cols=271 Identities=23% Similarity=0.329 Sum_probs=199.8
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee--------
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS-------- 821 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-------- 821 (1078)
..|+...+||+|.||.||+|+. ++|++||+|++-...... .-.....+|+.++..++|+|++.+++.|.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe--GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc--CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 4567778899999999999954 468889998764422111 11234578999999999999999999883
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecc
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDF 901 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 901 (1078)
+....|+||.+|+. +|.-++.. ...+++..++.++.+++..||.|+|.. .|+|||+||.|+|++.+|.+||+||
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence 23458999999988 89998843 235689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCC----CCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccc--cchhhhhh--
Q 039595 902 GIAKFVEPYS----SNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SSFSNMII-- 972 (1078)
Q Consensus 902 G~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~~~~-- 972 (1078)
|+++.+.... ...+..+-|..|.+||.+.+ ..|+++.|||..||++.||+|+.+-++...... ..+.....
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 9997664322 22455677999999998776 569999999999999999999998754322110 00000000
Q ss_pred -----------hhhhhc--CCCCCCCCCccHHHHH------HHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHH
Q 039595 973 -----------EVNQIL--DPRLSTPSPGVMDKLI------SIMEVAILCLDESPEARPTMEKGFGHHIGYCDEIL 1029 (1078)
Q Consensus 973 -----------~~~~~~--~~~~~~~~~~~~~~~~------~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~ 1029 (1078)
...+.+ .|-.........+... +..+++.+++..||.+|++++++++|.|+..+-+.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 000001 1100001111111122 56788889999999999999999999999875544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=292.29 Aligned_cols=257 Identities=24% Similarity=0.294 Sum_probs=205.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 827 (1078)
..+|....+||+|+||.|-+|+.+ +.+.||||++++....++. +.+--..|-+++.-. +-|.+++++.+|..-+.+|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD-Dvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD-DVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC-cccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 357888999999999999999654 5778999999887654322 222223444555544 5789999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
.||||+.||+|--.+ +.-+.+.+..+..++.+||-||-+||++ ||+.||+|.+||++|.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999998777 3445678889999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
--......+++||+.|+|||++...+|+..+|.|||||+||||+.|++||+..+. .+..+.+.......+..+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--~elF~aI~ehnvsyPKsl----- 573 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQAIMEHNVSYPKSL----- 573 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHccCcCcccc-----
Confidence 4445556789999999999999999999999999999999999999999765443 233333333222222222
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~ 1025 (1078)
..+.+++.+..+.+.|.+|.. -++|-.|+|+-.
T Consensus 574 -----SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 574 -----SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred -----cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 225567778889999999984 467889988654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=313.31 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=201.0
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe-
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH- 825 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 825 (1078)
...++|+..+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.++++++||||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc--hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 34678999999999999999999664 688999999865421 22334567789999999999999999998865554
Q ss_pred -----eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 826 -----SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 826 -----~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
.++|+||+ +++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 5699999843 4589999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh----
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN---- 975 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~---- 975 (1078)
||.+...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||..... ......+....
T Consensus 162 fg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~ 236 (343)
T cd07851 162 FGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPD 236 (343)
T ss_pred cccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCC
Confidence 9999865432 334467889999998865 3678999999999999999999999753221 10000000000
Q ss_pred -------------hhcCCCCCCCCCccH----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 976 -------------QILDPRLSTPSPGVM----DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 976 -------------~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
............... .....+.+++.+||+.||++|||++|++.|+|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 000000000000000 11346789999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-33 Score=308.49 Aligned_cols=244 Identities=24% Similarity=0.297 Sum_probs=194.5
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
..+.|+....+|.|+|+.|-++.. .+++..+||++.+.. ..-.+|+.++... +||||+++.+.+.++.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceecCCcee
Confidence 356788888899999999999954 578899999987651 1123355444444 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee-CCCCcEEEecccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL-DLEFEAHVSDFGIAK 905 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DfG~a~ 905 (1078)
|+|||++.||-+.+.+.. .+... .++..|+.+|+.|+.|||++ |+||||+||+|||+ +..++++|+|||.++
T Consensus 392 ~~v~e~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeehhccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhh
Confidence 999999999988777633 22233 77888999999999999999 99999999999999 688999999999998
Q ss_pred cccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
..... ....+-|..|.|||+.....|++++|+||||++||+|++|+.||.....+ +.....+-.+.+..
T Consensus 465 ~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s~- 533 (612)
T KOG0603|consen 465 ELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFSE- 533 (612)
T ss_pred hCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCcccc-
Confidence 76543 33446688999999999999999999999999999999999997644332 11112222232321
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.......+++.+||+.||.+||+++++..|+|.
T Consensus 534 -----~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 534 -----CVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----ccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 122356788999999999999999999999998
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=326.98 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=200.5
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEeC----C----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeE
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAELP----S----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKF 816 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 816 (1078)
++...++..+.+.+|+|+||.||+|... . ...||||.++... ...+.+.+..|+++++.+ +||||+.+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 3333444556669999999999999543 1 3479999987654 235678899999999999 69999999
Q ss_pred EeeeecCCeeEEEEeecCCCCHHHHhcCCC-----------CC--CcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 039595 817 HGFCSNARHSFLVCEYLHRGSLARILGNDA-----------TA--KELSWNRRINVIKGVANALSYLHHDCLPSIIHRDI 883 (1078)
Q Consensus 817 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 883 (1078)
+|+|...+..++|+||+..|+|.++++..+ .. ..++..+.+.++.|||.|++||++. ++||||+
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDL 444 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDL 444 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhh
Confidence 999999999999999999999999996544 01 1388999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEecccccccccCCCCCc-eeec--cccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 039595 884 SSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR-TEFV--GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 959 (1078)
Q Consensus 884 k~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~ 959 (1078)
.++|||++.+..+||+|||+|+......... .... -+..|||||.+....|+.++|||||||++||++| |..||..
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999999654433222 1122 3567999999999999999999999999999998 8889643
Q ss_pred ccccccchhhhhhhhhhhcCCCCC-CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 960 FSINFSSFSNMIIEVNQILDPRLS-TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.... ..+. . .+.+..+ ..+..... +++++++.||+.+|++||++.|+.+..
T Consensus 525 ~~~~-~~l~------~-~l~~G~r~~~P~~c~~---eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 525 IPPT-EELL------E-FLKEGNRMEQPEHCSD---EIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred CCcH-HHHH------H-HHhcCCCCCCCCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 1111 1111 1 2222222 11222233 566888889999999999999988653
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=303.88 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=194.4
Q ss_pred CCCccceeccCCceeEEEEEeC-C--CCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeec----C
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-S--GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSN----A 823 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~ 823 (1078)
+|++.+.||+|+||.||+|... + ++.||+|++..... .....+.+.+|+.+++++ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4788899999999999999654 4 78999999864321 222345677899999999 59999999987532 2
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 45788899886 589998843 35689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC----Cceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh-----
Q 039595 904 AKFVEPYSS----NRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE----- 973 (1078)
Q Consensus 904 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~----- 973 (1078)
++....... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|++||...+.. ........
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~ 229 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGTP 229 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCCC
Confidence 986543221 1233578999999998765 46899999999999999999999997543211 00000000
Q ss_pred ----hhh--------h---cC----CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 974 ----VNQ--------I---LD----PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 974 ----~~~--------~---~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
... . .. ..+....+ .....+.+++.+|++.||++|||++|++.|+|..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFP---NANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCC---CCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 000 0 00 00000000 1123678999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-33 Score=300.24 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=215.3
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCC-EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..+++.+..||-|+||.|-+++.+... .+|+|++++.... +....+.+..|-.+|.+.+.|.||++|..|.+...+||
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 345666778999999999999776433 4899999887655 34556778889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
.||-|-||.++..++ ..+.++...+..++..+++|++|||++ +||+||+||+|.+++.+|.+|+.|||+|+.+.
T Consensus 498 LmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 498 LMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999994 446688899999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc-CCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL-DPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 987 (1078)
. +....+++||+.|.|||++.++.++.++|.||+|+++||+++|.+||. ..+....++.+.+.-..+ -|+.-
T Consensus 572 ~-g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs--~~dpmktYn~ILkGid~i~~Pr~I---- 644 (732)
T KOG0614|consen 572 S-GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS--GVDPMKTYNLILKGIDKIEFPRRI---- 644 (732)
T ss_pred c-CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC--CCchHHHHHHHHhhhhhhhccccc----
Confidence 5 445678999999999999999999999999999999999999999965 333344444443332222 22111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhhH
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCDE 1027 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~~ 1027 (1078)
.....++|++.++.+|.+|.. +.||-+|.|+.--+
T Consensus 645 -----~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 645 -----TKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred -----chhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 124568888899999999986 89999999977533
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=283.09 Aligned_cols=256 Identities=19% Similarity=0.287 Sum_probs=200.7
Q ss_pred hhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeee-e
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFC-S 821 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~ 821 (1078)
...+++..-.+-+|+||.||+|.+. +.+.|.+|.++... .......+..|..++....|||+.++.+++ +
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3456777778999999999999543 34457788776542 233456788899999999999999999987 5
Q ss_pred cCCeeEEEEeecCCCCHHHHhc-----CCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcE
Q 039595 822 NARHSFLVCEYLHRGSLARILG-----NDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEA 896 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 896 (1078)
+....++++.++.-|+|..|+. +....+.++..+...++.|++.|++|||++ ++||.||.++|+++|+.-+|
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeE
Confidence 5667899999999999999996 444455677888999999999999999999 99999999999999999999
Q ss_pred EEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhh
Q 039595 897 HVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIE 973 (1078)
Q Consensus 897 kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 973 (1078)
|++|=.+++.+-+.+.. ....-.+..||+||.+....|+.++|||||||++|||+| |+.|| .+.+..++.....+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py--aeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY--AEIDPFEMEHYLKD 513 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc--cccCHHHHHHHHhc
Confidence 99999999976543322 223345779999999999999999999999999999998 99994 44444444444333
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
..++-.| -+.++ +++.++.-||+.+|++||+++|+..-.
T Consensus 514 GyRlaQP------~NCPD---eLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 514 GYRLAQP------FNCPD---ELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred cceecCC------CCCcH---HHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 3322222 22233 466777789999999999999987653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=288.30 Aligned_cols=228 Identities=20% Similarity=0.167 Sum_probs=181.3
Q ss_pred CCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCCHHH
Q 039595 762 GGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLAR 840 (1078)
Q Consensus 762 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~ 840 (1078)
|.||.||+|.. .+++.||+|++.... .+.+|...+....||||+++++++.+....++||||+++|+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 89999999955 478999999986542 12334444555679999999999999999999999999999999
Q ss_pred HhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceeeccc
Q 039595 841 ILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGT 920 (1078)
Q Consensus 841 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 920 (1078)
++.+. ..+++..+..++.|++.||+|+|+. +++||||||+||+++.++.++++|||.+...... .....++
T Consensus 75 ~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~ 145 (237)
T cd05576 75 HISKF---LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVE 145 (237)
T ss_pred HHHHh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcC
Confidence 98432 3589999999999999999999999 9999999999999999999999999988765432 2234557
Q ss_pred cccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHH
Q 039595 921 FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVA 1000 (1078)
Q Consensus 921 ~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 1000 (1078)
..|+|||.+.+..++.++||||+|+++|||++|+.|++...... ........+ .. ....+.+++
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~~~~~~~~---~~---~~~~~~~li 209 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NTHTTLNIP---EW---VSEEARSLL 209 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------ccccccCCc---cc---CCHHHHHHH
Confidence 78999999988889999999999999999999998854221110 000000111 11 123577899
Q ss_pred HhcccCCCCCCCCh-----hHHHHHhhh
Q 039595 1001 ILCLDESPEARPTM-----EKGFGHHIG 1023 (1078)
Q Consensus 1001 ~~cl~~dP~~RPt~-----~ell~h~~~ 1023 (1078)
.+|++.||++||++ +|++.|||+
T Consensus 210 ~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 210 QQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 99999999999996 999999994
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=316.66 Aligned_cols=263 Identities=21% Similarity=0.220 Sum_probs=174.3
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-C----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEee----
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-S----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGF---- 819 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~---- 819 (1078)
..++|+..+.||+|+||.||+|... + +..||||++.... ..+....+ .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 4578999999999999999999764 4 6899999875431 11111111 1112222222222211
Q ss_pred --eecCCeeEEEEeecCCCCHHHHhcCCCCC-----------------CcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 039595 820 --CSNARHSFLVCEYLHRGSLARILGNDATA-----------------KELSWNRRINVIKGVANALSYLHHDCLPSIIH 880 (1078)
Q Consensus 820 --~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 880 (1078)
...+...++|+||+.+++|.+++...... .......+..++.|++.||+|||++ +|+|
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiH 278 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVH 278 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 24567899999999999999998543210 0112344667999999999999999 9999
Q ss_pred cCCCCCCeeeCC-CCcEEEecccccccccCCC-CCceeeccccccccccccccC----------------------CCCc
Q 039595 881 RDISSKNVLLDL-EFEAHVSDFGIAKFVEPYS-SNRTEFVGTFGYAAPEIAYTM----------------------RATE 936 (1078)
Q Consensus 881 ~Dlk~~NIll~~-~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ 936 (1078)
|||||+|||++. ++.+||+|||+|+...... .......+++.|||||.+... .++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 999999999986 5899999999998654322 223456889999999965422 2345
Q ss_pred cchhHHHHHHHHHHHhCCCCCCcccccccchhhhh-------hhhhhhcCCCCCCCCCc----cHHHHHHHHHHHHhccc
Q 039595 937 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI-------IEVNQILDPRLSTPSPG----VMDKLISIMEVAILCLD 1005 (1078)
Q Consensus 937 ~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~ 1005 (1078)
++||||+||++|||+++..|++.... .+.... ........+........ .........+++.+||+
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNLI---QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHHH---HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 67999999999999998777432111 111100 01111111211110000 00011134589999999
Q ss_pred CCCCCCCChhHHHHHhhhhh
Q 039595 1006 ESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 1006 ~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.||++|||++|+++|||+..
T Consensus 436 ~dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFDR 455 (566)
T ss_pred CCcccCCCHHHHhCCcCcCC
Confidence 99999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=290.14 Aligned_cols=263 Identities=19% Similarity=0.242 Sum_probs=202.1
Q ss_pred CCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
-|.+++.||-|+||+|.++ +..+...||.|.+++..+- .......++.|..++..-+.+-||++|-.|.+.+.+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-MRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH-hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 5788889999999999999 5556778999999876543 2334556788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc---
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV--- 907 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~--- 907 (1078)
||++||++-.+|- ..+-+.+.-++.++.++..|+++.|.. |+|||||||+|||||.+|++||+|||++.-+
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999883 345678888999999999999999999 9999999999999999999999999998633
Q ss_pred ------cCCCCCc---------------------------------eeeccccccccccccccCCCCccchhHHHHHHHH
Q 039595 908 ------EPYSSNR---------------------------------TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 948 (1078)
Q Consensus 908 ------~~~~~~~---------------------------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ 948 (1078)
....... ...+||+.|+|||++....|+.-+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1110000 0147999999999999999999999999999999
Q ss_pred HHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh-cccCCCCCCC---ChhHHHHHhhhh
Q 039595 949 EVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAIL-CLDESPEARP---TMEKGFGHHIGY 1024 (1078)
Q Consensus 949 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~RP---t~~ell~h~~~~ 1024 (1078)
||+.|++||-... ..+....+..+...++-..... ... +..++|.+ |. +++.|. .++||-.|+|+.
T Consensus 863 em~~g~~pf~~~t--p~~tq~kv~nw~~~l~~~~~~~---ls~---e~~~li~kLc~--sad~RLGkng~d~vKaHpfFk 932 (1034)
T KOG0608|consen 863 EMLVGQPPFLADT--PGETQYKVINWRNFLHIPYQGN---LSK---EALDLIQKLCC--SADSRLGKNGADQVKAHPFFK 932 (1034)
T ss_pred HHhhCCCCccCCC--CCcceeeeeehhhccccccccc---cCH---HHHHHHHHHhc--ChhhhhcccchhhhhcCcccc
Confidence 9999999964322 2222222333333333222211 112 33344433 43 455555 577899999998
Q ss_pred hhHHHHH
Q 039595 1025 CDEILAV 1031 (1078)
Q Consensus 1025 ~~~~~~~ 1031 (1078)
.-+....
T Consensus 933 gIDfssl 939 (1034)
T KOG0608|consen 933 GIDFSSL 939 (1034)
T ss_pred ccchHhh
Confidence 7776663
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=284.77 Aligned_cols=265 Identities=27% Similarity=0.331 Sum_probs=201.2
Q ss_pred hhcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChh---hHHHHHHHHHHHhcCCCCceeeEEeeee-cC
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMA---DQDEFLNVVLALNEIRHRNIVKFHGFCS-NA 823 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~ 823 (1078)
..++|-..+.||+|+|+.||+| .....+.||||+-.......+.. -.+..-+|..+.+.++||.||++|+||. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3467888899999999999999 55567889999754332111111 1133567999999999999999999995 55
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEec
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE---FEAHVSD 900 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~D 900 (1078)
+..|-|+|||+|.+|..|++ ..+.+++++++.|+.||+.||.||.+. .++|+|-|+||.|||+-.. |.+||+|
T Consensus 541 dsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 67889999999999999994 445689999999999999999999987 4589999999999999544 7899999
Q ss_pred ccccccccCCCCC-------ceeeccccccccccccccC----CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhh
Q 039595 901 FGIAKFVEPYSSN-------RTEFVGTFGYAAPEIAYTM----RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 901 fG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 969 (1078)
||+++..+..... .....||+.|++||.+.-+ ..+.|+||||.||++|..+.|+.||...... .
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-----Q 691 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-----Q 691 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-----H
Confidence 9999988664433 2346899999999987533 4688999999999999999999997532211 1
Q ss_pred hhhhhhhhcCCC-CC-CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 970 MIIEVNQILDPR-LS-TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 970 ~~~~~~~~~~~~-~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+.....++... .. ++.+.. ..+..++|++||+.--++|....++..|||+..
T Consensus 692 dILqeNTIlkAtEVqFP~KPvV---sseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 692 DILQENTILKATEVQFPPKPVV---SSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred HHHhhhchhcceeccCCCCCcc---CHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 111111122111 10 011111 124568899999999999999999999998765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=280.26 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=197.3
Q ss_pred cCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-----C---CceeeEEeeee
Q 039595 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-----H---RNIVKFHGFCS 821 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~ 821 (1078)
.+|.+.++||.|.|++||+| ..++.+.||+|+.+... .-.+....||.++++++ | .+||+++++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 68999999999999999999 55678899999987642 22456678999999883 3 46999999994
Q ss_pred ----cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC----
Q 039595 822 ----NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE---- 893 (1078)
Q Consensus 822 ----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---- 893 (1078)
.+.++|||+|++ |-+|..+|..... +.++...+.+|++||+.||.|||.+| ||+|.||||+|||+..+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccch
Confidence 567999999998 5589998865443 45899999999999999999999998 99999999999999400
Q ss_pred --------------------------------------------------------------------------------
Q 039595 894 -------------------------------------------------------------------------------- 893 (1078)
Q Consensus 894 -------------------------------------------------------------------------------- 893 (1078)
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 039595 894 -------------------------------------------------------------------------------- 893 (1078)
Q Consensus 894 -------------------------------------------------------------------------------- 893 (1078)
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence
Q ss_pred --CcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccc-----cccc
Q 039595 894 --FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI-----NFSS 966 (1078)
Q Consensus 894 --~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~-----~~~~ 966 (1078)
-+|||+|||-|..+.. ..+...-|..|+|||++.+..|+..+||||++|++|||.||...|+.... +...
T Consensus 389 ~di~vKIaDlGNACW~~k---hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWVHK---HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred cceeEEEeeccchhhhhh---hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 0145555555554321 23334568899999999999999999999999999999999998864332 2222
Q ss_pred hhhhhhhh--------------hhhcCCC--CC---------------CCCCccHHHHHHHHHHHHhcccCCCCCCCChh
Q 039595 967 FSNMIIEV--------------NQILDPR--LS---------------TPSPGVMDKLISIMEVAILCLDESPEARPTME 1015 (1078)
Q Consensus 967 ~~~~~~~~--------------~~~~~~~--~~---------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1015 (1078)
++..+.-. +.+++.+ ++ .......++..++.+++.-||+.+|++||||.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 22222111 1111110 00 01111234556899999999999999999999
Q ss_pred HHHHHhhhh
Q 039595 1016 KGFGHHIGY 1024 (1078)
Q Consensus 1016 ell~h~~~~ 1024 (1078)
++++|||..
T Consensus 546 ~cl~hPwLn 554 (590)
T KOG1290|consen 546 QCLKHPWLN 554 (590)
T ss_pred HHhcCcccc
Confidence 999999965
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=254.09 Aligned_cols=213 Identities=24% Similarity=0.349 Sum_probs=172.4
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhc-CCCCceeeEEeeeecC
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE-IRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~ 823 (1078)
.+...++......||+|++|.|-+.++ .+|+..|+|+++... +..+.++...|+.+..+ ..+|.+|.+||.+.+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 334445566677899999999988854 589999999997654 34456666777776544 4899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcC-CCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 824 RHSFLVCEYLHRGSLARILGN-DATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
+..|+.||.|+- +|..+-++ -...+..++.-+-+|+..|.+||.|||++. .++|||+||+|||++.+|+||+||||
T Consensus 118 gdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 999999999966 77655422 234566888889999999999999999985 89999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccccccc----CCCCccchhHHHHHHHHHHHhCCCCCCccccccc
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYT----MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 965 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~ 965 (1078)
++..+.+. -..+...|...|||||.+.. ..|+.|+||||+|+.+.||.+++.||+.....+.
T Consensus 195 IsG~L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~ 260 (282)
T KOG0984|consen 195 ISGYLVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQ 260 (282)
T ss_pred cceeehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHH
Confidence 99877542 22344578889999998763 4689999999999999999999999876555443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=256.23 Aligned_cols=259 Identities=19% Similarity=0.291 Sum_probs=202.2
Q ss_pred hcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecC--Ce
Q 039595 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNA--RH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~ 825 (1078)
.++|++.+++|+|.|+.||.| ...+.++++||+++.. ..+.+.+|+.++..+. ||||+++++...++ ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 478999999999999999999 5667899999998654 3677899999999996 99999999998654 56
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEeccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIA 904 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~a 904 (1078)
..+|+||+.+.+...+- ..++..++..+..+++.||.|+|+. ||.|||+||.|+++|.. ...+++|+|+|
T Consensus 110 paLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred chhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence 78999999998777655 3477788999999999999999999 99999999999999876 56999999999
Q ss_pred ccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhh------------hh
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN------------MI 971 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~------------~~ 971 (1078)
.++.+. ......+.+..|..||.+..- .|+..-|+|||||++..|+..+.||-....+...... ..
T Consensus 181 EFYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 181 EFYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hhcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 998763 345566778889999988764 5889999999999999999999997433333222111 11
Q ss_pred hhhhhhcCCCCCC--------CC----C--ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 972 IEVNQILDPRLST--------PS----P--GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 972 ~~~~~~~~~~~~~--------~~----~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+....++|.+.. +. + ...-...+.++++.+.|..|..+|||++|++.|||+..
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1111223332211 00 0 00000136778888999999999999999999999764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=297.38 Aligned_cols=271 Identities=17% Similarity=0.224 Sum_probs=184.3
Q ss_pred hhcCCCccceeccCCceeEEEEEe-----------------CCCCEEEEEEeccccccCC----------hhhHHHHHHH
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-----------------PSGDIVAVKKFNSQLLSGN----------MADQDEFLNV 801 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~----------~~~~~~~~~e 801 (1078)
..++|++.++||+|+||+||+|.. ..++.||||++........ ....+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999953 2356799999864321100 0011223456
Q ss_pred HHHHhcCCCCce-----eeEEeeeec--------CCeeEEEEeecCCCCHHHHhcCCCC---------------------
Q 039595 802 VLALNEIRHRNI-----VKFHGFCSN--------ARHSFLVCEYLHRGSLARILGNDAT--------------------- 847 (1078)
Q Consensus 802 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~--------------------- 847 (1078)
+.++.+++|.++ ++++++|.. .+..|+||||+++|+|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777743 3568999999999999999854211
Q ss_pred CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC-ceeeccccccccc
Q 039595 848 AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN-RTEFVGTFGYAAP 926 (1078)
Q Consensus 848 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~gt~~y~aP 926 (1078)
...+++..+..++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||+++........ .....+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12346778899999999999999999 9999999999999999999999999999765432211 1223457899999
Q ss_pred cccccCC--------------------C--CccchhHHHHHHHHHHHhCCC-CCCcccc---cccchhhhhhhhhhhcCC
Q 039595 927 EIAYTMR--------------------A--TEKYDVYSFGVLVFEVIKGNH-PRDFFSI---NFSSFSNMIIEVNQILDP 980 (1078)
Q Consensus 927 E~~~~~~--------------------~--~~~sDvwSlG~il~elltG~~-p~~~~~~---~~~~~~~~~~~~~~~~~~ 980 (1078)
|.+.... + ..+.||||+||++|+|++|.. |+..... ..................
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1 134799999999999999886 5432111 111001111111111111
Q ss_pred CCCCCCCccHHHHHHHHHHHHhcccCCC---CCCCChhHHHHHhhhh
Q 039595 981 RLSTPSPGVMDKLISIMEVAILCLDESP---EARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 981 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~ell~h~~~~ 1024 (1078)
.+... ..........+++.+|+..+| .+|+|++|+++|+|+.
T Consensus 460 ~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 460 KYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred CCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 11111 111222356788889999766 6899999999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=302.23 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=192.6
Q ss_pred CCccceeccCCcee-EEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEEE
Q 039595 753 FDEKFCIGKGGQGS-VYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
|.-.+.+|.|+.|+ ||+|.+. |+.||||++-.. ..+.+.+|+..++.- +|||||++++.-.++...||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 33345689998875 6899875 889999998543 244567899999888 6999999999999999999999
Q ss_pred eecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---C--CcEEEeccccc
Q 039595 831 EYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL---E--FEAHVSDFGIA 904 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~DfG~a 904 (1078)
|.|.. +|.++++.. ...........+.+..|++.||++||+. +|||||+||+||||+. + .+++|+|||++
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99966 999999653 1111112145678999999999999998 9999999999999976 3 47999999999
Q ss_pred ccccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhC-CCCCCcccccccchhhhhhhhhhhcCC
Q 039595 905 KFVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG-NHPRDFFSINFSSFSNMIIEVNQILDP 980 (1078)
Q Consensus 905 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 980 (1078)
+........ ..+..||.+|+|||++....-+.++||||+||++|+.++| ..||...- ....+.........
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~---~R~~NIl~~~~~L~-- 733 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL---ERQANILTGNYTLV-- 733 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH---HhhhhhhcCcccee--
Confidence 988654322 3457799999999999999889999999999999999985 89965221 11111111100000
Q ss_pred CCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 981 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
.+. +.. +. ...++|.+|+++||..||++.+|+.||++...+.
T Consensus 734 ~L~-~~~---d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ek 775 (903)
T KOG1027|consen 734 HLE-PLP---DC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEK 775 (903)
T ss_pred eec-cCc---hH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHH
Confidence 001 111 11 5678999999999999999999999998886544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=274.87 Aligned_cols=243 Identities=29% Similarity=0.435 Sum_probs=194.5
Q ss_pred CceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCCHHHH
Q 039595 763 GQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARI 841 (1078)
Q Consensus 763 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 841 (1078)
+||.||+|..+ +|+.||+|++...... ...+.+.+|+..+++++|+||+++++++......++++||+.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999775 5899999998765322 1157889999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceeecccc
Q 039595 842 LGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF 921 (1078)
Q Consensus 842 l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 921 (1078)
+... ..+++..++.++.+++.++.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++.
T Consensus 78 ~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 150 (244)
T smart00220 78 LKKR---GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTP 150 (244)
T ss_pred HHhc---cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCc
Confidence 8442 2388999999999999999999999 99999999999999999999999999998765432 334556888
Q ss_pred ccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHH
Q 039595 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAI 1001 (1078)
Q Consensus 922 ~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 1001 (1078)
.|+|||...+..++.++||||+|+++|++++|..||+..... .... ........... ........++.+++.
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~------~~~~~~~~~~~-~~~~~~~~~~~~~i~ 222 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELF------KKIGKPKPPFP-PPEWKISPEAKDLIR 222 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHH------HHHhccCCCCc-cccccCCHHHHHHHH
Confidence 999999998888999999999999999999999997532111 1111 11111111111 100002236788999
Q ss_pred hcccCCCCCCCChhHHHHHhhh
Q 039595 1002 LCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 1002 ~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
+|+..+|++||++.++++|+|+
T Consensus 223 ~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHccCCchhccCHHHHhhCCCC
Confidence 9999999999999999999984
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=266.67 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=197.9
Q ss_pred CCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----Cee
Q 039595 753 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA-----RHS 826 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 826 (1078)
.+..+.||-|+||+||.+.+ .+|+.||.|++... .++....+.+.+|++++..++|.||+..+++..-. .++
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv--fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV--FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchH--HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34457899999999999955 58999999998654 34566778899999999999999999988876433 256
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+|+|.|.. +|..++ -....++...+.-+.+||++||+|||+. +|.||||||.|.+++.+...||||||+|+.
T Consensus 133 YV~TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 889998865 888887 3456688899999999999999999999 999999999999999999999999999997
Q ss_pred ccCCC-CCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccc--------------cchhhh
Q 039595 907 VEPYS-SNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--------------SSFSNM 970 (1078)
Q Consensus 907 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--------------~~~~~~ 970 (1078)
.+... ...+..+-|..|.|||++++. .|+.+.||||.||++.|++..+.-|+..+.-. +.+...
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 65433 334556778999999999875 58999999999999999999888765433210 111111
Q ss_pred h-hhhhhhcCCCCCCCC-------CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 971 I-IEVNQILDPRLSTPS-------PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 971 ~-~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. +....++......+. ......-.+..++...++..||++|.+.++.+.|++..
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 1 111111211111110 00001112455677778999999999999999998843
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=285.45 Aligned_cols=261 Identities=26% Similarity=0.365 Sum_probs=213.2
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|+..+.+|.|+||.||+|+. .+++..|+|+++... ..+.+-.++|+-+++..+|||||.++|.+...+..|+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 46899999999999999999955 478999999997653 2235567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
.||||.+|+|.+.- ...+++++.++..+++..++|++|+|+. |-+|||||-.||++++.|.+|++|||.+..+.
T Consensus 90 cMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 99999999999876 3467899999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
..-.....+.||+.|||||+.. .+.|..++|||+.|+...|+---++| .++. .............++|.-...
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp--lfdl--hpmr~l~LmTkS~~qpp~lkD 239 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP--LFDL--HPMRALFLMTKSGFQPPTLKD 239 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc--cccc--chHHHHHHhhccCCCCCcccC
Confidence 7666778899999999999753 56789999999999999999888888 2221 111111122222333332222
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
...+. ..+-++++.|+.++|++||+++.++.|+|.....
T Consensus 240 k~kws---~~fh~fvK~altknpKkRptaeklL~h~fvs~~l 278 (829)
T KOG0576|consen 240 KTKWS---EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL 278 (829)
T ss_pred Cccch---HHHHHHHHHHhcCCCccCCChhhheeceeeccch
Confidence 22222 3567788889999999999999999999977653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=260.89 Aligned_cols=263 Identities=22% Similarity=0.267 Sum_probs=201.0
Q ss_pred hcCCCccceeccCCceeEEEEE-eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA----- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 823 (1078)
..+|...+.+|.|+. .|..|. .-.++.||+|++... ..+....++..+|...+..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 357777888999998 566663 336899999998776 33455567788999999999999999999999533
Q ss_pred -CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 824 -RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 824 -~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
...|+|||||+. +|...+. -+++.+.+..++.|++.|+.|+|+. ||+||||||+||++..++.+||.|||
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence 467999999976 8888873 4477788999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccc-------------cccchhh
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI-------------NFSSFSN 969 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~-------------~~~~~~~ 969 (1078)
+|+.-+.. -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|...+. ....+..
T Consensus 164 ~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 164 LARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 99865543 356778899999999999998899999999999999999999987642211 0011111
Q ss_pred hhhhh----------------hhhc-CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 970 MIIEV----------------NQIL-DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 970 ~~~~~----------------~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..... ...+ |..+...............+++.+||-.||++|.+++++|+|||...
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 11000 0001 11111111111122335778999999999999999999999999863
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=274.51 Aligned_cols=275 Identities=20% Similarity=0.202 Sum_probs=211.8
Q ss_pred CCccHHHHHHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC------CC
Q 039595 739 GKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR------HR 811 (1078)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~ 811 (1078)
|.+.+.-.+....+|.+....|+|-|++|.+|... -|..||||++.... ...+.=..|+++++++. -.
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----~M~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----VMHKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-----HHhhhhhHHHHHHHHhhccCchhhh
Confidence 33444444556778999999999999999999544 58899999997643 23445567999999995 35
Q ss_pred ceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 039595 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 812 niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 891 (1078)
|+++++..|....++|||+|-+.- +|.+++++......+....+..+++|+..||..|... +|+|.||||+||||+
T Consensus 495 Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVN 570 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEec
Confidence 799999999999999999998754 9999998877777899999999999999999999998 999999999999998
Q ss_pred CC-CcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc------
Q 039595 892 LE-FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF------ 964 (1078)
Q Consensus 892 ~~-~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~------ 964 (1078)
+. ..+||||||.|.+.... .-+...-+..|.|||++.+.+|+...|+||.||+|||+.||+..|....-+.
T Consensus 571 E~k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred cCcceeeeccCccccccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 76 56999999999876542 2334445668999999999999999999999999999999998764221110
Q ss_pred ---cchhhhhhhhhhhcCCCC---------------------------------------CCCCCccHHHHHHHHHHHHh
Q 039595 965 ---SSFSNMIIEVNQILDPRL---------------------------------------STPSPGVMDKLISIMEVAIL 1002 (1078)
Q Consensus 965 ---~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~l~~li~~ 1002 (1078)
..+.+.+....++.+..+ ...+.+.......+.+|+.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 111111111111111100 00122334455688999999
Q ss_pred cccCCCCCCCChhHHHHHhhhh
Q 039595 1003 CLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 1003 cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
|+..||++|.|..|+|.|||++
T Consensus 729 ml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred HhccChhhcCCHHHHhcCCccc
Confidence 9999999999999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-29 Score=269.98 Aligned_cols=206 Identities=24% Similarity=0.342 Sum_probs=173.5
Q ss_pred HHHHHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccC--ChhhHH--HHHHHHHHHhcCC---CCceee
Q 039595 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG--NMADQD--EFLNVVLALNEIR---HRNIVK 815 (1078)
Q Consensus 744 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~--~~~~e~~~l~~l~---h~niv~ 815 (1078)
+...+...+|+..+.+|.|+||.|+.|.++ +...|+||.+.+...-. +.++++ .+--||.+|..++ |+||++
T Consensus 554 e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 554 EKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred eeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 334455668999999999999999999765 46789999987654321 111111 2446899999987 999999
Q ss_pred EEeeeecCCeeEEEEeecC-CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 039595 816 FHGFCSNARHSFLVCEYLH-RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF 894 (1078)
Q Consensus 816 l~~~~~~~~~~~lv~E~~~-~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 894 (1078)
++++|++++.+|++||-.. |-+|+++++ ....+++.++..|++||+.|+++||+. ||||||||-+||.++.+|
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNG 707 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCC
Confidence 9999999999999999754 449999994 445689999999999999999999999 999999999999999999
Q ss_pred cEEEecccccccccCCCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCC
Q 039595 895 EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPR 957 (1078)
Q Consensus 895 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~ 957 (1078)
-+|++|||.|..... .....++||..|.|||++.+..| ++.-|||++|++||-++....||
T Consensus 708 ~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred eEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999999999986643 34567899999999999999877 66789999999999999999885
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=242.74 Aligned_cols=212 Identities=33% Similarity=0.552 Sum_probs=184.6
Q ss_pred eccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCC
Q 039595 759 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGS 837 (1078)
Q Consensus 759 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 837 (1078)
||+|++|.||++... +++.+++|++....... ..+.+.+|+..++.++|++|+++++++......++++||+++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999765 48999999987653211 35678999999999999999999999999899999999999999
Q ss_pred HHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEecccccccccCCCCCcee
Q 039595 838 LARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-EFEAHVSDFGIAKFVEPYSSNRTE 916 (1078)
Q Consensus 838 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~ 916 (1078)
|.+++.... ..+++..++.++.+++++++|||+. +++|+||+|.||+++. ++.++++|||.+............
T Consensus 78 l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 78 LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 999985432 4588999999999999999999999 9999999999999999 899999999999876543322444
Q ss_pred eccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHH
Q 039595 917 FVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995 (1078)
Q Consensus 917 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1078)
..+...|++||..... .++.++|+|++|+++|++ ..
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~ 189 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PE 189 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HH
Confidence 5678899999998887 888999999999999999 36
Q ss_pred HHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 996 IMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 996 l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
+.+++.+|++.+|++||+++++++++
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 77889999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=236.67 Aligned_cols=257 Identities=19% Similarity=0.230 Sum_probs=188.7
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEee-eecCCe
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGF-CSNARH 825 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~ 825 (1078)
..+.|++.+.+|+|.||.+-+++++ +.+.+|+|.+.+.. ...++|.+|...--.+ .|.||+.-|+. |+..+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 3577999999999999999999765 67889999987653 3477888888765555 58999988874 677888
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--CCCcEEEecccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD--LEFEAHVSDFGI 903 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DfG~ 903 (1078)
+++++||++.|+|.+-+.. ..+-+....+++.|++.|+.|||++ ++||||||.+||||- +..+||+||||.
T Consensus 97 YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence 9999999999999988733 3366788899999999999999999 999999999999993 335899999999
Q ss_pred cccccCCCCCceeeccccccccccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTM-----RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
++..+..-. ...-+..|.|||..... ...+.+|||.||+++|.++||++||+........+.+..... .-.
T Consensus 170 t~k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~-~rk 245 (378)
T KOG1345|consen 170 TRKVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL-KRK 245 (378)
T ss_pred ccccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh-ccc
Confidence 986543211 12235679999976532 246789999999999999999999985443333333322211 111
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCC---CChhHHHHHhhhh
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEAR---PTMEKGFGHHIGY 1024 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ell~h~~~~ 1024 (1078)
.++.+... ......++++.++-+.++|++| .++++.....|..
T Consensus 246 ~~~~P~~F---~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 246 NPALPKKF---NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred CccCchhh---cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 22222222 2222356677788899999999 4555555555533
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-28 Score=256.31 Aligned_cols=283 Identities=21% Similarity=0.272 Sum_probs=174.9
Q ss_pred CccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccc-cccCCCCCcccC
Q 039595 189 RIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYK-NSLSGSIPSIIG 267 (1078)
Q Consensus 189 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~ 267 (1078)
.+|..+. ..-..++|..|+|+.+.|.+|+.+++|++||||+|+|+.+-|.+|.+|++|.+|.+.+ |+|+....+.|+
T Consensus 60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~ 137 (498)
T KOG4237|consen 60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG 137 (498)
T ss_pred cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence 3444443 3345788888888877778888888888888888888888888888888888887776 888866667888
Q ss_pred CCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccC------------ccCC
Q 039595 268 NLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLN------------GVIP 335 (1078)
Q Consensus 268 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~------------~~~p 335 (1078)
+|.+|+.|.+.-|++.-.....|..+++|..|.+.+|.+...--..|..+.+++++.+..|.+- ...|
T Consensus 138 gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ 217 (498)
T KOG4237|consen 138 GLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNP 217 (498)
T ss_pred hHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhch
Confidence 8888888888888888777788888888888888888887444447888888888888888732 1223
Q ss_pred CCCCCCCcCcEEEccCccCCCCCCccccc-cCCCCeEEcccccCccccC-CCCccCCCCceeecccCcCCCCCCcccccc
Q 039595 336 PSIGNLSSLRNLSLFNNGLYGSIPEEIGY-LKSLSELKLCKNNLSGVIP-HSVGNLTGLVLLNMCENHLFGPIPKSLKSL 413 (1078)
Q Consensus 336 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l 413 (1078)
..++..+...-..+.++++..+.+..|.. +..+..=..+.+..-++-| ..|..+++|++|+|++|+|+++-+.+|.++
T Consensus 218 ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~ 297 (498)
T KOG4237|consen 218 IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGA 297 (498)
T ss_pred hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcch
Confidence 33333333444444444444333322221 1111111111221222222 234555555555555555555555555555
Q ss_pred CCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccc
Q 039595 414 TSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNN 473 (1078)
Q Consensus 414 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 473 (1078)
..+++|.|..|+|..+...+|.++..|+.|+|.+|+|+.+.+.+|..+..|.+|++-.|.
T Consensus 298 a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np 357 (498)
T KOG4237|consen 298 AELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNP 357 (498)
T ss_pred hhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCc
Confidence 555555555555555555555555555555555555555555555555555555544443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=245.68 Aligned_cols=269 Identities=23% Similarity=0.335 Sum_probs=201.8
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEee
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGF 819 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 819 (1078)
.+....+.|..+++||+|.|++||+|... ..+.||+|.+.... ....+.+|++++..+ .+.||+++.++
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhh
Confidence 34445678999999999999999999543 46789999986542 245688999999999 59999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEE
Q 039595 820 CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHV 898 (1078)
Q Consensus 820 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl 898 (1078)
+..++..++|+||++.....++.. .++..++..++..+..||+++|.. |||||||||.|++.+.. +.-.|
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceE
Confidence 999999999999999998888872 366899999999999999999999 99999999999999754 78899
Q ss_pred ecccccccccCCC-------------C-------------------------------CceeeccccccccccccccC-C
Q 039595 899 SDFGIAKFVEPYS-------------S-------------------------------NRTEFVGTFGYAAPEIAYTM-R 933 (1078)
Q Consensus 899 ~DfG~a~~~~~~~-------------~-------------------------------~~~~~~gt~~y~aPE~~~~~-~ 933 (1078)
+|||+|...+.+. . .....+||++|.|||++... .
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 9999997221100 0 00124799999999998764 4
Q ss_pred CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh--------hhhh----h--hcC-------------------C
Q 039595 934 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI--------IEVN----Q--ILD-------------------P 980 (1078)
Q Consensus 934 ~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~--------~~~~----~--~~~-------------------~ 980 (1078)
-+.++||||.||++..+++++.||-....+........ .+.. . .+. .
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~ 334 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE 334 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence 68899999999999999999999754333322221111 0000 0 000 0
Q ss_pred CCCC------CCCccHHH-HHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 981 RLST------PSPGVMDK-LISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 981 ~~~~------~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
.+.. ......+. ...+++++.+|+..||.+|.|++++|.|+|+...+.
T Consensus 335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 0000 00001111 126789999999999999999999999999885433
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-28 Score=255.03 Aligned_cols=420 Identities=23% Similarity=0.250 Sum_probs=247.7
Q ss_pred EEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeeccc-c
Q 039595 202 LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIE-N 280 (1078)
Q Consensus 202 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N 280 (1078)
..+-++-.++ .+|..+. ..-..++|..|+|+.+.|.+|+.+++|+.|+|++|.|+.+-|++|.++++|..|.+-+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 3455555555 5666543 4667888888999888888888888999999999988888888888888888776655 8
Q ss_pred cccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCC-----
Q 039595 281 QLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLY----- 355 (1078)
Q Consensus 281 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~----- 355 (1078)
+|+......|++|.+|+.|.+.-|++.-.....|..+++|..|.+.+|.+..+--.+|..+..++.+.+..|.+.
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 888776677888888888888888888777788888888888888888887554447888888888888877632
Q ss_pred -------CCCCccccccCCCCeEEcccccCccccCCCCccC-CCCceeecccCcCCCC-CCccccccCCCCeEEccCccc
Q 039595 356 -------GSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNL-TGLVLLNMCENHLFGP-IPKSLKSLTSLKRVRFNQNNL 426 (1078)
Q Consensus 356 -------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l 426 (1078)
...|-+++...-..-..+.++++..+.+..|... ..+..-..+.+...+. ....|..+++|+.|+|++|+|
T Consensus 207 ~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i 286 (498)
T KOG4237|consen 207 PWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI 286 (498)
T ss_pred chhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence 1223334444444444445555544433333211 1111111111212222 223455555555555555555
Q ss_pred cccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCC-cccc
Q 039595 427 VGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGK-IPVQ 505 (1078)
Q Consensus 427 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~-~~~~ 505 (1078)
+.+...+|.+...++.|.|..|+|..+....|.++..|++|+|.+|+|+...|..|..+..|.+|+|-.|.+.-. --.+
T Consensus 287 ~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~w 366 (498)
T KOG4237|consen 287 TRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAW 366 (498)
T ss_pred chhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHH
Confidence 555555555555555555555555555555555555555555555555555555555555555555555544210 0001
Q ss_pred cccCccCcEEeccCCccCCCcccccccccccceeeccCccccC---CCCccc---------cccccccccc-ccCccccc
Q 039595 506 LEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS---SIPKSI---------GNLLKLYYLN-LSNNQFSH 572 (1078)
Q Consensus 506 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~---------~~l~~L~~L~-Ls~N~l~~ 572 (1078)
++. +|..+.-.+..| . ..-..++.++++.+.+.. ..|+.. ...+-+.+.. -|++.+ .
T Consensus 367 l~~-------Wlr~~~~~~~~~-C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~l-k 436 (498)
T KOG4237|consen 367 LGE-------WLRKKSVVGNPR-C-QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLL-K 436 (498)
T ss_pred HHH-------HHhhCCCCCCCC-C-CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccch-h
Confidence 100 011111111111 0 112234555555554432 122211 1222333322 333333 3
Q ss_pred ccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccC
Q 039595 573 TIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYN 640 (1078)
Q Consensus 573 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N 640 (1078)
.+|..+. ..-.+|++.+|.++ .+|.+ .+.+| .+||++|+++..-...|.+++.|.++-+++|
T Consensus 437 ~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 437 LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 4444432 24567888888887 45554 56677 8888888888777778888888888888887
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=235.43 Aligned_cols=198 Identities=31% Similarity=0.502 Sum_probs=170.8
Q ss_pred CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
|+..+.||+|++|.||+|... +++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 567788999999999999765 4899999998765322 246788899999999999999999999999899999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
|+++++|.+++..... .+++..+..++.+++.++.|+|+. +++|+|++|+||+++.++.++++|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 78 YCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred ccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999999999954321 178899999999999999999999 99999999999999999999999999998765432
Q ss_pred -CCceeecccccccccccc-ccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 039595 912 -SNRTEFVGTFGYAAPEIA-YTMRATEKYDVYSFGVLVFEVIKGNHPRD 958 (1078)
Q Consensus 912 -~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltG~~p~~ 958 (1078)
.......++..|++||.. ....++.++|||+||+++|||++|+.||+
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 123445678899999998 66678889999999999999999999974
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-26 Score=284.32 Aligned_cols=199 Identities=17% Similarity=0.218 Sum_probs=145.1
Q ss_pred cCCC-CceeeEEeee-------ecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 039595 807 EIRH-RNIVKFHGFC-------SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878 (1078)
Q Consensus 807 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 878 (1078)
.++| +||++++++| ...+..+.++||+ +++|.+++... ...+++.++..++.||++||+|||++ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4456 6888888877 2334677889987 55999999532 35589999999999999999999999 99
Q ss_pred EecCCCCCCeeeCC-------------------CCcEEEecccccccccCCC----------------CCceeecccccc
Q 039595 879 IHRDISSKNVLLDL-------------------EFEAHVSDFGIAKFVEPYS----------------SNRTEFVGTFGY 923 (1078)
Q Consensus 879 vH~Dlk~~NIll~~-------------------~~~~kl~DfG~a~~~~~~~----------------~~~~~~~gt~~y 923 (1078)
+||||||+|||++. ++.+|++|||+++...... ......+||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456677777765421100 001124578899
Q ss_pred ccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh-hhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 039595 924 AAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV-NQILDPRLSTPSPGVMDKLISIMEVAIL 1002 (1078)
Q Consensus 924 ~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~ 1002 (1078)
||||++.+..++.++|||||||++|||++|.+|+..... ..... ....++.. ........+++.+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 247 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-------TMSSLRHRVLPPQI-------LLNWPKEASFCLW 247 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-------HHHHHHHhhcChhh-------hhcCHHHHHHHHH
Confidence 999999999999999999999999999999888432111 01111 11111111 1112244577889
Q ss_pred cccCCCCCCCChhHHHHHhhhhh
Q 039595 1003 CLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 1003 cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
||+++|.+||+++|+++|+|+..
T Consensus 248 ~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred hCCCChhhCcChHHHhhchhhhh
Confidence 99999999999999999999753
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-24 Score=274.56 Aligned_cols=363 Identities=21% Similarity=0.259 Sum_probs=203.3
Q ss_pred CeEEEeccCccccC-CcccCCccCCCCCCcEEeccCCc------ccccCCCCCCCCC-CcceeccCCCccCCCCCccccC
Q 039595 77 SRVISINLSTLCLN-GTFQDFSFSSFPHLVNLNLSFNL------FFGNIPPQIGNLS-KLQNLDLGNNQLSGVISPEIGK 148 (1078)
Q Consensus 77 ~~v~~l~l~~~~l~-g~~~~~~~~~l~~L~~L~L~~n~------~~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~ 148 (1078)
.+|.++.|...... -.+....|.++++|+.|.+..+. +...+|..+..++ +|+.|++.++.+. .+|..+ .
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~ 609 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-R 609 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-C
Confidence 45555544322111 12334567788888888886553 2334666666663 5888888887776 567666 4
Q ss_pred ccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeee
Q 039595 149 LNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLD 228 (1078)
Q Consensus 149 l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 228 (1078)
..+|+.|+|++|++. .+|..+..+++|+.|+|+++...+.+|. ++.+++|+.|+|++|.....+|..++++++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 677888888888776 6777777788888888877765556663 77777888888877766667777777788888888
Q ss_pred cCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCC
Q 039595 229 LSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSG 308 (1078)
Q Consensus 229 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 308 (1078)
+++|..-+.+|..+ ++++|+.|+|++|...+.+|.. ..+|+.|+|++|.++ .+|..+ .+++|+.|.+.++....
T Consensus 688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~ 761 (1153)
T PLN03210 688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK 761 (1153)
T ss_pred CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh
Confidence 87765444556544 6777777777777655455543 346777777777765 344443 35556666555432210
Q ss_pred CCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCcc
Q 039595 309 SIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGN 388 (1078)
Q Consensus 309 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 388 (1078)
+.. .+....+..+...++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ +
T Consensus 762 -l~~----------------~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~ 823 (1153)
T PLN03210 762 -LWE----------------RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-N 823 (1153)
T ss_pred -ccc----------------cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-C
Confidence 000 0000011111122344455555544444445445555555555555443222334333 4
Q ss_pred CCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCC-CccCCccCccccCCCCCcee
Q 039595 389 LTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQ-NNFDGKISFNWRNLPKLDTF 467 (1078)
Q Consensus 389 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L 467 (1078)
+++|+.|++++|.....+|.. .++|++|++++|.+..++ ..+..+++|+.|++++ |++.. .+.....+++|+.+
T Consensus 824 L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~iP-~si~~l~~L~~L~L~~C~~L~~-l~~~~~~L~~L~~L 898 (1153)
T PLN03210 824 LESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEEVP-WWIEKFSNLSFLDMNGCNNLQR-VSLNISKLKHLETV 898 (1153)
T ss_pred ccccCEEECCCCCcccccccc---ccccCEeECCCCCCccCh-HHHhcCCCCCEEECCCCCCcCc-cCcccccccCCCee
Confidence 445555555554433333321 234555555555554432 2344555555665555 23333 22234455555555
Q ss_pred ccccc
Q 039595 468 IVSMN 472 (1078)
Q Consensus 468 ~l~~N 472 (1078)
++++|
T Consensus 899 ~l~~C 903 (1153)
T PLN03210 899 DFSDC 903 (1153)
T ss_pred ecCCC
Confidence 55544
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=218.82 Aligned_cols=170 Identities=21% Similarity=0.193 Sum_probs=127.8
Q ss_pred CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCce
Q 039595 836 GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT 915 (1078)
Q Consensus 836 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 915 (1078)
|+|.++++.. ...+++.+++.++.||+.||+|||++ + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899999532 34699999999999999999999998 5 999999999999999 99998664322
Q ss_pred eeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHH--
Q 039595 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKL-- 993 (1078)
Q Consensus 916 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 993 (1078)
..|++.|||||++.+..++.++|||||||++|||++|+.||.......... . .......+.............
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL-E---ILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH-H---HHHHHhccCCccccccHHHHHhh
Confidence 268899999999999999999999999999999999999975332211111 1 111111111111111111111
Q ss_pred HHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 994 ISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 994 ~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
..+.+++.+||..+|++||++.|+++|+|....+
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 2588999999999999999999999999976543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-23 Score=267.05 Aligned_cols=307 Identities=22% Similarity=0.236 Sum_probs=192.0
Q ss_pred cceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccc
Q 039595 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYK 255 (1078)
Q Consensus 176 L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 255 (1078)
|+.|++.++.+. .+|..+ ...+|+.|+|.+|++. .+|..+..+++|+.|+|++|...+.+| .+..+++|++|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecC
Confidence 444444444433 344444 2344555555555543 334444445555555555443322333 244455555555555
Q ss_pred cccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCC
Q 039595 256 NSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIP 335 (1078)
Q Consensus 256 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 335 (1078)
|.....+|..++++++|+.|++++|..-+.+|..+ ++++|+.|++++|...+.+|.. ..+|++|++++|.++ .+|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP 741 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFP 741 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccc
Confidence 44333445555555555555555543333444433 4455555555555444344432 245666677777665 344
Q ss_pred CCCCCCCcCcEEEccCccC-------CCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCc
Q 039595 336 PSIGNLSSLRNLSLFNNGL-------YGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPK 408 (1078)
Q Consensus 336 ~~l~~l~~L~~L~Ls~N~l-------~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 408 (1078)
..+ .+++|+.|++.++.. ....+......++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|.
T Consensus 742 ~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~ 820 (1153)
T PLN03210 742 SNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT 820 (1153)
T ss_pred ccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence 443 456667676665332 112222333457899999999988888999999999999999999876667777
Q ss_pred cccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcc
Q 039595 409 SLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKL 488 (1078)
Q Consensus 409 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L 488 (1078)
.+ ++++|+.|++++|......+. ...+|+.|+|++|.++.+ +..+..+++|+.|++++|+-...+|..+..++.|
T Consensus 821 ~~-~L~sL~~L~Ls~c~~L~~~p~---~~~nL~~L~Ls~n~i~~i-P~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L 895 (1153)
T PLN03210 821 GI-NLESLESLDLSGCSRLRTFPD---ISTNISDLNLSRTGIEEV-PWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHL 895 (1153)
T ss_pred CC-CccccCEEECCCCCccccccc---cccccCEeECCCCCCccC-hHHHhcCCCCCEEECCCCCCcCccCcccccccCC
Confidence 66 789999999999865433222 236899999999999865 4568899999999999866555678888899999
Q ss_pred cEEeccCCc
Q 039595 489 QFLDLSSNH 497 (1078)
Q Consensus 489 ~~L~Ls~N~ 497 (1078)
+.+++++|.
T Consensus 896 ~~L~l~~C~ 904 (1153)
T PLN03210 896 ETVDFSDCG 904 (1153)
T ss_pred CeeecCCCc
Confidence 999999874
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=243.66 Aligned_cols=262 Identities=29% Similarity=0.442 Sum_probs=124.5
Q ss_pred cEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccc
Q 039595 105 VNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHN 184 (1078)
Q Consensus 105 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n 184 (1078)
..|||++|+++ .+|+.+. ++|+.|++++|+++ .+|.. .++|++|+|++|+|+ .+|.. .++|+.|++++|
T Consensus 204 ~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 204 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSN 272 (788)
T ss_pred cEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCC
Confidence 34555555554 3454443 25555555555555 24431 345555555555555 34432 234455555555
Q ss_pred cccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCc
Q 039595 185 NVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS 264 (1078)
Q Consensus 185 ~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 264 (1078)
.++ .+|..+ ++|+.|+|++|+++. +|.. +++|+.|+|++|++++. |... .+|+.|++++|++++ +|.
T Consensus 273 ~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N~L~~-LP~ 339 (788)
T PRK15387 273 PLT-HLPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQLTS-LPT 339 (788)
T ss_pred chh-hhhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCccccC-CCCc---ccccccccccCcccc-ccc
Confidence 544 233321 334445555555542 2321 23455555555555532 2211 234444555555542 332
Q ss_pred ccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcC
Q 039595 265 IIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSL 344 (1078)
Q Consensus 265 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 344 (1078)
. ..+|++|+|++|+|++ +|... .+|+.|++++|+|+. +|.. ..+|
T Consensus 340 l---p~~Lq~LdLS~N~Ls~-------------------------LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~L 384 (788)
T PRK15387 340 L---PSGLQELSVSDNQLAS-------------------------LPTLP---SELYKLWAYNNRLTS-LPAL---PSGL 384 (788)
T ss_pred c---ccccceEecCCCccCC-------------------------CCCCC---cccceehhhcccccc-Cccc---cccc
Confidence 1 1244455555555442 22221 234445555555553 3322 1345
Q ss_pred cEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCc
Q 039595 345 RNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424 (1078)
Q Consensus 345 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 424 (1078)
+.|++++|++++ +|.. .++|+.|++++|+|++ +|..+ .+|+.|++++|+++ .+|..+.++++|+.|++++|
T Consensus 385 ~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N 455 (788)
T PRK15387 385 KELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 455 (788)
T ss_pred ceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCC
Confidence 556666665552 3332 2345566666666653 33322 34555666666665 35555666666666666666
Q ss_pred cccccchhhc
Q 039595 425 NLVGKVYEAF 434 (1078)
Q Consensus 425 ~l~~~~~~~~ 434 (1078)
.+++..+..+
T Consensus 456 ~Ls~~~~~~L 465 (788)
T PRK15387 456 PLSERTLQAL 465 (788)
T ss_pred CCCchHHHHH
Confidence 6665544443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=242.05 Aligned_cols=343 Identities=21% Similarity=0.307 Sum_probs=206.2
Q ss_pred ccccccCCCHHHHHHHHHHHHhcCCCCCCccccCCCCCCCCCCCCCCCCcccc----------------eEeeCCCCeEE
Q 039595 17 FSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFG----------------ISCNHAGSRVI 80 (1078)
Q Consensus 17 ~~~~~~~~~~~~~~all~~k~~~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~g----------------v~C~~~~~~v~ 80 (1078)
+.|+....+++|.++++++.+.+..+++-.+.-..|++ .+|+|-=.. |.|. ++.||
T Consensus 53 ~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~------~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt 124 (754)
T PRK15370 53 LCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGG------ADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVT 124 (754)
T ss_pred HhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCC------CCcccccCCcchhhheeeecCCceEEecC--CCccc
Confidence 34455567789999999999999776332222223873 468885433 6775 34566
Q ss_pred EeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCC--------CC-----CCCCCcceeccCCCccCCCCCcccc
Q 039595 81 SINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPP--------QI-----GNLSKLQNLDLGNNQLSGVISPEIG 147 (1078)
Q Consensus 81 ~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~--------~~-----~~l~~L~~L~Ls~n~l~~~~p~~~~ 147 (1078)
.+...+......-.. + ..-..-+-.+......-+. .+ +-..+...|++++++++ .+|..+.
T Consensus 125 ~l~~~g~~~~~~~~~-~----~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip 198 (754)
T PRK15370 125 YTRVTESEQASSASG-S----KDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP 198 (754)
T ss_pred ccccccccccccCCC-C----CChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc
Confidence 555444222211100 0 0000000000000000000 00 11134566777777766 4565553
Q ss_pred CccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCee
Q 039595 148 KLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTL 227 (1078)
Q Consensus 148 ~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 227 (1078)
+.|+.|+|++|+++ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|
T Consensus 199 --~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L 267 (754)
T PRK15370 199 --EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSL 267 (754)
T ss_pred --cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEE
Confidence 35777777777776 5665553 46777777777766 4565543 36777777777776 4565543 467777
Q ss_pred ecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCC
Q 039595 228 DLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLS 307 (1078)
Q Consensus 228 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 307 (1078)
+|++|+|+. +|..+. ++|+.|+|++|+|++ +|..+. ++|+.|++++|++++ +|..+ .++|+.|++++|.++
T Consensus 268 ~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt 338 (754)
T PRK15370 268 DLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALT 338 (754)
T ss_pred ECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCccc--cccceeccccCCccc
Confidence 777777774 455554 467777777777774 454433 367777777777774 34333 256777777777777
Q ss_pred CCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCC-
Q 039595 308 GSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSV- 386 (1078)
Q Consensus 308 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~- 386 (1078)
+ +|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|++++|++++ +|..+
T Consensus 339 ~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~-LP~sl~ 408 (754)
T PRK15370 339 S-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVR-LPESLP 408 (754)
T ss_pred c-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCccc-CchhHH
Confidence 4 555443 67888888888887 3555543 57888888888887 4565554 368888888888873 44433
Q ss_pred ---ccCCCCceeecccCcCC
Q 039595 387 ---GNLTGLVLLNMCENHLF 403 (1078)
Q Consensus 387 ---~~l~~L~~L~L~~N~l~ 403 (1078)
..++.+..|++.+|+++
T Consensus 409 ~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 409 HFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHhhcCCCccEEEeeCCCcc
Confidence 34577888888888886
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-23 Score=246.98 Aligned_cols=261 Identities=19% Similarity=0.171 Sum_probs=191.9
Q ss_pred ccceeccCCceeEEEEE-eCCCCEEEEEEeccc--cccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 755 EKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQ--LLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 755 ~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
..+.+|.|++|.|+.+. ....+.++.|.++.. ...........+..|..+-..+.|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45679999999888774 334555566654421 111111111225667778888999999888887776666666699
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
||++ +|+.++.+ ...++..++..+++|++.|++|+|+. |+.|||+|++|++++.+|.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99999843 34688899999999999999999999 99999999999999999999999999998764433
Q ss_pred ----CCceeeccccccccccccccCCCCc-cchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 912 ----SNRTEFVGTFGYAAPEIAYTMRATE-KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 912 ----~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
......+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||.........+.......... ....+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~---~~~~~~ 551 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN---IFEGPN 551 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc---cccChH
Confidence 2346788999999999999999876 58999999999999999999976554433221100000000 000111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.-..........++.+|+++||.+|.|+++|++.+|+..
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 111122335677889999999999999999999999654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=239.16 Aligned_cols=121 Identities=27% Similarity=0.310 Sum_probs=62.8
Q ss_pred cCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecC
Q 039595 511 SLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLS 590 (1078)
Q Consensus 511 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 590 (1078)
+|+.|+|++|+|++ +|.. ..+|+.|++++|.|+. +|... .+|+.|+|++|+|+. +|.. .++|+.|+++
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l~---~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS 410 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLTS-LPVL---PSELKELMVS 410 (788)
T ss_pred ccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Ccccc---cccceEEecCCcccC-CCCc---ccCCCEEEcc
Confidence 44444555554442 2221 1344445555555542 33221 345555666665553 3322 2356666666
Q ss_pred CCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCCC
Q 039595 591 HNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPN 648 (1078)
Q Consensus 591 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~ 648 (1078)
+|+|+. +|.. ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|+
T Consensus 411 ~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 411 GNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred CCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 666653 3432 234566666666666 4566666666666666666666665554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-21 Score=213.83 Aligned_cols=253 Identities=22% Similarity=0.259 Sum_probs=184.7
Q ss_pred CCCccceeccCCceeEEEEEeCCC--CEEEEEEeccccccCChhhHHHHHHHHHHHhcCC----CCceeeEEeee-ecCC
Q 039595 752 DFDEKFCIGKGGQGSVYKAELPSG--DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR----HRNIVKFHGFC-SNAR 824 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~ 824 (1078)
+|++.+.||+|+||.||.|..... +.+|+|......... ...+..|+.++..+. .+++..+++.. ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 899999999999999999965543 478888876542211 114566777777775 36899999998 5788
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-----CcEEEe
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-----FEAHVS 899 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~ 899 (1078)
..|+||+.+ |.+|.++..... .+.++...+.+|+.|++.+|+++|+. |++||||||.|+.+... ..+.+.
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence 899999987 669999875444 67899999999999999999999999 99999999999999865 469999
Q ss_pred ccccccccc---CCC-------CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhh
Q 039595 900 DFGIAKFVE---PYS-------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 900 DfG~a~~~~---~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 969 (1078)
|||+++.+. ... .......||..|+++..+.+.+.+.+.|+||++.++.|+..|..||........ ...
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~ 248 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSK 248 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHH
Confidence 999998322 111 112345699999999999999999999999999999999999999865443211 111
Q ss_pred hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
............ .......++..+... +-..+..++|....+...
T Consensus 249 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 249 FEKDPRKLLTDR---FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHHhhhhcccc---ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHH
Confidence 111111111111 111122333344333 444789999998776655
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=216.78 Aligned_cols=179 Identities=18% Similarity=0.149 Sum_probs=136.1
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEeC--CCCEEEEEEecccccc-CChhhHHHHHHHHHHHhcCCCCceee-EEeeee
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAELP--SGDIVAVKKFNSQLLS-GNMADQDEFLNVVLALNEIRHRNIVK-FHGFCS 821 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~ 821 (1078)
+....++|++.+.||+|+||+||+|..+ +++.||||++...... ......+.+.+|+.++++++|+|+++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3445678999999999999999999654 5778899987532110 12233567899999999999999985 4432
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCeeeCCCCcEEEec
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDI-SSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~D 900 (1078)
+..|+||||++|++|.... ... ...++.|+++||+|||++ ||+|||| ||+||+++.++.+||+|
T Consensus 91 --~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred --CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence 4579999999999997321 111 146789999999999999 9999999 99999999999999999
Q ss_pred ccccccccCCCCC--------ceeeccccccccccccccCC------CCccchhH
Q 039595 901 FGIAKFVEPYSSN--------RTEFVGTFGYAAPEIAYTMR------ATEKYDVY 941 (1078)
Q Consensus 901 fG~a~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~------~~~~sDvw 941 (1078)
||+|+.+...... -....+++.|+|||++...+ .+..+|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999976543211 13456788999999987543 23446766
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-22 Score=199.81 Aligned_cols=246 Identities=20% Similarity=0.323 Sum_probs=176.7
Q ss_pred CCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 753 FDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
.....+|.+...|+.|+|+++ |..+++|++..... .......|.+|.-.++-+.||||..++|.|..+....++..|
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhccCCCccccccccc-Ccchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 334556889999999999998 55567787765432 223345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 912 (1078)
|+.|+|+..++.. ..-..+..++.+++.+||+|++|||+-. +-|----+.+..|++|++.+++|+ ++-+++. .
T Consensus 269 mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfs----f 341 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFS----F 341 (448)
T ss_pred ccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceee----e
Confidence 9999999999654 3455777899999999999999999963 223344688999999999888774 1212111 1
Q ss_pred CceeeccccccccccccccCCCC---ccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 913 NRTEFVGTFGYAAPEIAYTMRAT---EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 913 ~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
......-.+.||+||.+..++-+ .++|+|||++++||+.|...||.....-.-.. ....+-+.+.++ +..
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----kialeglrv~ip---pgi 414 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----KIALEGLRVHIP---PGI 414 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----hhhhccccccCC---CCc
Confidence 12233457899999999876543 57999999999999999999965333211111 111111222222 222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHH
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGF 1018 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell 1018 (1078)
...+ -+++.-|+..||.+||.++.++
T Consensus 415 s~hm---~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 415 SRHM---NKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cHHH---HHHHHHHhcCCCCcCCCcceeh
Confidence 2333 3444559999999999987765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-20 Score=209.82 Aligned_cols=265 Identities=28% Similarity=0.411 Sum_probs=201.0
Q ss_pred CCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCC-ceeeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR-NIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E 831 (1078)
|+..+.||.|+||.||++... ..+|+|.+....... ......+.+|+..++.+.|+ +++++++++......++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 677889999999999999766 789999987764332 12466788999999999988 79999999988788899999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEecccccccccCC
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a~~~~~~ 910 (1078)
|+.++++.+++........++......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999997774332113688899999999999999999999 999999999999999998 7999999999865443
Q ss_pred CC------Cceeecccccccccccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 911 SS------NRTEFVGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 911 ~~------~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
.. ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... ...............+.
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTPS 234 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCcc
Confidence 32 2466789999999999987 57899999999999999999999996544321 00011111111111110
Q ss_pred CCCCCCcc--HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 982 LSTPSPGV--MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 982 ~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
........ ......+.+++.+|+..+|..|.++.+...+.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 11111000 11223677888899999999999999888875433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=196.61 Aligned_cols=202 Identities=19% Similarity=0.280 Sum_probs=171.2
Q ss_pred hhcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
..-.|.+.++||+|.||+++.| ..-+++.||||.-.... +..++..|....+.+ ..++|...|-+..++.+-
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS------~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS------EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC------CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 4457999999999999999999 45579999999865432 344567788888877 579999999998999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-----CcEEEecc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-----FEAHVSDF 901 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~Df 901 (1078)
.||+|.+ |-+|+|++. -..+.++.+.+..+|.|++.-++|+|++ .+|.|||||+|+||... ..+.++||
T Consensus 100 iLVidLL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEec
Confidence 9999987 668988873 2346799999999999999999999999 99999999999999754 35899999
Q ss_pred cccccccCCCCC-------ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 039595 902 GIAKFVEPYSSN-------RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI 962 (1078)
Q Consensus 902 G~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~ 962 (1078)
|+|+.+.+.... .....||.+||+-....+.+-+.+.|.-|+|-++.+++.|..||+....
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 999988654332 2346799999999999999999999999999999999999999986544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-21 Score=189.02 Aligned_cols=203 Identities=21% Similarity=0.324 Sum_probs=169.0
Q ss_pred HhhcCCCccceeccCCceeEEEE-EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC-CceeeEEeeeecCCe
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH-RNIVKFHGFCSNARH 825 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 825 (1078)
....+|.++++||.|+||.+|.| ...+|+.||||+-.... ...++.-|..+.+.+++ ..|..+..|..+...
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA------KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC------CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 34578999999999999999999 56789999999865432 22345667788888864 678888888888899
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEeccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE---FEAHVSDFG 902 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG 902 (1078)
-.+|||.. |.+|++.+. -....++.+.++-.+-|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|||
T Consensus 86 nvlVMdLL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred ceeeeecc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEecc
Confidence 99999987 669999872 2345689999999999999999999999 99999999999999765 468999999
Q ss_pred ccccccCCCC-------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 039595 903 IAKFVEPYSS-------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI 962 (1078)
Q Consensus 903 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~ 962 (1078)
+|+.+.+... ......||.+|.+--...+...+.+.|+-|+|.++.++-.|..||+....
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 9987744222 23456899999999988888889999999999999999999999986544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=228.85 Aligned_cols=264 Identities=26% Similarity=0.430 Sum_probs=207.0
Q ss_pred cceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeec
Q 039595 150 NQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDL 229 (1078)
Q Consensus 150 ~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 229 (1078)
.+...|+++++.++ .+|..+. +.|+.|+|++|+++ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 45789999999998 6887764 58999999999999 5777665 58999999999998 4676554 58999999
Q ss_pred CCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCC
Q 039595 230 SQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309 (1078)
Q Consensus 230 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~ 309 (1078)
++|+++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+|++|++++ +|..+. ++|+.|++++|.++.
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~- 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA- 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-
Confidence 999999 4677665 58999999999999 5677664 589999999999995 454443 478999999999985
Q ss_pred CCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccC
Q 039595 310 IPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNL 389 (1078)
Q Consensus 310 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 389 (1078)
+|..+. ++|++|++++|.+++ +|..+. ++|+.|++++|+++ .+|..+. ++|+.|+|++|+|+. +|..+.
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~-- 387 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP-- 387 (754)
T ss_pred CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--
Confidence 555443 689999999999986 566654 68999999999998 5776653 689999999999985 455443
Q ss_pred CCCceeecccCcCCCCCCcc----ccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccC
Q 039595 390 TGLVLLNMCENHLFGPIPKS----LKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD 451 (1078)
Q Consensus 390 ~~L~~L~L~~N~l~~~~~~~----l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 451 (1078)
..|+.|++++|++.. +|.. +..++++..+++.+|.+.. ..+++|+.| ++.+.+.
T Consensus 388 ~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~ 445 (754)
T PRK15370 388 AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQ 445 (754)
T ss_pred HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhccccc
Confidence 369999999999984 4544 3445788999999999873 233445555 3444443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8e-21 Score=222.47 Aligned_cols=248 Identities=20% Similarity=0.204 Sum_probs=179.4
Q ss_pred CCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEe
Q 039595 752 DFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 831 (1078)
+|...+.+|++.|=+|.+|++..|. |+||++-+..-.-.....++-.+|++ .+.++|||++++.-.-..++..|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777889999999999999888787 99999866542222222333334444 555699999999988888889999999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc--c-
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV--E- 908 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~--~- 908 (1078)
|+.. +|+|.+ ....-+...+...|+.|++.|+.-+|+. ||+|||||.+|||++.-.-+.|+||...+-. .
T Consensus 102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9977 999998 3445577788888999999999999999 9999999999999999999999999776532 1
Q ss_pred CCCCCce----eeccccccccccccccC----------C-CCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhh-h
Q 039595 909 PYSSNRT----EFVGTFGYAAPEIAYTM----------R-ATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNM-I 971 (1078)
Q Consensus 909 ~~~~~~~----~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~-~ 971 (1078)
+...... +...-.+|.|||.+... . .+++.||||+||+++|+++ |++||+...- ++ +... .
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-~a-Yr~~~~ 252 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-LA-YRSGNA 252 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-Hh-HhccCc
Confidence 1111111 12234589999987542 1 5778999999999999998 6888652111 00 0000 0
Q ss_pred hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 972 IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
....+.+.. +. -..+..++..|++.||++|.++++.|+.
T Consensus 253 ~~~e~~Le~-Ie---------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEK-IE---------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHh-Cc---------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000001100 00 0146788889999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-21 Score=213.50 Aligned_cols=241 Identities=25% Similarity=0.293 Sum_probs=188.2
Q ss_pred eccCCceeEEEEE----eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCeeEEEEeec
Q 039595 759 IGKGGQGSVYKAE----LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 759 lG~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 833 (1078)
+|+|+||.|+++. ...|+-+|.|+.++......... ....|..++...+ ||.+|++...++.+...+++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 7999999999873 23477899998877544332222 4456777778886 999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 039595 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN 913 (1078)
Q Consensus 834 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 913 (1078)
.||++...+. ....+++.....+...++-+++++|+. +++|||+|++||+++.+|++++.|||.++..-+....
T Consensus 80 rgg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred ccchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988873 344577788888899999999999999 9999999999999999999999999999876443222
Q ss_pred ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHH
Q 039595 914 RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKL 993 (1078)
Q Consensus 914 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 993 (1078)
+||..|||||++. .+..++|.||||++++||+||..||.. .... .+....+..+ ....
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~------~Il~~~~~~p----~~l~ 211 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMK------RILKAELEMP----RELS 211 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHH------HHhhhccCCc----hhhh
Confidence 8999999999998 678899999999999999999999653 1111 1221122211 1223
Q ss_pred HHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhhHHH
Q 039595 994 ISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCDEIL 1029 (1078)
Q Consensus 994 ~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~~~~ 1029 (1078)
....+++.++...+|..|.- ..|+.+|+|+...+..
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 35667778889999999985 5789999887764443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.7e-20 Score=190.53 Aligned_cols=174 Identities=11% Similarity=0.149 Sum_probs=134.5
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHH------HHHHHHHHhcCCCCceeeEEeeeec
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDE------FLNVVLALNEIRHRNIVKFHGFCSN 822 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~niv~l~~~~~~ 822 (1078)
...+|+..+.+|.|+||.||++.. ++..+|||.++..... .....+. +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~-~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKR-TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCc-hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357899999999999999999866 5778999999765432 2222222 6789999999999999999988653
Q ss_pred C--------CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 039595 823 A--------RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF 894 (1078)
Q Consensus 823 ~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 894 (1078)
. +..++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+||+++.+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 2 35789999999999988741 222 2456999999999999 999999999999999998
Q ss_pred cEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHH
Q 039595 895 EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 951 (1078)
Q Consensus 895 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell 951 (1078)
++++|||........... ..+.....+..++|+||||+.+..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754221110 11344556778999999999876554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=183.73 Aligned_cols=144 Identities=18% Similarity=0.179 Sum_probs=109.7
Q ss_pred cceeccCCceeEEEEEeCCCCEEEEEEeccccccCChh----------------------hHHHHHHHHHHHhcCCCCce
Q 039595 756 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMA----------------------DQDEFLNVVLALNEIRHRNI 813 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~ni 813 (1078)
...||+|+||.||+|...+|+.||||+++......... .......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987789999999997643211110 01123458999999988776
Q ss_pred eeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEecCCCCCCeeeCC
Q 039595 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL-HHDCLPSIIHRDISSKNVLLDL 892 (1078)
Q Consensus 814 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~NIll~~ 892 (1078)
.....+... ..++||||++++++..... ....++.+++..++.|++.+|.|+ |+. ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 443333222 2389999999987765431 224688899999999999999999 688 999999999999998
Q ss_pred CCcEEEeccccccccc
Q 039595 893 EFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 893 ~~~~kl~DfG~a~~~~ 908 (1078)
++.++++|||+|...+
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 5789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-19 Score=189.45 Aligned_cols=236 Identities=19% Similarity=0.230 Sum_probs=150.1
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC----------CceeeEEeee
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH----------RNIVKFHGFC 820 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~ 820 (1078)
.+...+.||.|+++.||.+++. +|+.+|||++.... .......+++++|.-....+.+ -.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 4456778999999999999765 69999999987654 2234456677777655555432 1122222211
Q ss_pred ---------ecC---C-----eeEEEEeecCCCCHHHHhcC----CCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 039595 821 ---------SNA---R-----HSFLVCEYLHRGSLARILGN----DATAKELSWNRRINVIKGVANALSYLHHDCLPSII 879 (1078)
Q Consensus 821 ---------~~~---~-----~~~lv~E~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 879 (1078)
... . ..+++|+-+. ++|.+++.. ......+....+..+..|+++.+++||+. |+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 111 1 2367888774 488887632 11223344455667789999999999999 999
Q ss_pred ecCCCCCCeeeCCCCcEEEecccccccccCCCCCceeeccccccccccccccC--------CCCccchhHHHHHHHHHHH
Q 039595 880 HRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM--------RATEKYDVYSFGVLVFEVI 951 (1078)
Q Consensus 880 H~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwSlG~il~ell 951 (1078)
|+||+|+|++++.+|.++|+||+........ ......+..|.+||..... .++.+.|.|++|+++|.|+
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999999887754331 1113456789999976442 4788999999999999999
Q ss_pred hCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCC
Q 039595 952 KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEAR 1011 (1078)
Q Consensus 952 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1011 (1078)
+|+.||+.......... .+.. +. +....+.++|..+|++||++|
T Consensus 245 C~~lPf~~~~~~~~~~~------------~f~~-C~---~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW------------DFSR-CR---DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG------------GGTT-SS------HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc------------cchh-cC---CcCHHHHHHHHHHccCCcccC
Confidence 99999875433211110 1111 11 223367788999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=175.66 Aligned_cols=185 Identities=13% Similarity=0.068 Sum_probs=140.5
Q ss_pred CccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCeeEEEEee
Q 039595 754 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 754 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
.+...|++|+||+||.+.. .+.+++.+.+..............+.+|+++++++. |++|++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998865 578888887765432111222335789999999995 5889999886 346999999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCeeeCCCCcEEEecccccccccCCC
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDI-SSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
+.|.+|..... . ....++.|++.+++++|++ ||+|||| ||+||+++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99999875431 0 1235788999999999999 9999999 7999999999999999999998655433
Q ss_pred CC-----c--------eeeccccccccccccccC-CCC-ccchhHHHHHHHHHHHhCCCC
Q 039595 912 SN-----R--------TEFVGTFGYAAPEIAYTM-RAT-EKYDVYSFGVLVFEVIKGNHP 956 (1078)
Q Consensus 912 ~~-----~--------~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlG~il~elltG~~p 956 (1078)
.. . .....++.|++|+...-- ..+ .+.+.++-|+-+|.++|++.|
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence 21 0 112357788888864432 333 567999999999999999998
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=178.81 Aligned_cols=143 Identities=19% Similarity=0.207 Sum_probs=111.4
Q ss_pred cceeccCCceeEEEEEeCCCCEEEEEEeccccccCC--------------------hh--hHHHHHHHHHHHhcCCCCce
Q 039595 756 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN--------------------MA--DQDEFLNVVLALNEIRHRNI 813 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------------~~--~~~~~~~e~~~l~~l~h~ni 813 (1078)
...||+|+||.||+|...+|+.||||+++....... .. ....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999877899999999976521100 00 01234578899999999987
Q ss_pred eeEEeeeecCCeeEEEEeecCCCCHHHH-hcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeC
Q 039595 814 VKFHGFCSNARHSFLVCEYLHRGSLARI-LGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 814 v~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~ 891 (1078)
.....+... ..++||||++|+++... +. ...++..++..++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444332 24899999998855433 31 2457788999999999999999999 8 999999999999998
Q ss_pred CCCcEEEeccccccccc
Q 039595 892 LEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 892 ~~~~~kl~DfG~a~~~~ 908 (1078)
++.++++|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=195.54 Aligned_cols=210 Identities=25% Similarity=0.440 Sum_probs=157.5
Q ss_pred HhcCCCCceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCc-EecCC
Q 039595 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI-IHRDI 883 (1078)
Q Consensus 805 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dl 883 (1078)
++.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. ....+++.-...+.++|+.||+|+|.. .| +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 3567899999999999999999999999999999999954 345688888999999999999999998 44 99999
Q ss_pred CCCCeeeCCCCcEEEecccccccccC--CCCCceeeccccccccccccccCC-------CCccchhHHHHHHHHHHHhCC
Q 039595 884 SSKNVLLDLEFEAHVSDFGIAKFVEP--YSSNRTEFVGTFGYAAPEIAYTMR-------ATEKYDVYSFGVLVFEVIKGN 954 (1078)
Q Consensus 884 k~~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlG~il~elltG~ 954 (1078)
++.|+++|..+.+|++|||+...... .........-..-|.|||.+.+.. .+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999987642 111122233456799999987641 467899999999999999999
Q ss_pred CCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 955 HPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 955 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
.||+........ ...+........+.+.+......+....+..++.+||..+|++||+++++-..
T Consensus 156 ~~~~~~~~~~~~-~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 156 GPFDLRNLVEDP-DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred CccccccccCCh-HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 998754433321 11111111111111222211111222268899999999999999998886554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=180.34 Aligned_cols=205 Identities=22% Similarity=0.324 Sum_probs=141.4
Q ss_pred CCCceeeEEeeeec---------------------------CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHH
Q 039595 809 RHRNIVKFHGFCSN---------------------------ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIK 861 (1078)
Q Consensus 809 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 861 (1078)
+|||||++.++|.+ +...|+||...+. +|.+++... ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 59999999987732 3457899998766 899999432 355667778999
Q ss_pred HHHHHHHHHHhcCCCCcEecCCCCCCeeeC--CCC--cEEEecccccccccC------CCCCceeecccccccccccccc
Q 039595 862 GVANALSYLHHDCLPSIIHRDISSKNVLLD--LEF--EAHVSDFGIAKFVEP------YSSNRTEFVGTFGYAAPEIAYT 931 (1078)
Q Consensus 862 ~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~DfG~a~~~~~------~~~~~~~~~gt~~y~aPE~~~~ 931 (1078)
|+++|+.|||++ ||.|||+|++|||+. +|+ ...|+|||.+---+. +.+......|....||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 999999999999994 343 478899998853322 2233445668889999999775
Q ss_pred CCC------CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 039595 932 MRA------TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLD 1005 (1078)
Q Consensus 932 ~~~------~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 1005 (1078)
.+- -.|+|.|+.|.+.||+++...||...+.-.-+... .....+ |.++...+ -.+.+++...++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~qL-Palp~~vp------p~~rqlV~~lL~ 495 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQL-PALPSRVP------PVARQLVFDLLK 495 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhhC-CCCcccCC------hHHHHHHHHHhc
Confidence 432 34899999999999999999996432221111111 111112 22222222 145677777899
Q ss_pred CCCCCCCChhHH---HHH-hhhhhhHHHHH
Q 039595 1006 ESPEARPTMEKG---FGH-HIGYCDEILAV 1031 (1078)
Q Consensus 1006 ~dP~~RPt~~el---l~h-~~~~~~~~~~~ 1031 (1078)
+||.+|+++.-. ++- .|.+.+++.+.
T Consensus 496 r~pskRvsp~iAANvl~LsLw~~~~~vka~ 525 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVLNLSLWRMGEDVKAM 525 (598)
T ss_pred CCccccCCccHHHhHHHHHHhcCchHHHHh
Confidence 999999985433 322 56665555443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-20 Score=174.80 Aligned_cols=158 Identities=30% Similarity=0.517 Sum_probs=86.8
Q ss_pred cCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccc
Q 039595 98 FSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177 (1078)
Q Consensus 98 ~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~ 177 (1078)
+..+.+++.|.||+|.++ .+|+.|++|.+|++|++++|+++ .+|.+|+.++.|++|+++.|++. .+|..||.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445556666666666665 45556666666666666666665 55666666666666666666665 4444444444444
Q ss_pred eeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccc
Q 039595 178 EFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNS 257 (1078)
Q Consensus 178 ~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 257 (1078)
.|||.+|++.. ..+|..|..|+.|+.|+|++|.+. .+|..+++|++|+.|.++.|.
T Consensus 106 vldltynnl~e-----------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 106 VLDLTYNNLNE-----------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred hhhcccccccc-----------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 44444444432 134444555555555555555554 344455555555555555555
Q ss_pred cCCCCCcccCCCcccceeeccccccc
Q 039595 258 LSGSIPSIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 258 l~~~~p~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
+- .+|..++.++.|+.|.+.+|+++
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee
Confidence 54 34555555555555555555554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-20 Score=175.78 Aligned_cols=161 Identities=28% Similarity=0.454 Sum_probs=137.3
Q ss_pred CeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEE
Q 039595 77 SRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156 (1078)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 156 (1078)
.++|.+.|+.+.++-. +..++.+.+|+.|++++|+++ .+|.+++.|++|+.|+++-|++. ..|..||.++.|+.||
T Consensus 33 s~ITrLtLSHNKl~~v--ppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 33 SNITRLTLSHNKLTVV--PPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhcccCceeec--CCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 4788888888766532 457889999999999999997 78999999999999999999998 8999999999999999
Q ss_pred ccCccCCC-CCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccC
Q 039595 157 LDMNQLHG-TIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235 (1078)
Q Consensus 157 L~~n~l~~-~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 235 (1078)
|.+|++.. .+|..|..++.|+.|+|+.|.+. .+|..+++|++|+.|.+.+|.+- .+|..++.|+.|++|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 99999984 68999989999999999999887 78888888888888888888876 57777888888888888888887
Q ss_pred CCCCCcccC
Q 039595 236 GLIPCTLDN 244 (1078)
Q Consensus 236 ~~~p~~l~~ 244 (1078)
- +|..+++
T Consensus 187 v-lppel~~ 194 (264)
T KOG0617|consen 187 V-LPPELAN 194 (264)
T ss_pred e-cChhhhh
Confidence 4 4444544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-20 Score=206.61 Aligned_cols=277 Identities=21% Similarity=0.219 Sum_probs=169.6
Q ss_pred EEEccCccCC-CCCCccccccCCCCeEEcccccCccc----cCCCCccCCCCceeecccCcCCC------CCCccccccC
Q 039595 346 NLSLFNNGLY-GSIPEEIGYLKSLSELKLCKNNLSGV----IPHSVGNLTGLVLLNMCENHLFG------PIPKSLKSLT 414 (1078)
Q Consensus 346 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~------~~~~~l~~l~ 414 (1078)
.|+|+.+.++ ...+..+..+.+|+.|+++++.++.. ++..+...+.++.|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677777776 34445566777788888888887532 34445566677777777776652 1223344455
Q ss_pred CCCeEEccCccccccchhhccCCCC---CcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCC-CcccE
Q 039595 415 SLKRVRFNQNNLVGKVYEAFGDHPN---LTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQF 490 (1078)
Q Consensus 415 ~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l-~~L~~ 490 (1078)
+|++|++++|.+.......+..+.+ |++|++++|++..... ..+...+..+ ++|+.
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceE
Confidence 5555555555554433333333222 5555555554432110 0112223344 67777
Q ss_pred EeccCCccCCC----cccccccCccCcEEeccCCccCCC----cccccccccccceeeccCccccCCC----Cccccccc
Q 039595 491 LDLSSNHIVGK----IPVQLEKLFSLNKLILSLNQLSGS----VPLEFGSLTELQYLDLSANKLSSSI----PKSIGNLL 558 (1078)
Q Consensus 491 L~Ls~N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~ 558 (1078)
|++++|.+++. .+..+..+..|++|++++|.+++. ++..+..+++|++|+|++|.+++.. +..+..++
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 78887777732 233455666788888888877742 2333455568888888888776433 23455667
Q ss_pred ccccccccCcccccccchhhhc-----ccccCeeecCCCccCCc----CCCCcccccccceeeccCccccCC----cccc
Q 039595 559 KLYYLNLSNNQFSHTIPIEFEK-----LIHLSKLDLSHNILQEE----IPPQVCNMESLEKLNLSHNNLSGF----IPRC 625 (1078)
Q Consensus 559 ~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~ 625 (1078)
+|++|++++|.+++.....+.. .+.|+.|++++|.++.. +...+..+++|+++++++|.++.. ..+.
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~ 301 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence 7888888888887544443332 36888888888888631 223345567888888888888855 4444
Q ss_pred cccC-CcCcEEEcccCcC
Q 039595 626 FEKM-RSLSCIDICYNEL 642 (1078)
Q Consensus 626 l~~l-~~L~~l~l~~N~l 642 (1078)
+... +.|+++++.+|+|
T Consensus 302 ~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 302 LLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhhcCCchhhcccCCCCC
Confidence 5555 6788888888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.4e-20 Score=207.29 Aligned_cols=58 Identities=21% Similarity=0.233 Sum_probs=33.3
Q ss_pred eeccCCCccC-CCCCccccCccceeEEEccCccCCCC----CCcccccccccceeeccccccc
Q 039595 130 NLDLGNNQLS-GVISPEIGKLNQLRRLYLDMNQLHGT----IPPVIGQLSLIHEFSFCHNNVS 187 (1078)
Q Consensus 130 ~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~i~~l~~L~~L~l~~n~~~ 187 (1078)
.|+|+.+.++ +..+..+..+.+|+.|+++++.++.. ++..+...+.|++|+++.+.+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~ 64 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETG 64 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccC
Confidence 4677777776 33444456666677777777776532 3444444445555555555443
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.7e-17 Score=166.35 Aligned_cols=137 Identities=12% Similarity=0.155 Sum_probs=104.6
Q ss_pred CCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-----CCCceeeEEeeeecCC---
Q 039595 753 FDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-----RHRNIVKFHGFCSNAR--- 824 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~--- 824 (1078)
+...+.||+|+||.||. ...++. .+||++.... ....+.+.+|+.+++.+ +||||++++|+++++.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 34457899999999996 323444 4799886532 22356789999999999 5799999999998763
Q ss_pred e-eEEEEee--cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEecCCCCCCeeeCCC----CcE
Q 039595 825 H-SFLVCEY--LHRGSLARILGNDATAKELSWNRRINVIKGVANAL-SYLHHDCLPSIIHRDISSKNVLLDLE----FEA 896 (1078)
Q Consensus 825 ~-~~lv~E~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ 896 (1078)
. +.+|+|| +.+|+|.+++++. .+++. ..++.|++.++ +|||++ +|+||||||+||+++.. +.+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence 4 3378999 5579999999442 24444 35677888777 999999 99999999999999743 479
Q ss_pred EEeccccc
Q 039595 897 HVSDFGIA 904 (1078)
Q Consensus 897 kl~DfG~a 904 (1078)
+|+||+-+
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-17 Score=196.09 Aligned_cols=223 Identities=22% Similarity=0.239 Sum_probs=151.7
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..+|+.++.|..|+||.||.++++ +.+++|+|+=+...+ .++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li---------lRn---ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI---------LRN---ILTFAGNPFVV-------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccchh---------hhc---cccccCCccee--------------
Confidence 358999999999999999999776 577888854222110 001 22222344433
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|+-.+.++. .+.++... +.+++|+|+. ||||||+||+|.+|+.-|.+|++|||+++..-
T Consensus 136 -------gDc~tllk~---~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -------GDCATLLKN---IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -------chhhhhccc---CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 455555532 22333222 7889999999 99999999999999999999999999997531
Q ss_pred CC---------------CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh
Q 039595 909 PY---------------SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973 (1078)
Q Consensus 909 ~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 973 (1078)
.. .-.....+||+.|.|||++....|++.+|.|++|+++||++-|+.||. .+..++.......
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff--Gdtpeelfg~vis 272 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF--GDTPEELFGQVIS 272 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc--CCCHHHHHhhhhh
Confidence 10 001234689999999999999999999999999999999999999954 3322222222222
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCC---ChhHHHHHhhhhhhHH
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARP---TMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~ell~h~~~~~~~~ 1028 (1078)
....++..-... . .+..+++.+.|+.+|..|- .+-++.+|.|+..-+.
T Consensus 273 d~i~wpE~dea~----p---~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 273 DDIEWPEEDEAL----P---PEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred hhccccccCcCC----C---HHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 112222221111 1 2566788889999999997 4667888887665333
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.5e-18 Score=187.09 Aligned_cols=180 Identities=22% Similarity=0.335 Sum_probs=139.0
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
.+.|+.|++|...+|.+|+.+.......++.....++.|++.|++| + +.+|||+||.||++..+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999877777888999999999999999999 5 999999999999999999999999999
Q ss_pred cccccCCC------CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhh
Q 039595 904 AKFVEPYS------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQ 976 (1078)
Q Consensus 904 a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 976 (1078)
........ ...+..+||..||+||.+.+..|+.|+||||+|++++|+++ =..+++ ........-..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-------r~~t~~d~r~g 475 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-------RIATLTDIRDG 475 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-------HHHhhhhhhcC
Confidence 98665433 23456789999999999999999999999999999999997 233311 11111111112
Q ss_pred hcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
+++|..... .++ =..++.+++.+.|.+||++.+...|.|.
T Consensus 476 ~ip~~~~~d---~p~----e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 476 IIPPEFLQD---YPE----EYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CCChHHhhc---CcH----HHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 222222211 122 2467778899999999988777777663
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-16 Score=189.10 Aligned_cols=198 Identities=22% Similarity=0.210 Sum_probs=159.6
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC---CCceeeEEeeeec
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR---HRNIVKFHGFCSN 822 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 822 (1078)
.+.-.+.|.+.+.+|+|+||+||+|...+|+.||+|+-+...... |.--..++.+++ -+.|..+..++.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 334456888999999999999999987779999999976654321 111122344444 2445556666666
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-------CCc
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-------EFE 895 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~ 895 (1078)
.+..++|+||.+.|+|.+++. ..+.+++.-+..++.|+++.+++||.. +||||||||+|+++.. ...
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 778899999999999999994 566789999999999999999999999 9999999999999942 245
Q ss_pred EEEecccccccccCC--CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 039595 896 AHVSDFGIAKFVEPY--SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 956 (1078)
++|+|||.+..+... .......++|-.+--+|...++++++.+|-|.++.+++-|+.|+.-
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999999999765432 2345667889999999999999999999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=168.34 Aligned_cols=148 Identities=19% Similarity=0.169 Sum_probs=113.5
Q ss_pred hcCCCccceeccCCceeEEEEE--eCCCCEEEEEEeccccccC------------------Chh--hHHHHHHHHHHHhc
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAE--LPSGDIVAVKKFNSQLLSG------------------NMA--DQDEFLNVVLALNE 807 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~------------------~~~--~~~~~~~e~~~l~~ 807 (1078)
..-|++.+.||+|+||.||+|. ..+|+.||+|+++...... ... ....+..|+..+++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458888999999999999997 5689999999987543110 000 11235689999999
Q ss_pred CCCC--ceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCC
Q 039595 808 IRHR--NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS-IIHRDIS 884 (1078)
Q Consensus 808 l~h~--niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk 884 (1078)
+.+. .+.+++++ ...++||||++|+++..... ........++..++.|++.++++||+. + ++|||+|
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dik 176 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLS 176 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCC
Confidence 9753 34445543 23589999999988876542 223455667789999999999999999 9 9999999
Q ss_pred CCCeeeCCCCcEEEeccccccccc
Q 039595 885 SKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 885 ~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|+||+++ ++.++++|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.3e-16 Score=160.60 Aligned_cols=148 Identities=21% Similarity=0.173 Sum_probs=113.7
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCC------------------hhhHHHHHHHHHHHh
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN------------------MADQDEFLNVVLALN 806 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~~~~e~~~l~ 806 (1078)
++.+....|...+.||+|+||.||+|..++|+.||||+++....... ......+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444455888899999999999999888899999998764321000 001123667888888
Q ss_pred cCCCC--ceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 039595 807 EIRHR--NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 884 (1078)
Q Consensus 807 ~l~h~--niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 884 (1078)
++.|+ .+++.++. ...++||||++|++|.+.... .....++.+++.++.++|+. +++|||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 88777 44455442 345899999999998765420 34567889999999999998 99999999
Q ss_pred CCCeeeCCCCcEEEeccccccccc
Q 039595 885 SKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 885 ~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|+||+++.++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.6e-16 Score=161.81 Aligned_cols=138 Identities=17% Similarity=0.303 Sum_probs=114.2
Q ss_pred ceeccCCceeEEEEEeCCCCEEEEEEeccccccCC----hhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 757 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN----MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
+.||+|++|.||+|.. .|..|++|+......... ......+.+|+.++..+.|++|+....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999977 578899998654322111 11234577899999999999988877777777888999999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++|++|.+++... .. ++..++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998432 11 7888999999999999999 999999999999999 88999999999874
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.5e-16 Score=188.64 Aligned_cols=153 Identities=30% Similarity=0.521 Sum_probs=105.7
Q ss_pred CCCHHHHHHHHHHHHhcCCCCCCccccCCCCCCCCCCCCCCCC-----cccceEeeCCCCeEEEeccCccccCCcccCCc
Q 039595 23 SDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPC-----SWFGISCNHAGSRVISINLSTLCLNGTFQDFS 97 (1078)
Q Consensus 23 ~~~~~~~~all~~k~~~~~~~~~~~~l~sW~~~~~~~~~~~~c-----~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~ 97 (1078)
++.++|.+||++||+++..+. ..+|+. |+| .|.||+|+.....
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~-----~~~W~g--------~~C~p~~~~w~Gv~C~~~~~~------------------- 415 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPL-----RFGWNG--------DPCVPQQHPWSGADCQFDSTK------------------- 415 (623)
T ss_pred ccCchHHHHHHHHHHhcCCcc-----cCCCCC--------CCCCCcccccccceeeccCCC-------------------
Confidence 456789999999999996431 248972 344 7999999632110
Q ss_pred cCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccc
Q 039595 98 FSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177 (1078)
Q Consensus 98 ~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~ 177 (1078)
....++.|+|++|.+.|.+|..++.|++|++|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|+.++.|++|+
T Consensus 416 --~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~ 493 (623)
T PLN03150 416 --GKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493 (623)
T ss_pred --CceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCC
Confidence 001245566677777777777777888888888888888777777777777777777777777777777777777777
Q ss_pred eeecccccccCCccCcccCC-CCCcEEEccCCC
Q 039595 178 EFSFCHNNVSGRIPSSLGNL-SKLALLYLNNNS 209 (1078)
Q Consensus 178 ~L~l~~n~~~~~~p~~l~~l-~~L~~L~L~~n~ 209 (1078)
+|+|++|+++|.+|..++.+ .++..+++.+|.
T Consensus 494 ~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred EEECcCCcccccCChHHhhccccCceEEecCCc
Confidence 77777777777777666543 344555555554
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=159.01 Aligned_cols=135 Identities=17% Similarity=0.335 Sum_probs=107.7
Q ss_pred eeccCCceeEEEEEeCCCCEEEEEEeccccccCC----hhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeec
Q 039595 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN----MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 833 (1078)
.||+|+||.||+|.+ +|..|++|+......... ....+++.+|+.++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 578899998654321111 112356778999999999887665555555666779999999
Q ss_pred CCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 834 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+|++|.+++.... . .++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH---H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998873211 0 7899999999999999 999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-15 Score=179.15 Aligned_cols=142 Identities=18% Similarity=0.260 Sum_probs=113.7
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccC----ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG----NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
...|...+.||+|+||+||+|.+... .+++|+........ .....+.+.+|+.+++.++|++++..+.++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556788999999999999977544 34444432211111 11224568899999999999999988888777778
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999883 4567999999999999999 99999999999999 67899999999997
Q ss_pred cc
Q 039595 906 FV 907 (1078)
Q Consensus 906 ~~ 907 (1078)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-16 Score=189.57 Aligned_cols=262 Identities=22% Similarity=0.225 Sum_probs=195.8
Q ss_pred hcCCCccceeccCCceeEEEEEeC--CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP--SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 826 (1078)
...|...+.||+|+|+.|-.+... ....+|+|.+.... ......+....|..+-+.+. |+|++.+++.....+..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 356778888999999999888543 34456666665442 22223344556777777776 99999999999999999
Q ss_pred EEEEeecCCCCHHHHh-cCCCCCCcCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEecCCCCCCeeeCCCC-cEEEecccc
Q 039595 827 FLVCEYLHRGSLARIL-GNDATAKELSWNRRINVIKGVANALSYLH-HDCLPSIIHRDISSKNVLLDLEF-EAHVSDFGI 903 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~ 903 (1078)
++++||.+||++.+.+ .... ...+...+-.++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred ccccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchh
Confidence 9999999999998877 3221 13555667789999999999999 77 999999999999999999 999999999
Q ss_pred cccccC-CCCC--ceeecc-ccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 904 AKFVEP-YSSN--RTEFVG-TFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 904 a~~~~~-~~~~--~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
|..+.. .+.. ....+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+........+......
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~----- 246 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN----- 246 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc-----
Confidence 987755 2222 344578 9999999998884 55778999999999999999999988655433222211111
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
........+........++..+++..+|..|.+.+++..++|...
T Consensus 247 --~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 --KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred --ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 100000111112224567778889999999999999999999777
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=4e-14 Score=146.27 Aligned_cols=140 Identities=20% Similarity=0.194 Sum_probs=98.3
Q ss_pred cceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhH--------------------HHHHHHHHHHhcCCCC--ce
Q 039595 756 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQ--------------------DEFLNVVLALNEIRHR--NI 813 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------~~~~~e~~~l~~l~h~--ni 813 (1078)
.+.||+|+||+||+|...+|+.||||++............ .....|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998778999999998754221111000 0013455555555433 24
Q ss_pred eeEEeeeecCCeeEEEEeecCCCCHHH-HhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeC
Q 039595 814 VKFHGFCSNARHSFLVCEYLHRGSLAR-ILGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 814 v~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~ 891 (1078)
.+.+++ ...++||||++++.+.. .+.... .. .++..++.+++.++.++|. . +|+|||+||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444443 23589999999954321 111100 11 6678899999999999999 7 999999999999999
Q ss_pred CCCcEEEeccccccccc
Q 039595 892 LEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 892 ~~~~~kl~DfG~a~~~~ 908 (1078)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 9999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.2e-14 Score=140.56 Aligned_cols=135 Identities=19% Similarity=0.173 Sum_probs=113.2
Q ss_pred ccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC--CceeeEEeeeecCCeeEEEEee
Q 039595 755 EKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH--RNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 755 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
..+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| ..++++++++..++..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 35679999999999998754 7899999755421 4568889999999976 5899999999888899999999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++++.+..+ +......++.+++++++++|....++++|||++|+||+++..+.+++.|||.++.
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998766533 4566778899999999999986444799999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-13 Score=146.34 Aligned_cols=139 Identities=15% Similarity=0.229 Sum_probs=106.5
Q ss_pred cceec-cCCceeEEEEEeCCCCEEEEEEeccccc-----c----CChhhHHHHHHHHHHHhcCCCCce--eeEEeeeecC
Q 039595 756 KFCIG-KGGQGSVYKAELPSGDIVAVKKFNSQLL-----S----GNMADQDEFLNVVLALNEIRHRNI--VKFHGFCSNA 823 (1078)
Q Consensus 756 ~~~lG-~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~----~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 823 (1078)
...|| .|+.|+||.+... +..+|||.+..... . ........+.+|+.++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999775 77899998854211 1 012234567889999999998875 6777764332
Q ss_pred -C---eeEEEEeecCC-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 824 -R---HSFLVCEYLHR-GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 824 -~---~~~lv~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
. ..++||||++| .+|.+++.. ..++.. .+.+|+.++.+||+. ||+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 699988843 234433 357899999999999 9999999999999999999999
Q ss_pred eccccccc
Q 039595 899 SDFGIAKF 906 (1078)
Q Consensus 899 ~DfG~a~~ 906 (1078)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999875
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1e-13 Score=168.15 Aligned_cols=114 Identities=32% Similarity=0.519 Sum_probs=66.3
Q ss_pred cccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEccc
Q 039595 560 LYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICY 639 (1078)
Q Consensus 560 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~ 639 (1078)
++.|+|++|.+.+.+|..+..+++|+.|+|++|.|++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 45555555555555555555555566666666655555555555555666666666666655565566666666666666
Q ss_pred CcCCCCCCCCcc-----ccCccccCCCCcCCCcccccccc
Q 039595 640 NELQGPIPNSTV-----FKDGLMEGNKGLCGNFEAFSSCD 674 (1078)
Q Consensus 640 N~l~~~~~~~~~-----~~~~~~~~n~~lc~~~~~~~~~~ 674 (1078)
|.++|.+|..-. .....+.+|+++||.|. ...|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~-l~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG-LRACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCC-CCCCc
Confidence 666655554211 11234678888888653 35675
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.8e-15 Score=161.42 Aligned_cols=163 Identities=36% Similarity=0.519 Sum_probs=93.4
Q ss_pred CCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCccccc
Q 039595 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGN 556 (1078)
Q Consensus 477 ~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 556 (1078)
.+|..+..+..|+.+.|.+|.|. .+|..+.++..|+.|+|+.|+++ .+|..++.++ |+.|-+++|+++ .+|..++.
T Consensus 89 elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~ 164 (722)
T KOG0532|consen 89 ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGL 164 (722)
T ss_pred cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCccccc
Confidence 34445555555555566666655 45555556666666666666665 4555555554 556666666665 45555555
Q ss_pred ccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEE
Q 039595 557 LLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCID 636 (1078)
Q Consensus 557 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~ 636 (1078)
+..|..||.+.|.|. ..|..++++.+|+.|.+..|++.. +|.+++.++ |..||+|+|+++ .+|-.|.+|+.|++|-
T Consensus 165 ~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~ 240 (722)
T KOG0532|consen 165 LPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQ 240 (722)
T ss_pred chhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeee
Confidence 556666666666664 455555666666666666666653 444444443 556666666665 4566666666666666
Q ss_pred cccCcCCCCCC
Q 039595 637 ICYNELQGPIP 647 (1078)
Q Consensus 637 l~~N~l~~~~~ 647 (1078)
|.+|||+.+..
T Consensus 241 LenNPLqSPPA 251 (722)
T KOG0532|consen 241 LENNPLQSPPA 251 (722)
T ss_pred eccCCCCCChH
Confidence 66666665443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.5e-13 Score=140.53 Aligned_cols=208 Identities=22% Similarity=0.306 Sum_probs=143.9
Q ss_pred HHHHHhcCCCCceeeEEeeeec-----CCeeEEEEeecCCCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHHhcC
Q 039595 801 VVLALNEIRHRNIVKFHGFCSN-----ARHSFLVCEYLHRGSLARILGNDAT-AKELSWNRRINVIKGVANALSYLHHDC 874 (1078)
Q Consensus 801 e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~ 874 (1078)
...-+-++.|.|||+++.|+.+ .....+++|||..|++..+|++.+. ...+..+...+|+-||..||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 3445566789999999999854 3467899999999999999976433 44577788889999999999999995
Q ss_pred CCCcEecCCCCCCeeeCCCCcEEEecccccccccCC-----CCCceeeccccccccccccccCCCCccchhHHHHHHHHH
Q 039595 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY-----SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFE 949 (1078)
Q Consensus 875 ~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~e 949 (1078)
.|.|+|+++.-+-|++..+|-+|++--.-.. .... ........+-++|.|||+-..-..+.++|||+||+...|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 6789999999999999999989885321111 1100 001122345689999998776677889999999999999
Q ss_pred HHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 950 VIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 950 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
|..|..--..... ...........++.-. +. .-.+++.+|+...|..||+|++++.|+-..
T Consensus 275 mailEiq~tnseS---~~~~ee~ia~~i~~le------n~-----lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 275 MAILEIQSTNSES---KVEVEENIANVIIGLE------NG-----LQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred HHHheeccCCCcc---eeehhhhhhhheeecc------Cc-----cccCcCcccccCCCCCCcchhhhhcCceee
Confidence 9987654111000 0000000000011000 00 112456779999999999999999997533
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.1e-13 Score=157.19 Aligned_cols=199 Identities=37% Similarity=0.546 Sum_probs=118.3
Q ss_pred eeccCCCccCCCCCccccCccceeEEEccCccCCCCCCccccccc-ccceeecccccccCCccCcccCCCCCcEEEccCC
Q 039595 130 NLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLS-LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN 208 (1078)
Q Consensus 130 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~-~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 208 (1078)
.|+++.|.+.. .+..+..++.++.|++..|.++ .+|+.++.++ +|++|++++|.+. .+|..++++++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 45566555532 2234455566666666666666 5666666663 6666666666665 44555666666666666666
Q ss_pred CCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCcccc
Q 039595 209 SLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPL 288 (1078)
Q Consensus 209 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 288 (1078)
+++ .+|...+.+++|+.|++++|+++. +|.....+..|++|.+++|++. .++..+.++.++..|.+.+|++.. .+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 665 344444456666666666666663 3444444455666666666433 344556666666666666666652 255
Q ss_pred ccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCC
Q 039595 289 SFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPS 337 (1078)
Q Consensus 289 ~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 337 (1078)
.++.+++++.|++++|.++.. +. ++.+.+++.|++++|.+....|..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhh
Confidence 566666666666666666633 22 666777777777777776554443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.2e-11 Score=143.41 Aligned_cols=144 Identities=19% Similarity=0.226 Sum_probs=98.9
Q ss_pred ceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhh------------------------------------HHHHHH
Q 039595 757 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMAD------------------------------------QDEFLN 800 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~------------------------------------~~~~~~ 800 (1078)
+.||.|++|.||+|+.++|+.||||+.+......-..+ .-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865321100000 002445
Q ss_pred HHHHHhcCC-----CCceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHH-HHHHHHhcC
Q 039595 801 VVLALNEIR-----HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN-ALSYLHHDC 874 (1078)
Q Consensus 801 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~ 874 (1078)
|...+.+++ +++|.-..-+.......++||||++|++|.++...... .. ...+++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 555555542 33332222222334457999999999999887632111 11 23456666666 46788988
Q ss_pred CCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 875 ~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|++|+|++|.||+++.+++++++|||++..+.
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.7e-14 Score=157.64 Aligned_cols=174 Identities=30% Similarity=0.483 Sum_probs=105.4
Q ss_pred CCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEE
Q 039595 125 LSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLY 204 (1078)
Q Consensus 125 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 204 (1078)
|+--...||+.|++. ++|.++..+..|+.|.|.+|.+. .||..+++|..|..|+|+.|+++ .+|..++.|+ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 333445555556555 45555555556666666666555 55666666666666666666555 4556665554 66677
Q ss_pred ccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccC
Q 039595 205 LNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSG 284 (1078)
Q Consensus 205 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 284 (1078)
+++|+++ .+|+.++.+..|..||.+.|++.. +|..++++.+|+.|.+..|++. .+|..+..| .|..||+|.|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-
Confidence 7777765 566666666677777777777663 4556677777777777777776 455555544 4667777777766
Q ss_pred ccccccccccCCceeeecccCCC
Q 039595 285 SIPLSFGNLSSWTLMSLFSNSLS 307 (1078)
Q Consensus 285 ~~p~~~~~l~~L~~L~l~~n~l~ 307 (1078)
.+|..|.++..|++|.|.+|.|.
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCC
Confidence 45555555555555555555444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.8e-13 Score=153.42 Aligned_cols=201 Identities=35% Similarity=0.506 Sum_probs=145.4
Q ss_pred eEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCC-CCcEEEccCCCCCCCCCCcccccCCCCeeecCC
Q 039595 153 RRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLS-KLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQ 231 (1078)
Q Consensus 153 ~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 231 (1078)
..|+++.|.+. ..+..+..++.++.|++.+|.++ .+|...+.++ +|+.|++++|++. .+|..++.+++|+.|++++
T Consensus 96 ~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 46777777765 23444556677888888888887 6677777774 8888888888876 5556677888888888888
Q ss_pred cccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCC
Q 039595 232 NQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIP 311 (1078)
Q Consensus 232 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p 311 (1078)
|+++.. |...+.+++|+.|++++|+++ .+|.....+..|+.|.+++|.+. ..+..+.++.++..+.+.+|++. .++
T Consensus 173 N~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 173 NDLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred chhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 888854 444447788888888888888 56665555666888888888533 35666777778888888888776 336
Q ss_pred ccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccc
Q 039595 312 PILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362 (1078)
Q Consensus 312 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 362 (1078)
..++.++++++|++++|+++...+ ++.+.+++.|++++|.+....|...
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred chhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 677778888888888888875433 7778888888888888876555443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.4e-11 Score=139.87 Aligned_cols=148 Identities=18% Similarity=0.208 Sum_probs=94.6
Q ss_pred hcCCCccceeccCCceeEEEEEeCC-CCEEEEEEeccccccC-------------------------Ch-----hhHH--
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSG-------------------------NM-----ADQD-- 796 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-------------------------~~-----~~~~-- 796 (1078)
..+|+. +.||+|++|.||+|+.++ |+.||||+.++..... +. +-.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 789999999999998876 9999999997542100 00 0011
Q ss_pred ----HHHHHHHHHhcCC----CCceeeEEeeee-cCCeeEEEEeecCCCCHHHHh--cCCC-CCCcCCHHHHHHHHHHHH
Q 039595 797 ----EFLNVVLALNEIR----HRNIVKFHGFCS-NARHSFLVCEYLHRGSLARIL--GNDA-TAKELSWNRRINVIKGVA 864 (1078)
Q Consensus 797 ----~~~~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~E~~~~g~L~~~l--~~~~-~~~~l~~~~~~~i~~~i~ 864 (1078)
.|.+|...+.+++ +...+.+-.++. -....++||||++|+.+.++- .... ....+....+..++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1334444443332 333333323222 234568999999999997742 1111 111233333444444544
Q ss_pred HHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeccccccccc
Q 039595 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEF----EAHVSDFGIAKFVE 908 (1078)
Q Consensus 865 ~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG~a~~~~ 908 (1078)
.. |++|+|+||.||+++.+| ++++.|||++..++
T Consensus 278 -------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 35 999999999999999988 99999999998664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.9e-12 Score=142.32 Aligned_cols=253 Identities=24% Similarity=0.253 Sum_probs=182.1
Q ss_pred CCCccceecc--CCceeEEEEEe---CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCe
Q 039595 752 DFDEKFCIGK--GGQGSVYKAEL---PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 752 ~~~~~~~lG~--G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 825 (1078)
.|...+.+|. |.+|.||.+.. .++..+|+|+-+.... .......=.+|+.....+ .|++.++.+..++..+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s--~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS--PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCC--CccccccccchhhcccccCccccccccCcccccCCc
Confidence 3555677899 99999999954 4688899998544322 112222234566666666 49999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEec
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN----ALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSD 900 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~D 900 (1078)
.++-+|++. .++.++.+.. ...++....+.+..+..+ |+.++|+. +++|-|+||.||+...+ ...+++|
T Consensus 193 lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 999999986 5888877432 233667788888888888 99999999 99999999999999999 8899999
Q ss_pred ccccccccCCCCCce-----eeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCc-ccccccchhhhhhhh
Q 039595 901 FGIAKFVEPYSSNRT-----EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF-FSINFSSFSNMIIEV 974 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~-~~~~~~~~~~~~~~~ 974 (1078)
||....+.+..-... ...|...|++||...+ .++.++|+|++|.+..+-.++..+... +...+....+.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~---- 341 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG---- 341 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc----
Confidence 999988765442222 2267889999998665 688999999999999999887655211 11111111111
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+..++... -..++...+..|++.+|..|++.+.+.++.+.-.
T Consensus 342 --~ip~e~~~~------~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 342 --YIPLEFCEG------GSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred --cCchhhhcC------cchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 011111111 1123444778899999999999999999987653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.7e-12 Score=130.94 Aligned_cols=134 Identities=33% Similarity=0.362 Sum_probs=85.7
Q ss_pred cccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCccccccccc
Q 039595 481 EIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKL 560 (1078)
Q Consensus 481 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 560 (1078)
.+.....|+++|||+|.|+ .+..+..-++.++.|++|+|.|... +.+..+++|+.||||+|.++ .+..+-.++.+.
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3444566778888888877 5556666667777777777777632 22667777777777777776 344455566677
Q ss_pred ccccccCcccccccchhhhcccccCeeecCCCccCCcC-CCCcccccccceeeccCccccC
Q 039595 561 YYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEI-PPQVCNMESLEKLNLSHNNLSG 620 (1078)
Q Consensus 561 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~ 620 (1078)
+.|+|++|.|. .-..+.+|.+|..||+++|+|.... ...++++|-|++|.|.+|+|++
T Consensus 355 KtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 355 KTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 77777777774 2334566666777777777765321 2345556666666666666553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-10 Score=133.22 Aligned_cols=169 Identities=18% Similarity=0.271 Sum_probs=127.8
Q ss_pred EeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCc
Q 039595 771 ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKE 850 (1078)
Q Consensus 771 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~ 850 (1078)
...++.+|.|...+.... ...+...+-+..++.++||+|+++++.++.++..|+|+|-+. .|..++++
T Consensus 33 ~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------ 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------ 100 (690)
T ss_pred eeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------
Confidence 445688888888765421 234456777888999999999999999999999999999874 46666632
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceeeccccccccccccc
Q 039595 851 LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY 930 (1078)
Q Consensus 851 l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 930 (1078)
+........+.||+.||.|||+.+ +++|++|....|+|+..|+.||++|-++..............---.|..|+.+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID 178 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence 335677778999999999999765 999999999999999999999999988875543332112222223466666544
Q ss_pred cCCCCccchhHHHHHHHHHHHhCCC
Q 039595 931 TMRATEKYDVYSFGVLVFEVIKGNH 955 (1078)
Q Consensus 931 ~~~~~~~sDvwSlG~il~elltG~~ 955 (1078)
... -..|.|-|||++||++.|..
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCccc
Confidence 332 34699999999999999933
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.2e-12 Score=148.50 Aligned_cols=264 Identities=23% Similarity=0.215 Sum_probs=181.8
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..+.+.+.+-+-+|.++.++.++- ..|...++|+........ ..+.+....+-.+.-..++|.++.....+......+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-TNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhc-cccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 456777788899999999998843 346556666543322111 111222233333333345677776666666677889
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+|++|..+++|...++.. +..+.+-+......+.++.+|||.. .+.|||++|.|.+...+|..+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999988543 3455566677788889999999998 7999999999999999999999999844321
Q ss_pred cC------C---------------------C----CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 039595 908 EP------Y---------------------S----SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956 (1078)
Q Consensus 908 ~~------~---------------------~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 956 (1078)
.. . . .......||+.|.|||...+......+|.|+.|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 00 0 0 011235689999999999999999999999999999999999999
Q ss_pred CCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChh---HHHHHhhhhhhHH
Q 039595 957 RDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME---KGFGHHIGYCDEI 1028 (1078)
Q Consensus 957 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~---ell~h~~~~~~~~ 1028 (1078)
|...... ... ..+...... .............+++.+.+..+|.+|-.+. ++-.|+|+....-
T Consensus 1035 ~na~tpq--~~f------~ni~~~~~~-~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1035 FNAETPQ--QIF------ENILNRDIP-WPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred CCCcchh--hhh------hccccCCCC-CCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 7533221 111 111111111 1111122234567778888999999999988 8888888765433
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.1e-11 Score=121.24 Aligned_cols=126 Identities=29% Similarity=0.333 Sum_probs=47.1
Q ss_pred ccCccCcEEeccCCccCCCcccccc-cccccceeeccCccccCCCCcccccccccccccccCcccccccchhh-hccccc
Q 039595 507 EKLFSLNKLILSLNQLSGSVPLEFG-SLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEF-EKLIHL 584 (1078)
Q Consensus 507 ~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L 584 (1078)
.+...+++|+|++|+|+.+ ..++ .+.+|+.|||++|.|+.. +.+..+++|++|++++|+|+.. ...+ ..+++|
T Consensus 16 ~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred ccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcC
Confidence 3444667777777777633 2344 467788888888888743 2577788888888888888753 3334 467888
Q ss_pred CeeecCCCccCCcCC-CCcccccccceeeccCccccCCc---ccccccCCcCcEEEc
Q 039595 585 SKLDLSHNILQEEIP-PQVCNMESLEKLNLSHNNLSGFI---PRCFEKMRSLSCIDI 637 (1078)
Q Consensus 585 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~l~~L~~l~l 637 (1078)
++|+|++|+|..... ..+..+++|+.|+|.+|+++... ...+..+|+|+.||-
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 888888888875322 34567888888888888887441 223567888888775
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7e-12 Score=145.94 Aligned_cols=246 Identities=28% Similarity=0.306 Sum_probs=119.7
Q ss_pred CCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEE
Q 039595 124 NLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALL 203 (1078)
Q Consensus 124 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 203 (1078)
.+..++.+++..|.+.. +-..+..+++|+.|++.+|++. .+...+..+.+|++|++++|.|+.. ..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence 44555555566665552 3334555666666666666655 2322234444444444444444432 233444445555
Q ss_pred EccCCCCCCCCCCcccccCCCCeeecCCcccCCCCC-CcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccc
Q 039595 204 YLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIP-CTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282 (1078)
Q Consensus 204 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 282 (1078)
++++|.++.. ..+..+++|+.+++++|+++...+ . ...+.+|+.+++.+|.+.. ...+..+..+..+++..|.+
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccc
Confidence 5555555422 233344555555555555543322 1 2444444444555444441 12222333333334444444
Q ss_pred cCccccccccccCCceeeecccCCCCCCCccccCCC--ccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCc
Q 039595 283 SGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLK--SLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPE 360 (1078)
Q Consensus 283 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 360 (1078)
+-..+ +..+. +|+.+++++|.+.. .+..+..+.++..|++.+|++... .
T Consensus 221 ~~~~~--------------------------l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~ 271 (414)
T KOG0531|consen 221 SKLEG--------------------------LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--E 271 (414)
T ss_pred eeccC--------------------------cccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--c
Confidence 32111 11111 36666666666652 224556666777777777776532 2
Q ss_pred cccccCCCCeEEcccccCccc---cCCC-CccCCCCceeecccCcCCCCCC
Q 039595 361 EIGYLKSLSELKLCKNNLSGV---IPHS-VGNLTGLVLLNMCENHLFGPIP 407 (1078)
Q Consensus 361 ~~~~l~~L~~L~L~~N~l~~~---~p~~-~~~l~~L~~L~L~~N~l~~~~~ 407 (1078)
.+.....+..+.+..|.+... .... ......++...+..|.+....+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 272 GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 344455566666666665421 1111 4456667777777777665444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.8e-10 Score=116.95 Aligned_cols=131 Identities=18% Similarity=0.093 Sum_probs=95.0
Q ss_pred cceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCce-eeEEeeeecCCeeEEEEeecC
Q 039595 756 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI-VKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~ 834 (1078)
++.++.|.++.||+++.. ++.|++|+...... ....+..|+.+++.+.+.++ .+++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 356899999999999865 78899998754321 12245678888888765444 45555433 34579999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC--LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|.++.+.- .....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCcccccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98775320 111345678999999999982 11259999999999999 67899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-11 Score=132.58 Aligned_cols=141 Identities=29% Similarity=0.252 Sum_probs=63.6
Q ss_pred CCcccEEeccCCccCCCcc-cccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCC--cccccccccc
Q 039595 485 SSKLQFLDLSSNHIVGKIP-VQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIP--KSIGNLLKLY 561 (1078)
Q Consensus 485 l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~ 561 (1078)
++.|+.|.|+.|.++...- .....+++|+.|+|..|....+-.....-+..|+.|||++|.+.+ .+ ...+.++.|+
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchh
Confidence 3455555555555542211 112334455555555553222223333344445555555554442 11 2233444445
Q ss_pred cccccCcccccc-cchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCC-cccccccCCcCcEEEccc
Q 039595 562 YLNLSNNQFSHT-IPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGF-IPRCFEKMRSLSCIDICY 639 (1078)
Q Consensus 562 ~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~l~l~~ 639 (1078)
.|+++.+.|..+ .|+. ........+++|++|++++|++... --+.+..+++|+.+.+..
T Consensus 275 ~Lnls~tgi~si~~~d~-------------------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~ 335 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDV-------------------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITL 335 (505)
T ss_pred hhhccccCcchhcCCCc-------------------cchhhhcccccceeeecccCccccccccchhhccchhhhhhccc
Confidence 555554444321 1111 0000013455666666666666422 123344556667777777
Q ss_pred CcCCCC
Q 039595 640 NELQGP 645 (1078)
Q Consensus 640 N~l~~~ 645 (1078)
|+++.+
T Consensus 336 n~ln~e 341 (505)
T KOG3207|consen 336 NYLNKE 341 (505)
T ss_pred cccccc
Confidence 777654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-11 Score=144.01 Aligned_cols=224 Identities=29% Similarity=0.290 Sum_probs=141.9
Q ss_pred ccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccc
Q 039595 194 LGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLH 273 (1078)
Q Consensus 194 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 273 (1078)
++.+++|+.|++.+|+|... ...+..+++|++|+|++|.|+.+. .+..++.|+.|++++|.|+.. ..+..++.|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhh
Confidence 44555555566666655532 222455666666666666666542 355555566666666666522 2344466666
Q ss_pred eeecccccccCccc-cccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCc--CcEEEcc
Q 039595 274 QLDLIENQLSGSIP-LSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSS--LRNLSLF 350 (1078)
Q Consensus 274 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls 350 (1078)
.+++++|++...-+ . ...+.+++.+.+.+|.+.. ...+..+..+..+++..|.++..-+ +..+.. |+.++++
T Consensus 166 ~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~ 240 (414)
T KOG0531|consen 166 LLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLS 240 (414)
T ss_pred cccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcc
Confidence 66666666664433 2 3555666666666666642 2344555566666888888874422 333333 8999999
Q ss_pred CccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCC---CCcc-ccccCCCCeEEccCccc
Q 039595 351 NNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGP---IPKS-LKSLTSLKRVRFNQNNL 426 (1078)
Q Consensus 351 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~~~~-l~~l~~L~~L~L~~N~l 426 (1078)
+|.+. ..+..+..+..+..|++..|++... ..+.....+..+....|.+... .... ......+..+.+..|.+
T Consensus 241 ~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (414)
T KOG0531|consen 241 GNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPI 317 (414)
T ss_pred cCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcc
Confidence 99998 4556788889999999999999754 3356677788888888887632 2222 45667788888888887
Q ss_pred cccc
Q 039595 427 VGKV 430 (1078)
Q Consensus 427 ~~~~ 430 (1078)
....
T Consensus 318 ~~~~ 321 (414)
T KOG0531|consen 318 RKIS 321 (414)
T ss_pred cccc
Confidence 6644
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9e-12 Score=130.87 Aligned_cols=245 Identities=22% Similarity=0.266 Sum_probs=115.4
Q ss_pred ccccCCCCeEEcccccCcccc----CCCCccCCCCceeecccCc---CCCCCCccccccCCCCeEEccCccccccchhhc
Q 039595 362 IGYLKSLSELKLCKNNLSGVI----PHSVGNLTGLVLLNMCENH---LFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAF 434 (1078)
Q Consensus 362 ~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~---l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 434 (1078)
+..+.+++.++|++|-+...- ...+.+.+.|+..++++-- +...+|..+.. ...++
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~-----------------l~~aL 88 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKM-----------------LSKAL 88 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHH-----------------HHHHH
Confidence 444566777777777765322 2223344455555544321 11122222211 12344
Q ss_pred cCCCCCcEecCCCCccCCccCcc----ccCCCCCceecccccccCCCCCc-------------cccCCCcccEEeccCCc
Q 039595 435 GDHPNLTFLDLSQNNFDGKISFN----WRNLPKLDTFIVSMNNIFGSIPL-------------EIGDSSKLQFLDLSSNH 497 (1078)
Q Consensus 435 ~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~l~~N~i~~~~~~-------------~~~~l~~L~~L~Ls~N~ 497 (1078)
...|+|++||||+|-|....... ++....|++|+|.+|.+...--. ..+.-++|++++..+|+
T Consensus 89 ~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNr 168 (382)
T KOG1909|consen 89 LGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNR 168 (382)
T ss_pred hcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccc
Confidence 55567777777777765332222 22344555555555554321111 11223344555555554
Q ss_pred cCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCC----CcccccccccccccccCcccccc
Q 039595 498 IVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSI----PKSIGNLLKLYYLNLSNNQFSHT 573 (1078)
Q Consensus 498 i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~ 573 (1078)
+...... .+...|...+.|+.+.++.|.|.... ...|..+++|+.|||.+|-++..
T Consensus 169 len~ga~--------------------~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~e 228 (382)
T KOG1909|consen 169 LENGGAT--------------------ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLE 228 (382)
T ss_pred cccccHH--------------------HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhH
Confidence 4322111 11223344445555555555543211 12344455555555555555432
Q ss_pred ----cchhhhcccccCeeecCCCccCCcCCCCc-----ccccccceeeccCccccCC----cccccccCCcCcEEEcccC
Q 039595 574 ----IPIEFEKLIHLSKLDLSHNILQEEIPPQV-----CNMESLEKLNLSHNNLSGF----IPRCFEKMRSLSCIDICYN 640 (1078)
Q Consensus 574 ----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~l~l~~N 640 (1078)
+...++.+++|+.|+++++.+...-..+| ...++|++|.|.+|.++.. +-..+...|.|..|+|++|
T Consensus 229 gs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN 308 (382)
T KOG1909|consen 229 GSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGN 308 (382)
T ss_pred HHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcc
Confidence 22334445555555555555544322221 1245666677777766522 2333445677777777777
Q ss_pred cCC
Q 039595 641 ELQ 643 (1078)
Q Consensus 641 ~l~ 643 (1078)
++.
T Consensus 309 ~l~ 311 (382)
T KOG1909|consen 309 RLG 311 (382)
T ss_pred ccc
Confidence 774
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.7e-11 Score=134.95 Aligned_cols=247 Identities=20% Similarity=0.200 Sum_probs=173.1
Q ss_pred hcCCCccceeccCCceeEEEEEe--CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL--PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
..+|..+..||.|.|+.|+.... .++..|++|........ ..+...-..|+.+...+ .|.+++..+..+...+..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~--~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT--FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc--hHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 45788899999999999999853 36789999987654321 11111223455555555 588888888888777888
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEecccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAK 905 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~a~ 905 (1078)
|+=.||+++++..... .....+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 8999999999887665 2334577788999999999999999998 99999999999999886 788999999987
Q ss_pred cccCCCCCceeeccccccc--cccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYA--APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
.+.. ........-+++ +|+......+-.++|++|||.-++|..+|.+--...... ..+......
T Consensus 416 ~~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----------~~i~~~~~p 481 (524)
T KOG0601|consen 416 RLAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----------LTIRSGDTP 481 (524)
T ss_pred ccce---ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----------eeeeccccc
Confidence 4321 111222233444 555556677889999999999999999987541100000 001111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
..+ .....+..+.+.+..+++..||.+.+...|.-
T Consensus 482 -~~~---~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 482 -NLP---GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -CCC---chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111 11235666777799999999999988777654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.9e-11 Score=131.72 Aligned_cols=163 Identities=27% Similarity=0.236 Sum_probs=108.2
Q ss_pred cCCCcccEEeccCCccCCCcc--cccccCccCcEEeccCCccCCCccc-ccccccccceeeccCccccCC-CCccccccc
Q 039595 483 GDSSKLQFLDLSSNHIVGKIP--VQLEKLFSLNKLILSLNQLSGSVPL-EFGSLTELQYLDLSANKLSSS-IPKSIGNLL 558 (1078)
Q Consensus 483 ~~l~~L~~L~Ls~N~i~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~ 558 (1078)
..+++++.||||+|-+....+ .-...+++|+.|+|+.|++...... .-..+++|+.|.|+.|.|+.. +......++
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fP 222 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFP 222 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCC
Confidence 345566666666665553322 2234566666666666666522111 112567788888888888742 222344568
Q ss_pred ccccccccCcccccccchhhhcccccCeeecCCCccCCcCC-CCcccccccceeeccCccccCC-cccc-----cccCCc
Q 039595 559 KLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIP-PQVCNMESLEKLNLSHNNLSGF-IPRC-----FEKMRS 631 (1078)
Q Consensus 559 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~~~~-----l~~l~~ 631 (1078)
+|+.|+|..|...........-+..|++|||++|++-+... ...+.++.|..|+++.+.++.+ .|+. ...+++
T Consensus 223 sl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~k 302 (505)
T KOG3207|consen 223 SLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPK 302 (505)
T ss_pred cHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccccc
Confidence 88999998885334555556677889999999998875331 3567889999999999988755 3433 457899
Q ss_pred CcEEEcccCcCCCC
Q 039595 632 LSCIDICYNELQGP 645 (1078)
Q Consensus 632 L~~l~l~~N~l~~~ 645 (1078)
|+.|+++.|++..+
T Consensus 303 L~~L~i~~N~I~~w 316 (505)
T KOG3207|consen 303 LEYLNISENNIRDW 316 (505)
T ss_pred ceeeecccCccccc
Confidence 99999999999753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-09 Score=110.23 Aligned_cols=140 Identities=17% Similarity=0.192 Sum_probs=99.6
Q ss_pred ceeccCCceeEEEEEeCC-------CCEEEEEEeccccc---------cCC---------hhhHHHH----HHHHHHHhc
Q 039595 757 FCIGKGGQGSVYKAELPS-------GDIVAVKKFNSQLL---------SGN---------MADQDEF----LNVVLALNE 807 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~---------~~~---------~~~~~~~----~~e~~~l~~ 807 (1078)
..||.|--+.||.|...+ +..+|||+.+.... .++ ....+.+ .+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996442 47899998853111 001 0112233 378888888
Q ss_pred CCC--CceeeEEeeeecCCeeEEEEeecCCCCHHH-HhcCCCCCCcCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEecCC
Q 039595 808 IRH--RNIVKFHGFCSNARHSFLVCEYLHRGSLAR-ILGNDATAKELSWNRRINVIKGVANALSYL-HHDCLPSIIHRDI 883 (1078)
Q Consensus 808 l~h--~niv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dl 883 (1078)
+.. -++.+.+++ ...++||||+.++.+.. .++ ...++.++...+..+++.++.++ |+. ++||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 456666764 45689999997754422 221 12345566778889999999999 788 9999999
Q ss_pred CCCCeeeCCCCcEEEeccccccccc
Q 039595 884 SSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 884 k~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
++.||+++ ++.+.++|||.+...+
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999996 5789999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-10 Score=144.32 Aligned_cols=131 Identities=29% Similarity=0.366 Sum_probs=95.0
Q ss_pred CCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCc--cCCCCCccccCccceeEEEccCccCCCCCCcccccccccc
Q 039595 100 SFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQ--LSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177 (1078)
Q Consensus 100 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~ 177 (1078)
+....+...+-+|.+. .++.... .++|++|-+..|. +....+..|..++.|++|||++|.--+++|.+|++|-+|+
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred chhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 3355667777777664 2332222 2368888888875 4422233467788888888888877778888888888888
Q ss_pred eeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcc
Q 039595 178 EFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQ 233 (1078)
Q Consensus 178 ~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 233 (1078)
.|+|+++.++ .+|.++++|++|.+|++..+.-...+|.....|++|++|.+..-.
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 8888888887 788888888888888888887666667777778888888877654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=7.1e-11 Score=117.45 Aligned_cols=125 Identities=33% Similarity=0.312 Sum_probs=44.3
Q ss_pred CCCcccEEeccCCccCCCcccccc-cCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCccc-ccccccc
Q 039595 484 DSSKLQFLDLSSNHIVGKIPVQLE-KLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI-GNLLKLY 561 (1078)
Q Consensus 484 ~l~~L~~L~Ls~N~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~ 561 (1078)
+..++++|+|++|+|+.+ . .+. .+.+|+.|+|++|+|+.. ..+..+++|+.|++++|+|+.. ...+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~I-e-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI-E-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred cccccccccccccccccc-c-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCC
Confidence 344577777777777732 2 343 466777778888877743 2466677888888888888743 3333 3577788
Q ss_pred cccccCcccccc-cchhhhcccccCeeecCCCccCCcCC---CCcccccccceeec
Q 039595 562 YLNLSNNQFSHT-IPIEFEKLIHLSKLDLSHNILQEEIP---PQVCNMESLEKLNL 613 (1078)
Q Consensus 562 ~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L 613 (1078)
+|+|++|+|... .-..+..+++|+.|+|.+|.++.... ..+..+|+|+.||-
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 888888888642 22456677888888888888864311 12456788887775
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.9e-11 Score=122.58 Aligned_cols=129 Identities=24% Similarity=0.266 Sum_probs=59.8
Q ss_pred CCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcc
Q 039595 295 SWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLC 374 (1078)
Q Consensus 295 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (1078)
.|+.+||++|.++ .+..+..-++.++.|++++|.+..+ +.+..+++|+.||||+|.++ .+..+-..+.+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 3444444444443 3333344444455555555554422 22444455555555555544 333333444444555555
Q ss_pred cccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccc-hhhccCCCCCcEecCCCCccCCc
Q 039595 375 KNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKV-YEAFGDHPNLTFLDLSQNNFDGK 453 (1078)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~ 453 (1078)
.|.|... ..+ ..+.+|..|++.+|+|..+. ...++.+|-|+.|.|.+|++...
T Consensus 361 ~N~iE~L--SGL------------------------~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 361 QNKIETL--SGL------------------------RKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhHhhh--hhh------------------------HhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 5544321 223 33444445555555554432 23455566666666666666543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.5e-11 Score=129.20 Aligned_cols=201 Identities=21% Similarity=0.208 Sum_probs=95.4
Q ss_pred cccCCCccCeeeccccccCcc----CCCCCCCCCcCcEEEccCc---cCCCCCCccccccCCCCeEEcccccCccccCCC
Q 039595 313 ILGNLKSLSTLGLYLNQLNGV----IPPSIGNLSSLRNLSLFNN---GLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHS 385 (1078)
Q Consensus 313 ~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N---~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 385 (1078)
.+-.+.+++.++|++|.+... +...+.+.++|+..++|+- ++...+|+.+..+ -.+
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l-----------------~~a 87 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKML-----------------SKA 87 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHH-----------------HHH
Confidence 344556666667777666432 2233445556666666542 1222333322110 011
Q ss_pred CccCCCCceeecccCcCCCCCCc----cccccCCCCeEEccCccccccchhh-------------ccCCCCCcEecCCCC
Q 039595 386 VGNLTGLVLLNMCENHLFGPIPK----SLKSLTSLKRVRFNQNNLVGKVYEA-------------FGDHPNLTFLDLSQN 448 (1078)
Q Consensus 386 ~~~l~~L~~L~L~~N~l~~~~~~----~l~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~Ls~N 448 (1078)
+...++|++|+||+|.+....+. .+.++++|++|.|.+|.+....... .+.-++|+++...+|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 22334555555555555433332 2344566677777776665433222 223355666666666
Q ss_pred ccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCC----cccccccCccCcEEeccCCccCC
Q 039595 449 NFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGK----IPVQLEKLFSLNKLILSLNQLSG 524 (1078)
Q Consensus 449 ~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~ 524 (1078)
++..-... .+...|...+.|+.+.++.|.|... ....|..+++|+.|||..|-++.
T Consensus 168 rlen~ga~--------------------~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~ 227 (382)
T KOG1909|consen 168 RLENGGAT--------------------ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTL 227 (382)
T ss_pred ccccccHH--------------------HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhh
Confidence 66533221 1122344445666666666666421 22334445555555555555442
Q ss_pred ----CcccccccccccceeeccCccccCCC
Q 039595 525 ----SVPLEFGSLTELQYLDLSANKLSSSI 550 (1078)
Q Consensus 525 ----~~~~~~~~l~~L~~L~Ls~N~l~~~~ 550 (1078)
.+...+..+++|+.|++++|.++...
T Consensus 228 egs~~LakaL~s~~~L~El~l~dcll~~~G 257 (382)
T KOG1909|consen 228 EGSVALAKALSSWPHLRELNLGDCLLENEG 257 (382)
T ss_pred HHHHHHHHHhcccchheeeccccccccccc
Confidence 12233444455555555555554433
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.5e-10 Score=143.29 Aligned_cols=179 Identities=25% Similarity=0.311 Sum_probs=120.6
Q ss_pred CCCCcEEeccCCcc-cccCCC-CCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccce
Q 039595 101 FPHLVNLNLSFNLF-FGNIPP-QIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHE 178 (1078)
Q Consensus 101 l~~L~~L~L~~n~~-~~~~p~-~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~ 178 (1078)
.+.|+.|-+..|.. ...++. .|..++.|++||||+|.=-+.+|.+|++|-+||+|+|++..+. .+|..+++|+.|.+
T Consensus 544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 34688999998862 334454 4778999999999998666689999999999999999999998 99999999999999
Q ss_pred eecccccccCCccCcccCCCCCcEEEccCCCCC--CCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCc----EEe
Q 039595 179 FSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLF--GYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD----TLF 252 (1078)
Q Consensus 179 L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~ 252 (1078)
|++..+.....+|..+..|++|++|.+..-... ...-..+.+|.+|+.|....... .+-..+..+++|. .+.
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~ 700 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLS 700 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhh
Confidence 999999877777777888999999999876522 11112334444444444432222 0111223333332 233
Q ss_pred ccccccCCCCCcccCCCcccceeeccccccc
Q 039595 253 LYKNSLSGSIPSIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 253 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
+..+... ..+..+..+.+|+.|.+.++.+.
T Consensus 701 ~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 701 IEGCSKR-TLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred hcccccc-eeecccccccCcceEEEEcCCCc
Confidence 2222222 23444555666666666665554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.95 E-value=5e-09 Score=111.48 Aligned_cols=143 Identities=20% Similarity=0.245 Sum_probs=109.6
Q ss_pred ceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC--CceeeEEeeeecC---CeeEEEEe
Q 039595 757 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH--RNIVKFHGFCSNA---RHSFLVCE 831 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~E 831 (1078)
+.++.|.++.||++...+|+.+++|+....... .....+..|.++++.+.+ ..+.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998776789999997553211 124467889999999865 3467778777654 36689999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC------------------------------------- 874 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------- 874 (1078)
|++|+++.+.+.. ..++.++...++.++++++.+||+..
T Consensus 81 ~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9999888765411 34677788888999999999998531
Q ss_pred ----------------CCCcEecCCCCCCeeeCC--CCcEEEeccccccc
Q 039595 875 ----------------LPSIIHRDISSKNVLLDL--EFEAHVSDFGIAKF 906 (1078)
Q Consensus 875 ----------------~~~ivH~Dlk~~NIll~~--~~~~kl~DfG~a~~ 906 (1078)
...++|+|+++.||+++. ++.+.++||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 67789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.7e-09 Score=100.36 Aligned_cols=134 Identities=19% Similarity=0.308 Sum_probs=98.8
Q ss_pred eeccCCceeEEEEEeCCCCEEEEEEeccccccCChh-----hHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMA-----DQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 758 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
.+++|+-+.+|.+.+. |..+++|.=.++... .++ ..++-.+|+.++.+.+--.|...+=+..+.....|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR-~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYR-HPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccC-ChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 5789999999999775 444555542221111 111 123456788888888766666555566677778899999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
++|..|.+++... ...++..+-.-+.-||.. ||+|||+.++||.+..++ +.++|||++.+-
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888432 245677777778889999 999999999999997665 999999999743
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.9e-09 Score=80.51 Aligned_cols=42 Identities=43% Similarity=0.862 Sum_probs=29.9
Q ss_pred HHHHHHHHHHHHhcCCCCCCccccCCCCCCCCCCCCCCCCcccceEee
Q 039595 26 SAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCN 73 (1078)
Q Consensus 26 ~~~~~all~~k~~~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~gv~C~ 73 (1078)
++|++|||+||+++..++ .+.+++|+.+. ..+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~--~~~l~~W~~~~----~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDP--SGVLSSWNPSS----DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC---CCCTT--TT------S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhccccc--CcccccCCCcC----CCCCeeeccEEeC
Confidence 579999999999998653 58899998421 3799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.5e-08 Score=96.40 Aligned_cols=148 Identities=15% Similarity=0.200 Sum_probs=105.6
Q ss_pred ccceeccCCceeEEEEEeCCCCEEEEEEeccccccC----ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 755 EKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG----NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 755 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
....+-||+-+.|+++.+. |+...||.=....... ..-...+..+|+..+.+.+--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567889999999999886 7777777432221111 1112345678888888886555555555566666678999
Q ss_pred eecCC-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEEEeccccccc
Q 039595 831 EYLHR-GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF---EAHVSDFGIAKF 906 (1078)
Q Consensus 831 E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~a~~ 906 (1078)
||++| .++.+++....... ...+....++++|-+.+.-||.. +|+|||+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988 47788875433222 22233367899999999999999 999999999999997664 468999999864
Q ss_pred c
Q 039595 907 V 907 (1078)
Q Consensus 907 ~ 907 (1078)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.3e-09 Score=85.54 Aligned_cols=59 Identities=39% Similarity=0.615 Sum_probs=31.8
Q ss_pred ccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCc
Q 039595 583 HLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNE 641 (1078)
Q Consensus 583 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~ 641 (1078)
+|++|++++|+|+...+..|..+++|++|++++|+++.+.|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555554444455555555555555555555555555555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.9e-09 Score=86.30 Aligned_cols=58 Identities=41% Similarity=0.540 Sum_probs=25.2
Q ss_pred cccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCcc
Q 039595 560 LYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNN 617 (1078)
Q Consensus 560 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 617 (1078)
|++|++++|+|+...+..|.++++|++|++++|+|+...+..|..+++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444443333344444444444444444444333444444444444444443
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.7e-10 Score=129.36 Aligned_cols=129 Identities=33% Similarity=0.312 Sum_probs=100.3
Q ss_pred CcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccc
Q 039595 486 SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNL 565 (1078)
Q Consensus 486 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 565 (1078)
..|...+.++|.++ ....++.-++.|+.|+|++|+++.. +.+..+++|++|||++|.++.+.--....+. |..|+|
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeee
Confidence 36788889999988 6777888888999999999999854 3788899999999999999843322333443 999999
Q ss_pred cCcccccccchhhhcccccCeeecCCCccCCcCC-CCcccccccceeeccCccccC
Q 039595 566 SNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIP-PQVCNMESLEKLNLSHNNLSG 620 (1078)
Q Consensus 566 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 620 (1078)
++|.++. -..+.+|.+|+.|||++|-|.+... ..++.+..|+.|+|.+|++-.
T Consensus 240 rnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 9999863 3457888999999999998876432 235667889999999999863
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.2e-07 Score=96.56 Aligned_cols=193 Identities=17% Similarity=0.232 Sum_probs=130.4
Q ss_pred CccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee-------ecCCe
Q 039595 754 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC-------SNARH 825 (1078)
Q Consensus 754 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~-------~~~~~ 825 (1078)
...+.||+|+-+.+|-..-- +. .+.|+++.... .... +.++++... .||-+-.-+.+- ..+..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Ppp----a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPP----AAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh-hc-hhheeecCCCc----hHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 34567999999999976221 22 35577765421 1121 122333333 676543311111 12233
Q ss_pred eEEEEeecCCCC-HHHHh---cCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecc
Q 039595 826 SFLVCEYLHRGS-LARIL---GNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDF 901 (1078)
Q Consensus 826 ~~lv~E~~~~g~-L~~~l---~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 901 (1078)
.-+.|..+.+.. ...+. .+.+.-....|.-.+++++.++.+.+.||.. |.+-||+.++|+||.+++.|.+.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 667788776642 22222 2233445678999999999999999999999 9999999999999999999999885
Q ss_pred cccccccCCCCCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCc
Q 039595 902 GIAKFVEPYSSNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKG-NHPRDF 959 (1078)
Q Consensus 902 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG-~~p~~~ 959 (1078)
..... ...+......+|...|.+||.-. +..-+...|-|.+|+++++++.| +.||..
T Consensus 162 Dsfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 162 DSFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred cceee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 43332 23344455678999999999644 34557789999999999999986 999753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.7e-08 Score=97.55 Aligned_cols=130 Identities=25% Similarity=0.305 Sum_probs=84.5
Q ss_pred eEEEEEeCCCCEEEEEEeccccc----------------------cCChhhHHHHHHHHHHHhcCCCC--ceeeEEeeee
Q 039595 766 SVYKAELPSGDIVAVKKFNSQLL----------------------SGNMADQDEFLNVVLALNEIRHR--NIVKFHGFCS 821 (1078)
Q Consensus 766 ~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 821 (1078)
.||.|...+|..+|||+.+.... ...........+|...|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999888899999998854211 00111224567899999999765 466776552
Q ss_pred cCCeeEEEEeecC--CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHH-HHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 822 NARHSFLVCEYLH--RGSLARILGNDATAKELSWNRRINVIKGVANALSY-LHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 822 ~~~~~~lv~E~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
..++||||++ |..+..+.... ++.++...++.+++..+.. +|.. |++|||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 3479999998 55554433111 1134556678888886666 4677 99999999999999887 9999
Q ss_pred eccccccccc
Q 039595 899 SDFGIAKFVE 908 (1078)
Q Consensus 899 ~DfG~a~~~~ 908 (1078)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.2e-07 Score=100.10 Aligned_cols=142 Identities=21% Similarity=0.151 Sum_probs=98.1
Q ss_pred eccCCceeEEEEEeCCCCEEEEEEeccccccC---C----hhhHHHHHHHHHHHhcCCCCc--eeeEEeeeec-----CC
Q 039595 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG---N----MADQDEFLNVVLALNEIRHRN--IVKFHGFCSN-----AR 824 (1078)
Q Consensus 759 lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~----~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----~~ 824 (1078)
+-......|+++.. +|+.|.||+........ . ......+.+|...+.++...+ +++.+++.+. ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33334445667766 47889999774332100 0 011123677888877774333 3344555542 23
Q ss_pred eeEEEEeecCCC-CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-------CCcE
Q 039595 825 HSFLVCEYLHRG-SLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-------EFEA 896 (1078)
Q Consensus 825 ~~~lv~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~ 896 (1078)
..++|||++++. +|.+++.... ..+.+......++.+++..+.-||.. ||+|||+++.|||++. ++.+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence 578999999986 7999884221 23455677788999999999999999 9999999999999975 4689
Q ss_pred EEecccccc
Q 039595 897 HVSDFGIAK 905 (1078)
Q Consensus 897 kl~DfG~a~ 905 (1078)
.++||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999885
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=9e-10 Score=125.25 Aligned_cols=105 Identities=33% Similarity=0.431 Sum_probs=56.3
Q ss_pred ccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeecc
Q 039595 535 ELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLS 614 (1078)
Q Consensus 535 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 614 (1078)
.|...+.++|.+. ....++.=++.|+.|||++|+++.. +.+..+++|+.|||+.|+|+....-....+. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 3555556666665 3444555555666666666666532 2555566666666666666532222222333 6666666
Q ss_pred CccccCCcccccccCCcCcEEEcccCcCCCC
Q 039595 615 HNNLSGFIPRCFEKMRSLSCIDICYNELQGP 645 (1078)
Q Consensus 615 ~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~ 645 (1078)
+|.++.. ..+.++++|+.||+++|-+++.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~h 269 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEH 269 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcc
Confidence 6665532 2345556666666666665543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.6e-06 Score=96.65 Aligned_cols=170 Identities=17% Similarity=0.255 Sum_probs=126.8
Q ss_pred CceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee----cCCeeEEEEeecCCC-
Q 039595 763 GQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS----NARHSFLVCEYLHRG- 836 (1078)
Q Consensus 763 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~E~~~~g- 836 (1078)
--.+.|++.. .+|..|++|+++...... ......-+++++++.|+|||++.++|. .+..+++||+|.++.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~----~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS----TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC----cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 3467899944 489999999995432211 111234577899999999999999885 345789999998864
Q ss_pred CHHHHhcCC------------CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 837 SLARILGND------------ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 837 ~L~~~l~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
+|.+.--.. ......+++..|.++.|+..||.++|+. |+.-+-+.+++|+++.+.+++|+.-|+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccce
Confidence 777754221 1223467889999999999999999999 9999999999999999999999888877
Q ss_pred ccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 956 (1078)
..+..... |-+ .--.+-|.-.||.++..+.||..-
T Consensus 441 Dvl~~d~~--------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 441 DVLQEDPT--------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eeecCCCC--------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 66544220 101 112357999999999999999643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3e-07 Score=95.12 Aligned_cols=139 Identities=22% Similarity=0.168 Sum_probs=100.5
Q ss_pred CCccceeccCCceeEEEEEeCCCCEEEEEEecccc------------------ccCChhhHHHHHHHHHHHhcCCCC--c
Q 039595 753 FDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQL------------------LSGNMADQDEFLNVVLALNEIRHR--N 812 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~~~~~e~~~l~~l~h~--n 812 (1078)
+.+...||-|--+.||.|..+.|.++|||.=+... .+--...+...++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44567899999999999998899999999532110 010112234567899999988644 6
Q ss_pred eeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 039595 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL 892 (1078)
Q Consensus 813 iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 892 (1078)
|.+.+++ ....+||||++|-.|...- ++.+..-.++..|++-+.-+-.. ||||||+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 7776664 5678999999996664321 12344555666666666655566 9999999999999999
Q ss_pred CCcEEEeccccccc
Q 039595 893 EFEAHVSDFGIAKF 906 (1078)
Q Consensus 893 ~~~~kl~DfG~a~~ 906 (1078)
||.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976653
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.4e-08 Score=104.47 Aligned_cols=209 Identities=24% Similarity=0.241 Sum_probs=102.8
Q ss_pred cCcEEEccCccCCCCCC-cccc-ccCCCCeEEcccccCcc--ccCCCCccCCCCceeecccCcCCCCCCccccccCCCCe
Q 039595 343 SLRNLSLFNNGLYGSIP-EEIG-YLKSLSELKLCKNNLSG--VIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKR 418 (1078)
Q Consensus 343 ~L~~L~Ls~N~l~~~~p-~~~~-~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 418 (1078)
-++.|.+.++.|..+.. ..|+ ..+.++++||.+|.|+. .+...+.+++.|+.|+++.|++...+...-..+.+|+.
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~ 125 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV 125 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence 34455555555432211 1122 24567777777777762 23334556677777777777765433222134445555
Q ss_pred EEccCccccccchh-hccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCc
Q 039595 419 VRFNQNNLVGKVYE-AFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNH 497 (1078)
Q Consensus 419 L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 497 (1078)
|-|.+-.+...... .+..+|.++.|++|.|.+ +.+++..|.
T Consensus 126 lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~--------------------------------------rq~n~Dd~c 167 (418)
T KOG2982|consen 126 LVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL--------------------------------------RQLNLDDNC 167 (418)
T ss_pred EEEcCCCCChhhhhhhhhcchhhhhhhhccchh--------------------------------------hhhcccccc
Confidence 55555444332221 223344444444444432 223333333
Q ss_pred cCCCccc--ccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCC-CcccccccccccccccCcccccc-
Q 039595 498 IVGKIPV--QLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSI-PKSIGNLLKLYYLNLSNNQFSHT- 573 (1078)
Q Consensus 498 i~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~- 573 (1078)
+...-+. .+..++.+..++++-|++.. -++++..+-+..|.|...- -..+..++.+-.|+|+.|+|...
T Consensus 168 ~e~~s~~v~tlh~~~c~~~~w~~~~~l~r-------~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswa 240 (418)
T KOG2982|consen 168 IEDWSTEVLTLHQLPCLEQLWLNKNKLSR-------IFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWA 240 (418)
T ss_pred ccccchhhhhhhcCCcHHHHHHHHHhHHh-------hcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHH
Confidence 3321111 11122233334444444442 2345555666666665322 23344556667778888877542
Q ss_pred cchhhhcccccCeeecCCCccCC
Q 039595 574 IPIEFEKLIHLSKLDLSHNILQE 596 (1078)
Q Consensus 574 ~~~~~~~l~~L~~L~Ls~N~l~~ 596 (1078)
-.+++.++++|..|.+++|.|.+
T Consensus 241 svD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 241 SVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred HHHHHcCCchhheeeccCCcccc
Confidence 23456677777777777777764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.5e-08 Score=112.93 Aligned_cols=160 Identities=16% Similarity=0.210 Sum_probs=108.3
Q ss_pred HHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC---------ceeeccccccccccccc
Q 039595 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN---------RTEFVGTFGYAAPEIAY 930 (1078)
Q Consensus 860 ~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~ 930 (1078)
+.+++.|+.|+|... ++||++|.|++|.++.++..|++.|+.+......... ..-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345559999999874 9999999999999999999999999998755431111 01122356899999999
Q ss_pred cCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCC
Q 039595 931 TMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPE 1009 (1078)
Q Consensus 931 ~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 1009 (1078)
+...+.++|+||+|+++|.+.. |+.-++..+.. ........ ..+-........... ++.+-+.+++..++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~--~~~~~~~~---~~~~~~~~~s~~~p~---el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL--LSYSFSRN---LLNAGAFGYSNNLPS---ELRESLKKLLNGDSA 254 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCc--chhhhhhc---ccccccccccccCcH---HHHHHHHHHhcCCcc
Confidence 9888999999999999999994 55443322211 11110000 001111111122222 455666778999999
Q ss_pred CCCChhHHHHHhhhhhhHHH
Q 039595 1010 ARPTMEKGFGHHIGYCDEIL 1029 (1078)
Q Consensus 1010 ~RPt~~ell~h~~~~~~~~~ 1029 (1078)
.||++.++...+|+...-+.
T Consensus 255 ~rp~~~~l~~~~ff~D~~~~ 274 (700)
T KOG2137|consen 255 VRPTLDLLLSIPFFSDPGLK 274 (700)
T ss_pred cCcchhhhhcccccCCchhh
Confidence 99999999999987754443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.8e-06 Score=85.49 Aligned_cols=141 Identities=19% Similarity=0.195 Sum_probs=103.0
Q ss_pred eccCCceeEEEEEeCCCCEEEEEEeccccccC--ChhhHHHHHHHHHHHhcCCCC--ceeeEEeeee-c----CCeeEEE
Q 039595 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG--NMADQDEFLNVVLALNEIRHR--NIVKFHGFCS-N----ARHSFLV 829 (1078)
Q Consensus 759 lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~----~~~~~lv 829 (1078)
-|+||-+-|+..... |+.+-+|+-....... .+-....|.+|...+.++..- .+.+.+ ++. . ....+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367888899998765 5578999865221111 123466789999988888532 244555 332 1 2346899
Q ss_pred EeecCCC-CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc--EEEecccccc
Q 039595 830 CEYLHRG-SLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE--AHVSDFGIAK 905 (1078)
Q Consensus 830 ~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfG~a~ 905 (1078)
+|-+++- +|.+++... ...+.+......++.+++..+.-||+. |+.|+|+.+.||+++.+|. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9987643 898888432 233567788889999999999999999 9999999999999987777 9999997665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.2e-06 Score=88.32 Aligned_cols=107 Identities=20% Similarity=0.278 Sum_probs=82.0
Q ss_pred HHHHHHHHHHHhcCCCC--ceeeEEeeeecC----CeeEEEEeecCCC-CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHH
Q 039595 795 QDEFLNVVLALNEIRHR--NIVKFHGFCSNA----RHSFLVCEYLHRG-SLARILGNDATAKELSWNRRINVIKGVANAL 867 (1078)
Q Consensus 795 ~~~~~~e~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L 867 (1078)
...+.+|...+..+..- .+++.+++.+.. ...++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 34567777777666432 345556665442 3458999999985 7999984322 255677888999999999
Q ss_pred HHHHhcCCCCcEecCCCCCCeeeCCCC---cEEEecccccccc
Q 039595 868 SYLHHDCLPSIIHRDISSKNVLLDLEF---EAHVSDFGIAKFV 907 (1078)
Q Consensus 868 ~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~a~~~ 907 (1078)
+-||.. ||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.8e-06 Score=100.77 Aligned_cols=145 Identities=21% Similarity=0.238 Sum_probs=92.2
Q ss_pred ceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhh--------------------------HH----------HHHH
Q 039595 757 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMAD--------------------------QD----------EFLN 800 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~--------------------------~~----------~~~~ 800 (1078)
..|+.++=|.||+|++++|+.||||+.+......-..+ .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999999999999999865321110000 01 2344
Q ss_pred HHHHHhcCC-----CCceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHH-HHHHHhcC
Q 039595 801 VVLALNEIR-----HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA-LSYLHHDC 874 (1078)
Q Consensus 801 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~ 874 (1078)
|...+.+++ .|.|.-..=|.+..+...++|||++|-.+.++..-.. ...+.+.+ +..++++ +.-+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~i---a~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKEL---AELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHH---HHHHHHHHHHHHHhc-
Confidence 444444442 3333222223333456689999999998888742111 22333333 3333322 1112223
Q ss_pred CCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 875 ~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|++|.|.+|.||+++.+|++.+.|||+...+++
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999987653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1078 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-47 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-46 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-14 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-14 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-11 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 9e-11 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-10 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-09 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-08 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-09 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 8e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-09 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 3e-09 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-09 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 5e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 1e-08 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 2e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 1e-08 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 2e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 2e-07 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 6e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 6e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-07 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 6e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-06 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 3e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-06 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 5e-06 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 3e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-06 | ||
| 2a0z_A | 705 | The Molecular Structure Of Toll-like Receptor 3 Lig | 9e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 1e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-05 | ||
| 3ulu_A | 694 | Structure Of Quaternary Complex Of Human Tlr3ecd Wi | 1e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 2v70_A | 220 | Third Lrr Domain Of Human Slit2 Length = 220 | 1e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-05 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 4fho_A | 231 | Crystal Structure Of An Internalin C2 (Inlc2) From | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 3e-05 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 4e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 2o6r_A | 177 | Structural Diversity Of The Hagfish Variable Lympho | 4e-05 | ||
| 2o6r_A | 177 | Structural Diversity Of The Hagfish Variable Lympho | 7e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 6e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-05 | ||
| 2r9u_A | 174 | Crystal Structure Of Lamprey Variable Lymphocyte Re | 9e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-04 | ||
| 2xot_A | 361 | Crystal Structure Of Neuronal Leucine Rich Repeat P | 1e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V70|A Chain A, Third Lrr Domain Of Human Slit2 Length = 220 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2O6R|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B61 Length = 177 | Back alignment and structure |
|
| >pdb|2O6R|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B61 Length = 177 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R9U|A Chain A, Crystal Structure Of Lamprey Variable Lymphocyte Receptor 2913 Ectodomain Length = 174 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2XOT|A Chain A, Crystal Structure Of Neuronal Leucine Rich Repeat Protein Amigo-1 Length = 361 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1078 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-169 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-159 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-111 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-110 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-83 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-68 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-50 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-38 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-105 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-103 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-51 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-19 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-11 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-99 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-84 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-74 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-52 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-90 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-62 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-44 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-86 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-82 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-81 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-78 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-67 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-52 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-84 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-72 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-72 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 8e-69 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-83 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-80 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-73 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-62 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-60 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-74 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 9e-69 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-64 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-63 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-52 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-33 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-21 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-62 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-58 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-56 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-62 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-59 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-42 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-31 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-57 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-56 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 6e-56 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-55 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-45 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 7e-55 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-54 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-53 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-33 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-26 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-14 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-54 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-52 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-48 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-23 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-54 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 8e-51 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-49 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 9e-49 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-46 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-42 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-42 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-35 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-23 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-19 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-47 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-47 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-47 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-47 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-47 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-45 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-41 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-17 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-46 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-46 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-46 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-45 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-44 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-43 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-32 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-24 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-23 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-22 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-07 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-41 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-41 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-40 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-41 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-36 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-30 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-19 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-06 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-41 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-37 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-32 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-18 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-15 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-39 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 5e-36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-35 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 7e-26 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 9e-19 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-39 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-38 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 6e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-34 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-07 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-39 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 9e-33 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-32 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 8e-28 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-22 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-39 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-38 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-38 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 8e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-36 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-36 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-29 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-23 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-37 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-37 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-34 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-31 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-37 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 7e-35 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-33 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-33 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-32 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-32 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-32 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-32 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-32 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-32 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 9e-32 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-29 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-26 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-24 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-05 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-30 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-30 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-14 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-31 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 7e-31 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-30 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-30 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-30 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-30 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-30 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-30 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-30 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-30 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 8e-30 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-30 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-30 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 8e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-22 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-17 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-14 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-29 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-29 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-29 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-29 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 9e-29 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 9e-27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-26 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-04 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-28 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 7e-28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-17 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-28 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-28 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-27 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-27 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-18 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-28 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-27 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-27 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-27 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-27 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-27 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-27 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-27 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 8e-27 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-27 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 8e-27 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-26 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-26 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-26 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-26 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-26 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-26 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-26 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-26 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-26 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-26 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-26 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-26 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-26 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-26 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-26 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 8e-26 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 9e-26 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 9e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-23 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-13 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-25 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-25 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-25 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-25 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 7e-25 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 8e-25 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-20 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 7e-20 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-18 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 8e-12 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-24 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-24 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-24 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-24 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-24 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 6e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-21 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-08 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 7e-24 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-24 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 8e-24 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 9e-24 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-23 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-23 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-23 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-21 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-23 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-23 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-23 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-23 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-23 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-23 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-23 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-23 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-23 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-23 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-23 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-21 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-21 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-20 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-19 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-18 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-23 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-22 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-16 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-23 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 8e-23 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 8e-23 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-22 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-22 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-22 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-22 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-22 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-22 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-22 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-22 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 9e-22 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-21 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-21 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-21 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-21 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-18 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-17 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-09 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-21 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-21 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 8e-21 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 8e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-07 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-20 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-20 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-20 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-20 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-20 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-20 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-20 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-20 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 6e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-12 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 7e-11 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-20 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-20 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-20 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-19 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-15 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-20 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-19 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-19 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-19 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-19 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-19 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-17 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 7e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 9e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-12 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 6e-07 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 5e-19 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 6e-19 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 7e-19 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-18 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-18 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-16 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-16 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 8e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-09 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-18 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-18 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-18 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-13 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-07 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 8e-18 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 8e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 9e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 8e-04 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 8e-18 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 9e-18 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-13 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-13 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-08 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-12 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-17 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-17 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-15 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 6e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-17 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-17 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-16 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-16 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-16 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-13 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-12 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-16 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 6e-16 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 6e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 6e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-07 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-16 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 8e-16 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 9e-16 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-15 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-14 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-13 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 9e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-06 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-15 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 9e-15 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-14 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-14 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-04 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-14 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 6e-14 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-14 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 6e-14 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-14 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 8e-14 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-13 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 6e-11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-10 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-10 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-13 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 8e-09 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-13 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-13 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 6e-12 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-10 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 9e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 6e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 7e-06 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-13 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-13 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 6e-13 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 5e-06 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-05 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 9e-13 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-12 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-12 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-12 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-12 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-12 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-12 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-05 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-12 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-12 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 6e-12 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-12 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 6e-12 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-12 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-11 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-11 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-11 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-11 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-11 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-11 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 6e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 5e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-04 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 5e-11 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-10 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-10 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-10 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-04 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-10 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-10 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-10 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-10 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 6e-10 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-09 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-09 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-09 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 6e-09 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 6e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 7e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 7e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-08 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 6e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 5e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 4e-04 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 9e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 1e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 2e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 3e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 7e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 2e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 2e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 7e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 9e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 1e-04 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-05 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 514 bits (1326), Expect = e-169
Identities = 177/597 (29%), Positives = 269/597 (45%), Gaps = 21/597 (3%)
Query: 81 SINLSTLCLNGTF--QDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQL 138
++LS ++G L +L +S N G++ + L+ LD+ +N
Sbjct: 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNF 212
Query: 139 SGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLS 198
S I P +G + L+ L + N+L G I + + + N G IP L
Sbjct: 213 STGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLK 269
Query: 199 KLALLYLNNNSLFGYIPT-VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNS 257
L L L N G IP + G +L+ LDLS N G +P + S L++L L N+
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 258 LSGSIP-SIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSW-TLMSLFSNSLSGSIPPILG 315
SG +P + ++ L LDL N+ SG +P S NLS+ + L SN+ SG I P L
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 389
Query: 316 N--LKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKL 373
+L L L N G IPP++ N S L +L L N L G+IP +G L L +LKL
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 374 CKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEA 433
N L G IP + + L L + N L G IP L + T+L + + N L G++ +
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 434 FGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDL 493
G NL L LS N+F G I + L ++ N G+IP + Q +
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK----QSGKI 565
Query: 494 SSNHIVGKIPVQLEKLFSLNKLILSLN--QLSGSVPLEFGSLTELQYLDLSANKLSSSIP 551
++N I GK V ++ + + N + G + L+ ++++
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625
Query: 552 KSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKL 611
+ N + +L++S N S IP E + +L L+L HN + IP +V ++ L L
Sbjct: 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNIL 685
Query: 612 NLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFK---DGLMEGNKGLCG 665
+LS N L G IP+ + L+ ID+ N L GPIP F+ N GLCG
Sbjct: 686 DLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 488 bits (1258), Expect = e-159
Identities = 184/647 (28%), Positives = 281/647 (43%), Gaps = 57/647 (8%)
Query: 16 NFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHA 75
+F + + E L+++K L ++NL L W+ S +PC++ G++C
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDKNL----LPDWS------SNKNPCTFDGVTCRD- 49
Query: 76 GSRVISINLSTLCLNGTFQDF--SFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDL 133
+V SI+LS+ LN F S S L +L LS + G++ + L +LDL
Sbjct: 50 -DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDL 107
Query: 134 GNNQLSGVISP--EIGKLNQLRRLYLDMNQLHGTIP-PVIGQLSLIHEFSFCHNNVSGRI 190
N LSG ++ +G + L+ L + N L +L+ + N++SG
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167
Query: 191 PSSL---GNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSN 247
+L L ++ N + G + + +L LD+S N + IP L + S
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSA 224
Query: 248 LDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLS 307
L L + N LSG I L L++ NQ G IP L S +SL N +
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFT 282
Query: 308 GSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEE-IGYL 365
G IP + G +L+ L L N G +PP G+ S L +L+L +N G +P + + +
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 342
Query: 366 KSLSELKLCKNNLSGVIPHSVGNLTG-LVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424
+ L L L N SG +P S+ NL+ L+ L++ N+ GPI +L
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK--------- 393
Query: 425 NLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGD 484
L L L N F GKI N +L + +S N + G+IP +G
Sbjct: 394 -------------NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440
Query: 485 SSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSAN 544
SKL+ L L N + G+IP +L + +L LIL N L+G +P + T L ++ LS N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 545 KLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCN 604
+L+ IPK IG L L L LSNN FS IP E L LDL+ N+ IP +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 605 MESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYN--ELQGPIPNS 649
++ N ++G + N E QG
Sbjct: 561 Q----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-111
Identities = 135/601 (22%), Positives = 218/601 (36%), Gaps = 32/601 (5%)
Query: 81 SINLSTL-CLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLS 139
+++ C + ++ LNL+ N S+L +LD+G N +S
Sbjct: 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 140 GVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSK 199
+ KL L+ L L N+L + + E N++ +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 200 LALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSN--LDTLFLYKNS 257
L L L++N L L++L L LS N++ L LD +N L L L N
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 258 LSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFG---NLSSWTLMSLFSNSLSGSIPPIL 314
+ P + L L L QL S+ +S +SL ++ LS +
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 315 GNLK--SLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELK 372
LK +L+ L L N LN V S L L L N + + L ++ L
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 373 LCKN---------NLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV--RF 421
L ++ +L + S L L LNM +N + G L +LK +
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 422 NQNNLVGKVYEAFGD--HPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479
+ +L E F H L L+L++N S + L L+ + +N I +
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 480 -LEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSG--SVPLEFGSLTEL 536
E + + LS N + + SL +L+L L S P F L L
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482
Query: 537 QYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSH--------TIPIEFEKLIHLSKLD 588
LDLS N +++ + L KL L+L +N + + L HL L+
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 589 LSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPN 648
L N E ++ L+ ++L NNL+ F SL +++ N +
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
Query: 649 S 649
Sbjct: 603 V 603
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-110
Identities = 138/617 (22%), Positives = 228/617 (36%), Gaps = 36/617 (5%)
Query: 80 ISINLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGN 135
+ N++ L L +F+ + L +L++ FN P L L+ L+L +
Sbjct: 23 LPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82
Query: 136 NQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLG 195
N+LS + L L+L N + + + HN +S +
Sbjct: 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142
Query: 196 NLSKLALLYLNNNSLFGYIPTVMGNLK--SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFL 253
L L L L+NN + + SL L+LS NQ+ P + L LFL
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFL 202
Query: 254 YKNSLSGSIPSIIG---NLKSLHQLDLIENQLSGSIPLSFGNLSSWTL--MSLFSNSLSG 308
L S+ + S+ L L +QLS + +F L L + L N+L+
Sbjct: 203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262
Query: 309 SIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSI---------P 359
L L L N + + S+ L ++R L+L + SI
Sbjct: 263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322
Query: 360 EEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL--FGPIPKSLKSL--TS 415
+LK L L + N++ G+ + L L L++ + ++ SL +
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
Query: 416 LKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFN-WRNLPKLDTFIVSMNNI 474
L + +N + +AF +L LDL N +++ WR L + +S N
Sbjct: 383 LHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY 442
Query: 475 FGSIPLEIGDSSKLQFLDLSSNHI--VGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGS 532
LQ L L + V P + L +L L LS N ++
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502
Query: 533 LTELQYLDLSANKLSS--------SIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHL 584
L +L+ LDL N L+ + L L+ LNL +N F F+ L L
Sbjct: 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562
Query: 585 SKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEK-MRSLSCIDICYNELQ 643
+DL N L N SL+ LNL N ++ + F R+L+ +D+ +N
Sbjct: 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
Query: 644 GPIPNSTVFKDGLMEGN 660
+ F + + E +
Sbjct: 623 CTCESIAWFVNWINETH 639
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = 4e-96
Identities = 123/575 (21%), Positives = 197/575 (34%), Gaps = 39/575 (6%)
Query: 83 NLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQL 138
L L L D +F+ +L L+L N L LDL +N L
Sbjct: 74 MLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGL 133
Query: 139 SGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH--EFSFCHNNVSGRIPSSLGN 196
S +L L+ L L N++ + + + N + P
Sbjct: 134 SSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHA 193
Query: 197 LSKLALLYLNNNSLFGYIPTVMG---NLKSLSTLDLSQNQLNGLIPCTLDNL--SNLDTL 251
+ +L L+LNN L + + S+ L LS +QL+ T L +NL L
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253
Query: 252 FLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS---------WTLMSLF 302
L N+L+ L L L N + S L + +T S+
Sbjct: 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS 313
Query: 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362
SL LK L L + N + G+ L +L+ LSL N+
Sbjct: 314 LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE 373
Query: 363 G----YLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKS-LKSLTSLK 417
L L L KN +S + + L L +L++ N + + + L ++
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 418 RVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDG--KISFNWRNLPKLDTFIVSMNNIF 475
+ + N + +F P+L L L + ++ L L +S NNI
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIA 493
Query: 476 GSIPLEIGDSSKLQFLDLSSNHI--------VGKIPVQLEKLFSLNKLILSLNQLSGSVP 527
+ KL+ LDL N++ G L+ L L+ L L N
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
Query: 528 LEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEK-LIHLSK 586
F L EL+ +DL N L++ N + L LNL N + F +L++
Sbjct: 554 EVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613
Query: 587 LDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGF 621
LD+ N + +N +H N+
Sbjct: 614 LDMRFNPFDCTCESI---AWFVNWINETHTNIPEL 645
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 2e-83
Identities = 112/475 (23%), Positives = 192/475 (40%), Gaps = 24/475 (5%)
Query: 200 LALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS 259
+ ++ L +P +++ L+L+ NQL L S L +L + N++S
Sbjct: 6 HEVADCSHLKLTQ-VPD--DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 260 GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKS 319
P + L L L+L N+LS +F ++ T + L SNS+ K+
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 320 LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLK--SLSELKLCKNN 377
L TL L N L+ + L +L+ L L NN + EE+ SL +L+L N
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 378 LSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLK---SLTSLKRVRFNQNNLVGKVYEAF 434
+ P + L L + L + + L + TS++ + + + L F
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 435 G--DHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLD 492
NLT LDLS NN + + ++ LP+L+ F + NNI + +++L+
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 493 LSSN---------HIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSA 543
L + + + L L L + N + G F L L+YL LS
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 544 NKLSSSIPKSIG----NLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIP 599
+ S + L+ LNL+ N+ S F L HL LDL N + +E+
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 600 PQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFK 653
Q +E++ ++ LS+N F + SL + + L+ + + F+
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 6e-68
Identities = 102/478 (21%), Positives = 171/478 (35%), Gaps = 34/478 (7%)
Query: 83 NLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIG---NLSKLQNLDLGN 135
+L L L+ F F + L L L+ ++ ++ + ++NL L N
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 136 NQLSGVISPEIGKLN--QLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSS 193
+QLS + L L L L N L+ L + F +NN+ S
Sbjct: 232 SQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291
Query: 194 LGNLSKLALLYLNNN---------SLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDN 244
L L + L L + SL LK L L++ N + G+
Sbjct: 292 LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351
Query: 245 LSNLDTLFLYKNSLSGSIPSIIG----NLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMS 300
L NL L L + S + LH L+L +N++S +F L ++
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 411
Query: 301 LFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYG--S 357
L N + + L+++ + L N+ + S + SL+ L L L S
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 358 IPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL--------FGPIPKS 409
P L++L+ L L NN++ + + L L +L++ N+L G
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
Query: 410 LKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIV 469
LK L+ L + N E F D L +DL NN + + + N L + +
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNL 591
Query: 470 SMNNIFGSIPLEIGDS-SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSV 526
N I G + L LD+ N + +N+ ++ +LS
Sbjct: 592 QKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-50
Identities = 75/378 (19%), Positives = 123/378 (32%), Gaps = 29/378 (7%)
Query: 83 NLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNI---------PPQIGNLSKLQ 129
L L S ++ LNL + +I L L+
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 130 NLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPP----VIGQLSLIHEFSFCHNN 185
+L++ +N + G+ S L L+ L L + V S +H + N
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNK 392
Query: 186 VSGRIPSSLGNLSKLALLYLNNNSLFGYIP-TVMGNLKSLSTLDLSQNQLNGLIPCTLDN 244
+S + L L +L L N + + L+++ + LS N+ L +
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL 452
Query: 245 LSNLDTLFLYKNSLSG--SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLF 302
+ +L L L + +L S PS L++L LDL N ++ L ++ L
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512
Query: 303 SNSLS--------GSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGL 354
N+L+ G L L L L L N + + +L L+ + L N L
Sbjct: 513 HNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL 572
Query: 355 YGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVG-NLTGLVLLNMCENHLFGPIPKSLKSL 413
SL L L KN ++ V G L L+M N +
Sbjct: 573 NTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFV 632
Query: 414 TSLKRVRFNQNNLVGKVY 431
+ N L
Sbjct: 633 NWINETHTNIPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-38
Identities = 56/296 (18%), Positives = 100/296 (33%), Gaps = 18/296 (6%)
Query: 72 CNHAGSRVISINLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQ-IGNLS 126
N + L L L + +FS HL L+L N + Q L
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 127 KLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHG--TIPPVIGQLSLIHEFSFCHN 184
+ + L N+ + + L+RL L L + P L + +N
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 185 NVSGRIPSSLGNLSKLALLYLNNNSL--------FGYIPTVMGNLKSLSTLDLSQNQLNG 236
N++ L L KL +L L +N+L G + L L L+L N +
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 237 LIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFG-NLSS 295
+ +L L + L N+L+ S+ N SL L+L +N ++ FG +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 296 WTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFN 351
T + + N + I + ++ + +L+ + +
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCN--TPPHYHGFPVRL 664
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 343 bits (882), Expect = e-105
Identities = 96/633 (15%), Positives = 183/633 (28%), Gaps = 60/633 (9%)
Query: 25 SSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINL 84
A L+ L +L W +A S G +
Sbjct: 14 DDAIVPIKLSRTAEYIKDYL--ALKEIW-----DALNGKNWSQQGFGTQPGAN---WNFN 63
Query: 85 STLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG---- 140
L + G S +S + L+L G +P IG L++L+ L LG++
Sbjct: 64 KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL 123
Query: 141 VISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH--EFSFCHNNVSGRIPSSLGNLS 198
I + T + + + I S
Sbjct: 124 FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183
Query: 199 KLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSL 258
K + +N++ + + L L + + C N +
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQ 237
Query: 259 SGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSL--------SGSI 310
+ NLK L +++ +P L L+++ N
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297
Query: 311 PPILGNLKSLSTLGLYLNQL-NGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLS 369
+ + + + N L + S+ + L L N L G +P G L+
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLA 356
Query: 370 ELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFG-PIPKSLKSLTSLKRVRFNQNNLVG 428
L L N ++ + + G + L+ N L P KS++ + + F+ N +
Sbjct: 357 SLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS 416
Query: 429 KVYEAFGDHP-------NLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNI------- 474
+ F N++ ++LS N + L + + N +
Sbjct: 417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476
Query: 475 FGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLE--KLFSLNKLILSLNQLSGSVPLEFGS 532
++ L +DL N + + L L + LS N S P + +
Sbjct: 477 LKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534
Query: 533 LTELQYLDLS------ANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSK 586
+ L+ + N+ P+ I L L + +N + + ++S
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISV 591
Query: 587 LDLSHNILQEEIPPQVCNMESLEKLNLSHNNLS 619
LD+ N VC L ++
Sbjct: 592 LDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-103
Identities = 85/595 (14%), Positives = 180/595 (30%), Gaps = 52/595 (8%)
Query: 89 LNGTFQDFSFSSFPHLVNLNLS--FNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEI 146
LNG N N + +++ + + ++ L L SG + I
Sbjct: 42 LNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAI 101
Query: 147 GKLNQLRRLYLDMNQLHG----TIPPVIGQLSLIHEFSFCHNNVSGRIPSSLG--NLSKL 200
G+L +L L L + P I + + + S L
Sbjct: 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161
Query: 201 ALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
+N++ I + + N + + + L+ L ++ +
Sbjct: 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVA 220
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSL 320
++ Q + L + NL T + +++ +P L L +
Sbjct: 221 ENICEAWENENSE-----YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM 275
Query: 321 STLGLYLNQL--------NGVIPPSIGNLSSLRNLSLFNNGL-YGSIPEEIGYLKSLSEL 371
+ + N+ + ++ + + N L + + +K L L
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGML 335
Query: 372 KLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVG--K 429
+ N L G +P + G+ L LN+ N + ++ + F N L
Sbjct: 336 ECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPN 394
Query: 430 VYEAFGDHPNLTFLDLSQNNFDG-------KISFNWRNLPKLDTFIVSMNNIFGSIPLEI 482
+++ ++ +D S N + + + +S N I
Sbjct: 395 IFD-AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453
Query: 483 GDSSKLQFLDLSSNHIVG-------KIPVQLEKLFSLNKLILSLNQLSG-SVPLEFGSLT 534
S L ++L N + + + L + L N+L+ S +L
Sbjct: 454 STGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLP 513
Query: 535 ELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSN------NQFSHTIPIEFEKLIHLSKLD 588
L +DLS N S P N L + N N+ P L++L
Sbjct: 514 YLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 589 LSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+ N ++ ++ ++ ++ L++ N + Y++ Q
Sbjct: 573 IGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 3e-51
Identities = 55/369 (14%), Positives = 117/369 (31%), Gaps = 46/369 (12%)
Query: 293 LSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNN 352
W ++ + S G N L ++ Q GV S+ + + LSL
Sbjct: 36 KEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQP-GV---SLNSNGRVTGLSLEGF 91
Query: 353 GLYGSIPEEIGYLKSLSELKLCKNNLSG----VIPHSVGNLTGLVLLNMCENHLFGPIPK 408
G G +P+ IG L L L L + P + H
Sbjct: 92 GASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVD 151
Query: 409 SLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFI 468
+L ++ + I + R K
Sbjct: 152 YDPREDFS----------------------DLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 469 VSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPL 528
NNI + + +KL+ + ++ V + + + + Q + L
Sbjct: 190 QLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDL 243
Query: 529 EFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQF--------SHTIPIEFEK 580
++ +L +L +++ + +P + L ++ +N++ N+ +
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPV 303
Query: 581 LIHLSKLDLSHNILQE-EIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICY 639
+ + + +N L+ + + M+ L L +N L G +P F L+ +++ Y
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362
Query: 640 NELQGPIPN 648
N++ N
Sbjct: 363 NQITEIPAN 371
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-19
Identities = 20/158 (12%), Positives = 50/158 (31%), Gaps = 13/158 (8%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPPQI--GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRR 154
+F + L +++L FN + L L +DL N S + + L+
Sbjct: 483 NFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
Query: 155 LYLDM------NQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN 208
+ N+ P I + + N++ + + +++L + +N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDN 597
Query: 209 SLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLS 246
+ + L ++ + C ++
Sbjct: 598 PNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 9e-11
Identities = 21/134 (15%), Positives = 34/134 (25%), Gaps = 22/134 (16%)
Query: 518 SLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE 577
L+ + S + L L S +P +IG L +L L L ++ +
Sbjct: 65 ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 578 FEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPR--CFEKMRSLSCI 635
P + S E+ + E L
Sbjct: 125 --------------------GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD 164
Query: 636 DICYNELQGPIPNS 649
I + Q I S
Sbjct: 165 CINSDPQQKSIKKS 178
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 324 bits (833), Expect = 7e-99
Identities = 120/556 (21%), Positives = 207/556 (37%), Gaps = 25/556 (4%)
Query: 83 NLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVI 142
N++ C+ F + NL+LSFN + +LQ LDL ++ +
Sbjct: 9 NITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 143 SPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLAL 202
L+ L L L N + LS + + N++ +G+L L
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 203 LYLNNNSL-FGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD----TLFLYKNS 257
L + +N + +P NL +L LDLS N++ + L L + +L L N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 258 LSGSIPSIIGNLKSLHQLDLIENQLSGSIP-LSFGNLSSWTLMSLFSNSLSGS------I 310
++ P + LH+L L N S ++ L+ + L
Sbjct: 189 MNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 311 PPILGNLKSLSTLGLYLNQLN---GVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKS 367
L L +L+ L L+ I L+++ + SL + + ++ Y
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFG 305
Query: 368 LSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
L+L + +L L + + F + L SL L + N +
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFL-DLSRNGLSFK 362
Query: 428 GKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEI-GDSS 486
G ++ +L +LDLS N +S N+ L +L+ +N+ +
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 487 KLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSANK 545
L +LD+S H L SL L ++ N + + F L L +LDLS +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 546 LSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNM 605
L P + +L L LN+S+N F ++ L L LD S N + ++ +
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541
Query: 606 E-SLEKLNLSHNNLSG 620
SL LNL+ N+ +
Sbjct: 542 PSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 3e-84
Identities = 115/513 (22%), Positives = 183/513 (35%), Gaps = 30/513 (5%)
Query: 156 YLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIP 215
Y M IP + N + S + +L +L L+ +
Sbjct: 12 YQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 216 TVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQL 275
+L LSTL L+ N + L LS+L L + +L+ IG+LK+L +L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 276 DLIENQL-SGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYL----NQL 330
++ N + S +P F NL++ + L SN + L L + L L L N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 331 NGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGY-LKSLSELKLCKNNLSGVI---PHSV 386
N I P L L+L NN ++ + L L +L
Sbjct: 190 NF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 387 GNLTGLVLLNMCENHL------FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNL 440
L GL L + E L I LT++ + + F +
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGW 306
Query: 441 TFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHI-- 498
L+L F + ++L +L + G D L+FLDLS N +
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 499 VGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI-GNL 557
G SL L LS N + + F L +L++LD + L S+ +L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 558 LKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHN 616
L YL++S+ F L L L ++ N QE P + + +L L+LS
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 617 NLSGFIPRCFEKMRSLSCIDICYNELQGPIPNS 649
L P F + SL +++ +N
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 9e-74
Identities = 99/446 (22%), Positives = 161/446 (36%), Gaps = 27/446 (6%)
Query: 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282
S LDLS N L L + + L L L + + +L L L L N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 283 SGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGV-IPPSIGNL 341
+F LSS + +L+ +G+LK+L L + N + +P NL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 342 SSLRNLSLFNNGLYGSIPEEIGYLKSLS----ELKLCKNNLSGVIPHSVGNLTGLVLLNM 397
++L +L L +N + ++ L + L L N ++ + P + + L L +
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTL 207
Query: 398 CENHLFGPIPK-SLKSLTSLKRVR------FNQNNLVGKVYEAFGDHPNLTFLDLSQNNF 450
N + K ++ L L+ R N+ NL A NLT +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 451 D---GKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLE 507
D I + L + +F + I + Q L+L + Q
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFGWQHLELVNCKFG-----QFP 320
Query: 508 KLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLS--SSIPKSIGNLLKLYYLNL 565
L + L+ G L L++LDLS N LS +S L YL+L
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 566 SNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPR 624
S N T+ F L L LD H+ L++ V ++ +L L++SH +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 625 CFEKMRSLSCIDICYNELQGPIPNST 650
F + SL + + N Q
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-52
Identities = 84/433 (19%), Positives = 149/433 (34%), Gaps = 37/433 (8%)
Query: 75 AGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNI---PPQIGNLSKLQNL 131
R+ + L + L L F L L NL
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 132 DLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIP 191
+ +L+ + + I + L+ + FS +
Sbjct: 258 TIEEFRLAYL------------------DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 192 SSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTL 251
S L L N FG PT LKSL L + N+ +L +L+ L
Sbjct: 300 FS--YNFGWQHLELVNCK-FGQFPT--LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFL 352
Query: 252 FLYKNSLS--GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309
L +N LS G SL LDL N + + +F L + ++L
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 411
Query: 310 IPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSI-PEEIGYLKS 367
+ +L++L L + LSSL L + N + P+ L++
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 368 LSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
L+ L L + L + P + +L+ L +LNM N+ F K L SL+ + ++ N+++
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 531
Query: 428 GKVYEAFGDHP-NLTFLDLSQNNFDGKISFNW--RNLPKLDTFIVSMNNIFGSIPLEIGD 484
+ P +L FL+L+QN+F + + +V + + + P +
Sbjct: 532 TSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 591
Query: 485 SSKLQFLDLSSNH 497
+ L+++
Sbjct: 592 MP-VLSLNITCQM 603
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 307 bits (787), Expect = 8e-90
Identities = 86/600 (14%), Positives = 180/600 (30%), Gaps = 52/600 (8%)
Query: 58 NASKISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGN 117
A ++ + N+ + L + G + + L+L+ G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIGK-------LNQLRRLYLDMNQLHGTIPPVI 170
+P IG L++L+ L G + + + + R+ + ++ +
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 171 GQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLS 230
L+ + + + S +L + L N +I + L L + +
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR--ITFISKAIQRLTKLQIIYFA 456
Query: 231 QNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSF 290
+ + + + NLK L ++L +P
Sbjct: 457 NSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511
Query: 291 GNLSSWTLMSLFSNSLSG---------SIPPILGNLKSLSTLGLYLNQLNGVIPP-SIGN 340
+L +++ N + + + N L S+
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQK 571
Query: 341 LSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCEN 400
+ L L +N + E G L++LKL N + + + L N
Sbjct: 572 MVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHN 629
Query: 401 HLFG-PIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHP-----NLTFLDLSQNNFDGKI 454
L P + KS+ + V F+ N + + N + + LS N
Sbjct: 630 KLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFP 689
Query: 455 SFNWRNLPKLDTFIVSMNNI-------FGSIPLEIGDSSKLQFLDLSSNHIVGKIP--VQ 505
+ + + T I+S N + ++ L +DL N + + +
Sbjct: 690 TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFR 748
Query: 506 LEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDL------SANKLSSSIPKSIGNLLK 559
L L+ + +S N S S P + + ++L+ + N++ P I
Sbjct: 749 ATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807
Query: 560 LYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLS 619
L L + +N + + L LD++ N VC L ++
Sbjct: 808 LIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-62
Identities = 70/538 (13%), Positives = 150/538 (27%), Gaps = 120/538 (22%)
Query: 83 NLSTLCLNGTFQDFSFSSFP---HLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLS 139
L + + F+ + N + + N NL L +++L N
Sbjct: 449 KLQIIYFANS----PFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504
Query: 140 GVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSK 199
+ + L +L+ L + N+ + + R+ K
Sbjct: 505 TQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWT--------------RLADDEDTGPK 549
Query: 200 LALLYLNNNSLFGY-IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSL 258
+ + Y+ N+L + + + L LD N++ L L L L N +
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA--FGTNVKLTDLKLDYNQI 607
Query: 259 SGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLK 318
+ L N+L IP F ++
Sbjct: 608 EEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN----------------------AKSVY 644
Query: 319 SLSTLGLYLNQLNGVIP-----PSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKL 373
+ ++ N++ + ++L N + E +S + L
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704
Query: 374 CKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYE- 432
N ++ + + P + K+ L + N L +
Sbjct: 705 SNNLMTSI-----------------PENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDF 747
Query: 433 AFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLD 492
P L+ +D+S N F S P + +SS+L+
Sbjct: 748 RATTLPYLSNMDVSYNCFS-------------------------SFPTQPLNSSQLKAFG 782
Query: 493 LSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPK 552
+ N++ P + L L + +N + + +
Sbjct: 783 IRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDE 823
Query: 553 SIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEK 610
+ +LY L++++N I L ++ Q+ + C+ +E+
Sbjct: 824 KL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI---RGCDALGIER 876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 2e-44
Identities = 52/383 (13%), Positives = 111/383 (28%), Gaps = 42/383 (10%)
Query: 280 NQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIG 339
+ + I + W + + + + + L+ +
Sbjct: 262 KETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLD 320
Query: 340 NLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCE 399
N + LSL G G +P+ IG L L L ++ + + +
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 400 NHLFGPIPK-SLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNW 458
+ + K L L Q+ + + + L
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINR--NPEMKPIKKDSRISLKDTQIGN------ 432
Query: 459 RNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILS 518
+ N I I +KLQ + +++
Sbjct: 433 ------------LTNRITFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSD 475
Query: 519 LNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSH------ 572
+ + L + +L +L ++L + +P + +L +L LN++ N+
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535
Query: 573 ---TIPIEFEKLIHLSKLDLSHNILQEEIPPQV--CNMESLEKLNLSHNNLSGFIPRCFE 627
+ + + + + +N L EE P M L L+ HN + F
Sbjct: 536 DWTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHNKVR--HLEAFG 592
Query: 628 KMRSLSCIDICYNELQGPIPNST 650
L+ + + YN+++ IP
Sbjct: 593 TNVKLTDLKLDYNQIEE-IPEDF 614
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 2e-86
Identities = 113/555 (20%), Positives = 180/555 (32%), Gaps = 36/555 (6%)
Query: 101 FPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMN 160
L SFN+ L L LDL Q+ + ++L L L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 161 QLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGN 220
L + + F +S L N L LYL +N +
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 221 LKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS-GSIPSIIGNLKSLHQLDLIE 279
+ L LD N ++ L + +L L L N I + L+
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGG 211
Query: 280 NQLSGSIPLSFGNLSSWTLMSLF--SNSLSGSIPPILGNLKSLSTLGLYL--NQLNGVIP 335
Q I N + +L P + L +S + L + +
Sbjct: 212 TQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271
Query: 336 PSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLL 395
+ S L+ L L L +P + L +L +L L N + S N L L
Sbjct: 272 NTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330
Query: 396 NMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD--GK 453
++ N + + NL LDLS ++ +
Sbjct: 331 SIKGNTKRLELGT-----------------------GCLENLENLRELDLSHDDIETSDC 367
Query: 454 ISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIP-VQLEKLFSL 512
+ RNL L + +S N + +L+ LDL+ + K + L L
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427
Query: 513 NKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIG---NLLKLYYLNLSNNQ 569
L LS + L S F L LQ+L+L N + L +L L LS
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 570 FSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKM 629
S F L ++ +DLSHN L + +++ + LNL+ N++S +P +
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPIL 546
Query: 630 RSLSCIDICYNELQG 644
I++ N L
Sbjct: 547 SQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 1e-82
Identities = 100/509 (19%), Positives = 185/509 (36%), Gaps = 16/509 (3%)
Query: 153 RRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFG 212
+ + L+ IP + + F N + ++ L L L L ++
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 213 YIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSL 272
+ L TL L+ N L + L L LF + +S + N K+L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 273 HQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLN- 331
L L N +S ++ +N++ + +L+ + L L LN +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 332 GVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGY--LKSLSELKLCKNNLSGVIPHSVGNL 389
I P + + ++L+ I + + ++SL + + P L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 390 TGLVL--LNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQ 447
+ + +N+ +++ F + + L+ + +L ++ L L LS
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSA 310
Query: 448 NNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLE-IGDSSKLQFLDLSSNHI--VGKIPV 504
N F+ + N P L + N + + + L+ LDLS + I +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 505 QLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI-GNLLKLYYL 563
QL L L L LS N+ F +L+ LDL+ +L +S NL L L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 564 NLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEI---PPQVCNMESLEKLNLSHNNLSG 620
NLS++ + F+ L L L+L N + + + LE L LS +LS
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 621 FIPRCFEKMRSLSCIDICYNELQGPIPNS 649
F ++ ++ +D+ +N L +
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 2e-81
Identities = 94/536 (17%), Positives = 180/536 (33%), Gaps = 38/536 (7%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
+FS +L L+L+ + + +L L L N L + + L+ L+
Sbjct: 52 TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT 216
+ L N L LYL +N +
Sbjct: 112 FIQTGISSI------------------------DFIPLHNQKTLESLYLGSNHISSIKLP 147
Query: 217 VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS-GSIPSIIGNLKSLHQL 275
+ L LD N ++ L + +L L L N I + L
Sbjct: 148 KGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSL 207
Query: 276 DLIENQLSGSIPLSFGNLSSWTLMSLF--SNSLSGSIPPILGNLKSLSTLGLYL--NQLN 331
+ Q I N + +L P + L +S + L +
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267
Query: 332 GVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTG 391
+ + S L+ L L L +P + L +L +L L N + S N
Sbjct: 268 NISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPS 326
Query: 392 LVLLNMCENHLFGPI-PKSLKSLTSLKRVRFNQNNL--VGKVYEAFGDHPNLTFLDLSQN 448
L L++ N + L++L +L+ + + +++ + +L L+LS N
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386
Query: 449 NFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEI-GDSSKLQFLDLSSNHIVGKIPVQLE 507
+ ++ P+L+ ++ + + L+ L+LS + + +
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 508 KLFSLNKLILSLNQLSGSVPLE---FGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLN 564
L +L L L N + +L L+ L LS LSS + +L + +++
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506
Query: 565 LSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSG 620
LS+N+ + + L + L+L+ N + +P + + +NL N L
Sbjct: 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 4e-78
Identities = 113/553 (20%), Positives = 195/553 (35%), Gaps = 22/553 (3%)
Query: 83 NLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQL 138
NL+ L L + +F S L L L+ N + L++L +
Sbjct: 58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117
Query: 139 SGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLS 198
S + + L LYL N + P + F +N + + +L
Sbjct: 118 SSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177
Query: 199 KLALLYLNNNSLF-GYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDN--LSNLDTLFLYK 255
+ L LN N I + +L+ Q +I L N + +L
Sbjct: 178 QATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237
Query: 256 NSLSGSIPSIIGNLK--SLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPI 313
P++ L S+ ++L ++ +F S + L + LS +P
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296
Query: 314 LGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEE-IGYLKSLSELK 372
L L +L L L N+ + S N SL +LS+ N + + L++L EL
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 373 LCKNNL--SGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKV 430
L +++ S + NL+ L LN+ N ++ K L+ + L K
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 431 YE-AFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIG---DSS 486
+ F + L L+LS + D + LP L + N+ +
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
Query: 487 KLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKL 546
+L+ L LS + L +N + LS N+L+ S L + YL+L++N +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535
Query: 547 SSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNME 606
S +P + L + +NL N T + L + L++ N
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCTCSNIY----FLEWYKENMQKLEDTEDTLCENPP 591
Query: 607 SLEKLNLSHNNLS 619
L + LS LS
Sbjct: 592 LLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 6e-67
Identities = 92/461 (19%), Positives = 157/461 (34%), Gaps = 31/461 (6%)
Query: 226 TLDLSQ---------------------NQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS 264
T + N L + T L NL L L + +
Sbjct: 16 TYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 265 IIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLG 324
+ L L L N L + + + +S L N K+L +L
Sbjct: 76 TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 325 LYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLC-KNNLSGVIP 383
L N ++ + P L+ L NN ++ E++ L+ + L L N I
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195
Query: 384 HSVGNLTGLVLLNMCENHLFGPIPKSLK--SLTSLKRVRFNQNNLVGKVYEAFGD--HPN 439
+ LN I K LK ++ SL F + F +
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255
Query: 440 LTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIV 499
+ ++L ++ F S + L ++ ++ +P + S L+ L LS+N
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFE 314
Query: 500 GKIPVQLEKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSANKLSSS--IPKSIGN 556
+ SL L + N + +L L+ LDLS + + +S + N
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
Query: 557 LLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSH 615
L L LNLS N+ F++ L LDL+ L+ + N+ L+ LNLSH
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434
Query: 616 NNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGL 656
+ L + F+ + +L +++ N T L
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-52
Identities = 75/394 (19%), Positives = 131/394 (33%), Gaps = 15/394 (3%)
Query: 76 GSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGN--LSKLQNLDL 133
+ +S+NL+ + G + +LN I + N + L
Sbjct: 178 QATNLSLNLNGNDIAGI--EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 134 GNNQLSGVISPEIGKL--NQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIP 191
+ + L + + L + S + E ++S +P
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP 294
Query: 192 SSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLI-PCTLDNLSNLDT 250
S L LS L L L+ N N SL+ L + N + L+NL NL
Sbjct: 295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 251 LFLYKNSLSGSIPSI--IGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSG 308
L L + + S + NL L L+L N+ +F L+ L L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 309 SIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIG---Y 364
NL L L L + L+ L +L++L+L N ++
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474
Query: 365 LKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424
L L L L +LS + H+ +L + +++ N L ++L L + + N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASN 533
Query: 425 NLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNW 458
++ + ++L QN D S +
Sbjct: 534 HISIILPSLLPILSQQRTINLRQNPLDCTCSNIY 567
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 4e-84
Identities = 99/338 (29%), Positives = 148/338 (43%), Gaps = 39/338 (11%)
Query: 25 SSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAG--SRVISI 82
+ + ALL K L N + LSSW + +W G+ C+ RV ++
Sbjct: 4 NPQDKQALLQIKKDLGNP----TTLSSWL----PTTDCCNRTWLGVLCDTDTQTYRVNNL 55
Query: 83 NLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGN-NQLSGV 141
+LS L L IP + NL L L +G N L G
Sbjct: 56 DLSGLNLPKP-----------------------YPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 142 ISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLA 201
I P I KL QL LY+ + G IP + Q+ + F +N +SG +P S+ +L L
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 202 LLYLNNNSLFGYIPTVMGNLKSLST-LDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
+ + N + G IP G+ L T + +S+N+L G IP T NL NL + L +N L G
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEG 211
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSL 320
+ G+ K+ ++ L +N L+ + G + + L +N + G++P L LK L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270
Query: 321 STLGLYLNQLNGVIPPSIGNLSSLRNLSLF-NNGLYGS 357
+L + N L G I P GNL + N L GS
Sbjct: 271 HSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 1e-72
Identities = 82/339 (24%), Positives = 130/339 (38%), Gaps = 57/339 (16%)
Query: 261 SIPSIIGNLKSL----HQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS--IPPIL 314
I +GN +L D G + + + L +L IP L
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 315 GNLKSLSTLGLY-LNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKL 373
NL L+ L + +N L G IPP+I L+ L L + + + G+IP+ + +K+L L
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 374 CKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEA 433
N LSG +P S+ +L LV + N + G IP S S + L
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL----------------- 175
Query: 434 FGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDL 493
T + +S+N G IP + + L F+DL
Sbjct: 176 ------FTSMTISRNRLTG------------------------KIPPTFANLN-LAFVDL 204
Query: 494 SSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKS 553
S N + G V + K+ L+ N L+ + + G L LDL N++ ++P+
Sbjct: 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQG 263
Query: 554 IGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHN 592
+ L L+ LN+S N IP L ++N
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 1e-72
Identities = 79/299 (26%), Positives = 132/299 (44%), Gaps = 11/299 (3%)
Query: 190 IPSSLGNLSKLA----LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG--LIPCTLD 243
I LGN + L+ N + G + ++ LDLS L IP +L
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 244 NLSNLDTLFLYK-NSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLF 302
NL L+ L++ N+L G IP I L LH L + +SG+IP + + +
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSL-RNLSLFNNGLYGSIPEE 361
N+LSG++PP + +L +L + N+++G IP S G+ S L ++++ N L G IP
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 362 IGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRF 421
L +L+ + L +N L G G+ +++ +N L + + +L +
Sbjct: 194 FANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL 251
Query: 422 NQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPL 480
N + G + + L L++S NN G+I NL + D + N PL
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 8e-69
Identities = 81/344 (23%), Positives = 142/344 (41%), Gaps = 61/344 (17%)
Query: 334 IPPSIGNLSSLRN----LSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGV--IPHSVG 387
I +GN ++L + N G + + ++ L L NL IP S+
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 388 NLTGLVLLNM-CENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLS 446
NL L L + N+L GPIP ++ LT L +L ++
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLT------------------------QLHYLYIT 109
Query: 447 QNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL 506
N G +IP + L LD S N + G +P +
Sbjct: 110 HTNVSG------------------------AIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
Query: 507 EKLFSLNKLILSLNQLSGSVPLEFGSLTEL-QYLDLSANKLSSSIPKSIGNLLKLYYLNL 565
L +L + N++SG++P +GS ++L + +S N+L+ IP + NL L +++L
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDL 204
Query: 566 SNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRC 625
S N + F + K+ L+ N L ++ +V ++L L+L +N + G +P+
Sbjct: 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQG 263
Query: 626 FEKMRSLSCIDICYNELQGPIPNSTVFKD---GLMEGNKGLCGN 666
+++ L +++ +N L G IP + NK LCG+
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 272 bits (699), Expect = 2e-83
Identities = 93/282 (32%), Positives = 145/282 (51%), Gaps = 16/282 (5%)
Query: 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVL 803
E+ A+D+F K +G+GG G VYK L G +VAVK+ + G + +F V
Sbjct: 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG---ELQFQTEVE 79
Query: 804 ALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDATAKELSWNRRINVIKG 862
++ HRN+++ GFC LV Y+ GS+A L + L W +R + G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN-RTEFVGTF 921
A L+YLH C P IIHRD+ + N+LLD EFEA V DFG+AK ++ ++ T GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII--------- 972
G+ APE T +++EK DV+ +GV++ E+I G D + ++
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
++ ++D L +++ +++VA+LC SP RP M
Sbjct: 260 KLEALVDVDLQGNYK--DEEVEQLIQVALLCTQSSPMERPKM 299
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 2e-80
Identities = 110/560 (19%), Positives = 182/560 (32%), Gaps = 51/560 (9%)
Query: 101 FPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMN 160
N++LSFN N S+LQ LDL ++ + L+ L L L N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 161 QLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGY-IPTVMG 219
+ P L+ + ++ +G L L L + +N + +P
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 220 NLKSLSTLDLSQNQLNGLIPCTLDNLSNLD----TLFLYKNSLSGSIPSIIGNLKSLHQL 275
NL +L +DLS N + + L L +L + N + I LH+L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHEL 209
Query: 276 DLIENQLSGSIP-LSFGNLSSWTLMSLFSNSLSGSI------PPILGNLKSLSTLGLYLN 328
L N S +I NL+ + L P I+ L ++ L
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269
Query: 329 QLN--GVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSV 386
N L+++ +SL + E++ L + + L
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQF---PT 324
Query: 387 GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLS 446
+L L L + N P+L++LDLS
Sbjct: 325 LDLPFLKSLTLTMNKGSIS--------------------------FKKVALPSLSYLDLS 358
Query: 447 QNNFD--GKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPV 504
+N G S++ L +S N + +LQ LD + +
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEF 417
Query: 505 Q-LEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI-GNLLKLYY 562
L L L +S F LT L L ++ N + ++ N L +
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477
Query: 563 LNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFI 622
L+LS Q F+ L L L++SHN L + SL L+ S N +
Sbjct: 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK 537
Query: 623 PRCFEKMRSLSCIDICYNEL 642
+SL+ ++ N +
Sbjct: 538 GILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 2e-73
Identities = 108/527 (20%), Positives = 182/527 (34%), Gaps = 29/527 (5%)
Query: 140 GVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSK 199
G ++P I + + +L +P I S N + S N S+
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 200 LALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS 259
L L L+ + L LS L L+ N + P + L++L+ L + L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 260 GSIPSIIGNLKSLHQLDLIENQLSG-SIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLK 318
IG L +L +L++ N + +P F NL++ + L N + L L+
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 319 SLSTLGLYLNQLN---GVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGY-LKSLSELKLC 374
+ L L+ I L L+L N +I + L L +L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 375 KN------NLSGVIPHSVGNLTGLVL--LNMCENHLFGPIPKSLKSLTSLKRVRFNQNNL 426
NL P + L + + + + F L ++ + ++
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 427 VGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSS 486
H L + + + + L L ++MN SI +
Sbjct: 298 KYLEDVPK--HFKWQSLSIIRCQLKQFPTLDLPFLKSLT---LTMNKG--SISFKKVALP 350
Query: 487 KLQFLDLSSNHI--VGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSAN 544
L +LDLS N + G SL L LS N + F L ELQ+LD +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409
Query: 545 KLSSSIPKS-IGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV- 602
L S +L KL YL++S F L L+ L ++ N ++ V
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 603 CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNS 649
N +L L+LS L F+ + L +++ +N L +
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 4e-62
Identities = 113/507 (22%), Positives = 176/507 (34%), Gaps = 47/507 (9%)
Query: 83 NLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQL 138
+LS L L G +F SFS L NL IG L L+ L++ +N +
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 139 SGVISPE-IGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNL 197
P L L + L N + + L N
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR--------------------ENP 180
Query: 198 SKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCT-LDNLSNLDTLFLYKN 256
L ++ N + +I L L L N + I T L NL+ L L
Sbjct: 181 QVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239
Query: 257 SLSGSI------PSIIGNLKSLH--QLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSG 308
PSI+ L + + L + F L++ + MSL S+
Sbjct: 240 EFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY 299
Query: 309 SIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSL 368
+ +L + QL +L L++L+L N SI + L SL
Sbjct: 300 --LEDVPKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKG--SISFKKVALPSL 352
Query: 369 SELKLCKNNLSGVIPHSVGNL--TGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNL 426
S L L +N LS S +L L L++ N + + L L+ + F + L
Sbjct: 353 SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTL 411
Query: 427 VGKVY-EAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEI-GD 484
AF L +LD+S N + L L+T ++ N+ + + +
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
Query: 485 SSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSAN 544
++ L FLDLS + + L L L +S N L + L L LD S N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 545 KLSSSIPKSIGNLLKLYYLNLSNNQFS 571
++ +S L + NL+NN +
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-60
Identities = 96/480 (20%), Positives = 170/480 (35%), Gaps = 30/480 (6%)
Query: 188 GRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSN 247
G + + + + ++ +P + + S +DLS N L L + N S
Sbjct: 2 GSLNPCIEVVPNITYQCMDQK--LSKVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 248 LDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLS 307
L L L + + L L L L N + P SF L+S + L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 308 GSIPPILGNLKSLSTLGLYLNQLNGV-IPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLK 366
+G L +L L + N ++ +P NL++L ++ L N + ++ +L+
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 367 SLS----ELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPK-SLKSLTSLKRVRF 421
L + N + I L L + N I K L++L L R
Sbjct: 178 ENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 422 NQNNLVGKVYEAFGD--------HPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNN 473
+ + + L+ N + L + ++ +
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 474 IFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSL 533
I ++ K Q L + + L L L L++N+ S+ + +L
Sbjct: 297 I--KYLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISFKKVAL 349
Query: 534 TELQYLDLSANKLSSSIPKSIGNL--LKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSH 591
L YLDLS N LS S S +L L +L+LS N + F L L LD H
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQH 408
Query: 592 NILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNST 650
+ L+ ++E L L++S+ N F + SL+ + + N + ++
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 4e-74
Identities = 101/288 (35%), Positives = 138/288 (47%), Gaps = 33/288 (11%)
Query: 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVL 803
++ +AT++FD KF IG G G VYK L G VA+K+ + G +EF +
Sbjct: 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI----EEFETEIE 87
Query: 804 ALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDATAKELSWNRRINVIKG 862
L+ RH ++V GFC L+ +Y+ G+L R L G+D +SW +R+ + G
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR---TEFVG 919
A L YLH IIHRD+ S N+LLD F ++DFGI+K T G
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG-TELDQTHLSTVVKG 203
Query: 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM--IIE---- 973
T GY PE R TEK DVYSFGV++FEV+ I S M + E
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA-----IVQSLPREMVNLAEWAVE 258
Query: 974 ------VNQILDPRL-STPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
+ QI+DP L P + K + A+ CL S E RP+M
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFG---DTAVKCLALSSEDRPSM 303
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 9e-69
Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 32/290 (11%)
Query: 744 EEIIKATDDFDEKFC------IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDE 797
E+ T++FDE+ +G+GG G VYK + VAVKK + + + +
Sbjct: 18 YELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQ 76
Query: 798 FLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI 857
F + + + +H N+V+ GF S+ LV Y+ GSL L LSW+ R
Sbjct: 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF--VEPYSSNRT 915
+ +G AN +++LH + IHRDI S N+LLD F A +SDFG+A+ + +
Sbjct: 137 KIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193
Query: 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE-- 973
VGT Y APE A T K D+YSFGV++ E+I G ++ ++++
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPA-----VDEHREPQLLLDIK 247
Query: 974 ---------VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
+ +D +++ ++ + VA CL E RP +
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMY---SVASQCLHEKKNKRPDI 294
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-64
Identities = 117/540 (21%), Positives = 197/540 (36%), Gaps = 56/540 (10%)
Query: 101 FPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMN 160
NL+LSFN + +LQ LDL ++ + L+ L L L N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 161 QLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGN 220
+ ++ + LS L L +L +G+
Sbjct: 87 PIQ-SLAL-----------------------GAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 221 LKSLSTLDLSQNQLNGL-IPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLH----QL 275
LK+L L+++ N + +P NL+NL+ L L N + + + L + L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 276 DLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQL---N 331
DL N ++ P +F + L +L +N S ++ + L L L L +
Sbjct: 183 DLSLNPMNFIQPGAFKEIRLHKL-TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 332 GVIPPSIGNLSSLRNLSL------FNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHS 385
+ L L NL++ + + I + L ++S L + V S
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301
Query: 386 -VGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLD 444
L L+N L SLKR+ F N + D P+L FLD
Sbjct: 302 YNFGWQHLELVNCKFGQF------PTLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLD 353
Query: 445 LSQN--NFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKI 502
LS+N +F G S + L +S N + ++ +L+ LD +++
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 503 PV-QLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI-GNLLKL 560
L +L L +S + F L+ L+ L ++ N + I L L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 561 YYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLS 619
+L+LS Q P F L L L+++ N L+ +P + + SL+K+ L N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-63
Identities = 112/487 (22%), Positives = 186/487 (38%), Gaps = 28/487 (5%)
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235
N + S + +L +L L+ + +L LSTL L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 236 GLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL-SGSIPLSFGNLS 294
L LS+L L + +L+ IG+LK+L +L++ N + S +P F NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 295 SWTLMSLFSNSLSGSIPPILGNLKSLS----TLGLYLNQLNGVIPPSIGNLSSLRNLSLF 350
+ + L SN + L L + +L L LN +N I P L L+L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208
Query: 351 NNGLYGSIPEE-IGYLKSLSELKLCK------NNLSGVIPHSVGNLTGLVLLNMCENHL- 402
NN ++ + I L L +L NL ++ L L + +L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 403 --FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRN 460
I LT++ + ++ + L+L F + ++
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKS 326
Query: 461 LPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHI--VGKIPVQLEKLFSLNKLILS 518
L +L N F + L L+FLDLS N + G SL L LS
Sbjct: 327 LKRLTFTSNKGGNAFSEVDL-----PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 519 LNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQFSHTIPIE 577
N + ++ F L +L++LD + L S+ +L L YL++S+
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 578 FEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCID 636
F L L L ++ N QE P + + +L L+LS L P F + SL ++
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 637 ICYNELQ 643
+ N+L+
Sbjct: 501 MASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-52
Identities = 99/446 (22%), Positives = 160/446 (35%), Gaps = 27/446 (6%)
Query: 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282
S LDLS N L L + + L L L + + +L L L L N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 283 SGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGV-IPPSIGNL 341
+F LSS + +L+ +G+LK+L L + N + +P NL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 342 SSLRNLSLFNNGLYGSIPEEIGYLKSLS----ELKLCKNNLSGVIPHSVGNLTGLVLLNM 397
++L +L L +N + ++ L + L L N ++ I L L +
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTL 207
Query: 398 CENHLFGPIPK-------SLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNF 450
N + K L+ + N+ NL A NLT +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 451 DG---KISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLE 507
D I + L + +F + I + + Q L+L +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTI-ERVKDFSYNFG-WQHLELVNCKFGQ---FPTL 322
Query: 508 KLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLS--SSIPKSIGNLLKLYYLNL 565
KL SL +L + N+ + L L++LDLS N LS +S L YL+L
Sbjct: 323 KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 566 SNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPR 624
S N T+ F L L LD H+ L++ V ++ +L L++SH +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 625 CFEKMRSLSCIDICYNELQGPIPNST 650
F + SL + + N Q
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-33
Identities = 70/366 (19%), Positives = 113/366 (30%), Gaps = 26/366 (7%)
Query: 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362
+ IP L S L L N L + S + L+ L L +
Sbjct: 16 ELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 363 GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFN 422
L LS L L N + + + L+ L L E +L + L +LK +
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 423 QNNL-VGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMN---NIFGSI 478
N + K+ E F + NL LDLS N + R L ++ +S++ N I
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 479 PLEIGDSSKLQFLDLSSNHIVGKIP-VQLEKLFSLNKLILSLNQLSGSVPLE------FG 531
+L L L +N + ++ L L L L + LE
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 532 SLTELQYLDLSANKL---SSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFE-KLIHLSKL 587
L L + L I L + +L + + HL +
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELV 312
Query: 588 DLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIP 647
+ ++SL++L + N + SL +D+ N L
Sbjct: 313 NCKFGQFPT------LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGC 364
Query: 648 NSTVFK 653
S
Sbjct: 365 CSQSDF 370
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 70/358 (19%), Positives = 113/358 (31%), Gaps = 43/358 (12%)
Query: 81 SINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGN---IPPQIGNLSKLQNLDLGNNQ 137
+ L + L L F L L NL + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 138 LSGV------ISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIP 191
L+ + I L + L + + H N G+ P
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQH--LELVNCKFGQFP 320
Query: 192 SSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN--GLIPCTLDNLSNLD 249
+ L L L +N V +L SL LDLS+N L+ G + ++L
Sbjct: 321 T--LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 250 TLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309
L L N + ++ S L+ L LD + L S
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV------------------- 416
Query: 310 IPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI-GYLKSL 368
+L++L L + LSSL L + N + +I L++L
Sbjct: 417 ----FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 369 SELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNL 426
+ L L + L + P + +L+ L +LNM N L LTSL+++ + N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-21
Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 4/159 (2%)
Query: 492 DLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIP 551
+ KIP L S L LS N L F S ELQ LDLS ++ +
Sbjct: 13 QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 552 KSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKL 611
+ +L L L L+ N F L L KL L + ++++L++L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 612 NLSHNNLSGF-IPRCFEKMRSLSCIDICYNELQGPIPNS 649
N++HN + F +P F + +L +D+ N++Q
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-62
Identities = 112/520 (21%), Positives = 198/520 (38%), Gaps = 61/520 (11%)
Query: 104 LVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLH 163
L + ++ + I L++ LG ++ +S L+Q+ L D +
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58
Query: 164 GTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKS 223
+ + L+ L + +NN L P + NL
Sbjct: 59 -------------------------KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTK 91
Query: 224 LSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS 283
L + ++ NQ+ + P L NL+NL L L+ N ++ P + NL +L++L+L N +S
Sbjct: 92 LVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS 147
Query: 284 GSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSS 343
LS L+S +S N ++ P L NL +L L + N+++ + L++
Sbjct: 148 DISALS--GLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTN 200
Query: 344 LRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLF 403
L +L NN + P +G L +L EL L N L + + +LT L L++ N +
Sbjct: 201 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQIS 256
Query: 404 GPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPK 463
P L LT L ++ N + LT L+L++N + + NL
Sbjct: 257 NLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISPIS--NLKN 310
Query: 464 LDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLS 523
L + NNI P+ +KLQ L +N + L L ++N L NQ+S
Sbjct: 311 LTYLTLYFNNISDISPV--SSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQIS 366
Query: 524 GSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIH 583
PL +LT + L L+ +++ N+ + P
Sbjct: 367 DLTPL--ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGS 422
Query: 584 LSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIP 623
++ D++ N+ + SG +
Sbjct: 423 YTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 4e-58
Identities = 105/449 (23%), Positives = 179/449 (39%), Gaps = 35/449 (7%)
Query: 201 ALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
+ + + L L + + + +L + TL + +
Sbjct: 5 SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK- 59
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSL 320
SI + L +L Q++ NQL+ PL NL+ + + +N ++ P L NL +L
Sbjct: 60 SIDGV-EYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTNL 114
Query: 321 STLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSG 380
+ L L+ NQ+ + P + NL++L L L +N + S + L SL +L N ++
Sbjct: 115 TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSF-GNQVTD 169
Query: 381 VIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNL 440
+ P + NLT L L++ N + L LT+L+ + N + G NL
Sbjct: 170 LKP--LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQI--SDITPLGILTNL 223
Query: 441 TFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVG 500
L L+ N + +L L ++ N I PL +KL L L +N I
Sbjct: 224 DELSLNGNQLKDIGTLA--SLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISN 279
Query: 501 KIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKL 560
P L L +L L L+ NQL P+ +L L YL L N +S P + +L KL
Sbjct: 280 ISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKL 333
Query: 561 YYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSG 620
L NN+ + L +++ L HN + + P + N+ + +L L+ +
Sbjct: 334 QRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
Query: 621 FIPRCFEKMRSLSCIDICYNELQGPIPNS 649
+ + + L P S
Sbjct: 390 APVNYKANVSIPNTVKNVTGALIAPATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-56
Identities = 111/447 (24%), Positives = 184/447 (41%), Gaps = 34/447 (7%)
Query: 83 NLSTLCLNGT-FQDFS-FSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG 140
++TL + + +L +N S N +I P + NL+KL ++ + NNQ++
Sbjct: 47 QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQ-LTDITP-LKNLTKLVDILMNNNQIAD 104
Query: 141 VISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKL 200
+ + L L L L NQ+ T + L+ ++ N +S S+L L+ L
Sbjct: 105 I--TPLANLTNLTGLTLFNNQI--TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSL 158
Query: 201 ALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
L N + NL +L LD+S N+++ + L L+NL++L N +S
Sbjct: 159 QQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISD 213
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSL 320
P +G L +L +L L NQL I + +L++ T + L +N +S P L L L
Sbjct: 214 ITP--LGILTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKL 267
Query: 321 STLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSG 380
+ L L NQ++ + P + L++L NL L N L P I LK+L+ L L NN+S
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323
Query: 381 VIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNL 440
+ P V +LT L L N + L +LT++ + N + + +
Sbjct: 324 ISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISD--LTPLANLTRI 377
Query: 441 TFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVG 500
T L L+ + N+ +T V P I D D++ N
Sbjct: 378 TQLGLNDQAWTNAPVNYKANVSIPNT--VKNVTGALIAPATISDGGSYTEPDITWNLP-S 434
Query: 501 KIPVQLEKLFSLNKLILSLNQLSGSVP 527
+ SG+V
Sbjct: 435 YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-62
Identities = 83/305 (27%), Positives = 129/305 (42%), Gaps = 49/305 (16%)
Query: 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-- 801
E + + +G G V+KA+L + VAVK F Q D+ + N
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-------DKQSWQNEYE 68
Query: 802 VLALNEIRHRNIVKFHGFCSNARHS----FLVCEYLHRGSLARILGNDATAKELSWNRRI 857
V +L ++H NI++F G +L+ + +GSL+ L A +SWN
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELC 124
Query: 858 NVIKGVANALSYLHHDCL-------PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910
++ + +A L+YLH D P+I HRDI SKNVLL A ++DFG+A E
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 911 SS--NRTEFVGTFGYAAPEIA-----YTMRATEKYDVYSFGVLVFEVIKGNHPRDF---- 959
S + VGT Y APE+ + A + D+Y+ G++++E+ D
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 960 FSINFS-------SFSNMIIEV-NQILDPRL--STPSPGVMDKLISIMEVAILCLDESPE 1009
+ + F S +M V ++ P L M L +E C D E
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE---ECWDHDAE 301
Query: 1010 ARPTM 1014
AR +
Sbjct: 302 ARLSA 306
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-59
Identities = 139/663 (20%), Positives = 220/663 (33%), Gaps = 75/663 (11%)
Query: 83 NLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQ 137
L L+ T SF L L L I + NL L+ LDLG+++
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 138 LSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNL 197
+ + L L L L L + NL
Sbjct: 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLK----------------------DGYFRNL 122
Query: 198 SKLALLYLNNNSLFG-YIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLS--NLDTLFLY 254
L L L+ N + Y+ G L SL ++D S NQ+ + L+ L L L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 255 KNSLSGSIPSIIGN-LKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPI 313
NSL + G + + L +S GN + + FSN++S S
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVS-------GNGWTVDITGNFSNAISKSQAFS 235
Query: 314 LGNLKSLSTLGLYLNQLNGVIPPSIGNL--SSLRNLSLFNNGLYGSIPEEIGYLKSLSEL 371
L + G + + + L SS+R+L L + ++ LK L L
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295
Query: 372 KLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVY 431
L N ++ + + L L +LN+ N L + L + + +N++
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 432 EAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFL 491
+ F L LDL N +P + +S N + ++P + +
Sbjct: 356 QTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL-VTLP---KINLTANLI 406
Query: 492 DLSSNHIVG-KIPVQLEKLFSLNKLILSLNQLSG-SVPLEFGSLTELQYLDLSANKLSSS 549
LS N + I L ++ L LIL+ N+ S S L+ L L N L +
Sbjct: 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466
Query: 550 IPKSI-----GNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCN 604
+ L L L L++N + P F L L L L+ N L +
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-L 524
Query: 605 MESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLMEGNKGLC 664
+LE L++S N L P F SLS +DI +N+ ST F + L N +
Sbjct: 525 PANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECELST-FINWLNHTNVTIA 580
Query: 665 GNFEAFSSCDAFMSHKQ-------------TSRKKWIVIVFPILGMVLLLISLIGFFFFF 711
G K +F + + L L +
Sbjct: 581 GPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTK 640
Query: 712 RQR 714
+
Sbjct: 641 FRG 643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-42
Identities = 92/429 (21%), Positives = 158/429 (36%), Gaps = 39/429 (9%)
Query: 220 NLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI-PSIIGNLKSLHQLDLI 278
L + L LS N + + + L L L L +I NL +L LDL
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 279 ENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP--ILGNLKSLSTLGLYLNQLNGV-IP 335
+++ P +F L + L+ LS ++ NLK+L+ L L NQ+ + +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 336 PSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLL 395
PS G L+SL+++ +N ++ + E L+ L L +L+ +S ++ +
Sbjct: 142 PSFGKLNSLKSIDFSSNQIF-LVCEHE--LEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198
Query: 396 NMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKIS 455
N N + + S T F+ N + + ++ +N
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFS-NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQ 257
Query: 456 FNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKL 515
+ L + S ++ LDLS + E L L L
Sbjct: 258 NTFAGLAR----------------------SSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295
Query: 516 ILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIP 575
L+ N+++ F L LQ L+LS N L + L K+ Y++L N +
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 576 IEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCI 635
F+ L L LDL N L + + S+ + LS N L + + I
Sbjct: 356 QTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLVTLPKINL----TANLI 406
Query: 636 DICYNELQG 644
+ N L+
Sbjct: 407 HLSENRLEN 415
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-31
Identities = 86/415 (20%), Positives = 146/415 (35%), Gaps = 28/415 (6%)
Query: 15 LNFSHNVTSDSSAEACALLNWKTSLQNQNLNS----SLLSSWTLYPTNASKISPCSWFGI 70
++FS N L +L +L + S +S N + +
Sbjct: 153 IDFSSNQIFLVCEHELEPLQ-GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV 211
Query: 71 SCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNL--SKL 128
S N V + ++ + Q FS H++ F+ L S +
Sbjct: 212 SGNG--WTVDITGNFSNAISKS-QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
Query: 129 QNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSG 188
++LDL + + + S L L+ L L N+++ L + + +N +
Sbjct: 269 RHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328
Query: 189 RIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNL 248
S+ L K+A + L N + L+ L TLDL N L T+ + ++
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSI 383
Query: 249 DTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSG-SIPLSFGNLSSWTLMSLFSNSLS 307
+FL N L ++ + + + L EN+L I + ++ L N S
Sbjct: 384 PDIFLSGNKLV----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439
Query: 308 GSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSI-----GNLSSLRNLSLFNNGLYGSIPEE 361
SL L L N L + LS L+ L L +N L P
Sbjct: 440 SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGV 499
Query: 362 IGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSL 416
+L +L L L N L+ + + L +L++ N L P P SL+ L
Sbjct: 500 FSHLTALRGLSLNSNRLTVLSHND--LPANLEILDISRNQLLAPNPDVFVSLSVL 552
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-57
Identities = 86/299 (28%), Positives = 141/299 (47%), Gaps = 32/299 (10%)
Query: 741 IMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLN 800
I ++ + EK IG G G+V++AE G VAVK Q + EFL
Sbjct: 34 IPWCDL-----NIKEK--IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVN--EFLR 83
Query: 801 VVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVI 860
V + +RH NIV F G + + +V EYL RGSL R+L ++L RR+++
Sbjct: 84 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGT 920
VA ++YLH+ P I+HR++ S N+L+D ++ V DFG+++ + GT
Sbjct: 144 YDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT 202
Query: 921 FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDP 980
+ APE+ + EK DVYSFGV+++E+ P + ++N + + +
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP--WGNLNPAQVVAAVGFKCK---- 256
Query: 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILAIEASA 1039
RL P + ++ +I+E C P RP+ I+ ++ + SA
Sbjct: 257 RLEIPR-NLNPQVAAIIE---GCWTNEPWKRPSFA-----------TIMDLLRPLIKSA 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-56
Identities = 67/268 (25%), Positives = 116/268 (43%), Gaps = 26/268 (9%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+ + + +G+G G V KA+ VA+K+ S+ +++ F+ + L+ + H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE------SERKAFIVELRQLSRVNH 60
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
NIVK +G C N LV EY GSL +L + ++ + ++YL
Sbjct: 61 PNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFE-AHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
H ++IHRD+ N+LL + DFG A + ++ T G+ + APE+
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNKGSAAWMAPEVF 175
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL--DPRLSTPSP 987
+EK DV+S+G++++EVI P F + + R
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKP-------FDEIGGPAFRIMWAVHNGTRPPLIK- 227
Query: 988 GVMDKLISIMEVAILCLDESPEARPTME 1015
+ + S+M C + P RP+ME
Sbjct: 228 NLPKPIESLMT---RCWSKDPSQRPSME 252
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 6e-56
Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 25/265 (9%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
IG GG G VY+A GD VAVK + ++H NI+ G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
C + LV E+ G L R+L K + + +N +A ++YLH + + I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 879 IHRDISSKNVLLDLEFEAH--------VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY 930
IHRD+ S N+L+ + E ++DFG+A+ + + + G + + APE+
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGAYAWMAPEVIR 187
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990
++ DV+S+GVL++E++ G P F I+ + + + L PS
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP--FRGIDGLAVAYGVAMNKL----ALPIPS-TCP 240
Query: 991 DKLISIMEVAILCLDESPEARPTME 1015
+ +ME C + P +RP+
Sbjct: 241 EPFAKLME---DCWNPDPHSRPSFT 262
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-55
Identities = 102/514 (19%), Positives = 186/514 (36%), Gaps = 75/514 (14%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177
I P+ + + LQ ++ L+ + E + Y ++ PP G+ +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 178 EFSF------------CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLS 225
+N +P +L L + NSL +P + +LKSL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHLES---LVASCNSL-TELPELPQSLKSLL 117
Query: 226 TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGS 285
+ + L+ L P L+ L + N L +P + N L +D+ N L
Sbjct: 118 VDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-K 167
Query: 286 IPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLR 345
+P +L ++ +N L +P + NL L+ + N L +P + L
Sbjct: 168 LPDLPPSL---EFIAAGNNQLE-ELPEL-QNLPFLTAIYADNNSLK-KLPDLPLS---LE 218
Query: 346 NLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGP 405
++ NN L E+ L L+ + N L +P +L L + + L
Sbjct: 219 SIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL--- 272
Query: 406 IPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLD 465
P+ +SLT L + L PNL +L+ S N + +L +L+
Sbjct: 273 -PELPQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEIR-SLCDLPPSLEELN 323
Query: 466 TFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGS 525
VS N + +P +L+ L S NH+ ++P E +L +L + N L
Sbjct: 324 ---VSNNKL-IELPALPP---RLERLIASFNHLA-EVP---ELPQNLKQLHVEYNPLR-E 371
Query: 526 VPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLS 585
P S+ +L+ N + +P+ N L L++ N P + +
Sbjct: 372 FPDIPESVEDLR-----MNSHLAEVPELPQN---LKQLHVETNPLRE-FP---DIPESVE 419
Query: 586 KLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLS 619
L ++ + + + LE H++
Sbjct: 420 DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-45
Identities = 102/500 (20%), Positives = 175/500 (35%), Gaps = 83/500 (16%)
Query: 166 IPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLS 225
I P + + E +N++ +P N+ Y + P G + ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 226 TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGS 285
L L L LS S+P + +L+S L N L+
Sbjct: 62 VSRLRDCLDR-----------QAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-E 105
Query: 286 IPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLR 345
+P +L S + + +LS P L LG+ NQL + P + N S L+
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLK 156
Query: 346 NLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGP 405
+ + NN L +P+ SL + N L + + NL L + N L
Sbjct: 157 IIDVDNNSL-KKLPDLPP---SLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSL-KK 209
Query: 406 IPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLD 465
+P SL S+ N + + P LT + N + +L L+
Sbjct: 210 LPDLPLSLESI-VAGNNILEEL----PELQNLPFLTTIYADNNLL-KTLPDLPPSLEALN 263
Query: 466 TFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGS 525
+N +P L FLD+S N + L+ LN S N++ S
Sbjct: 264 VR----DNYLTDLPELPQ---SLTFLDVSENIF-SGLSELPPNLYYLN---ASSNEIR-S 311
Query: 526 VPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLS 585
+ L+ L++S NKL +P L +L S N + +P E +L
Sbjct: 312 LC---DLPPSLEELNVSNNKL-IELPALPPRLERLI---ASFNHLA-EVP---ELPQNLK 360
Query: 586 KLDLSHNILQEEIPPQVCNME----------------SLEKLNLSHNNLSGFIPRCFEKM 629
+L + +N L E P ++E +L++L++ N L P +
Sbjct: 361 QLHVEYNPL-REFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFP---DIP 415
Query: 630 RSLSCIDICYNELQGPIPNS 649
S+ + + + P +
Sbjct: 416 ESVEDLRMNSERVVDPYEFA 435
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 7e-55
Identities = 93/482 (19%), Positives = 180/482 (37%), Gaps = 25/482 (5%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRL 155
+ +L L L + I +L L++LDL +N LS + S G L+ L+ L
Sbjct: 45 DLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYL 103
Query: 156 YLDMNQLHG-TIPPVIGQLSLIHEFSFCHNNVSGRIP-SSLGNLSKLALLYLNNNSLFGY 213
L N + + L+ + + I L+ L L + SL Y
Sbjct: 104 NLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163
Query: 214 IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLH 273
+ +++ + L L ++ L+ D LS++ L L +L+ S + +
Sbjct: 164 QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223
Query: 274 QLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGV 333
+ + + S SF L L + + + ++ + V
Sbjct: 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVV 277
Query: 334 IPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLV 393
++R L + L+ + L+ + + + + + V +L L
Sbjct: 278 SELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLE 337
Query: 394 LLNMCEN---HLFGPIPKSLKSLTSLKRVRFNQNNL--VGKVYEAFGDHPNLTFLDLSQN 448
L++ EN + + SL+ + +QN+L + K E NLT LD+S+N
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN 397
Query: 449 NFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEK 508
F + + + K+ +S I + I + L+ LD+S+N++ + L +
Sbjct: 398 TF-HPMPDSCQWPEKMRFLNLSSTGI-RVVKTCIPQT--LEVLDVSNNNL-DSFSLFLPR 452
Query: 509 LFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNN 568
L L +S N+L ++P + L + +S N+L S L L + L N
Sbjct: 453 LQELY---ISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 569 QF 570
+
Sbjct: 508 PW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-54
Identities = 102/546 (18%), Positives = 194/546 (35%), Gaps = 44/546 (8%)
Query: 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQ 161
+ F +IP + + +++LDL N+++ + ++ L+ L L ++
Sbjct: 5 DASGVCDGRSR-SFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 162 LHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFG-YIPTVMGN 220
++ L + N++S S G LS L L L N + ++ N
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
Query: 221 LKSLSTLDLS-QNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIE 279
L +L TL + + + L++L+ L + SL + +++ +H L L
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181
Query: 280 NQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIG 339
++ + + + LSS + L +L+ L + S + + + + S
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 340 NLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCE 399
L L L + + E + V + L++ +
Sbjct: 242 ELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 400 NHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWR 459
+LF + L +KR+ + + +L FLDLS+N
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM--------- 346
Query: 460 NLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHI--VGKIPVQLEKLFSLNKLIL 517
N+ G LQ L LS NH+ + K L L +L L +
Sbjct: 347 ------VEEYLKNSAC------KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 518 SLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE 577
S N +P ++++L+LS+ + + I L L++SNN +
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNNNLDS-FSLF 449
Query: 578 FEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDI 637
L L +L +S N L+ +P L + +S N L F+++ SL I +
Sbjct: 450 ---LPRLQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504
Query: 638 CYNELQ 643
N
Sbjct: 505 HTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-53
Identities = 103/494 (20%), Positives = 174/494 (35%), Gaps = 39/494 (7%)
Query: 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCT 241
+ IPS L + + L L+ N + + +L L L +++N +
Sbjct: 12 GRSRSFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 242 LDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSG-SIPLSFGNLSSWTLMS 300
+L +L+ L L N LS S G L SL L+L+ N + F NL++ +
Sbjct: 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129
Query: 301 LFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIP 359
+ + I L SL+ L + L S+ ++ + +L+L + +
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 360 EEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL-------FGPIPKSLKS 412
L S+ L+L NL+ + + F + K L+
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249
Query: 413 LTSLKRVRFNQNNLVGKVY-----------EAFGDHPNLTFLDLSQNNFDGKISFNWRNL 461
+ L V F+ L G + + L + Q +S + L
Sbjct: 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309
Query: 462 PKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSSNHIVGKIPVQ---LEKLFSLNKLIL 517
K+ V + +F +P L+FLDLS N +V + SL L+L
Sbjct: 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 518 SLNQLS--GSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIP 575
S N L +L L LD+S N +P S K+ +LNLS+
Sbjct: 369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRV--- 424
Query: 576 IEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCI 635
++ L LD+S+N L + L++L +S N L L +
Sbjct: 425 VKTCIPQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKTLPDASL--FPVLLVM 478
Query: 636 DICYNELQGPIPNS 649
I N+L+
Sbjct: 479 KISRNQLKSVPDGI 492
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-33
Identities = 71/394 (18%), Positives = 141/394 (35%), Gaps = 33/394 (8%)
Query: 81 SINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG 140
++ + + + F+ L L + + ++ + +L L ++ +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 141 VISPEIGKLNQLRRLYLDMNQL---HGTIPPVIGQLSLIHEFSFCHNNVSG-------RI 190
++ L+ +R L L L + PV S + + +F + ++ ++
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 191 PSSLGNLSKLALLYLNNNSLFGYIPTVMGNLK--------SLSTLDLSQNQLNGLIPCTL 242
+ LS++ N L + P+ + ++ L + Q L +
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306
Query: 243 DNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSI---PLSFGNLSSWTLM 299
L + + + + + S +LKSL LDL EN + G S +
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366
Query: 300 SLFSNSLS--GSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGS 357
L N L IL LK+L++L + N + +P S +R L+L + G+
Sbjct: 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RV 424
Query: 358 IPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLK 417
+ I ++L L + NNL L L L + N L +P + L
Sbjct: 425 VKTCI--PQTLEVLDVSNNNLDSFSLF----LPRLQELYISRNKLKT-LPDAS-LFPVLL 476
Query: 418 RVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD 451
++ ++N L F +L + L N +D
Sbjct: 477 VMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 80/447 (17%), Positives = 145/447 (32%), Gaps = 41/447 (9%)
Query: 83 NLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFG-NIPPQIGNLSKLQNLDLGNNQ 137
+L L L+ + F L LNL N + + NL+ LQ L +GN +
Sbjct: 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 138 LSGVISPE-IGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGN 196
I L L L + L + + IH + + + +
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194
Query: 197 LSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKN 256
LS + L L + +L + + + + S + + + L + + L L L +
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254
Query: 257 SLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGN 316
+ + D ++ L + + + L + +
Sbjct: 255 EVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308
Query: 317 LKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGL---YGSIPEEIGYLKSLSELKL 373
L+ + + + +++ V +L SL L L N + Y G SL L L
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 374 CKNNLS--GVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVY 431
+N+L + L L L++ N P+P S + ++ + + +
Sbjct: 369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKT 427
Query: 432 EAFGDHPNLTFLDLSQNNFDG-----------KISFN-------WRNLPKLDTFIVSMNN 473
L LD+S NN D IS N P L +S N
Sbjct: 428 CIP---QTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQ 484
Query: 474 IFGSIPLEI-GDSSKLQFLDLSSNHIV 499
+ S+P I + LQ + L +N
Sbjct: 485 L-KSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 52/368 (14%), Positives = 139/368 (37%), Gaps = 13/368 (3%)
Query: 292 NLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFN 351
+ + + S S + SIP L ++ +L L N++ + + ++L+ L L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 352 NGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFG-PIPKS 409
+ + +I + L SL L L N+LS + G L+ L LN+ N +
Sbjct: 60 SRI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 410 LKSLTSLKRVRFNQNNLVGKVYE-AFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFI 468
+LT+L+ +R ++ F +L L++ + S + +++ +
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 469 VSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPL 528
+ ++ + + S +++L+L ++ L + + + S
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 529 EFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLD 588
F L +L L +++ + + + ++ + + + + +L
Sbjct: 239 SFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292
Query: 589 LSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPN 648
+ L ++ +E ++++ + ++ + + ++SL +D+ N +
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 649 STVFKDGL 656
++ K
Sbjct: 353 NSACKGAW 360
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-26
Identities = 62/376 (16%), Positives = 122/376 (32%), Gaps = 31/376 (8%)
Query: 15 LNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSS------WTLYPTNASKISPCSWF 68
L + +++ + + + L+ S + L ++ +
Sbjct: 153 LEIKALSLRNYQSQSLKSI---RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA 209
Query: 69 GISCNHAGSRVISINLSTLCL-NGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSK 127
+ +S + L D SF+ L+ L + + + +
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTL 263
Query: 128 LQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVS 187
D ++ V + +RRL++ L + V L + + ++ V
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
Query: 188 GRIPSSLGNLSKLALLYLNNN---SLFGYIPTVMGNLKSLSTLDLSQNQLNGL--IPCTL 242
S +L L L L+ N + G SL TL LSQN L + L
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383
Query: 243 DNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLF 302
L NL +L + +N+ +P + + L+L + + + ++ +
Sbjct: 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVS 439
Query: 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362
+N+L S L L+ L + N+L + P L + + N L
Sbjct: 440 NNNLD-SFSLFLPRLQELY---ISRNKLKTL--PDASLFPVLLVMKISRNQLKSVPDGIF 493
Query: 363 GYLKSLSELKLCKNNL 378
L SL ++ L N
Sbjct: 494 DRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-14
Identities = 36/171 (21%), Positives = 62/171 (36%), Gaps = 12/171 (7%)
Query: 97 SFSSFPHLVNLNLSFNLF--FGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRR 154
++P L L LS N + L L +LD+ N + ++R
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414
Query: 155 LYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYI 214
L L + + + +NN+ L L +L Y++ N L +
Sbjct: 415 LNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFLPRLQEL---YISRNKL-KTL 466
Query: 215 PTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSI 265
P L + +S+NQL + D L++L ++L+ N S P I
Sbjct: 467 P-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 516
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-54
Identities = 83/373 (22%), Positives = 160/373 (42%), Gaps = 27/373 (7%)
Query: 224 LSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS 283
+TL +N + P +L+ L K S++ + L+S+ +L + +++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 284 GSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSS 343
SI L++ ++L N ++ P L NL L+ L + N++ ++ NL++
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 344 LRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLF 403
LR L L + + P + L + L L N+ + + N+TGL L + E+ +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 404 GPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPK 463
P + +LT L + N N + + +L + N N+ +
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQI--EDISPLASLTSLHYFTAYVNQITDITPVA--NMTR 222
Query: 464 LDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLS 523
L++ + N I PL + S+L +L++ +N I I ++ L L L + NQ+S
Sbjct: 223 LNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQIS 278
Query: 524 GSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIH 583
+L++L L L+ N+L + + IG L L L LS N + P L
Sbjct: 279 DISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334
Query: 584 LSKLDLSHNILQE 596
+ D ++ ++++
Sbjct: 335 MDSADFANQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 4e-52
Identities = 79/346 (22%), Positives = 153/346 (44%), Gaps = 25/346 (7%)
Query: 83 NLSTLCLNGTF--QDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG 140
L + + L ++ +I I L+ L+ L+L NQ++
Sbjct: 23 EGIRAVLQKASVTDVVTQEELESITKLVVAGEKV-ASIQG-IEYLTNLEYLNLNGNQITD 80
Query: 141 VISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKL 200
+ + L +L LY+ N++ T + L+ + E +N+S S L NL+K+
Sbjct: 81 I--SPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD--ISPLANLTKM 134
Query: 201 ALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
L L N + + N+ L+ L ++++++ + P + NL++L +L L N +
Sbjct: 135 YSLNLGANHNLSDLSPL-SNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSL 320
P + +L SLH NQ++ P+ N++ + + +N ++ P L NL L
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKITDLSP--LANLSQL 245
Query: 321 STLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSG 380
+ L + NQ++ + ++ +L+ L+ L++ +N + S + L L+ L L N L
Sbjct: 246 TWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGN 301
Query: 381 VIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNL 426
+G LT L L + +NH+ P L SL+ + F +
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 7e-48
Identities = 74/334 (22%), Positives = 140/334 (41%), Gaps = 23/334 (6%)
Query: 314 LGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKL 373
+L L + V+ L S+ L + + + + I YL +L L L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNL 73
Query: 374 CKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEA 433
N ++ + P + NL L L + N + +L++LT+L+ + N++N+
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNI--SDISP 127
Query: 434 FGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDL 493
+ + L+L N+ +S N+ L+ V+ + + P I + + L L L
Sbjct: 128 LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184
Query: 494 SSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKS 553
+ N I P L L SL+ +NQ++ P+ ++T L L + NK++ P
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKITDLSP-- 238
Query: 554 IGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNL 613
+ NL +L +L + NQ S I + L L L++ N + + + N+ L L L
Sbjct: 239 LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 614 SHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIP 647
++N L + +L+ + + N + P
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 10/163 (6%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
+S L N +I P + N+++L +L +GNN+++ + + L+QL L
Sbjct: 194 PLASLTSLHYFTAYVNQI-TDITP-VANMTRLNSLKIGNNKITDL--SPLANLSQLTWLE 249
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT 216
+ NQ+ + + L+ + + N +S S L NLS+L L+LNNN L
Sbjct: 250 IGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 217 VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS 259
V+G L +L+TL LSQN + + P L +LS +D+ +
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-54
Identities = 74/286 (25%), Positives = 129/286 (45%), Gaps = 34/286 (11%)
Query: 741 IMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADQD--- 796
+ EI +++++ IGKGG G V+K L +VA+K G +
Sbjct: 16 LADNEI-----EYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68
Query: 797 EFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRR 856
EF V ++ + H NIVK +G N +V E++ G L L + A + W+ +
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVK 124
Query: 857 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE-----AHVSDFGIAKFVEPYS 911
+ ++ +A + Y+ + P I+HRD+ S N+ L E A V+DFG+++
Sbjct: 125 LRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV 183
Query: 912 SNRTEFVGTFGYAAPEI--AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 969
+ +G F + APE A TEK D YSF ++++ ++ G P F ++
Sbjct: 184 ---SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKF 238
Query: 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ + + L R + P +L +++E LC P+ RP
Sbjct: 239 INMIREEGL--RPTIPE-DCPPRLRNVIE---LCWSGDPKKRPHFS 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-51
Identities = 51/262 (19%), Positives = 107/262 (40%), Gaps = 25/262 (9%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+ + G ++K G+ + VK + S + +F L H N++ G
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR--DFNEECPRLRIFSHPNVLPVLG 74
Query: 819 FCSN--ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
C + A H L+ ++ GSL +L ++ T + ++ + +A +++LH P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHT-LEP 132
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI---AYTMR 933
I ++S++V++D + A +S + + + + APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDT 187
Query: 934 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKL 993
D++SF VL++E++ P F ++ + R + P PG+ +
Sbjct: 188 NRRSADMWSFAVLLWELVTREVP--FADLSNMEIGMKVALEGL----RPTIP-PGISPHV 240
Query: 994 ISIMEVAILCLDESPEARPTME 1015
+M+ +C++E P RP +
Sbjct: 241 SKLMK---ICMNEDPAKRPKFD 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 2e-49
Identities = 74/317 (23%), Positives = 119/317 (37%), Gaps = 60/317 (18%)
Query: 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLN--V 801
E D+ IG+G G+VYK L VAVK F+ ++ F+N
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-------NRQNFINEKN 57
Query: 802 VLALNEIRHRNIVKFHGFC-----SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRR 856
+ + + H NI +F LV EY GSL + L + W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSS 113
Query: 857 INVIKGVANALSYLHHD------CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910
+ V L+YLH + P+I HRD++S+NVL+ + +SDFG++ +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 911 SSNRTEF--------VGTFGYAAPEIA-------YTMRATEKYDVYSFGVLVFEVIKGNH 955
R VGT Y APE+ A ++ D+Y+ G++ +E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 956 PRDFFSI-------------NFSSFSNMIIEV-NQILDPRLS---TPSPGVMDKLISIME 998
N +F +M + V + P+ + + L +E
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 999 VAILCLDESPEARPTME 1015
C D+ EAR T +
Sbjct: 294 ---DCWDQDAEARLTAQ 307
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 9e-49
Identities = 71/292 (24%), Positives = 125/292 (42%), Gaps = 49/292 (16%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLN--VVLALNEIRHRNIVK 815
C+GKG G V++ G+ VAVK F+S+ D+ + + +RH NI+
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 816 FHGFCSNARHS----FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
F +RHS +L+ Y GSL L L + ++ +A+ L++LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLH 122
Query: 872 HDCL-----PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS----NRTEFVGTFG 922
+ P+I HRD+ SKN+L+ + ++D G+A ++ VGT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 923 YAAPEI------AYTMRATEKYDVYSFGVLVFEVIKGNHPRD--------FFSINFS--S 966
Y APE+ + ++ D+++FG++++EV + F+ + + S
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 967 FSNMIIEV---NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
F +M V Q + S + L +M+ C ++P AR T
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTAL 291
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 55/324 (16%), Positives = 106/324 (32%), Gaps = 21/324 (6%)
Query: 104 LVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLH 163
NL + + + N D + N + L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAW----RQANSNNPQIETRTGRALK 69
Query: 164 GTIPPVIGQLSLIH--EFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNL 221
++ + + + P LS L + ++ L +P M
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQF 126
Query: 222 KSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGN---------LKSL 272
L TL L++N L L P ++ +L+ L L + +P + + L +L
Sbjct: 127 AGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 273 HQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNG 332
L L + S+P S NL + + + ++ LS ++ P + +L L L L
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 333 VIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGL 392
PP G + L+ L L + ++P +I L L +L L +P + L
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 393 VLLNMCENHLFGPIPKSLKSLTSL 416
++ + + + +
Sbjct: 304 CIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 52/307 (16%), Positives = 108/307 (35%), Gaps = 26/307 (8%)
Query: 83 NLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLF--FGNIPPQIGNLS--KLQNLDLGNNQL 138
+ S + N + + + + L+L + L
Sbjct: 34 QWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPL 93
Query: 139 SGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLS 198
+ +L+ L+ + +D L +P + Q + + + N + +P+S+ +L+
Sbjct: 94 P-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLN 150
Query: 199 KLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSL 258
+L L + +P + + + L NL +L L +
Sbjct: 151 RLRELSIRACPELTELPEPLASTDA---------------SGEHQGLVNLQSLRLEWTGI 195
Query: 259 SGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLK 318
S+P+ I NL++L L + + LS ++ + +L + L + + PPI G
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253
Query: 319 SLSTLGLY-LNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNN 377
L L L + L +P I L+ L L L +P I L + + + +
Sbjct: 254 PLKRLILKDCSNL-LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
Query: 378 LSGVIPH 384
+ + H
Sbjct: 313 QAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-46
Identities = 56/355 (15%), Positives = 114/355 (32%), Gaps = 51/355 (14%)
Query: 244 NLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFS 303
+ S + L+ ++ ++ + + D + N ++ + +
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTG 65
Query: 304 NSLSGSIPPILGNLKS--LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEE 361
+L + +L + L L L P LS L+++++ GL +P+
Sbjct: 66 RALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDT 122
Query: 362 IGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRF 421
+ L L L +N L +P S+ +L L L++ +P+ L S +
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS----- 176
Query: 422 NQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLE 481
NL L L S+P
Sbjct: 177 ----------GEHQGLVNLQSLRLEWTGIR-------------------------SLPAS 201
Query: 482 IGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDL 541
I + L+ L + ++ + + + L L +L L + P FG L+ L L
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 542 SANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQE 596
++P I L +L L+L +P +L + + ++ +
Sbjct: 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-43
Identities = 51/361 (14%), Positives = 105/361 (29%), Gaps = 51/361 (14%)
Query: 193 SLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLF 252
+ S LY ++ V+ + D ++ N +N
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIET 62
Query: 253 LYKNSLSGSIPSIIGNLKS--LHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSI 310
+L + ++ + L+L L
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLP-------------------------QF 96
Query: 311 PPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSE 370
P L L + + L +P ++ + L L+L N L ++P I L L E
Sbjct: 97 PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRE 154
Query: 371 LKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKV 430
L + +P + + + L +L+ +R + +
Sbjct: 155 LSIRACPELTELPEPLASTD---------------ASGEHQGLVNLQSLRLEWTGIR-SL 198
Query: 431 YEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQF 490
+ + NL L + + + +LPKL+ + + P G + L+
Sbjct: 199 PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257
Query: 491 LDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSI 550
L L + +P+ + +L L KL L +P L + + + +
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317
Query: 551 P 551
Sbjct: 318 Q 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 59/311 (18%), Positives = 109/311 (35%), Gaps = 24/311 (7%)
Query: 37 TSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLNG----- 91
+ +N S ++ Y S+ + H+ R + N +
Sbjct: 12 SGRENLYFQGS--TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK 69
Query: 92 -TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLN 150
T ++ P V L L P Q LS LQ++ + L + + +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 151 QLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGN---------LSKLA 201
L L L N L +P I L+ + E S +P L + L L
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 202 LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261
L L + +P + NL++L +L + + L+ L + +L L+ L L + +
Sbjct: 187 SLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRN 244
Query: 262 IPSIIGNLKSLHQLDLIE-NQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSL 320
P I G L +L L + + L ++PL L+ + L +P ++ L +
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 321 STLGLYLNQLN 331
+ + +
Sbjct: 304 CIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-42
Identities = 55/391 (14%), Positives = 103/391 (26%), Gaps = 75/391 (19%)
Query: 260 GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKS 319
GS + L + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 320 LSTLGLYLNQLNGVIPPSIGNLSS--LRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNN 377
L + + + L L + L P++ L L + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115
Query: 378 LSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDH 437
L +P ++ GL L + N L +P S+ SL
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPL-RALPASIASLN----------------------- 150
Query: 438 PNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNH 497
L L + +P + +
Sbjct: 151 -RLRELSIR------------------------ACPELTELPEPLASTD----------- 174
Query: 498 IVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNL 557
+ + L +L L L + S+P +L L+ L + + LS+ + +I +L
Sbjct: 175 ----ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHL 228
Query: 558 LKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNN 617
KL L+L P F L +L L +P + + LEKL+L
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
Query: 618 LSGFIPRCFEKMRSLSCIDICYNELQGPIPN 648
+P ++ + I + + +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 50/307 (16%), Positives = 92/307 (29%), Gaps = 25/307 (8%)
Query: 356 GSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTS 415
GS + L + + + H S +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-----N 56
Query: 416 LKRVRFNQNNLVGKVYEAFGD--HPNLTFLDLSQNNFDG--KISFNWRNLPKLDTFIVSM 471
++ + + D P L+L +F +L + +
Sbjct: 57 NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMT---IDA 113
Query: 472 NNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFG 531
+ +P + + L+ L L+ N + +P + L L +L + +P
Sbjct: 114 AGL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 532 S---------LTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLI 582
S L LQ L L + S +P SI NL L L + N+ + L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPL-SALGPAIHHLP 229
Query: 583 HLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNEL 642
L +LDL PP L++L L + +P ++ L +D+
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289
Query: 643 QGPIPNS 649
+P+
Sbjct: 290 LSRLPSL 296
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 29/149 (19%), Positives = 56/149 (37%), Gaps = 2/149 (1%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
+L +L L + ++P I NL L++L + N+ LS + P I L +L L
Sbjct: 178 EHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD 235
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT 216
L PP+ G + + + +P + L++L L L +P+
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 217 VMGNLKSLSTLDLSQNQLNGLIPCTLDNL 245
++ L + + + + L
Sbjct: 296 LIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 25/199 (12%), Positives = 56/199 (28%), Gaps = 33/199 (16%)
Query: 475 FGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVP------- 527
GS SS + L + + L + + +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 528 --------------LEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHT 573
LE + L+L + L P L L ++ +
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 574 IPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNL---------SGFIPR 624
+P ++ L L L+ N L +P + ++ L +L++ S
Sbjct: 119 LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 625 CFEKMRSLSCIDICYNELQ 643
+ + +L + + + ++
Sbjct: 178 EHQGLVNLQSLRLEWTGIR 196
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-47
Identities = 74/266 (27%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
IG G G+VYK + GD VAVK N + F N V L + RH NI+ F G
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 87
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
+ + + + +V ++ SL L T + + I++ + A + YLH SI
Sbjct: 88 YSTAPQLA-IVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVE--PYSSNRTEFVGTFGYAAPEI---AYTMR 933
IHRD+ S N+ L + + DFG+A S + G+ + APE+ +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 934 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM--IIEV--NQILDPRLSTPSPGV 989
+ + DVY+FG++++E++ G P +S+ +N IIE+ L P LS
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254
Query: 990 MDKLISIMEVAILCLDESPEARPTME 1015
++ +M CL + + RP+
Sbjct: 255 PKRMKRLMA---ECLKKKRDERPSFP 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-47
Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 35/289 (12%)
Query: 743 HEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNV 801
H + E +GKG G K +G+++ +K+ L+ + Q FL
Sbjct: 4 HRIFRPSDLIHGEV--LGKGCFGQAIKVTHRETGEVMVMKE----LIRFDEETQRTFLKE 57
Query: 802 VLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIK 861
V + + H N++KF G + + EY+ G+L I+ + + W++R++ K
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAK 115
Query: 862 GVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE------------- 908
+A+ ++YLH +IIHRD++S N L+ V+DFG+A+ +
Sbjct: 116 DIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 909 -PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 967
P R VG + APE+ EK DV+SFG+++ E+I + +
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----LP 227
Query: 968 SNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
M +N P P I C D PE RP+ K
Sbjct: 228 RTMDFGLNVRGFLDRYCP-PNCPPSFFPITV---RCCDLDPEKRPSFVK 272
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-47
Identities = 59/274 (21%), Positives = 108/274 (39%), Gaps = 38/274 (13%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
IGKG G VY G+ VA++ + + + + F V+A + RH N+V F G
Sbjct: 41 IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLK--AFKREVMAYRQTRHENVVLFMG 96
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
C + H ++ +L ++ + L N+ + + + + YLH I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR-----TEFVGTFGYAAPEI----- 928
+H+D+ SKNV D + ++DFG+ + R G + APEI
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 929 ----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII--EVNQILDPRL 982
+ ++ DV++ G + +E+ P F + I ++ + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP-------FKTQPAEAIIWQMGTGM--KP 261
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ G+ ++ I+ C E RPT K
Sbjct: 262 NLSQIGMGKEISDILL---FCWAFEQEERPTFTK 292
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-47
Identities = 67/459 (14%), Positives = 145/459 (31%), Gaps = 22/459 (4%)
Query: 190 IPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD 249
I N ++ + + ++SL + ++ + ++ LDLS N L+ + L + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 250 TLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309
L L N L ++ + +L +L LDL N + S + +N++S
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 310 IPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYG-SIPEEIGYLKSL 368
+ + + L N++ + G S ++ L L N + + E +L
Sbjct: 114 VSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 369 SELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVG 428
L L N + V L L++ N L + +S + + N LV
Sbjct: 172 EHLNLQYNFIYDVKGQV--VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV- 227
Query: 429 KVYEAFGDHPNLTFLDLSQNNFDGKISFNWR-NLPKLDTFIVSMNNIFGSIPLEIGDSSK 487
+ +A NL DL N F ++ ++ T V+ + + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVKKLTGQNEEECTV 285
Query: 488 LQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGS----VPLEFGSLTELQYLDLSA 543
+ ++L +L + +L GS + E + + +D
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 544 NKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVC 603
+ + I + L + L E
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
Query: 604 NMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNEL 642
+ ++ + + ++ D+ ++
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-45
Identities = 71/500 (14%), Positives = 148/500 (29%), Gaps = 64/500 (12%)
Query: 98 FSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYL 157
+ ++ + + + ++ LDL N LS + + ++ +L L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 158 DMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTV 217
N L+ L +LS L L LNNN +
Sbjct: 66 SSNVLYE--------------------------TLDLESLSTLRTLDLNNNYV-----QE 94
Query: 218 MGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDL 277
+ S+ TL + N ++ + ++L N ++ G + LDL
Sbjct: 95 LLVGPSIETLHAANNNISRVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 278 IENQLSG-SIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPP 336
N++ + + + ++L N + + + L TL L N+L + P
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGP 208
Query: 337 SIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLS-GVIPHSVGNLTGLVLL 395
+ + + +SL NN L I + + + ++L L N G + + +
Sbjct: 209 EFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267
Query: 396 NMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKIS 455
+++K LT L + DL D I+
Sbjct: 268 A----------KQTVKKLTGQNEEECTVPTLG--------HYGAYCCEDLPAPFADRLIA 309
Query: 456 FNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKL 515
+ L + + E + ++ + +D I + + L
Sbjct: 310 LKRKEHALLSG----QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITL 365
Query: 516 ILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSH-TI 574
L V + EL A + + L L ++ +
Sbjct: 366 EQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYV 424
Query: 575 PIEFEKLIHLSKLDLSHNIL 594
+ + + D+ +
Sbjct: 425 EQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-41
Identities = 63/395 (15%), Positives = 127/395 (32%), Gaps = 22/395 (5%)
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSL 320
+I I N + ++ L ++ + + + L N LS L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 321 STLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSG 380
L L N L + +LS+LR L L NN + +E+ S+ L NN+S
Sbjct: 61 ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 381 VIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAF-GDHPN 439
V S G + + N + + ++ + N + +
Sbjct: 114 V---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 440 LTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIV 499
L L+L N + KL T +S N + + E ++ + ++ L +N +V
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 500 GKIPVQLEKLFSLNKLILSLNQLS-GSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLL 558
I L +L L N G++ F +Q + + ++
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECT 284
Query: 559 KLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQ----EEIPPQVCNMESLEKLNLS 614
+ ++LI L + + + Q E + + N +++
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 615 HNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNS 649
I + + ++ ++ L + N
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNG 379
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 41/317 (12%), Positives = 82/317 (25%), Gaps = 31/317 (9%)
Query: 83 NLSTLCLNGTF-QDFSFSSF-PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG 140
L L L F D L L+LS N + P+ + + + + L NN+L
Sbjct: 170 TLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN-KLAFMGPEFQSAAGVTWISLRNNKLV- 227
Query: 141 VISPEIGKLNQLRRLYLDMNQLHGTIPPVI--------------------------GQLS 174
+I + L L N H +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 175 LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLN-NNSLFGYIPTVMGNLKSLSTLDLSQNQ 233
L H ++C ++ L L + L+ S + N +D + Q
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 234 LNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNL 293
+I TL K +L + + L +
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQS 407
Query: 294 SSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNG 353
L ++ + ++ +Y ++ + + L
Sbjct: 408 PLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALAS 467
Query: 354 LYGSIPEEIGYLKSLSE 370
++ E + ++L+
Sbjct: 468 ANATLQELVVREQNLAS 484
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-46
Identities = 63/292 (21%), Positives = 113/292 (38%), Gaps = 49/292 (16%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLN--VVLALNEIRHRNIVK 815
IGKG G V++ + G+ VAVK F+S+ ++ + + +RH NI+
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILG 100
Query: 816 FHGFCSNARHS----FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
F + + +LV +Y GSL L ++ I + A+ L++LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 872 HD-----CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS----NRTEFVGTFG 922
+ P+I HRD+ SKN+L+ ++D G+A + + VGT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 923 YAAPEI------AYTMRATEKYDVYSFGVLVFEVI---KGNHPRDFFSINFS-------S 966
Y APE+ + ++ D+Y+ G++ +E+ + + + + S
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 967 FSNMIIEV---NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
M V + S + + IM C + AR T
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTAL 325
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-46
Identities = 65/292 (22%), Positives = 112/292 (38%), Gaps = 49/292 (16%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLN--VVLALNEIRHRNIVK 815
IGKG G V+ + G+ VAVK F + ++ + + +RH NI+
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILG 95
Query: 816 FHGFCSNARHS----FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
F S +L+ +Y GSL L + L + + + L +LH
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLH 151
Query: 872 -----HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR----TEFVGTFG 922
P+I HRD+ SKN+L+ ++D G+A ++ VGT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 923 YAAPEI------AYTMRATEKYDVYSFGVLVFEVIKGNHPRD--------FFSINFS--S 966
Y PE+ ++ D+YSFG++++EV + + + S S
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 967 FSNMIIEV-NQILDPRL--STPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ +M V + L P S + ++ +M C +P +R T
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTAL 320
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-45
Identities = 99/467 (21%), Positives = 176/467 (37%), Gaps = 27/467 (5%)
Query: 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTL 242
N +S S + +LSKL +L +++N + +V + L LDLS N+L + +
Sbjct: 30 QNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI---SC 86
Query: 243 DNLSNLDTLFLYKNSL-SGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSL 301
NL L L N+ + I GN+ L L L L S L +L+ ++ +
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 302 FSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEE 361
+ P L+ +T L++ I ++S +L + + + +
Sbjct: 147 LGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 362 IGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRF 421
KL N + + T + + L T++
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI----------LQLVWHTTVWYFSI 254
Query: 422 NQNNLVGKVYEAFGDHPN-----LTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFG 476
+ L G++ D+ L+ + + F S+ + ++ +++
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLS--GSVPLEFGSLT 534
L S LD S+N + + L L LIL +NQL + +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 535 ELQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNI 593
LQ LD+S N +S K L LN+S+N + TI + LDL N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNK 432
Query: 594 LQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYN 640
++ IP QV +E+L++LN++ N L F+++ SL I + N
Sbjct: 433 IKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-44
Identities = 79/431 (18%), Positives = 163/431 (37%), Gaps = 26/431 (6%)
Query: 222 KSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQ 281
+ + L++SQN ++ L + +LS L L + N + S+ + L LDL N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 282 LSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP--ILGNLKSLSTLGLYLNQLNGVIPPSIG 339
L +S + + L N+ ++P GN+ L LGL L I
Sbjct: 81 LVK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 340 NLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCE 399
+L+ + L + E+ L+ + L + H + +++ + N+
Sbjct: 137 HLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 400 NHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWR 459
+++ K + + + + L + L ++ + N+F + W
Sbjct: 195 SNI--------KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 460 -NLPKLDTFIVSMNNIFGSIPLEIGDSS--KLQFLDLSSNHIVGKIPVQLEKLFSLNKLI 516
+ V + + +S L + S+ E ++N
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 517 LSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPI 576
+++ L ++ +LD S N L+ ++ ++ G+L +L L L NQ +
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSK 365
Query: 577 E---FEKLIHLSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSL 632
++ L +LD+S N + + C +SL LN+S N L+ I RC +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRI 423
Query: 633 SCIDICYNELQ 643
+D+ N+++
Sbjct: 424 KVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 3e-43
Identities = 89/480 (18%), Positives = 170/480 (35%), Gaps = 21/480 (4%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177
+P + K L++ N +S + + +I L++LR L + N++ V +
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 178 EFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGY-IPTVMGNLKSLSTLDLSQNQLNG 236
HN + I L L L+ N+ I GN+ L L LS L
Sbjct: 73 YLDLSHNKLVK-ISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129
Query: 237 LIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSW 296
+ +L+ L + + L+ + L + ++S
Sbjct: 130 SSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187
Query: 297 TLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYG 356
T+ +L +++ + + L N + + + + + +
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247
Query: 357 SIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSL 416
++ S+S +KL +S +L L + + + P + +++
Sbjct: 248 TVWY-----FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNM 302
Query: 417 KRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFG 476
F + LD S N + N +L +L+T I+ MN +
Sbjct: 303 NIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-K 361
Query: 477 SIPLEIGDS---SKLQFLDLSSNHI-VGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGS 532
+ + LQ LD+S N + + SL L +S N L+ ++
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-- 419
Query: 533 LTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHN 592
++ LDL +NK+ SIPK + L L LN+++NQ F++L L K+ L N
Sbjct: 420 PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-32
Identities = 90/457 (19%), Positives = 157/457 (34%), Gaps = 53/457 (11%)
Query: 98 FSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGV-ISPEIGKLNQLRRLY 156
F L L+LS N I L++LDL N + I E G ++QL+ L
Sbjct: 65 FKFNQELEYLDLSHNK-LVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT 216
L L + I L++ L L+
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPT----- 174
Query: 217 VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLD 276
N + LD+S + L + + + + + L+ + + +L+ ++
Sbjct: 175 ---NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231
Query: 277 LIENQLSGSIPLSFGNLSSWTLMSLFSNSLSG-----SIPPILGNLKSLSTLGLYLNQLN 331
N L ++ S+ + L G +LK+LS + +
Sbjct: 232 TTWNSFIR--ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289
Query: 332 GVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTG 391
S++ + +G + L N L+ + + G+LT
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349
Query: 392 LVLLNMCENHL--FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHP-NLTFLDLSQN 448
L L + N L I + + SL+++ +QN++ + +L L++S N
Sbjct: 350 LETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409
Query: 449 NFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEK 508
+ IF +P +++ LDL SN I IP Q+ K
Sbjct: 410 ILT--------------------DTIFRCLP------PRIKVLDLHSNKIK-SIPKQVVK 442
Query: 509 LFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSAN 544
L +L +L ++ NQL SVP F LT LQ + L N
Sbjct: 443 LEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 63/394 (15%), Positives = 118/394 (29%), Gaps = 53/394 (13%)
Query: 83 NLSTLCLNGT-FQDFSFSSFPHLVNLNLSFNLFFGNIPP-QIGNLSKLQNLDLGNNQLSG 140
L L L+ T + S HL + L L L +
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 141 VISPEIGKLNQLRRLYLDMNQLHG-----------TIPPVIGQLSLIHEFSFCHNNVSGR 189
I ++ L+++ + +I + + + + +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 190 IPSSLGNL---SKLALLYLNNNSL-----FGYIPTVMGNLKSLSTLDLSQNQLNGLIPCT 241
+ L + + ++N L F +LK+LS + +
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 242 LDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSL 301
+ SN++ + + LD N L+ ++ + G+L+ + L
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355
Query: 302 FSNSLSGSIPPILG---NLKSLSTLGLYLNQLNGVIPPSI-GNLSSLRNLSLFNNGLYGS 357
N L + I +KSL L + N ++ SL +L++ +N L +
Sbjct: 356 QMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414
Query: 358 IPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLK 417
I + + L L N + IP V L L LN+ N LKS+
Sbjct: 415 IFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN--------QLKSVPD-- 461
Query: 418 RVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD 451
F +L + L N +D
Sbjct: 462 --------------GIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 57/326 (17%), Positives = 115/326 (35%), Gaps = 10/326 (3%)
Query: 12 FLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGIS 71
N + + + + NL S + + +S + +
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
Query: 72 CNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLV--NLNLSFNLFFGNIPPQIGNLSKLQ 129
+ + +I + Q ++ + N+ L L F + +L L
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 130 NLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGR 189
+ ++ S + + ++ ++S F +N ++
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339
Query: 190 IPSSLGNLSKLALLYLNNNSL--FGYIPTVMGNLKSLSTLDLSQNQLNGLIPC-TLDNLS 246
+ + G+L++L L L N L I + +KSL LD+SQN ++
Sbjct: 340 VFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399
Query: 247 NLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSL 306
+L +L + N L+ +I + + LDL N++ SIP L + +++ SN L
Sbjct: 400 SLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
Query: 307 SGSIPP-ILGNLKSLSTLGLYLNQLN 331
S+P I L SL + L+ N +
Sbjct: 457 K-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 56/342 (16%), Positives = 116/342 (33%), Gaps = 27/342 (7%)
Query: 82 INLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGV 141
+ + + +L I ++S +L + + V
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 142 IS-----------PEIGKLNQLRRLYLDMNQLHGTIPPVIGQL---SLIHEFSFCHNNVS 187
+ ++ +L L L+ + I QL + + FS + +
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 188 GRIPSSLGNLS-----KLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTL 242
G++ + S L++ + ++ + +++ + + + +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 243 DNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLS---FGNLSSWTLM 299
+S L N L+ ++ G+L L L L NQL + + S +
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQL 379
Query: 300 SLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSI 358
+ NS+S KSL +L + N L I + ++ L L +N + SI
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI-KSI 436
Query: 359 PEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCEN 400
P+++ L++L EL + N L V LT L + + N
Sbjct: 437 PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 41/208 (19%), Positives = 78/208 (37%), Gaps = 44/208 (21%)
Query: 3 LPIFIILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKI 62
+ + FL L+FS+N+ +D+ E C L T L+ L + L + +++
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHL---TELETLILQMNQLKELSKIAEMTTQM 373
Query: 63 SPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQI 122
IS N ++ + S L++LN+S N+ I +
Sbjct: 374 KSLQQLDISQNS--------------VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 123 GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFC 182
+++ LDL +N++ I ++ KL L+ L + NQL ++P
Sbjct: 420 --PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP--------------- 460
Query: 183 HNNVSGRIPSSLGNLSKLALLYLNNNSL 210
L+ L ++L+ N
Sbjct: 461 --------DGIFDRLTSLQKIWLHTNPW 480
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-41
Identities = 79/404 (19%), Positives = 140/404 (34%), Gaps = 68/404 (16%)
Query: 190 IPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD 249
I S+L ++++ + Y L + + + + L LD+ ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 250 TLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309
L L + ++ +L + N + P F N+ T++ L N LS S
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 131
Query: 310 IPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSL 368
+P I N L+TL + N L + + +SL+NL L +N L + + + SL
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSL 188
Query: 369 SELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVG 428
+ N LS +L +++ + + N++
Sbjct: 189 FHANVSYNLLS-----------------------------TLAIPIAVEELDASHNSINV 219
Query: 429 KVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKL 488
LT L L N NL + L
Sbjct: 220 VRGPVN---VELTILKLQHN-----------NLTDTAWL---------------LNYPGL 250
Query: 489 QFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS 548
+DLS N + + K+ L +L +S N+L ++ L + L+ LDLS N L
Sbjct: 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-L 308
Query: 549 SIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHN 592
+ ++ +L L L +N ++ L L LSHN
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIVT---LKLSTHHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-41
Identities = 71/385 (18%), Positives = 141/385 (36%), Gaps = 46/385 (11%)
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKS 319
I S + + + + L++ +++ ++++ +P +L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 320 LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNL 378
+ L L Q+ + + +++ L + N + +P + + L+ L L +N+L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 379 SGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHP 438
S + N L L+M N+ L ++ + F
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNN-----------LERIED-------------DTFQATT 165
Query: 439 NLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHI 498
+L L LS N + +P L VS N + + ++ LD S N I
Sbjct: 166 SLQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSI 217
Query: 499 VGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLL 558
+ + L L L N L+ + L +DLS N+L + +
Sbjct: 218 N-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272
Query: 559 KLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNL 618
+L L +SNN+ + + + + L LDLSHN L + + LE L L HN++
Sbjct: 273 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSI 330
Query: 619 SGFIPRCFEKMRSLSCIDICYNELQ 643
+++L + +N+
Sbjct: 331 VTLKLSTHHTLKNL---TLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-40
Identities = 66/362 (18%), Positives = 126/362 (34%), Gaps = 22/362 (6%)
Query: 92 TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQ 151
D + ++++ + L+ + + N+ + + + + Q
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 152 LRRLYLDMNQLHGTIPPVI-GQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSL 210
+ L L+ Q+ I I + N + P N+ L +L L N L
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129
Query: 211 FGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLK 270
+ N L+TL +S N L + T ++L L L N L+ + + +
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 186
Query: 271 SLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQL 330
SL ++ N LS + + + NS++ + L+ L L N L
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL 238
Query: 331 NGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGNL 389
+ N L + L N L I ++ L L + N L + +
Sbjct: 239 TDT--AWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
Query: 390 TGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNN 449
L +L++ NHL + ++ L+ + + N++V L L LS N+
Sbjct: 295 PTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHND 350
Query: 450 FD 451
+D
Sbjct: 351 WD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 27/170 (15%), Positives = 58/170 (34%), Gaps = 2/170 (1%)
Query: 475 FGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLT 534
+ I + + + + L + + + + S
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 69
Query: 535 ELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNIL 594
+++ L+L+ ++ + + L + N + P F+ + L+ L L N L
Sbjct: 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129
Query: 595 QEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+P + N L L++S+NNL F+ SL + + N L
Sbjct: 130 -SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-41
Identities = 97/498 (19%), Positives = 182/498 (36%), Gaps = 59/498 (11%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177
+P + + + L L N +S + P+I L++LR L L N++ ++
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLD---------- 92
Query: 178 EFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL 237
L L +++N L I + SL LDLS N + L
Sbjct: 93 -------------FHVFLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDFDVL 136
Query: 238 IPCTL-DNLSNLDTLFLYKNSL-SGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS 295
C NL+ L L L + + S LDL+ + G S ++
Sbjct: 137 PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT 196
Query: 296 WTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNL-------SSLRNLS 348
T++ L + S + ++ +L L L +LN + +L N++
Sbjct: 197 -TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255
Query: 349 LFNNGLYGSIPEEIG---YLKSLSELKLCKNNLSGVIP-----HSVGNLTGLVLLNMCEN 400
L + ++ + + + L + ++ I +S L L++ ++
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315
Query: 401 HLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRN 460
+ + ++ + TFL+ +QN F +
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375
Query: 461 LPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLF----SLNKLI 516
L +L T I+ N + + + + L+ + ++ S+ L
Sbjct: 376 LKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434
Query: 517 LSLNQLSGSVPLEFGSLTE-LQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIP 575
LS N L+GSV F L ++ LDL N++ SIPK + +L L LN+++NQ ++P
Sbjct: 435 LSSNMLTGSV---FRCLPPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVP 489
Query: 576 IE-FEKLIHLSKLDLSHN 592
F++L L + L N
Sbjct: 490 DGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-36
Identities = 82/433 (18%), Positives = 146/433 (33%), Gaps = 34/433 (7%)
Query: 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282
L LSQN ++ L + LS L L L N + + + L LD+ N+L
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 283 SGSIPLSFGNLSSWTLMSLFSNSLSGSIPP--ILGNLKSLSTLGLYLNQLNGVIPPSIGN 340
+S ++S + L N +P GNL L+ LGL + + + +
Sbjct: 113 QN---ISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 341 LSSLRNLSLFNNGLYGS-IPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCE 399
L L + L + E + + + L L + S ++ L L +
Sbjct: 169 LH-LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227
Query: 400 NHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWR 459
L + L + S N+ L ++ + F W
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVT------------LQHIETTWKCSVKLFQFFW- 274
Query: 460 NLPKLDTFIVSMNNIFGSIPLEIGDSSK-----LQFLDLSSNHIVGKIPVQLEKLFSLNK 514
++ + I I E S+ L + + + +N
Sbjct: 275 -PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 515 LILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTI 574
+LS++ + S + +L+ + N + S+ + L +L L L N
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392
Query: 575 PIEFEKLIHLSKL---DLSHNILQEEIPPQVCN-MESLEKLNLSHNNLSGFIPRCFEKMR 630
++S L D+S N L + C ES+ LNLS N L+G + RC
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PP 450
Query: 631 SLSCIDICYNELQ 643
+ +D+ N +
Sbjct: 451 KVKVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 87/464 (18%), Positives = 151/464 (32%), Gaps = 69/464 (14%)
Query: 98 FSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGV-ISPEIGKLNQLRRLY 156
F L L++S N NI ++ L++LDL N + + E G L +L L
Sbjct: 96 FLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT 216
L + + L L + + + +L+L + +
Sbjct: 153 LSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 217 VMGNLKSLSTLDLSQNQLNGLIPCTLDNLS-----NLDTLFLYKNSLSGSIPSIIGNLK- 270
V ++ +L L LS +LN L L + + + + +
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 271 ----SLHQLDLIENQLSGSIPLSFGNLSSWTLMSLF-----SNSLSGSIPPILGNLKSLS 321
+ L++ ++ I S L SL + S + ++
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 322 TLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGV 381
L ++ + + SS L+ N S+ + LK L L L +N L
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-N 391
Query: 382 IPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLT 441
+ L + SL SL +++ ++
Sbjct: 392 FFKVALMTKNMSSLETLDV-----------SLNSLNSHAYDRT---------CAWAESIL 431
Query: 442 FLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGK 501
L+LS N ++F +P K++ LDL +N I
Sbjct: 432 VLNLSSNMLT--------------------GSVFRCLP------PKVKVLDLHNNRI-MS 464
Query: 502 IPVQLEKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSAN 544
IP + L +L +L ++ NQL SVP F LT LQY+ L N
Sbjct: 465 IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 71/421 (16%), Positives = 131/421 (31%), Gaps = 80/421 (19%)
Query: 37 TSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDF 96
+ + +L+ LL + + S + V+ + L +
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETESLQ--------IPNTTVLHLVFHPNSLFSVQVNM 215
Query: 97 SFSSFPHLVNLNLSFNLF----FGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQL 152
S ++ HL N+ N ++ L N+ L + + + S ++ +
Sbjct: 216 SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP 275
Query: 153 RRL-YLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLF 211
R + YL++ L T + + S L L + ++ N
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTY-----------------SETALKSLMIEHVKNQVFL 318
Query: 212 GYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKS 271
+ ++ LS + + + S+ L +N + S+ LK
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378
Query: 272 LHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQL- 330
L L L N L + + N+ SL TL + LN L
Sbjct: 379 LQTLILQRNGLK-NFFKVAL---------------------MTKNMSSLETLDVSLNSLN 416
Query: 331 NGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLT 390
+ + S+ L+L +N L GS+ + + L L N + IP V +L
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQ 473
Query: 391 GLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNF 450
L LN+ N LKS+ F +L ++ L N +
Sbjct: 474 ALQELNVASN--------QLKSVPD----------------GVFDRLTSLQYIWLHDNPW 509
Query: 451 D 451
D
Sbjct: 510 D 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 49/217 (22%), Positives = 81/217 (37%), Gaps = 10/217 (4%)
Query: 438 PNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSSN 496
P L LSQN+ + L +L +S N I S+ + L++LD+S N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHN 110
Query: 497 HIVGKIPVQLEKLFSLNKLILSLNQLSGSVPL--EFGSLTELQYLDLSANKLSSSIPKSI 554
+ I + SL L LS N +P+ EFG+LT+L +L LSA K +
Sbjct: 111 RLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV 166
Query: 555 GNL-LKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNL 613
+L L L+L + + + + L L + ++ +L L L
Sbjct: 167 AHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225
Query: 614 SHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNST 650
S+ L+ + S + +T
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 44/209 (21%), Positives = 75/209 (35%), Gaps = 52/209 (24%)
Query: 4 PIFIILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKIS 63
F LNF+ NV +DS + C+ L +L Q L N S +
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE 406
Query: 64 PCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFN----LFFGNIP 119
++++S LN D + + ++ LNLS N F +P
Sbjct: 407 -----------------TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
Query: 120 PQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEF 179
P+ ++ LDL NN++ I ++ L L+ L + NQL ++P
Sbjct: 450 PK------VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP------------ 489
Query: 180 SFCHNNVSGRIPSSLGNLSKLALLYLNNN 208
L+ L ++L++N
Sbjct: 490 -----------DGVFDRLTSLQYIWLHDN 507
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 8e-41
Identities = 99/426 (23%), Positives = 158/426 (37%), Gaps = 49/426 (11%)
Query: 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQ 281
++ +DLS N + L + L +L L + + + I + L SL L L NQ
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 282 LSGSIPLS-FGNLSSWTLMSLFSNSL-SGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSI 338
+ F L++ +++L +L + L SL L L N + + P S
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 339 -GNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNM 397
N+ L L N + SI EE L + L + + L +M
Sbjct: 150 FLNMRRFHVLDLTFNKV-KSICEED--LLNFQGKHFTLLRL-----------SSITLQDM 195
Query: 398 CENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFL-DLSQNNFDGKISF 456
E L + TS+ + + N + + F D T + L +N S
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 457 NWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL-EKLFSLNKL 515
F N F + +S ++ DLS + I + + L +L
Sbjct: 256 FGHT-----NFKDPDNFTFKGLE-----ASGVKTCDLSKSKI-FALLKSVFSHFTDLEQL 304
Query: 516 ILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIP 575
L+ N+++ F LT L L+LS N L S + NL KL L+LS N +
Sbjct: 305 TLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALG 363
Query: 576 IE-FEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLS 633
+ F L +L +L L N L+ +P + + SL+K+ L N C S
Sbjct: 364 DQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPW-----DC-------S 410
Query: 634 CIDICY 639
C I Y
Sbjct: 411 CPRIDY 416
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-37
Identities = 86/460 (18%), Positives = 156/460 (33%), Gaps = 85/460 (18%)
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLI 176
+P + +DL N ++ + +L L+ L ++ I
Sbjct: 27 ELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR--------- 71
Query: 177 HEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG 236
++ LS L +L L+ N L +L L L+Q L+G
Sbjct: 72 --------------NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDG 117
Query: 237 LI--PCTLDNLSNLDTLFLYKNSLSGSIPSII-GNLKSLHQLDLIENQLSGSIPLSFGNL 293
+ L++L+ L L N++ P+ N++ H LDL N++ N
Sbjct: 118 AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNF 177
Query: 294 SSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNG 353
L L S++ + L + +S+ L L NG
Sbjct: 178 QGKHFTLL--------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 354 LYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSL 413
S+ + + ++++ + S + S G+ N L
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGL---------EA 274
Query: 414 TSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNN 473
+ +K +++ + + F +L L L+QN + +N
Sbjct: 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI--------NKID---------DN 317
Query: 474 IFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL-EKLFSLNKLILSLNQLSGSVPLE-FG 531
F + + L L+LS N + G I ++ E L L L LS N + ++ + F
Sbjct: 318 AFWGL-------THLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL 368
Query: 532 SLTELQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQF 570
L L+ L L N+L S+P I L L + L N +
Sbjct: 369 GLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 75/385 (19%), Positives = 125/385 (32%), Gaps = 55/385 (14%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEI-GKLNQLRR 154
SFS L L + I LS L L L NQ + L L
Sbjct: 49 SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEV 107
Query: 155 LYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYI 214
L L L +++ F L+ L +L L +N++
Sbjct: 108 LTLTQCNL---------DGAVLSGNFFK-------------PLTSLEMLVLRDNNIKKIQ 145
Query: 215 P-TVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLY----------KNSLSGSIP 263
P + N++ LDL+ N++ + L N L + L
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 264 SIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWT-LMSLFSNSLSGSIPPILGN------ 316
S+ LDL N S+ F + + T + SL ++
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265
Query: 317 --------LKSLSTLGLYLNQLNGVIPPSI-GNLSSLRNLSLFNNGLYGSIPEEI-GYLK 366
+ T L +++ + S+ + + L L+L N + I + L
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLT 323
Query: 367 SLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNL 426
L +L L +N L + NL L +L++ NH+ +S L +LK + + N L
Sbjct: 324 HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQL 383
Query: 427 VGKVYEAFGDHPNLTFLDLSQNNFD 451
F +L + L N +D
Sbjct: 384 KSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 48/261 (18%), Positives = 95/261 (36%), Gaps = 27/261 (10%)
Query: 408 KSLKSL----TSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFN-WRNLP 462
+ L + + V + N++ +F +L FL + Q I N +R L
Sbjct: 20 RGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79
Query: 463 KLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSSNHI-VGKIPVQL-EKLFSLNKLILSL 519
L + N F + + + L+ L L+ ++ + + L SL L+L
Sbjct: 80 SLIILKLD-YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138
Query: 520 NQLSGSVPLE--FGSLTELQYLDLSANKLSSSIPKSIGNL--LKLYYLNLSNNQ------ 569
N + + F ++ LDL+ NK+ S + + N L LS+
Sbjct: 139 NNIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197
Query: 570 --FSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKL-----NLSHNNLSGFI 622
K ++ LDLS N +E + + + + K+ + S+N S F
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257
Query: 623 PRCFEKMRSLSCIDICYNELQ 643
F+ + + + + ++
Sbjct: 258 HTNFKDPDNFTFKGLEASGVK 278
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 7e-15
Identities = 28/123 (22%), Positives = 49/123 (39%), Gaps = 6/123 (4%)
Query: 534 TELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHN 592
+ Y+DLS N ++ S L L +L + I F L L L L +N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 593 ILQEEIPPQV-CNMESLEKLNLSHNNL-SGFIPR-CFEKMRSLSCIDICYNELQGPIPNS 649
++ + +LE L L+ NL + F+ + SL + + N ++ I +
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK-IQPA 147
Query: 650 TVF 652
+ F
Sbjct: 148 SFF 150
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-39
Identities = 76/372 (20%), Positives = 131/372 (35%), Gaps = 49/372 (13%)
Query: 125 LSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHN 184
+ L++G + L+ + + + L + N L ++P + +L +
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE----VSG 90
Query: 185 NVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDN 244
N +P L +L++ L P + L L + NQL L P
Sbjct: 91 NQLTSLPVLPPGLLELSIFSNPLTHL----PALPSGLCK---LWIFGNQLTSL-PVLPPG 142
Query: 245 LSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSN 304
L L + N L+ S+P++ L L NQL+ S+P+ L +S+ N
Sbjct: 143 LQELS---VSDNQLA-SLPALPSELCK---LWAYNNQLT-SLPMLPSGL---QELSVSDN 191
Query: 305 SLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGY 364
L+ S+P + L L L L P L+ L + N L S+P
Sbjct: 192 QLA-SLPTLPSELYKLWAYNNRLTSL----PALPSG---LKELIVSGNRL-TSLPVLPSE 242
Query: 365 LKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424
LK L + N L+ +P L L + N L +P+SL L+S V N
Sbjct: 243 LKELM---VSGNRLTS-LPMLPSGLLSLSVYR---NQL-TRLPESLIHLSSETTVNLEGN 294
Query: 425 NLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGD 484
L + +A + + FD + R L ++ + +P G+
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH---LAAADWL--VPAREGE 349
Query: 485 SSKLQFLDLSSN 496
+ +
Sbjct: 350 PAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-36
Identities = 81/412 (19%), Positives = 139/412 (33%), Gaps = 116/412 (28%)
Query: 221 LKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIEN 280
+ L++ ++ L L C +++ L + N+L+ S+P++ L++L ++ N
Sbjct: 39 NNGNAVLNVGESGLTTLPDCLPAHITTLV---IPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 281 QLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGN 340
QL+ S+P + L LS L L +
Sbjct: 92 QLT-------------------------SLPVLPPGLLELSIFSNPLTHLPAL------- 119
Query: 341 LSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCEN 400
S L L +F N L S+P L EL + N L+ +P L L N N
Sbjct: 120 PSGLCKLWIFGNQL-TSLPVLPP---GLQELSVSDNQLA-SLPALPSELCKLWAYN---N 171
Query: 401 HLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRN 460
L +P L L +S N
Sbjct: 172 QL-TSLPMLP---------------------------SGLQELSVSDNQL---------- 193
Query: 461 LPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLN 520
S+P +L L +N + +P L +LI+S N
Sbjct: 194 ---------------ASLPTLPS---ELYKLWAYNNRLT-SLPALPS---GLKELIVSGN 231
Query: 521 QLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEK 580
+L+ S+P+ +EL+ L +S N+L+S +P LL L ++ NQ + +P
Sbjct: 232 RLT-SLPVL---PSELKELMVSGNRLTS-LPMLPSGLLSL---SVYRNQLT-RLPESLIH 282
Query: 581 LIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSL 632
L + ++L N L E + + S + + R+L
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 5e-36
Identities = 77/421 (18%), Positives = 131/421 (31%), Gaps = 94/421 (22%)
Query: 197 LSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKN 256
+ A+L + + L +P + ++TL + N L L P L L+ + N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLTSL-PALPPELRTLE---VSGN 91
Query: 257 SLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGN 316
L+ S+P + L L L S + +F N L+ S+P +
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPG 142
Query: 317 LKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKN 376
L+ LS + NQL +P L L +NN L S+P L EL + N
Sbjct: 143 LQELS---VSDNQLA-SLPALPSEL---CKLWAYNNQL-TSLPMLPS---GLQELSVSDN 191
Query: 377 NLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGD 436
L+ +P L L N N L +P
Sbjct: 192 QLA-SLPTLPSELYKLWAYN---NRL-TSLPALP-------------------------- 220
Query: 437 HPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSN 496
L L +S N S+P+ +L+ L +S N
Sbjct: 221 -SGLKELIVS-------------------------GNRLTSLPVLPS---ELKELMVSGN 251
Query: 497 HIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGN 556
+ +P+ L SL+ + NQL+ +P L+ ++L N LS +++
Sbjct: 252 RLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 306
Query: 557 LLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHN 616
+ S + + + + L + + N
Sbjct: 307 ITSAP--GYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDN 364
Query: 617 N 617
Sbjct: 365 A 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-35
Identities = 75/300 (25%), Positives = 121/300 (40%), Gaps = 37/300 (12%)
Query: 99 SSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLD 158
+ P L L +S N ++P L +L L + S L +L++
Sbjct: 78 ALPPELRTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIF 129
Query: 159 MNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVM 218
NQL ++P + L E S N ++ +P+ L K L+ NN L +P +
Sbjct: 130 GNQLT-SLPVLPPGL---QELSVSDNQLA-SLPALPSELCK---LWAYNNQL-TSLPMLP 180
Query: 219 GNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLI 278
L+ L +S NQL L P S L L+ Y N L+ S+P++ LK L +
Sbjct: 181 SGLQE---LSVSDNQLASL-P---TLPSELYKLWAYNNRLT-SLPALPSGLKE---LIVS 229
Query: 279 ENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSI 338
N+L+ S+P+ L + + N L+ S+P + L SLS +Y NQL +P S+
Sbjct: 230 GNRLT-SLPVLPSEL---KELMVSGNRLT-SLPMLPSGLLSLS---VYRNQLT-RLPESL 280
Query: 339 GNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMC 398
+LSS ++L N L + + + S + L L
Sbjct: 281 IHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAAD 340
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 7e-26
Identities = 63/296 (21%), Positives = 110/296 (37%), Gaps = 54/296 (18%)
Query: 364 YLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQ 423
+ L + ++ L+ +P + + L + +N+L +P L +L +
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNL-TSLPALPPELRTL---EVSG 90
Query: 424 NNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIG 483
N L + L+ + S L KL F N S+P+
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPS----GLCKLWIF----GNQLTSLPVLPP 141
Query: 484 DSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSA 543
LQ L +S N + +P L KL NQL+ S+P+ L E L +S
Sbjct: 142 ---GLQELSVSDNQL-ASLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQE---LSVSD 190
Query: 544 NKLSSSIPKSIGNLLKLY-----------------YLNLSNNQFSHTIPIEFEKLIHLSK 586
N+L +S+P L KL+ L +S N+ + ++P L +
Sbjct: 191 NQL-ASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLP---VLPSELKE 245
Query: 587 LDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNEL 642
L +S N L +P L L++ N L+ +P + S + +++ N L
Sbjct: 246 LMVSGNRL-TSLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 9e-19
Identities = 35/200 (17%), Positives = 68/200 (34%), Gaps = 19/200 (9%)
Query: 99 SSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLD 158
L L++S N ++P L L NN+L+ + L+ L +
Sbjct: 178 MLPSGLQELSVSDNQL-ASLPTLPSEL---YKLWAYNNRLT-SLPALPS---GLKELIVS 229
Query: 159 MNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVM 218
N+L ++P + +L + N +P L L + N L +P +
Sbjct: 230 GNRL-TSLPVLPSELKELM----VSGNRLTSLPMLPSGLLSL---SVYRNQL-TRLPESL 280
Query: 219 GNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLI 278
+L S +T++L N L+ L +++ + S ++LH
Sbjct: 281 IHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH--LAA 338
Query: 279 ENQLSGSIPLSFGNLSSWTL 298
+ L + W +
Sbjct: 339 ADWLVPAREGEPAPADRWHM 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-39
Identities = 79/404 (19%), Positives = 140/404 (34%), Gaps = 68/404 (16%)
Query: 190 IPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD 249
I S+L ++++ + Y L + + + + L LD+ ++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 250 TLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309
L L + ++ +L + N + P F N+ T++ L N LS S
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 137
Query: 310 IPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSL 368
+P I N L+TL + N L + + +SL+NL L +N L + + + SL
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSL 194
Query: 369 SELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVG 428
+ N LS +L +++ + + N++
Sbjct: 195 FHANVSYNLLS-----------------------------TLAIPIAVEELDASHNSINV 225
Query: 429 KVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKL 488
LT L L N NL + L
Sbjct: 226 VRGPVN---VELTILKLQHN-----------NLTDTAWL---------------LNYPGL 256
Query: 489 QFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS 548
+DLS N + + K+ L +L +S N+L ++ L + L+ LDLS N L
Sbjct: 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-L 314
Query: 549 SIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHN 592
+ ++ +L L L +N ++ L L LSHN
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIVT---LKLSTHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-38
Identities = 79/486 (16%), Positives = 162/486 (33%), Gaps = 30/486 (6%)
Query: 83 NLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVI 142
N+ D + ++++ + L+ + + N+ + +
Sbjct: 8 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP 67
Query: 143 SPEIGKLNQLRRLYLDMNQLHGTIPPVI-GQLSLIHEFSFCHNNVSGRIPSSLGNLSKLA 201
+ + Q+ L L+ Q+ I I + N + P N+ L
Sbjct: 68 AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126
Query: 202 LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261
+L L N L + N L+TL +S N L + T ++L L L N L+
Sbjct: 127 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-H 185
Query: 262 IPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLS 321
+ + + SL ++ N LS + + + NS++ + L+
Sbjct: 186 VD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELT 235
Query: 322 TLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSG 380
L L N L + N L + L N L I ++ L L + N L
Sbjct: 236 ILKLQHNNLTDT--AWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV- 291
Query: 381 VIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNL 440
+ + L +L++ NHL + ++ L+ + + N++ V H L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI---VTLKLSTHHTL 347
Query: 441 TFLDLSQNNFDGKISFNW-RNLPKLDTFIVSMN-----NIFGSIPLEIGDSSKLQFL--D 492
L LS N++D RN+ + + + + + D L L
Sbjct: 348 KNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQY 407
Query: 493 LSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPK 552
++ +V K+ + + + + + L + L+ N+L + + +
Sbjct: 408 IALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQ 467
Query: 553 SIGNLL 558
+
Sbjct: 468 LTNEQI 473
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-37
Identities = 71/398 (17%), Positives = 126/398 (31%), Gaps = 51/398 (12%)
Query: 229 LSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIG-----NLKSLHQLDLIENQLS 283
N + + Y + + L + + + +
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 284 GSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLS 342
+ L++L + I ++ L + N + + P N+
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 123
Query: 343 SLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENH 401
L L L N L S+P I L+ L + NNL + + T L L + N
Sbjct: 124 LLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182
Query: 402 LFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNL 461
L + SL + SL + N L + LD S N+ +
Sbjct: 183 L-THVDLSL--IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV--------- 225
Query: 462 PKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQ 521
+ + +L L L N++ L L ++ LS N+
Sbjct: 226 ------------------VRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNE 265
Query: 522 LSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKL 581
L + F + L+ L +S N+L ++ + L L+LS+N H + +
Sbjct: 266 LEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQF 323
Query: 582 IHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLS 619
L L L HN + + +L+ L LSHN+
Sbjct: 324 DRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-34
Identities = 60/360 (16%), Positives = 124/360 (34%), Gaps = 41/360 (11%)
Query: 285 SIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSL 344
I + + + + + L + + + + + + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 345 RNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLF 403
L+L + + I Y ++ +L + N + + PH N+ L +L + N L
Sbjct: 78 ELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 404 GPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPK 463
+ L + + NNL + F +L L LS N
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH----------- 185
Query: 464 LDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLS 523
+++ L ++S N + L ++ +L S N ++
Sbjct: 186 ----------------VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 224
Query: 524 GSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIH 583
+ EL L L N L+ + N L ++LS N+ + F K+
Sbjct: 225 V---VRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR 279
Query: 584 LSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
L +L +S+N L + + +L+ L+LSHN+L + R + L + + +N +
Sbjct: 280 LERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 12/109 (11%), Positives = 37/109 (33%), Gaps = 2/109 (1%)
Query: 535 ELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNIL 594
+ +Y I ++ Y +++ E L + + ++ +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 595 QEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNEL 642
++P + + +E LNL+ + F ++ + + +N +
Sbjct: 64 -RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 111
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-39
Identities = 69/428 (16%), Positives = 139/428 (32%), Gaps = 68/428 (15%)
Query: 196 NLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYK 255
N + + L +L++LD + + + ++ L+ L L
Sbjct: 19 NFASEVAAAFEMQAT---DTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTS 73
Query: 256 NSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILG 315
N+++ ++ + +L L N+L+ L L+ T ++ +N L+ + +
Sbjct: 74 NNIT-TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLD--VS 124
Query: 316 NLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCK 375
L+ L N L + + + + L L N ++ L+ L
Sbjct: 125 QNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSF 179
Query: 376 NNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFG 435
N ++ + V L LN N++ T L
Sbjct: 180 NKITEL---DVSQNKLLNRLNCDTNNI-----------TKLD----------------LN 209
Query: 436 DHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSS 495
+ LTFLD S N + L +L F S+N + L++ SKL L
Sbjct: 210 QNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVNPL---TELDVSTLSKLTTLHCIQ 263
Query: 496 NHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIG 555
++ +++ + + L+ T+L LD A ++ +
Sbjct: 264 TDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITEL---DLS 315
Query: 556 NLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSH 615
KL YL L+N + + ++ L L + +Q+ V + +L +
Sbjct: 316 QNPKLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAE 370
Query: 616 NNLSGFIP 623
Sbjct: 371 GQTITMPK 378
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-33
Identities = 63/398 (15%), Positives = 138/398 (34%), Gaps = 41/398 (10%)
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS 305
N + + + L +L LD + ++ + L+ T + SN+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 306 LSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365
++ ++ L +L+ L N+L + + L+ L L+ N L + +
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKL-TKLD--VSQN 126
Query: 366 KSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNN 425
L+ L +N L+ + V + T L L+ N + + T L + + N
Sbjct: 127 PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 426 LVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS 485
+ + L L+ NN + +L S N + +++
Sbjct: 182 ITE---LDVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKL---TEIDVTPL 232
Query: 486 SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANK 545
++L + D S N + + + L L L L ++ T+L Y +
Sbjct: 233 TQLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCR 286
Query: 546 LSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNM 605
+ + + +LY L+ + ++ + L L L++ L E+ V +
Sbjct: 287 KIKELD--VTHNTQLYLLDCQAAGITE---LDLSQNPKLVYLYLNNTEL-TELD--VSHN 338
Query: 606 ESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
L+ L+ + ++ F K+ +L+ +
Sbjct: 339 TKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-32
Identities = 76/503 (15%), Positives = 149/503 (29%), Gaps = 96/503 (19%)
Query: 126 SKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNN 185
+ ++ + +L L L + + +
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG----------------- 59
Query: 186 VSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNL 245
+ L+ L L +N++ + + +L+ L N+L L + L
Sbjct: 60 --------IEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNKLTNL---DVTPL 105
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS 305
+ L L N L+ + + L L+ N L+ + + + T + N
Sbjct: 106 TKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNK 159
Query: 306 LSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365
+ + L+TL N++ + + L L+ N + + +
Sbjct: 160 KITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQN 211
Query: 366 KSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNN 425
L+ L N L+ + V LT L + N L +L LT+L
Sbjct: 212 IQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTELDVSTLSKLTTL----HCIQT 264
Query: 426 LVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS 485
+L +DL+ N L L++ +
Sbjct: 265 -------------DLLEIDLTHNT----------QLIYF-----QAEGCRKIKELDVTHN 296
Query: 486 SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANK 545
++L LD + I ++ L + L L L+ +L+ L+ T+L+ L
Sbjct: 297 TQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAH 350
Query: 546 LSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKL-----IHLSKLDLSHNILQEEIPP 600
+ S+G + L + Q + LD N + I P
Sbjct: 351 I-QDFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEP 406
Query: 601 QVCNMESLEKLNLSHNNLSGFIP 623
+ ++ NLS P
Sbjct: 407 GDGGVYDQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-28
Identities = 61/346 (17%), Positives = 110/346 (31%), Gaps = 37/346 (10%)
Query: 83 NLSTLCLNGT-FQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGV 141
L+ L S +L L N N+ + L+KL L+ N+L+ +
Sbjct: 65 GLTKLICTSNNITTLDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLTKL 121
Query: 142 ISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLA 201
++ + L L N L I + + + E N ++ + ++L
Sbjct: 122 ---DVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLT 173
Query: 202 LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261
L + N + + K L+ L+ N + L L+ L L N L+
Sbjct: 174 TLDCSFNKITELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-E 226
Query: 262 IPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLS 321
I + L L D N L+ L LS T + L I L + L
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLI 278
Query: 322 TLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGV 381
+ + + + L L G+ + + L L L L+ +
Sbjct: 279 Y--FQAEGCRKIKELDVTHNTQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELTEL 333
Query: 382 IPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
V + T L L+ H+ S+ + +L + +
Sbjct: 334 ---DVSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 54/304 (17%), Positives = 103/304 (33%), Gaps = 40/304 (13%)
Query: 83 NLSTLCLNGT-FQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGV 141
L+ L + S P L LN + N I + + ++L LD N+
Sbjct: 107 KLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTL-TEID--VSHNTQLTELDCHLNKKIT- 162
Query: 142 ISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLA 201
++ QL L N++ + + Q L++ + NN++ ++ L +L
Sbjct: 163 -KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLT 215
Query: 202 LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD------------ 249
L ++N L I + L L+ D S N L L TL L+ L
Sbjct: 216 FLDCSSNKL-TEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLT 272
Query: 250 ----TLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS 305
++ + + L+ LD ++ L + L +
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTE 329
Query: 306 LSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365
L+ + + + L +L + S+G + +L N ++P+E
Sbjct: 330 LT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTI-TMPKETLTN 383
Query: 366 KSLS 369
SL+
Sbjct: 384 NSLT 387
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-39
Identities = 56/331 (16%), Positives = 110/331 (33%), Gaps = 24/331 (7%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177
I N ++ + + ++ L ++ ++ L L N L + + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 178 EFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL 237
+ N + L +LS L L LNNN + + S+ TL + N ++ +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 238 IPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSG-SIPLSFGNLSSW 296
+ ++L N ++ G + LDL N++ + + +
Sbjct: 115 ---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 297 TLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYG 356
++L N + + + L TL L N+L + P + + + +SL NN L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-V 227
Query: 357 SIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSL 416
I + + + ++L L N G L N + +++K LT
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHC------GTLRDFFSKNQRVQTVA---KQTVKKLTGQ 278
Query: 417 KRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQ 447
L D P L
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRLIA 309
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 49/327 (14%), Positives = 108/327 (33%), Gaps = 16/327 (4%)
Query: 98 FSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYL 157
+ ++ + + + ++ LDL N LS + + ++ +L L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 158 DMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTV 217
N L + LS + +N V L + L+ NN++ +
Sbjct: 66 SSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-SRVSC- 116
Query: 218 MGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG-SIPSIIGNLKSLHQLD 276
+ + L+ N++ L S + L L N + + + + +L L+
Sbjct: 117 -SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 277 LIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPP 336
L N + + + + L SN L+ + P + ++ + L N+L +I
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 337 SIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLN 396
++ +L + L NG + + K+ + K + + + T L +
Sbjct: 232 ALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 397 MCENHLFGPIPKSLKSLTSLKRVRFNQ 423
L +L +
Sbjct: 291 YGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 50/360 (13%), Positives = 107/360 (29%), Gaps = 45/360 (12%)
Query: 214 IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLH 273
I + N ++ + L + + N+ L L N LS + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 274 QLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGV 333
L+L N L + +L +L TL L N +
Sbjct: 62 LLNLSSNVLY-------------------------ETLDL-ESLSTLRTLDLNNNYVQ-- 93
Query: 334 IPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLV 393
+ S+ L NN + + + + L N ++ + G + +
Sbjct: 94 ---ELLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 394 LLNMCENHLFG-PIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDG 452
L++ N + + S +L+ + N + + L LDLS N
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA- 204
Query: 453 KISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSL 512
+ +++ + + N + I + S L+ DL N ++ +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQ 262
Query: 513 NKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSH 572
++ + + + + L +P + L + L ++ H
Sbjct: 263 RVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL----IALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 51/288 (17%), Positives = 100/288 (34%), Gaps = 39/288 (13%)
Query: 357 SIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSL 416
+I E K+ ++L + + + L++ N L L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 417 KRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFG 476
+ + + N L L LDL+ N
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ------------------------- 93
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTEL 536
E+ ++ L ++N+I ++ + + L+ N+++ L+ G + +
Sbjct: 94 ----ELLVGPSIETLHAANNNI-SRVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 537 QYLDLSANKLSS-SIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQ 595
QYLDL N++ + + + + L +LNL N + L LDLS N L
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKL- 203
Query: 596 EEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+ P+ + + ++L +N L I + ++L D+ N
Sbjct: 204 AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 67/354 (18%), Positives = 115/354 (32%), Gaps = 64/354 (18%)
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSL 320
+I I N + ++ L ++ + + + L N LS L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 321 STLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSG 380
L L N L + +LS+LR L L NN + +E+ S+ L NN+S
Sbjct: 61 ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 381 VIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNL 440
V S G + + N +T L+ G +
Sbjct: 114 V---SCSRGQGKKNIYLANNK-----------ITMLRD-------------LDEGCRSRV 146
Query: 441 TFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVG 500
+LDL N + + S L+ L+L N I
Sbjct: 147 QYLDLKLNEI---------------DTV--------NFAELAASSDTLEHLNLQYNFIY- 182
Query: 501 KIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKL 560
+ L L LS N+L+ + EF S + ++ L NKL I K++ L
Sbjct: 183 DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNL 239
Query: 561 YYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQE--EIPPQVCNMESLEKLN 612
+ +L N F H + + ++ +++ + C + +L
Sbjct: 240 EHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 58/335 (17%), Positives = 116/335 (34%), Gaps = 23/335 (6%)
Query: 166 IPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLS 225
I + + +++ + S + + L L+ N L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 226 TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGS 285
L+LS N L + L++LS L TL L N + + S+ L N +S
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR- 113
Query: 286 IPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPS-IGNLSSL 344
+S + L +N ++ G + L L LN+++ V + +L
Sbjct: 114 --VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 345 RNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFG 404
+L+L N +Y + ++ L L L N L+ + + G+ +++ N L
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-V 227
Query: 405 PIPKSLKSLTSLKRVRFNQNNLV-GKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPK 463
I K+L+ +L+ N G + + F + + + + +P
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 464 LDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHI 498
L + +P + + L +H
Sbjct: 288 LGHY---GAYCCEDLP----APFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 28/176 (15%), Positives = 71/176 (40%), Gaps = 11/176 (6%)
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTEL 536
+I + ++ + ++ + + + + +++ +L LS N LS + T+L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 537 QYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQE 596
+ L+LS+N L + +L L L+L+NN E + L ++N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 597 EIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVF 652
+ + + + L++N ++ + +D+ NE+ + + +
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELA 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-37
Identities = 73/330 (22%), Positives = 129/330 (39%), Gaps = 30/330 (9%)
Query: 101 FPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDM 159
L+L N + + L+ L+L N +S V L LR L L
Sbjct: 31 PTETRLLDLGKN-RIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89
Query: 160 NQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMG 219
N+L IP LS L L ++ N + + +
Sbjct: 90 NRLK-LIPL-----------------------GVFTGLSNLTKLDISENKIVILLDYMFQ 125
Query: 220 NLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLI 278
+L +L +L++ N L + L++L+ L L K +L+ SIP+ + +L L L L
Sbjct: 126 DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184
Query: 279 ENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSI 338
++ SF L ++ + ++ P +L++L + L V ++
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAV 244
Query: 339 GNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNM 397
+L LR L+L N + +I + L L E++L L+ V P++ L L +LN+
Sbjct: 245 RHLVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303
Query: 398 CENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
N L S+ +L+ + + N L
Sbjct: 304 SGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-37
Identities = 71/315 (22%), Positives = 125/315 (39%), Gaps = 10/315 (3%)
Query: 309 SIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI-GYLKS 367
++P + L L N++ + + L L L N + ++ L +
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFN 81
Query: 368 LSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
L L L N L + L+ L L++ EN + + + L +LK + N+LV
Sbjct: 82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 428 GKVYEAFGDHPNLTFLDLSQNNFDGKISFNW-RNLPKLDTFIVSMNNIFGSIPLEIGDSS 486
+ AF +L L L + N I +L L + NI
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLY 200
Query: 487 KLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSANK 545
+L+ L++S + + +L L ++ L+ +VP L L++L+LS N
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNP 259
Query: 546 LSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVC-N 604
+S+ + LL+L + L Q + P F L +L L++S N L + V +
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 605 MESLEKLNLSHNNLS 619
+ +LE L L N L+
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-34
Identities = 63/305 (20%), Positives = 122/305 (40%), Gaps = 9/305 (2%)
Query: 342 SSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENH 401
+ R + ++PE I L L KN + + + L L + EN
Sbjct: 11 AQDRAVLCHRKRF-VAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 402 LFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNL 461
+ P + +L +L+ + N L F NLT LD+S+N + + +++L
Sbjct: 68 VSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL 127
Query: 462 PKLDTFIVSMNNIFGSIPLEI-GDSSKLQFLDLSSNHIVGKIPVQ-LEKLFSLNKLILSL 519
L + V N++ I + L+ L L ++ IP + L L L L L
Sbjct: 128 YNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRH 185
Query: 520 NQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFE 579
++ F L L+ L++S ++ + L L L++++ + +
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245
Query: 580 KLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDIC 638
L++L L+LS+N + I + + L+++ L L+ P F + L +++
Sbjct: 246 HLVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304
Query: 639 YNELQ 643
N+L
Sbjct: 305 GNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-31
Identities = 57/256 (22%), Positives = 111/256 (43%), Gaps = 10/256 (3%)
Query: 83 NLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQ 137
NL TL L F+ +L L++S N + + +L L++L++G+N
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI-VILLDYMFQDLYNLKSLEVGDND 139
Query: 138 LSGVISPEIGKLNQLRRLYLDMNQLHGTIPP-VIGQLSLIHEFSFCHNNVSGRIPSSLGN 196
L + LN L +L L+ L +IP + L + H N++ S
Sbjct: 140 LVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKR 198
Query: 197 LSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKN 256
L +L +L +++ + +L++L ++ L + + +L L L L N
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYN 258
Query: 257 SLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILG 315
+S S++ L L ++ L+ QL+ P +F L+ ++++ N L+ ++ +
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFH 317
Query: 316 NLKSLSTLGLYLNQLN 331
++ +L TL L N L
Sbjct: 318 SVGNLETLILDSNPLA 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 62/264 (23%), Positives = 106/264 (40%), Gaps = 28/264 (10%)
Query: 758 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
IG+G +VYK + + VA + Q +++ F L ++H NIV+F
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 817 HG----FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+ + LV E + G+L L K + + + + L +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH- 146
Query: 873 DCLPSIIHRDISSKNVLLDLEF-EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
P IIHRD+ N+ + + D G+A +S +GT + APE+ Y
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEM-YE 203
Query: 932 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991
+ E DVY+FG+ + E+ +P +S N QI S P D
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYP-------YSECQNA----AQIYRRVTSGVKPASFD 252
Query: 992 KLIS--IMEVAILCLDESPEARPT 1013
K+ + E+ C+ ++ + R +
Sbjct: 253 KVAIPEVKEIIEGCIRQNKDERYS 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 60/293 (20%), Positives = 119/293 (40%), Gaps = 50/293 (17%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DF+ C+G+GG G V++A+ A+K+ L +++ + V AL ++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKVMREVKALAKLE 61
Query: 810 HRNIVKFHGFC------------SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI 857
H IV++ S + ++ + + +L + T +E + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE--------- 908
++ +A A+ +LH ++HRD+ N+ ++ V DFG+ ++
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 909 ---PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 965
P + T VGT Y +PE + + K D++S G+++FE++ +P FS
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP-------FS 228
Query: 966 SFSNMIIEVNQILD---PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ + + + + P L T ++ M L SP RP
Sbjct: 229 TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDM------LSPSPMERPEAI 275
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 55/276 (19%), Positives = 105/276 (38%), Gaps = 36/276 (13%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+GG V E L G A+K+ D++E H NI++
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLV 92
Query: 818 GFCSNARHS----FLVCEYLHRGSLARILGNDATAKE-LSWNRRINVIKGVANALSYLHH 872
+C R + +L+ + RG+L + L+ ++ + ++ G+ L +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE---------FVGTFGY 923
HRD+ N+LL E + + D G + + T Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 924 AAPEI----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979
APE+ ++ + E+ DV+S G +++ ++ G P + + S + NQ+
Sbjct: 210 RAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVALAVQNQLSI 266
Query: 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
P+ S + L++ M + P RP +
Sbjct: 267 PQSPRHSSALWQ-LLNSM------MTVDPHQRPHIP 295
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-33
Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 36/282 (12%)
Query: 741 IMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDI-VAVKKFNSQLLSGNMADQ-DEF 798
+ HE+++ E+ IG+G G V+ L + + VAVK D +F
Sbjct: 111 LNHEDLV-----LGEQ--IGRGNFGEVFSGRLRADNTLVAVKSCRE----TLPPDLKAKF 159
Query: 799 LNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRIN 858
L L + H NIV+ G C+ + ++V E + G L + L +
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQ 217
Query: 859 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFV 918
++ A + YL IHRD++++N L+ + +SDFG+++ + +
Sbjct: 218 MVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274
Query: 919 GTFGY--AAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVN 975
APE R + + DV+SFG+L++E G P + + SN +
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP-------YPNLSNQ--QTR 325
Query: 976 QILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ ++ RL P D + +ME C P RP+
Sbjct: 326 EFVEKGGRLPCP-ELCPDAVFRLME---QCWAYEPGQRPSFS 363
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 63/270 (23%), Positives = 118/270 (43%), Gaps = 18/270 (6%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQD--EFLNVVLALNE 807
+F + IG+G VY+A L G VA+KK + M + + + + L +
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ---IFDLMDAKARADCIKEIDLLKQ 88
Query: 808 IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI-NVIKGVANA 866
+ H N++K++ +V E G L+R++ + K L R + + +A
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAP 926
L ++H ++HRDI NV + + D G+ +F ++ VGT Y +P
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
E + K D++S G L++E+ P F + + ++ ++ Q P L PS
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCDYPPL--PS 260
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTMEK 1016
++L ++ +C++ PE RP +
Sbjct: 261 DHYSEELRQLVN---MCINPDPEKRPDVTY 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 56/267 (20%), Positives = 108/267 (40%), Gaps = 18/267 (6%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+ + IG+G G + G +K+ N +S +++E V L ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS--KEREESRREVAVLANMK 81
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H NIV++ ++V +Y G L + + N ++ ++ + AL +
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
+H I+HRDI S+N+ L + + DFGIA+ + +GT Y +PEI
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
K D+++ G +++E+ H F + + + I ++ P S +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA--FEAGSMKNLVLKI--ISGSFPPVSLHYSYDL 253
Query: 990 MDKLISIMEVAILCLDESPEARPTMEK 1016
L+S +P RP++
Sbjct: 254 RS-LVS------QLFKRNPRDRPSVNS 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 56/282 (19%), Positives = 107/282 (37%), Gaps = 46/282 (16%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DF E IG GG G V+KA+ G +K+ + ++ V AL ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY--------NNEKAEREVKALAKLD 62
Query: 810 HRNIVKFHGF----------------CSNARHSFLVCEYLHRGSLARILGNDATAKELSW 853
H NIV ++G S + F+ E+ +G+L + + ++L
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDK 121
Query: 854 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN 913
+ + + + + Y+H +I+RD+ N+ L + + DFG+ ++
Sbjct: 122 VLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGK 177
Query: 914 RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973
RT GT Y +PE + ++ D+Y+ G+++ E++
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----------AFETSKF 227
Query: 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ D +S L+ + L + PE RP
Sbjct: 228 FTDLRDGIISDIFDKKEKTLLQKL------LSKKPEDRPNTS 263
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-32
Identities = 67/268 (25%), Positives = 114/268 (42%), Gaps = 42/268 (15%)
Query: 759 IGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADQDEFL-------NVVLALNEIRH 810
+G+GG G VY+AE + IVA+K L+S ++ F L
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALK-----LMSETLSSDPVFRTRMQREARTAGRLQ---E 93
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
++V H F ++ ++ LA +L L+ R + +++ + +AL
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAA 150
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT-EFVGTFGYAAPEIA 929
H HRD+ +N+L+ + A++ DFGIA + VGT Y APE
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS--SFSNMIIEVNQILDPRLSTPSP 987
AT + D+Y+ +++E + G+ P + S M +NQ + PR ST P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP-------YQGDQLSVMGAHINQAI-PRPSTVRP 259
Query: 988 GV---MDKLISIMEVAILCLDESPEARP 1012
G+ D +I+ + ++PE R
Sbjct: 260 GIPVAFDAVIAR------GMAKNPEDRY 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 83/272 (30%), Positives = 124/272 (45%), Gaps = 24/272 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEI 808
+DF+ +GKG G+VY A E S I+A+K +QL + Q V + +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSHL 66
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALS 868
RH NI++ +G+ +A +L+ EY G++ R L + R I +ANALS
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
Y H +IHRDI +N+LL E ++DFG + SS RT+ GT Y PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLCGTLDYLPPEM 178
Query: 929 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988
EK D++S GVL +E + G P F + + I V + + G
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISRVEFTFPDFV---TEG 233
Query: 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
D LIS + L +P RP + + H
Sbjct: 234 ARD-LISRL------LKHNPSQRPMLREVLEH 258
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-32
Identities = 61/265 (23%), Positives = 99/265 (37%), Gaps = 48/265 (18%)
Query: 758 CIGKGGQGSVYKAE---LPSGDIVAVKKFNSQLL--SGNMADQDEFLNVVLALNEIRHRN 812
CI GG G +Y A + +G V +K L SG+ Q + L E+ H +
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLK-----GLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 813 IVKFHGF-----CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANAL 867
IV+ F ++V EY+ SL R G ++L I + + AL
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPAL 195
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
SYLH +++ D+ +N++L E + + D G + + GT G+ APE
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQAPE 247
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987
I T T D+Y+ G + + + ++ DP L T
Sbjct: 248 IVRT-GPTVATDIYTVGRTLAALTLDLPT----------RNGRYVDGLPEDDPVLKTYDS 296
Query: 988 GVMDKLISIMEVAILCLDESPEARP 1012
+L+ +D P R
Sbjct: 297 --YGRLLRR------AIDPDPRQRF 313
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 64/271 (23%), Positives = 117/271 (43%), Gaps = 19/271 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+D++ + IG G G K G I+ K+ + ++ ++ ++ V L E++
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELK 63
Query: 810 HRNIVKFHG--FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRI-NVIKGVANA 866
H NIV+++ ++V EY G LA ++ ++ + V+ + A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 867 LSYLH--HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA 924
L H D +++HRD+ NV LD + + DFG+A+ + +S FVGT Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
+PE M EK D++S G L++E+ P F + + + I
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELAGKI--REGKFRRIPYR 239
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTME 1015
S + + +I+ M L+ RP++E
Sbjct: 240 YSDELNE-IITRM------LNLKDYHRPSVE 263
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-32
Identities = 81/454 (17%), Positives = 149/454 (32%), Gaps = 84/454 (18%)
Query: 102 PHLVNLNLSFNLFFGNIPPQIGNL----SKLQNLDL-GNNQLSGVISPEIGKLNQLRRLY 156
P N +LS N F+ I + K + L G N+ V + +NQ L
Sbjct: 6 PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQ 65
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT 216
L+ L ++P + ++ +L + N+L +P
Sbjct: 66 LNRLNLS-SLPDNLPP--------------------------QITVLEITQNAL-ISLPE 97
Query: 217 VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLD 276
+ +L+ LD N+L+ L P +L +LD + N L+ +P + L+ ++
Sbjct: 98 LPASLE---YLDACDNRLSTL-PELPASLKHLD---VDNNQLT-MLPELPALLEY---IN 146
Query: 277 LIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPP 336
NQL+ +P +L ++S+ +N L+ +P + +L++L + N L +P
Sbjct: 147 ADNNQLT-MLPELPTSL---EVLSVRNNQLT-FLPELPESLEALD---VSTNLLES-LPA 197
Query: 337 SIGNLSSLRN----LSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGL 392
N + IPE I L + L N LS I S+ T
Sbjct: 198 VPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256
Query: 393 VLLNMCENHLFGPIPKSLKSLTSLKRVRF-----NQNNLVGKVYEAFGDHPNLTFLDLSQ 447
+ + + L N+ + V +++ AF + S
Sbjct: 257 PDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHAN--TFSA 314
Query: 448 NNFDGKISFNWRNLPKLDTFIVSM--------------NNIFGSIPLEIGDSSKLQFLDL 493
+ + RN + + + D L + +L
Sbjct: 315 FLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNL 374
Query: 494 SSNHIV-----GKIPVQLEKLFSLNKLILSLNQL 522
+V G L SL + + L L
Sbjct: 375 RKTLLVHQASEGLFDNDTGALLSLGREMFRLEIL 408
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 71/400 (17%), Positives = 137/400 (34%), Gaps = 48/400 (12%)
Query: 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLD 243
+ S+ K AL N N + + + S L L++ L+ L P L
Sbjct: 23 SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLSSL-PDNL- 78
Query: 244 NLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFS 303
+ L + +N+L S+P + +L+ LD +N+LS ++P +L + + +
Sbjct: 79 -PPQITVLEITQNALI-SLPELPASLEY---LDACDNRLS-TLPELPASLKH---LDVDN 129
Query: 304 NSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIG 363
N L+ +P + L+ ++ NQL ++P + L LS+ NN L +PE
Sbjct: 130 NQLT-MLPELPALLEYIN---ADNNQLT-MLPELPTS---LEVLSVRNNQL-TFLPELPE 180
Query: 364 YLKSLSELKLCKNNLSGVIPHSVGNLTGL----VLLNMCENHLFGPIPKSLKSLTSLKRV 419
SL L + N L +P + EN + IP+++ SL +
Sbjct: 181 ---SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTI 235
Query: 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479
N L ++ E T +I F+ + + + + P
Sbjct: 236 ILEDNPLSSRIRE---SLSQQTAQPDYHGP---RIYFSMSDGQQNTLHRPLADAVTAWFP 289
Query: 480 LEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLN-----QLSGSVPLEFGSLT 534
+ L++L +++ V L+
Sbjct: 290 ENKQSDVSQIWHAFEHE------EHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLS 343
Query: 535 ELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTI 574
L + +++ +S + + L + NL H
Sbjct: 344 ASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQA 383
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 59/326 (18%), Positives = 113/326 (34%), Gaps = 39/326 (11%)
Query: 285 SIPLSFGNLSSWTLMSLFSNSLSG---SIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNL 341
SI L N S + + F N++SG + + G N+ ++ + +
Sbjct: 2 SIMLPINNNFSLSQ-NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 342 SSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENH 401
+ L L L S+P+ + ++ L++ +N L +P +L L + +
Sbjct: 59 NQFSELQLNRLNL-SSLPDNLP--PQITVLEITQNALI-SLPELPASLEYLDACDNRLST 114
Query: 402 LFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHP-NLTFLDLSQNNFDGKISFNWRN 460
L P+ SL L + N L + P L +++ N +++
Sbjct: 115 L----PELPASLKHL---DVDNNQL-----TMLPELPALLEYINADNN----QLTMLPEL 158
Query: 461 LPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSL- 519
L+ V N + +P L+ LD+S+N + +P + + +
Sbjct: 159 PTSLEVLSVRNNQL-TFLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 520 ---NQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPI 576
N+++ +P SL + L N LSS I +S+ + FS
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM--SD 270
Query: 577 EFEKLIHLSKLDLSHNILQEEIPPQV 602
+ +H D E V
Sbjct: 271 GQQNTLHRPLADAVTAWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-26
Identities = 72/372 (19%), Positives = 121/372 (32%), Gaps = 51/372 (13%)
Query: 83 NLSTLCLNGT-FQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGV 141
S L LN + P + L ++ N ++P + L+ LD +N+LS
Sbjct: 60 QFSELQLNRLNLSSLPDNLPPQITVLEITQNA-LISLPELPAS---LEYLDACDNRLS-T 114
Query: 142 ISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLA 201
+ L+ L +D NQL +P + L I+ NN +P +L
Sbjct: 115 LPELPA---SLKHLDVDNNQLT-MLPELPALLEYIN----ADNNQLTMLPELPTSLEV-- 164
Query: 202 LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL--IPCTLDNLSNLDT-LFLYKNSL 258
L + NN L ++P + +L+ LD+S N L L +P + + +N +
Sbjct: 165 -LSVRNNQL-TFLPELPESLE---ALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRI 219
Query: 259 SGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLK 318
+ IP I +L + L +N LS I S ++ S S N
Sbjct: 220 T-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTL 276
Query: 319 SLSTLGLYLNQLNGVIPPSI-----------------GNLSSLRNLSLFNN--GLYGSIP 359
+ L L + N G +
Sbjct: 277 HRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVA 336
Query: 360 EEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLF-----GPIPKSLKSLT 414
+ L + +EL+ ++ S + L N+ + L G +L
Sbjct: 337 AWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALL 396
Query: 415 SLKRVRFNQNNL 426
SL R F L
Sbjct: 397 SLGREMFRLEIL 408
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 54/303 (17%), Positives = 103/303 (33%), Gaps = 57/303 (18%)
Query: 337 SIGNLSSLRNLSLFNN--GLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVL 394
I N SL S +N G Y + + +N ++ +
Sbjct: 6 PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC--LINQFSE 63
Query: 395 LNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKI 454
L + +L +SL + P +T L+++QN +
Sbjct: 64 LQLNRLNL-----------SSLP--------------DNLP--PQITVLEITQNALI-SL 95
Query: 455 SFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNK 514
+L LD +N ++P L+ LD+ +N + +P E L
Sbjct: 96 PELPASLEYLD---AC-DNRLSTLPELPA---SLKHLDVDNNQLT-MLP---ELPALLEY 144
Query: 515 LILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTI 574
+ NQL+ +P T L+ L + N+L+ +P+ +L L ++S N ++
Sbjct: 145 INADNNQLT-MLP---ELPTSLEVLSVRNNQLTF-LPELPESLEAL---DVSTNLLE-SL 195
Query: 575 PIEFEKLIHLSK----LDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMR 630
P + H + N + IP + +++ + L N LS I +
Sbjct: 196 PAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254
Query: 631 SLS 633
+
Sbjct: 255 AQP 257
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 21/98 (21%), Positives = 34/98 (34%), Gaps = 9/98 (9%)
Query: 549 SIPKSIGNLLKLYYLNLSNNQFSHT---IPIEFEKLIHLSKLDLSHNILQEEIPPQVCNM 605
SI I N L N N S T ++K + + N + C +
Sbjct: 2 SIMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLI 58
Query: 606 ESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+L L+ NLS +P ++ ++I N L
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI 93
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 59/289 (20%), Positives = 113/289 (39%), Gaps = 49/289 (16%)
Query: 752 DFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-- 809
F K +G G +G++ + VAVK+ + S A E++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-------------FADREVQLL 71
Query: 810 -----HRNIVKFHGFCSNARHSFLVCEYLHRGSLA-RILGNDATAKELSWNRRINVIKGV 863
H N++++ + + ++ E +L + D L I +++
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGL---EPITLLQQT 127
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLL-----DLEFEAHVSDFGIAKFVEPYSS---NRT 915
+ L++LH +I+HRD+ N+L+ + +A +SDFG+ K + R+
Sbjct: 128 TSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 916 EFVGTFGYAAPEI---AYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMI 971
GT G+ APE+ T D++S G + + VI +G+HP F + ++
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP--FGKSLQRQANILL 242
Query: 972 IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ + LI M + +D P+ RP+ + H
Sbjct: 243 GACSLDCLHPEKHEDVIARE-LIEKM----IAMD--PQKRPSAKHVLKH 284
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 69/294 (23%), Positives = 113/294 (38%), Gaps = 21/294 (7%)
Query: 334 IPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLV 393
+P + L L NN + + LK+L L L N +S + P + L L
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 394 LLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNF-DG 452
L + +N L +P+ + +L+ +R ++N + F + ++L N
Sbjct: 104 RLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160
Query: 453 KISFNW-RNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQ-LEKLF 510
I + + KL ++ NI +IP G L L L N I K+ L+ L
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKI-TKVDAASLKGLN 216
Query: 511 SLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQF 570
+L KL LS N +S + L+ L L+ NKL +P + + + + L NN
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNI 275
Query: 571 SH------TIPIEFEKLIHLSKLDLSHNILQ-EEIPPQV-CNMESLEKLNLSHN 616
S P K S + L N +Q EI P + + L +
Sbjct: 276 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 69/277 (24%), Positives = 113/277 (40%), Gaps = 19/277 (6%)
Query: 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCT 241
C + ++P L ALL L NN + NLK+L TL L N+++ + P
Sbjct: 38 CSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95
Query: 242 LDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSL 301
L L+ L+L KN L +P K+L +L + EN+++ F L+ ++ L
Sbjct: 96 FAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 152
Query: 302 FSNSL-SGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIP 359
+N L S I +K LS + + + IP G SL L L N + +
Sbjct: 153 GTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI-TKVD 208
Query: 360 EEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKR 418
L +L++L L N++S V S+ N L L++ N L +P L ++
Sbjct: 209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQV 267
Query: 419 VRFNQNNL------VGKVYEAFGDHPNLTFLDLSQNN 449
V + NN+ + + + L N
Sbjct: 268 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 304
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 59/313 (18%), Positives = 110/313 (35%), Gaps = 49/313 (15%)
Query: 80 ISINLSTLCLNGTF----QDFSFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLG 134
+ + + L L +D F + +L L L N I P L KL+ L L
Sbjct: 50 LPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLS 108
Query: 135 NNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSL 194
NQL + L+ L + N++ + S
Sbjct: 109 KNQLKEL---PEKMPKTLQELRVHENEIT-KVR-----------------------KSVF 141
Query: 195 GNLSKLALLYLNNNSL--FGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLF 252
L+++ ++ L N L G +K LS + ++ + + +L L
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELH 198
Query: 253 LYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIP 311
L N ++ + + + L +L +L L N +S S N + L +N L +P
Sbjct: 199 LDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256
Query: 312 PILGNLKSLSTLGLYLNQLNGV------IPPSIGNLSSLRNLSLFNNGL-YGSIPEEI-G 363
L + K + + L+ N ++ + P +S +SLF+N + Y I
Sbjct: 257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
Query: 364 YLKSLSELKLCKN 376
+ + ++L
Sbjct: 317 CVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 72/337 (21%), Positives = 121/337 (35%), Gaps = 61/337 (18%)
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLI 176
++PP LDL NN+++ + + L L L L N++ I
Sbjct: 49 DLPPDT------ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KIS--------- 92
Query: 177 HEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG 236
P + L KL LYL+ N L +P K+L L + +N++
Sbjct: 93 --------------PGAFAPLVKLERLYLSKNQL-KELPE--KMPKTLQELRVHENEITK 135
Query: 237 LIPCTLDNLSNLDTLFLYKNSLSGSI--PSIIGNLKSLHQLDLIENQLSGSIPLSFGNLS 294
+ + L+ + + L N L S +K L + + + ++ +IP G
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP--QGLPP 192
Query: 295 SWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNG 353
S T + L N ++ + L L +L+ LGL N ++ V S+ N LR L L NN
Sbjct: 193 SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251
Query: 354 LYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSL 413
L +P + K + + L NN+S + ++ F P P
Sbjct: 252 LV-KVPGGLADHKYIQVVYLHNNNISAI-----------------GSNDFCP-PGYNTKK 292
Query: 414 TSLKRVRFNQNNLVGKVYE--AFGDHPNLTFLDLSQN 448
S V N + + F + L
Sbjct: 293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 69/334 (20%), Positives = 120/334 (35%), Gaps = 48/334 (14%)
Query: 271 SLHQLDLIENQLSGSIPLSFGNLSSWT-LMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLN 328
L + + L +P +L T L+ L +N ++ I NLK+L TL L N
Sbjct: 32 HLRVVQCSDLGLE-KVP---KDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINN 86
Query: 329 QLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGN 388
+++ + P + L L L L N L +PE++ K+L EL++ +N ++ V
Sbjct: 87 KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNG 143
Query: 389 LTGLVLLNMCENHL--FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLS 446
L ++++ + N L G + + + L +R N+ P+LT L L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLD 200
Query: 447 QNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL 506
N + + L L LS N I L
Sbjct: 201 GNKI--------TKVDA---------ASLKGLN-------NLAKLGLSFNSISAVDNGSL 236
Query: 507 EKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS------SIPKSIGNLLKL 560
L +L L+ N+L VP +Q + L N +S+ P
Sbjct: 237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 295
Query: 561 YYLNLSNNQFSHTI--PIEFEKLIHLSKLDLSHN 592
++L +N + P F + + + L +
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 60/309 (19%), Positives = 119/309 (38%), Gaps = 42/309 (13%)
Query: 343 SLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL 402
LR + + GL +P+++ + L L N ++ + NL L L + N +
Sbjct: 32 HLRVVQCSDLGL-EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 403 FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLP 462
P + L L+R+ ++N L + L L + +N +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKELPEKMP---KTLQELRVHENEI--------TKVR 137
Query: 463 KLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHI-VGKIPVQ-LEKLFSLNKLILSLN 520
K ++F + ++ ++L +N + I + + L+ + ++
Sbjct: 138 K---------SVFNGLN-------QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 521 QLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEK 580
++ ++P G L L L NK++ S+ L L L LS N S
Sbjct: 182 NIT-TIP--QGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238
Query: 581 LIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGF------IPRCFEKMRSLSC 634
HL +L L++N L ++P + + + ++ + L +NN+S P K S S
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297
Query: 635 IDICYNELQ 643
+ + N +Q
Sbjct: 298 VSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 6/144 (4%)
Query: 511 SLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQF 570
L + S L VP + + LDL NK++ NL L+ L L NN+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 571 SHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMR 630
S P F L+ L +L LS N L+ E+P ++ ++L++L + N ++ F +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 631 SLSCIDICYNELQGPIPNSTVFKD 654
+ +++ N L+ + F+
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQG 169
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 36/279 (12%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN--IVK 815
IG GG V++ I A+K N + D + N + LN+++ + I++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS--YRNEIAYLNKLQQHSDKIIR 92
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
+ + ++ ++V E L L K + R + K + A+ +H
Sbjct: 93 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEI----- 928
I+H D+ N L+ + + DFGIA ++P +++ + VGT Y PE
Sbjct: 147 -GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 929 ------AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
+ + K DV+S G +++ + G P F N I +++ I+DP
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNH 257
Query: 983 STPSPGVMDK-LISIMEVAILCLDESPEARPTMEKGFGH 1020
P + +K L +++ CL P+ R ++ + H
Sbjct: 258 EIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAH 293
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 61/278 (21%), Positives = 113/278 (40%), Gaps = 34/278 (12%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH--RNIVK 815
IG GG V++ I A+K N + D + N + LN+++ I++
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS--YRNEIAYLNKLQQHSDKIIR 73
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
+ + ++ ++V E L L K + R + K + A+ +H
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEI----- 928
I+H D+ N L+ + + DFGIA ++P +++ + VGT Y PE
Sbjct: 128 -GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 929 --AYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
++ K DV+S G +++ + G P F N I +++ I+DP
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNH 238
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
P + +K + +V CL P+ R ++ + H
Sbjct: 239 EIEFPDIPEK--DLQDVLKCCLKRDPKQRISIPELLAH 274
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 62/266 (23%), Positives = 112/266 (42%), Gaps = 33/266 (12%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEI------RH 810
+GKG VY+A + +G VA+K + + M + NE+ +H
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--------VQNEVKIHCQLKH 70
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
+I++ + + ++ + +LV E H G + R L K S N + + + + YL
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYL 128
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY 930
H I+HRD++ N+LL ++DFG+A ++ GT Y +PEIA
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990
+ DV+S G + + ++ G P F + + N ++ + + L S
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPP--FDTDTVKNTLNKVVLADYEMPSFL---SIEAK 240
Query: 991 DKLISIMEVAILCLDESPEARPTMEK 1016
D LI + L +P R ++
Sbjct: 241 D-LIHQL------LRRNPADRLSLSS 259
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 70/300 (23%), Positives = 113/300 (37%), Gaps = 57/300 (19%)
Query: 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI 808
DF+E +G+G G V KA A+KK + L+ V+ L +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK-----IRHTEEKLSTILSEVMLLASL 59
Query: 809 RHRNIVKFHGF-------------CSNARHSFLVCEYLHRGSLARIL--GNDATAKELSW 853
H+ +V+++ F+ EY G+L ++ N ++ W
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 854 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE----- 908
+ + + ALSY+H IIHRD+ N+ +D + DFG+AK V
Sbjct: 120 ----RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 909 ---------PYSSNRTEFVGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 958
S N T +GT Y A E + T EK D+YS G++ FE+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----- 227
Query: 959 FFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAIL--CLDESPEARPTMEK 1016
FS+ + + ++ + P D +E I+ +D P RP
Sbjct: 228 -----FSTGMERVNILKKLRSVSIEFPPD--FDDNKMKVEKKIIRLLIDHDPNKRPGART 280
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 61/278 (21%), Positives = 113/278 (40%), Gaps = 34/278 (12%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH--RNIVK 815
IG GG V++ I A+K N L + D + N + LN+++ I++
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVN--LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
+ + ++ ++V E L L K + R + K + A+ +H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEI----- 928
I+H D+ N L+ + + DFGIA ++P +++ + VG Y PE
Sbjct: 175 -GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 929 ------AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
+ + K DV+S G +++ + G P F N I +++ I+DP
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNH 285
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
P + +K + +V CL P+ R ++ + H
Sbjct: 286 EIEFPDIPEK--DLQDVLKCCLKRDPKQRISIPELLAH 321
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 69/273 (25%), Positives = 114/273 (41%), Gaps = 32/273 (11%)
Query: 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI 808
+ F + IGKG G V+K + + +VA+K + L + ++ + L++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLSQC 77
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVI-KGVANAL 867
+ K++G +++ EYL GS +L L +I I + + L
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLD-ETQIATILREILKGL 132
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
YLH + IHRDI + NVLL E ++DFG+A + R FVGT + APE
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM----IIEVNQILDPRLS 983
+ K D++S G+ E+ +G P S M +I N P L
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP-------HSELHPMKVLFLIPKNNP--PTLE 240
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ + + CL++ P RPT ++
Sbjct: 241 GNYSKPLKEFVE------ACLNKEPSFRPTAKE 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 22/260 (8%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
+GKGG ++ + + ++ A K S LL + ++ + + H+++V F
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGF 80
Query: 817 HGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
HGF + F+V E R SL + K L+ ++ + YLH +
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNR-- 135
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATE 936
+IHRD+ N+ L+ + E + DFG+A VE + GT Y APE+ +
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 937 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISI 996
+ DV+S G +++ ++ G P F + I + + + +P LI
Sbjct: 195 EVDVWSIGCIMYTLLVGKPP--FETSCLKETYLRIKKNEYSIPKHI---NPVAAS-LIQK 248
Query: 997 MEVAILCLDESPEARPTMEK 1016
M L P ARPT+ +
Sbjct: 249 M------LQTDPTARPTINE 262
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 22/260 (8%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
+GKGG ++ + + ++ A K S LL + ++ + + H+++V F
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGF 106
Query: 817 HGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
HGF + F+V E R SL + E R ++ + YLH +
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-ARYY--LRQIVLGCQYLHRNR-- 161
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATE 936
+IHRD+ N+ L+ + E + DFG+A VE + GT Y APE+ +
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 937 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISI 996
+ DV+S G +++ ++ G P F + I + + + +P LI
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP--FETSCLKETYLRIKKNEYSIPKHI---NPVAAS-LIQK 274
Query: 997 MEVAILCLDESPEARPTMEK 1016
M L P ARPT+ +
Sbjct: 275 M------LQTDPTARPTINE 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 59/314 (18%), Positives = 112/314 (35%), Gaps = 51/314 (16%)
Query: 712 RQRKKDSQEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKA- 770
R + E + L+ + E + + +G+G G V++
Sbjct: 29 RLGPETEDNEGVLLTEKLKPVDY----------EYREEVHWMTHQPRVGRGSFGEVHRMK 78
Query: 771 ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830
+ +G AVKK + + +E ++A + IV +G +
Sbjct: 79 DKQTGFQCAVKKVRLE-----VFRVEE----LVACAGLSSPRIVPLYGAVREGPWVNIFM 129
Query: 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 890
E L GSL +++ E +R + + L YLH I+H D+ + NVLL
Sbjct: 130 ELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLL 183
Query: 891 DLE-FEAHVSDFGIAKFVEPYSSNRTE-----FVGTFGYAAPEIAYTMRATEKYDVYSFG 944
+ A + DFG A ++P ++ GT + APE+ K D++S
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243
Query: 945 VLVFEVIKGNHPRDFFSINFSSFSNM--IIEVNQILDPRLSTP---SPGVMDKLISIMEV 999
++ ++ G HP ++ + +++ P P +P +
Sbjct: 244 CMMLHMLNGCHP-------WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI------ 290
Query: 1000 AILCLDESPEARPT 1013
L + P R +
Sbjct: 291 -QEGLRKEPVHRAS 303
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 78/296 (26%), Positives = 121/296 (40%), Gaps = 56/296 (18%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DD++ + IG G V A P + VA+K+ N L DE L + A+++
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN---LEKCQTSMDELLKEIQAMSQCH 71
Query: 810 HRNIVKFHGFCSNARHSFL-------VCEYLHRGSLARILGNDATAKELSWN----RRIN 858
H NIV ++ SF+ V + L GS+ I+ + E I
Sbjct: 72 HPNIVSYYT-------SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 859 VI-KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV-----EPYSS 912
I + V L YLH + IHRD+ + N+LL + ++DFG++ F+ +
Sbjct: 125 TILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 913 NRTEFVGTFGYAAPEI-----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 967
R FVGT + APE+ Y +A D++SFG+ E+ G P + +
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAP-------YHKY 230
Query: 968 SNM----IIEVNQILDPRLSTPSPGVMDKLI---SIMEVAILCLDESPEARPTMEK 1016
M + N P L T S ++ LCL + PE RPT +
Sbjct: 231 PPMKVLMLTLQNDP--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLN-------VVLALNEIRH 810
+G GG +VY AE VA+K + +++E L L+ H
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIK-----AIFIPPREKEETLKRFEREVHNSSQLS---H 70
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
+NIV +LV EY+ +L+ + + LS + IN + + + +
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHA 127
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFV-GTFGYAAPEIA 929
H I+HRDI +N+L+D + DFGIAK + S +T V GT Y +PE A
Sbjct: 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHP 956
E D+YS G++++E++ G P
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 40/270 (14%)
Query: 758 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
+GKG G VY +L + +A+K+ + + +E + ++H+NIV++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE----IALHKHLKHKNIVQY 84
Query: 817 HGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
G S + E + GSL+ +L + + + K + L YLH +
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142
Query: 877 SIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTEFVGTFGYAAPEI------ 928
I+HRDI NVL++ + + SDFG +K + + F GT Y APEI
Sbjct: 143 -IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 929 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI-----IEVNQILDPRLS 983
Y A D++S G + E+ G P F + + ++
Sbjct: 201 GYGKAA----DIWSLGCTIIEMATGKPP-------FYELGEPQAAMFKVGMFKVHPEIPE 249
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+ S + + C + P+ R
Sbjct: 250 SMSAEAKAFI-------LKCFEPDPDKRAC 272
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 24/295 (8%)
Query: 334 IPPSIGNLSSLRNLSLFNNGLYGSIPEE-IGYLKSLSELKLCKNNLSGVIPHSVGNLTGL 392
+P I L L NN + + ++ L+ L L L N +S + + L L
Sbjct: 48 VPKEIS--PDTTLLDLQNNDI-SELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 393 VLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNF-D 451
L + +NHL IP +L +SL +R + N + F N+ +++ N +
Sbjct: 105 QKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN 161
Query: 452 GKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQ-LEKLF 510
+ KL+ +S + IP ++ L L L N I I ++ L +
Sbjct: 162 SGFEPGAFDGLKLNYLRISEAKL-TGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYS 217
Query: 511 SLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQF 570
L +L L NQ+ L L+ L L NKLS +P + +L L + L N
Sbjct: 218 KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNI 276
Query: 571 SHTIPIE-------FEKLIHLSKLDLSHNILQ-EEIPPQV-CNMESLEKLNLSHN 616
+ + + K + + + L +N + E+ P + + +
Sbjct: 277 T-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 63/306 (20%), Positives = 115/306 (37%), Gaps = 23/306 (7%)
Query: 343 SLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL 402
LR + + GL ++P+EI + L L N++S + L L L + N +
Sbjct: 34 HLRVVQCSDLGL-KAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 403 FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLP 462
K+ L L+++ ++N+LV +L L + N + L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 463 KLDTFIVSMNNI-FGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQ 521
++ + N + D KL +L +S + IP L +LN+L L N+
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNK 204
Query: 522 LSGSVPLE-FGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEK 580
+ ++ LE ++L L L N++ S+ L L L+L NN+ S +P
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPD 262
Query: 581 LIHLSKLDLSHNILQEEIPPQV-------CNMESLEKLNLSHNNLSGFI--PRCFEKMRS 631
L L + L N + ++ ++L +N + + P F +
Sbjct: 263 LKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321
Query: 632 LSCIDI 637
I
Sbjct: 322 RLAIQF 327
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 65/333 (19%), Positives = 106/333 (31%), Gaps = 47/333 (14%)
Query: 271 SLHQLDLIENQLSGSIPLSFGNLSSWT-LMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLN 328
L + + L ++P +S T L+ L +N +S + L+ L L L N
Sbjct: 34 HLRVVQCSDLGLK-AVP---KEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNN 88
Query: 329 QLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGN 388
+++ + + L L+ L + N L IP + SL EL++ N + V
Sbjct: 89 KISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSG 145
Query: 389 LTGLVLLNMCENHL-FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQ 447
L + + M N L L +R ++ L G + L L L
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP---ETLNELHLDH 202
Query: 448 NNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLE 507
N + + KL L L N I L
Sbjct: 203 NKI--------QAIE---------LEDLLRYS-------KLYRLGLGHNQIRMIENGSLS 238
Query: 508 KLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS------SIPKSIGNLLKLY 561
L +L +L L N+LS VP L LQ + L N ++
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297
Query: 562 YLNLSNNQFSHTI--PIEFEKLIHLSKLDLSHN 592
++L NN + P F + + +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 61/277 (22%), Positives = 99/277 (35%), Gaps = 18/277 (6%)
Query: 181 FCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPC 240
C + +P + LL L NN + L+ L L L N+++ +
Sbjct: 39 QCSDLGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK 96
Query: 241 TLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMS 300
L L L++ KN L IP SL +L + +N++ F L + +
Sbjct: 97 AFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIE 153
Query: 301 LFSNSL-SGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIP 359
+ N L + P + L+ L + +L G IP +L L L +N + +I
Sbjct: 154 MGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPETLNELHLDHNKI-QAIE 209
Query: 360 EEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKR 418
E L L L N + + S+ L L L++ N L +P L L L+
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQV 268
Query: 419 VRFNQNNLVGKVYEAFGD------HPNLTFLDLSQNN 449
V + NN+ F + L N
Sbjct: 269 VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 67/334 (20%), Positives = 108/334 (32%), Gaps = 56/334 (16%)
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLI 176
I P LDL NN +S + + L L L L N++ I
Sbjct: 51 EISPDT------TLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIH--------- 94
Query: 177 HEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG 236
+ L KL LY++ N L IP SL L + N++
Sbjct: 95 --------------EKAFSPLRKLQKLYISKNHL-VEIPP--NLPSSLVELRIHDNRIRK 137
Query: 237 LIPCTLDNLSNLDTLFLYKNSL-SGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS 295
+ L N++ + + N L + + L+ L + E +L+G L+
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNE 197
Query: 296 WTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGL 354
+ L N + +I L L LGL NQ+ + S+ L +LR L L NN L
Sbjct: 198 ---LHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253
Query: 355 YGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLT 414
+P + LK L + L NN++ V + + V
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV---------------KRAYYN 297
Query: 415 SLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQN 448
+ + N F + +
Sbjct: 298 GI-SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 52/279 (18%), Positives = 96/279 (34%), Gaps = 36/279 (12%)
Query: 83 NLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQL 138
+L L L + +FS L L +S N IPP + S L L + +N++
Sbjct: 79 HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRI 135
Query: 139 SGVISPEI-GKLNQLRRLYLDMNQL-HGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGN 196
+ + L + + + N L + P ++ ++ IP L
Sbjct: 136 R-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL-- 191
Query: 197 LSKLALLYLNNNSLFGYIPT-VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYK 255
L L+L++N + I + L L L NQ+ + +L L L L L
Sbjct: 192 PETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN 250
Query: 256 NSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILG 315
N LS +P+ + +LK L + L N ++ F +
Sbjct: 251 NKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV------------------ 291
Query: 316 NLKSLSTLGLYLNQL-NGVIPPSI-GNLSSLRNLSLFNN 352
+ + L+ N + + P+ ++ + N
Sbjct: 292 KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-22
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 13/210 (6%)
Query: 438 PNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEI-GDSSKLQFLDLSSN 496
P+ T LDL N+ +++ L L ++ N I I + KLQ L +S N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKN 112
Query: 497 HIVGKIPVQLEKLF-SLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKL-SSSIPKSI 554
H+V +IP L SL +L + N++ F L + +++ N L +S
Sbjct: 113 HLV-EIP---PNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 555 GNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNL 613
+ LKL YL +S + + I + L++L L HN +Q I + L +L L
Sbjct: 169 FDGLKLNYLRISEAKLTG---IPKDLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGL 224
Query: 614 SHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
HN + + +L + + N+L
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 39/213 (18%), Positives = 76/213 (35%), Gaps = 19/213 (8%)
Query: 83 NLSTLCLNG----TFQDFSFSSFPHLVNLNLSFN-LFFGNIPPQIGNLSKLQNLDLGNNQ 137
+L L ++ FS ++ + + N L P + KL L + +
Sbjct: 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 138 LSGVISPEIGKLNQLRRLYLDMNQLHGTIPP-VIGQLSLIHEFSFCHNNVSGRIPSSLGN 196
L+G+ L L+LD N++ I + + S ++ HN + SL
Sbjct: 184 LTGI---PKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239
Query: 197 LSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIP------CTLDNLSNLDT 250
L L L+L+NN L +P + +LK L + L N + + + +
Sbjct: 240 LPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNG 298
Query: 251 LFLYKNSLSGSI--PSIIGNLKSLHQLDLIENQ 281
+ L+ N + P+ + + +
Sbjct: 299 ISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 42/144 (29%), Positives = 59/144 (40%), Gaps = 6/144 (4%)
Query: 511 SLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQF 570
L + S L +VP E + LDL N +S L LY L L NN+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 571 SHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMR 630
S F L L KL +S N L EIPP + SL +L + N + F +R
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 631 SLSCIDICYNELQGPIPNSTVFKD 654
+++CI++ N L+ F
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDG 171
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 75/289 (25%), Positives = 126/289 (43%), Gaps = 45/289 (15%)
Query: 743 HEEIIKA----------TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGN 791
EEI++ + IG+G G+VY A ++ +G VA+++ N Q
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----Q 57
Query: 792 MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKEL 851
++ +N +L + E ++ NIV + ++V EYL GSL ++ T +
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCM 113
Query: 852 SWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911
+ V + AL +LH + +IHRDI S N+LL ++ ++DFG + P
Sbjct: 114 DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 912 SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM- 970
S R+ VGT + APE+ K D++S G++ E+I+G P + + + +
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-------YLNENPLR 223
Query: 971 ---IIEVNQILDPRLSTP---SPGVMDKLISIMEVAILCLDESPEARPT 1013
+I N P L P S D L CL+ E R +
Sbjct: 224 ALYLIATNGT--PELQNPEKLSAIFRDFL-------NRCLEMDVEKRGS 263
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 78/300 (26%), Positives = 123/300 (41%), Gaps = 59/300 (19%)
Query: 739 GKIMHEEIIKA----------TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQL 787
G + HE+ A D IG+G G V A E SG VAVK + L
Sbjct: 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--L 80
Query: 788 LSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL-------VCEYLHRGSLAR 840
++ N V+ + + +H N+V+ + S+L + E+L G+L
Sbjct: 81 RKQQ--RRELLFNEVVIMRDYQHFNVVEMYK-------SYLVGEELWVLMEFLQGGALTD 131
Query: 841 ILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900
I+ + L+ + V + V AL+YLH +IHRDI S ++LL L+ +SD
Sbjct: 132 IV----SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSD 184
Query: 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 960
FG + R VGT + APE+ + D++S G++V E++ G P
Sbjct: 185 FGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP---- 240
Query: 961 SINFSSFSNM----IIEVNQILDPRLSTP---SPGVMDKLISIMEVAILCLDESPEARPT 1013
+ S S + + + P+L SP + D L L P+ R T
Sbjct: 241 ---YFSDSPVQAMKRLRDSPP--PKLKNSHKVSPVLRDFL-------ERMLVRDPQERAT 288
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 68/276 (24%), Positives = 112/276 (40%), Gaps = 51/276 (18%)
Query: 759 IGKGGQGSVYKAE---LPSGDIVAVKKFNSQLLSGNMADQDEFLN-------VVLALNEI 808
+G GG V+ A VAVK +L ++A F ALN
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVK-----VLRADLARDPSFYLRFRREAQNAAALN-- 70
Query: 809 RHRNIVKFH--GF--CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
H IV + G ++V EY+ +L I+ + ++ R I VI
Sbjct: 71 -HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADAC 126
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE---FVGTF 921
AL++ H + IIHRD+ N+++ V DFGIA+ + ++ T+ +GT
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD-- 979
Y +PE A + DVYS G +++EV+ G P F+ S + + + +
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-------FTGDSPVSVAYQHVREDP 236
Query: 980 PRLSTPSPGV---MDKLISIMEVAILCLDESPEARP 1012
S G+ +D ++ L ++PE R
Sbjct: 237 IPPSARHEGLSADLDAVVLK------ALAKNPENRY 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 77/271 (28%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEI 808
DDFD +GKG G+VY A E + I+A+K SQL + Q + + +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHL 71
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALS 868
RH NI++ + + + + +L+ E+ RG L + L R ++ +A+AL
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALH 128
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
Y H +IHRDI +N+L+ + E ++DFG + S R GT Y PE+
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTMCGTLDYLPPEM 183
Query: 929 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP--- 985
EK D++ GVL +E + G P F S + + I+ V L P
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPP--FDSPSHTETHRRIVNV------DLKFPPFL 235
Query: 986 SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
S G D LIS + L P R ++
Sbjct: 236 SDGSKD-LISKL------LRYHPPQRLPLKG 259
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 59/294 (20%), Positives = 112/294 (38%), Gaps = 39/294 (13%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G +V++ +GD+ A+K FN+ D + L ++ H+NIVK
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLF 73
Query: 818 GF--CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
+ RH L+ E+ GSL +L + A L + + V++ V +++L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 876 PSIIHRDISSKNVLLDLEFEAH----VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI--- 928
I+HR+I N++ + + ++DFG A+ +E GT Y P++
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDMYER 189
Query: 929 -AYTMRATEKY----DVYSFGVLVFEVIKG-----------NHPRDFFSINFSSFSNMII 972
+KY D++S GV + G + + I S I
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 973 EVNQILDPRLSTPSPGVMDKLIS------IMEVAILCLDESPEARPTMEKGFGH 1020
V + + + + +S + V L+ E ++ F
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 52/310 (16%)
Query: 718 SQEEQTISMNPLRLLSVLNFDGKIMHEEIIKATD---DFDEKFCIGKGGQGSVYKA-ELP 773
S E + P R L L+ E FD +G+G GSVYKA
Sbjct: 1 SLETVQLRNPPRRQLKKLD--------EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKE 52
Query: 774 SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYL 833
+G IVA+K+ + +D E + + + + ++VK++G ++V EY
Sbjct: 53 TGQIVAIKQVPVE------SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106
Query: 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE 893
GS++ I+ K L+ + +++ L YLH IHRDI + N+LL+ E
Sbjct: 107 GAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTE 161
Query: 894 FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 953
A ++DFG+A + + R +GT + APE+ + D++S G+ E+ +G
Sbjct: 162 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
Query: 954 N------HP-RDFFSINFSSFSNMIIEVNQILDPRLSTP---SPGVMDKLISIMEVAILC 1003
HP R F I + P P S D + C
Sbjct: 222 KPPYADIHPMRAIFMIPTNP------------PPTFRKPELWSDNFTD-FVK------QC 262
Query: 1004 LDESPEARPT 1013
L +SPE R T
Sbjct: 263 LVKSPEQRAT 272
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 65/279 (23%), Positives = 103/279 (36%), Gaps = 32/279 (11%)
Query: 342 SSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENH 401
+ + GL +P+ I + L L +NN+ + + +L L +L + N
Sbjct: 54 NQFSKVVCTRRGL-SEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 402 LFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNL 461
+ + L SL + N L AF L L L N ++
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI--------ESI 162
Query: 462 PKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQ-LEKLFSLNKLILSLN 520
P + F +P L LDL + I E LF+L L L +
Sbjct: 163 P---------SYAFNRVP-------SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206
Query: 521 QLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEK 580
+ +P L L+ L++S N P S L L L + N+Q S F+
Sbjct: 207 NIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264
Query: 581 LIHLSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNNL 618
L L +L+L+HN L +P + + L +L+L HN
Sbjct: 265 LASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 67/273 (24%), Positives = 101/273 (36%), Gaps = 39/273 (14%)
Query: 70 ISCNHAG-SRV---ISINLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQ 121
+ C G S V I N L L Q +F HL L L N I
Sbjct: 59 VVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVG 117
Query: 122 I-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFS 180
L+ L L+L +N L+ + S L++LR L+L N + +IP
Sbjct: 118 AFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPS------------ 164
Query: 181 FCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT-VMGNLKSLSTLDLSQNQLNGLIP 239
+ + L L L YI L +L L+L + +
Sbjct: 165 -----------YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-- 211
Query: 240 CTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLM 299
L L L+ L + N P L SL +L ++ +Q+S +F L+S +
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271
Query: 300 SLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLN 331
+L N+LS S+P + L+ L L L+ N N
Sbjct: 272 NLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-27
Identities = 55/265 (20%), Positives = 91/265 (34%), Gaps = 37/265 (13%)
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLI 176
IP + L+L N + + + L+ L L L N + I
Sbjct: 72 GIPSN------TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEV-------- 116
Query: 177 HEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG 236
+ L+ L L L +N L L L L L N +
Sbjct: 117 ---------------GAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES 161
Query: 237 LIPCTLDNLSNLDTLFLYK-NSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS 295
+ + + +L L L + L L +L L+L + +P + L
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVG 219
Query: 296 WTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGL 354
+ + N I P L SL L + +Q++ + + L+SL L+L +N L
Sbjct: 220 LEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
Query: 355 YGSIPEEI-GYLKSLSELKLCKNNL 378
S+P ++ L+ L EL L N
Sbjct: 279 -SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-26
Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 13/251 (5%)
Query: 398 CENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFN 457
C +P+ + ++ + + +NN+ + F +L L L +N+ +I
Sbjct: 61 CTRRGLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVG 117
Query: 458 -WRNLPKLDTFIVSMNNIFGSIPLEI-GDSSKLQFLDLSSNHIVGKIPVQ-LEKLFSLNK 514
+ L L+T + N + IP SKL+ L L +N I IP ++ SL +
Sbjct: 118 AFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMR 175
Query: 515 LILS-LNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHT 573
L L L +L F L L+YL+L + +P ++ L+ L L +S N F
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEI 233
Query: 574 IPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSL 632
P F L L KL + ++ + I + SL +LNL+HNNLS F +R L
Sbjct: 234 RPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL 292
Query: 633 SCIDICYNELQ 643
+ + +N
Sbjct: 293 VELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 16/85 (18%), Positives = 32/85 (37%), Gaps = 3/85 (3%)
Query: 559 KLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNL 618
+ + + S +P + L+L N +Q ++ LE L L N++
Sbjct: 55 QFSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 619 SGFIPRCFEKMRSLSCIDICYNELQ 643
F + SL+ +++ N L
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT 136
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 70/268 (26%), Positives = 116/268 (43%), Gaps = 41/268 (15%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
IG G G V+ + D VA+K + G M +++F+ + ++ H +V+ +G
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIK----TIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL--HHDCLP 876
C LV E++ G L+ L + + + V ++YL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---- 124
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAAPEIAY 930
+IHRD++++N L+ VSDFG+ +FV ++ + G +A+PE+
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVL-----DDQYTSSTGTKFPVKWASPEVFS 178
Query: 931 TMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSP 987
R + K DV+SFGVL++EV +G P + + SN EV + + RL P
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIP-------YENRSNS--EVVEDISTGFRLYKP-R 228
Query: 988 GVMDKLISIMEVAILCLDESPEARPTME 1015
+ IM C E PE RP
Sbjct: 229 LASTHVYQIM---NHCWRERPEDRPAFS 253
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 73/330 (22%), Positives = 131/330 (39%), Gaps = 74/330 (22%)
Query: 730 RLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLS 789
R+ ++ NF+ + + + + +G G G+V G VAVK+
Sbjct: 2 RIANIPNFEQSLKNLVVSEKI--------LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD 53
Query: 790 GNMADQDEFLNVVLALNEI-------RHRNIVKFHGFCSNARHSFLVCEYLHRGSLA-RI 841
+AL EI H N+++++ + R ++ E +L +
Sbjct: 54 -------------IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLV 99
Query: 842 LGNDATAKELSWNRR---INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH- 897
+ + + L + I++++ +A+ +++LH IIHRD+ +N+L+
Sbjct: 100 ESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTA 156
Query: 898 ------------VSDFGIAKFVEP----YSSNRTEFVGTFGYAAPEI-------AYTMRA 934
+SDFG+ K ++ + +N GT G+ APE+ R
Sbjct: 157 DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL 216
Query: 935 TEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDK- 992
T D++S G + + ++ KG HP F +S SN II LD ++ +
Sbjct: 217 TRSIDIFSMGCVFYYILSKGKHP---FGDKYSRESN-IIRGIFSLDEMKCLHDRSLIAEA 272
Query: 993 --LISIMEVAILCLDESPEARPTMEKGFGH 1020
LIS M + D P RPT K H
Sbjct: 273 TDLISQM----IDHD--PLKRPTAMKVLRH 296
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 6/255 (2%)
Query: 342 SSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENH 401
+ + L +P+ I + L L +N + + +S +L L +L + NH
Sbjct: 43 NQFSKVICVRKNL-REVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 402 LFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNL 461
+ + L +L + N L AF L L L N + S+ + +
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
Query: 462 PKLDTFIVSMNNIFGSIPLEI-GDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLN 520
P L + I S L++L+L+ ++ +IP L L L++L LS N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGN 217
Query: 521 QLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEK 580
LS P F L LQ L + +++ + NL L +NL++N + F
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277
Query: 581 LIHLSKLDLSHNILQ 595
L HL ++ L HN
Sbjct: 278 LHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 67/273 (24%), Positives = 103/273 (37%), Gaps = 39/273 (14%)
Query: 70 ISCNHAG-SRV---ISINLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQ 121
+ C V IS N L L+ + SF HL L LS N I
Sbjct: 48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIG 106
Query: 122 I-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFS 180
L+ L L+L +N+L+ + + L++L+ L+L N + +IP
Sbjct: 107 AFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPS------------ 153
Query: 181 FCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT-VMGNLKSLSTLDLSQNQLNGLIP 239
+ + L L L YI L +L L+L+ L +
Sbjct: 154 -----------YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-- 200
Query: 240 CTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLM 299
L L LD L L N LS P L L +L +I++Q+ +F NL S +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260
Query: 300 SLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLN 331
+L N+L+ +P + L L + L+ N N
Sbjct: 261 NLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 8/229 (3%)
Query: 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282
S + + L +P + +N L L++N + + +L+ L L L N +
Sbjct: 44 QFSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 283 SGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNL 341
+F L++ + LF N L+ +IP L L L L N + + + +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
Query: 342 SSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCEN 400
SLR L L I E L +L L L NL + ++ L L L++ N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGN 217
Query: 401 HLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNN 449
HL P S + L L+++ Q+ + AF + +L ++L+ NN
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 54/249 (21%), Positives = 95/249 (38%), Gaps = 10/249 (4%)
Query: 398 CENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNN--FDGKIS 455
C + +P + +S R+ N L + F LT L LS N F G S
Sbjct: 14 CNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 456 FNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL-EKLFSLNK 514
+ L +S N + ++ +L+ LD +++ + L +L
Sbjct: 72 QSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
Query: 515 LILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQFSHT 573
L +S + F L+ L+ L ++ N + I L L +L+LS Q
Sbjct: 131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 190
Query: 574 IPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKM-RS 631
P F L L L++SHN + + SL+ L+ S N++ + + S
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249
Query: 632 LSCIDICYN 640
L+ +++ N
Sbjct: 250 LAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 62/241 (25%), Positives = 100/241 (41%), Gaps = 10/241 (4%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLH--GTIPPVIGQLSL 175
+P I S L+L +N+L + KL QL +L L N L G +
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT-VMGNLKSLSTLDLSQNQL 234
+ N V + S+ L +L L +++L V +L++L LD+S
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 235 NGLIPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSGSIPLSFGNL 293
+ LS+L+ L + NS + I L++L LDL + QL P +F +L
Sbjct: 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 198
Query: 294 SSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNL-SSLRNLSLFN 351
SS ++++ N+ S+ L SL L LN + + + SSL L+L
Sbjct: 199 SSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257
Query: 352 N 352
N
Sbjct: 258 N 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 65/255 (25%), Positives = 110/255 (43%), Gaps = 11/255 (4%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS--G 260
+ N+ L +PT G S + L+L N+L L D L+ L L L N LS G
Sbjct: 12 IRCNSKGL-TSVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP--ILGNLK 318
SL LDL N + ++ +F L + ++L + + +L+
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLR 126
Query: 319 SLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNN 377
+L L + LSSL L + N + +I L++L+ L L +
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 378 LSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDH 437
L + P + +L+ L +LNM N+ F K L SL+ + ++ N+++ +
Sbjct: 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246
Query: 438 P-NLTFLDLSQNNFD 451
P +L FL+L+QN+F
Sbjct: 247 PSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 69/282 (24%), Positives = 105/282 (37%), Gaps = 33/282 (11%)
Query: 343 SLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL 402
S + + GL S+P I S + L+L N L + LT L L++ N L
Sbjct: 8 SGTEIRCNSKGL-TSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 403 --FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRN 460
G +S TSLK + + N ++ + F L LD +N +
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL--------KQ 115
Query: 461 LPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLN 520
+ + F L +LD+S H L SL L ++ N
Sbjct: 116 MSEFSVF---------------LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 521 QLSGSVPLE-FGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFE 579
+ + F L L +LDLS +L P + +L L LN+S+N F ++
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 580 KLIHLSKLDLSHNILQEEIPPQVCN--MESLEKLNLSHNNLS 619
L L LD S N + Q SL LNL+ N+ +
Sbjct: 221 CLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 61/280 (21%), Positives = 93/280 (33%), Gaps = 38/280 (13%)
Query: 65 CSWFGISCNHAG-SRV---ISINLSTLCLNG----TFQDFSFSSFPHLVNLNLSFN-LFF 115
CS I CN G + V I + + L L + F L L+LS N L F
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 116 GNIPPQI-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLS 174
Q + L+ LDL N + +S L QL L + L +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE------ 118
Query: 175 LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQ- 233
S +L L L +++ + L SL L ++ N
Sbjct: 119 ----------------FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162
Query: 234 LNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNL 293
+P L NL L L + L P+ +L SL L++ N + L
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222
Query: 294 SSWTLMSLFSNSLSGSIPP-ILGNL-KSLSTLGLYLNQLN 331
+S ++ N + + L + SL+ L L N
Sbjct: 223 NSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 40/143 (27%), Positives = 59/143 (41%), Gaps = 4/143 (2%)
Query: 511 SLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLS--SSIPKSIGNLLKLYYLNLSNN 568
S +L L N+L F LT+L L LS+N LS +S L YL+LS N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 569 QFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFE 627
T+ F L L LD H+ L++ V ++ +L L++SH + F
Sbjct: 89 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147
Query: 628 KMRSLSCIDICYNELQGPIPNST 650
+ SL + + N Q
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDI 170
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 74/266 (27%), Positives = 124/266 (46%), Gaps = 37/266 (13%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G V + VAVK + G+M +DEF + ++ H +VKF+G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVK----MIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSI 878
CS ++V EY+ G L L + K L ++ + + V +++L
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 879 IHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAAPEIAYTM 932
IHRD++++N L+D + VSDFG+ ++V ++V + G ++APE+ +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVL-----DDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 933 RATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSPGV 989
+ + K DV++FG+L++EV G P + ++N EV + RL P
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP-------YDLYTNS--EVVLKVSQGHRLYRP-HLA 230
Query: 990 MDKLISIMEVAILCLDESPEARPTME 1015
D + IM C E PE RPT +
Sbjct: 231 SDTIYQIM---YSCWHELPEKRPTFQ 253
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-28
Identities = 57/283 (20%), Positives = 101/283 (35%), Gaps = 31/283 (10%)
Query: 80 ISINLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLG 134
++ + +L L+ + +L L L+ N I +L L++LDL
Sbjct: 50 LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLS 108
Query: 135 NNQLSGVISPEI-GKLNQLRRLYLDMNQLHGTIPPVI---GQLSLIHEFSFCHNNVSGRI 190
N LS +S L+ L L L N T+ L + +
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 191 PSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDT 250
L+ L L ++ + L Y P + +++++S L L Q L+ +D S+++
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226
Query: 251 LFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSI 310
L L L ++LS S ++ + + SL +
Sbjct: 227 LELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QV 269
Query: 311 PPILGNLKSLSTLGLYLNQLNGVIPPSI-GNLSSLRNLSLFNN 352
+L + L L NQL +P I L+SL+ + L N
Sbjct: 270 MKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 59/273 (21%), Positives = 104/273 (38%), Gaps = 23/273 (8%)
Query: 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTL 242
+N ++ S L L L L +N + +L SL LDLS N L+ L
Sbjct: 61 NNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWF 120
Query: 243 DNLSNLDTLFLYKNSLSGSIP--SIIGNLKSLHQLDLIENQLSGSIPL-SFGNLSSWTLM 299
LS+L L L N ++ S+ +L L L + I F L+ +
Sbjct: 121 KPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179
Query: 300 SLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSI 358
+ ++ L S P L +++++S L L++ Q ++ + SS+ L L + L
Sbjct: 180 EIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238
Query: 359 PEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKR 418
+ LS +S+ + + + LF + K L ++ L
Sbjct: 239 F----------------SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281
Query: 419 VRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD 451
+ F++N L F +L + L N +D
Sbjct: 282 LEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 57/319 (17%), Positives = 116/319 (36%), Gaps = 28/319 (8%)
Query: 332 GVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTG 391
+ + + L SIP + +++ L L N ++ + +
Sbjct: 21 ESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVN 77
Query: 392 LVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD 451
L L + N + S SL SL+ + + N L F +LTFL+L N +
Sbjct: 78 LQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK 137
Query: 452 GKISFNW-RNLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSSNHIVGKIPVQLEKL 509
+ +L KL V + F I + + L+ L++ ++ + P L+ +
Sbjct: 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI 197
Query: 510 FSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI--------GNLLKLY 561
+++ LIL + Q + + + ++ L+L L + +
Sbjct: 198 QNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR 257
Query: 562 YLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNNLSG 620
+ +++ + ++ L +L+ S N L+ +P + + SL+K+ L N
Sbjct: 258 NVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW-- 313
Query: 621 FIPRCFEKMRSLSCIDICY 639
C SC I Y
Sbjct: 314 ---DC-------SCPRIDY 322
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 65/329 (19%), Positives = 117/329 (35%), Gaps = 73/329 (22%)
Query: 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQ 281
++ +LDLS N++ + L NL L L N ++ +I +L SL LDL N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 282 LSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSI-G 339
LS ++ L SL+ L L N + S+
Sbjct: 112 LS-------------------------NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS 146
Query: 340 NLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMC 398
+L+ L+ L + N + I + L L EL++ ++L P S+ ++ + L +
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 399 ENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNW 458
L + + ++ L+L + D +F++
Sbjct: 207 MKQH-----------ILLLEIFVDVT-------------SSVECLELRDTDLD---TFHF 239
Query: 459 RNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILS 518
L + S+ + + ++ + ++ L ++ L +L S
Sbjct: 240 SELSTGE---------TNSLI----KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285
Query: 519 LNQLSGSVPLE-FGSLTELQYLDLSANKL 546
NQL SVP F LT LQ + L N
Sbjct: 286 RNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 62/298 (20%), Positives = 113/298 (37%), Gaps = 28/298 (9%)
Query: 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362
S SL+ SIP G +++ +L L N++ + + +L+ L L +NG+ +I E+
Sbjct: 40 SGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDS 95
Query: 363 -GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSL-KSLTSLKRVR 420
L SL L L N LS + L+ L LN+ N SL LT L+ +R
Sbjct: 96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 421 FNQNNLVGKVYE-AFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479
+ K+ F L L++ ++ + +++ + I+ M +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH-ILLL 214
Query: 480 LEIGDS-SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQY 538
D S ++ L+L + ++LS +
Sbjct: 215 EIFVDVTSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRN 258
Query: 539 LDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHNILQ 595
+ ++ L + K + + L L S NQ ++P F++L L K+ L N
Sbjct: 259 VKITDESLFQ-VMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 7e-18
Identities = 33/171 (19%), Positives = 64/171 (37%), Gaps = 12/171 (7%)
Query: 98 FSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
FS L L + F I + L+ L+ L++ + L + + + L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204
Query: 157 LDMNQLHGTIPPVIGQ---------LSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNN 207
L M Q + + L +F + +S +SL + + +
Sbjct: 205 LHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 208 NSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSL 258
SLF + ++ + L L+ S+NQL + D L++L ++L+ N
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 69/289 (23%), Positives = 117/289 (40%), Gaps = 57/289 (19%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEF---LNVVLALN 806
+D + IG+G GSV K PSG I+AVK+ + + +Q + L+VV+
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMR-- 76
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRIN------VI 860
IV+F+G ++ E + S + + + I +
Sbjct: 77 SSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVL----DDVIPEEILGKIT 131
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI-AKFVEPYSSNRTEFVG 919
AL++L + IIHRDI N+LLD + DFGI + V+ S +T G
Sbjct: 132 LATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAG 187
Query: 920 TFGYAAPE--------IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI 971
Y APE Y +R+ DV+S G+ ++E+ G P + ++++
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRS----DVWSLGITLYELATGRFP-------YPKWNSVF 236
Query: 972 IEVNQILD---PRLSTPSPGV----MDKLISIMEVAILCLDESPEARPT 1013
++ Q++ P+LS ++ LCL + RP
Sbjct: 237 DQLTQVVKGDPPQLSNSEEREFSPSFINFVN------LCLTKDESKRPK 279
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 66/281 (23%), Positives = 107/281 (38%), Gaps = 43/281 (15%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKF 816
+ +GG VY+A+ + SG A+K+ LLS + V + ++ H NIV+F
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKR----LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 817 HGFCSNARHS-------FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
S + FL+ L +G L L + LS + + + A+ +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE------------F 917
+H P IIHRD+ +N+LL + + DFG A + Y
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 918 VGTFGYAAPEIAYTMR---ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974
T Y PEI EK D+++ G +++ + HP F + + I
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-------FEDGAKLRIVN 263
Query: 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ P T V LI M L +PE R ++
Sbjct: 264 GKYSIPPHDTQYT-VFHSLIRAM------LQVNPEERLSIA 297
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 41/219 (18%), Positives = 86/219 (39%), Gaps = 18/219 (8%)
Query: 750 TDDFDEKFCIGKGGQ--GSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALN 806
++ IGKG + +V A P+G+ V V++ N L + + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN--LEACSNEMVTFLQGELHVSK 81
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
H NIV + ++V ++ GS ++ ++ +++GV A
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVLKA 140
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT-------EFVG 919
L Y+HH +HR + + ++L+ ++ + ++S + + + V
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 920 TFGYAAPEIAYTMRA--TEKYDVYSFGVLVFEVIKGNHP 956
+ +PE+ K D+YS G+ E+ G+ P
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 64/265 (24%), Positives = 121/265 (45%), Gaps = 31/265 (11%)
Query: 758 CIGKGGQGSVYKAELPSGDI-VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
+G G G VY+ + VAVK L M + +EFL + EI+H N+V+
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTM-EVEEFLKEAAVMKEIKHPNLVQL 281
Query: 817 HGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
G C+ +++ E++ G+L L +E+S + + +++A+ YL
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK--- 337
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFGYAAPEIAYTMR 933
+ IHR+++++N L+ V+DFG+++ + + +F + APE +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNK 395
Query: 934 ATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSPGVM 990
+ K DV++FGVL++E+ G P + +V ++L+ R+ P G
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP-------YPGIDLS--QVYELLEKDYRMERP-EGCP 445
Query: 991 DKLISIMEVAILCLDESPEARPTME 1015
+K+ +M C +P RP+
Sbjct: 446 EKVYELM---RACWQWNPSDRPSFA 467
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 44/280 (15%)
Query: 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI 808
+ ++ +G G G VYKA +G + A K S + ++++ + L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEE--ELEDYIVEIEILATC 73
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALS 868
H IVK G + +++ E+ G++ I+ + L+ + V + + AL+
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALN 131
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
+LH IIHRD+ + NVL+ LE + ++DFG++ R F+GT + APE+
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 929 AYTMRATE-----KYDVYSFGVLVFEVIKGN------HP-RDFFSINFSSFSNMIIEVNQ 976
+ K D++S G+ + E+ + +P R I S
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---------- 238
Query: 977 ILDPRLSTP---SPGVMDKLISIMEVAILCLDESPEARPT 1013
P L TP S D + + LD++PE RP+
Sbjct: 239 --PPTLLTPSKWSVEFRD-FLK------IALDKNPETRPS 269
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 66/268 (24%), Positives = 120/268 (44%), Gaps = 41/268 (15%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
+G G G V + VA+K + G+M +DEF+ + + H +V+ +G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIK----MIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL--HHDCLP 876
C+ R F++ EY+ G L L + + + K V A+ YL
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---- 140
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAAPEIAY 930
+HRD++++N L++ + VSDFG++++V E+ + G ++ PE+
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-----DDEYTSSVGSKFPVRWSPPEVLM 194
Query: 931 TMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSP 987
+ + K D+++FGVL++E+ G P + F+N E + + RL P
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMP-------YERFTNS--ETAEHIAQGLRLYRP-H 244
Query: 988 GVMDKLISIMEVAILCLDESPEARPTME 1015
+K+ +IM C E + RPT +
Sbjct: 245 LASEKVYTIM---YSCWHEKADERPTFK 269
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 27/294 (9%), Positives = 63/294 (21%), Gaps = 52/294 (17%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+ G + V+ ++ + A+K F + + ++ + A + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLGESPEEAR 128
Query: 818 GFC--------------------------SNARHSFLVCEYLHRGSLARILGNDATAKE- 850
+ L+ L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 851 ---LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907
+ + + L ++H + N+ + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW-- 242
Query: 908 EPYSSNRTEFVGTFGYAAPEI--AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 965
+ YA E A T T + + G+ ++ V P +
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 966 SFSNMIIEVNQILDPRLSTP----SPGVMDKLISIMEVAILCLDESPEARPTME 1015
D V LI L+ R
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-LIGRF------LNFDRRRRLLPL 348
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 66/266 (24%), Positives = 123/266 (46%), Gaps = 35/266 (13%)
Query: 759 IGKGGQGSVYKAELPSGDI-VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G G G VY+ + VAVK L M + +EFL + EI+H N+V+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL-HHDCLP 876
G C+ +++ E++ G+L L + +E+S + + +++A+ YL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF-- 132
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE--PYSSNRTEFVGTFGY--AAPEIAYTM 932
IHRD++++N L+ V+DFG+++ + Y+++ F APE
Sbjct: 133 --IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG---AKFPIKWTAPESLAYN 187
Query: 933 RATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSPGV 989
+ + K DV++FGVL++E+ G P + +V ++L+ R+ P G
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP-------YPGIDLS--QVYELLEKDYRMERP-EGC 237
Query: 990 MDKLISIMEVAILCLDESPEARPTME 1015
+K+ +M C +P RP+
Sbjct: 238 PEKVYELM---RACWQWNPSDRPSFA 260
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 31/271 (11%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI- 808
F +G G G V+K G + AVK+ S D+ L V + ++
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG--PKDRARKLAEVGSHEKVG 114
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALS 868
+H V+ +L E SL + L + ++ AL+
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWG--ASLPEAQVWGYLRDTLLALA 171
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
+LH ++H D+ N+ L + DFG+ + + G Y APE+
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAPEL 227
Query: 929 ---AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985
+Y A DV+S G+ + EV + + L P +
Sbjct: 228 LQGSYGTAA----DVFSLGLTILEVACNMEL--PH--GGEGWQQLR---QGYLPPEFTAG 276
Query: 986 SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ ++ + L+ P+ R T E
Sbjct: 277 LSSELRSVLV------MMLEPDPKLRATAEA 301
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 62/291 (21%), Positives = 118/291 (40%), Gaps = 65/291 (22%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEF---LNVVLALN 806
DD + +G+G G V K +PSG I+AVK+ + N +Q L++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLLMDLDISM--R 61
Query: 807 EIRHRNIVKFHGFCSNARHSFL------VC-EYLHRGSLARILGNDATAKELSWNRRIN- 858
+ V F+G + +C E + SL + + + + I
Sbjct: 62 TVDCPFTVTFYG-------ALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPE 108
Query: 859 -----VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN 913
+ + AL +LH S+IHRD+ NVL++ + + DFGI+ ++
Sbjct: 109 DILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVA 165
Query: 914 RTEFVGTFGYAAPE--------IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 965
+ G Y APE Y++++ D++S G+ + E+ P +
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKS----DIWSLGITMIELAILRFP-------YD 214
Query: 966 SFSNMIIEVNQILD---PRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
S+ ++ Q+++ P+L P+ + + CL ++ + RPT
Sbjct: 215 SWGTPFQQLKQVVEEPSPQL--PADKFSAEFVDFTS---QCLKKNSKERPT 260
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-27
Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 31/264 (11%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G G V+ VA+K L G M + FL + ++RH +V+ +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIK----TLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
S ++V EY+ +GSL L + T K L + +++ +A+ ++Y+ +
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFGYAAPEIAYTMRA 934
+HRD+ + N+L+ V+DFG+A+ +E + +F + APE A R
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRF 358
Query: 935 TEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSPGVMD 991
T K DV+SFG+L+ E+ KG P + N EV ++ R+ P P +
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP-------YPGMVNR--EVLDQVERGYRMPCP-PECPE 408
Query: 992 KLISIMEVAILCLDESPEARPTME 1015
L +M C + PE RPT E
Sbjct: 409 SLHDLM---CQCWRKEPEERPTFE 429
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 31/262 (11%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G G G V+ VAVK L G+M D FL + +++H+ +V+ +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVK----SLKQGSM-SPDAFLAEANLMKQLQHQRLVRLY 74
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+ +++ EY+ GSL L + +L+ N+ +++ +A ++++ +
Sbjct: 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---N 129
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFGYAAPEIAYTMRA 934
IHRD+ + N+L+ ++DFG+A+ +E + +F + APE
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTF 187
Query: 935 TEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSPGVMD 991
T K DV+SFG+L+ E++ G P + +N EV Q L+ R+ P +
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP-------YPGMTNP--EVIQNLERGYRMVRP-DNCPE 237
Query: 992 KLISIMEVAILCLDESPEARPT 1013
+L +M LC E PE RPT
Sbjct: 238 ELYQLM---RLCWKERPEDRPT 256
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 56/284 (19%), Positives = 108/284 (38%), Gaps = 62/284 (21%)
Query: 759 IGKGGQGSVYKAELPSGDI--------VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+G+G ++K V +K L + + F ++++ H
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLK----VLDKAHRNYSESFFEAASMMSKLSH 71
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
+++V +G C + LV E++ GSL L + ++ ++ V K +A A+ +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFL 129
Query: 871 --HHDCLPSIIHRDISSKNVLLDLEFEAH--------VSDFGIAKFVEPYSSNR-----T 915
+ +IH ++ +KN+LL E + +SD GI+ V P +
Sbjct: 130 EENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 916 EFVGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIE 973
PE I D +SFG ++E+ G+ P S+ +
Sbjct: 185 ---------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-------LSALDSQ--R 226
Query: 974 VNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
Q + +L P +L +++ C+D P+ RP+
Sbjct: 227 KLQFYEDRHQLPAPKA---AELANLI---NNCMDYEPDHRPSFR 264
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 41/272 (15%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMA-DQDEFLNVVLALNEIRHRNI 813
IG G G V L VA+K L +G + +FL+ + + H NI
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIK----ALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL--H 871
++ G + R + +V EY+ GSL L + + + + +++GV + YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG-----YAAP 926
+HRD++++NVL+D VSDFG+++ +E + T G + AP
Sbjct: 171 G-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTTTGGKIPIRWTAP 223
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLS 983
E + DV+SFGV+++EV+ G P + + +N +V ++ RL
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP-------YWNMTNR--DVISSVEEGYRLP 274
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
P G L +M + C + RP
Sbjct: 275 AP-MGCPHALHQLM---LDCWHKDRAQRPRFS 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-26
Identities = 63/290 (21%), Positives = 111/290 (38%), Gaps = 41/290 (14%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G GG G V + +G+ VA+K+ +L + +++ + + + ++ H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 818 ------GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
+ L EY G L + L L ++ +++AL YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
+ IIHRD+ +N++L + + D G AK ++ FVGT Y APE+
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQYLAPEL 194
Query: 929 AYTMRATEKYDVYSFGVLVFEVIKGNHP-----------------RDFFSINFSSFSNMI 971
+ T D +SFG L FE I G P + + + + +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 972 IEVNQILDP-RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ + P LS G +++ + M L R T +
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCM------LMWHQRQRGTDPQNPNV 298
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/287 (19%), Positives = 99/287 (34%), Gaps = 46/287 (16%)
Query: 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI 808
T +F E IG G GSV+K + G I A+K+ S+ D+ L V A +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHAVL 67
Query: 809 -RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILG-NDATAKELSWNRRINVIKGVANA 866
+H ++V++ + H + EY + GSLA + N +++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS-------------------DFGIAKFV 907
L Y+H S++H DI N+ + + + D G +
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 908 EPYSSNRTEFVGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 966
S+ G + A E + K D+++ + V
Sbjct: 185 ----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--------PR 232
Query: 967 FSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+ E+ Q PR+ +L+ + + PE RP+
Sbjct: 233 NGDQWHEIRQGRLPRIPQVLSQEFTELLK------VMIHPDPERRPS 273
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 63/280 (22%), Positives = 99/280 (35%), Gaps = 44/280 (15%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEF---LNVVLALN 806
+D + +G G G V+K +G ++AVK+ SGN + L+VVL
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLK-- 79
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVI-KGVAN 865
IV+ G F+ E + + E R + + +
Sbjct: 80 SHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE----RILGKMTVAIVK 135
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI-AKFVEPYSSNRTEFVGTFGYA 924
AL YL +IHRD+ N+LLD + + DFGI + V+ + G Y
Sbjct: 136 ALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCAAYM 191
Query: 925 APE-IAYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979
APE I Y DV+S G+ + E+ G P + + + ++L
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP-------YKNCKTDFEVLTKVLQ 244
Query: 980 ---PRLSTP---SPGVMDKLISIMEVAILCLDESPEARPT 1013
P L S + CL + RP
Sbjct: 245 EEPPLLPGHMGFSGDFQS-FVK------DCLTKDHRKRPK 277
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 71/264 (26%), Positives = 120/264 (45%), Gaps = 31/264 (11%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G G V+ VA+K L G M + FL + ++RH +V+ +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIK----TLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
S ++V EY+ +GSL L + K L + +++ +A+ ++Y+ +
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFGYAAPEIAYTMRA 934
+HRD+ + N+L+ V+DFG+A+ +E + +F + APE A R
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRF 441
Query: 935 TEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSPGVMD 991
T K DV+SFG+L+ E+ KG P + N EV ++ R+ P P +
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVP-------YPGMVNR--EVLDQVERGYRMPCP-PECPE 491
Query: 992 KLISIMEVAILCLDESPEARPTME 1015
L +M C + PE RPT E
Sbjct: 492 SLHDLM---CQCWRKEPEERPTFE 512
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 43/277 (15%)
Query: 750 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI 808
F + IG G G+VY A ++ + ++VA+KK + N + + V L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDIIKEVRFLQKL 111
Query: 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALS 868
RH N +++ G ++LV EY GS + +L + K L V G L+
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLA 168
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
YLH ++IHRD+ + N+LL + DFG A + + FVGT + APE+
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWMAPEV 221
Query: 929 AYTMRATE---KYDVYSFGVLVFEVIKGN------HP-RDFFSINFSSFSNMIIEVNQIL 978
M + K DV+S G+ E+ + + + I +
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------ 269
Query: 979 DPRLSTP--SPGVMDKLISIMEVAILCLDESPEARPT 1013
P L + S + + CL + P+ RPT
Sbjct: 270 SPALQSGHWSEYFRN-FVD------SCLQKIPQDRPT 299
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G +V++ +GD+ A+K FN+ D + L ++ H+NIVK
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLF 73
Query: 818 GF--CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
+ RH L+ E+ GSL +L + A L + + V++ V +++L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 876 PSIIHRDISSKNVLLDLEFEAH----VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI--- 928
I+HR+I N++ + + ++DFG A+ +E GT Y P++
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDMYER 189
Query: 929 -AYTMRATEKY----DVYSFGVLVFEVIKGNHP 956
+KY D++S GV + G+ P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 62/246 (25%), Positives = 110/246 (44%), Gaps = 26/246 (10%)
Query: 718 SQEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGD 776
EE + + L + + E DDF++ +G G G V+K PSG
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGEL---KDDDFEKISELGAGNGGVVFKVSHKPSGL 59
Query: 777 IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG-FCSNARHSFLVCEYLHR 835
++A K + L A +++ + + L+E IV F+G F S+ + E++
Sbjct: 60 VMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDG 115
Query: 836 GSLARILGNDATAKELSWNRRINVI-KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF 894
GSL ++L E + + + V L+YL I+HRD+ N+L++
Sbjct: 116 GSLDQVLKKAGRIPE----QILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRG 169
Query: 895 EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE----IAYTMRATEKYDVYSFGVLVFEV 950
E + DFG++ + S FVGT Y +PE Y++++ D++S G+ + E+
Sbjct: 170 EIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQS----DIWSMGLSLVEM 223
Query: 951 IKGNHP 956
G +P
Sbjct: 224 AVGRYP 229
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 45/271 (16%)
Query: 759 IGKGGQGSVYKAELPSGDI---VAVKKFNSQLLSGNM--ADQDEFLNVVLALNEIRHRNI 813
+G G G+V K + VAVK L + A +DE L + ++ + I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVK----ILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL--H 871
V+ G C LV E G L + L + + + I ++ V+ + YL
Sbjct: 81 VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 136
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAA 925
+ +HRD++++NVLL + A +SDFG++K + ++ + + A
Sbjct: 137 N-----FVHRDLAARNVLLVTQHYAKISDFGLSKALR---ADENYYKAQTHGKWPVKWYA 188
Query: 926 PEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RL 982
PE + + K DV+SFGVL++E G P + EV +L+ R+
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKP-------YRGMKGS--EVTAMLEKGERM 239
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPT 1013
P G ++ +M LC E RP
Sbjct: 240 GCP-AGCPREMYDLM---NLCWTYDVENRPG 266
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 70/334 (20%), Positives = 128/334 (38%), Gaps = 46/334 (13%)
Query: 705 IGFFFFFRQRKKDSQEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQ 764
+ ++ D + + + + D E +K F ++ +GKG
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLK----FLQQ--LGKGNF 54
Query: 765 GSVYKAELP-----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGF 819
GSV +G++VAVK +L +F + L ++H NIVK+ G
Sbjct: 55 GSVEMCRYDPLQDNTGEVVAVK----KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 110
Query: 820 CSNARHS--FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH-HDCLP 876
C +A L+ EYL GSL L + + + + + + YL
Sbjct: 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKRY-- 166
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAAPEIAY 930
IHRD++++N+L++ E + DFG+ K + ++ + + APE
Sbjct: 167 --IHRDLATRNILVENENRVKIGDFGLTKVLP---QDKEYYKVKEPGESPIFWYAPESLT 221
Query: 931 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI----IEVNQILDP-----R 981
+ + DV+SFGV+++E+ F + V +++ R
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281
Query: 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
L P G D++ IM C + + RP+
Sbjct: 282 LPRP-DGCPDEIYMIMT---ECWNNNVNQRPSFR 311
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 72/309 (23%), Positives = 124/309 (40%), Gaps = 66/309 (21%)
Query: 740 KIMHEEIIKATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMAD 794
+ + E + A D F +G G G VYK + +G + A+K + ++G+ +
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGD--E 63
Query: 795 QDEFLNVVLALNEI-RHRNIVKFHG------FCSNARHSFLVCEYLHRGSLARILGNDAT 847
++E + L + HRNI ++G +LV E+ GS+ ++
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----- 118
Query: 848 AKELSWNRRIN------VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDF 901
+ + + + + + LS+LH +IHRDI +NVLL E + DF
Sbjct: 119 --KNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 902 GIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATE-----KYDVYSFGVLVFEVIKGN-- 954
G++ ++ R F+GT + APE+ + K D++S G+ E+ +G
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
Query: 955 ----HP-RDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS--IMEVAILCLDES 1007
HP R F I PR P+P + K S CL ++
Sbjct: 234 LCDMHPMRALFLI-----------------PR--NPAPRLKSKKWSKKFQSFIESCLVKN 274
Query: 1008 PEARPTMEK 1016
RP E+
Sbjct: 275 HSQRPATEQ 283
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 58/266 (21%), Positives = 103/266 (38%), Gaps = 34/266 (12%)
Query: 759 IGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRN 812
+G G G+VYK VA+K+ L E L+ + + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE----LREATSPKANKEILDEAYVMASVDNPH 78
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+ + G C L+ + + G L + + +N +A ++YL
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED 135
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF--GYAAPEIAY 930
L +HRD++++NVL+ ++DFG+AK + G + A E
Sbjct: 136 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 931 TMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSP 987
T + DV+S+GV V+E++ G+ P + E++ IL+ RL P P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP-------YDGIPAS--EISSILEKGERLPQP-P 242
Query: 988 GVMDKLISIMEVAILCLDESPEARPT 1013
+ IM C ++RP
Sbjct: 243 ICTIDVYMIM---RKCWMIDADSRPK 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 32/299 (10%), Positives = 83/299 (27%), Gaps = 55/299 (18%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQD--------------------- 796
+G+ + +A +G+ V + A +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 797 EFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYL-------HRGSLARILGNDATAK 849
L + + ++ K + R +++ + + + +L + ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 850 E-LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV- 907
+ L + R+ + V L+ LHH ++H + +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSI 962
S A + + D ++ G+ ++ + + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP------ 316
Query: 963 NFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021
+ + I + P P + L+ L E R +
Sbjct: 317 -NTD-DAALGGSEWIFRSCKNIPQP--VRALLEGF------LRYPKEDRLLPLQAMETP 365
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-26
Identities = 68/264 (25%), Positives = 119/264 (45%), Gaps = 31/264 (11%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G G G V+ A VAVK + G+M + FL + ++H +VK H
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVK----TMKPGSM-SVEAFLAEANVMKTLQHDKLVKLH 249
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+ +++ E++ +GSL L +D + + I+ +A ++++ +
Sbjct: 250 AVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFGYAAPEIAYTMRA 934
IHRD+ + N+L+ ++DFG+A+ +E + +F + APE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSF 362
Query: 935 TEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSPGVMD 991
T K DV+SFG+L+ E++ G P + SN EV + L+ R+ P +
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP-------YPGMSNP--EVIRALERGYRMPRP-ENCPE 412
Query: 992 KLISIMEVAILCLDESPEARPTME 1015
+L +IM + C PE RPT E
Sbjct: 413 ELYNIM---MRCWKNRPEERPTFE 433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 66/280 (23%), Positives = 113/280 (40%), Gaps = 40/280 (14%)
Query: 759 IGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+GKG GSV +G++VAVK +L +F + L ++H NI
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVK----KLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 814 VKFHGFCSNARHS--FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
VK+ G C +A L+ EYL GSL L + + + + + + YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 131
Query: 872 -HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YA 924
IHRD++++N+L++ E + DFG+ K + ++ F +
Sbjct: 132 TKRY----IHRDLATRNILVENENRVKIGDFGLTKVLP---QDKEFFKVKEPGESPIFWY 184
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI----IEVNQILDP 980
APE + + DV+SFGV+++E+ F + V +++
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 981 -----RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
RL P G D++ IM C + + RP+
Sbjct: 245 LKNNGRLPRP-DGCPDEIYMIMT---ECWNNNVNQRPSFR 280
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 41/272 (15%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRNI 813
+G G G V L VA+K L G Q +FL + + H NI
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIK----TLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL--H 871
++ G + ++ +V EY+ GSL L + + + + +++G+A+ + YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE-----PYSSNRTEFVGTFGYAAP 926
+HRD++++N+L++ VSDFG+ + +E Y++ + + +P
Sbjct: 167 G-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRWTSP 219
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLS 983
E + T DV+S+G++++EV+ G P + SN +V + +D RL
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQ--DVIKAVDEGYRLP 270
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
P L +M + C + RP E
Sbjct: 271 PP-MDCPAALYQLM---LDCWQKDRNNRPKFE 298
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 55/235 (23%), Positives = 88/235 (37%), Gaps = 35/235 (14%)
Query: 80 ISINLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLG 134
I + L+G SF + +L L L N+ I L+ L+ LDL
Sbjct: 30 IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLALLEQLDLS 88
Query: 135 NNQLSGVISPEI-GKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSS 193
+N + P L +L L+LD L + P
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG-----------------------PGL 124
Query: 194 LGNLSKLALLYLNNNSLFGYIPT-VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLF 252
L+ L LYL +N+L +P +L +L+ L L N+++ + L +LD L
Sbjct: 125 FRGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 253 LYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLS-FGNLSSWTLMSLFSNSL 306
L++N ++ P +L L L L N LS ++P L + + L N
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 59/233 (25%), Positives = 92/233 (39%), Gaps = 27/233 (11%)
Query: 101 FPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDM 159
+ L N ++P L L L +N L+ + + L L +L L
Sbjct: 31 PAASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89
Query: 160 NQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMG 219
N QL + P++ L +L L+L+ L P +
Sbjct: 90 N----------AQLRSVD-------------PATFHGLGRLHTLHLDRCGLQELGPGLFR 126
Query: 220 NLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIE 279
L +L L L N L L T +L NL LFL+ N +S L SL +L L +
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 280 NQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLN 331
N+++ P +F +L + LF+N+LS ++P L L++L L L N
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 9/201 (4%)
Query: 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQN-QLNGLIPCT 241
N +S +S L +L+L++N L L L LDLS N QL + P T
Sbjct: 41 GNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPAT 100
Query: 242 LDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSGSIP-LSFGNLSSWTLM 299
L L TL L + L + + L +L L L +N L ++P +F +L + T +
Sbjct: 101 FHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHL 158
Query: 300 SLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSI 358
L N +S S+P L SL L L+ N++ V P + +L L L LF N L ++
Sbjct: 159 FLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL-SAL 216
Query: 359 PEEI-GYLKSLSELKLCKNNL 378
P E L++L L+L N
Sbjct: 217 PTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 48/210 (22%), Positives = 78/210 (37%), Gaps = 7/210 (3%)
Query: 390 TGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNN 449
+ + N + S ++ +L + + N L AF L LDLS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 450 FDGKISFN-WRNLPKLDTFIVSMNNIFGSIPLEI-GDSSKLQFLDLSSNHIVGKIPVQ-L 506
+ + L +L T + + + + + LQ+L L N + +P
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 507 EKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLS 566
L +L L L N++S F L L L L N+++ P + +L +L L L
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 567 NNQFSHTIPIE-FEKLIHLSKLDLSHNILQ 595
N S +P E L L L L+ N
Sbjct: 210 ANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 28/111 (25%), Positives = 41/111 (36%), Gaps = 1/111 (0%)
Query: 534 TELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNI 593
Q + L N++S S L L L +N + F L L +LDLS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 594 LQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+ P + L L+L L P F + +L + + N LQ
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 45/286 (15%)
Query: 744 EEIIKATDDFDEKFCIGKGGQGSVYKAEL--PSGDI-VAVKKFNSQLLSGNMA-DQDEFL 799
+ +K + +G G GSV + I VA+K L G D +E +
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK----VLKQGTEKADTEEMM 58
Query: 800 NVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDATAKELSWNRRIN 858
++++ + IV+ G C LV E G L + L G +E+ +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR---EEIPVSNVAE 114
Query: 859 VIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE 916
++ V+ + YL + +HRD++++NVLL A +SDFG++K + ++ +
Sbjct: 115 LLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALG---ADDSY 166
Query: 917 FVGTFG------YAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSN 969
+ + APE + + + DV+S+GV ++E + G P +
Sbjct: 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-------YKKMKG 219
Query: 970 MIIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
EV ++ R+ P P +L ++M C E RP
Sbjct: 220 P--EVMAFIEQGKRMECP-PECPPELYALM---SDCWIYKWEDRPD 259
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 70/279 (25%), Positives = 117/279 (41%), Gaps = 39/279 (13%)
Query: 759 IGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+GKG GSV P GD +VAVK QL Q +F + L + I
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVK----QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 814 VKFHGFCSNARHS--FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
VK+ G LV EYL G L L L +R + + + YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG 144
Query: 872 -HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YA 924
C +HRD++++N+L++ E ++DFG+AK + ++ +V +
Sbjct: 145 SRRC----VHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY 197
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVI-KGNHP----RDFFSINFSSFSNMII-EVNQIL 978
APE + + DV+SFGV+++E+ + +F + + + ++L
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 979 DP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ RL P P ++ +M+ LC SP+ RP+
Sbjct: 258 EEGQRLPAP-PACPAEVHELMK---LCWAPSPQDRPSFS 292
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 73/272 (26%), Positives = 125/272 (45%), Gaps = 40/272 (14%)
Query: 759 IGKGGQGSVYKAEL--PSGDI---VAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRN 812
IG G G VYK L SG VA+K L +G Q +FL + + H N
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIK----TLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
I++ G S + ++ EY+ G+L + L E S + + +++G+A + YL +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG-----YAAPE 927
+HRD++++N+L++ VSDFG+++ +E + + G + APE
Sbjct: 166 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWTAPE 220
Query: 928 -IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLS 983
I+Y + T DV+SFG++++EV+ G P + SN EV + ++ RL
Sbjct: 221 AISYR-KFTSASDVWSFGIVMWEVMTYGERP-------YWELSNH--EVMKAINDGFRLP 270
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
TP + +M + C + RP
Sbjct: 271 TP-MDCPSAIYQLM---MQCWQQERARRPKFA 298
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 37/234 (15%), Positives = 70/234 (29%), Gaps = 28/234 (11%)
Query: 744 EEIIKATDDFDEKFCIGKGGQGSVYKAE------LPSGDIVAVKKFNSQLLSGNMADQDE 797
E + +G+G VY+A + +K N +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYI 113
Query: 798 FLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL--GNDATAKELSWNR 855
++ L +KF+ S LV E G+L + + K +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 856 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH-----------VSDFGIA 904
I+ + + +H IIH DI N +L F + D G +
Sbjct: 174 VISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 905 KFVEPYSSNR--TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
++ + T T G+ E+ + D + V+ ++ G +
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 77/311 (24%), Positives = 117/311 (37%), Gaps = 58/311 (18%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G G G VY+ ++ VAVK + D+ +FL L +++ H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALIISKFNHQN 94
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL----GNDATAKELSWNRRINVIKGVANALS 868
IV+ G + F++ E + G L L + L+ ++V + +A
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 869 YL--HHDCLPSIIHRDISSKNVLLDLEFEAHV---SDFGIAKFVEPYSSNRTEFVGTFGY 923
YL +H IHRDI+++N LL V DFG+A+ + Y ++ G
Sbjct: 155 YLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYR-KGGCAM 206
Query: 924 -----AAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQI 977
PE T K D +SFGVL++E+ G P + S SN EV +
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKSNQ--EVLEF 257
Query: 978 LDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILAI 1035
+ R+ P + IM C PE RP IL I
Sbjct: 258 VTSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFA-----------IILERIEYC 302
Query: 1036 EASADYGQTTL 1046
D T L
Sbjct: 303 TQDPDVINTAL 313
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 66/266 (24%), Positives = 105/266 (39%), Gaps = 31/266 (11%)
Query: 759 IGKGGQGSVYKAEL--PSGDI--VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
+G G G V + E PSG VAVK +LS A D+F+ V A++ + HRN++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA-MDDFIREVNAMHSLDHRNLI 84
Query: 815 KFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC 874
+ +G +V E GSL L VA + YL
Sbjct: 85 RLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 875 LPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGT---FGYAAPEIAYT 931
IHRD++++N+LL + DFG+ + + + F + APE T
Sbjct: 142 F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 932 MRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP---RLSTPSP 987
+ D + FGV ++E+ G P + + ++ +D RL P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP-------WIGLNGS--QILHKIDKEGERLPRP-E 248
Query: 988 GVMDKLISIMEVAILCLDESPEARPT 1013
+ ++M + C PE RPT
Sbjct: 249 DCPQDIYNVM---VQCWAHKPEDRPT 271
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 66/279 (23%), Positives = 116/279 (41%), Gaps = 40/279 (14%)
Query: 759 IGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+G+G G V P+ D +VAVK + + + + L + H +I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA---DAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 814 VKFHGFCSNARHS--FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
+K+ G C +A + LV EY+ GSL L + + + + + ++YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLH 151
Query: 872 -HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YA 924
IHRD++++NVLLD + + DFG+AK V + +
Sbjct: 152 AQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVP---EGHEYYRVREDGDSPVFWY 204
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVI-----KGNHPRDFFSINFSSFSNMI-IEVNQIL 978
APE + DV+SFGV ++E++ + P F + + M + + ++L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 979 DP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ RL P ++ +M+ C + RPT E
Sbjct: 265 ERGERLPRP-DKCPAEVYHLMK---NCWETEASFRPTFE 299
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 71/311 (22%), Positives = 124/311 (39%), Gaps = 29/311 (9%)
Query: 124 NLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183
L+ + G + ++ ++ L+ + L + TI + L+ +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLD 243
N ++ + L NL+K+ L L+ N L + L+S+ TLDL+ Q+ + P L
Sbjct: 73 NQITD--LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 244 NLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFS 303
LSNL L+L N ++ +I + L +L L + Q+S PL+ NLS T +
Sbjct: 127 GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADD 182
Query: 304 NSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIG 363
N +S I P L +L +L + L NQ++ V P + N S+L ++L N +
Sbjct: 183 NKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 364 YLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQ 423
L + +K SG + + +L S + FNQ
Sbjct: 239 NLVVPNVVK----GPSGAPIAPATISDNGTYAS-------PNLTWNLTSFINNVSYTFNQ 287
Query: 424 NNLVGKVYEAF 434
+ F
Sbjct: 288 SVTFKNTTVPF 298
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 58/269 (21%), Positives = 109/269 (40%), Gaps = 20/269 (7%)
Query: 83 NLSTLCLNGTF--QDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG 140
N + + + + + L+ I + L+ L L+L +NQ++
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQITD 77
Query: 141 VISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKL 200
+ + L ++ L L N L I L I ++ + L LS L
Sbjct: 78 L--APLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD--VTPLAGLSNL 131
Query: 201 ALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
+LYL+ N + P + L +L L + Q++ L P L NLS L TL N +S
Sbjct: 132 QVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS- 186
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSL 320
I + +L +L ++ L NQ+S PL+ N S+ +++L + +++ NL
Sbjct: 187 DISP-LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNNLVVP 243
Query: 321 STLGLYLNQLNGVIPPSIGNLSSLRNLSL 349
+ + + P +I + + + +L
Sbjct: 244 NV--VKGPSGAPIAPATISDNGTYASPNL 270
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 49/234 (20%), Positives = 96/234 (41%), Gaps = 18/234 (7%)
Query: 410 LKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIV 469
+L + ++ ++N+ D +T L I + L L +
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70
Query: 470 SMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE 529
N I + + + +K+ L+LS N + + L S+ L L+ Q++ PL
Sbjct: 71 KDNQI-TDLA-PLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTPLA 126
Query: 530 FGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDL 589
L+ LQ L L N++++ P + L L YL++ N Q S P+ L L+ L
Sbjct: 127 --GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKA 180
Query: 590 SHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
N + +I P + ++ +L +++L +N +S P +L + + +
Sbjct: 181 DDNKI-SDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 56/281 (19%), Positives = 100/281 (35%), Gaps = 20/281 (7%)
Query: 314 LGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKL 373
L + + + + + +L + LS F G+ +I E + YL +L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-TTI-EGVQYLNNLIGLEL 70
Query: 374 CKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEA 433
N ++ + P + NLT + L + N L ++ L S+K + +
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQI--TDVTP 124
Query: 434 FGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDL 493
NL L L N L L + + PL + SKL L
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKA 180
Query: 494 SSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKS 553
N I I L L +L ++ L NQ+S PL + + L + L+ +++
Sbjct: 181 DDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFY 236
Query: 554 IGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNIL 594
NL+ + + P + +L+ N+
Sbjct: 237 NNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 58/268 (21%), Positives = 107/268 (39%), Gaps = 21/268 (7%)
Query: 388 NLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQ 447
L + + ++++ + L + + + E NL L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72
Query: 448 NNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLE 507
N ++ +NL K+ +S N + I ++ LDL+S I P L
Sbjct: 73 NQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 508 KLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSN 567
L +L L L LNQ++ PL LT LQYL + ++S P + NL KL L +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 568 NQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFE 627
N+ S P+ L +L ++ L +N + + P + N +L + L++ ++
Sbjct: 183 NKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 628 KMRSLSCIDICYNELQGPIPNSTVFKDG 655
+ + + PI +T+ +G
Sbjct: 239 NLVVPNVV---KGPSGAPIAPATISDNG 263
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 59/307 (19%), Positives = 110/307 (35%), Gaps = 44/307 (14%)
Query: 192 SSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTL 251
L+ + +++ + +L ++TL + + + L+NL L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGL 68
Query: 252 FLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIP 311
L N ++ + + NL + +L+L N L ++
Sbjct: 69 ELKDNQIT-DLAP-LKNLTKITELELSGNPLK-------------------------NVS 101
Query: 312 PILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSEL 371
+ L+S+ TL L Q+ V P + LS+L+ L L N + + + L +L L
Sbjct: 102 A-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYL 156
Query: 372 KLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVY 431
+ +S + P + NL+ L L +N + P L SL +L V N +
Sbjct: 157 SIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQI--SDV 210
Query: 432 EAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFL 491
+ NL + L+ + F NL + V + P I D+
Sbjct: 211 SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV--VKGPSGAPIAPATISDNGTYASP 268
Query: 492 DLSSNHI 498
+L+ N
Sbjct: 269 NLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 52/303 (17%), Positives = 106/303 (34%), Gaps = 20/303 (6%)
Query: 232 NQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFG 291
+N + P L+N + K++++ ++ +L + L ++ +
Sbjct: 7 TAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ-- 60
Query: 292 NLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFN 351
L++ + L N ++ + P L NL ++ L L N L V I L S++ L L +
Sbjct: 61 YLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTS 116
Query: 352 NGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLK 411
+ + + L +L L L N ++ + P + LT L L++ + P L
Sbjct: 117 TQI--TDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LA 170
Query: 412 SLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSM 471
+L+ L ++ + N + PNL + L N N L ++
Sbjct: 171 NLSKLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTN 226
Query: 472 NNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFG 531
I + + S + + ++ L +L +V F
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFN 286
Query: 532 SLT 534
Sbjct: 287 QSV 289
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 53/254 (20%), Positives = 97/254 (38%), Gaps = 18/254 (7%)
Query: 365 LKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424
L + ++ K+N++ + +L G+ L+ + + ++ L +L + N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 425 NLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGD 484
+ + +T L+LS N + L + T ++ I PL
Sbjct: 74 QI--TDLAPLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITDVTPLA--G 127
Query: 485 SSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSAN 544
S LQ L L N I P L L +L L + Q+S PL +L++L L N
Sbjct: 128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADDN 183
Query: 545 KLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCN 604
K+S P + +L L ++L NNQ S P+ +L + L++ + + N
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 605 MESLEKLNLSHNNL 618
+ +
Sbjct: 240 LVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 40/187 (21%), Positives = 78/187 (41%), Gaps = 14/187 (7%)
Query: 456 FNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKL 515
F L +N+ ++ D + L + I ++ L +L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68
Query: 516 ILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIP 575
L NQ++ PL+ +LT++ L+LS N L + +I L + L+L++ Q + P
Sbjct: 69 ELKDNQITDLAPLK--NLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 576 IEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCI 635
L +L L L N + I P + + +L+ L++ + +S P + L+ +
Sbjct: 125 --LAGLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 636 DICYNEL 642
N++
Sbjct: 179 KADDNKI 185
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 17/189 (8%)
Query: 83 NLSTLCLNGT-FQDFS-FSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG 140
++ TL L T D + + +L L L N NI P + L+ LQ L +GN Q+S
Sbjct: 108 SIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVSD 165
Query: 141 VISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKL 200
+ + L++L L D N++ I P + L + E +N +S S L N S L
Sbjct: 166 L--TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD--VSPLANTSNL 219
Query: 201 ALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
++ L N ++ NL N + G + + D +L+
Sbjct: 220 FIVTLTNQTITNQPVFYNNNLVVP-------NVVKGPSGAPIAPATISDNGTYASPNLTW 272
Query: 261 SIPSIIGNL 269
++ S I N+
Sbjct: 273 NLTSFINNV 281
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 71/272 (26%), Positives = 109/272 (40%), Gaps = 43/272 (15%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
IGKG G VY E A+K + M + FL L + + H N++
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR---ITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 815 KFHGFCSNAR-HSFLVCEYLHRGSLA---RILGNDATAKELSWNRRINVIKGVANALSYL 870
G ++ Y+ G L R + T K+L I+ VA + YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGMEYL 140
Query: 871 --HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP--YSSNRTEFVGTF--GYA 924
+HRD++++N +LD F V+DFG+A+ + Y S + +
Sbjct: 141 AEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--R 981
A E T R T K DV+SFGVL++E++ +G P + ++ L R
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP-------YRHIDPF--DLTHFLAQGRR 246
Query: 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
L P D L +M+ C + P RPT
Sbjct: 247 LPQP-EYCPDSLYQVMQ---QCWEADPAVRPT 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 33/278 (11%)
Query: 746 IIKATDDFDEKFCIGKGGQGSVYKAEL--PSGDI-VAVKKFNSQLLSGNM-ADQDEFLNV 801
+K + +G G GSV + I VA+K L G AD +E +
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK----VLKQGTEKADTEEMMRE 386
Query: 802 VLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIK 861
++++ + IV+ G C LV E G L + L +E+ + ++
Sbjct: 387 AQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLH 443
Query: 862 GVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGT- 920
V+ + YL +HR+++++NVLL A +SDFG++K + S T
Sbjct: 444 QVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 921 --FGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQI 977
+ APE + + + DV+S+GV ++E + G P + EV
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-------YKKMKGP--EVMAF 551
Query: 978 LDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
++ R+ P P +L ++M C E RP
Sbjct: 552 IEQGKRMECP-PECPPELYALM---SDCWIYKWEDRPD 585
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 63/266 (23%), Positives = 109/266 (40%), Gaps = 45/266 (16%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHG 818
IGKG G V + G+ VAVK + + A FL + ++RH N+V+ G
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVK----CIKNDATAQ--AFLAEASVMTQLRHSNLVQLLG 81
Query: 819 FCSNARHS-FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL-HHDCLP 876
+ ++V EY+ +GSL L + L + + V A+ YL ++
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNF-- 138
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAAPEIAY 930
+HRD++++NVL+ + A VSDFG+ + + APE
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLT---------KEASSTQDTGKLPVKWTAPEALR 187
Query: 931 TMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSP 987
+ + K DV+SFG+L++E+ G P + +V ++ ++ P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLK--DVVPRVEKGYKMDAP-D 237
Query: 988 GVMDKLISIMEVAILCLDESPEARPT 1013
G + +M C RP+
Sbjct: 238 GCPPAVYEVM---KNCWHLDAAMRPS 260
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 75/306 (24%), Positives = 114/306 (37%), Gaps = 58/306 (18%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G G G VY+ ++ VAVK + D+ +FL L +++ H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALIISKFNHQN 135
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL----GNDATAKELSWNRRINVIKGVANALS 868
IV+ G + F++ E + G L L + L+ ++V + +A
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 869 YL--HHDCLPSIIHRDISSKNVLLDLEFEAHV---SDFGIAKFVEPYSSNRTEFVGTFGY 923
YL +H IHRDI+++N LL V DFG+A+ + Y + G
Sbjct: 196 YLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYYR-KGGCAM 247
Query: 924 -----AAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQI 977
PE T K D +SFGVL++E+ G P + S SN EV +
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKSNQ--EVLEF 298
Query: 978 LDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILAI 1035
+ R+ P + IM C PE RP IL I
Sbjct: 299 VTSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFA-----------IILERIEYC 343
Query: 1036 EASADY 1041
D
Sbjct: 344 TQDPDV 349
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 66/267 (24%), Positives = 109/267 (40%), Gaps = 38/267 (14%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRNI 813
IG+G G V++ S + VA+K + ++FL L + + H +I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIK----TCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL-HH 872
VK G + +++ E G L L L I ++ AL+YL
Sbjct: 79 VKLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK 135
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFGYAAPEIA 929
+HRDI+++NVL+ + DFG+++++E Y +++ + + APE
Sbjct: 136 RF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESI 189
Query: 930 YTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPS 986
R T DV+ FGV ++E++ G P F N +V ++ RL P
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNN--DVIGRIENGERLPMP- 239
Query: 987 PGVMDKLISIMEVAILCLDESPEARPT 1013
P L S+M C P RP
Sbjct: 240 PNCPPTLYSLM---TKCWAYDPSRRPR 263
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 36/278 (12%)
Query: 759 IGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+G+G G V P GD VAVK + SG + + L + H NI
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGN-HIADLKKEIEILRNLYHENI 85
Query: 814 VKFHGFCSNARHS--FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
VK+ G C+ + L+ E+L GSL L + +++ +++ + + YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLG 143
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAA 925
+HRD++++NVL++ E + + DFG+ K +E +++ + + A
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE---TDKEYYTVKDDRDSPVFWYA 197
Query: 926 PEIAYTMRATEKYDVYSFGVLVFEVI-----KGNHPRDFFSINFSSFSNMII-EVNQILD 979
PE + DV+SFGV + E++ + F + + M + + L
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 980 P--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
RL P P D++ +M C + P R + +
Sbjct: 258 EGKRLPCP-PNCPDEVYQLM---RKCWEFQPSNRTSFQ 291
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 61/292 (20%), Positives = 99/292 (33%), Gaps = 22/292 (7%)
Query: 83 NLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVI 142
+ + CL + L I L+ L + ++ I
Sbjct: 25 SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84
Query: 143 SPEIGKL---NQLRRLYLDMNQLHGTIPPVIGQLSL--IHEFSFCHNNVSGR--IPSSLG 195
++ + L+ L L+ ++ GT PP + + + ++ + + + + R + L
Sbjct: 85 LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144
Query: 196 NLSKLAL--LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG-------LIPCTLDNLS 246
K L L + + + +LSTLDLS N G L P L
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
Query: 247 NLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIP-LSFGNLSSWTLMSLFSNS 305
L + SG ++ L LDL N L + S S ++L
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 306 LSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGS 357
L +P L LS L L N+L+ PS L + NLSL N S
Sbjct: 265 LK-QVPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 8e-21
Identities = 49/276 (17%), Positives = 89/276 (32%), Gaps = 22/276 (7%)
Query: 387 GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYE---AFGDHPNLTFL 443
G + LL + + SLKR+ + ++ L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 444 DLSQNNFDGKISFNWRNLPKLDTFIVSMNNI----FGSIPLEIGDSSK--LQFLDLSSNH 497
L G D I+++ N+ + E+ K L+ L ++ H
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 498 IVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE----FGSLTELQYLDLSANKLSS---SI 550
+ Q+ +L+ L LS N G L LQ L L + +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 551 PKSIGNLLKLYYLNLSNNQFSHTIP-IEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLE 609
++L L+LS+N + L+ L+LS L +++P L
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPK--GLPAKLS 277
Query: 610 KLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGP 645
L+LS+N L +++ + + + N
Sbjct: 278 VLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 47/277 (16%), Positives = 77/277 (27%), Gaps = 44/277 (15%)
Query: 15 LNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNH 74
L + + LQ L + ++ +
Sbjct: 73 LTVRAARIPSRILFGALRVLGISGLQELTLENLEVT------------GTAPPPLLEATG 120
Query: 75 AGSRVISI-NLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDL 133
++++ N+S + + P L L+++ Q+ L LDL
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180
Query: 134 GNNQLSGVI----SPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGR 189
+N G + K L+ L L + SG
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGM---------------------ETPSGV 219
Query: 190 IPSSLGNLSKLALLYLNNNSLFGYIPTVM-GNLKSLSTLDLSQNQLNGLIPCTLDNLSNL 248
+ +L L L++NSL L++L+LS L + LS L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL 279
Query: 249 DTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGS 285
D L N L PS L + L L N S
Sbjct: 280 D---LSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 54/310 (17%), Positives = 95/310 (30%), Gaps = 44/310 (14%)
Query: 123 GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPP---VIGQLSLIHEF 179
G S L + + +I K L+RL + ++ I + +S + E
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 180 SFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIP 239
+ + V+G P L + L LN ++ S +T D +L +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNV------------SWATRDAWLAELQQWL- 147
Query: 240 CTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLM 299
L L + + + +L LDL +N G L
Sbjct: 148 -----KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI---------- 192
Query: 300 SLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIP 359
S P L+ L+ + +GV L+ L L +N L +
Sbjct: 193 -------SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 360 EEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKR 418
+ L+ L L L V L+ +L++ N L P + L +
Sbjct: 246 APSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS---VLDLSYNRLDR-NPSPDE-LPQVGN 300
Query: 419 VRFNQNNLVG 428
+ N +
Sbjct: 301 LSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 27/149 (18%), Positives = 51/149 (34%), Gaps = 10/149 (6%)
Query: 509 LFSLNKLILSLNQLSGSVP-LEFGSLTELQYLDLSANKLSSSIPKSIGNLL---KLYYLN 564
SL L+ ++ + + L+ L + A ++ S I +L L L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 565 LSNNQFSHTIPIEFEKLIH--LSKLDLSHNILQEEIPP----QVCNMESLEKLNLSHNNL 618
L N + + T P + L+ L+L + Q L+ L+++ +
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 619 SGFIPRCFEKMRSLSCIDICYNELQGPIP 647
F +LS +D+ N G
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-24
Identities = 71/285 (24%), Positives = 115/285 (40%), Gaps = 30/285 (10%)
Query: 746 IIKATDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLN 800
I E + G G G V + + A+K +S + + L
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLE 85
Query: 801 VVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRRINV 859
V L + H NI+K + F + R+ +LV E G L I+ + + +
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII----HRMKFNEVDAAVI 141
Query: 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFGIAKFVEPYSSNRTE 916
IK V + ++YLH +I+HRD+ +N+LL + + + DFG++ E E
Sbjct: 142 IKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-QKKMKE 197
Query: 917 FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQ 976
+GT Y APE+ + EK DV+S GV++F ++ G P F + +
Sbjct: 198 RLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP--FGGQTDQEILRKVEKGKY 254
Query: 977 ILD-PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
D P S G D LI M L D + R + ++ H
Sbjct: 255 TFDSPEWKNVSEGAKD-LIKQM----LQFD--SQRRISAQQALEH 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 7e-24
Identities = 44/289 (15%), Positives = 104/289 (35%), Gaps = 30/289 (10%)
Query: 740 KIMHE-EIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEF 798
K+M E + + + + K + +I + LS
Sbjct: 50 KVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPS 109
Query: 799 LNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRIN 858
+ + ++ +N V S + ++ + + +L + + ++ ++
Sbjct: 110 VKIRR-MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168
Query: 859 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE---------- 908
+ +A A+ +LH ++HRD+ N+ ++ V DFG+ ++
Sbjct: 169 IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 909 --PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 966
P + T VGT Y +PE + + K D++S G+++FE++ + FS+
Sbjct: 226 PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YS-------FST 275
Query: 967 FSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ + + + + + +++ L SP RP
Sbjct: 276 QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEAT 321
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 58/266 (21%), Positives = 104/266 (39%), Gaps = 34/266 (12%)
Query: 759 IGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRN 812
+G G G+VYK VA+K+ L E L+ + + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE----LREATSPKANKEILDEAYVMASVDNPH 78
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+ + G C L+ + + G L + + +N +A ++YL
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED 135
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF--GYAAPEIAY 930
L +HRD++++NVL+ ++DFG+AK + G + A E
Sbjct: 136 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 931 TMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSP 987
T + DV+S+GV V+E++ G+ P + E++ IL+ RL P P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP-------YDGIPAS--EISSILEKGERLPQP-P 242
Query: 988 GVMDKLISIMEVAILCLDESPEARPT 1013
+ IM + C ++RP
Sbjct: 243 ICTIDVYMIM---VKCWMIDADSRPK 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 55/286 (19%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G G V+ AE + +VAVK L + + + +F L ++H++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVK----ALKEASESARQDFQREAELLTMLQHQH 104
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL------------GNDATAKELSWNRRINVI 860
IV+F G C+ R +V EY+ G L R L G D L + + V
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 861 KGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFV 918
VA + YL H +HRD++++N L+ + DFG+++ + YS++ V
Sbjct: 165 SQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYR-V 216
Query: 919 GTFG-----YAAPE-IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMI 971
G + PE I Y + T + DV+SFGV+++E+ G P + SN
Sbjct: 217 GGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP-------WYQLSNT- 267
Query: 972 IEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
E + L P ++ +IM C P+ R +++
Sbjct: 268 -EAIDCITQGRELERP-RACPPEVYAIMR---GCWQREPQQRHSIK 308
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 59/271 (21%), Positives = 104/271 (38%), Gaps = 42/271 (15%)
Query: 759 IGKGGQGSVYKAELPSGDI----VAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRNI 813
+G+G G VY+ + VAVK D ++F++ + + + H +I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVK----TCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
VK G +++ E G L L + L + + A++YL
Sbjct: 76 VKLIGIIEEEPT-WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI 132
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG------YAAPE 927
+HRDI+ +N+L+ + DFG+++++E ++ + +PE
Sbjct: 133 NC---VHRDIAVRNILVASPECVKLGDFGLSRYIE-----DEDYYKASVTRLPIKWMSPE 184
Query: 928 IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLST 984
R T DV+ F V ++E++ G P F N +V +L+ RL
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQP-------FFWLENK--DVIGVLEKGDRLPK 235
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTME 1015
P L ++M C D P RP
Sbjct: 236 P-DLCPPVLYTLM---TRCWDYDPSDRPRFT 262
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 70/287 (24%), Positives = 123/287 (42%), Gaps = 56/287 (19%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G G V+ AE + +VAVK L +A + +F L ++H +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL-------------GNDATAKELSWNRRINV 859
IVKF+G C + +V EY+ G L + L EL ++ +++
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 860 IKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEF 917
+A+ + YL H +HRD++++N L+ + DFG+++ V YS++
Sbjct: 139 ASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYR- 190
Query: 918 VGTFG-----YAAPE-IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNM 970
VG + PE I Y + T + DV+SFGV+++E+ G P + SN
Sbjct: 191 VGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP-------WFQLSNT 242
Query: 971 IIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
EV + + L P ++ +M C P+ R ++
Sbjct: 243 --EVIECITQGRVLERP-RVCPKEVYDVML---GCWQREPQQRLNIK 283
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/283 (23%), Positives = 109/283 (38%), Gaps = 32/283 (11%)
Query: 750 TDDFDEKFCIGK----GGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA 804
D+ F + G G V+ E SG +K N ++ +
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV---PMEQIEAEIEV 73
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRRINVIKGV 863
L + H NI+K + + ++V E G L RI+ A K LS ++K +
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNRTEFVGT 920
NAL+Y H ++H+D+ +N+L + DFG+A+ + + T GT
Sbjct: 134 MNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAAGT 189
Query: 921 FGYAAPEI---AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQI 977
Y APE+ T K D++S GV+++ ++ G P F +
Sbjct: 190 ALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP--FTGTSLEEVQQKATYKEPN 243
Query: 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+P +D L+ M L D PE RP+ + H
Sbjct: 244 YAVECRPLTPQAVD-LLKQM----LTKD--PERRPSAAQVLHH 279
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 58/291 (19%), Positives = 105/291 (36%), Gaps = 16/291 (5%)
Query: 192 SSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTL 251
++ L S+ + L S+ + + + + + + L N+ L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 70
Query: 252 FLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIP 311
FL N L+ I + NLK+L L L EN++ L +L +SL N +S I
Sbjct: 71 FLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGIS-DIN 125
Query: 312 PILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSEL 371
L +L L +L L N++ + + L+ L LSL +N + S + L L L
Sbjct: 126 G-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNL 180
Query: 372 KLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVY 431
L KN++S + + L L +L + +L V+ +LV
Sbjct: 181 YLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238
Query: 432 EAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEI 482
+ + F ++SF + + + E+
Sbjct: 239 ISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEV 289
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 61/290 (21%), Positives = 108/290 (37%), Gaps = 42/290 (14%)
Query: 96 FSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRL 155
F +F + NL + Q L+ + + N+ + V I L + +L
Sbjct: 15 FPDDAFAETIKDNLKKKS-VTDAVTQ-NELNSIDQIIANNSDIKSV--QGIQYLPNVTKL 70
Query: 156 YLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIP 215
+L+ N+L I P L NL L L+L+ N +
Sbjct: 71 FLNGNKLT-DIKP-------------------------LTNLKNLGWLFLDENKIKDLSS 104
Query: 216 TVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQL 275
+ +LK L +L L N ++ + L +L L++L+L N + + +++ L L L
Sbjct: 105 --LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTL 158
Query: 276 DLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIP 335
L +NQ+S +PL+ L+ + L N +S + L LK+L L L+ +
Sbjct: 159 SLEDNQISDIVPLA--GLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPI 214
Query: 336 PSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHS 385
NL + + L PE I + + + S
Sbjct: 215 NHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEVS 262
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 2e-22
Identities = 45/240 (18%), Positives = 87/240 (36%), Gaps = 16/240 (6%)
Query: 410 LKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIV 469
+ + + ++ + ++ + + ++ + + LP + +
Sbjct: 17 DDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 72
Query: 470 SMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE 529
+ N + PL + L +L L N I + L+ L L L L N +S L
Sbjct: 73 NGNKLTDIKPLT--NLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDINGLV 128
Query: 530 FGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDL 589
L +L+ L L NK++ + L KL L+L +NQ S +P L L L L
Sbjct: 129 --HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 182
Query: 590 SHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNS 649
S N + ++ + +++L+ L L + + + L P S
Sbjct: 183 SKNHI-SDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 9e-22
Identities = 57/269 (21%), Positives = 109/269 (40%), Gaps = 18/269 (6%)
Query: 365 LKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424
+ L K +++ + L + + + + + ++ L ++ ++ N N
Sbjct: 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGN 75
Query: 425 NLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGD 484
L + + NL +L L +N +S + ++L KL + + N I I +
Sbjct: 76 KL--TDIKPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGI-SDIN-GLVH 129
Query: 485 SSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSAN 544
+L+ L L +N I I V L +L L+ L L NQ+S VPL LT+LQ L LS N
Sbjct: 130 LPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKN 185
Query: 545 KLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCN 604
+S +++ L L L L + + + L+ + + + L P + +
Sbjct: 186 HISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISD 241
Query: 605 MESLEKLNLSHNNLSGFIPRCFEKMRSLS 633
EK N+ + F + ++
Sbjct: 242 DGDYEKPNVKWHLPEFTNEVSFIFYQPVT 270
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 2e-21
Identities = 59/286 (20%), Positives = 105/286 (36%), Gaps = 20/286 (6%)
Query: 83 NLSTLCL--NGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG 140
L + + + + + + ++ I L + L L N+L+
Sbjct: 22 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFLNGNKLT- 78
Query: 141 VISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKL 200
I P + L L L+LD N++ + + L + S HN +S I + L +L +L
Sbjct: 79 DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQL 133
Query: 201 ALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
LYL NN + TV+ L L TL L NQ++ ++P L L+ L L+L KN +S
Sbjct: 134 ESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS- 188
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSG----SIPPILGN 316
+ + + LK+L L+L + NL + SL S
Sbjct: 189 DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEK 247
Query: 317 LKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362
L + N+++ + + + +
Sbjct: 248 PNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVS 293
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 49/296 (16%), Positives = 102/296 (34%), Gaps = 53/296 (17%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLA------------L 805
+ +G + E A+KK+ S L + + + +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 806 NEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-----ARILGNDATAKELSWNRRINVI 860
+I++ + G +N +++ EY+ S+ + + + +I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGT 920
K V N+ SY+H++ +I HRD+ N+L+D +SDFG ++++ GT
Sbjct: 158 KSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSRGT 213
Query: 921 FGYAAPEI-----AYTMRATEKYDVYSFGVLVFEVIKGNHP---------------RDFF 960
+ + PE +Y K D++S G+ ++ + P
Sbjct: 214 YEFMPPEFFSNESSY---NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
Query: 961 SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ N+ + S +D + + L ++P R T E
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDID-FLKLF------LRKNPAERITSED 319
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 74/276 (26%), Positives = 118/276 (42%), Gaps = 51/276 (18%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
IG+G G VY L D AVK N ++ + +FL + + + H N++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 815 KFHGFCSNARHS-FLVCEYLHRGSLA---RILGNDATAKELSWNRRINVIKGVANALSYL 870
G C + S +V Y+ G L R ++ T K+L I VA + YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 144
Query: 871 --HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV---EPYSSNRTEFVGTFG--- 922
+HRD++++N +LD +F V+DFG+A+ + E YS + T
Sbjct: 145 ASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK----TGAKLP 195
Query: 923 --YAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILD 979
+ A E T + T K DV+SFGVL++E++ +G P + + ++ L
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVNTF--DITVYLL 246
Query: 980 P--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
RL P D L +M + C E RP+
Sbjct: 247 QGRRLLQP-EYCPDPLYEVM---LKCWHPKAEMRPS 278
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 65/265 (24%), Positives = 107/265 (40%), Gaps = 37/265 (13%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG G V + G+ VAVK + + FL + ++RH N+V+
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVK----CIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 252
Query: 818 GFCSNARHSF-LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL-HHDCL 875
G + +V EY+ +GSL L + L + + V A+ YL ++
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGY--AAPEIAYTMR 933
+HRD++++NVL+ + A VSDFG+ K G APE +
Sbjct: 311 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKK 362
Query: 934 ATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSPGVM 990
+ K DV+SFG+L++E+ G P + +V ++ ++ P G
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLK--DVVPRVEKGYKMDAP-DGCP 412
Query: 991 DKLISIMEVAILCLDESPEARPTME 1015
+ +M C RPT
Sbjct: 413 PAVYDVM---KNCWHLDAATRPTFL 434
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 66/273 (24%), Positives = 109/273 (39%), Gaps = 48/273 (17%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADQDEFLNV---VLALNEIRHRNI 813
+G G G V+ A V VK ++L + + V + L+ + H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 814 VKFHGFCSNARHSFLVCEYLHRGS--LARILGNDATAKELSWNRRINVIKGVANALSYLH 871
+K N LV E G A I + + L+ I + + +A+ YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA--SYI--FRQLVSAVGYLR 147
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
IIHRDI +N+++ +F + DFG A ++E T F GT Y APE
Sbjct: 148 LKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPE---- 199
Query: 932 MRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP- 985
+ Y +++S GV ++ ++ +P E+ + ++ + P
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC--------------ELEETVEAAIHPPY 245
Query: 986 --SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
S +M L+S + L PE R T+EK
Sbjct: 246 LVSKELMS-LVSGL------LQPVPERRTTLEK 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 39/304 (12%), Positives = 83/304 (27%), Gaps = 64/304 (21%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG---------------------NMADQD 796
+G+ + +A + +G+ V N
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 797 EFLNVVLALNEIRHRNIVKFHGFCSNARH----SFLVCEYLHRGSLARILGN----DATA 848
L + + ++ K + R S + +L +T
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 849 KELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908
K L + R+ + V L+ LHH ++H + +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 255
Query: 909 PYSSNRTEFVGTFGYAAPEI-----------AYTMRATEKYDVYSFGVLVFEVIKGNHPR 957
R + G+ PE+ T +D ++ G++++ + + P
Sbjct: 256 --DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312
Query: 958 DFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKG 1017
+ + I + P P V L+ L E R +
Sbjct: 313 ------ITK-DAALGGSEWIFRSCKNIPQP-VRA-LLE------GFLRYPKEDRLLPLQA 357
Query: 1018 FGHH 1021
Sbjct: 358 METP 361
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 71/272 (26%), Positives = 114/272 (41%), Gaps = 43/272 (15%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
IG+G G VY L D AVK N ++ + +FL + + + H N++
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 815 KFHGFCSNARHS-FLVCEYLHRGSLA---RILGNDATAKELSWNRRINVIKGVANALSYL 870
G C + S +V Y+ G L R ++ T K+L I VA + +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFL 208
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA------ 924
+HRD++++N +LD +F V+DFG+A+ + Y G
Sbjct: 209 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFDSVHNKTGAKLPVKWM 263
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--R 981
A E T + T K DV+SFGVL++E++ +G P + + ++ L R
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVNTF--DITVYLLQGRR 314
Query: 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
L P D L +M + C E RP+
Sbjct: 315 LLQP-EYCPDPLYEVM---LKCWHPKAEMRPS 342
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 29/285 (10%)
Query: 746 IIKATDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLN 800
+ +T F +++ GKG G V + +G AVK + + + D++ L
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLR 75
Query: 801 VVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRRINV 859
V L ++ H NI+K + F + + +LV E G L I+ + K S +
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARI 131
Query: 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFGIAKFVEPYSSNRTE 916
I+ V + ++Y+H + I+HRD+ +N+LL + + DFG++ E S +
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKD 187
Query: 917 FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQ 976
+GT Y APE+ EK DV+S GV+++ ++ G P F N + +
Sbjct: 188 KIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP--FNGANEYDILKKVEKGKY 244
Query: 977 ILD-PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ P+ S D LI M L P R + H
Sbjct: 245 TFELPQWKKVSESAKD-LIRKM----LTYV--PSMRISARDALDH 282
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 33/267 (12%), Positives = 67/267 (25%), Gaps = 58/267 (21%)
Query: 758 CIGKGGQGSVYKAE---LPSGDIVAVKKFNSQLLSGNMADQD---EFLNVVLALNEIRHR 811
G ++A L VA+ + + D E L+ L L+ I
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALT----FVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
+ + +V E++ GSL + S I ++ +A A H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
+ V VS G +
Sbjct: 147 RA---GVALSIDHPSRVR--------VSIDGDVV------------LAYPATMPD----- 178
Query: 932 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS---PG 988
A + D+ G ++ ++ P + + + + + P+
Sbjct: 179 --ANPQDDIRGIGASLYALLVNRWPLP-----EAGVRSGLAPAERDTAGQPIEPADIDRD 231
Query: 989 VMDKLISIMEVAILCLDESPEARPTME 1015
+ ++ VA + R
Sbjct: 232 IPFQI---SAVAARSVQGDGGIRSAST 255
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 44/302 (14%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
+GKG GSV +A+L D VAVK + +++ +D +EFL + E H ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA--SSDIEEFLREAACMKEFDHPHVA 88
Query: 815 KFHGFCS------NARHSFLVCEYLHRGSLA---RILGNDATAKELSWNRRINVIKGVAN 865
K G ++ ++ G L L + + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 866 ALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF-- 921
+ YL + IHRD++++N +L + V+DFG+++ + R
Sbjct: 149 GMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP 980
+ A E T DV++FGV ++E++ +G P ++ N E+ L
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-------YAGIENA--EIYNYLIG 254
Query: 981 --RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILAIEAS 1038
RL P P M+++ +M C P+ RP+ F + IL + + S
Sbjct: 255 GNRLKQP-PECMEEVYDLMY---QCWSADPKQRPS----FTCLRMELENILGHLSVLSTS 306
Query: 1039 AD 1040
D
Sbjct: 307 QD 308
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 742 MHEEIIKATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLN 800
M I+ T F E +G G V+ + +G + A+K + + ++E
Sbjct: 2 MQTTNIRKTFIFMEV--LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENE--- 56
Query: 801 VVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILG------NDATAKELSW 853
+ L +I+H NIV + H +LV + + G L RIL DA+
Sbjct: 57 -IAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS------ 109
Query: 854 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL-DLEFEAHV--SDFGIAKFVEPY 910
VI+ V +A+ YLH + I+HRD+ +N+L E + + +DFG++K +
Sbjct: 110 ----LVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161
Query: 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 948
+ GT GY APE+ ++ D +S GV+ +
Sbjct: 162 -GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITY 198
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 65/277 (23%), Positives = 110/277 (39%), Gaps = 45/277 (16%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIV 814
+G+G GSV + L D VAVK S + +EFL+ + + H N++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS--QREIEEFLSEAACMKDFSHPNVI 99
Query: 815 KFHGFCS-----NARHSFLVCEYLHRGSLA---RILGNDATAKELSWNRRINVIKGVANA 866
+ G C ++ ++ G L + K + + + +A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 867 LSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG-- 922
+ YL + +HRD++++N +L + V+DFG++K + YS + G
Sbjct: 160 MEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGDYYR-QGRIAKM 211
Query: 923 ---YAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQIL 978
+ A E T K DV++FGV ++E+ +G P + N E+ L
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP-------YPGVQNH--EMYDYL 262
Query: 979 DP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
RL P +D+L IM C P RPT
Sbjct: 263 LHGHRLKQP-EDCLDELYEIMY---SCWRTDPLDRPT 295
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 63/265 (23%), Positives = 107/265 (40%), Gaps = 32/265 (12%)
Query: 759 IGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
+G G G+V+K V +K + SG + +LA+ + H +I
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQ-SFQAVTDHMLAIGSLDHAHI 77
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
V+ G C LV +YL GSL + L +N +A + YL
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF--GYAAPEIAYT 931
+ +HR+++++NVLL + V+DFG+A + P + A E +
Sbjct: 135 GM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 932 MRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLSTPSPG 988
+ T + DV+S+GV V+E++ G P ++ EV +L+ RL+ P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP-------YAGLRLA--EVPDLLEKGERLAQP-QI 241
Query: 989 VMDKLISIMEVAILCLDESPEARPT 1013
+ +M + C RPT
Sbjct: 242 CTIDVYMVM---VKCWMIDENIRPT 263
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 51/213 (23%), Positives = 79/213 (37%), Gaps = 34/213 (15%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177
+PP + L L N L + +L +L LD +L + +
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-----------TKLQ 71
Query: 178 EFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL 237
G L L L L++N L +P + L +L+ LD+S N+L L
Sbjct: 72 VD---------------GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 238 IPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSGSIPLS-FGNLSS 295
L L L L+L N L ++P ++ L +L L N L+ +P L +
Sbjct: 116 PLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLEN 173
Query: 296 WTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLN 328
+ L NSL +IP L L+ N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 52/214 (24%), Positives = 82/214 (38%), Gaps = 11/214 (5%)
Query: 240 CTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLM 299
C + +++ + K +L+ ++P + K L L EN L + + T +
Sbjct: 4 CEVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 300 SLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIP 359
+L L + + G L L TL L NQL +P L +L L + N L S+P
Sbjct: 61 NLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLP 116
Query: 360 EEI-GYLKSLSELKLCKNNLSGVIPHSV-GNLTGLVLLNMCENHLFGPIPKSLKSLTSLK 417
L L EL L N L +P + L L++ N+L L L +L
Sbjct: 117 LGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 418 RVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD 451
+ +N+L F L F L N +
Sbjct: 176 TLLLQENSLYTIPKGFF-GSHLLPFAFLHGNPWL 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 19/211 (9%)
Query: 220 NLKSLSTLDLSQNQLNGL---IPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLD 276
+ S ++ + L L +P + L L +N L + + L QL+
Sbjct: 8 KVASHLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 277 LIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPP 336
L +L+ + + G L + L N L S+P + L +L+ L + N+L +P
Sbjct: 62 LDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL 117
Query: 337 SI-GNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSV-GNLTGLV 393
L L+ L L N L ++P + L +L L NNL+ +P + L L
Sbjct: 118 GALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175
Query: 394 LLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424
L + EN L+ IPK L + N
Sbjct: 176 TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 9/174 (5%)
Query: 472 NNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFG 531
++P ++ L LS N + L L +L L +L+ + + G
Sbjct: 19 KRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DG 74
Query: 532 SLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLS 590
+L L LDLS N+L S +P L L L++S N+ + ++P+ L L +L L
Sbjct: 75 TLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLK 132
Query: 591 HNILQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
N L+ +PP + LEKL+L++NNL+ + +L + + N L
Sbjct: 133 GNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 54/205 (26%), Positives = 74/205 (36%), Gaps = 32/205 (15%)
Query: 80 ISINLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGN 135
+ + + L L+ TF + + L LNL G L L LDL +
Sbjct: 29 LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSH 86
Query: 136 NQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLG 195
NQL + L L L + N+L ++P +L
Sbjct: 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLP-----------------------LGALR 121
Query: 196 NLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYK 255
L +L LYL N L P ++ L L L+ N L L L+ L NLDTL L +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 256 NSLSGSIPSIIGNLKSLHQLDLIEN 280
NSL +IP L L N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 58/232 (25%), Positives = 84/232 (36%), Gaps = 37/232 (15%)
Query: 340 NLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCE 399
++S ++ L ++P ++ K + L L +N L ++ T L LN+
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 400 NHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWR 459
L T L + G P L LDLS N + +
Sbjct: 65 AEL-----------TKL---------------QVDGTLPVLGTLDLSHNQLQ-SLPLLGQ 97
Query: 460 NLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSSNHIVGKIPVQL-EKLFSLNKLIL 517
LP L VS N + S+PL +LQ L L N + +P L L KL L
Sbjct: 98 TLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155
Query: 518 SLNQLSGSVPLE-FGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNN 568
+ N L+ +P L L L L N L +IPK L + L N
Sbjct: 156 ANNNLT-ELPAGLLNGLENLDTLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 37/163 (22%), Positives = 61/163 (37%), Gaps = 14/163 (8%)
Query: 485 SSKLQFLDLSSNHIV---GKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDL 541
+ ++ ++ +P L LS N L T L L+L
Sbjct: 9 VASHLEVNCDKRNLTALPPDLPKDTTILH------LSENLLYTFSLATLMPYTRLTQLNL 62
Query: 542 SANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQ 601
+L + + G L L L+LS+NQ ++P+ + L L+ LD+S N L +P
Sbjct: 63 DRAEL-TKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG 118
Query: 602 V-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+ L++L L N L P L + + N L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 62/250 (24%), Positives = 93/250 (37%), Gaps = 50/250 (20%)
Query: 106 NLNLSFNLFFGNIPP-QIGNLSKLQNLDLGNNQLSGVISPEI-GKLNQLRRLYLDMNQLH 163
NL+LSFN ++ + +LQ LDL ++ I L+ L L L N +
Sbjct: 32 NLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 164 GTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKS 223
++ FS LS L L +L +G+LK+
Sbjct: 90 -SLALGA--------FS---------------GLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 224 LSTLDLSQNQLNGLI-PCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282
L L+++ N + P NL+NL+ L L N + SI +L+ LHQ+ L+ L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLNLSL 182
Query: 283 SGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLS 342
L N ++ I P L L L NQL V L+
Sbjct: 183 -----------------DLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLT 224
Query: 343 SLRNLSLFNN 352
SL+ + L N
Sbjct: 225 SLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 12/206 (5%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262
L L+ N L + L LDLS+ ++ + +LS+L TL L N + S+
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SL 91
Query: 263 PS-IIGNLKSLHQLDLIENQLSGSIP-LSFGNLSSWTLMSLFSNSLSGSIPP--ILGNLK 318
L SL +L +E L+ S+ G+L + +++ N + S NL
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149
Query: 319 SLSTLGLYLNQLNGVIPPSIGNLSSLR----NLSLFNNGLYGSIPEEIGYLKSLSELKLC 374
+L L L N++ + + L + +L L N + I L EL L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALD 208
Query: 375 KNNLSGVIPHSVGNLTGLVLLNMCEN 400
N L V LT L + + N
Sbjct: 209 TNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 438 PNLTFLDLSQNNFDGKISFN-WRNLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSS 495
+ LDLS N + + + P+L +S I +I S S L L L+
Sbjct: 28 FSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTG 85
Query: 496 NHIVGKIPVQL-EKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS-SIPKS 553
N I + + L SL KL+ L+ G L L+ L+++ N + S +P+
Sbjct: 86 NPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 554 IGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHL----SKLDLSHNILQEEIPPQVCNMESL 608
NL L +L+LS+N+ +I L + LDLS N + I P L
Sbjct: 145 FSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL 202
Query: 609 EKLNLSHNNLSGFIPRCFEKMRSLSCIDICYN 640
++L L N L F+++ SL I + N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 51/243 (20%), Positives = 87/243 (35%), Gaps = 36/243 (14%)
Query: 357 SIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSL 416
IP+ + S L L N L + +S + L +L++ + + +SL+ L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 417 KRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFG 476
+ N + AF +L L + N +L N G
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNL--------ASLE---------NFPIG 121
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQ--LEKLFSLNKLILSLNQLSGSVPLE-FGSL 533
+ L+ L+++ N I + L +L L LS N++ S+ L
Sbjct: 122 HLK-------TLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172
Query: 534 TELQY----LDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDL 589
++ LDLS N ++ I ++L L L NQ F++L L K+ L
Sbjct: 173 HQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWL 231
Query: 590 SHN 592
N
Sbjct: 232 HTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 37/173 (21%), Positives = 66/173 (38%), Gaps = 9/173 (5%)
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE-FGSLTE 535
IP + + LDLS N + L L LS ++ ++ + SL+
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 536 LQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQ 595
L L L+ N + S + L L L + L L +L+++HN++Q
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 596 EEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSLSCI----DICYNELQ 643
P+ N+ +LE L+LS N + + + + D+ N +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 47/190 (24%), Positives = 72/190 (37%), Gaps = 34/190 (17%)
Query: 98 FSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
+ S HL L L+ N ++ LS LQ L L+ + + IG L L+ L
Sbjct: 72 YQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT 216
+ N + + +P NL+ L L L++N + I
Sbjct: 131 VAHNLIQ-SFK----------------------LPEYFSNLTNLEHLDLSSNKI-QSIYC 166
Query: 217 -VMGNLKSL----STLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLK 270
+ L + +LDLS N +N + P + L L L N L S+P I L
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLK-SVPDGIFDRLT 224
Query: 271 SLHQLDLIEN 280
SL ++ L N
Sbjct: 225 SLQKIWLHTN 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 70/299 (23%), Positives = 119/299 (39%), Gaps = 54/299 (18%)
Query: 744 EEIIKATDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEF 798
E + F E++ I GKG G V K + + AVK N D
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTI 68
Query: 799 LNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGND----ATAKELSW 853
L V L ++ H NI+K ++ ++V E G L I+ A
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--- 125
Query: 854 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFGIAKFVEPY 910
+IK V + ++Y+H +I+HRD+ +N+LL + + + + DFG++ +
Sbjct: 126 -----IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176
Query: 911 SSNRTEFVGTFGYAAPEI---AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 967
++ + +GT Y APE+ Y EK DV+S GV+++ ++ G P F
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP-------FYGK 225
Query: 968 SNMIIEVNQILDPRLSTPS---PGVMDK---LISIMEVAILCLDESPEARPTMEKGFGH 1020
+ I + ++ + + + D LI M L P R T + H
Sbjct: 226 NEYDI-LKRVETGKYAFDLPQWRTISDDAKDLIRKM----LTFH--PSLRITATQCLEH 277
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 67/312 (21%), Positives = 116/312 (37%), Gaps = 64/312 (20%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
IG+G G V A E + I A+K N +++ N D + V + ++ H NI +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 817 HGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRRI------------------ 857
+ + ++ LV E H G L ++ + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 858 ------------------NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV- 898
N+++ + +AL YLH+ I HRDI +N L +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 899 -SDFGIAKFVEPYSSNR----TEFVGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFE 949
DFG++K ++ T GT + APE+ T E Y D +S GVL+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN--ESYGPKCDAWSAGVLLHL 268
Query: 950 VIKGNHPRDFFSINFSSFSNMIIEVN-QILDPRLSTPSPGVMDKLISIMEVAILCLDESP 1008
++ G P F +N + + ++ +P + SP D L+S + L +
Sbjct: 269 LLMGAVP--FPGVNDADTISQVLNKKLCFENPNYNVLSPLARD-LLSNL----LNRN--V 319
Query: 1009 EARPTMEKGFGH 1020
+ R + H
Sbjct: 320 DERFDAMRALQH 331
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 59/274 (21%), Positives = 105/274 (38%), Gaps = 30/274 (10%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
IGKG V + +G AVK + ++ S ++ + ++H +IV+
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 817 HGFCSNARHSFLVCEYLHRGSLA-RILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
S+ ++V E++ L I+ S + ++ + AL Y H +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-- 149
Query: 876 PSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM 932
+IIHRD+ VLL + + + FG+A + VGT + APE+
Sbjct: 150 -NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE 208
Query: 933 RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP---GV 989
+ DV+ GV++F ++ G P F + E I+ + +
Sbjct: 209 PYGKPVDVWGCGVILFILLSGCLP-------FYGTKERLFE--GIIKGKYKMNPRQWSHI 259
Query: 990 MDK---LISIMEVAILCLDESPEARPTMEKGFGH 1020
+ L+ M L LD P R T+ + H
Sbjct: 260 SESAKDLVRRM----LMLD--PAERITVYEALNH 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 54/293 (18%)
Query: 750 TDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA 804
F E++ I GKG G V K + + AVK N D L V
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVEL 74
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILG----NDATAKELSWNRRINV 859
L ++ H NI+K ++ ++V E G L I+ ++ A +
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------- 126
Query: 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNRTE 916
IK V + ++Y+H +I+HRD+ +N+LL+ + + + DFG++ + ++ +
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKD 182
Query: 917 FVGTFGYAAPEI---AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973
+GT Y APE+ Y EK DV+S GV+++ ++ G P F + I
Sbjct: 183 RIGTAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP-------FYGKNEYDI- 230
Query: 974 VNQILDPRLSTPSP---GVMDK---LISIMEVAILCLDESPEARPTMEKGFGH 1020
+ ++ + + P + D LI M L P R T + H
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKM----LTFH--PSLRITATQCLEH 277
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 54/294 (18%)
Query: 748 KATDDFDEKFCIGK----GGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVV 802
D + F + G VY+ + + A+K D+ +
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEI 99
Query: 803 LALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILG------NDATAKELSWNR 855
L + H NI+K LV E + G L RI+ DA
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-------- 151
Query: 856 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL-DLEFEAHV--SDFGIAKFVEPYSS 912
+ +K + A++YLH + I+HRD+ +N+L +A + +DFG++K VE
Sbjct: 152 --DAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QV 205
Query: 913 NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 972
GT GY APEI + D++S G++ + ++ G P F
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP-------FYDERGDQF 258
Query: 973 EVNQILDPRLSTPSP---GVMDK---LISIMEVAILCLDESPEARPTMEKGFGH 1020
+IL+ SP V L+ + + LD P+ R T + H
Sbjct: 259 MFRRILNCEYYFISPWWDEVSLNAKDLVRKL----IVLD--PKKRLTTFQALQH 306
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 67/294 (22%), Positives = 110/294 (37%), Gaps = 37/294 (12%)
Query: 746 IIKATDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVK---------KFNSQLLSGN 791
+ K E + G G G V E A+K S
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 792 MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKE 850
+E N + L + H NI+K + ++ +LV E+ G L +I+ +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRHK 142
Query: 851 LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFGIAKFV 907
N++K + + + YLH +I+HRDI +N+LL + + DFG++ F
Sbjct: 143 FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 967
+ +GT Y APE+ + EK DV+S GV+++ ++ G P F N
Sbjct: 200 SK-DYKLRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPP--FGGQNDQDI 255
Query: 968 SNMIIEVNQILD-PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ + D S + LI +M L D R T E+
Sbjct: 256 IKKVEKGKYYFDFNDWKNISDEAKE-LIKLM----LTYD--YNKRCTAEEALNS 302
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 77/284 (27%), Positives = 123/284 (43%), Gaps = 48/284 (16%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNV---VLALNEIRHRNI 813
+G G G V A E + VA++ + + G+ + D LNV + L ++ H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSL-ARILGND----ATAKELSWNRRINVIKGVANALS 868
+K F +A ++V E + G L +++GN AT K + A+
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--------FYQMLLAVQ 253
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
YLH + IIHRD+ +NVLL + E ++DFG +K + S RT GT Y A
Sbjct: 254 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLA 309
Query: 926 PEIAYTMRA---TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
PE+ ++ D +S GV++F + G P FS + +QI +
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-------FSEHRTQVSLKDQITSGKY 362
Query: 983 STPSP---GVMDK---LISIMEVAILCLDESPEARPTMEKGFGH 1020
+ V +K L+ + L +D P+AR T E+ H
Sbjct: 363 NFIPEVWAEVSEKALDLVKKL----LVVD--PKARFTTEEALRH 400
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 744 EEIIKATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEF 798
E ++ A+ F + + +GKG V + +G A K N++ LS D +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKL 75
Query: 799 LNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLA-RILGNDATAKE-LSWNRR 856
+++H NIV+ H +LV + + G L I A+E S
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-----VAREFYSEADA 130
Query: 857 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSN 913
+ I+ + +++Y H + I+HR++ +N+LL + + ++DFG+A V S
Sbjct: 131 SHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEA 186
Query: 914 RTEFVGTFGYAAPEI----AYTMRATEKYDVYSFGVLVF 948
F GT GY +PE+ Y ++ D+++ GV+++
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILY 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 63/278 (22%), Positives = 118/278 (42%), Gaps = 47/278 (16%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G G VY+ VA+K N + +M ++ EFLN + E +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE---AASMRERIEFLNEASVMKEFNCHH 89
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL-------GNDATAKELSWNRRINVIKGVAN 865
+V+ G S + + ++ E + RG L L N+ S ++ I + +A+
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 866 ALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGY 923
++YL + +HRD++++N ++ +F + DFG+ + + Y ++ G G
Sbjct: 150 GMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYR-KGGKGL 201
Query: 924 -----AAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQI 977
+PE T DV+SFGV+++E+ P + SN +V +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNE--QVLRF 252
Query: 978 LDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+ L P D L +M +C +P+ RP+
Sbjct: 253 VMEGGLLDKP-DNCPDMLFELMR---MCWQYNPKMRPS 286
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 49/225 (21%), Positives = 91/225 (40%), Gaps = 23/225 (10%)
Query: 734 VLNFDGKIMHEEIIKATDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLL 788
+ K + + + + + I G G G V++ E +G + K N+
Sbjct: 30 YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-- 87
Query: 789 SGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDAT 847
D+ N + +N++ H ++ H + L+ E+L G L RI
Sbjct: 88 --YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-----A 140
Query: 848 AKELSWNRR--INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGI 903
A++ + IN ++ L ++H SI+H DI +N++ + + + V DFG+
Sbjct: 141 AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 948
A + P T +AAPEI D+++ GVL +
Sbjct: 198 ATKLNP-DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 241
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 45/244 (18%), Positives = 104/244 (42%), Gaps = 21/244 (8%)
Query: 713 QRKKDSQEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCI----GKGGQGSVY 768
++ K + + T+S N + + + + + D + + I G G G V+
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVF--DIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 769 KA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827
+ E +G+ A K + + +D++ + ++ +RH +V H +
Sbjct: 175 RVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 828 LVCEYLHRGSL-ARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 886
++ E++ G L ++ ++S + + ++ V L ++H + + +H D+ +
Sbjct: 231 MIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPE 284
Query: 887 NVLLDLEFEAHV--SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFG 944
N++ + + DFG+ ++P + GT +AAPE+A D++S G
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG 343
Query: 945 VLVF 948
VL +
Sbjct: 344 VLSY 347
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 750 TDDFDEKFC----IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA 804
F E++ +GKG V + ++ +G A N++ LS D +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR--DHQKLEREARI 63
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLA-RILG------NDATAKELSWNRRI 857
++H NIV+ H S H +L+ + + G L I+ DA+
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------- 113
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNR 914
+ I+ + A+ + H ++HR++ +N+LL + + ++DFG+A VE
Sbjct: 114 HCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 915 TEFVGTFGYAAPEI----AYTMRATEKYDVYSFGVLVF 948
F GT GY +PE+ Y + D+++ GV+++
Sbjct: 171 FGFAGTPGYLSPEVLRKDPY----GKPVDLWACGVILY 204
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 49/226 (21%), Positives = 88/226 (38%), Gaps = 40/226 (17%)
Query: 748 KATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVV 802
+T F E + +G+G V + P+ AVK + A++ + L
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 803 LALNEIR-------HRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGN------DATA 848
L E+ H NI++ FLV + + +G L + +
Sbjct: 70 T-LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR- 127
Query: 849 KELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908
+++ + + LH +I+HRD+ +N+LLD + ++DFG + ++
Sbjct: 128 ---------KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 909 PYSSNRTEFVGTFGYAAPEI--AYTMRATEKY----DVYSFGVLVF 948
P E GT Y APEI Y D++S GV+++
Sbjct: 176 P-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 39/218 (17%)
Query: 750 TDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA 804
+ F + + + GKG V + +G A K N++ LS D +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARI 58
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLA-RILGN------DATAKELSWNRRI 857
+++H NIV+ H +LV + + G L I+ DA+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---------- 108
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE-AHV--SDFGIAKFVEPYSSNR 914
+ I+ + +++Y H + I+HR++ +N+LL + + A V +DFG+A V S
Sbjct: 109 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAW 164
Query: 915 TEFVGTFGYAAPEI----AYTMRATEKYDVYSFGVLVF 948
F GT GY +PE+ Y ++ D+++ GV+++
Sbjct: 165 HGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILY 198
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 41/226 (18%)
Query: 748 KATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVV 802
A +F +K+ IG+G V + +G AVK + +E
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 803 LALNEIR-------HRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGN------DATA 848
E H +I+ ++ FLV + + +G L + +
Sbjct: 147 R--RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR- 203
Query: 849 KELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908
++++ + A+S+LH + +I+HRD+ +N+LLD + +SDFG + +E
Sbjct: 204 ---------SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 909 PYSSNRTEFVGTFGYAAPEI--AYTMRATEKY----DVYSFGVLVF 948
P E GT GY APEI Y D+++ GV++F
Sbjct: 252 P-GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 66/299 (22%), Positives = 112/299 (37%), Gaps = 47/299 (15%)
Query: 739 GKIMHEEIIKATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDE 797
+ +H I+ TD ++ K IG G + + AVK + +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEE 65
Query: 798 FLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDA-TAKELSWNR 855
+ + L +H NI+ + ++ ++V E + G L +IL + +E S
Sbjct: 66 ---IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS--- 119
Query: 856 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH----VSDFGIAKFVEPYS 911
V+ + + YLH ++HRD+ N+L E + DFG AK + +
Sbjct: 120 --AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 912 SNRTEFVGTFGYAAPEI----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 967
T + APE+ Y D++S GVL++ ++ G P F+
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAAC----DIWSLGVLLYTMLTGYTP---FANGPDDT 227
Query: 968 SNMIIEVNQILDPRLSTPSP---GVMDK---LISIMEVAILCLDESPEARPTMEKGFGH 1020
I+ +I + S V D L+S M L +D P R T H
Sbjct: 228 PEEILA--RIGSGKFSLSGGYWNSVSDTAKDLVSKM----LHVD--PHQRLTAALVLRH 278
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 63/204 (30%), Positives = 90/204 (44%), Gaps = 30/204 (14%)
Query: 128 LQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVS 187
+ LDL +N+LS + S +L +LR LYL+ N+L T+P I F
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI--------FK------- 82
Query: 188 GRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSN 247
L L L++ +N L V L +L+ L L +NQL L P D+L+
Sbjct: 83 --------ELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK 134
Query: 248 LDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSGSIPLS-FGNLSSWTLMSLFSNS 305
L L L N L S+P + L SL +L L NQL +P F L+ + L +N
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQ 192
Query: 306 LSGSIPP-ILGNLKSLSTLGLYLN 328
L +P +L+ L L L N
Sbjct: 193 LK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 61/192 (31%), Positives = 92/192 (47%), Gaps = 16/192 (8%)
Query: 214 IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSL 272
IP LDL N+L+ L L+ L L+L N L ++P+ I LK+L
Sbjct: 35 IPA------DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 273 HQLDLIENQLSGSIPLS-FGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQL 330
L + +N+L ++P+ F L + + L N L S+PP + +L L+ L L N+L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 331 NGVIPPSI-GNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGN 388
+P + L+SL+ L L+NN L +PE L L LKL N L V + +
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDS 203
Query: 389 LTGLVLLNMCEN 400
L L +L + EN
Sbjct: 204 LEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 49/175 (28%), Positives = 87/175 (49%), Gaps = 11/175 (6%)
Query: 472 NNIFGSIPLEIGDS-SKLQFLDLSSNHIVGKIPVQL-EKLFSLNKLILSLNQLSGSVPLE 529
+N S+P + +KL+ L L+ N + +P + ++L +L L ++ N+L ++P+
Sbjct: 46 SNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIG 103
Query: 530 -FGSLTELQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSK 586
F L L L L N+L S +P + +L KL YL+L N+ ++P F+KL L +
Sbjct: 104 VFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161
Query: 587 LDLSHNILQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYN 640
L L +N L+ +P + L+ L L +N L F+ + L + + N
Sbjct: 162 LRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE-FGSLTE 535
+IP I + + LDL SN + +L L L L+ N+L ++P F L
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 536 LQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHNI 593
L+ L ++ NKL + +P + L+ L L L NQ ++P F+ L L+ L L +N
Sbjct: 87 LETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 594 LQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
LQ +P V + SL++L L +N L F+K+ L + + N+L+
Sbjct: 145 LQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 8/183 (4%)
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLS-FGNLSSWTLMSLFSN 304
++ L L N LS L L L L +N+L ++P F L + + + N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 305 SLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSI-GNLSSLRNLSLFNNGLYGSIPEEI 362
L ++P + L +L+ L L NQL +PP + +L+ L LSL N L S+P+ +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNEL-QSLPKGV 152
Query: 363 -GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRF 421
L SL EL+L N L V + LT L L + N L + SL LK ++
Sbjct: 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 422 NQN 424
+N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 45/125 (36%), Positives = 68/125 (54%), Gaps = 7/125 (5%)
Query: 534 TELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHN 592
+ + LDL +NKLSS K+ L KL L L++N+ T+P F++L +L L ++ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 593 ILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTV 651
LQ +P V + +L +L L N L PR F+ + L+ + + YNELQ +P V
Sbjct: 96 KLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKG-V 152
Query: 652 FKDGL 656
F D L
Sbjct: 153 F-DKL 156
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 69/270 (25%), Positives = 94/270 (34%), Gaps = 83/270 (30%)
Query: 303 SNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEE 361
S L+ +IP I + K L L N+L+ + + L+ LR L L +N L ++P
Sbjct: 25 SKKLT-AIPSNIPADTKKLD---LQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAG 79
Query: 362 I-GYLKSLSELKLCKNNLSGVIPHSV-GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV 419
I LK+L L + N L +P V L L L + N L SL
Sbjct: 80 IFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL-----------KSLPP- 126
Query: 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479
F LT+L L N ++LP +F
Sbjct: 127 ------------RVFDSLTKLTYLSLGYNEL--------QSLP---------KGVF---- 153
Query: 480 LEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE-FGSLTELQY 538
+KL SL +L L NQL VP F LTEL+
Sbjct: 154 ---------------------------DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKT 185
Query: 539 LDLSANKLSSSIPKSIGNLLKLYYLNLSNN 568
L L N+L + +L KL L L N
Sbjct: 186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 61/276 (22%), Positives = 103/276 (37%), Gaps = 52/276 (18%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADQD-----EFLNVVLALNEIRHR 811
+GKGG G+V+ L VA+K +++L + E + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGS--LARILGNDATAKELSWNRRINVIKGVANALSY 869
+++ + LV E I + S R V A+ +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS--RCF--FGQVVAAIQH 154
Query: 870 LHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI 928
H ++HRDI +N+L+DL A + DFG + T+F GT Y+ PE
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPE- 208
Query: 929 AYTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983
+ +Y V+S G+L+++++ G+ P + +IL+ L
Sbjct: 209 ---WISRHQYHALPATVWSLGILLYDMVCGDIPFE--------------RDQEILEAELH 251
Query: 984 TP---SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
P SP LI L P +RP++E+
Sbjct: 252 FPAHVSPDCCA-LIRRC------LAPKPSSRPSLEE 280
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 56/283 (19%)
Query: 759 IGKGGQGSVYKAELPSGD---IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIV 814
IG+G G V KA + A+K+ + D +F + L ++ H NI+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 815 KFHGFCSNARHSFLVCEYLHRGSL-------------ARILGNDATAKELSWNRRINVIK 861
G C + + +L EY G+L ++TA LS + ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 862 GVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVG 919
VA + YL IHRD++++N+L+ + A ++DFG+++ E Y
Sbjct: 150 DVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK------K 198
Query: 920 TFG-----YAAPE-IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMII 972
T G + A E + Y+ T DV+S+GVL++E++ G P + +
Sbjct: 199 TMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP-------YCGMTCA-- 248
Query: 973 EVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
E+ + L RL P D++ +M C E P RP+
Sbjct: 249 ELYEKLPQGYRLEKP-LNCDDEVYDLM---RQCWREKPYERPS 287
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 62/292 (21%), Positives = 107/292 (36%), Gaps = 50/292 (17%)
Query: 748 KATDDFDEKFCIGK----GGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVV 802
D ++ + + G G V A + + A KK + D D F +
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVDRFKQEI 57
Query: 803 LALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILG------NDATAKELSWNR 855
+ + H NI++ + + +LV E G L R++ +DA
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------- 109
Query: 856 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSS 912
++K V +A++Y H ++ HRD+ +N L + + DFG+A +P
Sbjct: 110 --RIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GK 163
Query: 913 NRTEFVGTFGYAAPEI---AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 969
VGT Y +P++ Y + D +S GV+++ ++ G P F + S
Sbjct: 164 MMRTKVGTPYYVSPQVLEGLY----GPECDEWSAGVMMYVLLCGYPP--FSAPTDSEVML 217
Query: 970 MIIEVNQILD-PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
I E SP LI + L P+ R T + H
Sbjct: 218 KIREGTFTFPEKDWLNVSPQAES-LIRRL----LTKS--PKQRITSLQALEH 262
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 74/284 (26%), Positives = 116/284 (40%), Gaps = 48/284 (16%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG----NMADQDEFLNVVLALNEIRHRNI 813
+G G G V A E + VA+K + + + + L ++ H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSL-ARILGND----ATAKELSWNRRINVIKGVANALS 868
+K F +A ++V E + G L +++GN AT K + A+
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--------FYQMLLAVQ 128
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
YLH + IIHRD+ +NVLL + E ++DFG +K + S RT GT Y A
Sbjct: 129 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLA 184
Query: 926 PEI---AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
PE+ T D +S GV++F + G P FS + +QI +
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-------FSEHRTQVSLKDQITSGKY 237
Query: 983 STPSP---GVMDK---LISIMEVAILCLDESPEARPTMEKGFGH 1020
+ V +K L+ + L +D P+AR T E+ H
Sbjct: 238 NFIPEVWAEVSEKALDLVKKL----LVVD--PKARFTTEEALRH 275
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-21
Identities = 26/167 (15%), Positives = 66/167 (39%), Gaps = 7/167 (4%)
Query: 94 QDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLR 153
+ + + L + L+ ++ I +++L + N + +P I L+ L
Sbjct: 36 ANITEAQMNSLTYITLANI-NVTDLTG-IEYAHNIKDLTINNIHATN-YNP-ISGLSNLE 91
Query: 154 RLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGY 213
RL + + P + L+ + H+ I + + L K+ + L+ N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 214 IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
I + L L +L++ + ++ +++ L+ L+ + ++ G
Sbjct: 152 IMPL-KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 27/183 (14%), Positives = 74/183 (40%), Gaps = 7/183 (3%)
Query: 462 PKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQ 521
++ + + + + L ++ L++ ++ +E ++ L ++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77
Query: 522 LSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKL 581
+ P+ L+ L+ L + ++S ++ L L L++S++ +I + L
Sbjct: 78 ATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 582 IHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNE 641
++ +DLS+N +I P + + L+ LN+ + + + E L+ +
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
Query: 642 LQG 644
+ G
Sbjct: 193 IGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 29/185 (15%), Positives = 66/185 (35%), Gaps = 10/185 (5%)
Query: 124 NLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183
N LG + + + ++N L + L + I I + + +
Sbjct: 21 TFKAYLNGLLGQSSTANI---TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLD 243
+ + + + LS L L + + + L SL+ LD+S + + I ++
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 244 NLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFS 303
L ++++ L N I + L L L++ + + + + + FS
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFS 190
Query: 304 NSLSG 308
++ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-18
Identities = 36/183 (19%), Positives = 69/183 (37%), Gaps = 10/183 (5%)
Query: 316 NLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCK 375
K+ L L Q + + ++SL ++L N + + I Y ++ +L +
Sbjct: 21 TFKAY--LNGLLGQ-SSTANITEAQMNSLTYITLANINV-TDL-TGIEYAHNIKDLTINN 75
Query: 376 NNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFG 435
+ + P + L+ L L + + +L LTSL + + + +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 436 DHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSS 495
P + +DLS N I + LP+L + + + + +E D KL L S
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPL-KTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFS 190
Query: 496 NHI 498
I
Sbjct: 191 QTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 31/201 (15%), Positives = 69/201 (34%), Gaps = 12/201 (5%)
Query: 226 TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGS 285
L +Q N IP L ++S + + SL + L ++
Sbjct: 5 QTGLKASQDNVNIP--DSTFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL 59
Query: 286 IPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLR 345
+ + +++ + + P + L +L L + + P++ L+SL
Sbjct: 60 TGIE--YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115
Query: 346 NLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGP 405
L + ++ SI +I L ++ + L N I + L L LN+ + +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY 174
Query: 406 IPKSLKSLTSLKRVRFNQNNL 426
++ L ++ +
Sbjct: 175 RG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 25/157 (15%), Positives = 52/157 (33%), Gaps = 29/157 (18%)
Query: 83 NLSTLCLNGT-FQDFS-FSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG 140
N+ L +N +++ S +L L + + P + L+ L LD+ ++
Sbjct: 67 NIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 141 VISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKL 200
I +I L ++ + L N ++ I L L +L
Sbjct: 127 SILTKINTLPKVNSIDLSYNG----------AITDI---------------MPLKTLPEL 161
Query: 201 ALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL 237
L + + + Y + + L+ L + G
Sbjct: 162 KSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 17/118 (14%), Positives = 43/118 (36%), Gaps = 7/118 (5%)
Query: 532 SLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSH 591
+ L + + + + L Y+ L+N + IE ++ L +++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINN 75
Query: 592 NILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNS 649
P + + +LE+L + +++ + SL+ +DI ++ I
Sbjct: 76 IHA-TNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 46/203 (22%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 752 DFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+ +G G G V+K E +G +A K ++ M D++E N + +N++ H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEVKNEISVMNQLDH 145
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRR--INVIKGVANAL 867
N+++ + + LV EY+ G L RI + + I +K + +
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRI-----IDESYNLTELDTILFMKQICEGI 200
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTEFVGTFGYAA 925
++H I+H D+ +N+L + DFG+A+ +P GT + A
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVNFGTPEFLA 256
Query: 926 PEIAYTMRATEKYDVYSFGVLVF 948
PE+ + D++S GV+ +
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAY 279
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 22/210 (10%)
Query: 750 TDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG--NMADQDEFLNVV 802
++ D+ + G G V K E +G A K + +++ V
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 803 LALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKE-LSWNRRINVI 860
L EI+H N++ H N L+ E + G L + KE L+ +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFL 120
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLL-DLEFEAH---VSDFGIAKFVEPYSSNRTE 916
K + N + YLH I H D+ +N++L D + DFG+A ++ +
Sbjct: 121 KQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKN 176
Query: 917 FVGTFGYAAPEIAYTMRATEKYDVYSFGVL 946
GT + APEI + D++S GV+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 22/212 (10%)
Query: 750 TDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG--NMADQDEFLNVV 802
++ + I G G V K E +G A K + ++E V
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 803 LALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKE-LSWNRRINVI 860
L ++ H N++ H N L+ E + G L + KE LS + I
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFI 121
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLL-DLEFEAH---VSDFGIAKFVEPYSSNRTE 916
K + + ++YLH I H D+ +N++L D + DFG+A +E
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKN 177
Query: 917 FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 948
GT + APEI + D++S GV+ +
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 70/315 (22%), Positives = 125/315 (39%), Gaps = 64/315 (20%)
Query: 759 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-R 809
+G+G G V AE D VAVK D + ++ + + I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 99
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-------------GNDATAKELSWNRR 856
H+NI+ G C+ +++ EY +G+L L N +++++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 857 INVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914
++ +A + YL IHRD++++NVL+ ++DFG+A+ + +
Sbjct: 160 VSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 915 TEFVGTFG-----YAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFS 968
T G + APE + T + DV+SFGVL++E+ G P +
Sbjct: 215 ---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-------YPGIP 264
Query: 969 NMIIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026
E+ ++L R+ P ++L +M C P RPT +
Sbjct: 265 VE--ELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFK--------QLV 310
Query: 1027 EILAVILAIEASADY 1041
E L IL + + +Y
Sbjct: 311 EDLDRILTLTTNEEY 325
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 22/212 (10%)
Query: 750 TDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG--NMADQDEFLNVV 802
++ + I G G V K E +G A K + ++E V
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 803 LALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKE-LSWNRRINVI 860
L ++ H NI+ H N L+ E + G L + KE LS + I
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFI 121
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLL-DLEFEAH---VSDFGIAKFVEPYSSNRTE 916
K + + ++YLH I H D+ +N++L D + DFG+A +E
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKN 177
Query: 917 FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 948
GT + APEI + D++S GV+ +
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 46/200 (23%), Positives = 78/200 (39%), Gaps = 28/200 (14%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G G V++ E S K + DQ + LN RHRNI+ H
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAK-----FVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 818 GFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRR--INVIKGVANALSYLHHDC 874
+ ++ E++ + RI N R ++ + V AL +LH
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERIN-----TSAFELNEREIVSYVHQVCEALQFLHSH- 121
Query: 875 LPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTEFVGTFGYAAPEI---- 928
+I H DI +N++ + + +FG A+ ++P N Y APE+
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHD 178
Query: 929 AYTMRATEKYDVYSFGVLVF 948
+ D++S G LV+
Sbjct: 179 VVSTAT----DMWSLGTLVY 194
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 61/291 (20%), Positives = 118/291 (40%), Gaps = 63/291 (21%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+ G VYK L VA+K ++EF + + ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD---KAEGPLREEFRHEAMLRARLQHPN 73
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARIL-------------GNDATAKELSWNRRINV 859
+V G + + ++ Y G L L + L +++
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 860 IKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RT 915
+ +A + YL HH ++H+D++++NVL+ + +SD G+ + V Y+++ +
Sbjct: 134 VAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYKL 186
Query: 916 EFVGTFGYA-------APE-IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSS 966
G + APE I Y + + D++S+GV+++EV G P +
Sbjct: 187 L-----GNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQP-------YCG 233
Query: 967 FSNMIIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+SN +V +++ L P + ++M I C +E P RP +
Sbjct: 234 YSNQ--DVVEMIRNRQVLPCP-DDCPAWVYALM---IECWNEFPSRRPRFK 278
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-20
Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 14/169 (8%)
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQ--LEKLFSLNKLILSLNQLSGSVPLE-FGSL 533
++P + S LDLS N++ ++ + +L +L+ L+LS N L+ + E F +
Sbjct: 32 NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 534 TELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHN 592
L+YLDLS+N L + +L L L L NN + FE + L KL LS N
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQN 146
Query: 593 ILQEEIPPQV----CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDI 637
+ P ++ + L L+LS N L +K+ + +
Sbjct: 147 QISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 41/191 (21%), Positives = 66/191 (34%), Gaps = 38/191 (19%)
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEI--GKLNQLRRLYLDMNQLHGTIPPVIGQLS 174
++P LDL +N LS + E +L L L L N L+ I
Sbjct: 36 SLPSYT------ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISS------ 81
Query: 175 LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQL 234
+ + L L L++N L + +L++L L L N +
Sbjct: 82 -----------------EAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI 124
Query: 235 NGLIPCTLDNLSNLDTLFLYKNSLSGSIP----SIIGNLKSLHQLDLIENQLSGSIPLSF 290
+ ++++ L L+L +N +S P L L LDL N+L
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183
Query: 291 GNLSSWTLMSL 301
L +W L
Sbjct: 184 QKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 42/163 (25%), Positives = 66/163 (40%), Gaps = 14/163 (8%)
Query: 101 FPHLVNLNLSFNLFFGNIPPQI--GNLSKLQNLDLGNNQLSGVISPEI-GKLNQLRRLYL 157
+ L+LS N + + L+ L +L L +N L+ IS E + LR L L
Sbjct: 38 PSYTALLDLSHN-NLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDL 95
Query: 158 DMNQLHGTIPP-VIGQLSLIHEFSFCHNNVSGRIPS-SLGNLSKLALLYLNNNSLFGYIP 215
N LH T+ + L + +N++ + + ++++L LYL+ N + P
Sbjct: 96 SSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFP 152
Query: 216 ----TVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLY 254
L L LDLS N+L L L L LY
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 6e-16
Identities = 42/139 (30%), Positives = 61/139 (43%), Gaps = 10/139 (7%)
Query: 486 SKLQFLDLSSNHIVGKIPVQ-LEKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSA 543
+ L L LS NH+ I + + +L L LS N L ++ F L L+ L L
Sbjct: 64 TNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYN 121
Query: 544 NKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE----FEKLIHLSKLDLSHNILQEEIP 599
N + + ++ +L L LS NQ S P+E KL L LDLS N L++
Sbjct: 122 NHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPL 180
Query: 600 PQVCNMESLEKLNLS-HNN 617
+ + + K L HNN
Sbjct: 181 TDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 44/149 (29%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 502 IPVQLEKLFSLNKLILSLNQLSGSVPLE--FGSLTELQYLDLSANKLSSSIPKSIGNLLK 559
+P L LS N LS + E LT L L LS N L+ ++ +
Sbjct: 37 LPSYTALLD------LSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89
Query: 560 LYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNN 617
L YL+LS+N HT+ F L L L L +N + + +M L+KL LS N
Sbjct: 90 LRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQ 147
Query: 618 LSGFIPRCF---EKMRSLSCIDICYNELQ 643
+S F K+ L +D+ N+L+
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 50/166 (30%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 438 PNLTFLDLSQNNFDGKISFNW--RNLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLS 494
LDLS NN ++ W L L + ++S N++ I E L++LDLS
Sbjct: 39 SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLS 96
Query: 495 SNHIVGKIPVQ-LEKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSANKLSSSIP- 551
SNH+ + L +L L+L N + V F + +LQ L LS N++ S P
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI-SRFPV 153
Query: 552 ---KSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSK--LDLSHN 592
K L KL L+LS+N+ + +KL K L L +N
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 38/173 (21%), Positives = 67/173 (38%), Gaps = 13/173 (7%)
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIP--LSFGNLSSWTLMSLFSNSLSGSIPP-ILGNL 317
++P + + LDL N LS + + L++ + L N L+ I +
Sbjct: 32 NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 318 KSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKN 376
+L L L N L+ + +L +L L L+NN + + + L +L L +N
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQN 146
Query: 377 NLSGVIP---HSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFN-QNN 425
+S L L+LL++ N L L+ L + + NN
Sbjct: 147 QISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 61/237 (25%), Positives = 89/237 (37%), Gaps = 38/237 (16%)
Query: 409 SLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFI 468
+ LT+L + + N+L EAF PNL +LDLS N+ L
Sbjct: 59 TPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL--------HTLD------ 104
Query: 469 VSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPL 528
+F + L+ L L +NHIV E + L KL LS NQ+S P+
Sbjct: 105 ---EFLFSDLQ-------ALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 529 E----FGSLTELQYLDLSANKLSSSIPKSIGNL--LKLYYLNLSNNQFS---HTIPIEFE 579
E L +L LDLS+NKL + L L L NN + F
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQL-FS 212
Query: 580 KLI--HLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSC 634
LS + L ++ N+ SL+ N S S + + + ++ C
Sbjct: 213 HWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKESAWEAHLGDTL-TIRC 268
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 53/197 (26%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG--NMADQDEFLNVVLALNEIRHRNIVK 815
+G G V K + +G A K + LS ++E V L EIRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 816 FHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKE-LSWNRRINVIKGVANALSYLHHD 873
H N L+ E + G L + KE L+ + +K + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 874 CLPSIIHRDISSKNVLL-DLEFEAH---VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
I H D+ +N++L D + DFGIA +E + GT + APEI
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIV 183
Query: 930 YTMRATEKYDVYSFGVL 946
+ D++S GV+
Sbjct: 184 NYEPLGLEADMWSIGVI 200
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 62/293 (21%), Positives = 115/293 (39%), Gaps = 63/293 (21%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
+G+G G V KA VAVK + + ++ + L+ L ++ H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE---NASPSELRDLLSEFNVLKQVNHPH 87
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSL------ARILGNDATAKELSWNRRINVIKG---- 862
++K +G CS L+ EY GSL +R +G S N
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 863 -----------VANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909
++ + YL ++HRD++++N+L+ + +SDFG+++ V
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDV-- 200
Query: 910 YSSNRTEFVGTFGYA------APEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSI 962
Y + +V A E + T + DV+SFGVL++E++ G +P
Sbjct: 201 YEED--SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP------ 252
Query: 963 NFSSFSNMIIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+ + +L R+ P +++ +M C + P+ RP
Sbjct: 253 -YPGIPPE--RLFNLLKTGHRMERP-DNCSEEMYRLML---QCWKQEPDKRPV 298
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 56/252 (22%), Positives = 94/252 (37%), Gaps = 22/252 (8%)
Query: 369 SELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVG 428
SE + + + N+ + + + L S+ ++ N +++
Sbjct: 5 SETITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-- 58
Query: 429 KVYEAFGDHPNLTFLDLSQNNFDGKIS--FNWRNLPKLDTFIVSMNNIFGSIPLEIGDSS 486
K + PN+T L L+ N K++ NL L + N + L+ D
Sbjct: 59 KSVQGIQYLPNVTKLFLNGN----KLTDIKPLANLKNLGWLFLDENKVKDLSSLK--DLK 112
Query: 487 KLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKL 546
KL+ L L N I I L L L L L N+++ L LT+L L L N++
Sbjct: 113 KLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQI 168
Query: 547 SSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNME 606
S +P + L KL L LS N S + L +L L+L + N+
Sbjct: 169 SDIVP--LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLV 224
Query: 607 SLEKLNLSHNNL 618
+ + +L
Sbjct: 225 VPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 16/206 (7%)
Query: 438 PNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNH 497
+L + + ++ N L +D I + ++I S+ I + L L+ N
Sbjct: 24 AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI-KSVQ-GIQYLPNVTKLFLNGNK 79
Query: 498 IVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNL 557
+ I L L +L L L N++ L+ L +L+ L L N +S + +L
Sbjct: 80 LT-DIKP-LANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGISDING--LVHL 133
Query: 558 LKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNN 617
+L L L NN+ + + +L L L L N + +I P + + L+ L LS N+
Sbjct: 134 PQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQI-SDIVP-LAGLTKLQNLYLSKNH 189
Query: 618 LSGFIPRCFEKMRSLSCIDICYNELQ 643
+S +++L +++ E
Sbjct: 190 ISDLRA--LAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 18/251 (7%)
Query: 83 NLSTLCL--NGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG 140
L + + + + + + ++ I L + L L N+L+
Sbjct: 25 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNS-DIKSVQG-IQYLPNVTKLFLNGNKLT- 81
Query: 141 VISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKL 200
I P + L L L+LD N++ + + L + S HN +S I + L +L +L
Sbjct: 82 DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQL 136
Query: 201 ALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
LYL NN + TV+ L L TL L NQ++ ++P L L+ L L+L KN +S
Sbjct: 137 ESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS- 191
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSL 320
+ + + LK+L L+L + NL + SL P I+ +
Sbjct: 192 DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDY 248
Query: 321 STLGLYLNQLN 331
+ +
Sbjct: 249 EKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 64/331 (19%), Positives = 117/331 (35%), Gaps = 67/331 (20%)
Query: 124 NLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183
++ +L ++ ++ +LN + ++ + + +
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--------------------- 58
Query: 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLD 243
+V G + L + L+LN N L P + NLK+L L L +N++ L L
Sbjct: 59 KSVQG-----IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LK 109
Query: 244 NLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFS 303
+L L +L L N +S I + +L L L L N+++
Sbjct: 110 DLKKLKSLSLEHNGIS-DINGL-VHLPQLESLYLGNNKIT-------------------- 147
Query: 304 NSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIG 363
I L L L TL L NQ++ + + L+ L+NL L N + S +
Sbjct: 148 -----DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI--SDLRALA 197
Query: 364 YLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQ 423
LK+L L+L + NL + + L P S V+++
Sbjct: 198 GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHL 257
Query: 424 NNLVGKVYEAFGDHPNLTFLDLSQNNFDGKI 454
+V F + ++ F G++
Sbjct: 258 PEFTNEVSFIFYQPVTIG---KAKARFHGRV 285
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 59/285 (20%), Positives = 95/285 (33%), Gaps = 40/285 (14%)
Query: 314 LGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKL 373
L + + L+S+ + N+ + S+ + I YL ++++L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSV-QGIQYLPNVTKLFL 75
Query: 374 CKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEA 433
N L+ + P + NL L L + EN + SLK L LK + N +
Sbjct: 76 NGNKLTDIKP--LANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGI--SDING 129
Query: 434 FGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDL 493
P L L L N KI+ + L +L +KL L L
Sbjct: 130 LVHLPQLESLYLGNN----KIT-DITVLSRL---------------------TKLDTLSL 163
Query: 494 SSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKS 553
N I I L L L L LS N +S L L L L+L + + +
Sbjct: 164 EDNQIS-DIV-PLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINH 219
Query: 554 IGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEI 598
NL+ + ++ I + + E+
Sbjct: 220 QSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 50/312 (16%), Positives = 95/312 (30%), Gaps = 42/312 (13%)
Query: 225 STLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSG 284
S + + D + L K S++ ++ L S+ Q+ + +
Sbjct: 5 SETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 59
Query: 285 SIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSL 344
S+ G + L +++ L L N+L + P + NL +L
Sbjct: 60 --------------------SVQG-----IQYLPNVTKLFLNGNKLTDIKP--LANLKNL 92
Query: 345 RNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFG 404
L L N + + LK L L L N +S + + +L L L + N +
Sbjct: 93 GWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITD 148
Query: 405 PIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKL 464
L LT L + N + L L LS+N+ + L L
Sbjct: 149 ITV--LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDLRALA--GLKNL 202
Query: 465 DTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSG 524
D + + + + +V + + + + L + +
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTN 262
Query: 525 SVPLEFGSLTEL 536
V F +
Sbjct: 263 EVSFIFYQPVTI 274
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 36/183 (19%), Positives = 78/183 (42%), Gaps = 14/183 (7%)
Query: 460 NLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSL 519
+ + ++ ++ + + + + +++ I + ++ L ++ KL L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 77
Query: 520 NQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFE 579
N+L+ PL +L L +L L NK+ + +L KL L+L +N S +
Sbjct: 78 NKLTDIKPLA--NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDINGLV-- 131
Query: 580 KLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICY 639
L L L L +N + +I + + L+ L+L N +S +P + L + +
Sbjct: 132 HLPQLESLYLGNNKI-TDITV-LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 640 NEL 642
N +
Sbjct: 188 NHI 190
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 6e-20
Identities = 67/270 (24%), Positives = 109/270 (40%), Gaps = 44/270 (16%)
Query: 759 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQ-DEFLNVVLALNEIRHRNI 813
IG+G G V++ S + VA+K + ++FL L + + H +I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIK----TCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDATAKELSWNRRINVIKGVANALSYLH- 871
VK G + +++ E G L L L I ++ AL+YL
Sbjct: 454 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLES 509
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG-----YAAP 926
+HRDI+++NVL+ + DFG+++++E + T + + G + AP
Sbjct: 510 KRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYME----DSTYYKASKGKLPIKWMAP 561
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDP--RLS 983
E R T DV+ FGV ++E++ G P F N +V ++ RL
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNN--DVIGRIENGERLP 612
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARPT 1013
P P L S+M C P RP
Sbjct: 613 MP-PNCPPTLYSLM---TKCWAYDPSRRPR 638
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 46/218 (21%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 746 IIKATDDFDEKFCI-----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFL 799
++ ++F+ + + G+G V + +G A K + + + E L
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEIL 76
Query: 800 NVVLALNEIRHR-NIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRRI 857
+ + L + ++ H N L+ EY G + + L A+ +S N I
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL--PELAEMVSENDVI 134
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNR 914
+IK + + YLH + +I+H D+ +N+LL + + DFG+++ + +
Sbjct: 135 RLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-ACEL 190
Query: 915 TEFVGTFGYAAPEI----AYTMRATEKYDVYSFGVLVF 948
E +GT Y APEI T D+++ G++ +
Sbjct: 191 REIMGTPEYLAPEILNYDPITTAT----DMWNIGIIAY 224
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 63/296 (21%), Positives = 115/296 (38%), Gaps = 70/296 (23%)
Query: 759 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-R 809
+G+G G V AE D VAVK D + ++ + + I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 145
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSL-------------ARILGNDATAKELSWNRR 856
H+NI+ G C+ +++ EY +G+L N +++++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 857 INVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914
++ +A + YL IHRD++++NVL+ ++DFG+A+ + + +
Sbjct: 206 VSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDY 258
Query: 915 TEFVGTFGYA------------APEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFS 961
Y APE + T + DV+SFGVL++E+ G P
Sbjct: 259 --------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP----- 305
Query: 962 INFSSFSNMIIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ E+ ++L R+ P ++L +M C P RPT +
Sbjct: 306 --YPGIPVE--ELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFK 353
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 72/326 (22%), Positives = 127/326 (38%), Gaps = 60/326 (18%)
Query: 759 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-R 809
+G+G G V AE D VAVK S D + ++ + + I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 133
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSL-------------ARILGNDATAKELSWNRR 856
H+NI+ G C+ +++ EY +G+L + ++LS
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 857 INVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914
++ VA + YL IHRD++++NVL+ + ++DFG+A+ + +
Sbjct: 194 VSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 915 TEFVGTFG-----YAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFS 968
T G + APE + T + DV+SFGVL++E+ G P +
Sbjct: 249 ---KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-------YPGVP 298
Query: 969 NMIIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026
E+ ++L R+ P ++L +M C P RPT F + D
Sbjct: 299 VE--ELFKLLKEGHRMDKP-SNCTNELYMMMR---DCWHAVPSQRPT----FKQLVEDLD 348
Query: 1027 EILAVILAIEASADYGQTTLCLETYS 1052
I+A+ E + + +
Sbjct: 349 RIVALTSNQEMGYYHHHHHHDYDIPT 374
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 65/310 (20%), Positives = 108/310 (34%), Gaps = 63/310 (20%)
Query: 749 ATDDFDEKF---------CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEF 798
+TD F +F +G+G V L + AVK Q E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE- 60
Query: 799 LNVVLALNEIR-HRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDA-TAKELSWNR 855
V L + + HRN+++ F +LV E + GS+ + I E S
Sbjct: 61 ---VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--- 114
Query: 856 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSS 912
V++ VA+AL +LH+ I HRD+ +N+L + + + DF + ++
Sbjct: 115 --VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 913 NR-------TEFVGTFGYAAPEI-AYTMRATEKY----DVYSFGVLV---------FEVI 951
G+ Y APE+ Y D++S GV++ F
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229
Query: 952 KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP---GVMDK---LISIMEVAILCLD 1005
G+ + NM+ E I + + P + LIS + L D
Sbjct: 230 CGSDCGWDRGEACPACQNMLFE--SIQEGKYEFPDKDWAHISCAAKDLISKL----LVRD 283
Query: 1006 ESPEARPTME 1015
+ R +
Sbjct: 284 --AKQRLSAA 291
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 52/153 (33%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262
L L + L L L+ L+L NQL L D+L+ L TL L N L+ S+
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98
Query: 263 PS-IIGNLKSLHQLDLIENQLSGSIPLS-FGNLSSWTLMSLFSNSLSGSIPP-ILGNLKS 319
P + +L L +L L NQL S+P F L+ + L +N L SIP L +
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156
Query: 320 LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNN 352
L TL L NQL V + L L+ ++LF N
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 54/178 (30%), Positives = 71/178 (39%), Gaps = 28/178 (15%)
Query: 129 QNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSG 188
+ LDL + L+ + L +L L LD NQL T+ + F
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGV----------FDD----- 81
Query: 189 RIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNL 248
L++L L L NN L V +L L L L NQL L D L+ L
Sbjct: 82 --------LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKL 133
Query: 249 DTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSGSIPL-SFGNLSSWTLMSLFSN 304
L L N L SIP+ L +L L L NQL S+P +F L ++LF N
Sbjct: 134 KELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 52/151 (34%), Positives = 74/151 (49%), Gaps = 6/151 (3%)
Query: 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLD 243
++ ++ L+KL L L+ N L V +L L TL L+ NQL L D
Sbjct: 45 TGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFD 104
Query: 244 NLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSGSIPLS-FGNLSSWTLMSL 301
+L+ LD L+L N L S+PS + L L +L L NQL SIP F L++ +SL
Sbjct: 105 HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSL 162
Query: 302 FSNSLSGSIPP-ILGNLKSLSTLGLYLNQLN 331
+N L S+P L L T+ L+ NQ +
Sbjct: 163 STNQLQ-SVPHGAFDRLGKLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 50/177 (28%), Positives = 64/177 (36%), Gaps = 26/177 (14%)
Query: 106 NLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGT 165
L+L L+KL L+L NQL + + L +L L L NQL +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 166 IPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLS 225
+P + L L K LYL N L V L L
Sbjct: 98 LPL--------------------GVFDHLTQLDK---LYLGGNQLKSLPSGVFDRLTKLK 134
Query: 226 TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP-SIIGNLKSLHQLDLIENQ 281
L L+ NQL + D L+NL TL L N L S+P L L + L NQ
Sbjct: 135 ELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 53/179 (29%), Positives = 81/179 (45%), Gaps = 22/179 (12%)
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE-FGSLTE 535
S+P I + + LDL S + L L L L NQL ++ F LTE
Sbjct: 28 SVPSGIPADT--EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 536 LQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHNI 593
L L L+ N+L +S+P + +L +L L L NQ ++P F++L L +L L+ N
Sbjct: 85 LGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142
Query: 594 LQEEIPPQVCN-MESLEKLNLSHNNLSGFIPRCFEKMRSL------------SCIDICY 639
LQ IP + + +L+ L+LS N L F+++ L S +I Y
Sbjct: 143 LQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILY 200
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 40/131 (30%), Positives = 63/131 (48%), Gaps = 2/131 (1%)
Query: 514 KLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHT 573
KL L L+ F LT+L +L+L N+L + +L +L L L+NNQ +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98
Query: 574 IPIEFEKLIHLSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSL 632
F+ L L KL L N L+ +P V + L++L L+ N L F+K+ +L
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNL 157
Query: 633 SCIDICYNELQ 643
+ + N+LQ
Sbjct: 158 QTLSLSTNQLQ 168
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 50/168 (29%), Positives = 73/168 (43%), Gaps = 10/168 (5%)
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKS 319
S+PS I +LDL L+ +F L+ T ++L N L ++ + +L
Sbjct: 28 SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 320 LSTLGLYLNQLNGVIPPSI-GNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNN 377
L TLGL NQL +P + +L+ L L L N L S+P + L L EL+L N
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQ 142
Query: 378 LSGVIPHSV-GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424
L IP LT L L++ N L + L L+ + N
Sbjct: 143 LQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 37/143 (25%), Positives = 53/143 (37%), Gaps = 37/143 (25%)
Query: 101 FPHLVN---LNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEIG---KLNQLR 153
F L L L+ N ++P + +L++L L LG NQL S G +L +L+
Sbjct: 79 FDDLTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK---SLPSGVFDRLTKLK 134
Query: 154 RLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSL-GNLSKLALLYLNNNSLFG 212
L L+ NQL IP+ L+ L L L+ N L
Sbjct: 135 ELRLNTNQLQ-------------------------SIPAGAFDKLTNLQTLSLSTNQLQS 169
Query: 213 YIPTVMGNLKSLSTLDLSQNQLN 235
L L T+ L NQ +
Sbjct: 170 VPHGAFDRLGKLQTITLFGNQFD 192
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-19
Identities = 66/278 (23%), Positives = 107/278 (38%), Gaps = 66/278 (23%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
D F+ IGKG G V + + + A+K N Q + NE+R
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ--------------KCVERNEVR 60
Query: 810 H----RNIVKF--HGFCSNARHSF-------LVCEYLHRGSL------ARILGNDAT--- 847
+ I++ H F N +SF +V + L G L +
Sbjct: 61 NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 848 AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907
EL AL YL + IIHRD+ N+LLD H++DF IA +
Sbjct: 121 ICEL------------VMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML 165
Query: 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSIN 963
+ T GT Y APE+ ++ R Y D +S GV +E+++G P + +
Sbjct: 166 PRETQITT-MAGTKPYMAPEM-FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP--YHIRS 221
Query: 964 FSSFSNMIIEVNQILDPRLSTP---SPGVMDKLISIME 998
+S ++ + ++ P S ++ L ++E
Sbjct: 222 STSSKEIV---HTFETTVVTYPSAWSQEMVSLLKKLLE 256
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 68/286 (23%), Positives = 111/286 (38%), Gaps = 57/286 (19%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-------H 810
+G+G K S AVK + ++ + EI H
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN-------------TQKEITALKLCEGH 65
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDA-TAKELSWNRRINVIKGVANALS 868
NIVK H + H+FLV E L+ G L RI + E S +++ + +A+S
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS-----YIMRKLVSAVS 120
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
++H ++HRD+ +N+L E + + DFG A+ P + T YAA
Sbjct: 121 HMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 926 PEI----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV-NQILDP 980
PE+ Y D++S GV+++ ++ G P F S + S +E+ +I
Sbjct: 178 PELLNQNGYDESC----DLWSLGVILYTMLSGQVP--FQSHDRSLTCTSAVEIMKKIKKG 231
Query: 981 RLSTPSP---GVMDK---LISIMEVAILCLDESPEARPTMEKGFGH 1020
S V + LI + L +D P R M +
Sbjct: 232 DFSFEGEAWKNVSQEAKDLIQGL----LTVD--PNKRLKMSGLRYN 271
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 66/295 (22%), Positives = 118/295 (40%), Gaps = 67/295 (22%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN 812
IG+G G V++A P +VAVK + Q +F + E + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASADMQADFQREAALMAEFDNPN 111
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSL---------------------ARILGNDATAKEL 851
IVK G C+ + L+ EY+ G L R + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 852 SWNRRINVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909
S ++ + + VA ++YL +HRD++++N L+ ++DFG+++ +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNI-- 224
Query: 910 YSSN--RTEFVGTFGY-----AAPE-IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFF 960
YS++ + PE I Y R T + DV+++GV+++E+ G P
Sbjct: 225 YSADYYK---ADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP---- 276
Query: 961 SINFSSFSNMIIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+ ++ EV + L+ P +L ++M LC + P RP+
Sbjct: 277 ---YYGMAHE--EVIYYVRDGNILACP-ENCPLELYNLMR---LCWSKLPADRPS 322
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 71/338 (21%), Positives = 136/338 (40%), Gaps = 55/338 (16%)
Query: 706 GFFFFFRQRKKDSQEEQTISMNPLRLLSVLNFDGKIMHE--EIIKATDDFDEKFCIGKGG 763
G + ++Q+ K + I + ++ +E E + F + +G G
Sbjct: 1 GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKT--LGAGA 58
Query: 764 QGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKF 816
G V +A VAVK S + + +++ ++ + ++ + +H NIV
Sbjct: 59 FGKVVEATAFGLGKEDAVLKVAVKMLKS---TAHADEKEALMSELKIMSHLGQHENIVNL 115
Query: 817 HGFCSNARHSFLVCEYLHRGSLARIL-----------GNDATAKELSWNRRINVIKGVAN 865
G C++ ++ EY G L L S ++ VA
Sbjct: 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQ 175
Query: 866 ALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGY 923
+++L + IHRD++++NVLL A + DFG+A+ + + + ++ G
Sbjct: 176 GMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDI--MNDS--NYIVK-GN 225
Query: 924 A-------APEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVN 975
A APE + T + DV+S+G+L++E+ G +P +N S F ++ +
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKLVKDGY 284
Query: 976 QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+++ P + SIM+ C P RPT
Sbjct: 285 -----QMAQP-AFAPKNIYSIMQ---ACWALEPTHRPT 313
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 41/213 (19%), Positives = 81/213 (38%), Gaps = 17/213 (7%)
Query: 80 ISINLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLG 134
+ + TL L T +FS+ P++ + +S ++ + NLSK+ ++++
Sbjct: 29 LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 135 NNQLSGVISPEI-GKLNQLRRLYLDMNQLHGTIPPV--IGQLSLIHEFSFCHNNVSGRIP 191
N + I P+ +L L+ L + L P + + + N IP
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 192 S-SLGNLSK-LALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQ-LNGLIPCTLDNL-SN 247
+ L L L NN + N L + L++N+ L + + S
Sbjct: 148 VNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 248 LDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIEN 280
L + + S++ ++PS L+ L +L
Sbjct: 207 PSLLDVSQTSVT-ALPS--KGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 46/208 (22%), Positives = 77/208 (37%), Gaps = 12/208 (5%)
Query: 128 LQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPP-VIGQLSLIHEFSFCHNNV 186
Q L L L + S L + R+Y+ ++ + LS + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 187 SGRIPSS-LGNLSKLALLYLNNNSLFGYIP--TVMGNLKSLSTLDLSQNQLNGLIP-CTL 242
I L L L L + N L P T + + L+++ N IP
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 243 DNLSN-LDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIP-LSFGNLSSW-TLM 299
L N TL LY N + S+ N L + L +N+ I +FG + S +L+
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 300 SLFSNSLSGSIPP-ILGNLKSLSTLGLY 326
+ S++ ++P L +LK L +
Sbjct: 211 DVSQTSVT-ALPSKGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 38/203 (18%), Positives = 74/203 (36%), Gaps = 10/203 (4%)
Query: 438 PNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEI-GDSSKLQFLDLSSN 496
P+ L L + + S + NLP + VS++ + + SK+ +++ +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 497 HIVGKIPVQ-LEKLFSLNKLILSLNQLSGSVP--LEFGSLTELQYLDLSANKLSSSIPKS 553
+ I L++L L L + L P + S L+++ N +SIP +
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 554 IGNLLK--LYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCN--MESLE 609
L L L NN F+ + L + L+ N I
Sbjct: 150 AFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 610 KLNLSHNNLSGFIPRCFEKMRSL 632
L++S +++ + E ++ L
Sbjct: 209 LLDVSQTSVTALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 41/203 (20%), Positives = 72/203 (35%), Gaps = 10/203 (4%)
Query: 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQ 281
S TL L + L + NL N+ +++ + + S NL + +++ +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 282 LSGSIPLS-FGNLSSWTLMSLFSNSLSGSIPPI--LGNLKSLSTLGLYLNQLNGVIPP-S 337
I L + +F+ L P + + + L + N IP +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 338 IGNLSS-LRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSV--GNLTGLVL 394
L + L L+NNG S+ L + L KN VI G +G L
Sbjct: 151 FQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 395 LNMCENHLFGPIPKSLKSLTSLK 417
L++ + + K L+ L L
Sbjct: 210 LDVSQTSVTALPSKGLEHLKELI 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 36/210 (17%), Positives = 76/210 (36%), Gaps = 12/210 (5%)
Query: 367 SLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIP-KSLKSLTSLKRVRFNQNN 425
S LKL + +L + H+ NL + + + + + S +L+ + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 426 LVGKV-YEAFGDHPNLTFLDLSQNN---FDGKISFNWRNLPKLDTFIVSMNNIFGSIPLE 481
+ + +A + P L FL + F + ++ N SIP+
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV--YSTDIFFILEITDNPYMTSIPVN 149
Query: 482 I--GDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE-FGSLTE-LQ 537
G ++ L L +N + L+ + L+ N+ + + FG +
Sbjct: 150 AFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 538 YLDLSANKLSSSIPKSIGNLLKLYYLNLSN 567
LD+S +++ K + +L +L N
Sbjct: 209 LLDVSQTSVTALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 19/121 (15%), Positives = 39/121 (32%), Gaps = 3/121 (2%)
Query: 533 LTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSH 591
Q L L L + + NL + + +S + + F L ++ +++ +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 592 NILQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCF-EKMRSLSCIDICYNELQGPIPNS 649
I P + L+ L + + L F ++I N IP +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 650 T 650
Sbjct: 150 A 150
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 61/275 (22%), Positives = 105/275 (38%), Gaps = 52/275 (18%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADQDE--FLNVVLALNEIRHR--N 812
+G GG GSVY + VA+K ++ + VVL L ++
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL-LKKVSSGFSG 109
Query: 813 IVKFHGFCSNARHSFLVCEY-LHRGSL-ARILGNDATAKELSWNRRINVIKGVANALSYL 870
+++ + L+ E L I A +EL+ R V A+ +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA--RSF--FWQVLEAVRHC 165
Query: 871 HHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
H+ ++HRDI +N+L+DL E + DFG ++ + T+F GT Y+ PE
Sbjct: 166 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPE-- 218
Query: 930 YTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
+Y V+S G+L+++++ G+ P + +I+ ++
Sbjct: 219 --WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVFF 262
Query: 985 P---SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
S LI L P RPT E+
Sbjct: 263 RQRVSSECQH-LIRWC------LALRPSDRPTFEE 290
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 64/287 (22%), Positives = 107/287 (37%), Gaps = 56/287 (19%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHR 811
+G+G G V +A+ D VAVK ++ ++ + L I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 91
Query: 812 NIVKFHGFCS-NARHSFLVCEYLHRGSL-------------ARILGNDATAKELSWNRRI 857
N+V G C+ ++ E+ G+L ++ D L+ I
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 858 NVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT 915
VA + +L IHRD++++N+LL + + DFG+A+ + Y
Sbjct: 152 CYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDI--YKDP-- 202
Query: 916 EFVGTFGYA------APEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFS 968
++V APE + T + DV+SFGVL++E+ G P I+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---- 258
Query: 969 NMIIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
E + L R+ P ++ M C P RPT
Sbjct: 259 ----EFCRRLKEGTRMRAP-DYTTPEMYQTML---DCWHGEPSQRPT 297
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 59/241 (24%), Positives = 94/241 (39%), Gaps = 44/241 (18%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177
P ++ +L ++ +LN + ++ + + + ++
Sbjct: 13 FPDDA--FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQG--------- 58
Query: 178 EFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMG---NLKSLSTLDLSQNQL 234
I L + L L N L + L +L+ L L+ NQL
Sbjct: 59 ------------IQY----LPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQL 97
Query: 235 NGLIPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSGSIPLS-FGN 292
L D L+NL L L +N L S+P + L +L L+L NQL S+P F
Sbjct: 98 QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDK 155
Query: 293 LSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFN 351
L++ T + L N L S+P + L L L LY NQL V L+SL+ + L +
Sbjct: 156 LTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHD 214
Query: 352 N 352
N
Sbjct: 215 N 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 7/173 (4%)
Query: 472 NNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFG 531
+ +S + + +++ I + ++ L ++ L L N+L +
Sbjct: 28 KKSVTDAVTQNELNS-IDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH-DISA-LK 82
Query: 532 SLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSH 591
LT L YL L+ N+L S L L L L NQ F+KL +L+ L+L+H
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAH 142
Query: 592 NILQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
N LQ +P V + +L +L+LS+N L F+K+ L + + N+L+
Sbjct: 143 NQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 26/221 (11%)
Query: 238 IPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWT 297
+ L K S++ + L S+ Q+ + + S+ L +
Sbjct: 17 AFAETIKAN------LKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQ-GIQYLPNVR 66
Query: 298 LMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGS 357
++L N L I L L +L+ L L NQL + L++L+ L L N L S
Sbjct: 67 YLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QS 123
Query: 358 IPEEI-GYLKSLSELKLCKNNLSGVIPHSV-GNLTGLVLLNMCENHLFGPIPKSL----- 410
+P+ + L +L+ L L N L +P V LT L L++ N L +SL
Sbjct: 124 LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-----QSLPEGVF 177
Query: 411 KSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD 451
LT LK +R QN L F +L ++ L N +D
Sbjct: 178 DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 218
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 39/140 (27%), Positives = 60/140 (42%), Gaps = 8/140 (5%)
Query: 98 FSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
+L L L+ N ++P + L+ L+ L L NQL + KL L L
Sbjct: 81 LKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139
Query: 157 LDMNQLHGTIPP-VIGQLSLIHEFSFCHNNVSGRIPSSL-GNLSKLALLYLNNNSLFGYI 214
L NQL ++P V +L+ + E +N + +P + L++L L L N L +
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-V 196
Query: 215 PT-VMGNLKSLSTLDLSQNQ 233
P V L SL + L N
Sbjct: 197 PDGVFDRLTSLQYIWLHDNP 216
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 8e-18
Identities = 45/281 (16%), Positives = 89/281 (31%), Gaps = 41/281 (14%)
Query: 343 SLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL 402
S R + + IP ++ ++ EL+ L + + L + + +N +
Sbjct: 10 SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 403 FGPIPKS-LKSLTSLKRVRFNQNNLVGKVY-EAFGDHPNLTFLDLSQNNFDGKISFNWRN 460
I +L L +R + N + + EAF + PNL +L +S ++
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI--------KH 118
Query: 461 LPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFS-----LNKL 515
LP + I S + LD+ N + I F L
Sbjct: 119 LPDV-HKI---------------HSLQKVLLDIQDNINIHTIE---RNSFVGLSFESVIL 159
Query: 516 ILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIP 575
L+ N + F + N L L++S +
Sbjct: 160 WLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219
Query: 576 IEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHN 616
E L L + +++P + + +L + +L++
Sbjct: 220 YGLENLKKLRARSTYNL---KKLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 44/255 (17%), Positives = 76/255 (29%), Gaps = 38/255 (14%)
Query: 80 ISINLSTLCLNG----TFQDFSFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLG 134
+ N L Q +FS F L + +S N I + NL KL + +
Sbjct: 28 LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 135 N-NQLSGVISPEI-GKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPS 192
N L I+PE L L+ L + + + + H
Sbjct: 88 KANNLL-YINPEAFQNLPNLQYLLISNTGI-----------KHLPDVHKIH--------- 126
Query: 193 SLGNLSKLALLYLNNNSLFGYIPTVM--GNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDT 250
+ LL + +N I G L L++N + + + +
Sbjct: 127 ----SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDEL 182
Query: 251 LFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSI 310
N+L + LD+ ++ NL L + + +L +
Sbjct: 183 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK--LRARSTYNLK-KL 239
Query: 311 PPILGNLKSLSTLGL 325
P L L +L L
Sbjct: 240 PT-LEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 7e-16
Identities = 42/163 (25%), Positives = 67/163 (41%), Gaps = 6/163 (3%)
Query: 486 SKLQFLDLSSNHIVGKIPVQ-LEKLFSLNKLILS-LNQLSGSVPLEFGSLTELQYLDLSA 543
L+ +++S N ++ I L L+++ + N L P F +L LQYL +S
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 544 NKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSK-LDLSHNILQEEIPPQ 601
+ + L+ L++ +N HTI F L S L L+ N +QE I
Sbjct: 114 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNS 172
Query: 602 VCNMESLEKLNL-SHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
N L++LNL +NNL F +DI +
Sbjct: 173 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 33/231 (14%), Positives = 64/231 (27%), Gaps = 9/231 (3%)
Query: 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282
S ++++ IP L N L L L ++++ +N +
Sbjct: 10 SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 283 SGSIPLS-FGNLSS-WTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIG 339
I F NL + +N+L I P NL +L L + + +
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125
Query: 340 NLSSLRNLSLFNNGLYGSIPEEI--GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNM 397
+ L + +N +I G L L KN + + + L
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 398 CENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQN 448
N+L + + ++ + + L
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 48/239 (20%), Positives = 85/239 (35%), Gaps = 30/239 (12%)
Query: 398 CENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFN 457
C+ IP L + +RF L AF +L +++SQN+ I +
Sbjct: 16 CQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 458 -WRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLI 516
+ NLPKL + I ++ L +++ P + L +L L+
Sbjct: 74 VFSNLPKLHE-------------IRIEKANNLLYIN----------PEAFQNLPNLQYLL 110
Query: 517 LSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI--GNLLKLYYLNLSNNQFSHTI 574
+S + + + LD+ N +I ++ G + L L+ N I
Sbjct: 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EI 169
Query: 575 PIEFEKLIHLSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSL 632
L +L+LS N EE+P V L++S + E ++ L
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL 228
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 21/132 (15%), Positives = 43/132 (32%), Gaps = 5/132 (3%)
Query: 511 SLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQF 570
S + ++++ +P + L KL + L + +S N
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 571 SHTIPIE-FEKLIHLSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEK 628
I + F L L ++ + I P+ N+ +L+ L +S+ +
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126
Query: 629 MRSLSCIDICYN 640
+DI N
Sbjct: 127 SLQKVLLDIQDN 138
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 26/155 (16%), Positives = 39/155 (25%), Gaps = 30/155 (19%)
Query: 83 NLSTLCLNGT----FQDFSFSSFPHLVNLNLSFNLFFGNIPPQI--GNLSKLQNLDLGNN 136
NL L ++ T D V L++ N+ I G + L L N
Sbjct: 105 NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164
Query: 137 QLSGVISPEIGKLNQLRRLYLDMNQLHGTIPP-VIGQLSLIHEFSFCHNNVSGRIPS--- 192
+ + + D N L +P V S + +PS
Sbjct: 165 GIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGL 222
Query: 193 ------------------SLGNLSKLALLYLNNNS 209
+L L L L S
Sbjct: 223 ENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPS 257
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 55/230 (23%), Positives = 92/230 (40%), Gaps = 40/230 (17%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLA---- 804
+DF +G+G +V A EL + A+K ++ N V
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY------VTRERDV 83
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL------ARILGNDAT---AKELSWNR 855
++ + H VK + + + Y G L T E
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----- 138
Query: 856 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN-R 914
+ +AL YLH IIHRD+ +N+LL+ + ++DFG AK + P S R
Sbjct: 139 -------IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 915 TE-FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 963
FVGT Y +PE+ A + D+++ G ++++++ G P F + N
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGN 236
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 37/132 (28%), Positives = 65/132 (49%), Gaps = 6/132 (4%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262
+ L N++ P K L +DLS NQ++ L P L +L++L LY N ++ +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 263 PS-IIGNLKSLHQLDLIENQLSGSIPL-SFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKS 319
P + L SL L L N+++ + + +F +L + L+SL+ N L +I L++
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRA 153
Query: 320 LSTLGLYLNQLN 331
+ T+ L N
Sbjct: 154 IQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 35/142 (24%), Positives = 57/142 (40%), Gaps = 10/142 (7%)
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPP-VIGQLSL 175
N+P I + L N + + +LRR+ L NQ+ + P L
Sbjct: 29 NLPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 176 IHEFSFCHNNVSGRIPSSL-GNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQL 234
++ N ++ +P SL L L LL LN N + +L +L+ L L N+L
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 235 NGLIPCTLDNLSNLDTLFLYKN 256
+ T L + T+ L +N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 31/135 (22%), Positives = 55/135 (40%), Gaps = 8/135 (5%)
Query: 502 IPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLY 561
+P + ++ L N + P F +L+ +DLS N++S P + L L
Sbjct: 30 LPETITEIR------LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83
Query: 562 YLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSG 620
L L N+ + FE L L L L+ N + + ++ +L L+L N L
Sbjct: 84 SLVLYGNKITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQT 142
Query: 621 FIPRCFEKMRSLSCI 635
F +R++ +
Sbjct: 143 IAKGTFSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 6/110 (5%)
Query: 486 SKLQFLDLSSNHIVGKIPVQL-EKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSA 543
KL+ +DLS+N I ++ + L SLN L+L N+++ +P F L LQ L L+A
Sbjct: 56 KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNA 113
Query: 544 NKLSSSIPKSI-GNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHN 592
NK++ + +L L L+L +N+ F L + + L+ N
Sbjct: 114 NKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 29/112 (25%), Positives = 54/112 (48%), Gaps = 4/112 (3%)
Query: 534 TELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHN 592
+ + L N + P + KL ++LSNNQ S + + F+ L L+ L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 593 ILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+ E +P + + SL+ L L+ N ++ F+ + +L+ + + N+LQ
Sbjct: 91 KITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 33/154 (21%), Positives = 61/154 (39%), Gaps = 30/154 (19%)
Query: 226 TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSG 284
+ L QN + + P L + L N +S + L+SL+ L L N+++
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 285 SIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSS 343
+P + L SL L L N++N + + +L +
Sbjct: 94 ------------------------ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129
Query: 344 LRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKN 376
L LSL++N L +I + L+++ + L +N
Sbjct: 130 LNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 30/133 (22%), Positives = 54/133 (40%), Gaps = 6/133 (4%)
Query: 322 TLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSG 380
+ L N + + P + LR + L NN + + + L+SL+ L L N ++
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 381 VIPHSV-GNLTGLVLLNMCENHLFGPIPK-SLKSLTSLKRVRFNQNNLVGKVYEAFGDHP 438
+P S+ L L LL + N + + + + L +L + N L F
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 439 NLTFLDLSQNNFD 451
+ + L+QN F
Sbjct: 153 AIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 37/137 (27%), Positives = 58/137 (42%), Gaps = 8/137 (5%)
Query: 438 PNLTFLDLSQNNFDGKISFN-WRNLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSS 495
+T + L QN I + KL I NN + + L L L
Sbjct: 32 ETITEIRLEQNTI-KVIPPGAFSPYKKL-RRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89
Query: 496 NHIVGKIPVQL-EKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSANKLSSSIPKS 553
N I ++P L E LFSL L+L+ N+++ + ++ F L L L L NKL + +
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147
Query: 554 IGNLLKLYYLNLSNNQF 570
L + ++L+ N F
Sbjct: 148 FSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 297 TLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSI-GNLSSLRNLSLFNNGL 354
T + L N++ IPP K L + L NQ++ + P L SL +L L+ N +
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 355 YGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSL 413
+P+ + L SL L L N ++ + + +L L LL++ +N L + L
Sbjct: 93 -TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 414 TSLKRVRFNQN 424
+++ + QN
Sbjct: 152 RAIQTMHLAQN 162
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 66/290 (22%), Positives = 116/290 (40%), Gaps = 47/290 (16%)
Query: 750 TDDFD-EKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE 807
TDD+ K +G G G V + +G A+K + E V
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----E---VDHHWQA 78
Query: 808 IRHRNIVKFHGFCSNARHS----FLVCEYLHRGSL-ARIL--GNDA-TAKELSWNRRINV 859
+IV N H ++ E + G L +RI G+ A T +E + +
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-----EI 133
Query: 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNRTE 916
++ + A+ +LH +I HRD+ +N+L + + ++DFG AK +
Sbjct: 134 MRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQT 188
Query: 917 FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQ 976
T Y APE+ + + D++S GV+++ ++ G P F+S + S + +
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP--FYSNTGQAISPGMKR--R 244
Query: 977 ILDPRLSTPSP---GVMDK---LISIMEVAILCLDESPEARPTMEKGFGH 1020
I + P+P V + LI ++ L D P R T+ + H
Sbjct: 245 IRLGQYGFPNPEWSEVSEDAKQLIRLL----LKTD--PTERLTITQFMNH 288
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-17
Identities = 80/459 (17%), Positives = 140/459 (30%), Gaps = 82/459 (17%)
Query: 222 KSLSTLDLSQNQLNGL-IPCTLDNLSNLDTLFLYKNSLS----GSIPSIIGNLKSLHQLD 276
+ +LD+ +L+ L L + L L+ I S + +L +L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 277 LIENQLSGS------IPLSFGNLSSWTLMSLFSNSLS----GSIPPILGNLKSLSTLGLY 326
L N+L L + L SL + L+ G + L L +L L L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKL-SLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 327 LNQLNGVIPPSIG-----NLSSLRNLSLFNNGL----YGSIPEEIGYLKSLSELKLCKNN 377
N L + L L L L + + EL + N+
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 378 LSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLT-SLKRVRFNQNNL----VGKVYE 432
++ G+ +L C+ LK L+ ++ + +
Sbjct: 182 INE---------AGVRVL--CQ---------GLKDSPCQLEALKLESCGVTSDNCRDLCG 221
Query: 433 AFGDHPNLTFLDLSQNNFDGK-----ISFNWRNLPKLDTFIVSMNNI----FGSIPLEIG 483
+L L L N +L T + I G + +
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281
Query: 484 DSSKLQFLDLSSNHI----VGKIPVQLEK-LFSLNKLILSLNQLSGSVPLEFGSL----T 534
L+ L L+ N + + L + L L + + + F S+
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR 341
Query: 535 ELQYLDLSANKLSSSIPKSIGNLLK-----LYYLNLSNNQFSHT----IPIEFEKLIHLS 585
L L +S N+L + + + L L L L++ S + + L
Sbjct: 342 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401
Query: 586 KLDLSHNILQEEIPPQVC-----NMESLEKLNLSHNNLS 619
+LDLS+N L + Q+ LE+L L S
Sbjct: 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-17
Identities = 87/459 (18%), Positives = 150/459 (32%), Gaps = 64/459 (13%)
Query: 126 SKLQNLDLGNNQLSGVISPEIGK-LNQLRRLYLDMNQLHGT----IPPVIGQLSLIHEFS 180
+Q+LD+ +LS E+ L Q + + LD L I + + E +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 181 FCHNNVSGRIPSSLGNL-----SKLALLYLNNNSL----FGYIPTVMGNLKSLSTLDLSQ 231
N + + K+ L L N L G + + + L +L L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 232 NQLNG-----LIPCTLDNLSNLDTLFLYKNSLS----GSIPSIIGNLKSLHQLDLIENQL 282
N L L LD L+ L L SLS + S++ +L + N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 283 S--GSIPLSFG---NLSSWTLMSLFSNSLS----GSIPPILGNLKSLSTLGLYLNQL--N 331
+ G L G + + L S ++ + I+ + SL L L N+L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 332 GVIPPSIGNL---SSLRNLSLFNNGL----YGSIPEEIGYLKSLSELKLCKNNL--SGVI 382
G+ G L S LR L ++ G+ G + + +SL EL L N L G
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 383 PHSVG---NLTGLVLLNMCENHL----FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFG 435
L L + L L ++ + N L
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362
Query: 436 D-----HPNLTFLDLSQNNFDGK----ISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS- 485
L L L+ + ++ L +S N + + L++ +S
Sbjct: 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 422
Query: 486 ----SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLN 520
L+ L L + ++ +L+ L + ++
Sbjct: 423 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-15
Identities = 87/448 (19%), Positives = 147/448 (32%), Gaps = 64/448 (14%)
Query: 176 IHEFSFCHNNVS-GRIPSSLGNLSKLALLYLNNNSL----FGYIPTVMGNLKSLSTLDLS 230
I +S R L L + ++ L++ L I + + +L+ L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 231 QNQLNG-----LIPCTLDNLSNLDTLFLYKNSLS----GSIPSIIGNLKSLHQLDLIENQ 281
N+L ++ + L L L+ G + S + L +L +L L +N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 282 L--SGSIPLSFGNLSSWTLM---SLFSNSLS----GSIPPILGNLKSLSTLGLYLNQLNG 332
L +G L G L + L SLS + +L L + N +N
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 333 VIPPSIG-----NLSSLRNLSLFNNGL----YGSIPEEIGYLKSLSELKLCKNNL--SGV 381
+ + L L L + G+ + + SL EL L N L G+
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 382 IPHSVGNL---TGLVLLNMCENHL----FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAF 434
G L + L L + E + G + + L++ SLK + N L +
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304
Query: 435 GD-----HPNLTFLDLSQNNFDGK----ISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS 485
+ L L + +F S L +S N + + E+
Sbjct: 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364
Query: 486 -----SKLQFLDLSSNHI----VGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSL--- 533
S L+ L L+ + + L SL +L LS N L + L+
Sbjct: 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 424
Query: 534 --TELQYLDLSANKLSSSIPKSIGNLLK 559
L+ L L S + + L K
Sbjct: 425 PGCLLEQLVLYDIYWSEEMEDRLQALEK 452
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-15
Identities = 56/352 (15%), Positives = 108/352 (30%), Gaps = 50/352 (14%)
Query: 342 SSLRNLSLFNNGL-YGSIPEEIGYLKSLSELKLCKNNLS----GVIPHSVGNLTGLVLLN 396
+++L + L E + L+ ++L L+ I ++ L LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 397 MCENHL----FGPIPKSLKSL-TSLKRVRFNQNNL----VGKVYEAFGDHPNLTFLDLSQ 447
+ N L + + L++ ++++ L G + P L L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 448 NNFDGK-----ISFNWRNLPKLDTFIVSMNNI----FGSIPLEIGDSSKLQFLDLSSNHI 498
N +L+ + ++ + + + L +S+N I
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 499 ----VGKIPVQLEK-LFSLNKLILSLNQLS----GSVPLEFGSLTELQYLDLSANKLSSS 549
V + L+ L L L ++ + S L+ L L +NKL
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 550 IPKSIGNLLK-----LYYLNLSNNQFSHT----IPIEFEKLIHLSKLDLSHNILQEEIPP 600
+ L L L + + + L +L L+ N L +E
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 601 QVCNM-----ESLEKLNLSHNNLSG----FIPRCFEKMRSLSCIDICYNELQ 643
+C LE L + + + + R L + I N L+
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-12
Identities = 76/444 (17%), Positives = 147/444 (33%), Gaps = 76/444 (17%)
Query: 80 ISINLSTLCLNGT-FQDFSF----SSFPHLVNLNLSFNLFFGNIPPQ--------IGNLS 126
+S+++ +L + D + + L + +
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDC----GLTEARCKDISSALRVNP 56
Query: 127 KLQNLDLGNNQLSG----VISPEIGKLN-QLRRLYLDMNQLHGT----IPPVIGQLSLIH 177
L L+L +N+L + + + ++++L L L G + + L +
Sbjct: 57 ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116
Query: 178 EFSFCHNNVSGRIPSSLG-----NLSKLALLYLNNNSL----FGYIPTVMGNLKSLSTLD 228
E N + L +L L L SL + +V+ L
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176
Query: 229 LSQNQLNG-----LIPCTLDNLSNLDTLFLYKNSLS----GSIPSIIGNLKSLHQLDLIE 279
+S N +N L D+ L+ L L ++ + I+ + SL +L L
Sbjct: 177 VSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236
Query: 280 NQL--SGSIPLSFGNL-SSWTLMSLF--SNSLS----GSIPPILGNLKSLSTLGLYLNQL 330
N+L G L G L S L +L+ ++ G + +L +SL L L N+L
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296
Query: 331 --NGVIPPSIG---NLSSLRNLSLFNNGL----YGSIPEEIGYLKSLSELKLCKNNL--S 379
G L +L + + + + L EL++ N L +
Sbjct: 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
Query: 380 GVIPHSVG---NLTGLVLLNMCENHL----FGPIPKSLKSLTSLKRVRFNQNNL----VG 428
GV G + L +L + + + + +L + SL+ + + N L +
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 416
Query: 429 KVYEAFGD-HPNLTFLDLSQNNFD 451
++ E+ L L L +
Sbjct: 417 QLVESVRQPGCLLEQLVLYDIYWS 440
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 66/265 (24%), Positives = 106/265 (40%), Gaps = 35/265 (13%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG V A + +G VA+K + L N + V + + H NIVK
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
+ +L+ EY G + L KE R + + +A+ Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-KEARSK--FRQIVSAVQYCHQKR--- 134
Query: 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEI----AYTMR 933
I+HRD+ ++N+LLD + ++DFG + F G YAAPE+ Y
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQGKKYDGP 193
Query: 934 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP---SPGVM 990
DV+S GV+++ ++ G+ P F N+ ++L + P S
Sbjct: 194 EV---DVWSLGVILYTLVSGSLP-------FDG-QNLKELRERVLRGKYRIPFYMSTDCE 242
Query: 991 DKLISIMEVAILCLDESPEARPTME 1015
+ L+ L +P R T+E
Sbjct: 243 N-LLKRF------LVLNPIKRGTLE 260
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 39/133 (29%), Positives = 63/133 (47%), Gaps = 7/133 (5%)
Query: 203 LYLNNNSLFGYIPT-VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261
L LNNN T + L L ++ S N++ + + S ++ + L N L +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95
Query: 262 IPS-IIGNLKSLHQLDLIENQLSGSIPL-SFGNLSSWTLMSLFSNSLSGSIPP-ILGNLK 318
+ + L+SL L L N+++ + SF LSS L+SL+ N ++ ++ P L
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153
Query: 319 SLSTLGLYLNQLN 331
SLSTL L N N
Sbjct: 154 SLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 36/142 (25%), Positives = 54/142 (38%), Gaps = 9/142 (6%)
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEI-GKLNQLRRLYLDMNQLHGTIPP-VIGQLS 174
+IP L L NN+ + + + I KL QLR++ N++ I S
Sbjct: 29 HIPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 175 LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQL 234
++E N + L L L L +N + L S+ L L NQ+
Sbjct: 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
Query: 235 NGLIPCTLDNLSNLDTLFLYKN 256
+ P D L +L TL L N
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 28/137 (20%), Positives = 57/137 (41%), Gaps = 11/137 (8%)
Query: 502 IPVQLEKLFSLNKLILSLNQLSGSVPL-EFGSLTELQYLDLSANKLSSSIPKSIGNLLKL 560
IP +L L+ N+ + F L +L+ ++ S NK++ + +
Sbjct: 30 IPQYTAELR------LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 561 YYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNL 618
+ L++N+ + + F+ L L L L N + + + S+ L+L N +
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
Query: 619 SGFIPRCFEKMRSLSCI 635
+ P F+ + SLS +
Sbjct: 142 TTVAPGAFDTLHSLSTL 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 31/110 (28%), Positives = 56/110 (50%), Gaps = 6/110 (5%)
Query: 486 SKLQFLDLSSNHIVGKIPVQ-LEKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSA 543
+L+ ++ S+N I I E +N+++L+ N+L +V + F L L+ L L +
Sbjct: 57 PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRS 114
Query: 544 NKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHN 592
N+++ S L + L+L +NQ + T+ F+ L LS L+L N
Sbjct: 115 NRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 24/112 (21%), Positives = 50/112 (44%), Gaps = 3/112 (2%)
Query: 534 TELQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHN 592
L L+ N+ + I L +L +N SNN+ + FE ++++ L+ N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 593 ILQEEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
L+ + ++ +ESL+ L L N ++ F + S+ + + N++
Sbjct: 92 RLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 31/132 (23%), Positives = 50/132 (37%), Gaps = 3/132 (2%)
Query: 322 TLGLYLNQLNGVIPPSI-GNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLS 379
L L N+ + I L LR ++ NN + I E ++E+ L N L
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLE 94
Query: 380 GVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPN 439
V L L L + N + S L+S++ + N + AF +
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 440 LTFLDLSQNNFD 451
L+ L+L N F+
Sbjct: 155 LSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 22/113 (19%), Positives = 41/113 (36%), Gaps = 28/113 (24%)
Query: 98 FSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEI-GKLNQLRRL 155
F + + L+ N N+ ++ L L+ L L +N+++ + + L+ +R L
Sbjct: 77 FEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLL 134
Query: 156 YLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN 208
L NQ+ T+ P + L L+ L L N
Sbjct: 135 SLYDNQIT-TVA-----------------------PGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 24/96 (25%), Positives = 44/96 (45%), Gaps = 6/96 (6%)
Query: 563 LNLSNNQFSHTIPI-EFEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSG 620
L L+NN+F+ F+KL L K++ S+N + + I + ++ L+ N L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLEN 95
Query: 621 FIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGL 656
+ F+ + SL + + N + + N F GL
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRITC-VGND-SF-IGL 128
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 58/286 (20%), Positives = 113/286 (39%), Gaps = 53/286 (18%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHR 811
+G G G V +A VAVK S ++ +++ ++ + L+ + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP---SAHLTEREALMSELKVLSYLGNHM 87
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSL---------------ARILGNDATAKELSWNRR 856
NIV G C+ + ++ EY G L + L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 857 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE 916
++ VA +++L + IHRD++++N+LL + DFG+A+ + + +
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI--KNDS--N 200
Query: 917 FVGTFGYA------APEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSN 969
+V APE + T + DV+S+G+ ++E+ G+ P ++
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----- 255
Query: 970 MIIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
+ +++ R+ +P ++ IM+ C D P RPT
Sbjct: 256 ---KFYKMIKEGFRMLSP-EHAPAEMYDIMK---TCWDADPLKRPT 294
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 4e-17
Identities = 56/257 (21%), Positives = 101/257 (39%), Gaps = 29/257 (11%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFL-----NVVLA 804
+DF IG+GG G VY +G + A+K + + + Q E L ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLALNERIMLSL 245
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
++ IV + + ++ G L L E +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEII 302
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE-FVGTFGY 923
L ++H+ +++RD+ N+LLD +SD G+A S + VGT GY
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHGY 356
Query: 924 AAPEI-----AYTMRATEKYDVYSFGVLVFEVIKGNHP-RDFFSINFSSFSNMIIEVNQI 977
APE+ AY A D +S G ++F++++G+ P R + + M + +
Sbjct: 357 MAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 978 LDPRLSTPSPGVMDKLI 994
L S +++ L+
Sbjct: 413 LPDSFSPELRSLLEGLL 429
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 61/321 (19%), Positives = 116/321 (36%), Gaps = 70/321 (21%)
Query: 759 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHR 811
+G G G V A VAVK + ++++ ++ + + ++ H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE---KADSSEREALMSELKMMTQLGSHE 109
Query: 812 NIVKFHGFCSNARHSFLVCEYLHRGSL--------------------ARILGNDATAKEL 851
NIV G C+ + +L+ EY G L + L + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 852 SWNRRINVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909
++ + VA + +L +HRD++++NVL+ + DFG+A+ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDI-- 222
Query: 910 YSSNRTEFVGTFGYA------APEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSI 962
S + +V APE + T K DV+S+G+L++E+ G +P +
Sbjct: 223 MSDS--NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 963 NFSSFSNMIIEVNQILDP--RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ +++ ++ P +++ IM+ C RP+
Sbjct: 281 DA--------NFYKLIQNGFKMDQP-FYATEEIYIIMQ---SCWAFDSRKRPSFP----- 323
Query: 1021 HIGYCDEILAVILAIEASADY 1041
L LA A Y
Sbjct: 324 ---NLTSFLGCQLADAEEAMY 341
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 42/272 (15%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALNEIRHRNIV 814
+G+G G V A + + VAVK + + + + + + + H N+V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPEN-----IKKEICINKMLNHENVV 68
Query: 815 KFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRRI--NVIKGVANALSYLH 871
KF+G +L EY G L RI + + + +R ++ GV YLH
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA--QRFFHQLMAGV----VYLH 122
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR---TEFVGTFGYAAPEI 928
I HRDI +N+LLD +SDFG+A + R GT Y APE+
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL 178
Query: 929 ----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
+ E DV+S G+++ ++ G P D S + +S+ + +
Sbjct: 179 LKRREF---HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--WKEKKTYLNPWKK 233
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ L+ + L E+P AR T+
Sbjct: 234 IDSAPLA-LLHKI------LVENPSARITIPD 258
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-16
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 23/215 (10%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE-- 807
+ F + +GKGG G V ++ +G + A KK L + + +ALNE
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKK----LEKKRIKKRKG---EAMALNEKQ 236
Query: 808 ----IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGV 863
+ R +V LV ++ G L + + A R + +
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEI 295
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTEFVGTF 921
L LH + I++RD+ +N+LLD H+ SD G+A V + + VGT
Sbjct: 296 CCGLEDLHRE---RIVYRDLKPENILLDD--HGHIRISDLGLAVHVPEGQTIKG-RVGTV 349
Query: 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
GY APE+ R T D ++ G L++E+I G P
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-16
Identities = 57/255 (22%), Positives = 99/255 (38%), Gaps = 24/255 (9%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE-- 807
D F + +G+GG G V+ ++ +G + A KK L + + A+ E
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK----LNKKRLKKRKG---YQGAMVEKK 237
Query: 808 ----IRHRNIVKFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRRINVIKG 862
+ R IV LV ++ G + I D R I
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
+ + L +LH +II+RD+ +NVLLD + +SD G+A ++ + + GT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN----MIIEVNQIL 978
+ APE+ D ++ GV ++E+I P F + + ++E
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP--FRARGEKVENKELKQRVLEQAVTY 412
Query: 979 DPRLSTPSPGVMDKL 993
+ S S + L
Sbjct: 413 PDKFSPASKDFCEAL 427
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 41/208 (19%), Positives = 81/208 (38%), Gaps = 18/208 (8%)
Query: 410 LKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIV 469
L + + + ++ + + + + +N ++ + L +
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHL 70
Query: 470 SMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE 529
S N I PL+ D +KL+ L ++ N + + + L++L L N+L + L
Sbjct: 71 SHNQISDLSPLK--DLTKLEELSVNRNRLK-NLNG-IPSA-CLSRLFLDNNELRDTDSLI 125
Query: 530 FGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDL 589
L L+ L + NKL S +G L KL L+L N+ ++T + +L ++ +DL
Sbjct: 126 --HLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDL 179
Query: 590 SHNILQEEIPPQVCNMESLEKLNLSHNN 617
+ E V L N +
Sbjct: 180 TGQKCVNE---PVKYQPELYITNTVKDP 204
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 39/182 (21%), Positives = 71/182 (39%), Gaps = 15/182 (8%)
Query: 438 PNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNH 497
N +L + + +S L + F +NI S+ + + L+ L LS N
Sbjct: 19 ANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNI-QSLA-GMQFFTNLKELHLSHNQ 74
Query: 498 IVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNL 557
I + L+ L L +L ++ N+L L L L L N+L S+ +L
Sbjct: 75 IS-DLS-PLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD--TDSLIHL 127
Query: 558 LKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNN 617
L L++ NN+ + + L L LDL N + + ++ + ++L+
Sbjct: 128 KNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQK 183
Query: 618 LS 619
Sbjct: 184 CV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 39/193 (20%), Positives = 72/193 (37%), Gaps = 13/193 (6%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
S + N N + ++ + + L+ L L +NQ+S +SP + L +L L
Sbjct: 36 SQKELSGVQNFNGDNSN-IQSLAG-MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELS 91
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT 216
++ N+L + I L +N + SL +L L +L + NN L +
Sbjct: 92 VNRNRLK-NLNG-IPSACL-SRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM- 145
Query: 217 VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLD 276
+G L L LDL N++ L L ++ + L L + +
Sbjct: 146 -LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVK 202
Query: 277 LIENQLSGSIPLS 289
+ + +S
Sbjct: 203 DPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 13/158 (8%)
Query: 486 SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANK 545
+ +L + V ++L + + + ++ T L+ L LS N+
Sbjct: 19 ANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAGMQ--FFTNLKELHLSHNQ 74
Query: 546 LSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNM 605
+S P + +L KL L+++ N+ + + LS+L L +N L + + ++
Sbjct: 75 ISDLSP--LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNEL-RDTDS-LIHL 127
Query: 606 ESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
++LE L++ +N L + + L +D+ NE+
Sbjct: 128 KNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 42/260 (16%), Positives = 89/260 (34%), Gaps = 41/260 (15%)
Query: 122 IGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181
L+ +LG ++ ++S +L+ ++ D + + ++
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG------------- 58
Query: 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCT 241
+ + L L+L++N + P + +L L L +++N+L L
Sbjct: 59 ------------MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG-- 102
Query: 242 LDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSL 301
+ + L LFL N L + +LK+L L + N+L + L LS ++ L
Sbjct: 103 IPSA-CLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDL 157
Query: 302 FSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEE 361
N ++ + L LK ++ + L + L + + P
Sbjct: 158 HGNEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYY 213
Query: 362 IGYLKSLSELKLCKNNLSGV 381
I S + +
Sbjct: 214 ISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 36/238 (15%), Positives = 83/238 (34%), Gaps = 19/238 (7%)
Query: 360 EEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV 419
L + + L K +++ ++ L+G+ N +++ ++ T+LK +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKEL 68
Query: 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479
+ N + D L L +++N ++ L + N + +
Sbjct: 69 HLSHNQI--SDLSPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELRDTDS 123
Query: 480 LEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYL 539
L L+ L + +N + I L L L L L N+++ + L L ++ ++
Sbjct: 124 LI--HLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWI 177
Query: 540 DLSANKLSSSIPKSIGNLLKLYYLN-LSNNQFSHTIPIEFEKLIHLSKLDLSHNILQE 596
DL+ K + + + +LY N + + P + +
Sbjct: 178 DLTGQKCVN---EPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVY 232
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 54/249 (21%), Positives = 102/249 (40%), Gaps = 26/249 (10%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+D++ IG+G G V + + A+K + + +D F +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFAN 127
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
+V+ + R+ ++V EY+ G L ++ N ++ V AL
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDA 183
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTE-FVGTFGYAAP 926
+H IHRD+ N+LLD H+ +DFG + R + VGT Y +P
Sbjct: 184 IHSM---GFIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 927 EIAYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
E+ + Y D +S GV ++E++ G+ P F++ +++ ++I++ +
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP--FYA------DSLVGTYSKIMNHKN 290
Query: 983 STPSPGVMD 991
S P D
Sbjct: 291 SLTFPDDND 299
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 5/104 (4%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262
LYL+ N +P + N K L+ +DLS N+++ L + N++ L TL L N L I
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 263 PS-IIGNLKSLHQLDLIENQLSGSIPL-SFGNLSSWTLMSLFSN 304
P LKSL L L N +S +P +F +LS+ + +++ +N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 37/131 (28%), Positives = 51/131 (38%), Gaps = 27/131 (20%)
Query: 153 RRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFG 212
LYLD NQ +P L N L L+ L+NN +
Sbjct: 34 TELYLDGNQFT-------------------------LVPKELSNYKHLTLIDLSNNRIST 68
Query: 213 YIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP-SIIGNLKS 271
N+ L TL LS N+L + P T D L +L L L+ N +S +P +L +
Sbjct: 69 LSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSA 127
Query: 272 LHQLDLIENQL 282
L L + N L
Sbjct: 128 LSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 514 KLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHT 573
+L L NQ + VP E + L +DLS N++S+ +S N+ +L L LS N+
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 574 IPIE-FEKLIHLSKLDLSHNILQEEIPPQV-CNMESLEKLNLSHN 616
IP F+ L L L L N + +P ++ +L L + N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 3/106 (2%)
Query: 251 LFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSI 310
L+L N + +P + N K L +DL N++S SF N++ + L N L I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 311 PP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLY 355
PP LKSL L L+ N ++ V + +LS+L +L++ N LY
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 31/102 (30%), Positives = 47/102 (46%), Gaps = 6/102 (5%)
Query: 472 NNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL-EKLFSLNKLILSLNQLSGSVPLE- 529
N F +P E+ + L +DLS+N I + Q + L LILS N+L +P
Sbjct: 40 GNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRT 97
Query: 530 FGSLTELQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQF 570
F L L+ L L N + S +P+ +L L +L + N
Sbjct: 98 FDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 563 LNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNNLSGF 621
L L NQF+ +P E HL+ +DLS+N + + Q NM L L LS+N L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 622 IPRCFEKMRSLSCIDICYNELQ 643
PR F+ ++SL + + N++
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 36/135 (26%), Positives = 50/135 (37%), Gaps = 35/135 (25%)
Query: 106 NLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLS----GVISPEIGKLNQLRRLYLDMNQ 161
L L N F +P ++ N L +DL NN++S S + QL L L N+
Sbjct: 35 ELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFS----NMTQLLTLILSYNR 89
Query: 162 LHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT-VMGN 220
L IPP F L L LL L+ N + +P +
Sbjct: 90 LR-CIPP--------RTFD---------------GLKSLRLLSLHGNDI-SVVPEGAFND 124
Query: 221 LKSLSTLDLSQNQLN 235
L +LS L + N L
Sbjct: 125 LSALSHLAIGANPLY 139
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-16
Identities = 69/303 (22%), Positives = 120/303 (39%), Gaps = 63/303 (20%)
Query: 747 IKATDDFDEKFC----IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV 801
IK D+ +G G G V + + + A+K +
Sbjct: 54 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------------DC 98
Query: 802 VLALNEIR-------HRNIVKFHGFCSNA----RHSFLVCEYLHRGSL-ARIL--GNDA- 846
A E+ +IV+ N + +V E L G L +RI G+ A
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 847 TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGI 903
T +E S ++K + A+ YLH +I HRD+ +N+L + ++DFG
Sbjct: 159 TEREAS-----EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 963
AK ++S T T Y APE+ + + D++S GV+++ ++ G P F+S +
Sbjct: 211 AKETTSHNSLTT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNH 267
Query: 964 FSSFSNMIIEVNQILDPRLSTPSP---GVMDK---LISIMEVAILCLDESPEARPTMEKG 1017
+ S + +I + P+P V ++ LI + L + P R T+ +
Sbjct: 268 GLAISPGMKT--RIRMGQYEFPNPEWSEVSEEVKMLIRNL----LKTE--PTQRMTITEF 319
Query: 1018 FGH 1020
H
Sbjct: 320 MNH 322
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 8e-16
Identities = 55/229 (24%), Positives = 88/229 (38%), Gaps = 35/229 (15%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLA 804
DDF+ IG+G V ++ +G + A+K N +M + E VL
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW----DMLKRGEVSCFREERDVLV 116
Query: 805 LNEIRHRNIVKFHGFCS--NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG 862
R I + H + + + +LV EY G L +L R +
Sbjct: 117 --NGDRRWITQLH--FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF--YLAE 170
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTE-FVG 919
+ A+ +H +HRDI N+LLD H+ +DFG + + R+ VG
Sbjct: 171 IVMAIDSVHRL---GYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 920 TFGYAAPEIAYTMRATEKYDVY-------SFGVLVFEVIKGNHPRDFFS 961
T Y +PEI + Y + GV +E+ G P F++
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP--FYA 272
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-16
Identities = 71/275 (25%), Positives = 108/275 (39%), Gaps = 48/275 (17%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
IG G G + ++VAVK + N+ Q E ++ +RH NIV+F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV--QRE----IINHRSLRHPNIVRF 81
Query: 817 HGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWN--RRI--NVIKGVANALSYLH 871
H ++ EY G L RI A S + R ++ GV SY H
Sbjct: 82 KEVILTPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLSGV----SYCH 133
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAH--VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
I HRD+ +N LLD + DFG +K +S ++ VGT Y APE+
Sbjct: 134 SM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL 189
Query: 930 YTMRATEKY-----DVYSFGVLVFEVIKGNHP--RDFFSINFSSFSNMIIEVN-QILDPR 981
++Y DV+S GV ++ ++ G +P ++ I+ V I P
Sbjct: 190 ----LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI--PD 243
Query: 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
SP LIS + P R ++ +
Sbjct: 244 DIRISPECCH-LISRI------FVADPATRISIPE 271
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 44/271 (16%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADQ--DEFLNVVLALNEIRHRNIV 814
+G G G V E +G VAVK N ++ S ++ + E + L RH +I+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHPHII 74
Query: 815 KFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
K + S F+V EY+ G L I + + + + + +A+ Y H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH 130
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMR 933
++HRD+ +NVLLD A ++DFG++ + RT G+ YAAPE+
Sbjct: 131 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVI---- 182
Query: 934 ATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP--- 985
+ Y D++S GV+++ ++ G P D ++ +I P
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFD--------DEHVPTLFKKIRGGVFYIPEYL 234
Query: 986 SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ V L+ M L P R T++
Sbjct: 235 NRSVAT-LLMHM------LQVDPLKRATIKD 258
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.6 bits (198), Expect = 1e-15
Identities = 41/250 (16%), Positives = 81/250 (32%), Gaps = 29/250 (11%)
Query: 416 LKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIF 475
L N + + L ++ + + +L +S+
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCR-DSATDEQLFRCELSVEKST 362
Query: 476 GSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSG----------- 524
+ E+ +LQ L+ + + I + + L L +L S
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421
Query: 525 ----------SVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTI 574
+ +++ L L+ L+ + LL + +L+LS+N+ +
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-AL 478
Query: 575 PIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGF-IPRCFEKMRSLS 633
P L L L S N L E + V N+ L++L L +N L + L
Sbjct: 479 PPALAALRCLEVLQASDNAL-ENVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 536
Query: 634 CIDICYNELQ 643
+++ N L
Sbjct: 537 LLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 2e-15
Identities = 58/345 (16%), Positives = 101/345 (29%), Gaps = 38/345 (11%)
Query: 25 SSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINL 84
S EAC + + L + +LL P + +P S +
Sbjct: 251 SREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLN 310
Query: 85 STLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISP 144
L + ++ S L +L +L + + V+
Sbjct: 311 DQLPQHTFRVIWTGSDSQKECVL---LKDRPECWCRDSATDEQLFRCELSVEKST-VLQS 366
Query: 145 EIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLY 204
E+ +L+ L + TI ++ L + S ++ + L
Sbjct: 367 ELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK--AVDPMRAAYLDD 424
Query: 205 LNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS 264
L + L M + L L+ L L C L+ L + L L N L ++P
Sbjct: 425 LRSKFLLENSVLKM-EYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPP 480
Query: 265 IIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLG 324
+ L+ L L +N L ++ G + NL L L
Sbjct: 481 ALAALRCLEVLQASDNALE---------------------NVDG-----VANLPRLQELL 514
Query: 325 LYLNQLNGV-IPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSL 368
L N+L + + L L+L N L L +
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 1e-14
Identities = 44/255 (17%), Positives = 82/255 (32%), Gaps = 11/255 (4%)
Query: 344 LRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLF 403
L SL + + S E L K+ S L +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDS-ATDEQLFRCELSVEKST 362
Query: 404 GPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPK 463
+ L+S L+ + + + L + + F + + +
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP---MR 418
Query: 464 LDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLS 523
+ + + + ++ L L+ + + LE+L + L LS N+L
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR 476
Query: 524 GSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFS-HTIPIEFEKLI 582
++P +L L+ L S N L + + + NL +L L L NN+
Sbjct: 477 -ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCP 533
Query: 583 HLSKLDLSHNILQEE 597
L L+L N L +E
Sbjct: 534 RLVLLNLQGNSLCQE 548
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.6 bits (185), Expect = 4e-14
Identities = 57/401 (14%), Positives = 117/401 (29%), Gaps = 71/401 (17%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLST-----LDLSQNQLNGLIPCTLDNLSNLDTLFLYKNS 257
N+ S + Y ++G + + + L+ L S + TL L +
Sbjct: 221 TDPNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDE 280
Query: 258 LSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLM--------SLFSNSLSGS 309
S+ + ++ + + + S+ + + +
Sbjct: 281 APLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC 340
Query: 310 IPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLS 369
+ L L + + V+ + + L+ L N +I I +++L
Sbjct: 341 WCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALD 396
Query: 370 ELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGK 429
L K L + L ++ + ++ + +
Sbjct: 397 PLLYEKETLQ--------YFSTLKAVDPMR----------------AAYLDDLRSKFLLE 432
Query: 430 VYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQ 489
++ ++ L L+ + L L+ +
Sbjct: 433 NSVLKMEYADVRVLHLAHKDL--------TVLCHLEQL------------------LLVT 466
Query: 490 FLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS- 548
LDLS N + +P L L L L S N L +V +L LQ L L N+L
Sbjct: 467 HLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQS 523
Query: 549 SIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDL 589
+ + + + +L LNL N I+ L +
Sbjct: 524 AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 3e-10
Identities = 29/135 (21%), Positives = 48/135 (35%), Gaps = 29/135 (21%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
+ +L+LS N +PP + L L+ L +N L V + L +L+ L
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELL 514
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN---SLFGY 213
L N+ + Q + I L + +L LL L N G
Sbjct: 515 LCNNR--------LQQSAAIQP---------------LVSCPRLVLLNLQGNSLCQEEGI 551
Query: 214 IPTVMGNLKSLSTLD 228
+ L S+S++
Sbjct: 552 QERLAEMLPSVSSIL 566
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 3/128 (2%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262
LYL++N + P V +L +L L L NQL L D+L+ L L L N L+ +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VL 103
Query: 263 PS-IIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLS 321
PS + L L +L + N+L+ +P L+ T ++L N L L SL+
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162
Query: 322 TLGLYLNQ 329
L+ N
Sbjct: 163 HAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 41/139 (29%), Positives = 64/139 (46%), Gaps = 15/139 (10%)
Query: 514 KLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQFSH 572
L L NQ++ P F SL L+ L L +N+L ++P + +L +L L+L NQ +
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 573 TIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSL 632
F++L+HL +L + N L E+P + + L L L N L F+++ SL
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 633 ------------SCIDICY 639
C DI Y
Sbjct: 162 THAYLFGNPWDCECRDIMY 180
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 42/151 (27%), Positives = 57/151 (37%), Gaps = 25/151 (16%)
Query: 106 NLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGT 165
L L N P +L L+ L LG+NQL + L QL L L NQL
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 166 IPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLS 225
+P + F L L L++ N L +P + L L+
Sbjct: 103 LPSAV--------FD---------------RLVHLKELFMCCNKL-TELPRGIERLTHLT 138
Query: 226 TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKN 256
L L QNQL + D LS+L +L+ N
Sbjct: 139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 37/121 (30%), Positives = 62/121 (51%), Gaps = 7/121 (5%)
Query: 525 SVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIH 583
SVP G T Q L L N+++ P +L+ L L L +NQ +P+ F+ L
Sbjct: 33 SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 584 LSKLDLSHNILQEEIPPQVCN-MESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNEL 642
L+ LDL N L +P V + + L++L + N L+ +PR E++ L+ + + N+L
Sbjct: 90 LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
Query: 643 Q 643
+
Sbjct: 148 K 148
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 7/134 (5%)
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLS-FGNLSSWTLMSLFSN 304
+N L+L+ N ++ P + +L +L +L L NQL ++P+ F +L+ T++ L +N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 305 SLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI- 362
L+ +P + L L L + N+L +P I L+ L +L+L N L SIP
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL-KSIPHGAF 155
Query: 363 GYLKSLSELKLCKN 376
L SL+ L N
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 43/131 (32%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 323 LGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGV 381
L L+ NQ+ + P +L +L+ L L +N L G++P + L L+ L L N L+ V
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 382 IPHSV-GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNL 440
+P +V L L L MC N L +P+ ++ LT L + +QN L + AF +L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 441 TFLDLSQNNFD 451
T L N +D
Sbjct: 162 THAYLFGNPWD 172
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 36/152 (23%), Positives = 58/152 (38%), Gaps = 26/152 (17%)
Query: 408 KSLKSL-----TSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNN--------FDGKI 454
K S+ T+ + + + N + F NL L L N FD
Sbjct: 29 KRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD--- 85
Query: 455 SFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSSNHIVGKIPVQLEKLFSLN 513
+L +L + N + +P + D L+ L + N + ++P +E+L L
Sbjct: 86 -----SLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLT 138
Query: 514 KLILSLNQLSGSVPLE-FGSLTELQYLDLSAN 544
L L NQL S+P F L+ L + L N
Sbjct: 139 HLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 67/272 (24%), Positives = 108/272 (39%), Gaps = 42/272 (15%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALNEIRHRNIV 814
+G+G G V A + + VAVK + + N+ + + H N+V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE------NIKKEICINKMLNHENVV 68
Query: 815 KFHGFCSNARHSFLVCEYLHRGSL-ARILGNDATAKELSWNRRI--NVIKGVANALSYLH 871
KF+G +L EY G L RI + + + +R ++ GV YLH
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA--QRFFHQLMAGV----VYLH 122
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR---TEFVGTFGYAAPEI 928
I HRDI +N+LLD +SDFG+A + R GT Y APE+
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL 178
Query: 929 ----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
+ E DV+S G+++ ++ G P D S + +S+ + +
Sbjct: 179 LKRREF---HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--WKEKKTYLNPWKK 233
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ L+ + L E+P AR T+
Sbjct: 234 IDSAPLA-LLHKI------LVENPSARITIPD 258
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 57/274 (20%), Positives = 106/274 (38%), Gaps = 42/274 (15%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
+G+G G V + + AVK + L + + L +RH+N+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 818 GFCSNA--RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
N + ++V EY G + + K + + + L YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-- 128
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN---RTEFVGTFGYAAPEIAYTM 932
I+H+DI N+LL +S G+A+ + P++++ RT G+ + PEIA
Sbjct: 129 -GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEIA--- 183
Query: 933 RATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSF--SNMIIEVNQILDPRLSTP 985
+ + D++S GV ++ + G +P F N+ I + P
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYP----------FEGDNIYKLFENIGKGSYAIP 233
Query: 986 ---SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
P + D L+ M L+ P R ++ +
Sbjct: 234 GDCGPPLSD-LLKGM------LEYEPAKRFSIRQ 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 56/285 (19%), Positives = 100/285 (35%), Gaps = 53/285 (18%)
Query: 738 DGKIMHEEIIKATDDFDEKF----CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMA 793
G+ ++I + I G G+V G VA+K+ + + G
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV 64
Query: 794 DQDEFLNVVLA---------LNEIRHRNIVK-FHGFCSNARHSF----LVCEYLHRGSLA 839
+ + L LN H NI+ F + LV E + LA
Sbjct: 65 NI--LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA 121
Query: 840 RILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAH 897
+++ +S + + L LH ++HRD+ N+LL +
Sbjct: 122 QVI--HDQRIVISPQHIQYFMYHILLGLHVLH-----EAGVVHRDLHPGNILLADNNDIT 174
Query: 898 VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVI----- 951
+ DF +A+ +N+T +V Y APE+ T+ D++S G ++ E+
Sbjct: 175 ICDFNLAREDTA-DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233
Query: 952 -KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995
+G+ + N I+EV + TP + S
Sbjct: 234 FRGSTFYNQL--------NKIVEV-------VGTPKIEDVVMFSS 263
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 33/208 (15%)
Query: 742 MHEEIIKATDDFD-EKFCIGKGGQGSVYKA---ELPSGDIVAVKKFNSQLLSGNMADQDE 797
+ E + D F+ E +G+G G VYKA + A+K+ +S
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS------MS 64
Query: 798 FLNVVLALNEIRHRNIVKFHG-FCSNARHS-FLVCEYL-HRGSLARILGNDATAKELSWN 854
+ L E++H N++ F S+A +L+ +Y H L I+ +K
Sbjct: 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH--DLWHIIKFHRASKANKKP 122
Query: 855 RRIN--VIKGVA----NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH----VSDFGIA 904
++ ++K + + + YLH + ++HRD+ N+L+ E ++D G A
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 905 KF----VEPYSSNRTEFVGTFGYAAPEI 928
+ ++P + V TF Y APE+
Sbjct: 180 RLFNSPLKPLADLDPVVV-TFWYRAPEL 206
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 62/292 (21%), Positives = 113/292 (38%), Gaps = 57/292 (19%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALN---------- 806
IGKG G V A A+K + +L+ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 807 -----EI------RHRNIVKFHG--FCSNARHSFLVCEYLHRGSLARILGNDATAKELSW 853
EI H N+VK N H ++V E +++G + + +++ +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 854 N--RRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911
+ + + YLH+ IIHRDI N+L+ + ++DFG++ +
Sbjct: 141 FYFQDL------IKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 912 SNRTEFVGTFGYAAPEI------AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 965
+ + VGT + APE ++ +A DV++ GV ++ + G P F
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQCP--FMDERIM 246
Query: 966 SFSNMIIEVNQILD-PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ I +Q L+ P + + D LI+ M LD++PE+R + +
Sbjct: 247 CLHSKI--KSQALEFPDQPDIAEDLKD-LITRM------LDKNPESRIVVPE 289
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 76.8 bits (188), Expect = 3e-14
Identities = 84/627 (13%), Positives = 175/627 (27%), Gaps = 161/627 (25%)
Query: 379 SGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVR--FNQNNLVGKVYEAFG- 435
+G + ++ + +N + KS+ S + + + V F
Sbjct: 11 TGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70
Query: 436 --DHPNLT---FL-DLSQNNFD---GKISFNWRNLPKLDT--FIVSMNNIFGSIPLEIGD 484
F+ ++ + N+ I R P + T +I + ++
Sbjct: 71 LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ-PSMMTRMYIEQRDRLYND------- 122
Query: 485 SSKLQFLDLSSNHIVGKIPVQ-LEKLFSLNKLILSLNQLSGSVPLE----FGSLTELQYL 539
N + K V L+ L + +L L V ++ G T +
Sbjct: 123 -----------NQVFAKYNVSRLQPYLKLRQALLELRPAKN-VLIDGVLGSGK-TWVALD 169
Query: 540 DLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIP 599
+ K+ + I ++LNL N T+ +KL++ + +
Sbjct: 170 VCLSYKVQCKMDFKI------FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 600 PQVCNMESLEKLNL----SHNN-------------LSGFIPRCFEKM----RSLSCIDIC 638
+ E L + N + F C K+ R D
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC--KILLTTRFKQVTDF- 280
Query: 639 YNELQGPIPNSTVFKDGLMEGNKGLCGNFEAFSSCDAFMSHKQTSRKKWIVIVFPILGMV 698
+ +T L + L E S ++ + + ++ P
Sbjct: 281 -------LSAATTTHISLDHHSMTL-TPDEVKSLLLKYLDCRPQDLPREVLTTNP----- 327
Query: 699 LLLISLIGFFF--------FFRQRKKDSQEEQTISM-----NP------LRLLSVLNFDG 739
+S+I ++ D I P LSV
Sbjct: 328 -RRLSIIAESIRDGLATWDNWKHVNCDKLTT-IIESSLNVLEPAEYRKMFDRLSVFPPSA 385
Query: 740 KIM------------HEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQL 787
I +++ + + + K + S +PS + K
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SIPSIYLELKVK----- 438
Query: 788 LSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR---------HSFLV-----CEYL 833
+ + L+ + + H NI K F S+ +S + E+
Sbjct: 439 -----LENEYALHRSI----VDHYNIPK--TFDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487
Query: 834 HRGSLARILGNDATAKELSW-NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL 892
R +L R++ D + ++I NA + + ++ N D
Sbjct: 488 ERMTLFRMVFLD-----FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN---DP 539
Query: 893 EFEAHVSDFGIAKFVEPYSSN--RTEF 917
++E V+ I F+ N +++
Sbjct: 540 KYERLVNA--ILDFLPKIEENLICSKY 564
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 2e-07
Identities = 95/560 (16%), Positives = 185/560 (33%), Gaps = 144/560 (25%)
Query: 153 RRLYLD-MNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNS-- 209
R+Y++ ++L+ F NVS R L + ALL L
Sbjct: 109 TRMYIEQRDRLYNDNQV------------FAKYNVS-R-LQPYLKL-RQALLELRPAKNV 153
Query: 210 -LFGYIPTVMGNL-KSLSTLDLSQNQLNGLIPCTLD------NLSNLDTLFLYKNSLSGS 261
+ G + K+ LD+ + + C +D NL N + S
Sbjct: 154 LIDG-----VLGSGKTWVALDVCLSYK---VQCKMDFKIFWLNLKNCN-----------S 194
Query: 262 IPSIIGNLKSL-HQLDLIENQL---SGSIPLSFGNLSSW--TLMSL--FSNSLSGSIPPI 313
+++ L+ L +Q+D S +I L ++ + L+ + N L +
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL-----V 249
Query: 314 LGNLKSLSTLG--------LYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365
L N+++ L + V ++ +L + L P+E
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT---PDE---- 302
Query: 366 KSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKS-LTSLKRVRFNQN 424
S L + +P V T L++ I +S++ L + +
Sbjct: 303 -VKSLLLKYLDCRPQDLPREV-LTTNPRRLSI--------IAESIRDGLATWDNWKHVNC 352
Query: 425 NLVGKVYEAFGDH--PNLT---FLDLSQNNFDGKISFN-----WRNLPKLDTFIVSMNNI 474
+ + + E+ + P F LS I W ++ K D +V +N +
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV-VNKL 411
Query: 475 FGSIPLEI-GDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSL 533
+E S + + ++ ++ V+LE ++L++ I+ +
Sbjct: 412 HKYSLVEKQPKESTISIPSI---YL--ELKVKLENEYALHRSIVD----------HYNIP 456
Query: 534 TELQYLDLSANKLSSSIPKSIG------------NLLKLYYLNLSNNQFSHTIPIEFEKL 581
DL L IG L ++ +L+ F +E +K+
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR---F-----LE-QKI 507
Query: 582 IHLSKLDLSH----NILQ--EEIPPQVC-NMESLEKLNLSHNNLSGFIPRCFEKMRSLSC 634
H S + N LQ + P +C N E+L N + F+P+ E +
Sbjct: 508 RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERL---VNAILDFLPKIEENLICSKY 564
Query: 635 IDICYNELQGPIPNSTVFKD 654
D+ L + +F++
Sbjct: 565 TDLLRIALMA--EDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 8e-05
Identities = 68/448 (15%), Positives = 132/448 (29%), Gaps = 123/448 (27%)
Query: 715 KKDSQEEQTISMNPLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAEL-- 772
T LRL L + M ++ ++ + KF + K E
Sbjct: 56 MSKDAVSGT-----LRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP------IKTEQRQ 104
Query: 773 PSGDIVAV-----KKFNS-QLLS-GNMADQDEFLNVVLALNEIRHRNIVKFHGF------ 819
PS + +N Q+ + N++ +L + AL E+R V G
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKT 164
Query: 820 ------CSNARHSFLVCE------YLHRGS--------------LARILGNDATAKELSW 853
C + + + C+ +L+ + L +I N + + S
Sbjct: 165 WVALDVCLSYK---VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS 221
Query: 854 N--RRINVIKGVANALSYL-----HHDCLPSIIHRDISSKNVLLDLEFEAHV----SDFG 902
N RI+ I+ L L + +CL ++ ++ + +
Sbjct: 222 NIKLRIHSIQ---AELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 903 IAKFVEPYSSNRTEFVG-TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP----- 956
+ F+ ++ + E KY L EV+ +P
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDE---VKSLLLKYLDCRPQDLPREVLTT-NPRRLSI 332
Query: 957 -----RDFFS-------INFSSFSNMI-IEVNQILDP-------------RLSTPSP-GV 989
RD + +N + +I +N L+P S P +
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNV-LEPAEYRKMFDRLSVFPPSAHIPTIL 391
Query: 990 MDKL------ISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILAIEASADYGQ 1043
+ + +M V S + E Y + L ++ +Y
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE------LKVKLENEYAL 445
Query: 1044 TTLCLETYSMLVLHLFDNPKLDPPSIDD 1071
++ Y+ + FD+ L PP +D
Sbjct: 446 HRSIVDHYN--IPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 57/376 (15%), Positives = 123/376 (32%), Gaps = 92/376 (24%)
Query: 9 LILFLLLNFSHNVTSDSSAEACALLNWKTS-----------LQNQNLNSSLL------SS 51
+L +L + + + ++ + N K L+++ + LL ++
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNA 256
Query: 52 WTLYPTNASKISPCSWFGISCNHAGSRVI----SINLSTLCLNGTFQDFSFSSFPHLVNL 107
NA F +SC +++ ++ T S +
Sbjct: 257 KAW---NA--------FNLSC-----KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 108 NLSFNLF-------FGNIPPQ-----------IG-----NLSKLQN-LDLGNNQLSGVIS 143
+ +L ++P + I L+ N + ++L+ +I
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360
Query: 144 PEIGKLN--QLRRLYLDMN--QLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGN-LS 198
+ L + R+++ ++ IP ++ LSLI +V + N L
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL--LSLI------WFDVIKSDVMVVVNKLH 412
Query: 199 KLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLF---LYK 255
K +L+ IP++ L+ L+ ++ L+ I +D+ + T L
Sbjct: 413 KYSLVEKQPKESTISIPSIY--LELKVKLE-NEYALHRSI---VDHYNIPKTFDSDDLIP 466
Query: 256 NSLSGSIPSIIGNLKSLHQLDLIEN-QLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPIL 314
L S IG H L IE+ + + F + + + +S + + +
Sbjct: 467 PYLDQYFYSHIG-----HHLKNIEHPERMTLFRMVFLDF-RFLEQKIRHDSTAWNASGSI 520
Query: 315 GNLKSLSTLGLYLNQL 330
N L L Y +
Sbjct: 521 LNT--LQQLKFYKPYI 534
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-14
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 56/277 (20%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADQ--DEFLNVVLALNEIRHRNIV 814
+G G G V + +G VAVK N ++ S ++ + E + L RH +I+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRHPHII 79
Query: 815 KFHGFCSNARHSFLVCEYLHRGSL-------ARILGNDATAKELSWNRRINVIKGVANAL 867
K + S F+V EY+ G L R+ ++ RR+ + + + +
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES--------RRL--FQQILSGV 129
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
Y H ++HRD+ +NVLLD A ++DFG++ + RT G+ YAAPE
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPE 185
Query: 928 IAYTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
+ + Y D++S GV+++ ++ G P D ++ +I D
Sbjct: 186 VI----SGRLYAGPEVDIWSSGVILYALLCGTLPFD--------DDHVPTLFKKICDGIF 233
Query: 983 STP---SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
TP +P V+ L+ M L P R T++
Sbjct: 234 YTPQYLNPSVIS-LLKHM------LQVDPMKRATIKD 263
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 33/224 (14%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
D FD +G G G V + SG+ A+K + Q + + + LN L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVN 99
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSL------ARILGNDAT---AKELSWNRRINVI 860
+VK + + ++V EY+ G + A +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ---------- 149
Query: 861 KGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE-FVG 919
+ YLH +I+RD+ +N+L+D + V+DFG AK V+ RT G
Sbjct: 150 --IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCG 200
Query: 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 963
T APEI + + D ++ GVL++E+ G P FF+
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQ 242
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-14
Identities = 56/270 (20%), Positives = 103/270 (38%), Gaps = 38/270 (14%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+DF+ IG+G G V +L + + A+K N + A+ F L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGD 132
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
+ I H + + +LV +Y G L +L R + + A+
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF--YLAEMVIAIDS 190
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTE-FVGTFGYAAP 926
+H +HRDI N+L+D H+ +DFG + + ++ VGT Y +P
Sbjct: 191 VHQL---HYVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 927 EIAYTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981
EI M + D +S GV ++E++ G P F++ +++ +I++ +
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP--FYA------ESLVETYGKIMNHK 297
Query: 982 LSTPSPGVMDKLISIMEVAILCLDESPEAR 1011
P + + S A+
Sbjct: 298 ERFQFPTQVTDV-------------SENAK 314
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-14
Identities = 63/301 (20%), Positives = 120/301 (39%), Gaps = 41/301 (13%)
Query: 713 QRKKDSQEEQTISMNPLRLLSVLNFDGKIMHEEIIKAT------DDFDEKFCIGKGGQGS 766
Q D ++Q + R S + G E + ++F+ +GKG G
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGK 163
Query: 767 VYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH----RNIVKF--HGF 819
V + +G A+K + V++A +E+ H +++ H F
Sbjct: 164 VILVKEKATGRYYAMKILKKE--------------VIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 820 CSNARHSF-------LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+ ++SF V EY + G L L + E +R + +AL YLH
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE---DRARFYGAEIVSALDYLHS 266
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM 932
+ ++++RD+ +N++LD + ++DFG+ K + F GT Y APE+
Sbjct: 267 EK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 933 RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDK 992
D + GV+++E++ G P F++ + +I+ L + ++
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 382
Query: 993 L 993
L
Sbjct: 383 L 383
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 70/295 (23%), Positives = 119/295 (40%), Gaps = 48/295 (16%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---------LNEI 808
IG G QG V A + VA+KK + F N A + +
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLS-----------RPFQNQTHAKRAYRELVLMKCV 81
Query: 809 RHRNIVK-FHGFCS-NARHSF----LVCEYLHRGSLARILGNDATAKELSWNRRINVIKG 862
H+NI+ + F + F +V E + +L +++ EL R ++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQ 135
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
+ + +LH IIHRD+ N+++ + + DFG+A+ S T +V T
Sbjct: 136 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRY 191
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
Y APE+ M E D++S G ++ E+IKG F + I + N++++ +L
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGT-----DHIDQWNKVIE-QL 242
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILAIEA 1037
TP P M KL + + + + EK F + D + A +A
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENRPKYA--GYSFEKLFPDVLFPADSEHNKLKASQA 295
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 60/277 (21%), Positives = 109/277 (39%), Gaps = 57/277 (20%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816
+G+G G V A + VA+K + L +M + E + L +RH +I+K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74
Query: 817 HGFCSNARHSFLVCEY---------LHRGSLARILGNDATAKELSWNRRINVIKGVANAL 867
+ + +V EY + + + + RR + + A+
Sbjct: 75 YDVITTPTDIVMVIEYAGGELFDYIVEKKRM-----TEDEG------RRF--FQQIICAI 121
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
Y H I+HRD+ +N+LLD ++DFG++ + + +T G+ YAAPE
Sbjct: 122 EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPE 177
Query: 928 IAYTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
+ + Y DV+S G++++ ++ G P D + ++
Sbjct: 178 VI----NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD--------DEFIPNLFKKVNSCVY 225
Query: 983 STP---SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
P SPG LI M + P R T+++
Sbjct: 226 VMPDFLSPGAQS-LIRRM------IVADPMQRITIQE 255
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 4/104 (3%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262
L L +N L V L L+ L LSQNQ+ L D L+ L L+L++N L S+
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SL 91
Query: 263 PS-IIGNLKSLHQLDLIENQLSGSIPL-SFGNLSSWTLMSLFSN 304
P+ + L L +L L NQL S+P F L+S + L +N
Sbjct: 92 PNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 6e-11
Identities = 38/119 (31%), Positives = 56/119 (47%), Gaps = 12/119 (10%)
Query: 214 IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSL 272
IP+ S + L+L N+L L D L+ L L L +N + S+P + L L
Sbjct: 26 IPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 273 HQLDLIENQLSGSIPLS-FGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQ 329
L L EN+L S+P F L+ ++L +N L S+P I L SL + L+ N
Sbjct: 79 TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 4/105 (3%)
Query: 514 KLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHT 573
+L L N+L F LT+L L LS N++ S L KL L L N+ +
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 574 IPIE-FEKLIHLSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHN 616
+P F+KL L +L L N L+ +P + + SL+K+ L N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 35/128 (27%), Positives = 53/128 (41%), Gaps = 24/128 (18%)
Query: 129 QNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSG 188
L+L +N+L + KL QL +L L NQ+ ++P + F
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGV----------FDK----- 74
Query: 189 RIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNL 248
L+KL +LYL+ N L V L L L L NQL + D L++L
Sbjct: 75 --------LTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSL 126
Query: 249 DTLFLYKN 256
++L+ N
Sbjct: 127 QKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 25/83 (30%), Positives = 39/83 (46%), Gaps = 2/83 (2%)
Query: 562 YLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCN-MESLEKLNLSHNNLSG 620
L L +N+ F+KL L+KL LS N +Q +P V + + L L L N L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQS 90
Query: 621 FIPRCFEKMRSLSCIDICYNELQ 643
F+K+ L + + N+L+
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLK 113
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 43/130 (33%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262
L L NSL V L SL+ L L N+L L + L++L L L N L S+
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SL 91
Query: 263 PS-IIGNLKSLHQLDLIENQLSGSIPL-SFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKS 319
P+ + L L +L L NQL S+P F L+ + L+ N L S+P + L S
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTS 149
Query: 320 LSTLGLYLNQ 329
L + L+ N
Sbjct: 150 LQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 46/140 (32%), Positives = 58/140 (41%), Gaps = 16/140 (11%)
Query: 514 KLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHT 573
L L N L F LT L L L NKL S L L YLNLS NQ
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 574 IPIEFEKLIHLSKLDLSHNILQEEIPPQVCN-MESLEKLNLSHNNLSGFIPR-CFEKMRS 631
F+KL L +L L+ N LQ +P V + + L+ L L N L +P F+++ S
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTS 149
Query: 632 L------------SCIDICY 639
L +C I Y
Sbjct: 150 LQYIWLHDNPWDCTCPGIRY 169
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 42/152 (27%), Positives = 59/152 (38%), Gaps = 26/152 (17%)
Query: 106 NLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGT 165
L+L N L+ L L LG N+L + + KL L L L NQL +
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 166 IPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT-VMGNLKSL 224
+P + F L++L L LN N L +P V L L
Sbjct: 91 LPNGV--------FD---------------KLTQLKELALNTNQL-QSLPDGVFDKLTQL 126
Query: 225 STLDLSQNQLNGLIPCTLDNLSNLDTLFLYKN 256
L L QNQL + D L++L ++L+ N
Sbjct: 127 KDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 38/120 (31%), Positives = 54/120 (45%), Gaps = 4/120 (3%)
Query: 525 SVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHL 584
SVP G + YLDL N L S L L L L N+ F KL L
Sbjct: 21 SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 585 SKLDLSHNILQEEIPPQVCN-MESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+ L+LS N LQ +P V + + L++L L+ N L F+K+ L + + N+L+
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 44/143 (30%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKS 319
S+P+ I LDL N L F L+S T + L N L S+P + L S
Sbjct: 21 SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 320 LSTLGLYLNQLNGVIPPSI-GNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNN 377
L+ L L NQL +P + L+ L+ L+L N L S+P+ + L L +L+L +N
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQ 135
Query: 378 LSGVIPH----SVGNLTGLVLLN 396
L V P + +L + L +
Sbjct: 136 LKSV-PDGVFDRLTSLQYIWLHD 157
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 37/172 (21%)
Query: 408 KSLKSL-----TSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLP 462
+ S+ + N+L F + +LT L L N
Sbjct: 17 QGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ----------- 65
Query: 463 KLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSSNHIVGKIPVQL-EKLFSLNKLILSLN 520
S+P + + + L +L+LS+N + +P + +KL L +L L+ N
Sbjct: 66 --------------SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTN 110
Query: 521 QLSGSVPLE-FGSLTELQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQF 570
QL S+P F LT+L+ L L N+L S+P + L L Y+ L +N +
Sbjct: 111 QLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDNPW 160
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 45/132 (34%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 249 DTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLS-FGNLSSWTLMSLFSNSLS 307
L L NSL + L SL QL L N+L S+P F L+S T ++L +N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 308 GSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSI-GNLSSLRNLSLFNNGLYGSIPEEI-GY 364
S+P + L L L L NQL +P + L+ L++L L+ N L S+P+ +
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDR 146
Query: 365 LKSLSELKLCKN 376
L SL + L N
Sbjct: 147 LTSLQYIWLHDN 158
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 60/251 (23%), Positives = 104/251 (41%), Gaps = 46/251 (18%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---------LNEI 808
IG G QG V A + VA+KK + F N A + +
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLS-----------RPFQNQTHAKRAYRELVLMKCV 118
Query: 809 RHRNIVKFH------GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG 862
H+NI+ + +LV E + +L +++ EL R ++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQ 172
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
+ + +LH IIHRD+ N+++ + + DFG+A+ S T +V T
Sbjct: 173 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRY 228
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
Y APE+ M E D++S G ++ E+++ + F + I + N++++ +L
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRH---KILFPGR-----DYIDQWNKVIE-QL 279
Query: 983 STPSPGVMDKL 993
TP P M KL
Sbjct: 280 GTPCPEFMKKL 290
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 203 LYLNNNSLFGYIPT-VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261
L LN+N L + G L L L+L +NQL G+ P + S++ L L +N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92
Query: 262 IPS-IIGNLKSLHQLDLIENQLSGSIPL-SFGNLSSWTLMSLFSN 304
I + + L L L+L +NQ+S + SF +L+S T ++L SN
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 32/121 (26%), Positives = 52/121 (42%), Gaps = 11/121 (9%)
Query: 214 IPTVMGNLKSLSTLDLSQNQLNGLIPC-TLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSL 272
IP + L L+ N+L + L +L L L +N L+G P+ +
Sbjct: 27 IPL------HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 273 HQLDLIENQLSGSIPL-SFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQL 330
+L L EN++ I F L ++L+ N +S + P +L SL++L L N
Sbjct: 81 QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPF 138
Query: 331 N 331
N
Sbjct: 139 N 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 39/118 (33%), Positives = 54/118 (45%), Gaps = 5/118 (4%)
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQL-EKLFSLNKLILSLNQLSGSVPLEFGSLTE 535
IP +I + L L+ N + L +L L KL L NQL+G P F +
Sbjct: 22 EIPRDIPLHT--TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 536 LQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHN 592
+Q L L NK+ K L +L LNL +NQ S + FE L L+ L+L+ N
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 5/105 (4%)
Query: 534 TELQYLDLSANKLSSSIPKSI-GNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHN 592
L L+ N+L + G L L L L NQ + P FE H+ +L L N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 593 ILQEEIPPQVCN-MESLEKLNLSHNNLSGFIPR-CFEKMRSLSCI 635
++E I ++ + L+ LNL N +S + FE + SL+ +
Sbjct: 89 KIKE-ISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSL 131
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 23/87 (26%), Positives = 40/87 (45%), Gaps = 6/87 (6%)
Query: 487 KLQFLDLSSNHIVGKIPVQL-EKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSAN 544
L L+L N + I E + +L L N++ + + F L +L+ L+L N
Sbjct: 55 HLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDN 112
Query: 545 KLSSSIPKSI-GNLLKLYYLNLSNNQF 570
++S + +L L LNL++N F
Sbjct: 113 QISC-VMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 5/110 (4%)
Query: 129 QNLDLGNNQLSGVISPEI-GKLNQLRRLYLDMNQLHGTIPP-VIGQLSLIHEFSFCHNNV 186
L L +N+L + S + G+L L +L L NQL I P S I E N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 187 SGRIPSSL-GNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235
I + + L +L L L +N + +P +L SL++L+L+ N N
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 30/112 (26%), Positives = 42/112 (37%), Gaps = 26/112 (23%)
Query: 98 FSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
F PHLV L L N I P S +Q L LG N++ + + L+QL+ L
Sbjct: 50 FGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN 208
L NQ+ + P S +L+ L L L +N
Sbjct: 109 LYDNQIS-CVM-----------------------PGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 20/84 (23%), Positives = 36/84 (42%), Gaps = 3/84 (3%)
Query: 562 YLNLSNNQFSHTIPI-EFEKLIHLSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNNLS 619
L L++N+ F +L HL KL+L N L I P +++L L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 620 GFIPRCFEKMRSLSCIDICYNELQ 643
+ F + L +++ N++
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 27/180 (15%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRN 812
+G+G G V K +G IVA+KKF +D D+ + + L ++RH N
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFL-------ESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+V C + +LV E++ ++ L + L + + + N + + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF----VEPYSSNRTEFVGTFGYAAPEI 928
+IIHRDI +N+L+ + DFG A+ E Y + V T Y APE+
Sbjct: 143 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY----DDEVATRWYRAPEL 195
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 43/180 (23%), Positives = 76/180 (42%), Gaps = 27/180 (15%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRN 812
IG+G G V+K +G IVA+KKF ++ D + + L +++H N
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFL-------ESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+V R LV EY ++ L D + + + ++ A+++ H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF----VEPYSSNRTEFVGTFGYAAPEI 928
+ IHRD+ +N+L+ + DFG A+ + Y + V T Y +PE+
Sbjct: 121 H---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY----DDEVATRWYRSPEL 173
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.8 bits (172), Expect = 6e-13
Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 34/183 (18%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRNI 813
IG+G G VYKA+ G+ A+KK + +DE + + L E++H NI
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA----NALSY 869
VK + + LV E+L + L ++L D L K N ++Y
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLE----SVTAKSFLLQLLNGIAY 115
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF----VEPYSSNRTEFVGTFGYAA 925
H ++HRD+ +N+L++ E E ++DFG+A+ V Y+ + T Y A
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE----IVTLWYRA 168
Query: 926 PEI 928
P++
Sbjct: 169 PDV 171
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-13
Identities = 56/260 (21%), Positives = 103/260 (39%), Gaps = 61/260 (23%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---------LNEI 808
+G G GSV A + SG+ VA+KK + F + + A L +
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLS-----------RPFQSEIFAKRAYRELLLLKHM 80
Query: 809 RHRNIVK-FHGFCSNARHS-----FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG 862
+H N++ F + +LV ++ L +I+G + S + ++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG-----LKFSEEKIQYLVYQ 134
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
+ L Y+H ++HRD+ N+ ++ + E + DFG+A+ + T +V T
Sbjct: 135 MLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRW 188
Query: 923 YAAPEIAYT-MRATEKYDVYSFGVLVFEVI------KGNHPRDFFSINFSSFSNMIIEVN 975
Y APE+ + M + D++S G ++ E++ KG D I++V
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--------TQILKV- 239
Query: 976 QILDPRLSTPSPGVMDKLIS 995
P + KL
Sbjct: 240 ------TGVPGTEFVQKLND 253
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 66/346 (19%), Positives = 109/346 (31%), Gaps = 70/346 (20%)
Query: 218 MGNLKSLSTLDLSQNQLNG----LIPCTLDNLSNLDTLFLYKNSLSG----SIPSIIGNL 269
M S+ L + + + L ++ + L N++ + I +
Sbjct: 1 MARF-SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 270 KSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQ 329
K L + + G + +L + L L T+ L N
Sbjct: 60 KDLEIAEFSDIFT--------GRVKDEIPEAL------RLLLQALLKCPKLHTVRLSDNA 105
Query: 330 L--NGVIP--PSIGNLSSLRNLSLFNNGLYGSIPEEIGYL-KSLSELKLCKNNLSGVIPH 384
P + + L +L L NNGL P+ + ++L EL + K
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKK-------- 154
Query: 385 SVGNLTGLVLLNMCENHLFGP----IPKSLKSLTSLKRVRFNQNNL-----VGKVYEAFG 435
N L + N L K+ +S L V+ QN + + E
Sbjct: 155 -AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213
Query: 436 DHPNLTFLDLSQNNF--DGKISF-----NWRNLPKLDTFIVSMNNI--FGSIP----LEI 482
L LDL N F G + +W NL +L ++ + G+
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG---LNDCLLSARGAAAVVDAFSK 270
Query: 483 GDSSKLQFLDLSSNHIVGKIPVQL-----EKLFSLNKLILSLNQLS 523
++ LQ L L N I L EK+ L L L+ N+ S
Sbjct: 271 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 61/332 (18%), Positives = 100/332 (30%), Gaps = 75/332 (22%)
Query: 343 SLRNLSLFNNGLYG----SIPEEIGYLKSLSELKLCKNN--------LSGVIPHSVGNLT 390
S+ SL + + S+ + S+ E+ L N LS I +L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK-DLE 63
Query: 391 GLVLLNMCENHLFGPIPKSLKSL-------TSLKRVRFNQNNL----VGKVYEAFGDHPN 439
++ + IP++L+ L L VR + N + + H
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 440 LTFLDLSQNNF-------------DGKISFNWRNLPKLDTFIVSMNNI--FGSIPL--EI 482
L L L N + ++ +N P L + I N +
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 483 GDSSKLQFLDLSSNHI-----VGKIPVQLEKLFSLNKLILSLNQLS--GSVPL--EFGSL 533
L + + N I + L L L L N + GS L S
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 534 TELQYLDLSANKLSSSIPKSIGNLLK------LYYLNLSNNQFSHTIPIEFEKLIHLSKL 587
L+ L L+ LS+ ++ + L L L N+ IE + + L +
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE------IELDAVRTLKTV 297
Query: 588 DLSHNILQEEIPPQVCNMESLEKLNLSHNNLS 619
+ E M L L L+ N S
Sbjct: 298 ------IDE-------KMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 55/367 (14%), Positives = 105/367 (28%), Gaps = 97/367 (26%)
Query: 190 IPSSLGNLSKLALLYLNNNSL----FGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNL 245
+ + L + + L+ N++ ++ + + K L + S + + L
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS--GSIPLSFGNLSSWTLMSLFS 303
+ + LH + L +N PL
Sbjct: 84 R--------------LLLQALLKCPKLHTVRLSDNAFGPTAQEPLI-------------- 115
Query: 304 NSLSGSIPPILGNLKSLSTLGLYLNQL-------------NGVIPPSIGNLSSLRNLSLF 350
L L L L+ N L + N LR++
Sbjct: 116 --------DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167
Query: 351 NNGLYG----SIPEEIGYLKSLSELKLCKNNL-----SGVIPHSVGNLTGLVLLNMCENH 401
N L + + L +K+ +N + ++ + L +L++ +N
Sbjct: 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227
Query: 402 LFGP-----IPKSLKSLTSLKRVRFNQNNL----VGKVYEAFGDHPN--LTFLDLSQNNF 450
F + +LKS +L+ + N L V +AF N L L L N
Sbjct: 228 -FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286
Query: 451 DGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHI--VGKIPVQLEK 508
+ + L T I L FL+L+ N + ++ +
Sbjct: 287 ELDA------VRTLKTVIDEKM-------------PDLLFLELNGNRFSEEDDVVDEIRE 327
Query: 509 LFSLNKL 515
+FS
Sbjct: 328 VFSTRGR 334
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 39/227 (17%), Positives = 67/227 (29%), Gaps = 49/227 (21%)
Query: 102 PHLVNLNLSFNLFFGNIPPQIGNL----SKLQNLDLGNNQLS-------------GVISP 144
P L + LS N F + + + L++L L NN L ++
Sbjct: 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153
Query: 145 EIGKLNQLRRLYLDMNQLHG----TIPPVIGQLSLIHEFSFCHNN-----VSGRIPSSLG 195
+ LR + N+L L+H N + + L
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213
Query: 196 NLSKLALLYLNNNSLFG-----YIPTVMGNLKSLSTLDLSQNQL---------NGLIPCT 241
+L +L L +N+ F + + + +L L L+ L +
Sbjct: 214 YCQELKVLDLQDNT-FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 272
Query: 242 LDNLSNLDTLFLYKNSLSGS-----IPSIIGNLKSLHQLDLIENQLS 283
L L L N + I + L L+L N+ S
Sbjct: 273 NIGLQTLR---LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 21/132 (15%), Positives = 39/132 (29%), Gaps = 22/132 (16%)
Query: 510 FSLNKLILSLNQLS--GSVPL--EFGSLTELQYLDLSANKLSSSIPKSIGNLLK----LY 561
FS+ L L+ ++ + ++ + LS N + + + + + L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 562 YLNLSNNQFSHTIPIEFE----------KLIHLSKLDLSHNILQEE----IPPQVCNMES 607
S+ E K L + LS N + +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 608 LEKLNLSHNNLS 619
LE L L +N L
Sbjct: 124 LEHLYLHNNGLG 135
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 59/264 (22%), Positives = 103/264 (39%), Gaps = 64/264 (24%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---------LNEI 808
IG+G G V A + + VA+KK + F + L
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISP------------FEHQTYCQRTLREIKILLRF 82
Query: 809 RHRNIVK-FHGFCSNARHSF----LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGV 863
RH NI+ + +V + + L ++L + LS + + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQI 137
Query: 864 ANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR---TEFV 918
L Y+H S ++HRD+ N+LL+ + + DFG+A+ +P + TE+V
Sbjct: 138 LRGLKYIH-----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 919 GTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVI------KGNHPRDFFSINFSSFSNMI 971
T Y APEI T+ D++S G ++ E++ G H D N I
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--------NHI 244
Query: 972 IEVNQILDPRLSTPSPGVMDKLIS 995
+ + L +PS ++ +I+
Sbjct: 245 LGI-------LGSPSQEDLNCIIN 261
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 60/260 (23%), Positives = 106/260 (40%), Gaps = 60/260 (23%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---------LNEI 808
+G G G+V A + +G VA+KK F + + A L +
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLY-----------RPFQSELFAKRAYRELRLLKHM 81
Query: 809 RHRNIVKFH------GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG 862
RH N++ + +LV ++ L +++ ++ +L +R ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE----KLGEDRIQFLVYQ 136
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
+ L Y+H IIHRD+ N+ ++ + E + DFG+A+ S T +V T
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRW 190
Query: 923 YAAPEIAYT-MRATEKYDVYSFGVLVFEVI------KGNHPRDFFSINFSSFSNMIIEVN 975
Y APE+ MR T+ D++S G ++ E+I KG+ D I++V
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL--------KEIMKV- 241
Query: 976 QILDPRLSTPSPGVMDKLIS 995
TP + +L S
Sbjct: 242 ------TGTPPAEFVQRLQS 255
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 43/189 (22%), Positives = 82/189 (43%), Gaps = 41/189 (21%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRN 812
+G+G G VYKA + + + VA+K+ + ++E + V L E++HRN
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIR-------LEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG----VANALS 868
I++ + L+ EY L + + ++S + VIK + N ++
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVS----MRVIKSFLYQLINGVN 146
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAH-----VSDFGIAKF----VEPYSSNRTEFVG 919
+ H +HRD+ +N+LL + + + DFG+A+ + ++ +
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE----II 199
Query: 920 TFGYAAPEI 928
T Y PEI
Sbjct: 200 TLWYRPPEI 208
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 61/239 (25%), Positives = 98/239 (41%), Gaps = 63/239 (26%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DF +G G G V+ +G A+K + +V+ L ++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE--------------IVVRLKQVE 51
Query: 810 H----RNI---------VKFHGFCSNARHSFLVCEYLHRGSL------ARILGNDAT--- 847
H R + ++ G +A+ F++ +Y+ G L ++ N
Sbjct: 52 HTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY 111
Query: 848 AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAK 905
A E V AL YLH II+RD+ +N+LLD H+ +DFG AK
Sbjct: 112 AAE------------VCLALEYLHSK---DIIYRDLKPENILLD--KNGHIKITDFGFAK 154
Query: 906 FVEPYSSNRTE-FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 963
+V + T GT Y APE+ T + D +SFG+L++E++ G P F+ N
Sbjct: 155 YVP----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDSN 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 34/183 (18%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRNI 813
+G+G G VYKA+ G IVA+K+ + +DE + + L E+ H NI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRI-------RLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA----NALSY 869
V + R LV E++ + L ++L D L + IK +++
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQ----DSQIKIYLYQLLRGVAH 134
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF----VEPYSSNRTEFVGTFGYAA 925
H I+HRD+ +N+L++ + ++DFG+A+ V Y+ V T Y A
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE----VVTLWYRA 187
Query: 926 PEI 928
P++
Sbjct: 188 PDV 190
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 2e-12
Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 35/184 (19%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRN 812
IG+G G+V+KA + +IVA+K+ + D DE + + L E++H+N
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVR-------LDDDDEGVPSSALREICLLKELKHKN 62
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA----NALS 868
IV+ H + + LV E+ + L + D+ +L ++K L
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLD----PEIVKSFLFQLLKGLG 115
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF----VEPYSSNRTEFVGTFGYA 924
+ H ++HRD+ +N+L++ E +++FG+A+ V YS+ V T Y
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE----VVTLWYR 168
Query: 925 APEI 928
P++
Sbjct: 169 PPDV 172
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 76/491 (15%), Positives = 148/491 (30%), Gaps = 71/491 (14%)
Query: 179 FSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMG------------NLKSLST 226
+ C+ R+ NL L L ++F IP G NL+ L +
Sbjct: 57 MALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKS 116
Query: 227 LDLSQNQL--NGLIPCTLDNLSNLDTLFLYKNSL--SGSIPSIIGNLKSLHQLDLIENQL 282
+ + + L +L+TL L K S + + SI+ + + + L + E+
Sbjct: 117 VHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEES-- 174
Query: 283 SGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSI---- 338
+ S L + + SL L Y+ + + P +
Sbjct: 175 ---------SFSEKDGKWLHE---------LAQHNTSLEVLNFYMTEFAKISPKDLETIA 216
Query: 339 GNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMC 398
N SL ++ + + + +L E N +P NL L
Sbjct: 217 RNCRSLVSVKV-GDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRL 275
Query: 399 ENHLFGP--IPKSLKSLTSLKRVRFNQNNLVG-KVYEAFGDHPNLTFLDLSQNNFD---G 452
GP +P ++++ L PNL L+ D
Sbjct: 276 GLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLE 335
Query: 453 KISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSS---------KLQFLDLSSNHI----V 499
++ + L +L + + +L+++ + + I +
Sbjct: 336 VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL 395
Query: 500 GKIPVQLEKLFSLNKLILSLNQLSGSVPLEFG------SLTELQYLDLSAN--KLSSSIP 551
I L+ L ++L + +PL+ G +L+ L+
Sbjct: 396 ESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGL 455
Query: 552 KSIGNLLK-LYYLNLSNNQFS-HTIPIEFEKLIHLSKLDLSH-NILQEEIPPQVCNMESL 608
IG + ++ L S + +L KL++ + I V + SL
Sbjct: 456 SYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSL 515
Query: 609 EKLNLSHNNLS 619
L + S
Sbjct: 516 RYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 57/454 (12%), Positives = 126/454 (27%), Gaps = 88/454 (19%)
Query: 179 FSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGY--IPTVMGNLKSLSTLDLSQNQL-- 234
F + + L L L+ S F + +++ + + + TL + ++
Sbjct: 119 FRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSE 178
Query: 235 --NGLIPCTLDNLSNLDTLFLYKNSLSG----SIPSIIGNLKSLHQLDLIENQLSGSIPL 288
+ + ++L+ L Y + + +I N +SL + +
Sbjct: 179 KDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKV----------- 227
Query: 289 SFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLS 348
G+ L+ F NL+ L + ++ L L
Sbjct: 228 --GDFEILELVGFFK---------AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLG 276
Query: 349 LFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSV----GNLTGLVLLNMCENHLFG 404
L G +P + + +L L L ++ NL L N+ +
Sbjct: 277 LSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLE 335
Query: 405 PIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDH---------PNLTFLDLSQNNFDGK-- 453
+ + K L L+ R + L ++ + ++ +
Sbjct: 336 VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL 395
Query: 454 --ISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSS------KLQFLDLSSN--------- 496
I +NL ++ +PL+ G S KL+
Sbjct: 396 ESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGL 455
Query: 497 HIVGKIPVQLEKLF-------------------SLNKLILSLNQLS-GSVPLEFGSLTEL 536
+G+ + + +L KL + S ++ L L
Sbjct: 456 SYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSL 515
Query: 537 QYLDLSANKLSSSIPKSIG---NLLKLYYLNLSN 567
+YL + + S + + + +
Sbjct: 516 RYLWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 59/398 (14%), Positives = 121/398 (30%), Gaps = 49/398 (12%)
Query: 83 NLSTLCLNG--TFQDFSFSSF----PHLVNLNLSFNLFFGNIPPQIGNLSK----LQNLD 132
+L TL L+ F S + L + + F + L++ L+ L+
Sbjct: 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLN 198
Query: 133 LGNNQLSGVISPEIGKL----NQLRRLYLDMNQL--HGTIPPVIGQLSLIHEFSFCHNNV 186
+ + + ++ + L + + ++ L S +
Sbjct: 199 FYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIG 258
Query: 187 SGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTL-DNL 245
+L KL L L+ +P + + LDL L CTL
Sbjct: 259 MPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKC 317
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS 305
NL+ L + + K L +L + + G +S L++L
Sbjct: 318 PNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ-- 375
Query: 306 LSGSIPPILGNLKSLSTLGLYLNQL--NGV--IPPSIGNLSSLRNLSLFNNGLYGSIPEE 361
+ L + +Y++ + + I + NL R + L +P +
Sbjct: 376 ----------GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLD 425
Query: 362 IG------YLKSLSELKL--CKNNLS----GVIPHSVGNLTGLVLLNMCENHLFGPIPKS 409
G K L + L+ I N+ + LL G + +
Sbjct: 426 NGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWM-LLGYVGESDEG-LMEF 483
Query: 410 LKSLTSLKRVRFNQNNLVGK-VYEAFGDHPNLTFLDLS 446
+ +L+++ + + A P+L +L +
Sbjct: 484 SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQ 521
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 43/184 (23%), Positives = 79/184 (42%), Gaps = 31/184 (16%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRN 812
+G G +VYK +G VA+K+ D +E + + E++H N
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAIREISLMKELKHEN 64
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA----NALS 868
IV+ + LV E++ L + + + T +N++K L+
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF----VEPYSSNRTEFVGTFGYA 924
+ H + I+HRD+ +N+L++ + + DFG+A+ V +SS V T Y
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE----VVTLWYR 175
Query: 925 APEI 928
AP++
Sbjct: 176 APDV 179
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 49/193 (25%), Positives = 76/193 (39%), Gaps = 42/193 (21%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVV-----------LALN 806
IG G G+VYKA + SG VA+K + + + L
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVR-------VPNGGGGGGGLPISTVREVALLRRLE 69
Query: 807 EIRHRNIVK----FHGFCSNARHS-FLVCEYLHRGSLARILGNDATAKELSWNRRINVIK 861
H N+V+ ++ LV E++ + L L + A L IK
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLP----AETIK 123
Query: 862 GVA----NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR--T 915
+ L +LH +C I+HRD+ +N+L+ ++DFG+A+ YS T
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALT 177
Query: 916 EFVGTFGYAAPEI 928
V T Y APE+
Sbjct: 178 PVVVTLWYRAPEV 190
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 6e-12
Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 34/184 (18%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRN 812
IG+G G VYKA +G++VA+KK + + E + + L E+ H N
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIR-------LDTETEGVPSTAIREISLLKELNHPN 63
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA----NALS 868
IVK +LV E+LH+ L + + + + + + +IK L+
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIP----LPLIKSYLFQLLQGLA 117
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF----VEPYSSNRTEFVGTFGYA 924
+ H ++HRD+ +N+L++ E ++DFG+A+ V Y+ V T Y
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE----VVTLWYR 170
Query: 925 APEI 928
APEI
Sbjct: 171 APEI 174
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 48/255 (18%)
Query: 758 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---------LNE 807
+G G GSV A + +G VAVKK + F +++ A L
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLS-----------RPFQSIIHAKRTYRELRLLKH 84
Query: 808 IRHRNIVK-FHGFCSNARHS-----FLVCEYLHRGSLARILGNDATAKELSWNRRINVIK 861
++H N++ F +LV + L I+ ++L+ + +I
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQKLTDDHVQFLIY 139
Query: 862 GVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF 921
+ L Y+H IIHRD+ N+ ++ + E + DFG+A+ + T +V T
Sbjct: 140 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATR 193
Query: 922 GYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDP 980
Y APEI M + D++S G ++ E++ G R F + I ++ IL
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGT-----DHIDQLKLILR- 244
Query: 981 RLSTPSPGVMDKLIS 995
+ TP ++ K+ S
Sbjct: 245 LVGTPGAELLKKISS 259
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 6e-12
Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 32/184 (17%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRN 812
+G+G +VYKA + + IVA+KK + G+ ++ + +N + L E+ H N
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKK----IKLGHRSEAKDGINRTALREIKLLQELSHPN 73
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG----VANALS 868
I+ + + LV +++ L I+ + L+ + IK L
Sbjct: 74 IIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLT----PSHIKAYMLMTLQGLE 126
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF----VEPYSSNRTEFVGTFGYA 924
YLH I+HRD+ N+LLD ++DFG+AK Y+ V T Y
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ----VVTRWYR 179
Query: 925 APEI 928
APE+
Sbjct: 180 APEL 183
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 50/222 (22%), Positives = 85/222 (38%), Gaps = 51/222 (22%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-------- 809
G+G G+V E +G VA+KK + E++
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKV--------------IQDPRFRNRELQIMQDLAVL 76
Query: 810 -HRNIVK-FHGFCSNARHSF------LVCEYLHRGSLARILGNDATAK-ELSWNRRINVI 860
H NIV+ F + +V EY+ +L R N + +I
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP----PILI 131
Query: 861 KG----VANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYSSNRT 915
K + ++ LH + ++ HRDI NVL++ + DFG AK + P N
Sbjct: 132 KVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-V 189
Query: 916 EFVGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKG 953
++ + Y APE+ + + Y D++S G + E++ G
Sbjct: 190 AYICSRYYRAPEL---IFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 1e-11
Identities = 66/250 (26%), Positives = 103/250 (41%), Gaps = 21/250 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALN 806
DF+ +GKG G V +E + ++ AVK ++ + D E V VLAL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD--DDVECTMVEKRVLALP 398
Query: 807 EIRHRNIVKFHGFCS-NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
+ + + H C + V EY++ G L + KE + +A
Sbjct: 399 -GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---PHAVFYAAEIAI 453
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTEFVGTFGY 923
L +L II+RD+ NV+LD E H+ +DFG+ K F GT Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKTFCGTPDY 508
Query: 924 AAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983
APEI + D ++FGVL++E++ G P F + I+E N +S
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGEDEDELFQSIMEHNVAYPKSMS 566
Query: 984 TPSPGVMDKL 993
+ + L
Sbjct: 567 KEAVAICKGL 576
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 20/102 (19%), Positives = 34/102 (33%), Gaps = 4/102 (3%)
Query: 544 NKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHNILQEEIPPQV 602
+ + L L + N Q + + L L L + + L + P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDA 75
Query: 603 -CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
L +LNLS N L + + + SL + + N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 21/101 (20%), Positives = 36/101 (35%), Gaps = 2/101 (1%)
Query: 519 LNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPK-SIGNLLKLYYLNLSNNQFSHTIPIE 577
+ L L + + + + L +L L + + P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 578 FEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNL 618
F LS+L+LS N L+ + + SL++L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 5e-11
Identities = 23/102 (22%), Positives = 36/102 (35%), Gaps = 2/102 (1%)
Query: 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT-VMGNLKSLSTLDLSQNQLNGLIPC 240
C + + L L LY+ N ++ + L L L + ++ L + P
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 241 TLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282
L L L N+L + L SL +L L N L
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 30/154 (19%), Positives = 54/154 (35%), Gaps = 10/154 (6%)
Query: 502 IPVQLEKLFSLNKLILSLNQLSGSVPLE-FGSLTELQYLDLSANKLSSSIPKSIGNLLKL 560
L +L +L + Q + L L EL+ L + + L P + +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 561 YYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSG 620
LNLS N ++ + + + L +L LS N L C + L++
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH-----CSCALRWLQRWEEEGLGGVP 136
Query: 621 FIPRCFEKMRSLSCIDI---CYNELQGPIPNSTV 651
L+ + L+ +PN++V
Sbjct: 137 EQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASV 170
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 23/101 (22%), Positives = 32/101 (31%), Gaps = 2/101 (1%)
Query: 159 MNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPS-SLGNLSKLALLYLNNNSLFGYIPTV 217
+ + E + + L L +L L + + L P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 218 MGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSL 258
LS L+LS N L L T+ LS L L L N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 22/95 (23%), Positives = 32/95 (33%), Gaps = 2/95 (2%)
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIP-VQLEKLFSLNKLILSLNQLSGSVPLEFGSLTE 535
+ + L L + + + + L L L L + + L P F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 536 LQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQF 570
L L+LS N L S+ L L L LS N
Sbjct: 82 LSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 23/120 (19%), Positives = 39/120 (32%), Gaps = 26/120 (21%)
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPE-IGKLNQLRRLYLDMNQLHGTIPPVIGQLSL 175
+ + L L + N Q + + L +LR L + + L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS-----------GLRF 70
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235
+ +F +L+ L L+ N+L + L SL L LS N L+
Sbjct: 71 VAPDAF-------------HFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 19/95 (20%), Positives = 32/95 (33%), Gaps = 2/95 (2%)
Query: 334 IPPSIGNLSSLRNLSLFNNGLYGSIPEE-IGYLKSLSELKLCKNNLSGVIPHSVGNLTGL 392
+ +L L + N + + L L L + K+ L V P + L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 393 VLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
LN+ N L + SL+ + + N L
Sbjct: 83 SRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 20/95 (21%), Positives = 35/95 (36%), Gaps = 2/95 (2%)
Query: 238 IPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSGSIPLSFGNLSSW 296
L NL L++ + + L L L ++++ L P +F
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 297 TLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLN 331
+ ++L N+L S+ SL L L N L+
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 22/118 (18%), Positives = 36/118 (30%), Gaps = 8/118 (6%)
Query: 239 PCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPL-SFGNLSSWT 297
C S L + + ++L +L + Q + L L
Sbjct: 4 ACCPHGSSGLRCT----RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR 59
Query: 298 LMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGL 354
+++ + L + P LS L L N L + SL+ L L N L
Sbjct: 60 NLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 5e-06
Identities = 17/96 (17%), Positives = 33/96 (34%), Gaps = 2/96 (2%)
Query: 357 SIPEEIGYLKSLSELKLCKNNLSGVIP-HSVGNLTGLVLLNMCENHLFGPIPKSLKSLTS 415
+ ++L+EL + + + L L L + ++ L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 416 LKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD 451
L R+ + N L ++ +L L LS N
Sbjct: 82 LSRLNLSFNALESLSWKTV-QGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 4e-05
Identities = 22/112 (19%), Positives = 37/112 (33%), Gaps = 15/112 (13%)
Query: 65 CSWF-GISCNHAGSRVI------SINLSTLCLNG-----TFQDFSFSSFPHLVNLNLSFN 112
G+ C G+ + NL+ L + + L NL + +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 113 LFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLH 163
+ P +L L+L N L +S + + L+ L L N LH
Sbjct: 67 G-LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 21/100 (21%), Positives = 33/100 (33%), Gaps = 2/100 (2%)
Query: 280 NQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSI 338
+ + T + + + + L L L L + + L V P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 339 GNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNL 378
L L+L N L S+ + SL EL L N L
Sbjct: 77 HFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 16/78 (20%), Positives = 29/78 (37%), Gaps = 1/78 (1%)
Query: 374 CKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPK-SLKSLTSLKRVRFNQNNLVGKVYE 432
C + + H + L L + + L+ L L+ + ++ L +
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 433 AFGDHPNLTFLDLSQNNF 450
AF P L+ L+LS N
Sbjct: 75 AFHFTPRLSRLNLSFNAL 92
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 50/272 (18%), Positives = 97/272 (35%), Gaps = 71/272 (26%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---------LNEI 808
+G GG G V+ A + VA+KK + + +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIV-------------LTDPQSVKHALREIKIIRRL 65
Query: 809 RHRNIVK----------FHGFCSNARHSF----LVCEYLHRGSLARILGNDATAKELSWN 854
H NIVK + +V EY+ LA +L L
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL----EQGPLLEE 120
Query: 855 RRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHVSDFGIAKFVEPYSSN 913
+ + L Y+H +++HRD+ N+ ++ E + DFG+A+ ++P+ S+
Sbjct: 121 HARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 914 R---TEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVI------KGNHPRDFFSIN 963
+ +E + T Y +P + + T+ D+++ G + E++ G H +
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM--- 234
Query: 964 FSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995
+I+E + +L+S
Sbjct: 235 -----QLILES-------IPVVHEEDRQELLS 254
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 68/232 (29%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---------LNEI 808
+G+G G V A P+G+IVA+KK F + A L
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEP------------FDKPLFALRTLREIKILKHF 66
Query: 809 RHRNIVK-FHGFCSNARHSF----LVCEY----LHRGSLARILGNDATAKELSWNRRINV 859
+H NI+ F+ ++ +F ++ E LHR ++L +D I
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD----------HIQY 116
Query: 860 I-----KGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912
+ + LH +IHRD+ N+L++ + V DFG+A+ ++ ++
Sbjct: 117 FIYQTLRA----VKVLH-----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 913 NR----------TEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKG 953
+ EFV T Y APE+ T + + DV+S G ++ E+
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 39/200 (19%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLA 804
+++ IG+G G V+KA +G VA+KK M ++ E + +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-------MENEKEGFPITALREIKI 69
Query: 805 LNEIRHRNIVKFHGFCSNARHS--------FLVCEYLHRGSLARILGNDATAKELSWNRR 856
L ++H N+V C +LV ++ LA +L + +
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFT---- 122
Query: 857 INVIKGVA----NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA-KFVEPYS 911
++ IK V N L Y+H + I+HRD+ + NVL+ + ++DFG+A F +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 912 SNRTEF---VGTFGYAAPEI 928
S + V T Y PE+
Sbjct: 180 SQPNRYTNRVVTLWYRPPEL 199
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 36/184 (19%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV-----VLALNEIRHRN 812
+G+G +VYK + ++VA+K+ + +E V L +++H N
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIR--------LEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG----VANALS 868
IV H + LV EYL + L + L D ++ ++ +K + L+
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIIN----MHNVKLFLFQLLRGLA 114
Query: 869 YLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF----VEPYSSNRTEFVGTFGYA 924
Y H ++HRD+ +N+L++ E ++DFG+A+ + Y + V T Y
Sbjct: 115 YCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE----VVTLWYR 167
Query: 925 APEI 928
P+I
Sbjct: 168 PPDI 171
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 61/263 (23%), Positives = 103/263 (39%), Gaps = 48/263 (18%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVL---ALN 806
+DFD +GKG G V +G A+K L + +DE + V L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI----LRKEVIIAKDEVAHTVTESRVLQ 60
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL------ARILGNDAT---AKELSWNRRI 857
RH + V EY + G L R+ + E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------- 113
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAK-FVEPYSSNR 914
+ +AL YLH +++RDI +N++LD + H+ +DFG+ K + ++ +
Sbjct: 114 -----IVSALEYLHSR---DVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATMK 163
Query: 915 TEFVGTFGYAAPEI----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM 970
T F GT Y APE+ Y D + GV+++E++ G P F++ + +
Sbjct: 164 T-FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP--FYNQDHERLFEL 216
Query: 971 IIEVNQILDPRLSTPSPGVMDKL 993
I+ LS + ++ L
Sbjct: 217 ILMEEIRFPRTLSPEAKSLLAGL 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 52/267 (19%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFL---NVVL 803
+ F+ +GKGG G V++ +G I A+K ++ N D N+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI-- 74
Query: 804 ALNEIRHRNIVKFHGFC-SNARHSFLVCEYLHRGSL------ARILGNDAT---AKELSW 853
L E++H IV + +L+ EYL G L I D E
Sbjct: 75 -LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE--- 129
Query: 854 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYS 911
++ AL +LH II+RD+ +N++L+ + HV +DFG+ K +
Sbjct: 130 ---------ISMALGHLHQK---GIIYRDLKPENIMLNH--QGHVKLTDFGLCK-ESIHD 174
Query: 912 SNRTE-FVGTFGYAAPEI----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 966
T F GT Y APEI + D +S G L+++++ G P F N
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP--FTGENRKK 228
Query: 967 FSNMIIEVNQILDPRLSTPSPGVMDKL 993
+ I++ L P L+ + ++ KL
Sbjct: 229 TIDKILKCKLNLPPYLTQEARDLLKKL 255
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 58/259 (22%), Positives = 93/259 (35%), Gaps = 48/259 (18%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQD----EFLNVV 802
++F+ +G G G V+ +G + A+K + + E V
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE--RQV 111
Query: 803 LALNEIRHRNIVKFHGFC-SNARHSFLVCEYLHRGSL------ARILGNDAT---AKELS 852
L + +V H + L+ +Y++ G L E+
Sbjct: 112 LEHIR-QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 168
Query: 853 WNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPY 910
AL +LH II+RDI +N+LLD HV +DFG++K
Sbjct: 169 -----------VLALEHLHKL---GIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVAD 212
Query: 911 SSNRTE-FVGTFGYAAPEIAYTMRATEKYDV--YSFGVLVFEVIKGNHPRDFFSINFSSF 967
+ R F GT Y AP+I + V +S GVL++E++ G P F +
Sbjct: 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNS 270
Query: 968 SNMIIEVNQILDPRLSTPS 986
I +IL P
Sbjct: 271 QAEISR--RILKSEPPYPQ 287
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 34/129 (26%), Positives = 52/129 (40%), Gaps = 11/129 (8%)
Query: 491 LDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSI 550
L I K+ L L + L LS N + L + L+ L L N + I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISSLS--GMENLRILSLGRNLI-KKI 85
Query: 551 PKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHNILQ--EEIPPQVCNMES 607
L L +S NQ + + EKL++L L +S+N + EI + ++
Sbjct: 86 ENLDAVADTLEELWISYNQIAS---LSGIEKLVNLRVLYMSNNKITNWGEIDK-LAALDK 141
Query: 608 LEKLNLSHN 616
LE L L+ N
Sbjct: 142 LEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 35/186 (18%), Positives = 60/186 (32%), Gaps = 45/186 (24%)
Query: 104 LVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLH 163
V L+ + + L ++L L N + IS + + LR L L N +
Sbjct: 27 KVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK 83
Query: 164 GTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMG--NL 221
+I + L L+++ N I ++ G L
Sbjct: 84 -------------------------KIENLDAVADTLEELWISYN----QIASLSGIEKL 114
Query: 222 KSLSTLDLSQNQLNGLIP-CTLDNLSNLDTLFLYKNSLSGSIPS----------IIGNLK 270
+L L +S N++ L L L+ L L N L ++ L
Sbjct: 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174
Query: 271 SLHQLD 276
+L +LD
Sbjct: 175 NLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 23/142 (16%), Positives = 54/142 (38%), Gaps = 7/142 (4%)
Query: 514 KLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHT 573
+L + + + +L ++L LS N + I S+ + L L+L N
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK-I-SSLSGMENLRILSLGRNLIKKI 85
Query: 574 IPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIP-RCFEKMRSL 632
++ L +L +S+N + + + + +L L +S+N ++ + + L
Sbjct: 86 ENLD-AVADTLEELWISYNQI-ASLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142
Query: 633 SCIDICYNELQGPIPNSTVFKD 654
+ + N L + +
Sbjct: 143 EDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 42/193 (21%), Positives = 67/193 (34%), Gaps = 41/193 (21%)
Query: 408 KSLKSLTSLKRVR-FNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDT 466
+ T ++V + K+ L LS NN + KIS +L +
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS----SLSGM-- 69
Query: 467 FIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSV 526
L+ L L N I KI +L +L +S NQ++
Sbjct: 70 -------------------ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLS 109
Query: 527 PLEFGSLTELQYLDLSANKLSS-SIPKSIGNLLKLYYLNLSNNQFSHTIPIEFE------ 579
+E L L+ L +S NK+++ + L KL L L+ N +
Sbjct: 110 GIE--KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI 167
Query: 580 ----KLIHLSKLD 588
+L +L KLD
Sbjct: 168 EVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 34/160 (21%), Positives = 59/160 (36%), Gaps = 31/160 (19%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262
L+ + + + LK+ L LS N + + +L + NL L L +N + I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KI 85
Query: 263 PSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLST 322
++ +L +L + NQ++ SLSG + L +L
Sbjct: 86 ENLDAVADTLEELWISYNQIA---------------------SLSG-----IEKLVNLRV 119
Query: 323 LGLYLNQLNGVIP-PSIGNLSSLRNLSLFNNGLYGSIPEE 361
L + N++ + L L +L L N LY E
Sbjct: 120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 35/140 (25%), Positives = 47/140 (33%), Gaps = 36/140 (25%)
Query: 99 SSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLD 158
S +L L+L NL I L+ L + NQ++ +S I KL LR LY+
Sbjct: 67 SGMENLRILSLGRNL-IKKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMS 123
Query: 159 MNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN---------- 208
N+ I I L L KL L L N
Sbjct: 124 NNK--------ITNWGEI---------------DKLAALDKLEDLLLAGNPLYNDYKENN 160
Query: 209 SLFGYIPTVMGNLKSLSTLD 228
+ Y V+ L +L LD
Sbjct: 161 ATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 28/139 (20%), Positives = 55/139 (39%), Gaps = 12/139 (8%)
Query: 234 LNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNL 293
++ + + L + + + + LK+ L L N + LS +
Sbjct: 17 RKSVVATEAEKVE----LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLS--GM 69
Query: 294 SSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNG 353
+ ++SL N + I + +L L + NQ+ + I L +LR L + NN
Sbjct: 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNK 126
Query: 354 LYGSIPEEIGYLKSLSELK 372
+ + EI L +L +L+
Sbjct: 127 I--TNWGEIDKLAALDKLE 143
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 5e-11
Identities = 66/251 (26%), Positives = 104/251 (41%), Gaps = 23/251 (9%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALN 806
+DF +GKG G V+ AE + A+K ++ + D E V VL+L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD--DDVECTMVEKRVLSLA 74
Query: 807 EIRHRNIVKFHG-FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
H + F + F V EYL+ G L + + +R +
Sbjct: 75 -WEHPFLTHMFCTFQTKENL-FFVMEYLNGGDLMYHIQSCHKFDL---SRATFYAAEIIL 129
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAK-FVEPYSSNRTEFVGTFG 922
L +LH I++RD+ N+LLD + H+ +DFG+ K + + T F GT
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNT-FCGTPD 183
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
Y APEI + D +SFGVL++E++ G P F + + I N L
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSIRMDNPFYPRWL 241
Query: 983 STPSPGVMDKL 993
+ ++ KL
Sbjct: 242 EKEAKDLLVKL 252
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-10
Identities = 65/263 (24%), Positives = 109/263 (41%), Gaps = 46/263 (17%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFL---NVVL 803
F+ +G+G G V+ + + + A+K L D+ ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDI-- 79
Query: 804 ALNEIRHRNIVKFHGFC-SNARHSFLVCEYLHRGSL------ARILGNDAT---AKELSW 853
L E+ H IVK H + +L+ ++L G L + + EL
Sbjct: 80 -LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-- 135
Query: 854 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAK-FVEPY 910
A AL +LH II+RD+ +N+LLD E H+ +DFG++K ++
Sbjct: 136 ----------ALALDHLHSL---GIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHE 180
Query: 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM 970
+ F GT Y APE+ T+ D +SFGVL+FE++ G P F + M
Sbjct: 181 KKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP--FQGKDRKETMTM 237
Query: 971 IIEVNQILDPRLSTPSPGVMDKL 993
I++ + LS + ++ L
Sbjct: 238 ILKAKLGMPQFLSPEAQSLLRML 260
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-10
Identities = 69/278 (24%), Positives = 108/278 (38%), Gaps = 77/278 (27%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVK---KFNSQLLSGNMADQDEFLNVVLALN 806
DF IGKG G V A AVK K +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQK-----------------KAILKKK 80
Query: 807 EIRH----RNIVKFHGFCSNARHSFLVC---------------EYLHRGSL------ARI 841
E +H RN+ N +H FLV +Y++ G L R
Sbjct: 81 EEKHIMSERNV-----LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC 135
Query: 842 LGNDAT---AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898
A E +A+AL YLH +I++RD+ +N+LLD + H+
Sbjct: 136 FLEPRARFYAAE------------IASALGYLHSL---NIVYRDLKPENILLDS--QGHI 178
Query: 899 --SDFGIAK-FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 955
+DFG+ K +E S+ T F GT Y APE+ + D + G +++E++ G
Sbjct: 179 VLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
Query: 956 PRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKL 993
P F+S N + + I+ L P ++ + +++ L
Sbjct: 238 P--FYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 273
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 16/154 (10%)
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF- 921
VA + +L IHRD++++N+LL + + DFG+A+ + +
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 922 -GYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILD 979
+ APE + T + DV+SFGVL++E+ G P I+ F + E
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGT---- 313
Query: 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
R+ P ++ M C P RPT
Sbjct: 314 -RMRAP-DYTTPEMYQTML---DCWHGEPSQRPT 342
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 23/140 (16%), Positives = 47/140 (33%), Gaps = 21/140 (15%)
Query: 759 IGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHR 811
+G+G G V +A+ + VAVK ++ ++ + L I H
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 86
Query: 812 NIVKFHGFCS-NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
N+V G C+ ++ E+ G+L+ L ++R + +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136
Query: 871 HHDCLPSIIHRDISSKNVLL 890
I D+ + +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSI 156
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 67/259 (25%), Positives = 106/259 (40%), Gaps = 39/259 (15%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALN 806
D+F+ +GKG G V A + +GD+ AVK ++ + D E +L+L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD--DDVECTMTEKRILSLA 80
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSL------ARILGNDAT---AKELSWNRRI 857
H + + F V E+++ G L +R A E
Sbjct: 81 -RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE------- 132
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAK-FVEPYSSNR 914
+ +AL +LH II+RD+ NVLLD E H +DFG+ K + +
Sbjct: 133 -----IISALMFLHDK---GIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGVTTA 182
Query: 915 TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974
T F GT Y APEI M D ++ GVL++E++ G+ P F + N I+
Sbjct: 183 T-FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP--FEAENEDDLFEAILND 239
Query: 975 NQILDPRLSTPSPGVMDKL 993
+ L + G++
Sbjct: 240 EVVYPTWLHEDATGILKSF 258
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-10
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 759 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK-F 816
IG G G VY+A+L SG++VA+KK + D+ + + ++ H NIV+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 817 HGFCSNARHS-----FLVCEY----LHRGSLARILGNDATAKELSWNRRINVIKG----V 863
+ F S+ LV +Y ++R + L + +K +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYR----VARHYSRAKQTLP----VIYVKLYMYQL 165
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYSSNRTEFVGTFG 922
+L+Y+H I HRDI +N+LLD + + DFG AK + N ++ +
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRY 221
Query: 923 YAAPEIAYT-MRATEKYDVYSFGVLVFEVIKG 953
Y APE+ + T DV+S G ++ E++ G
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 40/216 (18%)
Query: 759 IGKGGQGSVYKA--ELPSGDIVAVKKFNSQLLSGNMADQDEFL--------NVVLALNEI 808
IG+G G V+KA G VA+K+ + +E + V+ L
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIREVAVLRHLETF 71
Query: 809 RHRNIVK----FHGFCSNARHS-FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGV 863
H N+V+ ++ LV E++ + L L + + IK +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVP----TETIKDM 125
Query: 864 A----NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR--TEF 917
L +LH ++HRD+ +N+L+ + ++DFG+A+ YS T
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSV 179
Query: 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 953
V T Y APE+ D++S G + E+ +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 67/260 (25%), Positives = 105/260 (40%), Gaps = 41/260 (15%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALN 806
DF+ +GKG G V +E + ++ AVK ++ + D E V VLAL
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD--DDVECTMVEKRVLALP 77
Query: 807 EIRHRNIVKFHGFC-SNARHSFLVCEYLHRGSL------ARILGNDAT---AKELSWNRR 856
+ + + H C + V EY++ G L A E
Sbjct: 78 G-KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE------ 129
Query: 857 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAK-FVEPYSSN 913
+A L +L II+RD+ NV+LD E H+ +DFG+ K + +
Sbjct: 130 ------IAIGLFFLQSK---GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTT 178
Query: 914 RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973
+T F GT Y APEI + D ++FGVL++E++ G P F + I+E
Sbjct: 179 KT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGEDEDELFQSIME 235
Query: 974 VNQILDPRLSTPSPGVMDKL 993
N +S + + L
Sbjct: 236 HNVAYPKSMSKEAVAICKGL 255
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-10
Identities = 45/213 (21%), Positives = 85/213 (39%), Gaps = 35/213 (16%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVK- 815
+G+G V++A + + + V VK + + + L +R NI+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITL 96
Query: 816 ---FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
S R LV E+++ ++ + L+ + + AL Y H
Sbjct: 97 ADIVKDPVS--RTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 148
Query: 873 DCLPSIIHRDISSKNVLLDLEF-EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
I+HRD+ NV++D E + + D+G+A+F P V + + PE+
Sbjct: 149 M---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPEL--- 201
Query: 932 MRATEKY----DVYSFGVLVFEVIKGNHPRDFF 960
+ + Y D++S G ++ +I P FF
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEP--FF 232
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 32/218 (14%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-------- 809
+G G +V+ A+ + + VA+K + A +DE + ++ +N+
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA-EDE-IKLLQRVNDADNTKEDSMG 84
Query: 810 HRNIVK------FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGV 863
+I+K G N H +V E L LA I + L + ++I K +
Sbjct: 85 ANHILKLLDHFNHKG--PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQL 140
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH------VSDFGIAKFVEPYSSNRTEF 917
L Y+H C IIH DI +NVL+++ ++D G A + + T
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYTNS 195
Query: 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 955
+ T Y +PE+ D++S L+FE+I G+
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 68/254 (26%), Positives = 106/254 (41%), Gaps = 40/254 (15%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALN 806
DFD IG+G V L + I A+K +L++ + + +++ V
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD--EDIDWVQTEKHVFEQA 66
Query: 807 EIRHRNIVKFHGFC-SNARHSFLVCEYLHRGSL------ARILGNDAT---AKELSWNRR 856
H +V H C F V EY++ G L R L + + E
Sbjct: 67 -SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE------ 118
Query: 857 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAK-FVEPYSSN 913
++ AL+YLH II+RD+ NVLLD E H+ +D+G+ K + P +
Sbjct: 119 ------ISLALNYLHER---GIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTT 167
Query: 914 RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973
T F GT Y APEI D ++ GVL+FE++ G P D + + N
Sbjct: 168 ST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226
Query: 974 V-NQILDPRLSTPS 986
+ IL+ ++ P
Sbjct: 227 LFQVILEKQIRIPR 240
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 22/245 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNV---VLALN 806
DFD IG+G V L + I A++ +L++ + + +++ V
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD--EDIDWVQTEKHVFEQA 109
Query: 807 EIRHRNIVKFHGFC-SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
H +V H C F V EY++ G L + E ++
Sbjct: 110 -SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISL 164
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAK-FVEPYSSNRTEFVGTFG 922
AL+YLH II+RD+ NVLLD E H+ +D+G+ K + P + T F GT
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTST-FCGTPN 218
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV-NQILDPR 981
Y APEI D ++ GVL+FE++ G P D + + N + IL+ +
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278
Query: 982 LSTPS 986
+ P
Sbjct: 279 IRIPR 283
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 64/299 (21%), Positives = 111/299 (37%), Gaps = 76/299 (25%)
Query: 747 IKATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV 801
IK D+ +G G G V + + + A+K D +
Sbjct: 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARRE 60
Query: 802 VLALNEI-RHRNIVKFHGFCSNA----RHSFLVCEYLHRGSL-ARIL--GNDA-TAKELS 852
V + +IV+ N + +V E L G L +RI G+ A T +E S
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 853 WNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFV-- 907
++K + A+ YLH +I HRD+ +N+L + ++DFG AK
Sbjct: 121 -----EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172
Query: 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 967
E Y + D++S GV+++ ++ G P F+S + +
Sbjct: 173 EKYD------------------------KSCDMWSLGVIMYILLCGYPP--FYSNHGLAI 206
Query: 968 SNMIIEVNQILDPRLSTPSP---GVMDK---LISIMEVAILCLDESPEARPTMEKGFGH 1020
S + +I + P+P V ++ LI + L + P R T+ + H
Sbjct: 207 SPGMKT--RIRMGQYEFPNPEWSEVSEEVKMLIRNL----LKTE--PTQRMTITEFMNH 257
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK-FH 817
IG G G V++A+L D VA+KK + D+ + + ++H N+V
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKV--------LQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 818 GFCSNARHS-----FLVCEYLHRGSLARILGNDATAK-ELSWNRRINVIKG----VANAL 867
F SN LV EY+ ++ R + A K + + +IK + +L
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSL 154
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAP 926
+Y+H I HRDI +N+LLD + DFG AK + N ++ + Y AP
Sbjct: 155 AYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYICSRYYRAP 210
Query: 927 EIAYT-MRATEKYDVYSFGVLVFEVIKG 953
E+ + T D++S G ++ E+++G
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQG 238
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 32/142 (22%), Positives = 64/142 (45%), Gaps = 9/142 (6%)
Query: 142 ISPEIGK--LNQLRRLYLDMNQL-HGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLS 198
I E+ + ++ L LD ++ G + + + + S + ++ I ++L L+
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLN 64
Query: 199 KLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL-IPCTLDNLSNLDTLFLYKNS 257
KL L L++N + G + + +L+ L+LS N++ L L L NL +L L+
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCE 124
Query: 258 LSGSI---PSIIGNLKSLHQLD 276
++ ++ L L LD
Sbjct: 125 VTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 487 KLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKL 546
+L+FL + + I L KL L KL LS N++SG + + L +L+LS NK+
Sbjct: 43 ELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
Query: 547 SS-SIPKSIGNLLKLYYLNLSNN---QFSHTIPIEFEKLIHLSKLD 588
S + + L L L+L N + F+ L L+ LD
Sbjct: 101 KDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 24/114 (21%), Positives = 48/114 (42%), Gaps = 6/114 (5%)
Query: 532 SLTELQYLDLSANKLSS-SIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKLDL 589
+ ++++ L L ++ + + +L +L+ N + I KL L KL+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLEL 71
Query: 590 SHNILQEEIPPQVCNMESLEKLNLSHNNLSGF-IPRCFEKMRSLSCIDICYNEL 642
S N + + +L LNLS N + +K+ +L +D+ E+
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 29/136 (21%), Positives = 50/136 (36%), Gaps = 11/136 (8%)
Query: 100 SFPHLVNLNLSFNLFFGNIPPQIGNLSKLQN---LDLGNNQLSGVISPEIGKLNQLRRLY 156
+ + L L + N G + + L N L+ + + KLN+L++L
Sbjct: 15 TPSDVKELVLDNSRS--NEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLE 70
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSG-RIPSSLGNLSKLALLYLNNN---SLFG 212
L N++ G + + + + + N + L L L L L N +L
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130
Query: 213 YIPTVMGNLKSLSTLD 228
Y V L L+ LD
Sbjct: 131 YRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 20/89 (22%), Positives = 35/89 (39%), Gaps = 3/89 (3%)
Query: 196 NLSKLALLYLNNNSL-FGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLY 254
S + L L+N+ G + + + L L L + L L+ L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN--LPKLNKLKKLELS 72
Query: 255 KNSLSGSIPSIIGNLKSLHQLDLIENQLS 283
N +SG + + +L L+L N++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 26/130 (20%), Positives = 44/130 (33%), Gaps = 29/130 (22%)
Query: 244 NLSNLDTLFLYKNSLS-GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLF 302
S++ L L + + G + + + L L I L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT------------------- 55
Query: 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362
S++ L L L L L N+++G + +L +L+L N + I
Sbjct: 56 --SIAN-----LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI--KDLSTI 106
Query: 363 GYLKSLSELK 372
LK L LK
Sbjct: 107 EPLKKLENLK 116
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 19/84 (22%), Positives = 38/84 (45%), Gaps = 7/84 (8%)
Query: 563 LNLSNNQFSHTIPIE-FEKLIHLSKLDLSHNILQ--EEIPPQVCNMESLEKLNLSHNNLS 619
L L N++ + ++ L L + L +P + L+KL LS N +S
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVS 77
Query: 620 GFIPRCFEKMRSLSCIDICYNELQ 643
G + EK +L+ +++ N+++
Sbjct: 78 GGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 36/149 (24%), Positives = 58/149 (38%), Gaps = 7/149 (4%)
Query: 453 KISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSSNHIVGKIPVQLEKLFS 511
+ R + ++ + L+FL L + ++ + L KL
Sbjct: 15 HLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPK 72
Query: 512 LNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS-SIPKSIGNLLKLYYLNLSNN-- 568
L KL LS N++ G + + L L +L+LS NKL S + + L L L+L N
Sbjct: 73 LKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132
Query: 569 -QFSHTIPIEFEKLIHLSKLDLSHNILQE 596
+ F+ L L+ LD QE
Sbjct: 133 TNLNDYRESVFKLLPQLTYLDGYDREDQE 161
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 7/138 (5%)
Query: 149 LNQLRRLYLDMNQLH-GTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNN 207
+R L LD + + G I + + + S + + + S+L L KL L L+
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 208 NSLFGYIPTVMGNLKSLSTLDLSQNQLNGL-IPCTLDNLSNLDTLFLYKN---SLSGSIP 263
N +FG + + L +L+ L+LS N+L + L L L +L L+ +L+
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRE 140
Query: 264 SIIGNLKSLHQLDLIENQ 281
S+ L L LD + +
Sbjct: 141 SVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 28/106 (26%), Positives = 44/106 (41%), Gaps = 11/106 (10%)
Query: 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNL---KSLSTLDLSQNQLNGLIP 239
+ G+I L L L N L + NL L L+LS+N++ G +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKLELSENRIFGGLD 88
Query: 240 CTLDNLSNLDTLFLYKNSLSGSIPSI--IGNLKSLHQLDLIENQLS 283
+ L NL L L N L I ++ + L+ L LDL +++
Sbjct: 89 MLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 7/117 (5%)
Query: 528 LEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSK 586
++ EL LD + I + L +L+L N + KL L K
Sbjct: 21 RTPAAVREL-VLDNCKSNDGK-IEGLTAEFVNLEFLSLINVGLIS---VSNLPKLPKLKK 75
Query: 587 LDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGF-IPRCFEKMRSLSCIDICYNEL 642
L+LS N + + + +L LNLS N L +K+ L +D+ E+
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 22/89 (24%), Positives = 35/89 (39%), Gaps = 3/89 (3%)
Query: 196 NLSKLALLYLNNNSL-FGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLY 254
+ + L L+N G I + +L L L L + L L L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELS 79
Query: 255 KNSLSGSIPSIIGNLKSLHQLDLIENQLS 283
+N + G + + L +L L+L N+L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 33/142 (23%), Positives = 50/142 (35%), Gaps = 32/142 (22%)
Query: 99 SSFPHLVNLNLSFNLF--FGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
+ F +L L+L N+P L KL+ L+L N++ G + KL L L
Sbjct: 46 AEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN---SLFGY 213
L N+ + +S + L L L L L N +L Y
Sbjct: 102 LSGNK--------LKDISTL---------------EPLKKLECLKSLDLFNCEVTNLNDY 138
Query: 214 IPTVMGNLKSLSTLDLSQNQLN 235
+V L L+ LD +
Sbjct: 139 RESVFKLLPQLTYLDGYDREDQ 160
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 29/130 (22%), Positives = 42/130 (32%), Gaps = 29/130 (22%)
Query: 244 NLSNLDTLFLYKNSLS-GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLF 302
+ + L L + G I + +L L LI L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI------------------- 62
Query: 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362
S+S L L L L L N++ G + L +L +L+L N L +
Sbjct: 63 --SVSN-----LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL--KDISTL 113
Query: 363 GYLKSLSELK 372
LK L LK
Sbjct: 114 EPLKKLECLK 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 20/91 (21%), Positives = 40/91 (43%), Gaps = 7/91 (7%)
Query: 556 NLLKLYYLNLSNNQFSHTIPIEF-EKLIHLSKLDLSHNILQ--EEIPPQVCNMESLEKLN 612
+ L L N + + + ++L L L + L +P + L+KL
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLE 77
Query: 613 LSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
LS N + G + EK+ +L+ +++ N+L+
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 40/202 (19%), Positives = 72/202 (35%), Gaps = 52/202 (25%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVK---------KFNSQLLSG----NMADQDEFLNVVLAL 805
IG+GG G +Y A++ S + V N L + A + E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 806 NEIRHRNIVKFHGF----CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIK 861
++++ + K+ G + + F++ + L +I +A AK S K
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIY--EANAKRFS-------RK 152
Query: 862 GVA-------NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSS 912
V + L Y+H +H DI + N+LL+ + V D+G+A Y
Sbjct: 153 TVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY---RYCP 206
Query: 913 NRTE----------FVGTFGYA 924
GT +
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFT 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 60/298 (20%), Positives = 100/298 (33%), Gaps = 85/298 (28%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---------LNEI 808
IG G G V +A + +VA+KK F +++ LN +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKIL-----------RVFEDLIDCKRILREIAILNRL 109
Query: 809 RHRNIVK-FHGFCSNARHSF----LVCEYLHRGSLARILGNDATAKELSWNRRI-----N 858
H ++VK F +V E ++ T L+ I N
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF---RTPVYLT-ELHIKTLLYN 164
Query: 859 VIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR-- 914
++ G + Y+H S I+HRD+ N L++ + V DFG+A+ V+ +
Sbjct: 165 LLVG----VKYVH-----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 915 -------------------------TEFVGTFGYAAPEIAYTMRATEKY----DVYSFGV 945
T V T Y APE+ + E Y DV+S G
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL---ILLQENYTEAIDVWSIGC 272
Query: 946 LVFEVIKGNHPRDFFSIN----FSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEV 999
+ E++ + + F S + +Q + G D+L I +
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 38/198 (19%), Positives = 71/198 (35%), Gaps = 44/198 (22%)
Query: 759 IGKGGQGSVYKAE---------LPSGDIVAVK--KFNSQLLSG----NMADQDEFLNVVL 803
+ QG +Y+A P ++K + +L + A + +N
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 804 ALNEIRHRNIVKFHGFCSN-ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG 862
L I GF + ++ FLV L R SL L + + LS +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL-DVSPKHVLS-------ERS 160
Query: 863 VA-------NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFV------ 907
V +AL +LH + +H +++++N+ +D E ++ V + +G A
Sbjct: 161 VLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 908 EPYSSN-RTEFVGTFGYA 924
Y R+ G +
Sbjct: 218 VAYVEGSRSPHEGDLEFI 235
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.9 bits (136), Expect = 2e-08
Identities = 32/218 (14%), Positives = 66/218 (30%), Gaps = 23/218 (10%)
Query: 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479
Q + YE + ++ F W ++ + I + +
Sbjct: 108 SLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQ--VDLS 165
Query: 480 LEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGS--LTELQ 537
+ L L + + + L L + L SV + L L+
Sbjct: 166 PVLDAMPLLNNLKIKGTNNLSIGKKPRPNL---KSLEIISGGLPDSVVEDILGSDLPNLE 222
Query: 538 YLDL---SANKLSSSIPKSIGNLL------KLYYLNLSNNQFSHTIPI---EFEKLIHLS 585
L L + L L +L + + + + + E + L L
Sbjct: 223 KLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLE 282
Query: 586 KLDLSHNILQ----EEIPPQVCNMESLEKLNLSHNNLS 619
+D+S +L + V ++ L+ +N+ +N LS
Sbjct: 283 TMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 7e-07
Identities = 32/203 (15%), Positives = 71/203 (34%), Gaps = 27/203 (13%)
Query: 404 GPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKI-----SFNW 458
+ L ++ L ++ N + PNL L++ + +
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLS---IGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 459 RNLPKLDTFIVSMNNIFGSIP------LEIGDSSKLQFLDLSSNHIVGKIPVQL---EKL 509
NL KL ++ + F L++L + + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 510 FSLNKLILSLNQLS--GSVPL--EFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNL 565
L + +S L+ G+ L + L+++++ N LS + K + L + +++
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPM-KIDV 337
Query: 566 SNNQ-----FSHTIPIEFEKLIH 583
S++Q +S+ + E E H
Sbjct: 338 SDSQEYDDDYSYPMITELEHHHH 360
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 6e-05
Identities = 23/164 (14%), Positives = 57/164 (34%), Gaps = 21/164 (12%)
Query: 452 GKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL--EKL 509
+S +P L+ + N L+ L++ S + + + L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 510 FSLNKLILSL---NQLSGSVP------LEFGSLTELQYLDLSANKLSSSIPKSIGN---L 557
+L KL+L + + L++L + + + + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 558 LKLYYLNLSNNQFSHT----IPIEFEKLIHLSKLDLSHNILQEE 597
+L +++S + + +K+ HL +++ +N L +E
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 5e-04
Identities = 34/244 (13%), Positives = 69/244 (28%), Gaps = 27/244 (11%)
Query: 34 NWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLNGTF 93
++ + + NL +L L I + G C+ ++ G F
Sbjct: 86 SYDEAEEGVNLMDKILKDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLF 145
Query: 94 QDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLR 153
+ + ++ P + + L NL + +S L+
Sbjct: 146 WGDIDFEEQEISWIEQ------VDLSPVLDAMPLLNNLKIKGTNN---LSIGKKPRPNLK 196
Query: 154 RLYLDMNQLHGTIPPVIGQLSLIH----EFSFCHNNVSGRIPS-------SLGNLSKLAL 202
L + L ++ I L + + S L
Sbjct: 197 SLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKW 256
Query: 203 LYLNNNSLFGYIPTVMGN---LKSLSTLDLSQNQLNG----LIPCTLDNLSNLDTLFLYK 255
L + + + + L L T+D+S L L+ +D + +L + +
Sbjct: 257 LGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKY 316
Query: 256 NSLS 259
N LS
Sbjct: 317 NYLS 320
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 22/117 (18%), Positives = 48/117 (41%), Gaps = 6/117 (5%)
Query: 529 EFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIHLSKL 587
++ + + LDL K+ I L + ++ S+N+ ++ F L L L
Sbjct: 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK---LDGFPLLRRLKTL 69
Query: 588 DLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGF-IPRCFEKMRSLSCIDICYNELQ 643
+++N + + L +L L++N+L ++SL+ + I N +
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 23/104 (22%), Positives = 42/104 (40%), Gaps = 9/104 (8%)
Query: 181 FCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMG--NLKSLSTLDLSQNQLNGLI 238
I + L + + ++N I + G L+ L TL ++ N++ +
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNE----IRKLDGFPLLRRLKTLLVNNNRICRIG 80
Query: 239 PCTLDNLSNLDTLFLYKNSLSGSIPSI--IGNLKSLHQLDLIEN 280
L +L L L NSL + + + +LKSL L ++ N
Sbjct: 81 EGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 20/87 (22%), Positives = 36/87 (41%), Gaps = 3/87 (3%)
Query: 487 KLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKL 546
+ +D S N I K+ L L L+++ N++ +L +L L L+ N L
Sbjct: 43 QFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100
Query: 547 SS-SIPKSIGNLLKLYYLNLSNNQFSH 572
+ +L L YL + N ++
Sbjct: 101 VELGDLDPLASLKSLTYLCILRNPVTN 127
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 35/174 (20%), Positives = 59/174 (33%), Gaps = 33/174 (18%)
Query: 107 LNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTI 166
+ L+ L Q N + + LDL ++ VI L+Q + N+ I
Sbjct: 2 VKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----I 54
Query: 167 PPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLST 226
+ G L +L L +NNN + + L L+
Sbjct: 55 RKLDG----------------------FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92
Query: 227 LDLSQNQLNGL-IPCTLDNLSNLDTLFLYKN---SLSGSIPSIIGNLKSLHQLD 276
L L+ N L L L +L +L L + +N + +I + + LD
Sbjct: 93 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 20/92 (21%), Positives = 31/92 (33%), Gaps = 3/92 (3%)
Query: 192 SSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTL 251
+ N + L L + I + L +D S N++ L L L TL
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLD--GFPLLRRLKTL 69
Query: 252 FLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS 283
+ N + + L L +L L N L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 26/146 (17%), Positives = 43/146 (29%), Gaps = 31/146 (21%)
Query: 227 LDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSI 286
+ L+ + N L L + I ++ L +D +N++
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--- 55
Query: 287 PLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRN 346
L G L+ L TL + N++ + L L
Sbjct: 56 ------------------KLDG-----FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92
Query: 347 LSLFNNGLYGSIPEEIGYLKSLSELK 372
L L NN L ++ L SL L
Sbjct: 93 LILTNNSL--VELGDLDPLASLKSLT 116
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 23/135 (17%), Positives = 42/135 (31%), Gaps = 32/135 (23%)
Query: 99 SSFPHLVNLNLSFNLF--FGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
++ ++ S N P L +L+ L + NN++ + L L L
Sbjct: 39 ATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN---SLFGY 213
L N + +L + L +L L L + N + Y
Sbjct: 95 LTNNS--------LVELGDLDP---------------LASLKSLTYLCILRNPVTNKKHY 131
Query: 214 IPTVMGNLKSLSTLD 228
V+ + + LD
Sbjct: 132 RLYVIYKVPQVRVLD 146
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 58/305 (19%), Positives = 101/305 (33%), Gaps = 97/305 (31%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---------LNEI 808
IG+G G VY A + + VA+KK N F +++ LN +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVN-----------RMFEDLIDCKRILREITILNRL 82
Query: 809 RHRNIVK-FHGFCSNARHSF----LVCEYLHRGSLARILGNDATAKELSWNRRI-----N 858
+ I++ + + F +V E L ++ T L+ I N
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF---KTPIFLT-EEHIKTILYN 137
Query: 859 VIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR-- 914
++ G +++H IIHRD+ N LL+ + V DFG+A+ +
Sbjct: 138 LLLG----ENFIH-----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 915 --------------------TEFVGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEV 950
T V T Y APE+ + E Y D++S G + E+
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL---ILLQENYTKSIDIWSTGCIFAEL 245
Query: 951 I-----------------KGNHPRDFFSINFSSFSNMIIEVNQ---ILDPRLSTPSPGVM 990
+ G+ S + +Q I + + TP+ +
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN-IIGTPTEDDL 304
Query: 991 DKLIS 995
+
Sbjct: 305 KNINK 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 44/236 (18%), Positives = 81/236 (34%), Gaps = 53/236 (22%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK-- 815
+G G G V + ++ SG A+KK + D + + + H NI+K
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV--------LQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 816 --FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRIN--------------- 858
F+ + ++ N+ + +
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 859 VIKGVAN-------------------ALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHV 898
V+K A+ ++H I HRDI +N+L++ + +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKL 183
Query: 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKG 953
DFG AK + P + ++ + Y APE+ T D++S G + E+I G
Sbjct: 184 CDFGSAKKLIPSEPS-VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 36/104 (34%), Positives = 44/104 (42%), Gaps = 12/104 (11%)
Query: 182 CHNN----VSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL 237
C V IP++ L YL +N + P V L L+ LDL NQL L
Sbjct: 16 CSGKSLASVPTGIPTTTQVL------YLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVL 69
Query: 238 IPCTLDNLSNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIEN 280
D L+ L L L N L SIP NLKSL + L+ N
Sbjct: 70 PAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 10/93 (10%)
Query: 502 IPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI-GNLLKL 560
IP + L+ L NQ++ P F LT+L LDL N+L + +P + L +L
Sbjct: 28 IPTTTQVLY------LYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQL 80
Query: 561 YYLNLSNNQFSHTIPIE-FEKLIHLSKLDLSHN 592
L+L++NQ +IP F+ L L+ + L +N
Sbjct: 81 TQLSLNDNQL-KSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 525 SVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIH 583
SVP G T Q L L N+++ P L +L L+L NNQ + +P F+KL
Sbjct: 23 SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 584 LSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNN 617
L++L L+ N L+ IP N++SL + L NN
Sbjct: 80 LTQLSLNDNQLK-SIPRGAFDNLKSLTHIWL-LNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKS 319
S+P+ I + L L +NQ++ P F L+ T + L +N L+ +P + L
Sbjct: 23 SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 320 LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNN 352
L+ L L NQL + + NL SL ++ L NN
Sbjct: 80 LTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLS-FGNLSSWTLMSLFSN 304
+ L+LY N ++ P + L L +LDL NQL+ +P F L+ T +SL N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
Query: 305 SLSGSIPP-ILGNLKSLSTLGLYLN 328
L SIP NLKSL+ + L N
Sbjct: 89 QLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 34/142 (23%), Positives = 47/142 (33%), Gaps = 56/142 (39%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIG---KLNQLRRLYLDMNQLHGTIPPVIGQLS 174
+P I + Q L L +NQ++ E G +L QL RL LD NQL +P
Sbjct: 24 VPTGI--PTTTQVLYLYDNQIT---KLEPGVFDRLTQLTRLDLDNNQLT-VLP------- 70
Query: 175 LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQL 234
V L L+ L L+ NQL
Sbjct: 71 ----------------------------------------AGVFDKLTQLTQLSLNDNQL 90
Query: 235 NGLIPCTLDNLSNLDTLFLYKN 256
+ DNL +L ++L N
Sbjct: 91 KSIPRGAFDNLKSLTHIWLLNN 112
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 70/292 (23%), Positives = 106/292 (36%), Gaps = 103/292 (35%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA---LNEIR----- 809
+GKG G V+K+ + +G++VAVKK D F N A EI
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIF-----------DAFQNSTDAQRTFREIMILTEL 65
Query: 810 --HRNIVKFHGFC--SNARHSFLVCEY----LHRGSLARILGNDATAKELSWNRRI---- 857
H NIV N R +LV +Y LH A IL
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV----------HKQYVV 115
Query: 858 -NVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR 914
+IK + YLH S ++HRD+ N+LL+ E V+DFG+++
Sbjct: 116 YQLIKV----IKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 915 ---------------------TEFVGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFE 949
T++V T Y APEI + + KY D++S G ++ E
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEI---LLGSTKYTKGIDMWSLGCILGE 223
Query: 950 VI------KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLIS 995
++ G+ + II V + PS ++ + S
Sbjct: 224 ILCGKPIFPGSSTMNQL--------ERIIGV-------IDFPSNEDVESIQS 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 37/200 (18%), Positives = 65/200 (32%), Gaps = 51/200 (25%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVK------KFNSQLLSG----NMADQDEFLNVVLALNE 807
IG GG G +Y A + A + N L S + + + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 808 IRHRNIVKFHGF----CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGV 863
+ + I F+G + F+V E L L +I N V
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKIS---------GQNGTFK-KSTV 153
Query: 864 A-------NALSYLHHDCLPSIIHRDISSKNVLLDLEFE--AHVSDFGIAKFVEPYSSNR 914
+ L Y+H + +H DI + N+LL + +++D+G++ Y N
Sbjct: 154 LQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY---RYCPNG 207
Query: 915 TE----------FVGTFGYA 924
GT +
Sbjct: 208 NHKQYQENPRKGHNGTIEFT 227
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 60/410 (14%), Positives = 128/410 (31%), Gaps = 60/410 (14%)
Query: 196 NLSKLALLYLNNNSLFGY--IPTVMGNLKSLSTLDLSQNQLNGL----IPCTLDNLSNLD 249
+ +L L++ F + + ++L LDL ++ ++ + + D ++L
Sbjct: 128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187
Query: 250 TLFL--YKNSLS-GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSL 306
+L + + +S ++ ++ +L L L + ++PL L +L
Sbjct: 188 SLNISCLASEVSFSALERLVTRCPNLKSLKL-----NRAVPLE-------KLATLLQR-- 233
Query: 307 SGSIPPILGNLKSLSTLGLYLNQLNGV---IPPSIGNLSSLRNLSLFNNGLYGSIPEEIG 363
L+ L T G V + ++ LR LS F + + +P
Sbjct: 234 -------APQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS 286
Query: 364 YLKSLSELKLCKNNLS--GVIPHSVG--NLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV 419
L+ L L + ++ L L +L+ E+ + + K L L+
Sbjct: 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVF 346
Query: 420 RFNQNNLVGKVY------EAFGDH-PNLTFLDLSQNNFDGK----ISFNWRNLPKLDTFI 468
+ V + P L + I+ N N+ + I
Sbjct: 347 PSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCI 406
Query: 469 VSMNNIFGSIPLEIGDSS---------KLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSL 519
+ + LE D L+ L LS + L ++
Sbjct: 407 IEPKAPDY-LTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAF 465
Query: 520 NQLSG-SVPLEFGSLTELQYLDLSANKLSS-SIPKSIGNLLKLYYLNLSN 567
S + L+ L++ ++ + L + L +S+
Sbjct: 466 AGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 38/279 (13%), Positives = 81/279 (29%), Gaps = 33/279 (11%)
Query: 393 VLLNMCENHLFGPIPKSLKSLTSLK---RVRFNQNNLVGKVYEAFGDH---------PNL 440
V + C + + + S++ + F NLV + + L
Sbjct: 48 VFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107
Query: 441 TFLDLSQNNFD----GKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSS 495
+ L + I+ +++N L + S I + L+ LDL
Sbjct: 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLV--LSSCEGFSTDGLAAIAATCRNLKELDLRE 165
Query: 496 NHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSL-------TELQYLDLSANKLSS 548
+ + L ++SLN + + F +L L+ L L+
Sbjct: 166 SDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE 225
Query: 549 SIPKSIGNLLKLYYLNLS------NNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV 602
+ + +L L + + L L + + +P
Sbjct: 226 KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVY 285
Query: 603 CNMESLEKLNLSHNNLSGF-IPRCFEKMRSLSCIDICYN 640
L LNLS+ + + + + + L + +
Sbjct: 286 SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 29/79 (36%), Positives = 38/79 (48%), Gaps = 2/79 (2%)
Query: 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262
L+LNNN + P V +L +L L + N+L + D L+ L L L N L SI
Sbjct: 38 LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLK-SI 96
Query: 263 PS-IIGNLKSLHQLDLIEN 280
P NLKSL + L N
Sbjct: 97 PRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 502 IPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI-GNLLKL 560
IP ++L+ L+ NQ++ P F L LQ L ++NKL ++IP + L +L
Sbjct: 31 IPTDKQRLW------LNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPTGVFDKLTQL 83
Query: 561 YYLNLSNNQFSHTIPI-EFEKLIHLSKLDLSHN 592
L+L++N +IP F+ L L+ + L +N
Sbjct: 84 TQLDLNDNHL-KSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 525 SVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIE-FEKLIH 583
SVP G T+ Q L L+ N+++ P +L+ L L ++N+ + IP F+KL
Sbjct: 26 SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 584 LSKLDLSHNILQEEIPPQVC-NMESLEKLNLSHNN 617
L++LDL+ N L+ IP N++SL + L +NN
Sbjct: 83 LTQLDLNDNHLK-SIPRGAFDNLKSLTHIYL-YNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 4/93 (4%)
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKS 319
S+P+ I +L L NQ++ P F +L + + SN L+ +IP + L
Sbjct: 26 SVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 320 LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNN 352
L+ L L N L + + NL SL ++ L+NN
Sbjct: 83 LTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 29/85 (34%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 246 SNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLS-FGNLSSWTLMSLFSN 304
++ L+L N ++ P + +L +L QL N+L+ +IP F L+ T + L N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91
Query: 305 SLSGSIPP-ILGNLKSLSTLGLYLN 328
L SIP NLKSL+ + LY N
Sbjct: 92 HLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 33/142 (23%), Positives = 47/142 (33%), Gaps = 56/142 (39%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIG---KLNQLRRLYLDMNQLHGTIPPVIGQLS 174
+P I + Q L L NNQ++ E G L L++LY + N+L IP
Sbjct: 27 VPAGI--PTDKQRLWLNNNQIT---KLEPGVFDHLVNLQQLYFNSNKLT-AIP------- 73
Query: 175 LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQL 234
V L L+ LDL+ N L
Sbjct: 74 ----------------------------------------TGVFDKLTQLTQLDLNDNHL 93
Query: 235 NGLIPCTLDNLSNLDTLFLYKN 256
+ DNL +L ++LY N
Sbjct: 94 KSIPRGAFDNLKSLTHIYLYNN 115
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 33/240 (13%), Positives = 64/240 (26%), Gaps = 59/240 (24%)
Query: 747 IKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKF----NSQLLSGNMADQDEFLNVV 802
T+ IG+G G V++ VA+K + + +E L +
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 803 LALNEI---------RHRNIVKFHGFC------------------------------SNA 823
+ E+ R + +
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDI 883
F+V E+ G K S +++ + +L+ HRD+
Sbjct: 135 DQLFIVLEFEFGGIDL----EQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDL 188
Query: 884 SSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSF 943
NVLL + + ++ + + G I YT+ E+ + F
Sbjct: 189 HWGNVLLKKTSLKKLHYTL---------NGKSSTIPSCGLQVSIIDYTLSRLERDGIVVF 239
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 49/277 (17%), Positives = 89/277 (32%), Gaps = 88/277 (31%)
Query: 751 DDFDEKFCI----GKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLAL 805
D F+ ++ + G G +V+ + + VA+K S DE + ++ ++
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDE-IRLLKSV 90
Query: 806 NEIR-----HRNIVK------FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWN 854
+V+ G N H +V E L L + + S
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISG--VNGTHICMVFEVL-GHHLLKWI-------IKSNY 140
Query: 855 RRI------NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE--------------- 893
+ + +I+ V L YLH C IIH DI +N+LL +
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 894 ----------------------------------FEAHVSDFGIAKFVEPYSSNRTEFVG 919
+ ++D G A +V + TE +
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQ 255
Query: 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956
T Y + E+ D++S + FE+ G++
Sbjct: 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 44/253 (17%), Positives = 86/253 (33%), Gaps = 47/253 (18%)
Query: 411 KSLTSLKRVRFNQNNLVGKVYEAFGD-----HPNLTFLDLSQNNFDGK--------ISFN 457
+ S+ + + N+L K + N+T L+LS N K ++
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107
Query: 458 WRNLPKLDTFIVSMNNIFGSIPLEIGD-----SSKLQFLDLSSNHIVGKIPVQLEKLF-- 510
+ LD + N+ E + + L+L N + K +L ++
Sbjct: 108 PFTITVLD---LGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAA 164
Query: 511 ---SLNKLILSLNQLSGSVPLEFGSL-----TELQYLDLSANKLSSSIPKSIGNLLK--- 559
++N L L N L+ E + LDLSAN L + +
Sbjct: 165 IPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIP 224
Query: 560 --LYYLNLSNNQFSHT----IPIEFEKLIHLSKLDLSHNILQEEIPPQ-------VCNME 606
+ LNL N + + + L HL + L ++I++ Q N++
Sbjct: 225 NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQ 284
Query: 607 SLEKLNLSHNNLS 619
+ ++ + +
Sbjct: 285 KIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 56/348 (16%), Positives = 112/348 (32%), Gaps = 70/348 (20%)
Query: 313 ILGNLKSLSTLGLYLNQLNGVIPPSIG-----NLSSLRNLSLFNNGLYGSIPEEIGYL-- 365
+++L L LN L + + +S+ +L+L N L +E+ +
Sbjct: 17 FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 366 ---KSLSELKLCKNN--------LSGVIPHSVGNLTGLVLLNMCENHLFGP-----IPKS 409
+++ L L N L + +T L L N ++
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDL---GWNDF-SSKSSSEFKQA 132
Query: 410 LKSL-TSLKRVRFNQNNL----VGKVYEAFGDHP-NLTFLDLSQNNFDGK--------IS 455
+L S+ + N+L ++ + P N+ L+L NN K ++
Sbjct: 133 FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA 192
Query: 456 FNWRNLPKLDTFIVSMNNIFGSIPLEIGD-----SSKLQFLDLSSNHIVGKIPVQLEKLF 510
++ LD +S N + E+ + + L+L N + G L+ L
Sbjct: 193 SIPASVTSLD---LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLK 249
Query: 511 SLNK----LILSLNQLSGSVPLEFGSLTE-------LQYLDLSANKLSSSIPKSIGNLLK 559
K + L + + + +L + +D + ++ S I NL++
Sbjct: 250 DSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIR 309
Query: 560 -----LYYLNLSNN-----QFSHTIPIEFEKLIHLSKLDLSHNILQEE 597
+L N Q T + L + + L E
Sbjct: 310 ELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLLEH 357
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 49/326 (15%), Positives = 102/326 (31%), Gaps = 65/326 (19%)
Query: 340 NLSSLRNLSLFNNGLYGSIPEEIGYL-----KSLSELKLCKNNLSGVIPHSVG-----NL 389
+ +L L N LY E+ S++ L L N+L +
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 390 TGLVLLNMCENHL----FGPIPKSLKSL-TSLKRVRFNQNNLVGKVYEAFGD-----HPN 439
+ LN+ N L + K+L ++ ++ + N+ K F +
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 440 LTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHI- 498
+T L+L N+ K S + + + + + L+L N++
Sbjct: 140 ITSLNLRGNDLGIK----------------SSDELIQILA---AIPANVNSLNLRGNNLA 180
Query: 499 ---VGKIPVQLEKL-FSLNKLILSLNQLSGSVPLEFGSL-----TELQYLDLSANKLSSS 549
++ L + S+ L LS N L E + + L+L N L
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240
Query: 550 IPKSIGNLLK----LYYLNLSNNQFSHTIPIEFEKLI-------HLSKLDLSHNILQEEI 598
+++ L L + L + + + + L + +D + +
Sbjct: 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH 300
Query: 599 PPQVCNM-----ESLEKLNLSHNNLS 619
+ N+ + +L + L
Sbjct: 301 SIPISNLIRELSGKADVPSLLNQCLI 326
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 50/298 (16%), Positives = 97/298 (32%), Gaps = 68/298 (22%)
Query: 102 PHLVNLNLSFNLFFGNIPPQ---------IGNLSKLQNLDLGNNQLSGVISPEIGKL--- 149
+ +L+LS N N+ + + +L+L N L S E+ ++
Sbjct: 22 HGVTSLDLSLN----NLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 150 --NQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNN 207
+ L L N L L+ + + +L L
Sbjct: 78 IPANVTSLNLSGNFLS-----YKSSDELVKTLAAIP--------------FTITVLDLGW 118
Query: 208 NSL----FGYIPTVMGNL-KSLSTLDLSQNQL-----NGLIPCTLDNLSNLDTLFLYKNS 257
N NL S+++L+L N L + LI +N+++L L N+
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178
Query: 258 LSGS-----IPSIIGNLKSLHQLDLIENQL--SGSIPLSFG---NLSSWTLMSLFSNSLS 307
L+ + S+ LDL N L L++ + ++L N L
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238
Query: 308 GS----IPPILGNLKSLSTLGLYLNQLNGV-------IPPSIGNLSSLRNLSLFNNGL 354
G + + +LK L T+ L + + + + + N+ + + +
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 40/182 (21%), Positives = 70/182 (38%), Gaps = 32/182 (17%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVK----KFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813
IG G G +Y + +G+ VA+K K L E + + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL------HIES-KIYKMMQGGVG--I 67
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
+ ++ +V E L SL + + +++ S + + + + + Y+H
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGP-SLEDLF--NFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 874 CLPSIIHRDISSKNVLLDLEFEAH---VSDFGIAKFVE--------PYSSNRTEFVGTFG 922
+ IHRD+ N L+ L + + + DFG+AK PY N+ GT
Sbjct: 125 ---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK-NLTGTAR 180
Query: 923 YA 924
YA
Sbjct: 181 YA 182
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 55/216 (25%), Positives = 82/216 (37%), Gaps = 46/216 (21%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVK------KFNSQ-------LLSGNMADQDEFLNVVLA 804
IGKG G V KA VA+K +F+ Q L D+D +NV+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDATAKELSWNRRINVIKGV 863
L RN H + E L +L ++ N L R+ +
Sbjct: 165 LENFTFRN------------HICMTFELLSM-NLYELIKKNKFQGFSLPLVRKF--AHSI 209
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH--VSDFGIAKFVE----PYSSNRTEF 917
L LH IIH D+ +N+LL + + V DFG + + Y +R
Sbjct: 210 LQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR--- 263
Query: 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 953
F Y APE+ R D++S G ++ E++ G
Sbjct: 264 ---F-YRAPEVILGARYGMPIDMWSLGCILAELLTG 295
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 63/395 (15%), Positives = 115/395 (29%), Gaps = 75/395 (18%)
Query: 202 LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261
LL +N ++ + + NL +L + +L L L LD +
Sbjct: 6 LLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLD-HLFFHYEFQNQ 64
Query: 262 IPSIIGNLKSLHQLDLIENQLS--GSIPLSFG---NLSSWTLMSLFSNSLSG-SIPPILG 315
S SL QL+L +++ ++ + ++L S L + +L
Sbjct: 65 RFSAEVL-SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLP 123
Query: 316 NLKSLSTLGLYLNQL--NGVIPPSIG-----NLSSLRNLSLFNNGLYGS----IPEEIGY 364
LGL LN L + + + L L NN L + + E +
Sbjct: 124 VFLRARKLGLQLNSLGPEACK--DLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181
Query: 365 LKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424
S++ L L L GL LL L L+ + N
Sbjct: 182 NTSVTHLSLLHTGLGD---------EGLELL--AA---------QLDRNRQLQELNVAYN 221
Query: 425 NL----VGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPL 480
+ A +HP+L L L N + ++ G+
Sbjct: 222 GAGDTAALALARAAREHPSLELLHLYFNELS-------------SEGRQVLRDLGGAAE- 267
Query: 481 EIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLD 540
+++ + L + + + S ++ L EL D
Sbjct: 268 ---GGARVVVSLTEGTAVS---EYWSVILSEVQRNLNSWDRARVQRHL------ELLLRD 315
Query: 541 LSANKLSSSIPKSIGNLLK----LYYLNLSNNQFS 571
L ++ ++ P LL+ + L
Sbjct: 316 LEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 30/154 (19%), Positives = 59/154 (38%), Gaps = 20/154 (12%)
Query: 485 SSKLQFLDLSSNHIVGKIPVQ--LEKLFSLNKLILSLNQLSGSVPLEFGSL-----TELQ 537
L ++L+S + ++ L KL L LN L + L ++
Sbjct: 100 RHALDEVNLASCQL-DPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQIT 158
Query: 538 YLDLSANKLSSSIPKSIGNLLK----LYYLNLSNNQFSHT----IPIEFEKLIHLSKLDL 589
L LS N L+++ + L + +L+L + + + ++ L +L++
Sbjct: 159 TLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNV 218
Query: 590 SHNILQEEIPPQVCNM----ESLEKLNLSHNNLS 619
++N + + SLE L+L N LS
Sbjct: 219 AYNGAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 47/356 (13%), Positives = 96/356 (26%), Gaps = 77/356 (21%)
Query: 314 LGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKL 373
+ NL +L +L + + L +L E+ L SL +L L
Sbjct: 22 IKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV--LSSLRQLNL 79
Query: 374 CKNNLSG--------VIPHSVGNLTGLVLLNMCENHLFGPIPKSL-KSLTSLKRVRFNQN 424
++ V+ L +N+ L ++L +++ N
Sbjct: 80 AGVRMTPVKCTVVAAVLGSGRHALD---EVNLASCQLDPAGLRTLLPVFLRARKLGLQLN 136
Query: 425 NLVGKVYEAFGD-----HPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479
+L + + D +T L LS N G
Sbjct: 137 SLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAA----------------------GVAV 174
Query: 480 L--EIGDSSKLQFLDLSSNHI----VGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSL 533
L + ++ + L L + + + QL++ L +L ++ N + L
Sbjct: 175 LMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234
Query: 534 ----TELQYLDLSANKLS-------SSIPKSIGNLLKLYYLNLSNNQFS----------- 571
L+ L L N+LS + + ++ S
Sbjct: 235 AREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQ 294
Query: 572 ----HTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNM----ESLEKLNLSHNNLS 619
++ + L DL + P + + + L +
Sbjct: 295 RNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 36/213 (16%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVK------KFNSQ-------LLSGNMADQDEFLNVVLA 804
IGKG G V KA + VA+K F +Q L N D + +V
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-GNDATAKELSWNRRINVIKGV 863
RN H LV E L +L +L + L+ R+ + +
Sbjct: 122 KRHFMFRN------------HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKF--AQQM 166
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH--VSDFGIAKFVEPYSSNRTEFVGTF 921
AL +L L SIIH D+ +N+LL + + DFG + + +++ +
Sbjct: 167 CTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSR 222
Query: 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN 954
Y +PE+ M D++S G ++ E+ G
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 39/189 (20%), Positives = 65/189 (34%), Gaps = 44/189 (23%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G +++ L + VA+K + + + D+ ++ I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT-----GIPNVY 72
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA-------NALSYL 870
F H+ LV + L SL +L R +K VA + +
Sbjct: 73 YFGQEGLHNVLVIDLLGP-SLEDLL---------DLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEA-----HVSDFGIAKFVEPYSSNRTE--------- 916
H S+++RDI N L+ +V DFG+ K Y T+
Sbjct: 123 HEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---FYRDPVTKQHIPYREKK 176
Query: 917 -FVGTFGYA 924
GT Y
Sbjct: 177 NLSGTARYM 185
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 26/180 (14%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG G G + + L + + VA+K L L I + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
F +++ +V E L SL + D + S + + + + + Y+H +
Sbjct: 72 YFGPCGKYNAMVLELLGP-SLEDLF--DLCDRTFSLKTVLMIAIQLISRMEYVHSK---N 125
Query: 878 IIHRDISSKNVLLDLEFEA-----HVSDFGIAK-FVE-------PYSSNRTEFVGTFGYA 924
+I+RD+ +N L+ H+ DF +AK +++ PY +++ GT Y
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS-LTGTARYM 184
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 41/180 (22%), Positives = 70/180 (38%), Gaps = 28/180 (15%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG G G +Y + + + VA+K N + + + + + L I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRI---LQGGTG--IPNVR 69
Query: 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS 877
F ++ LV + L SL + + +++LS + + + N + ++H S
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSK---S 123
Query: 878 IIHRDISSKNVLLDLEFEAH---VSDFGIAKFVEPYSSNRTE----------FVGTFGYA 924
+HRDI N L+ L A+ + DFG+AK Y T GT YA
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---KYRDTSTHQHIPYRENKNLTGTARYA 180
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1078 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.83 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.32 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.31 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.2 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.08 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.01 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.99 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.81 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.79 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.72 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.45 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.41 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.18 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.14 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.05 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.98 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.81 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.71 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.7 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.68 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.48 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.34 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.33 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.18 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.98 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.87 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.78 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.61 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.44 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.31 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.3 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.08 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.77 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.58 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.84 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.86 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.77 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.12 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 85.39 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.97 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.83 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.68 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-89 Score=863.00 Aligned_cols=640 Identities=30% Similarity=0.474 Sum_probs=571.1
Q ss_pred cccCCCHHHHHHHHHHHHhcCCCCCCccccCCCCCCCCCCCCCCCCcccceEeeCCCCeEEEeccCccccCCc---ccC-
Q 039595 20 NVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLNGT---FQD- 95 (1078)
Q Consensus 20 ~~~~~~~~~~~all~~k~~~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~---~~~- 95 (1078)
+++.+.++||+|||+||+++.++ . .++||+. ++|||+|.||+|+ ++||+.++|++.++.|. +++
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~---~-~l~~W~~------~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~ 72 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDK---N-LLPDWSS------NKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSS 72 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCT---T-SSTTCCT------TSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHH
T ss_pred ccccCCHHHHHHHHHHHhhCCCc---c-cccCCCC------CCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChh
Confidence 34445689999999999999732 3 7999972 4789999999998 68999999999999887 442
Q ss_pred ---------------------CccCCCCCCcEEeccCCcccccCCC--CCCCCCCcceeccCCCccCCCCCccc-cCccc
Q 039595 96 ---------------------FSFSSFPHLVNLNLSFNLFFGNIPP--QIGNLSKLQNLDLGNNQLSGVISPEI-GKLNQ 151 (1078)
Q Consensus 96 ---------------------~~~~~l~~L~~L~L~~n~~~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~ 151 (1078)
..++++++|++|||++|.+.|.+|. .++++++|++|||++|.+++.+|..+ +++++
T Consensus 73 l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~ 152 (768)
T 3rgz_A 73 LLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNS 152 (768)
T ss_dssp TTTCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTT
T ss_pred HhccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCC
Confidence 4677888889999999988888888 88888999999999988888888776 78888
Q ss_pred eeEEEccCccCCCCCCcc---cccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeee
Q 039595 152 LRRLYLDMNQLHGTIPPV---IGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLD 228 (1078)
Q Consensus 152 L~~L~L~~n~l~~~~p~~---i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 228 (1078)
|++|+|++|++++..|.. ++.+++|++|++++|.+++.+|. +++++|++|+|++|++++.+|. ++++++|++|+
T Consensus 153 L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~ 229 (768)
T 3rgz_A 153 LEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLD 229 (768)
T ss_dssp CSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEE
T ss_pred CCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEE
Confidence 999999988888877776 78888888888888888877664 7889999999999999888887 89999999999
Q ss_pred cCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccc-cCCceeeecccCCC
Q 039595 229 LSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNL-SSWTLMSLFSNSLS 307 (1078)
Q Consensus 229 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~l~~n~l~ 307 (1078)
|++|++++.+|..|.++++|++|+|++|++++.+|.. .+++|++|+|++|+++|.+|..+... ++|+.|++++|.++
T Consensus 230 Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~ 307 (768)
T 3rgz_A 230 ISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307 (768)
T ss_dssp CCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEE
T ss_pred CcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCC
Confidence 9999999888989999999999999999998877765 78899999999999998899888775 89999999999999
Q ss_pred CCCCccccCCCccCeeeccccccCccCCCC-CCCCCcCcEEEccCccCCCCCCccccccC-CCCeEEcccccCccccCCC
Q 039595 308 GSIPPILGNLKSLSTLGLYLNQLNGVIPPS-IGNLSSLRNLSLFNNGLYGSIPEEIGYLK-SLSELKLCKNNLSGVIPHS 385 (1078)
Q Consensus 308 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~ 385 (1078)
+.+|..|+++++|++|+|++|++++.+|.. +..+++|++|++++|.+.+.+|..+..++ +|++|++++|++++.+|..
T Consensus 308 ~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~ 387 (768)
T 3rgz_A 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387 (768)
T ss_dssp ECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTT
T ss_pred CccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChh
Confidence 999999999999999999999998877765 88999999999999999988999998887 8999999999999888888
Q ss_pred Ccc--CCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCC
Q 039595 386 VGN--LTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPK 463 (1078)
Q Consensus 386 ~~~--l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 463 (1078)
+.. +++|++|++++|++++.+|..+..+++|++|++++|.+.+..+..|..+++|+.|++++|.+.+..+..+..+++
T Consensus 388 ~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 467 (768)
T 3rgz_A 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467 (768)
T ss_dssp TTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred hhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCC
Confidence 877 888999999999999999999999999999999999999888899999999999999999999988889999999
Q ss_pred CceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccC
Q 039595 464 LDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSA 543 (1078)
Q Consensus 464 L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 543 (1078)
|++|++++|++++.+|..++.+++|++|+|++|++++.+|.+++.+++|++|+|++|++++.+|..+..+++|++|+|++
T Consensus 468 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 547 (768)
T 3rgz_A 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547 (768)
T ss_dssp CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCS
T ss_pred ceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccc---------------------------------------------------------------------
Q 039595 544 NKLSSSIPKSI--------------------------------------------------------------------- 554 (1078)
Q Consensus 544 N~l~~~~~~~~--------------------------------------------------------------------- 554 (1078)
|++++.+|..+
T Consensus 548 N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~ 627 (768)
T 3rgz_A 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627 (768)
T ss_dssp SEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCS
T ss_pred CccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchh
Confidence 99987766543
Q ss_pred -ccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCc
Q 039595 555 -GNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLS 633 (1078)
Q Consensus 555 -~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 633 (1078)
..+++|++|+|++|++++.+|..|+.+++|+.|+|++|++++.+|..++++++|++|||++|+++|.+|..+..+++|+
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 707 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence 3457899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEcccCcCCCCCCCCcc---ccCccccCCCCcCCCcccccccccccC
Q 039595 634 CIDICYNELQGPIPNSTV---FKDGLMEGNKGLCGNFEAFSSCDAFMS 678 (1078)
Q Consensus 634 ~l~l~~N~l~~~~~~~~~---~~~~~~~~n~~lc~~~~~~~~~~~~~~ 678 (1078)
+||+++|+++|.||...+ ++...|.||+++||+|.. +|.+...
T Consensus 708 ~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~--~C~~~~~ 753 (768)
T 3rgz_A 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP--RCDPSNA 753 (768)
T ss_dssp EEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC--CCCSCC-
T ss_pred EEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc--CCCCCcc
Confidence 999999999999998765 566789999999999865 7865543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-70 Score=687.44 Aligned_cols=561 Identities=33% Similarity=0.440 Sum_probs=515.6
Q ss_pred CeEEEeccCccccCCcccCC-ccCCCCCCcEEeccCCcccccCCCCC-CCCCCcceeccCCCccCCCCCcc---ccCccc
Q 039595 77 SRVISINLSTLCLNGTFQDF-SFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDLGNNQLSGVISPE---IGKLNQ 151 (1078)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~-~~~~l~~L~~L~L~~n~~~~~~p~~~-~~l~~L~~L~Ls~n~l~~~~p~~---~~~l~~ 151 (1078)
.+.+.|+|+++.+.|.++.. .++++++|++|+|++|.+.+.+|..+ +++++|++|||++|++++..|.. ++++++
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~ 179 (768)
T 3rgz_A 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179 (768)
T ss_dssp TTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTT
T ss_pred CCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCC
Confidence 36677899999999887653 68999999999999999999998876 89999999999999999988877 899999
Q ss_pred eeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCC
Q 039595 152 LRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQ 231 (1078)
Q Consensus 152 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 231 (1078)
|++|++++|.+++.+|. +.+++|++|++++|.+++.+|. ++++++|++|+|++|++++.+|..++++++|++|+|++
T Consensus 180 L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~ 256 (768)
T 3rgz_A 180 LKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256 (768)
T ss_dssp CCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCS
T ss_pred CCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCC
Confidence 99999999999987765 7899999999999999998887 99999999999999999999999999999999999999
Q ss_pred cccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCC-cccceeecccccccCccccccccccCCceeeecccCCCCCC
Q 039595 232 NQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNL-KSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSI 310 (1078)
Q Consensus 232 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~ 310 (1078)
|++++.+|.. .+++|++|+|++|++++.+|..+.++ ++|++|+|++|++++.+|..|+.+++|+.|++++|.++|.+
T Consensus 257 n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~i 334 (768)
T 3rgz_A 257 NQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334 (768)
T ss_dssp SCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred CcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcC
Confidence 9999887765 88999999999999999899888775 99999999999999999999999999999999999999888
Q ss_pred Ccc-ccCCCccCeeeccccccCccCCCCCCCCC-cCcEEEccCccCCCCCCccccc--cCCCCeEEcccccCccccCCCC
Q 039595 311 PPI-LGNLKSLSTLGLYLNQLNGVIPPSIGNLS-SLRNLSLFNNGLYGSIPEEIGY--LKSLSELKLCKNNLSGVIPHSV 386 (1078)
Q Consensus 311 p~~-l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~p~~~ 386 (1078)
|.. ++++++|++|++++|++++.+|..+..++ +|+.|++++|.+.+.+|..+.. +++|++|++++|++++.+|..+
T Consensus 335 p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l 414 (768)
T 3rgz_A 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414 (768)
T ss_dssp CHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGG
T ss_pred CHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHH
Confidence 876 99999999999999999999999999887 9999999999999988888877 8899999999999999999999
Q ss_pred ccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCce
Q 039595 387 GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDT 466 (1078)
Q Consensus 387 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 466 (1078)
.++++|++|++++|++++.+|..+..+++|++|++++|.+.+..+..+..+++|++|++++|++++..+..+..+++|++
T Consensus 415 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 494 (768)
T 3rgz_A 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494 (768)
T ss_dssp GGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred hcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCE
Confidence 99999999999999999999999999999999999999999988899999999999999999999988889999999999
Q ss_pred ecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccc-----------------
Q 039595 467 FIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE----------------- 529 (1078)
Q Consensus 467 L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----------------- 529 (1078)
|++++|++++.+|.+++.+++|++|+|++|++++.+|..+.++++|+.|++++|++++.+|..
T Consensus 495 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~ 574 (768)
T 3rgz_A 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKR 574 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCE
T ss_pred EEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccc
Confidence 999999999999999999999999999999999999999999999999999999988766653
Q ss_pred -----------------------------------------------------cccccccceeeccCccccCCCCccccc
Q 039595 530 -----------------------------------------------------FGSLTELQYLDLSANKLSSSIPKSIGN 556 (1078)
Q Consensus 530 -----------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 556 (1078)
|..+++|++|||++|++++.+|..+++
T Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~ 654 (768)
T 3rgz_A 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654 (768)
T ss_dssp EEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGG
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhc
Confidence 334678999999999999999999999
Q ss_pred ccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEE
Q 039595 557 LLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCID 636 (1078)
Q Consensus 557 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~ 636 (1078)
+++|+.|+|++|++++.+|..|+++++|+.|||++|++++.+|..+..+++|++|||++|+++|.+|.. ..+.++....
T Consensus 655 l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~ 733 (768)
T 3rgz_A 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAK 733 (768)
T ss_dssp CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGG
T ss_pred cccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHH
Confidence 999999999999999999999999999999999999999999999999999999999999999999975 3455566667
Q ss_pred cccCcCC
Q 039595 637 ICYNELQ 643 (1078)
Q Consensus 637 l~~N~l~ 643 (1078)
+.+|+--
T Consensus 734 ~~gN~~L 740 (768)
T 3rgz_A 734 FLNNPGL 740 (768)
T ss_dssp GCSCTEE
T ss_pred hcCCchh
Confidence 8888743
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-63 Score=623.45 Aligned_cols=546 Identities=24% Similarity=0.263 Sum_probs=307.1
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeec
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l 181 (1078)
+++++|+|++|.+.+..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+.+++|++|++
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 45666666666666555555666666666666666666666666666666666666666666333335666666666666
Q ss_pred ccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCccc--CCCCCcEEeccccccC
Q 039595 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLD--NLSNLDTLFLYKNSLS 259 (1078)
Q Consensus 182 ~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~L~~N~l~ 259 (1078)
++|.+++..|..|+++++|++|+|++|.+++..|..++++++|++|+|++|++++..+..+. .+++|++|++++|+++
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 66666655555666666666666666666666666666666666666666666655554433 3456666666666666
Q ss_pred CCCCcccCCCcc---------------------------cceeecccccccCccccccccccC--CceeeecccCCCCCC
Q 039595 260 GSIPSIIGNLKS---------------------------LHQLDLIENQLSGSIPLSFGNLSS--WTLMSLFSNSLSGSI 310 (1078)
Q Consensus 260 ~~~p~~~~~l~~---------------------------L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~l~~n~l~~~~ 310 (1078)
+..|..|..+++ |+.|++++|.+++..|..|..++. |+.|++++|.+++..
T Consensus 185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~ 264 (680)
T 1ziw_A 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264 (680)
T ss_dssp CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEEC
T ss_pred ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccC
Confidence 655655555544 555555555555555555555543 555555555555555
Q ss_pred CccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCC-----CCCc----cccccCCCCeEEcccccCccc
Q 039595 311 PPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYG-----SIPE----EIGYLKSLSELKLCKNNLSGV 381 (1078)
Q Consensus 311 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-----~~p~----~~~~l~~L~~L~L~~N~l~~~ 381 (1078)
|..|+++++|++|++++|++++..|..|..+++|+.|++++|...+ .+|. .|..+++|++|++++|++++.
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~ 344 (680)
T 1ziw_A 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCC
T ss_pred cccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCC
Confidence 5555555555555555555555555555555555555555544332 1222 444555555555555555555
Q ss_pred cCCCCccCCCCceeecccCcCCC--CCCcccccc--CCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCc-cCc
Q 039595 382 IPHSVGNLTGLVLLNMCENHLFG--PIPKSLKSL--TSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGK-ISF 456 (1078)
Q Consensus 382 ~p~~~~~l~~L~~L~L~~N~l~~--~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~ 456 (1078)
.+..|.++++|++|++++|.+.. ..+..|..+ ++|+.|++++|.+.++.+..|..+++|+.|++++|.+.+. ...
T Consensus 345 ~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 424 (680)
T 1ziw_A 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSG
T ss_pred ChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcc
Confidence 55555555555555555555322 112222222 3455555555555555555555555555555555555432 224
Q ss_pred cccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccC--CCcccccccCccCcEEeccCCccCCCccccccccc
Q 039595 457 NWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIV--GKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLT 534 (1078)
Q Consensus 457 ~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 534 (1078)
.|.++++|++|++++|++.+..+..|..+++|+.|++++|.++ +..|..|.++++|+.|+|++|++++..+..|..++
T Consensus 425 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~ 504 (680)
T 1ziw_A 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504 (680)
T ss_dssp GGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred cccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccc
Confidence 5555555555555555555555555555555555555555554 33455555555555555555555555555555555
Q ss_pred ccceeeccCccccCCCC--------cccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCccccc
Q 039595 535 ELQYLDLSANKLSSSIP--------KSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNME 606 (1078)
Q Consensus 535 ~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 606 (1078)
+|++|+|++|++++..+ ..|.++++|++|+|++|+|+.+.+..|.++++|+.|+|++|+|++..+..|..++
T Consensus 505 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~ 584 (680)
T 1ziw_A 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV 584 (680)
T ss_dssp TCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred ccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCC
Confidence 55555555555553211 1245555555555555555543334455555555555555555544444455555
Q ss_pred ccceeeccCccccCCcccccc-cCCcCcEEEcccCcCCCCCC
Q 039595 607 SLEKLNLSHNNLSGFIPRCFE-KMRSLSCIDICYNELQGPIP 647 (1078)
Q Consensus 607 ~L~~L~L~~N~l~~~~~~~l~-~l~~L~~l~l~~N~l~~~~~ 647 (1078)
+|++|+|++|+|++..+..|. .+++|+.+++++|+|.+.++
T Consensus 585 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 585 SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 555555555555555555554 45555555555555555444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-62 Score=612.31 Aligned_cols=556 Identities=24% Similarity=0.242 Sum_probs=491.2
Q ss_pred EeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccc
Q 039595 107 LNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNV 186 (1078)
Q Consensus 107 L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~ 186 (1078)
+|.++++++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..++.+++|++|+|++|.+
T Consensus 9 ~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 85 (680)
T 1ziw_A 9 ADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85 (680)
T ss_dssp EECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCC
T ss_pred eECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCcc
Confidence 444455554 5776665 7999999999999987778899999999999999999999999999999999999999999
Q ss_pred cCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCccc
Q 039595 187 SGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSII 266 (1078)
Q Consensus 187 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 266 (1078)
++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++..+..+
T Consensus 86 ~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 165 (680)
T 1ziw_A 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165 (680)
T ss_dssp CCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHH
T ss_pred CccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHh
Confidence 97666689999999999999999998888899999999999999999999999999999999999999999998777665
Q ss_pred C--CCcccceeecccccccCccccccccc---------------------------cCCceeeecccCCCCCCCccccCC
Q 039595 267 G--NLKSLHQLDLIENQLSGSIPLSFGNL---------------------------SSWTLMSLFSNSLSGSIPPILGNL 317 (1078)
Q Consensus 267 ~--~l~~L~~L~Ls~N~l~~~~p~~~~~l---------------------------~~L~~L~l~~n~l~~~~p~~l~~l 317 (1078)
. .+++|+.|++++|++++..|..|..+ ++|+.|++++|.+++..|..|.++
T Consensus 166 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l 245 (680)
T 1ziw_A 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245 (680)
T ss_dssp GGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGG
T ss_pred hccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhcc
Confidence 4 56899999999999999988887765 456788888899998888889888
Q ss_pred Cc--cCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCcc-----ccC----CCC
Q 039595 318 KS--LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSG-----VIP----HSV 386 (1078)
Q Consensus 318 ~~--L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----~~p----~~~ 386 (1078)
+. |++|+|++|++++..|..|+.+++|+.|++++|.+.+..|..+..+++|+.|++++|...+ .+| ..|
T Consensus 246 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~ 325 (680)
T 1ziw_A 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325 (680)
T ss_dssp GGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTT
T ss_pred CcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhc
Confidence 66 9999999999999888999999999999999999998889999999999999999876543 223 378
Q ss_pred ccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccc--cccchhhccCC--CCCcEecCCCCccCCccCccccCCC
Q 039595 387 GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNL--VGKVYEAFGDH--PNLTFLDLSQNNFDGKISFNWRNLP 462 (1078)
Q Consensus 387 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l--~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~ 462 (1078)
..+++|++|++++|++.+..+..|.++++|++|++++|.+ ..+....|..+ ++|+.|++++|+++++.+..|..++
T Consensus 326 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~ 405 (680)
T 1ziw_A 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405 (680)
T ss_dssp TTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCT
T ss_pred ccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCC
Confidence 8899999999999999999999999999999999999975 34444555443 5899999999999999999999999
Q ss_pred CCceecccccccCCCCC-ccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccC--CCccccccccccccee
Q 039595 463 KLDTFIVSMNNIFGSIP-LEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLS--GSVPLEFGSLTELQYL 539 (1078)
Q Consensus 463 ~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L 539 (1078)
+|+.|++++|.+.+.++ ..+..+++|++|++++|++.+..+..|..+++|+.|++++|.++ +..|..|..+++|++|
T Consensus 406 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L 485 (680)
T 1ziw_A 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485 (680)
T ss_dssp TCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEE
T ss_pred CCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEE
Confidence 99999999999987665 68899999999999999999888999999999999999999987 5678999999999999
Q ss_pred eccCccccCCCCcccccccccccccccCcccccccc--------hhhhcccccCeeecCCCccCCcCCCCccccccccee
Q 039595 540 DLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIP--------IEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKL 611 (1078)
Q Consensus 540 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 611 (1078)
+|++|.|++..+..|.++++|++|+|++|++++..+ ..|.++++|+.|+|++|+|+...+..|.++++|++|
T Consensus 486 ~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 565 (680)
T 1ziw_A 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565 (680)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCccee
Confidence 999999998888889999999999999999986532 237899999999999999996555679999999999
Q ss_pred eccCccccCCcccccccCCcCcEEEcccCcCCCCCCCC-----ccccCccccCCCCcCC
Q 039595 612 NLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNS-----TVFKDGLMEGNKGLCG 665 (1078)
Q Consensus 612 ~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~~-----~~~~~~~~~~n~~lc~ 665 (1078)
+|++|++++..+..|..+++|+.|++++|++++..|.. .......+++||+.|.
T Consensus 566 ~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred ECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 99999999888888999999999999999999876642 1233456789999984
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-59 Score=590.99 Aligned_cols=521 Identities=24% Similarity=0.242 Sum_probs=412.5
Q ss_pred CCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCC-CccccCccceeEEEccCccCCCCCCcccccccccce
Q 039595 100 SFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVI-SPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHE 178 (1078)
Q Consensus 100 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~ 178 (1078)
-.++|++|||++|.+++..|..|+++++|++|||++|.+.+.+ |..|+++++|++|+|++|.+++..|..|+.+++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 4578999999999998888889999999999999999766666 677899999999999999998888899999999999
Q ss_pred eecccccccCCccCc--ccCCCCCcEEEccCCCCCCCCC-CcccccCCCCeeecCCcccCCCCCCcccCC--CCCcEEec
Q 039595 179 FSFCHNNVSGRIPSS--LGNLSKLALLYLNNNSLFGYIP-TVMGNLKSLSTLDLSQNQLNGLIPCTLDNL--SNLDTLFL 253 (1078)
Q Consensus 179 L~l~~n~~~~~~p~~--l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~L 253 (1078)
|+|++|.+++.+|.. |+++++|++|+|++|.+++..| ..|+++++|++|+|++|++++..|..+..+ ++|+.|+|
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L 181 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence 999999998877765 8899999999999999887655 578889999999999999988888888877 88999999
Q ss_pred cccccCCCCCcccCCCcc------cceeecccccccCccccccccc---cCCceeeecccCCCCCCCccccCCCccCeee
Q 039595 254 YKNSLSGSIPSIIGNLKS------LHQLDLIENQLSGSIPLSFGNL---SSWTLMSLFSNSLSGSIPPILGNLKSLSTLG 324 (1078)
Q Consensus 254 ~~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ 324 (1078)
++|.+.+..|..++.+++ |+.|++++|.+++..|..+... ..++.+.+..+.+.. .
T Consensus 182 ~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~---------------~ 246 (844)
T 3j0a_A 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA---------------G 246 (844)
T ss_dssp CCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBC---------------S
T ss_pred CCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccc---------------c
Confidence 999998888877776665 8888888888888777776543 345566655333221 1
Q ss_pred ccccccCccCCCCCCCC--CcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcC
Q 039595 325 LYLNQLNGVIPPSIGNL--SSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL 402 (1078)
Q Consensus 325 L~~N~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 402 (1078)
+..+.+.+..+..|..+ ++|+.|++++|.+.+..|..|..+++|+.|+|++|++++..|..|.++++|++|++++|++
T Consensus 247 ~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l 326 (844)
T 3j0a_A 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326 (844)
T ss_dssp SSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCC
T ss_pred ccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCC
Confidence 12233333334444443 5677777777777766666777777777777777777777677777777777777777777
Q ss_pred CCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccc
Q 039595 403 FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEI 482 (1078)
Q Consensus 403 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~ 482 (1078)
.+..|..|..+++|++|++++|.+..+....|..+++|+.|+|++|.++++. .+++|+.|++++|+++. +|..
T Consensus 327 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~~-l~~~- 399 (844)
T 3j0a_A 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLVT-LPKI- 399 (844)
T ss_dssp SCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCCC-CCCC-
T ss_pred CccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc-----CCCCcchhccCCCCccc-cccc-
Confidence 7777777777777777777777777777777777777777777777776533 26777788888887763 3332
Q ss_pred cCCCcccEEeccCCccCCCc-ccccccCccCcEEeccCCccCCCccc-ccccccccceeeccCcccc-----CCCCcccc
Q 039595 483 GDSSKLQFLDLSSNHIVGKI-PVQLEKLFSLNKLILSLNQLSGSVPL-EFGSLTELQYLDLSANKLS-----SSIPKSIG 555 (1078)
Q Consensus 483 ~~l~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~ 555 (1078)
..+++.|++++|++++.. +..+.++++|+.|+|++|++++..+. .+..+++|++|+|++|.++ +..+..|.
T Consensus 400 --~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 477 (844)
T 3j0a_A 400 --NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE 477 (844)
T ss_dssp --CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSS
T ss_pred --ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhc
Confidence 467899999999998653 23456889999999999999865543 4667899999999999997 44556789
Q ss_pred cccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEE
Q 039595 556 NLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCI 635 (1078)
Q Consensus 556 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l 635 (1078)
++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+. ++|+.|+|++|+|++..|..| ++|+.+
T Consensus 478 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l 552 (844)
T 3j0a_A 478 GLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVL 552 (844)
T ss_dssp CBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEE
T ss_pred CcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEE
Confidence 999999999999999999999999999999999999999987776665 899999999999999999776 478999
Q ss_pred EcccCcCCCCCCCC
Q 039595 636 DICYNELQGPIPNS 649 (1078)
Q Consensus 636 ~l~~N~l~~~~~~~ 649 (1078)
++++|++.+.++..
T Consensus 553 ~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 553 DITHNKFICECELS 566 (844)
T ss_dssp EEEEECCCCSSSCC
T ss_pred EecCCCcccccccH
Confidence 99999999988753
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-59 Score=572.80 Aligned_cols=518 Identities=23% Similarity=0.263 Sum_probs=400.2
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeec
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l 181 (1078)
+.+++|+|++|.+++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+.+++|++|++
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 47899999999999988999999999999999999999888999999999999999999999888999999999999999
Q ss_pred ccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCc--EEeccccccC
Q 039595 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD--TLFLYKNSLS 259 (1078)
Q Consensus 182 ~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~--~L~L~~N~l~ 259 (1078)
++|.+++..|..++++++|++|+|++|++++..+..+..+++|++|+|++|++++..|..|+.+++|+ +|++++|+++
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 99999987788999999999999999999975544555699999999999999988888899999999 8999999999
Q ss_pred CCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCC-----CCCccccCCC--ccCeeeccccccCc
Q 039595 260 GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSG-----SIPPILGNLK--SLSTLGLYLNQLNG 332 (1078)
Q Consensus 260 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~-----~~p~~l~~l~--~L~~L~L~~N~l~~ 332 (1078)
+..|..+.. .+|+.|++++|. .++..+..+..+....+.-+.+.+ ..+..+..+. +|+.|++++|++++
T Consensus 193 ~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~ 268 (606)
T 3t6q_A 193 GIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268 (606)
T ss_dssp EECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSS
T ss_pred ccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCc
Confidence 877777665 689999999986 345566666665554444333221 1122233332 56666666666666
Q ss_pred cCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccc
Q 039595 333 VIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKS 412 (1078)
Q Consensus 333 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 412 (1078)
..+..|+.+++|+.|++++|.++ .+|..+..+++|++|++++|++++..|..+.++++|+.|++++|.+.+.+|.
T Consensus 269 ~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~---- 343 (606)
T 3t6q_A 269 ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT---- 343 (606)
T ss_dssp CCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCS----
T ss_pred cCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccch----
Confidence 65556666666666666666666 5566666666666666666666665555666666666666666665543332
Q ss_pred cCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCcc--CccccCCCCCceecccccccCCCCCccccCCCcccE
Q 039595 413 LTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKI--SFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQF 490 (1078)
Q Consensus 413 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~ 490 (1078)
..+..+++|++|++++|.+++.. +..+..+++|++|++++|.+.+..|..+..+++|++
T Consensus 344 -------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 404 (606)
T 3t6q_A 344 -------------------GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404 (606)
T ss_dssp -------------------STTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSE
T ss_pred -------------------hhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCe
Confidence 23444445555555555554443 344555555555555555555566667777778888
Q ss_pred EeccCCccCCCccc-ccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCC---CCccccccccccccccc
Q 039595 491 LDLSSNHIVGKIPV-QLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSS---IPKSIGNLLKLYYLNLS 566 (1078)
Q Consensus 491 L~Ls~N~i~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls 566 (1078)
|++++|++++..+. .+..+++|+.|++++|++++..|..|..+++|++|+|++|++++. .+..+..+++|++|+|+
T Consensus 405 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls 484 (606)
T 3t6q_A 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484 (606)
T ss_dssp EECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECT
T ss_pred EECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECC
Confidence 88888888766544 377888888888888888877788888888888888888888762 33568888999999999
Q ss_pred CcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCC
Q 039595 567 NNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPI 646 (1078)
Q Consensus 567 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~ 646 (1078)
+|++++..|..|..+++|+.|+|++|++++..|..+..+++| +|+|++|++++.+|..|..+++|+.+++++|++++.+
T Consensus 485 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred CCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 999988888899999999999999999998888889999999 9999999999988988999999999999999999876
Q ss_pred CC
Q 039595 647 PN 648 (1078)
Q Consensus 647 ~~ 648 (1078)
+.
T Consensus 564 ~~ 565 (606)
T 3t6q_A 564 SN 565 (606)
T ss_dssp GG
T ss_pred Cc
Confidence 63
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-58 Score=564.57 Aligned_cols=527 Identities=20% Similarity=0.208 Sum_probs=429.3
Q ss_pred ccceEeeCC---------CCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCc
Q 039595 67 WFGISCNHA---------GSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQ 137 (1078)
Q Consensus 67 w~gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~ 137 (1078)
+.-|.|... ...++.++|+++.+.+ +.+..|+++++|++|+|++|.+.+..|..|+++++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSE-ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCc-CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 455788653 2468889999998875 445689999999999999999999999999999999999999999
Q ss_pred cCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCc
Q 039595 138 LSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTV 217 (1078)
Q Consensus 138 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 217 (1078)
+++..|..|+++++|++|+|++|++++..|..++.+++|++|++++|.+.+..+..+..+++|++|+|++|.+++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 99888999999999999999999999777888999999999999999999855455555999999999999999888889
Q ss_pred ccccCCCC--eeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeeccccccc-----Ccccccc
Q 039595 218 MGNLKSLS--TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS-----GSIPLSF 290 (1078)
Q Consensus 218 ~~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~ 290 (1078)
|+.+++|+ .|++++|++++..|..+.. .+|++|++++|. .++..+..+.++....+..+.+. ...+..|
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~ 248 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHh
Confidence 99999999 9999999999988877665 789999999997 34555555555554444333222 2234445
Q ss_pred cccc--CCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCC
Q 039595 291 GNLS--SWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSL 368 (1078)
Q Consensus 291 ~~l~--~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 368 (1078)
..+. +|+.|++++|.+++..+..|+++++|++|++++|+++ .+|..+..+++|++|++++|.+.+..|..+..+++|
T Consensus 249 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 327 (606)
T 3t6q_A 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327 (606)
T ss_dssp GGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTC
T ss_pred chhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcC
Confidence 5554 7899999999999988889999999999999999999 678889999999999999999998888999999999
Q ss_pred CeEEcccccCccccCC-CCccCCCCceeecccCcCCCCC--CccccccCCCCeEEccCccccccchhhccCCCCCcEecC
Q 039595 369 SELKLCKNNLSGVIPH-SVGNLTGLVLLNMCENHLFGPI--PKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDL 445 (1078)
Q Consensus 369 ~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 445 (1078)
++|++++|.+.+.+|. .+.++++|++|++++|.+.+.. +..+..+++|++|++++|.+.++.+..|..+++|++|++
T Consensus 328 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 407 (606)
T 3t6q_A 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407 (606)
T ss_dssp SEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred CEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence 9999999999866654 5899999999999999987655 666777777777777777776666666666666666666
Q ss_pred CCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCC
Q 039595 446 SQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGS 525 (1078)
Q Consensus 446 s~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 525 (1078)
++|++.+..+ +..+..+++|++|++++|.+++..|..+.++++|++|++++|++++.
T Consensus 408 ~~n~l~~~~~-----------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 464 (606)
T 3t6q_A 408 AFTRLKVKDA-----------------------QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464 (606)
T ss_dssp TTCCEECCTT-----------------------CCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGG
T ss_pred CCCcCCCccc-----------------------chhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCcc
Confidence 6666653322 22356667777777777777766777777777777777777777652
Q ss_pred ---cccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCc
Q 039595 526 ---VPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV 602 (1078)
Q Consensus 526 ---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 602 (1078)
.+..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|..+++| .|+|++|++++.+|..+
T Consensus 465 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~ 543 (606)
T 3t6q_A 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLL 543 (606)
T ss_dssp EECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGH
T ss_pred ccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhc
Confidence 23567778888888888888887778888888888888888888888888888888888 88888888887777777
Q ss_pred ccccccceeeccCccccCCcc
Q 039595 603 CNMESLEKLNLSHNNLSGFIP 623 (1078)
Q Consensus 603 ~~l~~L~~L~L~~N~l~~~~~ 623 (1078)
..+++|++|++++|++++..+
T Consensus 544 ~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 544 PILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp HHHHTSSEEECTTCCEECSGG
T ss_pred ccCCCCCEEeCCCCCccccCC
Confidence 888888888888888886544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=577.23 Aligned_cols=520 Identities=18% Similarity=0.231 Sum_probs=298.4
Q ss_pred CCHHHHHHHHHHHHhcCCCCCC-----ccccCCCCCCCCCCCCCCCCcc---cceEeeCCCCeEEEeccCccccCCcccC
Q 039595 24 DSSAEACALLNWKTSLQNQNLN-----SSLLSSWTLYPTNASKISPCSW---FGISCNHAGSRVISINLSTLCLNGTFQD 95 (1078)
Q Consensus 24 ~~~~~~~all~~k~~~~~~~~~-----~~~l~sW~~~~~~~~~~~~c~w---~gv~C~~~~~~v~~l~l~~~~l~g~~~~ 95 (1078)
....|+.||.+||.++..+.+. ....++|+ .++|||.| .||+|+.. +||++|+|++.++.|.++
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~------~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp- 98 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWN------FNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVP- 98 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCC------CSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEEC-
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCC------CCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCC-
Confidence 3457999999999999665321 11234675 35789999 99999865 899999998887777776
Q ss_pred CccCCCCCCcEEeccCCcc------cc------cCCCCCCCCCCcceeccCCCccCCCCCccccC-ccceeEEEccCccC
Q 039595 96 FSFSSFPHLVNLNLSFNLF------FG------NIPPQIGNLSKLQNLDLGNNQLSGVISPEIGK-LNQLRRLYLDMNQL 162 (1078)
Q Consensus 96 ~~~~~l~~L~~L~L~~n~~------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~L~~n~l 162 (1078)
..++++++|++|+|++|.+ .| .+|+.. +..|+ +++++|.+.+.+|..++. +..+..+++....+
T Consensus 99 ~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~ 175 (636)
T 4eco_A 99 DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175 (636)
T ss_dssp GGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCC
T ss_pred hHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccc
Confidence 3677777777777777765 22 333322 34455 556666555555555442 23333333332222
Q ss_pred CCCCCcccccccccceeecc--cccccCCccCcccCCCCCcEEEccCCCCCCC-CCCcccccCCCCeeecCCcccCCCCC
Q 039595 163 HGTIPPVIGQLSLIHEFSFC--HNNVSGRIPSSLGNLSKLALLYLNNNSLFGY-IPTVMGNLKSLSTLDLSQNQLNGLIP 239 (1078)
Q Consensus 163 ~~~~p~~i~~l~~L~~L~l~--~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p 239 (1078)
.. .....++.+.+. .|+++| +|..|+++++|++|+|++|++++. ++.. ...-+.+...+.+|
T Consensus 176 ~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~--------~~~~~~~~~~~~ip 240 (636)
T 4eco_A 176 KK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA--------WENENSEYAQQYKT 240 (636)
T ss_dssp CC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSS--------CSCTTSHHHHHHTT
T ss_pred cc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccc--------ccccccchhcccCc
Confidence 10 011112222222 345555 555555555555555555555543 0000 00000000000144
Q ss_pred Cccc--CCCCCcEEeccccccCCCCCcccCCCcccceeeccccc-ccC-ccccccccc------cCCceeeecccCCCCC
Q 039595 240 CTLD--NLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQ-LSG-SIPLSFGNL------SSWTLMSLFSNSLSGS 309 (1078)
Q Consensus 240 ~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L~l~~n~l~~~ 309 (1078)
..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..++.+ ++|+.|++++|+++ .
T Consensus 241 ~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ 319 (636)
T 4eco_A 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-T 319 (636)
T ss_dssp SCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-S
T ss_pred hhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-c
Confidence 4444 44444444444444444444444444444444444444 444 444444443 45555555555555 4
Q ss_pred CCc--cccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCC-CCeEEcccccCccccCCCC
Q 039595 310 IPP--ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKS-LSELKLCKNNLSGVIPHSV 386 (1078)
Q Consensus 310 ~p~--~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~ 386 (1078)
+|. .++++++|++|++++|+++|.+| .++.+++|+.|++++|++. .+|..+..+++ |++|++++|+++ .+|..+
T Consensus 320 ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~ 396 (636)
T 4eco_A 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396 (636)
T ss_dssp CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCC
T ss_pred cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhh
Confidence 444 55555555555555555555555 5555555555555555555 45555555555 555555555555 444444
Q ss_pred ccCC--CCceeecccCcCCCCCCcccc-------ccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCcc
Q 039595 387 GNLT--GLVLLNMCENHLFGPIPKSLK-------SLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFN 457 (1078)
Q Consensus 387 ~~l~--~L~~L~L~~N~l~~~~~~~l~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 457 (1078)
..++ +|++|++++|++.+.+|..+. .+++|++|++++|.+..++...+..+++|++|+|++|+++.++...
T Consensus 397 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~ 476 (636)
T 4eco_A 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476 (636)
T ss_dssp CTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSS
T ss_pred hhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHH
Confidence 4433 555566666665555555555 5556666666666666666666666667777777777776555555
Q ss_pred ccCCC-------CCceecccccccCCCCCcccc--CCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCccc
Q 039595 458 WRNLP-------KLDTFIVSMNNIFGSIPLEIG--DSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPL 528 (1078)
Q Consensus 458 ~~~l~-------~L~~L~l~~N~i~~~~~~~~~--~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 528 (1078)
+.... +|++|++++|+++ .+|..+. .+++|++|+|++|+|++ +|..+.++++|+.|+|++|+
T Consensus 477 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~------- 547 (636)
T 4eco_A 477 LKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR------- 547 (636)
T ss_dssp SEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB-------
T ss_pred hccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc-------
Confidence 54433 7777888888777 5667776 88899999999999986 78888888999999997665
Q ss_pred ccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCC
Q 039595 529 EFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQE 596 (1078)
Q Consensus 529 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 596 (1078)
++++|++.+.+|..+.++++|++|+|++|+|+ .+|..+. ++|+.|||++|++..
T Consensus 548 -----------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 548 -----------DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp -----------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTCE
T ss_pred -----------ccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCcc
Confidence 44555555555555666666666666666663 4444443 456666666665554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=575.22 Aligned_cols=518 Identities=22% Similarity=0.195 Sum_probs=384.4
Q ss_pred CcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccC-CCCCCCCCCcceeccCCCccCCCCC
Q 039595 65 CSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNI-PPQIGNLSKLQNLDLGNNQLSGVIS 143 (1078)
Q Consensus 65 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p 143 (1078)
|.|.+|.+ ...+++.|||+.+.+.+. .+..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i-~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p 90 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTV-TASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEE-CSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCcc-ChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence 67999988 456889999999888754 4568999999999999999877777 7789999999999999999999889
Q ss_pred ccccCccceeEEEccCccCCCCCCcc--cccccccceeecccccccCCcc-CcccCCCCCcEEEccCCCCCCCCCCcccc
Q 039595 144 PEIGKLNQLRRLYLDMNQLHGTIPPV--IGQLSLIHEFSFCHNNVSGRIP-SSLGNLSKLALLYLNNNSLFGYIPTVMGN 220 (1078)
Q Consensus 144 ~~~~~l~~L~~L~L~~n~l~~~~p~~--i~~l~~L~~L~l~~n~~~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~~~~~ 220 (1078)
..|+++++|++|+|++|.+++.+|.. ++.+++|++|+|++|.+.+..| ..|+++++|++|+|++|.+++..|..+..
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 99999999999999999999888876 9999999999999999998765 57999999999999999999999999998
Q ss_pred c--CCCCeeecCCcccCCCCCCcccCCCC------CcEEeccccccCCCCCcccCCC---cccceeeccccc--------
Q 039595 221 L--KSLSTLDLSQNQLNGLIPCTLDNLSN------LDTLFLYKNSLSGSIPSIIGNL---KSLHQLDLIENQ-------- 281 (1078)
Q Consensus 221 l--~~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~-------- 281 (1078)
+ ++|+.|+|++|.+++..|..++.+++ |++|++++|++++.+|..+... .+++.|.++.+.
T Consensus 171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~ 250 (844)
T 3j0a_A 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250 (844)
T ss_dssp HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence 8 89999999999999998888877776 9999999999998888777643 578888887443
Q ss_pred -ccCccccccccc--cCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCC
Q 039595 282 -LSGSIPLSFGNL--SSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSI 358 (1078)
Q Consensus 282 -l~~~~p~~~~~l--~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 358 (1078)
+.+..+..|..+ ++|+.|++++|.+.+..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+.+..
T Consensus 251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 330 (844)
T 3j0a_A 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330 (844)
T ss_dssp SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence 333333333333 34555555555555544555555555555555555555554555555555555555555555444
Q ss_pred CccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCC
Q 039595 359 PEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHP 438 (1078)
Q Consensus 359 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 438 (1078)
|..|..+++|+.|++++|++.+..+..|.++++|++|++++|.++ .+.. ++
T Consensus 331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~------------------------~i~~-----~~ 381 (844)
T 3j0a_A 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT------------------------TIHF-----IP 381 (844)
T ss_dssp SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSC------------------------CCSS-----CC
T ss_pred HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCC------------------------cccC-----CC
Confidence 555555555555555555555444444555555555555555544 3221 34
Q ss_pred CCcEecCCCCccCCccCccccCCCCCceecccccccCCCC-CccccCCCcccEEeccCCccCCCccc-ccccCccCcEEe
Q 039595 439 NLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSI-PLEIGDSSKLQFLDLSSNHIVGKIPV-QLEKLFSLNKLI 516 (1078)
Q Consensus 439 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~-~~~~~~l~~L~~L~Ls~N~i~~~~~~-~~~~l~~L~~L~ 516 (1078)
+|+.|++++|+++.+... ..+++.++++.|++.+.. +..+..+++|++|+|++|++++..+. .+..+++|+.|+
T Consensus 382 ~L~~L~l~~N~l~~l~~~----~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~ 457 (844)
T 3j0a_A 382 SIPDIFLSGNKLVTLPKI----NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF 457 (844)
T ss_dssp SCSEEEEESCCCCCCCCC----CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCE
T ss_pred CcchhccCCCCccccccc----ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCcccccc
Confidence 455555555554433211 234455555555554432 22345677888888888888755433 345678888888
Q ss_pred ccCCccC-----CCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCC
Q 039595 517 LSLNQLS-----GSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSH 591 (1078)
Q Consensus 517 Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 591 (1078)
|++|.++ +..+..|..+++|+.|+|++|.|++..|..|..+++|++|+|++|+|++..+..+. ++|+.|||++
T Consensus 458 Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~ 535 (844)
T 3j0a_A 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISR 535 (844)
T ss_dssp EESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEE
T ss_pred CCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCC
Confidence 8888886 34456788999999999999999998888999999999999999999987777766 8999999999
Q ss_pred CccCCcCCCCcccccccceeeccCccccCCcc
Q 039595 592 NILQEEIPPQVCNMESLEKLNLSHNNLSGFIP 623 (1078)
Q Consensus 592 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 623 (1078)
|+|++..|..+ .+|+.|++++|++.+..+
T Consensus 536 N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 536 NQLLAPNPDVF---VSLSVLDITHNKFICECE 564 (844)
T ss_dssp ECCCCCCSCCC---SSCCEEEEEEECCCCSSS
T ss_pred CcCCCCChhHh---CCcCEEEecCCCcccccc
Confidence 99998877665 478999999999987543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=560.40 Aligned_cols=520 Identities=21% Similarity=0.232 Sum_probs=399.6
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeec
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l 181 (1078)
++|++|+|++|.+.+..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|++
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 78999999999999888889999999999999999999877888999999999999999999888999999999999999
Q ss_pred ccccccCCccCcccCCCCCcEEEccCCCCCC-CCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCc----EEecccc
Q 039595 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFG-YIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD----TLFLYKN 256 (1078)
Q Consensus 182 ~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~L~~N 256 (1078)
++|.+.+..|..++++++|++|+|++|.+++ .+|..|+++++|++|+|++|++++..|..|+.+++|+ +|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 9999998777889999999999999999986 5688999999999999999999988888888777765 7999999
Q ss_pred ccCCCCCcccCCCcccceeeccccccc-CccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCC
Q 039595 257 SLSGSIPSIIGNLKSLHQLDLIENQLS-GSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIP 335 (1078)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 335 (1078)
.+++..+..+... +|+.|++++|.++ +..|..+.++++|+.+++..+.+.+.. .+.. +....+
T Consensus 192 ~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~--------~l~~-------~~~~~~ 255 (606)
T 3vq2_A 192 PIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER--------NLEI-------FEPSIM 255 (606)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC--------CCSC-------CCGGGG
T ss_pred CcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCC--------cccc-------cChHHh
Confidence 9986666666554 8999999999887 456777888888888887666554211 0000 000011
Q ss_pred CCCCCCCcCcEEEc-cCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccC
Q 039595 336 PSIGNLSSLRNLSL-FNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLT 414 (1078)
Q Consensus 336 ~~l~~l~~L~~L~L-s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 414 (1078)
..+..+ .++.+++ ..|.+.+.+|. +..+++|+.|++++|.+.. +| .+..+++|+.|++++|++ +.+| .+ .++
T Consensus 256 ~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~ 328 (606)
T 3vq2_A 256 EGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLP 328 (606)
T ss_dssp TTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCS
T ss_pred hhhhhc-cHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-CCC
Confidence 111111 2344444 44444444444 5555555555555555542 23 455555555555555555 3444 23 555
Q ss_pred CCCeEEccCccccccchhhccCCCCCcEecCCCCccCCcc--CccccCCCCCceecccccccCCCCCccccCCCcccEEe
Q 039595 415 SLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKI--SFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLD 492 (1078)
Q Consensus 415 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~ 492 (1078)
+|++|++++|...... .+..+++|++|++++|.+++.. +..+..+++|++|++++|.+.+ +|..+..+++|++|+
T Consensus 329 ~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~ 405 (606)
T 3vq2_A 329 FLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLD 405 (606)
T ss_dssp SCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEE
T ss_pred ccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeE
Confidence 5555555555332211 4455666666666666666553 4556666666666666666654 446778888999999
Q ss_pred ccCCccCCCcc-cccccCccCcEEeccCCccCCCcccccccccccceeeccCccccC-CCCcccccccccccccccCccc
Q 039595 493 LSSNHIVGKIP-VQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS-SIPKSIGNLLKLYYLNLSNNQF 570 (1078)
Q Consensus 493 Ls~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l 570 (1078)
+++|++.+..+ ..+.++++|++|++++|++++..|..|..+++|++|+|++|.+++ ..|..|..+++|++|+|++|++
T Consensus 406 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 485 (606)
T 3vq2_A 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485 (606)
T ss_dssp CTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred CCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcC
Confidence 99999987777 678889999999999999998888899999999999999999987 4788899999999999999999
Q ss_pred ccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCC-cCcEEEcccCcCCCCCCC
Q 039595 571 SHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMR-SLSCIDICYNELQGPIPN 648 (1078)
Q Consensus 571 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~l~l~~N~l~~~~~~ 648 (1078)
++..|..|.++++|+.|+|++|++++..|..+..+++|++|+|++|+++ .+|..+..++ +|+.|++++|++.+..+.
T Consensus 486 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 486 EQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 9888999999999999999999999888889999999999999999998 5677788887 599999999999987764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=556.62 Aligned_cols=534 Identities=23% Similarity=0.236 Sum_probs=404.4
Q ss_pred CCCCccc----ceEeeCC---------CCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCc
Q 039595 62 ISPCSWF----GISCNHA---------GSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKL 128 (1078)
Q Consensus 62 ~~~c~w~----gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L 128 (1078)
.+||.|. .|.|.+. ..+++.++|+++.+.+. ++..|.++++|++|+|++|.+.+..|..|+++++|
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L 82 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKIL-KSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEE-CTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEe-ChhhccCCccCcEEeCCCCcccccCHHHhhchhhc
Confidence 4567663 5778642 25788999999888764 44579999999999999999999889999999999
Q ss_pred ceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccC-CccCcccCCCCCcEEEccC
Q 039595 129 QNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSG-RIPSSLGNLSKLALLYLNN 207 (1078)
Q Consensus 129 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~-~~p~~l~~l~~L~~L~L~~ 207 (1078)
++|+|++|.+++..|..|+++++|++|+|++|.+++..|..++.+++|++|++++|.+.+ .+|..|+++++|++|+|++
T Consensus 83 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~ 162 (606)
T 3vq2_A 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162 (606)
T ss_dssp CEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCS
T ss_pred CEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccC
Confidence 999999999998889999999999999999999997777899999999999999999986 6799999999999999999
Q ss_pred CCCCCCCCCcccccCCCC----eeecCCcccCCCCCCcccCCCCCcEEeccccccC-CCCCcccCCCcccceeecccccc
Q 039595 208 NSLFGYIPTVMGNLKSLS----TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS-GSIPSIIGNLKSLHQLDLIENQL 282 (1078)
Q Consensus 208 n~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l 282 (1078)
|++++..|..|+.+++|+ +|++++|++++..+..+... +|++|++++|.++ +.+|..++++++|+.+++..+.+
T Consensus 163 n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~ 241 (606)
T 3vq2_A 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241 (606)
T ss_dssp SCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECC
T ss_pred CcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccc
Confidence 999998899999888776 79999999998776666655 9999999999997 46678899999999999987766
Q ss_pred cCccccccccccCCceeeecccCCCCCCCccccCCCccCeeec-cccccCccCCCCCCCCCcCcEEEccCccCCCCCCcc
Q 039595 283 SGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGL-YLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEE 361 (1078)
Q Consensus 283 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L-~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 361 (1078)
.+..... . +.+..+..+..+ +++.+++ ..|.+.+.+|. +..+++|+.|++++|.+. .+| .
T Consensus 242 ~~~~~l~--------~-------~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~ 302 (606)
T 3vq2_A 242 KDERNLE--------I-------FEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-D 302 (606)
T ss_dssp TTSCCCS--------C-------CCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-C
T ss_pred ccCCccc--------c-------cChHHhhhhhhc-cHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-h
Confidence 5321100 0 000111111111 2333333 34444444443 444555555555555543 233 4
Q ss_pred ccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccc--hhhccCCCC
Q 039595 362 IGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKV--YEAFGDHPN 439 (1078)
Q Consensus 362 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~ 439 (1078)
+..+++|++|++++|++ +.+| .+ .+++|+.|++++|+..+.. .+..+++|++|++++|.+.+.. +..+..+++
T Consensus 303 l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~ 377 (606)
T 3vq2_A 303 VPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377 (606)
T ss_dssp CCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSC
T ss_pred ccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCc
Confidence 44455555555555555 2334 22 4555555555555332222 3445555555555555555443 455566666
Q ss_pred CcEecCCCCccCCccCccccCCCCCceecccccccCCCCC-ccccCCCcccEEeccCCccCCCcccccccCccCcEEecc
Q 039595 440 LTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP-LEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILS 518 (1078)
Q Consensus 440 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls 518 (1078)
|++|++++|.+.+.. ..+..+++|++|++++|.+.+..+ ..+..+++|++|++++|.+++..|..+.++++|++|+++
T Consensus 378 L~~L~L~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 456 (606)
T 3vq2_A 378 LRHLDLSFNGAIIMS-ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMA 456 (606)
T ss_dssp CCEEECCSCSEEEEC-CCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECT
T ss_pred ccEeECCCCccccch-hhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECC
Confidence 666666666666544 556667777777777777776666 578888899999999999988888889999999999999
Q ss_pred CCccCC-CcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCc
Q 039595 519 LNQLSG-SVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEE 597 (1078)
Q Consensus 519 ~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 597 (1078)
+|++++ .+|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|+|+ .
T Consensus 457 ~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~ 535 (606)
T 3vq2_A 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-T 535 (606)
T ss_dssp TCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-C
T ss_pred CCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-c
Confidence 999987 47888999999999999999999888899999999999999999999888999999999999999999998 4
Q ss_pred CCCCccccc-ccceeeccCccccCCcc
Q 039595 598 IPPQVCNME-SLEKLNLSHNNLSGFIP 623 (1078)
Q Consensus 598 ~~~~~~~l~-~L~~L~L~~N~l~~~~~ 623 (1078)
+|..+..++ +|++|++++|++.+..+
T Consensus 536 ~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 536 SKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp EESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred cCHhHhhhcccCcEEEccCCCcccCCc
Confidence 666688887 59999999999987543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-56 Score=556.95 Aligned_cols=492 Identities=18% Similarity=0.232 Sum_probs=286.1
Q ss_pred CCCHHHHHHHHHHHHhcCCCCCCccccCCCCCCCCCCCCCCC--Ccc------------cceEeeCCCCeEEEeccCccc
Q 039595 23 SDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISP--CSW------------FGISCNHAGSRVISINLSTLC 88 (1078)
Q Consensus 23 ~~~~~~~~all~~k~~~~~~~~~~~~l~sW~~~~~~~~~~~~--c~w------------~gv~C~~~~~~v~~l~l~~~~ 88 (1078)
++..+|++||++||+++.++ +|+.+.+| ...+| |.| .||+|+. ++||+.|+|++++
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~--------~W~~~~~~-~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~ 334 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK--------NWRYYSGT-INNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFG 334 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG--------GCCCCCSS-CSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTC
T ss_pred ccchHHHHHHHHHHHHcCCC--------CCCcCCCc-ccccCCccccccccccccccCcCceEecC-CCCEEEEECccCC
Confidence 34568999999999999532 89753222 12455 999 9999986 6899999999999
Q ss_pred cCCcccCCccCCCCCCcEEec-cCCcccccCCCCCC--------------------------------------------
Q 039595 89 LNGTFQDFSFSSFPHLVNLNL-SFNLFFGNIPPQIG-------------------------------------------- 123 (1078)
Q Consensus 89 l~g~~~~~~~~~l~~L~~L~L-~~n~~~~~~p~~~~-------------------------------------------- 123 (1078)
+.|.++ ..++++++|++|+| ++|.+.|..|....
T Consensus 335 L~G~ip-~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~ 413 (876)
T 4ecn_A 335 AKGRVP-DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE 413 (876)
T ss_dssp CEEEEC-GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTT
T ss_pred CCCcCc-hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcc
Confidence 999997 58999999999999 99999887543211
Q ss_pred -------CCCCcceeccCC--CccCCCCCccccCccceeEEEccCccCCCC-----------------CCcccc--cccc
Q 039595 124 -------NLSKLQNLDLGN--NQLSGVISPEIGKLNQLRRLYLDMNQLHGT-----------------IPPVIG--QLSL 175 (1078)
Q Consensus 124 -------~l~~L~~L~Ls~--n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-----------------~p~~i~--~l~~ 175 (1078)
+...++.+.++. |+++| +|.+|+++++|++|+|++|+++|. +|+.++ .+++
T Consensus 414 ~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~ 492 (876)
T 4ecn_A 414 MKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKD 492 (876)
T ss_dssp SCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTT
T ss_pred ccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCC
Confidence 112233333433 66665 666677777777777777777662 555554 5555
Q ss_pred cceeecccccccCCccCcccCCCCCcEEEccCCC-CCC-CCCCcccccC-------CCCeeecCCcccCCCCCC--cccC
Q 039595 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNS-LFG-YIPTVMGNLK-------SLSTLDLSQNQLNGLIPC--TLDN 244 (1078)
Q Consensus 176 L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~l~~ 244 (1078)
|++|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..+++++ +|++|+|++|+++ .+|. .|++
T Consensus 493 L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~ 571 (876)
T 4ecn_A 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQK 571 (876)
T ss_dssp CCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTT
T ss_pred CCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhc
Confidence 5555555555555555555555555555555554 544 4454444433 5555555555555 4444 4555
Q ss_pred CCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccC-CceeeecccCCCCCCCccccCCCc--cC
Q 039595 245 LSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS-WTLMSLFSNSLSGSIPPILGNLKS--LS 321 (1078)
Q Consensus 245 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~l~~n~l~~~~p~~l~~l~~--L~ 321 (1078)
+++|++|+|++|+++ .+| .|+++++|+.|+|++|+++ .+|..+..+++ |+.|++++|.++ .+|..+..++. |+
T Consensus 572 L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~ 647 (876)
T 4ecn_A 572 MVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMG 647 (876)
T ss_dssp CTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEE
T ss_pred CCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCC
Confidence 555555555555555 444 4555555555555555555 44444555554 555555555554 44444444332 55
Q ss_pred eeeccccccCccCCCC---CC--CCCcCcEEEccCccCCCCCCccc-cccCCCCeEEcccccCccccCCCCccCCCCcee
Q 039595 322 TLGLYLNQLNGVIPPS---IG--NLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLL 395 (1078)
Q Consensus 322 ~L~L~~N~l~~~~p~~---l~--~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 395 (1078)
.|+|++|++++.+|.. +. .+.+|+.|+|++|.+. .+|..+ ..+++|+.|+|++|+++. +|..+....
T Consensus 648 ~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~-ip~~~~~~~----- 720 (876)
T 4ecn_A 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTS-IPENSLKPK----- 720 (876)
T ss_dssp EEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSC-CCTTSSSCT-----
T ss_pred EEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCc-cChHHhccc-----
Confidence 5555555554433321 11 1224455555555554 233322 244445555555554442 222111110
Q ss_pred ecccCcCCCCCCccccccCCCCeEEccCccccccchhhc-cCCCCCcEecCCCCccCCccCccccCCCCCceeccccccc
Q 039595 396 NMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAF-GDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNI 474 (1078)
Q Consensus 396 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i 474 (1078)
+..+.++++|++|++++|++..++...+ ..+++|+.|+|++|+++++ +..+..+++|+.|++++|.
T Consensus 721 -----------~~~l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~l-p~~l~~L~~L~~L~Ls~N~- 787 (876)
T 4ecn_A 721 -----------DGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQR- 787 (876)
T ss_dssp -----------TSCCTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSSC-CCGGGGCTTCCEEECCCCB-
T ss_pred -----------cccccccCCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCCcc-chhhhcCCCCCEEECCCCC-
Confidence 0001122356666666666664433322 2566666677766666652 3344455555555555543
Q ss_pred CCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCccc
Q 039595 475 FGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSI 554 (1078)
Q Consensus 475 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 554 (1078)
++++|++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+..+
T Consensus 788 -----------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~ 847 (876)
T 4ecn_A 788 -----------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSV 847 (876)
T ss_dssp -----------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGG
T ss_pred -----------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHc
Confidence 4455677767777777777777777777777 45666554 577777777777776666666
Q ss_pred ccccccccccccCcccc
Q 039595 555 GNLLKLYYLNLSNNQFS 571 (1078)
Q Consensus 555 ~~l~~L~~L~Ls~N~l~ 571 (1078)
.....+..+.|.+|++.
T Consensus 848 ~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 848 CPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp HHHHHTTCCEEECCTTS
T ss_pred cccccchheeecCCCcc
Confidence 66666777777777665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=501.51 Aligned_cols=512 Identities=20% Similarity=0.189 Sum_probs=437.2
Q ss_pred cceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccC
Q 039595 128 LQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNN 207 (1078)
Q Consensus 128 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 207 (1078)
.++++-++.+++ .+|..+. +++++|+|++|++++..|..|+.+++|++|++++|++++..|..|+++++|++|+|++
T Consensus 9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 85 (570)
T 2z63_A 9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (570)
T ss_dssp TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence 356777777887 6777664 5799999999999977788999999999999999999988888999999999999999
Q ss_pred CCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCC-CCCcccCCCcccceeecccccccCcc
Q 039595 208 NSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSG-SIPSIIGNLKSLHQLDLIENQLSGSI 286 (1078)
Q Consensus 208 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~ 286 (1078)
|++++..|..|+++++|++|++++|++++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~ 165 (570)
T 2z63_A 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (570)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred CcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceec
Confidence 99998888999999999999999999998777679999999999999999987 46899999999999999999999888
Q ss_pred ccccccccCC----ceeeecccCCCCCCCccccCCCccCeeeccccccCc-cCCCCCCCCCcCcEEEccCccCC------
Q 039595 287 PLSFGNLSSW----TLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNG-VIPPSIGNLSSLRNLSLFNNGLY------ 355 (1078)
Q Consensus 287 p~~~~~l~~L----~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~------ 355 (1078)
|..|+.+.+| ..+++++|.+++..|..+..+ +|+.|++++|.... .++..+..+++++.+.+.-+.+.
T Consensus 166 ~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~ 244 (570)
T 2z63_A 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244 (570)
T ss_dssp GGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCE
T ss_pred HHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhh
Confidence 8899999988 899999999998888888766 89999999885432 23444556666666655433222
Q ss_pred CCCCccccccC--CCCeEEcccc-cCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchh
Q 039595 356 GSIPEEIGYLK--SLSELKLCKN-NLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYE 432 (1078)
Q Consensus 356 ~~~p~~~~~l~--~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 432 (1078)
......+..+. +++.+++++| .+.+..|..+..+++|+.|++++|.+. .+|..+..+ +|++|++++|.+..++.
T Consensus 245 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~- 321 (570)
T 2z63_A 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPT- 321 (570)
T ss_dssp ECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCB-
T ss_pred hcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCc-
Confidence 11122233332 3567777777 777788888888999999999999887 477778888 89999999998886654
Q ss_pred hccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCC--CccccCCCcccEEeccCCccCCCcccccccCc
Q 039595 433 AFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSI--PLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLF 510 (1078)
Q Consensus 433 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~--~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~ 510 (1078)
..+++|+.|++++|.+....+. ..+++|++|++++|.+++.. +..+..+++|++|++++|.+++..+. +..++
T Consensus 322 --~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~ 396 (570)
T 2z63_A 322 --LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLE 396 (570)
T ss_dssp --CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCT
T ss_pred --ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccC
Confidence 4668899999999988765544 77899999999999988654 67788999999999999999965554 99999
Q ss_pred cCcEEeccCCccCCCcc-cccccccccceeeccCccccCCCCcccccccccccccccCcccc-cccchhhhcccccCeee
Q 039595 511 SLNKLILSLNQLSGSVP-LEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFS-HTIPIEFEKLIHLSKLD 588 (1078)
Q Consensus 511 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ 588 (1078)
+|+.|++++|++++..+ ..|..+++|++|+|++|.+.+..|..+.++++|++|+|++|+++ +.+|..|..+++|+.|+
T Consensus 397 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~ 476 (570)
T 2z63_A 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476 (570)
T ss_dssp TCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence 99999999999997766 57899999999999999999999999999999999999999997 57899999999999999
Q ss_pred cCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCCCCcc
Q 039595 589 LSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTV 651 (1078)
Q Consensus 589 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~~~~ 651 (1078)
|++|++++..|..+..+++|++|+|++|++++.+|..|..+++|+.|++++|+++|.+|....
T Consensus 477 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~ 539 (570)
T 2z63_A 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539 (570)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHH
T ss_pred CCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHH
Confidence 999999998899999999999999999999999999999999999999999999999987543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=500.42 Aligned_cols=475 Identities=22% Similarity=0.234 Sum_probs=327.1
Q ss_pred cCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccC
Q 039595 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGN 196 (1078)
Q Consensus 117 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~ 196 (1078)
.+|..+. ++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+.+++|++|++++|.+++..|..|++
T Consensus 19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 96 (549)
T 2z81_A 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP 96 (549)
T ss_dssp SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTT
T ss_pred cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhcc
Confidence 4566554 78999999999999887888999999999999999998777778888888888888888888777667888
Q ss_pred CCCCcEEEccCCCCCC-CCCCcccccCCCCeeecCCcccCCCC-CCcccCCCCCcEEeccccccCCCCCcccCCCcccce
Q 039595 197 LSKLALLYLNNNSLFG-YIPTVMGNLKSLSTLDLSQNQLNGLI-PCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQ 274 (1078)
Q Consensus 197 l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 274 (1078)
+++|++|+|++|.+++ .+|..++++++|++|++++|++.+.+ +..|.++++|++|++++|++++.+|..++++++|+.
T Consensus 97 l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 176 (549)
T 2z81_A 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176 (549)
T ss_dssp CTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEE
T ss_pred CCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCce
Confidence 8888888888888775 35667777888888888887743333 356777777777777777777777777777777777
Q ss_pred eecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccC
Q 039595 275 LDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGL 354 (1078)
Q Consensus 275 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 354 (1078)
|+++.|.+....+..+..+++|+.|++++|++++.... .......+++|+.|++++|.+
T Consensus 177 L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~---------------------~~~~~~~~~~L~~L~l~~n~l 235 (549)
T 2z81_A 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS---------------------PLPVDEVSSPMKKLAFRGSVL 235 (549)
T ss_dssp EEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCC---------------------CCSSCCCCCCCCEEEEESCEE
T ss_pred EecccCcccccchhhHhhcccccEEEccCCcccccccc---------------------ccchhhhhhcccceecccccc
Confidence 77777776533222234455555555555555542100 001122344555555555555
Q ss_pred CCCCC----ccccccCCCCeEEcccccCcccc------CCCCccCCCCceeecccCcCCCC-----CCccccccCCCCeE
Q 039595 355 YGSIP----EEIGYLKSLSELKLCKNNLSGVI------PHSVGNLTGLVLLNMCENHLFGP-----IPKSLKSLTSLKRV 419 (1078)
Q Consensus 355 ~~~~p----~~~~~l~~L~~L~L~~N~l~~~~------p~~~~~l~~L~~L~L~~N~l~~~-----~~~~l~~l~~L~~L 419 (1078)
.+..+ ..+..+++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+... .+..+....+|++|
T Consensus 236 ~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L 315 (549)
T 2z81_A 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315 (549)
T ss_dssp EHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEE
T ss_pred chhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEE
Confidence 44322 22344555666666666554421 12234455555666655554321 12222333455555
Q ss_pred EccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCC---ccccCCCcccEEeccCC
Q 039595 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP---LEIGDSSKLQFLDLSSN 496 (1078)
Q Consensus 420 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~---~~~~~l~~L~~L~Ls~N 496 (1078)
++++|.+..++...+..+++|++|++++|++. +..| ..++.+++|++|+|++|
T Consensus 316 ~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~------------------------~~~~~~~~~~~~l~~L~~L~Ls~N 371 (549)
T 2z81_A 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMV------------------------EEYLKNSACKGAWPSLQTLVLSQN 371 (549)
T ss_dssp EEESSCCCCCCHHHHHHCTTCCEEECCSSCCC------------------------HHHHHHHTCTTSSTTCCEEECTTS
T ss_pred EeccCccccCCHHHHhcCccccEEEccCCccc------------------------cccccchhhhhccccCcEEEccCC
Confidence 55555555444444444555555555555544 3332 23566778888888888
Q ss_pred ccCCCcc--cccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCccccccc
Q 039595 497 HIVGKIP--VQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTI 574 (1078)
Q Consensus 497 ~i~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 574 (1078)
+|++..+ ..+..+++|++|++++|+++ .+|..+..+++|++|+|++|+++. +|..+. ++|++|+|++|+|++.+
T Consensus 372 ~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~ 447 (549)
T 2z81_A 372 HLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS 447 (549)
T ss_dssp CCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC
T ss_pred cccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc
Confidence 8876543 45788888889999999888 567788888899999999998874 444332 57999999999998643
Q ss_pred chhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCCC
Q 039595 575 PIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPN 648 (1078)
Q Consensus 575 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~ 648 (1078)
..+++|++|+|++|+|+ .+|. ...+++|++|+|++|++++.+|..|..+++|+.|++++|+++|.+|.
T Consensus 448 ----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 448 ----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp ----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred ----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 57889999999999998 4665 46789999999999999999998999999999999999999998874
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=500.44 Aligned_cols=492 Identities=21% Similarity=0.212 Sum_probs=368.3
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeec
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l 181 (1078)
+++++|+|++|.+.+..+..|+++++|++|||++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 57999999999999888888999999999999999999877788999999999999999999777788999999999999
Q ss_pred ccccccCCccCcccCCCCCcEEEccCCCCCC-CCCCcccccCCCCeeecCCcccCCCCCCcccCCCCC----cEEecccc
Q 039595 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFG-YIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNL----DTLFLYKN 256 (1078)
Q Consensus 182 ~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L----~~L~L~~N 256 (1078)
++|++++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..++.+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999987666679999999999999999987 468899999999999999999998888888888888 88999999
Q ss_pred ccCCCCCcccCCCcccceeecccccccC-ccccccccccCCceeeecccCCCC------CCCccccCCC--ccCeeeccc
Q 039595 257 SLSGSIPSIIGNLKSLHQLDLIENQLSG-SIPLSFGNLSSWTLMSLFSNSLSG------SIPPILGNLK--SLSTLGLYL 327 (1078)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~n~l~~------~~p~~l~~l~--~L~~L~L~~ 327 (1078)
.+++..|..+..+ +|+.|++++|.... .+|..+..++.++.+.+..+.+.. .....+..+. .++.+++++
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 9998878777766 79999999886542 345566777777766554433221 1112222222 234455555
Q ss_pred c-ccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCC
Q 039595 328 N-QLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPI 406 (1078)
Q Consensus 328 N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 406 (1078)
| .+.+..|..+..+++|+.|++++|.+. .+|..+..+ +|++|++++|.+. .+|. ..+++|+.|++++|.+.+..
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~ 341 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAF 341 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBC
T ss_pred chhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccc
Confidence 5 455555666666666666666666665 455555555 6666666666665 2332 34555666666666554433
Q ss_pred CccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCC
Q 039595 407 PKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSS 486 (1078)
Q Consensus 407 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~ 486 (1078)
+. ..+++|++|++++|.+..... .+..+..+++|++|++++|.+.+..+. +..++
T Consensus 342 ~~--~~~~~L~~L~l~~n~l~~~~~----------------------~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~ 396 (570)
T 2z63_A 342 SE--VDLPSLEFLDLSRNGLSFKGC----------------------CSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLE 396 (570)
T ss_dssp CC--CBCTTCCEEECCSSCCBEEEE----------------------EEHHHHTCSCCCEEECCSCSEEEEEEE-EETCT
T ss_pred cc--ccCCCCCEEeCcCCccCcccc----------------------ccccccccCccCEEECCCCcccccccc-ccccC
Confidence 33 344445555554444443320 023344455555555555555443333 77778
Q ss_pred cccEEeccCCccCCCcc-cccccCccCcEEeccCCccCCCcccccccccccceeeccCcccc-CCCCccccccccccccc
Q 039595 487 KLQFLDLSSNHIVGKIP-VQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLS-SSIPKSIGNLLKLYYLN 564 (1078)
Q Consensus 487 ~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ 564 (1078)
+|++|++++|.+.+..+ ..+..+++|++|++++|++++..|..|..+++|++|+|++|.++ +.+|..+..+++|++|+
T Consensus 397 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~ 476 (570)
T 2z63_A 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476 (570)
T ss_dssp TCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence 88888888888876655 56788888999999999888888888888999999999999987 56888899999999999
Q ss_pred ccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCccc
Q 039595 565 LSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPR 624 (1078)
Q Consensus 565 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 624 (1078)
|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|++|++++|++++..|.
T Consensus 477 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 999999988888999999999999999999988777888999999999999999987653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=460.32 Aligned_cols=255 Identities=27% Similarity=0.367 Sum_probs=214.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
..|+..++||+|+||+||+|..+ +|+.||||++..... ...+.+.+|+.++++++|||||+++++|.+++.+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 56999999999999999999664 799999999975432 2345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
||||+||+|.+++.+ ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 150 mEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 150 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp ECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 999999999999943 4599999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
........+||+.|||||++.+..|+.++||||+||++|||++|++||..... ..... .+.....+.... .
T Consensus 223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~---~i~~~~~~~~~~----~ 293 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMK---MIRDNLPPRLKN----L 293 (346)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH---HHHHSSCCCCSC----G
T ss_pred CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHH---HHHcCCCCCCCc----c
Confidence 55566778999999999999999999999999999999999999999753221 11111 112222222211 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....++.+++.+||..||++|||++|+++|||+..
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 122336788999999999999999999999999864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=512.27 Aligned_cols=461 Identities=18% Similarity=0.234 Sum_probs=383.0
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccC------C------CCCccccCccceeEEEccCccCCCCCCcc
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLS------G------VISPEIGKLNQLRRLYLDMNQLHGTIPPV 169 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~------~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 169 (1078)
.+++.|+|++|++.|.+|+++++|++|++|||++|.+. | .+|.+. +..|+ ++++.|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 47889999999999999999999999999999999762 2 233332 44455 555555555555544
Q ss_pred cccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecC--CcccCCCCCCcccCCCC
Q 039595 170 IGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLS--QNQLNGLIPCTLDNLSN 247 (1078)
Q Consensus 170 i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~--~N~l~~~~p~~l~~l~~ 247 (1078)
+..+ +.++..+++....+.. .....++.+.+. .|++++ +|..|+++++
T Consensus 158 ~~~~-----------------------~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~ 207 (636)
T 4eco_A 158 FSDL-----------------------IKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTK 207 (636)
T ss_dssp SCHH-----------------------HHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTT
T ss_pred HHHH-----------------------HHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccC
Confidence 4321 1122222222222111 111223333333 577777 6777888888
Q ss_pred CcEEeccccccCCC-----------------CCcccC--CCcccceeecccccccCccccccccccCCceeeecccC-CC
Q 039595 248 LDTLFLYKNSLSGS-----------------IPSIIG--NLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS-LS 307 (1078)
Q Consensus 248 L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~-l~ 307 (1078)
|++|+|++|++++. +|..++ ++++|++|+|++|.+.|.+|..|+++++|+.|++++|+ ++
T Consensus 208 L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~ 287 (636)
T 4eco_A 208 LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287 (636)
T ss_dssp CCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSC
T ss_pred CCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCc
Confidence 88888888888764 899999 99999999999999999999999999999999999999 99
Q ss_pred C-CCCccccCC------CccCeeeccccccCccCCC--CCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccC
Q 039595 308 G-SIPPILGNL------KSLSTLGLYLNQLNGVIPP--SIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNL 378 (1078)
Q Consensus 308 ~-~~p~~l~~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 378 (1078)
| .+|..++++ ++|++|++++|+++ .+|. .++++++|+.|++++|++.|.+| .++.+++|++|+|++|++
T Consensus 288 ~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l 365 (636)
T 4eco_A 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI 365 (636)
T ss_dssp HHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEE
T ss_pred cccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCcc
Confidence 8 899988887 99999999999999 7888 89999999999999999999999 999999999999999999
Q ss_pred ccccCCCCccCCC-CceeecccCcCCCCCCccccccC--CCCeEEccCccccccchhhcc-------CCCCCcEecCCCC
Q 039595 379 SGVIPHSVGNLTG-LVLLNMCENHLFGPIPKSLKSLT--SLKRVRFNQNNLVGKVYEAFG-------DHPNLTFLDLSQN 448 (1078)
Q Consensus 379 ~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~Ls~N 448 (1078)
+ .+|..+.++++ |++|++++|+++ .+|..+..++ +|++|++++|.+.+..+..|. .+++|++|+|++|
T Consensus 366 ~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N 443 (636)
T 4eco_A 366 T-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443 (636)
T ss_dssp E-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSS
T ss_pred c-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCC
Confidence 9 78888999999 999999999998 7888887755 899999999999998888888 7889999999999
Q ss_pred ccCCccCccccCCCCCceecccccccCCCCCccccCCC-------cccEEeccCCccCCCcccccc--cCccCcEEeccC
Q 039595 449 NFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSS-------KLQFLDLSSNHIVGKIPVQLE--KLFSLNKLILSL 519 (1078)
Q Consensus 449 ~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~-------~L~~L~Ls~N~i~~~~~~~~~--~l~~L~~L~Ls~ 519 (1078)
.++.++...+..+++|++|++++|+++...+..+.... +|++|+|++|+|+ .+|..+. .+++|+.|+|++
T Consensus 444 ~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~ 522 (636)
T 4eco_A 444 QISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSY 522 (636)
T ss_dssp CCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCS
T ss_pred ccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCC
Confidence 99988888888999999999999999944434444333 9999999999999 6777776 899999999999
Q ss_pred CccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCC
Q 039595 520 NQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIP 599 (1078)
Q Consensus 520 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 599 (1078)
|++++ +|..+..+++|++|+|++|+ ++++|++.+.+|..|..+++|+.|+|++|+| +.+|
T Consensus 523 N~l~~-ip~~~~~l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip 582 (636)
T 4eco_A 523 NSFSK-FPTQPLNSSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVN 582 (636)
T ss_dssp SCCSS-CCCGGGGCSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCC
T ss_pred CCCCC-cChhhhcCCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccC
Confidence 99997 88899999999999999997 6889999999999999999999999999999 5678
Q ss_pred CCcccccccceeeccCccccCCc
Q 039595 600 PQVCNMESLEKLNLSHNNLSGFI 622 (1078)
Q Consensus 600 ~~~~~l~~L~~L~L~~N~l~~~~ 622 (1078)
..+. ++|++|+|++|++....
T Consensus 583 ~~~~--~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 583 EKIT--PNISVLDIKDNPNISID 603 (636)
T ss_dssp SCCC--TTCCEEECCSCTTCEEE
T ss_pred HhHh--CcCCEEECcCCCCcccc
Confidence 7765 79999999999887544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=461.61 Aligned_cols=258 Identities=20% Similarity=0.313 Sum_probs=209.4
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|+. .+|+.||||++..... .....+.+.+|+.++++++|||||++++++++++.+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 6899999999999999999965 4799999999976543 344567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
||||+||+|.+++... ....+++.+++.|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+....
T Consensus 102 mEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999999543 334578999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
........+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ......+ ....+.......
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i------~~~~~~~~~~~~ 249 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--KNLVLKI------ISGSFPPVSLHY 249 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH------HHTCCCCCCTTS
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHH------HcCCCCCCCccC
Confidence 33334567899999999999999999999999999999999999999753321 1111111 111111111222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. .++.+++.+||++||++|||++|+++|+|+..
T Consensus 250 s---~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 250 S---YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp C---HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred C---HHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 2 35778999999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=448.48 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=212.0
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+.... .....+.+.+|+.++++++|||||++++++++++.+|+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35799999999999999999965 57999999999765322 22345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||++||+|.+++++ .+.+++.++..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 110 vmEy~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 9999999999999943 45699999999999999999999999 99999999999999999999999999999875
Q ss_pred CCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
... ......+||+.|||||++.+..|+.++||||+||++|||+||++||...+ .......+... +..++.
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~----~~~~p~-- 255 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGLIFAKIIKL----EYDFPE-- 255 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHT----CCCCCT--
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcC----CCCCCc--
Confidence 432 23456789999999999999999999999999999999999999975322 22222222221 111211
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHH------HHHhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKG------FGHHIGY 1024 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~el------l~h~~~~ 1024 (1078)
... .++.+++.+||.+||++|||++|+ ++|||+.
T Consensus 256 -~~s---~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~ 295 (311)
T 4aw0_A 256 -KFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295 (311)
T ss_dssp -TCC---HHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred -ccC---HHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcC
Confidence 111 257789999999999999999985 6677754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=438.01 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=195.6
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.... .....+.+.+|+.++++++|||||++++++++++..|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 6899999999999999999965 47999999999765433 233466799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+ +|+|.+++.+ .+.+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 6799999843 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
. ......+||+.|||||++.+..| +.++||||+||++|||+||+.||.... .......+... .+.++. .
T Consensus 165 ~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~~~~i~~~----~~~~p~---~ 234 (275)
T 3hyh_A 165 G-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVLFKNISNG----VYTLPK---F 234 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHT----CCCCCT---T
T ss_pred C-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcC----CCCCCC---C
Confidence 2 23456789999999999998876 589999999999999999999975322 22222221111 111111 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. .++.+++.+||+.||++|||++|+++|||+..
T Consensus 235 ~s---~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 235 LS---PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp SC---HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred CC---HHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 11 25678999999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=461.61 Aligned_cols=255 Identities=27% Similarity=0.365 Sum_probs=215.0
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+.|+..++||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||+++++|.+++.+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT----CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 5799999999999999999966 479999999997543 22345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
||||+||+|.++++. ..+++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 227 mEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 227 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 999999999999943 4589999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
........+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .... ..+.....+.+... ...
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~---~~i~~~~~~~~~~~-~~~ 373 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAM---KMIRDNLPPRLKNL-HKV 373 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH---HHHHHSCCCCCSCT-TSS
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH---HHHHcCCCCCCccc-ccC
Confidence 65666778999999999999999999999999999999999999999753221 1111 11222222222211 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..++.+++.+||..||++|||++|+++|+|+..
T Consensus 374 ---s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 374 ---SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp ---CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 235778999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=439.25 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=201.8
Q ss_pred CccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec----CCeeEE
Q 039595 754 DEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN----ARHSFL 828 (1078)
Q Consensus 754 ~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 828 (1078)
++.++||+|+||+||+|.+ .++..||+|++..... .....+.|.+|+.++++++|||||+++++|++ +..+|+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 5667899999999999965 4789999999976532 34456789999999999999999999999864 356899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeeCC-CCcEEEecccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDL-EFEAHVSDFGIAK 905 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~-~~~~kl~DfG~a~ 905 (1078)
|||||+||+|.+++++ .+.+++..+..++.||+.||+|||++ + |+||||||+|||++. +|.+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 9999999999999953 45689999999999999999999998 7 999999999999984 7999999999998
Q ss_pred cccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
.... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ...... +.....+..
T Consensus 181 ~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~~------i~~~~~~~~ 250 (290)
T 3fpq_A 181 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRR------VTSGVKPAS 250 (290)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHH------HTTTCCCGG
T ss_pred eCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HHHHHH------HHcCCCCCC
Confidence 6432 34556789999999998865 6999999999999999999999997532211 111111 111111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+.. ...++.+++.+||++||++|||++|+++|||+..
T Consensus 251 ~~~~--~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 251 FDKV--AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGC--CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCcc--CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0100 1125778999999999999999999999999754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=497.87 Aligned_cols=488 Identities=17% Similarity=0.206 Sum_probs=344.1
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceecc-CCCccCCCCCccccCc---------cceeEEEcc-------CccCCC
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDL-GNNQLSGVISPEIGKL---------NQLRRLYLD-------MNQLHG 164 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~~~~l---------~~L~~L~L~-------~n~l~~ 164 (1078)
.+++.|+|++|++.|.+|+.|++|++|++||| ++|.++|..|-..... ..++..++. ...+.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 8899988754321111 011110000 000110
Q ss_pred -----------CCCcccccccccceeeccc--ccccCCccCcccCCCCCcEEEccCCCCCC-CCCCcccccCCCCeeecC
Q 039595 165 -----------TIPPVIGQLSLIHEFSFCH--NNVSGRIPSSLGNLSKLALLYLNNNSLFG-YIPTVMGNLKSLSTLDLS 230 (1078)
Q Consensus 165 -----------~~p~~i~~l~~L~~L~l~~--n~~~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~ 230 (1078)
..+........++.+.+.. |++++ +|..|++|++|++|+|++|++++ .+|..+ +.++
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~--------~~~s 473 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDW--------EDAN 473 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSC--------SCTT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccc--------cccc
Confidence 0111111222334444433 66666 67777777777777777777766 122111 1122
Q ss_pred CcccCCCCCCccc--CCCCCcEEeccccccCCCCCcccCCCcccceeeccccc-ccC-cccccccccc-------CCcee
Q 039595 231 QNQLNGLIPCTLD--NLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQ-LSG-SIPLSFGNLS-------SWTLM 299 (1078)
Q Consensus 231 ~N~l~~~~p~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L 299 (1078)
.|.+++.+|..++ ++++|++|+|++|++.+.+|..|+++++|+.|+|++|+ ++| .+|..++.++ +|+.|
T Consensus 474 ~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L 553 (876)
T 4ecn_A 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553 (876)
T ss_dssp SHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEE
T ss_pred cccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEE
Confidence 2444455777776 78888888888888877888888888888888888887 777 7777666665 88888
Q ss_pred eecccCCCCCCCc--cccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCC-CCeEEcccc
Q 039595 300 SLFSNSLSGSIPP--ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKS-LSELKLCKN 376 (1078)
Q Consensus 300 ~l~~n~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N 376 (1078)
++++|.++ .+|. .++++++|++|+|++|+++ .+| .|+.+++|+.|+|++|++. .+|..+..+++ |+.|+|++|
T Consensus 554 ~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N 629 (876)
T 4ecn_A 554 YMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHN 629 (876)
T ss_dssp ECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSS
T ss_pred EeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCC
Confidence 88888888 7777 7888888888888888888 666 7888888888888888888 78888888888 888888888
Q ss_pred cCccccCCCCccCCC--CceeecccCcCCCCCCccc---c--ccCCCCeEEccCccccccchhhccCCCCCcEecCCCCc
Q 039595 377 NLSGVIPHSVGNLTG--LVLLNMCENHLFGPIPKSL---K--SLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNN 449 (1078)
Q Consensus 377 ~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~~~~l---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 449 (1078)
+++ .+|..+..++. |+.|++++|++.+.+|... . .+++|+.|++++|.+..++...+..+++|+.|+|++|+
T Consensus 630 ~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~ 708 (876)
T 4ecn_A 630 KLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708 (876)
T ss_dssp CCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCC
T ss_pred CCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCc
Confidence 887 66777776654 8888888888887665432 2 23467778888888877777777777788888888887
Q ss_pred cCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccc--cCccCcEEeccCCccCCCcc
Q 039595 450 FDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLE--KLFSLNKLILSLNQLSGSVP 527 (1078)
Q Consensus 450 l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~ 527 (1078)
|+.++...+.... ..+.++++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|
T Consensus 709 L~~ip~~~~~~~~-----------------~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp 769 (876)
T 4ecn_A 709 MTSIPENSLKPKD-----------------GNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FP 769 (876)
T ss_dssp CSCCCTTSSSCTT-----------------SCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CC
T ss_pred CCccChHHhcccc-----------------ccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cc
Confidence 7744433322111 11234458888888888888 5677776 88888888888888886 67
Q ss_pred cccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccc
Q 039595 528 LEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMES 607 (1078)
Q Consensus 528 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 607 (1078)
..+..+++|+.|+|++|+ ++++|++.+.+|..|..+++|+.|+|++|+| +.+|..+. ++
T Consensus 770 ~~l~~L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~ 828 (876)
T 4ecn_A 770 TQPLNSSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQ 828 (876)
T ss_dssp CGGGGCTTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SS
T ss_pred hhhhcCCCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CC
Confidence 788888888888888876 5677777777777777777777777777777 45666654 57
Q ss_pred cceeeccCccccCCcccccccCCcCcEEEcccCcCC
Q 039595 608 LEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643 (1078)
Q Consensus 608 L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~ 643 (1078)
|+.|+|++|++....+..+.....+..+.|.+|++.
T Consensus 829 L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 829 LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp SCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred CCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 778888888777666666666666667777777665
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=444.11 Aligned_cols=255 Identities=25% Similarity=0.296 Sum_probs=204.4
Q ss_pred cCCCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
++|++.+.||+|+||+||+|+.. +++.||||++++..... .+...+.+|+.++++++|||||++++++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 57999999999999999999652 57899999997654322 2234678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+|||||+||+|.+++.+ .+.+++.++..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.
T Consensus 102 ~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 999999999999999953 45699999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
...........+||+.|||||++.+..|+.++||||+||++|||+||+.||...+ .......+... .+.++
T Consensus 176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~----~~~~p--- 246 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--RKETMTMILKA----KLGMP--- 246 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC----CCCCC---
T ss_pred ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--HHHHHHHHHcC----CCCCC---
Confidence 6554555567789999999999999999999999999999999999999975332 22222222111 11111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~ 1025 (1078)
.... .++.+++.+||++||++||| ++|+++|||+..
T Consensus 247 ~~~s---~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 247 QFLS---PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp TTSC---HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred CcCC---HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 1112 25778999999999999998 579999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=434.75 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=202.3
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.++||+|+||+||+|+++ ..||||+++... ......+.|.+|+.++++++|||||+++|++.+ +..||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3467888999999999999999875 369999987542 234556789999999999999999999999865 56899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
|||||++|+|.++++.. ...+++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+...
T Consensus 109 VmEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EEECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 99999999999999543 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCC--CCceeecccccccccccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 909 PYS--SNRTEFVGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 909 ~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
... ......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||...... ...... .......|...
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~~~~~~--~~~~~~~p~~~ 260 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQIIFM--VGRGYASPDLS 260 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHH--HHTTCCCCCST
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-HHHHHH--HhcCCCCCCcc
Confidence 432 22345689999999999864 46899999999999999999999997543221 111111 11122233333
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
....... ..+.+++.+||+.||++|||++|++++..
T Consensus 261 ~~~~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 261 KLYKNCP---KAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp TSCTTSC---HHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred cccccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2222222 35678899999999999999999998765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=441.42 Aligned_cols=254 Identities=23% Similarity=0.398 Sum_probs=200.6
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
++|.+.++||+|+||+||+|+++ +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 56778889999999999999764 4788999999753 3455678999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCC------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC
Q 039595 825 HSFLVCEYLHRGSLARILGNDAT------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL 892 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 892 (1078)
..|+|||||++|+|.++++.... ..++++.+++.|+.|||.||+|||++ +||||||||+|||++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence 99999999999999999965422 34699999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhh
Q 039595 893 EFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 893 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~ 969 (1078)
++.+||+|||+|+....... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .....
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~ 271 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAID 271 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence 99999999999987644322 2345679999999999999999999999999999999999 8999754322 11212
Q ss_pred hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 970 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.+.. -..+..+ .... .++.+++.+||+.||++|||++|+++++-
T Consensus 272 ~i~~---g~~~~~p---~~~~---~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 272 CITQ---GRELERP---RACP---PEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp HHHH---TCCCCCC---TTCC---HHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred HHHc---CCCCCCc---cccc---HHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 1111 1111111 1222 25778899999999999999999987753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=438.75 Aligned_cols=255 Identities=20% Similarity=0.317 Sum_probs=206.3
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
.++++.++||+|+||+||+|.+. +++.||||+++... .....++|.+|+.++++++|||||+++|+|.+++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 45667889999999999999763 46789999997542 2344678999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 039595 825 HSFLVCEYLHRGSLARILGNDAT-------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 891 (1078)
..++|||||++|+|.+++..... ...+++.++++|+.|||.||+|||++ +||||||||+|||++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence 99999999999999999954321 34689999999999999999999999 999999999999999
Q ss_pred CCCcEEEecccccccccCCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchh
Q 039595 892 LEFEAHVSDFGIAKFVEPYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFS 968 (1078)
Q Consensus 892 ~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~ 968 (1078)
+++.+||+|||+|+...... .......||+.|||||++.++.|+.++|||||||++|||+| |+.||..... ....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~ 257 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVV 257 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence 99999999999998764322 22345689999999999999999999999999999999998 8999754322 1222
Q ss_pred hhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 969 NMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 969 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
..+ ......+.+.... ..+.+++.+||+.||++|||++||++++-
T Consensus 258 ~~i------~~~~~~~~p~~~~---~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 258 EMI------RNRQVLPCPDDCP---AWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp HHH------HTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH------HcCCCCCCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 211 1111111122222 25778899999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=437.76 Aligned_cols=251 Identities=23% Similarity=0.400 Sum_probs=203.2
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
++|.+.+.||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 57888899999999999999763 4778999999753 3445678999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCC----------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 039595 825 HSFLVCEYLHRGSLARILGNDA----------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF 894 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 894 (1078)
..|+|||||++|+|.++++... ....+++.+++.|+.|||.||+|||++ +|+||||||+|||++.++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 9999999999999999996432 345699999999999999999999999 999999999999999999
Q ss_pred cEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhh
Q 039595 895 EAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMI 971 (1078)
Q Consensus 895 ~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~ 971 (1078)
.+||+|||+|+........ .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+....+
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i 243 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECI 243 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 9999999999876443222 233569999999999999999999999999999999998 8999754322 1222221
Q ss_pred hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHH
Q 039595 972 IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFG 1019 (1078)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 1019 (1078)
.. ......+.... .++.+++.+||+.||++|||++|+..
T Consensus 244 ~~------~~~~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 244 TQ------GRVLQRPRTCP---QEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp HH------TCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hc------CCCCCCCccch---HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 11111112222 25778899999999999999999854
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=477.06 Aligned_cols=492 Identities=22% Similarity=0.213 Sum_probs=356.4
Q ss_pred CCcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCC
Q 039595 64 PCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVIS 143 (1078)
Q Consensus 64 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 143 (1078)
.|.|.|| |+....+++. ++. .-.+.|++|+|++|.+++..|..|+++++|++|+|++|++++..|
T Consensus 3 ~C~~~~~-c~~~~~~l~~-----------ip~---~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~ 67 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTS-----------IPS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67 (549)
T ss_dssp EECTTSE-EECTTSCCSS-----------CCS---CCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT
T ss_pred cCCCCce-EECCCCcccc-----------ccc---cCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh
Confidence 5999999 9865433322 222 123789999999999999889999999999999999999998888
Q ss_pred ccccCccceeEEEccCccCCCCCCcccccccccceeecccccccC-CccCcccCCCCCcEEEccCCCCCCCCC-Cccccc
Q 039595 144 PEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSG-RIPSSLGNLSKLALLYLNNNSLFGYIP-TVMGNL 221 (1078)
Q Consensus 144 ~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l 221 (1078)
..|+++++|++|+|++|++++..|..++.+++|++|++++|.+++ .+|..++++++|++|++++|.+.+.+| ..|+++
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 999999999999999999998777789999999999999999997 467899999999999999999555555 689999
Q ss_pred CCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcc-cCCCcccceeecccccccCcc--cc-ccccccCCc
Q 039595 222 KSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSI-IGNLKSLHQLDLIENQLSGSI--PL-SFGNLSSWT 297 (1078)
Q Consensus 222 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~--p~-~~~~l~~L~ 297 (1078)
++|++|++++|++++..|..++.+++|++|+++.|.+.. +|.. +..+++|++|++++|++++.. |. ....+++|+
T Consensus 148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~ 226 (549)
T 2z81_A 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226 (549)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred cccCeeeccCCcccccChhhhhccccCceEecccCcccc-cchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence 999999999999999999999999999999999999874 4544 467899999999999999753 22 234567788
Q ss_pred eeeecccCCCCCCC----ccccCCCccCeeeccccccCccC------CCCCCCCCcCcEEEccCccCCCCCCccccccCC
Q 039595 298 LMSLFSNSLSGSIP----PILGNLKSLSTLGLYLNQLNGVI------PPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKS 367 (1078)
Q Consensus 298 ~L~l~~n~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~~------p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 367 (1078)
.|++++|.+++..+ ..+..+++|+.|++++|.+.+.. ...+..+.+|+.|++.++.+.... .+.
T Consensus 227 ~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~--~~~---- 300 (549)
T 2z81_A 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY--LFY---- 300 (549)
T ss_dssp EEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGG--GSC----
T ss_pred ceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhh--hcc----
Confidence 88888887765433 33455667777777777765431 112333444555555444433110 000
Q ss_pred CCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccc-cccCCCCeEEccCccccccch---hhccCCCCCcEe
Q 039595 368 LSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSL-KSLTSLKRVRFNQNNLVGKVY---EAFGDHPNLTFL 443 (1078)
Q Consensus 368 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L 443 (1078)
..+..+....+|+.|++++|++. .+|..+ ..+++|++|++++|.+.+..+ ..+..+++|++|
T Consensus 301 -------------~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L 366 (549)
T 2z81_A 301 -------------DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366 (549)
T ss_dssp -------------CCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEE
T ss_pred -------------cchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEE
Confidence 01111223456667777777665 344443 467777777777777766442 235667778888
Q ss_pred cCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccC
Q 039595 444 DLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLS 523 (1078)
Q Consensus 444 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~ 523 (1078)
++++|+++++... +..+..+++|++|++++|+|+ .+|..+..+++|++|++++|+++
T Consensus 367 ~Ls~N~l~~~~~~----------------------~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~ 423 (549)
T 2z81_A 367 VLSQNHLRSMQKT----------------------GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423 (549)
T ss_dssp ECTTSCCCCHHHH----------------------HHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS
T ss_pred EccCCcccccccc----------------------hhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc
Confidence 8888877643210 012344555666666666665 34555566666666666666665
Q ss_pred CCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcc
Q 039595 524 GSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVC 603 (1078)
Q Consensus 524 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 603 (1078)
. +|..+ .++|++|+|++|+|++.. ..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|+|++.+|..+.
T Consensus 424 ~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~ 494 (549)
T 2z81_A 424 V-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFD 494 (549)
T ss_dssp C-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGG
T ss_pred c-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHh
Confidence 3 23222 146777777777777532 46678888888888887 4554 45688888899999988887777788
Q ss_pred cccccceeeccCccccCCcc
Q 039595 604 NMESLEKLNLSHNNLSGFIP 623 (1078)
Q Consensus 604 ~l~~L~~L~L~~N~l~~~~~ 623 (1078)
.+++|++|+|++|++++..|
T Consensus 495 ~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 495 RLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp GCTTCCEEECCSSCBCCCHH
T ss_pred cCcccCEEEecCCCccCCCc
Confidence 88899999999999887766
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=474.19 Aligned_cols=513 Identities=22% Similarity=0.228 Sum_probs=360.6
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeec
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l 181 (1078)
+.+++|||++|.|++..|..|+++++|++|||++|+|++..|.+|++|++|++|+|++|++++..|..|+.|++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 47899999999998877788999999999999999999777778999999999999999998655567889999999999
Q ss_pred ccccccCCccCcccCCCCCcEEEccCCCCCCC-CCCcccccCCCCeeecCCcccCCCCCCcccCCCCCc----EEecccc
Q 039595 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGY-IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLD----TLFLYKN 256 (1078)
Q Consensus 182 ~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~L~~N 256 (1078)
++|++++..+..|+++++|++|+|++|.+++. +|..++++++|++|+|++|++++..|..|..+++++ .++++.|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 99999877777899999999999999998763 577888899999999999999988888877666544 6788888
Q ss_pred ccCCCCCcccCCCcccceeecccccccCc-cccccccccCCceeeecccCCC------CCCCccccCCCccCeeeccccc
Q 039595 257 SLSGSIPSIIGNLKSLHQLDLIENQLSGS-IPLSFGNLSSWTLMSLFSNSLS------GSIPPILGNLKSLSTLGLYLNQ 329 (1078)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~n~l~------~~~p~~l~~l~~L~~L~L~~N~ 329 (1078)
.++...+..+. ...++.|++++|..... .+..+..+..++...+..+... ......+..+..+..+.+..+.
T Consensus 212 ~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 212 PMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred cccccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 88855554444 45677888888866533 3345666666666555433322 2222333444444444444333
Q ss_pred cCc---cCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCC
Q 039595 330 LNG---VIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPI 406 (1078)
Q Consensus 330 l~~---~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 406 (1078)
... ..+..+..+.+++.+++.+|.+... ..+....+|+.|++.+|.+.+..+. .+..|+.+++.+|.+.
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~--- 362 (635)
T 4g8a_A 291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGG--- 362 (635)
T ss_dssp CCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSC---
T ss_pred hcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCC---
Confidence 221 1223344444555555555554422 1233444555555555555433221 2344444444444443
Q ss_pred CccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCc--cCccccCCCCCceecccccccCCCCCccccC
Q 039595 407 PKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGK--ISFNWRNLPKLDTFIVSMNNIFGSIPLEIGD 484 (1078)
Q Consensus 407 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~ 484 (1078)
... .+..+++|+.|++++|.+... .+..+..+.+|+.+++..|.+.. .+..+..
T Consensus 363 ---------------------~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~ 418 (635)
T 4g8a_A 363 ---------------------NAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLG 418 (635)
T ss_dssp ---------------------CBC--CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTT
T ss_pred ---------------------CCc--ccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccc
Confidence 221 122345555555555555322 22333445555555555555543 3345666
Q ss_pred CCcccEEeccCCccCCCc-ccccccCccCcEEeccCCccCCCcccccccccccceeeccCccc-cCCCCccccccccccc
Q 039595 485 SSKLQFLDLSSNHIVGKI-PVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKL-SSSIPKSIGNLLKLYY 562 (1078)
Q Consensus 485 l~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~ 562 (1078)
+++|+.+++++|.+.... +..|..+.+++.++++.|++.+..+..+..+++|+.|+|++|.+ .+..|..|..+++|++
T Consensus 419 l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~ 498 (635)
T 4g8a_A 419 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 498 (635)
T ss_dssp CTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred cccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCE
Confidence 777888888877665443 34567788888888888888877788888888888888888874 3456778888888888
Q ss_pred ccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccC-CcCcEEEcccCc
Q 039595 563 LNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKM-RSLSCIDICYNE 641 (1078)
Q Consensus 563 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l-~~L~~l~l~~N~ 641 (1078)
|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|..+ ++|+.|++++|+
T Consensus 499 L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np 578 (635)
T 4g8a_A 499 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 578 (635)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCC
T ss_pred EECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCC
Confidence 8888888888888888888889999999998888777788888889999999999988888888887 579999999999
Q ss_pred CCCCCC
Q 039595 642 LQGPIP 647 (1078)
Q Consensus 642 l~~~~~ 647 (1078)
|++...
T Consensus 579 ~~C~C~ 584 (635)
T 4g8a_A 579 FACTCE 584 (635)
T ss_dssp BCCSGG
T ss_pred CcccCC
Confidence 988664
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=472.15 Aligned_cols=460 Identities=22% Similarity=0.197 Sum_probs=280.9
Q ss_pred ceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCC
Q 039595 129 QNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN 208 (1078)
Q Consensus 129 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 208 (1078)
++||+++|+++ .+|..+. ++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57888888888 5777666 78888888888888666677888888888888888887777777888888888888888
Q ss_pred CCCCCCCCcccccCCCCeeecCCcccCC-CCCCcccCCCCCcEEeccccccCCCCCcccCCCccc--ceeecccccc--c
Q 039595 209 SLFGYIPTVMGNLKSLSTLDLSQNQLNG-LIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSL--HQLDLIENQL--S 283 (1078)
Q Consensus 209 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~ 283 (1078)
+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++ ..+..+++| +.|++++|.+ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 877 45554 67778888888887776 356777777777777777777764 345566666 7777777777 6
Q ss_pred Ccccccccccc-CCceeeecccCCCCCCCc-cccCCCccCeeeccccc-------cCccCCCCCCCCCcCcEEEccCccC
Q 039595 284 GSIPLSFGNLS-SWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQ-------LNGVIPPSIGNLSSLRNLSLFNNGL 354 (1078)
Q Consensus 284 ~~~p~~~~~l~-~L~~L~l~~n~l~~~~p~-~l~~l~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~Ls~N~l 354 (1078)
+..|..+..+. ....+++++|.+.+.++. .+.++++|+.|++++|. +.+.+| .++.+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 66666665554 233445555555544432 34555555555555554 443333 445555555555555544
Q ss_pred CCCCCcccc---ccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccch
Q 039595 355 YGSIPEEIG---YLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVY 431 (1078)
Q Consensus 355 ~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 431 (1078)
.+..+..+. ..++|++|++++|++++.+|..+... ....+++|+.+++++|.+ .++.
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~-------------------~~~~l~~L~~l~l~~n~~-~~p~ 292 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY-------------------SGTSLKALSIHQVVSDVF-GFPQ 292 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCC-------------------CSCCCCEEEEEEEEECCC-CSCT
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhc-------------------ccccCceeEeccccccce-ecch
Confidence 432211111 12345555555555444444444000 004444444444444444 2221
Q ss_pred hhccCC---CCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCccccccc
Q 039595 432 EAFGDH---PNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEK 508 (1078)
Q Consensus 432 ~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 508 (1078)
..+..+ .+|+.|++++|.+..... +..+++|++|++++|++++..|..+.+
T Consensus 293 ~~~~~~~~~~~L~~L~l~~n~l~~~~~--------------------------~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 346 (520)
T 2z7x_B 293 SYIYEIFSNMNIKNFTVSGTRMVHMLC--------------------------PSKISPFLHLDFSNNLLTDTVFENCGH 346 (520)
T ss_dssp HHHHHHHHTCCCSEEEEESSCCCCCCC--------------------------CSSCCCCCEEECCSSCCCTTTTTTCCC
T ss_pred hhhhcccccCceeEEEcCCCccccccc--------------------------hhhCCcccEEEeECCccChhhhhhhcc
Confidence 222211 346666666665542210 123455556666666665555555666
Q ss_pred CccCcEEeccCCccCC--CcccccccccccceeeccCccccCCCCc-ccccccccccccccCcccccccchhhhcccccC
Q 039595 509 LFSLNKLILSLNQLSG--SVPLEFGSLTELQYLDLSANKLSSSIPK-SIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLS 585 (1078)
Q Consensus 509 l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 585 (1078)
+++|++|+|++|++++ .+|..|..+++|++|+|++|.+++.+|. .+..+++|++|+|++|++++..|..+. ++|+
T Consensus 347 l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~ 424 (520)
T 2z7x_B 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIK 424 (520)
T ss_dssp CSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCC
T ss_pred CCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCC
Confidence 6666666666666654 3345566666666666666666653333 356666677777777777655555443 5777
Q ss_pred eeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCC
Q 039595 586 KLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIP 647 (1078)
Q Consensus 586 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~ 647 (1078)
.|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|++|++++|++++.++
T Consensus 425 ~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred EEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 7777777776 466666677777777777777775433447777777777788887777655
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=435.29 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=201.6
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.+.|+..++||+|+||+||+|++ .+|+.||||+++.... ..+|+.++++++|||||++++++.+++.+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35688889999999999999965 4799999999975432 1368999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEecccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHVSDFGIAKFV 907 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a~~~ 907 (1078)
|||||+||+|.+++++ .+.+++.++..++.||+.||+|||++ +||||||||+|||++.+| .+||+|||+|+.+
T Consensus 128 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 9999999999999953 35699999999999999999999999 999999999999999998 6999999999977
Q ss_pred cCCCCC-----ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 908 EPYSSN-----RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 908 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
...... ....+||+.|||||++.+..|+.++||||+||++|||+||++||..... ......+... .+..
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~~----~~~~ 275 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR--GPLCLKIASE----PPPI 275 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC--SCCHHHHHHS----CCGG
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHHHcC----CCCc
Confidence 543221 2335799999999999999999999999999999999999999754322 2222222111 1111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
....+... ..+.+++.+||++||++|||++|+++|+..
T Consensus 276 ~~~~~~~s---~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 REIPPSCA---PLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GGSCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhcCccCC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11111122 256788999999999999999999988653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=468.65 Aligned_cols=454 Identities=20% Similarity=0.200 Sum_probs=362.9
Q ss_pred cEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccc
Q 039595 105 VNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHN 184 (1078)
Q Consensus 105 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n 184 (1078)
++||+++|+++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57999999998 5888777 89999999999999888889999999999999999999888999999999999999999
Q ss_pred cccCCccCcccCCCCCcEEEccCCCCCC-CCCCcccccCCCCeeecCCcccCCCCCCcccCCCCC--cEEecccccc--C
Q 039595 185 NVSGRIPSSLGNLSKLALLYLNNNSLFG-YIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNL--DTLFLYKNSL--S 259 (1078)
Q Consensus 185 ~~~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l--~ 259 (1078)
.++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++ ..+..+++| ++|++++|++ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999 67877 89999999999999997 478999999999999999999986 457788888 9999999999 8
Q ss_pred CCCCcccCCCc-ccceeecccccccCcccc-ccccccCCceeeecccC-------CCCCCCccccCCCccCeeecccccc
Q 039595 260 GSIPSIIGNLK-SLHQLDLIENQLSGSIPL-SFGNLSSWTLMSLFSNS-------LSGSIPPILGNLKSLSTLGLYLNQL 330 (1078)
Q Consensus 260 ~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~n~-------l~~~~p~~l~~l~~L~~L~L~~N~l 330 (1078)
+..|..+..+. +...+++++|.+.+.++. .+..+++|+.+++++|. +.+.+| .++.+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 88898888876 455678899998876664 68899999999999998 777666 789999999999999998
Q ss_pred CccCCCCCC---CCCcCcEEEccCccCCCCCCccc-----cccCCCCeEEcccccCccccC-CCCccC---CCCceeecc
Q 039595 331 NGVIPPSIG---NLSSLRNLSLFNNGLYGSIPEEI-----GYLKSLSELKLCKNNLSGVIP-HSVGNL---TGLVLLNMC 398 (1078)
Q Consensus 331 ~~~~p~~l~---~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~ 398 (1078)
++..+..+. .+++|+.|++++|++.|.+|..+ +.+++|+.+++++|.+ .+| ..+..+ .+|+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~ 310 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVS 310 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEE
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcC
Confidence 754322111 13589999999999999999988 7777777777777777 233 333332 345555555
Q ss_pred cCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCC
Q 039595 399 ENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSI 478 (1078)
Q Consensus 399 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~ 478 (1078)
+|.+ ..... +..+++|++|++++|++++ ..
T Consensus 311 ~n~l------------------------~~~~~--~~~l~~L~~L~Ls~n~l~~------------------------~~ 340 (520)
T 2z7x_B 311 GTRM------------------------VHMLC--PSKISPFLHLDFSNNLLTD------------------------TV 340 (520)
T ss_dssp SSCC------------------------CCCCC--CSSCCCCCEEECCSSCCCT------------------------TT
T ss_pred CCcc------------------------ccccc--hhhCCcccEEEeECCccCh------------------------hh
Confidence 5554 33221 1455677777777776654 23
Q ss_pred CccccCCCcccEEeccCCccCC--CcccccccCccCcEEeccCCccCCCccc-ccccccccceeeccCccccCCCCcccc
Q 039595 479 PLEIGDSSKLQFLDLSSNHIVG--KIPVQLEKLFSLNKLILSLNQLSGSVPL-EFGSLTELQYLDLSANKLSSSIPKSIG 555 (1078)
Q Consensus 479 ~~~~~~l~~L~~L~Ls~N~i~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 555 (1078)
|..++.+++|++|++++|+|++ ..|..+..+++|++|++++|++++.+|. .|..+++|++|+|++|++++..|..+.
T Consensus 341 ~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 420 (520)
T 2z7x_B 341 FENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP 420 (520)
T ss_dssp TTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC
T ss_pred hhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc
Confidence 4455566667777777777765 3456677777888888888888764444 477788888888888888776666654
Q ss_pred cccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcc
Q 039595 556 NLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIP 623 (1078)
Q Consensus 556 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 623 (1078)
++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+...+..+..+++|++|+|++|++++..+
T Consensus 421 --~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 421 --PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp --TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred --ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 68899999999997 677777789999999999999985433348889999999999999987654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=425.65 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=197.4
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC-----
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR----- 824 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 824 (1078)
.+|++.+.||+|+||+||+|+.+ +|+.||||+++... .....+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 46899999999999999999654 79999999996542 3445677999999999999999999999986433
Q ss_pred -------eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEE
Q 039595 825 -------HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH 897 (1078)
Q Consensus 825 -------~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 897 (1078)
..|+|||||++|+|.+++.......+.++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 4799999999999999997665556677788999999999999999999 999999999999999999999
Q ss_pred EecccccccccCCCC------------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc
Q 039595 898 VSDFGIAKFVEPYSS------------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 965 (1078)
Q Consensus 898 l~DfG~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~ 965 (1078)
|+|||+|+....... .....+||+.|||||++.+..|+.++||||+||++|||++ ||.....
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--- 232 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--- 232 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---
Confidence 999999987654321 1234679999999999999999999999999999999996 6532111
Q ss_pred chhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 966 SFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 966 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.......+.....+ +..........+++.+||++||++|||++|+++|+|+..
T Consensus 233 ----~~~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 233 ----RVRTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp ----HHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred ----HHHHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 11111111111111 112222335678999999999999999999999999764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=434.04 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=211.1
Q ss_pred cHHHHHHhhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC-Ccee
Q 039595 742 MHEEIIKATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH-RNIV 814 (1078)
Q Consensus 742 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv 814 (1078)
...+++...++|++.+.||+|+||+||+|.+. .++.||||++.... ...+.+.|.+|+.++++++| ||||
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 34556666789999999999999999999754 23579999997543 33456779999999999965 8999
Q ss_pred eEEeeeec-CCeeEEEEeecCCCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 039595 815 KFHGFCSN-ARHSFLVCEYLHRGSLARILGNDA-------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIH 880 (1078)
Q Consensus 815 ~l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 880 (1078)
+++|+|.+ +...++|||||++|+|.++++... ....+++.+++.++.|||.||+|||++ +|||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ceec
Confidence 99999865 467899999999999999996432 134589999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCC
Q 039595 881 RDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPR 957 (1078)
Q Consensus 881 ~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~ 957 (1078)
|||||+|||+++++.+||+|||+|+........ .....||+.|||||++.+..|+.++|||||||++|||+| |+.||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 999999999999999999999999976543322 335679999999999999999999999999999999998 99997
Q ss_pred CcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 958 DFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
...... ..+...+ ..-..+..+ .... .++.+++.+||+.||++|||++|+++|.-
T Consensus 289 ~~~~~~-~~~~~~i---~~g~~~~~p---~~~~---~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 289 PGVKID-EEFCRRL---KEGTRMRAP---DYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp TTCCCS-HHHHHHH---HHTCCCCCC---TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHH-HHHHHHH---HcCCCCCCC---ccCC---HHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 643322 1111111 111112221 1122 25778899999999999999999999853
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=417.61 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=196.8
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC----ee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR----HS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 826 (1078)
++|.+.++||+|+||+||+|++ +|+.||||++.... .....+..|+..+.+++|||||++++++.+++ ..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4678889999999999999987 48999999986432 12223345676777899999999999997543 57
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCCeeeCCCCcEEEecc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC-----LPSIIHRDISSKNVLLDLEFEAHVSDF 901 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl~Df 901 (1078)
|+|||||++|+|.++++. ..++++++.+++.|++.||+|||+++ .++||||||||+|||++.++++||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 999999999999999943 45899999999999999999999752 348999999999999999999999999
Q ss_pred cccccccCCCCC----ceeeccccccccccccccC------CCCccchhHHHHHHHHHHHhCCCCCCcccccccchh---
Q 039595 902 GIAKFVEPYSSN----RTEFVGTFGYAAPEIAYTM------RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS--- 968 (1078)
Q Consensus 902 G~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~--- 968 (1078)
|+|+........ ....+||+.|||||++.+. .++.++|||||||++|||+||++||.........+.
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 999876543321 2346899999999998764 467899999999999999999888643322110000
Q ss_pred ----hhhhhhhhhcCCCCCCCCCc---cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 969 ----NMIIEVNQILDPRLSTPSPG---VMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 969 ----~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
........+......+..+. ..+....+.+++.+||+.||++|||++|+++..-
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 00011112222333222221 1234557889999999999999999999997643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=424.51 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=206.0
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec------C
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN------A 823 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~ 823 (1078)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ......+.+.+|+.++++++|||||++++++.. .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 6799999999999999999965 579999999997643 234456678899999999999999999998753 4
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
+.+|+|||||+ |+|.+++. ..+.+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 67899999996 58999994 346799999999999999999999999 999999999999999999999999999
Q ss_pred cccccCC----CCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh---
Q 039595 904 AKFVEPY----SSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN--- 975 (1078)
Q Consensus 904 a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~--- 975 (1078)
|+.+... .......+||+.|||||++.+. .++.++||||+||++|||++|++||...+. ......+....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--~~~l~~I~~~~g~p 282 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--VHQLQLIMMVLGTP 282 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHCCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCCC
Confidence 9876432 2234567899999999998875 569999999999999999999999753321 11111111100
Q ss_pred -----------------hhcCCCCCCCCCc-cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 976 -----------------QILDPRLSTPSPG-VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 976 -----------------~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..+.+....+... ......++.+++.+||..||++|||++|+++|||+..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 0011111100000 0001235789999999999999999999999999864
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=450.55 Aligned_cols=463 Identities=22% Similarity=0.204 Sum_probs=310.9
Q ss_pred CCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEc
Q 039595 126 SKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYL 205 (1078)
Q Consensus 126 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L 205 (1078)
...+++|+++|++++ +|..+. ++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 31 ~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 107 (562)
T 3a79_B 31 ELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV 107 (562)
T ss_dssp --CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEEC
Confidence 344899999999984 787665 78999999999999777788899999999999999998888888899999999999
Q ss_pred cCCCCCCCCCCcccccCCCCeeecCCcccCCC-CCCcccCCCCCcEEeccccccCCCCCcccCCCccc--ceeecccccc
Q 039595 206 NNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL-IPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSL--HQLDLIENQL 282 (1078)
Q Consensus 206 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l 282 (1078)
++|+++ .+|.. .+++|++|+|++|++++. +|..|+++++|++|+|++|++++. .+..+++| +.|++++|++
T Consensus 108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp TTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSC
T ss_pred CCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccc
Confidence 999987 56655 788899999999988874 467888888899999998888853 34445555 8888888888
Q ss_pred --cCcccccccccc-CCceeeecccCCCCCCCc-cccCCCccCeeeccccc-----cCccCCCCCCCCCcCcEEEccCcc
Q 039595 283 --SGSIPLSFGNLS-SWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQ-----LNGVIPPSIGNLSSLRNLSLFNNG 353 (1078)
Q Consensus 283 --~~~~p~~~~~l~-~L~~L~l~~n~l~~~~p~-~l~~l~~L~~L~L~~N~-----l~~~~p~~l~~l~~L~~L~Ls~N~ 353 (1078)
++..|..|..+. ....+++++|.+.+.++. .+.++++|+.|++++|+ +.+. +..+..+++|+.|+++++.
T Consensus 182 ~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~ 260 (562)
T 3a79_B 182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIE 260 (562)
T ss_dssp CCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEE
T ss_pred cccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCc
Confidence 777777777654 122456677776665543 34556666666666664 1111 1123444555555555554
Q ss_pred CCCCC----CccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCcccccc
Q 039595 354 LYGSI----PEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGK 429 (1078)
Q Consensus 354 l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 429 (1078)
+.+.. +..+ ...+|++|++++|++++.+|..+... ....++.|+.+++..|.+ .+
T Consensus 261 l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~-------------------~~~~L~~L~~~~~~~~~~-~~ 319 (562)
T 3a79_B 261 TTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTY-------------------SETALKSLMIEHVKNQVF-LF 319 (562)
T ss_dssp ECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCC-------------------CSCSCCEEEEEEEEECCC-SS
T ss_pred CcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhc-------------------ccccchheehhhccccee-ec
Confidence 43211 1111 11244555555555544444433000 003333333333333333 12
Q ss_pred chhhcc---CCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCccccc
Q 039595 430 VYEAFG---DHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL 506 (1078)
Q Consensus 430 ~~~~~~---~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~ 506 (1078)
+...+. ...+|+.|++++|.+.... ....+++|++|++++|++++..|..+
T Consensus 320 p~~~~~~~~~~~~L~~L~l~~n~~~~~~--------------------------~~~~l~~L~~L~l~~n~l~~~~~~~~ 373 (562)
T 3a79_B 320 SKEALYSVFAEMNIKMLSISDTPFIHMV--------------------------CPPSPSSFTFLNFTQNVFTDSVFQGC 373 (562)
T ss_dssp CHHHHHHHHHTCCCSEEEEESSCCCCCC--------------------------CCSSCCCCCEEECCSSCCCTTTTTTC
T ss_pred ChhhhhhhhccCcceEEEccCCCccccc--------------------------CccCCCCceEEECCCCccccchhhhh
Confidence 111111 1145666666666554211 01355667777777777777677777
Q ss_pred ccCccCcEEeccCCccCCC--cccccccccccceeeccCccccCCCC-cccccccccccccccCcccccccchhhhcccc
Q 039595 507 EKLFSLNKLILSLNQLSGS--VPLEFGSLTELQYLDLSANKLSSSIP-KSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIH 583 (1078)
Q Consensus 507 ~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 583 (1078)
.++++|+.|+|++|++++. +|..|..+++|++|+|++|.+++.+| ..+..+++|++|+|++|++++..|..+. ++
T Consensus 374 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~ 451 (562)
T 3a79_B 374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PK 451 (562)
T ss_dssp CSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TT
T ss_pred cccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--Cc
Confidence 7777777777777777753 34567778888888888888876333 4577778888888888888766655543 68
Q ss_pred cCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCCC
Q 039595 584 LSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPN 648 (1078)
Q Consensus 584 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~ 648 (1078)
|+.|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|+.|++++|+|+|.+|.
T Consensus 452 L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp CSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 888888888887 4666666888888888888888855444488888899999999998887764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=449.18 Aligned_cols=516 Identities=22% Similarity=0.216 Sum_probs=392.6
Q ss_pred cCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccC
Q 039595 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGN 196 (1078)
Q Consensus 117 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~ 196 (1078)
.+|+.+. +.+++|||++|+|++..|.+|+++++|++|+|++|+|++..|.+|+.|++|++|+|++|++++..|..|++
T Consensus 45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~ 122 (635)
T 4g8a_A 45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 122 (635)
T ss_dssp SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTT
T ss_pred ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcC
Confidence 4676553 57999999999999777788999999999999999999666678899999999999999998776778899
Q ss_pred CCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCC-CCCcccCCCCCcEEeccccccCCCCCcccCCCcccc--
Q 039595 197 LSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL-IPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLH-- 273 (1078)
Q Consensus 197 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-- 273 (1078)
+++|++|+|++|++++..+..|+++++|++|+|++|++++. .|..++.+++|++|+|++|++++..|..|..+.+++
T Consensus 123 L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~ 202 (635)
T 4g8a_A 123 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 202 (635)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhh
Confidence 99999999999999887777889999999999999998764 577788889999999999999887777777666544
Q ss_pred --eeecccccccCccccccccccCCceeeecccCCCCC-CCccccCCCccCeeeccccccC------ccCCCCCCCCCcC
Q 039595 274 --QLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS-IPPILGNLKSLSTLGLYLNQLN------GVIPPSIGNLSSL 344 (1078)
Q Consensus 274 --~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~l~~l~~L~~L~L~~N~l~------~~~p~~l~~l~~L 344 (1078)
.++++.|.++...+..+.. ..+..+++.+|..... .+..+..+..++...+..+... ......+..+..+
T Consensus 203 ~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l 281 (635)
T 4g8a_A 203 NLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 281 (635)
T ss_dssp CCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGS
T ss_pred hhhhhcccCcccccCcccccc-hhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccch
Confidence 5778888887665555443 3456677777765432 2344666666666665544332 2222333444444
Q ss_pred cEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCc
Q 039595 345 RNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424 (1078)
Q Consensus 345 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 424 (1078)
..+++..+...... ...+..+..+.+++.+.+.+|.+... ..+.....++.|++.+|
T Consensus 282 ~~~~l~~~~~~~~~---------------------~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~ 338 (635)
T 4g8a_A 282 TIEEFRLAYLDYYL---------------------DGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNC 338 (635)
T ss_dssp EEEEEEEECCCSCE---------------------EECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESC
T ss_pred hhhhhhhhhhcccc---------------------cchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccc
Confidence 44444433322111 11222333444455555555444322 12334455666666666
Q ss_pred cccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCC--CCCccccCCCcccEEeccCCccCCCc
Q 039595 425 NLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFG--SIPLEIGDSSKLQFLDLSSNHIVGKI 502 (1078)
Q Consensus 425 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~--~~~~~~~~l~~L~~L~Ls~N~i~~~~ 502 (1078)
.+..+... .++.|+.++++.|.+... ..+..+++|+.++++.|.+.. ..+..+..+.+|+.++++.|.+. ..
T Consensus 339 ~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~ 412 (635)
T 4g8a_A 339 KFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TM 412 (635)
T ss_dssp EESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EE
T ss_pred cccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cc
Confidence 65554433 346788888888887654 345678999999999999864 35566778899999999999987 45
Q ss_pred ccccccCccCcEEeccCCccCCCc-ccccccccccceeeccCccccCCCCcccccccccccccccCccc-ccccchhhhc
Q 039595 503 PVQLEKLFSLNKLILSLNQLSGSV-PLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQF-SHTIPIEFEK 580 (1078)
Q Consensus 503 ~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~ 580 (1078)
+..+..+++|+.++++.|+..... +..|..+++++.++++.|.+.+..+..+..+++|++|+|++|++ .+..|..|..
T Consensus 413 ~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~ 492 (635)
T 4g8a_A 413 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 492 (635)
T ss_dssp CSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred cccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhh
Confidence 667889999999999999877554 45788999999999999999999999999999999999999985 4467889999
Q ss_pred ccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCCCCcc-c----cCc
Q 039595 581 LIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTV-F----KDG 655 (1078)
Q Consensus 581 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~~~~-~----~~~ 655 (1078)
+++|+.|||++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.||+++|++++.+|..-. + ..-
T Consensus 493 l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L 572 (635)
T 4g8a_A 493 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 572 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEE
T ss_pred ccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEE
Confidence 99999999999999998899999999999999999999999999999999999999999999998876432 2 223
Q ss_pred cccCCCCcC
Q 039595 656 LMEGNKGLC 664 (1078)
Q Consensus 656 ~~~~n~~lc 664 (1078)
..++||+.|
T Consensus 573 ~L~~Np~~C 581 (635)
T 4g8a_A 573 NLTQNDFAC 581 (635)
T ss_dssp ECTTCCBCC
T ss_pred EeeCCCCcc
Confidence 578999988
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=418.28 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=202.2
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
+....++|++.+.||+|+||+||+|+.+ +++.||||++.... ...++.+|+.+++.+ +|||||++++++
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 3345678999999999999999999643 46789999986532 245678899999988 699999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEe
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVS 899 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~ 899 (1078)
.+.+..|+||||+++|+|.++++ .+++.++..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred EECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEEC
Confidence 99999999999999999999982 488999999999999999999999 99999999999999877 899999
Q ss_pred cccccccccCCCC----------------------------CceeeccccccccccccccC-CCCccchhHHHHHHHHHH
Q 039595 900 DFGIAKFVEPYSS----------------------------NRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEV 950 (1078)
Q Consensus 900 DfG~a~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~el 950 (1078)
|||+|+....... .....+||+.|||||++.+. .|+.++||||+||++|||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence 9999986543211 12345799999999999875 589999999999999999
Q ss_pred HhCCCCCCcccccccchhhhhhh-------------------------------hhhh--c---CCCCCCC-------CC
Q 039595 951 IKGNHPRDFFSINFSSFSNMIIE-------------------------------VNQI--L---DPRLSTP-------SP 987 (1078)
Q Consensus 951 ltG~~p~~~~~~~~~~~~~~~~~-------------------------------~~~~--~---~~~~~~~-------~~ 987 (1078)
++|+.||.....+.......... .... . .|..... ..
T Consensus 241 l~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 241 LSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE 320 (361)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred HHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence 99999974332221111110000 0000 0 0000000 00
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.......++.+++.+||..||++|||++|+++|||+.
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~ 357 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFK 357 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 0011123578999999999999999999999999975
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=441.51 Aligned_cols=457 Identities=21% Similarity=0.214 Sum_probs=343.5
Q ss_pred CcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeeccc
Q 039595 104 LVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183 (1078)
Q Consensus 104 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~ 183 (1078)
.+++|+++|++++ +|..+. ++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+.+++|++|+|++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 3899999999985 787665 8999999999999988888999999999999999999988899999999999999999
Q ss_pred ccccCCccCcccCCCCCcEEEccCCCCCCC-CCCcccccCCCCeeecCCcccCCCCCCcccCCCCC--cEEecccccc--
Q 039595 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGY-IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNL--DTLFLYKNSL-- 258 (1078)
Q Consensus 184 n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l-- 258 (1078)
|.++ .+|.. .+++|++|+|++|++++. +|..|+++++|++|+|++|++++. .+..+++| ++|+|++|++
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 9998 67877 899999999999999873 568999999999999999999864 45666666 9999999999
Q ss_pred CCCCCcccCCCc-ccceeecccccccCcccc-ccccccCCceeeecccC-----CCCCCCccccCCCccCeeeccccccC
Q 039595 259 SGSIPSIIGNLK-SLHQLDLIENQLSGSIPL-SFGNLSSWTLMSLFSNS-----LSGSIPPILGNLKSLSTLGLYLNQLN 331 (1078)
Q Consensus 259 ~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~n~-----l~~~~p~~l~~l~~L~~L~L~~N~l~ 331 (1078)
++..|..+..+. ..-.+++++|.+.+.++. .+..+++|+.+++++|. +.+ ....+..+++|+.|++.++.+.
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEEC
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCc
Confidence 888888888765 222668899999886664 57789999999999996 222 2345788899999999988876
Q ss_pred ccC----CCCCCCCCcCcEEEccCccCCCCCCccc-----cccCCCCeEEcccccCccccC-CCCccCCCCceeecccCc
Q 039595 332 GVI----PPSIGNLSSLRNLSLFNNGLYGSIPEEI-----GYLKSLSELKLCKNNLSGVIP-HSVGNLTGLVLLNMCENH 401 (1078)
Q Consensus 332 ~~~----p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~ 401 (1078)
+.. +..+ ..++|++|++++|.+.|.+|..+ ..+++|+.++++.|.+ .+| ..+..+
T Consensus 263 ~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~------------ 327 (562)
T 3a79_B 263 WKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSV------------ 327 (562)
T ss_dssp HHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHH------------
T ss_pred HHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhh------------
Confidence 431 1111 23489999999999999999887 5555555555555555 222 111111
Q ss_pred CCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCcc
Q 039595 402 LFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLE 481 (1078)
Q Consensus 402 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~ 481 (1078)
....+|++|++++|.+..... +..+++|++|++++|++++ ..|..
T Consensus 328 ---------~~~~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~l~~n~l~~------------------------~~~~~ 372 (562)
T 3a79_B 328 ---------FAEMNIKMLSISDTPFIHMVC--PPSPSSFTFLNFTQNVFTD------------------------SVFQG 372 (562)
T ss_dssp ---------HHTCCCSEEEEESSCCCCCCC--CSSCCCCCEEECCSSCCCT------------------------TTTTT
T ss_pred ---------hccCcceEEEccCCCcccccC--ccCCCCceEEECCCCcccc------------------------chhhh
Confidence 011334445555554433221 1455667777777776654 33445
Q ss_pred ccCCCcccEEeccCCccCCC--cccccccCccCcEEeccCCccCCCc-ccccccccccceeeccCccccCCCCccccccc
Q 039595 482 IGDSSKLQFLDLSSNHIVGK--IPVQLEKLFSLNKLILSLNQLSGSV-PLEFGSLTELQYLDLSANKLSSSIPKSIGNLL 558 (1078)
Q Consensus 482 ~~~l~~L~~L~Ls~N~i~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 558 (1078)
++.+++|++|+|++|+|++. .|..+.++++|+.|+|++|++++.+ +..|..+++|++|+|++|++++..|..+. +
T Consensus 373 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~ 450 (562)
T 3a79_B 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--P 450 (562)
T ss_dssp CCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--T
T ss_pred hcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--C
Confidence 55566666677777766653 2455677777777777777777633 34577778888888888888766665554 5
Q ss_pred ccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcc
Q 039595 559 KLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIP 623 (1078)
Q Consensus 559 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 623 (1078)
+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++++..+
T Consensus 451 ~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp TCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred cCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 7888888888887 566666688888999999998885333348888899999999999887654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=431.57 Aligned_cols=260 Identities=18% Similarity=0.203 Sum_probs=207.4
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN--MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.+...... .........++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999654 799999999976433211 11122233456777888999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+||||++||+|.+++.+ .+.+++.++..++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999943 45699999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
+... .....+||+.|||||++.+ ..|+.++||||+||++|||++|++||...... ..... ..........++.
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i-~~~i~~~~~~~p~- 415 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEI-DRMTLTMAVELPD- 415 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHH-HHHHHHCCCCCCT-
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHH-HHhhcCCCCCCCc-
Confidence 6542 3345789999999999974 57999999999999999999999997543221 11111 1111111122221
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCD 1026 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~ 1026 (1078)
... .++.+++.+||.+||.+|++ ++|+++|||+..-
T Consensus 416 --~~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 416 --SFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp --TSC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred --cCC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 111 25778999999999999998 7999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=433.45 Aligned_cols=258 Identities=19% Similarity=0.288 Sum_probs=213.1
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||+|++... ...+.+.+.+|+.+|+.++|||||+++++|.++..+|+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999965 47999999998754 34456778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC--CcEEEeccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE--FEAHVSDFGIAKF 906 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DfG~a~~ 906 (1078)
|||||+||+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 232 v~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 232 IYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999999999999432 34689999999999999999999999 99999999999999865 8999999999998
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
+... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+. ......+.
T Consensus 307 ~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~~~~i~------~~~~~~~~ 377 (573)
T 3uto_A 307 LDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVK------SCDWNMDD 377 (573)
T ss_dssp CCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHH------TTCCCCCS
T ss_pred ccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHH------hCCCCCCc
Confidence 7543 334567899999999999999999999999999999999999999753322 11111111 11111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
........++.+++.+||..||++|||++|+++|+|+..
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 111112235778999999999999999999999999763
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=399.14 Aligned_cols=298 Identities=33% Similarity=0.534 Sum_probs=188.9
Q ss_pred CCCHHHHHHHHHHHHhcCCCCCCccccCCCCCCCCCCCCCCCCc--ccceEeeCCC--CeEEEeccCccccCCcccCCcc
Q 039595 23 SDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCS--WFGISCNHAG--SRVISINLSTLCLNGTFQDFSF 98 (1078)
Q Consensus 23 ~~~~~~~~all~~k~~~~~~~~~~~~l~sW~~~~~~~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~l~g~~~~~~~ 98 (1078)
.|.++|++||++||+++.++ ..+++|+. ++|||. |.||+|+..+ ++|+.++|+++.+.|..
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~----~~l~~W~~------~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~----- 66 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNP----TTLSSWLP------TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY----- 66 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCC----GGGTTCCT------TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCE-----
T ss_pred CCCHHHHHHHHHHHHhcCCc----ccccCCCC------CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCc-----
Confidence 58899999999999999643 36899972 468998 9999998654 56766655554444410
Q ss_pred CCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCC-CccCCCCCccccCccceeEEEccCccCCCCCCcccccccccc
Q 039595 99 SSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGN-NQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177 (1078)
Q Consensus 99 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~ 177 (1078)
.+|..++++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..++.+++|+
T Consensus 67 ------------------~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 128 (313)
T 1ogq_A 67 ------------------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp ------------------ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred ------------------ccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence 4555555555555555553 555555555555555555555555555555555555555555
Q ss_pred eeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccC-CCCeeecCCcccCCCCCCcccCCCCCcEEecccc
Q 039595 178 EFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLK-SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKN 256 (1078)
Q Consensus 178 ~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 256 (1078)
+|++++|.+++.+|..++++++|++|+|++|++++.+|..+++++ +|++|+|++|++++.+|..+..++ |++|+|++|
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence 555555555555555555666666666666666555555555555 566666666666655555565554 666666666
Q ss_pred ccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCC
Q 039595 257 SLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPP 336 (1078)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 336 (1078)
++++.+|..|+++++|+.|+|++|++++.+|. +..+++|+.|++++|.+++.+|..+.++++|++|+|++|++++.+|.
T Consensus 208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred cccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence 66655566666666666666666666655444 55566666666666666666666666666777777777777666665
Q ss_pred CCCCCCcCcEEEccCcc-CCC
Q 039595 337 SIGNLSSLRNLSLFNNG-LYG 356 (1078)
Q Consensus 337 ~l~~l~~L~~L~Ls~N~-l~~ 356 (1078)
. ..+++|+.|++++|. +.|
T Consensus 287 ~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 287 G-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp S-TTGGGSCGGGTCSSSEEES
T ss_pred C-ccccccChHHhcCCCCccC
Confidence 4 666677777777766 443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=408.93 Aligned_cols=427 Identities=26% Similarity=0.288 Sum_probs=230.1
Q ss_pred CCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCccccccccccee
Q 039595 100 SFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEF 179 (1078)
Q Consensus 100 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L 179 (1078)
..++|++|++++|.+ |.+|..+++|++|++|++++|.++|.+|.+++++++|+.+++..+.. .++++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 356788888888888 77888888888888888888888888888888888877777665532 456777
Q ss_pred ecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccC
Q 039595 180 SFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS 259 (1078)
Q Consensus 180 ~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 259 (1078)
++++|.+++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++++. |.. .++|++|++++|+++
T Consensus 77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLE 144 (454)
T ss_dssp ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCS
T ss_pred EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCC
Confidence 888877775 4442 3678888888888876 5643 36788888888888763 321 167888888888888
Q ss_pred CCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCC
Q 039595 260 GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIG 339 (1078)
Q Consensus 260 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 339 (1078)
+ +| .|+++++|++|++++|++++ +|..+ .+|+.|++++|.+++ +| .++++++|++|++++|++++ +|...
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~- 214 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP- 214 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC-
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc-
Confidence 5 56 48888888888888888875 44433 467777777777775 44 46777777777777777765 33322
Q ss_pred CCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeE
Q 039595 340 NLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV 419 (1078)
Q Consensus 340 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 419 (1078)
++|+.|++++|.+. .+|. ++.+++|++|++++|++++ +|.. +++|+.|++++|++.+ +|.. .++|++|
T Consensus 215 --~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L 282 (454)
T 1jl5_A 215 --LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFL 282 (454)
T ss_dssp --TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred --CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEE
Confidence 46777777777776 4553 6677777777777777764 3332 3566666666666654 3322 2445555
Q ss_pred EccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCC-CcccEEeccCCcc
Q 039595 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDS-SKLQFLDLSSNHI 498 (1078)
Q Consensus 420 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l-~~L~~L~Ls~N~i 498 (1078)
++++|.+.++... .++|++|++++|+ +++. ..+ ++|++|++++|++
T Consensus 283 ~ls~N~l~~l~~~----~~~L~~L~l~~N~------------------------l~~i-----~~~~~~L~~L~Ls~N~l 329 (454)
T 1jl5_A 283 DVSENIFSGLSEL----PPNLYYLNASSNE------------------------IRSL-----CDLPPSLEELNVSNNKL 329 (454)
T ss_dssp ECCSSCCSEESCC----CTTCCEEECCSSC------------------------CSEE-----CCCCTTCCEEECCSSCC
T ss_pred ECcCCccCcccCc----CCcCCEEECcCCc------------------------CCcc-----cCCcCcCCEEECCCCcc
Confidence 5555555442210 1344444444444 4331 112 4678888888888
Q ss_pred CCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccC--CCCcccccccccccccccCcccccccch
Q 039595 499 VGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS--SIPKSIGNLLKLYYLNLSNNQFSHTIPI 576 (1078)
Q Consensus 499 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 576 (1078)
++ +|.. +++|+.|++++|++++ +|. .+++|++|+|++|++++ .+|..+.+ |+.|.+.+.+|.
T Consensus 330 ~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~ 393 (454)
T 1jl5_A 330 IE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPE 393 (454)
T ss_dssp SC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-------
T ss_pred cc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhccccccccc
Confidence 75 4433 4678888888888884 444 46788888888888887 55665543 234556566665
Q ss_pred hhhcccccCeeecCCCccCC--cCCCCcccccccceeeccCccccCCcccccccCC
Q 039595 577 EFEKLIHLSKLDLSHNILQE--EIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMR 630 (1078)
Q Consensus 577 ~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 630 (1078)
. +++|+.||+++|++++ .+| .+|+.|.+.+|.+.+..+.....+.
T Consensus 394 ~---~~~L~~L~ls~N~l~~~~~iP------~sl~~L~~~~~~~~~~~~~~~~~~~ 440 (454)
T 1jl5_A 394 L---PQNLKQLHVETNPLREFPDIP------ESVEDLRMNSERVVDPYEFAHETTD 440 (454)
T ss_dssp --------------------------------------------------------
T ss_pred c---cCcCCEEECCCCcCCccccch------hhHhheeCcCcccCCccccCHHHhh
Confidence 3 5788999999999986 333 3467778888888877666555443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=407.16 Aligned_cols=364 Identities=21% Similarity=0.220 Sum_probs=260.9
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCC-CccccCccceeEEEccCccCCCCCCcccccccccceee
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVI-SPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFS 180 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~ 180 (1078)
++|++|+|++|.+.+..|..|+++++|++|+|++|.+.+.+ |..|+++++|++|+|++|++++..|..++.+++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 78999999999999988999999999999999999998776 45799999999999999999988899999999999999
Q ss_pred cccccccCCccCc--ccCCCCCcEEEccCCCCCCCCCCc-ccccCCCCeeecCCcccCCCCCCcccCC--CCCcEEeccc
Q 039595 181 FCHNNVSGRIPSS--LGNLSKLALLYLNNNSLFGYIPTV-MGNLKSLSTLDLSQNQLNGLIPCTLDNL--SNLDTLFLYK 255 (1078)
Q Consensus 181 l~~n~~~~~~p~~--l~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~L~~ 255 (1078)
+++|.+++.+|.. ++++++|++|+|++|++++..|.. ++++++|++|+|++|++++..|..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999999877665 999999999999999999888876 8999999999999999999999888877 7899999999
Q ss_pred cccCCCCCcc--------cCCCcccceeecccccccCccccccccc---cCCceeeecccCCCCCCCccccCCCccCeee
Q 039595 256 NSLSGSIPSI--------IGNLKSLHQLDLIENQLSGSIPLSFGNL---SSWTLMSLFSNSLSGSIPPILGNLKSLSTLG 324 (1078)
Q Consensus 256 N~l~~~~p~~--------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ 324 (1078)
|.+.+..+.. +..+++|++|++++|++++..|..+... .+|+.|++++|.+.+...
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~------------- 256 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF------------- 256 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT-------------
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc-------------
Confidence 9999765544 3367899999999999999888887765 788999999887654321
Q ss_pred ccccccCccCCCCCCCC--CcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcC
Q 039595 325 LYLNQLNGVIPPSIGNL--SSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL 402 (1078)
Q Consensus 325 L~~N~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 402 (1078)
..+.+....+..+..+ ++|+.|++++|.+.+.+|..+..+++|++|+|++|++++..|..|.++++|++|++++|++
T Consensus 257 -~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 335 (455)
T 3v47_A 257 -GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335 (455)
T ss_dssp -TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred -chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCcc
Confidence 1111111111122211 3455555555555544444455555555555555555544444555555555555555555
Q ss_pred CCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCC
Q 039595 403 FGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479 (1078)
Q Consensus 403 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~ 479 (1078)
.+..|..|..+++|++|++++|.+.++.+..|..+++|++|++++|+++++.+..|..+++|++|++++|.+++..|
T Consensus 336 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 44444455555555555555555555545555555555555555555555444445555555555555555554433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=397.25 Aligned_cols=423 Identities=24% Similarity=0.295 Sum_probs=213.6
Q ss_pred CeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEE
Q 039595 77 SRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156 (1078)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 156 (1078)
.++..++++++.+ |.+++ .++++++|++|+|++|.+.|.+|..++++++|+++++++|.. .+|++|+
T Consensus 11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~ 77 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE 77 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence 4677899999988 88875 689999999999999999999999999999885555555432 3455555
Q ss_pred ccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCC
Q 039595 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG 236 (1078)
Q Consensus 157 L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 236 (1078)
+++|.+++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++
T Consensus 78 l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~ 145 (454)
T 1jl5_A 78 LNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK 145 (454)
T ss_dssp CTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS
T ss_pred ecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC
Confidence 55555553 3331 2455555555555554 4432 2555666666666553 2221 1456666666666664
Q ss_pred CCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccC
Q 039595 237 LIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGN 316 (1078)
Q Consensus 237 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~ 316 (1078)
+| .|+++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .|+.+++|+.|++++|.+++ +|...
T Consensus 146 -lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~-- 214 (454)
T 1jl5_A 146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP-- 214 (454)
T ss_dssp -CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--
T ss_pred -Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--
Confidence 34 35666666666666666653 34332 356666666666655 33 45666666666666666654 33222
Q ss_pred CCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceee
Q 039595 317 LKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLN 396 (1078)
Q Consensus 317 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 396 (1078)
++|++|++++|+++ .+| .++.+++|+.|++++|++++ +|.. +++|++|++++|++++ +|.. .++|+.|+
T Consensus 215 -~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ 283 (454)
T 1jl5_A 215 -LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLD 283 (454)
T ss_dssp -TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred -CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEE
Confidence 36666666666666 344 36666667777777776663 3432 3566777777777665 3332 35667777
Q ss_pred cccCcCCCCCCccccccCCCCeEEccCccccccchhhccCC-CCCcEecCCCCccCCccCccccCCCCCceecccccccC
Q 039595 397 MCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDH-PNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIF 475 (1078)
Q Consensus 397 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 475 (1078)
+++|++++. |.. .++|++|++++|.+.++. .+ ++|++|++++|+++++... +++|++|++++|+++
T Consensus 284 ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~-----~~~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~L~~N~l~ 350 (454)
T 1jl5_A 284 VSENIFSGL-SEL---PPNLYYLNASSNEIRSLC-----DLPPSLEELNVSNNKLIELPAL----PPRLERLIASFNHLA 350 (454)
T ss_dssp CCSSCCSEE-SCC---CTTCCEEECCSSCCSEEC-----CCCTTCCEEECCSSCCSCCCCC----CTTCCEEECCSSCCS
T ss_pred CcCCccCcc-cCc---CCcCCEEECcCCcCCccc-----CCcCcCCEEECCCCcccccccc----CCcCCEEECCCCccc
Confidence 777776652 110 146777777777776532 23 4788888888888764432 467777888888777
Q ss_pred CCCCccccCCCcccEEeccCCccCC--CcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccC--CCC
Q 039595 476 GSIPLEIGDSSKLQFLDLSSNHIVG--KIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS--SIP 551 (1078)
Q Consensus 476 ~~~~~~~~~l~~L~~L~Ls~N~i~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~ 551 (1078)
. +|. .+++|++|++++|++++ .+|..+.. |+.|++.+.+|.. +++|++||+++|.+++ .+|
T Consensus 351 ~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 351 E-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp C-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------------------
T ss_pred c-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccch
Confidence 4 444 36788888888888887 45555442 2346666666653 4789999999999986 444
Q ss_pred cccccccccccccccCcccccccchhhhc
Q 039595 552 KSIGNLLKLYYLNLSNNQFSHTIPIEFEK 580 (1078)
Q Consensus 552 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 580 (1078)
. +|+.|.+.+|.+.+..+.....
T Consensus 416 ~------sl~~L~~~~~~~~~~~~~~~~~ 438 (454)
T 1jl5_A 416 E------SVEDLRMNSERVVDPYEFAHET 438 (454)
T ss_dssp -----------------------------
T ss_pred h------hHhheeCcCcccCCccccCHHH
Confidence 3 4677788999887766555433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=383.02 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=213.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|+..+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 46899999999999999999965 579999999987543 2235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999999999943 3589999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .... .......+....+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~---~~~~~~~~~~~~~--- 239 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALY---LIATNGTPELQNP--- 239 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH---HHHHHCSCCCSCG---
T ss_pred CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HHHhCCCCCCCCc---
Confidence 6555566778999999999999999999999999999999999999997533221 1111 1111111111111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
......+.+++.+||+.||++|||++|+++|+|+...
T Consensus 240 -~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 240 -EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 1122357789999999999999999999999998753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=403.65 Aligned_cols=385 Identities=21% Similarity=0.201 Sum_probs=280.8
Q ss_pred CCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCcc-ccccccccCCceeeec
Q 039595 224 LSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSI-PLSFGNLSSWTLMSLF 302 (1078)
Q Consensus 224 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~ 302 (1078)
-+.++.+++.++. +|. +. ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+++
T Consensus 12 ~~~~~c~~~~l~~-lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 12 GYNAICINRGLHQ-VPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp TTEEECCSSCCSS-CCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred ccccCcCCCCccc-CCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 3467888888874 454 33 78899999999998877888888999999999998887555 4567888888888888
Q ss_pred ccCCCCCCCccccCCCccCeeeccccccCccCCC--CCCCCCcCcEEEccCccCCCCCCcc-ccccCCCCeEEcccccCc
Q 039595 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPP--SIGNLSSLRNLSLFNNGLYGSIPEE-IGYLKSLSELKLCKNNLS 379 (1078)
Q Consensus 303 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~ 379 (1078)
+|.+++..|..|+++++|++|+|++|++++..|. .|..+++|++|++++|.+.+..|.. +..+++|++|++++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 8888777777788888888888888887764433 3777778888888888877766665 677777888888888777
Q ss_pred cccCCCCccC--CCCceeecccCcCCCCCCcccc--------ccCCCCeEEccCccccccchhhccCC---CCCcEecCC
Q 039595 380 GVIPHSVGNL--TGLVLLNMCENHLFGPIPKSLK--------SLTSLKRVRFNQNNLVGKVYEAFGDH---PNLTFLDLS 446 (1078)
Q Consensus 380 ~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~l~--------~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls 446 (1078)
+..|..+.++ .+|+.|++++|.+.+..+..+. .+++|++|++++|.+.+..+..+... .+|+.|+++
T Consensus 168 ~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~ 247 (455)
T 3v47_A 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247 (455)
T ss_dssp CCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECT
T ss_pred ccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeec
Confidence 7777777665 5677777777777665443322 33455555555555554444333222 444555555
Q ss_pred CCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCccccccc--CccCcEEeccCCccCC
Q 039595 447 QNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEK--LFSLNKLILSLNQLSG 524 (1078)
Q Consensus 447 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~--l~~L~~L~Ls~N~l~~ 524 (1078)
+|.+.+.. +..+.+.+..+..+.. .++|+.|++++|++++
T Consensus 248 ~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 289 (455)
T 3v47_A 248 NSYNMGSS--------------------------------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA 289 (455)
T ss_dssp TCTTTSCC--------------------------------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCE
T ss_pred cccccccc--------------------------------------cchhhhccCcccccccccccCceEEEecCccccc
Confidence 44432210 1111222222222332 2577788888888877
Q ss_pred CcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCccc
Q 039595 525 SVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCN 604 (1078)
Q Consensus 525 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 604 (1078)
..|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..
T Consensus 290 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 369 (455)
T 3v47_A 290 LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLG 369 (455)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred cchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccc
Confidence 77778888888888888888888777888888888888888888888777888888999999999999998877888888
Q ss_pred ccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCCCCc
Q 039595 605 MESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNST 650 (1078)
Q Consensus 605 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~~~ 650 (1078)
+++|++|+|++|++++..+..|..+++|+.|++++|++++.+|...
T Consensus 370 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 370 LPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred cccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 9999999999999998877788899999999999999999888644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=385.20 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=212.2
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 346899999999999999999976 5899999999976532 3445677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.+++.. .+.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 99999999999999843 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCceeeccccccccccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRAT-EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
... ......+||+.|+|||++.+..+. .++||||+||++|||++|+.||+.... ......+. ......+.
T Consensus 165 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~------~~~~~~p~ 235 (328)
T 3fe3_A 165 TVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--KELRERVL------RGKYRIPF 235 (328)
T ss_dssp SSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH------HCCCCCCT
T ss_pred CCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHH------hCCCCCCC
Confidence 543 234556899999999999888765 799999999999999999999753321 11111111 11111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ..++.+++.+||..||.+|||++|+++|+|+..
T Consensus 236 -~~---s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 236 -YM---STDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp -TS---CHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred -CC---CHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 11 125778999999999999999999999999764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=379.74 Aligned_cols=267 Identities=26% Similarity=0.375 Sum_probs=218.6
Q ss_pred CCccHHHHHHhhcC----------CCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhc
Q 039595 739 GKIMHEEIIKATDD----------FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE 807 (1078)
Q Consensus 739 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~ 807 (1078)
+.++++++..+++. |+..+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|+.++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRD 98 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHh
Confidence 34667777777653 677789999999999999765 79999999986542 2346678899999999
Q ss_pred CCCCceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 039595 808 IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 887 (1078)
Q Consensus 808 l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 887 (1078)
++||||+++++++..++..++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N 171 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS 171 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence 9999999999999999999999999999999999843 3589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccch
Q 039595 888 VLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 967 (1078)
Q Consensus 888 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~ 967 (1078)
|+++.++.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~-- 247 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--V-- 247 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--H--
T ss_pred EEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H--
Confidence 999999999999999998776544445667899999999999999999999999999999999999999753321 1
Q ss_pred hhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 968 SNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 968 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...........+.... .......+.+++.+||+.||++|||++|+++|+|+..
T Consensus 248 -~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 248 -QAMKRLRDSPPPKLKN----SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp -HHHHHHHHSSCCCCTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred -HHHHHHhcCCCCCcCc----cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 1111111222222211 1111235778899999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=383.71 Aligned_cols=259 Identities=21% Similarity=0.274 Sum_probs=213.6
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 368999999999999999999665 7999999999764321 12345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.+ .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||+++...
T Consensus 83 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999999999843 35689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.. -...++. .
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~----~~~~~p~---~ 227 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILM----EEIRFPR---T 227 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH----CCCCCCT---T
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--HHHHHHHHHc----CCCCCCC---C
Confidence 44445566789999999999999999999999999999999999999975322 1111111111 1111111 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhhH
Q 039595 989 VMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~~ 1027 (1078)
. ..++.+++.+||+.||++|| +++|+++|+|+..-+
T Consensus 228 ~---s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 228 L---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp S---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred C---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 1 12577899999999999999 999999999987543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=384.75 Aligned_cols=262 Identities=21% Similarity=0.222 Sum_probs=212.8
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN--MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
..++|++.+.||+|+||+||+|..+ +|+.||+|++........ ....+.+.+|+.++++++||||+++++++.++..
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999665 799999999976543221 2245778999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEecc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF----EAHVSDF 901 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Df 901 (1078)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999943 45689999999999999999999999 999999999999998877 7999999
Q ss_pred cccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 902 GIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 902 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
|++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ......+ ....
T Consensus 164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~~~~~i------~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANI------TAVS 234 (361)
T ss_dssp SSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHH------HTTC
T ss_pred CCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH------HhcC
Confidence 999876543 233456799999999999999999999999999999999999999753221 1111111 1111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...+..........+.+++.+||..||++|||++|+++|||+..
T Consensus 235 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 11110000111235788999999999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=394.93 Aligned_cols=262 Identities=21% Similarity=0.256 Sum_probs=212.6
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||+||+|.. .+|+.||+|++..... ...+.+.+.+|+.++++++||||+++++++.+++..|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 457899999999999999999965 5789999999976532 2334567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEeccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD---LEFEAHVSDFGIA 904 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfG~a 904 (1078)
+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++ .++.+||+|||++
T Consensus 87 lv~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999999998843 35689999999999999999999999 999999999999998 4688999999999
Q ss_pred ccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
+.............||+.|+|||++.+..++.++||||+||++|+|++|+.||.... .......+.. .....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~------~~~~~ 232 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKA------GAYDF 232 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHH------TCCCC
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHh------CCCCC
Confidence 877655544556789999999999999999999999999999999999999975322 1112221111 11111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
+.+.......++.+++.+||+.||++|||++|+++|||....
T Consensus 233 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 111111122357789999999999999999999999998643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=387.13 Aligned_cols=259 Identities=24% Similarity=0.309 Sum_probs=207.0
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
..++|++.+.||+|+||+||+|+.+ +|+.||||++.+.... .....+.+.+|..+++.+ +||||+++++++.+.+..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4578999999999999999999764 6899999999764321 223456678899999988 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+||||+++|+|.+++.+ ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999943 35689999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
...........+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. .....+
T Consensus 174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~------~~~~~p- 244 (353)
T 3txo_A 174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--DDLFEAILN------DEVVYP- 244 (353)
T ss_dssp SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH------CCCCCC-
T ss_pred cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--HHHHHHHHc------CCCCCC-
Confidence 54444455667899999999999999999999999999999999999999753322 112221111 111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCCh------hHHHHHhhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTM------EKGFGHHIGYCD 1026 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~------~ell~h~~~~~~ 1026 (1078)
... ...+.+++.+||+.||++||++ +|+++|+|+..-
T Consensus 245 ~~~---~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 245 TWL---HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred CCC---CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 111 1257789999999999999998 899999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=388.58 Aligned_cols=265 Identities=25% Similarity=0.328 Sum_probs=210.6
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||+||+|+.+ +++.||+|++++.... .....+.+..|..++.++ +||||+++++++.+.+..|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 468999999999999999999765 6889999999875432 223344577888888876 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.+++.+ ...+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999943 35699999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchh-hhhhhhhhhcCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS-NMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 986 (1078)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||+.......... ........+.......+
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p- 282 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP- 282 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC-
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC-
Confidence 4444556677899999999999999999999999999999999999999864322110000 00001111111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCCh------hHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTM------EKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~------~ell~h~~~~~ 1025 (1078)
... ..++.+++.+||+.||++||++ +|+++|+|+..
T Consensus 283 ~~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 283 RSL---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp TTS---CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CcC---CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 111 1257789999999999999995 79999999865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=374.38 Aligned_cols=268 Identities=19% Similarity=0.249 Sum_probs=208.0
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.+.||+|+||+||+|...+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.++...++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 3578999999999999999999888899999999975432 22335678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++ +|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 97 v~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999986 888887543 34589999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh------------
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN------------ 975 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~------------ 975 (1078)
..........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ..........
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhc
Confidence 55555566788999999999876 568999999999999999999999976433221 1111100000
Q ss_pred --hhcCCCCCCCCCccH-----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 976 --QILDPRLSTPSPGVM-----DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 976 --~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
............... ....++.+++.+||+.||++|||++|+++|||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 000000000000000 01136789999999999999999999999999763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=379.17 Aligned_cols=257 Identities=21% Similarity=0.248 Sum_probs=210.8
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|..+ +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 468999999999999999999664 6889999998643 2345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC--CCcEEEeccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL--EFEAHVSDFGIAKF 906 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfG~a~~ 906 (1078)
||||+++|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||+++.
T Consensus 79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 79 IFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999999999999432 34689999999999999999999999 9999999999999987 78999999999987
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... +.......+.
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~------i~~~~~~~~~ 224 (321)
T 1tki_A 154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIEN------IMNAEYTFDE 224 (321)
T ss_dssp CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHH------HHHTCCCCCH
T ss_pred CCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HHHHHH------HHcCCCCCCh
Confidence 7542 334567899999999999998899999999999999999999999753322 111111 1111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
........++.+++.+||..||++|||++|+++|||+..
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 001111236789999999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=377.15 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=212.8
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG--NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
.++|++.+.||+|+||.||+|..+ +|+.||+|++....... .....+.+.+|+.++++++||||+++++++.++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999664 68999999997654321 122467899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF----EAHVSDFG 902 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG 902 (1078)
++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999943 45689999999999999999999999 999999999999999887 89999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. .....
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~----~~~~~ 236 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSA----VNYEF 236 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHH----TCCCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHHHh----cCCCc
Confidence 998765422 23456799999999999999999999999999999999999999753221 111111111 11111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
.. .........+.+++.+||+.||++|||++|+++|+|+.....
T Consensus 237 ~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 237 ED--EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp CH--HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred Cc--cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 10 000011235778999999999999999999999999876544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=382.27 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=212.2
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|..+ +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3568999999999999999999664 689999999976532 2345677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEeccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE---FEAHVSDFGIA 904 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~a 904 (1078)
+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.+ +.+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999999843 35689999999999999999999999 99999999999999865 45999999999
Q ss_pred ccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. .....
T Consensus 179 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~------~~~~~ 249 (362)
T 2bdw_A 179 IEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKA------GAYDY 249 (362)
T ss_dssp BCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH------TCCCC
T ss_pred eEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh------CCCCC
Confidence 876542 233456899999999999999999999999999999999999999653221 111111111 11111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
+.+.......++.+++.+||+.||++|||++|+++|+|+..
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 11111222346788999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=379.05 Aligned_cols=265 Identities=26% Similarity=0.330 Sum_probs=212.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+.... .....+.+.+|..+++++ +||||+++++++.+....|
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC-SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc-chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 367999999999999999999765 6889999999865432 344556788999999887 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.+++.+ ...+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||+++..
T Consensus 87 lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999999943 34689999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccch-hhhhhhhhhhcCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF-SNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 986 (1078)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||.......... .........+.......+
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p- 239 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP- 239 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC-
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC-
Confidence 444444566789999999999999999999999999999999999999986432111000 000000111111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCCh------hHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTM------EKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~------~ell~h~~~~~ 1025 (1078)
... ...+.+++.+||+.||++||++ +|+++|+|+..
T Consensus 240 ~~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 240 RSL---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp TTS---CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCC---CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 111 2257789999999999999995 89999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=384.93 Aligned_cols=265 Identities=20% Similarity=0.213 Sum_probs=212.2
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEecccccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLS-GNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ......+.+.+|+.+++.++||||+++++++.+++..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999965 47999999998653321 12224677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc---EEEecccc
Q 039595 828 LVCEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE---AHVSDFGI 903 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfG~ 903 (1078)
+||||+++|+|.+++.... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988874322 234589999999999999999999999 9999999999999987654 99999999
Q ss_pred cccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
++............+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..... +......
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~------i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLFEG------IIKGKYK 250 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHHHH------HHHTCCC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHHHH------HHcCCCC
Confidence 98876544445567899999999999999999999999999999999999999753221 11111 1111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
............+.+++.+||+.||++|||++|+++|+|+...
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 1100001112367889999999999999999999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=378.94 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=200.6
Q ss_pred hcCCCccceeccCCceeEEEEEe----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.++|++.+.||+|+||.||+|+. .+|+.||+|++++............+.+|+.++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999976 47899999999876443334455678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999943 34688999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ...++.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~----~~~~p~- 242 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KKTIDKILKC----KLNLPP- 242 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHT----CCCCCT-
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhC----CCCCCC-
Confidence 654433344556799999999999999999999999999999999999999753322 1111111111 111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~ 1026 (1078)
.. ...+.+++.+||+.||++|| +++|+++|+|+..-
T Consensus 243 --~~---~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 243 --YL---TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp --TS---CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred --CC---CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 11 12577899999999999999 88999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=377.26 Aligned_cols=279 Identities=33% Similarity=0.592 Sum_probs=224.4
Q ss_pred CccHHHHHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEee
Q 039595 740 KIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGF 819 (1078)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 819 (1078)
.++.+++....++|+..+.||+|+||.||+|..++|+.||||++...... .....+.+|+.++++++||||++++++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEE
Confidence 46678899999999999999999999999998888999999999765322 122358899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 820 CSNARHSFLVCEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 820 ~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
+..+...++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+++.++|+||||||+||+++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999996543 3345999999999999999999999986678999999999999999999999
Q ss_pred ecccccccccCCCCC-ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc---cchhhhhh--
Q 039595 899 SDFGIAKFVEPYSSN-RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF---SSFSNMII-- 972 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~---~~~~~~~~-- 972 (1078)
+|||+++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||+...... ........
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999999876543322 344569999999999998899999999999999999999999986322111 00101000
Q ss_pred ----hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 973 ----EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 973 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
......+..... .........+.+++.+||+.||++|||++|+++|+..
T Consensus 256 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 011112222221 2234556789999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=369.54 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=204.6
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
++|++.+.||+|+||+||+|...+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 57999999999999999999888899999999975432 2223466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++ +|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.++.....
T Consensus 80 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp ECCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 99986 999988543 35689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh-------------h
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN-------------Q 976 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-------------~ 976 (1078)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ........... .
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHCCCChhhchhhhccc
Confidence 4444556789999999998764 5899999999999999999999997643221 00111000000 0
Q ss_pred hcCCCCCCCCCc-----cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 977 ILDPRLSTPSPG-----VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 977 ~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..++......+. ......++.+++.+||+.||++|||++|+++|+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 011111100000 0011235778999999999999999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=369.65 Aligned_cols=267 Identities=19% Similarity=0.252 Sum_probs=207.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|... +++.||||++..... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 57999999999999999999664 689999999976542 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++ ++.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++....
T Consensus 80 ~e~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred EecCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 999987 55555532 235689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCceeeccccccccccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCC--------
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDP-------- 980 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 980 (1078)
.........||+.|+|||++.+.. ++.++||||+||++|||++|+.||.......................
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 555556678999999999998765 89999999999999999998888532211111111110000000000
Q ss_pred -CC---------CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 981 -RL---------STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 981 -~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. .............+.+++.+||+.||++|||++|+++|||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 00 0000000112236778999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=375.76 Aligned_cols=263 Identities=30% Similarity=0.442 Sum_probs=202.2
Q ss_pred HHHHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 744 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
+++....++|++.+.||+|+||+||+|+. +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34444567899999999999999999977 588999999876532 344466789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeeCCCCcEEEecc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAHVSDF 901 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~Df 901 (1078)
+..++||||+++|+|.+++........+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999996654445699999999999999999999999 8 999999999999999999999999
Q ss_pred cccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 902 GIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 902 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
|+++.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .. ......
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~---~~-~~~~~~ 257 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVA---AV-GFKCKR 257 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHH---HH-HHSCCC
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HH-HhcCCC
Confidence 99986654444445678999999999999999999999999999999999999997643321 1111 11 011111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
... ..... ..+.+++.+||+.||++|||++|+++..-
T Consensus 258 ~~~-~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~~L~ 294 (309)
T 3p86_A 258 LEI-PRNLN---PQVAAIIEGCWTNEPWKRPSFATIMDLLR 294 (309)
T ss_dssp CCC-CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC-CccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111 11112 25778999999999999999999997643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=381.36 Aligned_cols=261 Identities=23% Similarity=0.290 Sum_probs=211.9
Q ss_pred HHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCC
Q 039595 747 IKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 747 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 824 (1078)
....++|++.+.||+|+||+||+|+.+ +|+.||||++++.... .....+.+..|..+++.+ +||||+++++++.+..
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345678999999999999999999765 6899999999764321 122355677888888876 9999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..|+||||+++|+|.+++.. .+.+++.++..++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||++
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 99999999999999999943 35689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
+............+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. ..+.++.
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~----~~~~~p~ 239 (345)
T 1xjd_A 166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRM----DNPFYPR 239 (345)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH----CCCCCCT
T ss_pred hhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHh----CCCCCCc
Confidence 8654444445667899999999999999999999999999999999999999753321 112111111 1112211
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChh-HHHHHhhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTME-KGFGHHIGYCD 1026 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ell~h~~~~~~ 1026 (1078)
. . ..++.+++.+||..||++||++. |+++|+|+..-
T Consensus 240 ~---~---s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 240 W---L---EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp T---S---CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred c---c---CHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 1 1 12577899999999999999998 99999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=379.84 Aligned_cols=255 Identities=21% Similarity=0.259 Sum_probs=207.0
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|.. .+++.||||++...... .....+.+.+|+.+++.++||||+++++++..+...++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 36899999999999999999975 57999999998754321 11224568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+ +|+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 6799998843 35689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+.... ......+ ...... .+.
T Consensus 160 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i------~~~~~~-~p~ 229 (336)
T 3h4j_B 160 DG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI--PNLFKKV------NSCVYV-MPD 229 (336)
T ss_dssp TS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS--TTCBCCC------CSSCCC-CCT
T ss_pred CC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH--HHHHHHH------HcCCCC-Ccc
Confidence 42 23345689999999999988776 7899999999999999999999753221 1111111 011111 111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ...+.+++.+||+.||.+|||++|+++|||+..
T Consensus 230 ~~---s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 230 FL---SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp TS---CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred cC---CHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 11 125778999999999999999999999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=372.84 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=210.6
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 367999999999999999999664 7999999999764321 12345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||+++...
T Consensus 84 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 9999999999999953 34689999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... +.......+ ..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~------i~~~~~~~p-~~ 225 (318)
T 1fot_A 158 D---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEK------ILNAELRFP-PF 225 (318)
T ss_dssp S---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHH------HHHCCCCCC-TT
T ss_pred C---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHH------HHhCCCCCC-CC
Confidence 3 23456899999999999999999999999999999999999999753221 111111 111111111 11
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~ 1026 (1078)
.. .++.+++.+||..||++|| +++|+++|+|+..-
T Consensus 226 ~~---~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 226 FN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp SC---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CC---HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 11 2577899999999999999 99999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=370.80 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=202.1
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCC----------------------hhhHHHHHHHHHHHh
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN----------------------MADQDEFLNVVLALN 806 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~e~~~l~ 806 (1078)
.++|++.+.||+|+||.||+|.. .+++.||||++........ ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999965 4688999999976432111 112356889999999
Q ss_pred cCCCCceeeEEeeeec--CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 039595 807 EIRHRNIVKFHGFCSN--ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 884 (1078)
Q Consensus 807 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 884 (1078)
+++||||+++++++.+ ....++||||+++|+|.+++ ....+++.+++.++.||+.||+|||++ +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999976 67899999999999998765 235699999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCCCceeeccccccccccccccCC---CCccchhHHHHHHHHHHHhCCCCCCccc
Q 039595 885 SKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMR---ATEKYDVYSFGVLVFEVIKGNHPRDFFS 961 (1078)
Q Consensus 885 ~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~p~~~~~ 961 (1078)
|+||+++.++.+||+|||+++.............||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999987765444445668999999999998765 3788999999999999999999975322
Q ss_pred ccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 962 INFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. ......+.. . ...... .+... ..+.+++.+||+.||++|||++|+++|||+.
T Consensus 245 ~--~~~~~~~~~--~--~~~~~~-~~~~~---~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 245 I--MCLHSKIKS--Q--ALEFPD-QPDIA---EDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp H--HHHHHHHHH--C--CCCCCS-SSCCC---HHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred H--HHHHHHHhc--c--cCCCCC-ccccC---HHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 1 111111111 0 011111 11112 2577899999999999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=375.83 Aligned_cols=256 Identities=20% Similarity=0.337 Sum_probs=206.9
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR---- 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 824 (1078)
.++|++.+.||+|+||.||+|..+ +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 467999999999999999999765 79999999997543 3345678999999999999999999999985433
Q ss_pred -----------------------------------------------------eeEEEEeecCCCCHHHHhcCCCCCCcC
Q 039595 825 -----------------------------------------------------HSFLVCEYLHRGSLARILGNDATAKEL 851 (1078)
Q Consensus 825 -----------------------------------------------------~~~lv~E~~~~g~L~~~l~~~~~~~~l 851 (1078)
..++||||+++|+|.+++.+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 379999999999999999877666677
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC------------CCceeecc
Q 039595 852 SWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS------------SNRTEFVG 919 (1078)
Q Consensus 852 ~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~------------~~~~~~~g 919 (1078)
++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...... .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 8888999999999999999999 99999999999999999999999999998775432 12234579
Q ss_pred ccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 039595 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEV 999 (1078)
Q Consensus 920 t~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 999 (1078)
|+.|+|||++.+..++.++||||+||++|||++|..|+. . ..... ......... .........+.++
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--~-----~~~~~---~~~~~~~~~---~~~~~~~~~~~~l 305 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--E-----RVRII---TDVRNLKFP---LLFTQKYPQEHMM 305 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--H-----HHHHH---HHHHTTCCC---HHHHHHCHHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--H-----HHHHH---HHhhccCCC---cccccCChhHHHH
Confidence 999999999999999999999999999999999987721 1 01111 111111111 1112233466889
Q ss_pred HHhcccCCCCCCCChhHHHHHhhhh
Q 039595 1000 AILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 1000 i~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
+.+||+.||++|||++|+++|+|+.
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHSTTCC
T ss_pred HHHHccCCCCcCCCHHHHhhchhhh
Confidence 9999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=377.07 Aligned_cols=258 Identities=24% Similarity=0.291 Sum_probs=207.0
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 468999999999999999999665 799999999865432 2224568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 83 FLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 9999999999999943 34689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCC--CCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 909 PYS--SNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 909 ~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.............. .......
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------~~~~~~~ 230 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------KKTYLNP 230 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT------TCTTSTT
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc------ccccCCc
Confidence 322 22345679999999999987765 78999999999999999999998644332111111100 0111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.......+.+++.+||+.||++|||++|+++|+|+..
T Consensus 231 ---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 231 ---WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 1112235678999999999999999999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=391.65 Aligned_cols=269 Identities=21% Similarity=0.232 Sum_probs=212.7
Q ss_pred HHHHHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec
Q 039595 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN 822 (1078)
Q Consensus 744 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 822 (1078)
.++....++|++.++||+|+||+||+|+.+ +++.||+|++.+..... ....+.+.+|+.++..++||||++++++|.+
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 344455789999999999999999999765 57899999997532211 1123347889999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
++..|+||||+++|+|.+++.+. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999542 35689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC-ceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhh
Q 039595 903 IAKFVEPYSSN-RTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQ 976 (1078)
Q Consensus 903 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 976 (1078)
+|+........ ....+||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+.....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKE 298 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--hhHHHHhhhhccc
Confidence 99876543322 23468999999999987 4578999999999999999999999975332 1222222211111
Q ss_pred hcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCC--CCChhHHHHHhhhhh
Q 039595 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEA--RPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~h~~~~~ 1025 (1078)
. ..++....... .++.+++.+||..+|++ ||+++|+++|||+..
T Consensus 299 ~--~~~p~~~~~~s---~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 299 R--FQFPTQVTDVS---ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp H--CCCCSSCCCSC---HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred c--ccCCcccccCC---HHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 1 11111111112 25778899999888888 999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=376.20 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=186.5
Q ss_pred cceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCeeEEEEeec
Q 039595 756 KFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 833 (1078)
.+.||+|+||+||+|..+ +++.||||++... ....+.+|+.+++.+. ||||+++++++.++...|+||||+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 478999999999999664 7899999998643 2456788999999997 999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEEEecccccccccCC
Q 039595 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF---EAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 834 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~a~~~~~~ 910 (1078)
++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 89 NGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999999954 35689999999999999999999999 999999999999998766 8999999999876654
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
........||+.|+|||++.+..++.++||||+||++|||++|+.||......... .........+.............
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~ 241 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIKKGDFSFEGEAWK 241 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHTTTCCCCCSHHHH
T ss_pred CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHHcCCCCCCccccc
Confidence 44456678899999999999999999999999999999999999998644322110 00111112222222222211111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....++.+++.+||+.||++|||++|+++|+|+..
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 22346789999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=378.76 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=211.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|..+ +++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 468999999999999999999654 6899999999754322 22345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+||+++.+|.+||+|||+++...
T Consensus 93 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999999954 35689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeecccccccccccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
. .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .......... ....++.
T Consensus 167 ~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~-~~~~~p~- 241 (384)
T 4fr4_A 167 R-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFET-TVVTYPS- 241 (384)
T ss_dssp T-TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHH-CCCCCCT-
T ss_pred C-CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhh-cccCCCC-
Confidence 3 233456789999999999874 458999999999999999999999976433221 1111111111 1111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCC-hhHHHHHhhhhhhH
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPT-MEKGFGHHIGYCDE 1027 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ell~h~~~~~~~ 1027 (1078)
.. ...+.+++.+||+.||++||+ ++++.+|+|+..-.
T Consensus 242 --~~---s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 242 --AW---SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp --TS---CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred --cC---CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 11 135788999999999999998 99999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=377.95 Aligned_cols=258 Identities=22% Similarity=0.273 Sum_probs=211.4
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
..++|++.+.||+|+||+||+|+.+ +|+.||||++.+.... .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4578999999999999999999765 5889999999765322 123456678899999888 899999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+||||++||+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999999999999943 34689999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ...++.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~----~~~~p~-- 242 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEH----NVAYPK-- 242 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC----CCCCCT--
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHHHhC----CCCCCC--
Confidence 54444445667899999999999999999999999999999999999999753321 1222211111 111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~ 1025 (1078)
.. ..++.+++.+||..||++||+ ++|+++|+|+..
T Consensus 243 -~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 243 -SM---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp -TS---CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred -CC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 11 135778999999999999995 699999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=378.16 Aligned_cols=258 Identities=21% Similarity=0.260 Sum_probs=210.3
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|..+ +|+.||+|++.... ..+...+.+|+.++++++||||+++++++.++...++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 468999999999999999999664 78999999986542 3345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC--CCcEEEeccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL--EFEAHVSDFGIAKF 906 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfG~a~~ 906 (1078)
||||+++|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||+++.
T Consensus 126 v~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999999999432 34689999999999999999999999 9999999999999974 47899999999987
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......++..
T Consensus 201 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~---- 273 (387)
T 1kob_A 201 LNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWEFDEDA---- 273 (387)
T ss_dssp CCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCCCCCSST----
T ss_pred cCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCCccc----
Confidence 6543 234456899999999999999999999999999999999999999753321 111111111111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
......++.+++.+||+.||++|||++|+++|+|+..
T Consensus 274 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 274 --FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp --TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 1111236788999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=367.35 Aligned_cols=269 Identities=21% Similarity=0.283 Sum_probs=212.0
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC--ee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR--HS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~ 826 (1078)
.++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 367999999999999999999765 589999999975432 233567889999999999999999999987654 78
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----CCCCcEEEeccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----DLEFEAHVSDFG 902 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfG 902 (1078)
++||||+++|+|.+++........+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 99999999999999997655555599999999999999999999999 99999999999999 788889999999
Q ss_pred ccccccCCCCCceeeccccccccccccc--------cCCCCccchhHHHHHHHHHHHhCCCCCCcccccc--cchhhhhh
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAY--------TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SSFSNMII 972 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~~~~ 972 (1078)
+++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||....... ......+.
T Consensus 162 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 162 AARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred CceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 998765432 334567999999999986 5678999999999999999999999975332211 11111111
Q ss_pred hhh---------------hhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 973 EVN---------------QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 973 ~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
... ..+.+...............+.+++.+||+.||++|||++|+++|+-...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 000 00011222222223444557889999999999999999999999986443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.04 Aligned_cols=270 Identities=34% Similarity=0.527 Sum_probs=218.4
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
++..+.++|+..+.||+|+||.||+|..++++.||||++... .....+.+.+|+.++++++||||+++++++.+++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 344567899999999999999999999888999999998654 2334677899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999995433 234689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-cchhhhh------hhh
Q 039595 904 AKFVEPYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF-SSFSNMI------IEV 974 (1078)
Q Consensus 904 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~~~~~~~------~~~ 974 (1078)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ...
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98654322 22344568999999999999999999999999999999999999975432211 1111100 011
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
....++..... ........+.+++.+||+.||++|||++|+++++..
T Consensus 266 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 266 EQIVDPNLADK--IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp CSSSSSSCTTC--SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcChhhccc--cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 12222322222 234556688999999999999999999999988763
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=375.62 Aligned_cols=257 Identities=22% Similarity=0.253 Sum_probs=212.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|+.+ +|+.||||++.+.... .....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 468999999999999999999765 7999999999764322 12345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.+ .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||+++...
T Consensus 119 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999999999953 34689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ...++. .
T Consensus 193 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~----~~~~p~---~ 260 (350)
T 1rdq_E 193 G---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSG----KVRFPS---H 260 (350)
T ss_dssp S---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC----CCCCCT---T
T ss_pred C---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHHHHHcC----CCCCCC---C
Confidence 3 23456899999999999999999999999999999999999999753221 1111111111 111111 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhhHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~~~ 1028 (1078)
. ...+.+++.+||+.||++||+ ++|+++|+|+..-+-
T Consensus 261 ~---~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 261 F---SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp C---CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred C---CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 1 235778999999999999998 999999999875443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=364.22 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=206.4
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|+..+.||+|+||+||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 367899999999999999999764 6899999998543 35567789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.++++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++...
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 99999999999999542 35689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCc--------------eeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh-h
Q 039595 909 PYSSNR--------------TEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-E 973 (1078)
Q Consensus 909 ~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~-~ 973 (1078)
...... ....||+.|+|||++.+..++.++||||||+++|||++|..||............... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 322211 1457999999999999999999999999999999999999997644332211111111 1
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.....++..+ ..+.+++.+||+.||++|||++|+++..-
T Consensus 240 ~~~~~~~~~~----------~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 240 LDRYCPPNCP----------PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp HHHTCCTTCC----------TTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccCCCCCC----------HHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111122111 14678899999999999999999988544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=374.55 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=194.1
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||+||+|..+ +++.||||++.... ..+.+.+|+.++++++||||+++++++.++...+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 4567999999999999999999765 68899999987542 3456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEeccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL---EFEAHVSDFGIA 904 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfG~a 904 (1078)
+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 125 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp EEECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 99999999999999943 35689999999999999999999999 9999999999999975 889999999999
Q ss_pred ccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ..+.......
T Consensus 199 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~------~~i~~~~~~~ 270 (349)
T 2w4o_A 199 KIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MF------RRILNCEYYF 270 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HH------HHHHTTCCCC
T ss_pred cccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HH------HHHHhCCCcc
Confidence 866432 223456799999999999999999999999999999999999999753322110 11 1111111111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..+........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 11111122236788999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=368.95 Aligned_cols=267 Identities=20% Similarity=0.293 Sum_probs=196.0
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|..+ +|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS---EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS---TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc---ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 468999999999999999999664 68999999997543 22234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCC---CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 829 VCEYLHRGSLARILGND---ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
||||++ |+|.+++... .....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.++
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999998 5999988432 1224589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh---------
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN--------- 975 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~--------- 975 (1078)
.............||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+....
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCTTTCG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhHhh
Confidence 77554444456689999999999876 46899999999999999999999997643321 1111110000
Q ss_pred -----hhcCCCCCCCCC-ccH---------HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 976 -----QILDPRLSTPSP-GVM---------DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 976 -----~~~~~~~~~~~~-~~~---------~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....+......+ ... ....++.+++.+||+.||++|||++|+++|||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 000011110000 000 11236789999999999999999999999999765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=376.20 Aligned_cols=268 Identities=24% Similarity=0.274 Sum_probs=209.3
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG-NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
+....++|++.+.||+|+||+||+|.. .+++.||+|++....... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 456778899999999999999999965 478899999987643221 234567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCC-------------------------------------CCCcCCHHHHHHHHHHHHHH
Q 039595 824 RHSFLVCEYLHRGSLARILGNDA-------------------------------------TAKELSWNRRINVIKGVANA 866 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~ 866 (1078)
+..++||||+++|+|.+++.... ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999984210 01234677888999999999
Q ss_pred HHHHHhcCCCCcEecCCCCCCeeeCCCC--cEEEecccccccccCCCC----Cceeecccccccccccccc--CCCCccc
Q 039595 867 LSYLHHDCLPSIIHRDISSKNVLLDLEF--EAHVSDFGIAKFVEPYSS----NRTEFVGTFGYAAPEIAYT--MRATEKY 938 (1078)
Q Consensus 867 L~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~s 938 (1078)
|+|||++ +|+||||||+||+++.++ .+||+|||+++.+..... ......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999987643222 2345679999999999875 6789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHH
Q 039595 939 DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGF 1018 (1078)
Q Consensus 939 DvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell 1018 (1078)
|||||||++|||++|+.||...... . ....+.........+........+.+++.+||+.||++|||++|++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~--~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA--D------TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH--H------HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH--H------HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 9999999999999999997533221 1 1111122222222222222234678899999999999999999999
Q ss_pred HHhhhh
Q 039595 1019 GHHIGY 1024 (1078)
Q Consensus 1019 ~h~~~~ 1024 (1078)
+|+|+.
T Consensus 330 ~hp~~~ 335 (345)
T 3hko_A 330 QHPWIS 335 (345)
T ss_dssp HSHHHH
T ss_pred cChhhc
Confidence 999965
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=384.97 Aligned_cols=265 Identities=20% Similarity=0.243 Sum_probs=211.0
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
++....++|++.+.||+|+||+||+|+.+ +++.||+|++.+..... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 44445689999999999999999999765 68999999997532211 11233578899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...|+||||++||+|.++++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999943 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC-CceeeccccccccccccccCC----CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 904 AKFVEPYSS-NRTEFVGTFGYAAPEIAYTMR----ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 904 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
|+....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+ .......+.......
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIMNHKNSL 292 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTHHHHC
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--hhhHHHHHHhccccc
Confidence 987654322 223568999999999998765 7899999999999999999999975322 222222222111111
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCC--CCChhHHHHHhhhhh
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEA--RPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~h~~~~~ 1025 (1078)
.++.. .... .++.+++.+||..+|.+ ||+++|+++|+|+..
T Consensus 293 --~~p~~-~~~s---~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 293 --TFPDD-NDIS---KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp --CCCTT-CCCC---HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred --cCCCc-cccc---HHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 11110 1111 25778899999999988 999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=378.36 Aligned_cols=258 Identities=23% Similarity=0.276 Sum_probs=203.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHH-HhcCCCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLA-LNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||+||+|+.+ +++.||||++.+..... ......+..|..+ ++.++||||+++++++.+.+..|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 468999999999999999999765 68899999997764332 2234455666665 57789999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||++||+|.+++.+ ...+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999943 34688999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+. ......+ +
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~------~~~~~~~-~ 260 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNIL------NKPLQLK-P 260 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--HHHHHHHH------HSCCCCC-S
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHH------hcccCCC-C
Confidence 4444455667899999999999999999999999999999999999999753221 11111111 1111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCh----hHHHHHhhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTM----EKGFGHHIGYCD 1026 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~----~ell~h~~~~~~ 1026 (1078)
... ..+.+++.+||+.||++||++ +|+++|+|+..-
T Consensus 261 ~~~---~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 261 NIT---NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp SSC---HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred CCC---HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 111 257789999999999999997 699999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=376.92 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=205.2
Q ss_pred CccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 754 DEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 754 ~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 3356899999999999965 479999999987642 34567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee--CCCCcEEEecccccccccCC
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL--DLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll--~~~~~~kl~DfG~a~~~~~~ 910 (1078)
+++|+|.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.....
T Consensus 168 ~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 168 VDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp CTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 9999999988432 34689999999999999999999999 99999999999999 66789999999999876543
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccH
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVM 990 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 990 (1078)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... .+.............
T Consensus 243 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~------~i~~~~~~~~~~~~~ 313 (373)
T 2x4f_A 243 E-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--AETLN------NILACRWDLEDEEFQ 313 (373)
T ss_dssp C-BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHH------HHHHTCCCSCSGGGT
T ss_pred c-ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH------HHHhccCCCChhhhc
Confidence 2 23445799999999999999999999999999999999999999753322 11111 111111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHHHHH
Q 039595 991 DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVI 1032 (1078)
Q Consensus 991 ~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~~~~ 1032 (1078)
.....+.+++.+||+.||++|||++|+++|||+...+.....
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~~~~ 355 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRL 355 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCchhhhh
Confidence 122367899999999999999999999999998876655443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=374.68 Aligned_cols=258 Identities=25% Similarity=0.290 Sum_probs=197.8
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-----AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-----TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-----cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 468999999999999999999765 79999999996542 223567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc--EEEeccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE--AHVSDFGIAKF 906 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfG~a~~ 906 (1078)
||||+++|+|.+++.. .+.+++.+++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++.
T Consensus 94 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 94 IMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999999999999843 34689999999999999999999999 9999999999999987765 99999999975
Q ss_pred ccCCCCCceeeccccccccccccccCCCCcc-chhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEK-YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
... ........||+.|+|||++.+..++.+ +||||+||++|||++|+.||....... ...... ..+.......+
T Consensus 168 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~---~~~~~~~~~~~ 242 (361)
T 3uc3_A 168 SVL-HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTI---QRILSVKYSIP 242 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHH---HHHHTTCCCCC
T ss_pred ccc-cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHH---HHHhcCCCCCC
Confidence 432 223345679999999999988887655 899999999999999999976433211 111111 11222221111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
... .....+.+++.+||..||++|||++|+++|+|+..
T Consensus 243 ~~~--~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 243 DDI--RISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp TTS--CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred CcC--CCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 110 11135778999999999999999999999999854
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=373.74 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=204.2
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC--CceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH--RNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||.||+|...+++.||||++.... ......+.+.+|+.++++++| |||+++++++.++...+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 46799999999999999999988889999999987543 234456778999999999986 99999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+|||| .+|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++ ++.+||+|||+++..
T Consensus 86 lv~e~-~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEECC-CSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEeC-CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99995 57799999954 35689999999999999999999999 999999999999996 688999999999876
Q ss_pred cCCCC--Cceeecccccccccccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh
Q 039595 908 EPYSS--NRTEFVGTFGYAAPEIAYT-----------MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 908 ~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~ 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------HHHHH
Confidence 54322 2345679999999999865 6789999999999999999999999753222 11222
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....++......+.... ..+.+++.+||+.||++|||++|+++|+|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~--~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 231 HAIIDPNHEIEFPDIPE--KDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HHHHCTTSCCCCCCCSC--HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHhcCCcccCCcccCC--HHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 23333332222222211 25778999999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=376.22 Aligned_cols=257 Identities=20% Similarity=0.218 Sum_probs=205.4
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
..++|++.+.||+|+||+||+|..+ +|+.||||++.+... ...+|++++.++ +||||+++++++.++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 4578999999999999999999665 688999999976431 134577777777 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC----CcEEEeccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE----FEAHVSDFG 902 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfG 902 (1078)
|+||||+++|+|.+++.+ .+.+++.++..++.||+.||+|||++ ||+||||||+||++..+ +.+||+|||
T Consensus 92 ~lv~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEECCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 999999999999999954 34689999999999999999999999 99999999999998543 359999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc-ccchhhhhhhhhhhcCCC
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN-FSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 981 (1078)
+++............+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......+.. ..
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~------~~ 239 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS------GK 239 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH------CC
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc------CC
Confidence 9997765544555678999999999999888999999999999999999999997643221 1111111111 11
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
+.............+.+++.+||+.||++|||++|+++|+|+..
T Consensus 240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 11111111111235778999999999999999999999999854
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=384.59 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=210.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|... +|+.||||++...... .....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 367999999999999999999765 7999999999754321 12235678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 v~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999943 45699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.... ...... +.+.....+ .
T Consensus 168 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~------i~~~~~~~p-~ 237 (476)
T 2y94_A 168 DG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTLFKK------ICDGIFYTP-Q 237 (476)
T ss_dssp TT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHHHHH------HHTTCCCCC-T
T ss_pred cc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHHHHH------HhcCCcCCC-c
Confidence 42 23445689999999999988765 7899999999999999999999763321 111111 111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
... .++.+++.+||..||++|||++|+++|+|+..
T Consensus 238 ~~s---~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 238 YLN---PSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp TCC---HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred cCC---HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 111 25778999999999999999999999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=390.29 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=202.1
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 46899999999999999999965 47899999999764322 22334567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ + +|+||||||+|||++.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999943 3568999999999999999999998 7 9999999999999999999999999999865
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.. ....++..
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~----~~~~~p~~-- 371 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM----EEIRFPRT-- 371 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH----CCCCCCTT--
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHh----CCCCCCcc--
Confidence 4444445567899999999999999999999999999999999999999753322 111111111 11111111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~ 1026 (1078)
.. ..+.+++.+||+.||++|| +++|+++|+|+..-
T Consensus 372 -~~---~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 372 -LG---PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp -SC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -CC---HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 11 2577899999999999999 99999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=361.35 Aligned_cols=256 Identities=29% Similarity=0.416 Sum_probs=205.8
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
+.++|++.+.||+|+||+||+|... +++.||+|++...... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 4578999999999999999999654 6789999998654321 1223567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999999843 34589999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. .......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||..... ......+.. .....+..
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~----~~~~~~~~-- 229 (279)
T 3fdn_A 160 PS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKRISR----VEFTFPDF-- 229 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHH----TCCCCCTT--
T ss_pred Cc--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--HHHHHHHHh----CCCCCCCc--
Confidence 32 223456789999999999999999999999999999999999999753221 111111111 11111111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. ...+.+++.+||+.||++|||++|+++|+|+..
T Consensus 230 -~---~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 230 -V---TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp -S---CHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred -C---CHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 1 125678999999999999999999999999654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.35 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=209.8
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+.+|+.++++++||||+++++++.++...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 478999999999999999999654 689999999976532 34456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc---EEEecccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE---AHVSDFGIAK 905 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfG~a~ 905 (1078)
||||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||.+.
T Consensus 83 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999988843 35689999999999999999999999 9999999999999987655 9999999998
Q ss_pred cccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
..... .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||..... ......... .....+
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~------~~~~~~ 227 (284)
T 3kk8_A 157 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKA------GAYDYP 227 (284)
T ss_dssp ECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH------TCCCCC
T ss_pred EcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--hHHHHHHHh------ccccCC
Confidence 76542 223456799999999999999999999999999999999999999753222 111111111 111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 1111111235778999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.01 Aligned_cols=262 Identities=21% Similarity=0.224 Sum_probs=211.7
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG--NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
.++|++.+.||+|+||.||+|..+ +|+.||||++....... .....+.+.+|+.++++++||||+++++++.++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999765 68999999997654322 122467899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF----EAHVSDFG 902 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG 902 (1078)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999954 34689999999999999999999999 999999999999999888 79999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... +.....
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~------i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLAN------ITSVSY 235 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHH------HHTTCC
T ss_pred cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--HHHHHH------HHhccc
Confidence 998765432 23456799999999999999999999999999999999999999753321 111111 111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
..+..........+.+++.+||+.||++|||++|+++|+|+...
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 10000000112357889999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=360.90 Aligned_cols=261 Identities=24% Similarity=0.387 Sum_probs=189.4
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|.. .+|+.||||++...... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 346799999999999999999976 57999999998654321 1223567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++++|.+++... ...+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+...
T Consensus 88 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999999999542 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
...........||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .... .........+ .
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~------~~~~~~~~~~-~ 233 (278)
T 3cok_A 163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--NTLN------KVVLADYEMP-S 233 (278)
T ss_dssp C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCCCC-T
T ss_pred cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--HHHH------HHhhcccCCc-c
Confidence 54444444567999999999999989999999999999999999999997643321 1100 1111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
.. ..++.+++.+||+.||++|||++|+++|+|+....
T Consensus 234 ~~---~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 234 FL---SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp TS---CHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred cc---CHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 11 23577899999999999999999999999986543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=372.49 Aligned_cols=256 Identities=22% Similarity=0.374 Sum_probs=206.6
Q ss_pred hcCCCccceeccCCceeEEEEEeC--------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
.++|++.+.||+|+||.||+|... ++..||||+++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 468999999999999999999652 35579999997542 344567799999999999 899999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDAT-------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 887 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 887 (1078)
.+++..|+||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence 999999999999999999999965321 24589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccc
Q 039595 888 VLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINF 964 (1078)
Q Consensus 888 Ill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~ 964 (1078)
|+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-- 311 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 311 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 9999999999999999987654322 2234467889999999999999999999999999999999 9999754322
Q ss_pred cchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 965 SSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
....... .....+... .... ..+.+++.+||+.||++|||++|++++.-
T Consensus 312 ~~~~~~~---~~~~~~~~~---~~~~---~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 312 EELFKLL---KEGHRMDKP---ANCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp GGHHHHH---HTTCCCCCC---TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHH---hcCCCCCCC---CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111 111111111 1112 25778899999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=378.46 Aligned_cols=271 Identities=19% Similarity=0.242 Sum_probs=209.5
Q ss_pred hcCCCccceeccC--CceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 750 TDDFDEKFCIGKG--GQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
.++|++.+.||+| +||+||+|..+ +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+++..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 4689999999999 99999999765 799999999976532 234567788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+||||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999999543 234589999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCC-------CCceeecccccccccccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhh
Q 039595 907 VEPYS-------SNRTEFVGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQI 977 (1078)
Q Consensus 907 ~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 977 (1078)
..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 43211 11223478999999999987 5789999999999999999999999864332211000000000000
Q ss_pred cCCCC----------------------------------CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 978 LDPRL----------------------------------STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 978 ~~~~~----------------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.+... ....+........+.+++.+||+.||++|||++|+++|+|+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 00000 00000001112358889999999999999999999999998
Q ss_pred hhh
Q 039595 1024 YCD 1026 (1078)
Q Consensus 1024 ~~~ 1026 (1078)
...
T Consensus 338 ~~~ 340 (389)
T 3gni_B 338 KQI 340 (389)
T ss_dssp GGC
T ss_pred HHH
Confidence 753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.22 Aligned_cols=275 Identities=32% Similarity=0.495 Sum_probs=222.7
Q ss_pred CccHHHHHHhhcCCCcc------ceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCce
Q 039595 740 KIMHEEIIKATDDFDEK------FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI 813 (1078)
Q Consensus 740 ~~~~~~~~~~~~~~~~~------~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 813 (1078)
.+..+++.++++.|... +.||+|+||.||+|.. +++.||||++............+.+.+|+.++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 46788999999888877 8999999999999986 5889999999765433344456789999999999999999
Q ss_pred eeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC
Q 039595 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE 893 (1078)
Q Consensus 814 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 893 (1078)
+++++++.+++..++||||+++|+|.+++........+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCC
Confidence 999999999999999999999999999996555556799999999999999999999999 99999999999999999
Q ss_pred CcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc--cchhh
Q 039595 894 FEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SSFSN 969 (1078)
Q Consensus 894 ~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~ 969 (1078)
+.+||+|||+++........ .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||+...... .....
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHH
Confidence 99999999999876543222 234578999999998875 58899999999999999999999976443221 11111
Q ss_pred hhh----hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 970 MII----EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 970 ~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
... .....+++.... ........+.+++.+||+.||.+|||+++++++.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 249 EIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp HHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred Hhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111 112233333322 22344567889999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=366.60 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=204.2
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|... +|+.||||++.... ......+.+.+|+.++++++||||+++++++.+++..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 367999999999999999999764 69999999986542 233445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 80 v~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 80 VFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 9999999999998843 34589999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh--------------
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE-------------- 973 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~-------------- 973 (1078)
..........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||....... ....+..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 154 GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHH
T ss_pred CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhcccccccccccc
Confidence 54444556789999999999876 568999999999999999999999976433211 0000000
Q ss_pred hhhhcC-CCCCCCCCc------cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 974 VNQILD-PRLSTPSPG------VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 974 ~~~~~~-~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
...... .....+... .......+.+++.+||+.||++|||++|+++|+|+..-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 000000 011110000 01112357889999999999999999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.34 Aligned_cols=257 Identities=21% Similarity=0.264 Sum_probs=208.3
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|..+ ++..||+|++..... ...+.+.+|+.++++++||||+++++++.++...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 3467999999999999999999664 578999999876532 34677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFGIA 904 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~a 904 (1078)
+||||+++++|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||.+
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 99999999999998843 34589999999999999999999999 99999999999999 78899999999999
Q ss_pred ccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
...... .......||+.|+|||.+.+. ++.++||||+|+++|||++|+.||...... ..... +.......
T Consensus 157 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~------~~~~~~~~ 226 (277)
T 3f3z_A 157 ARFKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLK------IREGTFTF 226 (277)
T ss_dssp EECCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH------HHHCCCCC
T ss_pred eeccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHH------HHhCCCCC
Confidence 876543 234456799999999998764 899999999999999999999997543221 11111 11111111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
+..........+.+++.+||+.||++|||+.|+++|+|+..
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 11100111236788999999999999999999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=359.66 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=203.7
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|.. .+++.||+|++.... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR---SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG---CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc---cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 36799999999999999999965 468999999997653 23346778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeccccc
Q 039595 829 VCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFGIA 904 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~a 904 (1078)
||||+++|+|.+++... .....+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999988432 1235689999999999999999999999 99999999999999 45688999999999
Q ss_pred ccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
...... .......||+.|+|||.+. ..++.++||||+|+++|||++|+.||...... .... ......+....
T Consensus 175 ~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~----~~~~~~~~~~~ 246 (285)
T 3is5_A 175 ELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQ----KATYKEPNYAV 246 (285)
T ss_dssp CC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHCCCCCCC
T ss_pred eecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHh----hhccCCccccc
Confidence 866442 2334567999999999876 46899999999999999999999997543221 1111 11111222221
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...... ..+.+++.+||+.||++|||++|+++|+|+..
T Consensus 247 ~~~~~~---~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 247 ECRPLT---PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --CCCC---HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccCcCC---HHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 111112 25678999999999999999999999999763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=386.32 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=214.6
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|+..+.||+|+||+||+|+.+ +|+.||+|++.+.... .....+.+.+|+.++++++||||+++++++.+....|+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 468999999999999999999765 7999999999764322 12335678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 829 VCEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
||||++||+|.+++.... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999986533 245699999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..... ..+.......+ .
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~---~~i~~~~~~~p-~ 414 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELK---QRVLEQAVTYP-D 414 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHH---HHHHHCCCCCC-T
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHH---HHHhhcccCCC-c
Confidence 6544444556899999999999999999999999999999999999999764322110 01111 11111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYCD 1026 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~~ 1026 (1078)
.. ...+.+++.+||+.||++||+ ++++++|+|+..-
T Consensus 415 ~~---s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 415 KF---SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp TS---CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred cc---CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 11 125678899999999999996 4899999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=386.22 Aligned_cols=263 Identities=22% Similarity=0.267 Sum_probs=213.6
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|..+ +|+.||||++.+.... .......+.+|+.++++++||||+++++++.+.+..|+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 467999999999999999999764 7999999999764322 12235668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||++||+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999995432 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+..........+...
T Consensus 338 ~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~i~~~~~~~p~~--- 411 (576)
T 2acx_A 338 EG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVPEEYSER--- 411 (576)
T ss_dssp TT-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHHHHHCCCCCCTT---
T ss_pred cC-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHHhhcccccCCcc---
Confidence 42 23345689999999999999899999999999999999999999976433211 1111111111112222211
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~ 1026 (1078)
. ..++.+++.+||+.||++|| +++|+++|+|+..-
T Consensus 412 ~---s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 412 F---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred C---CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 1 13678899999999999999 78999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=380.01 Aligned_cols=267 Identities=23% Similarity=0.255 Sum_probs=210.8
Q ss_pred HHHHHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec
Q 039595 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN 822 (1078)
Q Consensus 744 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 822 (1078)
++.....++|++.+.||+|+||+||+|+.+ +|+.||||++.+.... .....+.+.+|..++..++||||+++++++.+
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 344455689999999999999999999764 7999999999753211 11223457889999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
....|+||||+++|+|.+++.+. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999532 23689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC-ceeeccccccccccccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh
Q 039595 903 IAKFVEPYSSN-RTEFVGTFGYAAPEIAY-------TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 903 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
+++........ ....+||+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+...
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~ 285 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--TAETYGKIVHY 285 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--HHHHHHHHHhc
Confidence 99876543322 23468999999999987 3568999999999999999999999975332 12222222211
Q ss_pred hhhc-CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCC---CChhHHHHHhhhhh
Q 039595 975 NQIL-DPRLSTPSPGVMDKLISIMEVAILCLDESPEAR---PTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ell~h~~~~~ 1025 (1078)
.... .|... .... .++.+++.+||. +|++| |+++|+++|+|+..
T Consensus 286 ~~~~~~p~~~---~~~s---~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 286 KEHLSLPLVD---EGVP---EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp HHHCCCC-------CCC---HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred ccCcCCCccc---cCCC---HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 1111 11111 1111 257789999999 99998 69999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=362.88 Aligned_cols=271 Identities=23% Similarity=0.290 Sum_probs=201.6
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccC-ChhhHHHHHHHHHHHhcC---CCCceeeEEeeeecC
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG-NMADQDEFLNVVLALNEI---RHRNIVKFHGFCSNA 823 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~ 823 (1078)
..++|++.+.||+|+||+||+|.. .+++.||||++....... .......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999975 578999999987543211 111233456677766666 599999999999765
Q ss_pred C-----eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 824 R-----HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 824 ~-----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
. ..++||||+. |+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 4 5799999997 59999996533 34489999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
+|||.++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......
T Consensus 162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLP 238 (308)
T ss_dssp CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred eeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCC
Confidence 999999876532 2334568999999999999999999999999999999999999997543221 1111111100000
Q ss_pred -CCCCC-----------CCCCccH-----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 979 -DPRLS-----------TPSPGVM-----DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 979 -~~~~~-----------~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
...+. ...+... .....+.+++.+||+.||++|||++|+++|+|+...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 00000 0000000 1123678899999999999999999999999987644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=374.65 Aligned_cols=257 Identities=22% Similarity=0.344 Sum_probs=205.0
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC--CCceeeEEeeeecCCeeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR--HRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~l 828 (1078)
++|++.+.||+|+||+||+|...+++.||||++..... .....+.+.+|+.++++++ ||||+++++++..++..|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 56999999999999999999888899999999976432 3445678999999999996 5999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||| +.+++|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++...
T Consensus 134 v~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 5678999999543 4688999999999999999999999 999999999999995 6899999999998765
Q ss_pred CCCC--Cceeecccccccccccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh
Q 039595 909 PYSS--NRTEFVGTFGYAAPEIAYT-----------MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN 975 (1078)
Q Consensus 909 ~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 975 (1078)
.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHHH
Confidence 4322 2345679999999999865 46899999999999999999999997532211 11222
Q ss_pred hhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 976 QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 976 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.+.++......+... ...+.+++.+||+.||++|||++|+++|+|+...
T Consensus 279 ~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 279 AIIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHCTTSCCCCCCCS--CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHhCccccCCCCccc--hHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 333333222222221 1257789999999999999999999999998743
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=377.05 Aligned_cols=222 Identities=18% Similarity=0.196 Sum_probs=122.2
Q ss_pred cCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCC
Q 039595 158 DMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL 237 (1078)
Q Consensus 158 ~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 237 (1078)
......+..+..++.+++|++|++++|.+++. | .++.+++|++|+|++|++++. | ++.+++|++|+|++|++++.
T Consensus 26 ~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~ 100 (457)
T 3bz5_A 26 AAFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL 100 (457)
T ss_dssp HHTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC
T ss_pred HhcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee
Confidence 33444445555666666777777776666653 4 566666666666666666653 3 66666666666666666654
Q ss_pred CCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCC
Q 039595 238 IPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNL 317 (1078)
Q Consensus 238 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l 317 (1078)
| ++++++|++|++++|++++ +| ++++++|++|++++|++++. .++.+++|+.|++++|...+.+ .++.+
T Consensus 101 -~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l 169 (457)
T 3bz5_A 101 -D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQ 169 (457)
T ss_dssp -C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTC
T ss_pred -e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccC
Confidence 2 6666666666666666664 33 56666666666666666653 2455555555555555433333 24445
Q ss_pred CccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeec
Q 039595 318 KSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNM 397 (1078)
Q Consensus 318 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 397 (1078)
++|++|++++|++++. | ++.+++|+.|++++|++++. .++.+++|++|++++|++++ +| +..+++|+.|++
T Consensus 170 ~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l 240 (457)
T 3bz5_A 170 TQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDC 240 (457)
T ss_dssp TTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEEC
T ss_pred CcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEe
Confidence 5555555555555442 2 44444555555555555432 24444444444444444443 22 344444444444
Q ss_pred ccCcCCC
Q 039595 398 CENHLFG 404 (1078)
Q Consensus 398 ~~N~l~~ 404 (1078)
++|++++
T Consensus 241 ~~N~l~~ 247 (457)
T 3bz5_A 241 SVNPLTE 247 (457)
T ss_dssp CSSCCSC
T ss_pred eCCcCCC
Confidence 4444443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=359.44 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=212.7
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 467999999999999999999765 6889999998765322 34456778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++.. ...+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+....
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998843 34689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .... .+.......+ ..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~------~~~~~~~~~~-~~ 237 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYL------RIKKNEYSIP-KH 237 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH------HHHTTCCCCC-TT
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH------HHhhccCCCc-cc
Confidence 5444555678999999999999988999999999999999999999997643221 1111 1111111111 11
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.. ..+.+++.+||+.||++|||++|+++|+|+.
T Consensus 238 ~~---~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 238 IN---PVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp SC---HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred cC---HHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 11 2577889999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=369.51 Aligned_cols=264 Identities=19% Similarity=0.268 Sum_probs=197.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|... +++.||||++...... .....+.+|+.++++++||||+++++++.+++..++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 57999999999999999999765 7899999998654311 1112345789999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++ +|.+++... ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred eccccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 999985 899888543 34589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhh-cCCCC-----
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQI-LDPRL----- 982 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~----- 982 (1078)
.........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+...... .+..+
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHhchhhhc
Confidence 4444556688999999999876 56899999999999999999999997643221 111111110000 00000
Q ss_pred ---------CCCCCc-----cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 ---------STPSPG-----VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ---------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...... ......++.+++.+||+.||++|||++|+++|||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 000000 0011235789999999999999999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=380.23 Aligned_cols=272 Identities=22% Similarity=0.266 Sum_probs=203.3
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccC----ChhhHHHHHHHHHHHhcCCCCceeeEEeeeec
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG----NMADQDEFLNVVLALNEIRHRNIVKFHGFCSN 822 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 822 (1078)
...++|++.+.||+|+||+||+|.. .+++.||||++....... .......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3457899999999999999999965 468999999997643221 11122357899999999999999999999865
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cEEEe
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF---EAHVS 899 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~ 899 (1078)
...++||||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 457999999999999998843 45689999999999999999999999 999999999999997544 59999
Q ss_pred cccccccccCCCCCceeecccccccccccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhh
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQ 976 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 976 (1078)
|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .....+.
T Consensus 285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~---- 358 (419)
T 3i6u_A 285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQIT---- 358 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHH----
T ss_pred ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHh----
Confidence 99999876542 23345689999999999863 568889999999999999999999976432211 1111111
Q ss_pred hcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHHHHHHH
Q 039595 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVILA 1034 (1078)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~~~~~~ 1034 (1078)
.................+.+++.+||+.||++|||++|+++|+|+...+.......
T Consensus 359 --~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 414 (419)
T 3i6u_A 359 --SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414 (419)
T ss_dssp --TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHHHHH
T ss_pred --cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHHHHH
Confidence 11111110000111236789999999999999999999999999987766555443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=363.39 Aligned_cols=274 Identities=23% Similarity=0.318 Sum_probs=209.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 468999999999999999999765 68999999986542 234445668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++...
T Consensus 102 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 102 VFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 9999999999888743 34589999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh-------------h
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE-------------V 974 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~-------------~ 974 (1078)
..........||+.|+|||.+.+. .++.++||||+||++|||++|+.||....... ........ .
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHH
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhh
Confidence 544445566899999999998875 78999999999999999999999976433211 01000000 0
Q ss_pred hh----hcCCCCCCCCCc---cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHHHHH
Q 039595 975 NQ----ILDPRLSTPSPG---VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVI 1032 (1078)
Q Consensus 975 ~~----~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~~~~ 1032 (1078)
.. ...+......+. .......+.+++.+||+.||++|||++|+++|+|+.........
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 319 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERF 319 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHHH
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhhh
Confidence 00 001111110000 00112368899999999999999999999999999876555443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=369.56 Aligned_cols=246 Identities=18% Similarity=0.183 Sum_probs=208.1
Q ss_pred CcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEcc
Q 039595 127 KLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLN 206 (1078)
Q Consensus 127 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~ 206 (1078)
.++......+...+..+.+++++++|++|++++|.+++ +| .++.+++|++|++++|.+++. | ++.+++|++|+|+
T Consensus 19 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls 93 (457)
T 3bz5_A 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACD 93 (457)
T ss_dssp HHHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECC
T ss_pred HHHHHHHHhcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECc
Confidence 34444444555666677789999999999999999995 46 689999999999999999974 4 8999999999999
Q ss_pred CCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCcc
Q 039595 207 NNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSI 286 (1078)
Q Consensus 207 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 286 (1078)
+|++++. | ++++++|++|+|++|++++. | ++.+++|++|++++|++++. + ++++++|++|++++|+..+.+
T Consensus 94 ~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~ 164 (457)
T 3bz5_A 94 SNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL 164 (457)
T ss_dssp SSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC
T ss_pred CCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc
Confidence 9999875 4 88999999999999999974 4 88999999999999999974 3 888999999999999766665
Q ss_pred ccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccC
Q 039595 287 PLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLK 366 (1078)
Q Consensus 287 p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 366 (1078)
.++.+++|+.|++++|++++ +| ++.+++|+.|++++|++++. .++.+++|+.|++++|++++ +| ++.++
T Consensus 165 --~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~ 233 (457)
T 3bz5_A 165 --DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLT 233 (457)
T ss_dssp --CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCT
T ss_pred --ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccC
Confidence 58889999999999999997 44 88999999999999999975 48889999999999999997 56 88899
Q ss_pred CCCeEEcccccCccccCCCCccCCCCceeecccC
Q 039595 367 SLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCEN 400 (1078)
Q Consensus 367 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 400 (1078)
+|+.|++++|++++.. +..+++|+.|++++|
T Consensus 234 ~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n 264 (457)
T 3bz5_A 234 QLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT 264 (457)
T ss_dssp TCSEEECCSSCCSCCC---CTTCTTCCEEECTTC
T ss_pred CCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC
Confidence 9999999999999764 446677777777665
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=366.08 Aligned_cols=257 Identities=22% Similarity=0.353 Sum_probs=213.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 468999999999999999999665 6889999998765322 34556778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999999843 35689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+... ...... .
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~----~~~~~~---~ 263 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLRIKKN----EYSIPK---H 263 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT----CCCCCT---T
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHhcC----CCCCCc---c
Confidence 5444555678999999999999989999999999999999999999997533211 111111110 111111 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ..+.+++.+||+.||++|||++|+++|+|+..
T Consensus 264 ~~---~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 264 IN---PVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp SC---HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CC---HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 11 25678899999999999999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=368.89 Aligned_cols=269 Identities=18% Similarity=0.220 Sum_probs=197.8
Q ss_pred HHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 747 IKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 747 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
....++|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+.+|+.++++++||||+++++++.++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 34567899999999999999999965 4789999999975432 22334567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee-----CCCCcEEEec
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL-----DLEFEAHVSD 900 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-----~~~~~~kl~D 900 (1078)
.++||||+++ +|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 108 ~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999999985 99999943 34589999999999999999999999 99999999999999 4555699999
Q ss_pred ccccccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc-
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL- 978 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 978 (1078)
||+++.............||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..............
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDD 259 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCT
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCch
Confidence 99998776544455667889999999999874 4899999999999999999999997543221 11111110000000
Q ss_pred ------------CCCCCCCCCccHH------HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 979 ------------DPRLSTPSPGVMD------KLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 979 ------------~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
............. ...++.+++.+||+.||++|||++|+++|+|+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 0000000000111 1236789999999999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=379.54 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=200.2
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA----- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 823 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 57899999999999999999965 478999999997652 2344567788999999999999999999999654
Q ss_pred -CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 824 -RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 824 -~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
...|+||||+++ ++.+.+. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 467999999987 5766662 2388999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh----------
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII---------- 972 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~---------- 972 (1078)
+|+.... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .....+.
T Consensus 210 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~--~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 210 LARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CC------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHH
T ss_pred eeeecCC-CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHH
Confidence 9987654 22345678999999999999999999999999999999999999997543211 1000000
Q ss_pred ------hhhhhcCCC--CCC-------------CCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 973 ------EVNQILDPR--LST-------------PSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 973 ------~~~~~~~~~--~~~-------------~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
......... ... ... .......++.+++.+||..||++|||++|+++|||+..
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 000011100 000 000 00111346889999999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=363.03 Aligned_cols=251 Identities=20% Similarity=0.224 Sum_probs=195.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 828 (1078)
++|+..++||+|+||+||+|... +|+.||||++..... .......+..|+..+.++ +||||+++++++.+++..++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 57999999999999999999765 799999999865432 233344455555555444 99999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+ +|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 66999888543 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... . ..+..........
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-~----------~~~~~~~~~~~~~- 274 (311)
T 3p1a_A 209 TA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-W----------QQLRQGYLPPEFT- 274 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-H----------HHHTTTCCCHHHH-
T ss_pred cC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-H----------HHHhccCCCcccc-
Confidence 42 23345579999999998876 789999999999999999999766421111 0 0111111100000
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
......+.+++.+||+.||++|||++|+++|||+.
T Consensus 275 -~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 275 -AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309 (311)
T ss_dssp -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred -cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence 01123678899999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=354.60 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=207.1
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|++.+.||+|+||+||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.++...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-----cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 36799999999999999999988888999999997542 2356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999543 34589999999999999999999999 999999999999999999999999999986543
Q ss_pred CC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 910 YS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 910 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... ..... .......+... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~~~~~---~~~~~~~~~~~---~ 230 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVE---DISTGFRLYKP---R 230 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH---HHHTTCCCCCC---T
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--HHHHH---HHhcCccCCCC---C
Confidence 21 12233456788999999999999999999999999999999 9999754322 11111 11111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.. ...+.+++.+||+.||++|||++|+++|....
T Consensus 231 ~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 231 LA---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11 23577899999999999999999999987644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=357.15 Aligned_cols=261 Identities=23% Similarity=0.284 Sum_probs=207.4
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG--NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
.++|++.+.||+|+||.||+|... +++.||+|++....... .....+.+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999765 78999999997654322 122467899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF----EAHVSDFG 902 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG 902 (1078)
++||||+++++|.+++.. ...+++.+++.++.||+.||+|||++ +++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999943 35689999999999999999999999 999999999999998887 89999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
.+....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... +.....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~------~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTN------ISAVNY 228 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH------HHTTCC
T ss_pred cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHH------hHhccc
Confidence 998765422 234457899999999999999999999999999999999999997543221 11111 111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.............+.+++.+||+.||++|||++|+++|+|+..
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 1000000011235788999999999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=368.83 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=207.7
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCC----hhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN----MADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
..++|++.+.||+|+||+||+|.. .+++.||||++........ ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999965 5789999999976543211 11234567899999999999999999999999
Q ss_pred CeeEEEEeecCCC-CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 824 RHSFLVCEYLHRG-SLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 824 ~~~~lv~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
+..++||||+.+| +|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999954 34589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
+++..... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ....
T Consensus 176 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------~~~~ 240 (335)
T 3dls_A 176 SAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------VEAA 240 (335)
T ss_dssp TCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------TTTC
T ss_pred cceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------Hhhc
Confidence 99876543 33445689999999999988776 88999999999999999999997532111 1111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...+ ... ...+.+++.+||++||++|||++|+++|+|+..
T Consensus 241 ~~~~-~~~---~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 241 IHPP-YLV---SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp CCCS-SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred cCCC-ccc---CHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 1111 111 125788999999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=369.86 Aligned_cols=266 Identities=25% Similarity=0.364 Sum_probs=211.2
Q ss_pred HHHHHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCCh----hhHHHHHHHHHHHhcC-CCCceeeEE
Q 039595 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNM----ADQDEFLNVVLALNEI-RHRNIVKFH 817 (1078)
Q Consensus 744 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~ 817 (1078)
+......++|++.+.||+|+||.||+|..+ +|+.||||++......... ...+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344455678999999999999999999775 7999999998764322111 1245678899999999 899999999
Q ss_pred eeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEE
Q 039595 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH 897 (1078)
Q Consensus 818 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 897 (1078)
+++......++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999943 35689999999999999999999999 999999999999999999999
Q ss_pred EecccccccccCCCCCceeecccccccccccccc------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh
Q 039595 898 VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT------MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI 971 (1078)
Q Consensus 898 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~ 971 (1078)
|+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......
T Consensus 241 l~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~- 316 (365)
T 2y7j_A 241 LSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRM- 316 (365)
T ss_dssp ECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH-
T ss_pred EEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHH-
Confidence 9999999877543 23345689999999999863 3578899999999999999999999753221 111111
Q ss_pred hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 972 IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
+.........+........+.+++.+||+.||++|||++|+++|||+.
T Consensus 317 -----i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 317 -----IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp -----HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred -----HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 111111111110011123578899999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=365.50 Aligned_cols=270 Identities=20% Similarity=0.244 Sum_probs=211.5
Q ss_pred ccHHHHHHhhcCCCcc-ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEE
Q 039595 741 IMHEEIIKATDDFDEK-FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFH 817 (1078)
Q Consensus 741 ~~~~~~~~~~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 817 (1078)
..++......++|.+. +.||+|+||+||+|..+ +++.||+|++..... .......+.+|+.+++.+ .||||++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 3445555667778887 88999999999999665 699999999976542 233467788999999999 569999999
Q ss_pred eeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CC
Q 039595 818 GFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL---EF 894 (1078)
Q Consensus 818 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~ 894 (1078)
+++.+.+..++||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence 9999999999999999999999998442 345689999999999999999999999 9999999999999998 78
Q ss_pred cEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh
Q 039595 895 EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 895 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+
T Consensus 172 ~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i--- 245 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--ETYLNI--- 245 (327)
T ss_dssp CEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---
T ss_pred cEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHH---
Confidence 99999999998765422 234567999999999999999999999999999999999999997543221 111111
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
............. .....+.+++.+||+.||++|||++|+++|+|+..
T Consensus 246 ~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 246 SQVNVDYSEETFS---SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp HHTCCCCCTTTTT---TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred HhcccccCchhhc---ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 1111111111111 11235778899999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.04 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=212.1
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.+.|+..+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++.++...++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 45799999999999999999965 4789999999976532 2346778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 98 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence 9999999999999943 4689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ........+.... .
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~---~~~~~~~~~~~~~---~ 242 (303)
T 3a7i_A 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVL---FLIPKNNPPTLEG---N 242 (303)
T ss_dssp TTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH---HHHHHSCCCCCCS---S
T ss_pred ccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHH---HHhhcCCCCCCcc---c
Confidence 5444455668999999999999999999999999999999999999997533221 111 1111111122211 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ..+.+++.+||+.||++|||++|+++|+|+..
T Consensus 243 ~~---~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 243 YS---KPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp CC---HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred cC---HHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 11 25778999999999999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=372.06 Aligned_cols=256 Identities=21% Similarity=0.239 Sum_probs=194.4
Q ss_pred hcCCCcc-ceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHH-hcCCCCceeeEEeeeec----
Q 039595 750 TDDFDEK-FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLAL-NEIRHRNIVKFHGFCSN---- 822 (1078)
Q Consensus 750 ~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~---- 822 (1078)
.++|.+. +.||+|+||+||+|..+ +|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 3567776 68999999999999654 7899999998532 3456777776 45589999999999865
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEe
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL---EFEAHVS 899 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~ 899 (1078)
....|+||||+++|+|.+++... ....+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence 56789999999999999999643 234689999999999999999999999 9999999999999998 7899999
Q ss_pred cccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc--cchhhhhhhhhhh
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF--SSFSNMIIEVNQI 977 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~~~~~~~~~ 977 (1078)
|||+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+..
T Consensus 207 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---- 281 (400)
T 1nxk_A 207 DFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---- 281 (400)
T ss_dssp CCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----
T ss_pred ecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----
Confidence 99999866432 23345688999999999999999999999999999999999999975433211 111111111
Q ss_pred cCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..+..+.+.......++.+++.+||+.||++|||++|+++|+|+..
T Consensus 282 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 282 --GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp --TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred --CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 1111111111112236788999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=353.90 Aligned_cols=259 Identities=24% Similarity=0.293 Sum_probs=209.8
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG---CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc---chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 3468999999999999999999765 78999999986543 2234577899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.+++.. ...+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 99999999999999843 35689999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCC--CCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 908 EPYS--SNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 908 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
.... .......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||+............. . ......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~--~~~~~~ 229 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----E--KKTYLN 229 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH----T--TCTTST
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh----h--cccccC
Confidence 4322 22345678999999999987665 7899999999999999999999864433211111110 0 011111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ......+.+++.+||+.||++|||++|+++|+|+..
T Consensus 230 ~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 230 PW---KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp TG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ch---hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 11 112235778999999999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=363.68 Aligned_cols=266 Identities=19% Similarity=0.249 Sum_probs=200.9
Q ss_pred hcCCCcc-ceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 750 TDDFDEK-FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~-~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
.++|++. +.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+++..
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 3578874 7899999999999975 479999999997542 23466788999999885 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc---EEEecccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE---AHVSDFGI 903 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfG~ 903 (1078)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 87 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 999999999999999953 34689999999999999999999999 9999999999999998776 99999999
Q ss_pred cccccCCCC-------Cceeecccccccccccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchh---
Q 039595 904 AKFVEPYSS-------NRTEFVGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS--- 968 (1078)
Q Consensus 904 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~--- 968 (1078)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 986542211 1224569999999999875 5688999999999999999999999864332110000
Q ss_pred ---h-hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 969 ---N-MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 969 ---~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. .......+.......+..........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 0 00001111111111111000111236789999999999999999999999999764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=357.58 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=195.3
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhc--CCCCceeeEEeeeec----C
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE--IRHRNIVKFHGFCSN----A 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~ 823 (1078)
.++|++.+.||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 46899999999999999999987 5899999998543 23445556555555 799999999998643 3
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEecCCCCCCeeeCCCCc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH--------HDCLPSIIHRDISSKNVLLDLEFE 895 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~NIll~~~~~ 895 (1078)
...++||||+++|+|.++++. ..+++..++.++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred ceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 568999999999999999932 46899999999999999999999 77 9999999999999999999
Q ss_pred EEEecccccccccCCCCC----ceeeccccccccccccccC------CCCccchhHHHHHHHHHHHhC----------CC
Q 039595 896 AHVSDFGIAKFVEPYSSN----RTEFVGTFGYAAPEIAYTM------RATEKYDVYSFGVLVFEVIKG----------NH 955 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltG----------~~ 955 (1078)
+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||++| +.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 999999999876543322 2334799999999999876 455799999999999999999 77
Q ss_pred CCCcccccccchhhhhhhhhhhcCCCCCCCCC--ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 956 PRDFFSINFSSFSNMIIEVNQILDPRLSTPSP--GVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 956 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
||............. .... ........... ........+.+++.+||+.||++|||++|+++..
T Consensus 232 pf~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDM-RKVV-CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp TTTTTSCSSCCHHHH-HHHH-TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccCCCCcchhhh-hHHH-hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 754332221111111 1111 11111111111 1123455789999999999999999999998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=386.24 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=212.2
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|..+ +|+.||||++...... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 467999999999999999999765 7999999999765432 23456789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEecccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFGIAK 905 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~a~ 905 (1078)
||||+.+|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999999843 35689999999999999999999999 99999999999999 567899999999998
Q ss_pred cccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
..... .......||+.|+|||++.+ .++.++||||+||++|+|++|++||..... ...... +........
T Consensus 178 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~------i~~~~~~~~ 247 (484)
T 3nyv_A 178 HFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKK------VEKGKYTFE 247 (484)
T ss_dssp HBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH------HHHCCCCCC
T ss_pred Ecccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHH------HHcCCCCCC
Confidence 77543 23445679999999999876 699999999999999999999999754322 111111 111122212
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+........+.+++.+||+.||++|||++|+++|||+..
T Consensus 248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 2222223346789999999999999999999999999763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=352.51 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=207.5
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|++.+.||+|+||.||+|+.+++..||+|++.... ...+++.+|+.++++++||||+++++++.++...++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-----MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-----BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-----CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 46899999999999999999998888899999986542 2356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999999999542 34589999999999999999999999 999999999999999999999999999987644
Q ss_pred CCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 910 YSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 910 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
... ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||+..... .... ..........+ .
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~---~~~~~~~~~~~---~ 228 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVVL---KVSQGHRLYRP---H 228 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH---HHHTTCCCCCC---T
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--HHHH---HHHcCCCCCCC---C
Confidence 321 1223456778999999999899999999999999999999 99997643321 1111 11111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
... ..+.+++.+||+.||++|||++|++++.....
T Consensus 229 ~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 229 LAS---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TSC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred cCh---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111 25778999999999999999999999876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=368.30 Aligned_cols=262 Identities=22% Similarity=0.239 Sum_probs=206.1
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-----CCceeeEEeeee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-----HRNIVKFHGFCS 821 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~ 821 (1078)
...++|++.++||+|+||+||+|.. .+++.||||++... ......+..|+.+++.+. ||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 4467899999999999999999976 47899999998642 234556778999999886 999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---------
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL--------- 892 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------- 892 (1078)
..+..++||||+ +++|.+++.... ...+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccc
Confidence 999999999999 889999995432 34589999999999999999999999 9999999999999975
Q ss_pred ----------------CCcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 039595 893 ----------------EFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956 (1078)
Q Consensus 893 ----------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 956 (1078)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 78999999999986543 23456789999999999999999999999999999999999999
Q ss_pred CCcccccccchhhhhhhhh-----------------hhcC-C----CCCCCCCccHH--------------HHHHHHHHH
Q 039595 957 RDFFSINFSSFSNMIIEVN-----------------QILD-P----RLSTPSPGVMD--------------KLISIMEVA 1000 (1078)
Q Consensus 957 ~~~~~~~~~~~~~~~~~~~-----------------~~~~-~----~~~~~~~~~~~--------------~~~~l~~li 1000 (1078)
|...... .....+.... .... . .++........ ....+.+++
T Consensus 259 f~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 259 FRTHEHM--EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CCCSSHH--HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCcHH--HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 7643221 1111000000 0000 0 00000000000 013567999
Q ss_pred HhcccCCCCCCCChhHHHHHhhhh
Q 039595 1001 ILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 1001 ~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.+||+.||++|||++|+++|+|+.
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999973
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=355.09 Aligned_cols=257 Identities=23% Similarity=0.391 Sum_probs=206.1
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.+.||+|+||+||+|.+.++..||+|++.... ...+++.+|+.++++++||||+++++++.++...++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-----CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 356899999999999999999998888899999997542 235678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++...
T Consensus 97 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 97 ITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999542 34689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
... .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ..... ...........
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~---~~~~~~~~~~~-- 244 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEH---IAQGLRLYRPH-- 244 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHH---HHTTCCCCCCT--
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHH---HhcccCCCCCC--
Confidence 321 11223456788999999999899999999999999999998 99997643321 11111 11111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
... ..+.+++.+||+.||++|||++|+++|......
T Consensus 245 -~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 245 -LAS---EKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -TCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 111 257789999999999999999999999875443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=367.42 Aligned_cols=260 Identities=24% Similarity=0.315 Sum_probs=200.1
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe---
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH--- 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 825 (1078)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ........+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 46899999999999999999975 5789999999976532 234455678999999999999999999999865543
Q ss_pred -eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 826 -SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 826 -~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
.|+||||+++|+|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999943 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC---CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 905 KFVEPYSS---NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 905 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~------~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQ------HVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH------HHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHH------HhcCC
Confidence 87654322 223457899999999999999999999999999999999999997543221 11111 00011
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
...+.........++.+++.+||+.||++||++.+++.|+|..
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 1000000001123577899999999999999999999999854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=357.32 Aligned_cols=259 Identities=23% Similarity=0.308 Sum_probs=199.5
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ......+.+.+|+.++++++||||+++++++.+++..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 46799999999999999999965 4789999999865432 234456788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 89 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999943 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........ ..........+......+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 238 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI----AIKHIQDSVPNVTTDVRK 238 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH----HHHHHSSCCCCHHHHSCT
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHhhccCCCcchhccc
Confidence 433 223446799999999999999999999999999999999999999764332110 000000000000000011
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. ...+.+++.+||++||++||+..+.+.+.|
T Consensus 239 ~~---~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 239 DI---PQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp TS---CHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred CC---CHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 11 135778999999999999995555454444
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=379.48 Aligned_cols=267 Identities=22% Similarity=0.285 Sum_probs=190.2
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee-----cC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS-----NA 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----~~ 823 (1078)
.++|++.+.||+|+||+||+|..+ +++.||||++.... ......+.+.+|+.++++++||||+++++++. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 468999999999999999999654 78999999996542 24455678999999999999999999999983 33
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...|+||||+. |+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CCEEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence 57899999985 699999843 35699999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC---------------------------CCceeecccccccccccc-ccCCCCccchhHHHHHHHHHHHh---
Q 039595 904 AKFVEPYS---------------------------SNRTEFVGTFGYAAPEIA-YTMRATEKYDVYSFGVLVFEVIK--- 952 (1078)
Q Consensus 904 a~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~ellt--- 952 (1078)
|+...... ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 98764321 123456789999999976 46679999999999999999999
Q ss_pred --------CCCCCCccccc-----------c--c--chhhhhhhhh-----------------------hhcCCCCCCC-
Q 039595 953 --------GNHPRDFFSIN-----------F--S--SFSNMIIEVN-----------------------QILDPRLSTP- 985 (1078)
Q Consensus 953 --------G~~p~~~~~~~-----------~--~--~~~~~~~~~~-----------------------~~~~~~~~~~- 985 (1078)
|+++|...... + . .......... ..+.......
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 45554221100 0 0 0000000000 0000000000
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.........++.+++.+||..||++|||++|+++|||+..
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 0001111336789999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=353.65 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=191.8
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|+..+.||+|+||.||+|.+. ++.||||++............+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367899999999999999999875 8899999987654333344467889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC---cEecCCCCCCeeeCC--------CCcEEE
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS---IIHRDISSKNVLLDL--------EFEAHV 898 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---ivH~Dlk~~NIll~~--------~~~~kl 898 (1078)
|||+++|+|.+++. ...+++..++.++.|++.||+|||++ + |+||||||+||+++. ++.+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999999993 34689999999999999999999999 7 999999999999986 678999
Q ss_pred ecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
+|||.++...... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||....... .... ......
T Consensus 158 ~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~--~~~~~~ 231 (271)
T 3dtc_A 158 TDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--VAYG--VAMNKL 231 (271)
T ss_dssp CCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHH--HHTSCC
T ss_pred ccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHh--hhcCCC
Confidence 9999998664322 234579999999999999999999999999999999999999976433211 1010 000111
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
..... ... ...+.+++.+||+.||++|||++|++++.
T Consensus 232 ~~~~~---~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 232 ALPIP---STC---PEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp CCCCC---TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCC---ccc---CHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 11111 111 13577899999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=382.87 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=208.5
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||+||+|... +++.||||++...... ......+.+|+.++++++||||+++++++.+....|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 3467999999999999999999764 7999999999654322 234677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEeccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD---LEFEAHVSDFGIA 904 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfG~a 904 (1078)
+||||+.+|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++ .++.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999999998843 35689999999999999999999999 999999999999995 4568999999999
Q ss_pred ccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
+..... ......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+ .......
T Consensus 172 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i------~~~~~~~ 241 (486)
T 3mwu_A 172 TCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRV------ETGKYAF 241 (486)
T ss_dssp TTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH------HHTCCCS
T ss_pred eECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH------HhCCCCC
Confidence 876543 23445679999999999876 599999999999999999999999753221 1111111 1111211
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..+........+.+++.+||+.||++|||++|+++|||+..
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 22222222346789999999999999999999999999763
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=360.44 Aligned_cols=254 Identities=23% Similarity=0.394 Sum_probs=202.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.++|++.+.||+|+||+||+|... .+..||||++.... .....+.+.+|+.++++++||||+++++++.+++.
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 457889999999999999999764 34469999997542 34456789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999543 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 906 FVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 906 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .... .........
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~---~~~~~~~~~ 274 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVIS---SVEEGYRLP 274 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHH---HHHTTCCCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHH---HHHcCCCCC
Confidence 77543222 223346778999999998899999999999999999999 99997533221 1111 111111111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. ... ...+.+++.+||+.||++|||++|+++..-
T Consensus 275 ~~---~~~---~~~l~~li~~~l~~dp~~Rps~~eil~~L~ 309 (325)
T 3kul_A 275 AP---MGC---PHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309 (325)
T ss_dssp CC---TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC---CCc---CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11 111 235778899999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=361.91 Aligned_cols=264 Identities=27% Similarity=0.347 Sum_probs=203.0
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC----e
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR----H 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 825 (1078)
.++|++.+.||+|+||+||+|+.. ++.||||++... ......+..|+.++++++||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 468999999999999999999876 789999998643 223445667899999999999999999997643 4
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC-------CCCcEecCCCCCCeeeCCCCcEEE
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC-------LPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
.++||||+++|+|.++++. ..+++.+++.++.|++.||+|||+.. .++|+||||||+||+++.++.+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 6999999999999999943 34899999999999999999999751 238999999999999999999999
Q ss_pred ecccccccccCCCCC--ceeecccccccccccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-hh--
Q 039595 899 SDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS-FS-- 968 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~-~~-- 968 (1078)
+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... +.
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543322 334679999999999886 35567899999999999999999997643322110 00
Q ss_pred -----hhhhhhhhhcCCCCCCCCCc---cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 969 -----NMIIEVNQILDPRLSTPSPG---VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 969 -----~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
...............+..+. .......+.+++.+||+.||++|||++|+++....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00011111111222211111 12334568899999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=369.25 Aligned_cols=260 Identities=24% Similarity=0.334 Sum_probs=207.2
Q ss_pred hcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
.++|++.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.++
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 467999999999999999999743 46689999986432 334456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCC----CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---cE
Q 039595 824 RHSFLVCEYLHRGSLARILGNDA----TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF---EA 896 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ 896 (1078)
...++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999995432 224589999999999999999999999 999999999999999555 59
Q ss_pred EEecccccccccCC--CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhh
Q 039595 897 HVSDFGIAKFVEPY--SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIE 973 (1078)
Q Consensus 897 kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 973 (1078)
||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i-- 299 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFV-- 299 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH--
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH--
Confidence 99999999865322 222344578999999999999999999999999999999998 9999753322 1111111
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
............. ..+.+++.+||+.||++|||++|++++++....
T Consensus 300 ----~~~~~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 300 ----TSGGRMDPPKNCP---GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp ----HTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HcCCCCCCCccCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 1111111111122 257788999999999999999999999886544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=370.77 Aligned_cols=265 Identities=23% Similarity=0.342 Sum_probs=209.2
Q ss_pred HHHHHHhhcCCCccceeccCCceeEEEEEe------CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceee
Q 039595 743 HEEIIKATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVK 815 (1078)
Q Consensus 743 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 815 (1078)
..++....++|++.+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|+.+++++ +||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 455556678999999999999999999963 246789999997542 334456789999999999 7999999
Q ss_pred EEeeeecCC-eeEEEEeecCCCCHHHHhcCCCC-----------------------------------------------
Q 039595 816 FHGFCSNAR-HSFLVCEYLHRGSLARILGNDAT----------------------------------------------- 847 (1078)
Q Consensus 816 l~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~----------------------------------------------- 847 (1078)
+++++.+.+ ..++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999987654 58999999999999999965432
Q ss_pred ----------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCC
Q 039595 848 ----------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS 911 (1078)
Q Consensus 848 ----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~ 911 (1078)
...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12289999999999999999999999 99999999999999999999999999998764432
Q ss_pred C--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 912 S--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 912 ~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
. ......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... ..... ......+... ..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~---~~~~~~~~~~---~~ 320 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRR---LKEGTRMRAP---DY 320 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHH---HHHTCCCCCC---TT
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHH---HHcCCCCCCC---CC
Confidence 2 2345678999999999999999999999999999999998 999975433221 11111 1111111111 11
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.. ..+.+++.+||+.||++|||++|+++|.-.
T Consensus 321 ~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 321 TT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC---HHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 11 257788999999999999999999998653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.58 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=203.1
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec----CCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN----ARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~ 825 (1078)
+.|++.+.||+|+||+||+|.. .++..||+|++..... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3578888999999999999965 4688999999876432 34456788999999999999999999998864 466
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeeC-CCCcEEEeccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLD-LEFEAHVSDFG 902 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~kl~DfG 902 (1078)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 8999999999999999943 35689999999999999999999998 8 99999999999997 78999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
++..... .......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||....... ... . .......
T Consensus 178 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~---~---~~~~~~~ 247 (290)
T 1t4h_A 178 LATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIY---R---RVTSGVK 247 (290)
T ss_dssp GGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHH---H---HHTTTCC
T ss_pred Ccccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-HHH---H---HHhccCC
Confidence 9975443 23455679999999998764 58999999999999999999999975432211 111 1 1111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....+ ......+.+++.+||+.||++|||++|+++|+|+..
T Consensus 248 ~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 PASFD--KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CGGGG--GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccccC--CCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 10000 011125788999999999999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.00 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=205.3
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|.....||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 3455566899999999999965 578899999987542 33456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-CCcEEEeccccccccc
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-EFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~a~~~~ 908 (1078)
|||+++++|.+++........+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||.+....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 99999999999996554445678899999999999999999999 9999999999999987 8999999999998765
Q ss_pred CCCCCceeeccccccccccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMR--ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
..........|++.|+|||++.+.. ++.++||||||+++|||++|+.||.......... .........+.....
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~- 250 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVGMFKVHPEIPES- 250 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHHHHHCCCCCCCTT-
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---Hhhcccccccccccc-
Confidence 4433445567999999999987654 8899999999999999999999975332211100 011111112222211
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
.. ..+.+++.+||+.||++|||++|+++|+|+....
T Consensus 251 --~~---~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 251 --MS---AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp --SC---HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred --CC---HHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 11 2577889999999999999999999999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=372.67 Aligned_cols=266 Identities=24% Similarity=0.341 Sum_probs=195.4
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecC--
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNA-- 823 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-- 823 (1078)
...++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++++. ||||+++++++...
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 3457899999999999999999965 579999999986542 23455677889999999997 99999999999644
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...|+||||++ |+|.++++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 47899999998 489998843 4688999999999999999999999 999999999999999999999999999
Q ss_pred cccccCC---------------------CCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 039595 904 AKFVEPY---------------------SSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFS 961 (1078)
Q Consensus 904 a~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~ 961 (1078)
|+.+... .......+||+.|+|||++.+ ..++.++||||+||++|||++|++||...+
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865321 112244689999999999886 678999999999999999999999975332
Q ss_pred ccccchhhhhhhh------------------------hhhc---CCCCCCCCCccH----------HHHHHHHHHHHhcc
Q 039595 962 INFSSFSNMIIEV------------------------NQIL---DPRLSTPSPGVM----------DKLISIMEVAILCL 1004 (1078)
Q Consensus 962 ~~~~~~~~~~~~~------------------------~~~~---~~~~~~~~~~~~----------~~~~~l~~li~~cl 1004 (1078)
.. .....+... .... ........+... ....++.+++.+||
T Consensus 236 ~~--~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 236 TM--NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HH--HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred HH--HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 11 111110000 0000 000000000000 01225789999999
Q ss_pred cCCCCCCCChhHHHHHhhhhh
Q 039595 1005 DESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 1005 ~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..||++|||++|+++|||+..
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSI 334 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTT
T ss_pred ccCcccCCCHHHHhCCHHHHH
Confidence 999999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=364.46 Aligned_cols=271 Identities=21% Similarity=0.210 Sum_probs=202.7
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN-MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
...++|++.+.||+|+||.||+|... +|+.||||++........ ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44578999999999999999999765 689999999875432211 1112467889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++ +|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999987 898888442 34688899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
.............||+.|+|||++.+. .++.++||||+||++|||++|.+||...... .................+..
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSS
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhh
Confidence 776555455567899999999998764 5899999999999999999999997543221 11111111000000000000
Q ss_pred -----------CCC-cc-----HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 985 -----------PSP-GV-----MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 985 -----------~~~-~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..+ .. .....++.+++.+||+.||++|||++|+++|+|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 000 00 111246889999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=355.07 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=208.2
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 368999999999999999999665 6789999998654321 12234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 92 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999999943 34689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||+..... .... .+.......+ ..
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~------~~~~~~~~~~-~~ 234 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETHR------RIVNVDLKFP-PF 234 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH------HHHTTCCCCC-TT
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHHH------HHhccccCCC-Cc
Confidence 32 234567899999999999999999999999999999999999997643221 1111 1111111111 11
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. ...+.+++.+||+.||++|||++|+++|+|+.
T Consensus 235 ~---~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 235 L---SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp S---CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred C---CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 1 12577899999999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=366.36 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=204.5
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+.|+..+.||+|+||+||+|.. .+|+.||||++...... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 4588899999999999999965 57899999998754321 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+. |++.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 588887743 235689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||...... .. .........+... .
T Consensus 207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~---~~~~~~~~~~~~~--~ 275 (348)
T 1u5q_A 207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SA---LYHIAQNESPALQ--S 275 (348)
T ss_dssp ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HH---HHHHHHSCCCCCC--C
T ss_pred ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HH---HHHHHhcCCCCCC--C
Confidence 23457999999999984 567899999999999999999999997533211 11 1111111111111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.... ..+.+++.+||+.||++|||++|+++|+|...
T Consensus 276 ~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 276 GHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp TTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCC---HHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 1122 25678899999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=368.53 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=207.3
Q ss_pred hcCCCccceeccCCceeEEEEEe----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 824 (1078)
.++|++.+.||+|+||+||+|+. .+++.||||+++...........+.+.+|+.+++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999976 378999999997644322223345567789999999 6999999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999943 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCC-CCceeecccccccccccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 905 KFVEPYS-SNRTEFVGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 905 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
+...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ . ..+........+.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~ 284 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-Q-AEISRRILKSEPP 284 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-H-HHHHHHHHHCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-H-HHHHHHHhccCCC
Confidence 8654322 22345679999999999986 3478999999999999999999999764332111 1 1111111111122
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~ 1026 (1078)
... .. ...+.+++.+||..||++|| +++|+++|+|+...
T Consensus 285 ~~~---~~---~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 285 YPQ---EM---SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp CCT---TS---CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCc---cc---CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 221 11 12567889999999999999 99999999998753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=367.46 Aligned_cols=346 Identities=28% Similarity=0.415 Sum_probs=175.4
Q ss_pred cccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEE
Q 039595 172 QLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTL 251 (1078)
Q Consensus 172 ~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 251 (1078)
.+++++.|++.++.+.. +| .+..+++|++|+|++|.+++..| ++++++|++|++++|++++..| +.++++|++|
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 45667777777776653 44 36667777777777777665433 6667777777777777766543 6667777777
Q ss_pred eccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccC
Q 039595 252 FLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLN 331 (1078)
Q Consensus 252 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 331 (1078)
+|++|++++..+ +.++++|++|++++|.+++. + .++.+++|+.|+++ |.+.+..+ +.++++|++|++++|+++
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS 190 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCC
Confidence 777777664422 66667777777777766642 2 25555555555553 33332211 444444444444444444
Q ss_pred ccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCcccc
Q 039595 332 GVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLK 411 (1078)
Q Consensus 332 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~ 411 (1078)
+. ..+..+++|++|++++|.+++..| ++.+++|+.|++++|++.+. ..+.
T Consensus 191 ~~--------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~ 240 (466)
T 1o6v_A 191 DI--------------------------SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 240 (466)
T ss_dssp CC--------------------------GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGG
T ss_pred CC--------------------------hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhh
Confidence 32 123444444444444444443322 33344444444444444321 2233
Q ss_pred ccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEE
Q 039595 412 SLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFL 491 (1078)
Q Consensus 412 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L 491 (1078)
.+++|++|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|
T Consensus 241 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--------------------------~~~l~~L~~L 292 (466)
T 1o6v_A 241 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--------------------------LAGLTALTNL 292 (466)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--------------------------GTTCTTCSEE
T ss_pred cCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--------------------------ccCCCccCeE
Confidence 34444444444444433322 3444444444444444443221 3334444444
Q ss_pred eccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccc
Q 039595 492 DLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFS 571 (1078)
Q Consensus 492 ~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 571 (1078)
++++|++++..+ +..+++|+.|+|++|++++..| +..+++|++|++++|++++. ..+.++++|++|++++|+++
T Consensus 293 ~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~ 366 (466)
T 1o6v_A 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQIS 366 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred EcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccC
Confidence 444444443322 4444455555555555544333 44445555555555555432 23444555555555555554
Q ss_pred cccchhhhcccccCeeecCCCccCC
Q 039595 572 HTIPIEFEKLIHLSKLDLSHNILQE 596 (1078)
Q Consensus 572 ~~~~~~~~~l~~L~~L~Ls~N~l~~ 596 (1078)
+..| +..+++|+.|++++|++++
T Consensus 367 ~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 367 DLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp BCGG--GTTCTTCCEEECCCEEEEC
T ss_pred ccch--hhcCCCCCEEeccCCcccC
Confidence 4443 4455555555555555543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=382.47 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=203.7
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|..+ +++.||+|++...... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 457999999999999999999765 7899999999765432 2235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEecccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE---FEAHVSDFGIAK 905 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~a~ 905 (1078)
||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.. +.+||+|||+++
T Consensus 114 v~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 114 VMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999998843 35689999999999999999999999 99999999999999764 559999999998
Q ss_pred cccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
..... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ......+.. ......
T Consensus 188 ~~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~------~~~~~~ 257 (494)
T 3lij_A 188 VFENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEILRKVEK------GKYTFD 257 (494)
T ss_dssp ECBTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH------TCCCCC
T ss_pred ECCCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh------CCCCCC
Confidence 76543 2344567999999999886 4689999999999999999999999753322 111111111 111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+........+.+++.+||+.||.+|||++|+++|||+..
T Consensus 258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 1111122236788999999999999999999999999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=352.07 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=200.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|..+ +|+.||||++...... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 468999999999999999999765 7999999998654321 12335678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++.. ...+++.++..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+....
T Consensus 89 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999943 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. .......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||+.... ......+.. .. ...+ .
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~---~~-~~~~---~ 232 (276)
T 2h6d_A 163 DG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFKKIRG---GV-FYIP---E 232 (276)
T ss_dssp C--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH---CC-CCCC---T
T ss_pred CC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhc---Cc-ccCc---h
Confidence 42 22345578999999999988765 6899999999999999999999753321 111111111 00 1111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ...+.+++.+||+.||++|||++|+++|+|+..
T Consensus 233 ~~---~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 233 YL---NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred hc---CHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 11 125778999999999999999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=357.81 Aligned_cols=256 Identities=25% Similarity=0.324 Sum_probs=205.7
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 467999999999999999999764 79999999997542 2234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEecccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFGIAK 905 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~a~ 905 (1078)
||||+++|+|.+++.. .+.+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||.+.
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 9999999999999843 34689999999999999999999999 99999999999999 788999999999997
Q ss_pred cccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
.... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... ......+.. .....+
T Consensus 158 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~------~~~~~~ 227 (304)
T 2jam_A 158 MEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKE------GYYEFE 227 (304)
T ss_dssp CCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHH------CCCCCC
T ss_pred ecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHc------CCCCCC
Confidence 5432 223445789999999999999999999999999999999999999753321 111111111 111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 1101111236788999999999999999999999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=383.24 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=205.9
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCC---------hhhHHHHHHHHHHHhcCCCCceeeEEe
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN---------MADQDEFLNVVLALNEIRHRNIVKFHG 818 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~l~~ 818 (1078)
..++|++.+.||+|+||+||+|..+ +++.||||++........ ....+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999664 688999999976532211 133567899999999999999999999
Q ss_pred eeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC---c
Q 039595 819 FCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF---E 895 (1078)
Q Consensus 819 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~ 895 (1078)
++.++...|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999998843 35689999999999999999999999 999999999999998876 6
Q ss_pred EEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh
Q 039595 896 AHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN 975 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 975 (1078)
+||+|||+++..... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+..
T Consensus 188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~-- 261 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDIIKKVEK-- 261 (504)
T ss_dssp EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH--
T ss_pred EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc--
Confidence 999999999876543 23445679999999999874 689999999999999999999999754322 111111111
Q ss_pred hhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 976 QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 976 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.......+........+.+++.+||..||.+|||++|+++|||+.
T Consensus 262 ----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 262 ----GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306 (504)
T ss_dssp ----CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ----CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence 111111111111123678899999999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=367.14 Aligned_cols=264 Identities=23% Similarity=0.348 Sum_probs=208.4
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEeC-CC-----CEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEe
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAELP-SG-----DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHG 818 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 818 (1078)
.....++|++.+.||+|+||.||+|... ++ ..||+|++.... .....+.+.+|+.+++++ +||||+++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3445678999999999999999999754 23 479999987542 334567789999999999 8999999999
Q ss_pred eeecCCeeEEEEeecCCCCHHHHhcCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 039595 819 FCSNARHSFLVCEYLHRGSLARILGNDA-----------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 887 (1078)
Q Consensus 819 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 887 (1078)
++.+++..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++ +|+||||||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 194 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN 194 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccce
Confidence 9999999999999999999999985421 134579999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccc
Q 039595 888 VLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINF 964 (1078)
Q Consensus 888 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~ 964 (1078)
|+++.++.+||+|||+++........ .....||+.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999999876443322 234567889999999999999999999999999999998 999975432211
Q ss_pred cchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 965 SSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...... .....+..... . ...+.+++.+||+.||.+|||++|++++.....
T Consensus 275 -~~~~~~---~~~~~~~~~~~---~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 275 -KFYKLV---KDGYQMAQPAF---A---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp -HHHHHH---HHTCCCCCCTT---C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHH---hcCCCCCCCCC---C---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 111111 11111111111 1 125778999999999999999999998765443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=367.06 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=208.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 367999999999999999999665 78999999987642 34456778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||++....
T Consensus 109 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999999943 346899999999999999999999832 89999999999999999999999999997653
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhh-------------------
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN------------------- 969 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~------------------- 969 (1078)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 22 233457899999999999999999999999999999999999997643321100000
Q ss_pred ---------------hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 970 ---------------MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 970 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
................... .....+.+++.+||+.||++|||++|+++|+|+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG--VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTT--TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcc--cccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 0000000000111000000 112257899999999999999999999999998753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=366.38 Aligned_cols=359 Identities=31% Similarity=0.455 Sum_probs=267.3
Q ss_pred cCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCC
Q 039595 133 LGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFG 212 (1078)
Q Consensus 133 Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~ 212 (1078)
+..+.+.+.++ ...+++|+.|++++|.+. .+|. +..+++|++|++++|.+.+..| ++++++|++|++++|.+++
T Consensus 31 ~~~~~~~~~i~--~~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 104 (466)
T 1o6v_A 31 LGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 104 (466)
T ss_dssp TTCSSTTSEEC--HHHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred hcccccccccC--hhHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCcccc
Confidence 34445554443 245789999999999998 5774 8899999999999999997654 9999999999999999997
Q ss_pred CCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCcccccccc
Q 039595 213 YIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGN 292 (1078)
Q Consensus 213 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 292 (1078)
..| ++++++|++|+|++|++++..+ +.++++|++|++++|++++ ++ .++++++|++|+++ |.+.+..+ +.+
T Consensus 105 ~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~--~~~ 175 (466)
T 1o6v_A 105 ITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLKP--LAN 175 (466)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCGG--GTT
T ss_pred Chh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCchh--hcc
Confidence 655 9999999999999999998644 9999999999999999996 44 48999999999997 56665443 899
Q ss_pred ccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEE
Q 039595 293 LSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELK 372 (1078)
Q Consensus 293 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 372 (1078)
+++|+.|++++|.+++. ..+.++++|++|++++|++++..| ++.+++|+.|++++|.+.+. ..+..+++|++|+
T Consensus 176 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 249 (466)
T 1o6v_A 176 LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLD 249 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEE
Confidence 99999999999999864 358899999999999999987655 77788999999999988753 3577888888888
Q ss_pred cccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCC
Q 039595 373 LCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDG 452 (1078)
Q Consensus 373 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 452 (1078)
+++|++++..+ +..+++|+.|++++|++.+..+ +..+++|++|++++|.+.++.+ +..+++|+.|++++|+++
T Consensus 250 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~- 322 (466)
T 1o6v_A 250 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS- 322 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCS-
T ss_pred CCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCC-
Confidence 88888876554 6677777777777777765433 4555555555555555544332 334444444444444443
Q ss_pred ccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCccccccc
Q 039595 453 KISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGS 532 (1078)
Q Consensus 453 ~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 532 (1078)
+..| +..+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..
T Consensus 323 -----------------------~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 373 (466)
T 1o6v_A 323 -----------------------DISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LAN 373 (466)
T ss_dssp -----------------------CCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTT
T ss_pred -----------------------Cchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhc
Confidence 3322 44556666666666666643 345666666666666666665554 566
Q ss_pred ccccceeeccCccccC
Q 039595 533 LTELQYLDLSANKLSS 548 (1078)
Q Consensus 533 l~~L~~L~Ls~N~l~~ 548 (1078)
+++|+.|++++|++++
T Consensus 374 l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 374 LTRITQLGLNDQAWTN 389 (466)
T ss_dssp CTTCCEEECCCEEEEC
T ss_pred CCCCCEEeccCCcccC
Confidence 6666666666666664
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=366.89 Aligned_cols=264 Identities=21% Similarity=0.329 Sum_probs=207.2
Q ss_pred HhhcCCCccceeccCCceeEEEEEe------CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
...++|++.+.||+|+||.||+|.. .++..||||++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3557899999999999999999975 245689999997542 223456789999999999 899999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCCCC--------------------CcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDATA--------------------KELSWNRRINVIKGVANALSYLHHDCLPSIIH 880 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 880 (1078)
..++..++||||+++|+|.+++...... ..+++.+++.++.||+.||+|||++ +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999654321 3479999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCC
Q 039595 881 RDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPR 957 (1078)
Q Consensus 881 ~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~ 957 (1078)
|||||+||+++.++.+||+|||++......... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999876543322 234567889999999999999999999999999999998 99997
Q ss_pred CcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 958 DFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
....... ..... ......+... ... ...+.+++.+||+.||++|||++|++++......+
T Consensus 276 ~~~~~~~-~~~~~---~~~~~~~~~~---~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDA-NFYKL---IQNGFKMDQP---FYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSH-HHHHH---HHTTCCCCCC---TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHH-HHHHH---HhcCCCCCCC---CCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 6433211 11111 1111111111 111 23578899999999999999999999998755443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=354.02 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=208.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee--cCCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS--NARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 826 (1078)
.++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+.+|+.++++++||||+++++++. .+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 468999999999999999999664 789999999976432 3445677899999999999999999999874 46789
Q ss_pred EEEEeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEecCCCCCCeeeCCCCcEEEec
Q 039595 827 FLVCEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPS-----IIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 99999999999999995422 234589999999999999999999999 8 99999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCC
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDP 980 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 980 (1078)
||.++.............|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+ .....+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i---~~~~~~ 234 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKI---REGKFR 234 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH---HHTCCC
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHH---hhcccc
Confidence 99998765433333456789999999999998999999999999999999999999764322 1111111 111111
Q ss_pred CCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 981 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
... ... ...+.+++.+||+.||++|||++|+++|+|....
T Consensus 235 ~~~---~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 235 RIP---YRY---SDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CCC---TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCC---ccc---CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 111 111 2357788999999999999999999999997653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=374.01 Aligned_cols=267 Identities=21% Similarity=0.283 Sum_probs=201.2
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA----- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 823 (1078)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+.+|+.++++++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 46899999999999999999965 468899999997542 2445567889999999999999999999999765
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...|+||||+++ +|.++++. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEecCCc-CHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 578999999874 99999953 35689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC----------------------Cceeecccccccccccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 039595 904 AKFVEPYSS----------------------NRTEFVGTFGYAAPEIA-YTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 960 (1078)
Q Consensus 904 a~~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltG~~p~~~~ 960 (1078)
|+....... .....+||+.|+|||++ .+..++.++||||+||++|||++|..||...
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 987644221 13567899999999986 5667999999999999999999876654321
Q ss_pred ccc----ccc-------------------hhhhhhhhh-----------------------hhcCCCCCCCC-CccHHHH
Q 039595 961 SIN----FSS-------------------FSNMIIEVN-----------------------QILDPRLSTPS-PGVMDKL 993 (1078)
Q Consensus 961 ~~~----~~~-------------------~~~~~~~~~-----------------------~~~~~~~~~~~-~~~~~~~ 993 (1078)
... +.. ......... ........... .......
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 100 000 000000000 00000000000 0000112
Q ss_pred HHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 994 ISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 994 ~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.++.+++.+||..||++|||++|+++|||+..
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 36789999999999999999999999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=393.58 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=212.5
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
..++|++.+.||+|+||+||+|..+ +++.||||++++.... .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4578999999999999999999654 6889999999764322 122345677888899887 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+||||+++|+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.
T Consensus 418 ~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999953 35699999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ..... .+.......+
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~~------~i~~~~~~~p- 562 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQ------SIMEHNVAYP- 562 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH------HHHSSCCCCC-
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHHH------HHHhCCCCCC-
Confidence 54444455677899999999999999999999999999999999999999754322 11222 1222222111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCCh-----hHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTM-----EKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~h~~~~~ 1025 (1078)
... ..++.+++.+||+.||++||++ +|+++|+|+..
T Consensus 563 ~~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 563 KSM---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp TTS---CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred ccC---CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 111 2357889999999999999998 99999999865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=362.99 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=204.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec------
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN------ 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 822 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 46899999999999999999976 57999999998665322 2234567889999999999999999999876
Q ss_pred --CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 823 --ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 823 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
.+..++||||+++ ++.+.+... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred cCCceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEcc
Confidence 4568999999986 777777432 34589999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC----CCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh
Q 039595 901 FGIAKFVEPYS----SNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN 975 (1078)
Q Consensus 901 fG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 975 (1078)
||+++...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+....
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~ 245 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLC 245 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHH
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHh
Confidence 99998764322 22345678999999999876 45899999999999999999999997643221 1111111111
Q ss_pred hhcCCCCCC----------------CCCccHHH------HHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 976 QILDPRLST----------------PSPGVMDK------LISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 976 ~~~~~~~~~----------------~~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....+.... ........ ...+.+++.+||+.||++|||++|+++|+|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 111111100 00111111 124789999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=360.29 Aligned_cols=270 Identities=23% Similarity=0.279 Sum_probs=206.0
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEecccccc----CChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLS----GNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
..++|++.+.||+|+||.||+|... +++.||||++...... ........+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999654 6889999998754321 1122234578999999999999999999999766
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc---EEEec
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE---AHVSD 900 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~D 900 (1078)
. .++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 8999999999999999843 45689999999999999999999999 9999999999999987664 99999
Q ss_pred ccccccccCCCCCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhh
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQI 977 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 977 (1078)
||.++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .....+...
T Consensus 161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~--- 235 (322)
T 2ycf_A 161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSG--- 235 (322)
T ss_dssp CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHT---
T ss_pred Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhC---
Confidence 9999876432 1223457899999999874 4678999999999999999999999976433221 111111110
Q ss_pred cCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHHHHHH
Q 039595 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILAVIL 1033 (1078)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~~~~~ 1033 (1078)
...............+.+++.+||+.||++|||++|+++|+|+...+......
T Consensus 236 ---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~~~~~ 288 (322)
T 2ycf_A 236 ---KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288 (322)
T ss_dssp ---CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHHHHHH
T ss_pred ---ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHHHHHH
Confidence 11000000001123678999999999999999999999999998766554443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=355.77 Aligned_cols=262 Identities=22% Similarity=0.358 Sum_probs=193.4
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... .....+.+.++...++.++||||+++++++.+++..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 46899999999999999999965 5789999999975421 12233445556666888999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 829 VCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
||||+++ +|.+++... .....+++..++.++.|++.||+|||++. +|+||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9999975 887777431 23456899999999999999999999853 8999999999999999999999999999876
Q ss_pred cCCCCCceeecccccccccccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIA----YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
... .......||+.|+|||.+ .+..++.++||||+||++|||++|+.||+............. ......
T Consensus 161 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~ 233 (290)
T 3fme_A 161 VDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV------EEPSPQ 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH------HSCCCC
T ss_pred ccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh------ccCCCC
Confidence 542 223345799999999996 566789999999999999999999999764332221111111 111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.+..... .++.+++.+||+.||++|||++|+++|||+...
T Consensus 234 ~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 LPADKFS---AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CCTTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccccCC---HHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 1111122 357789999999999999999999999998653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=369.85 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=203.8
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|.++ +++.||||+++... .....+.+.+|+.++++++||||+++++++..++..+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3468899999999999999999775 78999999986532 2334557889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.++++. ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 189 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999953 234589999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 908 EPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 908 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
..... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+. ... +...
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~---~~~--~~~~ 336 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVE---KGG--RLPC 336 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHH---TTC--CCCC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH---cCC--CCCC
Confidence 33211 1112345778999999998899999999999999999998 99997543321 1111111 111 1111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
..... ..+.+++.+||+.||++|||++++++..-
T Consensus 337 -~~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 337 -PELCP---DAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp -CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -CCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 11112 25778899999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=365.19 Aligned_cols=254 Identities=21% Similarity=0.387 Sum_probs=193.3
Q ss_pred hcCCCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.++|++.+.||+|+||.||+|+.+ ++..||||+++... .....+.+.+|+.++++++||||+++++++.++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 357999999999999999999764 57789999986542 34456789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++|+|.++++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999999543 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 906 FVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 906 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ...... ........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~---i~~~~~~~ 270 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKA---VDEGYRLP 270 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHH---HHTTEECC
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH---HHcCCCCC
Confidence 76543221 122345778999999999999999999999999999998 9999753321 111111 11111111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
. .... ...+.+++.+||+.||++||+++|+++..-
T Consensus 271 ~---~~~~---~~~l~~li~~cl~~dp~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 271 P---PMDC---PAALYQLMLDCWQKDRNNRPKFEQIVSILD 305 (373)
T ss_dssp C---CTTC---BHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C---Cccc---cHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence 1 1111 235788999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=365.16 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=207.2
Q ss_pred hhcCCCccceeccCCceeEEEEEeC--------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGF 819 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 819 (1078)
..++|++.+.||+|+||+||+|... .+..||||++.... .....+.+.+|+.+++++ +||||++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3468999999999999999999642 23579999997542 344567789999999999 99999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 039595 820 CSNARHSFLVCEYLHRGSLARILGNDAT-------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 886 (1078)
Q Consensus 820 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 886 (1078)
+..++..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 9999999999999999999999965331 24589999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEecccccccccCCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccc
Q 039595 887 NVLLDLEFEAHVSDFGIAKFVEPYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSIN 963 (1078)
Q Consensus 887 NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~ 963 (1078)
||+++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~- 299 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 299 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999998765432 22334567889999999999999999999999999999999 9999753321
Q ss_pred ccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 964 FSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
...... ......+... .... .++.+++.+||+.||++|||++|++++..
T Consensus 300 -~~~~~~---~~~~~~~~~~---~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 300 -EELFKL---LKEGHRMDKP---SNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp -HHHHHH---HHTTCCCCCC---SSCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHH---HHcCCCCCCC---ccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111 1111111111 1122 25778899999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.43 Aligned_cols=263 Identities=22% Similarity=0.353 Sum_probs=201.2
Q ss_pred hcCCCccceeccCCceeEEEEEe-----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN-- 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-- 822 (1078)
.++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 46899999999999999999974 36889999998653 34456788999999999999999999999854
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
....++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence 45689999999999999999543 33589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC---CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccch-------hhhhh
Q 039595 903 IAKFVEPYSS---NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF-------SNMII 972 (1078)
Q Consensus 903 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~-------~~~~~ 972 (1078)
+++....... ......++..|+|||.+.+..++.++||||||+++|||++|..||.......... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9987654322 1233457788999999999999999999999999999999999975432211000 00000
Q ss_pred hh-hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 973 EV-NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 973 ~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.. ................ ..+.+++.+||+.||++|||++|+++..-..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCP---DEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCC---HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11 1111111111111222 3577889999999999999999999875533
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=361.63 Aligned_cols=261 Identities=22% Similarity=0.392 Sum_probs=208.4
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS 821 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 821 (1078)
...++|++.+.||+|+||.||+|... +++.||||+++... .....+.+.+|+.++++++||||+++++++.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34578999999999999999999764 34789999987542 3344677999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCC---------------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDAT---------------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIH 880 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 880 (1078)
+++..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 99999999999999999999965321 25689999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCcEEEecccccccccCCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCC
Q 039595 881 RDISSKNVLLDLEFEAHVSDFGIAKFVEPYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPR 957 (1078)
Q Consensus 881 ~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~ 957 (1078)
|||||+||+++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999998664322 22344578899999999999999999999999999999999 99997
Q ss_pred CcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 958 DFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..... ...... +............. ..+.+++.+||+.||++|||+++++++.-...
T Consensus 278 ~~~~~--~~~~~~------~~~~~~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 278 YGMAH--EEVIYY------VRDGNILACPENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTSCH--HHHHHH------HHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCh--HHHHHH------HhCCCcCCCCCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 53321 111111 11111111111122 25778899999999999999999998765443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=351.15 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=202.0
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||+||+|... +++.||||++..... .......+.+|+..+..+ +||||+++++++.+++..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 467999999999999999999765 799999999976432 233456788899999998 9999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCC-CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-------------
Q 039595 828 LVCEYLHRGSLARILGNDAT-AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE------------- 893 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------------- 893 (1078)
+||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999954321 25589999999999999999999999 99999999999999844
Q ss_pred ------CcEEEecccccccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccc
Q 039595 894 ------FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 966 (1078)
Q Consensus 894 ------~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~ 966 (1078)
..+||+|||.+...... ....||+.|+|||.+.+. .++.++|||||||++|||++|.+|+.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 47999999999876542 234589999999999876 567899999999999999999987432111
Q ss_pred hhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 967 FSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 967 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. . .+............. ..+.+++.+||+.||++|||++|+++|+|+..
T Consensus 237 -~---~---~~~~~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 237 -W---H---EIRQGRLPRIPQVLS---QEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp -H---H---HHHTTCCCCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred -H---H---HHHcCCCCCCCcccC---HHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 0 1 111111111111122 25778899999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=355.94 Aligned_cols=258 Identities=27% Similarity=0.385 Sum_probs=206.7
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++++++||||+++++++......+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 4568999999999999999999665 68999999986532 2456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.+++.. ....+++.+++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 101 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEEECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 99999999999999842 235689999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
...........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...........+.... +
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~--~ 248 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFMIPTNPPPTFRK--P 248 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCCCCCSS--G
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhcCCCcccCC--c
Confidence 65444455667999999999999989999999999999999999999997533221 1111111111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
......+.+++.+||+.||++|||++|+++|+|+...
T Consensus 249 --~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 249 --ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp --GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 1112367889999999999999999999999998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=362.79 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=199.7
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA----- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 823 (1078)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 46899999999999999999965 579999999986542 2344567789999999999999999999999765
Q ss_pred -CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 824 -RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 824 -~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
...|+||||+ +++|.++++. ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence 3469999999 7899999843 4589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh--------
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE-------- 973 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~-------- 973 (1078)
+++.... .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.. .....+..
T Consensus 174 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 174 LARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPAE 248 (367)
T ss_dssp TCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHH
T ss_pred ccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence 9987643 2345678999999999887 67999999999999999999999997633221 10000000
Q ss_pred ------------hhhhcCCCCCCCCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 974 ------------VNQILDPRLSTPSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 974 ------------~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....+......... ........+.+++.+||..||++|||++|+++|||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 00000000000000 00111236788999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=356.43 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=203.6
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeec--CCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSN--ARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~ 825 (1078)
.++|++.+.||+|+||+||+|.. .+++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ...
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 36899999999999999999965 57899999998643 2567889999999997 9999999999987 677
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEeccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHVSDFGIA 904 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a 904 (1078)
.++||||+++++|.++++ .+++.++..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 108 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp EEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 899999999999999883 388899999999999999999999 999999999999999776 8999999999
Q ss_pred ccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh-----------
Q 039595 905 KFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII----------- 972 (1078)
Q Consensus 905 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~----------- 972 (1078)
+...... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...............
T Consensus 179 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 179 EFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp EECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred eEcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence 8765432 3345678999999999887 67899999999999999999999997433222111111000
Q ss_pred -hhhhhcCC--------CCCCC------CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 973 -EVNQILDP--------RLSTP------SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 973 -~~~~~~~~--------~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
......++ ..... .........++.+++.+||+.||++|||++|+++|+|+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 00000000 00000 0000111246789999999999999999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=351.57 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=211.0
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccC-----ChhhHHHHHHHHHHHhcCC-CCceeeEEeee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG-----NMADQDEFLNVVLALNEIR-HRNIVKFHGFC 820 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 820 (1078)
...++|++.+.||+|+||.||+|..+ +|+.||||++....... .....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999764 68999999997543111 1123456789999999995 99999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
..+...++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +++||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999943 35689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAY------TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
||.+...... .......|++.|+|||++. ...++.++||||||+++|||++|+.||..... ......
T Consensus 168 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~---- 240 (298)
T 1phk_A 168 FGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRM---- 240 (298)
T ss_dssp CTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----
T ss_pred ccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHH----
Confidence 9999876542 2334567899999999885 45678999999999999999999999753321 111111
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
+.........+........+.+++.+||+.||++|||++|+++|+|+....
T Consensus 241 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 241 --IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp --HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred --HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 111111111111122234678999999999999999999999999987543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=354.34 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=207.0
Q ss_pred hhcCCCccceeccCCceeEEEEEe------CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN 822 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 822 (1078)
..++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 356899999999999999999965 245789999987542 34456778999999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCC---------------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDAT---------------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHR 881 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 881 (1078)
++..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 9999999999999999999965332 23489999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 039595 882 DISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 958 (1078)
Q Consensus 882 Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~ 958 (1078)
||||+||+++.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||+||++|||++ |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876543221 233457889999999999899999999999999999999 999975
Q ss_pred cccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 959 FFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 959 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.... ........ ....+... .... ..+.+++.+||+.||++|||++|++++.-
T Consensus 255 ~~~~--~~~~~~~~---~~~~~~~~---~~~~---~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 255 GIPP--ERLFNLLK---TGHRMERP---DNCS---EEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp TCCG--GGHHHHHH---TTCCCCCC---TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCH--HHHHHHhh---cCCcCCCC---ccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 4332 11111111 11111111 1112 35778999999999999999999998854
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=352.54 Aligned_cols=260 Identities=20% Similarity=0.267 Sum_probs=204.2
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeee--ecCCe
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFC--SNARH 825 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~ 825 (1078)
..++|++.+.||+|+||.||+|... +++.||+|++............+.+.+|+.++++++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999764 68999999997654333334567899999999999999999999998 45568
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++| +.+++... ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999986 77777443 345689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC--CceeeccccccccccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 906 FVEPYSS--NRTEFVGTFGYAAPEIAYTMR--ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 906 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
....... ......||+.|+|||++.+.. ++.++||||+|+++|||++|+.||..... ......+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~------~~ 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIGK------GS 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHH------CC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHhc------CC
Confidence 7654222 233557899999999988654 37899999999999999999999763221 111111111 11
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...+ .... ..+.+++.+||+.||++|||++|+++|+|+..
T Consensus 230 ~~~~-~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 230 YAIP-GDCG---PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp CCCC-SSSC---HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred CCCC-CccC---HHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 1111 1111 25678999999999999999999999999754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=354.94 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=207.8
Q ss_pred hhcCCCccceeccCCceeEEEEEe------CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCS 821 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 821 (1078)
..++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 456899999999999999999974 356789999997542 334567899999999999 9999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCC---------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDAT---------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 886 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 886 (1078)
+++..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 99999999999999999999964322 22589999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccc
Q 039595 887 NVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSIN 963 (1078)
Q Consensus 887 NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~ 963 (1078)
||+++.++.+||+|||.++........ .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999877543322 234457889999999999999999999999999999999 99997643321
Q ss_pred ccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 964 FSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
. ..... ......+... ... ...+.+++.+||+.||++|||++|++++.-
T Consensus 255 ~-~~~~~---~~~~~~~~~~---~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 303 (313)
T 1t46_A 255 S-KFYKM---IKEGFRMLSP---EHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (313)
T ss_dssp H-HHHHH---HHHTCCCCCC---TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred h-HHHHH---hccCCCCCCc---ccC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 1 11111 1111111111 111 235788999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=371.92 Aligned_cols=251 Identities=15% Similarity=0.135 Sum_probs=195.5
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHH---HHHhcCCCCceeeEE-------e
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVV---LALNEIRHRNIVKFH-------G 818 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~ 818 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... .....+.+.+|+ ..+++++|||||+++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 46789999999999999999975 56999999999754322 334567789999 555666899999998 6
Q ss_pred eeecCC-----------------eeEEEEeecCCCCHHHHhcCCC----CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 039595 819 FCSNAR-----------------HSFLVCEYLHRGSLARILGNDA----TAKELSWNRRINVIKGVANALSYLHHDCLPS 877 (1078)
Q Consensus 819 ~~~~~~-----------------~~~lv~E~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 877 (1078)
++++++ ..|+||||+ +|+|.+++.... ....+++..++.++.||+.||+|||++ +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 665543 278999999 679999995421 112344588889999999999999999 9
Q ss_pred cEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceeeccccccccccccccC-----------CCCccchhHHHHHH
Q 039595 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-----------RATEKYDVYSFGVL 946 (1078)
Q Consensus 878 ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG~i 946 (1078)
|+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999998543 23445677 999999999987 89999999999999
Q ss_pred HHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 947 VFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 947 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
+|||++|+.||...... .... .+.. .. .... ..+.+++.+||+.||++|||++|+++|+|+..
T Consensus 303 l~elltg~~Pf~~~~~~--~~~~------~~~~-~~----~~~~---~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 303 IYWIWCADLPITKDAAL--GGSE------WIFR-SC----KNIP---QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHSSCCC--------CCSG------GGGS-SC----CCCC---HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHCCCCCcccccc--cchh------hhhh-hc----cCCC---HHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999997533221 1111 1111 11 1111 25778999999999999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=356.71 Aligned_cols=259 Identities=23% Similarity=0.370 Sum_probs=203.2
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 3468999999999999999999765 68999999986542 334678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.+++... ...+++.+++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 93 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999988432 34589999999999999999999999 9999999999999999999999999998644
Q ss_pred cCCCCCceeecccccccccccc-----ccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIA-----YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
...........||+.|+|||++ .+..++.++||||||+++|||++|+.||...... . ..........+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~---~~~~~~~~~~~~~ 242 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--R---VLLKIAKSDPPTL 242 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H---HHHHHHHSCCCCC
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--H---HHHHHhccCCccc
Confidence 3222223445789999999998 3667899999999999999999999997643321 1 1111111111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. ... .....+.+++.+||+.||++|||++|+++|+|+..
T Consensus 243 ~-~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 243 L-TPS---KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp S-SGG---GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred C-Ccc---ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 1 111 11235788999999999999999999999999774
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=358.11 Aligned_cols=269 Identities=27% Similarity=0.377 Sum_probs=189.9
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
...++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 34578999999999999999999654 689999999865421 23356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcC-----CCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecc
Q 039595 827 FLVCEYLHRGSLARILGN-----DATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDF 901 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 901 (1078)
++||||+++|+|.+++.. ......+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999853 12345689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC-----Cceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh
Q 039595 902 GIAKFVEPYSS-----NRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN 975 (1078)
Q Consensus 902 G~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 975 (1078)
|.+........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..... .
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~---~ 240 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLMLT---L 240 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHH---H
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHHHH---h
Confidence 99986643221 1234578999999999876 568999999999999999999999976433211 10000 0
Q ss_pred hhcCCCCCCC---CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 976 QILDPRLSTP---SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 976 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
....+..... ..........+.+++.+||+.||++|||++|+++|+|+...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 0000111000 000001123577899999999999999999999999986543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=363.34 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=197.2
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR---- 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 824 (1078)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 46899999999999999999965 478899999997542 23445677889999999999999999999997654
Q ss_pred --eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 825 --HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 825 --~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
..|+||||+++ +|.+++. ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence 78999999976 7888883 3488999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh----------
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII---------- 972 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~---------- 972 (1078)
+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+... .......
T Consensus 173 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 173 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp C-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHH
T ss_pred cccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 99866432 22345689999999999999999999999999999999999999976432210 0000000
Q ss_pred -----hhhhh--cCCCCCC------------CCC--ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 973 -----EVNQI--LDPRLST------------PSP--GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 973 -----~~~~~--~~~~~~~------------~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
..... ..+.... +.. ........+.+++.+||..||++|||++|+++|||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00000 0011100 000 01112457889999999999999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=366.49 Aligned_cols=263 Identities=9% Similarity=-0.012 Sum_probs=187.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHH---HHHhcCCCCceeeEE-------e
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVV---LALNEIRHRNIVKFH-------G 818 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~ 818 (1078)
..+|+..+.||+|+||+||+|.+. +|+.||||++...... .....+.+.+|+ ..++. +||||++++ +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-HHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence 346899999999999999999754 7899999999875322 234456677784 45555 799988755 4
Q ss_pred eeecC-----------------CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHH------HHHHHHHHHHHHHHHhcCC
Q 039595 819 FCSNA-----------------RHSFLVCEYLHRGSLARILGNDATAKELSWNRR------INVIKGVANALSYLHHDCL 875 (1078)
Q Consensus 819 ~~~~~-----------------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~ 875 (1078)
++... ...|+||||++ |+|.+++... ...+.+..+ ..++.||+.||+|||++
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-- 213 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSK-- 213 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence 44322 34799999999 7999999543 123344555 67889999999999999
Q ss_pred CCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceeecccccccccccccc--CCCCccchhHHHHHHHHHHHhC
Q 039595 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKG 953 (1078)
Q Consensus 876 ~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG 953 (1078)
+|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp -TEEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred -CCccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986542 2224567799999999987 7799999999999999999999
Q ss_pred CCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 954 NHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 954 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
+.||............... ...........+. .......+.+++.+||+.||++|||++|+++|||+...
T Consensus 290 ~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRPS-LRVPGTDSLAFGS--CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp SCSTTBCCTTCTTCCCBCC-TTSCCCCSCCCTT--SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCCCCcCcccccchhhhh-hhhccccccchhh--ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 9998654322111100000 0000111111111 01112367889999999999999999999999997643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=358.42 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=200.3
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeec---
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSN--- 822 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--- 822 (1078)
...++|++.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 4567899999999999999999976 478999999986532 2346788999999998 89999999999976
Q ss_pred ---CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEe
Q 039595 823 ---ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS 899 (1078)
Q Consensus 823 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 899 (1078)
....++||||+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence 56889999999999999999543 235689999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
|||++..............|++.|+|||++. +..++.++|||||||++|||++|+.||...... .. ....
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~~~~ 246 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--RA---LFLI 246 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HH---HHHH
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HH---HHHh
Confidence 9999987654434445567999999999987 567899999999999999999999997533221 11 1111
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....+... ..... ..+.+++.+||+.||++|||++|+++|+|+..
T Consensus 247 ~~~~~~~~~--~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 247 PRNPAPRLK--SKKWS---KKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHSCCCCCS--CSCSC---HHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred hcCccccCC--ccccC---HHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 111111111 11112 25778899999999999999999999999764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=350.97 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=195.1
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
++|++.+.||+|+||+||+|+.. ++.||||++... ...+.+.+|+.++++++||||+++++++.+ ..++||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 57889999999999999999875 788999998532 346678999999999999999999999874 479999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc-EEEecccccccccC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE-AHVSDFGIAKFVEP 909 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~kl~DfG~a~~~~~ 909 (1078)
||+++|+|.+++........+++.+++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999999976555556889999999999999999999932229999999999999998886 79999999976543
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||+........... .......+... ...
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~---~~~ 229 (307)
T 2eva_A 159 ---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW---AVHNGTRPPLI---KNL 229 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH---HHHTTCCCCCB---TTC
T ss_pred ---ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH---HHhcCCCCCcc---ccc
Confidence 223456899999999999999999999999999999999999997643322111111 11111111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
. ..+.+++.+||+.||++|||++|++++..
T Consensus 230 ~---~~l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 230 P---KPIESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C---HHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 1 25778899999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.83 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=201.1
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhH---HHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQ---DEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.++|++.+.||+|+||+||+|.. .+++.||+|++............ +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36899999999999999999966 47899999998765433222211 67899999999999999999999997665
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeeCCCCc-----EEE
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFE-----AHV 898 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~-----~kl 898 (1078)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7999999999999988543 34689999999999999999999999 8 999999999999988876 999
Q ss_pred ecccccccccCCCCCceeeccccccccccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhh
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY--TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQ 976 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 976 (1078)
+|||+++.... ......||+.|+|||.+. ...++.++||||+||++|||++|+.||+............ ....
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--~~~~ 245 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM--IREE 245 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH--HHHS
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH--Hhcc
Confidence 99999985432 345567999999999984 4567899999999999999999999986443321111111 1111
Q ss_pred hcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...+..... . ...+.+++.+||+.||++|||++|+++..
T Consensus 246 ~~~~~~~~~---~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 246 GLRPTIPED---C---PPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp CCCCCCCTT---S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCcc---c---CHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 122222211 1 13578899999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=370.16 Aligned_cols=263 Identities=19% Similarity=0.219 Sum_probs=202.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC------CCCceeeEEeeeec
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI------RHRNIVKFHGFCSN 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~ 822 (1078)
..+|++.+.||+|+||+||+|.. .+++.||||++... ......+.+|+.+++.+ .|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 45799999999999999999965 46899999998643 23345677788777776 57799999999999
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc--EEEec
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE--AHVSD 900 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~D 900 (1078)
....++||||+. ++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred CCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 999999999996 59999885432 34589999999999999999999999 9999999999999999987 99999
Q ss_pred ccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh--------
Q 039595 901 FGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-------- 972 (1078)
Q Consensus 901 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~-------- 972 (1078)
||+++.... .....+||+.|+|||++.+..++.++|||||||++|||++|++||....... .......
T Consensus 246 FG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 246 FGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD-QLACMIELLGMPSQK 321 (429)
T ss_dssp CTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHH
T ss_pred cccceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHH
Confidence 999976543 2334678999999999999999999999999999999999999976433210 0000000
Q ss_pred ------hhhhhcCCCC-----------------------------CCCCCccHHH-----HHHHHHHHHhcccCCCCCCC
Q 039595 973 ------EVNQILDPRL-----------------------------STPSPGVMDK-----LISIMEVAILCLDESPEARP 1012 (1078)
Q Consensus 973 ------~~~~~~~~~~-----------------------------~~~~~~~~~~-----~~~l~~li~~cl~~dP~~RP 1012 (1078)
.....++... .......... ...+.+++.+||+.||++||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 0000110000 0000000000 23578999999999999999
Q ss_pred ChhHHHHHhhhhhh
Q 039595 1013 TMEKGFGHHIGYCD 1026 (1078)
Q Consensus 1013 t~~ell~h~~~~~~ 1026 (1078)
|++|+++|||+...
T Consensus 402 ta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 402 TPGQALRHPWLRRR 415 (429)
T ss_dssp CHHHHHTSTTTC--
T ss_pred CHHHHhCChhhccC
Confidence 99999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=364.98 Aligned_cols=267 Identities=21% Similarity=0.287 Sum_probs=208.7
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC--ee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR--HS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~ 826 (1078)
.++|++.+.||+|+||+||+|... +|+.||||++..... ....+.+.+|+.++++++||||+++++++.+.. ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 367999999999999999999765 699999999975432 233567789999999999999999999997654 78
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----CCCCcEEEeccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----DLEFEAHVSDFG 902 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfG 902 (1078)
++||||+++|+|.+++........+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999999996654445599999999999999999999999 99999999999999 778889999999
Q ss_pred ccccccCCCCCceeecccccccccccccc--------CCCCccchhHHHHHHHHHHHhCCCCCCccccccc--chhhhhh
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYT--------MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS--SFSNMII 972 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~--~~~~~~~ 972 (1078)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .....+.
T Consensus 162 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 162 AARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 998765422 2344679999999999875 5678899999999999999999999754322111 1111110
Q ss_pred hhh---------------hhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 973 EVN---------------QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 973 ~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
... ..+.+..+............+.+++.+||+.||++||+++|++++...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 000 000111222222224455578899999999999999999999887644
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.86 Aligned_cols=251 Identities=18% Similarity=0.291 Sum_probs=201.2
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--CeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA--RHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 827 (1078)
.++|++.+.||+|+||+||+|..+ ++.||||++.... ......+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 468999999999999999999875 8899999997643 2344567799999999999999999999999876 7889
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
+||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ + ++||||||+||+++.++.++++|||++.
T Consensus 86 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence 999999999999999653 234689999999999999999999998 8 9999999999999999999999998876
Q ss_pred cccCCCCCceeeccccccccccccccCCCCc---cchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATE---KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
.... ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||...... .... ........+..
T Consensus 162 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~--~~~~~~~~~~~ 232 (271)
T 3kmu_A 162 SFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--EIGM--KVALEGLRPTI 232 (271)
T ss_dssp TTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--HHHH--HHHHSCCCCCC
T ss_pred eecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--HHHH--HHHhcCCCCCC
Confidence 4322 2347899999999998765544 899999999999999999997643221 1100 11111111222
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. ... ..+.+++.+||+.||++|||++|+++..-
T Consensus 233 ~~---~~~---~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 233 PP---GIS---PHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp CT---TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC---CCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 112 25778899999999999999999997654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=372.84 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=203.2
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.+.||+|+||+||+|.++++..||||+++... ...+.|.+|+.++++++||||+++++++. ....++
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 456788999999999999999998888899999997542 24678999999999999999999999987 567899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.++++.. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 260 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999999543 223588899999999999999999999 99999999999999999999999999998764
Q ss_pred CCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
... .......+|+.|+|||++....++.++|||||||++|||++ |+.||..... ......+. ....... .
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~---~~~~~~~---~ 407 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALE---RGYRMPR---P 407 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHH---HTCCCCC---C
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH---cCCCCCC---C
Confidence 321 11233456789999999998999999999999999999999 9999753322 11111111 1111111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.... ..+.+++.+||+.||++|||++++++..
T Consensus 408 ~~~~---~~l~~li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 408 ENCP---EELYNIMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 1112 2577889999999999999999988654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=358.60 Aligned_cols=267 Identities=21% Similarity=0.348 Sum_probs=212.2
Q ss_pred HHHHHHhhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeE
Q 039595 743 HEEIIKATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKF 816 (1078)
Q Consensus 743 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 816 (1078)
.+++....++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3445556789999999999999999999653 36789999987542 33456678999999999999999999
Q ss_pred EeeeecCCeeEEEEeecCCCCHHHHhcCCC-------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 039595 817 HGFCSNARHSFLVCEYLHRGSLARILGNDA-------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVL 889 (1078)
Q Consensus 817 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl 889 (1078)
++++.++...++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||++ +|+||||||+||+
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence 999999999999999999999999985421 124578999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccc
Q 039595 890 LDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSS 966 (1078)
Q Consensus 890 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~ 966 (1078)
++.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~ 248 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--Q 248 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--H
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--H
Confidence 99999999999999986643221 1233457889999999999999999999999999999999 89997543221 1
Q ss_pred hhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 967 FSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 967 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
... .+............. ..+.+++.+||+.||++|||++|++++......
T Consensus 249 ~~~------~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 VLR------FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHH------HHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH------HHHcCCcCCCCCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111 111111111112222 257788999999999999999999999765543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=347.45 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=208.4
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
...++|++.+.||+|+||.||+|..+ +++.||||++...... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 34578999999999999999999765 7899999999765322 33467789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC---CcEEEecccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE---FEAHVSDFGI 903 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~ 903 (1078)
++||||+++++|.+++.. ...+++.+++.++.||+.||+|||++ +++||||||+||+++.+ +.+||+|||.
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 999999999999998843 34689999999999999999999999 99999999999999764 4799999999
Q ss_pred cccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
+....... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ......+. .....
T Consensus 171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~------~~~~~ 240 (287)
T 2wei_A 171 STCFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVE------TGKYA 240 (287)
T ss_dssp GGTBCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH------HCCCC
T ss_pred ceeecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHH------cCCCC
Confidence 98765432 2334568999999998876 489999999999999999999999753322 11111111 11111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...+........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 111111112236788999999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=354.51 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=184.9
Q ss_pred hhcCCCccceeccCCceeEEEEEeCC-CC---EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPS-GD---IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
..++|++.+.||+|+||+||+|.... ++ .||||++..... .....+.+.+|+.++++++||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 35689999999999999999997653 32 799999876432 2344678999999999999999999999998766
Q ss_pred ee------EEEEeecCCCCHHHHhcCCC---CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 039595 825 HS------FLVCEYLHRGSLARILGNDA---TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE 895 (1078)
Q Consensus 825 ~~------~lv~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 895 (1078)
.. ++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 55 99999999999999984322 223589999999999999999999999 9999999999999999999
Q ss_pred EEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhh
Q 039595 896 AHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMII 972 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 972 (1078)
+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~-- 251 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNY-- 251 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH--
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHH--
Confidence 99999999987644322 2234567889999999999999999999999999999999 99997643321 11111
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHH
Q 039595 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFG 1019 (1078)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 1019 (1078)
+............. ..+.+++.+||+.||++|||+.++++
T Consensus 252 ----~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 252 ----LIGGNRLKQPPECM---EEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp ----HHTTCCCCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ----HhcCCCCCCCCccC---HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111111111122 35788999999999999999555443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=356.90 Aligned_cols=274 Identities=20% Similarity=0.250 Sum_probs=204.2
Q ss_pred HHHHHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccC-------ChhhHHHHHHHHHHHhcCCCCceee
Q 039595 743 HEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG-------NMADQDEFLNVVLALNEIRHRNIVK 815 (1078)
Q Consensus 743 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~ 815 (1078)
.+++....++|++.+.||+|+||.||+|...+|+.||||++....... +....+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456777889999999999999999999988889999999986543221 2223477899999999999999999
Q ss_pred EEeeee-----cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 039595 816 FHGFCS-----NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 890 (1078)
Q Consensus 816 l~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 890 (1078)
+++++. .....|+||||++ |+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 999983 3446899999998 588888853 234689999999999999999999999 99999999999999
Q ss_pred CCCCcEEEecccccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhh
Q 039595 891 DLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 891 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 969 (1078)
+.++.+||+|||.++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~ 244 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--NQLN 244 (362)
T ss_dssp CTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH
T ss_pred cCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence 99999999999999854432 23345678999999999887 67899999999999999999999997643211 1111
Q ss_pred hhh-----------------hhhhhcCCCCCCCCCccH-----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 970 MII-----------------EVNQILDPRLSTPSPGVM-----DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 970 ~~~-----------------~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+. .................. .....+.+++.+||+.||++|||++|+++|||+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 000 000111111111111111 11235789999999999999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=354.66 Aligned_cols=254 Identities=15% Similarity=0.143 Sum_probs=202.6
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... .+.+.+|+.+++++ +||||+++++++..+...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 46799999999999999999975 5789999999865421 23478899999999 9999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc-----EEEeccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE-----AHVSDFG 902 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DfG 902 (1078)
+||||+ +|+|.+++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 999999 89999999543 35699999999999999999999999 9999999999999999887 9999999
Q ss_pred ccccccCCCCC-------ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-cchhhhhhhh
Q 039595 903 IAKFVEPYSSN-------RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF-SSFSNMIIEV 974 (1078)
Q Consensus 903 ~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~~~~~~~~~~ 974 (1078)
+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 99876443221 245689999999999999999999999999999999999999986543221 1111111111
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
........ ...... ++.+++.+||+.||.+||+++++.+..
T Consensus 236 ~~~~~~~~--~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 236 KRATPIEV--LCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp HHHSCHHH--HTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred hccCCHHH--HhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 11111000 000111 678899999999999999999988743
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=343.88 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=205.8
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 36789999999999999999988888899999997643 2346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 82 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp ECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence 9999999999999543 34588999999999999999999999 999999999999999999999999999986543
Q ss_pred CC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 910 YS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 910 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. .......++..|+|||.+.+..++.++||||+|+++|||++ |+.||..... ...... ......+... .
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~---i~~~~~~~~~---~ 228 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVED---ISTGFRLYKP---R 228 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH---HHTTCCCCCC---T
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHHHH---HhcCCcCCCC---c
Confidence 11 11223456788999999998899999999999999999999 8999753321 111111 1111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.. ...+.+++.+||+.||++|||++|++++....
T Consensus 229 ~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 229 LA---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC---cHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 23577899999999999999999999876543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=361.78 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=187.7
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA----- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 823 (1078)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 47899999999999999999964 578999999986542 2344567788999999999999999999998654
Q ss_pred -CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 824 -RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 824 -~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
...|+|+||+ +++|.++++. ..+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5689999999 6799988843 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh-------
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV------- 974 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~------- 974 (1078)
+++.... .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.. .....+...
T Consensus 178 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 178 LARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAE 252 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHH
T ss_pred ccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 9986543 2345689999999999887 67899999999999999999999997543221 111100000
Q ss_pred ----------hhhcCCCCCCCCCccH----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 ----------NQILDPRLSTPSPGVM----DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 ----------~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...+......+..... .....+.+++.+||..||++|||++|+++|+|+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 0000000000000000 11235789999999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=353.65 Aligned_cols=257 Identities=22% Similarity=0.375 Sum_probs=205.4
Q ss_pred hhcCCCccceeccCCceeEEEEEeC--------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGF 819 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 819 (1078)
..++|++.+.||+|+||.||+|... ++..||||++.... .....+.+.+|+.+++++ +||||++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3578999999999999999999753 46789999987542 344567789999999999 89999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 039595 820 CSNARHSFLVCEYLHRGSLARILGNDAT-------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 886 (1078)
Q Consensus 820 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 886 (1078)
+.+.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 9999999999999999999999965432 23489999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccc
Q 039595 887 NVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSIN 963 (1078)
Q Consensus 887 NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~ 963 (1078)
||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~- 265 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV- 265 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-
Confidence 99999999999999999987654322 1233456889999999998899999999999999999999 9999753321
Q ss_pred ccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 964 FSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
....... .....+... ... ...+.+++.+||+.||++|||++|++++.-
T Consensus 266 -~~~~~~~---~~~~~~~~~---~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 266 -EELFKLL---KEGHRMDKP---ANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp -HHHHHHH---HHTCCCCCC---TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHHH---hcCCCCCCC---ccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111111 111111111 111 135778899999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.90 Aligned_cols=264 Identities=22% Similarity=0.317 Sum_probs=197.3
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|.. .+|+.||||++..... ......+.+.+|+.++++++||||+++++++..++..+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 346799999999999999999965 5799999999975432 23455677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCC-CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 828 LVCEYLHRGSLARILGNDA-TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 9999999999999985321 235589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
............|++.|+|||.+.+..++.++||||||+++|||++|+.||............ .......+... .
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~--~ 260 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---KIEQCDYPPLP--S 260 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH---HHHTTCSCCCC--T
T ss_pred ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH---HhhcccCCCCc--c
Confidence 655444445567999999999999999999999999999999999999997533222111111 11111111111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
... ...+.+++.+||+.||++|||+++++++....
T Consensus 261 ~~~---~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 261 DHY---SEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccc---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111 22577889999999999999999999875433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=344.60 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=193.8
Q ss_pred hhcCCCccceeccCCceeEEEEEeCC----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
..++|++.+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+.++++++||||+++++++. ++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 34689999999999999999997642 4579999986532 3445677899999999999999999999985 45
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred ccEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence 789999999999999999533 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 905 KFVEPYSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 905 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
+....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+ .....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i---~~~~~~~~ 238 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI---ENGERLPM 238 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH---HTTCCCCC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHH---HcCCCCCC
Confidence 87654322 2234456789999999998899999999999999999997 99997643221 111111 11111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+... ..+.+++.+||+.||++|||++|++++.....
T Consensus 239 ---~~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 239 ---PPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ---CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11122 35778899999999999999999998866443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=354.83 Aligned_cols=255 Identities=21% Similarity=0.376 Sum_probs=196.4
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCE----EEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDI----VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
.++|+..+.||+|+||+||+|.+. +++. ||+|.+.... .....+.+.+|+.++++++||||+++++++.++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 367999999999999999999754 4554 5777775432 2344678999999999999999999999998765
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
.++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred -eEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence 78999999999999999543 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 905 KFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 905 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
+........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||+..... ........ .. .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~---~~--~ 237 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK---GE--R 237 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT---TC--C
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHc---CC--C
Confidence 876543322 234456889999999999999999999999999999999 99997643321 11111111 11 1
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.. ..... ...+.+++.+||+.||++|||++|++++.-..
T Consensus 238 ~~-~~~~~---~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 238 LP-QPPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp CC-CCTTB---CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred CC-CCccC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11 11111 23577899999999999999999999886543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=357.84 Aligned_cols=271 Identities=21% Similarity=0.295 Sum_probs=210.9
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCCh-------------hhHHHHHHHHHHHhcCCCCceeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNM-------------ADQDEFLNVVLALNEIRHRNIVKF 816 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l 816 (1078)
.++|++.+.||+|+||.||+|.. +|+.||||++......... ...+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999987 8999999999764332111 112778999999999999999999
Q ss_pred EeeeecCCeeEEEEeecCCCCHHHH------hcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCee
Q 039595 817 HGFCSNARHSFLVCEYLHRGSLARI------LGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVL 889 (1078)
Q Consensus 817 ~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIl 889 (1078)
++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.|++.||+|||+ + +|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 532 225679999999999999999999999 8 9999999999999
Q ss_pred eCCCCcEEEecccccccccCCCCCceeeccccccccccccccC-CCCc-cchhHHHHHHHHHHHhCCCCCCcccccccch
Q 039595 890 LDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATE-KYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 967 (1078)
Q Consensus 890 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlG~il~elltG~~p~~~~~~~~~~~ 967 (1078)
++.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++|||||||++|||++|+.||...... ...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHH
Confidence 999999999999999876432 33456789999999999887 5666 999999999999999999997643321 111
Q ss_pred hhhhhhhhhhcCCCC---CCCC-C-----ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHH
Q 039595 968 SNMIIEVNQILDPRL---STPS-P-----GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEI 1028 (1078)
Q Consensus 968 ~~~~~~~~~~~~~~~---~~~~-~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~ 1028 (1078)
...+.......+... .... . ........+.+++.+||+.||++|||++|+++|+|+.....
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 111111000000000 0000 0 00111236788999999999999999999999999876443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=348.50 Aligned_cols=260 Identities=23% Similarity=0.390 Sum_probs=210.5
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
...++|++.+.||+|+||+||+|..+ ++..||+|++... ....+.+.+|+.++++++||||+++++++.++...
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 35678999999999999999999765 5889999998643 23467789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+..
T Consensus 85 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999999543 345689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 907 VEPYSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 907 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
...... ......+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||...... ..... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~---~~~~~~~~~~- 234 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYEL---LEKDYRMERP- 234 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH---HHTTCCCCCC-
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH---HhccCCCCCC-
Confidence 654322 2234567889999999999999999999999999999999 99997543321 11111 1111111111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhH
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~ 1027 (1078)
.... ..+.+++.+||+.||++|||++|+++.......+
T Consensus 235 --~~~~---~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 235 --EGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp --TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCC---HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 3577899999999999999999999876544433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=354.41 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=198.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCE----EEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDI----VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
++|++.+.||+|+||+||+|.+. +++. ||+|++.... .......+.+|+.++++++||||+++++++. +..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 57899999999999999999754 4554 7778775432 1222345678999999999999999999987 456
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred cEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 88999999999999999543 35688999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 906 FVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 906 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
....... ......||..|+|||.+.+..++.++|||||||++|||++ |+.||..... ............ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~---~~~ 238 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKGER---LAQ 238 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHHTTCB---CCC
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHHcCCC---CCC
Confidence 7754332 2345678889999999999999999999999999999999 9999764322 112111111111 111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
... .. ..+.+++.+||+.||++|||++|++++.....
T Consensus 239 ~~~---~~---~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 PQI---CT---IDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CTT---BC---TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCc---Cc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 11 14668889999999999999999999975443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=350.44 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=203.3
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC--CCceeeEEeeeecCCee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR--HRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~ 826 (1078)
..++|++.+.||+|+||.||+|..++++.||||++..... .....+.+.+|+.++++++ ||||+++++++..+...
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 4568999999999999999999888899999999975432 3445678899999999997 59999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||| +.+++|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeecccccc
Confidence 99999 567899999954 34689999999999999999999999 999999999999996 58999999999987
Q ss_pred ccCCCC--Cceeecccccccccccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh
Q 039595 907 VEPYSS--NRTEFVGTFGYAAPEIAYT-----------MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973 (1078)
Q Consensus 907 ~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 973 (1078)
...... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-------~~ 248 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SK 248 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-------HH
Confidence 644322 2234578999999999875 468889999999999999999999975332211 11
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.....++......+... ...+.+++.+||+.||++|||++|+++|+|+...
T Consensus 249 ~~~~~~~~~~~~~~~~~--~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 249 LHAIIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHCTTSCCCCCCCS--CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHhcccccCCcccc--hHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 22222322222211111 1257788999999999999999999999998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.91 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=198.7
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec-----
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN----- 822 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----- 822 (1078)
..++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 346799999999999999999976 47999999998542 3346778999999999999999999998754
Q ss_pred --------CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 039595 823 --------ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF 894 (1078)
Q Consensus 823 --------~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 894 (1078)
....++||||+++|+|.+++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCC
Confidence 45789999999999999999542 34578899999999999999999999 999999999999999999
Q ss_pred cEEEecccccccccCCC--------------CCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCc
Q 039595 895 EAHVSDFGIAKFVEPYS--------------SNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 959 (1078)
Q Consensus 895 ~~kl~DfG~a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~ 959 (1078)
.+||+|||.+....... .......||+.|+|||++.+. .++.++||||+||++|||++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 99999999998664321 122345789999999998864 68999999999999999998 4321
Q ss_pred ccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhhHHHH
Q 039595 960 FSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCDEILA 1030 (1078)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~~~~~ 1030 (1078)
... .......... ....++.... ......+.+++.+||+.||++|||++|+++|+|+.......
T Consensus 231 ~~~-~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (303)
T 1zy4_A 231 GME-RVNILKKLRS----VSIEFPPDFD--DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294 (303)
T ss_dssp HHH-HHHHHHHHHS----TTCCCCTTCC--TTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHH
T ss_pred chh-HHHHHHhccc----cccccCcccc--ccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHH
Confidence 111 0111111111 1111111111 11223567899999999999999999999999987654443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=352.09 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=209.4
Q ss_pred HHHHHHhhcCCCccceeccCCceeEEEEEe------CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceee
Q 039595 743 HEEIIKATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVK 815 (1078)
Q Consensus 743 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 815 (1078)
..+.....++|++.+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.+++++ +||||++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeee
Confidence 344555678999999999999999999963 356789999997542 334456789999999999 7999999
Q ss_pred EEeeeecC-CeeEEEEeecCCCCHHHHhcCCCC-------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 039595 816 FHGFCSNA-RHSFLVCEYLHRGSLARILGNDAT-------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHR 881 (1078)
Q Consensus 816 l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 881 (1078)
+++++... ...++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 99998765 458999999999999999965432 12378999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 039595 882 DISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 958 (1078)
Q Consensus 882 Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~ 958 (1078)
||||+||+++.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999876543322 234567899999999999999999999999999999998 999975
Q ss_pred cccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 959 FFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 959 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
...... ...... ......... ... ...+.+++.+||+.||++|||++|+++|....
T Consensus 253 ~~~~~~-~~~~~~---~~~~~~~~~---~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 253 GVKIDE-EFCRRL---KEGTRMRAP---DYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TCCCSH-HHHHHH---HHTCCCCCC---TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhH-HHHHHh---ccCccCCCC---CCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 433221 111111 111111111 111 12577889999999999999999999986543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=363.05 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=197.8
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR----- 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 824 (1078)
..+|+..+.||+|+||+||+|+...+..||+|++...... ..+|+.+++.++||||+++++++...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 3579999999999999999998877777999998653211 236899999999999999999984433
Q ss_pred -eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEeccc
Q 039595 825 -HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-LEFEAHVSDFG 902 (1078)
Q Consensus 825 -~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfG 902 (1078)
..++||||++++.+............+++..++.++.||+.||+|||++ +|+||||||+||+++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 3789999998854443332222345689999999999999999999999 999999999999999 79999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh---------
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII--------- 972 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~--------- 972 (1078)
+|+..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ........
T Consensus 188 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 188 SAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp TCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHH
T ss_pred CcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 99876442 233456789999999998765 5899999999999999999999997643321 00100000
Q ss_pred --h-hhhhcCCCCCCCCCccHH------HHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 973 --E-VNQILDPRLSTPSPGVMD------KLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 973 --~-~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. ........+....+.... ...++.+++.+||+.||++|||++|+++|+|+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 0 001111111111110000 1236889999999999999999999999999764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=366.62 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=198.9
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC-eeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR-HSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~l 828 (1078)
.++|++.+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 467889999999999999999876 7899999987542 3567899999999999999999999986654 7899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.++++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999999543 223478999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+. .......+ .
T Consensus 341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~---~~~~~~~p---~ 409 (450)
T 1k9a_A 341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVE---KGYKMDAP---D 409 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--TTHHHHHH---TTCCCCCC---T
T ss_pred cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH---cCCCCCCC---C
Confidence 22 223367889999999999999999999999999999998 9999764332 11111111 11111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
... ..+.+++.+||+.||++|||++++++..
T Consensus 410 ~~~---~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 410 GCP---PAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCC---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 122 2577889999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.64 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=193.7
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.+.||+|+||+||+|... ..||||+++... ......+.+.+|+.++++++||||+++++++. ....++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~l 96 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 96 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEE
Confidence 3568999999999999999999864 469999987543 23455678999999999999999999999764 566899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++++|.+++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999999533 35689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC--CCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 909 PYS--SNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 909 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
... .......||+.|+|||.+. +..++.++||||+|+++|||++|+.||...... ........ .....+...
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~--~~~~~~~~~ 248 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVG--RGSLSPDLS 248 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-HHHHHHHH--HTSCCCCTT
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-HHHHHHhc--ccccCcchh
Confidence 322 2234567999999999986 567889999999999999999999997643321 11111111 111222222
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
...... ...+.+++.+||+.||++|||++|+++..-.
T Consensus 249 ~~~~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 285 (289)
T 3og7_A 249 KVRSNC---PKRMKRLMAECLKKKRDERPSFPRILAEIEE 285 (289)
T ss_dssp SSCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccccC---CHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 211222 2367889999999999999999999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=341.42 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=203.8
Q ss_pred cCCCccc-eeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 751 DDFDEKF-CIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
++|.+.. .||+|+||.||+|.+. ++..||||+++... .....+.+.+|+.++++++||||+++++++. .+..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 84 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEAL 84 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCc
Confidence 4566665 8999999999999753 57789999997642 3455678999999999999999999999994 5568
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999999999999953 235689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 907 VEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 907 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
....... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+ .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i---~~~~~~~~ 234 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFI---EQGKRMEC 234 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHH---HTTCCCCC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH---hcCCcCCC
Confidence 6543221 223456889999999998889999999999999999998 9999754332 1111111 11111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. .... ..+.+++.+||+.||++||+++|++++++...
T Consensus 235 ~---~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 235 P---PECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp C---TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---CCcC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1112 36778899999999999999999999987443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=366.43 Aligned_cols=265 Identities=18% Similarity=0.267 Sum_probs=186.0
Q ss_pred cCCCc-cceeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeee--ecCC
Q 039595 751 DDFDE-KFCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFC--SNAR 824 (1078)
Q Consensus 751 ~~~~~-~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~ 824 (1078)
+.|++ .++||+|+||+||+|..+ +++.||||++.... ....+.+|+.++++++||||+++++++ ..+.
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS------CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC------CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 45665 457999999999999765 57899999986542 134578899999999999999999999 4577
Q ss_pred eeEEEEeecCCCCHHHHhcCC------CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----CCCC
Q 039595 825 HSFLVCEYLHRGSLARILGND------ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----DLEF 894 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~ 894 (1078)
..|+||||+.+ +|.+++... .....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 89999999975 888877421 1223589999999999999999999999 99999999999999 6779
Q ss_pred cEEEecccccccccCCC---CCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccc----
Q 039595 895 EAHVSDFGIAKFVEPYS---SNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS---- 966 (1078)
Q Consensus 895 ~~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~---- 966 (1078)
.+||+|||+++...... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.....+...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 99999999998765422 223456899999999998874 5899999999999999999999998543321100
Q ss_pred hhhhhhhhhhhcCCCCCCCC-----------------------CccHH--------HHHHHHHHHHhcccCCCCCCCChh
Q 039595 967 FSNMIIEVNQILDPRLSTPS-----------------------PGVMD--------KLISIMEVAILCLDESPEARPTME 1015 (1078)
Q Consensus 967 ~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~--------~~~~l~~li~~cl~~dP~~RPt~~ 1015 (1078)
...........+........ ..... ....+.+++.+||..||++|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 00000000000000000000 00000 012577899999999999999999
Q ss_pred HHHHHhhhhh
Q 039595 1016 KGFGHHIGYC 1025 (1078)
Q Consensus 1016 ell~h~~~~~ 1025 (1078)
|+++|+|+..
T Consensus 330 e~L~hp~f~~ 339 (405)
T 3rgf_A 330 QAMQDPYFLE 339 (405)
T ss_dssp HHHTSGGGTS
T ss_pred HHhcChhhcc
Confidence 9999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=373.08 Aligned_cols=253 Identities=23% Similarity=0.403 Sum_probs=205.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|.++ ++..||||+++... ...+.|.+|+.++++++||||+++++++.+....++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 467889999999999999999776 48899999986542 246789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.++++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999543 235689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+ ........ .
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~~---~~~~~~~~---~ 441 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELL---EKDYRMER---P 441 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHH---HTTCCCCC---C
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---HcCCCCCC---C
Confidence 322 11223456789999999999899999999999999999999 9999754332 1111111 11111111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.... ..+.+++.+||+.||++|||++++++..-
T Consensus 442 ~~~~---~~l~~li~~cl~~dP~~RPs~~el~~~L~ 474 (495)
T 1opk_A 442 EGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFE 474 (495)
T ss_dssp TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC---HHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 1112 25778899999999999999999988754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=358.78 Aligned_cols=265 Identities=20% Similarity=0.225 Sum_probs=198.2
Q ss_pred HHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec---
Q 039595 747 IKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN--- 822 (1078)
Q Consensus 747 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--- 822 (1078)
....++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcCCCCccchhheeeecCc
Confidence 34567899999999999999999965 5799999999865421 12368999999999999999999843
Q ss_pred -----------------------------------CCeeEEEEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHH
Q 039595 823 -----------------------------------ARHSFLVCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANA 866 (1078)
Q Consensus 823 -----------------------------------~~~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~ 866 (1078)
....++||||+++ +|.+.+... .....+++..+..++.||+.|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 3348899999985 877776421 234568999999999999999
Q ss_pred HHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEecccccccccCCCCCceeeccccccccccccccC-CCCccchhHHHH
Q 039595 867 LSYLHHDCLPSIIHRDISSKNVLLD-LEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFG 944 (1078)
Q Consensus 867 L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG 944 (1078)
|+|||++ ||+||||||+||+++ .++.+||+|||.|+..... .......||+.|+|||.+.+. .++.++||||+|
T Consensus 154 L~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 154 VGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 9999999 999999999999997 6899999999999876443 233456789999999998875 489999999999
Q ss_pred HHHHHHHhCCCCCCcccccccchhhhhhhh-------hhhcCCC-----CCCCCCccH------HHHHHHHHHHHhcccC
Q 039595 945 VLVFEVIKGNHPRDFFSINFSSFSNMIIEV-------NQILDPR-----LSTPSPGVM------DKLISIMEVAILCLDE 1006 (1078)
Q Consensus 945 ~il~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~-----~~~~~~~~~------~~~~~l~~li~~cl~~ 1006 (1078)
|++|||++|+.||...... ......+... ....++. +........ .....+.+++.+||+.
T Consensus 230 ~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999997643221 1111110000 0000111 100000000 0123578999999999
Q ss_pred CCCCCCChhHHHHHhhhhh
Q 039595 1007 SPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 1007 dP~~RPt~~ell~h~~~~~ 1025 (1078)
||++|||++|+++|+|+..
T Consensus 309 dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp SGGGSCCHHHHHTSGGGHH
T ss_pred ChhhCCCHHHHhcCHHHHH
Confidence 9999999999999999764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=348.47 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=197.0
Q ss_pred HHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhc--CCCCceeeEEeeeecC-
Q 039595 747 IKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE--IRHRNIVKFHGFCSNA- 823 (1078)
Q Consensus 747 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~- 823 (1078)
....++|++.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 344578999999999999999999876 899999998543 13334445555544 4999999999999776
Q ss_pred ---CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCCeeeCCCCc
Q 039595 824 ---RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC-----LPSIIHRDISSKNVLLDLEFE 895 (1078)
Q Consensus 824 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~ 895 (1078)
...++||||+++|+|.++++. ..+++.+++.++.|++.||+|||++. .++|+||||||+||+++.++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 789999999999999999943 35899999999999999999999752 238999999999999999999
Q ss_pred EEEecccccccccCCCCC----ceeeccccccccccccccCCCCcc------chhHHHHHHHHHHHhC----------CC
Q 039595 896 AHVSDFGIAKFVEPYSSN----RTEFVGTFGYAAPEIAYTMRATEK------YDVYSFGVLVFEVIKG----------NH 955 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlG~il~elltG----------~~ 955 (1078)
+||+|||+++........ .....||+.|+|||++.+..++.+ +|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999999866443222 124579999999999988776665 9999999999999999 55
Q ss_pred CCCcccccccchhhhhhhhhhhcCCCCCCCCCc---cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 956 PRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG---VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 956 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
||............. .. ...........+. .......+.+++.+||+.||++|||++|++++.-.
T Consensus 261 p~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDM-RE--IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TTTTTSCSSCCHHHH-HH--HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cHhhhcCCCCchhhh-HH--HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 543322211111111 11 1111111111111 12445578899999999999999999999988653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=361.56 Aligned_cols=263 Identities=21% Similarity=0.250 Sum_probs=203.4
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC--------CCceeeEEeee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR--------HRNIVKFHGFC 820 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~ 820 (1078)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.++++++ ||||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 36899999999999999999965 46889999998643 334567889999999885 78899999998
Q ss_pred e----cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC--
Q 039595 821 S----NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-- 894 (1078)
Q Consensus 821 ~----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-- 894 (1078)
. .+...|+||||+ +|++.+++... ....+++.+++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 7 567899999999 55666666332 2356899999999999999999999953 899999999999999775
Q ss_pred -----------------------------------------------cEEEecccccccccCCCCCceeecccccccccc
Q 039595 895 -----------------------------------------------EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927 (1078)
Q Consensus 895 -----------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE 927 (1078)
.+||+|||.++..... .....||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE 263 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence 7999999999876532 34457899999999
Q ss_pred ccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-hhhhhhhhhhhcC------------------C-----CCC
Q 039595 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS-FSNMIIEVNQILD------------------P-----RLS 983 (1078)
Q Consensus 928 ~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~------------------~-----~~~ 983 (1078)
++.+..++.++|||||||++|||++|+.||......... ............. . ...
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999998644321100 0000000000000 0 000
Q ss_pred C------------CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 984 T------------PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 984 ~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. ...........+.+++.+||+.||++|||++|+++|+|+.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0 0011234455788999999999999999999999999974
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=365.44 Aligned_cols=323 Identities=19% Similarity=0.191 Sum_probs=200.0
Q ss_pred cEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccc
Q 039595 105 VNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHN 184 (1078)
Q Consensus 105 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n 184 (1078)
+.++.++++++ .+|..+. ++|++|||++|++++..|..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 45666666665 4555443 46777777777777666666777777777777777666555555555555555555555
Q ss_pred cccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCc
Q 039595 185 NVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS 264 (1078)
Q Consensus 185 ~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 264 (1078)
.+++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~----- 165 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT----- 165 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS-----
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc-----
Confidence 555433334455555555555555555444445555555555555555555444444555555555555555544
Q ss_pred ccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcC
Q 039595 265 IIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSL 344 (1078)
Q Consensus 265 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 344 (1078)
+..+..|..+++|+.|++++|.+.+..+..|.++++|+.|++++|.+.+.+|..+....+|
T Consensus 166 -------------------~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L 226 (477)
T 2id5_A 166 -------------------SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226 (477)
T ss_dssp -------------------SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred -------------------ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence 4444444444444444444454444444455566666666666665555555555555577
Q ss_pred cEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCc
Q 039595 345 RNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQN 424 (1078)
Q Consensus 345 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 424 (1078)
+.|++++|++++..+..+..+++|+.|+|++|++++..+..|.++++|+.|++++|++.+..|..|..+++|++|++++|
T Consensus 227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 306 (477)
T 2id5_A 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306 (477)
T ss_dssp SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence 77777777777444456677777777777777777766667777777777777777777777777777777777777777
Q ss_pred cccccchhhccCCCCCcEecCCCCccCCcc
Q 039595 425 NLVGKVYEAFGDHPNLTFLDLSQNNFDGKI 454 (1078)
Q Consensus 425 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 454 (1078)
.++.+....|..+++|+.|+|++|++.+..
T Consensus 307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 307 QLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp CCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred cCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 777777777777778888888888776543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=357.37 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=204.3
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC----
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA---- 823 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 823 (1078)
..++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.++++++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc---CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 3468999999999999999999654 78899999986432 334457789999999999999999999998654
Q ss_pred -CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 824 -RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 824 -~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
...++||||+.+ +|.++++. ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence 468999999975 99999843 3589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC---Cceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh-----
Q 039595 903 IAKFVEPYSS---NRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE----- 973 (1078)
Q Consensus 903 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~----- 973 (1078)
.++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+..
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSP 251 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--GHHHHHHHHHCSC
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHHHhCCC
Confidence 9987653221 1245689999999998664 45899999999999999999999997543221 11111100
Q ss_pred ---------------hhhhcCCCCCCCC-CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 974 ---------------VNQILDPRLSTPS-PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 974 ---------------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
...........+. ........++.+++.+||+.||++|||++|+++|||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 0000000000000 000011236789999999999999999999999999764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=346.10 Aligned_cols=249 Identities=21% Similarity=0.341 Sum_probs=198.8
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CC-------CEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SG-------DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS 821 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 821 (1078)
.++|++.+.||+|+||+||+|... ++ ..||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 367899999999999999999654 33 479999986542 344678999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc------
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE------ 895 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~------ 895 (1078)
+++..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred eCCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence 999999999999999999999542 23489999999999999999999999 9999999999999998887
Q ss_pred --EEEecccccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCC-CCcccccccchhhhh
Q 039595 896 --AHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHP-RDFFSINFSSFSNMI 971 (1078)
Q Consensus 896 --~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p-~~~~~~~~~~~~~~~ 971 (1078)
+||+|||.+..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|..| |...... .... .
T Consensus 158 ~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~-~ 230 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQ-F 230 (289)
T ss_dssp CEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH-H
T ss_pred ceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHH-H
Confidence 99999999975432 234568999999999987 6799999999999999999996554 3321111 0000 0
Q ss_pred hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 972 IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. ...+......+ ..+.+++.+||+.||++|||++|++++.-..
T Consensus 231 ~----~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 231 Y----EDRHQLPAPKA------AELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp H----HTTCCCCCCSS------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred h----hccCCCCCCCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 0 01111111111 1467889999999999999999999986544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=357.09 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=200.3
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee--
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS-- 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-- 826 (1078)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 46899999999999999999965 478999999997643 2334467788999999999999999999999877655
Q ss_pred ----EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 827 ----FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 827 ----~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
++||||+. |+|.+++. ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred ceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 58988872 3489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh--------
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE-------- 973 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~-------- 973 (1078)
+++.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+..
T Consensus 190 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 190 LARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTE 264 (371)
T ss_dssp CC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHH
T ss_pred ccccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCcHH
Confidence 9986543 2345678999999999887 67899999999999999999999997643211 11110000
Q ss_pred ------------hhhhcCCCCCCCCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 974 ------------VNQILDPRLSTPSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 974 ------------~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.............. ........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 00000000000000 00011236789999999999999999999999999763
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=368.33 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=197.6
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.+.||+|+||.||+|.++.+..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 346788999999999999999998877889999987542 235679999999999999999999999876 67899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.++++.. ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 256 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 99999999999999432 234589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... ......+ ........ .
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i---~~~~~~~~---~ 403 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV---ERGYRMPC---P 403 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH---HTTCCCCC---C
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---HcCCCCCC---C
Confidence 322 22234457889999999999999999999999999999999 9999753322 1111111 11111111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.... ..+.+++.+||+.||++|||++++++..
T Consensus 404 ~~~~---~~l~~li~~cl~~dP~~Rpt~~~l~~~L 435 (452)
T 1fmk_A 404 PECP---ESLHDLMCQCWRKEPEERPTFEYLQAFL 435 (452)
T ss_dssp TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCC---HHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1122 2577889999999999999999988653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=347.65 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=201.4
Q ss_pred CCccceeccCCceeEEEEEeC-----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--CCe
Q 039595 753 FDEKFCIGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN--ARH 825 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 825 (1078)
|++.+.||+|+||+||+|.++ +++.||||++.... .....+.+.+|+.++++++||||+++++++.+ ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 489999999999999988643 68899999997542 34456779999999999999999999999976 467
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence 8999999999999999943 3489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC---CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc------hhhhhhhhhh
Q 039595 906 FVEPYSS---NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS------FSNMIIEVNQ 976 (1078)
Q Consensus 906 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~------~~~~~~~~~~ 976 (1078)
....... ......||..|+|||.+.+..++.++||||+|+++|||++|+.||......... ..........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 7754332 123456788899999999989999999999999999999999997533221100 0000011111
Q ss_pred hcCCCCCC-CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 977 ILDPRLST-PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 977 ~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
........ ..... ...+.+++.+||+.||++|||++|+++..-
T Consensus 263 ~~~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 263 LLERGERLPRPDKC---PAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcccCCCCCccc---cHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111111 11112 236788999999999999999999997643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=351.07 Aligned_cols=260 Identities=25% Similarity=0.349 Sum_probs=203.4
Q ss_pred hcCCCccceeccCCceeEEEEEe------CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 46899999999999999999974 257789999986432 334566788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCC----CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcE
Q 039595 824 RHSFLVCEYLHRGSLARILGNDAT----AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL---EFEA 896 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ 896 (1078)
...++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999964321 24589999999999999999999999 9999999999999984 4569
Q ss_pred EEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhh
Q 039595 897 HVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIE 973 (1078)
Q Consensus 897 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 973 (1078)
||+|||.++....... ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~-- 258 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFV-- 258 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH--
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHH--
Confidence 9999999986543221 2234567899999999999999999999999999999998 9999753321 1111111
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
............. ..+.+++.+||+.||++|||++|+++++|....
T Consensus 259 ----~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 259 ----TSGGRMDPPKNCP---GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ----HTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hcCCCCCCCCCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 1111111111122 257789999999999999999999999986544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=357.37 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=189.3
Q ss_pred CCCccceeccCCceeEEEEEeC--CC--CEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee-cCCee
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP--SG--DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS-NARHS 826 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~ 826 (1078)
.|++.+.||+|+||+||+|... ++ ..||||.+... ......+.+.+|+.++++++||||+++++++. .++..
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4677789999999999999653 22 36899988653 23455678999999999999999999999864 45688
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|+|.++++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 167 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence 9999999999999999543 34578999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCC----CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 907 VEPYSS----NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 907 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||..... ........... .+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--~~~~~~~~~~~---~~~ 316 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGR---RLL 316 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--SCHHHHHHTTC---CCC
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--HHHHHHHHcCC---CCC
Confidence 643221 1234567889999999999999999999999999999999 6777653322 11111111111 111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
...... ..+.+++.+||+.||++|||++|++++.-
T Consensus 317 ---~p~~~~---~~l~~li~~cl~~dp~~RPs~~ell~~L~ 351 (373)
T 3c1x_A 317 ---QPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRIS 351 (373)
T ss_dssp ---CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111112 25778899999999999999999997644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.69 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=203.3
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec-----
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN----- 822 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----- 822 (1078)
...+|+..+.||+|+||.||+|... +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 3467999999999999999999765 79999999986542 246789999999999999999998854
Q ss_pred -----------CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 039595 823 -----------ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 823 -----------~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 891 (1078)
....++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 45589999999999999999543 235689999999999999999999999 999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh
Q 039595 892 LEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI 971 (1078)
Q Consensus 892 ~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~ 971 (1078)
.++.+||+|||.+....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.... ..
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~- 227 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KF- 227 (284)
T ss_dssp ETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HH-
T ss_pred CCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HH-
Confidence 99999999999998765432 2344579999999999999999999999999999999999999842111 01
Q ss_pred hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 972 IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
............. . ..+.+++.+||+.||++|||++|++++++....
T Consensus 228 --~~~~~~~~~~~~~---~---~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 228 --FTDLRDGIISDIF---D---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp --HHHHHTTCCCTTS---C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred --HHHhhcccccccC---C---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 1111111221111 1 256788999999999999999999999886543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=352.46 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=205.3
Q ss_pred cCCCccceeccCCceeEEEEEe-----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee--cC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS--NA 823 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~ 823 (1078)
++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++++++||||+++++++. +.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 6899999999999999999973 36889999998754 3445677899999999999999999999885 55
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...++||||+++|+|.+++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 6789999999999999999532 24589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC---CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccch------hhhhhhh
Q 039595 904 AKFVEPYSS---NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF------SNMIIEV 974 (1078)
Q Consensus 904 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~------~~~~~~~ 974 (1078)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... .......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 987654332 1234467888999999999899999999999999999999999964322211000 0000111
Q ss_pred hhhcCCCCC-CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 975 NQILDPRLS-TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 975 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
......... ...... ...+.+++.+||+.||++|||++|++++.-..
T Consensus 254 ~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 254 LELLEEGQRLPAPPAC---PAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred HHHhhcccCCCCCCcc---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111111 111112 23577889999999999999999998886543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.62 Aligned_cols=260 Identities=21% Similarity=0.326 Sum_probs=200.7
Q ss_pred cCCCccceeccCCceeEEEEEe-----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC--
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA-- 823 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-- 823 (1078)
++|+..+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 5688999999999999999973 368899999997543 233457789999999999999999999999776
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...++||||+++|+|.+++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence 6689999999999999999432 34589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC---CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc-------ccchhhhhhh
Q 039595 904 AKFVEPYSS---NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN-------FSSFSNMIIE 973 (1078)
Q Consensus 904 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~-------~~~~~~~~~~ 973 (1078)
+........ ......||..|+|||.+.+..++.++||||+|+++|||++|+.|+...... ..........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987754432 223456788899999999999999999999999999999999985322110 0000000001
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
................. ..+.+++.+||+.||++|||++|+++..
T Consensus 253 ~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCP---DEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HHHHHTTCCCCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCC---HHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 11111111111111122 3577899999999999999999999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=349.01 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=203.3
Q ss_pred HHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhc--CCCCceeeEEeeeecC
Q 039595 746 IIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE--IRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 746 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~ 823 (1078)
-....++|++.+.||+|+||.||+|+. +|+.||||++... ..+.+.+|+++++. ++||||+++++++...
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 344567899999999999999999987 4899999998543 24567778888777 7999999999999876
Q ss_pred C----eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEecCCCCCCeeeC
Q 039595 824 R----HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH--------HDCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 824 ~----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~NIll~ 891 (1078)
. ..++||||+++|+|.+++.+ ..+++.+++.++.|++.||+||| +. +|+||||||+||+++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 5 78999999999999999943 35899999999999999999999 77 999999999999999
Q ss_pred CCCcEEEecccccccccCCCCC----ceeeccccccccccccccCC------CCccchhHHHHHHHHHHHhC--------
Q 039595 892 LEFEAHVSDFGIAKFVEPYSSN----RTEFVGTFGYAAPEIAYTMR------ATEKYDVYSFGVLVFEVIKG-------- 953 (1078)
Q Consensus 892 ~~~~~kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltG-------- 953 (1078)
.++.+||+|||++......... .....||+.|+|||.+.+.. ++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999876543321 23457999999999988752 34689999999999999999
Q ss_pred --CCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc---cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 954 --NHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG---VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 954 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
+.||.............. ..+.........+. .......+.+++.+||+.||++|||++|++++...
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMR---KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHH---HHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCccccCcCcccHHHHH---HHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 677643322111111111 11112222222111 12445578899999999999999999999988653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.05 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=194.8
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
..++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+.+|+.++++++||||+++++++..++..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 4578999999999999999999764 788999999976532 23444577899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++++|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 99999999999999953 34689999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 908 EPYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 908 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ..... +......
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~---~~~~~-~~~~~~~ 258 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAH---INQAI-PRPSTVR 258 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHH---HHSCC-CCGGGTS
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHH---hccCC-CCccccC
Confidence 5432 2234567899999999999999999999999999999999999997643221 11111 11111 1100011
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCC-ChhHHHHHhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARP-TMEKGFGHHI 1022 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ell~h~~ 1022 (1078)
+... ..+.+++.+||+.||++|| +++++++...
T Consensus 259 ~~~~---~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 259 PGIP---VAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp TTCC---THHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCC---HHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 1111 2577889999999999999 8888776543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=349.89 Aligned_cols=261 Identities=18% Similarity=0.227 Sum_probs=205.5
Q ss_pred hcCCCccceeccCCceeEEEEEe--CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc------eeeEEeeee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL--PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN------IVKFHGFCS 821 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~ 821 (1078)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.+++.++|++ ++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 46899999999999999999965 36889999998643 234567888999988887654 999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---------
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL--------- 892 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------- 892 (1078)
..+..++||||+ +++|.+++... ....+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence 999999999999 88999998543 234688999999999999999999999 9999999999999987
Q ss_pred ----------CCcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 039595 893 ----------EFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI 962 (1078)
Q Consensus 893 ----------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~ 962 (1078)
++.+||+|||.++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 67899999999986543 23456789999999999999999999999999999999999999764332
Q ss_pred cccchhhhhhhhhhhc----------------------------------CCCCCCCCCccHHHHHHHHHHHHhcccCCC
Q 039595 963 NFSSFSNMIIEVNQIL----------------------------------DPRLSTPSPGVMDKLISIMEVAILCLDESP 1008 (1078)
Q Consensus 963 ~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 1008 (1078)
.. ....+....... ................++.+++.+||+.||
T Consensus 240 ~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 240 KE--HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HH--HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HH--HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 11 011000000000 000000001112334578899999999999
Q ss_pred CCCCChhHHHHHhhhhh
Q 039595 1009 EARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 1009 ~~RPt~~ell~h~~~~~ 1025 (1078)
++|||++|+++|+|+..
T Consensus 318 ~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 318 AKRITLREALKHPFFDL 334 (339)
T ss_dssp TTSCCHHHHTTSGGGGG
T ss_pred ccccCHHHHhcCHHHHH
Confidence 99999999999999764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=355.09 Aligned_cols=265 Identities=16% Similarity=0.168 Sum_probs=194.9
Q ss_pred hcCCCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCC-------hhhHHHHHHHHHHHhcCCCCceeeEEe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGN-------MADQDEFLNVVLALNEIRHRNIVKFHG 818 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~ 818 (1078)
.++|++.+.||+|+||+||+|... ++..||||++........ ......+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999765 578899999875421100 001234667888999999999999999
Q ss_pred eeec----CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC
Q 039595 819 FCSN----ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF 894 (1078)
Q Consensus 819 ~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 894 (1078)
++.. ....|+||||+ +++|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9977 78899999999 9999999943 23799999999999999999999999 999999999999998887
Q ss_pred --cEEEecccccccccCCC-------CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc
Q 039595 895 --EAHVSDFGIAKFVEPYS-------SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 965 (1078)
Q Consensus 895 --~~kl~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~ 965 (1078)
.+||+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999998764321 112455799999999999999999999999999999999999999753222221
Q ss_pred chhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 966 SFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 966 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
............+++......+ .......+.+++.+||+.||++|||++++++...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 324 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAP-SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN 324 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSC-TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred HHHHHHHhhcccccHHHHhhcc-ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 1111111111111110000000 0011126788899999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=345.13 Aligned_cols=256 Identities=18% Similarity=0.205 Sum_probs=202.4
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ..+.+.+|+.+++.+ +|++++++++++.++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 46799999999999999999975 578999999986532 123477889999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc-----EEEeccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE-----AHVSDFG 902 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DfG 902 (1078)
+||||+ +++|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 83 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 999999 99999999543 34589999999999999999999999 9999999999999987776 9999999
Q ss_pred ccccccCCCC-------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-cchhhhhhhh
Q 039595 903 IAKFVEPYSS-------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF-SSFSNMIIEV 974 (1078)
Q Consensus 903 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~~~~~~~~~~ 974 (1078)
.++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9987654322 2345679999999999999999999999999999999999999986543211 1111111111
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
... +......... ...+.+++.+||+.||++||+++++++...
T Consensus 237 ~~~--~~~~~~~~~~---~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 237 KQS--TPLRELCAGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp HHH--SCHHHHTTTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ccC--ccHHHHHhhC---cHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 100 0000000011 126778999999999999999999887644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=364.97 Aligned_cols=261 Identities=23% Similarity=0.274 Sum_probs=196.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec------C
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN------A 823 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~ 823 (1078)
.+|+..+.||+|+||+||+|... +|+.||||++..... .+.+|+.++++++||||+++++++.. .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 46899999999999999999764 699999999865321 12468999999999999999998843 2
Q ss_pred CeeEEEEeecCCCCHHHHhcC-CCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEecc
Q 039595 824 RHSFLVCEYLHRGSLARILGN-DATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDF 901 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Df 901 (1078)
...++||||+++ ++.+.+.. ......+++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence 246799999986 66665532 12345689999999999999999999999 99999999999999965 67899999
Q ss_pred cccccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh------
Q 039595 902 GIAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV------ 974 (1078)
Q Consensus 902 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~------ 974 (1078)
|+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...+...
T Consensus 202 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 202 GSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 279 (420)
T ss_dssp TTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHH
T ss_pred hhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 999876442 223456789999999998765 7999999999999999999999997643221 1111111000
Q ss_pred -hhhcCCCCC-----CCCCccH------HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 -NQILDPRLS-----TPSPGVM------DKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 -~~~~~~~~~-----~~~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....+.+. ....... ....++.+++.+||..||++|||++|+++|+|+..
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 000111111 0000000 11236789999999999999999999999999853
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.67 Aligned_cols=252 Identities=22% Similarity=0.379 Sum_probs=202.3
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.+.||+|+||.||+|..++++.||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 457899999999999999999998888899999986542 235678999999999999999999999874 56899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999432 223689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... .......+...
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~---~~~~~~~~~~~--- 232 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQ---NLERGYRMVRP--- 232 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH---HHHTTCCCCCC---
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHHHH---HHhcccCCCCc---
Confidence 4321 1223456789999999998889999999999999999999 9999753322 11111 11111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
... ...+.+++.+||+.||++|||++++++..
T Consensus 233 ~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 233 DNC---PEELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccc---cHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 111 13677899999999999999999988754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=352.43 Aligned_cols=263 Identities=23% Similarity=0.320 Sum_probs=201.9
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA----- 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 823 (1078)
.++|++.+.||+|+||.||+|... +|+.||||++... ........+.+|+.++++++||||+++++++..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 468999999999999999999765 6899999998643 2344456788999999999999999999988654
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...++||||+. |+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 67899999997 589998843 4689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCC----------ceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh
Q 039595 904 AKFVEPYSSN----------RTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 972 (1078)
Q Consensus 904 a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~ 972 (1078)
++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~ 236 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--HQLLLIF 236 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH
Confidence 9876432211 123578999999998764 67899999999999999999999997643311 0000000
Q ss_pred hh------------------hhhcC--CCCCCCC--CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 973 EV------------------NQILD--PRLSTPS--PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 973 ~~------------------~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ..... +...... ........++.+++.+||+.||++|||++|+++|+|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 00000 0000000 000011236788999999999999999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=347.46 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=200.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCE--EEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDI--VAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
++|++.+.||+|+||.||+|... ++.. ||+|++.... .....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 68999999999999999999654 5664 4999886532 223456688999999999 999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC
Q 039595 827 FLVCEYLHRGSLARILGNDA-------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE 893 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 893 (1078)
++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence 99999999999999996542 234689999999999999999999999 99999999999999999
Q ss_pred CcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhh
Q 039595 894 FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMII 972 (1078)
Q Consensus 894 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 972 (1078)
+.+||+|||+++..... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~--- 252 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYE--- 252 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH---
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--HHHHH---
Confidence 99999999999754321 12234467889999999998889999999999999999998 9999753322 11111
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.......+... .... ..+.+++.+||+.||++|||++|++++...
T Consensus 253 ~~~~~~~~~~~---~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 253 KLPQGYRLEKP---LNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HGGGTCCCCCC---TTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcCCCCCCC---CCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111111111 1112 357789999999999999999999988653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=356.12 Aligned_cols=271 Identities=21% Similarity=0.232 Sum_probs=193.6
Q ss_pred HHHHHHhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee
Q 039595 743 HEEIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS 821 (1078)
Q Consensus 743 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 821 (1078)
.++.....++|++.+.||+|+||+||+|... +|+.||||++.... .....+.+++..++.++||||+++++++.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-----TCCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-----cccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 3556677899999999999999999999764 78999999986532 12234567788888899999999999985
Q ss_pred cCC-------eeEEEEeecCCCCHHHHhc-CCCCCCcCCHHHHHHHHHHHHHHHHHHH--hcCCCCcEecCCCCCCeeeC
Q 039595 822 NAR-------HSFLVCEYLHRGSLARILG-NDATAKELSWNRRINVIKGVANALSYLH--HDCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 822 ~~~-------~~~lv~E~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlk~~NIll~ 891 (1078)
..+ ..++||||+++ ++.+.+. .......+++..+..++.|++.|+.||| +. +|+||||||+||+++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVN 165 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEE
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEe
Confidence 433 27899999987 4444332 1234556889999999999999999999 88 999999999999999
Q ss_pred C-CCcEEEecccccccccCCCCCceeeccccccccccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccchhh
Q 039595 892 L-EFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 892 ~-~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 969 (1078)
. ++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ....
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~ 242 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLH 242 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH
T ss_pred CCCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHH
Confidence 7 8999999999998765432 334567899999999987654 899999999999999999999997643321 1111
Q ss_pred hhhh--------hhhhcCCCCCC------CC--------CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 970 MIIE--------VNQILDPRLST------PS--------PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 970 ~~~~--------~~~~~~~~~~~------~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+.. ......+.... .. .........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 1100 00000010000 00 000112346889999999999999999999999999765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=339.11 Aligned_cols=256 Identities=20% Similarity=0.308 Sum_probs=200.6
Q ss_pred hhcCCCccceeccCCceeEEEEEeCC----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
..++|++.+.||+|+||+||+|.... +..||+|++.... .....+.+.+|+.++++++||||+++++++.++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 34689999999999999999996532 3369999987542 344567899999999999999999999998754
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred CCEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCC
Confidence 568999999999999999542 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 905 KFVEPYSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 905 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........ ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~---~~~~~~ 235 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEK---GDRLPK 235 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHH---TCCCCC
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhc---CCCCCC
Confidence 87654322 2234567889999999998899999999999999999998 99997533221 11111111 111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. .... ..+.+++.+||+.||++|||++|++++....
T Consensus 236 ~---~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 236 P---DLCP---PVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp C---TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---CCCC---HHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 1 1111 2577899999999999999999999986543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=356.25 Aligned_cols=262 Identities=17% Similarity=0.210 Sum_probs=196.3
Q ss_pred hhcCCCccceeccCCceeEEEEEeCC------CCEEEEEEeccccccCC-------hhhHHHHHHHHHHHhcCCCCceee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPS------GDIVAVKKFNSQLLSGN-------MADQDEFLNVVLALNEIRHRNIVK 815 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~ 815 (1078)
..++|++.+.||+|+||+||+|.++. ++.||||++........ ......+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999997654 47899999865421000 000122345666778889999999
Q ss_pred EEeeeecC----CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC
Q 039595 816 FHGFCSNA----RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 891 (1078)
Q Consensus 816 l~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~ 891 (1078)
+++++... ...++||||+ +|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99998654 5589999999 99999999542 35699999999999999999999999 999999999999999
Q ss_pred --CCCcEEEecccccccccCCCC-------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 039595 892 --LEFEAHVSDFGIAKFVEPYSS-------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI 962 (1078)
Q Consensus 892 --~~~~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~ 962 (1078)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 889999999999987643221 12345699999999999999999999999999999999999999864322
Q ss_pred cccchhhhh----hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 963 NFSSFSNMI----IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 963 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
+........ .......++.+.. .... .++.+++.+||+.||++||+++++++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPA--ANAP---GEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCT--TCCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhccc--ccCH---HHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 211111110 1111122211110 1111 2577888999999999999999988753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=350.65 Aligned_cols=259 Identities=20% Similarity=0.251 Sum_probs=177.6
Q ss_pred hhcCCCccc-eeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec----
Q 039595 749 ATDDFDEKF-CIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN---- 822 (1078)
Q Consensus 749 ~~~~~~~~~-~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---- 822 (1078)
..++|++.+ .||+|+||+||+|..+ +|+.||||++... .....+....++.++||||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 457888855 6999999999999765 7999999998543 1122223334567799999999999865
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEe
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL---EFEAHVS 899 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~ 899 (1078)
+...++||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CceEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence 45689999999999999999653 235699999999999999999999999 9999999999999976 4559999
Q ss_pred cccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcC
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 979 (1078)
|||+++.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..... ..+..
T Consensus 174 Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~--~~~~~ 247 (336)
T 3fhr_A 174 DFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--SPGMK--RRIRL 247 (336)
T ss_dssp CCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccccceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--hhhHH--Hhhhc
Confidence 9999986543 223456789999999999888899999999999999999999999754332111 00000 00000
Q ss_pred CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 980 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....+.+........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 1111111111112236788999999999999999999999999764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=349.33 Aligned_cols=264 Identities=24% Similarity=0.337 Sum_probs=183.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHH-HHhcCCCCceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVL-ALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
.++|+..+.||+|+||.||+|..+ +|+.||||++.... ......++..|+. +++.++||||+++++++.+++..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 368999999999999999999764 78999999997542 2233445555555 778889999999999999999999
Q ss_pred EEEeecCCCCHHHHhcC--CCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 828 LVCEYLHRGSLARILGN--DATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
+||||+++ +|.+++.. ......+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 99999986 88777742 112456899999999999999999999952 89999999999999999999999999998
Q ss_pred cccCCCCCceeecccccccccccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIA----YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
...... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.............. ....+.
T Consensus 175 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~ 249 (327)
T 3aln_A 175 QLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV----KGDPPQ 249 (327)
T ss_dssp C-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC----CSCCCC
T ss_pred eccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh----cCCCCC
Confidence 764322 23344799999999998 456789999999999999999999999764332111111100 001111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
+..... ......+.+++.+||+.||++|||++|+++|+|+...
T Consensus 250 ~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 250 LSNSEE--REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCSS--CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCccc--ccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 111100 1112367889999999999999999999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=349.64 Aligned_cols=269 Identities=21% Similarity=0.285 Sum_probs=202.9
Q ss_pred HhhcCCCccceeccCCceeEEEEEe--CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC---CCCceeeEEeeee-
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL--PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI---RHRNIVKFHGFCS- 821 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~- 821 (1078)
.+.++|++.+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3567899999999999999999976 467899999987543221 1122355666666555 8999999999986
Q ss_pred ----cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEE
Q 039595 822 ----NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH 897 (1078)
Q Consensus 822 ----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 897 (1078)
.....++||||++ |+|.+++.... ...+++.+++.++.||+.||+|||++ ||+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 5678899999998 59999985432 34589999999999999999999999 999999999999999999999
Q ss_pred EecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh--
Q 039595 898 VSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN-- 975 (1078)
Q Consensus 898 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-- 975 (1078)
|+|||.++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 161 l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~ 238 (326)
T 1blx_A 161 LADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLP 238 (326)
T ss_dssp ECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred EecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCC
Confidence 9999999865432 2234567899999999999999999999999999999999999997643221 00101000000
Q ss_pred --h-----------hcCCCCCCCCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 976 --Q-----------ILDPRLSTPSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 976 --~-----------~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. .+......... ........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 0 00000000000 00111235778999999999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=358.09 Aligned_cols=264 Identities=23% Similarity=0.262 Sum_probs=203.0
Q ss_pred hhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CC-----ceeeEEeeee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HR-----NIVKFHGFCS 821 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~ 821 (1078)
..++|++.+.||+|+||+||+|... +++.||||++... ......+..|+.+++.++ |+ +|+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 4578999999999999999999654 6889999998643 233556777888887774 44 5999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--CCCcEEEe
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD--LEFEAHVS 899 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~ 899 (1078)
..+..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||++ ..+|+||||||+||+++ .++.+||+
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999999965 9999985432 34589999999999999999999942 12899999999999995 47889999
Q ss_pred cccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh-----
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV----- 974 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~----- 974 (1078)
|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 204 DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~--~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 204 DFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV--DQMNKIVEVLGIPP 278 (382)
T ss_dssp CCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCC
T ss_pred eccCceeccc---ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence 9999987643 234567899999999999999999999999999999999999997643221 111110000
Q ss_pred ----------hhhcCC----------------CCCCC-----------------------CCccHHHHHHHHHHHHhccc
Q 039595 975 ----------NQILDP----------------RLSTP-----------------------SPGVMDKLISIMEVAILCLD 1005 (1078)
Q Consensus 975 ----------~~~~~~----------------~~~~~-----------------------~~~~~~~~~~l~~li~~cl~ 1005 (1078)
...+.. ....+ ......+...+.+++.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 000000 00000 00112233478899999999
Q ss_pred CCCCCCCChhHHHHHhhhhh
Q 039595 1006 ESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 1006 ~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.||++|||++|+++|||+..
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~ 378 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKK 378 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC
T ss_pred CChhhCCCHHHHhcCccccc
Confidence 99999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=347.67 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=196.0
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee-------
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS------- 821 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~------- 821 (1078)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 468999999999999999999765 5899999998643 3445678899999999999999999999873
Q ss_pred -------cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CC
Q 039595 822 -------NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-LE 893 (1078)
Q Consensus 822 -------~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~ 893 (1078)
+....++||||++ |+|.+++.. +.+++..++.++.|++.||+|||++ +|+||||||+||+++ .+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 4467899999998 599999942 4689999999999999999999999 999999999999997 56
Q ss_pred CcEEEecccccccccCCC---CCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhh
Q 039595 894 FEAHVSDFGIAKFVEPYS---SNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 969 (1078)
Q Consensus 894 ~~~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 969 (1078)
+.+||+|||.++...... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~ 235 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQ 235 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence 799999999998764321 12234567999999998865 67899999999999999999999997643321 1000
Q ss_pred hhhhh---------hhhc-------CCCCCCCCCcc----HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 970 MIIEV---------NQIL-------DPRLSTPSPGV----MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 970 ~~~~~---------~~~~-------~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.+... .... ......+.... .....++.+++.+||+.||++|||++|+++|+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 00000 0000 00000000000 011236789999999999999999999999999764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=359.26 Aligned_cols=302 Identities=24% Similarity=0.227 Sum_probs=190.3
Q ss_pred CCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeec
Q 039595 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLF 302 (1078)
Q Consensus 223 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 302 (1078)
+|+.|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|.++++|+.|+++
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 112 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS 112 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence 44444444444444444444444444444444444444444444444444444444444444333344444444444444
Q ss_pred ccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCcccc
Q 039595 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVI 382 (1078)
Q Consensus 303 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 382 (1078)
+|.+++..|..|.++++|++|+|++|++++..+..|..+++|+.|++++|++++..+..+..+++|+.|+|++|.+.+..
T Consensus 113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~ 192 (477)
T 2id5_A 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR 192 (477)
T ss_dssp TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEEC
T ss_pred CCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeC
Confidence 44444455556666777777777777777766777777777788888888777666666777888888888888887777
Q ss_pred CCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCC
Q 039595 383 PHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLP 462 (1078)
Q Consensus 383 p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 462 (1078)
+..|.++++|+.|++++|...+.+|.......+|++|++++|.+..+....|..+++|+.|+|++|.++++....
T Consensus 193 ~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~----- 267 (477)
T 2id5_A 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSM----- 267 (477)
T ss_dssp TTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTS-----
T ss_pred hhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhh-----
Confidence 777888888888888887776666665555567777777777777777777777777888888777776554444
Q ss_pred CCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeecc
Q 039595 463 KLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLS 542 (1078)
Q Consensus 463 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 542 (1078)
|..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus 268 -------------------~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 328 (477)
T 2id5_A 268 -------------------LHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD 328 (477)
T ss_dssp -------------------CTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECC
T ss_pred -------------------ccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEcc
Confidence 4445555555666666655555566666666666666666665555566666666666666
Q ss_pred CccccC
Q 039595 543 ANKLSS 548 (1078)
Q Consensus 543 ~N~l~~ 548 (1078)
+|++..
T Consensus 329 ~N~l~c 334 (477)
T 2id5_A 329 SNPLAC 334 (477)
T ss_dssp SSCEEC
T ss_pred CCCccC
Confidence 666653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=347.12 Aligned_cols=257 Identities=20% Similarity=0.284 Sum_probs=199.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee----cCC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS----NAR 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~ 824 (1078)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 46899999999999999999976 57999999998643 3455678899999999999999999999986 345
Q ss_pred eeEEEEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 825 HSFLVCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
..++||||+++|+|.+++... .....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 789999999999999998542 1245689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCC---------ceeeccccccccccccccCC---CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh
Q 039595 904 AKFVEPYSSN---------RTEFVGTFGYAAPEIAYTMR---ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI 971 (1078)
Q Consensus 904 a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~ 971 (1078)
+......... .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||+.............
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 260 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence 8765321111 12345799999999987554 68999999999999999999999753221111111111
Q ss_pred hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 972 IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. .. ... ..... ...+.+++.+||+.||++|||++|++++..
T Consensus 261 ~~---~~--~~~-~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 261 QN---QL--SIP-QSPRH---SSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp HC---C----CC-CCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hc---cC--CCC-ccccC---CHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 11 01 111 11111 236788999999999999999999998765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=343.61 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=195.7
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecC
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNA 823 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 823 (1078)
...++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34578999999999999999999653 345899999875432 334467789999999999999999999999765
Q ss_pred C-----eeEEEEeecCCCCHHHHhcCC---CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc
Q 039595 824 R-----HSFLVCEYLHRGSLARILGND---ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE 895 (1078)
Q Consensus 824 ~-----~~~lv~E~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 895 (1078)
. ..++||||+++|+|.+++... .....+++.+++.++.||+.||.|||++ +|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 4 359999999999999998432 2345699999999999999999999999 9999999999999999999
Q ss_pred EEEecccccccccCCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhh
Q 039595 896 AHVSDFGIAKFVEPYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMII 972 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 972 (1078)
+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ......
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~- 262 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYL- 262 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH-
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHH-
Confidence 9999999998764432 12234567889999999999999999999999999999999 88897543221 111111
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.....+... .... ..+.+++.+||+.||++|||+++++++.-..
T Consensus 263 --~~~~~~~~~---~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 263 --LHGHRLKQP---EDCL---DELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp --HTTCCCCCB---TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HcCCCCCCC---cccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111111 1111 3578899999999999999999999886543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=340.78 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=197.1
Q ss_pred cCCCccceeccCCceeEEEEEeCC----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeee-ecCCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFC-SNARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~ 825 (1078)
.+|++.+.||+|+||+||+|...+ +..||+|++... ......+.+.+|+.++++++||||+++++++ ..++.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 568889999999999999997542 235899998753 2345567889999999999999999999985 55678
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++|+|.++++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred eEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence 89999999999999999542 35689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCC----CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCC
Q 039595 906 FVEPYS----SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDP 980 (1078)
Q Consensus 906 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 980 (1078)
...... .......||+.|+|||.+.+..++.++||||+|+++|||++ |.+||..... .......... ..+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~~~~~~~~~---~~~ 251 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQG---RRL 251 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--TTHHHHHHTT---CCC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhcC---CCC
Confidence 664322 12344567889999999999999999999999999999999 5555432221 1111111111 111
Q ss_pred CCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 981 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. ..... ..+.+++.+||+.||++|||++|+++..-
T Consensus 252 ~~---~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~ 287 (298)
T 3f66_A 252 LQ---PEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRIS 287 (298)
T ss_dssp CC---CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC---CccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 11111 25778899999999999999999997643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=346.83 Aligned_cols=253 Identities=24% Similarity=0.421 Sum_probs=195.9
Q ss_pred cCCCccceeccCCceeEEEEEeCC-----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPS-----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.+|+..+.||+|+||+||+|.... +..||||++.... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 467788999999999999996542 2359999987542 33456678999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999542 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 906 FVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 906 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
........ .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ...... ..... .
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~---~~~~~--~ 268 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKA---INDGF--R 268 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH---HHTTC--C
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHHH---HHCCC--c
Confidence 76543221 223346789999999999999999999999999999999 9999753321 111111 11111 1
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. ..... ...+.+++.+||+.||++||+++|++++..
T Consensus 269 ~~-~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 305 (333)
T 1mqb_A 269 LP-TPMDC---PSAIYQLMMQCWQQERARRPKFADIVSILD 305 (333)
T ss_dssp CC-CCTTC---BHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CC-CcccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 11112 235778899999999999999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=349.31 Aligned_cols=257 Identities=22% Similarity=0.327 Sum_probs=199.7
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe---
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH--- 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 825 (1078)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 36799999999999999999965 478999999997643 233446678899999999999999999999977654
Q ss_pred ---eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 826 ---SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 826 ---~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
.++||||+. |+|.+++. ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred ceeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999997 58888772 2489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh--------
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE-------- 973 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~-------- 973 (1078)
.++.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+..
T Consensus 172 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 172 LARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTE 246 (353)
T ss_dssp CTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--HHHHHHHHHHCBCCHH
T ss_pred cccCCCC---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 9986543 2345678999999999887 67899999999999999999999997543211 11110000
Q ss_pred ------------hhhhc----CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 974 ------------VNQIL----DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 974 ------------~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....+ .+.+....+ .....+.+++.+||+.||++|||++|+++|+|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFP---RASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCT---TSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcC---CcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00000 011111111 12336788999999999999999999999999763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=358.55 Aligned_cols=257 Identities=23% Similarity=0.305 Sum_probs=191.3
Q ss_pred CCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEEE
Q 039595 752 DFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..|+||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 45556889999999998776678999999998643 244678899999876 8999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCc----CCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-------------
Q 039595 831 EYLHRGSLARILGNDATAKE----LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE------------- 893 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------------- 893 (1078)
||+. |+|.+++........ .++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence 9996 599999965432111 13445678999999999999999 99999999999999754
Q ss_pred CcEEEecccccccccCCCCC----ceeecccccccccccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCccc
Q 039595 894 FEAHVSDFGIAKFVEPYSSN----RTEFVGTFGYAAPEIAYT-------MRATEKYDVYSFGVLVFEVIK-GNHPRDFFS 961 (1078)
Q Consensus 894 ~~~kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-G~~p~~~~~ 961 (1078)
+.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999877543221 234579999999999875 678999999999999999999 999975322
Q ss_pred ccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 962 INFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
... .. ........... ..........++.+++.+||+.||++|||++|+++|||+...
T Consensus 245 ~~~---~~---i~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 245 SRE---SN---IIRGIFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp THH---HH---HHHTCCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred hhH---HH---HhcCCCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 110 11 11111111100 111122344578899999999999999999999999998643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=347.15 Aligned_cols=254 Identities=20% Similarity=0.362 Sum_probs=194.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCE----EEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDI----VAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+.... .....+.+.+|+.++++++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 367999999999999999999754 4554 5667665432 3345678999999999999999999999998765
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
.++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred -ceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 78999999999999999543 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 905 KFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 905 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
+....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||+..... ........ ..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~------~~ 236 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK------GE 236 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT------TC
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc------CC
Confidence 87644322 2234456889999999999999999999999999999999 99997643321 11111111 11
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
......... .++.+++.+||+.||++|||++|+++..-.
T Consensus 237 ~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 275 (327)
T 3lzb_A 237 RLPQPPICT---IDVYMIMRKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp CCCCCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111112 257789999999999999999999987543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=371.69 Aligned_cols=269 Identities=24% Similarity=0.264 Sum_probs=207.5
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec------
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN------ 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 822 (1078)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 47899999999999999999965 468999999986542 34556779999999999999999999999765
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCc---EEEe
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFE---AHVS 899 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~ 899 (1078)
++..++||||+++|+|.+++........+++..++.++.|++.||+|||+. ||+||||||+||+++.++. +||+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 678899999999999999997655555789999999999999999999999 9999999999999997765 9999
Q ss_pred cccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc---hhh-------
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS---FSN------- 969 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~---~~~------- 969 (1078)
|||.+....... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......... ...
T Consensus 167 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 167 DLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp SCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 999998765432 334568999999999999999999999999999999999999997532111000 000
Q ss_pred --hhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 970 --MIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 970 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
........+......+..........+.+++.+||..||++|||++|+++|+|+..
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00000000111111111122233457889999999999999999999999999664
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=348.24 Aligned_cols=260 Identities=26% Similarity=0.340 Sum_probs=193.1
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHH--HHHHhcCCCCceeeEEeeee-----c
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNV--VLALNEIRHRNIVKFHGFCS-----N 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e--~~~l~~l~h~niv~l~~~~~-----~ 822 (1078)
.++|++.+.||+|+||+||+|+. +++.||||++.... ...+..| +..+..++||||+++++++. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 46899999999999999999976 58999999986432 3334444 44455689999999998542 3
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC------CCCcEecCCCCCCeeeCCCCcE
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC------LPSIIHRDISSKNVLLDLEFEA 896 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~ 896 (1078)
...+++||||+++|+|.+++.. ...++..++.++.||+.||+|||+.+ .++|+||||||+||+++.++.+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred CceEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 3467899999999999999943 33588999999999999999999863 2389999999999999999999
Q ss_pred EEecccccccccCCC--------CCceeecccccccccccccc-------CCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 039595 897 HVSDFGIAKFVEPYS--------SNRTEFVGTFGYAAPEIAYT-------MRATEKYDVYSFGVLVFEVIKGNHPRDFFS 961 (1078)
Q Consensus 897 kl~DfG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~elltG~~p~~~~~ 961 (1078)
||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999998764321 11234579999999999886 456789999999999999999977753221
Q ss_pred ccc--cchhh----------hh--hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 962 INF--SSFSN----------MI--IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 962 ~~~--~~~~~----------~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
... ..... .. ........+.+.............+.+++.+||+.||++|||++|+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 110 00000 00 00111122333333333344555789999999999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=339.45 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=199.0
Q ss_pred hhcCCCccc-eeccCCceeEEEEEe---CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 749 ATDDFDEKF-CIGKGGQGSVYKAEL---PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 749 ~~~~~~~~~-~lG~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
..++|++.+ .||+|+||+||+|.+ .+++.||||++.... ......+.+.+|+.+++.++||||+++++++ ..+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 346788887 999999999999954 246789999997653 2234467899999999999999999999999 456
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 78999999999999999954 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCC
Q 039595 905 KFVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDP 980 (1078)
Q Consensus 905 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 980 (1078)
......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... .....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~---~~~~~~ 239 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAML---EKGERM 239 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHH---HTTCCC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH---HcCCCC
Confidence 876543322 122346788999999998889999999999999999999 99997643321 111111 111111
Q ss_pred CCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 981 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
... ... ...+.+++.+||+.||++||+++|+++..-
T Consensus 240 ~~~---~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 240 GCP---AGC---PREMYDLMNLCWTYDVENRPGFAAVELRLR 275 (291)
T ss_dssp CCC---TTC---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCC---CCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 111 235778999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=338.08 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=197.0
Q ss_pred CCCccceeccCCceeEEEEEeC-CC---CEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee-
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SG---DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS- 826 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~- 826 (1078)
.|+..+.||+|+||+||+|.+. ++ ..||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT---EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc---cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 4666789999999999999643 23 379999986532 344567889999999999999999999999766554
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+.+|+|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++.
T Consensus 99 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EEEECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEEEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 999999999999999954 235688999999999999999999999 999999999999999999999999999986
Q ss_pred ccCC----CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCC-CCcccccccchhhhhhhhhhhcCCC
Q 039595 907 VEPY----SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP-RDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 907 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++|..| |..... ......... .....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~---~~~~~ 248 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLAQ---GRRLP 248 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHHT---TCCCC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhhc---CCCCC
Confidence 5332 1223345678999999999999999999999999999999996555 332211 111111111 11111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
. ..... ..+.+++.+||+.||.+|||++++++..-
T Consensus 249 ~---~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 249 Q---PEYCP---DSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp C---CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C---Cccch---HHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1 11111 25778999999999999999999987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=348.68 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=185.7
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeee-------
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFC------- 820 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~------- 820 (1078)
..+|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++++. ||||+++++++
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 45899999999999999999975 47899999998543 3445667889999999996 99999999998
Q ss_pred -ecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeeCCCCcEE
Q 039595 821 -SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDLEFEAH 897 (1078)
Q Consensus 821 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~k 897 (1078)
......++||||+. |+|.+++........+++.+++.++.||+.||+|||++ + |+||||||+||+++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 34456899999996 69999886544456799999999999999999999998 8 99999999999999999999
Q ss_pred EecccccccccCCCCC------------ceeecccccccccccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 039595 898 VSDFGIAKFVEPYSSN------------RTEFVGTFGYAAPEIA---YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI 962 (1078)
Q Consensus 898 l~DfG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~ 962 (1078)
|+|||+++........ .....||+.|+|||++ .+..++.++|||||||++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999876543221 1245689999999998 566789999999999999999999999753221
Q ss_pred cccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 963 NFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. .. .......... .... ..+.+++.+||+.||++|||++|++++.+..
T Consensus 259 ~--~~------~~~~~~~~~~---~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 259 L--RI------VNGKYSIPPH---DTQY---TVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ---------------CCCCTT---CCSS---GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred H--Hh------hcCcccCCcc---cccc---hHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 00 0000110111 1111 1366889999999999999999999987643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=349.97 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=204.5
Q ss_pred HHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCC--hhhHHHHHHHHHHHhcCC--CCceeeEEeeee
Q 039595 747 IKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN--MADQDEFLNVVLALNEIR--HRNIVKFHGFCS 821 (1078)
Q Consensus 747 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~ 821 (1078)
....++|++.+.||+|+||.||+|.. .+++.||||++........ ....+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999965 5789999999976543211 012234667889999986 599999999999
Q ss_pred cCCeeEEEEeecCC-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCcEEEe
Q 039595 822 NARHSFLVCEYLHR-GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-LEFEAHVS 899 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~ 899 (1078)
.++..++|+||+.+ ++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+||+++ .++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 899999843 35689999999999999999999999 999999999999999 78999999
Q ss_pred cccccccccCCCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL 978 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 978 (1078)
|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .......
T Consensus 193 Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~~~~- 261 (320)
T 3a99_A 193 DFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQVF- 261 (320)
T ss_dssp CCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHHCCCC-
T ss_pred eCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hhccccc-
Confidence 99999876532 2345679999999999887665 7889999999999999999999753211 0110001
Q ss_pred CCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 979 DPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 979 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.. .... .++.+++.+||+.||++|||++|+++|+|+...
T Consensus 262 ---~~---~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 262 ---FR---QRVS---SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ---CS---SCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ---cc---ccCC---HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 11 1111 257789999999999999999999999997653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=343.90 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=186.3
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|+..+.||+|+||.||+|... +|+.||||++..... .....+.+.++..+++.++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 468999999999999999999764 799999999976431 12223445556667888899999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
||||+ ++.+..+... ....+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||.+...
T Consensus 102 v~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 99999 5566655532 23568999999999999999999998 5 8999999999999999999999999999766
Q ss_pred cCCCCCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
... .......|++.|+|||++. ...++.++|||||||++|||++|+.||............ ......+..
T Consensus 176 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~ 250 (318)
T 2dyl_A 176 VDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK----VLQEEPPLL 250 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH----HHHSCCCCC
T ss_pred cCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH----HhccCCCCC
Confidence 442 2234457999999999984 456889999999999999999999997643322111111 111111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.. .... ...+.+++.+||+.||.+|||++|+++|+|+...
T Consensus 251 ~~-~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 251 PG-HMGF---SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CS-SSCC---CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred Cc-cCCC---CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 11 1111 2257788999999999999999999999997643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=352.71 Aligned_cols=247 Identities=15% Similarity=0.108 Sum_probs=195.6
Q ss_pred hhcCCCccceeccCCceeEEEEE------eCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC---CCceeeEEee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAE------LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR---HRNIVKFHGF 819 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~ 819 (1078)
..++|++.+.||+|+||+||+|. ..+++.||||++... ...++..|+.++++++ |+||++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34679999999999999999993 446889999998653 2456777788877776 9999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHhcCC--CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-----
Q 039595 820 CSNARHSFLVCEYLHRGSLARILGND--ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL----- 892 (1078)
Q Consensus 820 ~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~----- 892 (1078)
+..++..|+||||+++|+|.+++... .....+++.+++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 99999999999999999999999532 1345699999999999999999999999 9999999999999998
Q ss_pred ------CCcEEEecccccccccCC--CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc
Q 039595 893 ------EFEAHVSDFGIAKFVEPY--SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF 964 (1078)
Q Consensus 893 ------~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~ 964 (1078)
++.+||+|||+|+..... .......+||+.|||||++.+..++.++|||||||++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 899999999999765432 223345679999999999999999999999999999999999999964222110
Q ss_pred cchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 965 SSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
. .....+... ...+ .+.+++.+|++.+|.+|++..+.+.+.
T Consensus 293 ~-----------~~~~~~~~~--~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 293 C-----------KPEGLFRRL--PHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp E-----------EECSCCTTC--SSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred e-----------eechhcccc--CcHH---HHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 0 011111111 1122 455777889999999997655444443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=358.68 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=191.5
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 828 (1078)
..+|+..+.||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +|||||++++++.+....|+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 356889999999999997766556799999999865422 1245789999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-----CCcEEEecccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-----EFEAHVSDFGI 903 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DfG~ 903 (1078)
||||+. |+|.+++.... ....+.+++.++.||+.||+|||++ +|+||||||+||+++. ...+||+|||+
T Consensus 96 v~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999996 59999996432 2344556788999999999999999 9999999999999953 23688999999
Q ss_pred cccccCCC---CCceeeccccccccccccc---cCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhh
Q 039595 904 AKFVEPYS---SNRTEFVGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQ 976 (1078)
Q Consensus 904 a~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 976 (1078)
++...... .......||+.|+|||++. ...++.++||||+||++|||++ |+.||...... ... .
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~------~~~---~ 240 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR------QAN---I 240 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH------HHH---H
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH------HHH---H
Confidence 98765432 2234567999999999987 4567889999999999999999 89996422111 000 1
Q ss_pred hcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
...................+.+++.+||+.||++|||++|+++|||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 241 LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred HhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 11111111111112233457789999999999999999999999998653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=371.05 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=202.2
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.+.||+|+||.||+|.++.+..||||+++... ...+.|.+|+.++++++||||+++++++.+ ...++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 456788999999999999999998878889999997542 235679999999999999999999999976 67899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.++++.. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 339 v~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999999432 234589999999999999999999999 99999999999999999999999999998664
Q ss_pred CCC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 909 PYS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 909 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
... .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+ ........ .
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~i---~~~~~~~~---~ 486 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV---ERGYRMPC---P 486 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHHH---HTTCCCCC---C
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---HcCCCCCC---C
Confidence 311 11223456789999999999999999999999999999999 9999753321 1111111 11111111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.... ..+.+++.+||+.||++|||++++++..
T Consensus 487 ~~~~---~~l~~li~~cl~~dP~~RPt~~~l~~~L 518 (535)
T 2h8h_A 487 PECP---ESLHDLMCQCWRKEPEERPTFEYLQAFL 518 (535)
T ss_dssp TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1122 2577889999999999999999988754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=354.16 Aligned_cols=258 Identities=17% Similarity=0.192 Sum_probs=199.5
Q ss_pred hcCCCccceeccCCceeEEEEEeCC---------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceee-----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPS---------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK----- 815 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~----- 815 (1078)
.++|++.+.||+|+||.||+|.... ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhh
Confidence 3689999999999999999997653 789999998643 24778999999999999988
Q ss_pred ----------EEeeeec-CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 039595 816 ----------FHGFCSN-ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 884 (1078)
Q Consensus 816 ----------l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 884 (1078)
+++++.. +...++||||+ +|+|.+++... ....+++.+++.++.||+.||+|||++ +|+|||||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dik 186 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVT 186 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCC
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCC
Confidence 5667655 78899999999 99999999543 235799999999999999999999999 99999999
Q ss_pred CCCeeeCCCC--cEEEecccccccccCCCC-------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCC
Q 039595 885 SKNVLLDLEF--EAHVSDFGIAKFVEPYSS-------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 955 (1078)
Q Consensus 885 ~~NIll~~~~--~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~ 955 (1078)
|+||+++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 999999999987643221 1234579999999999999999999999999999999999999
Q ss_pred CCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 956 PRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 956 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
||.................... .+.+.............+.+++.+||+.||++|||++++++...
T Consensus 267 pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 267 PWTNCLPNTEDIMKQKQKFVDK-PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHS-CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred CcccCCcCHHHHHHHHHhccCC-hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 9765432222222221111111 11111111111111236788899999999999999999987643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=335.93 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=192.2
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec-CCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN-ARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|+.+ |+.||||++... ...+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 468999999999999999999875 889999998643 235678999999999999999999998754 457899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999999432 223378999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... .......+... .
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~---~~~~~~~~~~~---~ 237 (278)
T 1byg_A 169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVP---RVEKGYKMDAP---D 237 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHH---HHTTTCCCCCC---T
T ss_pred cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH---HHhcCCCCCCc---c
Confidence 32 233467889999999999999999999999999999998 9999754322 11111 11111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. ...+.+++.+||+.||++|||++|+++...
T Consensus 238 ~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 269 (278)
T 1byg_A 238 GC---PPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269 (278)
T ss_dssp TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cC---CHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence 11 235778899999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=370.23 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=194.4
Q ss_pred CCCccc-eeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 752 DFDEKF-CIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 752 ~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
++.+.. .||+|+||.||+|.++ ++..||||+++... .....+.+.+|+.++++++|||||++++++.. +..+
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 344444 7999999999999653 45679999997642 23456789999999999999999999999976 5689
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 412 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999999999999999542 45689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 908 EPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 908 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+.. ......
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~---~~~~~~- 560 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ---GKRMEC- 560 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHHHT---TCCCCC-
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc---CCCCCC-
Confidence 432221 223345789999999999999999999999999999998 9999764332 111111111 111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
..... ..+.+++.+||+.||++||+++++++..
T Consensus 561 --p~~~~---~~l~~li~~cl~~dP~~RPs~~~l~~~L 593 (613)
T 2ozo_A 561 --PPECP---PELYALMSDCWIYKWEDRPDFLTVEQRM 593 (613)
T ss_dssp --CTTCC---HHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred --CCcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 11122 3577889999999999999999987653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=352.15 Aligned_cols=264 Identities=20% Similarity=0.225 Sum_probs=201.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-----------CCceeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-----------HRNIVKFH 817 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~ 817 (1078)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.++++++ ||||++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 36899999999999999999975 57899999998643 334567888999888876 89999999
Q ss_pred eeeecCC----eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--
Q 039595 818 GFCSNAR----HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-- 891 (1078)
Q Consensus 818 ~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-- 891 (1078)
+++...+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ +|+||||||+||+++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 9987544 789999999 889999995432 345899999999999999999999953 899999999999994
Q ss_pred ----CCCcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-cc
Q 039595 892 ----LEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF-SS 966 (1078)
Q Consensus 892 ----~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~~ 966 (1078)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4458999999999876542 334578999999999999999999999999999999999999986433210 00
Q ss_pred hhhhhhhhhhhcC------------------C-----CCCC------------CCCccHHHHHHHHHHHHhcccCCCCCC
Q 039595 967 FSNMIIEVNQILD------------------P-----RLST------------PSPGVMDKLISIMEVAILCLDESPEAR 1011 (1078)
Q Consensus 967 ~~~~~~~~~~~~~------------------~-----~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~R 1011 (1078)
............. . .... ...........+.+++.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 0000000000000 0 0000 001113445578899999999999999
Q ss_pred CChhHHHHHhhhhh
Q 039595 1012 PTMEKGFGHHIGYC 1025 (1078)
Q Consensus 1012 Pt~~ell~h~~~~~ 1025 (1078)
||++|+++|+|+..
T Consensus 326 pt~~ell~hp~f~~ 339 (373)
T 1q8y_A 326 ADAGGLVNHPWLKD 339 (373)
T ss_dssp BCHHHHHTCGGGTT
T ss_pred CCHHHHhhChhhhc
Confidence 99999999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=347.58 Aligned_cols=262 Identities=19% Similarity=0.237 Sum_probs=203.6
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CC-CEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc------eeeEEeeee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SG-DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN------IVKFHGFCS 821 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~ 821 (1078)
.++|++.+.||+|+||+||+|... ++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 468999999999999999999764 44 68999998643 234567888999999987766 999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee-----------
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----------- 890 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----------- 890 (1078)
..+..++||||+ ++++.+++... ....+++.+++.++.||+.||+|||++ +|+||||||+||++
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred eCCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence 999999999999 56777776432 234689999999999999999999999 99999999999999
Q ss_pred --------CCCCcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 039595 891 --------DLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI 962 (1078)
Q Consensus 891 --------~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~ 962 (1078)
+.++.+||+|||.++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 5678999999999986543 23456799999999999999999999999999999999999999764332
Q ss_pred cccchhhhhhhhhh---------------hcC-------------------CCCCCCCCccHHHHHHHHHHHHhcccCCC
Q 039595 963 NFSSFSNMIIEVNQ---------------ILD-------------------PRLSTPSPGVMDKLISIMEVAILCLDESP 1008 (1078)
Q Consensus 963 ~~~~~~~~~~~~~~---------------~~~-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP 1008 (1078)
.. ....+..... ... +...............+.+++.+||+.||
T Consensus 245 ~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 245 RE--HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp HH--HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HH--HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 10 0000000000 000 00000001112234478899999999999
Q ss_pred CCCCChhHHHHHhhhhhh
Q 039595 1009 EARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 1009 ~~RPt~~ell~h~~~~~~ 1026 (1078)
++|||++|+++|+|+..-
T Consensus 323 ~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTSCCHHHHTTSGGGGGC
T ss_pred hhCcCHHHHhcChhhcCC
Confidence 999999999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=344.17 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=204.3
Q ss_pred hcCCCccceeccCCceeEEEEEe-----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
.++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 45789999999999999999973 36889999998753 3345678999999999999999999999986543
Q ss_pred --eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 825 --HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 825 --~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence 789999999999999999543 24589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccch-------hhhhh
Q 039595 903 IAKFVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF-------SNMII 972 (1078)
Q Consensus 903 ~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~-------~~~~~ 972 (1078)
+++........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+... .....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 99877543321 223456778999999998889999999999999999999999964321111000 00000
Q ss_pred hhhhhcCCCC-CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 973 EVNQILDPRL-STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 973 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.....+.... ....... ...+.+++.+||+.||++|||++|+++..-....
T Consensus 271 ~~~~~~~~~~~~~~~~~~---~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGC---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHTTCCCCCCTTC---CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcc---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111 1111112 2357789999999999999999999987554433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=334.47 Aligned_cols=257 Identities=17% Similarity=0.224 Sum_probs=195.4
Q ss_pred HhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeee-ecCCe
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFC-SNARH 825 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~ 825 (1078)
...++|++.+.||+|+||+||+|.. .+++.||||++..... .+.+.+|+.+++.++|++++..++++ ..+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 3457899999999999999999975 5789999998755421 23477899999999888777666655 67788
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFG 902 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG 902 (1078)
.++||||+ +|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred eEEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 89999999 89999998532 34589999999999999999999999 99999999999999 788999999999
Q ss_pred ccccccCCCC-------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc-chhhhhhhh
Q 039595 903 IAKFVEPYSS-------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS-SFSNMIIEV 974 (1078)
Q Consensus 903 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~-~~~~~~~~~ 974 (1078)
.++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .........
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 9987654322 22356799999999999999999999999999999999999999865432211 111111111
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.... + ........ ...+.+++.+||+.||++|||++++++..
T Consensus 234 ~~~~-~-~~~~~~~~---~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 234 KMST-P-IEVLCKGY---PSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHS-C-HHHHTTTS---CHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred cccc-h-hhhhhccC---CHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 1111 1 00000001 12678899999999999999999998753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=334.21 Aligned_cols=254 Identities=17% Similarity=0.213 Sum_probs=198.6
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeee-ecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFC-SNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~ 827 (1078)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+.+++.++|++++..++++ ..+...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 46899999999999999999975 5799999999865421 23578899999999988866665555 6778889
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEeccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD---LEFEAHVSDFGIA 904 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfG~a 904 (1078)
+||||+ +++|.+++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||.+
T Consensus 82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 999999 88999999532 34689999999999999999999999 999999999999994 7899999999999
Q ss_pred ccccCCCC-------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-cchhhhhhhhhh
Q 039595 905 KFVEPYSS-------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF-SSFSNMIIEVNQ 976 (1078)
Q Consensus 905 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~~~~~~~~~~~~ 976 (1078)
+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 87654332 1245679999999999999999999999999999999999999986543221 111111111111
Q ss_pred hcC-CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 977 ILD-PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 977 ~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
... +.... .. ...+.+++.+||+.||++|||++++++..
T Consensus 236 ~~~~~~~~~---~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 236 STPIEVLCK---GY---PSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HSCHHHHTT---TS---CHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred CCchHHHHh---hC---CHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 110 00000 11 12578899999999999999999988754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=344.56 Aligned_cols=256 Identities=22% Similarity=0.283 Sum_probs=195.0
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCCh--hhHHHHHHHHHHHhcC----CCCceeeEE
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNM--ADQDEFLNVVLALNEI----RHRNIVKFH 817 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~~~~e~~~l~~l----~h~niv~l~ 817 (1078)
+.....++|++.+.||+|+||.||+|.. .+++.||||++......... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3445567899999999999999999965 47889999999764322111 1223456788888888 899999999
Q ss_pred eeeecCCeeEEEEee-cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC-CCCc
Q 039595 818 GFCSNARHSFLVCEY-LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-LEFE 895 (1078)
Q Consensus 818 ~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~ 895 (1078)
+++...+..++|+|| +.+++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 999999999999999 789999999953 34589999999999999999999999 999999999999999 8899
Q ss_pred EEEecccccccccCCCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh
Q 039595 896 AHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV 974 (1078)
Q Consensus 896 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 974 (1078)
+||+|||.++..... ......|+..|+|||++.+..+ +.++||||+|+++|||++|+.||..... ....
T Consensus 179 ~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~ 248 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------ILEA 248 (312)
T ss_dssp EEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHHT
T ss_pred EEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------Hhhh
Confidence 999999999876542 2345678999999999887665 4589999999999999999999753211 0110
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 975 NQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
...+.. .. ...+.+++.+||+.||++|||++|+++|+|+...
T Consensus 249 ----~~~~~~---~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 249 ----ELHFPA---HV---SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp ----CCCCCT---TS---CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred ----ccCCcc---cC---CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 011111 11 1257789999999999999999999999997753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.80 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=192.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC--CCC--EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP--SGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.++|++.+.||+|+||+||+|.+. +++ .||||+++..... .....+.+.+|+.++++++||||+++++++..+.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 367999999999999999999753 333 6899998765322 3345678899999999999999999999998765
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++|+||+++|+|.+++... ...+++.++..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 88999999999999999532 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 906 FVEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 906 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
........ .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.. ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~----~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDK----EGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT----SCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHc----cCCC
Confidence 76543322 233467889999999998889999999999999999999 99997543221 11111100 0111
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. ..... ...+.+++.+||+.||++|||+++++++..
T Consensus 244 ~~-~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 280 (291)
T 1u46_A 244 LP-RPEDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280 (291)
T ss_dssp CC-CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC-CCcCc---CHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 11 11111 235788999999999999999999998654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=369.60 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=193.9
Q ss_pred ceeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeec
Q 039595 757 FCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 833 (1078)
+.||+|+||+||+|.+. +++.||||+++.... .....+++.+|+.++++++|||||++++++.. +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG--CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 47999999999999542 467899999976432 33456789999999999999999999999975 4578999999
Q ss_pred CCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC-
Q 039595 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS- 912 (1078)
Q Consensus 834 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~- 912 (1078)
++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 452 ~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 452 ELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999999943 35689999999999999999999999 999999999999999999999999999987654322
Q ss_pred --CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 913 --NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 913 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+. ........ ...
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~---~~~~~~~p---~~~ 597 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLE---KGERMGCP---AGC 597 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH---TTCCCCCC---TTC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH---cCCCCCCC---CCC
Confidence 2234457889999999999999999999999999999998 9999754332 11111111 11111111 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
. .++.+++.+||+.||++||+++++++..-.
T Consensus 598 ~---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 598 P---REMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp C---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2 357788999999999999999999876543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=345.76 Aligned_cols=312 Identities=20% Similarity=0.240 Sum_probs=206.5
Q ss_pred CCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCccccccccccee
Q 039595 100 SFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEF 179 (1078)
Q Consensus 100 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L 179 (1078)
.++++++|++++|.+....+..+..+++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..++.+++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46778888888888765444446778888888888888876666678888888888888888876666777777777777
Q ss_pred ecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccC
Q 039595 180 SFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS 259 (1078)
Q Consensus 180 ~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 259 (1078)
++++|.++...+..|+++++|++|+|++|.+++..|..|+++++|++|++++|++++. .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 7777777743333457777777777777777766666677777777777777777654 2455667777777777666
Q ss_pred CCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCC
Q 039595 260 GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIG 339 (1078)
Q Consensus 260 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 339 (1078)
+ +...++|+.|++++|.+++. |.. ..++|++|++++|++++. ..+.
T Consensus 200 ~-----~~~~~~L~~L~l~~n~l~~~-~~~--------------------------~~~~L~~L~l~~n~l~~~--~~l~ 245 (390)
T 3o6n_A 200 T-----LAIPIAVEELDASHNSINVV-RGP--------------------------VNVELTILKLQHNNLTDT--AWLL 245 (390)
T ss_dssp E-----EECCSSCSEEECCSSCCCEE-ECC--------------------------CCSSCCEEECCSSCCCCC--GGGG
T ss_pred c-----cCCCCcceEEECCCCeeeec-ccc--------------------------ccccccEEECCCCCCccc--HHHc
Confidence 3 12234566666666666533 211 124455555555555532 3455
Q ss_pred CCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeE
Q 039595 340 NLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV 419 (1078)
Q Consensus 340 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 419 (1078)
.+++|+.|++++|.+.+..|..+..+++|++|+|++|++++ +|..+..+++|++|++++|++. .+|..+..+++|++|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L 323 (390)
T 3o6n_A 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323 (390)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEE
Confidence 55666666666666665556666666666666666666654 3444455666666666666665 345556666777777
Q ss_pred EccCccccccchhhccCCCCCcEecCCCCccCCc
Q 039595 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGK 453 (1078)
Q Consensus 420 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 453 (1078)
++++|.+..+. +..+++|+.|++++|++++.
T Consensus 324 ~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 324 YLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp ECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred ECCCCccceeC---chhhccCCEEEcCCCCccch
Confidence 77777776653 55667788888888887754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=340.11 Aligned_cols=284 Identities=19% Similarity=0.258 Sum_probs=208.2
Q ss_pred cCCCHHHHHHHHHHHHhcCCCCCCccccCCCCCCCCCCCCCCCCcccceEeeCCCCeEEEeccCccccCCcccCCccCCC
Q 039595 22 TSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSF 101 (1078)
Q Consensus 22 ~~~~~~~~~all~~k~~~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l 101 (1078)
.++..+|++||++||+++..++ .+.+++|... .....++|.|.||+|+.....+ .....
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~--~~~~~~w~~~--~~~~~~~~~~~g~~~~~~~~~l-----------------~~~~~ 80 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADR--NRWHSAWRQA--NSNNPQIETRTGRALKATADLL-----------------EDATQ 80 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCC--TTHHHHHHHH--TTTCTTSCCSHHHHHHHHHHHH-----------------HHHTS
T ss_pred cccCchHHHHHHHHHHhccCCc--hhhhhhhccc--ccccccccccCCcchhhhHHHH-----------------hcccc
Confidence 3456789999999999996653 4667899421 1135789999999996321100 11234
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeec
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l 181 (1078)
++++.|+|++|.+. .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++.+++|++|++
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 67888999999887 78888888999999999999998 78888999999999999999998 88888999999999999
Q ss_pred ccccccCCccCcccC---------CCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEe
Q 039595 182 CHNNVSGRIPSSLGN---------LSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLF 252 (1078)
Q Consensus 182 ~~n~~~~~~p~~l~~---------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 252 (1078)
++|++.+.+|..++. +++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..+..+++|++|+
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD 235 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEE
Confidence 998888888887765 777777777777776 566667777777777777777765 344566677777777
Q ss_pred ccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccC
Q 039595 253 LYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLN 331 (1078)
Q Consensus 253 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 331 (1078)
|++|.+.+.+|..++++++|++|+|++|.+.+.+|..++.+++|+.|++++|++.+.+|..++++++|+.+++..|.+.
T Consensus 236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 7777766666666777777777777776666666666666666666666666666666666666666666666655443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=360.82 Aligned_cols=312 Identities=20% Similarity=0.240 Sum_probs=211.7
Q ss_pred CCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCccccccccccee
Q 039595 100 SFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEF 179 (1078)
Q Consensus 100 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L 179 (1078)
.+++++.|++++|.+.+..+..++++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+.+++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 35677888888887765555556778888888888888877666778888888888888888776666667777777777
Q ss_pred ecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccC
Q 039595 180 SFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS 259 (1078)
Q Consensus 180 ~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 259 (1078)
+|++|.+++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++. .++.+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccc
Confidence 7777777754444557777777777777777766666677777777777777777654 2455566677777776665
Q ss_pred CCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCC
Q 039595 260 GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIG 339 (1078)
Q Consensus 260 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 339 (1078)
+ +...++|+.|++++|.++...+.. .++|+.|+|++|.+++ +..+.
T Consensus 206 ~-----l~~~~~L~~L~ls~n~l~~~~~~~---------------------------~~~L~~L~L~~n~l~~--~~~l~ 251 (597)
T 3oja_B 206 T-----LAIPIAVEELDASHNSINVVRGPV---------------------------NVELTILKLQHNNLTD--TAWLL 251 (597)
T ss_dssp E-----EECCTTCSEEECCSSCCCEEECSC---------------------------CSCCCEEECCSSCCCC--CGGGG
T ss_pred c-----ccCCchhheeeccCCccccccccc---------------------------CCCCCEEECCCCCCCC--Chhhc
Confidence 3 223345666666666665322211 1356666666666654 24566
Q ss_pred CCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeE
Q 039595 340 NLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV 419 (1078)
Q Consensus 340 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 419 (1078)
.+++|+.|+|++|.+.+.+|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.+. .+|..+..+++|++|
T Consensus 252 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L 329 (597)
T 3oja_B 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329 (597)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred cCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEE
Confidence 66666666666666666666666666677777777776665 3445566677777777777776 456666777777777
Q ss_pred EccCccccccchhhccCCCCCcEecCCCCccCCc
Q 039595 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGK 453 (1078)
Q Consensus 420 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 453 (1078)
++++|.+.++. +..+++|+.|++++|++.+.
T Consensus 330 ~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 330 YLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp ECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred ECCCCCCCCcC---hhhcCCCCEEEeeCCCCCCh
Confidence 77777777664 55677899999999988764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=338.80 Aligned_cols=259 Identities=23% Similarity=0.350 Sum_probs=197.7
Q ss_pred HhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeE
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 827 (1078)
...++|++.+.||+|+||.||+|..+. .||+|++..... .....+.+.+|+.++++++||||+++++++.+....+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 345789999999999999999998753 499999875432 2223345778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
+||||+++++|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++ ++.+||+|||+++..
T Consensus 106 iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999542 34688999999999999999999999 999999999999998 789999999998765
Q ss_pred cCC-----CCCceeecccccccccccccc---------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh
Q 039595 908 EPY-----SSNRTEFVGTFGYAAPEIAYT---------MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973 (1078)
Q Consensus 908 ~~~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 973 (1078)
... ........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... .... .
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---~ 254 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AIIW---Q 254 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--HHHH---H
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---H
Confidence 321 122334568999999999874 45788999999999999999999997543221 1111 1
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
......+.... .... ..+.+++.+||+.||++|||++++++..-....
T Consensus 255 ~~~~~~~~~~~--~~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 255 MGTGMKPNLSQ--IGMG---KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHTTCCCCCCC--SSCC---TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred hccCCCCCCCc--CCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111222111 0111 246788999999999999999999987654443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=341.55 Aligned_cols=333 Identities=19% Similarity=0.165 Sum_probs=166.6
Q ss_pred CcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEE
Q 039595 269 LKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLS 348 (1078)
Q Consensus 269 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 348 (1078)
+++++.|++++|.++...+..|..+++|+.|++++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 45667777777766654444455566666666666665555555555555555555555555555555555555555555
Q ss_pred ccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccc
Q 039595 349 LFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVG 428 (1078)
Q Consensus 349 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 428 (1078)
+++|++....+..|..+++|++|++++|++++..|..+.++++|++|++++|++++
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~------------------------ 179 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH------------------------ 179 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB------------------------
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc------------------------
Confidence 55555553333334555555555555555555555555555555555555555443
Q ss_pred cchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCccccccc
Q 039595 429 KVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEK 508 (1078)
Q Consensus 429 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 508 (1078)
+. +..+++|+.|++++|.++... ...+|++|++++|.+... |.. .
T Consensus 180 ~~---~~~l~~L~~L~l~~n~l~~~~-----------------------------~~~~L~~L~l~~n~l~~~-~~~--~ 224 (390)
T 3o6n_A 180 VD---LSLIPSLFHANVSYNLLSTLA-----------------------------IPIAVEELDASHNSINVV-RGP--V 224 (390)
T ss_dssp CC---GGGCTTCSEEECCSSCCSEEE-----------------------------CCSSCSEEECCSSCCCEE-ECC--C
T ss_pred cc---cccccccceeecccccccccC-----------------------------CCCcceEEECCCCeeeec-ccc--c
Confidence 21 222344555555555444211 112344444444444322 111 1
Q ss_pred CccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeee
Q 039595 509 LFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLD 588 (1078)
Q Consensus 509 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 588 (1078)
.++|+.|++++|++++. ..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|+.|+
T Consensus 225 ~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~ 301 (390)
T 3o6n_A 225 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 301 (390)
T ss_dssp CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEE
T ss_pred cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEE
Confidence 23444444444444432 234444555555555555554444455555555555555555542 333444455555555
Q ss_pred cCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCCC--CccccCccccCCCCcCCC
Q 039595 589 LSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPN--STVFKDGLMEGNKGLCGN 666 (1078)
Q Consensus 589 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~--~~~~~~~~~~~n~~lc~~ 666 (1078)
|++|++++ +|..+..+++|++|+|++|++++.. +..+++|+.|++++|++++.... ...+....+.+++..|..
T Consensus 302 L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 302 LSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp CCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCCT
T ss_pred CCCCccee-cCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceecc
Confidence 55555542 3344445555555555555555331 44455555555555555542211 011233445566666765
Q ss_pred c
Q 039595 667 F 667 (1078)
Q Consensus 667 ~ 667 (1078)
+
T Consensus 378 ~ 378 (390)
T 3o6n_A 378 D 378 (390)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=344.45 Aligned_cols=255 Identities=19% Similarity=0.252 Sum_probs=198.5
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC-CceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH-RNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.++||+|+||.||+|.. .+++.||||++..... ...+..|+.+++.++| ++|..+..++.+....+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS------SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 46899999999999999999975 5799999998765432 2246789999999976 56666777778888999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---CCCCcEEEeccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DLEFEAHVSDFGIA 904 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~a 904 (1078)
+||||+ +++|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 80 lvme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 999999 88999999532 34699999999999999999999999 99999999999999 58899999999999
Q ss_pred ccccCCCCC-------ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc-chhhhhhhhhh
Q 039595 905 KFVEPYSSN-------RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS-SFSNMIIEVNQ 976 (1078)
Q Consensus 905 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~-~~~~~~~~~~~ 976 (1078)
+.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 231 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 231 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH--
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc--
Confidence 877543321 2356799999999999999999999999999999999999999865433211 111111100
Q ss_pred hcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
............. ..++.+++.+||+.||++||+++++++..
T Consensus 232 ~~~~~~~~l~~~~---p~~l~~li~~cl~~dP~~RPs~~el~~~L 273 (483)
T 3sv0_A 232 KVATSIEALCRGY---PTEFASYFHYCRSLRFDDKPDYSYLKRLF 273 (483)
T ss_dssp HHHSCHHHHHTTS---CHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred cccccHHHHhcCC---cHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 0000000000001 12678899999999999999999988754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=360.89 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=200.0
Q ss_pred hhcCCCccceeccCCceeEEEEEeC----CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR 824 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 824 (1078)
..++|++.+.||+|+||+||+|.+. .+..||||++.... .....+.+.+|+.++++++||||+++++++.+ +
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence 4567899999999999999999764 24579999986532 33445779999999999999999999999854 5
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++||||+++|+|.++++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 689999999999999999542 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 905 KFVEPYSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 905 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
+....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... ..... ......+..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~---i~~~~~~~~ 613 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR---IENGERLPM 613 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH---HHHTCCCCC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH---HHcCCCCCC
Confidence 87654322 2234457789999999999999999999999999999997 99997533221 11111 111111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. +... ..+.+++.+||+.||++|||++|++++.-..
T Consensus 614 ~---~~~~---~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 614 P---PNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp C---TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---cccc---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 1112 2577899999999999999999999876543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=358.75 Aligned_cols=334 Identities=19% Similarity=0.171 Sum_probs=184.3
Q ss_pred CcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEE
Q 039595 269 LKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLS 348 (1078)
Q Consensus 269 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 348 (1078)
+.+++.|++++|.+++..+..|..+++|+.|++++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 45677777777777765555566666666666666666665555666666666666666666665555666666666666
Q ss_pred ccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccc
Q 039595 349 LFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVG 428 (1078)
Q Consensus 349 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 428 (1078)
|++|.+++..+..|+.+++|++|+|++|.+++..|..|.++++|++|++++|.+++.. +..
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~---------------- 190 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSL---------------- 190 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGG----------------
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhh----------------
Confidence 6666666444444556666666666666666555555666666666666655554431 222
Q ss_pred cchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCccccccc
Q 039595 429 KVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEK 508 (1078)
Q Consensus 429 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 508 (1078)
+++|+.|++++|.+++. ....+|+.|++++|.+....+ .+
T Consensus 191 --------l~~L~~L~l~~n~l~~l-----------------------------~~~~~L~~L~ls~n~l~~~~~-~~-- 230 (597)
T 3oja_B 191 --------IPSLFHANVSYNLLSTL-----------------------------AIPIAVEELDASHNSINVVRG-PV-- 230 (597)
T ss_dssp --------CTTCSEEECCSSCCSEE-----------------------------ECCTTCSEEECCSSCCCEEEC-SC--
T ss_pred --------hhhhhhhhcccCccccc-----------------------------cCCchhheeeccCCccccccc-cc--
Confidence 34455555555544321 111234444444444432211 11
Q ss_pred CccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeee
Q 039595 509 LFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLD 588 (1078)
Q Consensus 509 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 588 (1078)
.++|+.|+|++|++++ +..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|+.|+
T Consensus 231 ~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~ 307 (597)
T 3oja_B 231 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 307 (597)
T ss_dssp CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEE
T ss_pred CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEE
Confidence 1345555555555543 2344555555555555555555555555555555555555555543 344445555566666
Q ss_pred cCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCCCC--ccccCccccCCCCcCCC
Q 039595 589 LSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNS--TVFKDGLMEGNKGLCGN 666 (1078)
Q Consensus 589 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~~--~~~~~~~~~~n~~lc~~ 666 (1078)
|++|.++ .+|..+..+++|++|+|++|++++.. +..+++|+.|++++|+|+|..... ..+....+.+++..|+.
T Consensus 308 Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 308 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCT
T ss_pred CCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCc
Confidence 6666555 34444555566666666666665432 445566666666666666543211 12334456788888886
Q ss_pred cc
Q 039595 667 FE 668 (1078)
Q Consensus 667 ~~ 668 (1078)
+.
T Consensus 384 ~~ 385 (597)
T 3oja_B 384 DY 385 (597)
T ss_dssp TC
T ss_pred ch
Confidence 43
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=325.08 Aligned_cols=237 Identities=20% Similarity=0.246 Sum_probs=181.8
Q ss_pred hcCCCcc-ceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHH-hcCCCCceeeEEeeeec----
Q 039595 750 TDDFDEK-FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLAL-NEIRHRNIVKFHGFCSN---- 822 (1078)
Q Consensus 750 ~~~~~~~-~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~---- 822 (1078)
.++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|+.++ +..+||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 4567776 7799999999999965 57899999998532 3456777777 66699999999999876
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEe
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL---EFEAHVS 899 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~ 899 (1078)
....++||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CceEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 67889999999999999999543 234689999999999999999999999 9999999999999998 7899999
Q ss_pred cccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcC
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 979 (1078)
|||++.... +..++.++||||+||++|||++|+.||....... ..... ......
T Consensus 163 Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~--~~~~~~ 216 (299)
T 3m2w_A 163 DFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGM--KTRIRM 216 (299)
T ss_dssp CCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCS--CCSSCT
T ss_pred ccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh--hhHHH--HHHHhh
Confidence 999986432 2357789999999999999999999975332210 00000 000001
Q ss_pred CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 980 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.....+.+........+.+++.+||+.||++|||++|+++|+|+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 1111110000111236788999999999999999999999999764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=334.94 Aligned_cols=252 Identities=15% Similarity=0.147 Sum_probs=189.9
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEecccccc----CChhhHHHHHHHHHHHhcCC---------CCceeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLS----GNMADQDEFLNVVLALNEIR---------HRNIVKF 816 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~---------h~niv~l 816 (1078)
.++|++.+.||+|+||+||+|+. +|+.||||++...... ......+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999987 6899999999765321 12334577888999988886 6666665
Q ss_pred Eee-----------------eec-------------CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHH
Q 039595 817 HGF-----------------CSN-------------ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866 (1078)
Q Consensus 817 ~~~-----------------~~~-------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 866 (1078)
.++ +.+ .+..|+||||+++|++.+.+.+ ..+++.+++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 554 333 6889999999999977666622 458999999999999999
Q ss_pred HHHHH-hcCCCCcEecCCCCCCeeeCCCC--------------------cEEEecccccccccCCCCCceeecccccccc
Q 039595 867 LSYLH-HDCLPSIIHRDISSKNVLLDLEF--------------------EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925 (1078)
Q Consensus 867 L~~LH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~a 925 (1078)
|+||| ++ +|+||||||+|||++.++ .+||+|||+|+.... ...+||+.|||
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccC
Confidence 99999 88 999999999999999887 899999999987653 24589999999
Q ss_pred ccccccCCCCccchhHHHHHH-HHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 039595 926 PEIAYTMRATEKYDVYSFGVL-VFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCL 1004 (1078)
Q Consensus 926 PE~~~~~~~~~~sDvwSlG~i-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 1004 (1078)
||++.+.. +.++||||+|++ .+++++|..||... .+ ............................++.+++.+||
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--LW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--HH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--hh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence 99998766 899999998777 78889999995311 00 00011111111111111111112334567899999999
Q ss_pred cCCCCCCCChhHHH-HHhhhh
Q 039595 1005 DESPEARPTMEKGF-GHHIGY 1024 (1078)
Q Consensus 1005 ~~dP~~RPt~~ell-~h~~~~ 1024 (1078)
+.| |++|++ +|||+.
T Consensus 321 ~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 321 NFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp GSS-----SHHHHHHHCGGGC
T ss_pred ccC-----CHHHHHhcCCCcC
Confidence 976 999999 999963
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=336.99 Aligned_cols=251 Identities=15% Similarity=0.126 Sum_probs=186.3
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC-Cceee------------
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH-RNIVK------------ 815 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~------------ 815 (1078)
...|...+.||+|+||+||+|.+ .+|+.||||++...... .....+.+.+|+.+++.++| ++...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34577888999999999999974 57999999998744322 23345678999999999987 22111
Q ss_pred ---------EEeeeec-----CCeeEEEEeecCCCCHHHHhcC----CCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 039595 816 ---------FHGFCSN-----ARHSFLVCEYLHRGSLARILGN----DATAKELSWNRRINVIKGVANALSYLHHDCLPS 877 (1078)
Q Consensus 816 ---------l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 877 (1078)
+..++.. ....+++|+++ +++|.++++. ......+++..++.++.||+.||+|||++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 1111111 22456777765 5799998841 12345688889999999999999999999 9
Q ss_pred cEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceeecccccccccccc----------ccCCCCccchhHHHHHHH
Q 039595 878 IIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA----------YTMRATEKYDVYSFGVLV 947 (1078)
Q Consensus 878 ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlG~il 947 (1078)
|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999999865432 344567 999999998 555688999999999999
Q ss_pred HHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 948 FEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 948 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
|||++|+.||...... ... ...+.... ... ..+.+++.+||+.||++|||+.|+++|+|+..
T Consensus 308 ~elltg~~Pf~~~~~~--~~~------~~~~~~~~-----~~~---~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 308 YWIWCADLPNTDDAAL--GGS------EWIFRSCK-----NIP---QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHSSCCCCTTGGG--SCS------GGGGSSCC-----CCC---HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHCCCCCCCcchh--hhH------HHHHhhcc-----cCC---HHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999997643221 111 11111111 111 35788999999999999999999999999754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=320.53 Aligned_cols=307 Identities=23% Similarity=0.365 Sum_probs=180.7
Q ss_pred cCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccc
Q 039595 98 FSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177 (1078)
Q Consensus 98 ~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~ 177 (1078)
+..+++|++|++++|.+.. +| .++.+++|++|+|++|++++. |. +..+++|++|+|++|.+++ +| .++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence 3456777888888887753 33 377778888888888877743 33 7778888888888877763 33 466677777
Q ss_pred eeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccc
Q 039595 178 EFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNS 257 (1078)
Q Consensus 178 ~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 257 (1078)
+|++++|.+.+. |. +..+++|++|++++|...+.++ .+..+++|++|++++|.+++..+ +..+++|++|++++|+
T Consensus 114 ~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 114 ELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 777777766643 22 6666677777777665443333 36666666666666666665433 5666666666666666
Q ss_pred cCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCC
Q 039595 258 LSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPS 337 (1078)
Q Consensus 258 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 337 (1078)
+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.++ +..+
T Consensus 189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~------------------------~~~~-- 238 (347)
T 4fmz_A 189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT------------------------DLSP-- 238 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC------------------------CCGG--
T ss_pred cccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccC------------------------CCcc--
Confidence 664322 5566666666666666654433 444455555555555544 3322
Q ss_pred CCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCC
Q 039595 338 IGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLK 417 (1078)
Q Consensus 338 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 417 (1078)
+..+++|+.|++++|.+.+. ..+..+++|++|++++|++++. ..+..+++|+.|++++|++.+..+..+..+++|+
T Consensus 239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence 44444555555555544432 2344455555555555555433 2345555555555555555555555555555566
Q ss_pred eEEccCccccccchhhccCCCCCcEecCCCCccC
Q 039595 418 RVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD 451 (1078)
Q Consensus 418 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 451 (1078)
+|++++|.++++.+ +..+++|++|++++|.|+
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 66666666555544 555666777777777654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=326.35 Aligned_cols=253 Identities=32% Similarity=0.504 Sum_probs=241.6
Q ss_pred CCcceeccCCCccCC--CCCccccCccceeEEEccC-ccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcE
Q 039595 126 SKLQNLDLGNNQLSG--VISPEIGKLNQLRRLYLDM-NQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLAL 202 (1078)
Q Consensus 126 ~~L~~L~Ls~n~l~~--~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~ 202 (1078)
.++++|+|++|+++| .+|..|+++++|++|+|++ |.+++.+|..|+.+++|++|++++|.+++.+|..|+++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 478899999999999 8999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCC-CCcEEeccccccCCCCCcccCCCcccceeeccccc
Q 039595 203 LYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLS-NLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQ 281 (1078)
Q Consensus 203 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 281 (1078)
|+|++|.+++.+|..++++++|++|+|++|++++.+|..+..++ +|++|+|++|++++.+|..++.++ |++|+|++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999999999999999999999999999999999999999998 999999999999999999999997 9999999999
Q ss_pred ccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCcc
Q 039595 282 LSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEE 361 (1078)
Q Consensus 282 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 361 (1078)
+++..|..|..+++|+.|++++|.+++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|++++.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9999999999999999999999999987776 889999999999999999999999999999999999999999999986
Q ss_pred ccccCCCCeEEccccc-Cccc
Q 039595 362 IGYLKSLSELKLCKNN-LSGV 381 (1078)
Q Consensus 362 ~~~l~~L~~L~L~~N~-l~~~ 381 (1078)
..+++|+.|++++|+ +.|.
T Consensus 288 -~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 288 -GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp -TTGGGSCGGGTCSSSEEEST
T ss_pred -ccccccChHHhcCCCCccCC
Confidence 889999999999998 6553
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=355.81 Aligned_cols=241 Identities=25% Similarity=0.360 Sum_probs=196.1
Q ss_pred hcCCCccceeccCCceeEEEEEeC--CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe--
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP--SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH-- 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 825 (1078)
.++|++.+.||+|+||+||+|.+. +|+.||||++... ......+.+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 368999999999999999999764 6899999998643 234456678999999999999999999999976554
Q ss_pred ---eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 826 ---SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 826 ---~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
.|+||||+++++|.+++.. .+++.+++.++.||+.||.|||++ +|+||||||+||+++.+ .+||+|||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 6999999999999887732 689999999999999999999999 99999999999999875 99999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
+++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||...... ..
T Consensus 227 ~a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~~ 284 (681)
T 2pzi_A 227 AVSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------GL 284 (681)
T ss_dssp TCEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------SC
T ss_pred cchhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------cc
Confidence 99876542 4457999999999987654 89999999999999999998885421110 00
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ..........+.+++.+||++||++||+..+.+.|.|...
T Consensus 285 ~~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 PE-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CT-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cc-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 0111122346789999999999999999999998888654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=314.13 Aligned_cols=285 Identities=28% Similarity=0.420 Sum_probs=177.4
Q ss_pred CccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCee
Q 039595 148 KLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTL 227 (1078)
Q Consensus 148 ~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 227 (1078)
.+++|++|++++|.++ .+|. ++.+++|++|++++|.+++. |. +.++++|++|+|++|.+++. +.+.++++|++|
T Consensus 42 ~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L 115 (347)
T 4fmz_A 42 ELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLREL 115 (347)
T ss_dssp HHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEE
T ss_pred hcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEE
Confidence 3444444444444443 2222 34444444444444444422 22 55566666666666665532 245666666666
Q ss_pred ecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCC
Q 039595 228 DLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLS 307 (1078)
Q Consensus 228 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 307 (1078)
+|++|++++..+ +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|.++
T Consensus 116 ~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~ 190 (347)
T 4fmz_A 116 YLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190 (347)
T ss_dssp ECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCC
T ss_pred ECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccc
Confidence 666666665422 5666666666666664443333 36666666666666666664433 556666666666666665
Q ss_pred CCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCc
Q 039595 308 GSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVG 387 (1078)
Q Consensus 308 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 387 (1078)
+..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+++. ..+.
T Consensus 191 ~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~ 262 (347)
T 4fmz_A 191 DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVK 262 (347)
T ss_dssp CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGT
T ss_pred cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHh
Confidence 4332 6677778888888888776544 7777888888888888875433 77788888888888888754 3577
Q ss_pred cCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCc
Q 039595 388 NLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGK 453 (1078)
Q Consensus 388 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 453 (1078)
.+++|++|++++|++.+. ..+..+++|++|++++|.+....+..|..+++|++|++++|++++.
T Consensus 263 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 263 DLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp TCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred cCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 777888888888877654 3466677777777777777766666677777777777777766643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=313.22 Aligned_cols=231 Identities=13% Similarity=0.081 Sum_probs=179.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||.||+|... +++.||||++...... .....+.+.+|+..+++++||||+++++++.+++..|+|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc-CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 57999999999999999999765 5899999999765322 344457889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||++|++|.++++.. ....++.+++.|++.||+|||++ ||+||||||+||+++.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999431 35567899999999999999999 99999999999999999999998543
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
|++ .++.++|||||||++|||+||+.||....... ....... .............
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~-~~~~~~~----~~~~~~~~~~~~~ 229 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS-GLAPAER----DTAGQPIEPADID 229 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC-CSEECCB----CTTSCBCCHHHHC
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch-hhHHHHH----HhccCCCChhhcc
Confidence 333 37889999999999999999999976443211 0000000 0000000000000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
......+.+++.+||+.||++| |++|+++....
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 0111257889999999999999 99999987543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=309.89 Aligned_cols=249 Identities=25% Similarity=0.300 Sum_probs=121.2
Q ss_pred cceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccC
Q 039595 128 LQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNN 207 (1078)
Q Consensus 128 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 207 (1078)
|+++++++++++ .+|..+. ++|++|+|++|.+++..|..++.+++|++|++++|.+++..|..|+++++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 444444444443 3333332 3444444444444433333444444444444444444444444455555555555555
Q ss_pred CCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccC--CCCCcccCCCcccceeecccccccCc
Q 039595 208 NSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS--GSIPSIIGNLKSLHQLDLIENQLSGS 285 (1078)
Q Consensus 208 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~ 285 (1078)
|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++ +..|..+..+ +|++|++++|++++
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG- 186 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence 5554 2333332 45555555555555444444555555555555555553 2344445544 55555555555553
Q ss_pred cccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCcccccc
Q 039595 286 IPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365 (1078)
Q Consensus 286 ~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 365 (1078)
+|..+. ++|+.|++++|.+++..+..+.++++|++|+|++|++++..+..+..+++|+.|++++|+++ .+|..+..+
T Consensus 187 l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 263 (332)
T 2ft3_A 187 IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263 (332)
T ss_dssp CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence 232221 34444444444444444445555555555555555555544445555555555555555555 455555555
Q ss_pred CCCCeEEcccccCccccCCCCc
Q 039595 366 KSLSELKLCKNNLSGVIPHSVG 387 (1078)
Q Consensus 366 ~~L~~L~L~~N~l~~~~p~~~~ 387 (1078)
++|++|++++|++++..+..|.
T Consensus 264 ~~L~~L~l~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 264 KLLQVVYLHTNNITKVGVNDFC 285 (332)
T ss_dssp TTCCEEECCSSCCCBCCTTSSS
T ss_pred ccCCEEECCCCCCCccChhHcc
Confidence 5555555555555554444443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-32 Score=308.52 Aligned_cols=289 Identities=21% Similarity=0.250 Sum_probs=223.2
Q ss_pred ccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeee
Q 039595 149 LNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLD 228 (1078)
Q Consensus 149 l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 228 (1078)
..+|+.++++++.++ .+|..+. ++|++|++++|.+.+..|..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus 32 ~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp EEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred cccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 357899999999998 8888774 6899999999999987788899999999999999999988888999999999999
Q ss_pred cCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeeccccccc--CccccccccccCCceeeecccCC
Q 039595 229 LSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS--GSIPLSFGNLSSWTLMSLFSNSL 306 (1078)
Q Consensus 229 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~l~~n~l 306 (1078)
|++|+++. +|..+. ++|++|++++|++++..+..|.++++|+.|++++|.++ +..|..|..+ +|+.|++++|.+
T Consensus 109 L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 109 ISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CCSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 99999985 455554 78999999999999777777899999999999999986 4677777777 888888888888
Q ss_pred CCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCC
Q 039595 307 SGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSV 386 (1078)
Q Consensus 307 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 386 (1078)
++ +|..+. ++|++|++++|++++..+..+..+++|+.|++++|++.+..+..+..+++|++|+|++|+++ .+|..+
T Consensus 185 ~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l 260 (332)
T 2ft3_A 185 TG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260 (332)
T ss_dssp SS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred Cc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence 75 454443 67888888888888777778888888888888888888777777888888888888888887 566667
Q ss_pred ccCCCCceeecccCcCCCCCCcccccc------CCCCeEEccCcccc--ccchhhccCCCCCcEecCCCC
Q 039595 387 GNLTGLVLLNMCENHLFGPIPKSLKSL------TSLKRVRFNQNNLV--GKVYEAFGDHPNLTFLDLSQN 448 (1078)
Q Consensus 387 ~~l~~L~~L~L~~N~l~~~~~~~l~~l------~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N 448 (1078)
..+++|+.|++++|++++..+..|... ..|+.|++++|.+. .+.+..|..+++|+.|++++|
T Consensus 261 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp GGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred hcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 777888888888887777666665543 33455555555544 344444555555555555444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-32 Score=306.68 Aligned_cols=199 Identities=25% Similarity=0.309 Sum_probs=106.7
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeec
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l 181 (1078)
+.|++|+|++|.+.+..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 56677777777776655556777777777777777776666666777777777777777666 5555443 45555555
Q ss_pred ccccccCCccCcccCCCCCcEEEccCCCCCC--CCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccC
Q 039595 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFG--YIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS 259 (1078)
Q Consensus 182 ~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 259 (1078)
++|.+.+..+..++++++|++|++++|.+.. ..+..+.++++|++|++++|+++. +|..+. ++|++|++++|+++
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKIT 205 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCC
Confidence 5555554444445555555555555555532 344445555555555555555543 232222 44444444444444
Q ss_pred CCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCC
Q 039595 260 GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSL 306 (1078)
Q Consensus 260 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l 306 (1078)
+..|..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+
T Consensus 206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 252 (330)
T 1xku_A 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252 (330)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred ccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcC
Confidence 44444444444444444444444443333333333333333333333
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-32 Score=303.83 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=144.7
Q ss_pred CCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecc
Q 039595 103 HLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFC 182 (1078)
Q Consensus 103 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~ 182 (1078)
+++.++++++.+. .+|..+. +.|++|+|++|++++..+..|+++++|++|+|++|++++..|..++.+++|++|+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 5677787777775 4565443 567777777777776655567777777777777777776556666666666666666
Q ss_pred cccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCC--CCCCcccCCCCCcEEeccccccCC
Q 039595 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG--LIPCTLDNLSNLDTLFLYKNSLSG 260 (1078)
Q Consensus 183 ~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~ 260 (1078)
+|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|+++. ..+..|.++++|++|++++|+++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 66665 4555443 566666666666665555556666666666666666542 445555555666666666665553
Q ss_pred CCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCC
Q 039595 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGN 340 (1078)
Q Consensus 261 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 340 (1078)
+|..+. ++|++|++++|++++..|. .+.++++|++|+|++|++++..+..+..
T Consensus 186 -l~~~~~--~~L~~L~l~~n~l~~~~~~------------------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 238 (330)
T 1xku_A 186 -IPQGLP--PSLTELHLDGNKITKVDAA------------------------SLKGLNNLAKLGLSFNSISAVDNGSLAN 238 (330)
T ss_dssp -CCSSCC--TTCSEEECTTSCCCEECTG------------------------GGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred -CCcccc--ccCCEEECCCCcCCccCHH------------------------HhcCCCCCCEEECCCCcCceeChhhccC
Confidence 333322 4555555555555444444 4444444444444444444444444445
Q ss_pred CCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCC
Q 039595 341 LSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSV 386 (1078)
Q Consensus 341 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 386 (1078)
+++|+.|++++|+++ .+|..+..+++|++|++++|++++..+..|
T Consensus 239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f 283 (330)
T 1xku_A 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283 (330)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence 555555555555554 444445555555555555555554444433
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-35 Score=348.07 Aligned_cols=355 Identities=19% Similarity=0.140 Sum_probs=185.8
Q ss_pred CCCCeeecCCcccCCCCCCc-ccCCCCCcEEeccccccCC----CCCcccCCCcccceeecccccccCccccccc-ccc-
Q 039595 222 KSLSTLDLSQNQLNGLIPCT-LDNLSNLDTLFLYKNSLSG----SIPSIIGNLKSLHQLDLIENQLSGSIPLSFG-NLS- 294 (1078)
Q Consensus 222 ~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~- 294 (1078)
++|++|+|++|+++...... +..+++|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+. .+.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 56788888888877543332 6677888888888888773 3455667778888888888887654443332 233
Q ss_pred ---CCceeeecccCCCC----CCCccccCCCccCeeeccccccCccCCCCC-----CCCCcCcEEEccCccCCCCC----
Q 039595 295 ---SWTLMSLFSNSLSG----SIPPILGNLKSLSTLGLYLNQLNGVIPPSI-----GNLSSLRNLSLFNNGLYGSI---- 358 (1078)
Q Consensus 295 ---~L~~L~l~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~---- 358 (1078)
+|+.|++++|.++. .++..+.++++|++|+|++|++++..+..+ ...++|+.|++++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 46666666666663 345556666666666666666653322211 12345666666666655422
Q ss_pred CccccccCCCCeEEcccccCccccCCCCc-----cCCCCceeecccCcCCCC----CCccccccCCCCeEEccCcccccc
Q 039595 359 PEEIGYLKSLSELKLCKNNLSGVIPHSVG-----NLTGLVLLNMCENHLFGP----IPKSLKSLTSLKRVRFNQNNLVGK 429 (1078)
Q Consensus 359 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~ 429 (1078)
+..+..+++|++|++++|.++...+..+. ..++|+.|++++|.+++. ++..+..+++|++|++++|.+...
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 33444455666666666655543332222 133555555555555442 233344444444444444444332
Q ss_pred ch-----hhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCccc
Q 039595 430 VY-----EAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPV 504 (1078)
Q Consensus 430 ~~-----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~ 504 (1078)
.. ..+..+++|++|++++|.++..... .++..+..+++|++|++++|.|++..+.
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCG--------------------DLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH--------------------HHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHH--------------------HHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 21 1111233444444444433321000 0233344455556666666655433333
Q ss_pred ccccC-----ccCcEEeccCCccCCC----cccccccccccceeeccCccccCCCCccccc-----ccccccccccCccc
Q 039595 505 QLEKL-----FSLNKLILSLNQLSGS----VPLEFGSLTELQYLDLSANKLSSSIPKSIGN-----LLKLYYLNLSNNQF 570 (1078)
Q Consensus 505 ~~~~l-----~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l 570 (1078)
.+... ++|++|+|++|.+++. ++..+..+++|++|+|++|.+++..+..+.. .++|++|+|++|++
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 33221 4566666666655533 2344445556666666666555443333332 34566666666666
Q ss_pred cc----ccchhhhcccccCeeecCCCccCC
Q 039595 571 SH----TIPIEFEKLIHLSKLDLSHNILQE 596 (1078)
Q Consensus 571 ~~----~~~~~~~~l~~L~~L~Ls~N~l~~ 596 (1078)
++ .+|..+..+++|++|+|++|++++
T Consensus 383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 383 SDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 54 445555556666666666666554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-34 Score=343.56 Aligned_cols=377 Identities=19% Similarity=0.114 Sum_probs=219.7
Q ss_pred CCCcEEeccccccCCCCCc-ccCCCcccceeecccccccCc----cccccccccCCceeeecccCCCCCCCcc-ccCCCc
Q 039595 246 SNLDTLFLYKNSLSGSIPS-IIGNLKSLHQLDLIENQLSGS----IPLSFGNLSSWTLMSLFSNSLSGSIPPI-LGNLKS 319 (1078)
Q Consensus 246 ~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~-l~~l~~ 319 (1078)
++|++|+|++|+++..... .+..+++|++|+|++|.+++. ++..+..+++|+.|++++|.+++..+.. +..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~- 81 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ- 81 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC-
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh-
Confidence 4566666666666532222 255566666666666666532 3344444455555555555554322211 11222
Q ss_pred cCeeeccccccCccCCCCCCCCC-cCcEEEccCccCCC----CCCccccccCCCCeEEcccccCccccCCCCc-----cC
Q 039595 320 LSTLGLYLNQLNGVIPPSIGNLS-SLRNLSLFNNGLYG----SIPEEIGYLKSLSELKLCKNNLSGVIPHSVG-----NL 389 (1078)
Q Consensus 320 L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l 389 (1078)
... +|++|++++|.+++ .++..+..+++|++|+|++|.+++..+..+. ..
T Consensus 82 --------------------~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 141 (461)
T 1z7x_W 82 --------------------TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141 (461)
T ss_dssp --------------------STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred --------------------hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence 000 34455555554442 2344444455555555555554432222111 13
Q ss_pred CCCceeecccCcCCCCC----CccccccCCCCeEEccCccccccchhhcc-----CCCCCcEecCCCCccCCcc----Cc
Q 039595 390 TGLVLLNMCENHLFGPI----PKSLKSLTSLKRVRFNQNNLVGKVYEAFG-----DHPNLTFLDLSQNNFDGKI----SF 456 (1078)
Q Consensus 390 ~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~----~~ 456 (1078)
++|++|++++|++++.. +..+..+++|++|++++|.+.......+. ..++|++|++++|.++... +.
T Consensus 142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 221 (461)
T 1z7x_W 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence 34555555555554422 33444455566666666655444333332 2446666666666665432 33
Q ss_pred cccCCCCCceecccccccCCCC-----CccccCCCcccEEeccCCccCCC----cccccccCccCcEEeccCCccCCCcc
Q 039595 457 NWRNLPKLDTFIVSMNNIFGSI-----PLEIGDSSKLQFLDLSSNHIVGK----IPVQLEKLFSLNKLILSLNQLSGSVP 527 (1078)
Q Consensus 457 ~~~~l~~L~~L~l~~N~i~~~~-----~~~~~~l~~L~~L~Ls~N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~ 527 (1078)
.+..+++|++|++++|.+.+.. +..+..+++|++|++++|+|++. ++..+..+++|++|+|++|++++..+
T Consensus 222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 301 (461)
T 1z7x_W 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301 (461)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHH
Confidence 3445566666666666554432 22233577888888888888754 56667778889999999988875544
Q ss_pred cccccc-----cccceeeccCccccCC----CCcccccccccccccccCcccccccchhhhc-----ccccCeeecCCCc
Q 039595 528 LEFGSL-----TELQYLDLSANKLSSS----IPKSIGNLLKLYYLNLSNNQFSHTIPIEFEK-----LIHLSKLDLSHNI 593 (1078)
Q Consensus 528 ~~~~~l-----~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~ 593 (1078)
..+... ++|++|+|++|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|+.|+|++|+
T Consensus 302 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 444332 6888889988888765 3455666788888888888887766665543 5688888888888
Q ss_pred cCC----cCCCCcccccccceeeccCccccCCcccccc-----cCCcCcEEEcccCcCC
Q 039595 594 LQE----EIPPQVCNMESLEKLNLSHNNLSGFIPRCFE-----KMRSLSCIDICYNELQ 643 (1078)
Q Consensus 594 l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~-----~l~~L~~l~l~~N~l~ 643 (1078)
+++ .++..+..+++|++|+|++|++++.....+. ...+|+.|++.+|.+.
T Consensus 382 i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred CChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence 875 5666777788888888888888755333332 2345777777776655
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=303.54 Aligned_cols=283 Identities=19% Similarity=0.199 Sum_probs=176.7
Q ss_pred CCCCcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCC
Q 039595 62 ISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGV 141 (1078)
Q Consensus 62 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 141 (1078)
..+|.|.|+ |+-...+++. ++. .-.++|++|+|++|.+.+..+..++++++|++|+|++|++++.
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~-----------iP~---~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 91 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNS-----------IPS---GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91 (353)
T ss_dssp CCEECTTSE-EECCSTTCSS-----------CCT---TCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred CCCCCCCeE-eeCCCCCccc-----------ccc---cccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCcc
Confidence 567999998 8754332221 111 2235788888888888766666788888888888888888876
Q ss_pred CCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCcc-CcccCCCCCcEEEccCC-CCCCCCCCccc
Q 039595 142 ISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIP-SSLGNLSKLALLYLNNN-SLFGYIPTVMG 219 (1078)
Q Consensus 142 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p-~~l~~l~~L~~L~L~~n-~l~~~~p~~~~ 219 (1078)
.|..|+++++|++|+|++|++++..+..++.+++|++|++++|.+++..+ ..++++++|++|++++| .+.+..|..|+
T Consensus 92 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 171 (353)
T 2z80_A 92 EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171 (353)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT
T ss_pred CHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHcc
Confidence 67778888888888888888874333346777777777777777764322 36677777777777777 35544556677
Q ss_pred ccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCcee
Q 039595 220 NLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLM 299 (1078)
Q Consensus 220 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 299 (1078)
++++|++|++++|++++..|..|.++++|++|++++|+++...+..+..+++|+.|++++|++++..+..+..
T Consensus 172 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~------- 244 (353)
T 2z80_A 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST------- 244 (353)
T ss_dssp TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-----------
T ss_pred CCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc-------
Confidence 7777777777777777666667777777777777777765333333445666777777777766554433221
Q ss_pred eecccCCCCCCCccccCCCccCeeeccccccCc----cCCCCCCCCCcCcEEEccCccCCCCCCcc-ccccCCCCeEEcc
Q 039595 300 SLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNG----VIPPSIGNLSSLRNLSLFNNGLYGSIPEE-IGYLKSLSELKLC 374 (1078)
Q Consensus 300 ~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~ 374 (1078)
......++.++|+++.+++ .+|..+..+++|+.|++++|+++ .+|.. |..+++|++|+|+
T Consensus 245 --------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~ 309 (353)
T 2z80_A 245 --------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLH 309 (353)
T ss_dssp ----------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred --------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEee
Confidence 1123334444444444443 23445555666666666666666 33333 4566666666666
Q ss_pred cccCccc
Q 039595 375 KNNLSGV 381 (1078)
Q Consensus 375 ~N~l~~~ 381 (1078)
+|++.+.
T Consensus 310 ~N~~~~~ 316 (353)
T 2z80_A 310 TNPWDCS 316 (353)
T ss_dssp SSCBCCC
T ss_pred CCCccCc
Confidence 6666543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=291.78 Aligned_cols=286 Identities=22% Similarity=0.239 Sum_probs=166.9
Q ss_pred CCCcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCC--
Q 039595 63 SPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSG-- 140 (1078)
Q Consensus 63 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~-- 140 (1078)
..|.|.+|.|+..+ ++. ++ ..-.++|++|+|++|.+....+..|+++++|++|+|++|+++.
T Consensus 5 C~C~~~~l~c~~~~--l~~-----------ip---~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 68 (306)
T 2z66_A 5 CSCSGTEIRCNSKG--LTS-----------VP---TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68 (306)
T ss_dssp CEEETTEEECCSSC--CSS-----------CC---SCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE
T ss_pred CeeCCCEEEcCCCC--ccc-----------CC---CCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc
Confidence 34899999997532 111 11 1123567777777777764333346777777777777777762
Q ss_pred CCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCcc-CcccCCCCCcEEEccCCCCCCCCCCccc
Q 039595 141 VISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIP-SSLGNLSKLALLYLNNNSLFGYIPTVMG 219 (1078)
Q Consensus 141 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~~~~ 219 (1078)
.+|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|.+.+..+ ..+..+++|++|++++|.+++..|..+.
T Consensus 69 ~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 147 (306)
T 2z66_A 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147 (306)
T ss_dssp EEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTT
T ss_pred CcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcc
Confidence 23555666777777777777666 455556566666666666666554433 3455555555555555555555555555
Q ss_pred ccCCCCeeecCCcccCC-CCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCce
Q 039595 220 NLKSLSTLDLSQNQLNG-LIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTL 298 (1078)
Q Consensus 220 ~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 298 (1078)
++++|++|+|++|++++ .+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 148 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l---------------- 211 (306)
T 2z66_A 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF---------------- 211 (306)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC----------------
T ss_pred cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCcc----------------
Confidence 55555555555555554 3444555555555555555555544444455555555555555544
Q ss_pred eeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCC-CcCcEEEccCccCCCCCC--ccccccCCCCeEEccc
Q 039595 299 MSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNL-SSLRNLSLFNNGLYGSIP--EEIGYLKSLSELKLCK 375 (1078)
Q Consensus 299 L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~ 375 (1078)
++..+..+..+++|++|+|++|++++..|..+..+ ++|+.|++++|.+.+..+ .....+.+.+.+.+..
T Consensus 212 --------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~ 283 (306)
T 2z66_A 212 --------FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEV 283 (306)
T ss_dssp --------SBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCG
T ss_pred --------CccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccc
Confidence 44444456666677777777777776667677766 377777777777765322 1122344455556666
Q ss_pred ccCccccCCCCccC
Q 039595 376 NNLSGVIPHSVGNL 389 (1078)
Q Consensus 376 N~l~~~~p~~~~~l 389 (1078)
+.+....|..+.+.
T Consensus 284 ~~~~C~~p~~~~g~ 297 (306)
T 2z66_A 284 ERMECATPSDKQGM 297 (306)
T ss_dssp GGCBEEESGGGTTC
T ss_pred cccccCCchhhCCc
Confidence 77777667665543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-33 Score=339.78 Aligned_cols=448 Identities=16% Similarity=0.153 Sum_probs=266.4
Q ss_pred CCcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcc---cccCCCCCC------------CCCCc
Q 039595 64 PCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLF---FGNIPPQIG------------NLSKL 128 (1078)
Q Consensus 64 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~---~~~~p~~~~------------~l~~L 128 (1078)
|++|.+|.+... .++. + . .+.. ..++..+.++++|++|+|+++.. .+.+|..++ ++++|
T Consensus 41 ck~W~~~~~~~~-~~l~-~--~-~~~~-~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L 114 (592)
T 3ogk_B 41 CRRWFKIDSETR-EHVT-M--A-LCYT-ATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114 (592)
T ss_dssp CHHHHHHHHHHC-CEEE-E--S-CGGG-SCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred hHHHHHhhhccc-cEEE-E--e-eccc-cChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence 558999965422 2332 2 1 1111 12233456788999999988643 245665555 67888
Q ss_pred ceeccCCCccCCCCCccccCc--cceeEEEccCcc-CCC-CCCcccccccccceeecccccccCC----ccCcccCCCCC
Q 039595 129 QNLDLGNNQLSGVISPEIGKL--NQLRRLYLDMNQ-LHG-TIPPVIGQLSLIHEFSFCHNNVSGR----IPSSLGNLSKL 200 (1078)
Q Consensus 129 ~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~L~~n~-l~~-~~p~~i~~l~~L~~L~l~~n~~~~~----~p~~l~~l~~L 200 (1078)
++|+|++|.+++..+..++.+ .+|++|+|++|. ++. .++..+..+++|++|+|++|.+++. ++..+.++++|
T Consensus 115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L 194 (592)
T 3ogk_B 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194 (592)
T ss_dssp CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence 888888888776666666664 448888888776 221 1233334678888888888877655 44455677888
Q ss_pred cEEEccCCCCCCC----CCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccC---CCCCcccCCCcccc
Q 039595 201 ALLYLNNNSLFGY----IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS---GSIPSIIGNLKSLH 273 (1078)
Q Consensus 201 ~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~ 273 (1078)
++|+|++|.+++. ++..+.++++|++|+|++|.+.+ +|..+.++++|++|+++++... +..+..+..+++|+
T Consensus 195 ~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~ 273 (592)
T 3ogk_B 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC 273 (592)
T ss_dssp CEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCC
T ss_pred cEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhcccccc
Confidence 8888888887632 33345567888888888888776 4667777888888888754332 23345567777788
Q ss_pred eeecccccccCccccccccccCCceeeecccCCCCCCC-ccccCCCccCeeeccccccC-ccCCCCCCCCCcCcEEEccC
Q 039595 274 QLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIP-PILGNLKSLSTLGLYLNQLN-GVIPPSIGNLSSLRNLSLFN 351 (1078)
Q Consensus 274 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~ 351 (1078)
.|+++++. .+.+|..+..+++|+.|++++|.+++... ..+.++++|++|+++ +.+. +.++..+..+++|+.|++++
T Consensus 274 ~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~ 351 (592)
T 3ogk_B 274 RLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIER 351 (592)
T ss_dssp EEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEEC
T ss_pred ccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeec
Confidence 88777753 33566667777777777777777654332 335677777777777 3332 22233334566677777772
Q ss_pred -----------ccCCCCC-CccccccCCCCeEEcccccCccccCCCCcc-CCCCceeecc----cCcCCCC-----CCcc
Q 039595 352 -----------NGLYGSI-PEEIGYLKSLSELKLCKNNLSGVIPHSVGN-LTGLVLLNMC----ENHLFGP-----IPKS 409 (1078)
Q Consensus 352 -----------N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~ 409 (1078)
|.+++.. +.....+++|++|+++.|++++..+..+.. +++|+.|+++ .|.+++. ++..
T Consensus 352 g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~ 431 (592)
T 3ogk_B 352 GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSL 431 (592)
T ss_dssp CCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHH
T ss_pred CccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHH
Confidence 4444321 222334667777777666666555544443 6666676664 4555543 2223
Q ss_pred ccccCCCCeEEccCcc--ccccchhhcc-CCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCC
Q 039595 410 LKSLTSLKRVRFNQNN--LVGKVYEAFG-DHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSS 486 (1078)
Q Consensus 410 l~~l~~L~~L~L~~N~--l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~ 486 (1078)
+.++++|++|+++.|. ++......+. .+++|++|++++|++++. .++..+..++
T Consensus 432 ~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~-----------------------~~~~~~~~~~ 488 (592)
T 3ogk_B 432 LIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE-----------------------GLMEFSRGCP 488 (592)
T ss_dssp HHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHH-----------------------HHHHHHTCCT
T ss_pred HHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHH-----------------------HHHHHHhcCc
Confidence 4455556666654322 3333322222 244555555555544321 2233345567
Q ss_pred cccEEeccCCccCCC-cccccccCccCcEEeccCCccCCCccccc-ccccccceeeccC
Q 039595 487 KLQFLDLSSNHIVGK-IPVQLEKLFSLNKLILSLNQLSGSVPLEF-GSLTELQYLDLSA 543 (1078)
Q Consensus 487 ~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~ 543 (1078)
+|++|+|++|.|++. ++..+..+++|++|+|++|++++.....+ ..++.+....+..
T Consensus 489 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~ 547 (592)
T 3ogk_B 489 NLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPS 547 (592)
T ss_dssp TCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred ccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence 777777777776543 23334567777777777777775433323 2445555544443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-30 Score=290.81 Aligned_cols=274 Identities=19% Similarity=0.191 Sum_probs=153.8
Q ss_pred EEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeeccccc
Q 039595 106 NLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNN 185 (1078)
Q Consensus 106 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~ 185 (1078)
..++++|.++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|++++
T Consensus 35 ~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~--------------------- 90 (353)
T 2z80_A 35 ICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT--------------------- 90 (353)
T ss_dssp EEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCE---------------------
T ss_pred EeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCc---------------------
Confidence 3555555554 3444333 355555555555554333345555555555555555554
Q ss_pred ccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCC-CcccCCCCCcEEecccc-ccCCCCC
Q 039595 186 VSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIP-CTLDNLSNLDTLFLYKN-SLSGSIP 263 (1078)
Q Consensus 186 ~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N-~l~~~~p 263 (1078)
..|..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++..+ ..|.++++|++|++++| .+.+..|
T Consensus 91 ---~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 167 (353)
T 2z80_A 91 ---IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167 (353)
T ss_dssp ---ECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred ---cCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCH
Confidence 334444555555555555555543333334555555555555555553322 24555555555555555 2443334
Q ss_pred cccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCC---C
Q 039595 264 SIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIG---N 340 (1078)
Q Consensus 264 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~---~ 340 (1078)
..|+++++|++|++++|++++..|..|..+++|+.|++++|.++...+..+..+++|++|++++|++++..+..+. .
T Consensus 168 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~ 247 (353)
T 2z80_A 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247 (353)
T ss_dssp TTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------C
T ss_pred HHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccc
Confidence 4555555555555555555555555555555555555555555432223344466666666666666654443332 3
Q ss_pred CCcCcEEEccCccCCC----CCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCC
Q 039595 341 LSSLRNLSLFNNGLYG----SIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPI 406 (1078)
Q Consensus 341 l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 406 (1078)
...++.++++++.+.+ .+|..+..+++|++|++++|+++...+..|.++++|++|++++|++.+..
T Consensus 248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 5567788888887765 36777888888888888888888554444678888888888888877644
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=283.90 Aligned_cols=283 Identities=22% Similarity=0.228 Sum_probs=191.0
Q ss_pred EEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeeccccc
Q 039595 106 NLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNN 185 (1078)
Q Consensus 106 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~ 185 (1078)
.++.+++.++ .+|..+. ++|++|+|++|+++...+..|+++++|++|+|++|.++..
T Consensus 11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-------------------- 67 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK-------------------- 67 (306)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEE--------------------
T ss_pred EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcc--------------------
Confidence 3555556664 4555443 5777777777777743333467777777777777776621
Q ss_pred ccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCC-CcccCCCCCcEEeccccccCCCCCc
Q 039595 186 VSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIP-CTLDNLSNLDTLFLYKNSLSGSIPS 264 (1078)
Q Consensus 186 ~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~ 264 (1078)
+.+|..+..+++|++|+|++|.++ .+|..+.++++|++|++++|++++..+ ..+..+++|++|++++|++++..|.
T Consensus 68 --~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 144 (306)
T 2z66_A 68 --GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 144 (306)
T ss_dssp --EEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTT
T ss_pred --cCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchh
Confidence 111333344455555555555554 234445555555555555555554433 3555666666666666666655566
Q ss_pred ccCCCcccceeecccccccC-ccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCc
Q 039595 265 IIGNLKSLHQLDLIENQLSG-SIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSS 343 (1078)
Q Consensus 265 ~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 343 (1078)
.+.++++|++|+|++|.+++ ..|..|..+++|+.|++++|.+++..|..+.++++|++|+|++|++++..+..+..+++
T Consensus 145 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 224 (306)
T 2z66_A 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 224 (306)
T ss_dssp TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTT
T ss_pred hcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCccc
Confidence 66666666666666666665 45666667777777777777777667788899999999999999999887778999999
Q ss_pred CcEEEccCccCCCCCCccccccC-CCCeEEcccccCccccC--CCCccCCCCceeecccCcCCCCCCccccccC
Q 039595 344 LRNLSLFNNGLYGSIPEEIGYLK-SLSELKLCKNNLSGVIP--HSVGNLTGLVLLNMCENHLFGPIPKSLKSLT 414 (1078)
Q Consensus 344 L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 414 (1078)
|+.|++++|++.+..|..+..++ +|++|+|++|.+++..+ ....-+...+.+....+.+....|..+.+.+
T Consensus 225 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~~ 298 (306)
T 2z66_A 225 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 298 (306)
T ss_dssp CCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTTCB
T ss_pred CCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCCce
Confidence 99999999999999999999984 99999999999986432 1122334455566667777777777766543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-32 Score=331.67 Aligned_cols=232 Identities=13% Similarity=0.086 Sum_probs=122.4
Q ss_pred CCCcccccccccceeecccccc---cCCccCccc------------CCCCCcEEEccCCCCCCCCCCccccc--CCCCee
Q 039595 165 TIPPVIGQLSLIHEFSFCHNNV---SGRIPSSLG------------NLSKLALLYLNNNSLFGYIPTVMGNL--KSLSTL 227 (1078)
Q Consensus 165 ~~p~~i~~l~~L~~L~l~~n~~---~~~~p~~l~------------~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L 227 (1078)
.++..+..+++|++|+++++.. .+.+|..++ ++++|++|+|++|.+++..+..++.. ++|++|
T Consensus 64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L 143 (592)
T 3ogk_B 64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143 (592)
T ss_dssp CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence 3344556777788888876432 234444333 56777777777776665544555543 347777
Q ss_pred ecCCcc-cCC-CCCCcccCCCCCcEEeccccccCCC----CCcccCCCcccceeecccccccC----ccccccccccCCc
Q 039595 228 DLSQNQ-LNG-LIPCTLDNLSNLDTLFLYKNSLSGS----IPSIIGNLKSLHQLDLIENQLSG----SIPLSFGNLSSWT 297 (1078)
Q Consensus 228 ~L~~N~-l~~-~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~ 297 (1078)
+|++|. ++. .++....++++|++|+|++|.+++. ++..+.++++|+.|++++|.+++ .++..+.++++|+
T Consensus 144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~ 223 (592)
T 3ogk_B 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223 (592)
T ss_dssp EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence 777665 211 1112223566777777777766544 22334456667777777666652 2333445556666
Q ss_pred eeeecccCCCCCCCccccCCCccCeeeccccccC---ccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcc
Q 039595 298 LMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLN---GVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLC 374 (1078)
Q Consensus 298 ~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (1078)
.|++++|.+.+ +|..+.++++|+.|+++.+... +..+..+..+++|+.|+++++... .+|..+..+++|++|+|+
T Consensus 224 ~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls 301 (592)
T 3ogk_B 224 SVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLL 301 (592)
T ss_dssp EEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEET
T ss_pred EEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecC
Confidence 66666666554 4455566666666666542221 122334445555555555554322 344445555555555555
Q ss_pred cccCccccC-CCCccCCCCceeecc
Q 039595 375 KNNLSGVIP-HSVGNLTGLVLLNMC 398 (1078)
Q Consensus 375 ~N~l~~~~p-~~~~~l~~L~~L~L~ 398 (1078)
+|.+++... ..+.++++|+.|+++
T Consensus 302 ~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 302 YALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp TCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred CCcCCHHHHHHHHHhCcCCCEEecc
Confidence 555433221 112344444444444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=281.53 Aligned_cols=235 Identities=20% Similarity=0.262 Sum_probs=178.1
Q ss_pred CCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEE
Q 039595 125 LSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLY 204 (1078)
Q Consensus 125 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 204 (1078)
.+++++|+|++|+++ .+|..++++++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 578999999999998 78888999999999999999998 88988888999999999998888 7788888888888888
Q ss_pred ccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccC
Q 039595 205 LNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSG 284 (1078)
Q Consensus 205 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 284 (1078)
|++|++.+.+|..++.. ..+..|.++++|++|+|++|+++ .+|..++++++|++|+|++|++++
T Consensus 157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 220 (328)
T 4fcg_A 157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220 (328)
T ss_dssp EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence 88888888888766541 01223445666666666666666 555566666666666666666664
Q ss_pred ccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccc
Q 039595 285 SIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGY 364 (1078)
Q Consensus 285 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 364 (1078)
+|..++.+++|+.|++++|.+.+.+|..++++++|++|+|++|++.+.+|..+.++++|+.|+|++|.+.+.+|..++.
T Consensus 221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 3445666666666666666666667777777777777777777777777777777888888888888877788888888
Q ss_pred cCCCCeEEcccccCc
Q 039595 365 LKSLSELKLCKNNLS 379 (1078)
Q Consensus 365 l~~L~~L~L~~N~l~ 379 (1078)
+++|+.+++..|.+.
T Consensus 300 L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 300 LPANCIILVPPHLQA 314 (328)
T ss_dssp SCTTCEEECCGGGSC
T ss_pred ccCceEEeCCHHHHH
Confidence 888888887776665
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-31 Score=293.34 Aligned_cols=251 Identities=20% Similarity=0.180 Sum_probs=131.0
Q ss_pred CCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCcc-CCCCCcccc-------CccceeEEEccCccCCCCCCccc--
Q 039595 101 FPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQL-SGVISPEIG-------KLNQLRRLYLDMNQLHGTIPPVI-- 170 (1078)
Q Consensus 101 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l-~~~~p~~~~-------~l~~L~~L~L~~n~l~~~~p~~i-- 170 (1078)
.+.|++|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+
T Consensus 42 ~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 117 (312)
T 1wwl_A 42 GRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117 (312)
T ss_dssp EEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSS
T ss_pred CCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHH
Confidence 34455555555555 445444433 55555555555 233444443 45555555555555555555443
Q ss_pred ccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcE
Q 039595 171 GQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDT 250 (1078)
Q Consensus 171 ~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 250 (1078)
+.+++|++|++++|.+++. |..++.+.. ..+++|++|+|++|++++..|..|+++++|++
T Consensus 118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~-------------------~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 177 (312)
T 1wwl_A 118 ATGPDLNILNLRNVSWATR-DAWLAELQQ-------------------WLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177 (312)
T ss_dssp CCSCCCSEEEEESCBCSSS-SSHHHHHHT-------------------TCCTTCCEEEEESCSCCCCCTTTCCCCSSCCE
T ss_pred hcCCCccEEEccCCCCcch-hHHHHHHHH-------------------hhcCCCcEEEeeCCCCccchHHHhccCCCCCE
Confidence 4444455555554444443 444444400 00044555555555555444444555555555
Q ss_pred EeccccccCCC--CCccc--CCCcccceeecccccccCc--cc-cccccccCCceeeecccCCCCCCC-ccccCCCccCe
Q 039595 251 LFLYKNSLSGS--IPSII--GNLKSLHQLDLIENQLSGS--IP-LSFGNLSSWTLMSLFSNSLSGSIP-PILGNLKSLST 322 (1078)
Q Consensus 251 L~L~~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~~~--~p-~~~~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~ 322 (1078)
|+|++|++.+. .|..+ +++++|++|+|++|++++. ++ ..+..+++|+.|++++|.+++.+| ..+..+++|++
T Consensus 178 L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 257 (312)
T 1wwl_A 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257 (312)
T ss_dssp EECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCE
T ss_pred EECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCE
Confidence 55555544432 12222 4555555555555555421 11 223445555555555555555443 34555667777
Q ss_pred eeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCcc
Q 039595 323 LGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSG 380 (1078)
Q Consensus 323 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 380 (1078)
|+|++|+++ .+|..+. ++|+.|++++|++++. |. +..+++|++|+|++|++++
T Consensus 258 L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 258 LNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp EECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred EECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 777777776 4555555 6777777777777754 44 6677777777777777764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=298.27 Aligned_cols=265 Identities=28% Similarity=0.391 Sum_probs=162.1
Q ss_pred CCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecc
Q 039595 103 HLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFC 182 (1078)
Q Consensus 103 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~ 182 (1078)
.++.|++++|+++ .+|..+. ++|++|+|++|+++ .+|. .+++|++|+|++|+++ .+|. .+++|++|+++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 4677888888887 6777665 78888888888888 4665 5788888888888887 5666 56777888888
Q ss_pred cccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCC
Q 039595 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262 (1078)
Q Consensus 183 ~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 262 (1078)
+|.+++ +|. .+++|+.|+|++|++++ +|.. +++|++|+|++|++++. |. .+++|+.|++++|++++ +
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-C
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-C
Confidence 887774 444 56777888888888774 4443 37777888888877753 43 23567777777777774 4
Q ss_pred CcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCC
Q 039595 263 PSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLS 342 (1078)
Q Consensus 263 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 342 (1078)
| ..+++|+.|+|++|++++ +|.. +++|+.|++++|.++. +|.. +++|++|+|++|++++
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~---------- 235 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS---------- 235 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC----------
T ss_pred c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc----------
Confidence 4 345677777777777764 2321 2445555555555542 2221 2344444444444443
Q ss_pred cCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEcc
Q 039595 343 SLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFN 422 (1078)
Q Consensus 343 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 422 (1078)
+| ..+++|+.|+|++|+|++ +|. .+++|+.|++++|+|+ .+|..+.++++|+.|+++
T Consensus 236 ---------------lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 236 ---------------LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp ---------------CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred ---------------CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 23 223445555555555442 222 3344555555555554 334455555555555555
Q ss_pred Cccccccchhhcc
Q 039595 423 QNNLVGKVYEAFG 435 (1078)
Q Consensus 423 ~N~l~~~~~~~~~ 435 (1078)
+|.+.+..+..+.
T Consensus 293 ~N~l~~~~~~~l~ 305 (622)
T 3g06_A 293 GNPLSERTLQALR 305 (622)
T ss_dssp SCCCCHHHHHHHH
T ss_pred CCCCCCcCHHHHH
Confidence 5555555444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-30 Score=285.54 Aligned_cols=250 Identities=22% Similarity=0.236 Sum_probs=198.8
Q ss_pred CCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCccc-------
Q 039595 123 GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLG------- 195 (1078)
Q Consensus 123 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~------- 195 (1078)
+..++|++|++++|.+ .+|..+... |++|+|++|+++ .+.+|..+.
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~-----------------------~~~~~~~~~~~~~~~~ 92 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVR-----------------------AARIPSRILFGALRVL 92 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEE-----------------------EEECBHHHHHHHHHHH
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--Hhhccccccccc-----------------------CCCcCHHHHHHHHHhc
Confidence 3445555555555555 445444433 555555555542 233444444
Q ss_pred CCCCCcEEEccCCCCCCCCCCcc--cccCCCCeeecCCcccCCCCCCcccCC-----CCCcEEeccccccCCCCCcccCC
Q 039595 196 NLSKLALLYLNNNSLFGYIPTVM--GNLKSLSTLDLSQNQLNGLIPCTLDNL-----SNLDTLFLYKNSLSGSIPSIIGN 268 (1078)
Q Consensus 196 ~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~ 268 (1078)
++++|++|+|++|++++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|++
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 67788888888888887777765 7888888888888888876 7777777 99999999999999988899999
Q ss_pred CcccceeecccccccCc--ccccc--ccccCCceeeecccCCCC--CC-CccccCCCccCeeeccccccCccCC-CCCCC
Q 039595 269 LKSLHQLDLIENQLSGS--IPLSF--GNLSSWTLMSLFSNSLSG--SI-PPILGNLKSLSTLGLYLNQLNGVIP-PSIGN 340 (1078)
Q Consensus 269 l~~L~~L~Ls~N~l~~~--~p~~~--~~l~~L~~L~l~~n~l~~--~~-p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~ 340 (1078)
+++|++|+|++|++.+. .|..+ +.+++|+.|++++|++++ .+ ...+.++++|++|+|++|++++.+| ..+..
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 251 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence 99999999999998876 34444 899999999999999984 22 2445788999999999999998775 56777
Q ss_pred CCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCC
Q 039595 341 LSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGP 405 (1078)
Q Consensus 341 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 405 (1078)
+++|+.|+|++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|++|++++|++++.
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 899999999999999 7888777 8999999999999977 65 99999999999999999763
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=268.46 Aligned_cols=207 Identities=22% Similarity=0.232 Sum_probs=137.8
Q ss_pred CCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCcc-CCCCCCccccccccccee
Q 039595 101 FPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQ-LHGTIPPVIGQLSLIHEF 179 (1078)
Q Consensus 101 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~i~~l~~L~~L 179 (1078)
.+.|++|+|++|.+.+..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|. +++..|..++.+++|++|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 4577777777777776666667777777777777777776667777777777777777776 554446666666666666
Q ss_pred ecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccC
Q 039595 180 SFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLS 259 (1078)
Q Consensus 180 ~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 259 (1078)
++++|.+++..|..++++++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|..+++|++|+|++|+++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 66666666666666666666666666666666555555666666666666666666555555666666666666666666
Q ss_pred CCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCC
Q 039595 260 GSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLS 307 (1078)
Q Consensus 260 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 307 (1078)
+..|..|.++++|+.|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus 191 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence 655666666666666666666666555555555555555555555554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=269.31 Aligned_cols=225 Identities=24% Similarity=0.263 Sum_probs=130.3
Q ss_pred ceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCC
Q 039595 129 QNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN 208 (1078)
Q Consensus 129 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 208 (1078)
++++.++++++ .+|..+ .++|++|+|++|.+++..|..++.+++|++|++++|.+++..|..|+++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 56677777776 455443 356777777777766544455566666666666666665555555555666666666665
Q ss_pred C-CCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccc
Q 039595 209 S-LFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIP 287 (1078)
Q Consensus 209 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 287 (1078)
. +.+..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++.
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-- 168 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV-- 168 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE--
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccccc--
Confidence 4 4444455555555555555555555555555555555555555555555544444455555555555555555433
Q ss_pred cccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCC
Q 039595 288 LSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKS 367 (1078)
Q Consensus 288 ~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 367 (1078)
.+..+.++++|++|++++|++++..|..|..+++|+.|++++|.+++..+..+..+++
T Consensus 169 ----------------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 226 (285)
T 1ozn_A 169 ----------------------PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (285)
T ss_dssp ----------------------CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred ----------------------CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence 3334555555566666666665555566666666666666666666544455666666
Q ss_pred CCeEEcccccCcc
Q 039595 368 LSELKLCKNNLSG 380 (1078)
Q Consensus 368 L~~L~L~~N~l~~ 380 (1078)
|++|++++|.+..
T Consensus 227 L~~L~l~~N~~~c 239 (285)
T 1ozn_A 227 LQYLRLNDNPWVC 239 (285)
T ss_dssp CCEEECCSSCEEC
T ss_pred cCEEeccCCCccC
Confidence 6666666666553
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=282.66 Aligned_cols=225 Identities=21% Similarity=0.183 Sum_probs=98.3
Q ss_pred ceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecC
Q 039595 151 QLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLS 230 (1078)
Q Consensus 151 ~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 230 (1078)
+|++|+|++|++++..|..|+.+++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 44444444444443334444444444444444444444444444555555555555555554444445555555555555
Q ss_pred CcccCCCCCCcccCCCCCcEEecccc-ccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCC
Q 039595 231 QNQLNGLIPCTLDNLSNLDTLFLYKN-SLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309 (1078)
Q Consensus 231 ~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~ 309 (1078)
+|++++..+..|.++++|++|+|++| .+....+..|.++++|++|+|++|++++. | .+..+++|+.|++++|.+++.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEE
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCccc
Confidence 55555444444555555555555542 22222223344555555555555554432 1 233333333333333333333
Q ss_pred CCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEccccc
Q 039595 310 IPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNN 377 (1078)
Q Consensus 310 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 377 (1078)
.|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np 301 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSC
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCC
Confidence 33334444444444444444444434444444444444444444443333333334444444444443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=302.48 Aligned_cols=188 Identities=19% Similarity=0.152 Sum_probs=134.5
Q ss_pred eccCCceeEEEE-EeCCCCEEEEEEeccccccC------ChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCeeEEEE
Q 039595 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG------NMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 759 lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
.+.|++|.+..+ +...|+.||||++.+..... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 567777777666 34468999999997653221 123345799999999999 7999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||++||+|.+++.+. ++++.. +|+.||+.||+|+|++ |||||||||+|||++.+|.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999543 445554 4889999999999999 9999999999999999999999999999987665
Q ss_pred CCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 956 (1078)
.......+||+.|||||++.+ .+..++|+||+|+++|++.++..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 555667889999999999876 467789999999999888776544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=279.87 Aligned_cols=224 Identities=26% Similarity=0.280 Sum_probs=99.2
Q ss_pred ceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEecccc
Q 039595 177 HEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKN 256 (1078)
Q Consensus 177 ~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 256 (1078)
+.|+|++|++.+..+..|+++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 67 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 146 (440)
T 3zyj_A 67 RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNN 146 (440)
T ss_dssp SEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSC
T ss_pred cEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCC
Confidence 33333333333333344444444444444444444333344444444444444444444433334444444444444444
Q ss_pred ccCCCCCcccCCCcccceeeccccc-ccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCC
Q 039595 257 SLSGSIPSIIGNLKSLHQLDLIENQ-LSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIP 335 (1078)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 335 (1078)
+++...+..|.++++|++|+|++|. +....+..|.++++|+.|++++|+++ .+| .+..+++|++|+|++|++++..|
T Consensus 147 ~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~ 224 (440)
T 3zyj_A 147 PIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRP 224 (440)
T ss_dssp CCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECT
T ss_pred cccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccCh
Confidence 4443333344444444444444422 22122223333333333333333333 122 23444555555555555554445
Q ss_pred CCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcC
Q 039595 336 PSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL 402 (1078)
Q Consensus 336 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 402 (1078)
..|..+++|+.|+|++|++.+..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++
T Consensus 225 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~ 291 (440)
T 3zyj_A 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291 (440)
T ss_dssp TTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCE
T ss_pred hhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCc
Confidence 5555555555555555555544444455555555555555555544444444444555555544443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=281.56 Aligned_cols=248 Identities=23% Similarity=0.262 Sum_probs=156.9
Q ss_pred eeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCC
Q 039595 152 LRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQ 231 (1078)
Q Consensus 152 L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 231 (1078)
.+.++.+++.++ .+|..+. +++++|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 456677777776 5665543 4667777777777766666677777777777777777666666666677777777777
Q ss_pred cccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCC
Q 039595 232 NQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIP 311 (1078)
Q Consensus 232 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p 311 (1078)
|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|...+.++ +
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~-----------------------~ 189 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS-----------------------E 189 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC-----------------------T
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccC-----------------------h
Confidence 77666555556666666666666666665555566666666666666632222222 2
Q ss_pred ccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCC
Q 039595 312 PILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTG 391 (1078)
Q Consensus 312 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 391 (1078)
..|.++++|++|+|++|++++. | .+..+++|+.|+|++|.+.+..|..|..+++|+.|+|++|++++..|..|.++++
T Consensus 190 ~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 267 (452)
T 3zyi_A 190 GAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS 267 (452)
T ss_dssp TTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence 2345555555555555555533 2 3555666666666666666655666666666666666666666666666666666
Q ss_pred CceeecccCcCCCCCCccccccCCCCeEEccCcccc
Q 039595 392 LVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427 (1078)
Q Consensus 392 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 427 (1078)
|+.|+|++|++++..+..|..+++|++|++++|.+.
T Consensus 268 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 666666666666666666666666667777666653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=277.79 Aligned_cols=249 Identities=25% Similarity=0.305 Sum_probs=150.6
Q ss_pred cceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccc
Q 039595 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYK 255 (1078)
Q Consensus 176 L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 255 (1078)
...++..++++. .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 344555555554 4555444 4555555555555555555555555555555555555555555555555555555555
Q ss_pred cccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccc-cccCccC
Q 039595 256 NSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYL-NQLNGVI 334 (1078)
Q Consensus 256 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~ 334 (1078)
|++++..+..|.++++|++|+|++|++++..+ ..|.++++|++|+|++ |.+....
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~------------------------~~~~~l~~L~~L~l~~~~~l~~i~ 177 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPS------------------------YAFNRIPSLRRLDLGELKRLSYIS 177 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECT------------------------TTTTTCTTCCEEECCCCTTCCEEC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCH------------------------HHhhhCcccCEeCCCCCCCcceeC
Confidence 55554444455555555555555555554433 4455555555555555 2333333
Q ss_pred CCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccC
Q 039595 335 PPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLT 414 (1078)
Q Consensus 335 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 414 (1078)
+..|.++++|+.|+|++|+++ .+| .+..+++|++|+|++|++++..|..|.++++|+.|++++|++.+..+..|..++
T Consensus 178 ~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 255 (440)
T 3zyj_A 178 EGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255 (440)
T ss_dssp TTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCT
T ss_pred cchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCC
Confidence 445666666666666666665 333 356666666677777766666666666667777777777776666666666777
Q ss_pred CCCeEEccCccccccchhhccCCCCCcEecCCCCccCCc
Q 039595 415 SLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGK 453 (1078)
Q Consensus 415 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 453 (1078)
+|++|++++|+++.+....|..+++|+.|+|++|++.+.
T Consensus 256 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 256 SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp TCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 777777777777777777777778888888888887653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-29 Score=279.83 Aligned_cols=257 Identities=17% Similarity=0.138 Sum_probs=130.9
Q ss_pred CcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeeccc
Q 039595 104 LVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183 (1078)
Q Consensus 104 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~ 183 (1078)
++.++++++.+...++..+..+++|++|+|++|++++..|..|+++++|++|+|++|++++..| ++.+++|++|++++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3445555555544444444555666666666666666555666666666666666666664333 55566666666666
Q ss_pred ccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCC
Q 039595 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP 263 (1078)
Q Consensus 184 n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 263 (1078)
|.+++.. ..++|++|++++|++++..+.. +++|++|+|++|++++..|..+..+++|++|+|++|++++..|
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence 6555321 2355666666666655443322 3455555666655555555555555555555555555554444
Q ss_pred ccc-CCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCC
Q 039595 264 SII-GNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLS 342 (1078)
Q Consensus 264 ~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 342 (1078)
..+ ..+++|++|+|++|++++..+ ...+++|+.|++++|++++. |..+..+++|++|+|++|++++ +|..+..++
T Consensus 162 ~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~ 237 (317)
T 3o53_A 162 AELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQ 237 (317)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCT
T ss_pred HHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccc-hhhHhhcCC
Confidence 443 245555555555555553311 11244444444444444422 2224444444444444444442 233344444
Q ss_pred cCcEEEccCccCC-CCCCccccccCCCCeEEcc
Q 039595 343 SLRNLSLFNNGLY-GSIPEEIGYLKSLSELKLC 374 (1078)
Q Consensus 343 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~ 374 (1078)
+|+.|++++|.+. +.+|..+..+++|+.|+++
T Consensus 238 ~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred CCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 4444444444444 3334444444444444444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-29 Score=278.48 Aligned_cols=258 Identities=17% Similarity=0.159 Sum_probs=158.6
Q ss_pred CcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEcc
Q 039595 127 KLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLN 206 (1078)
Q Consensus 127 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~ 206 (1078)
+++.++++++.+...++..+..+++|++|+|++|.+++..|..++.+++|++|++++|.+++..| ++.+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 45566777777764444455667788888888888887666778888888888888888776554 7777778888888
Q ss_pred CCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCcc
Q 039595 207 NNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSI 286 (1078)
Q Consensus 207 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 286 (1078)
+|++++.. ..++|++|++++|++++..+.. +++|++|++++|++++..|..++.+++|++|+|++|++++..
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 87776432 3367777777777777654433 456777777777777666666777777777777777777655
Q ss_pred ccccc-cccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCcccccc
Q 039595 287 PLSFG-NLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365 (1078)
Q Consensus 287 p~~~~-~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 365 (1078)
|..+. .+++|+.|++++|.+++. + ....+++|++|+|++|++++. |..+..+++|+.|++++|+++ .+|..+..+
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l 236 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCC
T ss_pred HHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcC
Confidence 55542 455555555555555533 1 112345555555555555533 222444555555555555554 344444445
Q ss_pred CCCCeEEcccccCc-cccCCCCccCCCCceeecc
Q 039595 366 KSLSELKLCKNNLS-GVIPHSVGNLTGLVLLNMC 398 (1078)
Q Consensus 366 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~ 398 (1078)
++|+.|++++|.+. +.+|..+..+++|+.|+++
T Consensus 237 ~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp TTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred CCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 55555555555554 3344444444444444444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-26 Score=249.47 Aligned_cols=216 Identities=27% Similarity=0.354 Sum_probs=121.4
Q ss_pred CCCCcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCC
Q 039595 62 ISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGV 141 (1078)
Q Consensus 62 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 141 (1078)
.++|.|.|+.|.-.. ..+.++++++.++ .+|..+. +.|++|+|++|++++.
T Consensus 2 ~~~C~~~~~~C~c~~--------------------------~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~ 52 (270)
T 2o6q_A 2 EALCKKDGGVCSCNN--------------------------NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSL 52 (270)
T ss_dssp CCCBGGGTCSBEEET--------------------------TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCC
T ss_pred CccCCCCCCCCEeCC--------------------------CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCee
Confidence 479999999996321 2234555556655 3454443 4566667766666655
Q ss_pred CCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCccccc
Q 039595 142 ISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNL 221 (1078)
Q Consensus 142 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 221 (1078)
.+..|+++++|++|+|++|++++..+..++.+++|++|++++|.+.+..+..+.++++|++|+|++|++++..|..|+++
T Consensus 53 ~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 132 (270)
T 2o6q_A 53 PSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL 132 (270)
T ss_dssp CTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTC
T ss_pred CHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcC
Confidence 55566666666666666666663322333555555555555555554444455555556666666665555555555555
Q ss_pred CCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeee
Q 039595 222 KSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSL 301 (1078)
Q Consensus 222 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 301 (1078)
++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|++
T Consensus 133 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 212 (270)
T 2o6q_A 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence 55556666555555544444555555555555555555544445555555555555555555444334444444444444
Q ss_pred cccCC
Q 039595 302 FSNSL 306 (1078)
Q Consensus 302 ~~n~l 306 (1078)
++|.+
T Consensus 213 ~~N~~ 217 (270)
T 2o6q_A 213 QENPW 217 (270)
T ss_dssp CSSCB
T ss_pred cCCCe
Confidence 44443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-25 Score=268.34 Aligned_cols=269 Identities=24% Similarity=0.296 Sum_probs=188.3
Q ss_pred CCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEc
Q 039595 126 SKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYL 205 (1078)
Q Consensus 126 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L 205 (1078)
.++++|++++|+++ .+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|.++ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 35889999999998 7788776 78999999999888 5665 4566666666666665 3444 4566666666
Q ss_pred cCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCc
Q 039595 206 NNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGS 285 (1078)
Q Consensus 206 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 285 (1078)
++|++++ +|. .+++|+.|+|++|++++ +|.. +++|++|+|++|++++ +|.. +++|+.|++++|++
T Consensus 109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l--- 173 (622)
T 3g06_A 109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQL--- 173 (622)
T ss_dssp CSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC---
T ss_pred cCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCc---cCCCCEEECCCCCC---
Confidence 6666654 232 34556666666666654 2322 2555555555555553 2321 23444555555544
Q ss_pred cccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCcccccc
Q 039595 286 IPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL 365 (1078)
Q Consensus 286 ~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 365 (1078)
++ +| ..+++|+.|++++|++++ +|.. +++|+.|++++|.++ .+|.. +
T Consensus 174 ---------------------~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~ 220 (622)
T 3g06_A 174 ---------------------TS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---P 220 (622)
T ss_dssp ---------------------SC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---C
T ss_pred ---------------------CC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---C
Confidence 43 33 345678888888888875 3432 368889999999998 45543 4
Q ss_pred CCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecC
Q 039595 366 KSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDL 445 (1078)
Q Consensus 366 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 445 (1078)
++|+.|+|++|+|++ +| ..+++|+.|++++|+|+. +|. .+++|+.|++++|.|..+ +..|..+++|+.|+|
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~~l-p~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRL-PESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCCSC-CGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCCcC-CHHHhhccccCEEEe
Confidence 789999999999996 44 456899999999999985 444 678999999999999976 456899999999999
Q ss_pred CCCccCCccCccccCCC
Q 039595 446 SQNNFDGKISFNWRNLP 462 (1078)
Q Consensus 446 s~N~l~~~~~~~~~~l~ 462 (1078)
++|++++..+..+..++
T Consensus 292 ~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 292 EGNPLSERTLQALREIT 308 (622)
T ss_dssp CSCCCCHHHHHHHHHHH
T ss_pred cCCCCCCcCHHHHHhcc
Confidence 99999987766555443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=283.79 Aligned_cols=235 Identities=20% Similarity=0.190 Sum_probs=117.6
Q ss_pred CCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEc
Q 039595 126 SKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYL 205 (1078)
Q Consensus 126 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L 205 (1078)
++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| ++.+++|++|+|++|.+++.. ..++|++|+|
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L 106 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHA 106 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEEC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEEC
Confidence 355555555555555555555555555555555555554333 444445555555555444221 1245555555
Q ss_pred cCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccC-CCcccceeecccccccC
Q 039595 206 NNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIG-NLKSLHQLDLIENQLSG 284 (1078)
Q Consensus 206 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~ 284 (1078)
++|.+++..+. .+++|+.|+|++|++++..|..|+++++|++|+|++|.+++.+|..+. ++++|+.|+|++|.+++
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 55555443332 234455555555555544444444445555555555555444444443 34445555555544443
Q ss_pred ccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccc
Q 039595 285 SIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGY 364 (1078)
Q Consensus 285 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 364 (1078)
..+ +..+++|++|+|++|++++.+| .+..+++|+.|+|++|.+++ +|..+..
T Consensus 184 ~~~--------------------------~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~ 235 (487)
T 3oja_A 184 VKG--------------------------QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRF 235 (487)
T ss_dssp EEC--------------------------CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred ccc--------------------------cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhcc
Confidence 311 2234555555555555554322 25555555555555555553 4445555
Q ss_pred cCCCCeEEcccccCc-cccCCCCccCCCCceeecc
Q 039595 365 LKSLSELKLCKNNLS-GVIPHSVGNLTGLVLLNMC 398 (1078)
Q Consensus 365 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~ 398 (1078)
+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus 236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 555566666665555 4444555555555555554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-30 Score=314.94 Aligned_cols=453 Identities=13% Similarity=0.127 Sum_probs=225.7
Q ss_pred CCcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccc---cCCCC------------CCCCCCc
Q 039595 64 PCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFG---NIPPQ------------IGNLSKL 128 (1078)
Q Consensus 64 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~---~~p~~------------~~~l~~L 128 (1078)
|++|.++... .+..+++... .+..+...+.++++|+.|+|+++.... ..|.. ...+++|
T Consensus 34 ck~W~~~~~~----~~~~l~~~~~--~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 34 CKSWYEIERW----CRRKVFIGNC--YAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp CHHHHHHHHH----HCCEEEESST--TSSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHhhhh----hceEEeeccc--cccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 5579998322 2223334321 122233345678889999999875432 12221 2345667
Q ss_pred ceeccCCCccCCCCCcccc-CccceeEEEccCc-cCCCC-CCcccccccccceeecccccccCCccCccc----CCCCCc
Q 039595 129 QNLDLGNNQLSGVISPEIG-KLNQLRRLYLDMN-QLHGT-IPPVIGQLSLIHEFSFCHNNVSGRIPSSLG----NLSKLA 201 (1078)
Q Consensus 129 ~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n-~l~~~-~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~----~l~~L~ 201 (1078)
++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|++++|.+++..+..+. .+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 7777777666655555554 4666777777666 33321 333344566666666666665544333332 445666
Q ss_pred EEEccCCCCCCCCCCc----ccccCCCCeeecCCc-ccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceee
Q 039595 202 LLYLNNNSLFGYIPTV----MGNLKSLSTLDLSQN-QLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLD 276 (1078)
Q Consensus 202 ~L~L~~n~l~~~~p~~----~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 276 (1078)
.|+|++|. ....... +.++++|++|+|++| .+++ +|..+..+++|++|+++.+...
T Consensus 188 ~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~----------------- 248 (594)
T 2p1m_B 188 SLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAE----------------- 248 (594)
T ss_dssp EEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCC-----------------
T ss_pred EEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCc-----------------
Confidence 66666665 1111111 223456666666665 3333 4455555566666654332210
Q ss_pred cccccccCccccccccccCCcee-eecccCCCCCCCccccCCCccCeeeccccccCccCC-CCCCCCCcCcEEEccCccC
Q 039595 277 LIENQLSGSIPLSFGNLSSWTLM-SLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIP-PSIGNLSSLRNLSLFNNGL 354 (1078)
Q Consensus 277 Ls~N~l~~~~p~~~~~l~~L~~L-~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l 354 (1078)
++.|.+.+ ++..+.++++|+.+ .+.+.. .+.++..+..+++|++|+|++|.+++... ..+..+++|+.|++++| +
T Consensus 249 ~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~-~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~ 325 (594)
T 2p1m_B 249 VRPDVYSG-LSVALSGCKELRCLSGFWDAV-PAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-I 325 (594)
T ss_dssp CCHHHHHH-HHHHHHTCTTCCEEECCBTCC-GGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-G
T ss_pred cchhhHHH-HHHHHhcCCCcccccCCcccc-hhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-c
Confidence 22222222 12233444444444 121111 11233333344455555555554432211 11234455555555554 2
Q ss_pred CCC-CCccccccCCCCeEEcc---------cccCccccCCCCc-cCCCCceeecccCcCCCCCCcccc-ccCCCCeEEcc
Q 039595 355 YGS-IPEEIGYLKSLSELKLC---------KNNLSGVIPHSVG-NLTGLVLLNMCENHLFGPIPKSLK-SLTSLKRVRFN 422 (1078)
Q Consensus 355 ~~~-~p~~~~~l~~L~~L~L~---------~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~L~ 422 (1078)
.+. ++.....+++|++|+++ .+.+++.....+. ++++|+.|.+..|.+++..+..+. .+++|++|+++
T Consensus 326 ~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~ 405 (594)
T 2p1m_B 326 EDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC 405 (594)
T ss_dssp HHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred CHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence 211 11112234555555552 2233322211121 245555555555555443333333 35556666665
Q ss_pred --C----ccccccc-----hhhccCCCCCcEecCCCCccCCccCccccC-CCCCceecccccccCCCCCccc-cCCCccc
Q 039595 423 --Q----NNLVGKV-----YEAFGDHPNLTFLDLSQNNFDGKISFNWRN-LPKLDTFIVSMNNIFGSIPLEI-GDSSKLQ 489 (1078)
Q Consensus 423 --~----N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~l~~N~i~~~~~~~~-~~l~~L~ 489 (1078)
+ |.++... ...+..+++|+.|++++ .++......+.. +++|+.|++++|.+++.....+ ..+++|+
T Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~ 484 (594)
T 2p1m_B 406 IIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLR 484 (594)
T ss_dssp ESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCC
T ss_pred cccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcC
Confidence 2 3343211 11244556777777765 444433333333 6667777777777655444444 5578888
Q ss_pred EEeccCCccCCCccc-ccccCccCcEEeccCCccCCCccccc-ccccccceeeccCcc
Q 039595 490 FLDLSSNHIVGKIPV-QLEKLFSLNKLILSLNQLSGSVPLEF-GSLTELQYLDLSANK 545 (1078)
Q Consensus 490 ~L~Ls~N~i~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~ 545 (1078)
+|+|++|.+++.... ....+++|+.|++++|+++......+ ..+++|+...+..+.
T Consensus 485 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 485 KLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp EEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred EEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 999999888644443 34457889999999998853333333 456777666666554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-27 Score=277.21 Aligned_cols=235 Identities=24% Similarity=0.267 Sum_probs=170.6
Q ss_pred CCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecC
Q 039595 366 KSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDL 445 (1078)
Q Consensus 366 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 445 (1078)
++|++|+|++|.+++..|..|.++++|++|+|++|.+++..| +..+++|++|++++|.+.++... ++|++|++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~~L~~L~L 106 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----PSIETLHA 106 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----TTCCEEEC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----CCcCEEEC
Confidence 367777777777776666666666666666666666655443 55555555555555555443321 44555555
Q ss_pred CCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCC
Q 039595 446 SQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGS 525 (1078)
Q Consensus 446 s~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 525 (1078)
++|.++ +..+. .+++|+.|+|++|.|++..|..+..+++|+.|+|++|++++.
T Consensus 107 ~~N~l~------------------------~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (487)
T 3oja_A 107 ANNNIS------------------------RVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159 (487)
T ss_dssp CSSCCC------------------------CEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEE
T ss_pred cCCcCC------------------------CCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCc
Confidence 555444 33322 346788888888888877788888888888888888888877
Q ss_pred cccccc-cccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCccc
Q 039595 526 VPLEFG-SLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCN 604 (1078)
Q Consensus 526 ~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 604 (1078)
.|..|. .+++|++|+|++|.|++..+ +..+++|++|+|++|+|++.+| .|..+++|+.|+|++|.|++ +|..+..
T Consensus 160 ~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~ 235 (487)
T 3oja_A 160 NFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRF 235 (487)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred ChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhcc
Confidence 777775 68888888888888886532 3357889999999999986444 58889999999999999985 6777888
Q ss_pred ccccceeeccCcccc-CCcccccccCCcCcEEEcc
Q 039595 605 MESLEKLNLSHNNLS-GFIPRCFEKMRSLSCIDIC 638 (1078)
Q Consensus 605 l~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~l~l~ 638 (1078)
+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus 236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 899999999999998 6678888888888888886
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-29 Score=303.81 Aligned_cols=424 Identities=15% Similarity=0.121 Sum_probs=224.9
Q ss_pred cccCCCCCcEEEccCCCCC---CCCCCc------------ccccCCCCeeecCCcccCCCCCCccc-CCCCCcEEecccc
Q 039595 193 SLGNLSKLALLYLNNNSLF---GYIPTV------------MGNLKSLSTLDLSQNQLNGLIPCTLD-NLSNLDTLFLYKN 256 (1078)
Q Consensus 193 ~l~~l~~L~~L~L~~n~l~---~~~p~~------------~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N 256 (1078)
.+..+++|+.|+|++|... +..|.. ...+++|++|+|++|.+++..+..+. .+++|++|+|++|
T Consensus 61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~ 140 (594)
T 2p1m_B 61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC 140 (594)
T ss_dssp HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence 3556778888888877532 122221 12455666666666666554444443 4566666666666
Q ss_pred -ccCCC-CCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccc--cCc
Q 039595 257 -SLSGS-IPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQ--LNG 332 (1078)
Q Consensus 257 -~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~--l~~ 332 (1078)
.++.. ++..+.++++|++|+|++|.+++..+..+.. ....+++|++|++++|. ++.
T Consensus 141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~--------------------~~~~~~~L~~L~l~~~~~~~~~ 200 (594)
T 2p1m_B 141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSH--------------------FPDTYTSLVSLNISCLASEVSF 200 (594)
T ss_dssp EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGG--------------------SCTTCCCCCEEECTTCCSCCCH
T ss_pred CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHH--------------------HhhcCCcCcEEEecccCCcCCH
Confidence 33321 2333345566666666666655443333221 11234455555555544 110
Q ss_pred c-CCCCCCCCCcCcEEEccCc-cCCCCCCccccccCCCCeEEccc-------ccCccccCCCCccCCCCcee-ecccCcC
Q 039595 333 V-IPPSIGNLSSLRNLSLFNN-GLYGSIPEEIGYLKSLSELKLCK-------NNLSGVIPHSVGNLTGLVLL-NMCENHL 402 (1078)
Q Consensus 333 ~-~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~-------N~l~~~~p~~~~~l~~L~~L-~L~~N~l 402 (1078)
. ++..+..+++|+.|++++| .+. .+|..+..+++|++|+++. |.+.+. +..+.++++|+.| .+.+...
T Consensus 201 ~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l-~~~l~~~~~L~~Ls~~~~~~~ 278 (594)
T 2p1m_B 201 SALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGL-SVALSGCKELRCLSGFWDAVP 278 (594)
T ss_dssp HHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHH-HHHHHTCTTCCEEECCBTCCG
T ss_pred HHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHH-HHHHhcCCCcccccCCcccch
Confidence 0 0011122355555555555 222 2444555555555555332 223322 2244555556555 2222211
Q ss_pred CCCCCccccccCCCCeEEccCccccccchh-hccCCCCCcEecCCCCccCCccC-ccccCCCCCceeccc---------c
Q 039595 403 FGPIPKSLKSLTSLKRVRFNQNNLVGKVYE-AFGDHPNLTFLDLSQNNFDGKIS-FNWRNLPKLDTFIVS---------M 471 (1078)
Q Consensus 403 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~---------~ 471 (1078)
+.++..+..+++|++|++++|.+...... .+..+++|+.|++++| +..... .....+++|++|+++ .
T Consensus 279 -~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~ 356 (594)
T 2p1m_B 279 -AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPN 356 (594)
T ss_dssp -GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCS
T ss_pred -hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccC
Confidence 22333344556666666666664433222 2345566666666665 321111 112235556666552 2
Q ss_pred cccCCCCCcccc-CCCcccEEeccCCccCCCcccccc-cCccCcEEecc--C----CccCCCc-----ccccccccccce
Q 039595 472 NNIFGSIPLEIG-DSSKLQFLDLSSNHIVGKIPVQLE-KLFSLNKLILS--L----NQLSGSV-----PLEFGSLTELQY 538 (1078)
Q Consensus 472 N~i~~~~~~~~~-~l~~L~~L~Ls~N~i~~~~~~~~~-~l~~L~~L~Ls--~----N~l~~~~-----~~~~~~l~~L~~ 538 (1078)
+.+++.....+. .+++|+.|+++.|.+++.....+. .+++|+.|+++ + |++++.. +..+..+++|+.
T Consensus 357 ~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~ 436 (594)
T 2p1m_B 357 VALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRR 436 (594)
T ss_dssp SCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCE
T ss_pred CCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccE
Confidence 333332222222 367777777777777755555554 46778888887 3 5555221 122556677888
Q ss_pred eeccCccccCCCCccccc-ccccccccccCcccccccchhh-hcccccCeeecCCCccCCcCCC-CcccccccceeeccC
Q 039595 539 LDLSANKLSSSIPKSIGN-LLKLYYLNLSNNQFSHTIPIEF-EKLIHLSKLDLSHNILQEEIPP-QVCNMESLEKLNLSH 615 (1078)
Q Consensus 539 L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~ 615 (1078)
|+|++ .+++..+..+.. +++|++|+|++|.+++..+..+ .++++|+.|+|++|.+++.... ....+++|++|++++
T Consensus 437 L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~ 515 (594)
T 2p1m_B 437 LSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515 (594)
T ss_dssp EECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEES
T ss_pred EeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeC
Confidence 88866 555544445554 6778888888888766555555 5678888888888887543333 334577888888888
Q ss_pred ccccCCccccc-ccCCcCcEEEcccCc
Q 039595 616 NNLSGFIPRCF-EKMRSLSCIDICYNE 641 (1078)
Q Consensus 616 N~l~~~~~~~l-~~l~~L~~l~l~~N~ 641 (1078)
|+++......+ ..+|+|+...+..+.
T Consensus 516 ~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 516 CSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp SCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred CCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 87754444444 456777665555443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-25 Score=242.36 Aligned_cols=211 Identities=26% Similarity=0.256 Sum_probs=169.1
Q ss_pred CCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEecc
Q 039595 439 NLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILS 518 (1078)
Q Consensus 439 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls 518 (1078)
+|++|++++|.++++.+..|..+++|++|++++|.+++..+..|..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45566666666655555555566666666666666665566677778888888888888887777788888888888888
Q ss_pred CCccCCCcccccccccccceeeccCccccCC-CCcccccccccccccccCcccccccchhhhcccccC----eeecCCCc
Q 039595 519 LNQLSGSVPLEFGSLTELQYLDLSANKLSSS-IPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLS----KLDLSHNI 593 (1078)
Q Consensus 519 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~ 593 (1078)
+|++++..+..+..+++|++|+|++|.+++. +|..|.++++|++|+|++|++++..+..|..+++|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 8888877777788888999999999988864 588888999999999999999887788888888887 89999999
Q ss_pred cCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCCCCc
Q 039595 594 LQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNST 650 (1078)
Q Consensus 594 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~~~ 650 (1078)
+++..+..+. ..+|++|+|++|++++..+..|..+++|+.|++++|++++..|...
T Consensus 189 l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~ 244 (276)
T 2z62_A 189 MNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 244 (276)
T ss_dssp CCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTH
T ss_pred ccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchH
Confidence 9876555554 4589999999999998888888999999999999999999887543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=245.26 Aligned_cols=225 Identities=25% Similarity=0.326 Sum_probs=110.4
Q ss_pred CCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecc
Q 039595 103 HLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFC 182 (1078)
Q Consensus 103 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~ 182 (1078)
.+..+++..+.+...+ .+..+++|+.|++++|.++. + +.++.+++|++|+|++|.+++ + +.++.+++|++|+++
T Consensus 20 ~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECC
Confidence 3444455555444332 23455556666666665552 2 235555666666666665553 2 244455555555555
Q ss_pred cccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCC
Q 039595 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262 (1078)
Q Consensus 183 ~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 262 (1078)
+|.+++..|..++++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 55555444444555555555555555555444444555555555555555555444444455555555555555555444
Q ss_pred CcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCC
Q 039595 263 PSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGN 340 (1078)
Q Consensus 263 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 340 (1078)
+..|+++++|++|+|++|++++..|..|..+++|+.|++++|.+.+. +++|+.|+++.|+++|.+|.+++.
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~ 244 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGS 244 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSC
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccc
Confidence 44445555555555555555544444444444444444444443321 223444444444444444444433
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=239.22 Aligned_cols=224 Identities=21% Similarity=0.225 Sum_probs=112.5
Q ss_pred eccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCC
Q 039595 131 LDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSL 210 (1078)
Q Consensus 131 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l 210 (1078)
.+.++.++. .+|..+. ++|++|+|++|++++..+..++.+++|++|++++|.+.+..+..|+++++|++|+|++|.+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 344444444 4454443 3566666666666544444555555555555555555544444555555555555555555
Q ss_pred CCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCC-CCcccCCCcccceeecccccccCccccc
Q 039595 211 FGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS-IPSIIGNLKSLHQLDLIENQLSGSIPLS 289 (1078)
Q Consensus 211 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 289 (1078)
++..|..|.++++|++|++++|++++..+..+.++++|++|++++|++++. +|..|+++++|++|+|++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 544445555555555555555555544444455555555555555555432 3444555555555555555554443333
Q ss_pred cccccCCceeeecccCCCCCCCccccCCCccC-eeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCC
Q 039595 290 FGNLSSWTLMSLFSNSLSGSIPPILGNLKSLS-TLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSL 368 (1078)
Q Consensus 290 ~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 368 (1078)
|..+.+|+ .|. .|++++|++++..+..+.. .+|+.|++++|++++..+..+..+++|
T Consensus 169 ~~~l~~L~---------------------~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L 226 (276)
T 2z62_A 169 LRVLHQMP---------------------LLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSL 226 (276)
T ss_dssp GHHHHTCT---------------------TCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSC
T ss_pred hhhhhhcc---------------------ccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccc
Confidence 33333322 111 4555555555443333332 255555555555554444444555555
Q ss_pred CeEEcccccCc
Q 039595 369 SELKLCKNNLS 379 (1078)
Q Consensus 369 ~~L~L~~N~l~ 379 (1078)
+.|++++|++.
T Consensus 227 ~~L~l~~N~~~ 237 (276)
T 2z62_A 227 QKIWLHTNPWD 237 (276)
T ss_dssp CEEECCSSCBC
T ss_pred cEEEccCCccc
Confidence 55555555554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=242.15 Aligned_cols=229 Identities=26% Similarity=0.327 Sum_probs=136.3
Q ss_pred CCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEE
Q 039595 125 LSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLY 204 (1078)
Q Consensus 125 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 204 (1078)
+..+..+++..+.+... ..+..+++|+.|++++|.++ .+ +.++.+++|++|++++|.+.+. ..++++++|++|+
T Consensus 18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 91 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI 91 (272)
T ss_dssp HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEE
T ss_pred HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-cc-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEE
Confidence 45566777777776643 34567777888888887776 33 2466666666666666666642 3566666666666
Q ss_pred ccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccC
Q 039595 205 LNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSG 284 (1078)
Q Consensus 205 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 284 (1078)
|++|.+++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|+++++|++|++++|++++
T Consensus 92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 171 (272)
T 3rfs_A 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS 171 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence 66666665555556666666666666666665555556666666666666666665555555566666666666666555
Q ss_pred ccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccc
Q 039595 285 SIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGY 364 (1078)
Q Consensus 285 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 364 (1078)
..+.. ++++++|++|++++|++++..|..+..+++|+.|++++|.+.+.
T Consensus 172 ~~~~~------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------- 220 (272)
T 3rfs_A 172 LPEGV------------------------FDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------- 220 (272)
T ss_dssp CCTTT------------------------TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------
T ss_pred cCHHH------------------------hcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------
Confidence 44444 44555555555555555555454555555555555555555432
Q ss_pred cCCCCeEEcccccCccccCCCCccCC
Q 039595 365 LKSLSELKLCKNNLSGVIPHSVGNLT 390 (1078)
Q Consensus 365 l~~L~~L~L~~N~l~~~~p~~~~~l~ 390 (1078)
+++|+.|+++.|+++|.+|..++.+.
T Consensus 221 ~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 221 CPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred CcHHHHHHHHHHhCCCcccCcccccC
Confidence 23455555666666666665555444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=231.22 Aligned_cols=192 Identities=26% Similarity=0.349 Sum_probs=133.0
Q ss_pred CCCcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCC
Q 039595 63 SPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVI 142 (1078)
Q Consensus 63 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 142 (1078)
+||.|.|.+|.... ++++++++.+. .+|..+. +.|++|+|++|++++..
T Consensus 3 ~Cp~~~gC~C~~~~----------------------------~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~ 51 (251)
T 3m19_A 3 TCETVTGCTCNEGK----------------------------KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLS 51 (251)
T ss_dssp -CHHHHSSEEEGGG----------------------------TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCC
T ss_pred cCCCCCceEcCCCC----------------------------eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccC
Confidence 58899999996322 23444555554 4555444 56777777777777666
Q ss_pred CccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccC
Q 039595 143 SPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLK 222 (1078)
Q Consensus 143 p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 222 (1078)
|..|+++++|++|+|++|++++..|..+..+++|++|++++|.+++..+..|+.+++|++|+|++|++++..+..|.+++
T Consensus 52 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 131 (251)
T 3m19_A 52 DATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLT 131 (251)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred HhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCC
Confidence 66677777777777777777766666666667777777777776666566667777777777777777766666667777
Q ss_pred CCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCc
Q 039595 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGS 285 (1078)
Q Consensus 223 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 285 (1078)
+|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++.
T Consensus 132 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 132 KLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 777777777777766666677777777777777777766666677777777777777777643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=230.23 Aligned_cols=179 Identities=32% Similarity=0.370 Sum_probs=81.1
Q ss_pred ceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEecccc
Q 039595 177 HEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKN 256 (1078)
Q Consensus 177 ~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 256 (1078)
++|++++|++++..+..|+++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 40 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 119 (270)
T 2o6q_A 40 KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRN 119 (270)
T ss_dssp SEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSS
T ss_pred CEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCC
Confidence 33333333333333334444444444555444444333333444455555555555554444444444445555555555
Q ss_pred ccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCC
Q 039595 257 SLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPP 336 (1078)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 336 (1078)
++++..+..|+++++|++|+|++|++++..+.. |.++++|++|+|++|++++..+.
T Consensus 120 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~------------------------~~~l~~L~~L~L~~n~l~~~~~~ 175 (270)
T 2o6q_A 120 QLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGV------------------------FDKLTSLKELRLYNNQLKRVPEG 175 (270)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT------------------------TTTCTTCCEEECCSSCCSCCCTT
T ss_pred ccCeeCHHHhCcCcCCCEEECCCCcCCccCHhH------------------------ccCCcccceeEecCCcCcEeChh
Confidence 544444444444444555555444444333333 33444444444444444443333
Q ss_pred CCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCc
Q 039595 337 SIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLS 379 (1078)
Q Consensus 337 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 379 (1078)
.|..+++|+.|++++|++++..+..+..+++|+.|+|++|.+.
T Consensus 176 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 176 AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred HhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 4444444444444444444333333444445555555555443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=230.16 Aligned_cols=202 Identities=26% Similarity=0.264 Sum_probs=94.6
Q ss_pred ccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCC
Q 039595 146 IGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLS 225 (1078)
Q Consensus 146 ~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 225 (1078)
++++++|+++++++|.++ .+|..+. +++++|+|++|.+++..|..|.++++|++|+|++|.+++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 555666666666666665 4554442 3445555555555444444445555555555555544432221 3444444
Q ss_pred eeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccC
Q 039595 226 TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS 305 (1078)
Q Consensus 226 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~ 305 (1078)
+|+|++|+++ .+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~--------------------- 138 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT--------------------- 138 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC---------------------
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc---------------------
Confidence 4444444444 233344444444444444444443333344444444444444444433
Q ss_pred CCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccC
Q 039595 306 LSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNL 378 (1078)
Q Consensus 306 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 378 (1078)
..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+++ .+|..+..+.+|+.|+|++|.+
T Consensus 139 ---~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 139 ---LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp ---CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred ---cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence 33333444444444444444444443344444455555555555554 3444444444445555554444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=229.66 Aligned_cols=203 Identities=22% Similarity=0.259 Sum_probs=167.5
Q ss_pred CCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCC
Q 039595 121 QIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKL 200 (1078)
Q Consensus 121 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L 200 (1078)
.++++++|+++++++|+++ .+|..+. ++|++|+|++|.+++..|..+..+++|++|+|++|.+++. |.. +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcC
Confidence 3678999999999999998 6787765 7899999999999988889999999999999999999964 433 899999
Q ss_pred cEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccc
Q 039595 201 ALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIEN 280 (1078)
Q Consensus 201 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 280 (1078)
++|+|++|+++ .+|..+.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 99999999998 67888999999999999999999988899999999999999999999888888999999999999999
Q ss_pred cccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeecccccc
Q 039595 281 QLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQL 330 (1078)
Q Consensus 281 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 330 (1078)
++++..+..|..+++|+.|++++|+++ .+|..+..+.+|+.|+|++|.+
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence 998665555555555555555555555 3344444444444444444443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.5e-25 Score=261.37 Aligned_cols=187 Identities=14% Similarity=0.189 Sum_probs=146.6
Q ss_pred CccceeccCCceeEEEEEeCCCCEEEEEEeccccccCC----hhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 754 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN----MADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 754 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
...+.||+|+||+||+|.. .++.+|+|+......... ....+.+.+|+.++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 478899998755332211 11235589999999999999999666666677778999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.++++. +..++.|++.||+|||++ +|+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999943 568999999999999999 9999999999999998 999999999997754
Q ss_pred CCCC-------ceeecccccccccccccc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 039595 910 YSSN-------RTEFVGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPR 957 (1078)
Q Consensus 910 ~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~ 957 (1078)
.... .....||+.|||||++.. ..|+..+|+||..+-..+-..++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 135689999999999987 56888899999999888888877774
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.8e-24 Score=236.89 Aligned_cols=224 Identities=20% Similarity=0.238 Sum_probs=163.3
Q ss_pred CcceeccCCCccCCCCCc---cccCccceeEEEccCccCCCCCCccc--ccccccceeecccccccCCcc----CcccCC
Q 039595 127 KLQNLDLGNNQLSGVISP---EIGKLNQLRRLYLDMNQLHGTIPPVI--GQLSLIHEFSFCHNNVSGRIP----SSLGNL 197 (1078)
Q Consensus 127 ~L~~L~Ls~n~l~~~~p~---~~~~l~~L~~L~L~~n~l~~~~p~~i--~~l~~L~~L~l~~n~~~~~~p----~~l~~l 197 (1078)
.++.|.+.++.++...-. .+..+++|++|+|++|.+++.+|..+ +.+++|++|++++|.+++..| ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 456666666655421100 12234567777777777777777776 777777777777777776554 344568
Q ss_pred CCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCC---C-CCcccCCCCCcEEeccccccCCCCCc----ccCCC
Q 039595 198 SKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL---I-PCTLDNLSNLDTLFLYKNSLSGSIPS----IIGNL 269 (1078)
Q Consensus 198 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~-p~~l~~l~~L~~L~L~~N~l~~~~p~----~~~~l 269 (1078)
++|++|+|++|++++..|..|+++++|++|+|++|++.+. . +..+..+++|++|+|++|+++ .++. .++++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 8888888888888877778888888888888888887642 1 223467888888888888887 3333 25677
Q ss_pred cccceeecccccccCccccccccc---cCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcE
Q 039595 270 KSLHQLDLIENQLSGSIPLSFGNL---SSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRN 346 (1078)
Q Consensus 270 ~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 346 (1078)
++|++|+|++|++++..|..+..+ ++|+.|++++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 888888888888888777777766 58888888888888 5666664 7899999999999865 33 678899999
Q ss_pred EEccCccCCC
Q 039595 347 LSLFNNGLYG 356 (1078)
Q Consensus 347 L~Ls~N~l~~ 356 (1078)
|++++|.+++
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999998874
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.2e-26 Score=256.82 Aligned_cols=267 Identities=16% Similarity=0.180 Sum_probs=151.2
Q ss_pred CCcccceEeeCCCCeEEEeccCccccCCcccCCccCCC--CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCC
Q 039595 64 PCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSF--PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGV 141 (1078)
Q Consensus 64 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l--~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 141 (1078)
|.+|.++.|+.. .+..+++++..+.. ..+..+ +.++.|++++|.+.+..+. +..+++|++|+|++|.+++.
T Consensus 36 c~~W~~~~~~~~--~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~ 108 (336)
T 2ast_B 36 CKRWYRLASDES--LWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS 108 (336)
T ss_dssp CHHHHHHHTCST--TSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred HHHHHHHhcCch--hheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence 558999988632 45566666654432 234444 6677777777777655444 45667777777777766654
Q ss_pred -CCccccCccceeEEEccCccCCCCCCcccccccccceeecccc-cccCC-ccCcccCCCCCcEEEccCC-CCCCC-CCC
Q 039595 142 -ISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHN-NVSGR-IPSSLGNLSKLALLYLNNN-SLFGY-IPT 216 (1078)
Q Consensus 142 -~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n-~~~~~-~p~~l~~l~~L~~L~L~~n-~l~~~-~p~ 216 (1078)
+|..+..+++|++|+|++|.+++..|..++.+++|++|++++| .+++. +|..+.++++|++|+|++| .+++. ++.
T Consensus 109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~ 188 (336)
T 2ast_B 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 188 (336)
T ss_dssp HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHH
T ss_pred HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHH
Confidence 5566666777777777777666666666666666666666666 45442 4555566666666666666 55532 344
Q ss_pred cccccC-CCCeeecCCc--ccC-CCCCCcccCCCCCcEEeccccc-cCCCCCcccCCCcccceeecccccccCccccccc
Q 039595 217 VMGNLK-SLSTLDLSQN--QLN-GLIPCTLDNLSNLDTLFLYKNS-LSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFG 291 (1078)
Q Consensus 217 ~~~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 291 (1078)
.+..++ +|++|+|++| .++ +.+|..+..+++|++|++++|. +++..+..+.++++|++|++++|. +..+.
T Consensus 189 ~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~--- 263 (336)
T 2ast_B 189 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPE--- 263 (336)
T ss_dssp HHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGG---
T ss_pred HHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHH---
Confidence 455566 6666666666 333 2334445555566666666555 444444455555555555555553 11121
Q ss_pred cccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCC-CcCcEEEccCccCCCCCCccccc
Q 039595 292 NLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNL-SSLRNLSLFNNGLYGSIPEEIGY 364 (1078)
Q Consensus 292 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~ 364 (1078)
....++++++|++|++++| ++ ...+..+ .+|+.|++++|++++..|..++.
T Consensus 264 ------------------~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 264 ------------------TLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp ------------------GGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred ------------------HHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 1113445555666666555 22 1223333 23555556666666666555543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-25 Score=255.35 Aligned_cols=257 Identities=19% Similarity=0.172 Sum_probs=196.4
Q ss_pred EEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCC----ccccCcc-ceeEEEccCccCCCCCCcccccc-----cc
Q 039595 106 NLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVIS----PEIGKLN-QLRRLYLDMNQLHGTIPPVIGQL-----SL 175 (1078)
Q Consensus 106 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~p~~i~~l-----~~ 175 (1078)
+++|++|.++|.+|..+...++|++|||++|.+++..+ ..+.+++ +|++|+|++|.+++..+..++.+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46788888988888877777789999999999887666 6677888 89999999999988778888776 88
Q ss_pred cceeecccccccCCccCcccCC-----CCCcEEEccCCCCCCCCCCcccc-----cCCCCeeecCCcccCCCC----CCc
Q 039595 176 IHEFSFCHNNVSGRIPSSLGNL-----SKLALLYLNNNSLFGYIPTVMGN-----LKSLSTLDLSQNQLNGLI----PCT 241 (1078)
Q Consensus 176 L~~L~l~~n~~~~~~p~~l~~l-----~~L~~L~L~~n~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~----p~~ 241 (1078)
|++|+|++|.+++..+..++.. ++|++|+|++|++++..+..++. .++|++|+|++|++++.. +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999887777655443 88999999999988766555433 268999999999988543 333
Q ss_pred ccCCC-CCcEEeccccccCCCCCcccC----CC-cccceeecccccccCc----ccccccc-ccCCceeeecccCCCCCC
Q 039595 242 LDNLS-NLDTLFLYKNSLSGSIPSIIG----NL-KSLHQLDLIENQLSGS----IPLSFGN-LSSWTLMSLFSNSLSGSI 310 (1078)
Q Consensus 242 l~~l~-~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~l~~n~l~~~~ 310 (1078)
+..++ +|++|+|++|++++..+..+. .+ ++|++|+|++|.+++. ++..+.. .++|+.|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 899999999999876665443 34 5899999999998863 4555555 358889999999888654
Q ss_pred C----ccccCCCccCeeeccccccCcc-------CCCCCCCCCcCcEEEccCccCCCCCCccc
Q 039595 311 P----PILGNLKSLSTLGLYLNQLNGV-------IPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362 (1078)
Q Consensus 311 p----~~l~~l~~L~~L~L~~N~l~~~-------~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 362 (1078)
+ ..+..+++|++|+|++|.+.+. ++..+..+++|+.|++++|.+.+..+..+
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 4 3457778899999999985433 23467788888899999988876644433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-23 Score=219.51 Aligned_cols=178 Identities=16% Similarity=0.220 Sum_probs=98.2
Q ss_pred CCcEEeccCCcccccCCCCCCCCCCcceeccCCCc-cCCCCCccccCccceeEEEccC-ccCCCCCCcccccccccceee
Q 039595 103 HLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQ-LSGVISPEIGKLNQLRRLYLDM-NQLHGTIPPVIGQLSLIHEFS 180 (1078)
Q Consensus 103 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~i~~l~~L~~L~ 180 (1078)
.|++|+|++|.+++..+..|+++++|++|+|++|+ +++..+..|+++++|++|+|++ |++++..|..++.+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67777777777766555567777777777777775 6644444666677777777766 666643344555555555555
Q ss_pred cccccccCCccCcccCCCCCc---EEEccCC-CCCCCCCCcccccCCCC-eeecCCcccCCCCCCcccCCCCCcEEeccc
Q 039595 181 FCHNNVSGRIPSSLGNLSKLA---LLYLNNN-SLFGYIPTVMGNLKSLS-TLDLSQNQLNGLIPCTLDNLSNLDTLFLYK 255 (1078)
Q Consensus 181 l~~n~~~~~~p~~l~~l~~L~---~L~L~~n-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 255 (1078)
+++|.+++ +|. ++.+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++...+..|.. ++|++|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 55555554 443 55555554 5555555 55444444455555555 5555555555322222222 4455555555
Q ss_pred cc-cCCCCCcccCCC-cccceeeccccccc
Q 039595 256 NS-LSGSIPSIIGNL-KSLHQLDLIENQLS 283 (1078)
Q Consensus 256 N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~ 283 (1078)
|+ +++..+..|.++ ++|+.|++++|+++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 52 443334444444 44555555554444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-24 Score=247.36 Aligned_cols=251 Identities=19% Similarity=0.203 Sum_probs=157.1
Q ss_pred EEcccccCccccCCCCccCCCCceeecccCcCCCCCC----ccccccC-CCCeEEccCccccccchhhccCC-----CCC
Q 039595 371 LKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIP----KSLKSLT-SLKRVRFNQNNLVGKVYEAFGDH-----PNL 440 (1078)
Q Consensus 371 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~----~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L 440 (1078)
++++.|.+++.+|..+...++|++|++++|.+.+..+ ..|..++ +|++|++++|.+.......+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4566677766666655555556666666666665555 4555555 56666666666555544444433 555
Q ss_pred cEecCCCCccCCccCccccCCCCCceecccccccCCCCCccc----cCC-CcccEEeccCCccCCCccccccc-----Cc
Q 039595 441 TFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEI----GDS-SKLQFLDLSSNHIVGKIPVQLEK-----LF 510 (1078)
Q Consensus 441 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~----~~l-~~L~~L~Ls~N~i~~~~~~~~~~-----l~ 510 (1078)
++|+|++|.++ +..+..+ ..+ ++|++|+|++|+|++..+..+.. .+
T Consensus 83 ~~L~Ls~n~l~------------------------~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 138 (362)
T 3goz_A 83 TSLNLSGNFLS------------------------YKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138 (362)
T ss_dssp CEEECCSSCGG------------------------GSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCT
T ss_pred cEEECcCCcCC------------------------hHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCC
Confidence 55555555554 3333322 223 56777777777777655544432 24
Q ss_pred cCcEEeccCCccCCCccc----cccccc-ccceeeccCccccCCCCcccccc-----cccccccccCcccccc----cch
Q 039595 511 SLNKLILSLNQLSGSVPL----EFGSLT-ELQYLDLSANKLSSSIPKSIGNL-----LKLYYLNLSNNQFSHT----IPI 576 (1078)
Q Consensus 511 ~L~~L~Ls~N~l~~~~~~----~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~----~~~ 576 (1078)
+|++|+|++|++++..+. .+..++ +|++|+|++|.|++..+..+... ++|++|+|++|+|++. ++.
T Consensus 139 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 777777777777743333 334444 78888888888876666544433 5788888888888753 344
Q ss_pred hhhc-ccccCeeecCCCccCCcCC----CCcccccccceeeccCccccCCc-------ccccccCCcCcEEEcccCcCCC
Q 039595 577 EFEK-LIHLSKLDLSHNILQEEIP----PQVCNMESLEKLNLSHNNLSGFI-------PRCFEKMRSLSCIDICYNELQG 644 (1078)
Q Consensus 577 ~~~~-l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~-------~~~l~~l~~L~~l~l~~N~l~~ 644 (1078)
.+.. .++|+.|||++|+|++..+ ..+..+++|++|+|++|++.+.. +..+..+++|+.||+++|++..
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 4555 3478888888888876443 23456678888888888855443 3356677888888888888775
Q ss_pred C
Q 039595 645 P 645 (1078)
Q Consensus 645 ~ 645 (1078)
.
T Consensus 299 ~ 299 (362)
T 3goz_A 299 S 299 (362)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=234.24 Aligned_cols=225 Identities=20% Similarity=0.185 Sum_probs=167.8
Q ss_pred ceeEEEccCccCCCC-CCc--ccccccccceeecccccccCCccCcc--cCCCCCcEEEccCCCCCCCCC----Cccccc
Q 039595 151 QLRRLYLDMNQLHGT-IPP--VIGQLSLIHEFSFCHNNVSGRIPSSL--GNLSKLALLYLNNNSLFGYIP----TVMGNL 221 (1078)
Q Consensus 151 ~L~~L~L~~n~l~~~-~p~--~i~~l~~L~~L~l~~n~~~~~~p~~l--~~l~~L~~L~L~~n~l~~~~p----~~~~~l 221 (1078)
.++.|.+..+.++.. +.. ....+++|++|++++|.+.+.+|..+ +.+++|++|+|++|++++..| ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 467777777766521 111 12234668888888888888888887 888888888888888887655 344568
Q ss_pred CCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCC--C--CcccCCCcccceeecccccccCccc--c-cccccc
Q 039595 222 KSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS--I--PSIIGNLKSLHQLDLIENQLSGSIP--L-SFGNLS 294 (1078)
Q Consensus 222 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p--~-~~~~l~ 294 (1078)
++|++|+|++|++++..|..|..+++|++|+|++|++.+. + +..++++++|++|+|++|++++..+ . .++.++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV 224 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC
Confidence 8888888888888888778888888888888888887642 1 2334678888888888888863222 1 356778
Q ss_pred CCceeeecccCCCCCCCccccCC---CccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeE
Q 039595 295 SWTLMSLFSNSLSGSIPPILGNL---KSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSEL 371 (1078)
Q Consensus 295 ~L~~L~l~~n~l~~~~p~~l~~l---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 371 (1078)
+|+.|+|++|.+++..|..+..+ ++|++|+|++|+++ .+|..+. ++|+.|+|++|++++. |. +..+++|+.|
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L 299 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNL 299 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence 88888888888888777777766 58888888888888 4566664 7888888888888853 33 6777888888
Q ss_pred EcccccCcc
Q 039595 372 KLCKNNLSG 380 (1078)
Q Consensus 372 ~L~~N~l~~ 380 (1078)
+|++|+++.
T Consensus 300 ~L~~N~l~~ 308 (310)
T 4glp_A 300 TLDGNPFLV 308 (310)
T ss_dssp ECSSTTTSC
T ss_pred ECcCCCCCC
Confidence 888888863
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-23 Score=220.05 Aligned_cols=178 Identities=16% Similarity=0.243 Sum_probs=78.1
Q ss_pred ccceeecccccccCCccCcccCCCCCcEEEccCCC-CCCCCCCcccccCCCCeeecCC-cccCCCCCCcccCCCCCcEEe
Q 039595 175 LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNS-LFGYIPTVMGNLKSLSTLDLSQ-NQLNGLIPCTLDNLSNLDTLF 252 (1078)
Q Consensus 175 ~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~ 252 (1078)
+|++|++++|++++..+..|+++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 34444444444443333344444555555555553 4433333444455555555554 445444444444455555555
Q ss_pred ccccccCCCCCcccCCCcccc---eeecccc-cccCccccccccccCCc-eeeecccCCCCCCCccccCCCccCeeeccc
Q 039595 253 LYKNSLSGSIPSIIGNLKSLH---QLDLIEN-QLSGSIPLSFGNLSSWT-LMSLFSNSLSGSIPPILGNLKSLSTLGLYL 327 (1078)
Q Consensus 253 L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~ 327 (1078)
+++|++++ +|. |+.+++|+ +|++++| ++++..+..|..+++|+ .|++++|.++...+..+.. ++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 55555543 333 44444444 5555554 44443333344444444 4444444443111112222 4444444444
Q ss_pred cc-cCccCCCCCCCC-CcCcEEEccCccCC
Q 039595 328 NQ-LNGVIPPSIGNL-SSLRNLSLFNNGLY 355 (1078)
Q Consensus 328 N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~ 355 (1078)
|+ +++..+..|..+ ++|+.|++++|+++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 42 444334444444 44444444444444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-24 Score=245.00 Aligned_cols=233 Identities=15% Similarity=0.183 Sum_probs=112.3
Q ss_pred cceeEEEccCccCCCCCCcccccccccceeecccccccCC-ccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeee
Q 039595 150 NQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGR-IPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLD 228 (1078)
Q Consensus 150 ~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 228 (1078)
++++.|++++|.+++..|. +..+++|++|++++|.+++. +|..+..+++|++|+|++|.+++..|..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 3344444444444332222 22344444444444444333 444444445555555555554444444444455555555
Q ss_pred cCCc-ccCCC-CCCcccCCCCCcEEecccc-ccCCC-CCcccCCCc-ccceeecccc--ccc-CccccccccccCCceee
Q 039595 229 LSQN-QLNGL-IPCTLDNLSNLDTLFLYKN-SLSGS-IPSIIGNLK-SLHQLDLIEN--QLS-GSIPLSFGNLSSWTLMS 300 (1078)
Q Consensus 229 L~~N-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~ 300 (1078)
|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|++|+|++| .++ +.+|..+..+++|+.|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 5555 34431 3333445555555555555 55432 344455555 5666666555 333 23444445555555555
Q ss_pred ecccC-CCCCCCccccCCCccCeeeccccc-cCccCCCCCCCCCcCcEEEccCccCCCCCCcccccc-CCCCeEEccccc
Q 039595 301 LFSNS-LSGSIPPILGNLKSLSTLGLYLNQ-LNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYL-KSLSELKLCKNN 377 (1078)
Q Consensus 301 l~~n~-l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~ 377 (1078)
+++|. +++..+..+.++++|++|++++|. +.......++++++|+.|++++| +.. ..+..+ .+++.|++++|+
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~ 304 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSH 304 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCC
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEeccc
Confidence 55555 444445555666666666666664 22111124555666666666666 322 122332 235555566666
Q ss_pred CccccCCCCc
Q 039595 378 LSGVIPHSVG 387 (1078)
Q Consensus 378 l~~~~p~~~~ 387 (1078)
+++..|..++
T Consensus 305 l~~~~~~~~~ 314 (336)
T 2ast_B 305 FTTIARPTIG 314 (336)
T ss_dssp SCCTTCSSCS
T ss_pred CccccCCccc
Confidence 6666555544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-25 Score=255.74 Aligned_cols=251 Identities=18% Similarity=0.225 Sum_probs=122.3
Q ss_pred cCCCCCCCCCCcceeccCCCccCCCCC----ccccCccceeEEEccCc---cCCCCCCcccccccccceeecccccccCC
Q 039595 117 NIPPQIGNLSKLQNLDLGNNQLSGVIS----PEIGKLNQLRRLYLDMN---QLHGTIPPVIGQLSLIHEFSFCHNNVSGR 189 (1078)
Q Consensus 117 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~~L~~L~L~~n---~l~~~~p~~i~~l~~L~~L~l~~n~~~~~ 189 (1078)
.++..+..+++|++|+|++|++++..+ ..+..+++|++|+|++| ++++.+|..+..+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l---------------- 86 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL---------------- 86 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHH----------------
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHH----------------
Confidence 355566666777777777777765432 33556777777777664 3334444443111
Q ss_pred ccCcccCCCCCcEEEccCCCCCC----CCCCcccccCCCCeeecCCcccCCCCCCccc----CC---------CCCcEEe
Q 039595 190 IPSSLGNLSKLALLYLNNNSLFG----YIPTVMGNLKSLSTLDLSQNQLNGLIPCTLD----NL---------SNLDTLF 252 (1078)
Q Consensus 190 ~p~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~----~l---------~~L~~L~ 252 (1078)
...+.++++|++|+|++|.+++ .+|..+.++++|++|+|++|.+++..+..+. .+ ++|++|+
T Consensus 87 -~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~ 165 (386)
T 2ca6_A 87 -LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165 (386)
T ss_dssp -HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred -HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEE
Confidence 1222455555555555555554 2444455555555555555555432222222 12 4455555
Q ss_pred ccccccC-CCCC---cccCCCcccceeecccccccCccccccccccCCceeeecccCCCC---CCCccccCCCccCeeec
Q 039595 253 LYKNSLS-GSIP---SIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSG---SIPPILGNLKSLSTLGL 325 (1078)
Q Consensus 253 L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~---~~p~~l~~l~~L~~L~L 325 (1078)
|++|+++ +.+| ..+..+++|++|+|++|+++.. | ..|..+.++++|++|+|
T Consensus 166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~----------------------g~~~l~~~~l~~~~~L~~L~L 223 (386)
T 2ca6_A 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE----------------------GIEHLLLEGLAYCQELKVLDL 223 (386)
T ss_dssp CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH----------------------HHHHHHHTTGGGCTTCCEEEC
T ss_pred CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHh----------------------HHHHHHHHHhhcCCCccEEEC
Confidence 5555444 1222 2333444444444444444310 0 11223344444444444
Q ss_pred cccccC----ccCCCCCCCCCcCcEEEccCccCCCC----CCcccc--ccCCCCeEEcccccCcc----ccCCCC-ccCC
Q 039595 326 YLNQLN----GVIPPSIGNLSSLRNLSLFNNGLYGS----IPEEIG--YLKSLSELKLCKNNLSG----VIPHSV-GNLT 390 (1078)
Q Consensus 326 ~~N~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~--~l~~L~~L~L~~N~l~~----~~p~~~-~~l~ 390 (1078)
++|.++ +.+|..+..+++|+.|+|++|.+++. ++..+. .+++|++|+|++|.+++ .+|..+ .+++
T Consensus 224 s~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~ 303 (386)
T 2ca6_A 224 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303 (386)
T ss_dssp CSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCT
T ss_pred cCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCC
Confidence 444443 23344444455555555555555433 333342 25556666666665554 244444 4456
Q ss_pred CCceeecccCcCCCCC
Q 039595 391 GLVLLNMCENHLFGPI 406 (1078)
Q Consensus 391 ~L~~L~L~~N~l~~~~ 406 (1078)
+|++|++++|++++..
T Consensus 304 ~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 304 DLLFLELNGNRFSEED 319 (386)
T ss_dssp TCCEEECTTSBSCTTS
T ss_pred CceEEEccCCcCCcch
Confidence 6666666666665544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.3e-22 Score=208.39 Aligned_cols=186 Identities=26% Similarity=0.308 Sum_probs=108.5
Q ss_pred CCCcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCC
Q 039595 63 SPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVI 142 (1078)
Q Consensus 63 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 142 (1078)
..|.|.+|.|+..+- + ..+.+-.++|++|+|++|.+.+..+..++++++|++|+|++|++++..
T Consensus 5 C~C~~~~v~c~~~~l--~--------------~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (208)
T 2o6s_A 5 CSCSGTTVECYSQGR--T--------------SVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLP 68 (208)
T ss_dssp CEEETTEEECCSSCC--S--------------SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CEECCCEEEecCCCc--c--------------CCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccC
Confidence 348999999975321 0 011122345666666666665444444555666666666666655443
Q ss_pred CccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccC
Q 039595 143 SPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLK 222 (1078)
Q Consensus 143 p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 222 (1078)
+..|+.+++|++|+|++|+++ +..+..++++++|++|+|++|++++..+..|.+++
T Consensus 69 ~~~~~~l~~L~~L~Ls~n~l~------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 124 (208)
T 2o6s_A 69 NGVFNKLTSLTYLNLSTNQLQ------------------------SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT 124 (208)
T ss_dssp TTTTTTCTTCCEEECCSSCCC------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhcCCCCCcCEEECCCCcCC------------------------ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCC
Confidence 344455555555555555555 33334455566666666666666655555566666
Q ss_pred CCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccC
Q 039595 223 SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS 295 (1078)
Q Consensus 223 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 295 (1078)
+|++|+|++|++++..+..|..+++|++|+|++|.+.+ .+++|++|+++.|+++|.+|..++.++.
T Consensus 125 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 125 QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred cCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 66666666666665555556666666666666665553 2345666777777777777766665544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.2e-22 Score=212.73 Aligned_cols=178 Identities=24% Similarity=0.286 Sum_probs=100.9
Q ss_pred CcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEcc
Q 039595 127 KLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLN 206 (1078)
Q Consensus 127 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~ 206 (1078)
..++++++++.++ .+|..+. ++|++|+|++|.+++..|..++.+++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4556667766666 4555554 466666666666665555556666666666666666665555555556666666666
Q ss_pred CCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCcc
Q 039595 207 NNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSI 286 (1078)
Q Consensus 207 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 286 (1078)
+|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|+++++|++|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 66655555555555555666666665555554444555555555555555555444445555555555555555555444
Q ss_pred ccccccccCCceeeecccCCC
Q 039595 287 PLSFGNLSSWTLMSLFSNSLS 307 (1078)
Q Consensus 287 p~~~~~l~~L~~L~l~~n~l~ 307 (1078)
+..|..+++|+.|++++|.+.
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBC
T ss_pred HHHHhCCCCCCEEEeeCCcee
Confidence 444444444444444444443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.3e-25 Score=254.90 Aligned_cols=235 Identities=18% Similarity=0.192 Sum_probs=159.1
Q ss_pred cccCCCCCcEEEccCCC---CCCCCCCcc-------cccCCCCeeecCCcccCC----CCCCcccCCCCCcEEecccccc
Q 039595 193 SLGNLSKLALLYLNNNS---LFGYIPTVM-------GNLKSLSTLDLSQNQLNG----LIPCTLDNLSNLDTLFLYKNSL 258 (1078)
Q Consensus 193 ~l~~l~~L~~L~L~~n~---l~~~~p~~~-------~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l 258 (1078)
.+..+++|++|+|++|. +++.+|..+ ..+++|++|+|++|++++ .+|..+..+++|++|+|++|.+
T Consensus 55 ~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l 134 (386)
T 2ca6_A 55 NIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 134 (386)
T ss_dssp TTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred HHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCC
Confidence 35556666666666643 333344333 455666666666666654 2444455555555555555555
Q ss_pred CCCCCcccCCCcccceeecccccccCccccccccc---------cCCceeeecccCCC-CCCC---ccccCCCccCeeec
Q 039595 259 SGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNL---------SSWTLMSLFSNSLS-GSIP---PILGNLKSLSTLGL 325 (1078)
Q Consensus 259 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---------~~L~~L~l~~n~l~-~~~p---~~l~~l~~L~~L~L 325 (1078)
++..+..+.. .+..+ ++|+.|++++|.++ +.++ ..+..+++|++|+|
T Consensus 135 ~~~~~~~l~~--------------------~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 194 (386)
T 2ca6_A 135 GPQAGAKIAR--------------------ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM 194 (386)
T ss_dssp HHHHHHHHHH--------------------HHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEEC
T ss_pred CHHHHHHHHH--------------------HHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEEC
Confidence 4222222211 11112 56666666666665 3334 46778889999999
Q ss_pred cccccC--c---cCCCCCCCCCcCcEEEccCccCC----CCCCccccccCCCCeEEcccccCccc----cCCCC--ccCC
Q 039595 326 YLNQLN--G---VIPPSIGNLSSLRNLSLFNNGLY----GSIPEEIGYLKSLSELKLCKNNLSGV----IPHSV--GNLT 390 (1078)
Q Consensus 326 ~~N~l~--~---~~p~~l~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~--~~l~ 390 (1078)
++|+++ + ..|..+..+++|+.|+|++|.++ +.+|..+..+++|++|+|++|++++. ++..+ +.++
T Consensus 195 ~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~ 274 (386)
T 2ca6_A 195 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274 (386)
T ss_dssp CSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSC
T ss_pred cCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCC
Confidence 999998 3 45558899999999999999996 57888899999999999999999876 45556 3489
Q ss_pred CCceeecccCcCCC----CCCccc-cccCCCCeEEccCccccccch--h-hccCCCCCcEecCCC
Q 039595 391 GLVLLNMCENHLFG----PIPKSL-KSLTSLKRVRFNQNNLVGKVY--E-AFGDHPNLTFLDLSQ 447 (1078)
Q Consensus 391 ~L~~L~L~~N~l~~----~~~~~l-~~l~~L~~L~L~~N~l~~~~~--~-~~~~l~~L~~L~Ls~ 447 (1078)
+|+.|++++|.+++ .+|..+ .++++|++|++++|.+++... . ....+++++.+++..
T Consensus 275 ~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l~~ 339 (386)
T 2ca6_A 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE 339 (386)
T ss_dssp CCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHHHHTCCEECC
T ss_pred CeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhhhcCcchhhh
Confidence 99999999999988 477777 668999999999999987762 2 223344555455543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=223.95 Aligned_cols=128 Identities=28% Similarity=0.400 Sum_probs=62.2
Q ss_pred cCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCe
Q 039595 147 GKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLST 226 (1078)
Q Consensus 147 ~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 226 (1078)
..+++|++|++++|.++ .+| .+..+++|++|++++|.+.+..+ ++++++|++|+|++|.+++. ..+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 34555555555555554 233 34444444444444444443222 55555555555555555432 23455555555
Q ss_pred eecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccC
Q 039595 227 LDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSG 284 (1078)
Q Consensus 227 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 284 (1078)
|+|++|++++. | .+..+++|++|++++|++++..+ ++.+++|++|+|++|++++
T Consensus 112 L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 112 LDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp EECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred EECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 55555555543 2 14555555555555555553322 4445555555555555543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-22 Score=242.91 Aligned_cols=188 Identities=23% Similarity=0.277 Sum_probs=107.0
Q ss_pred CcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeeccc
Q 039595 104 LVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183 (1078)
Q Consensus 104 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~ 183 (1078)
|+.|+|++|++.+ +|..+. ++|++|+|++|+|+ .+| +.+++|++|+|++|++++ +|. ++. +|++|+|++
T Consensus 61 L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 61 FSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDN 129 (571)
T ss_dssp CSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCS
T ss_pred ccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCC
Confidence 4445555555544 444442 55666666666555 344 335556666666666654 555 443 566666666
Q ss_pred ccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCC
Q 039595 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP 263 (1078)
Q Consensus 184 n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 263 (1078)
|.+++ +|. .+++|+.|+|++|++++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|
T Consensus 130 N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp 196 (571)
T 3cvr_A 130 NQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLP 196 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCC
T ss_pred CcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chh
Confidence 66654 444 45666666666666654 443 35566666666666665 344 44 66666666666666 444
Q ss_pred cccCCCccc-------ceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCc
Q 039595 264 SIIGNLKSL-------HQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKS 319 (1078)
Q Consensus 264 ~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~ 319 (1078)
. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|..++.++.
T Consensus 197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 4 443 55 66666666666 35555556666666666666666666666655443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=5.1e-22 Score=221.14 Aligned_cols=192 Identities=26% Similarity=0.363 Sum_probs=109.2
Q ss_pred CCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEE
Q 039595 124 NLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALL 203 (1078)
Q Consensus 124 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 203 (1078)
++++|++|++++|.++. +| .+..+++|++|+|++|.+++ +|. ++.+++|++|++++|.+.+. ..++++++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence 44555555555555542 33 35555555555555555553 233 55555555555555555532 246666677777
Q ss_pred EccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeeccccccc
Q 039595 204 YLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 204 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
+|++|++++. | .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++..+ +.++++|+.|+|++|+++
T Consensus 113 ~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 7777776653 2 26667777777777777765533 6667777777777777764332 667777777777777776
Q ss_pred CccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccC
Q 039595 284 GSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLN 331 (1078)
Q Consensus 284 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 331 (1078)
+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|+++
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 4433 4444444444444444443321 444455555555555544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.9e-22 Score=224.50 Aligned_cols=180 Identities=19% Similarity=0.180 Sum_probs=84.0
Q ss_pred CcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCc-ccccccccce-eecccccccCCccCcccCCCCCcEEE
Q 039595 127 KLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPP-VIGQLSLIHE-FSFCHNNVSGRIPSSLGNLSKLALLY 204 (1078)
Q Consensus 127 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~i~~l~~L~~-L~l~~n~~~~~~p~~l~~l~~L~~L~ 204 (1078)
++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|. .|..++++++ +.+..|++.+..|..|.++++|++|+
T Consensus 31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~ 110 (350)
T 4ay9_X 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110 (350)
T ss_dssp TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence 445555555555432223445555555555555554444432 2344444333 23333444444445555555555555
Q ss_pred ccCCCCCCCCCCcccccCCCCeeecCC-cccCCCCCCcccCCC-CCcEEeccccccCCCCCcccCCCcccceeeccc-cc
Q 039595 205 LNNNSLFGYIPTVMGNLKSLSTLDLSQ-NQLNGLIPCTLDNLS-NLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIE-NQ 281 (1078)
Q Consensus 205 L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~ 281 (1078)
+++|++++..+..+....++..|++.+ |+++...+..|..+. .++.|+|++|+|+. +|.......+|+.|++++ |.
T Consensus 111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~ 189 (350)
T 4ay9_X 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNN 189 (350)
T ss_dssp EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTT
T ss_pred ccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCc
Confidence 555555544444444455555555543 344444444444443 35555555555553 333333344555555543 33
Q ss_pred ccCccccccccccCCceeeecccCCC
Q 039595 282 LSGSIPLSFGNLSSWTLMSLFSNSLS 307 (1078)
Q Consensus 282 l~~~~p~~~~~l~~L~~L~l~~n~l~ 307 (1078)
++...+..|..+++|+.|++++|+|+
T Consensus 190 l~~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 190 LEELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp CCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred ccCCCHHHhccCcccchhhcCCCCcC
Confidence 43322233444444444444444444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=4e-21 Score=218.21 Aligned_cols=100 Identities=17% Similarity=0.160 Sum_probs=40.7
Q ss_pred cCeeeccccccCccCCCCCCCCCcCcEEEccC-ccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecc
Q 039595 320 LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFN-NGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMC 398 (1078)
Q Consensus 320 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 398 (1078)
++.|+|++|+|+.+.+..| ...+|+.|++++ |.++...++.|..+++|++|+|++|+|+.+.+..+.++++|+.++
T Consensus 156 l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~-- 232 (350)
T 4ay9_X 156 SVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS-- 232 (350)
T ss_dssp CEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTT--
T ss_pred hhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhcc--
Confidence 4444444444443222222 233444555442 333322223344455555555555555443333333333222222
Q ss_pred cCcCCCCCCccccccCCCCeEEccCc
Q 039595 399 ENHLFGPIPKSLKSLTSLKRVRFNQN 424 (1078)
Q Consensus 399 ~N~l~~~~~~~l~~l~~L~~L~L~~N 424 (1078)
+.--..+| .+..+++|+.+++.++
T Consensus 233 -~~~l~~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 233 -TYNLKKLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp -CTTCCCCC-CTTTCCSCCEEECSCH
T ss_pred -CCCcCcCC-CchhCcChhhCcCCCC
Confidence 22112233 2445555555555443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.4e-21 Score=198.53 Aligned_cols=172 Identities=24% Similarity=0.284 Sum_probs=134.9
Q ss_pred ceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecC
Q 039595 151 QLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLS 230 (1078)
Q Consensus 151 ~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 230 (1078)
+|++|+|++|++++..+..++.+++|++|++++|++++..+..|+++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44444444444443333334455555555555555554445567889999999999999998877889999999999999
Q ss_pred CcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCC
Q 039595 231 QNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSI 310 (1078)
Q Consensus 231 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~ 310 (1078)
+|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+.+ .+++|+.|+++.|+++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCcee
Confidence 999999888889999999999999999998777789999999999999998875 4568999999999999999
Q ss_pred CccccCCCccCeeeccccccCcc
Q 039595 311 PPILGNLKSLSTLGLYLNQLNGV 333 (1078)
Q Consensus 311 p~~l~~l~~L~~L~L~~N~l~~~ 333 (1078)
|..++.++. ++..+...+.
T Consensus 182 p~~~~~l~~----~~~~C~~~~~ 200 (208)
T 2o6s_A 182 RNSAGSVAP----DSAKCSGSGK 200 (208)
T ss_dssp BCTTSSBCT----TCSBBTTTCC
T ss_pred eccCccccC----CccccccCCC
Confidence 999998776 3444444433
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.5e-22 Score=216.04 Aligned_cols=156 Identities=17% Similarity=0.114 Sum_probs=122.6
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCC-----h---------hhHHHHHHHHHHHhcCCC
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN-----M---------ADQDEFLNVVLALNEIRH 810 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~---------~~~~~~~~e~~~l~~l~h 810 (1078)
........|++.+.||+|+||.||+|...+|+.||||+++....... . .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34445567778899999999999999877899999999864321110 0 13567889999999999
Q ss_pred CceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 039595 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 890 (1078)
Q Consensus 811 ~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 890 (1078)
| +++.+++.. +..|+||||++||+|.+ +.. .+...++.|++.||+|||+. ||+||||||+||++
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence 4 566665543 55699999999999988 521 23457999999999999999 99999999999999
Q ss_pred CCCCcEEEecccccccccCCCCCceeecccccccccccccc
Q 039595 891 DLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931 (1078)
Q Consensus 891 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 931 (1078)
+ ++.+||+|||+|+. +..|+|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE-------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE-------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE-------------CCCCCHHHHHHH
Confidence 9 99999999999973 335789998753
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.5e-21 Score=229.81 Aligned_cols=211 Identities=25% Similarity=0.337 Sum_probs=177.7
Q ss_pred ccCCCCCCCCCCCCCCCC-----cccce-EeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCcccccCCCC
Q 039595 48 LLSSWTLYPTNASKISPC-----SWFGI-SCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQ 121 (1078)
Q Consensus 48 ~l~sW~~~~~~~~~~~~c-----~w~gv-~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~ 121 (1078)
.+.+|.. ..++| .|.|+ .|.. .+++.|+|+++.+.+ ++... +++|++|+|++|.++ .+|
T Consensus 32 ~l~~W~~------~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l---~~~L~~L~Ls~N~l~-~ip-- 96 (571)
T 3cvr_A 32 AWDKWEK------QALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNL---PPQITVLEITQNALI-SLP-- 96 (571)
T ss_dssp HHHHHHT------TCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCC---CTTCSEEECCSSCCS-CCC--
T ss_pred HHHHHhc------cCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhH---cCCCCEEECcCCCCc-ccc--
Confidence 4567852 35678 79999 7864 378889999998887 65432 388999999999998 677
Q ss_pred CCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCc
Q 039595 122 IGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLA 201 (1078)
Q Consensus 122 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~ 201 (1078)
+.+++|++|+|++|+|++ +|. +.+ +|++|+|++|++++ +|. .+++|++|++++|.+++ +|. .+++|+
T Consensus 97 -~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~ 163 (571)
T 3cvr_A 97 -ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLE 163 (571)
T ss_dssp -CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCC
T ss_pred -cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcC
Confidence 568999999999999997 777 766 99999999999996 887 68999999999999996 776 678999
Q ss_pred EEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCC-------cEEeccccccCCCCCcccCCCcccce
Q 039595 202 LLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNL-------DTLFLYKNSLSGSIPSIIGNLKSLHQ 274 (1078)
Q Consensus 202 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~ 274 (1078)
+|+|++|++++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+.++++|+.
T Consensus 164 ~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~ 234 (571)
T 3cvr_A 164 VLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234 (571)
T ss_dssp EEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEE
T ss_pred EEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCE
Confidence 99999999987 676 76 99999999999999 4566 664 77 99999999999 57888888999999
Q ss_pred eecccccccCccccccccccC
Q 039595 275 LDLIENQLSGSIPLSFGNLSS 295 (1078)
Q Consensus 275 L~Ls~N~l~~~~p~~~~~l~~ 295 (1078)
|+|++|++++.+|..+..+..
T Consensus 235 L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 235 IILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp EECCSSSCCHHHHHHHHHHHH
T ss_pred EEeeCCcCCCcCHHHHHHhhc
Confidence 999999999999998887654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.3e-22 Score=246.01 Aligned_cols=268 Identities=18% Similarity=0.140 Sum_probs=96.4
Q ss_pred CCHHHHHHHHHHHHhcCCCCCCccccCCCCCCCCCCCCCCCCcccceEeeCCCCeEEEeccCccccCCcccCCccCCCCC
Q 039595 24 DSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPH 103 (1078)
Q Consensus 24 ~~~~~~~all~~k~~~~~~~~~~~~l~sW~~~~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~ 103 (1078)
....+++||+++..+..... ...-++|.. ..+.++.|.|++++. .+|++++|..+.+... ....
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-------~~~~ 192 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSK--TAKKQQPTG-----DSTPSGTATNSAVST--PLTPKIELFANGKDEA-------NQAL 192 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHH--TTC-------------------------------------------------------
T ss_pred ccccchhhhhhhhhhccccc--CcccCCCcC-----CCCccccCCCceecC--CccceEEeeCCCCCcc-------hhhH
Confidence 44678899999998874321 112234531 234567899999864 5788888876655442 1234
Q ss_pred CcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeeccc
Q 039595 104 LVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183 (1078)
Q Consensus 104 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~ 183 (1078)
|+.++|+.|.+.+ ++++.|.+. ..|..+..++.|+.|+|++|.+. .+|..++.+++|++|+|++
T Consensus 193 l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~ 256 (727)
T 4b8c_D 193 LQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNG 256 (727)
T ss_dssp --------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTT
T ss_pred hhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeC
Confidence 5556666665543 233344443 34455555566666666666655 5555555566666666666
Q ss_pred ccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCC
Q 039595 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP 263 (1078)
Q Consensus 184 n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 263 (1078)
|.++ .+|..|++|++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|++|++|++|+|++|.|++.+|
T Consensus 257 N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p 333 (727)
T 4b8c_D 257 NSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFL 333 (727)
T ss_dssp SCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHH
T ss_pred CcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCCh
Confidence 6655 55556666666666666666665 45555666666666666666665 345556666666666666666665555
Q ss_pred cccCCCcc-cceeecccccccCccccccccccCCceeeeccc--------CCCCCCCccccCCCccCeeeccccccCc
Q 039595 264 SIIGNLKS-LHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSN--------SLSGSIPPILGNLKSLSTLGLYLNQLNG 332 (1078)
Q Consensus 264 ~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n--------~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 332 (1078)
..+..+.. +..|+|++|.++|.+|..+ ..|+++.| .+.+..+..+.++..+....+++|-+.+
T Consensus 334 ~~~~~~~~~~~~l~l~~N~l~~~~p~~l------~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 334 KILTEKSVTGLIFYLRDNRPEIPLPHER------RFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp HHHHHHHHHHHHHHHHHCCCCCCCCCC-----------------------------------------------CCCG
T ss_pred HHHhhcchhhhHHhhccCcccCcCcccc------ceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 55544321 2235566666666555433 33334433 3444445556677777778888887754
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=7.6e-23 Score=245.72 Aligned_cols=224 Identities=20% Similarity=0.193 Sum_probs=109.1
Q ss_pred cccceEeeCCCCeEEEeccCccccCCcccCCccCCCCCCcEEeccCCc-------ccccCCC---CCCCCCCcceeccCC
Q 039595 66 SWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNL-------FFGNIPP---QIGNLSKLQNLDLGN 135 (1078)
Q Consensus 66 ~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~-------~~~~~p~---~~~~l~~L~~L~Ls~ 135 (1078)
.|.++.|+....+|..+++....+.-... .+-..+.+.+.. ..+..+. .+..++.|+.|+|++
T Consensus 286 ~W~~~~~~~~~~~vw~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~L~~L~Ls~ 358 (567)
T 1dce_A 286 EWRTPDGRNRPSHVWLCDLPAASLNDQLP-------QHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSV 358 (567)
T ss_dssp CCBCTTSSCCSEEEEEEECCGGGTSTTSS-------EEEEEEEETTTTEEEEEEEETTCSEEEEECCSTTTTSSSCCCCH
T ss_pred eeccCCcccccceeEEeecCccccccccc-------cceEEEeeccCCCCccccccCCCchhhhcccccCccceeccCCh
Confidence 58888888777888888887544321100 000000000000 0000000 123445555555555
Q ss_pred CccCCCCCccccCccceeEEEccCcc-------------CCCCCCcccccccccceee-cccc-------------cccC
Q 039595 136 NQLSGVISPEIGKLNQLRRLYLDMNQ-------------LHGTIPPVIGQLSLIHEFS-FCHN-------------NVSG 188 (1078)
Q Consensus 136 n~l~~~~p~~~~~l~~L~~L~L~~n~-------------l~~~~p~~i~~l~~L~~L~-l~~n-------------~~~~ 188 (1078)
|+++ .+|.+|++|++|+.|++++|. +.+.+|..++.+++|+.|+ ++.| .+.+
T Consensus 359 n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~ 437 (567)
T 1dce_A 359 EKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLK 437 (567)
T ss_dssp HHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHH
T ss_pred hhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhhhhhcccccc
Confidence 5554 455555555555555554443 3445555555555555555 3333 3332
Q ss_pred CccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCC
Q 039595 189 RIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGN 268 (1078)
Q Consensus 189 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 268 (1078)
..+ ..|+.|+|++|++++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .+++
T Consensus 438 l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~ 506 (567)
T 1dce_A 438 MEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVAN 506 (567)
T ss_dssp HHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTT
T ss_pred cCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCC
Confidence 111 135555555555554 343 555555555555555555 345555555555555555555554 34 4555
Q ss_pred CcccceeecccccccCcc-ccccccccCCceeeecccCCCC
Q 039595 269 LKSLHQLDLIENQLSGSI-PLSFGNLSSWTLMSLFSNSLSG 308 (1078)
Q Consensus 269 l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~n~l~~ 308 (1078)
+++|+.|+|++|+|++.. |..|+.+++|+.|+|++|.+++
T Consensus 507 l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~ 547 (567)
T 1dce_A 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547 (567)
T ss_dssp CSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence 555555555555555443 4444444444444444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-20 Score=224.19 Aligned_cols=189 Identities=25% Similarity=0.375 Sum_probs=99.6
Q ss_pred CCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecc
Q 039595 103 HLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFC 182 (1078)
Q Consensus 103 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~ 182 (1078)
.+..++|+.+.+.+.++ +..|++|+.|+|++|.++. +| .++.+++|++|+|++|++++..| ++.+++|++|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 34445555555554333 4556666666666666653 33 46666666666666666664332 5555555555555
Q ss_pred cccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCC
Q 039595 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262 (1078)
Q Consensus 183 ~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 262 (1078)
+|.+.+ + ..++.+++|+.|+|++|.+++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++..
T Consensus 96 ~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~ 169 (605)
T 1m9s_A 96 ENKIKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 169 (605)
T ss_dssp SSCCCC-C-TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred CCCCCC-C-hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence 555553 2 2455555555555555555542 2355555555555555555543 34555555555555555555443
Q ss_pred CcccCCCcccceeecccccccCccccccccccCCceeeecccCCC
Q 039595 263 PSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLS 307 (1078)
Q Consensus 263 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 307 (1078)
| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+.
T Consensus 170 ~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 170 P--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp G--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred h--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 3 55555555555555555432 12333333444444333333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.5e-19 Score=190.05 Aligned_cols=135 Identities=27% Similarity=0.346 Sum_probs=76.4
Q ss_pred CCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEc
Q 039595 126 SKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYL 205 (1078)
Q Consensus 126 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L 205 (1078)
++|++|+|++|++++..|..|+.+++|++|+|++|++++..+..++.+++|++|+|++|.+++..+..|..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 34444444444444444444444444444444444443222233344455555555555555444445566666666666
Q ss_pred cCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCC
Q 039595 206 NNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261 (1078)
Q Consensus 206 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 261 (1078)
++|+++ .+|..+.++++|++|+|++|++++..+..|..+++|+.|+|++|.+...
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 666666 5566666677777777777777766556666777777777777776643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=200.36 Aligned_cols=172 Identities=28% Similarity=0.452 Sum_probs=105.4
Q ss_pred CCCCCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccce
Q 039595 99 SSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHE 178 (1078)
Q Consensus 99 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~ 178 (1078)
..+++|++|++++|.+.+. | .++.+++|++|+|++|++++..+ ++++++|++|+|++|++++ +| .++.+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 4456667777777766543 3 36666777777777777765333 6667777777777776663 33 3666666666
Q ss_pred eecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEecccccc
Q 039595 179 FSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSL 258 (1078)
Q Consensus 179 L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 258 (1078)
|++++|.+++. ..++.+++|+.|+|++|++++. ..++.+++|++|+|++|++++..| +..+++|++|+|++|++
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 66666666642 3466666666666666666543 455666666666666666665433 66666666666666666
Q ss_pred CCCCCcccCCCcccceeecccccccC
Q 039595 259 SGSIPSIIGNLKSLHQLDLIENQLSG 284 (1078)
Q Consensus 259 ~~~~p~~~~~l~~L~~L~Ls~N~l~~ 284 (1078)
++ +| .+..+++|+.|++++|+++.
T Consensus 191 ~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 191 SD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred CC-Ch-hhccCCCCCEEECcCCcccC
Confidence 63 23 25666666666666666653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=219.28 Aligned_cols=195 Identities=23% Similarity=0.390 Sum_probs=149.0
Q ss_pred CCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEE
Q 039595 124 NLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALL 203 (1078)
Q Consensus 124 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 203 (1078)
.+..+..++|+.+.+...+ .+..|++|+.|+|++|.+. .+| .++.+++|++|+|++|.+++..| ++++++|+.|
T Consensus 19 ~l~~l~~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred HHHHHHHHhccCCCccccc--chhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence 3556777888888887543 3678888999999999887 444 57888888888888888886554 8888888888
Q ss_pred EccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeeccccccc
Q 039595 204 YLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 204 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
+|++|.+++ +| .+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++. ..++.+++|+.|+|++|+++
T Consensus 93 ~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 93 FLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166 (605)
T ss_dssp ECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred ECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence 888888875 33 678888888888888888864 3577888888888888888854 56778888888888888888
Q ss_pred CccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccC
Q 039595 284 GSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVI 334 (1078)
Q Consensus 284 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 334 (1078)
+..| +..+++|+.|+|++|.+++. ..+..+++|+.|+|++|++.+..
T Consensus 167 ~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 167 DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred Cchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence 7666 77777777777777777753 34677777777777777776543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=191.32 Aligned_cols=157 Identities=20% Similarity=0.222 Sum_probs=134.0
Q ss_pred cEEeccCCccCCCcccccccCccCcEEeccCCccCCCcc-cccccccccceeeccCccccCCCCcccccccccccccccC
Q 039595 489 QFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVP-LEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSN 567 (1078)
Q Consensus 489 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 567 (1078)
+.+++++|.++. +|..+. ..++.|+|++|+|++..+ ..|..+++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 478888888874 455443 356788999998886644 4588899999999999999888778899999999999999
Q ss_pred cccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCC
Q 039595 568 NQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIP 647 (1078)
Q Consensus 568 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~ 647 (1078)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|++++|+|++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99988888889999999999999999998888889999999999999999998889999999999999999999998766
Q ss_pred C
Q 039595 648 N 648 (1078)
Q Consensus 648 ~ 648 (1078)
.
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=9.4e-20 Score=200.93 Aligned_cols=188 Identities=23% Similarity=0.397 Sum_probs=84.5
Q ss_pred cceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccC
Q 039595 128 LQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNN 207 (1078)
Q Consensus 128 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 207 (1078)
+..+.+..+.+++. ..+..+++|++|++++|.++ .+| .++.+++|++|++++|.+++..| ++++++|++|+|++
T Consensus 26 ~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCcccc--cchhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 33444444444432 12334555555555555554 222 24444444444444444443322 45555555555555
Q ss_pred CCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccc
Q 039595 208 NSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIP 287 (1078)
Q Consensus 208 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 287 (1078)
|.+++ +| .+..+++|++|+|++|++++. ..+..+++|++|++++|++++. ..++.+++|++|+|++|++++..|
T Consensus 100 n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 55543 22 245555555555555555542 2344455555555555555432 334445555555555555543322
Q ss_pred cccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccC
Q 039595 288 LSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLN 331 (1078)
Q Consensus 288 ~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 331 (1078)
+..+++|+.|++++|.+++. + .+..+++|+.|++++|+++
T Consensus 174 --l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp --GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred --hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence 33333444444444433321 1 1344444444444444443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=190.82 Aligned_cols=155 Identities=23% Similarity=0.303 Sum_probs=117.2
Q ss_pred cEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCc
Q 039595 489 QFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNN 568 (1078)
Q Consensus 489 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 568 (1078)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46677777776 3444443 56777777777777666667777778888888888887777777888888888888888
Q ss_pred ccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCC
Q 039595 569 QFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPI 646 (1078)
Q Consensus 569 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~ 646 (1078)
+|+...+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|++++|+|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 887666666777888888888888887777777778888888888888888777777888888888888888887644
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.3e-19 Score=185.69 Aligned_cols=153 Identities=25% Similarity=0.317 Sum_probs=85.6
Q ss_pred cEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCC-ccccCccceeEEEccCccCCCCCCcccccccccceeeccc
Q 039595 105 VNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVIS-PEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183 (1078)
Q Consensus 105 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~ 183 (1078)
+.+++++|.++ .+|..+. ..+++|+|++|++++..| ..|+.+++|++|+|++|+++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-------------------- 70 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-------------------- 70 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC--------------------
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC--------------------
Confidence 35666666664 3454443 234566666666554433 22455555555555555554
Q ss_pred ccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCC
Q 039595 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP 263 (1078)
Q Consensus 184 n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 263 (1078)
+..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|
T Consensus 71 ----~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 146 (220)
T 2v70_A 71 ----DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAP 146 (220)
T ss_dssp ----EECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCT
T ss_pred ----EECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECH
Confidence 3334455555555555555555555555555556666666666666665555556666666666666666665555
Q ss_pred cccCCCcccceeecccccccC
Q 039595 264 SIIGNLKSLHQLDLIENQLSG 284 (1078)
Q Consensus 264 ~~~~~l~~L~~L~Ls~N~l~~ 284 (1078)
..|..+++|+.|+|++|.+.+
T Consensus 147 ~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 147 GAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp TTTTTCTTCCEEECCSCCEEC
T ss_pred HHhcCCCCCCEEEecCcCCcC
Confidence 566666666666666666554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.4e-19 Score=184.69 Aligned_cols=152 Identities=23% Similarity=0.316 Sum_probs=84.1
Q ss_pred cEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccc
Q 039595 105 VNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHN 184 (1078)
Q Consensus 105 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n 184 (1078)
+.+++++++++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~--------------------- 69 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS--------------------- 69 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCC---------------------
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCC---------------------
Confidence 34666666654 3454433 45555666665555444445555555555555555554
Q ss_pred cccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCc
Q 039595 185 NVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS 264 (1078)
Q Consensus 185 ~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 264 (1078)
+..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+.
T Consensus 70 ---~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (220)
T 2v9t_B 70 ---ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146 (220)
T ss_dssp ---EECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ---CcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH
Confidence 33444555555555555555555544444455555566666666655555555555556666666666666555555
Q ss_pred ccCCCcccceeeccccccc
Q 039595 265 IIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 265 ~~~~l~~L~~L~Ls~N~l~ 283 (1078)
.|..+++|+.|+|++|.+.
T Consensus 147 ~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 147 TFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp TTTTCTTCCEEECCSSCEE
T ss_pred HHhCCCCCCEEEeCCCCcC
Confidence 5555666666666666554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-21 Score=235.33 Aligned_cols=205 Identities=20% Similarity=0.172 Sum_probs=160.1
Q ss_pred ccCccceeEEEccCccCCCCCCcccccccccceeeccccc-------------ccCCccCcccCCCCCcEEE-ccCCCCC
Q 039595 146 IGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNN-------------VSGRIPSSLGNLSKLALLY-LNNNSLF 211 (1078)
Q Consensus 146 ~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~-------------~~~~~p~~l~~l~~L~~L~-L~~n~l~ 211 (1078)
+..+++|+.|+|++|+++ .+|++|+.|++|++|++++|. +.+.+|..++++++|+.|+ ++.|.+
T Consensus 345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~- 422 (567)
T 1dce_A 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL- 422 (567)
T ss_dssp CSTTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH-
T ss_pred cccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc-
Confidence 367899999999999998 899999999999999997775 5667777777777777777 555543
Q ss_pred CCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccc
Q 039595 212 GYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFG 291 (1078)
Q Consensus 212 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 291 (1078)
.+|+.+.+++|.++...+ ..|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+
T Consensus 423 ----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 423 ----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred ----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 345556666666664322 247888888888885 565 888888888888888888 6777888
Q ss_pred cccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccC-CCCCCCCCcCcEEEccCccCCCCCCcc---ccccCC
Q 039595 292 NLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVI-PPSIGNLSSLRNLSLFNNGLYGSIPEE---IGYLKS 367 (1078)
Q Consensus 292 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~ 367 (1078)
.+++|+.|+|++|.+++ +| .++++++|++|+|++|+|++.. |..++.+++|+.|+|++|.+++.+|.. +..+++
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~ 561 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 561 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTT
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcc
Confidence 88888888888888886 55 7888888888888888888776 888888888888888888888655432 334788
Q ss_pred CCeEEc
Q 039595 368 LSELKL 373 (1078)
Q Consensus 368 L~~L~L 373 (1078)
|+.|++
T Consensus 562 L~~L~l 567 (567)
T 1dce_A 562 VSSILT 567 (567)
T ss_dssp CSEEEC
T ss_pred cCccCC
Confidence 888864
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.2e-19 Score=186.54 Aligned_cols=156 Identities=26% Similarity=0.323 Sum_probs=124.4
Q ss_pred ccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccC
Q 039595 488 LQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSN 567 (1078)
Q Consensus 488 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 567 (1078)
.+.++.+++.++ .+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|.|+...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 456777787777 4444333 6788888888888877788888888888888888888766667778888888888888
Q ss_pred cccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCC
Q 039595 568 NQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIP 647 (1078)
Q Consensus 568 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~ 647 (1078)
|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|++++..+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 8888777777888888888888888887 567777888888888888888887777778888888888888888887665
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=5e-19 Score=201.76 Aligned_cols=175 Identities=24% Similarity=0.217 Sum_probs=97.1
Q ss_pred cEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCcccc-CccceeEEEccCccCCCCCCcccccccccceeeccc
Q 039595 105 VNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIG-KLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183 (1078)
Q Consensus 105 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~ 183 (1078)
+.+++++|++. .+|..+. +.+++|+|++|+|++..+..+. ++++|++|+|++|++++..|..|+.+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46778888776 3565554 3577777777777765555565 777777777777777644445555555555555555
Q ss_pred ccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcc---cCCCCCcEEeccccccCC
Q 039595 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTL---DNLSNLDTLFLYKNSLSG 260 (1078)
Q Consensus 184 n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~L~L~~N~l~~ 260 (1078)
|++++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 55554444455555555555555555555445555555555555555555554333333 334455555555555543
Q ss_pred CCCcccCCCcc--cceeecccccc
Q 039595 261 SIPSIIGNLKS--LHQLDLIENQL 282 (1078)
Q Consensus 261 ~~p~~~~~l~~--L~~L~Ls~N~l 282 (1078)
..+..+..+++ |+.|+|++|.+
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~ 201 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPL 201 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCE
T ss_pred cCHHHhhhccHhhcceEEecCCCc
Confidence 33334444443 24444444444
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.5e-19 Score=200.80 Aligned_cols=154 Identities=22% Similarity=0.262 Sum_probs=81.0
Q ss_pred ceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccc-cccccceeecccccccCCccCcccCCCCCcEEEccC
Q 039595 129 QNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIG-QLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNN 207 (1078)
Q Consensus 129 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~-~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 207 (1078)
+++++++++++ .+|..+. ..+++|+|++|++++..+..+. .+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46667777666 3555443 2356666666666644444444 555555555555555544444555555555555555
Q ss_pred CCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCccc---CCCcccceeecccccccC
Q 039595 208 NSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSII---GNLKSLHQLDLIENQLSG 284 (1078)
Q Consensus 208 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 284 (1078)
|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 55554444445555555555555555555445555555555555555555553333333 334455555555555443
Q ss_pred c
Q 039595 285 S 285 (1078)
Q Consensus 285 ~ 285 (1078)
.
T Consensus 178 l 178 (361)
T 2xot_A 178 L 178 (361)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.6e-19 Score=221.88 Aligned_cols=224 Identities=22% Similarity=0.203 Sum_probs=130.3
Q ss_pred CCCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeec
Q 039595 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181 (1078)
Q Consensus 102 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l 181 (1078)
+.++.|+|.+|.+... | ...|+.++|+.|.|.+ ++++.|.+. ..|..+..++.|++|+|
T Consensus 173 ~~~~~l~L~~n~~~~~-~-----~~~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-N-----QALLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCcc-h-----hhHhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence 4577788877777642 2 2346667777776653 345567766 67888999999999999
Q ss_pred ccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCC
Q 039595 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGS 261 (1078)
Q Consensus 182 ~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 261 (1078)
++|.+. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-T 307 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-c
Confidence 999998 78988999999999999999998 88999999999999999999999 67999999999999999999998 7
Q ss_pred CCcccCCCcccceeecccccccCccccccccccC-CceeeecccCCCCCCCccccCCCccCeeecccc--------ccCc
Q 039595 262 IPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS-WTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLN--------QLNG 332 (1078)
Q Consensus 262 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N--------~l~~ 332 (1078)
+|..|+++++|++|+|++|.|++.+|..+..+.. +..++|++|.+++.+|.. |..|+++.| .+.+
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~ 381 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQ 381 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccc
Confidence 7888999999999999999999999998877643 335889999999998865 455666666 4555
Q ss_pred cCCCCCCCCCcCcEEEccCccCCC
Q 039595 333 VIPPSIGNLSSLRNLSLFNNGLYG 356 (1078)
Q Consensus 333 ~~p~~l~~l~~L~~L~Ls~N~l~~ 356 (1078)
..+..+..+..++...+++|-+.+
T Consensus 382 ~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 382 STEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp --------------------CCCG
T ss_pred cccchhhcccccceeeeecccccc
Confidence 555666777778888888888764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=8.1e-19 Score=190.24 Aligned_cols=146 Identities=26% Similarity=0.388 Sum_probs=59.3
Q ss_pred CCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEE
Q 039595 125 LSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLY 204 (1078)
Q Consensus 125 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 204 (1078)
+.++..+++++|.+++ ++ .+..+++|++|++++|.++ .+| .++.+++|++|++++|.+++..| ++++++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 3344444444444442 22 3444444444444444444 233 33344444444444444443222 44444444444
Q ss_pred ccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeeccccccc
Q 039595 205 LNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 205 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
|++|++++. |. +.. ++|++|+|++|++++. + .+..+++|++|+|++|++++. + .++.+++|++|+|++|+++
T Consensus 92 L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 92 VNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp CCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred CCCCccCCc-Cc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 444444432 21 111 4444444444444432 1 244444444444444444422 1 2344444444444444443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2e-18 Score=178.63 Aligned_cols=152 Identities=20% Similarity=0.267 Sum_probs=76.5
Q ss_pred CCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEE
Q 039595 124 NLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALL 203 (1078)
Q Consensus 124 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 203 (1078)
.+++|++|++++|+++ .+| .+..+++|++|++++|.++ .++.+..+++|++|++++|.+++..|..++.+++|++|
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 3444444444444444 233 3444444455555444332 22344445555555555555554445555555555555
Q ss_pred EccCCCCCCCCCCcccccCCCCeeecCCcc-cCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccc
Q 039595 204 YLNNNSLFGYIPTVMGNLKSLSTLDLSQNQ-LNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282 (1078)
Q Consensus 204 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 282 (1078)
+|++|++++..|..++.+++|++|+|++|+ ++. +| .+..+++|++|++++|++++ ++ .+..+++|++|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence 555555555445555555555555555555 332 23 45555566666666666553 22 455566666666666655
Q ss_pred c
Q 039595 283 S 283 (1078)
Q Consensus 283 ~ 283 (1078)
.
T Consensus 194 ~ 194 (197)
T 4ezg_A 194 G 194 (197)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-18 Score=189.18 Aligned_cols=170 Identities=22% Similarity=0.317 Sum_probs=91.6
Q ss_pred CccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCee
Q 039595 148 KLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTL 227 (1078)
Q Consensus 148 ~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 227 (1078)
.+.+++.++++.|.++ .++ .+..+++|++|++++|.++ .+| .++.+++|++|+|++|++++..| ++++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 4555666666666665 333 4555666666666666555 233 45556666666666666554333 5555666666
Q ss_pred ecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCC
Q 039595 228 DLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLS 307 (1078)
Q Consensus 228 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 307 (1078)
+|++|++++. |. +.. ++|++|+|++|++++. + .++.+++|+.|+|++|++++. +
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-------------------- 144 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-------------------- 144 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G--------------------
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h--------------------
Confidence 6666665543 22 222 5555555555555532 2 355555555555555555543 1
Q ss_pred CCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCC
Q 039595 308 GSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYG 356 (1078)
Q Consensus 308 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 356 (1078)
.++.+++|++|+|++|++++. ..+..+++|+.|++++|.+.+
T Consensus 145 -----~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 145 -----MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp -----GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred -----HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 344555555555555555543 445555555555555555553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.2e-18 Score=177.12 Aligned_cols=153 Identities=16% Similarity=0.234 Sum_probs=82.5
Q ss_pred cCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCe
Q 039595 147 GKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLST 226 (1078)
Q Consensus 147 ~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 226 (1078)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..++.+++|++|++++|++++..|..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45555555555555555 444 4555555555555555443 2235555555555555555555545555555555555
Q ss_pred eecCCcccCCCCCCcccCCCCCcEEeccccc-cCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccC
Q 039595 227 LDLSQNQLNGLIPCTLDNLSNLDTLFLYKNS-LSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS 305 (1078)
Q Consensus 227 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~ 305 (1078)
|+|++|++++..|..+..+++|++|+|++|+ ++ .+| .+..+++|++|++++|++++. + .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 5555555555445555555555555555555 33 333 355555555555555555542 2 45555555555555555
Q ss_pred CC
Q 039595 306 LS 307 (1078)
Q Consensus 306 l~ 307 (1078)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 43
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-18 Score=195.16 Aligned_cols=218 Identities=11% Similarity=0.043 Sum_probs=139.3
Q ss_pred cCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccc----cCCCCCccccCCCcc
Q 039595 413 LTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNN----IFGSIPLEIGDSSKL 488 (1078)
Q Consensus 413 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~----i~~~~~~~~~~l~~L 488 (1078)
+++|+.|.+.+ .+..+...+|.++++|+.|++++|.+..+...+|.+..++..+....+. ........|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 56666666655 5555666666666666666666666655555566555555544443321 122233344455555
Q ss_pred c-EEeccCCccCCCccccc----ccCccCcEEeccCCccCCCccccc-ccccccceeeccCccccCCCCccccccccccc
Q 039595 489 Q-FLDLSSNHIVGKIPVQL----EKLFSLNKLILSLNQLSGSVPLEF-GSLTELQYLDLSANKLSSSIPKSIGNLLKLYY 562 (1078)
Q Consensus 489 ~-~L~Ls~N~i~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 562 (1078)
+ .+.+.... .++..+ ....++..+.+.++-.. .....+ ..+++|+.|+|++|.++.+.+.+|.++++|++
T Consensus 179 ~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~ 254 (329)
T 3sb4_A 179 ETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLK 254 (329)
T ss_dssp EEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCE
T ss_pred ceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCE
Confidence 5 44443321 122211 12345566666554221 111112 23678888888888888777778888888888
Q ss_pred ccccCcccccccchhhhcccccC-eeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEc
Q 039595 563 LNLSNNQFSHTIPIEFEKLIHLS-KLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDI 637 (1078)
Q Consensus 563 L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l 637 (1078)
|+|.+| ++.+.+.+|.++.+|+ .++|.+ .++...+..|.++++|+.|++++|+++.+.+..|.++++|+.++.
T Consensus 255 l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 255 IKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 888887 7777778888888888 888888 677666778888888888888888888888888888888888763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.8e-18 Score=192.97 Aligned_cols=294 Identities=12% Similarity=0.084 Sum_probs=155.0
Q ss_pred CCCccccC--ccceeEEEccCccCCCCCCccccc-ccccceeeccccccc--CCccCcccCCCCCcEEEccCCCCCCCCC
Q 039595 141 VISPEIGK--LNQLRRLYLDMNQLHGTIPPVIGQ-LSLIHEFSFCHNNVS--GRIPSSLGNLSKLALLYLNNNSLFGYIP 215 (1078)
Q Consensus 141 ~~p~~~~~--l~~L~~L~L~~n~l~~~~p~~i~~-l~~L~~L~l~~n~~~--~~~p~~l~~l~~L~~L~L~~n~l~~~~p 215 (1078)
.++..++. +.+++.|.++++ +.+.--..+.. +++|++|+|++|++. ...+.. ++.++.+.+..|.+ .+
T Consensus 14 ~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I---~~ 86 (329)
T 3sb4_A 14 TLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFV---PA 86 (329)
T ss_dssp CGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEE---CT
T ss_pred cHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccc---cccccccccccccc---CH
Confidence 33444433 667777777753 11111122333 556777777777665 211111 22234444444432 22
Q ss_pred Ccccc--------cCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccc----c
Q 039595 216 TVMGN--------LKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL----S 283 (1078)
Q Consensus 216 ~~~~~--------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l----~ 283 (1078)
.+|.+ +++|+.|+|.+ +++.+.+.+|.++++|++|++.+|.+..+.+.+|.++.++..+.++.+.. .
T Consensus 87 ~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~ 165 (329)
T 3sb4_A 87 YAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKN 165 (329)
T ss_dssp TTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTST
T ss_pred HHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccc
Confidence 44555 66666666666 66655555666666666666666666655555666665565555544221 1
Q ss_pred CccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccc-cCccCCCCCCCCCcCcEEEccCccCCCCCCccc
Q 039595 284 GSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQ-LNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362 (1078)
Q Consensus 284 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 362 (1078)
...+..|.++..|+. .+.+.... +.......--...+++.+.+.++-.. .....+
T Consensus 166 ~i~~~~f~~~~~L~~-----------------------~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l 221 (329)
T 3sb4_A 166 RWEHFAFIEGEPLET-----------------------TIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLI 221 (329)
T ss_dssp TTTTSCEEESCCCEE-----------------------EEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHH
T ss_pred cccccccccccccce-----------------------eEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHH
Confidence 112223333333331 22221110 00000000112344555555544221 111111
Q ss_pred c-ccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCC-eEEccCccccccchhhccCCCCC
Q 039595 363 G-YLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLK-RVRFNQNNLVGKVYEAFGDHPNL 440 (1078)
Q Consensus 363 ~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L 440 (1078)
. .+++|+.|+|++|+++.+.+.+|.++++|+.+++.+| +....+.+|.++++|+ .+.+.+ .+..+...+|.++++|
T Consensus 222 ~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L 299 (329)
T 3sb4_A 222 RDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNL 299 (329)
T ss_dssp HHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTE
T ss_pred HHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccC
Confidence 1 2567777777777777666667777777777777766 5555666677777776 777766 6666666777777777
Q ss_pred cEecCCCCccCCccCccccCCCCCceec
Q 039595 441 TFLDLSQNNFDGKISFNWRNLPKLDTFI 468 (1078)
Q Consensus 441 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 468 (1078)
+.|++++|.++.+...+|.++++|+.++
T Consensus 300 ~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 300 RYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CEEEeCCCccCccchhhhcCCcchhhhc
Confidence 7777777777666666666666666554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=1e-17 Score=172.28 Aligned_cols=129 Identities=25% Similarity=0.330 Sum_probs=60.4
Q ss_pred cEEeccCCccCCCcccccccCccCcEEeccCCccCCCccc-ccccccccceeeccCccccCCCCcccccccccccccccC
Q 039595 489 QFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPL-EFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSN 567 (1078)
Q Consensus 489 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 567 (1078)
+.+++++|.++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45556666554 33333322 455555555555433332 244445555555555555444444444444444444444
Q ss_pred cccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccC
Q 039595 568 NQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSG 620 (1078)
Q Consensus 568 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 620 (1078)
|+|++..+..|.++++|+.|+|++|+|++..|..+..+++|++|+|++|++++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 44444444444444444444444444444444444444444444444444443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=178.98 Aligned_cols=142 Identities=15% Similarity=0.113 Sum_probs=108.6
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCE--EEEEEeccccccCC--------------------hhhHHHHHHHHHHHhc
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDI--VAVKKFNSQLLSGN--------------------MADQDEFLNVVLALNE 807 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~~--------------------~~~~~~~~~e~~~l~~ 807 (1078)
.-|++.+.||+|+||.||+|.. .+|+. ||||+++....... ......+.+|+..+++
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999977 67888 99999754321100 0112367889999999
Q ss_pred CCCCce--eeEEeeeecCCeeEEEEeecCC-C----CHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHH-hcCCCCcE
Q 039595 808 IRHRNI--VKFHGFCSNARHSFLVCEYLHR-G----SLARILGNDATAKELSWNRRINVIKGVANALSYLH-HDCLPSII 879 (1078)
Q Consensus 808 l~h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~iv 879 (1078)
+.|+++ +..+++ ...++||||+.+ | +|.++... .++.++..++.|++.|+.||| +. ||+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 988754 344443 357899999942 3 67766521 234567889999999999999 88 999
Q ss_pred ecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 880 HRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 880 H~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999988 9999999999754
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=163.35 Aligned_cols=92 Identities=29% Similarity=0.447 Sum_probs=48.3
Q ss_pred ccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccc
Q 039595 194 LGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLH 273 (1078)
Q Consensus 194 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 273 (1078)
|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++.+|..|..+++|+
T Consensus 50 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 129 (192)
T 1w8a_A 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129 (192)
T ss_dssp GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC
T ss_pred cccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCC
Confidence 44455555555555555544455555555555555555555554444455555555555555555554455555555555
Q ss_pred eeecccccccCc
Q 039595 274 QLDLIENQLSGS 285 (1078)
Q Consensus 274 ~L~Ls~N~l~~~ 285 (1078)
+|+|++|.+++.
T Consensus 130 ~L~L~~N~l~c~ 141 (192)
T 1w8a_A 130 SLNLASNPFNCN 141 (192)
T ss_dssp EEECTTCCBCCS
T ss_pred EEEeCCCCccCc
Confidence 555555555443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2e-16 Score=158.94 Aligned_cols=108 Identities=21% Similarity=0.253 Sum_probs=43.2
Q ss_pred CCcceeccCCCccC-CCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEE
Q 039595 126 SKLQNLDLGNNQLS-GVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLY 204 (1078)
Q Consensus 126 ~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 204 (1078)
++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|++++|.+++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34444444444444 34444444444444444444444422 3333333333333333333333333333344444444
Q ss_pred ccCCCCCCCCC-CcccccCCCCeeecCCcccC
Q 039595 205 LNNNSLFGYIP-TVMGNLKSLSTLDLSQNQLN 235 (1078)
Q Consensus 205 L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 235 (1078)
|++|.+++..+ ..+..+++|++|++++|+++
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~ 133 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence 44444432211 33333444444444444444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.5e-15 Score=174.28 Aligned_cols=262 Identities=10% Similarity=0.062 Sum_probs=139.5
Q ss_pred CcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEc
Q 039595 342 SSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRF 421 (1078)
Q Consensus 342 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 421 (1078)
..++.+.+.+ .++......|.+. +|+.+.+..| ++.+...+|.+. +|+.+.+.+ .+....+.+|.++++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4455555543 2333334445443 4666665544 444444555552 455555543 344344445555555555555
Q ss_pred cCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCC
Q 039595 422 NQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGK 501 (1078)
Q Consensus 422 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 501 (1078)
.+|.+..+...+|. ..+|+.+.+..+ ++.+... .|.++++|+.+++..| ++.+
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~------------------------aF~~~~~L~~l~l~~~-l~~I 240 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQ------------------------AFLKTSQLKTIEIPEN-VSTI 240 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTT------------------------TTTTCTTCCCEECCTT-CCEE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhh------------------------HhhCCCCCCEEecCCC-ccCc
Confidence 55555555555544 244555555422 4444444 4444455555555443 3334
Q ss_pred cccccccCccCcEEeccCCccCCCcccccccccccceeeccCcccc-----CCCCcccccccccccccccCcccccccch
Q 039595 502 IPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLS-----SSIPKSIGNLLKLYYLNLSNNQFSHTIPI 576 (1078)
Q Consensus 502 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 576 (1078)
...+|.+ .+|+.+.+ .|.++.+...+|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|. |.++.+...
T Consensus 241 ~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~ 317 (401)
T 4fdw_A 241 GQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQG 317 (401)
T ss_dssp CTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTT
T ss_pred ccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhh
Confidence 4444444 45555555 33344444555555666666666555443 3445566666666666666 335555666
Q ss_pred hhhcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCC-cCcEEEcccC
Q 039595 577 EFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMR-SLSCIDICYN 640 (1078)
Q Consensus 577 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~l~l~~N 640 (1078)
+|.++++|+.++|..| ++.....+|.++ +|+.+++++|.+....+..|..++ +++.|.+..|
T Consensus 318 aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~ 380 (401)
T 4fdw_A 318 LLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAE 380 (401)
T ss_dssp TTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGG
T ss_pred hhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHH
Confidence 6767777777777544 555555566666 677777777766666666666663 4566665544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.7e-16 Score=157.06 Aligned_cols=133 Identities=26% Similarity=0.313 Sum_probs=106.2
Q ss_pred ccceeEEEccCccCC-CCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCee
Q 039595 149 LNQLRRLYLDMNQLH-GTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTL 227 (1078)
Q Consensus 149 l~~L~~L~L~~n~l~-~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 227 (1078)
.++|++|+|++|.++ +.+|..++.+++|++|++++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 367889999999887 78888888888888888888888765 778888888888888888887777777778888888
Q ss_pred ecCCcccCCCC-CCcccCCCCCcEEeccccccCCCCC---cccCCCcccceeeccccccc
Q 039595 228 DLSQNQLNGLI-PCTLDNLSNLDTLFLYKNSLSGSIP---SIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 228 ~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
+|++|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 88888888642 2677788888888888888885544 36777888888888888776
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.4e-16 Score=154.88 Aligned_cols=128 Identities=21% Similarity=0.222 Sum_probs=83.3
Q ss_pred CCCCcEEeccCCccc-ccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCccccccccccee
Q 039595 101 FPHLVNLNLSFNLFF-GNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEF 179 (1078)
Q Consensus 101 l~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L 179 (1078)
.++|++|++++|.+. +.+|..++.+++|++|+|++|.+++. ..++.+++|++|+|++|.+++.+|..++.+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 466777888888777 67777777777888888887777754 667777777777777777776566666666666666
Q ss_pred ecccccccCC-ccCcccCCCCCcEEEccCCCCCCCCC---CcccccCCCCeeecC
Q 039595 180 SFCHNNVSGR-IPSSLGNLSKLALLYLNNNSLFGYIP---TVMGNLKSLSTLDLS 230 (1078)
Q Consensus 180 ~l~~n~~~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~L~ 230 (1078)
++++|.+++. .|..++++++|++|++++|.+++..+ ..++.+++|++|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 6666666542 23555555555555555555554433 345555555555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.7e-15 Score=171.00 Aligned_cols=272 Identities=10% Similarity=0.060 Sum_probs=198.6
Q ss_pred CCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCcee
Q 039595 316 NLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLL 395 (1078)
Q Consensus 316 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 395 (1078)
.+..++.+.+.. .++.+...+|.++ +|+.+.+.+| ++......|.+. +|+.+.+.. .+..+.+.+|.++++|+.+
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKA 185 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCee
Confidence 346777887764 5676777889886 7999999877 765666677774 799999996 7887888999999999999
Q ss_pred ecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccC
Q 039595 396 NMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIF 475 (1078)
Q Consensus 396 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 475 (1078)
++.+|.+......+|. ..+|+.+.+.. .+..+...+|..+++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++
T Consensus 186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~ 260 (401)
T 4fdw_A 186 DLSKTKITKLPASTFV-YAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT 260 (401)
T ss_dssp ECTTSCCSEECTTTTT-TCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC
T ss_pred ecCCCcceEechhhEe-ecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc
Confidence 9999999887778887 58999999984 599999999999999999999875 66666666665 55555555 23344
Q ss_pred CCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccc
Q 039595 476 GSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIG 555 (1078)
Q Consensus 476 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 555 (1078)
......|.++++|+.+++.+|.+. .+.+..+.+..|.++++|+.++|. |.++.+...+|.
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~-------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~ 320 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFN-------------------DDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLG 320 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCC-------------------CCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTT
T ss_pred EEChhHhhCCCCCCEEEeCCcccc-------------------CCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhc
Confidence 444444445555555554444432 001113445667777777777777 346666667777
Q ss_pred cccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCccccc-ccceeeccCcccc
Q 039595 556 NLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNME-SLEKLNLSHNNLS 619 (1078)
Q Consensus 556 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~ 619 (1078)
++++|+.++|..| ++.+...+|.++ +|+.+++++|.+.......|..++ +++.|++..|.+.
T Consensus 321 ~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 321 GNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp TCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 7788888888554 666677778888 888888888887766666777774 6788888777654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.9e-15 Score=155.32 Aligned_cols=127 Identities=31% Similarity=0.394 Sum_probs=67.0
Q ss_pred ceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCC
Q 039595 129 QNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN 208 (1078)
Q Consensus 129 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 208 (1078)
+++++++|+++ .+|..+. ++|++|+|++|+++ .+ |..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~i------------------------p~~~~~l~~L~~L~Ls~N 64 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LV------------------------PKELSNYKHLTLIDLSNN 64 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SC------------------------CGGGGGCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hh------------------------HHHhhcccCCCEEECCCC
Confidence 35566666655 4454432 34555555555554 33 444445555555555555
Q ss_pred CCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeeccccccc
Q 039595 209 SLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 209 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 65 ~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 65 RISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 555444445555555555555555555554555555555555555555555444444555555555555555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.3e-16 Score=153.94 Aligned_cols=127 Identities=25% Similarity=0.290 Sum_probs=59.9
Q ss_pred CCcceeccCCCccC-CCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEE
Q 039595 126 SKLQNLDLGNNQLS-GVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLY 204 (1078)
Q Consensus 126 ~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 204 (1078)
++|++|++++|.++ +.+|..++.+++|++|++++|.++ +. ..++++++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~------------------------~~--~~~~~l~~L~~L~ 70 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT------------------------SI--ANLPKLNKLKKLE 70 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCC------------------------CC--TTCCCCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCC------------------------Cc--hhhhcCCCCCEEE
Confidence 44455555555544 444444444444444444444444 22 3344444555555
Q ss_pred ccCCCCCCCCCCcccccCCCCeeecCCcccCCC-CCCcccCCCCCcEEeccccccCCCCC---cccCCCcccceeecc
Q 039595 205 LNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL-IPCTLDNLSNLDTLFLYKNSLSGSIP---SIIGNLKSLHQLDLI 278 (1078)
Q Consensus 205 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls 278 (1078)
|++|.+++.+|..++++++|++|++++|++++. .|..+..+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 71 Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555444444444455555555555555442 12444445555555555555543333 244445555555543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-15 Score=154.83 Aligned_cols=127 Identities=20% Similarity=0.262 Sum_probs=87.4
Q ss_pred cEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccc
Q 039595 105 VNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHN 184 (1078)
Q Consensus 105 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n 184 (1078)
+.+++++|.+. .+|..+. ++|++|+|++|+++ .+|..|.++++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 57999999987 6777664 68999999999998 78899999999999999999998655555666655555555555
Q ss_pred cccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccC
Q 039595 185 NVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235 (1078)
Q Consensus 185 ~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 235 (1078)
.+++..|..|.++++|++|+|++|.+++..+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 555554445555555555555555555444444444555555555555444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-15 Score=154.89 Aligned_cols=132 Identities=27% Similarity=0.285 Sum_probs=79.8
Q ss_pred cEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCC
Q 039595 513 NKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHN 592 (1078)
Q Consensus 513 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 592 (1078)
+.+++++|+++. +|..+ .++|+.|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 10 ~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 345555555542 22222 145566666666665555555566666666666666666555555666666666666666
Q ss_pred ccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCCC
Q 039595 593 ILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIP 647 (1078)
Q Consensus 593 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~ 647 (1078)
+|++..+..+..+++|++|+|++|++++..+..|..+++|+.|++++|++++.+|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6665555556666677777777777766555556667777777777777776554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=4.2e-15 Score=150.68 Aligned_cols=112 Identities=25% Similarity=0.286 Sum_probs=60.9
Q ss_pred ccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEecc
Q 039595 175 LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLY 254 (1078)
Q Consensus 175 ~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 254 (1078)
+|++|++++|.+.+..+..++++++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 108 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence 34444444444443333444555555555555555555444455555666666666666655555455555666666666
Q ss_pred ccccCCCCCcccCCCcccceeecccccccCcc
Q 039595 255 KNSLSGSIPSIIGNLKSLHQLDLIENQLSGSI 286 (1078)
Q Consensus 255 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 286 (1078)
+|++++..+..+..+++|++|+|++|.+.+..
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 66665444444555666666666666555433
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=5.3e-16 Score=173.27 Aligned_cols=144 Identities=11% Similarity=0.087 Sum_probs=102.3
Q ss_pred HhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCC----------hhhHH--------HHHHHHHHHhcCC
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN----------MADQD--------EFLNVVLALNEIR 809 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~--------~~~~e~~~l~~l~ 809 (1078)
....-|++.++||+|+||.||+|...+|+.||||+++....... ..... ...+|...+.++.
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 33445999999999999999999888999999999764321100 00011 1234555566654
Q ss_pred CCcee--eEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 039595 810 HRNIV--KFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 887 (1078)
Q Consensus 810 h~niv--~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 887 (1078)
+.++. ..+++ ...++||||++|++|.++.. ......++.|++.++.|||++ |||||||||.|
T Consensus 172 ~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N 235 (397)
T 4gyi_A 172 EEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKH---GLIHGDFNEFN 235 (397)
T ss_dssp HTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred hcCCCCCeeeec----cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence 44332 22221 23479999999988866541 123456889999999999999 99999999999
Q ss_pred eeeCCCC----------cEEEecccccccc
Q 039595 888 VLLDLEF----------EAHVSDFGIAKFV 907 (1078)
Q Consensus 888 Ill~~~~----------~~kl~DfG~a~~~ 907 (1078)
||++++| .+.|+||+-+...
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9998876 3899999987643
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.9e-14 Score=164.37 Aligned_cols=330 Identities=13% Similarity=0.046 Sum_probs=159.6
Q ss_pred CCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccc
Q 039595 214 IPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNL 293 (1078)
Q Consensus 214 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 293 (1078)
-..+|.++++|+.+.|.. .++.+...+|.++++|+.+++.++ ++.+-..+|.++.+|+.+.+..+ +......+|.++
T Consensus 63 g~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~ 139 (394)
T 4fs7_A 63 GYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGC 139 (394)
T ss_dssp CTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTC
T ss_pred HHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecc
Confidence 335666777777777753 355555566777777777777544 44333455666666666655433 222223333333
Q ss_pred cCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEc
Q 039595 294 SSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKL 373 (1078)
Q Consensus 294 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 373 (1078)
.. +...... .+......+|.++++|+.+.+.++... .....|..+.+|+.+.+
T Consensus 140 ~~------------------------~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l 192 (394)
T 4fs7_A 140 DF------------------------KEITIPE--GVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKL 192 (394)
T ss_dssp CC------------------------SEEECCT--TCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCC
T ss_pred cc------------------------cccccCc--cccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEc
Confidence 22 2111111 111122345555666666666544322 33344555666666666
Q ss_pred ccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCc
Q 039595 374 CKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGK 453 (1078)
Q Consensus 374 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 453 (1078)
..| ++.+...+|.++..|+.+.+..+... +...+.....|+.+.+.. .+..+...+|.....++.+.+..+.. .+
T Consensus 193 ~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~-~~~~i~~~~f~~~~~l~~~~~~~~~~-~i 267 (394)
T 4fs7_A 193 PRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPD-SFTELGKSVFYGCTDLESISIQNNKL-RI 267 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECT-TCCEECSSTTTTCSSCCEEEECCTTC-EE
T ss_pred CCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECC-CceecccccccccccceeEEcCCCcc-ee
Confidence 554 44444555666666666655544321 122223334555555532 33444555555555666665554422 23
Q ss_pred cCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccc
Q 039595 454 ISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSL 533 (1078)
Q Consensus 454 ~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 533 (1078)
....|.....++.+ .+..+.+. ...|..+.+|+.+.+..+ ++.+...+|.++
T Consensus 268 ~~~~F~~~~~l~~~------------------------~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c 319 (394)
T 4fs7_A 268 GGSLFYNCSGLKKV------------------------IYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESC 319 (394)
T ss_dssp CSCTTTTCTTCCEE------------------------EECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTC
T ss_pred ecccccccccccee------------------------ccCceeec---cccccccccccccccccc-cceechhhhcCC
Confidence 33444444444444 33333221 223444444444444432 333334445555
Q ss_pred cccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccce
Q 039595 534 TELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEK 610 (1078)
Q Consensus 534 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 610 (1078)
.+|+.++|..+ ++.+...+|.++.+|+.+++..| ++.+...+|.++.+|+.+++..+ ++ .+...|.++++|+.
T Consensus 320 ~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 320 TSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp TTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred CCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 55555555433 44344455555555555555544 44444555555556666655543 22 12234555555554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-17 Score=171.02 Aligned_cols=153 Identities=23% Similarity=0.341 Sum_probs=78.1
Q ss_pred CCCCCcEEeccCCcccccCCC------CCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccc
Q 039595 100 SFPHLVNLNLSFNLFFGNIPP------QIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQL 173 (1078)
Q Consensus 100 ~l~~L~~L~L~~n~~~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l 173 (1078)
....++.++|+.+.+.|.+|. .++.+++|++|+|++|++++ +| .++++++|++|+|++|.++ .+|..++.+
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~ 92 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA 92 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence 344555555666666655554 45555555555555555553 44 5555555555555555555 444444444
Q ss_pred cccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCC-CcccCCCCCcEEe
Q 039595 174 SLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIP-CTLDNLSNLDTLF 252 (1078)
Q Consensus 174 ~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~ 252 (1078)
++|++| +|++|++++ +| .++++++|++|+|++|++++..+ ..+..+++|++|+
T Consensus 93 ~~L~~L------------------------~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~ 146 (198)
T 1ds9_A 93 DTLEEL------------------------WISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp HHCSEE------------------------EEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred CcCCEE------------------------ECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEE
Confidence 444444 444444443 22 34445555555555555553221 2445555555555
Q ss_pred ccccccCCCCCc----------ccCCCcccceeeccccccc
Q 039595 253 LYKNSLSGSIPS----------IIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 253 L~~N~l~~~~p~----------~~~~l~~L~~L~Ls~N~l~ 283 (1078)
+++|.+++.+|. .+..+++|+.|| +|.++
T Consensus 147 l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 147 LAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp ECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred ecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 555555444333 255566666665 44444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=9.6e-17 Score=166.07 Aligned_cols=153 Identities=22% Similarity=0.253 Sum_probs=119.1
Q ss_pred CCcccEEeccCCccCCCccc------ccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCccccccc
Q 039595 485 SSKLQFLDLSSNHIVGKIPV------QLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLL 558 (1078)
Q Consensus 485 l~~L~~L~Ls~N~i~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 558 (1078)
...++.++++.|.+.+..|. .+..+++|++|+|++|++++ +| .+..+++|++|+|++|.++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34455555555555555444 78888888888888888886 55 7888888999999999888 5677777788
Q ss_pred ccccccccCcccccccchhhhcccccCeeecCCCccCCcCC-CCcccccccceeeccCccccCCcccc----------cc
Q 039595 559 KLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIP-PQVCNMESLEKLNLSHNNLSGFIPRC----------FE 627 (1078)
Q Consensus 559 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------l~ 627 (1078)
+|++|+|++|+|++ +| .+..+++|+.|+|++|++++..+ ..+..+++|++|++++|++++.+|.. +.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 89999999999875 44 68888999999999999875332 46778899999999999998776653 78
Q ss_pred cCCcCcEEEcccCcCCC
Q 039595 628 KMRSLSCIDICYNELQG 644 (1078)
Q Consensus 628 ~l~~L~~l~l~~N~l~~ 644 (1078)
.+++|+.|| +|+++.
T Consensus 172 ~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 172 RLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HCSSCSEEC--CGGGTT
T ss_pred hCCCcEEEC--CcccCH
Confidence 899999887 777764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.2e-13 Score=159.31 Aligned_cols=327 Identities=13% Similarity=0.063 Sum_probs=142.1
Q ss_pred cccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCccc
Q 039595 193 SLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSL 272 (1078)
Q Consensus 193 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 272 (1078)
.|.++++|+.+.|.. .++.+-..+|.++++|+.++|..+ ++.+....|.++++|+.+.+..+ +...-..+|.+...+
T Consensus 66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~ 142 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFK 142 (394)
T ss_dssp TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCS
T ss_pred HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccccc
Confidence 344444555555432 233233344555555555555433 33333344555555555444432 222223344444332
Q ss_pred ceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCc
Q 039595 273 HQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNN 352 (1078)
Q Consensus 273 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 352 (1078)
+....... ......+|.++.+|+.+.+.++. .......|.++.+|+.+.+..| ++.+....|.++..|+.+.+.++
T Consensus 143 ~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~ 218 (394)
T 4fs7_A 143 EITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNS 218 (394)
T ss_dssp EEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTT
T ss_pred ccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCC
Confidence 22222211 11223345555555555544332 2122344555555655555544 33344455555666665555544
Q ss_pred cCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchh
Q 039595 353 GLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYE 432 (1078)
Q Consensus 353 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 432 (1078)
... +.+......+|+.+.+..+ ++.+....|.++..|+.+.+..+.. ......|..+..++.+.+..+. +...
T Consensus 219 ~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~~---i~~~ 291 (394)
T 4fs7_A 219 LYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSVI---VPEK 291 (394)
T ss_dssp CCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEECSSE---ECTT
T ss_pred ceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc-eeeccccccccccceeccCcee---eccc
Confidence 332 2222333345555555432 2223334455555555555544422 1233344444444444443322 2223
Q ss_pred hccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccC
Q 039595 433 AFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSL 512 (1078)
Q Consensus 433 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L 512 (1078)
+|....+|+.+.+..+ ++.+.. ..|.++.+|+.++|.++ ++.+...+|.++.+|
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~------------------------~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L 345 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGE------------------------EAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSL 345 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECT------------------------TTTTTCTTCCEECCCTT-CCEECTTTTTTCTTC
T ss_pred cccccccccccccccc-cceech------------------------hhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCC
Confidence 3444444444444322 333333 33444444444444322 333344455555555
Q ss_pred cEEeccCCccCCCcccccccccccceeeccCccccCCCCccccccccccc
Q 039595 513 NKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYY 562 (1078)
Q Consensus 513 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 562 (1078)
+.+.+..| ++.+...+|.++.+|+.+++..+ ++ .+..+|.++++|+.
T Consensus 346 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 346 SNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp CEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred CEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 55555444 44344455555555555555543 22 22334555555543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=7.1e-15 Score=148.81 Aligned_cols=105 Identities=21% Similarity=0.236 Sum_probs=50.6
Q ss_pred ccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCC--Ccccccccceee
Q 039595 535 ELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPP--QVCNMESLEKLN 612 (1078)
Q Consensus 535 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~ 612 (1078)
+|++|+|++|.|++. ..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+. +|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEE
Confidence 444444444444432 344444455555555555544333334455555555555555532 222 444555555555
Q ss_pred ccCccccCCccc----ccccCCcCcEEEcccCcCC
Q 039595 613 LSHNNLSGFIPR----CFEKMRSLSCIDICYNELQ 643 (1078)
Q Consensus 613 L~~N~l~~~~~~----~l~~l~~L~~l~l~~N~l~ 643 (1078)
+++|+++.. |. .+..+++|+.||+++|...
T Consensus 120 l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCHH
Confidence 555555532 33 2555555555555555443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.6e-14 Score=146.17 Aligned_cols=131 Identities=21% Similarity=0.256 Sum_probs=75.8
Q ss_pred cCccceeEEEccCccCCCCCCccccccc-ccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCC
Q 039595 147 GKLNQLRRLYLDMNQLHGTIPPVIGQLS-LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLS 225 (1078)
Q Consensus 147 ~~l~~L~~L~L~~n~l~~~~p~~i~~l~-~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 225 (1078)
.++.+|++|++++|+++ .+|. +..+. +|++|++++|.+++. ..++.+++|++|+|++|++++..|..++.+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 33444444444444444 2222 22222 444444444444432 4566667777777777777654444456677777
Q ss_pred eeecCCcccCCCCCC--cccCCCCCcEEeccccccCCCCCcc----cCCCcccceeeccccccc
Q 039595 226 TLDLSQNQLNGLIPC--TLDNLSNLDTLFLYKNSLSGSIPSI----IGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 226 ~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 283 (1078)
+|+|++|+++. +|. .+..+++|++|++++|.++ .+|.. +..+++|++||++.|.+.
T Consensus 92 ~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 77777777754 343 5666777777777777776 34443 667777777777777664
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=8e-14 Score=139.98 Aligned_cols=108 Identities=27% Similarity=0.359 Sum_probs=58.7
Q ss_pred ceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccccccceeeccCc
Q 039595 537 QYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHN 616 (1078)
Q Consensus 537 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 616 (1078)
+.+++++|.++. +|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 444555555542 333332 44555555555555555555555555555555555555544444555556666666666
Q ss_pred cccCCcccccccCCcCcEEEcccCcCCCCCC
Q 039595 617 NLSGFIPRCFEKMRSLSCIDICYNELQGPIP 647 (1078)
Q Consensus 617 ~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~ 647 (1078)
+|++..+..|..+++|+.|+|++|+|++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 6655555555566666666666666655443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=5.8e-13 Score=133.65 Aligned_cols=86 Identities=34% Similarity=0.446 Sum_probs=38.7
Q ss_pred CCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeec
Q 039595 198 SKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDL 277 (1078)
Q Consensus 198 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 277 (1078)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 33444444444444444444444444444444444444443334444444444444444444433334444444444444
Q ss_pred cccccc
Q 039595 278 IENQLS 283 (1078)
Q Consensus 278 s~N~l~ 283 (1078)
++|+++
T Consensus 110 ~~N~~~ 115 (170)
T 3g39_A 110 LNNPWD 115 (170)
T ss_dssp CSSCBC
T ss_pred CCCCCC
Confidence 444444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=9.7e-13 Score=132.48 Aligned_cols=86 Identities=30% Similarity=0.391 Sum_probs=42.1
Q ss_pred CCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeec
Q 039595 198 SKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDL 277 (1078)
Q Consensus 198 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 277 (1078)
++|++|+|++|++++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 44444555555554444444445555555555555555443334444555555555555555433334555555555555
Q ss_pred cccccc
Q 039595 278 IENQLS 283 (1078)
Q Consensus 278 s~N~l~ 283 (1078)
++|.+.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 555544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-12 Score=131.90 Aligned_cols=104 Identities=26% Similarity=0.404 Sum_probs=68.1
Q ss_pred EEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcc
Q 039595 154 RLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQ 233 (1078)
Q Consensus 154 ~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 233 (1078)
.+++++|+++ .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4444444443 4444443 455555555555555556667777777777777777776555566777777777777777
Q ss_pred cCCCCCCcccCCCCCcEEeccccccCC
Q 039595 234 LNGLIPCTLDNLSNLDTLFLYKNSLSG 260 (1078)
Q Consensus 234 l~~~~p~~l~~l~~L~~L~L~~N~l~~ 260 (1078)
|++..+..|..+++|++|+|++|.+..
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred cceeCHHHhccccCCCEEEeCCCCccc
Confidence 776655567777777777777777774
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.2e-11 Score=140.20 Aligned_cols=330 Identities=10% Similarity=0.115 Sum_probs=148.1
Q ss_pred CcccCCCc-ccceeecccccccCccccccccccCCceeeecccC---CCCCCCccccCCCccCeeeccccccCccCCCCC
Q 039595 263 PSIIGNLK-SLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNS---LSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSI 338 (1078)
Q Consensus 263 p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~---l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l 338 (1078)
..+|.+.. .|+.+.+..+ ++.+-..+|.++.+|+.+.+..|. ++..-...|.++.+|+.+.+..+ ++.+....|
T Consensus 56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF 133 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF 133 (394)
T ss_dssp TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence 45566653 4777777643 554555666666666666666553 33233345555555655555433 333444455
Q ss_pred CCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCe
Q 039595 339 GNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKR 418 (1078)
Q Consensus 339 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 418 (1078)
..+.+|+.+.+..+ +.......|..+.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+
T Consensus 134 ~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~------------------ 192 (394)
T 4gt6_A 134 HHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAK------------------ 192 (394)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTT------------------
T ss_pred hhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCc------------------
Confidence 55555555555433 22233334445555555555433 22233333322 33444443322
Q ss_pred EEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCcc
Q 039595 419 VRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHI 498 (1078)
Q Consensus 419 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i 498 (1078)
+..+...+|....+++......+.........+......... ...+.....+..+.+. +.+
T Consensus 193 -------~~~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~ip-~~v 253 (394)
T 4gt6_A 193 -------VTRIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYA-----------LIRYPSQREDPAFKIP-NGV 253 (394)
T ss_dssp -------CCEECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEE-----------EEECCTTCCCSEEECC-TTE
T ss_pred -------ccccccchhhhccccceecccccccccccceeeccccccccc-----------ccccccccccceEEcC-Ccc
Confidence 222333444444444444433332221111111100000000 0001111122222222 122
Q ss_pred CCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhh
Q 039595 499 VGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEF 578 (1078)
Q Consensus 499 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 578 (1078)
+.....+|.++..|+.+.+..+..+ +....|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|
T Consensus 254 ~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF 330 (394)
T 4gt6_A 254 ARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAF 330 (394)
T ss_dssp EEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred eEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHh
Confidence 2233445555555555555444332 344455555666666554 3344444555666666666666543 444455566
Q ss_pred hcccccCeeecCCCccCCcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCc
Q 039595 579 EKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNE 641 (1078)
Q Consensus 579 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~ 641 (1078)
.++.+|+.+.|..+ ++.....+|.++.+|+.+++.+|... -..+....+|+.+.+..|.
T Consensus 331 ~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 331 AGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp TTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC---------
T ss_pred hCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCC
Confidence 66666666666543 44444455666666666666665443 1344555566666655443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.31 E-value=5.7e-11 Score=136.70 Aligned_cols=331 Identities=9% Similarity=0.065 Sum_probs=154.4
Q ss_pred CCcccccC-CCCeeecCCcccCCCCCCcccCCCCCcEEeccccc---cCCCCCcccCCCcccceeecccccccCcccccc
Q 039595 215 PTVMGNLK-SLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNS---LSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSF 290 (1078)
Q Consensus 215 p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 290 (1078)
..+|.+.+ .|+.+.+-.+ ++.+-..+|.++++|+.+.+..|. ++.+-..+|.++.+|+.+.+..+ ++......|
T Consensus 56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF 133 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF 133 (394)
T ss_dssp TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence 34566663 5777777643 555556677777777777777664 44333456666666666665443 333333444
Q ss_pred ccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCe
Q 039595 291 GNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSE 370 (1078)
Q Consensus 291 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 370 (1078)
..+.+|+.+.+ ..+ ++.+....|..+.+|+.+.+.++ +.......|.. .+|+.
T Consensus 134 ~~c~~L~~i~l------------------------p~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~ 186 (394)
T 4gt6_A 134 HHCEELDTVTI------------------------PEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQ 186 (394)
T ss_dssp TTCTTCCEEEC------------------------CTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSE
T ss_pred hhhcccccccc------------------------cce-eeeecccceecccccccccccce-eeEeccccccc-cceeE
Confidence 45555554444 322 22233344455555555555433 22122222322 34555
Q ss_pred EEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCcc
Q 039595 371 LKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNF 450 (1078)
Q Consensus 371 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 450 (1078)
+.+..+-. .....+|.++..+.......+.........+....... .....+.....+..+.+. +.+
T Consensus 187 i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~ip-~~v 253 (394)
T 4gt6_A 187 IHIPAKVT-RIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGD-----------YALIRYPSQREDPAFKIP-NGV 253 (394)
T ss_dssp EEECTTCC-EECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSC-----------EEEEECCTTCCCSEEECC-TTE
T ss_pred EEECCccc-ccccchhhhccccceecccccccccccceeeccccccc-----------ccccccccccccceEEcC-Ccc
Confidence 55543322 23344455555555544433332211100010000000 000001111112222221 122
Q ss_pred CCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCccccc
Q 039595 451 DGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEF 530 (1078)
Q Consensus 451 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 530 (1078)
+.+...+|.+..+|+.+.+..+. .......|.++..|+.+.+. +.++.+...+|.++.+|+.+.+..+ ++.+...+|
T Consensus 254 ~~i~~~aF~~c~~L~~i~lp~~~-~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF 330 (394)
T 4gt6_A 254 ARIETHAFDSCAYLASVKMPDSV-VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAF 330 (394)
T ss_dssp EEECTTTTTTCSSCCEEECCTTC-CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred eEcccceeeecccccEEeccccc-ceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHh
Confidence 22333344444444444443221 12333445555666666664 3344455556666666666666543 444445667
Q ss_pred ccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCcc
Q 039595 531 GSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNIL 594 (1078)
Q Consensus 531 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 594 (1078)
.++.+|+.+.|..+ ++.+...+|.++++|+.+++.+|... ...|.....|+.+.+..|.+
T Consensus 331 ~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 331 AGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC----------
T ss_pred hCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCE
Confidence 77777777777544 55555667777777777777776543 13556666777777766654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=5e-14 Score=160.02 Aligned_cols=141 Identities=20% Similarity=0.190 Sum_probs=71.3
Q ss_pred CcccEEeccCCccCCCccccc-ccCccCcEEeccCCccCCCccccc-----ccccccceeeccCccccCC----CCcccc
Q 039595 486 SKLQFLDLSSNHIVGKIPVQL-EKLFSLNKLILSLNQLSGSVPLEF-----GSLTELQYLDLSANKLSSS----IPKSIG 555 (1078)
Q Consensus 486 ~~L~~L~Ls~N~i~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~~~~~~ 555 (1078)
.+|++|+|++|.|+......+ ..+++|+.|+|++|+|+......+ ...++|++|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 456666666666653332222 234456666666666653333332 2235566666666666532 222234
Q ss_pred cccccccccccCccccccc----chhhhcccccCeeecCCCccCCcCC----CCcccccccceeeccCccccCCccccc
Q 039595 556 NLLKLYYLNLSNNQFSHTI----PIEFEKLIHLSKLDLSHNILQEEIP----PQVCNMESLEKLNLSHNNLSGFIPRCF 626 (1078)
Q Consensus 556 ~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~l 626 (1078)
.+++|++|+|++|+|++.. +..+...++|++|+|++|.|++... ..+...++|++|+|++|+|+......+
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 4556666666666665422 3334455566666666666654221 122234556666666666554443333
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=1.3e-13 Score=156.63 Aligned_cols=160 Identities=21% Similarity=0.241 Sum_probs=124.8
Q ss_pred CCcccEEeccCCccCCCcccccccC-----ccCcEEeccCCccCCCccccc-ccccccceeeccCccccCCCCcccc---
Q 039595 485 SSKLQFLDLSSNHIVGKIPVQLEKL-----FSLNKLILSLNQLSGSVPLEF-GSLTELQYLDLSANKLSSSIPKSIG--- 555 (1078)
Q Consensus 485 l~~L~~L~Ls~N~i~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~--- 555 (1078)
++.|+.|+|++|.|+......+... .+|+.|+|++|.|+......+ ..+++|+.|+|++|.|++.....+.
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3579999999999986554444433 699999999999975443333 4568899999999999865555553
Q ss_pred --cccccccccccCcccccc----cchhhhcccccCeeecCCCccCCcC----CCCcccccccceeeccCccccCC----
Q 039595 556 --NLLKLYYLNLSNNQFSHT----IPIEFEKLIHLSKLDLSHNILQEEI----PPQVCNMESLEKLNLSHNNLSGF---- 621 (1078)
Q Consensus 556 --~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~---- 621 (1078)
..++|++|+|++|+|+.. ++..+..+++|++|||++|.|++.. ...+...++|++|+|++|.|+..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 357899999999999753 3444577899999999999997632 34566778999999999999864
Q ss_pred cccccccCCcCcEEEcccCcCCC
Q 039595 622 IPRCFEKMRSLSCIDICYNELQG 644 (1078)
Q Consensus 622 ~~~~l~~l~~L~~l~l~~N~l~~ 644 (1078)
+...+...++|++|||++|+++.
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHHhCCCCCEEeccCCCCCH
Confidence 34455667999999999999874
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=8.7e-12 Score=141.02 Aligned_cols=102 Identities=24% Similarity=0.196 Sum_probs=53.0
Q ss_pred EeccCC-ccCCCcccccccCccCcEEeccC-CccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCc
Q 039595 491 LDLSSN-HIVGKIPVQLEKLFSLNKLILSL-NQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNN 568 (1078)
Q Consensus 491 L~Ls~N-~i~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 568 (1078)
++++++ +|++ +|. +..+++|+.|+|++ |+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455555 5553 344 55555555555553 5555444455555555555555555555555555555555555555555
Q ss_pred ccccccchhhhcccccCeeecCCCccC
Q 039595 569 QFSHTIPIEFEKLIHLSKLDLSHNILQ 595 (1078)
Q Consensus 569 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 595 (1078)
+|++..+..|..+. |+.|+|++|.+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 55544444444333 555555555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.20 E-value=2.5e-11 Score=137.31 Aligned_cols=92 Identities=24% Similarity=0.240 Sum_probs=46.5
Q ss_pred ccCcccCCCCCcEEEccC-CCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCC
Q 039595 190 IPSSLGNLSKLALLYLNN-NSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGN 268 (1078)
Q Consensus 190 ~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 268 (1078)
+|. |+.+++|+.|+|++ |+|++..|..|++|++|++|+|++|+|++..|..|.+|++|++|+|++|+|++.++..|..
T Consensus 24 ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 102 (347)
T 2ifg_A 24 LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG 102 (347)
T ss_dssp TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS
T ss_pred cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHccc
Confidence 444 44445555555553 5554444444555555555555555555554545555555555555555555444444444
Q ss_pred Ccccceeeccccccc
Q 039595 269 LKSLHQLDLIENQLS 283 (1078)
Q Consensus 269 l~~L~~L~Ls~N~l~ 283 (1078)
++ |+.|+|++|.+.
T Consensus 103 ~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 103 LS-LQELVLSGNPLH 116 (347)
T ss_dssp CC-CCEEECCSSCCC
T ss_pred CC-ceEEEeeCCCcc
Confidence 33 555555555554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=7.7e-11 Score=127.50 Aligned_cols=148 Identities=13% Similarity=0.025 Sum_probs=114.9
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecC
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNA 823 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 823 (1078)
.+....+.|+.....+.|+++.||++... ++.+++|+....... ....+.+|+.+++.+. +..+.++++++.+.
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~----~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~ 82 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC----CHHHHHHHHHHHHHHhcCCCCCeEEEEEecC
Confidence 34445567888888999999999999754 789999998653211 1234778888888884 67788999999888
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC----------------------------- 874 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------- 874 (1078)
+..|+||||++|.++.+... +..+...++.+++++++.||+..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred CceEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence 99999999999999987641 11233468899999999999810
Q ss_pred ---------------------------CCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 875 ---------------------------LPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 875 ---------------------------~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.+.++|||++|.||+++.++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876667899998875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.08 E-value=4.8e-09 Score=119.94 Aligned_cols=316 Identities=9% Similarity=0.027 Sum_probs=138.2
Q ss_pred CcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCc
Q 039595 240 CTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKS 319 (1078)
Q Consensus 240 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~ 319 (1078)
+++....+|+.+.+.. .++.+-..+|.++.+|+.++|..+ ++.+-..+|.++ +|+.+.+..+ ++......|.+ .+
T Consensus 40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~ 114 (379)
T 4h09_A 40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TD 114 (379)
T ss_dssp TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CC
T ss_pred cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CC
Confidence 3566667788887764 355444567888888888888654 554555566665 4555544322 32222223333 24
Q ss_pred cCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeeccc
Q 039595 320 LSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCE 399 (1078)
Q Consensus 320 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 399 (1078)
|+.+.+..+ ++......|.+. +|+.+.+..+ ++......|....+++.+.+..+.........+. .
T Consensus 115 L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~-~---------- 180 (379)
T 4h09_A 115 LDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVL-Y---------- 180 (379)
T ss_dssp CSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEE-E----------
T ss_pred cccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeeccccee-c----------
Confidence 555555433 222222333332 3333333322 2212233344444444444433322111000000 0
Q ss_pred CcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCC
Q 039595 400 NHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479 (1078)
Q Consensus 400 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~ 479 (1078)
+. .......+.....+..+.+.. ....+....|....+|+.+.+..+ +..+...+|
T Consensus 181 ~~-~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f--------------------- 236 (379)
T 4h09_A 181 NK-NKTILESYPAAKTGTEFTIPS-TVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAF--------------------- 236 (379)
T ss_dssp ET-TSSEEEECCTTCCCSEEECCT-TCCEECTTTTTTCSSCSEEECCTT-CCEECTTTT---------------------
T ss_pred cc-ccceecccccccccccccccc-ceeEEeecccccccccceeeeccc-eeEEccccc---------------------
Confidence 00 001111222222333332221 122233334444444554444332 233333334
Q ss_pred ccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccc
Q 039595 480 LEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLK 559 (1078)
Q Consensus 480 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 559 (1078)
.++..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.+....|.++.+|+.+++.++.++.+...+|.++.+
T Consensus 237 ---~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~ 311 (379)
T 4h09_A 237 ---YGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK 311 (379)
T ss_dssp ---TTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred ---cCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCC
Confidence 44444444444433 33333444444555555554332 33233344555555555555555554444455555555
Q ss_pred cccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCcccc
Q 039595 560 LYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNM 605 (1078)
Q Consensus 560 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 605 (1078)
|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.....+|.++
T Consensus 312 L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 312 LSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred CCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 555555433 44344455555555555555443 443334445444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.01 E-value=2e-08 Score=114.77 Aligned_cols=131 Identities=15% Similarity=0.139 Sum_probs=62.0
Q ss_pred CCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccC
Q 039595 335 PPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLT 414 (1078)
Q Consensus 335 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 414 (1078)
...+..+.+|+.+.+..+ +.......+..+.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ +......+|.+++
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence 344455555555555433 22233344555555555555443 44344445555555555555332 3333334455555
Q ss_pred CCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecc
Q 039595 415 SLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIV 469 (1078)
Q Consensus 415 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 469 (1078)
+|+.+.+.++.+..+...+|.++.+|+.++|..+ ++.+...+|.++.+|+++.+
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 5555555555555555555555555555555432 44444444444444444433
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.99 E-value=3.8e-12 Score=135.57 Aligned_cols=123 Identities=11% Similarity=0.057 Sum_probs=57.9
Q ss_pred CCCcccceEeeCCCCeEEEeccCc---cccCCcccCCccCCCCCCcEEeccCCcccccCCC-CCCCCCCcce--eccCCC
Q 039595 63 SPCSWFGISCNHAGSRVISINLST---LCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPP-QIGNLSKLQN--LDLGNN 136 (1078)
Q Consensus 63 ~~c~w~gv~C~~~~~~v~~l~l~~---~~l~g~~~~~~~~~l~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~--L~Ls~n 136 (1078)
..|.|.|+.|+..+.+|+.+...+ ..+.|.+.+..+..++. .|...+|...+.++- .+...+.|+. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 358999999997766776555443 23334443222222221 122233333332221 1334444554 555555
Q ss_pred ccC---CCCCccccCccceeEEEccCccCCC--CCCcccccccccceeeccccccc
Q 039595 137 QLS---GVISPEIGKLNQLRRLYLDMNQLHG--TIPPVIGQLSLIHEFSFCHNNVS 187 (1078)
Q Consensus 137 ~l~---~~~p~~~~~l~~L~~L~L~~n~l~~--~~p~~i~~l~~L~~L~l~~n~~~ 187 (1078)
... +.++....++++|+.|+|++|+|++ .+|..++.+++|+.|+|++|.++
T Consensus 154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~ 209 (267)
T 3rw6_A 154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 209 (267)
T ss_dssp SHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred HHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence 322 1111112345666666666666664 33344444444444444444444
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.96 E-value=5.1e-10 Score=120.79 Aligned_cols=137 Identities=15% Similarity=0.090 Sum_probs=99.8
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc--eeeEEeeeecCCeeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN--IVKFHGFCSNARHSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~l 828 (1078)
..|......+.|..+.||++...+|+.+++|+.... ....+..|+.+++.+.+.+ +.+++++...++..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 345443333466679999998777888999997543 1234667888888875434 5668888888888999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC---------------------------------- 874 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------- 874 (1078)
||||++|.++. ... .+ ...++.++++.+..||+..
T Consensus 93 v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999998873 211 11 2357778888888888742
Q ss_pred ---------------------CCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 875 ---------------------LPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 875 ---------------------~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
...++|||++|.||+++.++.+.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667899999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=6.8e-09 Score=117.68 Aligned_cols=144 Identities=15% Similarity=0.226 Sum_probs=107.1
Q ss_pred CccceeccCCceeEEEEEeCCCCEEEEEEec--cccccCChhhHHHHHHHHHHHhcCC--CCceeeEEeeeecC---Cee
Q 039595 754 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFN--SQLLSGNMADQDEFLNVVLALNEIR--HRNIVKFHGFCSNA---RHS 826 (1078)
Q Consensus 754 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~ 826 (1078)
...+.++.|.++.||++... +..+++|+.. .... ......+.+|+.+++.+. +..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34667999999999999875 4678888865 3211 112345778888888886 45688899988766 458
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC-------------------------------- 874 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------- 874 (1078)
|+||||++|..+.+.. ...++..+...++.+++++|+.||+..
T Consensus 117 ~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 9999999997774321 234678888999999999999999831
Q ss_pred -----------------------CCCcEecCCCCCCeeeCCCCc--EEEeccccccc
Q 039595 875 -----------------------LPSIIHRDISSKNVLLDLEFE--AHVSDFGIAKF 906 (1078)
Q Consensus 875 -----------------------~~~ivH~Dlk~~NIll~~~~~--~kl~DfG~a~~ 906 (1078)
.+.++|||+++.||+++.++. +.|.||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246899999999999997753 68999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.81 E-value=1.9e-09 Score=121.07 Aligned_cols=85 Identities=15% Similarity=0.228 Sum_probs=48.2
Q ss_pred cccccceeeccCccccCCCCcccc---cccccccccccCccccccc----chhhhcccccCeeecCCCccCCcCCCCccc
Q 039595 532 SLTELQYLDLSANKLSSSIPKSIG---NLLKLYYLNLSNNQFSHTI----PIEFEKLIHLSKLDLSHNILQEEIPPQVCN 604 (1078)
Q Consensus 532 ~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 604 (1078)
.+++|++|+|++|.+.+..+..+. .+++|++|+|+.|.|++.. +..+..+++|+.|+|++|.|+......+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 356677777777666543322222 3567777777777776532 223345677777777777776433222222
Q ss_pred ccccceeeccCcc
Q 039595 605 MESLEKLNLSHNN 617 (1078)
Q Consensus 605 l~~L~~L~L~~N~ 617 (1078)
.- ...+++++|+
T Consensus 330 al-g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL-PMKIDVSDSQ 341 (362)
T ss_dssp HC-CSEEECCSBC
T ss_pred Hc-CCEEEecCCc
Confidence 00 2457777776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.79 E-value=9.7e-10 Score=123.54 Aligned_cols=211 Identities=14% Similarity=0.209 Sum_probs=102.6
Q ss_pred CCcceeccCCCccCC-CC-------CccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCC
Q 039595 126 SKLQNLDLGNNQLSG-VI-------SPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNL 197 (1078)
Q Consensus 126 ~~L~~L~Ls~n~l~~-~~-------p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l 197 (1078)
++++.|.+......| .. ..++.++++|+.|.+..+..... .++... .+.++..+..+
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~--------------~is~~~-~~~L~~ll~~~ 171 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQ--------------EISWIE-QVDLSPVLDAM 171 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTC--------------CGGGCB-CCBCHHHHHTC
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhc--------------cccccc-ccCHHHHHhcC
Confidence 456677776655442 11 23455667777777765432100 000000 01233344556
Q ss_pred CCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCccc--CCCCCcEEeccc--cccCCC-----CCccc--
Q 039595 198 SKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLD--NLSNLDTLFLYK--NSLSGS-----IPSII-- 266 (1078)
Q Consensus 198 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~L~~--N~l~~~-----~p~~~-- 266 (1078)
++|+.|+|++|.-. .++. + .+++|+.|+|..|.++......+. .+++|+.|+|+. |...+. +...+
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 66777777665311 1222 2 256666666666665532222222 456666666642 211111 00111
Q ss_pred CCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCcc----CCCCCCCCC
Q 039595 267 GNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGV----IPPSIGNLS 342 (1078)
Q Consensus 267 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~ 342 (1078)
..+++|++|+|++|.+.+..+..+.. ...+++|++|+|+.|.+++. ++..+..++
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~---------------------a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~ 307 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLE---------------------SDILPQLETMDISAGVLTDEGARLLLDHVDKIK 307 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHH---------------------CSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHT
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHh---------------------CccCCCCCEEECCCCCCChHHHHHHHhhcccCC
Confidence 13455555655555554322211110 02356677777777776642 233445567
Q ss_pred cCcEEEccCccCCCCCCccccc-cCCCCeEEccccc
Q 039595 343 SLRNLSLFNNGLYGSIPEEIGY-LKSLSELKLCKNN 377 (1078)
Q Consensus 343 ~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~ 377 (1078)
+|+.|+|++|.+++..-..+.. + ...++++.++
T Consensus 308 ~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 308 HLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp TCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred cceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 7788888877776443333332 2 3557777776
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.72 E-value=5.2e-09 Score=115.64 Aligned_cols=182 Identities=21% Similarity=0.220 Sum_probs=122.7
Q ss_pred cceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCc--eeeEEeeeecCC---eeEEE
Q 039595 756 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRN--IVKFHGFCSNAR---HSFLV 829 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv 829 (1078)
.+.++.|.+..||++. +.+++|+.... .....+.+|..+++.+ .+.. +.+++.....+. ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999863 45889985432 2356788899998877 3322 445555544333 45899
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC----------------------------------- 874 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------- 874 (1078)
||+++|.++.+... ..++.+++..++.++++.++.||+..
T Consensus 95 m~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 99999988765331 34677888889999999999999611
Q ss_pred --------------------CCCcEecCCCCCCeeeCC--CCcEEEecccccccccCCCCCceeecccccc---cccccc
Q 039595 875 --------------------LPSIIHRDISSKNVLLDL--EFEAHVSDFGIAKFVEPYSSNRTEFVGTFGY---AAPEIA 929 (1078)
Q Consensus 875 --------------------~~~ivH~Dlk~~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y---~aPE~~ 929 (1078)
.+.++|+|++|.||+++. ++.+.++||+.+...+... .......+ ..|+..
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~----Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN----DFISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH----HHHTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH----HHHHHHhhccccCHHHH
Confidence 135799999999999998 4568899999987543211 00111111 222211
Q ss_pred cc-----C---------CCCccchhHHHHHHHHHHHhCCCC
Q 039595 930 YT-----M---------RATEKYDVYSFGVLVFEVIKGNHP 956 (1078)
Q Consensus 930 ~~-----~---------~~~~~sDvwSlG~il~elltG~~p 956 (1078)
.. + ......+.|++|.++|.+.+|+.+
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence 10 0 012236899999999999999988
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.45 E-value=2.7e-08 Score=105.87 Aligned_cols=80 Identities=31% Similarity=0.365 Sum_probs=50.9
Q ss_pred ccccccccccccCccccc--ccchhhhcccccCeeecCCCccCCcCCCCccccc--ccceeeccCccccCCcc-------
Q 039595 555 GNLLKLYYLNLSNNQFSH--TIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNME--SLEKLNLSHNNLSGFIP------- 623 (1078)
Q Consensus 555 ~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~------- 623 (1078)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|++.+..|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 345667777777777765 2345566777777777777777653 2333344 77777777777775444
Q ss_pred cccccCCcCcEEE
Q 039595 624 RCFEKMRSLSCID 636 (1078)
Q Consensus 624 ~~l~~l~~L~~l~ 636 (1078)
..+..+|+|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 2356777777665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.41 E-value=2e-08 Score=101.78 Aligned_cols=17 Identities=18% Similarity=0.319 Sum_probs=8.4
Q ss_pred cCCCcccEEeccCC-ccC
Q 039595 483 GDSSKLQFLDLSSN-HIV 499 (1078)
Q Consensus 483 ~~l~~L~~L~Ls~N-~i~ 499 (1078)
...++|++|+|++| .|.
T Consensus 33 ~~~~~L~~L~L~~n~~i~ 50 (185)
T 1io0_A 33 NNDPDLEEVNLNNIMNIP 50 (185)
T ss_dssp TTCTTCCEEECTTCTTCC
T ss_pred hcCCCCCEEEecCCCCCC
Confidence 33445555555555 444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.40 E-value=5e-08 Score=98.85 Aligned_cols=116 Identities=11% Similarity=0.085 Sum_probs=66.6
Q ss_pred cccccCccCcEEeccCC-ccCCC----cccccccccccceeeccCccccCCC----CcccccccccccccccCcccccc-
Q 039595 504 VQLEKLFSLNKLILSLN-QLSGS----VPLEFGSLTELQYLDLSANKLSSSI----PKSIGNLLKLYYLNLSNNQFSHT- 573 (1078)
Q Consensus 504 ~~~~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~- 573 (1078)
..+...+.|++|+|++| .|... +...+...++|++|+|++|.|.... ...+...++|++|+|++|+|++.
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34455566777777776 66532 2334445566777777777665432 22333445677777777776543
Q ss_pred ---cchhhhcccccCeeec--CCCccCCcCC----CCcccccccceeeccCcccc
Q 039595 574 ---IPIEFEKLIHLSKLDL--SHNILQEEIP----PQVCNMESLEKLNLSHNNLS 619 (1078)
Q Consensus 574 ---~~~~~~~l~~L~~L~L--s~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~ 619 (1078)
+...+...+.|++|+| ++|.|+.... ..+...++|++|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2334555566777777 6677654322 22333466777777777764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=5.8e-06 Score=89.31 Aligned_cols=134 Identities=16% Similarity=0.164 Sum_probs=97.8
Q ss_pred eeccCCce-eEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCeeEEEEeecC
Q 039595 758 CIGKGGQG-SVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 758 ~lG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
.+..|..| .||+.... ++..+++|+-... ....+..|...++.+. +--|.++++++.+++..++|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 45556665 68988654 4667999986432 2456778888888773 3347788999998999999999999
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC---------------------------------------- 874 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------- 874 (1078)
|.++.+.... ...+...++.+++..+..||...
T Consensus 104 G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 104 GKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp SEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9888776521 11334456777777777777531
Q ss_pred ---------------CCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 875 ---------------LPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 875 ---------------~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1136899999999999988777899999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.2e-05 Score=88.52 Aligned_cols=137 Identities=18% Similarity=0.134 Sum_probs=97.0
Q ss_pred cceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCC---ceeeEEeeee-cCCeeEEEEe
Q 039595 756 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR---NIVKFHGFCS-NARHSFLVCE 831 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E 831 (1078)
.+.++.|....||+. |+.+++|+... ......+..|..+++.+.+. .|.+.+.++. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456889999999998 56788888422 22356788999999998642 3667777764 4566789999
Q ss_pred ecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 039595 832 YLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD-------------------------------------- 873 (1078)
Q Consensus 832 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------- 873 (1078)
|++|..+.+... ..++..+...++.++++.|+.||+.
T Consensus 94 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 94 KVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred ccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 999988866321 1234555666666666666666643
Q ss_pred -------------------CCCCcEecCCCCCCeeeCC---CCc-EEEecccccccc
Q 039595 874 -------------------CLPSIIHRDISSKNVLLDL---EFE-AHVSDFGIAKFV 907 (1078)
Q Consensus 874 -------------------~~~~ivH~Dlk~~NIll~~---~~~-~kl~DfG~a~~~ 907 (1078)
..+.++|+|+++.||+++. ++. +.|+||+.+..-
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999987 455 589999988643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.81 E-value=3.3e-06 Score=83.10 Aligned_cols=83 Identities=12% Similarity=0.089 Sum_probs=46.8
Q ss_pred ccceeeccCccccCCCCcccccccccccccccCcc-cccccchhhhcc----cccCeeecCCC-ccCCcCCCCccccccc
Q 039595 535 ELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQ-FSHTIPIEFEKL----IHLSKLDLSHN-ILQEEIPPQVCNMESL 608 (1078)
Q Consensus 535 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N-~l~~~~~~~~~~l~~L 608 (1078)
+|+.|||+++.|+...-..+..+++|++|+|++|. |++..-..+..+ ++|+.|+|+++ +|++.--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45666666666555444555556666666666663 554444444443 35666666665 3555433445556666
Q ss_pred ceeeccCcc
Q 039595 609 EKLNLSHNN 617 (1078)
Q Consensus 609 ~~L~L~~N~ 617 (1078)
++|+|++++
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666664
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.71 E-value=8.4e-06 Score=80.24 Aligned_cols=83 Identities=17% Similarity=0.173 Sum_probs=43.8
Q ss_pred CcccEEeccCCccCCCcccccccCccCcEEeccCCc-cCCCcccccccc----cccceeeccCcc-ccCCCCcccccccc
Q 039595 486 SKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQ-LSGSVPLEFGSL----TELQYLDLSANK-LSSSIPKSIGNLLK 559 (1078)
Q Consensus 486 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~ 559 (1078)
..|+.||++++.|+...-..+.++++|+.|+|+++. |++..-..+..+ ++|++|+|++|. |++..-..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 457777777777765555555666666666666663 543322333332 245555555543 44333333444445
Q ss_pred cccccccCc
Q 039595 560 LYYLNLSNN 568 (1078)
Q Consensus 560 L~~L~Ls~N 568 (1078)
|++|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 555555544
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00014 Score=81.96 Aligned_cols=83 Identities=4% Similarity=-0.040 Sum_probs=53.9
Q ss_pred ccee-ccCCceeEEEEEeC-------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-C--CceeeEEeeeecC-
Q 039595 756 KFCI-GKGGQGSVYKAELP-------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-H--RNIVKFHGFCSNA- 823 (1078)
Q Consensus 756 ~~~l-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~- 823 (1078)
.+.| +.|....+|+.... +++.+++|+........ ......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~-~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVP-VFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCC-SSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccc-cCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 4567 88999999998654 26688999865432000 000123566777777663 2 3577788877655
Q ss_pred --CeeEEEEeecCCCCHH
Q 039595 824 --RHSFLVCEYLHRGSLA 839 (1078)
Q Consensus 824 --~~~~lv~E~~~~g~L~ 839 (1078)
+..++||||++|..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 4578999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00011 Score=84.12 Aligned_cols=79 Identities=14% Similarity=-0.064 Sum_probs=49.1
Q ss_pred cceeccCCceeEEEEEeC-CCCEEEEEEeccccc-c--CChhhHHHHHHHHHHHhcCCC--C-ceeeEEeeeecCCeeEE
Q 039595 756 KFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLL-S--GNMADQDEFLNVVLALNEIRH--R-NIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~--~~~~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l 828 (1078)
.+.+|.|.++.||++... +++.|+||....... . ......+.+..|.++++.+.. | .+.+++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 467999999999999654 468899998654221 0 001123445667777776632 3 445666543 345689
Q ss_pred EEeecCCC
Q 039595 829 VCEYLHRG 836 (1078)
Q Consensus 829 v~E~~~~g 836 (1078)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.62 E-value=8.5e-05 Score=83.04 Aligned_cols=140 Identities=18% Similarity=0.242 Sum_probs=77.6
Q ss_pred ceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-----CCCceeeEE-e--eeecCCeeEE
Q 039595 757 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-----RHRNIVKFH-G--FCSNARHSFL 828 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~l 828 (1078)
+.|+.|..+.||++...+| .+++|+.... ...+..|..+++.+ ..|.++... | +...++..++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP--------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC--------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC--------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 4566678899999977654 5899988642 12223344444333 234433311 1 1234667899
Q ss_pred EEeecCCCCHH-----------HH---hcC---CC--CC------CcCCHHH----------------------------
Q 039595 829 VCEYLHRGSLA-----------RI---LGN---DA--TA------KELSWNR---------------------------- 855 (1078)
Q Consensus 829 v~E~~~~g~L~-----------~~---l~~---~~--~~------~~l~~~~---------------------------- 855 (1078)
||||++|..+. +. ++. .. .. ....|..
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986542 11 111 00 00 0012211
Q ss_pred ---HHHHHHHHHHHHHHHHh----------cCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 856 ---RINVIKGVANALSYLHH----------DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 856 ---~~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
...+..++..+++++++ ...+.++|||+++.||+++.++.+.|+||+.+.
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 01112234445666653 123489999999999999888899999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00056 Score=74.73 Aligned_cols=77 Identities=19% Similarity=0.145 Sum_probs=60.6
Q ss_pred CccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC---CCceeeEEeeeecCCeeEEEE
Q 039595 754 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR---HRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 754 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 830 (1078)
...+.|+.|....+|+... ++..+++|+.... ....+..|.+.++.+. ...+++++.+....+..++||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3456799999999999976 4678899986532 2556788888888773 356888999888888999999
Q ss_pred eecCCCCH
Q 039595 831 EYLHRGSL 838 (1078)
Q Consensus 831 E~~~~g~L 838 (1078)
||+++..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00085 Score=77.20 Aligned_cols=77 Identities=14% Similarity=0.147 Sum_probs=47.5
Q ss_pred CCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCceeecc--ccccccccccccC---CCCccchhHHHHHHHHHH
Q 039595 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVG--TFGYAAPEIAYTM---RATEKYDVYSFGVLVFEV 950 (1078)
Q Consensus 876 ~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDvwSlG~il~el 950 (1078)
+.++|||+++.||+++.++ ++++||+.+..-...... ....+ ...|++|+..... ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999998877 999999998753321100 00011 1346666654321 112234555777777877
Q ss_pred HhCC
Q 039595 951 IKGN 954 (1078)
Q Consensus 951 ltG~ 954 (1078)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.33 E-value=6.4e-05 Score=75.40 Aligned_cols=63 Identities=14% Similarity=0.173 Sum_probs=29.6
Q ss_pred CCcccEEeccCC-ccCCC----cccccccCccCcEEeccCCccCCC----cccccccccccceeeccCcccc
Q 039595 485 SSKLQFLDLSSN-HIVGK----IPVQLEKLFSLNKLILSLNQLSGS----VPLEFGSLTELQYLDLSANKLS 547 (1078)
Q Consensus 485 l~~L~~L~Ls~N-~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 547 (1078)
-+.|++|+|++| +|... +...+..-+.|+.|+|++|+|.+. +...+..-+.|+.|+|++|.|.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 345666666653 55422 223333344555555555555422 2223333445555555555554
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.21 E-value=4.8e-05 Score=76.31 Aligned_cols=67 Identities=16% Similarity=0.145 Sum_probs=38.8
Q ss_pred cccCccCcEEeccCC-ccCCC----cccccccccccceeeccCccccCCCCcc----cccccccccccccCccccc
Q 039595 506 LEKLFSLNKLILSLN-QLSGS----VPLEFGSLTELQYLDLSANKLSSSIPKS----IGNLLKLYYLNLSNNQFSH 572 (1078)
Q Consensus 506 ~~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~ 572 (1078)
+.+-+.|++|+|++| +|... +...+..-+.|+.|+|++|.|.+..... +..-+.|++|+|++|+|+.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 344457777787774 66532 2334555566777777777776433322 3344566666666666654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00065 Score=73.72 Aligned_cols=80 Identities=18% Similarity=0.208 Sum_probs=56.6
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-C--CceeeEEeeeecCCeeE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-H--RNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~ 827 (1078)
.+..-++.+|.|..+.||+.+..+|+.|++|+-.... ......|..|...++.+. . --+.+++++. ..+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA----PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC----CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC----cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 3455677899999999999999999999999865432 222345778888888773 2 2345555542 347
Q ss_pred EEEeecCCCCH
Q 039595 828 LVCEYLHRGSL 838 (1078)
Q Consensus 828 lv~E~~~~g~L 838 (1078)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00092 Score=62.65 Aligned_cols=60 Identities=18% Similarity=0.251 Sum_probs=42.6
Q ss_pred CeeecCCCccC-CcCCCCcccccccceeeccCccccCCcccccccCCcCcEEEcccCcCCCCC
Q 039595 585 SKLDLSHNILQ-EEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPI 646 (1078)
Q Consensus 585 ~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~ 646 (1078)
..++.+++.|+ ..+|..+ .++|++|+|++|+|+.+.+..|..+++|+.|+|++|+|.+..
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC 71 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDC 71 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSG
T ss_pred CEEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccC
Confidence 36777777775 2345433 236788888888888777777888888888888888887643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0079 Score=66.36 Aligned_cols=158 Identities=13% Similarity=0.125 Sum_probs=88.0
Q ss_pred ccHHHHHHhhcCCCc-----cceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCC--ce
Q 039595 741 IMHEEIIKATDDFDE-----KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR--NI 813 (1078)
Q Consensus 741 ~~~~~~~~~~~~~~~-----~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--ni 813 (1078)
.+.+++......|.. ...++ |....||++...+|+.+++|+..... ...+.+..|..+++.+... .+
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-----~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-----WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-----CCHHHHHHHHHHHHHHHHcCCee
Confidence 455666655554432 34566 88889999877777789999986321 1234555677766665321 23
Q ss_pred eeEEee-----eecCCeeEEEEeecCCCCHH-----------HHh---c----CCC--CCCcCCHHHH----HHH-----
Q 039595 814 VKFHGF-----CSNARHSFLVCEYLHRGSLA-----------RIL---G----NDA--TAKELSWNRR----INV----- 859 (1078)
Q Consensus 814 v~l~~~-----~~~~~~~~lv~E~~~~g~L~-----------~~l---~----~~~--~~~~l~~~~~----~~i----- 859 (1078)
++++.. ...++..++||||++|..+. +.+ + ... .....++... ..+
T Consensus 85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 444432 12345668899999875431 111 1 000 0111222211 001
Q ss_pred ----------HHHHHHHHHHHHhc----CCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 860 ----------IKGVANALSYLHHD----CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 860 ----------~~~i~~~L~~LH~~----~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
...+...++.+... ....++|||+++.||+++ + .+.++||+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 223688999999999999 4 899999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0026 Score=70.57 Aligned_cols=31 Identities=35% Similarity=0.416 Sum_probs=27.3
Q ss_pred CCcEecCCCCCCeeeCCC----CcEEEeccccccc
Q 039595 876 PSIIHRDISSKNVLLDLE----FEAHVSDFGIAKF 906 (1078)
Q Consensus 876 ~~ivH~Dlk~~NIll~~~----~~~kl~DfG~a~~ 906 (1078)
+.++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999875 6899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.61 E-value=0.022 Score=62.55 Aligned_cols=158 Identities=13% Similarity=0.161 Sum_probs=85.8
Q ss_pred ccHHHHHHhhcCCCc-----cceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc--e
Q 039595 741 IMHEEIIKATDDFDE-----KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN--I 813 (1078)
Q Consensus 741 ~~~~~~~~~~~~~~~-----~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--i 813 (1078)
++.+++.....+|.. .+.|+.|....+|+....+| .+++|+..... ..+.+..|..+++.+.... +
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~v 79 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSC 79 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCC
Confidence 455666666666654 34577788899999977655 68899876521 1123344555555542111 2
Q ss_pred eeEEee------eecCCeeEEEEeecCCCCHHH-----------H---hcC---CCCCC---cC---CHHHHHH------
Q 039595 814 VKFHGF------CSNARHSFLVCEYLHRGSLAR-----------I---LGN---DATAK---EL---SWNRRIN------ 858 (1078)
Q Consensus 814 v~l~~~------~~~~~~~~lv~E~~~~g~L~~-----------~---l~~---~~~~~---~l---~~~~~~~------ 858 (1078)
.+++.. ....+..+++++|++|..+.. . ++. ..... .. .|.....
T Consensus 80 P~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~ 159 (322)
T 2ppq_A 80 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA 159 (322)
T ss_dssp CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred CcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence 333321 123456789999999865311 0 111 00000 01 1211100
Q ss_pred ------HHHHHHHHHHHHHhc----CCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 859 ------VIKGVANALSYLHHD----CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 859 ------i~~~i~~~L~~LH~~----~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
+...+...++++++. ...+++|+|+.+.||+++.++.+.++||+.+.
T Consensus 160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 12478999999999999887667899998775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0055 Score=66.80 Aligned_cols=74 Identities=11% Similarity=0.112 Sum_probs=43.1
Q ss_pred CCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCce-eeEEeeeecCCeeEEEEe
Q 039595 753 FDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI-VKFHGFCSNARHSFLVCE 831 (1078)
Q Consensus 753 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E 831 (1078)
+.-.+.|+.|....+|++ +.+++|+..... . ...+ ..+|..+++.+...++ .++++++. +.-++|+|
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~-~~~~---r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e 87 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGT-E-EYIN---RANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTR 87 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC------CCC---HHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEE
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCc-c-ceeC---HHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEe
Confidence 333678999999999998 558888875421 1 0111 2345555555532222 45665543 33478999
Q ss_pred ec-CCCCH
Q 039595 832 YL-HRGSL 838 (1078)
Q Consensus 832 ~~-~~g~L 838 (1078)
|+ +|.++
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 55443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0047 Score=57.78 Aligned_cols=55 Identities=31% Similarity=0.344 Sum_probs=24.5
Q ss_pred EEEccCCCCC-CCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEecccccc
Q 039595 202 LLYLNNNSLF-GYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSL 258 (1078)
Q Consensus 202 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 258 (1078)
.++.+++.++ ..+|..+. ++|++|+|++|+|+.+.+..|..+++|++|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555553 23343221 2344555555555444444444444444444444433
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0044 Score=71.14 Aligned_cols=73 Identities=15% Similarity=0.172 Sum_probs=48.4
Q ss_pred cceeccCCceeEEEEEeCC--------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc-eeeEEeeeecCCee
Q 039595 756 KFCIGKGGQGSVYKAELPS--------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN-IVKFHGFCSNARHS 826 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~ 826 (1078)
.+.|+.|....||++...+ ++.|++|+..... ..+.+..|..+++.+...+ ..++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~------~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE------TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC------CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC------cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 4568889999999997653 5789999874311 1134456887777774223 3667776653
Q ss_pred EEEEeecCCCCH
Q 039595 827 FLVCEYLHRGSL 838 (1078)
Q Consensus 827 ~lv~E~~~~g~L 838 (1078)
.+|+||++|.++
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.08 E-value=0.016 Score=64.91 Aligned_cols=141 Identities=15% Similarity=0.197 Sum_probs=82.4
Q ss_pred cceeccCCceeEEEEEeC--------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCee
Q 039595 756 KFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 826 (1078)
.+.+..|....+|++... +++.|++|+.... ........+|..+++.+. +.-..++++++.+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence 356777889999999764 2478999985321 122445567888887773 3334667777654
Q ss_pred EEEEeecCCCCHHH--------------H---hcCCC--CCCcCC--HHHHHHHHHHHHH-------------------H
Q 039595 827 FLVCEYLHRGSLAR--------------I---LGNDA--TAKELS--WNRRINVIKGVAN-------------------A 866 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~--------------~---l~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~ 866 (1078)
.+||||++|..+.. . ++... -.+... +.++.++..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 28999999865431 0 11111 111222 3455555544422 2
Q ss_pred HHHHHh----c-CCCCcEecCCCCCCeeeCCC----CcEEEecccccc
Q 039595 867 LSYLHH----D-CLPSIIHRDISSKNVLLDLE----FEAHVSDFGIAK 905 (1078)
Q Consensus 867 L~~LH~----~-~~~~ivH~Dlk~~NIll~~~----~~~kl~DfG~a~ 905 (1078)
+..|.+ . ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 333322 1 12368999999999999876 789999998875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.89 E-value=0.02 Score=66.07 Aligned_cols=74 Identities=14% Similarity=0.048 Sum_probs=45.9
Q ss_pred cceeccCCceeEEEEEeCC-CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc-eeeEEeeeecCCeeEEEEeec
Q 039595 756 KFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN-IVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~ 833 (1078)
.+.|+.|-...+|++...+ +..|++|+..... . ...+ -..|..+++.+...+ ..++++++.. .+|+||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~id---R~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EIIN---REREKKISCILYNKNIAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCSC---HHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhcC---HHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence 4568889999999998764 4788899874321 1 1111 145777777775333 3577777642 2599999
Q ss_pred CCCCH
Q 039595 834 HRGSL 838 (1078)
Q Consensus 834 ~~g~L 838 (1078)
+|.++
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.77 E-value=0.058 Score=59.66 Aligned_cols=31 Identities=26% Similarity=0.290 Sum_probs=27.7
Q ss_pred CCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 876 ~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888999999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.59 E-value=0.05 Score=54.70 Aligned_cols=103 Identities=15% Similarity=0.116 Sum_probs=66.8
Q ss_pred CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCCce
Q 039595 836 GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT 915 (1078)
Q Consensus 836 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 915 (1078)
-+|.++|+. ...+++++++|.++.|.+.+|.-.-.+. .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence 378888853 3568999999999999999987762211 111223457899999999998764 1111
Q ss_pred eeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 039595 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 956 (1078)
Q Consensus 916 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 956 (1078)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122466888753 3557788999999999999864444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.58 E-value=0.01 Score=66.77 Aligned_cols=74 Identities=9% Similarity=0.058 Sum_probs=41.7
Q ss_pred cceeccCCceeEEEEEeCC---------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc-eeeEEeeeecCCe
Q 039595 756 KFCIGKGGQGSVYKAELPS---------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN-IVKFHGFCSNARH 825 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~ 825 (1078)
.+.++.|....+|++...+ ++.+++|+...... .......|..+++.+...+ +.++++.+.
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-----ELYNTISEFEVYKTMSKYKIAPQLLNTFN---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-----GTSCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-----ceecHHHHHHHHHHHHhcCCCCceEEecC----
Confidence 3467888889999997653 26888888654211 1111245666666653222 446665542
Q ss_pred eEEEEeecCCCCH
Q 039595 826 SFLVCEYLHRGSL 838 (1078)
Q Consensus 826 ~~lv~E~~~~g~L 838 (1078)
-++||||++|..+
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 2689999987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.86 E-value=0.12 Score=58.56 Aligned_cols=74 Identities=7% Similarity=0.003 Sum_probs=45.9
Q ss_pred cceeccCCceeEEEEEeCC--------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCee
Q 039595 756 KFCIGKGGQGSVYKAELPS--------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 826 (1078)
++.+..|....+|+....+ ++.|++|+..... . ...+ ..+|..+++.+. +.-..++++.+. -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~-~~id---R~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-G-KFYD---SKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCC---HHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-c-hhcC---HHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 4567788899999997653 5789999864321 1 1111 234666666553 222456665443 2
Q ss_pred EEEEeecCCCCH
Q 039595 827 FLVCEYLHRGSL 838 (1078)
Q Consensus 827 ~lv~E~~~~g~L 838 (1078)
++|+||++|..+
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998654
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.77 E-value=0.076 Score=38.15 Aligned_cols=27 Identities=33% Similarity=0.666 Sum_probs=12.6
Q ss_pred eehhHHH-HHHHHHHHhhhcceeeeccc
Q 039595 690 IVFPILG-MVLLLISLIGFFFFFRQRKK 716 (1078)
Q Consensus 690 ii~~~~~-~~~lll~~i~~~~~~r~rk~ 716 (1078)
|+..+++ +++++++++++++++|+|++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 4444544 44444444444555555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.12 E-value=0.084 Score=37.78 Aligned_cols=27 Identities=22% Similarity=0.512 Sum_probs=12.2
Q ss_pred eehhHHH-HHHHHHHHhhhcceeeeccc
Q 039595 690 IVFPILG-MVLLLISLIGFFFFFRQRKK 716 (1078)
Q Consensus 690 ii~~~~~-~~~lll~~i~~~~~~r~rk~ 716 (1078)
|+..++| ++++++++.++++++|+|++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 3444444 44444444444455554443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=85.39 E-value=0.16 Score=36.24 Aligned_cols=26 Identities=19% Similarity=0.521 Sum_probs=12.2
Q ss_pred eehhHHHHHHHHHHHhhhcceeeecc
Q 039595 690 IVFPILGMVLLLISLIGFFFFFRQRK 715 (1078)
Q Consensus 690 ii~~~~~~~~lll~~i~~~~~~r~rk 715 (1078)
|++.++|+++++++.+++++|.|||+
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhh
Confidence 45555554444444444444444444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.97 E-value=1.8 Score=48.80 Aligned_cols=29 Identities=24% Similarity=0.339 Sum_probs=24.7
Q ss_pred CcEecCCCCCCeee------CCCCcEEEecccccc
Q 039595 877 SIIHRDISSKNVLL------DLEFEAHVSDFGIAK 905 (1078)
Q Consensus 877 ~ivH~Dlk~~NIll------~~~~~~kl~DfG~a~ 905 (1078)
.++|+|+.+.||++ ++++.+.++||-+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456789999998876
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.83 E-value=1.9 Score=43.35 Aligned_cols=117 Identities=9% Similarity=0.062 Sum_probs=79.8
Q ss_pred CCCCceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 039595 808 IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 887 (1078)
Q Consensus 808 l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 887 (1078)
..||+.++. .+-++.+.+.+.++.-+.+ ..+- .-+..+..++++++.+|+....++++. +|--++|+|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNH--TPFD----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTS--EEGG----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCccc--CCHH----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 368888876 5666667666666654432 2221 234578899999999999988666644 788999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 039595 888 VLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 958 (1078)
Q Consensus 888 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~ 958 (1078)
++++.++.+++.-.|+-..+. |. ..+...=.-.+=|++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~-----------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVD-----------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBS-----------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCC-----------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999887654332 22 11111223345678888999988854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.68 E-value=2.5 Score=42.52 Aligned_cols=115 Identities=10% Similarity=0.069 Sum_probs=77.3
Q ss_pred CCCceeeEEeeeecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHH-HHHhcCCCCcEecCCCCCC
Q 039595 809 RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALS-YLHHDCLPSIIHRDISSKN 887 (1078)
Q Consensus 809 ~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlk~~N 887 (1078)
.||++ -..+-.+++.+.+.++.-+++.=+..+ ...+..++++++.+|+.... +++. -+|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 68888 444446777777777766454323333 34778999999999888776 5554 4788899999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 039595 888 VLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 958 (1078)
Q Consensus 888 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~ 958 (1078)
++++.++.+++.-.|+-..+ +|..+ +..-=.-.+=|++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~~l-----------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL-----------------PPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTTB-----------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCcccC-----------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999988765432 23221 111112245577788888887743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1078 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-24 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.004 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 8e-57
Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 21/270 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
IG G G+VYK + VAVK N + F N V L + RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRH 63
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
NI+ F G+ + +V ++ SL L + + I++ + A + YL
Sbjct: 64 VNILLFMGYSTA-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR--TEFVGTFGYAAPEI 928
H SIIHRD+ S N+ L + + DFG+A +S + + G+ + APE+
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 929 AYTMRA---TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985
+ + DVY+FG++++E++ G P + +IN ++ L P LS
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVG-RGYLSPDLSKV 234
Query: 986 SPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ +M CL + + RP
Sbjct: 235 RSNCPKAMKRLMA---ECLKKKRDERPLFP 261
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-54
Identities = 68/276 (24%), Positives = 127/276 (46%), Gaps = 19/276 (6%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+D++ + IG G G K G I+ K+ + ++ A++ ++ V L E++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELK 61
Query: 810 HRNIVKFHGFCSNARHS--FLVCEYLHRGSLARILGNDATAKE-LSWNRRINVIKGVANA 866
H NIV+++ + ++ ++V EY G LA ++ ++ L + V+ + A
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 867 LSYLH--HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYA 924
L H D +++HRD+ NV LD + + DFG+A+ + +S FVGT Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
+PE M EK D++S G L++E+ P F++FS + +I + +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-------FTAFSQKEL-AGKIREGKFRR 233
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
D+L I+ L+ RP++E+ +
Sbjct: 234 IPYRYSDELNEIIT---RMLNLKDYHRPSVEEILEN 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 6e-53
Identities = 58/267 (21%), Positives = 111/267 (41%), Gaps = 21/267 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+ +G G G V+ VAVK L D FL + +++H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-----LKQGSMSPDAFLAEANLMKQLQH 67
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
+ +V+ + + +++ EY+ GSL L + +L+ N+ +++ +A ++++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN-RTEFVGTFGYAAPEIA 929
IHRD+ + N+L+ ++DFG+A+ +E R + APE
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
T K DV+SFG+L+ E++ + + + +++ P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMVRP------DNC 235
Query: 990 MDKLISIMEVAILCLDESPEARPTMEK 1016
++L +M LC E PE RPT +
Sbjct: 236 PEELYQLMR---LCWKERPEDRPTFDY 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-52
Identities = 66/307 (21%), Positives = 123/307 (40%), Gaps = 47/307 (15%)
Query: 749 ATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE 807
DDF++ +G G G V+K PSG ++A K + ++ A +++ + + L+E
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHE 60
Query: 808 IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANAL 867
IV F+G + + E++ GSL ++L A + V V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGL 117
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
+YL I+HRD+ N+L++ E + DFG++ + S FVGT Y +PE
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPE 173
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII--------------- 972
+ + D++S G+ + E+ G +P + M
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP--IPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 973 -----------------EVNQILDPRLSTPSPGVMDKLISIMEVAIL--CLDESPEARPT 1013
+ ++LD ++ P P + + S+ + CL ++P R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 1014 MEKGFGH 1020
+++ H
Sbjct: 292 LKQLMVH 298
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 63/267 (23%), Positives = 113/267 (42%), Gaps = 21/267 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+ IG G G V+ + D VA+K +S +++F+ + ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSH 59
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
+V+ +G C LV E++ G L+ L + + + V ++YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYL 117
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE-FVGTFGYAAPEIA 929
C +IHRD++++N L+ VSDFG+ +FV + +A+PE+
Sbjct: 118 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
R + K DV+SFGVL++EV + + + S I ++ PRL++
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKI-PYENRSNSEVVEDISTGFRLYKPRLAST---- 229
Query: 990 MDKLISIMEVAILCLDESPEARPTMEK 1016
+ ++ C E PE RP +
Sbjct: 230 -----HVYQIMNHCWKERPEDRPAFSR 251
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-51
Identities = 75/271 (27%), Positives = 118/271 (43%), Gaps = 22/271 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+DF+ +GKG G+VY A S I+A+K L + + V + +R
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLR 64
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H NI++ +G+ +A +L+ EY G++ R L + R I +ANALSY
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSY 121
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
H +IHRDI +N+LL E ++DFG + SS RT GT Y PE+
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLCGTLDYLPPEMI 176
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
EK D++S GVL +E + G P F + + I V ++ + +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISRVEFTFPDFVTEGARDL 234
Query: 990 MDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ + L +P RP + + H
Sbjct: 235 ISR----------LLKHNPSQRPMLREVLEH 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 7e-51
Identities = 59/267 (22%), Positives = 115/267 (43%), Gaps = 23/267 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
D +G G G V + VA+K +S +DEF+ + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSH 58
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
+V+ +G C+ R F++ EY+ G L L + + + K V A+ YL
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYL 116
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV-EPYSSNRTEFVGTFGYAAPEIA 929
+HRD++++N L++ + VSDFG++++V + ++ ++ PE+
Sbjct: 117 ESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 930 YTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988
+ + K D+++FGVL++E+ G P + S + I + ++ P L++
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTNSETAEHIAQGLRLYRPHLASE--- 228
Query: 989 VMDKLISIMEVAILCLDESPEARPTME 1015
+ + C E + RPT +
Sbjct: 229 ------KVYTIMYSCWHEKADERPTFK 249
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 7e-51
Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 21/266 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+ + +G+G G V+ VA+K + FL + ++RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRH 71
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
+V+ + S ++V EY+ +GSL T K L + +++ +A+ ++Y+
Sbjct: 72 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP-YSSNRTEFVGTFGYAAPEIA 929
+HRD+ + N+L+ V+DFG+A+ +E + R + APE A
Sbjct: 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
R T K DV+SFG+L+ E+ + N + ++Q+ P
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRV------PYPGMVNREV-LDQVERGYRMPCPPEC 239
Query: 990 MDKLISIMEVAILCLDESPEARPTME 1015
+ L +M C + PE RPT E
Sbjct: 240 PESLHDLMC---QCWRKEPEERPTFE 262
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-50
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 25/279 (8%)
Query: 747 IKATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNV 801
I + D +K+ IG+G G+VY A ++ +G VA+++ N Q ++ +N
Sbjct: 12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINE 67
Query: 802 VLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIK 861
+L + E ++ NIV + ++V EYL GSL ++ + + V +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCR 123
Query: 862 GVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTF 921
AL +LH + +IHRDI S N+LL ++ ++DFG + P S R+ VGT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981
+ APE+ K D++S G++ E+I+G P + + N +I P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIA---TNGTPE 235
Query: 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
L P + + CLD E R + ++ H
Sbjct: 236 LQNP-EKLSAIFRDFLN---RCLDMDVEKRGSAKELLQH 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 2e-49
Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 29/278 (10%)
Query: 751 DDFDEKF----CIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLAL 805
DD ++ F IG G G+VY A + + ++VA+KK + N + + V L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDIIKEVRFL 69
Query: 806 NEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
++RH N +++ G ++LV EY + + + K L V G
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQ 126
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
L+YLH ++IHRD+ + N+LL + DFG A + P +S FVGT + A
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMA 179
Query: 926 PEIAYTM---RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
PE+ M + K DV+S G+ E+ + P + + M + +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-------LFNMNAMSALYHIAQNESP 232
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ S + + ++ CL + P+ RPT E H
Sbjct: 233 ALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLKH 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 6e-49
Identities = 60/290 (20%), Positives = 118/290 (40%), Gaps = 36/290 (12%)
Query: 744 EEIIKATDDFDEKF---------CIGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSG 790
E+ +A +F ++ IG G G V L VA+K S
Sbjct: 10 EDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK 69
Query: 791 NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKE 850
+ +FL+ + + H N++ G + + ++ E++ GSL L + +
Sbjct: 70 ---QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQ 124
Query: 851 LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910
+ + + +++G+A + YL +HRD++++N+L++ VSDFG+++F+E
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 911 SSNRTE-----FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 965
+S+ T + APE + T DV+S+G++++EV+ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER------PYW 235
Query: 966 SFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+N + +N I P L +M C + RP
Sbjct: 236 DMTNQDV-INAIEQDYRLPPPMDCPSALHQLML---DCWQKDRNHRPKFG 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 6e-49
Identities = 63/266 (23%), Positives = 106/266 (39%), Gaps = 25/266 (9%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+ IGKG G V + G+ VAVK + A FL + ++RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRH 59
Query: 811 RNIVKFHGFCSNARHS-FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
N+V+ G + ++V EY+ +GSL L L + + V A+ Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
L + +HRD++++NVL+ + A VSDFG+ K SS + + APE
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWTAPEAL 172
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
+ + K DV+SFG+L++E+ + + V ++ G
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRV------PYPRIPLKDV-VPRVEKGYKMDAPDGC 225
Query: 990 MDKLISIMEVAILCLDESPEARPTME 1015
+ +M+ C RP+
Sbjct: 226 PPAVYEVMK---NCWHLDAAMRPSFL 248
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 8e-49
Identities = 62/280 (22%), Positives = 121/280 (43%), Gaps = 24/280 (8%)
Query: 747 IKATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLAL 805
+ D ++ +G G G VYKA+ + + A K +++ + + ++++ + L
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDIL 63
Query: 806 NEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
H NIVK + +++ E+ G++ ++ + L+ ++ V K +
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLD 121
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
AL+YLH IIHRD+ + N+L L+ + ++DFG++ R F+GT + A
Sbjct: 122 ALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178
Query: 926 PEIAYTMRA-----TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDP 980
PE+ + K DV+S G+ + E+ + P +N I +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEPPTLA 236
Query: 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ S S D + CL+++ +AR T + H
Sbjct: 237 QPSRWSSNFKD-FLK------KCLEKNVDARWTTSQLLQH 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 8e-49
Identities = 60/275 (21%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 753 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHR 811
FD + IG+G +VYK + VA + + L+ + ++ F L ++H
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHP 68
Query: 812 NIVKFHGFC----SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANAL 867
NIV+F+ + LV E + G+L L K + + + + L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGL 125
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAP 926
+LH P IIHRD+ N+ + + D G+A +S +GT + AP
Sbjct: 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAP 182
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD-PRLSTP 985
E+ Y + E DVY+FG+ + E+ +P +S N ++ + ++
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASF 234
Query: 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ ++ I+E C+ ++ + R +++ H
Sbjct: 235 DKVAIPEVKEIIE---GCIRQNKDERYSIKDLLNH 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-48
Identities = 59/280 (21%), Positives = 110/280 (39%), Gaps = 28/280 (10%)
Query: 744 EEIIKATDDFD-EKFCIGKGGQGSVYKAEL---PSGDIVAVKKFNSQLLSGNMADQDEFL 799
+++ D+ +G G GSV + VA+K D +E +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA---DTEEMM 57
Query: 800 NVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINV 859
++++ + IV+ G C LV E G L + L +E+ + +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAEL 114
Query: 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTE 916
+ V+ + YL + +HRD++++NVLL A +SDFG++K + Y + R+
Sbjct: 115 LHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 917 FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVN 975
+ APE + + + DV+S+GV ++E + G P + + +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-------YKKMKGPEV-MA 223
Query: 976 QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
I + P +L ++M C E RP
Sbjct: 224 FIEQGKRMECPPECPPELYALMS---DCWIYKWEDRPDFL 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-48
Identities = 66/264 (25%), Positives = 112/264 (42%), Gaps = 27/264 (10%)
Query: 759 IGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK 815
+G G G+V K VAVK ++ + +DE L + ++ + IV+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL--KDELLAEANVMQQLDNPYIVR 72
Query: 816 FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCL 875
G C LV E G L + L + + + I ++ V+ + YL
Sbjct: 73 MIGICEA-ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 876 PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFGYAAPEIAYTM 932
+ +HRD++++NVLL + A +SDFG++K + Y +T + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 933 RATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991
+ + K DV+SFGVL++E G P + + S + M+ + R+ P G
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAMLEK-----GERMGCP-AGCPR 237
Query: 992 KLISIMEVAILCLDESPEARPTME 1015
++ +M LC E RP
Sbjct: 238 EMYDLMN---LCWTYDVENRPGFA 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 7e-48
Identities = 63/290 (21%), Positives = 112/290 (38%), Gaps = 45/290 (15%)
Query: 758 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IGKG G V++ + G+ VAVK F+S+ + +RH NI+ F
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFI 63
Query: 818 GFCSNARHS----FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
+ + +LV +Y GSL L ++ I + A+ L++LH +
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHME 119
Query: 874 CL-----PSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP----YSSNRTEFVGTFGYA 924
+ P+I HRD+ SKN+L+ ++D G+A + VGT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 925 APEIAYTM------RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI------- 971
APE+ + ++ D+Y+ G++ +E+ + + +++
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 972 ----IEVNQILDPRL--STPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ Q L P + S + + IM C + AR T
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTAL 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (430), Expect = 1e-47
Identities = 58/294 (19%), Positives = 115/294 (39%), Gaps = 45/294 (15%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLA 804
++ + IG+G G V++A P +VAVK + + Q +F
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD---MQADFQREAAL 69
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGN-------------------- 844
+ E + NIVK G C+ + L+ EY+ G L L +
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 845 -DATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903
LS ++ + + VA ++YL +HRD++++N L+ ++DFG+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGL 186
Query: 904 AKFVEP--YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 961
++ + Y + PE + R T + DV+++GV+++E+
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP---- 242
Query: 962 INFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+ ++ + + + D + +L ++M LC + P RP+
Sbjct: 243 --YYGMAHEEV-IYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFC 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (430), Expect = 7e-47
Identities = 55/284 (19%), Positives = 119/284 (41%), Gaps = 24/284 (8%)
Query: 740 KIMHEEIIKATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEF 798
+I H+ ++ D +D +G G G V++ E +G+ A K +++ + +D++
Sbjct: 18 EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKF----VMTPHESDKETV 70
Query: 799 LNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRIN 858
+ ++ +RH +V H + ++ E++ G L + + ++S + +
Sbjct: 71 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVE 128
Query: 859 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTE 916
++ V L ++H + +H D+ +N++ + + DFG+ ++P S +
Sbjct: 129 YMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV- 184
Query: 917 FVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQ 976
GT +AAPE+A D++S GVL + ++ G P F N + +
Sbjct: 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDW 242
Query: 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+D G+ + + L P R T+ + H
Sbjct: 243 NMDDSA---FSGISEDGKDFIR---KLLLADPNTRMTIHQALEH 280
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 8e-47
Identities = 62/268 (23%), Positives = 118/268 (44%), Gaps = 23/268 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
D K +G G G VY+ VAVK L + + +EFL + EI+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKEAAVMKEIK 71
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H N+V+ G C+ +++ E++ G+L L + +E+S + + +++A+ Y
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEY 130
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP-YSSNRTEFVGTFGYAAPEI 928
L + IHRD++++N L+ V+DFG+++ + + + APE
Sbjct: 131 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 929 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP- 987
+ + K DV++FGVL++E+ + + +V ++L+ P
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMS--PYP------GIDLSQVYELLEKDYRMERPE 239
Query: 988 GVMDKLISIMEVAILCLDESPEARPTME 1015
G +K+ +M C +P RP+
Sbjct: 240 GCPEKVYELMR---ACWQWNPSDRPSFA 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 9e-47
Identities = 64/274 (23%), Positives = 107/274 (39%), Gaps = 22/274 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+D+D +G+G G V A + + VAVK + + + + + +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKMLN 61
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H N+VKF+G +L EY G L + D + + + Y
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 118
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR--TEFVGTFGYAAPE 927
LH I HRDI +N+LLD +SDFG+A + R + GT Y APE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 928 IAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
+ E DV+S G+++ ++ G P D S + +S+ + P
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------KTYLNPW 229
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ ++++ L E+P AR T+
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIPDIKKD 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 62/273 (22%), Positives = 119/273 (43%), Gaps = 26/273 (9%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNMADQDEFLNVVLAL 805
+ IG G G VYK L + VA+K + + +FL +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK---QRVDFLGEAGIM 63
Query: 806 NEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
+ H NI++ G S + ++ EY+ G+L + L E S + + +++G+A
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAA 121
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFG 922
+ YL + + +HRD++++N+L++ VSDFG+++ +E + +
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
+ APE + T DV+SFG++++EV+ + N EV + ++
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGF 230
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
P+P MD +I ++ + C + RP
Sbjct: 231 RLPTP--MDCPSAIYQLMMQCWQQERARRPKFA 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 3e-46
Identities = 59/276 (21%), Positives = 106/276 (38%), Gaps = 22/276 (7%)
Query: 748 KATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALN 806
K +DF +G+G +V A EL + A+K + + ++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMS 63
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
+ H VK + + + Y G L + + + +A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSA 120
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYA 924
L YLH IIHRD+ +N+LL+ + ++DFG AK + P S FVGT Y
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
+PE+ A + D+++ G ++++++ G P F + + +I +I+
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP-------FRAGNEYLI-FQKIIKLEYDF 229
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
P K ++E L R E+ G+
Sbjct: 230 PE-KFFPKARDLVE---KLLVLDATKRLGCEEMEGY 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 5e-45
Identities = 66/295 (22%), Positives = 118/295 (40%), Gaps = 29/295 (9%)
Query: 732 LSVLNFDGKIMHEEIIKATDDFDEKF--CIGKGGQGSVYKAELPSGD----IVAVKKFNS 785
LS LN + + ++ F IG+G G VY L D AVK N
Sbjct: 6 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN- 64
Query: 786 QLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS-FLVCEYLHRGSLARILGN 844
++ + +FL + + + H N++ G C + S +V Y+ G L + N
Sbjct: 65 --RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122
Query: 845 DATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904
+ + + + +HRD++++N +LD +F V+DFG+A
Sbjct: 123 ETHNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 905 KFVEP----YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 960
+ + N+T + A E T + T K DV+SFGVL++E++ P +
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YP 236
Query: 961 SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTME 1015
+N + +++ ++L P + EV + C E RP+
Sbjct: 237 DVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVMLKCWHPKAEMRPSFS 282
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (410), Expect = 3e-44
Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 21/273 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
D +D +G G G V++ E +G + K N+ D+ N + +N++
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLH 84
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H ++ H + L+ E+L G L + + ++S IN ++ L +
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKH 142
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
+H SI+H DI +N++ + + + V DFG+A + P T +AAPE
Sbjct: 143 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIVKVTTATAEFAAPE 198
Query: 928 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987
I D+++ GVL + ++ G P F + + + D
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDED---AFS 253
Query: 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
V + ++ L + P R T+ H
Sbjct: 254 SVSPEAKDFIK---NLLQKEPRKRLTVHDALEH 283
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-44
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 34/283 (12%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGD---IVAVKKFNSQLLSGNMADQDEFLNVVLALNE 807
+D + IG+G G V KA + A+K+ + D +F + L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCK 66
Query: 808 I-RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-------------GNDATAKELSW 853
+ H NI+ G C + + +L EY G+L L ++TA LS
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 854 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN 913
+ ++ VA + YL IHRD++++N+L+ + A ++DFG+++ E Y
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK- 182
Query: 914 RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE 973
+T + A E T DV+S+GVL++E++ + + + + +
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQ 241
Query: 974 VNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
RL P D++ +M C E P RP+ +
Sbjct: 242 -----GYRLEKP-LNCDDEVYDLMR---QCWREKPYERPSFAQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 4e-44
Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 26/281 (9%)
Query: 748 KATDDFDEKF----CIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVV 802
K +D + + +G G V AE + +VA+K + L G + N +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEI 58
Query: 803 LALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG 862
L++I+H NIV + H +L+ + + G L + + +I
Sbjct: 59 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQ 115
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLEFE---AHVSDFGIAKFVEPYSSNRTEFVG 919
V +A+ YLH I+HRD+ +N+L E +SDFG++K +P S + G
Sbjct: 116 VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTACG 171
Query: 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979
T GY APE+ ++ D +S GV+ + ++ G P F+ N + I++ D
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKAEYEFD 229
Query: 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ D + +++ PE R T E+ H
Sbjct: 230 SPY---WDDISDSAKDFIR---HLMEKDPEKRFTCEQALQH 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-44
Identities = 62/290 (21%), Positives = 115/290 (39%), Gaps = 39/290 (13%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA 804
+ +G G G V +A + VAVK S ++ +++ ++ +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 805 LNEI-RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGN---------------DATA 848
L+ + H NIV G C+ + ++ EY G L L +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 849 KELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908
L ++ VA +++L + IHRD++++N+LL + DFG+A+ ++
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 909 PYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 966
S+ + + APE + T + DV+S+G+ ++E+ S
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 967 FSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
F MI E ++L P ++ IM+ C D P RPT ++
Sbjct: 257 FYKMIKEGFRMLSP------EHAPAEMYDIMK---TCWDADPLKRPTFKQ 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-43
Identities = 55/295 (18%), Positives = 104/295 (35%), Gaps = 44/295 (14%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADQDEFLNVVLA 804
++ + +G G G V A VAVK + S +++ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS---EREALMSELKM 93
Query: 805 LNEI-RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL--------------------G 843
+ ++ H NIV G C+ + +L+ EY G L L
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 844 NDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903
+ L++ + VA + +L S +HRD++++NVL+ + DFG+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 904 AKFVEP--YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 961
A+ + R + APE + T K DV+S+G+L++E+
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN----- 265
Query: 962 INFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+ I + +++ IM+ C RP+
Sbjct: 266 -PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPN 316
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-43
Identities = 63/273 (23%), Positives = 102/273 (37%), Gaps = 23/273 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALN 806
D +G G G V + E + VAVK +LS D+F+ V A++
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMH 66
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
+ HRN+++ +G +V E GSL L VA
Sbjct: 67 SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEG 123
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFGY 923
+ YL IHRD++++N+LL + DFG+ + + + + F +
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 924 AAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983
APE T + D + FGV ++E+ + +N S + I + RL
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDKE----GERLP 235
Query: 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
P + ++M C PE RPT
Sbjct: 236 RP-EDCPQDIYNVMV---QCWAHKPEDRPTFVA 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-43
Identities = 60/272 (22%), Positives = 101/272 (37%), Gaps = 19/272 (6%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+DF +GKG G V+ AE + A+K ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H + + F V EYL+ G L + + + +R + L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQF 118
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
LH I++RD+ N+LLD + ++DFG+ K + F GT Y APEI
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
+ D +SFGVL++E++ G P F + + I N L + +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233
Query: 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021
+ K PE R + H
Sbjct: 234 LVK----------LFVREPEKRLGVRGDIRQH 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-43
Identities = 61/271 (22%), Positives = 108/271 (39%), Gaps = 26/271 (9%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALN 806
+ + CIG+G G V++ S + VA+K + + +++FL L +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMR 63
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
+ H +IVK G + +++ E G L L I ++ A
Sbjct: 64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTA 120
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNR-TEFVGTFGYAA 925
L+YL +HRDI+++NVL+ + DFG+++++E + + ++ + A
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 926 PEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
PE R T DV+ FGV ++E++ G P N + +I +
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERLP 229
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTME 1015
P L S+M C P RP
Sbjct: 230 MPPNCPPTLYSLMT---KCWAYDPSRRPRFT 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-42
Identities = 55/279 (19%), Positives = 104/279 (37%), Gaps = 27/279 (9%)
Query: 745 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNMADQDEFL 799
I+K T+ F + +G G G+VYK VA+K+ + + E L
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEIL 59
Query: 800 NVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINV 859
+ + + + ++ + G C + L+ + + G L + +N
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDY--VREHKDNIGSQYLLNW 116
Query: 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP--YSSNRTEF 917
+A ++YL ++HRD++++NVL+ ++DFG+AK + +
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 918 VGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQI 977
+ A E T + DV+S+GV V+E++ + I
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------PYDGIPASEISSILE 227
Query: 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
RL P P + IM C ++RP +
Sbjct: 228 KGERLPQP-PICTIDVYMIMV---KCWMIDADSRPKFRE 262
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 3e-42
Identities = 58/281 (20%), Positives = 119/281 (42%), Gaps = 31/281 (11%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA 804
+ +G+G G VY+ VA+K N + +M ++ EFLN
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASV 76
Query: 805 LNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-------GNDATAKELSWNRRI 857
+ E ++V+ G S + + ++ E + RG L L N+ S ++ I
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 858 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP--YSSNRT 915
+ +A+ ++YL+ + +HRD++++N ++ +F + DFG+ + + Y
Sbjct: 137 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 916 EFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN 975
+ + + +PE T DV+SFGV+++E+ + SN + +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP------YQGLSNEQV-LR 246
Query: 976 QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
+++ L D L +M +C +P+ RP+ +
Sbjct: 247 FVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLE 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-42
Identities = 56/276 (20%), Positives = 109/276 (39%), Gaps = 26/276 (9%)
Query: 752 DFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALN 806
+ EK+ +G+G G V++ E S K + DQ + LN
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILN 56
Query: 807 EIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
RHRNI+ H + ++ E++ + + + +A EL+ ++ + V A
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEA 114
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV--SDFGIAKFVEPYSSNRTEFVGTFGYA 924
L +LH +I H DI +N++ + + +FG A+ ++P + R Y
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYY 170
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
APE+ + D++S G LV+ ++ G +P F + I+ D
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEE--- 225
Query: 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ + + ++ L + ++R T + H
Sbjct: 226 AFKEISIEAMDFVD---RLLVKERKSRMTASEALQH 258
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (380), Expect = 4e-41
Identities = 66/272 (24%), Positives = 113/272 (41%), Gaps = 23/272 (8%)
Query: 750 TDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI 808
+D ++ +G GG V+ A L VAVK + L + + F +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAAL 64
Query: 809 RHRNIVKFHGFCSNARHS----FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVA 864
H IV + + ++V EY+ +L I+ + ++ R I VI
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADAC 121
Query: 865 NALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTE---FVGTF 921
AL++ H IIHRD+ N+++ V DFGIA+ + ++ T+ +GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 922 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981
Y +PE A + DVYS G +++EV+ G P F + S + + + I
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPIPP-- 234
Query: 982 LSTPSPGVMDKLISIMEVAILCLDESPEARPT 1013
S G+ L +++ L ++PE R
Sbjct: 235 -SARHEGLSADLDAVVL---KALAKNPENRYQ 262
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (376), Expect = 2e-40
Identities = 68/284 (23%), Positives = 117/284 (41%), Gaps = 30/284 (10%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDE-----FLNVVLA 804
++++ K +G+G V + P+ AVK + A++ + L V
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 805 LNEIR-HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGV 863
L ++ H NI++ FLV + + +G L L LS +++ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRAL 119
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGY 923
+ LH I+HRD+ +N+LLD + ++DFG + ++P E GT Y
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSY 175
Query: 924 AAPEIAYTMRA------TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN-Q 976
APEI ++ D++S GV+++ ++ G+ P F+ MI+ N Q
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMIMSGNYQ 233
Query: 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
P S V D L+S L P+ R T E+ H
Sbjct: 234 FGSPEWDDYSDTVKD-LVS------RFLVVQPQKRYTAEEALAH 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (372), Expect = 1e-39
Identities = 55/264 (20%), Positives = 100/264 (37%), Gaps = 23/264 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DF +G G G V+ +G A+K +++ + + + L L+ +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVT 62
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H I++ G +A+ F++ +Y+ G L +L +
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLA 116
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
L + II+RD+ +N+LLD ++DFG AK+V GT Y APE+
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVV 173
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
T + D +SFG+L++E++ G P F+ N I+ P + +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231
Query: 990 MDKLISIMEVAILCLDESPEARPT 1013
+ + + R
Sbjct: 232 LSR----------LITRDLSQRLG 245
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 63/290 (21%), Positives = 116/290 (40%), Gaps = 40/290 (13%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADQDEFLNVV 802
D +G+G G V AE D VAVK S D + ++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEM 69
Query: 803 LALNEI-RHRNIVKFHGFCSNARHSFLVCEYLHRGSLARIL-------------GNDATA 848
+ I +H+NI+ G C+ +++ EY +G+L L +
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 849 KELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908
++LS ++ VA + YL IHRD++++NVL+ + ++DFG+A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 909 PYSSNRTEFV--GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 966
+ + APE + T + DV+SFGVL++E+ + +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-PYPGVPVEE 245
Query: 967 FSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
++ E +++ P ++L +M C P RPT ++
Sbjct: 246 LFKLLKEGHRMDKP------SNCTNELYMMMR---DCWHAVPSQRPTFKQ 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-39
Identities = 56/281 (19%), Positives = 104/281 (37%), Gaps = 26/281 (9%)
Query: 751 DDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLL--SGNMADQDEFLNVVL 803
++ D+ + +G G V K E +G A K + S +++ V
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 804 ALNEIRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGV 863
L EI+H N++ H N L+ E + G L L + L+ +K +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQI 122
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLE----FEAHVSDFGIAKFVEPYSSNRTEFVG 919
N + ++ I H D+ +N++L + DFG+A ++ + G
Sbjct: 123 LNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFG 178
Query: 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979
T + APEI + D++S GV+ + ++ G P F + VN +
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFE 236
Query: 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ + + I L + P+ R T++ H
Sbjct: 237 DEYFSNTSALAKDFIR------RLLVKDPKKRMTIQDSLQH 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (359), Expect = 5e-38
Identities = 38/270 (14%), Positives = 84/270 (31%), Gaps = 28/270 (10%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG G G +Y + +G+ VA+K + + ++ +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 818 GFC-SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
+C + ++ +V E L ++ S + + + + + Y+H
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---K 122
Query: 877 SIIHRDISSKNVL---LDLEFEAHVSDFGIAKFVEPYSSN-------RTEFVGTFGYAAP 926
+ IHRD+ N L ++ DFG+AK ++ GT YA+
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 927 EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
+ + + D+ S G ++ G + + + +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTMEK 1016
G + + + C + +P
Sbjct: 242 KGYPSEFATYLN---FCRSLRFDDKPDYSY 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (355), Expect = 1e-37
Identities = 58/290 (20%), Positives = 116/290 (40%), Gaps = 30/290 (10%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH 810
+ + IG+G G VYKA+ G+ A+KK + + + + L E++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKH 59
Query: 811 RNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYL 870
NIVK + + LV E+L + + + L + + + N ++Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYC 116
Query: 871 HHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAY 930
H ++HRD+ +N+L++ E E ++DFG+A+ T + T Y AP++
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 931 -TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV--------------N 975
+ + + D++S G + E++ G F ++ + I +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 976 QILDPRLSTPSPGVMDKLISIMEVAIL-----CLDESPEARPTMEKGFGH 1020
DP + P + + ++ + + L P R T ++ H
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 58/292 (19%), Positives = 109/292 (37%), Gaps = 32/292 (10%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
++F + IG+G G VYKA +G++VA+KK + + + + L E+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST--AIREISLLKELN 59
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H NIVK +LV E+LH+ + + + + + + L++
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAF 117
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
H ++HRD+ +N+L++ E ++DFG+A+ T V T Y APEI
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 930 Y-TMRATEKYDVYSFGVLVFEVIKGNHP--------------------RDFFSINFSSFS 968
+ D++S G + E++ + +S
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 969 NMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
+ + S P + + S++ L P R + + H
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALAH 283
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-37
Identities = 55/288 (19%), Positives = 101/288 (35%), Gaps = 36/288 (12%)
Query: 751 DDFDEKFCIGKGGQGSVYKA------ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLA 804
D +G+G G V +A + + VAVK + + +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKIL 70
Query: 805 LNEIRHRNIVKFHGFC-SNARHSFLVCEYLHRGSLARIL-------------GNDATAKE 850
++ H N+V G C ++ E+ G+L+ L D
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 851 LSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV--E 908
L+ I VA + +L IHRD++++N+LL + + DFG+A+ + +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS 968
P + + + APE + T + DV+SFGVL++E+ +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVK 241
Query: 969 NMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
++ + ++ M C P RPT +
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTML---DCWHGEPSQRPTFSE 286
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (356), Expect = 5e-37
Identities = 51/276 (18%), Positives = 97/276 (35%), Gaps = 21/276 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQD--EFLNVVLALNE 807
+DF IG+GG G VY +G + A+K + + + + ++ ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 808 IRHRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANAL 867
IV + + ++ G L L E + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILGL 120
Query: 868 SYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE 927
++H+ +++RD+ N+LLD +SD G+A VGT GY APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPE 175
Query: 928 IAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986
+ A D +S G ++F++++G+ P + E++++
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK------TKDKHEIDRMTLTMAVELP 229
Query: 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022
+L S++E L R +
Sbjct: 230 DSFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEV 262
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 57/272 (20%), Positives = 107/272 (39%), Gaps = 29/272 (10%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLN-VVLALNEIRHRNIVKF 816
+G G G V + + + A+K D + V L + +IV+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRI 70
Query: 817 HGFCSNA----RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
N + +V E L G L + D + + ++K + A+ YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 873 DCLPSIIHRDISSKNVLLDLEFE---AHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
+I HRD+ +N+L + ++DFG AK ++S T T Y APE+
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVL 185
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS-PG 988
+ + D++S GV+++ ++ G P F+S + + S + ++ P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
V +++ ++ L P R T+ + H
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTITEFMNH 272
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-35
Identities = 59/269 (21%), Positives = 103/269 (38%), Gaps = 32/269 (11%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLS--GNMADQDEFLNVVLALNEIR--HRNI 813
+G GG GSVY + VA+K +S G + + V+ L ++ +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 814 VKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
++ + L+ E + L + V A+ + H+
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN- 128
Query: 874 CLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPE-IAYT 931
++HRDI +N+L+DL E + DFG ++ + T+F GT Y+ PE I Y
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYH 184
Query: 932 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991
V+S G+L+++++ G+ P + II R+S+ ++
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFE--------HDEEIIRGQVFFRQRVSSECQHLIR 236
Query: 992 KLISIMEVAILCLDESPEARPTMEKGFGH 1020
CL P RPT E+ H
Sbjct: 237 W----------CLALRPSDRPTFEEIQNH 255
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (336), Expect = 4e-35
Identities = 46/276 (16%), Positives = 94/276 (34%), Gaps = 38/276 (13%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN-IVKF 816
IG+G G +++ L + VA+K + +D + + + I
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 817 HGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
+ F H+ LV + L + D ++ S K + + +H
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 877 SIIHRDISSKNVLLDLEFEAH-----VSDFGIAKFVEPYSSN-------RTEFVGTFGYA 924
S+++RDI N L+ + V DFG+ KF + + GT Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 925 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984
+ + + D+ + G + ++G+ P + + +I + + ST
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-----KAATNKQKYERIGEKKQST 235
Query: 985 P----SPGVMDKLISIMEVAILCLDESPEARPTMEK 1016
P G ++ M + + +A P +
Sbjct: 236 PLRELCAGFPEEFYKYMH---YARNLAFDATPDYDY 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 8e-35
Identities = 53/296 (17%), Positives = 106/296 (35%), Gaps = 29/296 (9%)
Query: 748 KATDDFDEKFCIGKGGQGSVYKAE--LPSGDIVAVKKFNSQLLSGNMADQDE-FLNVVLA 804
+A ++ IG+G G V+KA G VA+K+ Q M + V+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 805 LNEIRHRNIVKFHGFCSNAR-----HSFLVCEYLHRGSLARILGNDATAKELSWNRRINV 859
L H N+V+ C+ +R LV E++ + + + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDM 121
Query: 860 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVG 919
+ + L +LH ++HRD+ +N+L+ + ++DFG+A+ + + V
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVV 177
Query: 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP----------RDFFSINFSSFSN 969
T Y APE+ D++S G + E+ + +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 970 MIIEVNQILDPRLSTPSPGVMDKLISIMEVAIL-----CLDESPEARPTMEKGFGH 1020
+ + S ++K ++ ++ CL +P R + H
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 60/286 (20%), Positives = 100/286 (34%), Gaps = 35/286 (12%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDE-FLNVVLALNEIRHRNIVKF 816
+G+G +VYKA + IVA+KK S + L + L E+ H NI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 817 HGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLP 876
+ + LV +++ I N L+ + + L YLH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 877 SIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA-T 935
I+HRD+ N+LLD ++DFG+AK + T V T Y APE+ + R
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 936 EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN-------------------- 975
D+++ G ++ E++ + I E
Sbjct: 180 VGVDMWAVGCILAELLLRVPF--LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 976 -QILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
L D L+ +++ +P AR T +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-34
Identities = 57/273 (20%), Positives = 101/273 (36%), Gaps = 20/273 (7%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+DFD +GKG G V +G A+K +++ + + L R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTR 63
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H + V EY + G L L + + R + +AL Y
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEY 120
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
LH +++RDI +N++LD + ++DFG+ K + F GT Y APE+
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
D + GV+++E++ G P F + + + IL + P +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP-------FYNQDHERL-FELILMEEIRFP-RTL 228
Query: 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022
+ S++ L + P+ R +
Sbjct: 229 SPEAKSLLA---GLLKKDPKQRLGGGPSDAKEV 258
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-33
Identities = 64/297 (21%), Positives = 107/297 (36%), Gaps = 40/297 (13%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+ + IG G G VY+A+L SG++VA+KK D+ + + ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLD 71
Query: 810 HRNIVKFHGFC------SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGV 863
H NIV+ F + + LV +Y+ + L + +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 864 ANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAH-VSDFGIAKFVEPYSSNRTEFVGTFG 922
+L+Y+H I HRDI +N+LLD + + DFG AK + N + +
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 923 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV-------- 974
A I T DV+S G ++ E++ G F + II+V
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 975 ---------NQILDPRLSTPSPGVMDKLISIMEVAIL--CLDESPEARPTMEKGFGH 1020
+ P V +A+ L+ +P AR T + H
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-33
Identities = 59/293 (20%), Positives = 109/293 (37%), Gaps = 44/293 (15%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G V A + + VA+KK + + L + L RH NI+ +
Sbjct: 16 IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 818 GFCSNA----RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHD 873
+ +L L ++L + LS + + + L Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS- 127
Query: 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP---YSSNRTEFVGTFGYAAPEIAY 930
+++HRD+ N+LL+ + + DFG+A+ +P ++ TE+V T Y APEI
Sbjct: 128 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 931 T-MRATEKYDVYSFGVLVFEVIKGNHP----------------------RDFFSINFSSF 967
T+ D++S G ++ E++ D I
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 968 SNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020
N ++ + + P K + +++ L +P R +E+ H
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALAH 295
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 51/290 (17%), Positives = 111/290 (38%), Gaps = 28/290 (9%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
+++ IG+G G+V+KA+ + +IVA+K+ + L + L E++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--ALREICLLKELK 59
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
H+NIV+ H + + LV E+ + + V + L
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKG 113
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
L +++HRD+ +N+L++ E +++FG+A+ + V T Y P++
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 930 YTMRA-TEKYDVYSFGVLVFEVIKGNHP-----------RDFFSINFSSFSNMIIEVNQI 977
+ + + D++S G + E+ P + F + + + ++
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 978 LDPRLSTPSPGVMDKLISIMEVAIL-------CLDESPEARPTMEKGFGH 1020
D + P + + ++ L +P R + E+ H
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 58/272 (21%), Positives = 97/272 (35%), Gaps = 22/272 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALN 806
++F+ +G G G V+ +G + A+K + + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 807 EIRHR-NIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVAN 865
IR +V H L+ +Y++ G L L E +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 866 ALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRT-EFVGTFGYA 924
+ L H II+RDI +N+LLD ++DFG++K + R +F GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 925 APEIAYTMRA--TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982
AP+I + + D +S GVL++E++ G P F + I +P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPPY 255
Query: 983 STPSPGVMDKLISIMEVAILCLDESPEARPTM 1014
+ LI L + P+ R
Sbjct: 256 PQEMSALAKDLIQ------RLLMKDPKKRLGC 281
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 3e-32
Identities = 57/263 (21%), Positives = 94/263 (35%), Gaps = 23/263 (8%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
D FD +G G G V + SG+ A+K + Q + + + LN L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVN 99
Query: 810 HRNIVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
+VK + + ++V EY+ G + L S + Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEY 156
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIA 929
LH +I+RD+ +N+L+D + V+DFG AK GT APEI
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEII 210
Query: 930 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989
+ + D ++ GVL++E+ G P FF+ I+ S+ +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 990 MDKLISIMEVAILCLDESPEARP 1012
+ L R
Sbjct: 269 LRN----------LLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-30
Identities = 61/311 (19%), Positives = 115/311 (36%), Gaps = 50/311 (16%)
Query: 744 EEIIKATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEF 798
+E+ K + + +G G G+V A + +G VA+KK S A +
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR--A 64
Query: 799 LNVVLALNEIRHRNIVKFHGFC------SNARHSFLVCEYLHRGSLARILGNDATAKELS 852
+ L +RH N++ + +LV ++ + ++L
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLG 119
Query: 853 WNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912
+R ++ + L Y+H IIHRD+ N+ ++ + E + DFG+A+ + S
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD---S 173
Query: 913 NRTEFVGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVIKGNHP--------------- 956
T +V T Y APE I MR T+ D++S G ++ E+I G
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 957 -------RDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPE 1009
+ N + + ++ ++ ++++E L E
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAE 290
Query: 1010 ARPTMEKGFGH 1020
R T + H
Sbjct: 291 QRVTAGEALAH 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 9e-30
Identities = 54/296 (18%), Positives = 100/296 (33%), Gaps = 42/296 (14%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG+G G V+KA +G VA+KK + L + L ++H N+V
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF--PITALREIKILQLLKHENVVNLI 75
Query: 818 GFC--------SNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSY 869
C +LV ++ + + + + V++ + N L Y
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYY 132
Query: 870 LHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS----NRTEFVGTFGYAA 925
+H + I+HRD+ + NVL+ + ++DFG+A+ + T V T Y
Sbjct: 133 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 926 PEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHP----------RDFFSINFSSFSNMIIEV 974
PE+ R D++ G ++ E+ + + S + V
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 975 NQILDPRLSTPSPGVMDKLISIMEVAIL----------CLDESPEARPTMEKGFGH 1020
+ G K+ ++ + L P R + H
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-28
Identities = 58/309 (18%), Positives = 110/309 (35%), Gaps = 46/309 (14%)
Query: 744 EEIIKATDDFDEKF----CIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEF 798
+E+ K + E++ +G G GSV A +G VAVKK + S +
Sbjct: 7 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRT 64
Query: 799 LNVVLALNEIRHRNIVKFHGFCSNAR-----HSFLVCEYLHRGSLARILGNDATAKELSW 853
+ L ++H N++ + AR + + +L L I ++L+
Sbjct: 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKLTD 120
Query: 854 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN 913
+ +I + L Y+H IIHRD+ N+ ++ + E + DFG+A+ +
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EM 175
Query: 914 RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP----------------- 956
+ A + M + D++S G ++ E++ G
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 957 -----RDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEAR 1011
I+ S N I + Q+ + G + ++E L + R
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKR 292
Query: 1012 PTMEKGFGH 1020
T + H
Sbjct: 293 ITAAQALAH 301
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 4e-28
Identities = 59/246 (23%), Positives = 100/246 (40%), Gaps = 28/246 (11%)
Query: 759 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817
IG G QG V A + VA+KK + + A + ++ + + H+NI+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR--AYRELVLMKCVNHKNIISLL 82
Query: 818 GFCSNARHS------FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLH 871
+ + +LV E + I EL R ++ + + +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH 136
Query: 872 HDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYT 931
IIHRD+ N+++ + + DFG+A+ S T +V T Y APE+
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 192
Query: 932 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMD 991
M E D++S G ++ E+++ F ++ N +IE L TP P M
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKIL--FPGRDYIDQWNKVIEQ-------LGTPCPEFMK 243
Query: 992 KLISIM 997
KL +
Sbjct: 244 KLQPTV 249
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 112 bits (280), Expect = 2e-27
Identities = 55/302 (18%), Positives = 105/302 (34%), Gaps = 49/302 (16%)
Query: 751 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR 809
DD+ +G+G V++A + + + V VK + + + L +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLR 87
Query: 810 -HRNIVKFHGFCSN--ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANA 866
NI+ + +R LV E+++ ++ + L+ + + A
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKA 141
Query: 867 LSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAA 925
L Y H I+HRD+ NV++D E + + D+G+A+F P V + +
Sbjct: 142 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKG 197
Query: 926 PEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHP------------RDFFSINFSSFSNMII 972
PE+ + D++S G ++ +I P R + + I
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 973 EVNQILDPRLSTPSPGVMDKLISIMEVAIL--------------CLDESPEARPTMEKGF 1018
+ N LDPR + K + L ++R T +
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
Query: 1019 GH 1020
H
Sbjct: 318 EH 319
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 104 bits (260), Expect = 5e-25
Identities = 88/336 (26%), Positives = 131/336 (38%), Gaps = 38/336 (11%)
Query: 28 EACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGS--RVISINLS 85
+ ALL K L N + LSSW + +W G+ C+ RV +++LS
Sbjct: 7 DKQALLQIKKDLGN----PTTLSSWL----PTTDCCNRTWLGVLCDTDTQTYRVNNLDLS 58
Query: 86 TLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDL-GNNQLSGVISP 144
L L + IP + NL L L + G N L G I P
Sbjct: 59 GLNLPKPYP-----------------------IPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 145 EIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLY 204
I KL QL LY+ + G IP + Q+ + F +N +SG +P S+ +L L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 205 LNNNSLFGYIPTVMGNLKSLST-LDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP 263
+ N + G IP G+ L T + +S+N+L G IP T NL+ +
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV 215
Query: 264 SIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTL 323
+ Q + G + + L +N + G++P L LK L +L
Sbjct: 216 LFGSDKN--TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 324 GLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIP 359
+ N L G I P GNL + NN P
Sbjct: 274 NVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 87.5 bits (215), Expect = 3e-19
Identities = 63/276 (22%), Positives = 102/276 (36%), Gaps = 5/276 (1%)
Query: 331 NGVIPPSIGNLSSLRNLSLFNNGLYG--SIPEEIGYLKSLSELKLCKN-NLSGVIPHSVG 387
GV+ + + NL L L IP + L L+ L + NL G IP ++
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 388 NLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQ 447
LT L L + ++ G IP L + +L + F+ N L G + + PNL +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 448 NNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLE 507
N G I ++ + KL T + N + L F S +++ L
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF-VDLSRNMLEGDASVLF 217
Query: 508 KLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSN 567
+ I + G L LDL N++ ++P+ + L L+ LN+S
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 568 NQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVC 603
N IP + L ++N P C
Sbjct: 278 NNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.1 bits (188), Expect = 1e-15
Identities = 63/296 (21%), Positives = 101/296 (34%), Gaps = 27/296 (9%)
Query: 374 CKNNLSGVIPHSVGNLTGLVLLNMCENHLFG--PIPKSLKSLTSLKRVRFNQN-NLVGKV 430
C GV+ + + L++ +L PIP SL +L L + NLVG +
Sbjct: 34 CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI 93
Query: 431 YEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQF 490
A L +L ++ N G I + L T S N + G++P I L
Sbjct: 94 PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 491 LDLSSNHIVGKIPVQLEKLFSLNKLILSL-NQLSGSVPLEFGSLTELQYLDLSANKLSSS 549
+ N I G IP L + N+L+G +P F +L +
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA 213
Query: 550 IPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLE 609
+ N+ + K ++ DL +N + +P + ++ L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLH 271
Query: 610 KLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKDGLMEGNKGLCG 665
LN+S NNL G IP+ ++ NK LCG
Sbjct: 272 SLNVSFNNLCGEIPQ-GGNLQRFDVSAY--------------------ANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 2e-08
Identities = 40/214 (18%), Positives = 65/214 (30%), Gaps = 3/214 (1%)
Query: 531 GSLTELQYLDLSANKLSS--SIPKSIGNLLKLYYLNLSNN-QFSHTIPIEFEKLIHLSKL 587
+ LDLS L IP S+ NL L +L + IP KL L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 588 DLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIP 647
++H + IP + +++L L+ S+N LSG +P + +L I N + G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 648 NSTVFKDGLMEGNKGLCGNFEAFSSCDAFMSHKQTSRKKWIVIVFPILGMVLLLISLIGF 707
+S L + ++ + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 708 FFFFRQRKKDSQEEQTISMNPLRLLSVLNFDGKI 741
D + L G +
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (250), Expect = 6e-24
Identities = 66/264 (25%), Positives = 108/264 (40%), Gaps = 7/264 (2%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177
+P I Q + L N++S V + L L+L N L L+L+
Sbjct: 26 VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 178 EFSFCHNNVSGRI-PSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG 236
+ N + P++ L +L L+L+ L P + L +L L L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 237 LIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSW 296
L T +L NL LFL+ N +S L SL +L L +N+++ P +F +L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 297 TLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYG 356
+ LF+N+LS L L++L L L N + + L+ ++ +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPC 262
Query: 357 SIPEEIGYLKSLSELKLCKNNLSG 380
S+P+ L +L N+L G
Sbjct: 263 SLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (220), Expect = 4e-20
Identities = 63/276 (22%), Positives = 104/276 (37%), Gaps = 8/276 (2%)
Query: 226 TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGS 285
T Q L +P + + +FL+ N +S + ++L L L N L+
Sbjct: 15 TTSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 286 IPLSFGNLSSWTLMSLFSNSLSGSIPP-ILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSL 344
+F L+ + L N+ S+ P L L TL L L + P L++L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 345 RNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFG 404
+ L L +N L + L +L+ L L N +S V + L L L + +N +
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 405 PIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKL 464
P + + L L + NNL EA L +L L+ N + L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP-LWAWL 250
Query: 465 DTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVG 500
F S + + S+P + L++N + G
Sbjct: 251 QKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (219), Expect = 7e-20
Identities = 59/265 (22%), Positives = 96/265 (36%), Gaps = 7/265 (2%)
Query: 357 SIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSL 416
++P I + + L N +S V S L +L + N L + L L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 417 KRVRFNQNNLVGKVYE-AFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIF 475
+++ + N + V F L L L + +R L L + N +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 476 GSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTE 535
D L L L N I L SL++L+L N+++ P F L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 536 LQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQ 595
L L L AN LS+ +++ L L YL L++N + L K S + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVP 261
Query: 596 EEIPPQVCNMESLEKLNLSHNNLSG 620
+P + + L+ N+L G
Sbjct: 262 CSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.2 bits (196), Expect = 6e-17
Identities = 59/279 (21%), Positives = 98/279 (35%), Gaps = 8/279 (2%)
Query: 294 SSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNG 353
S L ++P + + + L+ N+++ V S +L L L +N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 354 LYGSIPEEIGYLKSLSELKLCKNNLSGVI-PHSVGNLTGLVLLNMCENHLFGPIPKSLKS 412
L L L +L L N + P + L L L++ L P +
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 413 LTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMN 472
L +L+ + N L + F D NLT L L N +R L LD ++ N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 473 NIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGS 532
+ P D +L L L +N++ L L +L L L+ N
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PL 246
Query: 533 LTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFS 571
LQ S++++ S+P+ + L+ N
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (183), Expect = 3e-15
Identities = 43/243 (17%), Positives = 78/243 (32%), Gaps = 4/243 (1%)
Query: 42 QNLNSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSF 101
++ ++ + + + + + + ++LS + +F
Sbjct: 45 SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL 104
Query: 102 PHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQ 161
L L+L P L+ LQ L L +N L + L L L+L N+
Sbjct: 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164
Query: 162 LHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNL 221
+ L + N V+ P + +L +L LYL N+L + L
Sbjct: 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224
Query: 222 KSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQ 281
++L L L+ N + L + + S+P L L N
Sbjct: 225 RALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAAND 280
Query: 282 LSG 284
L G
Sbjct: 281 LQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 6e-15
Identities = 57/253 (22%), Positives = 88/253 (34%), Gaps = 4/253 (1%)
Query: 398 CENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFN 457
C +P + + +R+ + N + +F NLT L L N +
Sbjct: 18 CPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 458 WRNLPKLDTFIVSMNNIFGSI-PLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLI 516
+ L L+ +S N S+ P +L L L + P L +L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 517 LSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPI 576
L N L F L L +L L N++SS ++ L L L L N+ +H P
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 577 EFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCID 636
F L L L L N L + + +L+ L L+ N R L
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFR 254
Query: 637 ICYNELQGPIPNS 649
+E+ +P
Sbjct: 255 GSSSEVPCSLPQR 267
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 36/158 (22%), Positives = 56/158 (35%), Gaps = 5/158 (3%)
Query: 525 SVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHL 584
+VP+ + + Q + L N++S S L L L +N + F L L
Sbjct: 25 AVPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 585 SKLDLSHNILQEEIPPQV-CNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+LDLS N + P + L L+L L P F + +L + + N LQ
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 644 GPIPNSTVFKDGLMEGNKGLCGNFEAFSSCDAFMSHKQ 681
++ L L GN + AF
Sbjct: 143 ALPDDTFRDLGNLTH--LFLHGNRISSVPERAFRGLHS 178
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (254), Expect = 1e-23
Identities = 82/386 (21%), Positives = 136/386 (35%), Gaps = 35/386 (9%)
Query: 220 NLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIE 279
L L + + + + +L + TL + + SI + L +L Q++
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDGV-EYLNNLTQINFSN 75
Query: 280 NQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIG 339
NQL+ P NL+ + + +N ++ P + TL +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 340 ---------NLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELK----LCKNNLSGVIPHSV 386
+S + LS + S ++ LK L+ L L ++ +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 387 GNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLS 446
LT L L N + P + T+L + N N L NLT LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 447 QNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL 506
N + L KL + N I PL + N + +
Sbjct: 250 NNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNL----ELNENQLEDISPI 303
Query: 507 EKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLS 566
L +L L L N +S P SLT+LQ L + NK+S S+ NL + +L+
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 567 NNQFSHTIPIEFEKLIHLSKLDLSHN 592
+NQ S P L +++L L+
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.3 bits (246), Expect = 1e-22
Identities = 80/386 (20%), Positives = 141/386 (36%), Gaps = 35/386 (9%)
Query: 184 NNVSGRIP-SSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTL 242
NV+ + + L ++ L L S+ G + L +L+ ++ S NQL + P L
Sbjct: 32 TNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--L 84
Query: 243 DNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLF 302
NL+ L + + N ++ P + L + NL++ + L
Sbjct: 85 KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT----DIDPLKNLTNLNRLELS 140
Query: 303 SNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362
SN++ + L L++L + NL++L L + +N S +
Sbjct: 141 SNTI-----SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVSDISVL 193
Query: 363 GYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFN 422
L +L L N +S + P LT L L++ N L +L SLT+L +
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 423 QNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEI 482
N + LT L L N + I
Sbjct: 250 NNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS--- 304
Query: 483 GDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLS 542
+ L +L L N+I P + L L +L + N++S +LT + +L
Sbjct: 305 -NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 543 ANKLSSSIPKSIGNLLKLYYLNLSNN 568
N++S P + NL ++ L L++
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.2 bits (238), Expect = 1e-21
Identities = 75/382 (19%), Positives = 127/382 (33%), Gaps = 75/382 (19%)
Query: 316 NLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCK 375
L L + + + +L + L G+ SI + + YL +L+++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 75
Query: 376 NNLSGVIPHSVGNLTGLVLLNM------------------------------CENHLFGP 405
N L+ + P + NLT LV + M
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 406 IPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWR------ 459
+ + S ++ + + +L L IS N
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 460 -NLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILS 518
L L++ I + N I PL I + L L L+ N + L L +L L L+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 519 LNQLSGSVPLEFGSLTELQYLDLSANKLSSSIP--------------------KSIGNLL 558
NQ+S P LT+L L L AN++S+ P I NL
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 559 KLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNL 618
L YL L N S P L L +L ++N + + + N+ ++ L+ HN +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 619 SGFIPRCFEKMRSLSCIDICYN 640
S P + ++ + +
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.8 bits (224), Expect = 7e-20
Identities = 80/340 (23%), Positives = 140/340 (41%), Gaps = 31/340 (9%)
Query: 122 IGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSF 181
+ L+ L ++ NNQL+ + + L +L + ++ NQ+ P
Sbjct: 62 VEYLNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 182 CHNNVSGRIP------------SSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDL 229
+ +++ ++S L+ L FG T + L +L+TL+
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 230 SQNQLNGLIPCTLD-NLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPL 288
N + ++ L+NL++L N +S P I +L +L L NQL
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IG 235
Query: 289 SFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLS 348
+ +L++ T + L +N +S P L L L+ L L NQ++ + P + L++L NL
Sbjct: 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 291
Query: 349 LFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPK 408
L N I LK+L+ L L NN+S + P V +LT L L N +
Sbjct: 292 LNEN--QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VS 345
Query: 409 SLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQN 448
SL +LT++ + N + + +T L L+
Sbjct: 346 SLANLTNINWLSAGHNQISDLT--PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.5 bits (218), Expect = 4e-19
Identities = 68/388 (17%), Positives = 140/388 (36%), Gaps = 31/388 (7%)
Query: 96 FSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRL 155
F+ ++ + L + +L ++ L + + + LN L ++
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQI 71
Query: 156 YLDMNQLHGTIP----PVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLF 211
NQL P + + + + ++ + L + ++
Sbjct: 72 NFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131
Query: 212 GYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFL-------YKNSLSGSIPS 264
+ + + ++S + + + +++L L +S S S
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191
Query: 265 IIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLG 324
++ L +L L NQ+S P G L++ +SL N L L +L +L+ L
Sbjct: 192 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 325 LYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPH 384
L NQ++ + P + L+ L L L N + P + L +L+ L+L +N
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDIS 301
Query: 385 SVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLD 444
+ NL L L + N++ P + SLT L+R+ F N + + + N+ +L
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 445 LSQNNFDGKISFNWRNLPKLDTFIVSMN 472
N NL ++ ++
Sbjct: 358 AGHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.1 bits (204), Expect = 3e-17
Identities = 53/240 (22%), Positives = 91/240 (37%), Gaps = 16/240 (6%)
Query: 65 CSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGN 124
++ + + ++ + N + +L +L + N P I
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL- 218
Query: 125 LSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHN 184
+ L L L NQL + + L L L L NQ+ P + L+ + E N
Sbjct: 219 -TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 273
Query: 185 NVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDN 244
+S P + L N + + NLK+L+ L L N ++ + P + +
Sbjct: 274 QISNISPLAGLTALTNLELNENQL----EDISPISNLKNLTYLTLYFNNISDISP--VSS 327
Query: 245 LSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSN 304
L+ L LF N +S S + NL +++ L NQ+S PL NL+ T + L
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 1e-07
Identities = 24/158 (15%), Positives = 55/158 (34%), Gaps = 8/158 (5%)
Query: 3 LPIFIILILFLLLNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKI 62
+ L L+ ++N S+ + + + L +++ + L ++
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISN-ISPLAGLTALTNLEL 292
Query: 63 SPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQI 122
+ IS + + L ++ SS L L + N +
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDIS---PVSSLTKLQRLFFANNKVSD--VSSL 347
Query: 123 GNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMN 160
NL+ + L G+NQ+S + + L ++ +L L+
Sbjct: 348 ANLTNINWLSAGHNQISDLT--PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 1e-07
Identities = 41/271 (15%), Positives = 92/271 (33%), Gaps = 21/271 (7%)
Query: 388 NLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQ 447
L + + + ++ + ++ L + ++ ++ + K + NLT ++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 75
Query: 448 NNFDGKISF-NWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQL 506
N N L + + +I L L ++ + +
Sbjct: 76 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 507 EKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGN---------- 556
S N + + + ++ L AN + N
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 557 LLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHN 616
L L L +NNQ S P+ +L +L L+ N L++ + ++ +L L+L++N
Sbjct: 196 LTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 617 NLSGFIPRCFEKMRSLSCIDICYNELQGPIP 647
+S P + L+ + + N++ P
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.4 bits (88), Expect = 0.004
Identities = 20/130 (15%), Positives = 51/130 (39%), Gaps = 6/130 (4%)
Query: 532 SLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSH 591
+L E L ++ ++ ++ +L ++ L +E+ L +L++++ S+
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEY--LNNLTQINFSN 75
Query: 592 NILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTV 651
N L + P + N+ L + +++N ++ P + + P+ N T
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 652 FKDGLMEGNK 661
+ N
Sbjct: 134 LNRLELSSNT 143
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.9 bits (237), Expect = 4e-22
Identities = 61/317 (19%), Positives = 110/317 (34%), Gaps = 29/317 (9%)
Query: 65 CSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGN 124
C + C+ G + +L L+L N N
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPP----------------DTALLDLQNNKITEIKDGDFKN 53
Query: 125 LSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHN 184
L L L L NN++S + L +L RLYL NQL + L +
Sbjct: 54 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT 113
Query: 185 NVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDN 244
V + + L + + L S G +K LS + ++ + + +
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSS-GIENGAFQGMKKLSYIRIADTNITTIPQGLPPS 172
Query: 245 LSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSN 304
L+ L L N ++ + + L +L +L L N +S S N + L +N
Sbjct: 173 LTELH---LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229
Query: 305 SLSGSIPPILGNLKSLSTLGLYLNQLNGV------IPPSIGNLSSLRNLSLFNNGL--YG 356
L +P L + K + + L+ N ++ + P +S +SLF+N + +
Sbjct: 230 KLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288
Query: 357 SIPEEIGYLKSLSELKL 373
P + + ++L
Sbjct: 289 IQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 93.6 bits (231), Expect = 2e-21
Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 17/276 (6%)
Query: 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCT 241
C + ++P L ALL L NN + NLK+L TL L N+++ + P
Sbjct: 17 CSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 242 LDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSL 301
L L+ L+L KN L + L+ L + N+++ F L+ ++ L
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHE---NEITKVRKSVFNGLNQMIVVEL 131
Query: 302 FS--NSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIP 359
+ SG +K LS + + + + G SL L L N +
Sbjct: 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDA 188
Query: 360 EEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV 419
+ L +L++L L N++S V S+ N L L++ N L +P L ++ V
Sbjct: 189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247
Query: 420 RFNQNNLVGKVYEAF------GDHPNLTFLDLSQNN 449
+ NN+ F + + + L N
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 89.3 bits (220), Expect = 7e-20
Identities = 57/301 (18%), Positives = 102/301 (33%), Gaps = 38/301 (12%)
Query: 357 SIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSL 416
+P+++ + L L N ++ + NL L L + N + P + L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 417 KRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFG 476
+R+ ++N L + L + + FN N + + G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSG 140
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTEL 536
KL ++ ++ +I + G L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT---------------------------TIPQGLPPSL 173
Query: 537 QYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQE 596
L L NK++ S+ L L L LS N S HL +L L++N L
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 232
Query: 597 EIPPQVCNMESLEKLNLSHNNLSGFIPRCF------EKMRSLSCIDICYNELQ-GPIPNS 649
++P + + + ++ + L +NN+S F K S S + + N +Q I S
Sbjct: 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
Query: 650 T 650
T
Sbjct: 293 T 293
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.7 bits (169), Expect = 3e-13
Identities = 41/205 (20%), Positives = 74/205 (36%), Gaps = 10/205 (4%)
Query: 477 SIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTEL 536
+P ++ LDL +N I + L +L+ LIL N++S P F L +L
Sbjct: 24 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 537 QYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQE 596
+ L LS N+L K L +L N+ + F L + ++L N L+
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 597 --EIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKD 654
M+ L + ++ N++ SL+ + + N++ S +
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLKGLN 195
Query: 655 GLMEGNKGLCGNFEAFSSCDAFMSH 679
L + + A H
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPH 220
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.8 bits (133), Expect = 8e-09
Identities = 40/247 (16%), Positives = 74/247 (29%), Gaps = 9/247 (3%)
Query: 15 LNFSHNVTSDSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPCSWFGISCNH 74
L +N S S A A L L L ++ + +
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
Query: 75 AGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLG 134
I + +F + L+ G L L L
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLD 179
Query: 135 NNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSL 194
N+++ V + + LN L +L L N + + + E +N + ++P L
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 238
Query: 195 GNLSKLALLYLNNNSLFG------YIPTVMGNLKSLSTLDLSQNQLN--GLIPCTLDNLS 246
+ + ++YL+NN++ P S S + L N + + P T +
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298
Query: 247 NLDTLFL 253
+ L
Sbjct: 299 VRAAVQL 305
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.3 bits (238), Expect = 1e-21
Identities = 55/248 (22%), Positives = 97/248 (39%), Gaps = 30/248 (12%)
Query: 759 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVK-- 815
+G G +V+ A+ + + VA+K + G+ + + + L + + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKI-----VRGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 816 -------------FHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKG 862
F+ N H +V E L LA I + L + ++I K
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQ 133
Query: 863 VANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGIAKFVEP--YSSNRTEFVG 919
+ L Y+H C IIH DI +NVL+++ ++ IA Y + T +
Sbjct: 134 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 920 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979
T Y +PE+ D++S L+FE+I G+ F S++ + QI++
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIE 249
Query: 980 PRLSTPSP 987
PS
Sbjct: 250 LLGELPSY 257
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.3 bits (205), Expect = 1e-18
Identities = 26/166 (15%), Positives = 52/166 (31%), Gaps = 18/166 (10%)
Query: 759 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMA------DQDEFLNVVLALNEIRHRN 812
+G+G + +V+ VK S F + + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 813 IVKFHGFCSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH 872
+ K G +++ ++ L + + V+ + ++ +H
Sbjct: 68 LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 873 DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSNRTEFV 918
I+H D+S NVL+ E + DF + VE E +
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQS--VEVGEEGWREIL 161
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 9e-10
Identities = 44/197 (22%), Positives = 66/197 (33%), Gaps = 6/197 (3%)
Query: 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCT 241
C +P L +L+L+ N L+ + + L+ L+L + +L
Sbjct: 17 CDKRNLTALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQV 72
Query: 242 LDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSL 301
L L TL L N L D+ N+L+ + L + L
Sbjct: 73 DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQELYL 131
Query: 302 FSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEE 361
N L P +L L L L N L + + L +L L L N LY +IP+
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 362 IGYLKSLSELKLCKNNL 378
L L N
Sbjct: 191 FFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 44/210 (20%), Positives = 69/210 (32%), Gaps = 7/210 (3%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
S + +N +PP + L L N L + +L +L
Sbjct: 5 EVSKVASHLEVNCD-KRNLTALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT 216
LD +L + + S + +L L+ L + + SL
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 217 VMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLD 276
+ L L L N+L L P L L+ L L N+L+ ++ L++L L
Sbjct: 122 GL---GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 277 LIENQLSGSIPLSFGNLSSWTLMSLFSNSL 306
L EN L +IP F L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 3e-09
Identities = 47/208 (22%), Positives = 78/208 (37%), Gaps = 7/208 (3%)
Query: 289 SFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLS 348
++S ++ +L+ ++PP L K + L L N L ++ + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 349 LFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPK 408
L + + G L L L L N L + L +L++ N L
Sbjct: 62 LDRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPLG 118
Query: 409 SLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFI 468
+L+ L L+ + N L P L L L+ NN + L LDT +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 469 VSMNNIFGSIPLEIGDSSKLQFLDLSSN 496
+ N+++ +IP S L F L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 4e-09
Identities = 36/207 (17%), Positives = 59/207 (28%), Gaps = 25/207 (12%)
Query: 337 SIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLN 396
+ ++S ++ L ++P ++ K + L L +N L ++ T L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 397 M-CENHLFGPIPKSLKSLTSLKRVRFNQ--------------------NNLVGKVYEAFG 435
+ + +L L +L N L A
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 436 DHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSS 495
L L L N PKL+ ++ NN+ + L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 496 NHIVGKIPVQLEKLFSLNKLILSLNQL 522
N + IP L L N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 45/212 (21%), Positives = 76/212 (35%), Gaps = 7/212 (3%)
Query: 240 CTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLM 299
C + +++ + K +L+ ++P + K L L EN L + + L
Sbjct: 4 CEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTR--LT 58
Query: 300 SLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIP 359
L + + + G L L TL L NQL + + + N L
Sbjct: 59 QLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPL 117
Query: 360 EEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV 419
+ L L EL L N L + P + L L++ N+L L L +L +
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFD 451
+N+L + + F L F L N +
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 8e-08
Identities = 33/180 (18%), Positives = 54/180 (30%), Gaps = 46/180 (25%)
Query: 101 FPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQ----------------------- 137
L+LS NL + + ++L L+L +
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQL 89
Query: 138 ----------------------LSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSL 175
L+ + + L +L+ LYL N+L P ++
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235
+ + S +NN++ L L L L L NSL+ IP L L N
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 36/192 (18%), Positives = 51/192 (26%), Gaps = 48/192 (25%)
Query: 472 NNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQ---------- 521
++P ++ L LS N + L L +L L +
Sbjct: 19 KRNLTALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTL 76
Query: 522 -----------------------------------LSGSVPLEFGSLTELQYLDLSANKL 546
L+ L ELQ L L N+L
Sbjct: 77 PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136
Query: 547 SSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNME 606
+ P + KL L+L+NN + L +L L L N L IP
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195
Query: 607 SLEKLNLSHNNL 618
L L N
Sbjct: 196 LLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 9e-05
Identities = 31/197 (15%), Positives = 64/197 (32%), Gaps = 9/197 (4%)
Query: 507 EKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLS 566
K+ S ++ L+ ++P + + L LS N L + ++ +L LNL
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 567 NNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCF 626
+ + ++ + + +P + +L L++S N L+
Sbjct: 64 RAELTKLQVDGTLPVLGTLD---LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 627 EKMRSLSCIDICYNELQGPIPNSTVFKDGLMEGNKGLCGNFEAFSSCDAFMSHKQT---S 683
+ L + + NEL+ P L + + E + + + T
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 684 RKKWIVIVFPILGMVLL 700
I G LL
Sbjct: 181 ENSLYTIPKGFFGSHLL 197
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 56.6 bits (135), Expect = 2e-09
Identities = 36/228 (15%), Positives = 74/228 (32%), Gaps = 18/228 (7%)
Query: 340 NLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCE 399
L++ ++ + + ++ + L ++ L ++ + V L L+ L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 400 NHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWR 459
N + P + + + N V + + N +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 460 NLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSL 519
L I +++ + G L+ Q D L L L L
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD----------LTPLANLSKLTTLKADD 182
Query: 520 NQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSN 567
N++S P SL L + L N++S P + N L+ + L+N
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 39/227 (17%), Positives = 81/227 (35%), Gaps = 18/227 (7%)
Query: 316 NLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCK 375
L + + + + + + +L + LS F G+ + E + YL +L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72
Query: 376 NNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFG 435
N ++ + P N+ + LK+++++ ++ + +
Sbjct: 73 NQITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 436 DHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSS 495
+I+ + +S+ N S + + SKL L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 496 NHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLS 542
N I P L L +L ++ L NQ+S PL + + L + L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 31/218 (14%), Positives = 65/218 (29%), Gaps = 22/218 (10%)
Query: 388 NLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQ 447
L + + ++++ + + L + + + E NL L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72
Query: 448 NNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLE 507
N + +I + ++ L+
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 508 KLFSLNKLILSLNQL--------------SGSVPLEFGSLTELQYLDLSANKLSSSIPKS 553
L+ I +++ L S +L++L L NK+S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 554 IGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSH 591
+ +L L ++L NNQ S P +L + L++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 39/228 (17%), Positives = 72/228 (31%), Gaps = 18/228 (7%)
Query: 124 NLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183
L+ + G + ++ ++ L+ + L + TI + L+ +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLD 243
N ++ P L N I + T + L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 244 NLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFS 303
L + L+G ++ + DL NLS T +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP----------LANLSKLTTLKADD 182
Query: 304 NSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFN 351
N +S P L +L +L + L NQ++ V P + N S+L ++L N
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 4e-06
Identities = 35/230 (15%), Positives = 70/230 (30%), Gaps = 18/230 (7%)
Query: 96 FSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRL 155
F + + + + + + +L + L ++ + + LN L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGL 68
Query: 156 YLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIP 215
L NQ+ + L+ I E N + + K L + +
Sbjct: 69 ELKDNQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 216 TVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQL 275
+ I + +L + S + + NL L L
Sbjct: 127 GLSNLQVL--------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTL 178
Query: 276 DLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGL 325
+N++S P +L + + L +N +S P L N +L + L
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 18/110 (16%), Positives = 37/110 (33%), Gaps = 5/110 (4%)
Query: 52 WTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSF 111
L + ++ I+ + + ++ ++ ++ L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 112 NLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQ 161
N P + +L L + L NNQ+S V + + L + L NQ
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLT-NQ 227
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 3e-09
Identities = 39/283 (13%), Positives = 80/283 (28%), Gaps = 24/283 (8%)
Query: 296 WTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIP-PSIGNLSSLRNLSLFNNGL 354
W + L +L P + G L S + + P + ++++ L N+ +
Sbjct: 2 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVI 58
Query: 355 YG-SIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSL 413
++ + L L L LS I +++ + LV LN+ F
Sbjct: 59 EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118
Query: 414 TSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNN 473
+ + N + + ++Q N G ++
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178
Query: 474 IFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILS-LNQLSGSVPLEFGS 532
S + + +L L L LS + LE G
Sbjct: 179 ---------------HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 223
Query: 533 LTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIP 575
+ L+ L + ++ L L ++ + F+
Sbjct: 224 IPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 8e-09
Identities = 35/254 (13%), Positives = 79/254 (31%), Gaps = 15/254 (5%)
Query: 103 HLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEI-GKLNQLRRLYLDMNQ 161
++ F + + ++Q++DL N+ + I + ++L+ L L+ +
Sbjct: 24 GVIAFRCP-RSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 162 LHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNL 221
L I + + S + + + S L LN + F + +
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 222 KSLSTLDLSQNQLNGL---------IPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSL 272
+ + ++Q L+G + + L L L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 273 HQLDLIE-NQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLN 331
L L + L G + + + +F G++ + L L + +
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFT 259
Query: 332 GVIPPSIGNLSSLR 345
+ P+IGN +
Sbjct: 260 TIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 9e-09
Identities = 33/160 (20%), Positives = 58/160 (36%), Gaps = 5/160 (3%)
Query: 491 LDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPL-EFGSLTELQYLDLSANKLS-S 548
LDL+ ++ + +L S + + PL E S +Q++DLS + + S
Sbjct: 5 LDLTGKNLHPDV---TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 549 SIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESL 608
++ + KL L+L + S I K +L +L+LS E Q
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 609 EKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPN 648
L+ + F + + + I L G N
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 38/284 (13%), Positives = 88/284 (30%), Gaps = 22/284 (7%)
Query: 107 LNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHG-T 165
L+L+ ++ ++ + + + + + E +++ + L + + T
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVST 62
Query: 166 IPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLS 225
+ ++ Q S + S +S I ++L S L L L+ S F
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT------- 115
Query: 226 TLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGS 285
+ + L L + + S NL + + +
Sbjct: 116 ----LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV 171
Query: 286 IPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGL-YLNQLNGVIPPSIGNLSSL 344
L S L L L L L + +G + +L
Sbjct: 172 RRCPN----LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227
Query: 345 RNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGN 388
+ L +F G++ ++L L++ ++ + + ++GN
Sbjct: 228 KTLQVFGIVPDGTLQLLK---EALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 51/262 (19%), Positives = 92/262 (35%), Gaps = 17/262 (6%)
Query: 78 RVISINLSTLCLNGTFQD---FSFSSFPHLVNLNLSFNLFFGNIPPQI-GNLSKLQNLDL 133
R++S + +F D S + +++LS ++ + I SKLQNL L
Sbjct: 19 RLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78
Query: 134 GNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLI--------HEFSFCHNN 185
+LS I + K + L RL L S F F +
Sbjct: 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH 138
Query: 186 VSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQL-NGLIPCTLDN 244
V + +++L L N + T++ +L LDLS + +
Sbjct: 139 VQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ 198
Query: 245 LSNLDTLFLYK-NSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFS 303
L+ L L L + + +G + +L L + G++ L L + +
Sbjct: 199 LNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINC 255
Query: 304 NSLSGSIPPILGNLKSLSTLGL 325
+ + P +GN K+ G+
Sbjct: 256 SHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 6e-06
Identities = 36/249 (14%), Positives = 76/249 (30%), Gaps = 13/249 (5%)
Query: 395 LNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGK- 453
L++ +L + L S + R ++ + + E F + +DLS + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVST 62
Query: 454 ISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLN 513
+ KL + + I + +S L L+LS + +Q
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 514 KLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSS---------SIPKSIGNLLKLYYLN 564
L+L+ ++ LS ++
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 565 LSNNQFSHTIPIEFEKLIHLSKLDLSH-NILQEEIPPQVCNMESLEKLNLSHNNLSGFIP 623
+ + EF +L +L L LS + E ++ + +L+ L + G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 624 RCFEKMRSL 632
E + L
Sbjct: 243 LLKEALPHL 251
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 8e-09
Identities = 56/343 (16%), Positives = 99/343 (28%), Gaps = 28/343 (8%)
Query: 270 KSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQ 329
+ H+L+L LS S+P +L S + NSL+ +P + +LKSL L
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 330 LNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNL 389
L+ + P L S ++ NN +P +L
Sbjct: 93 LSDLPP----------LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142
Query: 390 TGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNN 449
+ N L + + + + +
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLP---DLPLSLESIVAGNNILEELPE 199
Query: 450 FDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKL 509
+ + S + L
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 510 FSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQ 569
L + LN S + L+ L++S NKL +P L + L S N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLER---LIASFNH 315
Query: 570 FSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLN 612
+ +P E +L +L + +N L+ E P ++E L ++N
Sbjct: 316 LA-EVP---ELPQNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 3e-08
Identities = 54/338 (15%), Positives = 105/338 (31%), Gaps = 28/338 (8%)
Query: 222 KSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQ 281
+ L+L+ L+ L P + +L++L NSL+ +P + +LKSL +
Sbjct: 38 RQAHELELNNLGLSSL-P---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 282 LSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNL 341
L L L + S+ ++ N +
Sbjct: 93 L-------------SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLP 139
Query: 342 SSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENH 401
SL ++ NN L + + +P S+ ++ +
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199
Query: 402 LFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNL 461
L + + + ++ F + L
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 462 PKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQ 521
+L + +N I L+ L++S+N ++ ++P L +LI S N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNH 315
Query: 522 LSGSVPLEFGSLTELQYLDLSANKLSS--SIPKSIGNL 557
L+ VP L+ L + N L IP+S+ +L
Sbjct: 316 LA-EVP---ELPQNLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.1 bits (128), Expect = 4e-08
Identities = 60/345 (17%), Positives = 105/345 (30%), Gaps = 30/345 (8%)
Query: 240 CTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLM 299
C L+ L LS S+P + +L+SL N L+ +P +L S +
Sbjct: 35 CLDRQAHELE---LNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVD 86
Query: 300 SLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIP 359
+ +LS P + S + P + N S L+ + + NN L
Sbjct: 87 NNNLKALSDLPPLLEYLGVSNN---------QLEKLPELQNSSFLKIIDVDNNSLKKLPD 137
Query: 360 EEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRV 419
+ + + + L + + L+ +
Sbjct: 138 LPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEEL 197
Query: 420 RFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIP 479
QN A + +LP+L + ++
Sbjct: 198 PELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS 257
Query: 480 LEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYL 539
L +L+ SSN I + SL +L +S N+L +P L+ L
Sbjct: 258 GLSELPPNLYYLNASSNE----IRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERL 309
Query: 540 DLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHL 584
S N L + +P+ NL L++ N P E + L
Sbjct: 310 IASFNHL-AEVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 9e-07
Identities = 24/92 (26%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 541 LSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPP 600
N S+ I L LN+SNN+ +P +L +L S N L E +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLAE-VPE 321
Query: 601 QVCNMESLEKLNLSHNNLSGFIPRCFEKMRSL 632
++L++L++ +N L P E + L
Sbjct: 322 L---PQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 21/92 (22%), Positives = 34/92 (36%), Gaps = 9/92 (9%)
Query: 204 YLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIP 263
N+ I ++ SL L++S N+L L L+ L N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL----PPRLERLIASFNHLA-EVP 320
Query: 264 SIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS 295
+ NLK L + N L P ++
Sbjct: 321 ELPQNLKQ---LHVEYNPLR-EFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 5e-06
Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 9/94 (9%)
Query: 252 FLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIP 311
Y N+ S I S+ SL +L++ N+L +P L + N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVP 320
Query: 312 PILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLR 345
+ NLK L + N L P ++ LR
Sbjct: 321 ELPQNLKQLH---VEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 23/97 (23%), Positives = 34/97 (35%), Gaps = 9/97 (9%)
Query: 177 HEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG 236
+ N S I S L L ++NN L +P + L+ L S N L
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLE---RLIASFNHLAE 318
Query: 237 LIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLH 273
+ NL L + N L P I +++ L
Sbjct: 319 VPEL----PQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 24/163 (14%), Positives = 41/163 (25%), Gaps = 12/163 (7%)
Query: 45 NSSLLSSWTLYPTNASKISPCSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHL 104
L + + + L + FS L
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262
Query: 105 VNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHG 164
N I L+ L++ NN+L + + L RL N L
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHL-A 317
Query: 165 TIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNN 207
+P + L +H N P ++ L +N+
Sbjct: 318 EVPELPQNLKQLH----VEYNPLREFPDIPESVED---LRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 2e-05
Identities = 18/93 (19%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 156 YLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIP 215
+N I + + E + +N + +P+ L + L + N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHL-AEVP 320
Query: 216 TVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNL 248
+ NLK L + N L P +++ +L
Sbjct: 321 ELPQNLK---QLHVEYNPLREF-PDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 5e-04
Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 9/86 (10%)
Query: 564 NLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIP 623
N S+ I + L +L++S+N L E+P LE+L S N+L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPR---LERLIASFNHLAE-VP 320
Query: 624 RCFEKMRSLSCIDICYNELQGPIPNS 649
+ ++ L + YN L+ P+
Sbjct: 321 ELPQNLKQL---HVEYNPLRE-FPDI 342
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (128), Expect = 2e-08
Identities = 42/231 (18%), Positives = 74/231 (32%), Gaps = 7/231 (3%)
Query: 343 SLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHL 402
S R + + IP ++ ++ EL+ L + + L + + +N +
Sbjct: 9 SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 403 FGPIPKSLKSLTSLKRVRFNQ--NNLVGKVYEAFGDHPNLTFLDLSQNNFDGKI--SFNW 458
I + S + NNL+ EAF + PNL +L +S
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 459 RNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILS 518
L ++N +G S + L L+ N I +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 519 LNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQ 569
N L F + LD+S ++ S + NL KL + N +
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 5e-05
Identities = 27/253 (10%), Positives = 57/253 (22%), Gaps = 23/253 (9%)
Query: 65 CSWFGISCNHAGSRVISINLSTLCLNGTFQDFSFSSFPHLVNLNLSFNLFFGNIPPQIGN 124
CS C + I +L + + L
Sbjct: 8 CSNRVFLCQESKVTEIPSDL----------------PRNAIELRFVLTKLRVIQKGAFSG 51
Query: 125 LSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDM----NQLHGTIPPVIGQLSLIHEFS 180
L+ +++ N + VI ++ S
Sbjct: 52 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 111
Query: 181 FCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPC 240
+ L + N N + +G L L++N + + C
Sbjct: 112 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNC 171
Query: 241 TLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMS 300
+ + N+L + LD+ ++ NL S
Sbjct: 172 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 231
Query: 301 LFSNSLSGSIPPI 313
++ +P +
Sbjct: 232 TYNLK---KLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 32/213 (15%), Positives = 56/213 (26%), Gaps = 6/213 (2%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIH 177
IP + L +L + L ++ + N + I +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 178 EFSFCH--NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPT--VMGNLKSLSTLDLSQNQ 233
NN+ P + NL L L ++N + + K L + + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 234 LNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNL 293
+ L+L KN + + N L F
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 294 SSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLY 326
S ++ + + L NLK L Y
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 11/78 (14%), Positives = 19/78 (24%)
Query: 561 YYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSG 620
L L+ N F +N L+E L++S +
Sbjct: 156 VILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215
Query: 621 FIPRCFEKMRSLSCIDIC 638
E ++ L
Sbjct: 216 LPSYGLENLKKLRARSTY 233
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 3e-08
Identities = 34/125 (27%), Positives = 52/125 (41%), Gaps = 9/125 (7%)
Query: 515 LILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTI 574
L L+ L+ V L + +LDLS N+L + P ++ L L L + +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57
Query: 575 PIEFEKLIHLSKLDLSHNILQE-EIPPQVCNMESLEKLNLSHNNLS---GFIPRCFEKMR 630
L L +L L +N LQ+ + + L LNL N+L G R E +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 631 SLSCI 635
S+S I
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 5e-08
Identities = 25/126 (19%), Positives = 46/126 (36%), Gaps = 9/126 (7%)
Query: 131 LDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRI 190
L L + L+ + + +L + L L N+L P + L + +
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL---EN 57
Query: 191 PSSLGNLSKLALLYLNNNSLFGY-IPTVMGNLKSLSTLDLSQNQL---NGLIPCTLDNLS 246
+ NL +L L L NN L + + L L+L N L G+ + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 247 NLDTLF 252
++ ++
Sbjct: 118 SVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 1e-07
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 6/109 (5%)
Query: 537 QYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQE 596
+ L L+ L+ + LL + +L+LS+N+ P L L L S N
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--AL 55
Query: 597 EIPPQVCNMESLEKLNLSHNNLSGF-IPRCFEKMRSLSCIDICYNELQG 644
E V N+ L++L L +N L + L +++ N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 4e-05
Identities = 32/127 (25%), Positives = 45/127 (35%), Gaps = 9/127 (7%)
Query: 153 RRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFG 212
R L+L L T+ + QL L+ HN + P +L L L L +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNAL 55
Query: 213 YIPTVMGNLKSLSTLDLSQNQLNGL-IPCTLDNLSNLDTLFLYKNSLS---GSIPSIIGN 268
+ NL L L L N+L L + L L L NSL G +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 269 LKSLHQL 275
L S+ +
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 6e-05
Identities = 24/103 (23%), Positives = 38/103 (36%), Gaps = 6/103 (5%)
Query: 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTL 242
H +++ + L L + L L++N L P + L+ L L S N L +
Sbjct: 7 HKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVAN 63
Query: 243 DNLSNLDTLFLYKNSL-SGSIPSIIGNLKSLHQLDLIENQLSG 284
L L L N L + + + L L+L N L
Sbjct: 64 LP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 2e-04
Identities = 26/120 (21%), Positives = 41/120 (34%), Gaps = 7/120 (5%)
Query: 250 TLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGS 309
L L L+ + + L + LDL N+L P + L L L ++ +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAAL--RCLEVLQASDNALE 56
Query: 310 IPPILGNLKSLSTLGLYLNQLNGVIPP-SIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSL 368
+ NL L L L N+L + + L L+L N L L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 23/106 (21%), Positives = 40/106 (37%), Gaps = 4/106 (3%)
Query: 325 LYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPH 384
L+L + + + L + +L L +N L +P + L+ L L+ N L V
Sbjct: 3 LHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDGV 61
Query: 385 SVGNLTGLVLLNMCENHLFG-PIPKSLKSLTSLKRVRFNQNNLVGK 429
+ L +C N L + L S L + N+L +
Sbjct: 62 ANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (122), Expect = 4e-08
Identities = 33/154 (21%), Positives = 64/154 (41%), Gaps = 13/154 (8%)
Query: 492 DLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIP 551
+L + ++ + + K + ++ L L L + + L+ + +++++
Sbjct: 3 ELKPEQV-EQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLR 58
Query: 552 KSIGNLLKLYYLNLSNNQFSHT--IPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLE 609
N+ +L LNLSNN+ + +K +L L+LS N L+ E LE
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 610 KLNLSHNNLS-------GFIPRCFEKMRSLSCID 636
+L L N+LS +I E+ L +D
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 1e-05
Identities = 30/144 (20%), Positives = 52/144 (36%), Gaps = 6/144 (4%)
Query: 517 LSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPI 576
L Q+ + L + L L S + LN ++ + T+ I
Sbjct: 4 LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSS-MAATLRI 59
Query: 577 EFEKLIHLSKLDLSHNIL--QEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSC 634
E + L L+LS+N L +++ V +L+ LNLS N L K L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 635 IDICYNELQGPIPNSTVFKDGLME 658
+ + N L + + + + E
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRE 143
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 1e-04
Identities = 29/118 (24%), Positives = 44/118 (37%), Gaps = 15/118 (12%)
Query: 494 SSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLE--FGSLTELQYLDLSANKLSSSIP 551
+ + + + E + L L LS N+L + L+ L+LS N+L S
Sbjct: 49 RRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE 108
Query: 552 KSIGNLLKLYYLNLSNNQFSHTIPIE-------FEKLIHLSKLDLSHNILQEEIPPQV 602
LKL L L N S T + E+ L +LD E+PP +
Sbjct: 109 LDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD------GHELPPPI 160
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 2e-04
Identities = 24/109 (22%), Positives = 41/109 (37%), Gaps = 3/109 (2%)
Query: 189 RIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGL--IPCTLDNLS 246
R L + +L ++ + + + N+ L +L+LS N+L L + +
Sbjct: 33 RSDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91
Query: 247 NLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSS 295
NL L L N L L +L L N LS + +S+
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 50.2 bits (118), Expect = 2e-07
Identities = 41/166 (24%), Positives = 63/166 (37%), Gaps = 7/166 (4%)
Query: 118 IPPQIGNLSKLQNLDLGNNQLSGVISPEI-GKLNQLRRLYLDMNQLHGTIPPVIGQLSLI 176
IP I L L +N+L + S + G+L L +L L NQL G P S I
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 177 HEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNG 236
E N + L +L L L +N + +P +L SL++L+L+ N N
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 237 LIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282
L L + PS ++ + DL ++
Sbjct: 141 NCHLA-WFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 43/191 (22%), Positives = 69/191 (36%), Gaps = 17/191 (8%)
Query: 65 CSWFGISCNHAG----SRVISINLSTLCLNG-----TFQDFSFSSFPHLVNLNLSFNLFF 115
C + C G R I ++ + L LN D F PHLV L L N
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 116 GNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSL 175
G P S +Q L LG N++ + + L+QL+ L L NQ+ +P L+
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235
+ + N + L LN + P+ ++ + DL ++
Sbjct: 128 LTSLNLASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFK 183
Query: 236 GLIPCTLDNLS 246
C+ +N
Sbjct: 184 ----CSSENSE 190
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.6 bits (101), Expect = 4e-05
Identities = 48/180 (26%), Positives = 69/180 (38%), Gaps = 7/180 (3%)
Query: 472 NNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFS-LNKLILSLNQLSGSVPLEF 530
IP +I L L+ N + L L KL L NQL+G P F
Sbjct: 17 GRGLKEIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74
Query: 531 GSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLS 590
+ +Q L L NK+ K L +L LNL +NQ S +P FE L L+ L+
Sbjct: 75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-L 133
Query: 591 HNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNST 650
+ E L K +L+ P K+R + D+ ++E + NS
Sbjct: 134 ASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFKCSSENSE 190
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.6 bits (101), Expect = 4e-05
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 5/168 (2%)
Query: 182 CHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVM-GNLKSLSTLDLSQNQLNGLIPC 240
C IP + L LN+N L + G L L L+L +NQL G+ P
Sbjct: 15 CTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72
Query: 241 TLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMS 300
+ S++ L L +N + + L L L+L +NQ+S +P SF +L+S T ++
Sbjct: 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132
Query: 301 LFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLS 348
L SN + + + L L P + ++ +++L
Sbjct: 133 LASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV-QIKDLP 178
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.0 bits (89), Expect = 0.001
Identities = 37/165 (22%), Positives = 65/165 (39%), Gaps = 7/165 (4%)
Query: 334 IPPSIGNLSSLRNLSLFNNGLYGSIPEEI-GYLKSLSELKLCKNNLSGVIPHSVGNLTGL 392
IP I L L +N L + + G L L +L+L +N L+G+ P++ + +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 393 VLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDG 452
L + EN + K L LK + N + + +F +LT L+L+ N F+
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 453 KISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNH 497
W L ++ P ++ +Q DL +
Sbjct: 141 NCHLAW-FAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSE 181
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (117), Expect = 2e-07
Identities = 18/121 (14%), Positives = 38/121 (31%), Gaps = 3/121 (2%)
Query: 528 LEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKL 587
++ + + LDL K+ I L + ++ S+N+ F L L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTL 68
Query: 588 DLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIP 647
+++N + + L +L L++N+L
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 648 N 648
+
Sbjct: 129 H 129
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 22/139 (15%), Positives = 52/139 (37%), Gaps = 7/139 (5%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLY 156
+++ L+L I L + +D +N++ + L +L+ L
Sbjct: 13 QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 69
Query: 157 LDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSG----RIPSSLGNLSKLALLYLNNNSLFG 212
++ N++ + L + E +N++ +SL +L+ L +L +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 213 YIPTVMGNLKSLSTLDLSQ 231
Y V+ + + LD +
Sbjct: 130 YRLYVIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (109), Expect = 2e-06
Identities = 22/136 (16%), Positives = 39/136 (28%), Gaps = 7/136 (5%)
Query: 192 SSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTL 251
+ N + L L + I + L +D S N++ L L L TL
Sbjct: 12 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKTL 68
Query: 252 FLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIP 311
+ N + + L L +L L N L L + +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 312 P----ILGNLKSLSTL 323
++ + + L
Sbjct: 129 HYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 30/161 (18%), Positives = 50/161 (31%), Gaps = 31/161 (19%)
Query: 120 PQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEF 179
Q N + + LDL ++ VI L+Q + N++
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---------------- 54
Query: 180 SFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIP 239
L +L L +NNN + + L L+ L L+ N L L
Sbjct: 55 ----------KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 104
Query: 240 CT----LDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLD 276
L +L+ L L + +I + + LD
Sbjct: 105 LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 25/215 (11%), Positives = 52/215 (24%), Gaps = 10/215 (4%)
Query: 485 SSKLQFLDLSSNHIVGKIPVQL-EKLFSLNKLILSLNQLSG----SVPLEFGSLTELQYL 539
S +Q LD+ + +L L + L L+ + L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 540 DLSANKLSSSIPKSIGNLL-----KLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNIL 594
+L +N+L + L K+ L+L N + + ++
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 120
Query: 595 QEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQGPIPNSTVFKD 654
+ + L+ + C S + + D
Sbjct: 121 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 180
Query: 655 GLMEGNKGLCGNFEAFSSCDAFMSHKQTSRKKWIV 689
G + LC + + +
Sbjct: 181 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC 215
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 6e-06
Identities = 16/91 (17%), Positives = 29/91 (31%), Gaps = 5/91 (5%)
Query: 223 SLSTLDLSQNQLNGL-IPCTLDNLSNLDTLFLYKNSLSG----SIPSIIGNLKSLHQLDL 277
+ +LD+ +L+ L L + L L+ I S + +L +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 278 IENQLSGSIPLSFGNLSSWTLMSLFSNSLSG 308
N+L + SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 8e-06
Identities = 21/93 (22%), Positives = 35/93 (37%), Gaps = 15/93 (16%)
Query: 536 LQYLDLSANKLSSSIPKSIGNLLK----LYYLNLSNNQFSHTIPIEFEKLI-----HLSK 586
L+ L L+ +S S S+ L L L+LSNN ++ + + L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 587 LDLSHNILQEEIPPQVCNMESLEKLNLSHNNLS 619
L L EE+ + L+ L +L
Sbjct: 431 LVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 17/80 (21%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 511 SLNKLILSLNQLSGSVPLEFGS----LTELQYLDLSANKLSSSIPKSIGNLLK-----LY 561
L L L+ +S S + L+ LDLS N L + + ++ L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 562 YLNLSNNQFSHTIPIEFEKL 581
L L + +S + + L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 17/81 (20%), Positives = 29/81 (35%), Gaps = 9/81 (11%)
Query: 559 KLYYLNLSNNQFSHT----IPIEFEKLIHLSKLDLSHNILQEEIPPQVC-----NMESLE 609
L L L++ S + + L +LDLS+N L + Q+ LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 610 KLNLSHNNLSGFIPRCFEKMR 630
+L L S + + +
Sbjct: 430 QLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 21/107 (19%), Positives = 31/107 (28%), Gaps = 9/107 (8%)
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSL----FGYIPTVMGNLKSLSTLDLSQ 231
I V S L +L+L + + + + SL LDLS
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406
Query: 232 NQLNGLIPCTL-----DNLSNLDTLFLYKNSLSGSIPSIIGNLKSLH 273
N L L L+ L LY S + + L+
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 7e-04
Identities = 11/91 (12%), Positives = 26/91 (28%), Gaps = 5/91 (5%)
Query: 439 NLTFLDLSQNNF-DGKISFNWRNLPKLDTFIVSMNNI----FGSIPLEIGDSSKLQFLDL 493
++ LD+ D + + L + + + I + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 494 SSNHIVGKIPVQLEKLFSLNKLILSLNQLSG 524
SN + + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 16/90 (17%), Positives = 32/90 (35%), Gaps = 5/90 (5%)
Query: 176 IHEFSFCHNNVS-GRIPSSLGNLSKLALLYLNNNSL----FGYIPTVMGNLKSLSTLDLS 230
I +S R L L + ++ L++ L I + + +L+ L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 231 QNQLNGLIPCTLDNLSNLDTLFLYKNSLSG 260
N+L + + + + K SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 15/89 (16%), Positives = 28/89 (31%), Gaps = 5/89 (5%)
Query: 301 LFSNSLSGS-IPPILGNLKSLSTLGLYLNQLNGV----IPPSIGNLSSLRNLSLFNNGLY 355
+ LS + +L L+ + L L I ++ +L L+L +N L
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68
Query: 356 GSIPEEIGYLKSLSELKLCKNNLSGVIPH 384
+ K+ K +L
Sbjct: 69 DVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.004
Identities = 15/119 (12%), Positives = 31/119 (26%), Gaps = 9/119 (7%)
Query: 81 SINLSTLCLNGT-FQDFSF----SSFPHLVNLNLSFNLF----FGNIPPQIGNLSKLQNL 131
S+++ +L + D + + L +I + L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 132 DLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRI 190
+L +N+L V + + Q + L G L +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 119
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 5e-06
Identities = 34/217 (15%), Positives = 73/217 (33%), Gaps = 22/217 (10%)
Query: 357 SIPEEIGY------LKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSL 410
++P I + L K +++ + + L + + + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 411 KSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVS 470
+ L ++ ++ N N L + NL +L L +N S K + +
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122
Query: 471 MNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEF 530
+ + S + ++ V +L+ L + I + +
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI--------VPL 174
Query: 531 GSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSN 567
LT+LQ L LS N +S +++ L L L L +
Sbjct: 175 AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 33/228 (14%), Positives = 66/228 (28%), Gaps = 40/228 (17%)
Query: 124 NLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCH 183
++ +L ++ ++ +LN + ++ + + +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG---------------- 63
Query: 184 NNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLD 243
+ L + L+LN N L P L+ L
Sbjct: 64 ----------IQYLPNVTKLFLNGNKLTDIKP--------LANLKNLGWLFLDENKVKDL 105
Query: 244 NLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFS 303
+ + I I G + L + L+ +SL
Sbjct: 106 SSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 165
Query: 304 NSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFN 351
N +S +P L L L L L N ++ + ++ L +L L LF+
Sbjct: 166 NQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 28/193 (14%), Positives = 56/193 (29%), Gaps = 22/193 (11%)
Query: 196 NLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYK 255
++ L S+ + L S+ + + + + + + L N+ LFL
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 256 NSLSG---------------SIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMS 300
N L+ + L L + L +
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 301 LFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPE 360
+ + + + + I P + L+ L+NL L N + S
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI--SDLR 194
Query: 361 EIGYLKSLSELKL 373
+ LK+L L+L
Sbjct: 195 ALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 42/201 (20%), Positives = 67/201 (33%), Gaps = 48/201 (23%)
Query: 94 QDFSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLR 153
Q FS +F + NL + L+ + + N+ + V I L +
Sbjct: 16 QIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVT 71
Query: 154 RLYLDMNQLHGTIP----------------------------------------PVIGQL 173
+L+L+ N+L P + G +
Sbjct: 72 KLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 174 SLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQ 233
L S N + L L+KL L L +N + +P + L L L LS+N
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189
Query: 234 LNGLIPCTLDNLSNLDTLFLY 254
++ L L L NLD L L+
Sbjct: 190 ISDLRA--LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 28/197 (14%), Positives = 68/197 (34%), Gaps = 22/197 (11%)
Query: 456 FNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKL 515
F+ + + ++ ++ + + + + +++ I ++ L ++ KL
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 516 ILSLNQLSGSVPLEFGSLTELQYLDLSANKLS---------------SSIPKSIGNLLKL 560
L+ N+L+ PL +LD + K + I L+ L
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 561 YYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSG 620
L + I + + +I P + + L+ L LS N++S
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD 192
Query: 621 FIPRCFEKMRSLSCIDI 637
R +++L +++
Sbjct: 193 L--RALAGLKNLDVLEL 207
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 41/331 (12%), Positives = 97/331 (29%), Gaps = 24/331 (7%)
Query: 319 SLSTLGLYLNQLNGV----IPPSIGNLSSLRNLSLFNNGL----YGSIPEEIGYLKSLSE 370
S+ L L+ + + + S++ + L N + + E I K L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 371 LKLCKN---NLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLV 427
+ + IP ++ L +L + + + +++ +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 428 GKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSK 487
+Y +++ + ++ +N P L + I N + ++ +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC-GRNRLENGSMKEWAKTF 182
Query: 488 LQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLS 547
L + +V L + + +L + S+
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT-----FTHLGSSALAI 237
Query: 548 SSIPKSIGNLLKLYYLNLSNNQFSHTI-PIEFEKLIHLSKLDLSHNILQEEIPPQVC--- 603
+ L L LS + + + I L L L +N ++ + +
Sbjct: 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297
Query: 604 --NMESLEKLNLSHNNLSGFIPRCFEKMRSL 632
M L L L+ N S +++R +
Sbjct: 298 DEKMPDLLFLELNGNRFSE-EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 43/333 (12%), Positives = 92/333 (27%), Gaps = 45/333 (13%)
Query: 309 SIPPILGNLKSLSTLGLYLNQLNG----VIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGY 364
S+ +L S+ + L N + + +I + L + E
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 365 LKSLSELKLCKNNLSGVIPH---SVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRF 421
L+ L + L L V ++ + ++ + L +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 422 NQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLE 481
+ V + + P L + +N + W + + ++ + I E
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 482 IGDSSKLQFLD-------------LSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVP- 527
+ L+ L ++ + + L+ +L +L L+ LS
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 528 -----LEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLI 582
LQ L L N++ +++ ++ EK+
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI-------------------DEKMP 302
Query: 583 HLSKLDLSHNILQEEIPPQVCNMESLEKLNLSH 615
L L+L+ N EE E
Sbjct: 303 DLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.001
Identities = 40/332 (12%), Positives = 83/332 (25%), Gaps = 47/332 (14%)
Query: 261 SIPSIIGNLKSLHQLDLIENQLSGSIPLSFG-------NLSSWTLMSLFSNSLSGSIPPI 313
S+ +++ S+ ++ L N + +L +F+ + IP
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 314 LGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKL 373
L L L+ + L + + L + K+
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 374 CKNNLSGVIPHSVGNLTGLVLLNMCENHL----FGPIPKSLKSLTSLKRVRFNQNNLVGK 429
+ + N L + N L K+ +S L V+ QN + +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 430 VYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSM---------NNIFGSIPL 480
E +L + + + +
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 481 EIGD------SSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLT 534
+ D + LQ L L N I L+ + +
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI-------------------DEKMP 302
Query: 535 ELQYLDLSANKLS--SSIPKSIGNLLKLYYLN 564
+L +L+L+ N+ S + I +
Sbjct: 303 DLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.002
Identities = 11/109 (10%), Positives = 24/109 (22%), Gaps = 5/109 (4%)
Query: 536 LQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFS----HTIPIEFEKLIHLSKLDLSH 591
L+ ++ S + + + + LS N + L + S
Sbjct: 10 LKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 592 NILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYN 640
+ L + L L + I +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 117
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 35/312 (11%), Positives = 87/312 (27%), Gaps = 18/312 (5%)
Query: 343 SLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVG-------NLTGLVLL 395
SL+ ++ S+ + S+ E+ L N + + +L
Sbjct: 9 SLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 396 NMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKIS 455
++ + IP++L+ L + + LS++ +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 456 FNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKL 515
+ L ++ ++ + ++ L+ + N + + K F ++L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 516 ILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIP 575
+ ++ + + E L+ L + N +
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLA---YCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 576 IEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRC-----FEKMR 630
+ L + + L+ L L +N + R EKM
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFS--KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302
Query: 631 SLSCIDICYNEL 642
L +++ N
Sbjct: 303 DLLFLELNGNRF 314
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 18/133 (13%), Positives = 38/133 (28%), Gaps = 1/133 (0%)
Query: 117 NIPPQIGNLSKLQNLDLGNNQLSGVISPEI-GKLNQLRRLYLDMNQLHGTIPPVIGQLSL 175
+ + L L + N Q + L +LR L + + L P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235
+ + N + ++ LS L+ N + + + + +L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQ 141
Query: 236 GLIPCTLDNLSNL 248
L ++ N
Sbjct: 142 CHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.001
Identities = 19/113 (16%), Positives = 35/113 (30%), Gaps = 3/113 (2%)
Query: 532 SLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEK-LIHLSKLDLS 590
L + + + L L + N Q + + + L L L +
Sbjct: 6 CPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 591 HNILQEEIPPQVCNMESLEKLNLSHNNLSGFIPRCFEKMRSLSCIDICYNELQ 643
+ L+ P L +LNLS N L + + + + + N L
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL-QELVLSGNPLH 116
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 32/200 (16%), Positives = 64/200 (32%), Gaps = 16/200 (8%)
Query: 316 NLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCK 375
L L + + + +L + L G+ + + YL +L+++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 71
Query: 376 NNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFG 435
N L+ + P + I N +
Sbjct: 72 NQLTDITPLKNLT------KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125
Query: 436 DHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSS 495
+ NL L+LS N + + ++ ++ + + + + L+ LD+SS
Sbjct: 126 NLTNLNRLELSSNTISDISALSGLT----SLQQLNFSSNQVTDLKPLANLTTLERLDISS 181
Query: 496 NHIVGKIPVQLEKLFSLNKL 515
N + I V L KL +L L
Sbjct: 182 NKVSD-ISV-LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 29/190 (15%), Positives = 61/190 (32%), Gaps = 20/190 (10%)
Query: 388 NLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQ 447
L + + + ++ + S L + ++ ++ + K + NLT ++ S
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 71
Query: 448 NNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLE 507
N + + + F + ++ K L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 508 KLFSLNKLILSLNQLSG--------------SVPLEFGSLTELQYLDLSANKLSSSIPKS 553
+L + I ++ LSG + +LT L+ LD+S+NK+S
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189
Query: 554 IGNLLKLYYL 563
+ L L L
Sbjct: 190 LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 27/194 (13%), Positives = 59/194 (30%), Gaps = 14/194 (7%)
Query: 96 FSFSSFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRL 155
F+ ++ + L + +L ++ L + + + LN L ++
Sbjct: 12 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQI 67
Query: 156 YLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIP 215
NQL P + + + + + I
Sbjct: 68 NFSNNQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 119
Query: 216 TVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQL 275
+ + L + L L++L L N ++ P + NL +L +L
Sbjct: 120 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERL 177
Query: 276 DLIENQLSGSIPLS 289
D+ N++S L+
Sbjct: 178 DISSNKVSDISVLA 191
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 39.3 bits (90), Expect = 0.001
Identities = 33/186 (17%), Positives = 54/186 (29%), Gaps = 24/186 (12%)
Query: 97 SFSSFPHLVNLNLSFNLFFGNIPP------QIGNLSKLQNLDLGNNQLSGVISPEIGKLN 150
F +V G IPP + L ++L L N + + + +
Sbjct: 13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGME 70
Query: 151 QLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSL 210
LR L L N + +L + + S L NL L + +
Sbjct: 71 NLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNW 130
Query: 211 FGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLK 270
+ L L L L+ N L N+ S ++ L
Sbjct: 131 GEIDK--LAALDKLEDLLLAGNPLYNDYKEN--------------NATSEYRIEVVKRLP 174
Query: 271 SLHQLD 276
+L +LD
Sbjct: 175 NLKKLD 180
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1078 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.48 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.47 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.43 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.74 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.58 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.34 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.84 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.69 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.66 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.05 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.05 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.99 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.15 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=432.51 Aligned_cols=254 Identities=29% Similarity=0.417 Sum_probs=211.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|..+ +|+.||+|++.+.... .....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 67999999999999999999764 7899999998754322 223456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.+ ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 mEy~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EeecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999943 35699999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.......||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+ .......+ ...
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i------~~~~~~~p-~~~ 227 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKRI------SRVEFTFP-DFV 227 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHH------HTTCCCCC-TTS
T ss_pred --CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHHHHH------HcCCCCCC-ccC
Confidence 234567899999999999999999999999999999999999999753321 1111111 11111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
. .++.+++.+||++||++|||++|+++|||+..
T Consensus 228 s---~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 228 T---EGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp C---HHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred C---HHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 1 25778999999999999999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=434.38 Aligned_cols=257 Identities=24% Similarity=0.299 Sum_probs=207.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 35799999999999999999976 4799999999976432 2234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 81 vmEy~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEeccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 9999999999999943 45699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC--CCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 909 PYS--SNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 909 ~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
... ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||............. ...+....+
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~------~~~~~~~~~ 228 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------KEKKTYLNP 228 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH------HTTCTTSTT
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH------hcCCCCCCc
Confidence 332 23456789999999999988775 678999999999999999999986443221111111 011111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.... ..++.+++.+||+.||++|||++|+++|||+.
T Consensus 229 ~~~~---s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 264 (271)
T d1nvra_ 229 WKKI---DSAPLALLHKILVENPSARITIPDIKKDRWYN 264 (271)
T ss_dssp GGGS---CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred cccC---CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 1111 23567889999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=432.98 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=213.8
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc----ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 4799999999999999999965 579999999987543 22456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||++||+|.+++.+ ..+++.+++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 96 mEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 999999999998843 4589999999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
........+||+.|||||++.+..++.++||||+||++|||++|+.||...... ..... ......+.+.. ..
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~---~~~~~~~~~~~-~~-- 240 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL---IATNGTPELQN-PE-- 240 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH---HHHHCSCCCSS-GG--
T ss_pred ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHH---HHhCCCCCCCC-cc--
Confidence 555566778999999999999999999999999999999999999997532211 11111 11111111111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
.....+.+++.+||++||++|||++|+++|+|+...
T Consensus 241 -~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 241 -KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp -GSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -cCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 112367789999999999999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=431.15 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=199.4
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec--CCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN--ARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 826 (1078)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... .....+.+.+|+.++++++|||||++++++.+ +...
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 36799999999999999999965 4799999999976532 34456778999999999999999999999854 4568
Q ss_pred EEEEeecCCCCHHHHhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhcCC--CCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 827 FLVCEYLHRGSLARILGND-ATAKELSWNRRINVIKGVANALSYLHHDCL--PSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~--~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
|+||||+++|+|.+++.+. .....+++.+++.++.||+.||+|||++.. .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 9999999999999998542 234569999999999999999999999710 1399999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
|+............+||+.|||||++.+..++.++|||||||++|||+||+.||...+. ......+ ......
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i------~~~~~~ 232 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKI------REGKFR 232 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH------HHTCCC
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHH------HcCCCC
Confidence 99876555555667899999999999999999999999999999999999999754322 1111111 111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
..+.... .++.+++.+||+.||++|||++|+++|||.
T Consensus 233 ~~~~~~s---~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 RIPYRYS---DELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCcccC---HHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 1112222 257788999999999999999999999994
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=429.89 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=209.6
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+.|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 5689999999999999999976 479999999987542 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++.+. .+.+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 88 mEy~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 88 IEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999999987432 34699999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCceeeccccccccccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
.........||+.|||||++. +..|+.++||||+||++|||+||+.||..... ......+. ....+....
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~~~~~i~---~~~~~~~~~ 237 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIA---KSEPPTLAQ 237 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHHHHH---HSCCCCCSS
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HHHHHHHH---cCCCCCCCc
Confidence 323334578999999999984 45689999999999999999999999754322 11111111 111111111
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. ....++.+++.+||+.||++|||++|+++|||+..
T Consensus 238 -~~---~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 238 -PS---RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -GG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -cc---cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 11 12236788999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=435.68 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=209.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||+|+++... .....+.+.+|+.++++++|||||+++++|.+++..|+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 57899999999999999999975 478999999997643 23446778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeCCCCcEEEecccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFV 907 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~ 907 (1078)
||||++||+|.+++.+ .+.+++..+..++.|++.||+|||+ + +|+||||||+|||++.+|.+||+|||+|+..
T Consensus 82 VmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 9999999999999953 3568999999999999999999997 5 8999999999999999999999999999876
Q ss_pred cCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh----------------
Q 039595 908 EPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI---------------- 971 (1078)
Q Consensus 908 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~---------------- 971 (1078)
.+. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..............
T Consensus 156 ~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 156 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 432 23456899999999999999999999999999999999999999754322110000000
Q ss_pred ------------------hhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 972 ------------------IEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 972 ------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
...........+.... .....++.+++.+||..||++|||++|+++|||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCcc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000000000000000 0112367889999999999999999999999997653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-48 Score=429.68 Aligned_cols=257 Identities=25% Similarity=0.333 Sum_probs=194.3
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.+.|++.+.||+|+||+||+|..+ +|+.||||++...... ...+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 467999999999999999999764 7899999999765432 224568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC---CCCcEEEecccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD---LEFEAHVSDFGIAK 905 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfG~a~ 905 (1078)
||||++||+|.+++.. .+.+++.++..++.||+.||+|||++ +|+||||||+||++. .++.+||+|||+|+
T Consensus 85 vmE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEeccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 9999999999999953 45699999999999999999999999 999999999999995 57899999999998
Q ss_pred cccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
..... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+. ......+
T Consensus 159 ~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~------~~~~~~~ 229 (307)
T d1a06a_ 159 MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQIL------KAEYEFD 229 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH------TTCCCCC
T ss_pred EccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHh------ccCCCCC
Confidence 76542 233457899999999999999999999999999999999999999753221 11111111 1111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.+.......++.+++.+||+.||++|||++|+++|||+.
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 111111123578899999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=418.29 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=200.7
Q ss_pred CccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec----CCeeEE
Q 039595 754 DEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN----ARHSFL 828 (1078)
Q Consensus 754 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 828 (1078)
+..++||+|+||+||+|... +++.||+|++..... .....+.+.+|++++++++|||||++++++++ +..+|+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 55678999999999999654 788999999876532 34456789999999999999999999999864 456899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeeC-CCCcEEEecccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLD-LEFEAHVSDFGIAK 905 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~kl~DfG~a~ 905 (1078)
||||+++|+|.+++.+ ...+++.+++.++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 9999999999999943 35689999999999999999999998 7 99999999999996 57999999999998
Q ss_pred cccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
.... ......+||+.|||||++.+ .++.++||||+||++|||++|+.||...... ...... ......+. ..
T Consensus 164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~~~~~~---i~~~~~~~--~~ 234 (270)
T d1t4ha_ 164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRR---VTSGVKPA--SF 234 (270)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHH---HTTTCCCG--GG
T ss_pred eccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-HHHHHH---HHcCCCCc--cc
Confidence 6432 33456789999999998875 5999999999999999999999997532211 111111 11111110 00
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.... ..++.+++.+||++||++|||++|+++|||+.
T Consensus 235 ~~~~---~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 235 DKVA---IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GGCC---CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CccC---CHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0111 12577899999999999999999999999973
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=424.33 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=204.4
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.... .....+.+.+|+.++++++|||||++++++.++...|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 6799999999999999999976 47999999999754322 123456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++. ..+.+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+.+..
T Consensus 87 mEy~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 87 LSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999984 345699999999999999999999999 999999999999999999999999999987754
Q ss_pred CC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 910 YS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 910 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.. ......+||+.|||||++.+..++.++||||+||++|||++|+.||...+. ......+... ...++.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~~----~~~~p~--- 231 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQKIIKL----EYDFPE--- 231 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHTT----CCCCCT---
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHHHHcC----CCCCCc---
Confidence 32 223456899999999999999999999999999999999999999763321 1111111111 111111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. ..++.+++.+||+.||++|||++|+++|+|
T Consensus 232 ~~---s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 232 KF---FPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp TC---CHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred cC---CHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 11 125778999999999999999998644433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-47 Score=429.72 Aligned_cols=258 Identities=19% Similarity=0.286 Sum_probs=212.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++... ...+.+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46899999999999999999965 47999999999654 23456788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC--CCcEEEeccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL--EFEAHVSDFGIAKF 906 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfG~a~~ 906 (1078)
||||++||+|.+++.+. ...+++.++..++.||+.||+|||++ +||||||||+|||++. ++.+||+|||+|+.
T Consensus 101 vmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 101 IYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999999998432 34699999999999999999999999 9999999999999964 58899999999987
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.... .......||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+.. .....+.
T Consensus 176 ~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~------~~~~~~~ 246 (350)
T d1koaa2 176 LDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKS------CDWNMDD 246 (350)
T ss_dssp CCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH------TCCCSCC
T ss_pred cccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHh------CCCCCCc
Confidence 7543 344567899999999999999999999999999999999999999753321 111111111 1111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
........++.+++.+||..||++|||++|+++|||+..
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 111112236788999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=421.32 Aligned_cols=262 Identities=21% Similarity=0.245 Sum_probs=212.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG--NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++.+..... .....+.+.+|+.++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999976 579999999997654322 223467899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC----cEEEeccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF----EAHVSDFG 902 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG 902 (1078)
|+||||+++|+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999943 35699999999999999999999999 999999999999998876 49999999
Q ss_pred ccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
+|+..... .......||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+ .....
T Consensus 163 ~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i------~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANV------SAVNY 233 (293)
T ss_dssp TCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH------HTTCC
T ss_pred hhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--HHHHHHH------HhcCC
Confidence 99877543 334456899999999999999999999999999999999999999753322 1111111 11111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYCD 1026 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~~ 1026 (1078)
..+..........+.+++.+||+.||++|||++|+++|+|+...
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11100001112357789999999999999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-47 Score=427.92 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=211.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ..+.+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46799999999999999999965 579999999987642 3446678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeC--CCCcEEEeccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD--LEFEAHVSDFGIAKF 906 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DfG~a~~ 906 (1078)
||||++||+|.+++.. ....+++.+++.++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|+.
T Consensus 104 vmE~~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 104 ILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEcCCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccccee
Confidence 9999999999998743 234699999999999999999999999 999999999999998 578999999999998
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
+... .......||+.|||||++.+..++.++||||+||++|||+||+.||..... ......+... ...+...
T Consensus 179 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~----~~~~~~~- 250 (352)
T d1koba_ 179 LNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRC----DWEFDED- 250 (352)
T ss_dssp CCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHC----CCCCCSS-
T ss_pred cCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC----CCCCCcc-
Confidence 7643 345567899999999999999999999999999999999999999753222 1111111111 1111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.......++.+++.+||+.||++|||++|+++|+|+.
T Consensus 251 -~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~ 287 (352)
T d1koba_ 251 -AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287 (352)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred -cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 1111123577899999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-48 Score=425.69 Aligned_cols=254 Identities=27% Similarity=0.370 Sum_probs=206.6
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
+.|+..+.||+|+||+||+|.. .+|+.||||++...... .....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 3589999999999999999965 57889999999765322 234456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+.+|++..++. ..+.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999987763 235699999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceeecccccccccccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||..... ... .........+... .
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~~---~~~i~~~~~~~~~--~ 236 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSA---LYHIAQNESPALQ--S 236 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH---HHHHHHSCCCCCS--C
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HHH---HHHHHhCCCCCCC--C
Confidence 335679999999999864 4589999999999999999999999753221 111 1111111111111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.... ..+.+++.+||+.||++|||++|+++|+|...
T Consensus 237 ~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 237 GHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp TTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCC---HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1122 25778899999999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=413.56 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=195.7
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
++|++.+.||+|+||+||+|.+++++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-----cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 578899999999999999999888889999998653 233567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++... ...+++..++.++.|||.||+|+|++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 80 E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp ECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence 999999999998543 35688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhC-CCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 911 SS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG-NHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 911 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ......||+.|||||++.+..++.++|||||||++|||+|+ ++||.... .......+. ....+..+. .
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~---~~~~~~~p~---~ 226 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDIS---TGFRLYKPR---L 226 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHH---HTCCCCCCT---T
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHH---hcCCCCCcc---c
Confidence 32 23446789999999999999999999999999999999995 55543221 111222111 111111111 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
.. .++.+++.+||+.||++|||++|+++|.-
T Consensus 227 ~~---~~l~~li~~cl~~~p~~Rps~~~il~~L~ 257 (263)
T d1sm2a_ 227 AS---THVYQIMNHCWKERPEDRPAFSRLLRQLA 257 (263)
T ss_dssp SC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cC---HHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 11 25778999999999999999999998843
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=425.17 Aligned_cols=257 Identities=21% Similarity=0.280 Sum_probs=215.3
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++++.||+|+||+||+|+. .+|+.||||++++.... .....+.+.+|+.++++++||||+++++++.+++..|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 46899999999999999999965 57999999999765332 12346778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+...
T Consensus 83 v~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ceeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999999999943 45689999999999999999999999 99999999999999999999999999999776
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.........+||+.|||||++.+..|+.++||||+||++|||++|++||...+ .......+.. ....++. .
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--~~~~~~~i~~----~~~~~p~---~ 227 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILM----EEIRFPR---T 227 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH----CCCCCCT---T
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--HHHHHHHHhc----CCCCCCc---c
Confidence 55555667899999999999999999999999999999999999999965332 2222222111 1112211 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYC 1025 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~ 1025 (1078)
.. .++.++|.+||++||++||+ ++|+++|||+..
T Consensus 228 ~s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 228 LS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp SC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CC---HHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 12 25678999999999999994 899999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=413.70 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=200.9
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|++.+.||+|+||+||+|+++ ..||||+++.... .....+.|.+|+.++++++|||||++++++.+ +..++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 467999999999999999999865 4699999975532 34456789999999999999999999998764 568999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++... ...+++.++..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999999999543 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred CC--CCceeecccccccccccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCC
Q 039595 910 YS--SNRTEFVGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLST 984 (1078)
Q Consensus 910 ~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 984 (1078)
.. .......||+.|||||++.+ ..|+.++|||||||++|||+||+.||....... ...... ......|....
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~--~~~~~~p~~~~ 233 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMV--GRGYLSPDLSK 233 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHH--HHTSCCCCGGG
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHH--hcCCCCCcchh
Confidence 32 22345689999999999864 358999999999999999999999976433211 111111 11122222222
Q ss_pred CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 985 PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 985 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
...... .++.+++.+||+.||++|||++|++++..
T Consensus 234 ~~~~~~---~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 234 VRSNCP---KAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp SCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 222222 25778899999999999999999998865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=417.90 Aligned_cols=256 Identities=21% Similarity=0.338 Sum_probs=204.5
Q ss_pred hhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
..++|++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 346899999999999999999999888899999986532 335679999999999999999999998865 56799
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++... ....+++.++++++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 v~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence 99999999999988432 334589999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
.... ......||+.|||||++.++.++.++|||||||++|||+||+.|+..... ...... .......+..+ .
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~---~i~~~~~~~~p---~ 233 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQ---NLERGYRMVRP---D 233 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHH---HHHTTCCCCCC---T
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHH---HHHhcCCCCCc---c
Confidence 4322 23445789999999999999999999999999999999996555322111 111111 11111112111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHH--Hhhhh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFG--HHIGY 1024 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~--h~~~~ 1024 (1078)
... .++.+++.+||+.||++|||++|+++ |+|+.
T Consensus 234 ~~~---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCP---EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCh---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 122 25778899999999999999999988 45544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=405.63 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=208.8
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|+|.+++..++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-----CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 5899999999999999999999888899999997642 23567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++.. ....+++..+.+++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 79 Ey~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 79 EYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp ECCTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EccCCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 99999999999743 345688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 911 SS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 911 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+.... ......+.. ...+.. +..
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~~~i~~---~~~~~~---p~~ 225 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQ---GLRLYR---PHL 225 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHT---TCCCCC---CTT
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--HHHHHHHHh---CCCCCC---ccc
Confidence 32 2344678999999999999999999999999999999998 8999764432 222222211 111111 111
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.. ..+.+++.+||+.||++|||++|+++|.
T Consensus 226 ~~---~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 226 AS---EKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp CC---HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cc---HHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 12 2678999999999999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.8e-47 Score=417.69 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=210.5
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|+. .+|+.||||++++.... .....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 6799999999999999999976 47999999999764322 223467789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||++||++..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999884 345578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. ......+... ...++. ..
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~~----~~~~p~---~~ 224 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEKILNA----ELRFPP---FF 224 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHC----CCCCCT---TS
T ss_pred ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--HHHHHHHHcC----CCCCCC---CC
Confidence 23456899999999999999999999999999999999999999753321 1111111111 111111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhh
Q 039595 990 MDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYC 1025 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~ 1025 (1078)
. .++.+++.+||.+||.+|| |++|+++|||+..
T Consensus 225 s---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 225 N---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp C---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred C---HHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 1 2577899999999999996 9999999999865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-46 Score=406.60 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=211.3
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCCh-----hhHHHHHHHHHHHhcCC-CCceeeEEeeeec
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNM-----ADQDEFLNVVLALNEIR-HRNIVKFHGFCSN 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 822 (1078)
.++|++.+.||+|+||+||+|+. .+|+.||||++++....... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999965 57899999999765433211 12346889999999997 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
++..|+||||+++|+|.++++. .+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999953 45699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccccccc------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhh
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYT------MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQ 976 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 976 (1078)
+++.+.... .....+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ......+
T Consensus 156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--~~~~~~i----- 227 (277)
T d1phka_ 156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMI----- 227 (277)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH-----
T ss_pred heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--HHHHHHH-----
Confidence 999876533 3455789999999999863 3468899999999999999999999753322 1111111
Q ss_pred hcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 977 ILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.......+.+.......++.+++.+||++||++|||++|+++|+|+..
T Consensus 228 -~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 228 -MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 111111111111222236788999999999999999999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-47 Score=413.73 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=206.1
Q ss_pred HhhcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 748 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 748 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
...++|++.+.||+|+||+||+|.++ +|+.||||+++.. ..+.++|.+|+.++++++|||||+++++|.+++..
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-----cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 34568999999999999999999765 6889999998653 23467799999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999998543 345789999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCC-ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 907 VEPYSSN-RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 907 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
....... .....|++.|||||++.+..++.++|||||||++|||++|+.||... .+....... ...-..+..+.
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-~~~~~~~~~---i~~~~~~~~~~- 239 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYEL---LEKDYRMERPE- 239 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHH---HHTTCCCCCCT-
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc-chHHHHHHH---HhcCCCCCCCc-
Confidence 6543322 23456899999999999999999999999999999999977764321 111111111 11111122211
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
... .++.+++.+||+.||++|||++|+++.
T Consensus 240 --~~~---~~l~~li~~cl~~dP~~Rps~~ei~~~ 269 (287)
T d1opja_ 240 --GCP---EKVYELMRACWQWNPSDRPSFAEIHQA 269 (287)
T ss_dssp --TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --cch---HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 122 257889999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-46 Score=411.28 Aligned_cols=252 Identities=23% Similarity=0.444 Sum_probs=192.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCC---EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGD---IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
++|++.+.||+|+||+||+|.++ +++ .||||++.... .....+.|.+|+.++++++|||||+++|++.+++..
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 46777889999999999999765 332 58899886542 344567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|+|.+++... .+.+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999999988543 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCC-----ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCC
Q 039595 907 VEPYSSN-----RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDP 980 (1078)
Q Consensus 907 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 980 (1078)
....... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||..... ......+ ..-.
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i---~~~~-- 250 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAI---EQDY-- 250 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH---HTTC--
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHH---HcCC--
Confidence 6543221 223467999999999999999999999999999999998 8999753322 1111111 1111
Q ss_pred CCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 981 RLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 981 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
+.. ...... ..+.+++.+||+.||++|||++|++++.
T Consensus 251 ~~~-~~~~~~---~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 251 RLP-PPMDCP---SALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp CCC-CCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCC-CCccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 111 111222 2577889999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=417.38 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=210.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHH-hcCCCCceeeEEeeeecCCeeEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLAL-NEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
++|++.+.||+|+||+||+|+.+ +|+.||||++++..... ....+.+..|..++ +.++|||||++++++.+++..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 67999999999999999999664 79999999997643221 22344556666655 47899999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.++++ ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 81 vmEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999994 345689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. -.+.++..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~----~~~~~p~~--- 225 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRM----DNPFYPRW--- 225 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH----CCCCCCTT---
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHc----CCCCCCcc---
Confidence 555556677899999999999999999999999999999999999999753322 222221111 12222211
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChh-HHHHHhhhhh
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTME-KGFGHHIGYC 1025 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~-ell~h~~~~~ 1025 (1078)
.. .++.+++.+||..||++|||++ |+++|||+..
T Consensus 226 ~s---~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 226 LE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SC---HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred CC---HHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 11 2577899999999999999996 8999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=415.49 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=202.7
Q ss_pred hcCCCccceeccCCceeEEEEEeCC-C-----CEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeec
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPS-G-----DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSN 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 822 (1078)
.++|++.+.||+|+||+||+|++.. + ..||||++.... .......+.+|+.++.++ +|||||++++++.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4689999999999999999996542 2 269999986543 233456788999999998 89999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCC--------------------CCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDAT--------------------AKELSWNRRINVIKGVANALSYLHHDCLPSIIHRD 882 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 882 (1078)
.+..++||||+++|+|.++++.... ...+++.+++.++.||+.||+|||++ +|||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999965321 23589999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 039595 883 ISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 959 (1078)
Q Consensus 883 lk~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~ 959 (1078)
|||+||+++.++.+||+|||+|+........ .....||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876554332 234678999999999999999999999999999999998 8999754
Q ss_pred ccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 960 FSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.... ..+...+ .....+..+ .... .++.+++.+||+.||++|||++|+++|+
T Consensus 270 ~~~~-~~~~~~~---~~~~~~~~p---~~~~---~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 270 IPVD-ANFYKLI---QNGFKMDQP---FYAT---EEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CCCS-HHHHHHH---HTTCCCCCC---TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHH-HHHHHHH---hcCCCCCCC---CcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 3321 1111111 111111111 1112 2578899999999999999999999885
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-46 Score=417.92 Aligned_cols=255 Identities=22% Similarity=0.265 Sum_probs=211.6
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++++.||+|+||+||+|.. .+|+.||||++.+.... .....+.+.+|+.+++.++|||||++++++.+....++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 6899999999999999999976 47999999999754322 223456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+.+|+|.+++.+ .+.+++.+++.++.||+.||.|||++ +||||||||+|||++.+|.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999843 34689999999999999999999999 999999999999999999999999999997753
Q ss_pred CCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
......||+.|||||++.+..++.++||||+||++|||+||+.||.... .......+. ......+ ...
T Consensus 194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~------~~~~~~p-~~~ 261 (350)
T d1rdqe_ 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIV------SGKVRFP-SHF 261 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHH------HCCCCCC-TTC
T ss_pred ---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHHHh------cCCCCCC-ccC
Confidence 2345689999999999999999999999999999999999999975322 111111111 1111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhhhH
Q 039595 990 MDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYCDE 1027 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~~~ 1027 (1078)
. .++.+++.+||..||.+|+ |++|+++|+|+....
T Consensus 262 s---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 262 S---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp C---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred C---HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 1 2577899999999999994 999999999986543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=403.85 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=200.1
Q ss_pred cCCCccc-eeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 751 DDFDEKF-CIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
++|.+.. +||+|+||+||+|.++ ++..||||+++... .....++|.+|+.++++++|||||+++|++.+ +..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 4566666 4999999999999654 34579999997542 34556789999999999999999999999975 457
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+||||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 84 ~lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 899999999999999843 235689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC---CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 907 VEPYSS---NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 907 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
...... ......||+.|||||++.++.++.++|||||||++|||+| |+.||..... ......+. ....+..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~---~~~~~~~ 233 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIE---QGKRMEC 233 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHH---TTCCCCC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH---cCCCCCC
Confidence 754332 2234568999999999999999999999999999999998 9999764332 12222111 1111222
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
+ +... .++.+++.+||+.||++|||+.++.+.
T Consensus 234 p---~~~~---~~l~~li~~cl~~~p~~RPs~~~i~~~ 265 (285)
T d1u59a_ 234 P---PECP---PELYALMSDCWIYKWEDRPDFLTVEQR 265 (285)
T ss_dssp C---TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C---CcCC---HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1 2222 256788999999999999999998654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=413.14 Aligned_cols=256 Identities=21% Similarity=0.257 Sum_probs=209.8
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 828 (1078)
.++|++.+.||+|+||+||+|..+ +|+.||||+++... .+...+.+|+.++++++|||||++++++++++.+|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 478999999999999999999664 78899999997542 335568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC--CcEEEeccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE--FEAHVSDFGIAKF 906 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DfG~a~~ 906 (1078)
||||++||+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 79 vmE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 79 IFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999999999432 34689999999999999999999999 99999999999999854 5899999999987
Q ss_pred ccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
... ........||+.|+|||...+..++.++||||+||++|||++|+.||..... ......+ .......+.
T Consensus 154 ~~~-~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--~~~~~~i------~~~~~~~~~ 224 (321)
T d1tkia_ 154 LKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENI------MNAEYTFDE 224 (321)
T ss_dssp CCT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHH------HHTCCCCCH
T ss_pred ccc-CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--HHHHHHH------HhCCCCCCh
Confidence 644 2334567899999999999999999999999999999999999999753322 1111111 111111111
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
........++.+++.+||..||++|||++|+++|||+.
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 00011123578999999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=401.67 Aligned_cols=243 Identities=26% Similarity=0.363 Sum_probs=192.2
Q ss_pred ceeccCCceeEEEEEeC---CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEeec
Q 039595 757 FCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEYL 833 (1078)
Q Consensus 757 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 833 (1078)
++||+|+||+||+|.++ +++.||||+++... .+....++|.+|+.++++++|||||+++|+|+++ ..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcC
Confidence 56999999999999654 35689999997543 2344567899999999999999999999999754 578999999
Q ss_pred CCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 039595 834 HRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSSN 913 (1078)
Q Consensus 834 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 913 (1078)
++|+|.++++. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 90 ~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 90 ELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp TTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999999953 35699999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCcc
Q 039595 914 ---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPGV 989 (1078)
Q Consensus 914 ---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 989 (1078)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ......+. ....+..+ ...
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~---~~~~~~~p---~~~ 235 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLE---KGERMGCP---AGC 235 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH---TTCCCCCC---TTC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHH---cCCCCCCC---ccc
Confidence 234578999999999999999999999999999999998 8999764322 11111111 11111111 122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCChhHHHH
Q 039595 990 MDKLISIMEVAILCLDESPEARPTMEKGFG 1019 (1078)
Q Consensus 990 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 1019 (1078)
. .++.+++.+||+.||++|||++++.+
T Consensus 236 ~---~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 236 P---REMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp C---HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C---HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2 25678899999999999999999854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-45 Score=413.96 Aligned_cols=259 Identities=19% Similarity=0.204 Sum_probs=205.5
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG--NMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+..... .........+|+.+++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999764 79999999986543211 111122233457778888999999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
|+||||++||+|.+++.+ ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999943 35688999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCC
Q 039595 907 VEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTP 985 (1078)
Q Consensus 907 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 985 (1078)
.... .....+||+.|||||++.. ..|+.++||||+||++|||+||+.||...... .... . ...........
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~-~--~~~~~~~~~~~- 228 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHE-I--DRMTLTMAVEL- 228 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHH-H--HHHSSSCCCCC-
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHH-H--HHhcccCCCCC-
Confidence 6543 2345689999999999875 56899999999999999999999997643321 1111 1 11111111111
Q ss_pred CCccHHHHHHHHHHHHhcccCCCCCCCC-----hhHHHHHhhhhh
Q 039595 986 SPGVMDKLISIMEVAILCLDESPEARPT-----MEKGFGHHIGYC 1025 (1078)
Q Consensus 986 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~h~~~~~ 1025 (1078)
..... .++.++|.+||++||++||| ++|+++|||+..
T Consensus 229 ~~~~s---~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 229 PDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp CSSSC---HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred CCCCC---HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 11122 25788999999999999999 799999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=399.74 Aligned_cols=253 Identities=22% Similarity=0.383 Sum_probs=194.9
Q ss_pred cCCCccceeccCCceeEEEEEeCCC-----CEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSG-----DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
..|+..+.||+|+||+||+|.++.. ..||||++.... .....++|.+|+.++++++|||||+++|++.+...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 4688889999999999999976532 369999986543 33456679999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+.+|++.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999999987432 35699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC---CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 906 FVEPYSS---NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 906 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
....... ......||+.|||||++.++.++.++|||||||++|||++|+.|+..... ...... .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~---~i~~~~~~~~ 234 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMK---AINDGFRLPT 234 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHH---HHHTTCCCCC
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHHH---HHhccCCCCC
Confidence 7654322 22345689999999999999999999999999999999997666432211 111111 1111111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
+ .... ..+.+++.+||+.||++|||++|+++..
T Consensus 235 ~---~~~~---~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 235 P---MDCP---SAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp C---TTCB---HHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred c---hhhH---HHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 1 1222 3577899999999999999999998743
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=410.91 Aligned_cols=257 Identities=21% Similarity=0.240 Sum_probs=202.8
Q ss_pred hcCCCccc-eeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhc-CCCCceeeEEeeeec----
Q 039595 750 TDDFDEKF-CIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNE-IRHRNIVKFHGFCSN---- 822 (1078)
Q Consensus 750 ~~~~~~~~-~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~---- 822 (1078)
.++|++.. .||+|+||+||+|.. .+++.||||+++.. +.+.+|+.++.+ .+|||||+++++|++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 46888865 599999999999965 57999999998532 346778887654 589999999999865
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEe
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL---EFEAHVS 899 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~ 899 (1078)
+..+|+|||||+||+|.+++... ....+++.+++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 46789999999999999999643 335699999999999999999999999 9999999999999986 4679999
Q ss_pred cccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcC
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILD 979 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 979 (1078)
|||+|+..... ......+||+.|||||++.+..|+.++||||+||++|||+||++||...... ...... ...+..
T Consensus 157 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~--~~~~~~--~~~i~~ 231 (335)
T d2ozaa1 157 DFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGM--KTRIRM 231 (335)
T ss_dssp CCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCS
T ss_pred ccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH--HHHHHH--HHHHhc
Confidence 99999876543 3345568999999999999999999999999999999999999997532211 111100 011111
Q ss_pred CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 980 PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 980 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.....+.+.......++.+++.+||+.||++|||++|+++|||+.
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 222222222222334688999999999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=406.48 Aligned_cols=262 Identities=21% Similarity=0.173 Sum_probs=200.7
Q ss_pred ccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCCh-hhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEEee
Q 039595 755 EKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNM-ADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVCEY 832 (1078)
Q Consensus 755 ~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 832 (1078)
..++||+|+||+||+|..+ +|+.||||+++........ ...+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999764 7999999999765332211 1134688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCCCC
Q 039595 833 LHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPYSS 912 (1078)
Q Consensus 833 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~~ 912 (1078)
+.++++..+. .....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998777666 3345688999999999999999999999 999999999999999999999999999987766555
Q ss_pred CceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh-----hhcC-------
Q 039595 913 NRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN-----QILD------- 979 (1078)
Q Consensus 913 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-----~~~~------- 979 (1078)
.....+||+.|||||++.+. .|+.++||||+||++|||+||++||...... +....+.... ....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHHhcCCCChhhccchhccch
Confidence 55667899999999998754 6799999999999999999999997543221 1111111000 0000
Q ss_pred -CCCCCCCCccH-----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 980 -PRLSTPSPGVM-----DKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 980 -~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
........... ....++.+++.+||+.||++|||++|+++|||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 284 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence 00000000000 1123688999999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=400.68 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=195.9
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
.++|++.+.||+|+||+||+|.++++++||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-----CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 46899999999999999999998888899999986542 235679999999999999999999999865 567999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+++|+|.+++... ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+|+....
T Consensus 90 ~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999999988442 234589999999999999999999999 999999999999999999999999999987643
Q ss_pred CC-CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCCCc
Q 039595 910 YS-SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSPG 988 (1078)
Q Consensus 910 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 988 (1078)
.. .......||+.|+|||++.++.++.++|||||||++|||++|..||..... ....... ......+... +.
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~---i~~~~~~~~~---~~ 238 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQ---VERGYRMPCP---PE 238 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHH---HHTTCCCCCC---TT
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHH---HHhcCCCCCC---cc
Confidence 32 233456799999999999999999999999999999999997666432211 1111111 1111111121 12
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCChhHHHH
Q 039595 989 VMDKLISIMEVAILCLDESPEARPTMEKGFG 1019 (1078)
Q Consensus 989 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 1019 (1078)
.. .++.+++.+||+.||++|||+++|++
T Consensus 239 ~~---~~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 239 CP---ESLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp SC---HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC---HHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22 25778899999999999999999886
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=399.16 Aligned_cols=266 Identities=21% Similarity=0.283 Sum_probs=204.9
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|+.++++++|||||++++++.++...|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 6899999999999999999965 5799999999965432 222356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
|||+.++ +.+++.. .....+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||.|+....
T Consensus 80 ~e~~~~~-~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp EECCSEE-HHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred EeecCCc-hhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC
Confidence 9999775 4444422 2345699999999999999999999999 999999999999999999999999999988766
Q ss_pred CCCCceeeccccccccccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh-------------h
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV-------------N 975 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~-------------~ 975 (1078)
.........||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+.. .......... .
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhccccccc
Confidence 555566678999999999877655 588999999999999999999998643221 1011100000 0
Q ss_pred hhcCCCCCCCCCc-cH----HHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 976 QILDPRLSTPSPG-VM----DKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 976 ~~~~~~~~~~~~~-~~----~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
....+........ .. ....++.+++.+||..||++|||++|+++|+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~ 287 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhc
Confidence 0000000000000 00 1123678899999999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.5e-45 Score=399.45 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=205.4
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLVC 830 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 830 (1078)
++|++.++||+|+||+||+|++++|+.||||+++.... .....+.+.+|+.++++++|||||++++++..+...++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 68999999999999999999988999999999976532 2233567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+.++.+..+.. ..+.+++.++..++.||+.||+|||+. +||||||||+|||++.++.+|++|||.|......
T Consensus 80 e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 80 EHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp ECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9999877777763 346799999999999999999999999 9999999999999999999999999999887665
Q ss_pred CCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhh-----------hhh--
Q 039595 911 SSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIE-----------VNQ-- 976 (1078)
Q Consensus 911 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~-----------~~~-- 976 (1078)
........|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... ....+.... ...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCChhhccchhhhh
Confidence 5555666899999999998754 5799999999999999999999997643221 000100000 000
Q ss_pred hcCCCCCCCC----Cc-cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 977 ILDPRLSTPS----PG-VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 977 ~~~~~~~~~~----~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
.......... .. ......++.+++.+||..||++|||++|+++|||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0000000000 00 001123677999999999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=398.88 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=202.2
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCCh--hhHHHHHHHHHHHhcCC--CCceeeEEeeeecCCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNM--ADQDEFLNVVLALNEIR--HRNIVKFHGFCSNARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 825 (1078)
++|++.+.||+|+||+||+|.. .+|+.||||++.+....... ....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999965 57999999999765432211 12234668999999886 8999999999999999
Q ss_pred eEEEEeecCC-CCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC-CcEEEecccc
Q 039595 826 SFLVCEYLHR-GSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE-FEAHVSDFGI 903 (1078)
Q Consensus 826 ~~lv~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~ 903 (1078)
.++||||+.+ +++.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 588888843 45689999999999999999999999 99999999999999854 7999999999
Q ss_pred cccccCCCCCceeeccccccccccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
|+.... .......||+.|||||++.+..+ +.++||||+||++|||++|+.||.... .+......+++.
T Consensus 158 a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~i~~~~~~~~~~- 226 (273)
T d1xwsa_ 158 GALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQVFFRQR- 226 (273)
T ss_dssp CEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHHCCCCCSSC-
T ss_pred ceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------HHhhcccCCCCC-
Confidence 986543 23456789999999999987665 678999999999999999999975321 111111111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
.. .++.+++.+||+.||++|||++|+++|||+..
T Consensus 227 ------~s---~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 227 ------VS---SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp ------CC---HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred ------CC---HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 11 25778999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=389.98 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=193.6
Q ss_pred hcCCCccceeccCCceeEEEEEeCC----CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.++|++.+.||+|+||+||+|.+.. +..||||+++... .....+.|.+|+.++++++|||||+++|++.+ +.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-Ce
Confidence 4689999999999999999997642 3468899886432 34456789999999999999999999999964 67
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++||||+++|++.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 82 ~~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp CEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 8999999999999998743 235689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC-CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCC
Q 039595 906 FVEPYSS-NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLS 983 (1078)
Q Consensus 906 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1078)
....... ......||+.|+|||++.+..++.++|||||||++|||+| |++||..... ......+. ....+..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i~---~~~~~~~- 230 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIE---NGERLPM- 230 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH---TTCCCCC-
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHHH---cCCCCCC-
Confidence 7654332 2345678999999999999999999999999999999998 8999754332 22221111 1111111
Q ss_pred CCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 984 TPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 984 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
++... ..+.+++.+||+.||++|||++|++++.-.
T Consensus 231 --~~~~~---~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 231 --PPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp --CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 12222 257789999999999999999999998643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=388.64 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=193.2
Q ss_pred hcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec-CCeeEE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN-ARHSFL 828 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 828 (1078)
.++|++.+.||+|+||.||+|.++ |+.||||+++.. ...+.|.+|++++++++||||++++|++.+ .+..++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 357888999999999999999885 789999998643 235678999999999999999999999854 567899
Q ss_pred EEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccccc
Q 039595 829 VCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVE 908 (1078)
Q Consensus 829 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~ 908 (1078)
||||+++|+|.+++... ....+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++...
T Consensus 79 v~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence 99999999999999532 233589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCCCCCCC
Q 039595 909 PYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPSP 987 (1078)
Q Consensus 909 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 987 (1078)
. ......+|+.|+|||++.++.++.++|||||||++|||+| |++||..... ...... ......+....
T Consensus 155 ~---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~---i~~~~~~~~~~--- 223 (262)
T d1byga_ 155 S---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPR---VEKGYKMDAPD--- 223 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHH---HTTTCCCCCCT---
T ss_pred C---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHH---HHcCCCCCCCc---
Confidence 3 2334568999999999999999999999999999999998 7888653322 122221 11112222222
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 988 GVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 988 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
... .++.+++.+||+.||++|||++|++++.
T Consensus 224 ~~~---~~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 224 GCP---PAVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCC---HHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 122 2567899999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-44 Score=393.29 Aligned_cols=256 Identities=26% Similarity=0.347 Sum_probs=195.8
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR---- 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 824 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.... .+....+.+.+|+.++++++|||||++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 36799999999999999999965 5799999999976543 23445667999999999999999999999986543
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..|+||||++||+|.+++. ..+.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.++++|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 4799999999999999884 345699999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCC---CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 905 KFVEPYS---SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 905 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
....... ......+||+.|||||++.+..++.++||||+||++|||+||++||..... ......... -++.
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~~~~----~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVR----EDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHH----CCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--HHHHHHHHh----cCCC
Confidence 7654322 233456899999999999999999999999999999999999999753322 111111111 0111
Q ss_pred CCC-CCCccHHHHHHHHHHHHhcccCCCCCCC-ChhHHHHHhh
Q 039595 982 LST-PSPGVMDKLISIMEVAILCLDESPEARP-TMEKGFGHHI 1022 (1078)
Q Consensus 982 ~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ell~h~~ 1022 (1078)
... ..+... .++.+++.+||++||++|| |+++++ |.|
T Consensus 233 ~~~~~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~-~~l 271 (277)
T d1o6ya_ 233 PPSARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMR-ADL 271 (277)
T ss_dssp CGGGTSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHH-HHH
T ss_pred CCchhccCCC---HHHHHHHHHHccCCHhHCHhHHHHHH-HHH
Confidence 110 111112 3577899999999999999 555554 444
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=397.51 Aligned_cols=254 Identities=21% Similarity=0.361 Sum_probs=198.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCC----EEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARH 825 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 825 (1078)
.+|++.+.||+|+||+||+|.+. +|+ +||+|+++... .....++|.+|+.++++++|||||+++|+|.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 46999999999999999999654 454 58888886532 334567899999999999999999999999875 5
Q ss_pred eEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 826 SFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 826 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.++++||+.+|+|.+++... ...+++..+++++.|||.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 67888999999999988543 45689999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 906 FVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 906 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
........ .....||+.|||||++.++.++.++|||||||++|||+| |++||+.... ......+.. -..+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~---~~~~~~ 234 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK---GERLPQ 234 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHH---TCCCCC
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc---CCCCCC
Confidence 77543332 234568999999999999999999999999999999998 7888764332 222222211 111111
Q ss_pred CCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 983 STPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 983 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
++... .++.+++.+||+.||++|||++|+++|....
T Consensus 235 ---p~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 235 ---PPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ---CTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CcccC---HHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11122 2577899999999999999999999996543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-44 Score=393.60 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=205.3
Q ss_pred HHhhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeee
Q 039595 747 IKATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFC 820 (1078)
Q Consensus 747 ~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 820 (1078)
+...++|++.+.||+|+||+||+|+++ +++.||||+++... .....++|.+|+.++++++||||+++++++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 334678999999999999999999764 35789999986542 334467899999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCC---------------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDA---------------------TAKELSWNRRINVIKGVANALSYLHHDCLPSII 879 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 879 (1078)
.+....++||||+++|+|.+++.... ....+++.+++.|+.|++.||+|||++ +||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 99999999999999999999985321 123488999999999999999999999 999
Q ss_pred ecCCCCCCeeeCCCCcEEEecccccccccCCC--CCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCC-CC
Q 039595 880 HRDISSKNVLLDLEFEAHVSDFGIAKFVEPYS--SNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN-HP 956 (1078)
Q Consensus 880 H~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~-~p 956 (1078)
||||||+|||++.++.+||+|||+|+...... .......|++.|||||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998664332 2234567899999999999999999999999999999999986 56
Q ss_pred CCcccccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 957 RDFFSINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 957 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
|.... ..+.... +........+..... ++.+++.+||+.||++||||.||++..-
T Consensus 243 ~~~~~--~~e~~~~------v~~~~~~~~p~~~~~---~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 243 YYGMA--HEEVIYY------VRDGNILACPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp TTTSC--HHHHHHH------HHTTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCC--HHHHHHH------HHcCCCCCCCccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 44322 1122121 112222111122222 5778999999999999999999977543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=394.79 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=195.2
Q ss_pred HHHHhhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEE
Q 039595 745 EIIKATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFH 817 (1078)
Q Consensus 745 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 817 (1078)
+++...++|++.+.||+|+||+||+|.+. +++.||||+++... ...+.+.+.+|...+.++ +|+||+.++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 33344578999999999999999999653 34689999987542 334456677787777776 689999999
Q ss_pred eeeec-CCeeEEEEeecCCCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 039595 818 GFCSN-ARHSFLVCEYLHRGSLARILGNDA-------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDI 883 (1078)
Q Consensus 818 ~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 883 (1078)
+++.. +...++||||+++|+|.++++... ....+++.+++.++.||+.||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 98755 457899999999999999995432 134589999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCC-CCCCcc
Q 039595 884 SSKNVLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN-HPRDFF 960 (1078)
Q Consensus 884 k~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~-~p~~~~ 960 (1078)
||+|||++.++.+||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+||. +||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654332 234567999999999999999999999999999999999974 565433
Q ss_pred cccccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 961 SINFSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
... ..+...+ .....+..+. ... .++.+++.+||+.||++|||++|+++|.-
T Consensus 241 ~~~-~~~~~~~---~~~~~~~~~~---~~~---~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 241 KID-EEFCRRL---KEGTRMRAPD---YTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp CCS-HHHHHHH---HHTCCCCCCT---TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHH-HHHHHHH---hcCCCCCCCc---cCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 221 1111111 1111222211 112 25778999999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=388.45 Aligned_cols=252 Identities=26% Similarity=0.357 Sum_probs=190.9
Q ss_pred cCCCccceeccCCceeEEEEEeC--CC--CEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP--SG--DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 826 (1078)
++|++.+.||+|+||+||+|++. ++ ..||||++.+.... .....++|.+|+.++++++|||||+++|++.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 57999999999999999999653 23 36899998765432 33446789999999999999999999999976 467
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKF 906 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~ 906 (1078)
++||||+++|++.+++.. ....+++..++.++.|||.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999988743 235699999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCC---ceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccchhhhhhhhhhhcCCCC
Q 039595 907 VEPYSSN---RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIEVNQILDPRL 982 (1078)
Q Consensus 907 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 982 (1078)
....... .....||..|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+ .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--~~~~~~i------~~~~~ 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILHKI------DKEGE 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH------HTSCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--HHHHHHH------HhCCC
Confidence 7554332 234567889999999999999999999999999999998 8999753322 1111111 11111
Q ss_pred CCC-CCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHH
Q 039595 983 STP-SPGVMDKLISIMEVAILCLDESPEARPTMEKGFGH 1020 (1078)
Q Consensus 983 ~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h 1020 (1078)
..+ ..... ..+.+++.+||+.||++|||++|+.+-
T Consensus 233 ~~~~~~~~~---~~l~~li~~cl~~dp~~RPt~~ei~~~ 268 (273)
T d1u46a_ 233 RLPRPEDCP---QDIYNVMVQCWAHKPEDRPTFVALRDF 268 (273)
T ss_dssp CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccc---HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111 11122 257789999999999999999998753
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.4e-43 Score=394.78 Aligned_cols=297 Identities=33% Similarity=0.532 Sum_probs=190.6
Q ss_pred CCHHHHHHHHHHHHhcCCCCCCccccCCCCCCCCCCCCCCCC--cccceEeeCCC--CeEEEeccCccccCCcccCCccC
Q 039595 24 DSSAEACALLNWKTSLQNQNLNSSLLSSWTLYPTNASKISPC--SWFGISCNHAG--SRVISINLSTLCLNGTFQDFSFS 99 (1078)
Q Consensus 24 ~~~~~~~all~~k~~~~~~~~~~~~l~sW~~~~~~~~~~~~c--~w~gv~C~~~~--~~v~~l~l~~~~l~g~~~~~~~~ 99 (1078)
|.++||+|||+||++++++ ..++||.. ++||| .|+||+|+..+ +||+.|+|+++++.|..
T Consensus 3 c~~~e~~aLl~~k~~~~~~----~~l~sW~~------~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~------ 66 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNP----TTLSSWLP------TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY------ 66 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCC----GGGTTCCT------TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCE------
T ss_pred CCHHHHHHHHHHHHHCCCC----CcCCCCCC------CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCC------
Confidence 7899999999999999764 46999972 47999 49999998754 48888877776666543
Q ss_pred CCCCCcEEeccCCcccccCCCCCCCCCCcceeccCC-CccCCCCCccccCccceeEEEccCccCCCCCCcccccccccce
Q 039595 100 SFPHLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGN-NQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHE 178 (1078)
Q Consensus 100 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~ 178 (1078)
.+|+++++|++|++|||++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+.+|+.
T Consensus 67 -----------------~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 67 -----------------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp -----------------ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred -----------------CCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 3455555555555555554 4555555555555555555555555555555555555555555
Q ss_pred eecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCC-CeeecCCcccCCCCCCcccCCCCCcEEeccccc
Q 039595 179 FSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSL-STLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNS 257 (1078)
Q Consensus 179 L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 257 (1078)
+++++|.+.+.+|.+++++++|+++++++|.+++.+|+.+..+.++ +.+++++|++++..|..+.++..+ .+++.+|.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 5555555555556666666666666666666665566555555554 556666666666555555554333 46666666
Q ss_pred cCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCC
Q 039595 258 LSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPS 337 (1078)
Q Consensus 258 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 337 (1078)
+.+.+|..+..+++|+.|++++|.+++.+| .++.+++|+.|++++|+++|.+|..|+++++|++|+|++|+|+|.+|.
T Consensus 209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~- 286 (313)
T d1ogqa_ 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ- 286 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred cccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-
Confidence 666666666666666666666666665443 455566666666666666666666666666777777777777666663
Q ss_pred CCCCCcCcEEEccCcc-CCC
Q 039595 338 IGNLSSLRNLSLFNNG-LYG 356 (1078)
Q Consensus 338 l~~l~~L~~L~Ls~N~-l~~ 356 (1078)
++++++|+.+++++|+ +.|
T Consensus 287 ~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 287 GGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp STTGGGSCGGGTCSSSEEES
T ss_pred cccCCCCCHHHhCCCccccC
Confidence 4666677777777765 444
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=392.87 Aligned_cols=267 Identities=21% Similarity=0.284 Sum_probs=199.3
Q ss_pred hhcCCCccceeccCCceeEEEEEe-CC-CCEEEEEEeccccccCChhhHHHHHHHHHHHhcC---CCCceeeEEeeee--
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL-PS-GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI---RHRNIVKFHGFCS-- 821 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-- 821 (1078)
..++|++.+.||+|+||+||+|.. ++ ++.||||+++....... ....+.+|+.+++.+ +||||++++++|.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 357899999999999999999976 44 56799999976533221 122345666665554 8999999999984
Q ss_pred ---cCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEE
Q 039595 822 ---NARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHV 898 (1078)
Q Consensus 822 ---~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 898 (1078)
.....+++|||+++|.+..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ccccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 3357899999999887655442 2345689999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh----
Q 039595 899 SDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV---- 974 (1078)
Q Consensus 899 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~---- 974 (1078)
+|||.++.... ........||+.|||||++.+..|+.++||||+||++|||++|++||...... ..........
T Consensus 158 ~dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 158 ADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPG 235 (305)
T ss_dssp CSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred cchhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCc
Confidence 99999986543 23345678999999999999999999999999999999999999997643321 0011100000
Q ss_pred -----------hhhcCCCCCCCCCc-cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 975 -----------NQILDPRLSTPSPG-VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 975 -----------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
..........+... .......+.+++.+||+.||++|||++|+++|||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 00000000000000 001122567899999999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=389.49 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=205.4
Q ss_pred hhcCCCccceeccCCceeEEEEEe------CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeee
Q 039595 749 ATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCS 821 (1078)
Q Consensus 749 ~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 821 (1078)
..++|++.+.||+|+||.||+|++ .+++.||||+++... ......+|.+|+.+++++ +|||||++++++.
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 347899999999999999999965 246689999997543 345567899999999999 6999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHhcCCC---------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 039595 822 NARHSFLVCEYLHRGSLARILGNDA---------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 886 (1078)
Q Consensus 822 ~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 886 (1078)
+++..++||||+++|+|.+++++.. ....+++.++..++.||+.|++|||++ ++|||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence 9999999999999999999985432 233589999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhC-CCCCCccccc
Q 039595 887 NVLLDLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG-NHPRDFFSIN 963 (1078)
Q Consensus 887 NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~p~~~~~~~ 963 (1078)
||+++.++.+|++|||.++........ .....||+.|+|||++.+..++.++|||||||++|||+|+ .+||.....
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~- 253 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV- 253 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999977553332 2346789999999999999999999999999999999994 555432222
Q ss_pred ccchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 964 FSSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...+...+. .-..+..+. ... ..+.+++.+||+.||++|||++|+++..
T Consensus 254 ~~~~~~~i~---~~~~~~~~~---~~~---~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 254 DSKFYKMIK---EGFRMLSPE---HAP---AEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp SHHHHHHHH---HTCCCCCCT---TSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHh---cCCCCCCcc---ccc---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111111111 111222111 111 2578899999999999999999999743
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=388.70 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=198.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCC--EEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeeeecCCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGD--IVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 826 (1078)
++|++.++||+|+||+||+|.++ +|. .||||++.... .....+.|.+|+.+++++ +|||||+++|++.+++..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 68999999999999999999765 444 47788875432 223456799999999998 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhcCC-------------CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCC
Q 039595 827 FLVCEYLHRGSLARILGND-------------ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLE 893 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 893 (1078)
++||||+++|+|.++++.. .....+++.++.+++.||+.||.|+|++ +|+||||||+|||++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence 9999999999999999654 2346799999999999999999999999 99999999999999999
Q ss_pred CcEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCC-CCCCcccccccchhhhhh
Q 039595 894 FEAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN-HPRDFFSINFSSFSNMII 972 (1078)
Q Consensus 894 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~-~p~~~~~~~~~~~~~~~~ 972 (1078)
+.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||.... .......+
T Consensus 164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i- 239 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKL- 239 (309)
T ss_dssp GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHG-
T ss_pred CceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHHH-
Confidence 999999999998654322 233457899999999999999999999999999999999975 4654322 11221111
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 973 EVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.....+..+ .... .++.+++.+||+.||++|||++|++++.
T Consensus 240 --~~~~~~~~~---~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 240 --PQGYRLEKP---LNCD---DEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp --GGTCCCCCC---TTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HhcCCCCCC---ccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111112111 1222 2577889999999999999999999884
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-43 Score=384.45 Aligned_cols=262 Identities=23% Similarity=0.291 Sum_probs=196.1
Q ss_pred cCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC----ee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR----HS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 826 (1078)
++|...+.||+|+||+||+|++ +|+.||||+++... ........|+..+++++|||||++++++.+.+ ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 5677888999999999999987 58999999986431 11222334566667789999999999996543 67
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCCeeeCCCCcEEEecc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC-----LPSIIHRDISSKNVLLDLEFEAHVSDF 901 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl~Df 901 (1078)
|+||||+++|+|.+++++ ..+++.++++++.|+|.||+|+|+.. .++|+||||||+|||++.++.+||+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 999999999999999953 35899999999999999999999731 238999999999999999999999999
Q ss_pred cccccccCCCC----CceeeccccccccccccccCC------CCccchhHHHHHHHHHHHhCCCCCCcccccccchh---
Q 039595 902 GIAKFVEPYSS----NRTEFVGTFGYAAPEIAYTMR------ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS--- 968 (1078)
Q Consensus 902 G~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~--- 968 (1078)
|+++....... ......||+.|||||++.+.. ++.++|||||||++|||+||..||...........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 99987754332 234567999999999987643 57799999999999999999988653322111000
Q ss_pred ----hhhhhhhhhcCCCCCCCCCc---cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhh
Q 039595 969 ----NMIIEVNQILDPRLSTPSPG---VMDKLISIMEVAILCLDESPEARPTMEKGFGHHI 1022 (1078)
Q Consensus 969 ----~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~ 1022 (1078)
...............+..+. ..+....+.+++.+||+.||++|||+.|+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 00111112222233222211 2234456889999999999999999999988754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=389.15 Aligned_cols=263 Identities=21% Similarity=0.346 Sum_probs=209.9
Q ss_pred HHHHHhhcCCCccceeccCCceeEEEEEeC------CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEE
Q 039595 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFH 817 (1078)
Q Consensus 744 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 817 (1078)
++++...++|+..+.||+|+||+||+|.++ +++.||||+++... ...+...|.+|+.++++++|||||+++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 344445688999999999999999999653 35789999997542 344566799999999999999999999
Q ss_pred eeeecCCeeEEEEeecCCCCHHHHhcCC-------CCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 039595 818 GFCSNARHSFLVCEYLHRGSLARILGND-------ATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 890 (1078)
Q Consensus 818 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll 890 (1078)
+++..+...++||||+++|+|.+++... .....+++..+.+++.|+|+||.|||++ +|+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceee
Confidence 9999999999999999999999988432 2234578999999999999999999999 99999999999999
Q ss_pred CCCCcEEEecccccccccCCCCC--ceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCC-CCCCcccccccch
Q 039595 891 DLEFEAHVSDFGIAKFVEPYSSN--RTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN-HPRDFFSINFSSF 967 (1078)
Q Consensus 891 ~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~-~p~~~~~~~~~~~ 967 (1078)
+.++++||+|||+|+........ .....||+.|+|||.+.+..++.++|||||||++|||+||+ +||..... ...
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--~~~ 244 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQV 244 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHH
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 99999999999999876543322 23457899999999999999999999999999999999985 66543221 111
Q ss_pred hhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhh
Q 039595 968 SNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIG 1023 (1078)
Q Consensus 968 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~ 1023 (1078)
.. .+.+........... ..+.+++.+||+.||++|||++|++++.-.
T Consensus 245 ~~------~i~~~~~~~~p~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~ 291 (308)
T d1p4oa_ 245 LR------FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKE 291 (308)
T ss_dssp HH------HHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred HH------HHHhCCCCCCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 122222222222222 257888999999999999999999987543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=385.18 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=200.0
Q ss_pred hcCCCccceeccCCceeEEEEEeCC--------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcC-CCCceeeEEeee
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELPS--------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEI-RHRNIVKFHGFC 820 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 820 (1078)
.++|++.+.||+|+||.||+|+... +..||||+++... ......++.+|...+.++ +|||||+++++|
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 4689999999999999999996532 2479999997643 334567788888888888 899999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHhcCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 039595 821 SNARHSFLVCEYLHRGSLARILGNDA-------------TAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 887 (1078)
Q Consensus 821 ~~~~~~~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 887 (1078)
.+++..++||||+++|+|.+++.... ....+++.++++++.||+.||+|||++ +||||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence 99999999999999999999996443 234689999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCC--CceeeccccccccccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccc
Q 039595 888 VLLDLEFEAHVSDFGIAKFVEPYSS--NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINF 964 (1078)
Q Consensus 888 Ill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~ 964 (1078)
||++.++.+||+|||+++....... ......||+.|+|||.+.++.|+.++|||||||++|||++ |++||.....
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-- 243 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 243 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--
Confidence 9999999999999999997754332 2344678999999999999999999999999999999998 6888653322
Q ss_pred cchhhhhhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 965 SSFSNMIIEVNQILDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
...... ...-..+.. +.... .++.+++.+||+.||++|||++|+++.+
T Consensus 244 ~~~~~~---i~~~~~~~~---p~~~~---~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 244 EELFKL---LKEGHRMDK---PSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHHHH---HHTTCCCCC---CSSCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHH---HHcCCCCCC---Cccch---HHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 111111 111111211 12222 2578899999999999999999999854
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=384.22 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=196.0
Q ss_pred cceeccCCceeEEEEEeCCC----CEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec-CCeeEEEE
Q 039595 756 KFCIGKGGQGSVYKAELPSG----DIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN-ARHSFLVC 830 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 830 (1078)
.++||+|+||+||+|.+..+ ..||||+++.. ......++|.+|++++++++||||++++|++.+ ++..++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 46799999999999976432 25899998643 245567889999999999999999999999864 56899999
Q ss_pred eecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccCC
Q 039595 831 EYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEPY 910 (1078)
Q Consensus 831 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~~ 910 (1078)
||+++|+|.+++... ....++.++++++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 109 E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp ECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999999998543 34577889999999999999999999 9999999999999999999999999999876443
Q ss_pred CC----CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCCCCCCC
Q 039595 911 SS----NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPRLSTPS 986 (1078)
Q Consensus 911 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 986 (1078)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ......+.... .+.. +
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~---~~~~---p 256 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGR---RLLQ---P 256 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTC---CCCC---C
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCC---CCCC---c
Confidence 22 223457899999999999999999999999999999999988875432221 11222211111 1111 1
Q ss_pred CccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHh
Q 039595 987 PGVMDKLISIMEVAILCLDESPEARPTMEKGFGHH 1021 (1078)
Q Consensus 987 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~ 1021 (1078)
.... ..+.+++.+||+.||++||+++||++|.
T Consensus 257 ~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 257 EYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCc---HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1122 2577889999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=385.29 Aligned_cols=266 Identities=20% Similarity=0.273 Sum_probs=201.4
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec------
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN------ 822 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 822 (1078)
.++|++.+.||+|+||+||+|.. ++|+.||||++...... ....+++.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 47899999999999999999975 57999999998765322 2345678899999999999999999998854
Q ss_pred --CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEec
Q 039595 823 --ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSD 900 (1078)
Q Consensus 823 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 900 (1078)
....|+||||+.++.+..+. .....+++.+++.+++||+.||.|||++ +|+||||||+|||++.++.+|++|
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred ccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence 34689999999887766555 3345689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC----CCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhh
Q 039595 901 FGIAKFVEPYS----SNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVN 975 (1078)
Q Consensus 901 fG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 975 (1078)
||+++.+.... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||+.... ......+....
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~~~ 238 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLC 238 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHH
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHHHHHHhc
Confidence 99998765322 123345799999999998765 689999999999999999999999753322 11111111111
Q ss_pred hhcCCCC----------------CCCCCccHHH------HHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 976 QILDPRL----------------STPSPGVMDK------LISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 976 ~~~~~~~----------------~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
....+.. .......... ...+.+++.+||+.||++|||++|+++|||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 1111110 0000111111 125678999999999999999999999999763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=381.21 Aligned_cols=265 Identities=19% Similarity=0.248 Sum_probs=210.6
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCCeeEEE
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNARHSFLV 829 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 829 (1078)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ......+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh--CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 5899999999999999999965 578999999997653 2344567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccccccccC
Q 039595 830 CEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAKFVEP 909 (1078)
Q Consensus 830 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~~~~~ 909 (1078)
+|++.++++..++. ..+.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.|+....
T Consensus 80 ~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 80 FEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eeeccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999999988874 345688999999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCceeeccccccccccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhc----------
Q 039595 910 YSSNRTEFVGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQIL---------- 978 (1078)
Q Consensus 910 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------- 978 (1078)
.........+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.......... ..+.......
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HHHHHHHCCCCTTTCTTGGG
T ss_pred CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH-HHHHhhcCCCChhhhhhhhh
Confidence 555556667889999999987665 6999999999999999999999963222111111 1110000000
Q ss_pred -----C----CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 979 -----D----PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 979 -----~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. +...............+.+++.+||+.||++|||++|+++|||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~ 287 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence 0 000000001111123577899999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=388.13 Aligned_cols=262 Identities=21% Similarity=0.279 Sum_probs=209.6
Q ss_pred hcCCCccceeccCCceeEEEEEe----CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC-CceeeEEeeeecCC
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH-RNIVKFHGFCSNAR 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~ 824 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++++.....+....+.+.+|+.++++++| |||+++++++++..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 37799999999999999999964 25889999999765544344445678899999999976 89999999999999
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..++||||+.+|+|.+++.. .+.+++..+..++.||+.|++|+|++ +|+||||||+||+++.++.+||+|||+|
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999943 34578899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCC-CCceeeccccccccccccccC--CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhhcCCC
Q 039595 905 KFVEPYS-SNRTEFVGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQILDPR 981 (1078)
Q Consensus 905 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 981 (1078)
+.+.... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... .....+........+.
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~--~~~~~i~~~~~~~~~~ 254 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEPP 254 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHHCCCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcccCCCC
Confidence 8764332 234556899999999998764 4688999999999999999999997544322 1222222211122222
Q ss_pred CCCCCCccHHHHHHHHHHHHhcccCCCCCCC-----ChhHHHHHhhhhh
Q 039595 982 LSTPSPGVMDKLISIMEVAILCLDESPEARP-----TMEKGFGHHIGYC 1025 (1078)
Q Consensus 982 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~h~~~~~ 1025 (1078)
.+.. . ..++.+++.+||++||++|| |++|+++|||+..
T Consensus 255 ~~~~---~---s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 255 YPQE---M---SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp CCTT---S---CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred Cccc---C---CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 2211 1 23677889999999999999 5899999999764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=388.46 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=198.3
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR---- 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 824 (1078)
.++|++++.||+|+||+||+|.. .+|+.||||+++... ......+.+.+|+.++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 46899999999999999999965 579999999997643 23445677899999999999999999999997554
Q ss_pred --eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccc
Q 039595 825 --HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFG 902 (1078)
Q Consensus 825 --~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 902 (1078)
.+|+||||+ +++|..+.+ ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 579999999 557888773 34699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh----------
Q 039595 903 IAKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI---------- 971 (1078)
Q Consensus 903 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~---------- 971 (1078)
.|+.... ..+..+||+.|+|||.+.+. .++.++||||+||++|||++|++||...+... ......
T Consensus 167 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 167 LARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEF 242 (346)
T ss_dssp TCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHH
T ss_pred ceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCcHHH
Confidence 9987653 34556899999999998764 57899999999999999999999975432210 000000
Q ss_pred ---------hhhhhhcCCCCCCCCC-ccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 972 ---------IEVNQILDPRLSTPSP-GVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 972 ---------~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
........+....... ........+.+++.+||..||++|||++|+++|||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 0000001111100000 00011225678999999999999999999999999764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=387.79 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=199.0
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeecCC----
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSNAR---- 824 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 824 (1078)
.++|++++.||+|+||+||+|.. .+|+.||||++.+.. .....+.+.+|+.++++++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 45799999999999999999965 589999999997532 3445677899999999999999999999986543
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEeccccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGIA 904 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a 904 (1078)
..+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 33555566779999999943 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCC---CCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh--------
Q 039595 905 KFVEPYS---SNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII-------- 972 (1078)
Q Consensus 905 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~-------- 972 (1078)
+...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||....... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQ 234 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH--HHHHHhhhccCCCh
Confidence 8664322 12345679999999999854 567899999999999999999999986432210 000000
Q ss_pred ------------hhhhhcCCCCCCCCCc-cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 973 ------------EVNQILDPRLSTPSPG-VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 973 ------------~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
............+... ......++.+++.+||..||++|||++|+++|||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~ 299 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 0000000000000000 001112578999999999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=387.18 Aligned_cols=261 Identities=23% Similarity=0.248 Sum_probs=196.7
Q ss_pred CCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec------CC
Q 039595 752 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN------AR 824 (1078)
Q Consensus 752 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 824 (1078)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+.++++++||||++++++|.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 6889999999999999999764 799999999976431 12368999999999999999999843 34
Q ss_pred eeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEecccc
Q 039595 825 HSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHVSDFGI 903 (1078)
Q Consensus 825 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~ 903 (1078)
+.|+||||+++|.+..+.........+++.+++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence 5789999998764444432223455799999999999999999999999 999999999999999775 899999999
Q ss_pred cccccCCCCCceeecccccccccccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh-----------
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI----------- 971 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~----------- 971 (1078)
++..... ......+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .......
T Consensus 170 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 170 AKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred hhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhh
Confidence 9876543 23445689999999998775 57899999999999999999999997643321 1010000
Q ss_pred hhh-hhhcCCCCCCCCCc------cHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 972 IEV-NQILDPRLSTPSPG------VMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 972 ~~~-~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
... .......+...... ......++.+++.+||..||++|||++|+++|+|+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 000 00011111110000 0111235788999999999999999999999999753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.1e-42 Score=383.51 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=200.4
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeec--CCee
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSN--ARHS 826 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~ 826 (1078)
++|+++++||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|+.+++++. ||||+++++++.. ....
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 6899999999999999999966 57999999998643 2567889999999995 9999999999974 4578
Q ss_pred EEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCC-cEEEecccccc
Q 039595 827 FLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEF-EAHVSDFGIAK 905 (1078)
Q Consensus 827 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~a~ 905 (1078)
++||||+.+|+|..+. +.+++.++..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus 108 ~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence 9999999999997764 3589999999999999999999999 999999999999998655 69999999998
Q ss_pred cccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhh------------
Q 039595 906 FVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII------------ 972 (1078)
Q Consensus 906 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~------------ 972 (1078)
..... ......+||+.|+|||.+.+. .++.++||||+||++|||++|+.||...............
T Consensus 179 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 179 FYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp ECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 77543 234556789999999998765 4799999999999999999999997543322111100000
Q ss_pred h--------hhhhcCCCCCC------CCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhh
Q 039595 973 E--------VNQILDPRLST------PSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGY 1024 (1078)
Q Consensus 973 ~--------~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~ 1024 (1078)
. ........... ..........++.+++.+||..||++|||++|+++|||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~ 323 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0 00000000000 0001111123678999999999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=380.90 Aligned_cols=261 Identities=21% Similarity=0.261 Sum_probs=195.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeee------cC
Q 039595 751 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCS------NA 823 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~------~~ 823 (1078)
++|++.++||+|+||+||+|.+. +|+.||||++..... .....+.+.+|+.++++++|||||+++++|. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 67999999999999999999764 799999999976542 3445667899999999999999999999995 34
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...|+||||+.++.+ +.+. ..+++.+++.++.||+.||+|||+. ||+||||||+|||++.++.+|++|||.
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp CEEEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ceeEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 688999999977544 4442 3488999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhh------------
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI------------ 971 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~------------ 971 (1078)
++.... .......+||+.|+|||++.+..++.++||||+||++|||++|++||...+... ....+
T Consensus 166 ~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred hhcccc-ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH--HHHHHHHhccCCCHHHH
Confidence 986654 233455679999999999999999999999999999999999999975332110 00000
Q ss_pred ----hhhhhhcCC---------------C-CCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 972 ----IEVNQILDP---------------R-LSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 972 ----~~~~~~~~~---------------~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
......... . .............++.+++++||..||++|||++|+++|||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000000000 0 01111111223457889999999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-41 Score=379.04 Aligned_cols=262 Identities=20% Similarity=0.289 Sum_probs=199.9
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCceeeEEeeeec-----C
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNIVKFHGFCSN-----A 823 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~ 823 (1078)
.++|++.+.||+|+||+||+|.. .+|+.||||++.+.. ......+.+.+|+.++++++|||||++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 46899999999999999999965 579999999997653 234456678899999999999999999999853 3
Q ss_pred CeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEecccc
Q 039595 824 RHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVSDFGI 903 (1078)
Q Consensus 824 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 903 (1078)
...+++++|+.+|+|.+++.. +.+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence 344667788889999999943 4599999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhh--------
Q 039595 904 AKFVEPYSSNRTEFVGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEV-------- 974 (1078)
Q Consensus 904 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~-------- 974 (1078)
+..... ......|++.|+|||...+. .++.++||||+||++|+|++|+.||...+.. .....+...
T Consensus 168 a~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred hcccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChHH
Confidence 976532 34456789999999987765 4689999999999999999999997543221 111111000
Q ss_pred ---------hhhcCCCCCCCCCcc----HHHHHHHHHHHHhcccCCCCCCCChhHHHHHhhhhh
Q 039595 975 ---------NQILDPRLSTPSPGV----MDKLISIMEVAILCLDESPEARPTMEKGFGHHIGYC 1025 (1078)
Q Consensus 975 ---------~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ell~h~~~~~ 1025 (1078)
............... .....++.+++.+||..||++|||++|+++|||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 000000000000000 011235778999999999999999999999999764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-39 Score=357.30 Aligned_cols=253 Identities=17% Similarity=0.226 Sum_probs=189.2
Q ss_pred hcCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCc-eeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRN-IVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||+||+|.+ .+|+.||||++..... .+++..|+++++.++|++ |+.+.+++.+++..+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 36799999999999999999965 5789999999865421 234678999999998766 555566668888999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC---CCcEEEeccccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL---EFEAHVSDFGIA 904 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfG~a 904 (1078)
+||||+. |++.+.+.. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+|++|||+|
T Consensus 80 ivme~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EEEECCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEEEcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 9999995 466666532 335689999999999999999999999 9999999999999864 457999999999
Q ss_pred ccccCCCC-------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccchhhhhhhhhhh
Q 039595 905 KFVEPYSS-------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIEVNQI 977 (1078)
Q Consensus 905 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 977 (1078)
+.+..... ......||+.|||||.+.+..++.++|||||||++|||+||+.||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 98754322 23456799999999999999999999999999999999999999865433221111100000000
Q ss_pred cCCCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHH
Q 039595 978 LDPRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGF 1018 (1078)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell 1018 (1078)
..+ ......... .++.+++.+||+.||++||+++++.
T Consensus 234 ~~~-~~~~~~~~p---~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 234 STP-IEVLCKGYP---SEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp HSC-HHHHTTTSC---HHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred CCC-hhHhccCCC---HHHHHHHHHHccCChhHCcCHHHHH
Confidence 000 000001111 2567888999999999999988654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-39 Score=352.04 Aligned_cols=252 Identities=19% Similarity=0.221 Sum_probs=195.4
Q ss_pred hcCCCccceeccCCceeEEEEEeC-CCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC-CceeeEEeeeecCCeeE
Q 039595 750 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH-RNIVKFHGFCSNARHSF 827 (1078)
Q Consensus 750 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~ 827 (1078)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... +.+.+.+|++.++.+.| +|++.+++++..+...+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc------CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 368999999999999999999754 78999999886532 12346678888888865 89999999999999999
Q ss_pred EEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCC-----CCcEEEeccc
Q 039595 828 LVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDL-----EFEAHVSDFG 902 (1078)
Q Consensus 828 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DfG 902 (1078)
+||||+ +|+|.+++... ...+++.++..++.|++.||+|||++ ||+||||||+||+++. ++.+||+|||
T Consensus 78 ~vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccc
Confidence 999998 67999988532 34689999999999999999999999 9999999999999974 5789999999
Q ss_pred ccccccCCCC-------CceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc-chhhhhhhh
Q 039595 903 IAKFVEPYSS-------NRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS-SFSNMIIEV 974 (1078)
Q Consensus 903 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~-~~~~~~~~~ 974 (1078)
+|+....... .....+||+.|||||++.+..++.++|||||||++|||+||+.||........ .....+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 9987643221 23456799999999999999999999999999999999999999864433211 111111111
Q ss_pred hhhcC-CCCCCCCCccHHHHHHHHHHHHhcccCCCCCCCChhHHHH
Q 039595 975 NQILD-PRLSTPSPGVMDKLISIMEVAILCLDESPEARPTMEKGFG 1019 (1078)
Q Consensus 975 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 1019 (1078)
..... +.+. +..++ ++.+++..|++.+|++||+++.+.+
T Consensus 232 ~~~~~~~~l~---~~~p~---~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 232 KQSTPLRELC---AGFPE---EFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHSCHHHHT---TTSCH---HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCCChHHhc---CCCCH---HHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11111 0011 11122 4677788899999999999876543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-36 Score=344.14 Aligned_cols=263 Identities=18% Similarity=0.185 Sum_probs=194.1
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-----------CCceeeEEe
Q 039595 751 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-----------HRNIVKFHG 818 (1078)
Q Consensus 751 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~ 818 (1078)
.+|+++++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+.++++++ |+||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 3599999999999999999976 579999999997542 23456778888887775 578999998
Q ss_pred eeec--CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeCCCC-
Q 039595 819 FCSN--ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDLEF- 894 (1078)
Q Consensus 819 ~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~- 894 (1078)
++.. ....+++++++..+..............+++..+..++.||+.|++|||+ . ||+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence 8753 45666777776655433333233455678999999999999999999998 5 999999999999998765
Q ss_pred -----cEEEecccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-cc--
Q 039595 895 -----EAHVSDFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF-SS-- 966 (1078)
Q Consensus 895 -----~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~~-- 966 (1078)
.++++|||.+..... .....+||+.|+|||++.+..++.++||||+||+++||++|+.||....... ..
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred ccccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 399999999986543 2345679999999999999999999999999999999999999976432210 00
Q ss_pred --hhhhhhh--------------hhhhcC-----CCCCC------------CCCccHHHHHHHHHHHHhcccCCCCCCCC
Q 039595 967 --FSNMIIE--------------VNQILD-----PRLST------------PSPGVMDKLISIMEVAILCLDESPEARPT 1013 (1078)
Q Consensus 967 --~~~~~~~--------------~~~~~~-----~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1013 (1078)
....... .....+ ..... ...........+.+++.+||..||++|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 0000000 000000 00000 01112334557899999999999999999
Q ss_pred hhHHHHHhhhh
Q 039595 1014 MEKGFGHHIGY 1024 (1078)
Q Consensus 1014 ~~ell~h~~~~ 1024 (1078)
++|+++|||+.
T Consensus 322 a~e~L~Hp~f~ 332 (362)
T d1q8ya_ 322 AGGLVNHPWLK 332 (362)
T ss_dssp HHHHHTCGGGT
T ss_pred HHHHhcCcccC
Confidence 99999999976
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.6e-32 Score=304.86 Aligned_cols=252 Identities=32% Similarity=0.501 Sum_probs=234.9
Q ss_pred CcceeccCCCccCC--CCCccccCccceeEEEccC-ccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEE
Q 039595 127 KLQNLDLGNNQLSG--VISPEIGKLNQLRRLYLDM-NQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALL 203 (1078)
Q Consensus 127 ~L~~L~Ls~n~l~~--~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 203 (1078)
+++.|||++|+++| .+|++|++|++|++|+|++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 57778888888887 4899999999999999986 89999999999999999999999999999999999999999999
Q ss_pred EccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCC-cEEeccccccCCCCCcccCCCcccceeecccccc
Q 039595 204 YLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNL-DTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282 (1078)
Q Consensus 204 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 282 (1078)
++++|.+.+.+|..++++++|+.+++++|.+++.+|..+..+.++ +.+++++|++++..|..+.++..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 999999999999999999999999999999999999999998886 889999999999999999887554 799999999
Q ss_pred cCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccc
Q 039595 283 SGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEI 362 (1078)
Q Consensus 283 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 362 (1078)
.|.+|..+..+++++.+++++|.+.+.+| .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+++|.+|. +
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~ 287 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-G 287 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-S
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-c
Confidence 99999999999999999999999998765 688999999999999999999999999999999999999999999985 6
Q ss_pred cccCCCCeEEccccc-Cccc
Q 039595 363 GYLKSLSELKLCKNN-LSGV 381 (1078)
Q Consensus 363 ~~l~~L~~L~L~~N~-l~~~ 381 (1078)
+.+++|+.+++++|+ +.|.
T Consensus 288 ~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp TTGGGSCGGGTCSSSEEEST
T ss_pred ccCCCCCHHHhCCCccccCC
Confidence 889999999999997 5554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=3e-28 Score=278.57 Aligned_cols=356 Identities=26% Similarity=0.361 Sum_probs=196.3
Q ss_pred EccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccC
Q 039595 156 YLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLN 235 (1078)
Q Consensus 156 ~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 235 (1078)
.++.+.+++.++ ...+.+|++|++++|+++. + +.++.|++|++|+|++|++++.. .++++++|++|++++|+++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc
Confidence 455555555443 2355566666666666653 2 34566666666666666665432 2566666666666666666
Q ss_pred CCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCcccc
Q 039595 236 GLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILG 315 (1078)
Q Consensus 236 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~ 315 (1078)
+..| ++++++|+.|++++|.+++..+ ......+..+....|.+....+.......
T Consensus 102 ~i~~--l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~--------------------- 156 (384)
T d2omza2 102 DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSL--------------------- 156 (384)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTC---------------------
T ss_pred cccc--cccccccccccccccccccccc--ccccccccccccccccccccccccccccc---------------------
Confidence 5422 5566666666666666654322 23334555555555555433222211111
Q ss_pred CCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCcee
Q 039595 316 NLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLL 395 (1078)
Q Consensus 316 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 395 (1078)
........... ...+.............|... ....+..+++++.+++++|.+++..| +...++|+.|
T Consensus 157 ---~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L 224 (384)
T d2omza2 157 ---QQLSFGNQVTD-----LKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 224 (384)
T ss_dssp ---SEEEEEESCCC-----CGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred ---cccccccccch-----hhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEE
Confidence 11111111111 111222333334444444332 23344555556666666665554433 3344555555
Q ss_pred ecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccC
Q 039595 396 NMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIF 475 (1078)
Q Consensus 396 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 475 (1078)
++++|++++. ..+..+++|+.+++++|.+.++. .+..+++|+.|++++|++.+..
T Consensus 225 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--------------------- 279 (384)
T d2omza2 225 SLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--------------------- 279 (384)
T ss_dssp ECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG---------------------
T ss_pred ECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC---------------------
Confidence 5555555432 23445555555555555554433 2445555666666655554321
Q ss_pred CCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccc
Q 039595 476 GSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIG 555 (1078)
Q Consensus 476 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 555 (1078)
.+..++.++.+++++|++++. ..+..+++++.|++++|++++.. .+..+++|++|+|++|+|++ ++ .+.
T Consensus 280 -----~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~ 348 (384)
T d2omza2 280 -----PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLA 348 (384)
T ss_dssp -----GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGG
T ss_pred -----ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHc
Confidence 244556667777777777642 34666777777778877777643 36777888888888888774 33 577
Q ss_pred cccccccccccCcccccccchhhhcccccCeeecCCC
Q 039595 556 NLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHN 592 (1078)
Q Consensus 556 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 592 (1078)
++++|++|+|++|+|++..| +.++++|+.|+|++|
T Consensus 349 ~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 78888888888888876544 778888888888887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=5.5e-28 Score=276.32 Aligned_cols=360 Identities=27% Similarity=0.376 Sum_probs=213.6
Q ss_pred cceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccC
Q 039595 128 LQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNN 207 (1078)
Q Consensus 128 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 207 (1078)
....+++.+.+++.++ ...+.+|++|+++++.++ .+ +.|+.|++|++|+|++|++++. | .++++++|++|++++
T Consensus 24 ~~~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~ 97 (384)
T d2omza2 24 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNN 97 (384)
T ss_dssp HHHHHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCS
T ss_pred HHHHHhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccc
Confidence 3345777788887654 457889999999999998 45 5789999999999999999965 3 399999999999999
Q ss_pred CCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccc
Q 039595 208 NSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIP 287 (1078)
Q Consensus 208 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 287 (1078)
|++.+.. .++++++|+.|++++|.+++..+ ......+..+....|.+....+.................. .
T Consensus 98 n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~ 168 (384)
T d2omza2 98 NQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----L 168 (384)
T ss_dssp SCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----C
T ss_pred ccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccch-----h
Confidence 9998654 38899999999999999997643 4556788899999998875544333333233222222211 2
Q ss_pred cccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCC
Q 039595 288 LSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKS 367 (1078)
Q Consensus 288 ~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 367 (1078)
..+.............|... ....+..+++++.+++++|.+++..| +..+++|+.|++++|++++ + ..+..+++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~ 242 (384)
T d2omza2 169 KPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTN 242 (384)
T ss_dssp GGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTT
T ss_pred hhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccc
Confidence 22333333444444444332 23445566666666666666665433 3445566666666666653 2 24555566
Q ss_pred CCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCC
Q 039595 368 LSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQ 447 (1078)
Q Consensus 368 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 447 (1078)
|+.|++++|.+++..+ +..+++|+.|++++|++. .+. .+..++.++.++++.
T Consensus 243 L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~------------------------~~~--~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 243 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS------------------------NIS--PLAGLTALTNLELNE 294 (384)
T ss_dssp CSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC------------------------CCG--GGTTCTTCSEEECCS
T ss_pred cchhccccCccCCCCc--ccccccCCEeeccCcccC------------------------CCC--ccccccccccccccc
Confidence 6666666666554332 444555555555555544 332 244455566666666
Q ss_pred CccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcc
Q 039595 448 NNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVP 527 (1078)
Q Consensus 448 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 527 (1078)
|.+++.. .+..+++++.|++++|+|++.. .+..+++|++|++++|+|++ ++
T Consensus 295 n~l~~~~--------------------------~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~ 345 (384)
T d2omza2 295 NQLEDIS--------------------------PISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS 345 (384)
T ss_dssp SCCSCCG--------------------------GGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG
T ss_pred ccccccc--------------------------ccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch
Confidence 6554321 1223334444444444444322 14444455555555555442 12
Q ss_pred cccccccccceeeccCccccCCCCcccccccccccccccCc
Q 039595 528 LEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNN 568 (1078)
Q Consensus 528 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 568 (1078)
.|.++++|++|+|++|+|++..| +.++++|++|+|++|
T Consensus 346 -~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 346 -SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp -GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred -hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 34445555555555555543322 445555555555554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=7.5e-26 Score=249.67 Aligned_cols=280 Identities=21% Similarity=0.238 Sum_probs=158.6
Q ss_pred ccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecc
Q 039595 319 SLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMC 398 (1078)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 398 (1078)
.+++++-+++.++. +|..+. +++++|+|++|+|+...+.+|..+++|++|++++|.+....|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~~-lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCCc-cCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 45566666666663 354443 467777777777764444466677777777777777776666667777777777777
Q ss_pred cCcCCCCCCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCC
Q 039595 399 ENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSI 478 (1078)
Q Consensus 399 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~ 478 (1078)
+|+++.... . ....+..|.+.+|.+..+....+.....+..++...|.... ....
T Consensus 88 ~n~l~~l~~-~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~----------------------~~~~ 142 (305)
T d1xkua_ 88 KNQLKELPE-K--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIE 142 (305)
T ss_dssp SSCCSBCCS-S--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBC
T ss_pred CCccCcCcc-c--hhhhhhhhhccccchhhhhhhhhhccccccccccccccccc----------------------cCCC
Confidence 776654322 2 12345555666666665555555555555555555554321 1122
Q ss_pred CccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCccccccc
Q 039595 479 PLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLL 558 (1078)
Q Consensus 479 ~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 558 (1078)
+..+..+++|+.+++++|.+.. +|..+ .++|+.|++++|.++...+..|..++.+++|++++|.+.+..+..+.+++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~ 219 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred ccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc
Confidence 3344555566666666666653 23222 34566666666666655556666666666666666666655556666666
Q ss_pred ccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCc------ccccccceeeccCcccc--CCcccccccCC
Q 039595 559 KLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQV------CNMESLEKLNLSHNNLS--GFIPRCFEKMR 630 (1078)
Q Consensus 559 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~--~~~~~~l~~l~ 630 (1078)
+|++|+|++|+|+ .+|.+|..+++|+.|+|++|+|+......| ..+.+|+.|+|++|+++ ...|..|..+.
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~ 298 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCC
T ss_pred cceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccc
Confidence 6666666666665 345556666666666666666654322222 23344555555555543 23444444433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=5.6e-25 Score=242.60 Aligned_cols=247 Identities=26% Similarity=0.326 Sum_probs=152.1
Q ss_pred CCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeec
Q 039595 198 SKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDL 277 (1078)
Q Consensus 198 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 277 (1078)
+++++|+|++|+|+...+.+|.++++|++|++++|+++...|..|.++++|++|++++|+++. +|..+ ...|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEEC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhc
Confidence 345555555555554333445555555555555555555545555555555555555555552 33222 234555555
Q ss_pred ccccccCccccccccccCCceeeecccCCC--CCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCC
Q 039595 278 IENQLSGSIPLSFGNLSSWTLMSLFSNSLS--GSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLY 355 (1078)
Q Consensus 278 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 355 (1078)
++|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|+++. +|..+ +++|+.|++++|...
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~ 184 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKIT 184 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCC
T ss_pred cccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCC
Confidence 555555544444555555555555554332 2334456667777777777777763 33332 467777777777777
Q ss_pred CCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEccCccccccchhhcc
Q 039595 356 GSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFNQNNLVGKVYEAFG 435 (1078)
Q Consensus 356 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 435 (1078)
+..+..+..+++++.|++++|.+++..+..+.++++|++|+|++|+|+. +|..|..+++|++|++++|+|+.+....|.
T Consensus 185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~ 263 (305)
T d1xkua_ 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFC 263 (305)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred CCChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhcc
Confidence 7777777777777777777777777777777777777777777777763 466777777777777777777776655543
Q ss_pred ------CCCCCcEecCCCCccC
Q 039595 436 ------DHPNLTFLDLSQNNFD 451 (1078)
Q Consensus 436 ------~l~~L~~L~Ls~N~l~ 451 (1078)
.+++|+.|+|++|+++
T Consensus 264 ~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 264 PPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCTTSCCCSEEECCSSSSC
T ss_pred CcchhcccCCCCEEECCCCcCc
Confidence 3466777777777765
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.4e-25 Score=239.85 Aligned_cols=222 Identities=26% Similarity=0.307 Sum_probs=123.0
Q ss_pred EEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecc-cc
Q 039595 106 NLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFC-HN 184 (1078)
Q Consensus 106 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~-~n 184 (1078)
.++.+++++. .+|..+. +.+++|+|++|+|++..+.+|.++++|++|++++|++.+..+..+..+..++.+... .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3456666665 5565543 567777777777775444567777777777777777765555555555555555543 33
Q ss_pred cccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCc
Q 039595 185 NVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPS 264 (1078)
Q Consensus 185 ~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 264 (1078)
.+....|..|+++++|++|++++|.+.+..+..+..+++|+.+++++|+++++.+..|..+++|++|++++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 44444445555555555555555555544445555555555555555555554445555555555555555555554455
Q ss_pred ccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeecccccc
Q 039595 265 IIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQL 330 (1078)
Q Consensus 265 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 330 (1078)
+|.++++|+++++++|++++..|..|..+++|+.|++++|.+.+..+..|+++++|++|++++|.+
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l 237 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCE
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCC
Confidence 555555555555555555554444444444444444444444444444444444444444444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=9.5e-25 Score=237.88 Aligned_cols=223 Identities=24% Similarity=0.274 Sum_probs=105.5
Q ss_pred eccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCC
Q 039595 131 LDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSL 210 (1078)
Q Consensus 131 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l 210 (1078)
++.++++++ .+|..+. +.+++|+|++|+|++..|..|..+++|++|++++|++.+..+..+.++..++.+...
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~---- 88 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS---- 88 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC----
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc----
Confidence 345555555 4554443 345556666555552222334444444444444444444444444444444444332
Q ss_pred CCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCcccccc
Q 039595 211 FGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSF 290 (1078)
Q Consensus 211 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 290 (1078)
..|.++...|..|.++++|++|++++|.+....+..+..+.+|+.+++++|++++..+..|
T Consensus 89 -------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f 149 (284)
T d1ozna_ 89 -------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149 (284)
T ss_dssp -------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred -------------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHh
Confidence 2233333334444444444444444444443333344444444444444444444333444
Q ss_pred ccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccccCCCCe
Q 039595 291 GNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGYLKSLSE 370 (1078)
Q Consensus 291 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 370 (1078)
..+++|+.|++++|++++..+..|.++++|+.+++++|++++..|..|..+++|++|++++|++.+..+..|..+++|++
T Consensus 150 ~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~ 229 (284)
T d1ozna_ 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence 44444444444444444444444555555555555555555555555555555555555555555555555555555555
Q ss_pred EEcccccCc
Q 039595 371 LKLCKNNLS 379 (1078)
Q Consensus 371 L~L~~N~l~ 379 (1078)
|++++|.+.
T Consensus 230 L~l~~N~l~ 238 (284)
T d1ozna_ 230 LRLNDNPWV 238 (284)
T ss_dssp EECCSSCEE
T ss_pred EEecCCCCC
Confidence 555555554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.8e-22 Score=217.15 Aligned_cols=176 Identities=26% Similarity=0.272 Sum_probs=87.2
Q ss_pred CCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecc
Q 039595 199 KLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLI 278 (1078)
Q Consensus 199 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 278 (1078)
+|++|+|++|+|++..+..|.++++|++|+|++|+|+.. | .++.+++|++|+|++|++++ .+..+.++++|++|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccccccccc-ccccccccccccccccc
Confidence 444555555555443334455555555555555555432 2 23445555555555555542 33444555555555555
Q ss_pred cccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCC
Q 039595 279 ENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSI 358 (1078)
Q Consensus 279 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 358 (1078)
+|.+.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l 187 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-cc
Confidence 55555444444444444444444444444444444445555555555555555544455555555555555555555 44
Q ss_pred CccccccCCCCeEEcccccC
Q 039595 359 PEEIGYLKSLSELKLCKNNL 378 (1078)
Q Consensus 359 p~~~~~l~~L~~L~L~~N~l 378 (1078)
|+.+..+++|+.|+|++|.+
T Consensus 188 p~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCB
T ss_pred ChhHCCCCCCCEEEecCCCC
Confidence 54444555555555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=3.3e-22 Score=215.08 Aligned_cols=176 Identities=28% Similarity=0.247 Sum_probs=103.4
Q ss_pred cceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccc
Q 039595 176 IHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYK 255 (1078)
Q Consensus 176 L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 255 (1078)
+++|+|++|.+++..+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++|++++. +..+.++++|+.|++++
T Consensus 33 l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~ 109 (266)
T d1p9ag_ 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSF 109 (266)
T ss_dssp CCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEECCS
T ss_pred CCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccccc-ccccccccccccccccc
Confidence 4444444444443333445555555555555555542 22 234555555555555555532 44555555666666666
Q ss_pred cccCCCCCcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCC
Q 039595 256 NSLSGSIPSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIP 335 (1078)
Q Consensus 256 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 335 (1078)
|.+.+..+..+..+.++++|++++|.+++..+..+..+++++.+++++|++++..+..|..+++|++|+|++|+|+ .+|
T Consensus 110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp 188 (266)
T d1p9ag_ 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (266)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred cccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccC
Confidence 6555555555555566666666666666555555556666666666666666555666677777777777777777 556
Q ss_pred CCCCCCCcCcEEEccCccCC
Q 039595 336 PSIGNLSSLRNLSLFNNGLY 355 (1078)
Q Consensus 336 ~~l~~l~~L~~L~Ls~N~l~ 355 (1078)
..+..+++|+.|+|++|.+.
T Consensus 189 ~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 189 KGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTTTCCCSEEECCSCCBC
T ss_pred hhHCCCCCCCEEEecCCCCC
Confidence 66667777777777777664
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=6.7e-22 Score=201.05 Aligned_cols=172 Identities=16% Similarity=0.103 Sum_probs=121.6
Q ss_pred CccceeccCCceeEEEEEeCCCCEEEEEEeccccccC--------------ChhhHHHHHHHHHHHhcCCCCceeeEEee
Q 039595 754 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG--------------NMADQDEFLNVVLALNEIRHRNIVKFHGF 819 (1078)
Q Consensus 754 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 819 (1078)
.+.++||+|+||+||+|...+|+.||||+++...... .......+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999999988889999999875422110 01112345678889999999999998876
Q ss_pred eecCCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeeCCCCcEEEe
Q 039595 820 CSNARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDLEFEAHVS 899 (1078)
Q Consensus 820 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 899 (1078)
.. .+++|||++++.+.+ ++...+..++.|++.+++|||++ ||+||||||+|||++++ .++++
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 32 379999998864432 34455678999999999999999 99999999999999865 58999
Q ss_pred cccccccccCCCCCceeeccccccccccccccCCCCccchhHHHHHH
Q 039595 900 DFGIAKFVEPYSSNRTEFVGTFGYAAPEIAYTMRATEKYDVYSFGVL 946 (1078)
Q Consensus 900 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~i 946 (1078)
|||.|......... .-...+... -.| +..+.|+.++|+||..--
T Consensus 145 DFG~a~~~~~~~~~-~~l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWR-EILERDVRN-IIT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHH-HHHHHHHHH-HHH-HHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcH-HHHHHHHHH-HHH-HHcCCCCCcccHHHHHHH
Confidence 99999765422110 000000000 011 234678899999997543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=2.2e-18 Score=193.12 Aligned_cols=314 Identities=26% Similarity=0.276 Sum_probs=145.2
Q ss_pred CCcEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecc
Q 039595 103 HLVNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFC 182 (1078)
Q Consensus 103 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~ 182 (1078)
+++.|||++|+++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. ++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~----lp-------- 97 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD----LP-------- 97 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS----CC--------
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh----hc--------
Confidence 4666777777665 45542 345666666666666 455443 34566666666655 2221 11
Q ss_pred cccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCC
Q 039595 183 HNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSI 262 (1078)
Q Consensus 183 ~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 262 (1078)
+.|++|++++|.++. +|. ++.+++|+.|++++|.++.. |.. ...+..|.+..+... .
T Consensus 98 ---------------~~L~~L~L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~ 154 (353)
T d1jl5a_ 98 ---------------PLLEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--E 154 (353)
T ss_dssp ---------------TTCCEEECCSSCCSS-CCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--S
T ss_pred ---------------ccccccccccccccc-ccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc--c
Confidence 235555555555542 332 34455555555555555432 111 233444444444333 1
Q ss_pred CcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCC
Q 039595 263 PSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLS 342 (1078)
Q Consensus 263 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 342 (1078)
+..++.++.++.|++++|.+...... ......+...++.+. .++ .+..++.|+.+++++|.... .+. ...
T Consensus 155 ~~~l~~l~~l~~L~l~~n~~~~~~~~----~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~ 224 (353)
T d1jl5a_ 155 LPELQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPP 224 (353)
T ss_dssp CCCCTTCTTCCEEECCSSCCSSCCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCT
T ss_pred cccccccccceecccccccccccccc----ccccccccccccccc-ccc-cccccccccccccccccccc-ccc---ccc
Confidence 23344455555555555554422111 011222333333222 112 23455566666666655542 222 223
Q ss_pred cCcEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCCCCccccccCCCCeEEcc
Q 039595 343 SLRNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLKSLTSLKRVRFN 422 (1078)
Q Consensus 343 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 422 (1078)
++..+.+.+|.+.. .+. ...++...++..+.+.+.. .. .......++..|.+
T Consensus 225 ~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~l~-~l---~~~~~~~~~~~~~~-------------------- 276 (353)
T d1jl5a_ 225 SLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIFSGLS-EL---PPNLYYLNASSNEI-------------------- 276 (353)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSEES-CC---CTTCCEEECCSSCC--------------------
T ss_pred cccccccccccccc-ccc---ccccccccccccccccccc-cc---cchhcccccccCcc--------------------
Confidence 45555555555542 121 1234444555544443211 00 01122233333332
Q ss_pred CccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCc
Q 039595 423 QNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKI 502 (1078)
Q Consensus 423 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~ 502 (1078)
..+ +..+++|++|+|++|+|+.++. .+++|+.|++++|+|+. +|. .+.+|++|++++|+|+ .+
T Consensus 277 ----~~~----~~~~~~L~~L~Ls~N~l~~lp~----~~~~L~~L~L~~N~L~~-l~~---~~~~L~~L~L~~N~L~-~l 339 (353)
T d1jl5a_ 277 ----RSL----CDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLR-EF 339 (353)
T ss_dssp ----SEE----CCCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-SC
T ss_pred ----ccc----cccCCCCCEEECCCCccCcccc----ccCCCCEEECCCCcCCc-ccc---ccCCCCEEECcCCcCC-CC
Confidence 221 1123445555555555544321 24455555555555543 332 2457888888888887 44
Q ss_pred ccccccCccCcEEecc
Q 039595 503 PVQLEKLFSLNKLILS 518 (1078)
Q Consensus 503 ~~~~~~l~~L~~L~Ls 518 (1078)
|.. ..+|+.|.++
T Consensus 340 p~~---~~~L~~L~~~ 352 (353)
T d1jl5a_ 340 PDI---PESVEDLRMN 352 (353)
T ss_dssp CCC---CTTCCEEECC
T ss_pred Ccc---ccccCeeECc
Confidence 542 2356666654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=2.4e-18 Score=192.74 Aligned_cols=95 Identities=28% Similarity=0.359 Sum_probs=56.7
Q ss_pred ccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEecc
Q 039595 175 LIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLY 254 (1078)
Q Consensus 175 ~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 254 (1078)
++++|+|++|.++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++.. +. +. +.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~-lp--~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SD-LP--PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CS-CC--TTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hh-hc--ccccccccc
Confidence 4667777777765 45643 345667777777766 455443 4566667777766632 21 11 346666666
Q ss_pred ccccCCCCCcccCCCcccceeeccccccc
Q 039595 255 KNSLSGSIPSIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 255 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
+|.+. .+|. ++.+++|+.|++++|.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred ccccc-cccc-hhhhccceeecccccccc
Confidence 66666 3443 456666666666666665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=8.4e-19 Score=183.37 Aligned_cols=188 Identities=27% Similarity=0.385 Sum_probs=99.8
Q ss_pred cCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccce
Q 039595 195 GNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQ 274 (1078)
Q Consensus 195 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 274 (1078)
+.+.+|+.|++.+|.++.. +.+.++++|++|++++|++++..| +..+++|++|++++|.++. ++ .+.++++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-cccccccccc
Confidence 4445555555555555432 234555555555555555554322 4555555555555555542 22 3445555555
Q ss_pred eecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccC
Q 039595 275 LDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGL 354 (1078)
Q Consensus 275 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 354 (1078)
+++++|...+.. .+...+.+..+.++++.+... ..+.++++|++|++++|.++... .++++++|+.|+|++|++
T Consensus 112 l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l 185 (227)
T d1h6ua2 112 LDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKI 185 (227)
T ss_dssp EECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred cccccccccccc--hhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCcc
Confidence 555555544322 233344444555555544422 22455566666666666665332 256666667777776666
Q ss_pred CCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecc
Q 039595 355 YGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMC 398 (1078)
Q Consensus 355 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 398 (1078)
++ ++ .++.+++|++|+|++|+++++.| +.++++|++|+++
T Consensus 186 ~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 186 SD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred CC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 64 22 25666667777777766665432 5566666666664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=9.1e-19 Score=183.11 Aligned_cols=208 Identities=25% Similarity=0.345 Sum_probs=97.0
Q ss_pred CCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEE
Q 039595 125 LSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLY 204 (1078)
Q Consensus 125 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 204 (1078)
|.++..++++.+++++.+ .++.+.+|++|++++|.++ .++ .+..+++|++|++++|.+++..| +..+++|++++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 334444555555555432 3445555555555555555 232 34445555555555554443222 45555555555
Q ss_pred ccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccC
Q 039595 205 LNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSG 284 (1078)
Q Consensus 205 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 284 (1078)
+++|.++. + ..+.++++|+.+++++|+..+.. .+...+.++.+.++.+.+.... .+.++++|+.|++++|.+++
T Consensus 92 ~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 92 LSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp CCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCC
T ss_pred cccccccc-c-ccccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhcccccccccccccccccc
Confidence 55555542 2 23445555555555555544331 2344455555555555544221 23444455555555554442
Q ss_pred ccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCCCCCCccccc
Q 039595 285 SIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLYGSIPEEIGY 364 (1078)
Q Consensus 285 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 364 (1078)
.. .++++++|+.|+|++|++++. + .++++++|++|+|++|++++. + .+..
T Consensus 166 ~~--------------------------~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~ 215 (227)
T d1h6ua2 166 LT--------------------------PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLAN 215 (227)
T ss_dssp CG--------------------------GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTT
T ss_pred ch--------------------------hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-cccc
Confidence 21 134444444444444444432 1 144445555555555555432 2 1445
Q ss_pred cCCCCeEEcc
Q 039595 365 LKSLSELKLC 374 (1078)
Q Consensus 365 l~~L~~L~L~ 374 (1078)
+++|+.|+++
T Consensus 216 l~~L~~L~ls 225 (227)
T d1h6ua2 216 TSNLFIVTLT 225 (227)
T ss_dssp CTTCCEEEEE
T ss_pred CCCCCEEEee
Confidence 5555555544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=6.9e-22 Score=230.57 Aligned_cols=139 Identities=22% Similarity=0.148 Sum_probs=65.0
Q ss_pred CCcccEEeccCCccCCCccccc-----ccCccCcEEeccCCccCCCcccc----cccccccceeeccCccccCCCC----
Q 039595 485 SSKLQFLDLSSNHIVGKIPVQL-----EKLFSLNKLILSLNQLSGSVPLE----FGSLTELQYLDLSANKLSSSIP---- 551 (1078)
Q Consensus 485 l~~L~~L~Ls~N~i~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~~~---- 551 (1078)
.+.++.+++++|.+.......+ .....|+.+++++|.++...... +...++|++|+|++|.|++...
T Consensus 282 ~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~ 361 (460)
T d1z7xw1 282 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 361 (460)
T ss_dssp CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred cccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhh
Confidence 4455555555555542221111 11234555666655555332222 2233456666666666543211
Q ss_pred cccc-cccccccccccCcccccc----cchhhhcccccCeeecCCCccCCcCCCCcc-----cccccceeeccCccccCC
Q 039595 552 KSIG-NLLKLYYLNLSNNQFSHT----IPIEFEKLIHLSKLDLSHNILQEEIPPQVC-----NMESLEKLNLSHNNLSGF 621 (1078)
Q Consensus 552 ~~~~-~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~ 621 (1078)
..+. ..+.|++|+|++|+|++. ++..+..+++|++|||++|+|+......+. +...|+.|++.+|.+...
T Consensus 362 ~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred hhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 1121 234466666666666532 223344556666666666666542222211 122466666666666544
Q ss_pred cc
Q 039595 622 IP 623 (1078)
Q Consensus 622 ~~ 623 (1078)
..
T Consensus 442 ~~ 443 (460)
T d1z7xw1 442 ME 443 (460)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=6.3e-21 Score=222.30 Aligned_cols=378 Identities=19% Similarity=0.126 Sum_probs=212.5
Q ss_pred CCcEEeccccccCCCC-CcccCCCcccceeecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeec
Q 039595 247 NLDTLFLYKNSLSGSI-PSIIGNLKSLHQLDLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGL 325 (1078)
Q Consensus 247 ~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L 325 (1078)
+|++|++++|++++.. ...+..+++|+.|+|++|.++.... ..+...+..+++|++|+|
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~--------------------~~l~~~L~~~~~L~~LdL 62 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC--------------------KDISSALRVNPALAELNL 62 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHH--------------------HHHHHHHHTCTTCCEEEC
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHH--------------------HHHHHHHhcCCCCCEEEC
Confidence 4566666666665311 2223445556666666665542100 012233444555555555
Q ss_pred cccccCcc----CCCCCC-CCCcCcEEEccCccCCCC----CCccccccCCCCeEEcccccCccccCCCCc-----cCCC
Q 039595 326 YLNQLNGV----IPPSIG-NLSSLRNLSLFNNGLYGS----IPEEIGYLKSLSELKLCKNNLSGVIPHSVG-----NLTG 391 (1078)
Q Consensus 326 ~~N~l~~~----~p~~l~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~ 391 (1078)
++|+|+.. +...+. ...+|+.|+|++|++++. ++..+..+++|++|+|++|.++......+. ....
T Consensus 63 s~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~ 142 (460)
T d1z7xw1 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 142 (460)
T ss_dssp TTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCC
T ss_pred cCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccc
Confidence 55554311 111221 123566666666665532 233445556666666666665432111110 1111
Q ss_pred CceeecccCcCCCC----CCccccccCCCCeEEccCccccccchh----hc-cCCCCCcEecCCCCccCCccC----ccc
Q 039595 392 LVLLNMCENHLFGP----IPKSLKSLTSLKRVRFNQNNLVGKVYE----AF-GDHPNLTFLDLSQNNFDGKIS----FNW 458 (1078)
Q Consensus 392 L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~----~~-~~l~~L~~L~Ls~N~l~~~~~----~~~ 458 (1078)
..........+... ....+.....++.+.++++........ .+ ........+++..+.+..... ..+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 222 (460)
T d1z7xw1 143 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 222 (460)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHH
T ss_pred cccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccc
Confidence 22222222222110 011233445666677766655432211 11 222345667777666543221 223
Q ss_pred cCCCCCceecccccccCCC-----CCccccCCCcccEEeccCCccCCC----cccccccCccCcEEeccCCccCCCcccc
Q 039595 459 RNLPKLDTFIVSMNNIFGS-----IPLEIGDSSKLQFLDLSSNHIVGK----IPVQLEKLFSLNKLILSLNQLSGSVPLE 529 (1078)
Q Consensus 459 ~~l~~L~~L~l~~N~i~~~-----~~~~~~~l~~L~~L~Ls~N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 529 (1078)
...+.++.+.++.|.+... .+..+.....++.+++++|.+... ....+...+.++.+++++|.++......
T Consensus 223 ~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~ 302 (460)
T d1z7xw1 223 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302 (460)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred cccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 3556677777777765331 223344567899999999988743 2234556789999999999987432222
Q ss_pred c-----ccccccceeeccCccccCCCCccc----ccccccccccccCcccccccch----hhh-cccccCeeecCCCccC
Q 039595 530 F-----GSLTELQYLDLSANKLSSSIPKSI----GNLLKLYYLNLSNNQFSHTIPI----EFE-KLIHLSKLDLSHNILQ 595 (1078)
Q Consensus 530 ~-----~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~~~----~~~-~l~~L~~L~Ls~N~l~ 595 (1078)
+ .....|+.+++++|.++......+ ...++|++|+|++|+|++.... .+. ..+.|++|+|++|.|+
T Consensus 303 l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~ 382 (460)
T d1z7xw1 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 382 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred hhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence 2 234689999999999886544444 3456899999999999754333 332 4567999999999997
Q ss_pred Cc----CCCCcccccccceeeccCccccCCccccc----c-cCCcCcEEEcccCcCCC
Q 039595 596 EE----IPPQVCNMESLEKLNLSHNNLSGFIPRCF----E-KMRSLSCIDICYNELQG 644 (1078)
Q Consensus 596 ~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l----~-~l~~L~~l~l~~N~l~~ 644 (1078)
+. +...+...++|++|+|++|+|+......| . ....|+.+++++|.+..
T Consensus 383 ~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred hHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 53 23345567899999999999986543333 2 33479999999998874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=4.6e-18 Score=179.70 Aligned_cols=219 Identities=17% Similarity=0.139 Sum_probs=105.9
Q ss_pred cEEEccCccCCCCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeecccCcCCCC-CCccccccCCCCeEEcc-
Q 039595 345 RNLSLFNNGLYGSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNMCENHLFGP-IPKSLKSLTSLKRVRFN- 422 (1078)
Q Consensus 345 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~- 422 (1078)
+.++.+++.++ .+|+.+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+... .+..|..+++++++.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 34555555555 4444332 3456666666666554444556666666666666655442 23455566666666554
Q ss_pred CccccccchhhccCCCCCcEecCCCCccCCccCccccCCCCCceecccccccCCCCCccccCCCcccEEeccCCccCCCc
Q 039595 423 QNNLVGKVYEAFGDHPNLTFLDLSQNNFDGKISFNWRNLPKLDTFIVSMNNIFGSIPLEIGDSSKLQFLDLSSNHIVGKI 502 (1078)
Q Consensus 423 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~ 502 (1078)
.|.+.......|..+++|++|++++|.+.......+ +..+..+..+..+++.+....
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~-----------------------~~~l~~l~~~~~~n~~l~~i~ 144 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK-----------------------IHSLQKVLLDIQDNINIHTIE 144 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTT-----------------------TCBSSCEEEEEESCTTCCEEC
T ss_pred cccccccccccccccccccccccchhhhcccccccc-----------------------ccccccccccccccccccccc
Confidence 345566666666666677777777666654322111 112223333333333443333
Q ss_pred ccccccCc-cCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcc
Q 039595 503 PVQLEKLF-SLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKL 581 (1078)
Q Consensus 503 ~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 581 (1078)
+..|.+++ .++.|++++|+++...+..|.....++.+++++|.|+...+..|.++++|++|+|++|+|+...+..|.++
T Consensus 145 ~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 224 (242)
T d1xwdc1 145 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224 (242)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred ccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence 33333332 34444444444443222222222222223344445543333445555555555555555554444445555
Q ss_pred cccCeeec
Q 039595 582 IHLSKLDL 589 (1078)
Q Consensus 582 ~~L~~L~L 589 (1078)
++|+.|++
T Consensus 225 ~~L~~l~~ 232 (242)
T d1xwdc1 225 KKLRARST 232 (242)
T ss_dssp CEEESSSE
T ss_pred cccccCcC
Confidence 55555544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.3e-18 Score=179.94 Aligned_cols=198 Identities=15% Similarity=0.049 Sum_probs=78.1
Q ss_pred CcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCC-CCcccCCCCCcEEecc-ccccCCCCCcccCCCcccceeec
Q 039595 200 LALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLI-PCTLDNLSNLDTLFLY-KNSLSGSIPSIIGNLKSLHQLDL 277 (1078)
Q Consensus 200 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L 277 (1078)
+++|+|++|+++...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+. .|.+....+..|.++++|++|++
T Consensus 31 l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l 110 (242)
T d1xwdc1 31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 110 (242)
T ss_dssp CSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEE
T ss_pred CCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccccc
Confidence 344444444443322233444444444444444433322 2233444444444332 23333333334444444444444
Q ss_pred ccccccCcccc-ccccccCCceeeecccCCCCCCCccccCCC-ccCeeeccccccCccCCCCCCCCCcCcEEEccCccCC
Q 039595 278 IENQLSGSIPL-SFGNLSSWTLMSLFSNSLSGSIPPILGNLK-SLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLY 355 (1078)
Q Consensus 278 s~N~l~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 355 (1078)
++|++....+. .+..+..+..+...++.+....+..|.+++ .++.|++++|+++...+..+.....++.+++++|+++
T Consensus 111 ~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~ 190 (242)
T d1xwdc1 111 SNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE 190 (242)
T ss_dssp ESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCC
T ss_pred chhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccc
Confidence 44444322111 111222222223333333322223333332 4445555555555433333322222222234445555
Q ss_pred CCCCccccccCCCCeEEcccccCccccCCCCccCCCCceeec
Q 039595 356 GSIPEEIGYLKSLSELKLCKNNLSGVIPHSVGNLTGLVLLNM 397 (1078)
Q Consensus 356 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 397 (1078)
...+..|..+++|++|+|++|+|+...+..|.++++|+++++
T Consensus 191 ~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 191 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 333333455555555555555555444444444444444443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=5.2e-18 Score=172.07 Aligned_cols=108 Identities=27% Similarity=0.393 Sum_probs=59.1
Q ss_pred cceeecccccccCCc-cCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEecc
Q 039595 176 IHEFSFCHNNVSGRI-PSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLY 254 (1078)
Q Consensus 176 L~~L~l~~n~~~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 254 (1078)
+++|+|++|.|++.+ +..|+++++|+.|+|++|.+.+..+..+..+++|++|+|++|+|++..|.+|.++++|++|+|+
T Consensus 31 l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~ 110 (192)
T d1w8aa_ 31 TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110 (192)
T ss_dssp CSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECC
T ss_pred CCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccC
Confidence 334444444443322 2344555555555555555555555555555555555555555555555555555566666666
Q ss_pred ccccCCCCCcccCCCcccceeeccccccc
Q 039595 255 KNSLSGSIPSIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 255 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
+|+|++..|++|..+++|++|+|++|.+.
T Consensus 111 ~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 111 DNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp SSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CccccccCHHHhcCCcccccccccccccc
Confidence 66655555555555566666666655554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=6.8e-18 Score=171.16 Aligned_cols=154 Identities=21% Similarity=0.276 Sum_probs=90.8
Q ss_pred eeccCCCccCCCCCccccCccceeEEEccCccCCCCC-CcccccccccceeecccccccCCccCcccCCCCCcEEEccCC
Q 039595 130 NLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTI-PPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN 208 (1078)
Q Consensus 130 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 208 (1078)
+++.++++++ .+|..+. +++++|+|++|+|++.+ +..++.+++|++|+|++|.+.+..+..+..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3444444444 3444432 34555555555555433 234455566666666666666566666677777777777777
Q ss_pred CCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccccCccc
Q 039595 209 SLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLSGSIP 287 (1078)
Q Consensus 209 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 287 (1078)
++++..|++|.++++|++|+|++|+|+++.|.+|..+++|++|+|++|.+....+. ..-...++.+.+..|.++...|
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSS
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCC
Confidence 77766666777777777777777777776667777777777777777777643221 1111234555555555554333
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=1.3e-17 Score=171.61 Aligned_cols=118 Identities=25% Similarity=0.356 Sum_probs=48.7
Q ss_pred EEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCccc
Q 039595 155 LYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQL 234 (1078)
Q Consensus 155 L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 234 (1078)
.++..+.+++.++. ..|.+|++|++++|.+.+. ..+..+++|++|+|++|++++.. .++++++|++|++++|++
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCc--hhHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 34444444433332 2344444444444444421 12444444444444444444321 134444444444444444
Q ss_pred CCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeecccccc
Q 039595 235 NGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQL 282 (1078)
Q Consensus 235 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 282 (1078)
++. | .+.++++|+.|++++|.+.. + ..+..+++|+.+++++|.+
T Consensus 103 ~~l-~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l 146 (210)
T d1h6ta2 103 KDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKI 146 (210)
T ss_dssp CCG-G-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCC
T ss_pred ccc-c-cccccccccccccccccccc-c-ccccccccccccccccccc
Confidence 432 2 24444444444444444431 1 1233344444444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.5e-17 Score=169.45 Aligned_cols=147 Identities=28% Similarity=0.390 Sum_probs=64.0
Q ss_pred CCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEE
Q 039595 125 LSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLY 204 (1078)
Q Consensus 125 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 204 (1078)
|.+|++|++++|.++.. ..+..+++|++|+|++|++++ +| .++.+++|++|++++|++++ +| .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCc--hhHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-cccccccccccc
Confidence 44455555555555432 124445555555555555542 22 13444444444444444442 22 244444444444
Q ss_pred ccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccceeeccccccc
Q 039595 205 LNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 205 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
+++|.+... ..+.++++|+.+++++|.+++. ..+..+++|+++++++|++++. + .++++++|+.|+|++|+++
T Consensus 119 l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred ccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCC
Confidence 444444321 2344444444444444444432 2233444444444444444422 1 1444444444444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.3e-17 Score=168.26 Aligned_cols=161 Identities=27% Similarity=0.428 Sum_probs=79.2
Q ss_pred CCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCccccee
Q 039595 196 NLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLHQL 275 (1078)
Q Consensus 196 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 275 (1078)
.+.+|++|++++|.++.. +.+..+++|++|+|++|++++..| ++++++|++|++++|.+.. ++ .++++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 455555666666655532 235556666666666666665432 5566666666666666552 22 25556666666
Q ss_pred ecccccccCccccccccccCCceeeecccCCCCCCCccccCCCccCeeeccccccCccCCCCCCCCCcCcEEEccCccCC
Q 039595 276 DLIENQLSGSIPLSFGNLSSWTLMSLFSNSLSGSIPPILGNLKSLSTLGLYLNQLNGVIPPSIGNLSSLRNLSLFNNGLY 355 (1078)
Q Consensus 276 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 355 (1078)
++++|.+.... .+..+++|+.|++++|++.. + +.+..+++|+.|++.+|++++.. .++++++|+.|++++|+++
T Consensus 112 ~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 112 TLFNNQITDID--PLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp ECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred ccccccccccc--ccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence 66665554321 23334444444444444331 1 12444445555555555544321 2444455555555555544
Q ss_pred CCCCccccccCCCCe
Q 039595 356 GSIPEEIGYLKSLSE 370 (1078)
Q Consensus 356 ~~~p~~~~~l~~L~~ 370 (1078)
+ ++ .++.+++|++
T Consensus 186 ~-i~-~l~~L~~L~~ 198 (199)
T d2omxa2 186 D-IS-VLAKLTNLES 198 (199)
T ss_dssp C-CG-GGGGCTTCSE
T ss_pred C-Cc-cccCCCCCCc
Confidence 2 22 2444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.9e-17 Score=167.43 Aligned_cols=84 Identities=38% Similarity=0.544 Sum_probs=34.1
Q ss_pred ccCCCCCcEEEccCCCCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEeccccccCCCCCcccCCCcccc
Q 039595 194 LGNLSKLALLYLNNNSLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKNSLSGSIPSIIGNLKSLH 273 (1078)
Q Consensus 194 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 273 (1078)
++++++|++|++++|.+... + .++++++|+.|++++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|+
T Consensus 80 l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~ 153 (199)
T d2omxa2 80 LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQ 153 (199)
T ss_dssp GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred ccCCcccccccccccccccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-cc-ccccccccc
Confidence 34444444444444444321 1 234444444444444444332 123344444444444444432 11 234444444
Q ss_pred eeeccccccc
Q 039595 274 QLDLIENQLS 283 (1078)
Q Consensus 274 ~L~Ls~N~l~ 283 (1078)
.|++++|+++
T Consensus 154 ~L~l~~n~l~ 163 (199)
T d2omxa2 154 QLNFSSNQVT 163 (199)
T ss_dssp EEECCSSCCC
T ss_pred cccccccccc
Confidence 4444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=3.2e-15 Score=145.89 Aligned_cols=126 Identities=19% Similarity=0.139 Sum_probs=66.9
Q ss_pred cCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCee
Q 039595 508 KLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKL 587 (1078)
Q Consensus 508 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 587 (1078)
+...+++|+|++|+|+. ++..+..+++|+.|||++|.|+.. +.|..+++|++|+|++|+|+...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence 34444445555555542 233444455555555555555432 235555556666666666654444445556666666
Q ss_pred ecCCCccCCcCC-CCcccccccceeeccCccccCCc---ccccccCCcCcEEE
Q 039595 588 DLSHNILQEEIP-PQVCNMESLEKLNLSHNNLSGFI---PRCFEKMRSLSCID 636 (1078)
Q Consensus 588 ~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~l~~L~~l~ 636 (1078)
++++|+|+.... ..+..+++|++|++++|+++... +..+..+|+|++||
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 666666653211 24555666666666666665332 23456667777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=3.3e-14 Score=131.67 Aligned_cols=102 Identities=25% Similarity=0.382 Sum_probs=53.7
Q ss_pred ceeccCCCccCCCCCccccCccceeEEEccCccCCCCCCcccccccccceeecccccccCCccCcccCCCCCcEEEccCC
Q 039595 129 QNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGTIPPVIGQLSLIHEFSFCHNNVSGRIPSSLGNLSKLALLYLNNN 208 (1078)
Q Consensus 129 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~i~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 208 (1078)
|+|||++|+++ .++ .++++++|++|++++|+++ .+|+.++.+++|++|++++|.+++ +| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 34555555555 232 3555555555555555554 444445555555555555555442 22 3555666666666666
Q ss_pred CCCCCCC-CcccccCCCCeeecCCcccC
Q 039595 209 SLFGYIP-TVMGNLKSLSTLDLSQNQLN 235 (1078)
Q Consensus 209 ~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 235 (1078)
+++.... ..++.+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 6653321 34555566666666666655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=3.1e-14 Score=131.93 Aligned_cols=117 Identities=29% Similarity=0.325 Sum_probs=59.5
Q ss_pred EEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCc
Q 039595 514 KLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNI 593 (1078)
Q Consensus 514 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 593 (1078)
.|+|++|+|+. ++ .+..+++|++||+++|+|+ .+|..+..+++|++|++++|+|++ +| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 45555555542 22 2455555555555555555 334445555555555555555543 22 35555566666666666
Q ss_pred cCCcCC-CCcccccccceeeccCccccCC---cccccccCCcCcEE
Q 039595 594 LQEEIP-PQVCNMESLEKLNLSHNNLSGF---IPRCFEKMRSLSCI 635 (1078)
Q Consensus 594 l~~~~~-~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~l~~L~~l 635 (1078)
|+.... ..+..+++|++|++++|+++.. .......+|+|+.+
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 554321 3455556666666666665432 12223345555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=9.9e-15 Score=142.38 Aligned_cols=130 Identities=18% Similarity=0.120 Sum_probs=102.3
Q ss_pred cccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCccccccccc
Q 039595 481 EIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKL 560 (1078)
Q Consensus 481 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 560 (1078)
.|.+..++++|+|++|+|+. ++..+..+++|+.|+|++|+|+. + ..|..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 35567788899999999984 46666778889999999999884 3 357888999999999999987666667788999
Q ss_pred ccccccCcccccccc-hhhhcccccCeeecCCCccCCcCC---CCcccccccceeec
Q 039595 561 YYLNLSNNQFSHTIP-IEFEKLIHLSKLDLSHNILQEEIP---PQVCNMESLEKLNL 613 (1078)
Q Consensus 561 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L 613 (1078)
++|+|++|+|+.... ..+..+++|+.|++++|.++.... ..+..+++|++||-
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 999999999975322 467888999999999999975321 24677899998873
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.48 E-value=2.5e-15 Score=167.27 Aligned_cols=185 Identities=21% Similarity=0.250 Sum_probs=118.7
Q ss_pred CCCCCceecccccccCCCC----CccccCCCcccEEeccCCccCCCcccc-------------cccCccCcEEeccCCcc
Q 039595 460 NLPKLDTFIVSMNNIFGSI----PLEIGDSSKLQFLDLSSNHIVGKIPVQ-------------LEKLFSLNKLILSLNQL 522 (1078)
Q Consensus 460 ~l~~L~~L~l~~N~i~~~~----~~~~~~l~~L~~L~Ls~N~i~~~~~~~-------------~~~l~~L~~L~Ls~N~l 522 (1078)
..++|++|++++|.+.... ...+...++|++|++++|.+....... ....+.|+.|++++|++
T Consensus 91 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i 170 (344)
T d2ca6a1 91 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 170 (344)
T ss_dssp TCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCC
T ss_pred hCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccc
Confidence 3444555555555444321 222334567777777777664211111 12356788888888887
Q ss_pred CCCc----ccccccccccceeeccCccccCC-----CCcccccccccccccccCcccccc----cchhhhcccccCeeec
Q 039595 523 SGSV----PLEFGSLTELQYLDLSANKLSSS-----IPKSIGNLLKLYYLNLSNNQFSHT----IPIEFEKLIHLSKLDL 589 (1078)
Q Consensus 523 ~~~~----~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L 589 (1078)
+... ...+...+.|+.|+|++|.|... +...+..+++|+.|+|++|.++.. +...+..+++|++|+|
T Consensus 171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~L 250 (344)
T d2ca6a1 171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250 (344)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhh
Confidence 6332 23345667888888888887642 334566778888999998888643 3345677888999999
Q ss_pred CCCccCCcCCCCc----c--cccccceeeccCccccCC----cccccc-cCCcCcEEEcccCcCCC
Q 039595 590 SHNILQEEIPPQV----C--NMESLEKLNLSHNNLSGF----IPRCFE-KMRSLSCIDICYNELQG 644 (1078)
Q Consensus 590 s~N~l~~~~~~~~----~--~l~~L~~L~L~~N~l~~~----~~~~l~-~l~~L~~l~l~~N~l~~ 644 (1078)
++|.|++.....+ . ..+.|++|++++|+|+.. +...+. ++++|+.|++++|++..
T Consensus 251 s~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 9998876432222 2 235789999999998753 233343 57889999999999874
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.9e-15 Score=162.91 Aligned_cols=102 Identities=14% Similarity=0.132 Sum_probs=50.6
Q ss_pred cEEeccCCcccccCCCCCCCCCCcceeccCCCccCCCCCccccCccceeEEEccCccCCCC-CCcccccccccceeeccc
Q 039595 105 VNLNLSFNLFFGNIPPQIGNLSKLQNLDLGNNQLSGVISPEIGKLNQLRRLYLDMNQLHGT-IPPVIGQLSLIHEFSFCH 183 (1078)
Q Consensus 105 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~i~~l~~L~~L~l~~ 183 (1078)
+.|||+++.+.+.....+.. ..+..+.++...+...+ .......+|++|||+++.+++. ++..+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 36777777664322211111 12345555554444222 2233445667777766665532 233344555555555555
Q ss_pred ccccCCccCcccCCCCCcEEEccCC
Q 039595 184 NNVSGRIPSSLGNLSKLALLYLNNN 208 (1078)
Q Consensus 184 n~~~~~~p~~l~~l~~L~~L~L~~n 208 (1078)
|.+++..+..++.+++|++|+|+++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c 105 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGC 105 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred cCCCcHHHHHHhcCCCCcCcccccc
Confidence 5555544555555555555555553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=4.5e-15 Score=165.21 Aligned_cols=135 Identities=19% Similarity=0.174 Sum_probs=70.3
Q ss_pred CcccEEeccCCccCCCc----ccccccCccCcEEeccCCccCCC-----cccccccccccceeeccCccccCC----CCc
Q 039595 486 SKLQFLDLSSNHIVGKI----PVQLEKLFSLNKLILSLNQLSGS-----VPLEFGSLTELQYLDLSANKLSSS----IPK 552 (1078)
Q Consensus 486 ~~L~~L~Ls~N~i~~~~----~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~ 552 (1078)
+.|+.+++++|+++... ...+...+.|+.|+|++|+|+.. +...+...++|+.|+|++|.++.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 34555555555554221 22233445566666666655421 223345556666666666665432 223
Q ss_pred ccccccccccccccCcccccccchhh----hc--ccccCeeecCCCccCCcCC----CCcc-cccccceeeccCccccC
Q 039595 553 SIGNLLKLYYLNLSNNQFSHTIPIEF----EK--LIHLSKLDLSHNILQEEIP----PQVC-NMESLEKLNLSHNNLSG 620 (1078)
Q Consensus 553 ~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~--l~~L~~L~Ls~N~l~~~~~----~~~~-~l~~L~~L~L~~N~l~~ 620 (1078)
.+..+++|++|+|++|.|++.....+ .. ...|++|||++|+|+.... ..+. ++++|++|+|++|++..
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 34555666666666666654333222 21 2456777777776654221 1121 35567777777777753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=2.5e-14 Score=154.10 Aligned_cols=182 Identities=19% Similarity=0.172 Sum_probs=85.9
Q ss_pred cCCCCceeecccCcCCCC-CCccccccCCCCeEEccCccccccchhhccCCCCCcEecCCCC-ccCCccCccccCCCCCc
Q 039595 388 NLTGLVLLNMCENHLFGP-IPKSLKSLTSLKRVRFNQNNLVGKVYEAFGDHPNLTFLDLSQN-NFDGKISFNWRNLPKLD 465 (1078)
Q Consensus 388 ~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~ 465 (1078)
...+|++|+++++.+.+. +...+..+++|++|+++++.+.......+..+++|++|+++++ .++....
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l---------- 113 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFAL---------- 113 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHH----------
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccccccc----------
Confidence 334555666655555432 2233445556666666666555555555555666666666653 2321110
Q ss_pred eecccccccCCCCCccccCCCcccEEeccCC-ccCCC-ccccccc-CccCcEEeccCC--ccCCC-ccccccccccccee
Q 039595 466 TFIVSMNNIFGSIPLEIGDSSKLQFLDLSSN-HIVGK-IPVQLEK-LFSLNKLILSLN--QLSGS-VPLEFGSLTELQYL 539 (1078)
Q Consensus 466 ~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N-~i~~~-~~~~~~~-l~~L~~L~Ls~N--~l~~~-~~~~~~~l~~L~~L 539 (1078)
......+++|++|+++++ .++.. ....+.. .+.|+.|+++++ .++.. +...+..+++|++|
T Consensus 114 -------------~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L 180 (284)
T d2astb2 114 -------------QTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180 (284)
T ss_dssp -------------HHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred -------------chhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccc
Confidence 001122344445555443 22211 1111212 234555555543 22211 11222345556666
Q ss_pred eccCc-cccCCCCcccccccccccccccCc-ccccccchhhhcccccCeeecCCC
Q 039595 540 DLSAN-KLSSSIPKSIGNLLKLYYLNLSNN-QFSHTIPIEFEKLIHLSKLDLSHN 592 (1078)
Q Consensus 540 ~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N 592 (1078)
+|++| .+++.....+.++++|++|+|+++ .+++.....+.++++|+.|+++++
T Consensus 181 ~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 66554 344444455555666666666663 455444455556666666666655
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.39 E-value=1.1e-14 Score=147.21 Aligned_cols=148 Identities=23% Similarity=0.238 Sum_probs=105.9
Q ss_pred ccEEeccCC--ccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCcccccccccccccc
Q 039595 488 LQFLDLSSN--HIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLLKLYYLNL 565 (1078)
Q Consensus 488 L~~L~Ls~N--~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 565 (1078)
++.++++++ .+. ..+..+..+++|++|+|++|+|+.. + .|..+++|++|+|++|.|+ .++..+..+++|++|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 444555543 233 4556778888888888888888743 3 4778888888888888887 45555566678888888
Q ss_pred cCcccccccchhhhcccccCeeecCCCccCCcCC-CCcccccccceeeccCccccCCcccc----------cccCCcCcE
Q 039595 566 SNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIP-PQVCNMESLEKLNLSHNNLSGFIPRC----------FEKMRSLSC 634 (1078)
Q Consensus 566 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------l~~l~~L~~ 634 (1078)
++|+|+.. ..+..+++|+.|+|++|+|+.... ..+..+++|+.|+|++|++....+.. +..+|+|+.
T Consensus 101 ~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~ 178 (198)
T d1m9la_ 101 SYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKK 178 (198)
T ss_dssp SEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCE
T ss_pred cccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCE
Confidence 88888743 357788888888888888875322 35778888888888888887554332 567888988
Q ss_pred EEcccCcCC
Q 039595 635 IDICYNELQ 643 (1078)
Q Consensus 635 l~l~~N~l~ 643 (1078)
|| +.+++
T Consensus 179 LD--~~~I~ 185 (198)
T d1m9la_ 179 LD--GMPVD 185 (198)
T ss_dssp ES--SGGGT
T ss_pred eC--CccCC
Confidence 76 44444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.27 E-value=7e-14 Score=141.28 Aligned_cols=134 Identities=24% Similarity=0.222 Sum_probs=102.8
Q ss_pred CccccCCCcccEEeccCCccCCCcccccccCccCcEEeccCCccCCCcccccccccccceeeccCccccCCCCccccccc
Q 039595 479 PLEIGDSSKLQFLDLSSNHIVGKIPVQLEKLFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSIPKSIGNLL 558 (1078)
Q Consensus 479 ~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 558 (1078)
+..+..+++|++|+|++|+|+.. + .+.++++|+.|+|++|+|+ .++..+..+++|++|++++|+|+.. ..+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccc
Confidence 34567778888999999988843 3 4788889999999999887 4555566677899999999998853 3578888
Q ss_pred ccccccccCcccccccc-hhhhcccccCeeecCCCccCCcCCCC----------cccccccceeeccCcccc
Q 039595 559 KLYYLNLSNNQFSHTIP-IEFEKLIHLSKLDLSHNILQEEIPPQ----------VCNMESLEKLNLSHNNLS 619 (1078)
Q Consensus 559 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~----------~~~l~~L~~L~L~~N~l~ 619 (1078)
+|++|+|++|+|+.... ..|..+++|+.|+|++|++....+.. +..+++|+.|| +.+++
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 99999999999975432 46888999999999999887644432 45688899887 55555
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=2.6e-12 Score=124.03 Aligned_cols=89 Identities=26% Similarity=0.228 Sum_probs=38.9
Q ss_pred cccccccceeeccCc-cccCCCCcccccccccccccccCcccccccchhhhcccccCeeecCCCccCCcCCCCccccccc
Q 039595 530 FGSLTELQYLDLSAN-KLSSSIPKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESL 608 (1078)
Q Consensus 530 ~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 608 (1078)
+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|+|+...+..+. ..+|
T Consensus 27 l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~-~~~l 105 (156)
T d2ifga3 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ-GLSL 105 (156)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTC-SCCC
T ss_pred ccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhc-cccc
Confidence 333444444444333 24433334444444444444444444444444444444555555555555432222222 2235
Q ss_pred ceeeccCcccc
Q 039595 609 EKLNLSHNNLS 619 (1078)
Q Consensus 609 ~~L~L~~N~l~ 619 (1078)
++|+|++|++.
T Consensus 106 ~~L~L~~Np~~ 116 (156)
T d2ifga3 106 QELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCC
T ss_pred cccccCCCccc
Confidence 55555555543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=8.2e-12 Score=120.45 Aligned_cols=104 Identities=22% Similarity=0.202 Sum_probs=66.1
Q ss_pred eeecccccccCCccCcccCCCCCcEEEccCC-CCCCCCCCcccccCCCCeeecCCcccCCCCCCcccCCCCCcEEecccc
Q 039595 178 EFSFCHNNVSGRIPSSLGNLSKLALLYLNNN-SLFGYIPTVMGNLKSLSTLDLSQNQLNGLIPCTLDNLSNLDTLFLYKN 256 (1078)
Q Consensus 178 ~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 256 (1078)
.++.+++++. .+|..+..+++|++|++++| .++...+++|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3444444444 34556666667777777544 366555556777777777777777777666666777777777777777
Q ss_pred ccCCCCCcccCCCcccceeeccccccc
Q 039595 257 SLSGSIPSIIGNLKSLHQLDLIENQLS 283 (1078)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 283 (1078)
+|+...+..|..+ +|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 91 ALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCcccChhhhccc-cccccccCCCccc
Confidence 7774444444433 5777777777664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.74 E-value=7.3e-10 Score=107.31 Aligned_cols=108 Identities=27% Similarity=0.189 Sum_probs=62.7
Q ss_pred ccccceeeccCccccCCCCcccccccccccccccCccccccc--chhhhcccccCeeecCCCccCCcCCCCcccccccce
Q 039595 533 LTELQYLDLSANKLSSSIPKSIGNLLKLYYLNLSNNQFSHTI--PIEFEKLIHLSKLDLSHNILQEEIPPQVCNMESLEK 610 (1078)
Q Consensus 533 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 610 (1078)
+..+..++..+|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|||++|+|+...+-.+....+|+.
T Consensus 41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~ 119 (162)
T d1koha1 41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119 (162)
T ss_dssp TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSS
T ss_pred ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccce
Confidence 333444444444433 33334455667777777777776432 344666777777777777776533322333446777
Q ss_pred eeccCccccCCcc-------cccccCCcCcEEEcccCcCC
Q 039595 611 LNLSHNNLSGFIP-------RCFEKMRSLSCIDICYNELQ 643 (1078)
Q Consensus 611 L~L~~N~l~~~~~-------~~l~~l~~L~~l~l~~N~l~ 643 (1078)
|+|++|++++... ..+..+|+|+.|| |+++.
T Consensus 120 L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v~ 157 (162)
T d1koha1 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHELP 157 (162)
T ss_dssp CCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEECC
T ss_pred eecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCCc
Confidence 7777777765433 2356778888765 55553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=3.7e-09 Score=102.23 Aligned_cols=107 Identities=22% Similarity=0.166 Sum_probs=67.9
Q ss_pred CccCcEEeccCCccCCCcccccccccccceeeccCccccCCC--CcccccccccccccccCcccccccchhhhcccccCe
Q 039595 509 LFSLNKLILSLNQLSGSVPLEFGSLTELQYLDLSANKLSSSI--PKSIGNLLKLYYLNLSNNQFSHTIPIEFEKLIHLSK 586 (1078)
Q Consensus 509 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 586 (1078)
+..+..++..+|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+..+.+..+|+.
T Consensus 41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~ 119 (162)
T d1koha1 41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119 (162)
T ss_dssp TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSS
T ss_pred ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccce
Confidence 333444444444333 34444556777888888888887542 345667788888888888887654445555567888
Q ss_pred eecCCCccCCcCCCC-------cccccccceeeccCccc
Q 039595 587 LDLSHNILQEEIPPQ-------VCNMESLEKLNLSHNNL 618 (1078)
Q Consensus 587 L~Ls~N~l~~~~~~~-------~~~l~~L~~L~L~~N~l 618 (1078)
|++++|++....... +..+|+|+.|| ++++
T Consensus 120 L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred eecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 888888887544322 45678888776 4444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.34 E-value=7.5e-07 Score=93.24 Aligned_cols=149 Identities=13% Similarity=0.045 Sum_probs=103.2
Q ss_pred HHHHHhhcCCCccceeccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeec
Q 039595 744 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSN 822 (1078)
Q Consensus 744 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 822 (1078)
.++.+....|+.++..+.++.+.||+... +++.+++|+....... ....+.+|..++..+. +--+.+++.+..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~ 81 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence 45666677887777655555678999875 4667888887544211 2223566777766553 4346778888888
Q ss_pred CCeeEEEEeecCCCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 039595 823 ARHSFLVCEYLHRGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC---------------------------- 874 (1078)
Q Consensus 823 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------- 874 (1078)
++..++||++++|.++.+..... .....++.++++.++.||+..
T Consensus 82 ~~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 82 DGWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred CCceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 88999999999998887654211 122335666677777777531
Q ss_pred ----------------------------CCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 875 ----------------------------LPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 875 ----------------------------~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
...++|+|+.|.||++++++.+-|.||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0126899999999999987777799999876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.84 E-value=1.1e-05 Score=83.70 Aligned_cols=130 Identities=15% Similarity=0.086 Sum_probs=84.9
Q ss_pred eeccCCc-eeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC--CCceeeEEeeeecCCeeEEEEeecC
Q 039595 758 CIGKGGQ-GSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR--HRNIVKFHGFCSNARHSFLVCEYLH 834 (1078)
Q Consensus 758 ~lG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~ 834 (1078)
.+..|.. +.||+....++..+++|...... ...+..|...++.+. .-.+.+++.+..+++..++||||++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455554 68999988888889999865432 122455666665552 2336778888888888999999998
Q ss_pred CCCHHHHhcCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 039595 835 RGSLARILGNDATAKELSWNRRINVIKGVANALSYLHHDC---------------------------------------- 874 (1078)
Q Consensus 835 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------- 874 (1078)
|.++.+.- .... ..+.++++.++-||+..
T Consensus 90 G~~~~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 90 GQDLLSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp SEETTTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cccccccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 86553211 1111 12233444444444311
Q ss_pred ---------------CCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 875 ---------------LPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 875 ---------------~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
.+.++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1237999999999999987777899998875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.69 E-value=4.3e-06 Score=80.42 Aligned_cols=64 Identities=16% Similarity=0.129 Sum_probs=31.8
Q ss_pred cCccCcEEeccCC-ccCCC----cccccccccccceeeccCccccCCCC----cccccccccccccccCcccc
Q 039595 508 KLFSLNKLILSLN-QLSGS----VPLEFGSLTELQYLDLSANKLSSSIP----KSIGNLLKLYYLNLSNNQFS 571 (1078)
Q Consensus 508 ~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~ 571 (1078)
+.+.|++|+|+++ .++.. +...+...+.|+.|+|++|.+..... ..+...+.|++|+|++|.|+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 3456777777653 35421 12234445556666666666543222 22233345555555555554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.66 E-value=8e-06 Score=78.48 Aligned_cols=109 Identities=13% Similarity=0.130 Sum_probs=63.8
Q ss_pred CCcccEEeccCC-ccCCC----cccccccCccCcEEeccCCccCC----CcccccccccccceeeccCccccCCCC----
Q 039595 485 SSKLQFLDLSSN-HIVGK----IPVQLEKLFSLNKLILSLNQLSG----SVPLEFGSLTELQYLDLSANKLSSSIP---- 551 (1078)
Q Consensus 485 l~~L~~L~Ls~N-~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~---- 551 (1078)
.++|++|+|+++ .|... +...+...+.|++|+|++|.++. .+...+...+.|+.|+|++|.|+....
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 456777777763 45422 22345555677777777777763 233345556778888888887764322
Q ss_pred cccccccccccccccCcccccc-------cchhhhcccccCeeecCCCc
Q 039595 552 KSIGNLLKLYYLNLSNNQFSHT-------IPIEFEKLIHLSKLDLSHNI 593 (1078)
Q Consensus 552 ~~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~Ls~N~ 593 (1078)
..+...++|++|+|++|++... +...+...+.|+.|+++.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 2344556677777777755422 22334445666666665553
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.05 E-value=4.5e-05 Score=72.99 Aligned_cols=65 Identities=12% Similarity=0.093 Sum_probs=32.2
Q ss_pred ccCccCcEEeccC-CccCCC----cccccccccccceeeccCccccCCCC----cccccccccccccccCcccc
Q 039595 507 EKLFSLNKLILSL-NQLSGS----VPLEFGSLTELQYLDLSANKLSSSIP----KSIGNLLKLYYLNLSNNQFS 571 (1078)
Q Consensus 507 ~~l~~L~~L~Ls~-N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~ 571 (1078)
.+.+.|++|+|++ +.++.. +...+...++|++|+|++|.++.... ..+...++++.|++++|.++
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 3456677777765 345421 12233455566666666665543222 22233445555555555553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.05 E-value=0.00055 Score=75.05 Aligned_cols=80 Identities=14% Similarity=-0.051 Sum_probs=48.6
Q ss_pred cceeccCCceeEEEEEeC-CCCEEEEEEeccccc--c-CChhhHHHHHHHHHHHhcC-C--CCceeeEEeeeecCCeeEE
Q 039595 756 KFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLL--S-GNMADQDEFLNVVLALNEI-R--HRNIVKFHGFCSNARHSFL 828 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~-~~~~~~~~~~~e~~~l~~l-~--h~niv~l~~~~~~~~~~~l 828 (1078)
.+.||.|....||++... +++.|+||.-..... . ......++...|.+.++.+ . ...+++++.+. +...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 456899999999999765 467899997543211 1 1122233445566666655 2 23466676653 345689
Q ss_pred EEeecCCCC
Q 039595 829 VCEYLHRGS 837 (1078)
Q Consensus 829 v~E~~~~g~ 837 (1078)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.99 E-value=9.4e-05 Score=70.67 Aligned_cols=111 Identities=15% Similarity=0.125 Sum_probs=66.2
Q ss_pred CCCcccEEeccC-CccCCC----cccccccCccCcEEeccCCccCCCc----ccccccccccceeeccCccccCCC----
Q 039595 484 DSSKLQFLDLSS-NHIVGK----IPVQLEKLFSLNKLILSLNQLSGSV----PLEFGSLTELQYLDLSANKLSSSI---- 550 (1078)
Q Consensus 484 ~l~~L~~L~Ls~-N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~---- 550 (1078)
+.++|++|+|++ +.|+.. +...+...+.|++|+|++|.++... ...+...+.++.|++++|.+....
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 446777777776 445422 2334456677888888888776432 234455678888888888776432
Q ss_pred Cccccccccccc--ccccCcccccc----cchhhhcccccCeeecCCCcc
Q 039595 551 PKSIGNLLKLYY--LNLSNNQFSHT----IPIEFEKLIHLSKLDLSHNIL 594 (1078)
Q Consensus 551 ~~~~~~l~~L~~--L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l 594 (1078)
...+...++|+. |++++|.++.. +...+...+.|+.|+++.|..
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 234555566765 44456666542 233345566677777665543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.72 E-value=0.0018 Score=68.91 Aligned_cols=135 Identities=13% Similarity=0.116 Sum_probs=76.2
Q ss_pred ceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCCCce--eeEE-----eeeecCCeeEEEEeecCCC
Q 039595 764 QGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRHRNI--VKFH-----GFCSNARHSFLVCEYLHRG 836 (1078)
Q Consensus 764 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~E~~~~g 836 (1078)
--.||+++.++|+.|++|+.+... ...+++..|...+..+....+ +..+ ..+..++..+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 348999998899999999976432 235567778777776642221 1111 1224566788999999764
Q ss_pred CHH-----H------Hh-------cCC--CCCCcCCH-------------------HHHHHHHHHHHHHHHHHHh----c
Q 039595 837 SLA-----R------IL-------GND--ATAKELSW-------------------NRRINVIKGVANALSYLHH----D 873 (1078)
Q Consensus 837 ~L~-----~------~l-------~~~--~~~~~l~~-------------------~~~~~i~~~i~~~L~~LH~----~ 873 (1078)
.+. . .+ ... ......+. .....+...+...++.+.. .
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 331 0 00 000 00111111 1111122222233333322 2
Q ss_pred CCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 874 CLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 874 ~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
...+++|+|+.+.||++++ + ..+.||+.+.
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 2347899999999999974 3 4589999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.64 E-value=0.058 Score=56.32 Aligned_cols=158 Identities=13% Similarity=0.122 Sum_probs=80.6
Q ss_pred ccHHHHHHhhcCCCccce-----eccCCceeEEEEEeCCCCEEEEEEeccccccCChhhHHHHHHHHHHHhcCCC-----
Q 039595 741 IMHEEIIKATDDFDEKFC-----IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIRH----- 810 (1078)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~-----lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----- 810 (1078)
.+.+++.....+|.+.+. |..|---+.|+.+..+|+ +++|++.... . .+++..|+.++..+..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~---~---~~~l~~~~~~l~~L~~~g~pv 75 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV---E---KNDLPFFLGLMQHLAAKGLSC 75 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---------CCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC---C---HHHHHHHHHHHHhhhhccccc
Confidence 456788888888877543 446666788999876654 8999875431 1 1223334444444422
Q ss_pred CceeeEEe---eeecCCeeEEEEeecCCCCHHH-----------H---hc---CC---CCCCcC----------------
Q 039595 811 RNIVKFHG---FCSNARHSFLVCEYLHRGSLAR-----------I---LG---ND---ATAKEL---------------- 851 (1078)
Q Consensus 811 ~niv~l~~---~~~~~~~~~lv~E~~~~g~L~~-----------~---l~---~~---~~~~~l---------------- 851 (1078)
|..+...+ +.......+.++.+..+..... . ++ .. ......
T Consensus 76 p~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (316)
T d2ppqa1 76 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA 155 (316)
T ss_dssp CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred cccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhh
Confidence 22221110 1122345566677666533310 0 00 00 000000
Q ss_pred --CHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeeCCCCcEEEecccccc
Q 039595 852 --SWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDLEFEAHVSDFGIAK 905 (1078)
Q Consensus 852 --~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~a~ 905 (1078)
........+..+...+...+. ....|+||+|+.++||+++.+...-|.||+.+.
T Consensus 156 ~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 156 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111122222222222222 123479999999999999988878899999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.15 E-value=0.021 Score=62.05 Aligned_cols=73 Identities=14% Similarity=0.148 Sum_probs=47.9
Q ss_pred cceeccCCceeEEEEEeCC--------CCEEEEEEeccccccCChhhHHHHHHHHHHHhcCC-CCceeeEEeeeecCCee
Q 039595 756 KFCIGKGGQGSVYKAELPS--------GDIVAVKKFNSQLLSGNMADQDEFLNVVLALNEIR-HRNIVKFHGFCSNARHS 826 (1078)
Q Consensus 756 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 826 (1078)
++.|+.|-.=.+|++..++ .+.|.+++.... .......+|..+++.+. +.-..++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~------~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP------ETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC------CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc------chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 3568889999999997653 346777765421 11223456777777763 4445578887753
Q ss_pred EEEEeecCCCCH
Q 039595 827 FLVCEYLHRGSL 838 (1078)
Q Consensus 827 ~lv~E~~~~g~L 838 (1078)
.+|+||++|..+
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 579999987544
|